Mammalian Phenotype Ontology Annotations

Mammalian Phenotype Ontology Annotations
Query Results - Summary

13945 genotypes with 33250 annotations displayed of selected term and subterms
Searched Term: abnormal homeostasis
Allelic Composition (Genetic Background)	Annotated Term	Reference
0610040J01Rik^{em1(IMPC)Ccpcz}/0610040J01Rik^{em1(IMPC)Ccpcz} (C57BL/6NCrl-0610040J01Rik^{em1(IMPC)Ccpcz}/Ccpcz)	increased circulating HDL cholesterol level	J:211773
1500009L16Rik^em1(IMPC)Mbp/1500009L16Rik^em1(IMPC)Mbp (C57BL/6NCrl-1500009L16Rik^em1(IMPC)Mbp/Mmucd)	increased circulating alkaline phosphatase level	J:211773
	increased circulating aspartate transaminase level	J:211773
	increased circulating calcium level	J:211773
	increased circulating serum albumin level	J:211773
1700008P02Rik^em1(IMPC)J/1700008P02Rik^em1(IMPC)J (C57BL/6NJ-1700008P02Rik^em1(IMPC)J/Mmjax)	increased circulating cholesterol level	J:211773
	increased circulating HDL cholesterol level	J:211773
	increased circulating phosphate level	J:211773
1700016H13Rik^em1(IMPC)Bay/1700016H13Rik^em1(IMPC)Bay (C57BL/6N-1700016H13Rik^em1(IMPC)Bay/BayMmucd)	decreased body temperature	J:211773
1700016L21Rik^{Tg(Itgax-HBEGF/EGFP)57Lan}/0 (B6.FVB-1700016L21Rik^{Tg(Itgax-HBEGF/EGFP)57Lan}/J)	decreased circulating interferon-gamma level	J:96123
	decreased circulating interleukin-12 level	J:96123
1700016L21Rik^{Tg(Itgax-HBEGF/EGFP)57Lan}/0 (C.FVB-1700016L21Rik^{Tg(Itgax-HBEGF/EGFP)57Lan}/J)	decreased circulating interferon-gamma level	J:96123
	decreased circulating interleukin-12 level	J:96123
1700016L21Rik^{Tg(Itgax-HBEGF/EGFP)57Lan}/0 (B6.FVB-1700016L21Rik^{Tg(Itgax-HBEGF/EGFP)57Lan})	abnormal circulating cytokine level	J:194800
1700025G04Rik^em1(IMPC)Mbp/1700025G04Rik^em1(IMPC)Mbp (C57BL/6NCrl-1700025G04Rik^em1(IMPC)Mbp/Mmucd)	increased circulating bilirubin level	J:211773
1700030J22Rik^em1(IMPC)J/1700030J22Rik^em1(IMPC)J (C57BL/6NJ-1700030J22Rik^em1(IMPC)J/Mmjax)	decreased circulating bilirubin level	J:211773
	increased circulating glucose level	J:211773
1700034E13Rik^em1(IMPC)Mbp/1700034E13Rik^em1(IMPC)Mbp (C57BL/6NCrl-1700034E13Rik^em1(IMPC)Mbp/Mmucd)	increased circulating alkaline phosphatase level	J:211773
1700093K21Rik^em1(IMPC)J/1700093K21Rik^em1(IMPC)J (C57BL/6NJ-1700093K21Rik^em1(IMPC)J/Mmjax)	increased circulating phosphate level	J:211773
1700123O20Rik^{tm1a(EUCOMM)Wtsi}/1700123O20Rik^{tm1a(EUCOMM)Wtsi} (C57BL/6N-A^tm1Brd 1700123O20Rik^{tm1a(EUCOMM)Wtsi}/WtsiFlmg)	increased circulating iron level	J:211773
2010003K11Rik^em1Cya/2010003K11Rik^em1Cya (C57BL/6-2010003K11Rik^em1Cya/Cya)	abnormal intestinal lipid absorption	J:326325
	impaired glucose tolerance	J:326325
	increased circulating alanine transaminase level	J:326325
	increased circulating cholesterol level	J:326325
	increased circulating insulin level	J:326325
	increased circulating triglyceride level	J:326325
	increased fasting circulating glucose level	J:326325
	increased liver cholesterol level	J:326325
	increased liver triglyceride level	J:326325
	increased susceptibility to diet-induced obesity	J:326325
	insulin resistance	J:326325
2210408I21Rik^{tm1b(EUCOMM)Wtsi}/2210408I21Rik^{tm1b(EUCOMM)Wtsi} (C57BL/6N-2210408I21Rik^{tm1b(EUCOMM)Wtsi}/Tcp)	impaired glucose tolerance	J:211773
2610005L07Rik^{Gt(ROSA)73Sor}/2610005L07Rik^{Gt(ROSA)73Sor} Pdgfra^tm1Sor/Pdgfra⁺ (either: (involves: 129S4/SvJaeSor) or (involves: 129S4/SvJaeSor * C57BL/6))	decreased circulating estradiol level	J:142042
2610318N02Rik^{tm1b(EUCOMM)Wtsi}/2610318N02Rik^{tm1b(EUCOMM)Wtsi} (C57BL/6N-2610318N02Rik^{tm1b(EUCOMM)Wtsi}/Wtsi)	decreased circulating creatinine level	J:211773
2700049A03Rik^tm1.2Arte/2700049A03Rik^tm1.2Arte (either: (involves: C57BL/6NTac) or (involves: C57BL/6NTac * CD-1))	pericardial edema	J:175541
2700097O09Rik^{tm1.1(KOMP)Vlcg}/2700097O09Rik^{tm1.1(KOMP)Vlcg} (C57BL/6N-2700097O09Rik^{tm1.1(KOMP)Vlcg}/MbpMmucd)	increased circulating alkaline phosphatase level	J:211773
3425401B19Rik^{em2(IMPC)Ccpcz}/3425401B19Rik^{em2(IMPC)Ccpcz} (C57BL/6NCrl-3425401B19Rik^{em2(IMPC)Ccpcz}/Ph)	decreased circulating potassium level	J:211773
4833411C07Rik^em1Cecad/4833411C07Rik^em1Cecad (C57BL/6N-4833411C07Rik^em1Cecad)	impaired glucose tolerance	J:285483
	increased circulating glucose level	J:285483
	insulin resistance	J:285483
4833420G17Rik^em1(IMPC)Mbp/4833420G17Rik^em1(IMPC)Mbp (C57BL/6NCrl-4833420G17Rik^em1(IMPC)Mbp/Mmucd)	increased circulating bilirubin level	J:211773
4921509C19Rik^{tm1.1(KOMP)Vlcg}/4921509C19Rik^{tm1.1(KOMP)Vlcg} (B6N(Cg)-4921509C19Rik^{tm1.1(KOMP)Vlcg}/J)	increased circulating sodium level	J:211773
4930404H24Rik^{tm1a(KOMP)Wtsi}/4930404H24Rik^{tm1a(KOMP)Wtsi} (C57BL/6N-4930404H24Rik^{tm1a(KOMP)Wtsi}/Wtsi)	decreased circulating serum albumin level	J:211773
4930505A04Rik^{tm1b(KOMP)Wtsi}/4930505A04Rik^{tm1b(KOMP)Wtsi} (C57BL/6N-4930505A04Rik^{tm1b(KOMP)Wtsi}/Bay)	decreased circulating alkaline phosphatase level	J:211773
	decreased circulating glucose level	J:211773
4930563E22Rik^{tm1.1(KOMP)Vlcg}/4930563E22Rik^{tm1.1(KOMP)Vlcg} (B6N(Cg)-4930563E22Rik^{tm1.1(KOMP)Vlcg}/J)	decreased fasting circulating glucose level	J:211773
4931414P19Rik^em1Lych/4931414P19Rik^em1Lych (involves: C57BL/6)	decreased thyroxine level	J:275266
	decreased triiodothyronine level	J:275266
	increased circulating thyroid-stimulating hormone level	J:275266
4931429L15Rik^{tm1a(EUCOMM)Wtsi}/4931429L15Rik^{tm1a(EUCOMM)Wtsi} (C57BL/6N-4931429L15Rik^{tm1a(EUCOMM)Wtsi}/Wtsi)	decreased circulating calcium level	J:211773
	increased blood urea nitrogen level	J:211773
4933402J07Rik^em1(IMPC)J/4933402J07Rik^em1(IMPC)J (C57BL/6NJ-4933402J07Rik^em1(IMPC)J/Mmjax)	improved glucose tolerance	J:211773
4933402N03Rik^{tm2a(KOMP)Wtsi}/4933402N03Rik^{tm2a(KOMP)Wtsi} (C57BL/6N-4933402N03Rik^{tm2a(KOMP)Wtsi}/Wtsi)	decreased circulating fructosamine level	J:211773
	increased circulating calcium level	J:211773
4933428G20Rik^{tm1.1(KOMP)Vlcg}/4933428G20Rik^{tm1.1(KOMP)Vlcg} (C57BL/6N-4933428G20Rik^{tm1.1(KOMP)Vlcg}/MbpMmucd)	increased circulating alanine transaminase level	J:211773
	increased circulating aspartate transaminase level	J:211773
4933430I17Rik^{tm1b(EUCOMM)Wtsi}/4933430I17Rik^{tm1b(EUCOMM)Wtsi} (C57BL/6N-4933430I17Rik^{tm1b(EUCOMM)Wtsi}/Ics)	increased circulating alanine transaminase level	J:211773
4933434E20Rik^{tm1a(EUCOMM)Wtsi}/4933434E20Rik⁺ (C57BL/6N-4933434E20Rik^{tm1a(EUCOMM)Wtsi}/Wtsi)	decreased circulating cholesterol level	J:211773
	decreased circulating fructosamine level	J:211773
	decreased circulating HDL cholesterol level	J:211773
	decreased circulating serum albumin level	J:211773
	increased circulating alanine transaminase level	J:211773
4933434E20Rik^{tm1a(EUCOMM)Wtsi}/4933434E20Rik^{tm1a(EUCOMM)Wtsi} (C57BL/6N-4933434E20Rik^{tm1a(EUCOMM)Wtsi}/Wtsi)	subcutaneous edema	J:239583
6430548M08Rik^em1(IMPC)Mbp/6430548M08Rik^em1(IMPC)Mbp (C57BL/6N-6430548M08Rik^em1(IMPC)Mbp/MbpMmucd)	increased circulating alkaline phosphatase level	J:211773
	increased circulating calcium level	J:211773
7630403G23Rik^{Tg(Th-cre)1Tmd}/7630403G23Rik⁺ Trpc5^tm1.1Mfre/Trpc5^tm1.1Mfre (involves: 129S1/Sv * 129S4/SvJaeSor * 129X1/SvJ * C57BL/6N * SJL)	decreased circulating luteinizing hormone level	J:277600
	decreased circulating prolactin level	J:277600
a/a Hps6^ru/Hps6^ru (B6.Cg-Hps6^ru)	decreased platelet ATP level	J:7327
	decreased platelet serotonin level	J:7327, J:29748
	increased bleeding time	J:7327
a/a Rab27a^ash/Rab27a^ash (involves: C3H/HeSnJ * C57BL/6J)	decreased platelet serotonin level	J:77395
a/a Rab27a^ash/Rab27a^ash (involves: C3H/HeSnJ * C57BL/6J)	increased bleeding time	J:77395
a/a Rmi1^{Gt(pUHachi)0283Imeg}/Rmi1⁺ (involves: C57BL/6 * KK)	decreased circulating glucose level	J:168271
	improved glucose tolerance	J:168271
a/A^y Guq1^KK/Guq1^KK (involves: C57BL/6J * KK-A^y)	increased urine glucose level	J:131439
a/A^y Guq2^C57BL/6J/Guq2^C57BL/6J (involves: C57BL/6J * KK-A^y)	increased urine glucose level	J:131439
A1cf^{Tg(Myh6-cre/Esr1*)1Jmk}/A1cf⁺ Dusp12^em1Zhzy/Dusp12^em1Zhzy (involves: FVB/N)	insulin resistance	J:345360
A1cf^{Tg(Myh6-cre/Esr1)1Jmk}/A1cf⁺ Tg(Myh6-2A)#Know/0 (involves: BALB/c C57BL/6 * FVB/N)	ascites	J:128060
	pleural effusion	J:128060
A1cf^{tm1b(EUCOMM)Hmgu}/A1cf^{tm1b(EUCOMM)Hmgu} (B6N(Cg)-A1cf^{tm1b(EUCOMM)Hmgu}/J)	increased circulating sodium level	J:211773
A1cf^{tm1c(EUCOMM)Hmgu}/A1cf^{tm1c(EUCOMM)Hmgu} Speer6-ps1^{Tg(Alb-cre)21Mgn}/Speer6-ps1⁺ (involves: C57BL/6N * DBA)	abnormal blood homeostasis	J:281365
	abnormal urine homeostasis	J:281365
	decreased circulating glucose level	J:281365
	decreased circulating insulin level	J:281365
	decreased circulating ketone body level	J:281365
	decreased fasting circulating glucose level	J:281365
	decreased liver triglyceride level	J:281365
	decreased susceptibility to diet-induced obesity	J:281365
	decreased urine uric acid level	J:281365
	impaired gluconeogenesis	J:281365
	improved glucose tolerance	J:281365
	increased circulating cholesterol level	J:281365
	increased circulating triglyceride level	J:281365
	increased insulin sensitivity	J:281365
	increased liver glycogen level	J:281365
A^tm1Brd/A^tm1Brd Ypel4^{tm1a(EUCOMM)Wtsi}/Ypel4^{tm1a(EUCOMM)Wtsi} (C57BL/6N-A^tm1Brd Ypel4^{tm1a(EUCOMM)Wtsi}/WtsiIeg)	increased circulating erythropoietin level	J:313842
A^w-J/A^w-J (C57BL/6J-A^w-J/J)	decreased circulating pituitary hormone level	J:52183
A^y/a (involves: KK)	abnormal lipid homeostasis	J:26460
	hyperglycemia	J:26460
	impaired glucose tolerance	J:26460
	increased circulating insulin level	J:26460
	increased urine glucose level	J:26460
	insulin resistance	J:26460
A^y/a Apoe^tm1Unc/Apoe^tm1Unc (involves: 129P2/OlaHsd * C57BL/6J * KK/TaJcl)	decreased circulating adiponectin level	J:177084
	hyperglycemia	J:177084
	increased circulating cholesterol level	J:177084
	increased circulating insulin level	J:177084
	increased circulating leptin level	J:177084
	increased circulating triglyceride level	J:177084
	insulin resistance	J:177084
A^y/a Apoe^tm1Unc/Apoe^tm1Unc Ccr2^tm1Mae/Ccr2^tm1Mae (involves: 129P2/OlaHsd * C57BL/6J * KK/TaJcl)	decreased circulating adiponectin level	J:177084
	increased circulating cholesterol level	J:177084
	increased circulating leptin level	J:177084
A^y/a Rmi1^{Gt(pUHachi)0283Imeg}/Rmi1⁺ (involves: C57BL/6 * KK)	decreased circulating glucose level	J:168271
	improved glucose tolerance	J:168271
A^y/A (involves: C57BL/6)	increased circulating leptin level	J:131039
Aak1^{tm1b(EUCOMM)Hmgu}/Aak1^{tm1b(EUCOMM)Hmgu} (C57BL/6N-Aak1^{tm1b(EUCOMM)Hmgu}/Orl)	decreased circulating cholesterol level	J:211773
	decreased circulating serum albumin level	J:211773
	decreased circulating total protein level	J:211773
	impaired glucose tolerance	J:211773
	increased circulating alanine transaminase level	J:211773
	increased circulating alkaline phosphatase level	J:211773
	increased circulating aspartate transaminase level	J:211773
Aasdh^em1(IMPC)Tcp/Aasdh^em1(IMPC)Tcp (C57BL/6N-Aasdh^em1(IMPC)Tcp/Tcp)	increased circulating alanine transaminase level	J:211773
Aasdhppt^{tm1.1(KOMP)Vlcg}/Aasdhppt⁺ (B6N(Cg)-Aasdhppt^{tm1.1(KOMP)Vlcg}/J)	improved glucose tolerance	J:211773
Abca1^m4620Dajl/Abca1⁺ (involves: C3H/HeSnJ * C57BL/6J * SWR)	decreased circulating cholesterol level	J:149088
	decreased circulating HDL cholesterol level	J:149088
Abca1^m4620Dajl/Abca1^m4620Dajl (involves: C3H/HeSnJ * C57BL/6J * SWR)	decreased circulating cholesterol level	J:149088
	decreased circulating HDL cholesterol level	J:149088
	increased circulating triglyceride level	J:149088
Abca1^mpc227H/Abca1^mpc227H (involves: BALB/c * C3H/HeH * C57BL/6J)	decreased circulating cholesterol level	J:234901
Abca1^tm1.1Jp/Abca1^tm1.1Jp (involves: 129S6/SvEvTac * C57BL/6)	abnormal circulating phospholipid level	J:98093
	decreased circulating cholesterol level	J:98093
	decreased circulating HDL cholesterol level	J:98093
Abca1^tm1Blt/Abca1^tm1Blt (C57BL/6-Abca1^tm1Blt)	abnormal platelet physiology	J:95088
Abca1^tm1Jdm/Abca1⁺ (DBA/1LacJ-Abca1^tm1Jdm)	abnormal circulating phospholipid level	J:61679
	abnormal lipid homeostasis	J:61679
	decreased circulating cholesterol level	J:61679
	decreased circulating HDL cholesterol level	J:61679
	decreased circulating LDL cholesterol level	J:61679
Abca1^tm1Jdm/Abca1^tm1Jdm (DBA/1LacJ-Abca1^tm1Jdm)	abnormal circulating phospholipid level	J:61679
	abnormal fat-soluble vitamin level	J:60210
	abnormal lipid homeostasis	J:61679
	decreased circulating cholesterol level	J:60210, J:61679
	decreased circulating HDL cholesterol level	J:60210, J:61679
	decreased circulating LDL cholesterol level	J:61679
	increased intestinal cholesterol absorption	J:61679
Abca1^tm1Jdm/Abca1^tm1Jdm (involves: DBA/1LacJ)	abnormal cholesterol homeostasis	J:89906
	abnormal testosterone level	J:89906
	decreased circulating HDL cholesterol level	J:89906
	decreased circulating phytosterol level	J:87209
Abca1^tm1Jdm/Abca1^tm1Jdm (involves: C57BL/6 * DBA/1LacJ)	decreased circulating cholesterol level	J:132254
Abca1^tm1Jdm/Abca1^tm1Jdm (involves: C57BL/6 * DBA/1LacJ)	decreased circulating HDL cholesterol level	J:132254
Abca1^tm1Jdm/Abca1^tm1Jdm Tgm2^tm1Gml/Tgm2^tm1Gml (involves: C57BL/6 * DBA/1LacJ)	decreased circulating cholesterol level	J:132254
	decreased circulating HDL cholesterol level	J:132254
Abca1^tm1Jp/Abca1⁺ Speer6-ps1^{Tg(Alb-cre)21Mgn}/Speer6-ps1⁺ (involves: 129S6/SvEvTac * B6.Cg-Tg(Alb-cre)21Mgn/J)	abnormal cholesterol homeostasis	J:98093
	abnormal circulating phospholipid level	J:98093
	decreased circulating cholesterol level	J:98093
	decreased circulating HDL cholesterol level	J:98093
Abca1^tm1Jp/Abca1⁺ Tg(Vil1-cre)997Gum/0 (involves: 129S6/SvEvTac * C57BL/6 * SJL)	decreased circulating cholesterol level	J:107802
	decreased circulating HDL cholesterol level	J:107802
Abca1^tm1Jp/Abca1^tm1Jp Speer6-ps1^{Tg(Alb-cre)21Mgn}/Speer6-ps1⁺ (involves: 129S6/SvEvTac * B6.Cg-Tg(Alb-cre)21Mgn/J)	abnormal cholesterol homeostasis	J:98093
	abnormal circulating phospholipid level	J:98093
	decreased circulating cholesterol level	J:98093
	decreased circulating HDL cholesterol level	J:98093
	decreased circulating LDL cholesterol level	J:98093
	increased circulating triglyceride level	J:98093
Abca1^tm1Jp/Abca1^tm1Jp Speer6-ps1^{Tg(Alb-cre)21Mgn}/Speer6-ps1⁺ (involves: 129S6/SvEvTac * C57BL/6 * DBA)	decreased circulating HDL cholesterol level	J:107802
Abca1^tm1Jp/Abca1^tm1Jp Speer6-ps1^{Tg(Alb-cre)21Mgn}/Speer6-ps1⁺ Tg(Vil1-cre)997Gum/0 (involves: 129S6/SvEvTac * C57BL/6 * DBA * SJL)	decreased circulating HDL cholesterol level	J:107802
Abca1^tm1Jp/Abca1^tm1Jp Tg(Vil1-cre)997Gum/0 (involves: 129S6/SvEvTac * C57BL/6 * SJL)	decreased circulating cholesterol level	J:107802
	decreased circulating HDL cholesterol level	J:107802
	decreased circulating LDL cholesterol level	J:107802
Abca1^tm1Wpfl/Abca1⁺ (involves: 129P2/OlaHsd * C57BL/6J)	decreased circulating cholesterol level	J:64390
Abca1^tm1Wpfl/Abca1⁺ (involves: 129P2/OlaHsd * C57BL/6J)	decreased circulating HDL cholesterol level	J:64390
Abca1^tm1Wpfl/Abca1^tm1Wpfl (involves: 129P2/OlaHsd * C57BL/6J)	decreased circulating cholesterol level	J:68431, J:64390
	decreased circulating estradiol level	J:64390
	decreased circulating HDL cholesterol level	J:68431, J:64390
	decreased circulating progesterone level	J:64390
	decreased intestinal cholesterol absorption	J:68431
Abca1^tm1Wpfl/Abca1^tm1Wpfl Npc1^m1N/Npc1^m1N (involves: 129P2/OlaHsd * BALB/c)	decreased brain cholesterol level	J:130969
	increased cholesterol level	J:130969
Abca1^tm2Jp/Abca1⁺ Tg(APOA1)427Bres/? (involves: 129X1/SvJ * C57BL/6J * CBA/J)	abnormal circulating cholesterol level	J:104719
	abnormal circulating protein level	J:104719
	decreased circulating HDL cholesterol level	J:104719
	decreased circulating phospholipid level	J:104719
Abca1^tm2Jp/Abca1^tm2Jp Tg(APOA1)427Bres/? (involves: 129X1/SvJ * C57BL/6J * CBA/J)	abnormal circulating cholesterol level	J:104719
	abnormal circulating protein level	J:104719
	decreased circulating HDL cholesterol level	J:104719
	decreased circulating phospholipid level	J:104719
Abca2^em1(IMPC)J/Abca2^em1(IMPC)J (C57BL/6NJ-Abca2^em1(IMPC)J/Mmjax)	increased circulating phosphate level	J:211773
Abca2^tm1Nina/Abca2^tm1Nina (involves: 129X1/SvJ * C57BL/6)	abnormal lipid level	J:123521
Abca3^tm1Frm/Abca3^tm1Frm (involves: 129S/SvEv)	abnormal lipid homeostasis	J:120296
Abca3^tm1Frm/Abca3^tm1Frm (involves: 129S/SvEv)	cyanosis	J:120296
Abca3^tm1Holz/Abca3^tm1Holz (involves: 129S6/SvEvTac * C57BL/6)	cyanosis	J:122736
Abca3^tm1Nina/Abca3^tm1Nina (involves: 129P2/OlaHsd * C57BL/6J)	cyanosis	J:121155
Abca4^tm1Ght/Abca4^tm1Ght (involves: 129S4/SvJae)	abnormal vitamin A level	J:141801
Abca5^tm1Akya/Abca5^tm1Akya (involves: C57BL/6NCrj * CBA/JNCrj)	abnormal cardiac thrombosis	J:99152
Abca5^tm1Akya/Abca5^tm1Akya (involves: C57BL/6NCrlj * CBA/JNCrlj * ICR)	abnormal cardiac thrombosis	J:99152
	edema	J:99152
Abca6^{tm2b(KOMP)Wtsi}/Abca6^{tm2b(KOMP)Wtsi} (C57BL/6N-Abca6^{tm2b(KOMP)Wtsi}/Tcp)	decreased circulating serum albumin level	J:211773
	increased circulating aspartate transaminase level	J:211773
Abca7^tm1Frm/Abca7^tm1Frm (involves: 129S4/SvJae * C57BL/6)	decreased circulating cholesterol level	J:96865
Abca7^tm1Frm/Abca7^tm1Frm (involves: 129S4/SvJae * C57BL/6)	decreased circulating HDL cholesterol level	J:96865
Abca7^{tm2b(EUCOMM)Hmgu}/Abca7^{tm2b(EUCOMM)Hmgu} (B6N(Cg)-Abca7^{tm2b(EUCOMM)Hmgu}/J)	decreased circulating glucose level	J:211773
	decreased circulating iron level	J:211773
	increased fasting circulating glucose level	J:211773
Abca8b^{tm1a(EUCOMM)Wtsi}/Abca8b^{tm1a(EUCOMM)Wtsi} (involves: C57BL/6J * C57BL/6N)	decreased circulating cholesterol level	J:269226
	decreased circulating HDL cholesterol level	J:269226
	decreased circulating LDL cholesterol level	J:269226
	decreased circulating triglyceride level	J:269226
Abca12^el12/Abca12⁺ (involves: 129/Sv * C57BL/6)	abnormal lipid homeostasis	J:161652
Abca12^el12/Abca12^el12 (involves: 129/Sv * C57BL/6)	abnormal lipid homeostasis	J:161652
	dehydration	J:161652
	impaired skin barrier function	J:161652
	increased cholesterol level	J:161652
Abca12^em1(IMPC)J/Abca12^em1(IMPC)J (C57BL/6NJ-Abca12^em1(IMPC)J/Mmjax)	edema	J:211773
Abca12^smsk/Abca12^smsk (involves: C57BL/6J)	dehydration	J:262458
Abca12^smsk/Abca12^smsk (involves: C57BL/6J)	impaired skin barrier function	J:262458
Abca12^tm1Lex/Abca12^tm1Lex (involves: 129S/SvEvBrd * C57BL/6J)	abnormal lipid homeostasis	J:144062
	impaired skin barrier function	J:144062
Abca12^tm1Shzu/Abca12^tm1Shzu (B6.129S-Abca12^tm1Shzu)	dehydration	J:139048
Abca12^tm1Shzu/Abca12^tm1Shzu (B6.129S-Abca12^tm1Shzu)	impaired skin barrier function	J:139048
Abca13^{tm1b(EUCOMM)Wtsi}/Abca13^{tm1b(EUCOMM)Wtsi} (C57BL/6N-Abca13^{tm1b(EUCOMM)Wtsi}/Bay)	decreased circulating alkaline phosphatase level	J:211773
Abca16^em1(IMPC)J/Abca16^em1(IMPC)J (C57BL/6NJ-Abca16^em1(IMPC)J/J)	decreased circulating sodium level	J:211773
	increased circulating aspartate transaminase level	J:211773
Abca17^{tm1b(EUCOMM)Wtsi}/Abca17^{tm1b(EUCOMM)Wtsi} (C57BL/6N-Abca17^{tm1b(EUCOMM)Wtsi}/Bay)	decreased circulating potassium level	J:211773
	increased circulating alkaline phosphatase level	J:211773
Abcb1a^tm1Bor/Abcb1a^tm1Bor Npc1^m1N/Npc1^m1N (involves: 129/Ola * BALB/c)	increased liver cholesterol level	J:76395
Abcb4^em1(IMPC)H/Abcb4^em1(IMPC)H (C57BL/6NTac-Abcb4^em1(IMPC)H/H)	decreased circulating glucose level	J:211773
	decreased circulating HDL cholesterol level	J:211773
	increased circulating alanine transaminase level	J:211773
	increased circulating alkaline phosphatase level	J:211773
	increased circulating amylase level	J:211773
	increased circulating aspartate transaminase level	J:211773
	increased circulating bilirubin level	J:211773
	increased circulating creatinine level	J:211773
	increased circulating potassium level	J:211773
Abcb4^tm1Bor/Abcb4^tm1Bor (either: (involves: 129P2/OlaHsd) or (involves: 129P2/OlaHsd * FVB/N))	abnormal blood homeostasis	J:15531
	abnormal circulating alanine transaminase level	J:15531
	abnormal circulating alkaline phosphatase level	J:15531
	abnormal circulating aspartate transaminase level	J:15531
	abnormal circulating bilirubin level	J:15531
Abcb4^tm1Bor/Abcb4^tm1Bor (involves: 129P2/OlaHsd * FVB/N)	abnormal circulating enzyme level	J:114411
	abnormal lipid homeostasis	J:114411
	abnormal sodium ion homeostasis	J:175015
	decreased circulating cholesterol level	J:114411
	decreased intestinal cholesterol absorption	J:114411
	increased bile salt level	J:175015
	increased circulating alanine transaminase level	J:114411, J:175015
	increased circulating aspartate transaminase level	J:114411
	increased circulating bilirubin level	J:114411
Abcb4^tm1Bor/Abcb4^tm1Bor (FVB.129P2-Abcb4^tm1Bor/J)	abnormal circulating enzyme level	J:105357
	increased circulating alanine transaminase level	J:100491, J:217802
	increased circulating alkaline phosphatase level	J:105357, J:217802
	increased circulating aspartate transaminase level	J:100491, J:217802
	increased circulating bilirubin level	J:105357, J:217802
Abcb4^tm1Bor/Abcb4^tm1Bor (C.129P2-Abcb4^tm1Bor)	decreased circulating calcium level	J:199949
	decreased vitamin D level	J:199949
	increased circulating phosphate level	J:199949
	increased transforming growth factor beta level	J:199949
	increased tumor necrosis factor (ligand) superfamily member 11 level	J:199949
Abcb4^tm1Bor/Abcb4^tm1Bor (CAnNCrl.12P2(FVB)-Abcb4^tm1Bor)	increased circulating alanine transaminase level	J:217802
	increased circulating alkaline phosphatase level	J:217802
	increased circulating aspartate transaminase level	J:217802
	increased circulating bilirubin level	J:217802
Abcb4^tm1Bor/Abcb4^tm1Bor Pemt^tm1J/Pemt^tm1J (involves: 129P2/OlaHsd * C57BL/6 * FVB/N)	decreased bile salt level	J:175015
	decreased circulating alanine transaminase level	J:175015
Abcb4^tm1Bor/Abcb4^tm1Bor Por^tm1Wolf/Por^tm1Wolf Speer6-ps1^{Tg(Alb-cre)21Mgn}/Speer6-ps1⁺ (involves: 129P2/OlaHsd * C57BL/6 * DBA * FVB/N)	abnormal bile salt homeostasis	J:215915
	increased bile salt level	J:215915
	increased circulating alanine transaminase level	J:215915
	increased circulating alkaline phosphatase level	J:215915
	increased circulating bilirubin level	J:215915
Abcb4^tm1Bor/Abcb4^tm1Bor Tg(ABCG5/ABCG8)14-2Hobb/0 (involves: 129P2/OlaHsd * C57BL/6J * FVB/N * SJL)	decreased intestinal cholesterol absorption	J:100491
	increased circulating alanine transaminase level	J:100491
	increased circulating aspartate transaminase level	J:100491
Abcb7^tm1Mdf/Y Speer6-ps1^{Tg(Alb-cre)21Mgn}/Speer6-ps1⁺ (either: B6.Cg-Speer6-ps1^{Tg(Alb-cre)21Mgn} Abcb7^tm1Mdf or (involves: 129S4/SvJae * 129S6/SvEvTac * C57BL/6 * DBA))	abnormal circulating enzyme level	J:106838
	hemosiderosis	J:106838
Abcb8^tm1Hard/Abcb8^tm1Hard A1cf^{Tg(Myh6-cre/Esr1*)1Jmk}/A1cf⁺ (involves: FVB)	increased heart iron level	J:182234
Abcb10^tm1.1Tafu/Abcb10^tm1.2Tafu Tg(Mx1-cre)1Cgn/0 (involves: C57BL/6J * C57BL/6NCrlj * CBA/J * CBA/JNCrlJ)	abnormal iron level	J:223428
Abcb10^tm1.2Tafu/Abcb10^tm1.2Tafu (involves: C57BL/6NCrlj * CBA/JNCrlj)	abnormal iron level	J:223428
Abcb11^{tm1a(EUCOMM)Hmgu}/Abcb11^{tm1a(EUCOMM)Hmgu} (C57BL/6N-Abcb11^{tm1a(EUCOMM)Hmgu}/Ieg)	increased circulating alanine transaminase level	J:165965
	increased circulating alkaline phosphatase level	J:165965
	increased circulating aspartate transaminase level	J:165965
	increased circulating potassium level	J:165965
Abcb11^{tm1b(EUCOMM)Hmgu}/Abcb11⁺ (C57BL/6N-Abcb11^{tm1b(EUCOMM)Hmgu}/Ieg)	decreased circulating triglyceride level	J:211773
	increased circulating alkaline phosphatase level	J:211773
	increased circulating amylase level	J:211773
	increased circulating aspartate transaminase level	J:211773
	increased circulating bilirubin level	J:211773
	increased circulating fructosamine level	J:211773
	increased circulating unsaturated transferrin level	J:211773
Abcb11^tm1Wng/Abcb11^tm1Wng (involves: 129S6/SvEvTac * C57BL/6J)	abnormal bile salt level	J:67548
	abnormal phospholipid level	J:67548
	decreased liver glycogen level	J:67548
	increased bile salt level	J:67548
	increased cholesterol level	J:67548
Abcc1^tm1Acs/Abcc1^tm1Acs (involves: 129S1/Sv * C57BL/6)	abnormal homeostasis	J:44305
Abcc1^tm1Bor/Abcc1^tm1Bor Tg(Thy1-APPDutch)#Jckr/0 (FVB.Cg-Abcc1^tm1Bor Tg(Thy1-AppDutch)#Jckr)	abnormal homeostasis	J:178230
Abcc2^tm1Ahs/Abcc2^tm1Ahs (involves: 129P2/OlaHsd * FVB)	abnormal blood homeostasis	J:107822
	bilirubinuria	J:107822
	increased circulating bilirubin level	J:107822
Abcc2^tm1Ahs/Abcc2^tm1Ahs (FVB.129P2-Abcc2^tm1Ahs)	bilirubinuria	J:216646
Abcc2^tm1Ahs/Abcc2^tm1Ahs (FVB.129P2-Abcc2^tm1Ahs)	increased circulating bilirubin level	J:216646
Abcc2^tm1Ahs/Abcc2^tm1Ahs (B6.129P2(FVB)-Abcc2^tm1Ahs)	increased circulating bilirubin level	J:208127
Abcc2^tm1Dgen/Abcc2^tm1Dgen (involves: 129P2/OlaHsd * C57BL/6)	decreased circulating alkaline phosphatase level	J:134950
	increased circulating bilirubin level	J:134950
	increased circulating cholesterol level	J:134950
Abcc2^{tm2b(KOMP)Wtsi}/Abcc2^{tm2b(KOMP)Wtsi} (C57BL/6N-Abcc2^{tm2b(KOMP)Wtsi}/H)	increased circulating alanine transaminase level	J:211773
	increased circulating aspartate transaminase level	J:211773
	increased circulating bilirubin level	J:211773
	increased circulating cholesterol level	J:211773
	increased circulating HDL cholesterol level	J:211773
Abcc3^tm1Bor/Abcc3^tm1Bor (involves: 129P2/Ola * FVB/N)	abnormal bile salt homeostasis	J:149653
Abcc3^tm1Kruh/Abcc3^tm1Kruh (involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)	abnormal bile salt level	J:114229
	increased circulating bilirubin level	J:114229
Abcc3^tm1Kruh/Abcc3^tm1Kruh Slc51a^tm1Pda/Slc51a^tm1Pda (involves: 129S1/Sv * 129S6/SvEvTac * 129X1/SvJ * C57BL/6)	abnormal bile salt homeostasis	J:132778
Abcc4^{Gt(RRC212)Byg}/Abcc4^{Gt(RRC212)Byg} (involves: 129P2/OlaHsd * C57BL/6)	decreased prostaglandin level	J:139829
Abcc4^tm1Jsch/Abcc4^tm1Jsch (involves: 129X1/SvJ)	abnormal urine organic anion level	J:92788
Abcc4^tm1Kruh/Abcc4^tm1Kruh (B6.129-Abcc4^tm1Kruh)	abnormal blood homeostasis	J:117326
Abcc5^em1(IMPC)H/Abcc5^em1(IMPC)H (C57BL/6N-Abcc5^em1(IMPC)H/H)	decreased circulating calcium level	J:211773
	decreased circulating glucose level	J:211773
	impaired glucose tolerance	J:211773
	increased blood urea nitrogen level	J:211773
Abcc6^tm1Aabb/Abcc6^tm1Aabb (involves: 129P2/OlaHsd * C57BL/6)	decreased circulating HDL cholesterol level	J:105062
	increased circulating creatinine level	J:105062
Abcc6^{tm1c(EUCOMM)Wtsi}/Abcc6^{tm1c(EUCOMM)Wtsi} E2f1^{Tg(Wnt1-cre)2Sor}/? (B6.Cg-E2f1^{Tg(Wnt1-cre)2Sor} Abcc6^{tm1c(EUCOMM)Wtsi})	calcinosis	J:252837
Abcc6^{tm1c(EUCOMM)Wtsi}/Abcc6^{tm1c(EUCOMM)Wtsi} E2f1^{Tg(Wnt1-cre)2Sor}/? Speer6-ps1^{Tg(Alb-cre)21Mgn}/? (B6.Cg-E2f1^{Tg(Wnt1-cre)2Sor} Abcc6^{tm1c(EUCOMM)Wtsi} Speer6-ps1^{Tg(Alb-cre)21Mgn})	calcinosis	J:252837
Abcc6^{tm1c(EUCOMM)Wtsi}/Abcc6^{tm1c(EUCOMM)Wtsi} Speer6-ps1^{Tg(Alb-cre)21Mgn}/? (B6.Cg-Abcc6^{tm1c(EUCOMM)Wtsi} Speer6-ps1^{Tg(Alb-cre)21Mgn})	calcinosis	J:252837
Abcc6^{tm1c(EUCOMM)Wtsi}/Abcc6^{tm1c(EUCOMM)Wtsi} Speer6-ps1^{Tg(Alb-cre)21Mgn}/? Tg(Cdx1-cre)23Kem/? (B6.Cg-Abcc6^{tm1c(EUCOMM)Wtsi} Speer6-ps1^{Tg(Alb-cre)21Mgn} Tg(Cdx1-cre)23Kem)	calcinosis	J:252837
Abcc6^{tm1c(EUCOMM)Wtsi}/Abcc6^{tm1c(EUCOMM)Wtsi} Tg(CMV-cre)1Cgn/? (B6.Cg-Abcc6^{tm1c(EUCOMM)Wtsi} Tg(CMV-cre)1Cgn)	calcinosis	J:252837
Abcc6^tm1Jfk/Abcc6^tm1Jfk (involves: 129S1/Sv * C57BL/6J)	calcinosis	J:101372
Abcc6^tm1Jfk/Abcc6^tm1Jfk (B6.129S1-Abcc6^tm1Jfk)	calcinosis	J:252837
Abcc6^tm1Jfk/Abcc6^tm1Jfk Enpp1^asj/Enpp1⁺ (B6.Cg-Abcc6^tm1Jfk Enpp1^asj)	calcinosis	J:252837
Abcc6^tm1Jfk/Abcc6^tm1Jfk Enpp1^asj/Enpp1^asj (B6.Cg-Abcc6^tm1Jfk Enpp1^asj)	calcinosis	J:252837
Abcc6^tm1Jfk/Abcc6^tm1Jfk Nt5e^tm1Lft/Nt5e^tm1Lft (B6.Cg-Abcc6^tm1Jfk Nt5e^tm1Lft)	calcinosis	J:252837
Abcc6^tm1Jfk/Abcc6^tm1Jfk Samd9l^tm1Homy/Samd9l^tm1Homy (B6.129-Samd9l^tm1Homy Abcc6^tm1Jfk)	calcinosis	J:225110
Abcc8^em1(IMPC)J/Abcc8^em1(IMPC)J (C57BL/6NJ-Abcc8^em1(IMPC)J/Mmjax)	impaired glucose tolerance	J:211773
Abcc8^tm1.1Fmas/Abcc8^tm1.1Fmas (B6.129S2(Cg)-Abcc8^tm1.1Fmas)	decreased circulating glucose level	J:208932
	decreased insulin secretion	J:208932
	impaired glucose tolerance	J:208932
	increased circulating glucose level	J:208932
	increased insulin secretion	J:208932
Abcc8^tm1.1Mgn/Abcc8^tm1.1Mgn (involves: 129X1/SvJ * C57BL/6)	decreased insulin secretion	J:79352
	hypoglycemia	J:79352
	impaired glucose tolerance	J:79352
Abcc8^tm1Jbry/Abcc8^tm1Jbry (involves: 129X1/SvJ * C57BL/6)	hypoglycemia	J:61356
Abcc8^tm1Jbry/Abcc8^tm1Jbry (involves: 129X1/SvJ * C57BL/6)	impaired glucose tolerance	J:61356
Abcc8^tm1Jbry/Abcc8^tm1Jbry (involves: 129X1/SvJ)	abnormal insulin secretion	J:179577
	decreased circulating glucose level	J:179577
	decreased insulin secretion	J:179577
	increased circulating glucose level	J:179577
Abcc8^tm1Jbry/Abcc8^tm1Jbry Sstr5^tm1Fcb/Sstr5^tm1Fcb (involves: 129X1/SvJ)	abnormal insulin secretion	J:179577
	decreased circulating glucose level	J:179577
	decreased insulin secretion	J:179577
	increased circulating glucose level	J:179577
Abcc9^tm1.1Mcn/Abcc9^tm1.1Mcn Tg(Tagln-cre)1Her/0 (involves: 129 * 129S1/Sv * 129X1/SvJ * C57BL/6J)	decreased fatty acid oxidation	J:216539
	decreased oxygen consumption	J:216539
	hypoxia	J:216539
Abcc9^tm1Cfb/Abcc9^tm1Cfb (involves: CD-1)	hypoglycemia	J:71840
	improved glucose tolerance	J:71840
	increased insulin sensitivity	J:71840
Abcd1^tm1Kan/Y (involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)	abnormal lipid homeostasis	J:44812
Abcd1^tm1Kan/Y (involves: 129 * BALB/cJ * C57BL/6J * Swiss)	increased fatty acids level	J:257393
Abcd1^tm1Kan/Y Gt(ROSA)26Sor^{tm2.1(CAG-ELOVL1)Geno}/Gt(ROSA)26Sor⁺ Cnp^tm1(cre)Kan/Cnp⁺ (involves: 129 * 129S1/Sv * 129X1/SvJ * C57BL/6J)	increased fatty acids level	J:257393
Abcd1^tm1Kan/Y Gt(ROSA)26Sor^{tm2.1(CAG-ELOVL1)Geno}/Gt(ROSA)26Sor⁺ Tg(CMV-cre)1Cgn/0 (involves: 129 * BALB/cJ * C57BL/6J * Swiss)	increased fatty acids level	J:257393
Abcd1^tm1Kan/Abcd1^tm1Kan (involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)	abnormal lipid homeostasis	J:44812
Abcd1^tm1Kds/Y (either: (involves: 129S4/SvJae * C57BL/6) or (involves: 129/Sv * 129S4/SvJae * C57BL/6))	abnormal lipid homeostasis	J:42479
	increased saturated fatty acids level	J:42479
Abcd1^tm1Kds/Y (involves: 129S4/SvJae * C57BL/6J)	increased fatty acids level	J:94583
Abcd1^tm1Kds/Y Abcd2^tm1Apuj/Abcd2^tm1Apuj (involves: 129S1/Sv * 129S4/SvJae * 129X1/SvJ * C57BL/6J)	increased fatty acids level	J:94583, J:104122
Abcd1^tm1Kds/Abcd1^tm1Kds (either: (involves: 129S4/SvJae * C57BL/6) or (involves: 129/Sv * 129S4/SvJae * C57BL/6))	abnormal lipid homeostasis	J:42479
	increased saturated fatty acids level	J:42479
Abcd1^tm1Ymd/Y (involves: 129S/SvEv * C57BL/6J * DBA/2J)	abnormal lipid homeostasis	J:40230
Abcd1^tm1Ymd/Abcd1^tm1Ymd (involves: 129S/SvEv * C57BL/6J * DBA/2J)	abnormal lipid homeostasis	J:40230
Abcd2^tm1Apuj/Abcd2^tm1Apuj (involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)	increased fatty acids level	J:94583, J:104122
Abcd3^em1(IMPC)J/Abcd3^em1(IMPC)J (C57BL/6NJ-Abcd3^em1(IMPC)J/J)	abnormal cholesterol homeostasis	J:211773
	decreased circulating triglyceride level	J:211773
	improved glucose tolerance	J:211773
	increased circulating alkaline phosphatase level	J:211773
	increased circulating calcium level	J:211773
	increased circulating total protein level	J:211773
	increased fasting circulating glucose level	J:211773
Abcd3^tm1Safe/Abcd3^tm1Safe (involves: 129S4/SvJae * C57BL/6J)	abnormal blood homeostasis	J:217065
Abce1^{tm1b(EUCOMM)Hmgu}/Abce1⁺ (C57BL/6N-Abce1^{tm1b(EUCOMM)Hmgu}/H)	decreased circulating creatinine level	J:211773
Abcg1^tm1Asch/Abcg1^tm1Asch (involves: 129X1/SvJ * C57BL/6)	decreased susceptibility to diet-induced obesity	J:122438
	hypoglycemia	J:122438
	increased body temperature	J:122438
	increased energy expenditure	J:122438
	increased oxygen consumption	J:122438
Abcg1^tm1Dgen/Abcg1⁺ Abcg4^tm1Dgen/Abcg4^tm1Dgen (involves: 129P2/OlaHsd)	abnormal lipid homeostasis	J:141549
	abnormal lipid level	J:141549
Abcg1^tm1Dgen/Abcg1^tm1Dgen (B6.129P2-Abcg1^tm1Dgen)	abnormal phospholipid level	J:117028
	increased cholesterol level	J:117028
	increased triglyceride level	J:117028
Abcg1^tm1Dgen/Abcg1^tm1Dgen (involves: 129P2/OlaHsd * C57BL/6)	lipidosis	J:132952
Abcg1^tm1Dgen/Abcg1^tm1Dgen (involves: 129P2/OlaHsd)	abnormal lipid level	J:141549
Abcg1^tm1Dgen/Abcg1^tm1Dgen Abcg4^tm1Dgen/Abcg4⁺ (involves: 129P2/OlaHsd)	abnormal lipid homeostasis	J:141549
	abnormal lipid level	J:141549
Abcg1^tm1Dgen/Abcg1^tm1Dgen Abcg4^tm1Dgen/Abcg4^tm1Dgen (involves: 129P2/OlaHsd)	abnormal cholesterol homeostasis	J:141549
	abnormal lipid homeostasis	J:141549
	abnormal lipid level	J:141549
Abcg2^em1Omw/Abcg2^em1Omw (C57BL/6J-Abcg2^em1Omw)	increased blood uric acid level	J:292268
	increased circulating glucose level	J:292268
	increased circulating insulin level	J:292268
	increased circulating insulin-like growth factor I level	J:292268
	increased circulating potassium level	J:292268
	increased urine osmolality	J:292268
	increased urine sodium level	J:292268
Abcg2^{tm1.1(KOMP)Vlcg}/Abcg2^{tm1.1(KOMP)Vlcg} (B6N(Cg)-Abcg2^{tm1.1(KOMP)Vlcg}/J)	decreased blood urea nitrogen level	J:211773
	increased circulating cholesterol level	J:211773
	increased circulating HDL cholesterol level	J:211773
Abcg2^tm1.1Ssf/Abcg2^tm1.1Ssf (involves: 129 * C57BL/6 * FVB)	abnormal glucose homeostasis	J:201884
	decreased liver glycogen level	J:201884
	impaired glucose tolerance	J:201884
	increased porphyrin level	J:201884
Abcg2^tm1Ahs/Abcg2^tm1Ahs (either: (involves: 129P2/OlaHsd * FVB) or (involves: FVB))	increased circulating bilirubin level	J:80519
	phototoxicity	J:80519
	porphyria	J:80519
Abcg2^tm1Ahs/Abcg2^tm1Ahs (FVB.129P2-Abcg2^tm1Ahs/Tac)	abnormal homeostasis	J:220924
	increased blood uric acid level	J:220924
	increased urine uric acid level	J:220924
Abcg4^tm1Dgen/Abcg4^tm1Dgen (Not Specified)	abnormal lipid level	J:141549
Abcg5^tm1.1Hobb/Abcg5^tm1.1Hobb Abcg8^tm1.1Hobb/Abcg8^tm1.1Hobb Speer6-ps1^{Tg(Alb-cre)21Mgn}/? (involves: C57BL/6 * DBA * SJL)	abnormal intestinal cholesterol absorption	J:215443
	abnormal phytosterol level	J:215443
	decreased circulating cholesterol level	J:215443
	decreased phytosterol level	J:215443
	increased cholesterol level	J:215443
	increased circulating phytosterol level	J:215443
Abcg5^tm1.1Hobb/Abcg5^tm1.1Hobb Abcg8^tm1.1Hobb/Abcg8^tm1.1Hobb Tg(CAG-cre/Esr1)5Amc/? (involves: C57BL/6 CBA * SJL)	abnormal phytosterol level	J:215443
	decreased cholesterol level	J:215443
	decreased circulating cholesterol level	J:215443
	decreased phytosterol level	J:215443
	increased circulating phytosterol level	J:215443
	increased intestinal phytosterol absorption	J:215443
	increased phytosterol level	J:215443
Abcg5^tm1.1Hobb/Abcg5^tm1.1Hobb Abcg8^tm1.1Hobb/Abcg8^tm1.1Hobb Tg(Vil1-cre)997Gum/? (involves: C57BL/6 * SJL)	increased circulating phytosterol level	J:215443
	increased intestinal phytosterol absorption	J:215443
	increased phytosterol level	J:215443
Abcg5^tm1Plo/Abcg5^tm1Plo (involves: 129P2/OlaHsd * C57BL/6J)	abnormal phospholipid level	J:87209
	decreased cholesterol level	J:87209
	decreased circulating cholesterol level	J:87209
	increased circulating phytosterol level	J:87209
	increased circulating triglyceride level	J:87209
	increased circulating VLDL triglyceride level	J:87209
Abcg5^tm1Plo/Abcg5^tm1Plo (involves: 129P2/OlaHsd)	abnormal cholesterol homeostasis	J:112995
Abcg5^tm1Plo/Abcg5^tm1Plo (involves: 129P2/OlaHsd)	abnormal lipid homeostasis	J:112995
Abcg5^trac/Abcg5^trac (A/J-Abcg5^trac)	abnormal circulating cholesterol level	J:157223
	abnormal circulating lipid level	J:157223
	abnormal platelet activation	J:157223
	decreased platelet aggregation	J:157223
	increased bleeding time	J:157223
Abcg8^{tm1b(KOMP)Wtsi}/Abcg8^{tm1b(KOMP)Wtsi} (C57BL/6N-Abcg8^{tm1b(KOMP)Wtsi}/Ccpcz)	abnormal cholesterol homeostasis	J:211773
	decreased circulating iron level	J:211773
	decreased circulating serum albumin level	J:211773
	decreased circulating sodium level	J:211773
	increased circulating alanine transaminase level	J:211773
	increased circulating alkaline phosphatase level	J:211773
	increased circulating aspartate transaminase level	J:211773
	increased circulating cholesterol level	J:211773
	increased circulating creatinine level	J:211773
	increased circulating potassium level	J:211773
	increased circulating triglyceride level	J:211773
Abcg8^tm1Elk/Abcg8⁺ (involves: 129S6/SvEvTac * C57BL/6J)	decreased circulating cholesterol level	J:94759
Abcg8^tm1Elk/Abcg8^tm1Elk (involves: 129S6/SvEvTac * C57BL/6J)	decreased cholesterol level	J:94759
	decreased circulating cholesterol level	J:94759
	increased circulating free fatty acids level	J:192806
	increased circulating phytosterol level	J:94759
	increased circulating triglyceride level	J:94759
Abhd4^tm1Crv/Abhd4^tm1Crv (B6.129S6-Abhd4^tm1Crv)	abnormal lipid homeostasis	J:276423
Abhd5^tm1.1Lqyu/Abhd5^tm1.1Lqyu Speer6-ps1^{Tg(Alb-cre)21Mgn}/Speer6-ps1⁺ (involves: 129S1/Sv * 129S4/SvJaeSor * 129X1/SvJ * C57BL/6 * DBA)	abnormal lipid level	J:199570
	abnormal phospholipid level	J:199570
	decreased fatty acid oxidation	J:199570
	increased circulating alanine transaminase level	J:199570
	increased circulating aspartate transaminase level	J:199570
	increased liver cholesterol level	J:199570
	increased liver free fatty acids level	J:199570
	increased liver triglyceride level	J:199570
Abhd5^tm1.1Rze/Abhd5^tm1.1Rze (involves: 129P2/OlaHsd * C57BL/6)	abnormal lipid homeostasis	J:160725
	abnormal lipid level	J:160725
	decreased circulating glucose level	J:160725
	decreased circulating triglyceride level	J:160725
	decreased fatty acids level	J:160725
	impaired lipolysis	J:160725
	impaired skin barrier function	J:160725
	increased liver triglyceride level	J:160725
	increased triglyceride level	J:160725
Abhd5^tm1Murm/Abhd5^tm1Murm (B6.129S-Abhd5^tm1Murm)	abnormal ceramide level	J:240682
Abhd5^tm1Murm/Abhd5^tm1Murm (B6.129S-Abhd5^tm1Murm)	increased triglyceride level	J:240682
Abhd5^tm1Rze/Abhd5^tm1Rze Tg(Ckmm-cre)5Khn/0 (involves: 129P2/OlaHsd * C57BL/6 * FVB)	abnormal glucose homeostasis	J:197835
	abnormal lipid homeostasis	J:197835
	decreased circulating free fatty acids level	J:197835
	decreased circulating glucose level	J:197835
	decreased circulating insulin level	J:197835
	decreased circulating triglyceride level	J:197835
	decreased liver triglyceride level	J:197835
	decreased oxygen consumption	J:197835
	impaired lipolysis	J:197835
	improved glucose tolerance	J:197835
	increased cardiac muscle triglyceride level	J:197835
	increased respiratory quotient	J:197835
	increased skeletal muscle triglyceride level	J:197835
Abhd6^{tm1a(EUCOMM)Hmgu}/Abhd6⁺ (C57BL/6N-Abhd6^{tm1a(EUCOMM)Hmgu})	increased insulin secretion	J:215257
Abhd6^{tm1a(EUCOMM)Hmgu}/Abhd6^{tm1a(EUCOMM)Hmgu} (C57BL/6N-Abhd6^{tm1a(EUCOMM)Hmgu})	abnormal body temperature homeostasis	J:234876
	abnormal lipid level	J:215257
	decreased circulating insulin level	J:234876
	decreased insulin secretion	J:234876
	decreased liver triglyceride level	J:234876
	decreased susceptibility to diet-induced obesity	J:234876
	improved glucose tolerance	J:234876
	increased circulating insulin level	J:215257
	increased energy expenditure	J:234876
	increased fatty acid beta-oxidation	J:234876
	increased insulin secretion	J:215257, J:234876
	increased insulin sensitivity	J:234876
	increased oxygen consumption	J:234876
Abhd6^{tm1c(EUCOMM)Hmgu}/Abhd6^{tm1c(EUCOMM)Hmgu} Tg(Ins1-cre/ERT)1Lphi/0 (involves: C57BL/6N * CD-1)	improved glucose tolerance	J:215257
	increased circulating insulin level	J:215257
	increased insulin secretion	J:215257
Abhd8^{tm1b(EUCOMM)Wtsi}/Abhd8^{tm1b(EUCOMM)Wtsi} (C57BL/6N-Abhd8^{tm1b(EUCOMM)Wtsi}/Bay)	decreased circulating calcium level	J:211773
	decreased circulating chloride level	J:211773
	decreased circulating cholesterol level	J:211773
	increased circulating potassium level	J:211773
Abhd10^em1(IMPC)Mbp/Abhd10^em1(IMPC)Mbp (C57BL/6NCrl-Abhd10^em1(IMPC)Mbp/Mmucd)	increased circulating bilirubin level	J:211773
Abhd11^tm1Esco/Abhd11^tm1Esco (involves: C57BL/6)	decreased circulating glucose level	J:294591
	decreased circulating insulin level	J:294591
	decreased susceptibility to diet-induced obesity	J:294591
	improved glucose tolerance	J:294591
	increased insulin sensitivity	J:294591
Abhd12^tm1Crv/Abhd12^tm1Crv (involves: C57BL/6)	abnormal phospholipid level	J:193716
Abhd12b^em1(IMPC)J/Abhd12b^em1(IMPC)J (C57BL/6NJ-Abhd12b^em1(IMPC)J/Mmjax)	increased fasting circulating glucose level	J:211773
Abhd14a^{tm2a(EUCOMM)Wtsi}/Abhd14a^{tm2a(EUCOMM)Wtsi} (C57BL/6N-Abhd14a^{tm2a(EUCOMM)Wtsi}/Wtsi)	decreased circulating HDL cholesterol level	J:211773
	improved glucose tolerance	J:211773
Abhd16a^{tm1a(EUCOMM)Wtsi}/Abhd16a^{tm1a(EUCOMM)Wtsi} (involves: C57BL/6N * C57BL/6NTac)	abnormal phospholipid level	J:232688
Abhd16a^{tm1a(EUCOMM)Wtsi}/Abhd16a^{tm1a(EUCOMM)Wtsi} (C57BL/6N-Abhd16a^{tm1a(EUCOMM)Wtsi}/Wtsi)	decreased circulating magnesium level	J:211773
	decreased fasting circulating glucose level	J:211773
Abhd17a^{tm1a(KOMP)Wtsi}/Abhd17a^{tm1a(KOMP)Wtsi} (C57BL/6N-Abhd17a^{tm1a(KOMP)Wtsi}/Wtsi)	improved glucose tolerance	J:211773
Abhd17c^em1(IMPC)Mbp/Abhd17c^em1(IMPC)Mbp (C57BL/6N-Abhd17c^em1(IMPC)Mbp/MbpMmucd)	decreased circulating alanine transaminase level	J:211773
Abi1^tm1.2Lko/Abi1^tm1.2Lko (involves: 129S/SvEv * 129S4/SvJaeSor * C57BL/6 * CBA)	cardiac edema	J:171342
	pericardial edema	J:171342
Abi1^tm1Pen/Abi1^tm1Pen (involves: CD-1)	edema	J:169009
Abi2^{tm1b(EUCOMM)Wtsi}/Abi2^{tm1b(EUCOMM)Wtsi} (C57BL/6N-Abi2^{tm1b(EUCOMM)Wtsi}/Tcp)	increased circulating alanine transaminase level	J:211773
	increased fasting circulating glucose level	J:211773
Abi3bp^{tm1e.1(KOMP)Mbp}/Abi3bp^{tm1e.1(KOMP)Mbp} (C57BL/6N-Abi3bp^{tm1e.1(KOMP)Mbp}/Tcp)	increased circulating alkaline phosphatase level	J:211773
Abl1^tm1Mlg/Abl1^tm1Mlg Abl2^tm1Ajk/Abl2⁺ (involves: 129S/SvEv * 129S4/SvJae * C57BL/6J)	edema	J:51887
	hemopericardium	J:51887
	pericardial edema	J:51887
Abl1^tm1Mlg/Abl1^tm1Mlg Abl2^tm1Ajk/Abl2^tm1Ajk (involves: 129S/SvEv * 129S4/SvJae * C57BL/6J)	hemopericardium	J:51887
Ablp^BALB/cJ/? (involves: BALB/cJ * C57BL/6J)	abnormal enzyme/coenzyme level	J:94275
Abtb1^{em1(IMPC)Ccpcz}/Abtb1^{em1(IMPC)Ccpcz} (C57BL/6N-Abtb1^{em1(IMPC)Ccpcz}/Ccpcz)	increased fasting circulating glucose level	J:211773
Acaca^tm1Jkus/Acaca^tm1Jkus Tg(Fabp1-cre)1Mmt/0 (involves: 129X1/SvJ * C57BL/6J * SJL)	abnormal lipid homeostasis	J:118861
	decreased liver triglyceride level	J:118861
	increased circulating aspartate transaminase level	J:118861
Acaca^tm2Sjw/Acaca^tm2Sjw Speer6-ps1^{Tg(Alb-cre)21Mgn}/Speer6-ps1⁺ (involves: 129S7/SvEvBrd * C57BL/6J * FVB)	abnormal glucose homeostasis	J:110200
	abnormal lipid level	J:110200
	decreased circulating free fatty acids level	J:110200
	decreased circulating ketone body level	J:110200
	decreased fatty acids level	J:110200
	decreased liver triglyceride level	J:110200
	hyperglycemia	J:110200
	increased circulating free fatty acids level	J:110200
	increased circulating insulin level	J:110200
Acacb^tm1.1Dejs/Acacb^tm1.1Dejs (B6.Cg-Acacb^tm1.1Dejs)	abnormal glucose homeostasis	J:157000
	abnormal lipid homeostasis	J:157000
	increased fatty acid oxidation	J:157000
	increased skeletal muscle glycogen level	J:157000
Acacb^tm1.2Lowl/Acacb^tm1.2Lowl (involves: 129S6/SvEvTac * FVB/N)	abnormal enzyme/coenzyme level	J:159285
	decreased respiratory quotient	J:159285
	increased circulating insulin level	J:159285
	increased oxygen consumption	J:159285
Acacb^tm1Sjw/Acacb^tm1Sjw (Not Specified)	abnormal energy expenditure	J:68427
	abnormal enzyme/coenzyme level	J:68427
	abnormal lipid homeostasis	J:68427
	decreased circulating free fatty acids level	J:68427
	decreased circulating glucose level	J:68427
	decreased circulating leptin level	J:68427
	decreased fatty acids level	J:68427
	decreased liver glycogen level	J:68427
	decreased liver triglyceride level	J:68427
	increased circulating ketone body level	J:68427
	increased circulating triglyceride level	J:68427
	increased fatty acid beta-oxidation	J:68427
	increased fatty acid oxidation	J:68427
Acad8^m1Ytc/Acad8^m1Ytc (involves: C57BL/6)	abnormal circulating amino acid level	J:222356
	abnormal circulating enzyme level	J:222356
	abnormal urine homeostasis	J:222356
	decreased circulating carnitine level	J:222356
	impaired adaptive thermogenesis	J:222356
	increased oxygen consumption	J:222356
Acad9^{tm1c(KOMP)Wtsi}/Acad9^{tm1c(KOMP)Wtsi} Tg(ACTA1-cre)79Jme/0 (involves: C57BL/6J * C57BL/6N * FVB/N * SJL)	lactic acidosis	J:326969
Acad12^{tm1b(EUCOMM)Wtsi}/Acad12^{tm1b(EUCOMM)Wtsi} (C57BL/6N-Acad12^{tm1b(EUCOMM)Wtsi}/Wtsi)	increased circulating insulin level	J:211773
Acadl^tm1Uab/Acadl^tm1Uab (involves: 129S6/SvEvTac * C57BL/6NTac)	abnormal adaptive thermogenesis	J:50729
	abnormal lipid homeostasis	J:72193
	dicarboxylic aciduria	J:72193, J:51660
	hypoglycemia	J:51660
	increased circulating carnitine level	J:72193
	increased circulating free fatty acids level	J:51660
	increased fatty acids level	J:72193
	increased unsaturated fatty acids level	J:51660
	lipidosis	J:51660
Acadm^tm1Uab/Acadm^tm1Uab (involves: 129P2/OlaHsd * C57BL/6)	abnormal blood homeostasis	J:115759
	decreased circulating glucose level	J:115759
	impaired adaptive thermogenesis	J:115759
	increased circulating carnitine level	J:115759
Acads^del-J/Acads⁺ Otc^spf/Y (involves: BALB/cByJ * CD-1)	aciduria	J:4165
Acads^del-J/Acads⁺ Otc^spf/Y (involves: BALB/cByJ * CD-1)	oroticaciduria	J:4165
Acads^del-J/Acads^del-J (involves: BALB/cByJ)	abnormal adaptive thermogenesis	J:50729
	abnormal fatty acid oxidation	J:14707
	decreased circulating carnitine level	J:14707
	decreased circulating glycine level	J:14707
	ethylmalonic aciduria	J:4165, J:9743
	hypoglycemia	J:14707
	increased circulating HDL cholesterol level	J:164460
	organic aciduria	J:14707, J:4165, J:9743
Acads^del-J/Acads^del-J Otc^spf/Y (involves: BALB/cByJ * CD-1)	aciduria	J:4165
Acads^del-J/Acads^del-J Otc^spf/Otc⁺ (involves: BALB/cByJ * CD-1)	aciduria	J:4165
Acads^del-J/Acads^del-J Otc^spf/Otc^spf (involves: BALB/cByJ * CD-1)	oroticaciduria	J:4165
Acads^{Hdlq8-C57BL/6J}/Acads^{Hdlq8-C57BL/6J} (involves: C57BL/6J * NZB/BlNJ)	decreased circulating HDL cholesterol level	J:84430
Acads^{Hdlq8-NZB/BlNJ}/Acads^{Hdlq8-NZB/BlNJ} (involves: C57BL/6J * NZB/BlNJ)	increased circulating HDL cholesterol level	J:84430
Acadsb^em1(IMPC)J/Acadsb^em1(IMPC)J (C57BL/6NJ-Acadsb^em1(IMPC)J/J)	abnormal cholesterol homeostasis	J:211773
Acadvl^em1(IMPC)H/Acadvl^em1(IMPC)H (C57BL/6NTac-Acadvl^em1(IMPC)H/H)	decreased fasting circulating glucose level	J:211773
	impaired glucose tolerance	J:211773
Acadvl^tm1Uab/Acadvl^tm1Uab (involves: 129S6/SvEvTac * C57BL/6)	abnormal lipid homeostasis	J:72193
	increased circulating carnitine level	J:72193
Acadvl^tm1Vje/Acadvl⁺ (involves: 129/Sv * C57BL/6)	abnormal amino acid level	J:102010
Acadvl^tm1Vje/Acadvl^tm1Vje (involves: 129/Sv * C57BL/6)	abnormal amino acid level	J:102010
	impaired adaptive thermogenesis	J:102010
	impaired glucose tolerance	J:102010
Acadvl^tm1Vje/Acadvl^tm1Vje (involves: 129/Sv * Black Swiss * C57BL/6)	abnormal amino acid level	J:106714
	decreased glycogen level	J:106714
	hypoglycemia	J:106714
	impaired adaptive thermogenesis	J:106714
Acadvl^tm1Zkhu/Acadvl^tm1Zkhu Tg(Myh6-cre)1Jmk/0 (involves: 129S6/SvEvTac * C57BL/6J * C57BL/6NCr)	abnormal adaptive thermogenesis	J:208711
	decreased circulating glucose level	J:208711
	decreased core body temperature	J:208711
	decreased respiratory quotient	J:208711
Acan^cmd/Acan^cmd (involves: STOCK T t^low Itpr3^tf)	polyhydramnios	J:23353
Acan^{tm1b(EUCOMM)Hmgu}/Acan⁺ (C57BL/6N-Acan^{tm1b(EUCOMM)Hmgu}/H)	increased circulating HDL cholesterol level	J:211773
Acap1^{tm1.1(KOMP)Vlcg}/Acap1^{tm1.1(KOMP)Vlcg} (B6N(Cg)-Acap1^{tm1.1(KOMP)Vlcg}/J)	decreased circulating glucose level	J:211773
Acat2^{tm1b(KOMP)Wtsi}/Acat2⁺ (C57BL/6N-Acat2^{tm1b(KOMP)Wtsi}/Bay)	increased circulating chloride level	J:211773
Acbd3^{tm1b(EUCOMM)Hmgu}/Acbd3⁺ (C57BL/6N-Acbd3^{tm1b(EUCOMM)Hmgu}/Ieg)	decreased circulating triglyceride level	J:211773
	increased circulating aspartate transaminase level	J:211773
Acbd5^{tm1a(EUCOMM)Wtsi}/Acbd5^{tm1a(EUCOMM)Wtsi} (C57BL/6N-A^tm1Brd Acbd5^{tm1a(EUCOMM)Wtsi}/WtsiCnbc)	abnormal ether lipid level	J:299448
	abnormal glycerol level	J:299448
	abnormal lipid homeostasis	J:299448
	increased fatty acids level	J:299448
Acbd5^{tm1b(EUCOMM)Wtsi}/Acbd5^{tm1b(EUCOMM)Wtsi} (C57BL/6N-Acbd5^{tm1b(EUCOMM)Wtsi}/Wtsi)	decreased circulating calcium level	J:211773
	decreased circulating serum albumin level	J:211773
	decreased circulating total protein level	J:211773
	decreased circulating triglyceride level	J:211773
	improved glucose tolerance	J:211773
	increased blood urea nitrogen level	J:211773
	increased circulating alkaline phosphatase level	J:211773
	increased circulating creatinine level	J:211773
Acd^acd/Acd^acd (DW/J-Acd^acd Pou1f1⁺)	abnormal adrenocorticotropin level	J:18027
	abnormal corticosterone level	J:18027
	abnormal pituitary hormone level	J:18027
	decreased circulating corticosterone level	J:18027
	increased adrenocorticotropin level	J:18027
Acd^tm1.1Blas/Acd^tm1.1Blas Tg(KRT5-cre)1Tak/? (involves: 129S1/Sv * 129X1/SvJ * C3H * C57BL/6 * SJL)	impaired skin barrier function	J:160600
Ace2^{em1(ACE2)Yowa}/Ace2^{em1(ACE2)Yowa} (C57BL/6-Ace2^{em1(ACE2)Yowa})	abnormal circulating cytokine level	J:288243
	increased circulating interferon-gamma level	J:288243
	increased circulating interleukin-9 level	J:288243
Ace2^em1Cya/Y (C57BL/6J-Ace2^em1Cya/Cya)	intestinal edema	J:299383
Ace2^tm1Cof/Y (129S6/SvEvTac-Ace2^tm1Cof)	increased angiotensin II level	J:113108
Ace2^tm1Cof/Y (129S6/SvEvTac-Ace2^tm1Cof)	increased circulating angiotensin II level	J:113108
Ace2^tm1Hira/Y (involves: 129S7/SvEvBrd * C57BL/6)	increased angiotensin II level	J:135766
Ace2^tm1Hira/Y (involves: 129S7/SvEvBrd * C57BL/6)	increased circulating angiotensin II level	J:135766
Ace2^tm1Pngr/Y (involves: 129P2/OlaHsd * C57BL/6)	abnormal cytokine level	J:124548
Ace2^tm1Pngr/Y (involves: 129P2/OlaHsd)	increased angiotensin II level	J:100334
	increased circulating angiotensin II level	J:100334
	pulmonary edema	J:100334
Ace2^tm1Pngr/Y (involves: 129P2/OlaHsd * C57BL/6J)	pulmonary edema	J:277074
Ace2^tm1Pngr/Ace2^tm1Pngr (involves: 129P2/OlaHsd)	increased angiotensin II level	J:100334
	increased circulating angiotensin II level	J:100334
	pulmonary edema	J:100334
Ace2^tm1Pngr/Ace2^tm1Pngr (involves: 129P2/OlaHsd * C57BL/6J)	pulmonary edema	J:277074
Ace^tm1Keb/Ace^tm1Keb (involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)	abnormal urine homeostasis	J:33018
	decreased urine aldosterone level	J:33018
	decreased urine osmolality	J:33018
	increased circulating creatinine level	J:33018
	increased urine potassium level	J:33018
Ace^tm1Keb/Ace^tm5Keb (involves: 129S1/Sv * 129X1/SvJ)	increased circulating renin level	J:89512
Ace^tm1Mcf/Ace^tm1Mcf (Not Specified)	decreased urine osmolality	J:32114
Ace^tm1Mcf/Ace^tm1Mcf (Not Specified)	increased blood urea nitrogen level	J:32114
Ace^tm1Unc/Ace⁺ (involves: 129P2/OlaHsd * C57BL/6J)	increased insulin secretion	J:128859
Ace^tm1Unc/Ace^tm1Unc (involves: 129P2/OlaHsd)	decreased angiotensin II level	J:100334
Ace^tm1Unc/Ace^tm1Unc (involves: 129P2/OlaHsd)	decreased circulating angiotensin II level	J:100334
Ace^tm1Unc/Ace^tm1Unc Ace2^tm1Pngr/Y (involves: 129P2/OlaHsd)	decreased angiotensin II level	J:100334
	decreased circulating angiotensin II level	J:100334
Ace^tm1Unc/Ace^tm1Unc Ace2^tm1Pngr/Ace2^tm1Pngr (involves: 129P2/OlaHsd)	decreased angiotensin II level	J:100334
	decreased circulating angiotensin II level	J:100334
Ace^tm2Keb/Ace^tm2Keb (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	decreased urine osmolality	J:40475
Ace^tm3Unc/Ace⁺ (involves: 129P2/OlaHsd * C57BL/6J)	decreased insulin secretion	J:128859
Ace^tm3Unc/Ace⁺ (B6.129P2-Ace^tm3Unc)	albuminuria	J:72577
Ace^tm4Keb/Ace^tm4Keb (involves: 129S1/Sv * 129X1/SvJ)	decreased urine osmolality	J:83894
Ace^tm4Keb/Ace^tm4Keb Bdkrb2^tm1Jfh/Bdkrb2^tm1Jfh (involves: 129S1/Sv * 129S7/SvEvBrd * 129X1/SvJ)	decreased urine osmolality	J:83894
Ace^tm6Keb/Ace^tm6Keb (involves: 129 * C57BL/6)	abnormal interleukin level	J:122178
Ace^tm8.1Keb/Ace^tm8.1Keb (involves: 129 * C57BL/6 * FVB/N)	abnormal circulating protein level	J:163902
	decreased circulating angiotensin II level	J:163902
	decreased urine osmolality	J:163902
Ace^tm8Keb/Ace^tm8Keb (involves: 129)	abnormal homeostasis	J:163902
Ace^tm9Keb/Ace^tm9Keb (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	abnormal circulating angiotensinogen level	J:185888
	abnormal urine osmolality	J:185888
	decreased circulating angiotensinogen level	J:185888
	decreased urine osmolality	J:185888
Acer1^{tm1a(EUCOMM)Wtsi}/Acer1^{tm1a(EUCOMM)Wtsi} (C57BL/6N-Acer1^{tm1a(EUCOMM)Wtsi})	abnormal ceramide level	J:235775
	abnormal lipid level	J:235775
	abnormal sphingomyelin level	J:235775
	decreased sphingosine level	J:235775
	impaired skin barrier function	J:235775
	increased energy expenditure	J:235775
Acer2^em1Mvw/Acer2^em1Mvw (C57BL/6J-Acer2^em1Mvw/MvwJ)	abnormal sphingolipid level	J:256650
Acer3^tm1Cmao/Acer3^tm1Cmao (B6.129S6-Acer3^tm1Cmao/Cmao)	abnormal ceramide level	J:228886
	abnormal sphingolipid level	J:228886
	abnormal sphingomyelin level	J:228886
	increased sphingosine level	J:228886
Ache^tm1.1Hssh/Ache^tm1.1Hssh (involves: 129S4/SvJae * C57BL/6)	abnormal body temperature homeostasis	J:140622
	decreased body temperature	J:140622
Ache^tm1.1Pata/Ache^tm1.1Pata (involves: 129X1/SvJ * C57BL/6)	abnormal platelet physiology	J:132775
Ache^tm1.1Pata/Ache^tm1.1Pata (involves: 129X1/SvJ)	decreased body temperature	J:147483
Ache^tm4Pata/Ache^tm4Pata (involves: 129X1/SvJ)	decreased body temperature	J:147483
Ache^tm4Pata/Ache^tm4Pata Prima1^tm1Vebe/Prima1^tm1Vebe (involves: 129X1/SvJ * C57BL/6 * DBA/2)	abnormal body temperature homeostasis	J:147425
Ackr1^tm1Scp/Ackr1^tm1Scp (involves: 129P2/OlaHsd)	abnormal circulating chemokine level	J:162629
Ackr1^tm1Skmz/Ackr1^tm1Skmz (involves: 129P2/OlaHsd * C57BL/6J)	abnormal chemokine level	J:82938
	abnormal homeostasis	J:82938
Ackr3^tm1.1Twb/Ackr3^tm1.1Twb (involves: 129S/SvEv * BALB/cJ * C57BL/6)	cyanosis	J:167833
Ackr3^tm1Jgo/Ackr3^tm1Jgo (involves: 129S/SvEvBrd * C57BL/6)	abnormal atrial thrombosis	J:136246
Ackr4^tm1.1Rjbn/Ackr4^tm1.1Rjbn (B6.129S6-Ackr4^tm1.1Rjbn)	abnormal chemokine level	J:166490
Ackr4^tm1.1Rjbn/Ackr4^tm1.1Rjbn (B6.129S6-Ackr4^tm1.1Rjbn)	abnormal circulating chemokine level	J:166490
Acmsd^{tm1b(EUCOMM)Hmgu}/Acmsd^{tm1b(EUCOMM)Hmgu} (C57BL/6N-Acmsd^{tm1b(EUCOMM)Hmgu}/Ieg)	decreased circulating bilirubin level	J:211773
Aco1^tm1Roua/Aco1^tm1Roua (involves: C57BL/6)	abnormal iron homeostasis	J:87889
Acot5^{tm1a(KOMP)Wtsi}/Acot5^{tm1a(KOMP)Wtsi} (C57BL/6N-Acot5^{tm1a(KOMP)Wtsi}/Wtsi)	increased circulating triglyceride level	J:211773
Acot7^tm1.1Mwol/Acot7^tm1.1Mwol Tg(Nes-cre)1Kln/0 (involves: C57BL/6 * SJL)	abnormal circulating lipid level	J:203753
	abnormal glucose homeostasis	J:203753
	abnormal lipid homeostasis	J:203753
	abnormal phospholipid level	J:203753
	decreased susceptibility to induced hypothermia	J:203753
	increased circulating free fatty acids level	J:203753
	increased circulating triglyceride level	J:203753
	increased energy expenditure	J:203753
	increased fatty acids level	J:203753
	increased liver triglyceride level	J:203753
	increased triglyceride level	J:203753
Acot11^tm1Deco/Acot11^tm1Deco (involves: 129S6/SvEvTac * C57BL/6)	decreased circulating cholesterol level	J:182660
	decreased circulating glucose level	J:182660
	decreased circulating HDL cholesterol level	J:182660
	decreased susceptibility to diet-induced obesity	J:182660
	improved glucose tolerance	J:182660
	increased circulating triglyceride level	J:182660
	increased energy expenditure	J:182660
	increased fatty acid oxidation	J:182660
	increased fatty acids level	J:182660
	increased oxygen consumption	J:182660
	increased respiratory quotient	J:182660
Acot12^em1Holi/Acot12^em1Holi (involves: C57BL/6J * C57BL/6N)	abnormal ion homeostasis	J:335836
	abnormal phospholipid level	J:335836
	increased circulating cholesterol level	J:335836
	increased circulating phospholipid level	J:335836
	increased liver cholesterol level	J:335836
	increased liver triglyceride level	J:335836
Acot13^tm1Deco/Acot13^tm1Deco (involves: 129 * C57BL/6)	abnormal gluconeogenesis	J:183258
	abnormal glucose homeostasis	J:183258
	abnormal lipid level	J:183258
	decreased circulating free fatty acids level	J:183258
	decreased circulating ketone body level	J:183258
	decreased liver cholesterol level	J:183258
	decreased liver triglyceride level	J:183258
	decreased oxygen consumption	J:183258
	decreased respiratory quotient	J:183258
	improved glucose tolerance	J:183258
Acot13^tm1Deco/Acot13^tm1Deco (Not Specified)	abnormal adaptive thermogenesis	J:204997
	abnormal circadian temperature homeostasis	J:204997
	increased core body temperature	J:204997
	increased energy expenditure	J:204997
	increased oxygen consumption	J:204997
	increased respiratory quotient	J:204997
Acox1^lampe1/Acox1^lampe1 (involves: C57BL/6J)	increased circulating alanine transaminase level	J:174942
Acox1^lampe1/Acox1^lampe1 (involves: C57BL/6J)	increased circulating alkaline phosphatase level	J:174942
Acox1^tm1Jkr/Acox1^tm1Jkr (involves: 129P2/OlaHsd * C57BL/6J)	hyperlipidemia	J:35794
Acox3^em1(IMPC)J/Acox3^em1(IMPC)J (C57BL/6NJ-Acox3^em1(IMPC)J/Mmjax)	impaired glucose tolerance	J:211773
	increased blood urea nitrogen level	J:211773
Acoxl^em1(IMPC)Mbp/Acoxl^em1(IMPC)Mbp (C57BL/6NCrl-Acoxl^em1(IMPC)Mbp/Mmucd)	improved glucose tolerance	J:211773
Acp6^{em1(IMPC)Hmgu}/Acp6⁺ (C57BL/6NCrl-Acp6^{em1(IMPC)Hmgu}/Ieg)	increased circulating serum albumin level	J:211773
Acsbg1^tm1Mld/Acsbg1^tm1Mld (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	decreased fatty acids level	J:150391
	increased circulating testosterone level	J:150391
	increased fatty acids level	J:150391
Acsf3^{em1(IMPC)Hmgu}/Acsf3^{em1(IMPC)Hmgu} (C57BL/6NCrl-Acsf3^{em1(IMPC)Hmgu}/Ieg)	increased circulating iron level	J:211773
Acsl1^tm1Rcol/Acsl1^tm1Rcol Speer6-ps1^{Tg(Alb-cre)21Mgn}/Speer6-ps1⁺ (involves: 129P2/OlaHsd * C57BL/6 * DBA)	abnormal lipid homeostasis	J:155714
Acsl1^tm1Rcol/Acsl1^tm1Rcol Tg(Fabp4-cre)1Rev/0 (involves: 129P2/OlaHsd * C57BL/6)	decreased circulating glycerol level	J:162996
	decreased fatty acid oxidation	J:162996
	hyperlipidemia	J:162996
	hypoglycemia	J:162996
	impaired adaptive thermogenesis	J:162996
	increased circulating free fatty acids level	J:162996
	increased circulating triglyceride level	J:162996
	increased fatty acids level	J:162996
	increased triglyceride level	J:162996
Acsl4^tm1Tty/Acsl4⁺ (involves: C57BL/6NCrj * CBA/JNCrj)	increased prostaglandin level	J:70023
Acsl5^{tm1.1(KOMP)Vlcg}/Acsl5^{tm1.1(KOMP)Vlcg} (C57BL/6N-Acsl5^{tm1.1(KOMP)Vlcg}/Ucd)	decreased circulating cholesterol level	J:211773
	decreased circulating glucose level	J:211773
	decreased circulating HDL cholesterol level	J:211773
	decreased circulating total protein level	J:211773
	decreased circulating triglyceride level	J:211773
	increased circulating bilirubin level	J:211773
Acsm2^{tm1.1(KOMP)Vlcg}/Acsm2^{tm1.1(KOMP)Vlcg} (B6N(Cg)-Acsm2^{tm1.1(KOMP)Vlcg}/J)	decreased circulating chloride level	J:211773
	decreased circulating glucose level	J:211773
Acss1^tm1Jsak/Acss1^tm1Jsak (B6.129-Acss1^tm1Jsak/Jsak)	abnormal blood homeostasis	J:146647
	abnormal body temperature homeostasis	J:146647
	abnormal carbon dioxide level	J:146647
	abnormal circulating free fatty acids level	J:146647
	decreased circulating leptin level	J:146647
	hypoglycemia	J:146647
	impaired adaptive thermogenesis	J:146647
Acta1^tm1Jll/Acta1^tm1Jll (involves: 129P2/OlaHsd * Black Swiss)	decreased glycogen level	J:78070
	decreased liver glycogen level	J:78070
	decreased skeletal muscle glycogen level	J:78070
Actb^tm1(INSR)Dac/Actb^tm1(INSR)Dac Insr^tm1Dac/Insr^tm1Dac (involves: 129S1/Sv * 129S4/SvJae * 129X1/SvJ)	increased circulating ketone body level	J:91350
Actb^tm1(INSR)Dac/Actb^tm1(INSR)Dac Insr^tm1Dac/Insr^tm1Dac Tg(Camk2a-cre)#Szi/? (involves: 129S1/Sv * 129S4/SvJae * 129X1/SvJ * C57BL/6J * CBA)	increased circulating glucose level	J:91350
	increased circulating insulin level	J:91350
Actb^tm1(INSR)Dac/Actb^tm1(INSR)Dac Insr^tm1Dac/Insr^tm1Dac Tg(Hsp70-1-cre)6Arge/? (involves: 129S1/Sv * 129S4/SvJae * 129X1/SvJ * C57BL/6 * CBA)	increased circulating glucose level	J:91350
	increased circulating insulin level	J:91350
Actb^tm1(INSR)Dac/Actb^tm1(INSR)Dac Insr^tm1Dac/Insr^tm1Dac Tg(Nes-cre)1Kln/? (involves: 129S1/Sv * 129S4/SvJae * 129X1/SvJ * C57BL/6 * SJL)	increased circulating glucose level	J:91350
	increased circulating insulin level	J:91350
Actb^tm1(INSR)Dac/Actb^tm1(INSR)Dac Insr^tm1Dac/Insr^tm1Dac Tg(Syn1-cre)671Jxm/? (involves: 129S1/Sv * 129S4/SvJae * 129X1/SvJ * C57BL/6 * CBA)	increased circulating glucose level	J:91350
	increased circulating insulin level	J:91350
Actb^{tm3.1(Sirt1)Npa}/Actb⁺ (involves: 129/Sv * C57BL/6 * C57BL/6J)	decreased circulating adiponectin level	J:160212
	decreased circulating cholesterol level	J:160212
	decreased circulating free fatty acids level	J:160212
	decreased circulating HDL cholesterol level	J:160212
	decreased circulating insulin level	J:160212
	decreased circulating LDL cholesterol level	J:160212
	decreased circulating leptin level	J:160212
	decreased fasting circulating glucose level	J:160212
	improved glucose tolerance	J:160212
	increased oxygen consumption	J:160212
Actb^{tm4(cre/ERT2)Npa}/Actb⁺ Sgpl1^tm1.1Npa/Sgpl1^tm1.1Npa (involves: BALB/cJ * C57BL/6)	abnormal lipid homeostasis	J:199525
Actc1^tm1Jll/Actc1^tm1Jll Tg(Myh6-Actg2)1Jll/0 (involves: 129P2/OlaHsd * Black Swiss * FVB/N)	abnormal cardiac thrombosis	J:40165
Actg2^em1(IMPC)J/Actg2^em1(IMPC)J (C57BL/6NJ-Actg2^em1(IMPC)J/J)	increased circulating creatinine level	J:211773
Actl6a^em1(IMPC)J/Actl6a⁺ (C57BL/6NJ-Actl6a^em1(IMPC)J/Mmjax)	decreased circulating bilirubin level	J:211773
	decreased circulating phosphate level	J:211773
Actl10^{tm1a(EUCOMM)Wtsi}/Actl10^{tm1a(EUCOMM)Wtsi} (C57BL/6N-Actl10^{tm1a(EUCOMM)Wtsi}/Wtsi)	decreased circulating fructosamine level	J:211773
Actn4^tm1.1Mrpk/Actn4^tm1.1Mrpk (involves: 129S4/SvJae * 129X1/SvJ)	increased urine protein level	J:90755
Actn4^{tm1a(EUCOMM)Wtsi}/Actn4^{tm1a(EUCOMM)Wtsi} (C57BL/6N-Actn4^{tm1a(EUCOMM)Wtsi}/Wtsi)	hemopericardium	J:239583
	subcutaneous edema	J:239583
Actn4^tm1Mrpk/Actn4^tm1Mrpk (involves: 129 * C57BL/6)	abnormal blood urea nitrogen level	J:83911
	albuminuria	J:118122, J:83911
	increased urine microalbumin level	J:83911
	increased urine protein level	J:90755
Actr3b^em1(IMPC)J/Actr3b^em1(IMPC)J (C57BL/6NJ-Actr3b^em1(IMPC)J/Mmjax)	decreased circulating calcium level	J:211773
Actr6^{tm1a(EUCOMM)Wtsi}/Actr6⁺ (C57BL/6N-Actr6^{tm1a(EUCOMM)Wtsi}/Wtsi)	increased circulating glycerol level	J:211773
Actr8^{tm1.1(KOMP)Vlcg}/Actr8⁺ (B6N(Cg)-Actr8^{tm1.1(KOMP)Vlcg}/J)	increased circulating sodium level	J:211773
Acvr1^{tm1.1(KOMP)Vlcg}/Acvr1⁺ (C57BL/6N-Acvr1^{tm1.1(KOMP)Vlcg}/MbpMmucd)	increased circulating total protein level	J:211773
Acvr1^tm1Emsh/Acvr1⁺ (chimera involves: BALB/c * C57BL/6 * CD-1)	edema	J:194134
Acvr2a^tm1Zuk/Acvr2a^tm1Zuk (either: 129 or (involves: 129S7/SvEvBrd * C57BL/6))	suppressed circulating follicle stimulating hormone level	J:23924
Acvr2b^tm1Enl/Acvr2b^tm1Enl (either: (involves: 129S4/SvJae) or (involves: 129S4/SvJae * C57BL/6J))	cyanosis	J:42018
Acvrl1^tm1Dgen/Acvrl1^tm1Dgen (involves: 129P2/OlaHsd * C57BL/6)	pericardial effusion	J:186473
Acvrl1^tm1Enl/Acvrl1⁺ (B6.Cg-Acvrl1^tm1Enl)	decreased circulating angiotensin II level	J:226550
	increased circulating adrenaline level	J:226550
	increased circulating noradrenaline level	J:226550
Acy1^em1(IMPC)J/Acy1^em1(IMPC)J (C57BL/6NJ-Acy1^em1(IMPC)J/J)	increased circulating bilirubin level	J:211773
Acy3^em1(IMPC)J/Acy3^em1(IMPC)J (C57BL/6NJ-Acy3^em1(IMPC)J/Mmjax)	abnormal cholesterol homeostasis	J:211773
	decreased circulating calcium level	J:211773
	decreased circulating total protein level	J:211773
	increased circulating creatinine level	J:211773
Acyp1^em1(IMPC)J/Acyp1^em1(IMPC)J (C57BL/6NJ-Acyp1^em1(IMPC)J/Mmjax)	increased circulating glucose level	J:211773
Ad/Ad (involves: Chr 7 marker stock * Wild stock)	abnormal protein level	J:6095
Ad/Ad (involves: Chr 7 marker stock * Wild stock)	increased circulating insulin level	J:6095
Ad/Ad⁺ (involves: Chr 7 marker stock * Wild stock)	abnormal protein level	J:6095
Ad/Ad⁺ (involves: Chr 7 marker stock * Wild stock)	increased circulating insulin level	J:6095
Ada^tm1Mw/Ada^tm1Mw (involves: 129S7/SvEvBrd * C57BL/6)	abnormal enzyme/coenzyme level	J:25085
	cyanosis	J:25085
	decreased circulating serum albumin level	J:25085
	decreased circulating total protein level	J:25085
Ada^tm1Mw/Ada^tm1Mw Tg(Afp-ADA)#Xiay/0 (involves: 129S7/SvEvBrd * C3H/HeJ * C57BL/6J)	increased urine protein level	J:234143
Ada^tm1Vlr/Ada^tm1Vlr (either: 129P2/OlaHsd-Ada^tm1Vlr or (involves: (129P2/OlaHsd * FVB/N))	cyanosis	J:26731
Adad1^em1(IMPC)J/Adad1⁺ (C57BL/6NJ-Adad1^em1(IMPC)J/J)	decreased circulating chloride level	J:211773
Adad1^em1(IMPC)J/Adad1⁺ (C57BL/6NJ-Adad1^em1(IMPC)J/J)	decreased circulating iron level	J:211773
Adad2^em1(IMPC)J/Adad2^em1(IMPC)J (C57BL/6NJ-Adad2^em1(IMPC)J/J)	decreased circulating glucose level	J:211773
Adam10^tm1Beni/Adam10^tm1Beni Adam17^tm1.1Srj/Adam17^tm1.1Srj Tg(Pf4-icre)Q3Rsko/0 (involves: 129/Sv * 129S/SvEv * C57BL/6)	abnormal platelet physiology	J:165863
Adam10^tm1Beni/Adam10^tm1Beni Tg(Pf4-icre)Q3Rsko/0 (involves: 129/Sv * C57BL/6)	abnormal platelet physiology	J:165863
Adam17^m1Btlr/Adam17^m1Btlr (C57BL/6J-Adam17^m1Btlr)	decreased circulating tumor necrosis factor level	J:166602
Adam17^m1Btlr/Adam17^m1Btlr (C57BL/6J-Adam17^m1Btlr)	decreased transforming growth factor beta level	J:166602
Adam17^tm1.1Srj/Adam17^tm1.1Srj (involves: 129S/SvEv * C57BL/6 * SJL)	abnormal chemokine level	J:163380
Adam17^tm1.1Srj/Adam17^tm1.1Srj (involves: 129S/SvEv)	abnormal platelet physiology	J:165863
Adam17^tm1.2Bbl/Adam17^tm1.2Bbl Sox9^tm3(cre)Crm/Sox9⁺ (involves: 129P2/OlaHsd * 129S7/SvEvBrd * C57BL/6)	increased circulating interleukin-17 level	J:144795
Adam17^tm1.2Bbl/Adam17^tm1.2Bbl Sox9^tm3(cre)Crm/Sox9⁺ (B6.129(SJL)-Sox9^tm3(cre)Crm Adam17^tm1.2Bbl)	abnormal circulating chemokine level	J:229771
	impaired skin barrier function	J:229771
Adam17^tm1Bbl/Adam17^tm1Bbl Lyz2^tm1(cre)Ifo/0 (involves: 129P2/OlaHsd)	decreased circulating tumor necrosis factor level	J:139846
Adam17^tm1Bbl/Adam17^tm1Bbl Tg(Mx1-cre)1Cgn/0 (involves: 129P2/OlaHsd * C57BL/6 * CBA)	decreased circulating tumor necrosis factor level	J:139846
Adam17^tm1Imx/Adam17^tm1Imx (involves: 129 * C57BL/6J)	nuchal edema	J:166217
Adam17^tm1Imx/Adam17^tm1Imx (involves: 129 * DBA/1J)	cyanosis	J:68672
Adam19^{Gt(Betageo)1Bbl}/Adam19^{Gt(Betageo)1Bbl} (involves: 129/Sv * 129P2/OlaHsd * C57BL/6)	edema	J:87592
Adam33^{tm1b(EUCOMM)Hmgu}/Adam33^{tm1b(EUCOMM)Hmgu} (C57BL/6N-Adam33^{tm1b(EUCOMM)Hmgu}/Ieg)	increased circulating creatinine level	J:211773
	increased circulating potassium level	J:211773
Adamdec1^tm1Dgen/Adamdec1^tm1Dgen (B6.129P2-Adamdec1^tm1Dgen)	decreased circulating interleukin-10 level	J:301741
	increased circulating interleukin-1 beta level	J:301741
	increased circulating interleukin-6 level	J:301741
Adamts1^tm1Hku/Adamts1^tm1Hku (involves: 129S6/SvEvTac * C57BL/6)	decreased urine chloride ion level	J:62260
	decreased urine potassium level	J:62260
	decreased urine sodium level	J:62260
Adamts2^tm1Prc/Adamts2^tm1Prc (involves: 129 * 129S1/Sv * 129X1/SvJ * C57BL/6)	abnormal homeostasis	J:271185
Adamts3^tm1.2Itl/Adamts3^tm1.2Itl (involves: BALB/cJ * C57BL/6NTac * SJL)	skin edema	J:245044
Adamts3^{tm1b(KOMP)Wtsi}/Adamts3^{tm1b(KOMP)Wtsi} (C57BL/6N-Adamts3^{tm1b(KOMP)Wtsi}/Wtsi)	hemopericardium	J:239583
	retropleural edema	J:239583
	subcutaneous edema	J:239583
Adamts6^b2b1879.1Clo/Adamts6^b2b1879.1Clo (C57BL/6J-Adamts6^b2b1879.1Clo)	hydrops fetalis	J:175213
Adamts6^b2b2029Clo/Adamts6^b2b2029Clo (C57BL/6J-Adamts6^b2b2029Clo)	hydrops fetalis	J:175213
Adamts6^b2b2182Clo/Adamts6^b2b2182Clo (C57BL/6J-Adamts6^b2b2182Clo)	hydrops fetalis	J:175213
Adamts6^b2b2187.1Clo/Adamts6^b2b2187.1Clo (C57BL/6J-Adamts6^b2b2187.1Clo)	hydrops fetalis	J:175213
Adamts6^b2b2228Clo/Adamts6^b2b2228Clo (C57BL/6J-Adamts6^b2b2228Clo)	hydrops fetalis	J:175213
Adamts6^b2b2405Clo/Adamts6^b2b2405Clo (C57BL/6J-Adamts6^b2b2405Clo)	hydrops fetalis	J:175213
Adamts6^b2b2407Clo/Adamts6^b2b2407Clo (C57BL/6J-Adamts6^b2b2407Clo)	hydrops fetalis	J:175213
Adamts6^b2b2744Clo/Adamts6^b2b2744Clo (C57BL/6J-Adamts6^b2b2744Clo)	hydrops fetalis	J:175213
Adamts6^b2b2966.2Clo/Adamts6^b2b2966.2Clo (C57BL/6J-Adamts6^b2b2966.2Clo)	hydrops fetalis	J:175213
Adamts6^em1(IMPC)Mbp/Adamts6^em1(IMPC)Mbp (C57BL/6N-Adamts6^em1(IMPC)Mbp/MbpMmucd)	edema	J:211773
Adamts7^{tm1a(KOMP)Wtsi}/Adamts7^{tm1a(KOMP)Wtsi} (involves: C57BL/6N)	abnormal triglyceride level	J:230573
	increased oxygen consumption	J:230573
Adamts7^{tm1a(KOMP)Wtsi}/Adamts7^{tm1a(KOMP)Wtsi} (C57BL/6-Adamts7^{tm1a(KOMP)Wtsi})	increased collagen level	J:221183
Adamts13^s/Adamts13^s (129.B6-Adamts13^s)	increased susceptibility to induced thrombosis	J:148975
Adamts13^tm1Dgi/Adamts13^tm1Dgi (involves: 129X1/SvJ * C57BL/6J * CASA/Rk)	abnormal platelet physiology	J:101752
	abnormal thrombosis	J:101752
	increased circulating von Willebrand factor level	J:101752
Adamts13^tm1Dgi/Adamts13^tm1Dgi (B6.129X1-Adamts13^tm1Dgi)	increased susceptibility to induced thrombosis	J:133469
Adamts13^tm1Dgi/Adamts13^tm1Dgi Vwf^tm1Wgr/Vwf^tm1Wgr (B6.129-Adamts13^tm1Dgi Vwf^tm1Wgr)	decreased susceptibility to induced thrombosis	J:133469
Adamts13^tm1Myta/Adamts13^tm1Myta (involves: 129S6/SvEvTac)	abnormal blood coagulation	J:125786
	abnormal platelet activation	J:125786
	abnormal thrombosis	J:125786
Adamts14^{Gt(511E11)Cmhd}/Adamts14^{Gt(511E11)Cmhd} Adamts2^tm1Prc/Adamts2^tm1Prc (involves: 129 * 129S1/Sv * 129X1/SvJ * C57BL/6)	abnormal homeostasis	J:271185
Adamts15^{tm1.1(KOMP)Vlcg}/Adamts15^{tm1.1(KOMP)Vlcg} (C57BL/6N-Adamts15^{tm1.1(KOMP)Vlcg}/Ucd)	increased circulating insulin level	J:211773
Adamts16^em1(IMPC)H/Adamts16^em1(IMPC)H (C57BL/6N-Adamts16^em1(IMPC)H/H)	decreased circulating potassium level	J:211773
	increased circulating HDL cholesterol level	J:211773
Adamts17^tm1.2Taks/Adamts17^tm1.2Taks (involves: C57BL * C57BL/6 * DBA)	increased collagen level	J:295274
Adamtsl2^{tm1b(KOMP)Wtsi}/Adamtsl2^{tm1b(KOMP)Wtsi} (C57BL/6-Adamtsl2^{tm1b(KOMP)Wtsi})	cyanosis	J:221347
Adar^em1Stsn/Adar^tm1Olds (involves: 129S/SvEv * C57BL/6J)	abnormal homeostasis	J:308678
	decreased circulating serum albumin level	J:308678
	increased circulating alkaline phosphatase level	J:308678
Adar^em1Stsn/Adar^tm1Olds Eif2ak2^tm1Jcbe/Eif2ak2^tm1Jcbe (involves: 129S/SvEv * 129S4/SvJae * C57BL/6J)	abnormal homeostasis	J:308678
Adar^em3Qwan/Adar^em3Qwan (Not Specified)	abnormal chemokine level	J:325221
	increased circulating interleukin-1 level	J:325221
	increased circulating interleukin-6 level	J:325221
	increased circulating interleukin-17 level	J:325221
	increased CXCL10 level	J:325221
Adar^{tm1b(EUCOMM)Wtsi}/Adar⁺ (B6N(Cg)-Adar^{tm1b(EUCOMM)Wtsi}/J)	decreased circulating glucose level	J:211773
Adar^tm1Knk/Adar^tm1Knk Speer6-ps1^{Tg(Alb-cre)21Mgn}/Speer6-ps1⁺ (involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * DBA)	abnormal circulating enzyme level	J:87714
	hyperglycemia	J:87714
	increased circulating alanine transaminase level	J:87714
	increased circulating alkaline phosphatase level	J:87714
	increased circulating aspartate transaminase level	J:87714
	increased circulating lactate dehydrogenase level	J:87714
Adar^tm2Phs/Adar^tm2Phs (B6.Cg-Adar^tm2Phs)	abnormal circulating interferon-beta level	J:142338
Adar^tm2Phs/Adar^tm2Phs (B6.Cg-Adar^tm2Phs)	increased circulating interferon-alpha level	J:142338
Adck2^{tm1(KOMP)Vlcg}/Adck2⁺ (C57BL/6-Adck2^{tm1(KOMP)Vlcg})	abnormal enzyme/coenzyme level	J:280282
	abnormal homeostasis	J:280282
	decreased circulating carnitine level	J:280282
	decreased circulating free fatty acids level	J:280282
	decreased fatty acid beta-oxidation	J:280282
	decreased glycerol level	J:280282
	increased carbon dioxide production	J:280282
	increased circulating lactate level	J:280282
	increased fatty acids level	J:280282
	increased liver free fatty acids level	J:280282
	increased oxygen consumption	J:280282
	increased respiratory quotient	J:280282
	organic aciduria	J:280282
Adck2^{tm1.1(KOMP)Vlcg}/Adck2^{tm1.1(KOMP)Vlcg} (B6N(Cg)-Adck2^{tm1.1(KOMP)Vlcg}/J)	increased circulating potassium level	J:211773
Adcy1^{tm1b(EUCOMM)Wtsi}/Adcy1^{tm1b(EUCOMM)Wtsi} (C57BL/6N-Adcy1^{tm1b(EUCOMM)Wtsi}/H)	improved glucose tolerance	J:211773
	increased circulating creatine kinase level	J:211773
	increased circulating phosphate level	J:211773
Adcy2^{tm1a(KOMP)Wtsi}/Adcy2^{tm1a(KOMP)Wtsi} (C57BL/6N-Adcy2^{tm1a(KOMP)Wtsi}/Wtsi)	increased circulating HDL cholesterol level	J:211773
Adcy3^Jll/Adcy3⁺ (C57BL/6J-Adcy3^Jll)	decreased susceptibility to diet-induced obesity	J:223554
Adcy3^Jll/Adcy3⁺ (involves: 129S1/SvImJ * C57BL/6J)	decreased circulating glucose level	J:223554
	decreased circulating insulin level	J:223554
	decreased circulating leptin level	J:223554
	decreased susceptibility to diet-induced obesity	J:223554
	increased oxygen consumption	J:223554
Adcy3^Jll/Adcy3^Jll (involves: 129S1/SvImJ * C57BL/6J)	decreased susceptibility to diet-induced obesity	J:223554
Adcy3^tm1.1Dek/Adcy3^tm1.1Dek Adcy6^tm1.1Dek/Adcy6^tm1.1Dek Tg(AQP2-cre)2Dek/0 (involves: 129X1/SvJ * C57BL/6 * CBA)	decreased urine osmolality	J:207417
	decreased urine potassium level	J:207417
	decreased urine sodium level	J:207417
Adcy3^tm1Drs/Adcy3^tm1Drs (involves: 129X1/SvJ * C57BL/6)	decreased circulating renin level	J:144961
Adcy3^tm1Drs/Adcy3^tm1Drs (involves: 129X1/SvJ * C57BL/6)	increased circulating creatinine level	J:144961
Adcy3^tm2.1Drs/Adcy3^tm2.1Drs Ndor1^{Tg(UBC-cre/ERT2)1Ejb}/Ndor1⁺ (involves: 129 * 129X1/SvJ * C57BL/6)	increased circulating corticosterone level	J:281839
Adcy6^{tm1.1(KOMP)Vlcg}/Adcy6^{tm1.1(KOMP)Vlcg} (C57BL/6N-Adcy6^{tm1.1(KOMP)Vlcg}/Ucd)	increased blood urea nitrogen level	J:211773
	increased circulating alkaline phosphatase level	J:211773
Adcy6^tm1.1Dek/Adcy6^tm1.1Dek Tg(Aqp2-cre)1Dek/0 (involves: 129X1/SvJ * C57BL/6 * SJL)	decreased urine osmolality	J:180012
Adcy6^tm1Hkh/Adcy6^tm1Hkh (involves: 129S1/Sv * 129X1/SvJ)	abnormal calcium ion homeostasis	J:143138
Adcy6^tm1Yich/Adcy6^tm1Yich (involves: 129S6/SvEvTac)	abnormal renal water reabsorption	J:161317
	decreased urine chloride ion level	J:161317
	decreased urine osmolality	J:161317
	decreased urine potassium level	J:161317
	decreased urine sodium level	J:161317
	decreased urine urea nitrogen level	J:161317
Adcy6^tm2Yich/Adcy6^tm2Yich (involves: 129S6/SvEvTac)	abnormal renal water reabsorption	J:161317
	decreased urine chloride ion level	J:161317
	decreased urine creatinine level	J:161317
	decreased urine osmolality	J:161317
	decreased urine potassium level	J:161317
	decreased urine sodium level	J:161317
	decreased urine urea nitrogen level	J:161317
Adcy8^tm1Ljm/Adcy8^tm1Ljm (involves: 129S1/Sv * 129X1/SvJ * Black Swiss)	abnormal corticosterone level	J:63173
Adcy9^{tm1b(EUCOMM)Wtsi}/Adcy9⁺ (C57BL/6N-Adcy9^{tm1b(EUCOMM)Wtsi}/Wtsi)	decreased circulating chloride level	J:211773
	increased circulating insulin level	J:211773
Adcy9^{tm1b(EUCOMM)Wtsi}/Adcy9^{tm1b(EUCOMM)Wtsi} (C57BL/6N-Adcy9^{tm1b(EUCOMM)Wtsi}/Wtsi)	retropleural edema	J:239583
Adcy10^tm1Lex/Adcy10^tm1Lex (involves: 129S5/SvEvBrd * C57BL/6J)	increased circulating cholesterol level	J:103485
	increased triglyceride level	J:103485
Adcyap1^tm1Eid/Adcyap1^tm1Eid (involves: 129S4/SvJae * C57BL/6)	decreased adrenaline level	J:73702
	decreased circulating adrenaline level	J:73702
	hypoglycemia	J:73702
Adcyap1^tm1Nms/Adcyap1^tm1Nms (either: (involves: 129S1/Sv * 129X1/SvJ * C57BL/6) or (involves: C57BL/6))	decreased liver glycogen level	J:71968
	hypoglycemia	J:71968
	impaired adaptive thermogenesis	J:79468
	increased circulating cholesterol level	J:71968
	increased circulating corticosterone level	J:71968
	increased circulating free fatty acids level	J:71968
	increased circulating insulin level	J:71968
	increased circulating ketone body level	J:71968
	increased circulating triglyceride level	J:71968
Adcyap1^tm1Nms/Adcyap1^tm1Nms (B6.129-Adcyap1^tm1Nms)	decreased circulating progesterone level	J:131950
Adcyap1^tm1Nms/Adcyap1^tm1Nms (B6.129-Adcyap1^tm1Nms)	decreased circulating prolactin level	J:131950
Adcyap1r1^tm1Bbt/Adcyap1r1^tm1Bbt (involves: 129 * C57BL/6J)	decreased circulating insulin level	J:62115
	impaired glucose tolerance	J:62115
	increased circulating insulin level	J:62115
Add2^tm1Feb/Add2^tm1Feb (B6.129-Add2^tm1Feb)	increased circulating bilirubin level	J:63047
Add2^tm1Llp/Add2^tm1Llp (involves: 129S4/SvJae * C57BL/6J)	increased kidney iron level	J:71029
	increased liver iron level	J:71029
	increased spleen iron level	J:71029
Adgra1^tm1.1Zgwg/Adgra1^tm1.1Zgwg (Not Specified)	abnormal adaptive thermogenesis	J:329982
	decreased fasting circulating glucose level	J:329982
	increased carbon dioxide production	J:329982
	increased energy expenditure	J:329982
	increased oxygen consumption	J:329982
Adgra1^{tm1b(EUCOMM)Hmgu}/Adgra1^{tm1b(EUCOMM)Hmgu} (B6N(Cg)-Adgra1^{tm1b(EUCOMM)Hmgu}/J)	improved glucose tolerance	J:211773
Adgrb1^tm1Egvm/Adgrb1^tm1Egvm (involves: 129S6/SvEvTac * C57BL/6)	abnormal protein level	J:222100
Adgrb1^{tm2a(EUCOMM)Wtsi}/Adgrb1^{tm2a(EUCOMM)Wtsi} (C57BL/6N-Adgrb1^{tm2a(EUCOMM)Wtsi}/Wtsi)	decreased circulating serum albumin level	J:211773
	increased circulating chloride level	J:211773
	increased circulating insulin level	J:211773
Adgrf5^m1Btlr/Adgrf5^m1Btlr (C57BL/6J-Adgrf5^m1Btlr)	increased circulating glucose level	J:225045
Adgrf5^tm1.1Bstc/Adgrf5^tm1.2Bstc Tg(Sftpc-cre)1Blh/0 (involves: 129S4/SvJae * C57BL/6 * C57BL/6J * DBA/2)	pulmonary alveolar proteinosis	J:196943
Adgrf5^tm1.1Bstc/Adgrf5^tm1.2Bstc Tg(SFTPC-rtTA)5Jaw/0 Tg(tetO-cre)1Jaw/0 (involves: 129S4/SvJae * C57BL/6 * C57BL/6J)	abnormal lipid level	J:196943
	increased cholesterol level	J:196943
Adgrf5^tm1.2Bstc/Adgrf5^tm1.2Bstc (involves: 129S4/SvJae * C57BL/6J)	abnormal lipid level	J:196943
	increased cholesterol level	J:196943
	pulmonary alveolar proteinosis	J:196943
Adgrf5^{tm1b(KOMP)Wtsi}/Adgrf5^{tm1b(KOMP)Wtsi} (C57BL/6N-Adgrf5^{tm1b(KOMP)Wtsi}/Tcp)	decreased circulating cholesterol level	J:211773
	increased fasting circulating glucose level	J:211773
Adgrg2^tm1Bend/Y (involves: 129P2/OlaHsd * C57BL/6)	abnormal fluid regulation	J:93019
Adgrg5^{tm1b(EUCOMM)Wtsi}/Adgrg5^{tm1b(EUCOMM)Wtsi} (C57BL/6N-Adgrg5^{tm1b(EUCOMM)Wtsi}/BayMmucd)	increased circulating amylase level	J:211773
Adgrg6^tm1Apr/Adgrg6^tm1Apr (either: 129S/SvEv-Gpr126^tm1Apr or B6.129S-Gpr126^tm1Apr or (involves: 129S/SvEv * MF1))	edema	J:167309
Adgrg6^tm1Taki/Adgrg6^tm1Taki (involves: C57BL/6)	increased cardiac muscle triglyceride level	J:202002
Adgrg6^tm1Taki/Adgrg6^tm1Taki (involves: C57BL/6)	pericardial edema	J:202002
Adgrl3^{Gt(S17-5H1)Sor}/Adgrl3^{Gt(S17-5H1)Sor} (involves: 129S4/SvJaeSor * C57BL/6)	decreased circulating calcium level	J:259247
	increased dopamine level	J:185872
	increased serotonin level	J:185872
Adh7^tm1Gdu/Adh7^tm1Gdu (involves: 129S1/Sv * 129X1/SvJ * Black Swiss)	abnormal vitamin A level	J:55555
Adh7^tm1Gdu/Adh7^tm1Gdu (B6.129(Cg)-Adh7^tm1Gdu)	increased dopamine level	J:167234
Adig^{tm1.1(KOMP)Vlcg}/Adig^{tm1.1(KOMP)Vlcg} (B6J.B6N-Adig^{tm1.1(KOMP)Vlcg})	decreased circulating insulin level	J:304292
	decreased circulating leptin level	J:304292
	decreased susceptibility to diet-induced obesity	J:304292
	improved glucose tolerance	J:304292
	increased energy expenditure	J:304292
	increased insulin sensitivity	J:304292
Adig^{tm1.1(KOMP)Vlcg}/Adig^{tm1.1(KOMP)Vlcg} Lep^ob/Lep^ob (B6.Cg-Adig^{tm1.1(KOMP)Vlcg} Lep^ob)	impaired glucose tolerance	J:304292
Adip1^LG/J/? Capn10^tm1Chev/Capn10⁺ ((B6.129-Capn10^tm1Chev x LG/J)F1)	decreased circulating cholesterol level	J:153477
	decreased circulating free fatty acids level	J:153477
	decreased circulating glucose level	J:153477
	decreased circulating triglyceride level	J:153477
	increased circulating leptin level	J:153477
Adip1^SM/J/? Capn10^tm1Chev/Capn10⁺ ((B6.129-Capn10^tm1Chev x SM/J)F1)	decreased circulating cholesterol level	J:153477
	decreased circulating free fatty acids level	J:153477
	decreased circulating glucose level	J:153477
	decreased circulating triglyceride level	J:153477
Adipoq^tm1Chan/Adipoq⁺ (B6.129-Adipoq^tm1Chan)	decreased circulating adiponectin level	J:122020
Adipoq^tm1Chan/Adipoq⁺ Tg(MMTV-PyVT)634Mul/0 (B6.Cg-Adipoq^tm1Chan Tg(MMTV-PyVT)634Mul)	decreased circulating adiponectin level	J:147458
Adipoq^tm1Chan/Adipoq⁺ Tg(MMTV-PyVT)634Mul/0 (FVB.Cg-Adipoq^tm1Chan Tg(MMTV-PyVT)634Mul)	decreased circulating adiponectin level	J:147458
Adipoq^tm1Chan/Adipoq^tm1Chan (B6.129-Adipoq^tm1Chan)	abnormal nitric oxide homeostasis	J:122020
	decreased circulating adiponectin level	J:122020
	decreased fatty acid beta-oxidation	J:79122
Adipoq^tm1Chan/Adipoq^tm1Chan (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	albuminuria	J:136297
Adipoq^tm1Chan/Adipoq^tm1Chan (involves: 129S1/Sv * 129X1/SvJ)	abnormal lipid homeostasis	J:138678
Adipoq^tm1Far/Adipoq^tm1Far (involves: C57BL/6J)	impaired glucose tolerance	J:111346
Adipoq^tm1Far/Adipoq^tm1Far (involves: 129S4/SvJae * C57BL/6J)	impaired glucose tolerance	J:111346
	increased circulating glucose level	J:111346
	increased liver triglyceride level	J:111346
Adipoq^tm1Far/Adipoq^tm1Far Dgat1^tm1Far/Dgat1^tm1Far (involves: 129S4/SvJae * C57BL/6J)	abnormal glucose tolerance	J:111346
	decreased circulating glucose level	J:111346
	decreased circulating leptin level	J:111346
	decreased liver cholesterol level	J:111346
	decreased liver triglyceride level	J:111346
	increased oxygen consumption	J:111346
Adipoq^tm1Ish/Adipoq⁺ Bglap/Bglap2^tm1Kry/Bglap⁺ (involves: 129S7/SvEvBrd)	decreased circulating adiponectin level	J:126780
	insulin resistance	J:126780
Adipoq^tm1Ish/Adipoq⁺ Bglap/Bglap2^tm1Kry/Bglap2⁺ (involves: 129S7/SvEvBrd)	decreased circulating adiponectin level	J:126780
	insulin resistance	J:126780
Adipoq^tm1Ish/Adipoq^tm1Ish (involves: 129S7/SvEvBrd * C57BL/6J)	abnormal energy homeostasis	J:199264
	abnormal gas homeostasis	J:199264
	abnormal glucose homeostasis	J:199264
	abnormal hormone level	J:199264
	abnormal lipid level	J:77479
	abnormal urine homeostasis	J:199264
	decreased insulin secretion	J:199264
	hyperglycemia	J:77479, J:103106
	impaired glucose tolerance	J:199264
	increased adiponectin level	J:199264
	increased carbon dioxide production	J:199264
	increased circulating adiponectin level	J:199264
	increased circulating free fatty acids level	J:77479
	increased circulating glucose level	J:106599
	increased circulating insulin level	J:77479
	increased circulating osteocalcin level	J:199264
	increased energy expenditure	J:199264
	increased noradrenaline level	J:199264
	increased oxygen consumption	J:199264
	increased susceptibility to diet-induced obesity	J:103106
	increased urine adrenaline level	J:199264
	insulin resistance	J:77479
	pulmonary edema	J:106599
Adipoq^tm1Ish/Adipoq^tm1Ish Lep^ob/Lep^ob (involves: 129S7/SvEvBrd * C57BL/6J)	decreased carbon dioxide production	J:199264
	decreased energy expenditure	J:199264
	decreased oxygen consumption	J:199264
	impaired glucose tolerance	J:199264
	increased circulating glucose level	J:199264
	increased urine adrenaline level	J:199264
Adipoq^tm1Pesch/Adipoq^tm1Pesch (involves: 129S7/SvEvBrd)	abnormal gluconeogenesis	J:107486
Adipoq^tm1Pesch/Adipoq^tm1Pesch (involves: 129S7/SvEvBrd)	impaired glucose tolerance	J:107486
Adipoq^tm1Pesch/Adipoq^tm1Pesch (B6.129S7-Adipoq^tm1Pesch)	decreased susceptibility to induced hypothermia	J:210480
	increased core body temperature	J:210480
	increased energy expenditure	J:210480
	increased oxygen consumption	J:210480
Adipoq^tm1Pesch/Adipoq^tm1Pesch Lep^ob/Lep^ob (involves: 129S7/SvEvBrd * C57BL/6J)	impaired glucose tolerance	J:107486
Adipoq^tm1Tka/Adipoq⁺ (involves: 129S4/SvJae * C57BL/6)	impaired glucose tolerance	J:77876
Adipoq^tm1Tka/Adipoq⁺ (involves: 129S4/SvJae * C57BL/6)	insulin resistance	J:77876
Adipoq^tm1Tka/Adipoq^tm1Tka (involves: 129S4/SvJae * C57BL/6)	impaired glucose tolerance	J:77876
	increased circulating triglyceride level	J:77876
	insulin resistance	J:77876
Adipor1^{tm1b(EUCOMM)Hmgu}/Adipor1^{tm1b(EUCOMM)Hmgu} (C57BL/6N-Adipor1^{tm1b(EUCOMM)Hmgu}/H)	decreased circulating calcium level	J:211773
	increased blood urea nitrogen level	J:211773
	increased circulating alanine transaminase level	J:211773
	increased circulating cholesterol level	J:211773
	increased circulating HDL cholesterol level	J:211773
	increased circulating phosphate level	J:211773
Adipor1^{tm1b(EUCOMM)Hmgu}/Adipor1^{tm1b(EUCOMM)Hmgu} (C57BL/6N-Adipor1^{tm1b(EUCOMM)Hmgu}/Orl)	decreased circulating alkaline phosphatase level	J:211773
	decreased circulating calcium level	J:211773
	increased circulating phosphate level	J:211773
	increased circulating triglyceride level	J:211773
Adipor1^tm1Dgen/Adipor1^tm1Dgen (B6.129P2-Adipor1^tm1Dgen/Mmnc)	abnormal lipid homeostasis	J:122027
	decreased energy expenditure	J:122027
	impaired glucose tolerance	J:122027
	increased circulating cholesterol level	J:122027
	increased circulating leptin level	J:122027
	increased liver triglyceride level	J:122027
Adipor1^tm1Dgen/Adipor1^tm1Dgen (involves: 129P2/OlaHsd)	abnormal adaptive thermogenesis	J:210480
	decreased adiponectin level	J:210480
	decreased circulating adiponectin level	J:210480
	impaired adaptive thermogenesis	J:210480
Adipor1^tm1Tka/Adipor1^tm1Tka (involves: 129S4/SvJae * C57BL/6)	abnormal glucose homeostasis	J:117919
	hyperglycemia	J:117919
	impaired glucose tolerance	J:117919
	increased circulating glucose level	J:117919
	increased circulating insulin level	J:117919
	insulin resistance	J:117919
Adipor1^tm1Tka/Adipor1^tm1Tka Adipor2^tm1Tka/Adipor2^tm1Tka (involves: 129S4/SvJae * C57BL/6)	abnormal circulating glucose level	J:117919
	abnormal gluconeogenesis	J:117919
	abnormal glucose homeostasis	J:117919
	hyperglycemia	J:117919
	impaired glucose tolerance	J:117919
	increased liver triglyceride level	J:117919
	insulin resistance	J:117919
Adipor1^tm2Tka/Adipor1^tm2Tka Tg(Ckmm-cre)5Khn/0 (B6.Cg-Adipor1^tm2Tka Tg(Ckmm-cre)5Khn)	abnormal glucose homeostasis	J:159462
	decreased oxygen consumption	J:159462
	increased circulating glucose level	J:159462
	increased circulating insulin level	J:159462
	increased skeletal muscle triglyceride level	J:159462
	insulin resistance	J:159462
Adipor2^tm1Dgen/Adipor2^tm1Dgen (B6.129P2-Adipor2^tm1Dgen)	abnormal hormone level	J:122027
	abnormal lipid homeostasis	J:122027
	decreased circulating cholesterol level	J:122027
	decreased circulating HDL cholesterol level	J:122027
	decreased circulating insulin level	J:122027
	decreased liver triglyceride level	J:122027
	decreased susceptibility to diet-induced obesity	J:122027
	improved glucose tolerance	J:122027
	increased circulating adiponectin level	J:122027
	increased energy expenditure	J:122027
Adipor2^tm1Dgen/Adipor2^tm1Dgen (B6.129P2-Adipor2^tm1Dgen/J)	abnormal adaptive thermogenesis	J:210480
	impaired adaptive thermogenesis	J:210480
Adipor2^tm1Tka/Adipor2^tm1Tka (involves: 129S4/SvJae * C57BL/6)	abnormal glucose homeostasis	J:117919
	hyperglycemia	J:117919
	impaired glucose tolerance	J:117919
	increased circulating insulin level	J:117919
	insulin resistance	J:117919
Adipor2^tm2Dgen/Adipor2^tm2Dgen (involves: 129P2/OlaHsd * C57BL/6)	abnormal glucose homeostasis	J:129554
	decreased circulating cholesterol level	J:129554
	decreased circulating HDL cholesterol level	J:129554
	decreased circulating insulin level	J:129554
	decreased circulating LDL cholesterol level	J:129554
	decreased circulating triglyceride level	J:129554
	decreased circulating VLDL cholesterol level	J:129554
	decreased susceptibility to diet-induced obesity	J:129554
	increased circulating adiponectin level	J:129554
	increased circulating glucose level	J:129554
Adissp^{tm1c(EUCOMM)Hmgu}/Adissp^{tm1c(EUCOMM)Hmgu} Tg(Adipoq-cre)1Evdr/0 (involves: C57BL/6J * C57BL/6N * FVB/NJ)	impaired adaptive thermogenesis	J:332979
	impaired glucose tolerance	J:332979
	increased circulating glucose level	J:332979
	increased fasting circulating glucose level	J:332979
	increased susceptibility to diet-induced obesity	J:332979
	insulin resistance	J:332979
Adk^tm1Bois/Adk^tm1Bois (involves: 129P3/JEmsJ * C57BL/6)	abnormal body temperature homeostasis	J:81518
Adk^tm1Bois/Adk^tm1Bois (involves: 129P3/JEmsJ * C57BL/6)	abnormal homeostasis	J:81518
Adm^tm1Hku/Adm^tm1Hku (involves: 129S6/SvEvTac * C57BL/6)	hydrops fetalis	J:89608
Adm^tm1Hku/Adm^tm1Hku (involves: 129S6/SvEvTac * C57BL/6)	pericardial effusion	J:89608
Adm^tm1Unc/Adm^tm1Unc (involves: 129S6/SvEvTac)	hydrops fetalis	J:67044, J:106927
Adm^tm1Unc/Adm^tm1Unc (129S6/SvEvTac-Adm^tm1Unc)	edema	J:130930
Adm^tm1Unc/Adm^tm1Unc (129S6/SvEvTac-Adm^tm1Unc)	lymphedema	J:130930
Adnp2^em3(IMPC)Tcp/Adnp2^em3(IMPC)Tcp (C57BL/6NCrl-Adnp2^em3(IMPC)Tcp/Tcp)	decreased circulating total protein level	J:211773
Adora1^tm1Bbf/Adora1^tm1Bbf (involves: 129P2/OlaHsd * C57BL)	abnormal body temperature homeostasis	J:70664
Adora1^tm1Jgsc/Adora1^tm1Jgsc (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	increased circulating creatinine level	J:127544
Adora2a^em1(IMPC)H/Adora2a^em1(IMPC)H (C57BL/6N-Adora2a^em1(IMPC)H/H)	increased circulating alanine transaminase level	J:211773
	increased circulating aspartate transaminase level	J:211773
	increased circulating glucose level	J:211773
Adora2a^tm1Map/Adora2a^tm1Map (involves: 129S1/Sv * 129X1/SvJ * CD-1)	increased platelet aggregation	J:42276
Adora2b^{tm1.1(KOMP)Vlcg}/Adora2b⁺ (B6N(Cg)-Adora2b^{tm1.1(KOMP)Vlcg}/J)	increased fasting circulating glucose level	J:211773
Adora2b^{tm1.1(KOMP)Vlcg}/Adora2b^{tm1.1(KOMP)Vlcg} (B6N(Cg)-Adora2b^{tm1.1(KOMP)Vlcg}/J)	decreased circulating glucose level	J:211773
	increased circulating alkaline phosphatase level	J:211773
Adora2b^tm1Kra/Adora2b^tm1Kra (involves: 129 * C57BL/6J)	abnormal cytokine level	J:111715
	abnormal interleukin level	J:111715
	abnormal tumor necrosis factor level	J:111715
	increased circulating interleukin-6 level	J:111715
Adora2b^tm1Till/Adora2b^tm1Till (B6.129P2-Adora2b^tm1Till)	impaired adaptive thermogenesis	J:125297
Adora3^tm1Jbsn/Adora3^tm1Jbsn (B6.129P2-Adora3^tm1Jbsn)	decreased circulating creatinine level	J:82054
Adprm^{tm1b(EUCOMM)Hmgu}/Adprm^{tm1b(EUCOMM)Hmgu} (C57BL/6N-Adprm^{tm1b(EUCOMM)Hmgu}/Ieg)	decreased respiratory quotient	J:211773
Adprs^{em1(IMPC)Wtsi}/Adprs^{em1(IMPC)Wtsi} (C57BL/6N-Adprs^{em1(IMPC)Wtsi}/WtsiIeg)	increased circulating alkaline phosphatase level	J:211773
Adra1b^tm1Cta/Adra1b^tm1Cta (involves: 129P2/OlaHsd * C57BL/6J)	abnormal glucose homeostasis	J:87718
	decreased circulating free fatty acids level	J:87718
	decreased skeletal muscle glycogen level	J:87718
	hyperglycemia	J:87718
	impaired glucose tolerance	J:87718
	increased circulating insulin level	J:87718
	increased circulating leptin level	J:87718
	increased liver glycogen level	J:87718
	increased susceptibility to diet-induced obesity	J:87718
	insulin resistance	J:87718
Adra1b^tm1Cta/Adra1b^tm1Cta (involves: 129 * C57BL/6J)	decreased circulating testosterone level	J:125763
Adra1b^tm1Cta/Adra1b^tm1Cta (involves: 129 * C57BL/6J)	increased circulating luteinizing hormone level	J:125763
Adra2a^m1Btlr/Adra2a^m1Btlr (C57BL/6J-Adra2a^m1Btlr)	decreased circulating glucose level	J:267700
Adra2a^m1Btlr/Adra2a^m1Btlr (C57BL/6J-Adra2a^m1Btlr)	increased circulating insulin level	J:267700
Adra2a^m2Btlr/Adra2a^m2Btlr (C57BL/6J-Adra2a^m2Btlr)	decreased circulating glucose level	J:267701
Adra2a^{tm1.1(KOMP)Vlcg}/Adra2a^{tm1.1(KOMP)Vlcg} (C57BL/6N-Adra2a^{tm1.1(KOMP)Vlcg}/Ucd)	decreased fasting circulating glucose level	J:211773
	improved glucose tolerance	J:211773
Adra2a^tm1Bkk/Adra2a^tm1Bkk (involves: 129S1/Sv * 129X1/SvJ)	abnormal glucose homeostasis	J:130781
	hypoglycemia	J:130781
Adra2b^tm1Gsb/Adra2b^tm1Gsb (B6.129-Adra2b^tm1Gsb)	cyanosis	J:166788
Adrb1^tm1Bkk/Adrb1^tm1Bkk Adrb2^tm1Bkk/Adrb2^tm1Bkk (involves: 129S1/Sv * 129X1/SvJ * C57BL/6J * DBA/2 * FVB/N)	decreased oxygen consumption	J:55553
Adrb1^tm1Bkk/Adrb1^tm1Bkk Adrb2^tm1Bkk/Adrb2^tm1Bkk Adrb3^tm1Lowl/Adrb3^tm1Lowl (involves: 129S1/Sv * 129X1/SvJ * C57BL/6J * DBA/2 * FVB/N)	decreased oxygen consumption	J:79309
	impaired adaptive thermogenesis	J:79309
	increased circulating leptin level	J:79309
Adrb2^tm1Bkk/Adrb2^tm1Bkk (FVB.129-Adrb2^tm1Bkk)	decreased respiratory quotient	J:55552
Adrb2^tm1Kry/Adrb2⁺ Lep^ob/Lep⁺ Tg(Col1a1-cre)1Kry/0 (involves: C57BL/6 * C57BL/10J * FVB)	decreased circulating glucose level	J:145998
	increased circulating insulin level	J:145998
Adrb2^tm1Kry/Adrb2^tm1Kry Tg(Col1a1-cre)1Kry/0 (involves: FVB)	abnormal insulin secretion	J:145998
	decreased circulating glucose level	J:145998
	increased circulating insulin level	J:145998
Adrm1^{Gt(OST128063)Lex}/Adrm1^{Gt(OST128063)Lex} (involves: 129S5/SvEvBrd * C57BL/6J)	increased circulating follicle stimulating hormone level	J:166694
	increased circulating growth hormone level	J:166694
Ads4^NZB/Ads4^NZB (involves: NZB * NZW)	increased urine protein level	J:11074
Adss2^{tm1b(EUCOMM)Wtsi}/Adss2⁺ (C57BL/6N-Adss2^{tm1b(EUCOMM)Wtsi}/Bay)	decreased blood urea nitrogen level	J:211773
	decreased circulating creatinine level	J:211773
	increased circulating HDL cholesterol level	J:211773
Adtrp^em1Sagh/Adtrp^em1Sagh (involves: C57BL/6)	increased fatty acids level	J:289837
Adtrp^em1Sagh/Adtrp^em1Sagh Aig1^em1Sagh/Aig1^em1Sagh (involves: C57BL/6)	increased fatty acids level	J:289837
Adtrp^tm1.1Clu/Adtrp^tm1.1Clu (involves: 129S4/SvJaeSor * C57BL/6)	increased bleeding time	J:295059
	skin edema	J:295059
Aebp1^tm1Hsro/Aebp1^tm1Hsro (involves: 129S4/SvJae * C57BL/6J)	decreased circulating cholesterol level	J:125333
	decreased circulating triglyceride level	J:125333
	decreased susceptibility to diet-induced obesity	J:125333
Aec1^NOD/Uf/Aec1^NOD/Uf Aec2^NOD/Uf/Aec2^NOD/Uf (B6.NOD-Aec2^NOD/Uf Aec1^NOD/Uf)	decreased salivation	J:128900, J:129282, J:129916
Afap1l2^{tm1b(KOMP)Wtsi}/Afap1l2^{tm1b(KOMP)Wtsi} (C57BL/6N-Afap1l2^{tm1b(KOMP)Wtsi}/Ucd)	improved glucose tolerance	J:211773
	increased circulating alkaline phosphatase level	J:211773
Aff3^{tm1a(EUCOMM)Wtsi}/Aff3^{tm1a(EUCOMM)Wtsi} (C57BL/6N-Aff3^{tm1a(EUCOMM)Wtsi}/Wtsi)	decreased circulating fructosamine level	J:211773
	decreased circulating serum albumin level	J:211773
	increased circulating alkaline phosphatase level	J:211773
	increased circulating chloride level	J:211773
Aff4^em1(IMPC)Mbp/Aff4^em1(IMPC)Mbp (C57BL/6N-Aff4^em1(IMPC)Mbp/MbpMmucd)	edema	J:211773
Afmid^{tm1a(EUCOMM)Wtsi}/Afmid^{tm1a(EUCOMM)Wtsi} (C57BL/6N-Afmid^{tm1a(EUCOMM)Wtsi}/H)	hyperglycemia	J:226537
Afmid^{tm1b(EUCOMM)Wtsi}/Afmid⁺ (C57BL/6N-Afmid^{tm1b(EUCOMM)Wtsi}/H)	impaired glucose tolerance	J:226537
Afmid^{tm1b(EUCOMM)Wtsi}/Afmid^{tm1b(EUCOMM)Wtsi} (C57BL/6N-Afmid^{tm1b(EUCOMM)Wtsi}/H)	abnormal urine homeostasis	J:226537
	decreased insulin secretion	J:226537
	impaired glucose tolerance	J:226537
	increased circulating fructosamine level	J:226537
	increased circulating glucose level	J:211773, J:226537
Afp^{tm1(Cebpa)Ndw}/Afp⁺ (involves: 129S7/SvEvBrd)	increased liver glycogen level	J:103404
Afp^tm1Ibmm/Afp^tm1Ibmm (either: (involves: 129P2/OlaHsd * C57BL/6) or (involves: 129P2/OlaHsd * CD-1))	decreased circulating progesterone level	J:79500
	increased circulating follicle stimulating hormone level	J:79500
	increased circulating luteinizing hormone level	J:79500
Afp^tm2Ibmm/Afp^tm2Ibmm (either: (involves: 129P2/OlaHsd * C57BL/6) or (involves: 129P2/OlaHsd * CD-1))	decreased circulating progesterone level	J:79500
	increased circulating follicle stimulating hormone level	J:79500
	increased circulating luteinizing hormone level	J:79500
Aftph^em1(IMPC)J/Aftph⁺ (C57BL/6NJ-Aftph^em1(IMPC)J/Mmjax)	decreased circulating phosphate level	J:211773
Aga^tm1Pltn/Aga^tm1Pltn (involves: 129S4/SvJae * C57BL/6)	aspartylglucosaminuria	J:45587
Aga^tm1Vk/Aga^tm1Vk (involves: 129S1/Sv * 129X1/SvJ * Black Swiss)	abnormal urine homeostasis	J:37022, J:60272
	aspartylglucosaminuria	J:37022
	colorless urine	J:91114
Agap1^{tm1a(EUCOMM)Wtsi}/Agap1^{tm1a(EUCOMM)Wtsi} (C57BL/6N-Agap1^{tm1a(EUCOMM)Wtsi}/Wtsi)	increased circulating alkaline phosphatase level	J:211773
	increased circulating potassium level	J:211773
Agap2^tm1.1Kye/Agap2^tm1.1Kye (Not Specified)	abnormal gluconeogenesis	J:174775
	hyperglycemia	J:174775
	increased insulin sensitivity	J:174775
	insulin resistance	J:174775
Agap2^tm1Kye/Agap2^tm1Kye Speer6-ps1^{Tg(Alb-cre)21Mgn}/Speer6-ps1⁺ (involves: C57BL/6 * DBA/2)	abnormal gluconeogenesis	J:174775
	decreased circulating triglyceride level	J:174775
	decreased liver cholesterol level	J:174775
	decreased liver free fatty acids level	J:174775
	decreased liver triglyceride level	J:174775
	hyperglycemia	J:174775
	impaired glucose tolerance	J:174775
	increased circulating insulin level	J:174775
	insulin resistance	J:174775
Agbl4^em1(IMPC)Mbp/Agbl4^em1(IMPC)Mbp (C57BL/6NCrl-Agbl4^em1(IMPC)Mbp/Mmucd)	increased circulating bilirubin level	J:211773
Agbl4^{Tn(pb-Act-RFP)1.080115015-HRAZhu}/Agbl4^{Tn(pb-Act-RFP)1.080115015-HRAZhu} (involves: FVB/N)	abnormal hemostasis	J:233744
	abnormal platelet physiology	J:233744
	decreased platelet aggregation	J:233744
	increased bleeding time	J:233744
Ager^tm1.1Arnd/Ager^tm1.1Arnd (involves: 129P2/OlaHsd * C57BL/6)	increased circulating glucose level	J:82491
Ager^tm1.1Arnd/Ager^tm1.1Arnd (B6.129P2-Ager^tm1.1Arnd)	decreased circulating interleukin-6 level	J:104998
Ager^tm1.1Hyam/Ager⁺ Tg(Ins2-Nos2)40Okam/0 (involves: 129P2/OlaHsd * C57BL/6 * CD-1 * DBA/2)	hyperglycemia	J:116040
Ager^tm1.1Hyam/Ager^tm1.1Hyam (involves: 129P2/OlaHsd * C57BL/6J * CD-1)	abnormal blood homeostasis	J:116507
	increased circulating glucose level	J:116507
Ager^tm1.1Hyam/Ager^tm1.1Hyam Tg(Ins2-Nos2)40Okam/0 (involves: 129P2/OlaHsd * C57BL/6 * CD-1 * DBA/2)	albuminuria	J:116040
	decreased circulating creatinine level	J:116040
	hyperglycemia	J:116040
Agl^{tm1a(EUCOMM)Wtsi}/Agl^{tm1a(EUCOMM)Wtsi} (involves: C57BL/6N)	hypoglycemia	J:212003
	increased cardiac muscle glycogen level	J:212003
	increased circulating alanine transaminase level	J:212003
	increased circulating alkaline phosphatase level	J:212003
	increased circulating aspartate transaminase level	J:212003
	increased circulating creatine kinase level	J:212003
	increased liver glycogen level	J:212003
	increased skeletal muscle glycogen level	J:212003
Agl^{tm1b(EUCOMM)Wtsi}/Agl^{tm1b(EUCOMM)Wtsi} (C57BL/6N-Agl^{tm1b(EUCOMM)Wtsi}/H)	decreased circulating glucose level	J:211773
	impaired glucose tolerance	J:211773
	increased circulating alanine transaminase level	J:211773
	increased circulating alkaline phosphatase level	J:211773
	increased circulating amylase level	J:211773
	increased circulating aspartate transaminase level	J:211773
	increased circulating bilirubin level	J:211773
	increased circulating cholesterol level	J:211773
	increased circulating creatine kinase level	J:211773
	increased circulating iron level	J:211773
	increased fasting circulating glucose level	J:211773
Agl^tm1Geno/Agl^tm1Geno (C57BL/6J-Agl^tm1Geno)	decreased circulating glucose level	J:218471
	decreased fasting circulating glucose level	J:218471
	increased brain glycogen level	J:218471
	increased cardiac muscle glycogen level	J:218471
	increased circulating alanine transaminase level	J:218471
	increased circulating alkaline phosphatase level	J:218471
	increased circulating aspartate transaminase level	J:218471
	increased circulating creatine kinase level	J:218471
	increased glycogen level	J:218471
	increased liver glycogen level	J:218471
	increased skeletal muscle glycogen level	J:218471
Agmo^{tm2a(EUCOMM)Wtsi}/Agmo^{tm2a(EUCOMM)Wtsi} (involves: C57BL/6N)	decreased circulating cholesterol level	J:308367
Ago2^tm1.1Tara/Ago2^tm1.1Tara Lep^ob/Lep^ob Tg(Ins2-cre)23Herr/0 (involves: 129P2/OlaHsd * C57BL/6J * CBA/J)	decreased circulating glucose level	J:210552
	decreased circulating insulin level	J:210552
	improved glucose tolerance	J:210552
	increased circulating insulin level	J:210552
Ago2^tm1.1Tara/Ago2^tm1.1Tara Tg(Ins2-cre)23Herr/0 (involves: 129P2/OlaHsd * C57BL/6J * CBA/J)	improved glucose tolerance	J:210552
Ago2^tm1Ghan/Ago2^tm1Ghan (involves: C57BL/6)	pericardial edema	J:93081
Agpat1^{tm1.1(KOMP)Vlcg}/Agpat1⁺ (B6N(Cg)-Agpat1^{tm1.1(KOMP)Vlcg}/J)	decreased circulating calcium level	J:211773
	decreased circulating chloride level	J:211773
	decreased circulating glucose level	J:211773
	increased circulating alanine transaminase level	J:211773
	increased circulating alkaline phosphatase level	J:211773
	increased circulating potassium level	J:211773
	increased urine glucose level	J:211773
	increased urine microalbumin level	J:211773
Agpat1^tm1Garg/Agpat1^tm1Garg (involves: 129S6/SvEvTac * C57BL/6)	decreased circulating glucose level	J:250301
	decreased circulating insulin-like growth factor I level	J:250301
	decreased circulating leptin level	J:250301
	hypoglycemia	J:250301
	impaired gluconeogenesis	J:250301
	increased circulating follicle stimulating hormone level	J:250301
	increased circulating luteinizing hormone level	J:250301
Agpat2^{Gt(OST438470)Lex}/Agpat2^{Gt(OST438470)Lex} (involves: 129S5/SvEvBrd * C57BL/6)	hyperglycemia	J:186035
	increased circulating glucose level	J:186035
	increased circulating insulin level	J:186035
Agpat2^tm1Garg/Agpat2^tm1Garg (involves: 129S6/SvEvTac)	abnormal fatty acids level	J:146649
	abnormal gas homeostasis	J:146649
	abnormal glucose homeostasis	J:146649
	abnormal lipid homeostasis	J:146649
	abnormal phospholipid level	J:146649
	decreased body temperature	J:146649
	decreased circulating free fatty acids level	J:146649
	decreased circulating leptin level	J:146649
	decreased respiratory quotient	J:146649
	hyperglycemia	J:146649
	improved glucose tolerance	J:231617
	increased carbon dioxide production	J:146649
	increased circulating cholesterol level	J:231617
	increased circulating glucose level	J:231617
	increased circulating insulin level	J:231617, J:146649
	increased circulating triglyceride level	J:146649
	increased liver triglyceride level	J:231617, J:146649
	increased oxygen consumption	J:146649
	insulin resistance	J:231617, J:146649
Agpat2^tm1Garg/Agpat2^tm1Garg Mogat1^tm1Far/Mogat1^tm1Far (involves: 129S4/SvJae * 129S6/SvEvTac)	improved glucose tolerance	J:231617
	increased circulating glucose level	J:231617
	increased circulating insulin level	J:231617
	increased liver triglyceride level	J:231617
	insulin resistance	J:231617
Agpat3^{tm1a(EUCOMM)Wtsi}/Agpat3⁺ (B6JTyr;B6N-Agpat3^{tm1a(EUCOMM)Wtsi}/Wtsi)	decreased circulating alanine transaminase level	J:175295
	decreased circulating aspartate transaminase level	J:175295
	decreased lactate dehydrogenase level	J:175295
Agpat3^{tm1a(EUCOMM)Wtsi}/Agpat3^{tm1a(EUCOMM)Wtsi} (involves: C57BL/6N)	abnormal phospholipid level	J:245638
Agpat3^{tm1a(EUCOMM)Wtsi}/Agpat3^{tm1a(EUCOMM)Wtsi} (involves: C57BL/6J * C57BL/6N)	abnormal phospholipid level	J:246569
Agpat4^{tm1b(KOMP)Wtsi}/Agpat4^{tm1b(KOMP)Wtsi} (C57BL/6N-Agpat4^{tm1b(KOMP)Wtsi}/H)	increased fasting circulating glucose level	J:211773
Agpat4^tm1Lex/Agpat4^tm1Lex (B6;129S5-Agpat4^tm1Lex/Mmucd)	abnormal phospholipid level	J:231388
Agps^bs2/Agps^bs2 (STOCK Agps^bs2/J)	abnormal lipid level	J:171265
Agr2^tm1.1Lex/Agr2^tm1.1Lex (involves: 129S5/SvEvBrd * BALB/cJ * C57BL/6)	decreased circulating serum albumin level	J:195573
Agrp^tm1(cre)Lowl/Agrp⁺ Slc32a1^tm1Lowl/Slc32a1^tm1Lowl (involves: 129S6/SvEvTac * C57BL/6)	decreased respiratory quotient	J:140858
	decreased susceptibility to diet-induced obesity	J:140858
	increased oxygen consumption	J:140858
Agrp^tm1Dgen/Agrp^tm1Dgen (involves: 129P2/OlaHsd * C57BL/6)	decreased circulating ketone body level	J:199803
	decreased circulating VLDL triglyceride level	J:199803
	decreased liver triglyceride level	J:199803
	increased noradrenaline level	J:199803
Agrp^tm1Mws/Agrp^tm1Mws (B6.129S1-Agrp^tm1Mws)	abnormal blood homeostasis	J:117539
	abnormal energy expenditure	J:117539
	decreased cholesterol level	J:117539
	decreased circulating leptin level	J:117539
	decreased respiratory quotient	J:117539
	increased circulating thyroxine level	J:117539
	increased circulating triiodothyronine level	J:117539
	increased core body temperature	J:117539
Agrp^tm1Sqn/Agrp^tm1Sqn (involves: 129S7/SvEvBrd * C57BL/6J)	abnormal energy expenditure	J:116654
	impaired adaptive thermogenesis	J:116654
Agrp^{tm2(HBEGF)Rpa}/Agrp⁺ Lep^ob/Lep^ob (involves: 129S4/SvJaeSor * C57BL/6)	decreased body temperature	J:181947
	improved glucose tolerance	J:181947
Agrp^{tm2(HBEGF)Rpa}/Agrp⁺ Tph2^tm1Mscl/Tph2^tm1Mscl (involves: 129S4/SvJaeSor * 129S6/SvEvTac * C57BL/6 * C57BL/6NCr)	decreased serotonin level	J:182577
Agt^tm1.1Itl/Agt^tm1.1Itl Tg(Fabp4-cre)1Rev/0 (involves: C57BL/6 * C57BL/6J * C57BL/6NTac * SJL)	decreased circulating angiotensinogen level	J:178836
Agt^tm1Afu/Agt⁺ (involves: C57BL/6 * CBA * ICR)	abnormal blood homeostasis	J:21887
Agt^tm1Afu/Agt⁺ (involves: C57BL/6 * CBA * ICR)	decreased circulating angiotensinogen level	J:21887
Agt^tm1Afu/Agt^tm1Afu (involves: C57BL/6 * CBA * ICR)	abnormal blood homeostasis	J:73163
	abnormal enzyme/coenzyme level	J:38494
	decreased circulating angiotensinogen level	J:21887
	increased circulating renin level	J:73163, J:36820
Agt^tm1Afu/Agt^tm1Afu (involves: C57BL/6 * CBA)	decreased circulating aldosterone level	J:46506
	decreased urine aldosterone level	J:46506
	decreased urine osmolality	J:46506
	decreased urine potassium level	J:46506
	decreased urine sodium level	J:46506
	increased circulating antidiuretic hormone level	J:46506
	increased urine antidiuretic hormone level	J:46506
Agt^tm1Afu/Agt^tm1Afu Tg(Fabp4-Agt)2Mte/0 (involves: C57BL/6 * CBA * DBA/2 * ICR)	decreased circulating angiotensinogen level	J:73163
Agt^tm1Ii/Agt^tm1Ii (involves: 129P2/OlaHsd * C57BL/6)	decreased urine osmolality	J:140022
Agt^tm1Ii/Agt^tm1Ii (involves: 129P2/OlaHsd * C57BL/6)	increased circulating creatinine level	J:140022
Agt^tm1Unc/Agt⁺ (involves: 129P2/OlaHsd * C57BL/6J)	decreased circulating angiotensinogen level	J:18272, J:24156
Agt^tm1Unc/Agt⁺ (involves: 129P2/OlaHsd * C57BL/6J)	increased circulating renin level	J:24156
Agt^tm1Unc/Agt^tm1Unc (involves: 129P2/OlaHsd * C57BL/6J)	decreased circulating angiotensinogen level	J:24156
Agt^tm1Unc/Agt^tm2Unc (involves: 129P2/OlaHsd * C57BL/6J)	decreased circulating angiotensinogen level	J:24156
Agt^tm2Unc/Agt⁺ (involves: 129P2/OlaHsd * C57BL/6J)	increased circulating angiotensinogen level	J:18272, J:24156
Agt^tm2Unc/Agt^tm2Unc (involves: 129P2/OlaHsd * C57BL/6J)	increased circulating angiotensinogen level	J:24156
Agtr1a^tm1.1Cof/Agtr1a^tm1.1Cof Hprt1^{tm1(Pck1-cre)Vhh}/Hprt1⁺ (involves: 129 * 129P2/OlaHsd)	abnormal renal water reabsorption	J:172240
Agtr1a^tm1Afu/Agtr1a^tm1Afu (involves: C57BL/6 * CBA * ICR)	increased circulating renin level	J:28041
Agtr1a^tm1Ecl/Agtr1a^tm1Ecl (involves: 129S2/SvPas * C57BL/6)	abnormal blood homeostasis	J:124206
	decreased circulating angiotensin II level	J:124206
	decreased circulating renin level	J:124206
	decreased urine creatinine level	J:124206
	decreased urine potassium level	J:124206
	increased blood urea nitrogen level	J:124206
	increased urine osmolality	J:124206
Agtr1a^tm1Unc/Agtr1a^tm1Unc Agtr1b^tm1Cof/Agtr1b^tm1Cof (involves: 129P2/OlaHsd * C57BL/6)	abnormal circulating protein level	J:137944
Agtr1a^tm1Unc/Agtr1a^tm1Unc Agtr2^tm1Tin/Y (involves: 129P2/OlaHsd * C57BL/6)	abnormal circulating protein level	J:137944
Agtr1a^tm1Unc/Agtr1a^tm1Unc Agtr2^tm1Tin/Agtr2^tm1Tin (involves: 129P2/OlaHsd * C57BL/6)	abnormal circulating protein level	J:137944
Agtr1a^tm1Unc/Agtr1a^tm1Unc Hprt1^{tm1(Ggt1-Agtr1)Cof}/Y (involves: 129P2/OlaHsd)	decreased urine osmolality	J:91837
Agtr2^{tm1a(EUCOMM)Wtsi}/Agtr2^{tm1a(EUCOMM)Wtsi} (B6JTyr;B6N-Agtr2^{tm1a(EUCOMM)Wtsi}/Wtsi)	decreased circulating alanine transaminase level	J:175295
	decreased circulating LDL cholesterol level	J:175295
Agtr2^tm1Tin/Y (involves: 129P2/OlaHsd * C57BL/6)	abnormal aldosterone level	J:102984
	abnormal corticosterone level	J:102984
	decreased body temperature	J:29457
	increased adrenaline level	J:102984
	increased circulating adrenocorticotropin level	J:102984
	increased circulating corticosterone level	J:102984
	increased noradrenaline level	J:102984
Agtr2^tm1Tin/Y (involves: 129P2/OlaHsd)	abnormal circulating insulin level	J:105210
	abnormal circulating leptin level	J:105210
	abnormal glucose homeostasis	J:105210
	abnormal lipid homeostasis	J:105210
	abnormal respiratory quotient	J:105210
	abnormal skeletal muscle triglyceride level	J:105210
	abnormal urine homeostasis	J:60075
	abnormal urine sodium level	J:60075
	decreased susceptibility to diet-induced obesity	J:105210
	increased energy expenditure	J:105210
	increased insulin sensitivity	J:105210
Agtr2^tm1Tin/Agtr2^tm1Tin (involves: 129P2/OlaHsd * C57BL/6)	abnormal aldosterone level	J:102984
	abnormal corticosterone level	J:102984
	increased adrenaline level	J:102984
	increased circulating adrenocorticotropin level	J:102984
	increased circulating corticosterone level	J:102984
	increased noradrenaline level	J:102984
Agtr2^tm1Tin/Agtr2^tm1Tin (involves: 129P2/OlaHsd)	abnormal urine homeostasis	J:60075
Agtr2^tm1Tin/Agtr2^tm1Tin (involves: 129P2/OlaHsd)	abnormal urine sodium level	J:60075
Agtrap^Gt(XE129)Byg/Agtrap^Gt(XE129)Byg (involves: 129P2/OlaHsd)	abnormal blood homeostasis	J:185854
	decreased urine pH	J:185854
Agtrap^tm1Tamk/Agtrap^tm1Tamk (involves: C57BL/6N)	increased circulating free fatty acids level	J:263253
	increased circulating insulin level	J:263253
	increased circulating serum albumin level	J:263253
	increased circulating triglyceride level	J:263253
	insulin resistance	J:263253
Agxt2^tm1Lex/Agxt2^tm1Lex (involves: 129S5/SvEvBrd * C57BL/6)	increased circulating citrulline level	J:207876
Agxt^tm1Ull/Agxt^tm1Ull (B6.129X1-Agxt^tm1Ull)	crystalluria	J:117145
Agxt^tm1Ull/Agxt^tm1Ull (B6.129X1-Agxt^tm1Ull)	hyperoxaluria	J:117145
Agxt^tm1Ull/Agxt^tm1Ull (involves: 129X1/SvJ * C57BL/6J)	hyperoxaluria	J:283585
Agxt^tm1Ull/Agxt^tm1Ull Prodh2^em1Jkni/Prodh2^em1Jkni (involves: 129X1/SvJ * C57BL/6J)	abnormal urine homeostasis	J:283585
	hyperoxaluria	J:283585
Ahcy^em1Cya/Ahcy⁺ (C57BL/6N-Ahcy^em1Cya/Cya)	abnormal nitric oxide homeostasis	J:298071
Ahcyl1^{tm1a(EUCOMM)Wtsi}/Ahcyl1^{tm1a(EUCOMM)Wtsi} (C57BL/6N-Ahcyl1^{tm1a(EUCOMM)Wtsi}/Wtsi)	increased circulating alkaline phosphatase level	J:211773
	increased circulating thyroxine level	J:211773
Ahi1^tm1Jgg/Ahi1⁺ Lrp6^Gt(Ex187)Byg/Lrp6⁺ (involves: 129P2/OlaHsd * 129S1/Sv * 129X1/SvJ)	increased circulating creatinine level	J:154321
Ahi1^tm1Jgg/Ahi1^tm1Jgg Tg(TCF/Lef1-lacZ)34Efu/0 (involves: 129S1/Sv * 129X1/SvJ)	decreased circulating serum albumin level	J:154321
	increased circulating creatinine level	J:154321
Ahnak^{tm1b(KOMP)Mbp}/Ahnak⁺ (C57BL/6N-Ahnak^{tm1b(KOMP)Mbp}/H)	improved glucose tolerance	J:211773
Ahnak^tm1Ysb/Ahnak^tm1Ysb (involves: 129S4/SvJae)	decreased susceptibility to diet-induced obesity	J:167048
Ahr^b-1/Ahr^b-1 Aip^tm2.1Bra/Aip^tm2.1Bra Speer6-ps1^{Tg(Alb-cre)21Mgn}/Speer6-ps1⁺ (B6.Cg-Speer6-ps1^{Tg(Alb-cre)21Mgn} Aip^tm2.1Bra)	abnormal circulating alanine transaminase level	J:166864
Ahr^tm1Bra/Ahr^tm1Bra (B6.129-Ahr^tm1Bra/J)	abnormal chemokine level	J:118646
	abnormal cytokine level	J:118646
	abnormal interleukin level	J:118646
	abnormal tumor necrosis factor level	J:118646
	pulmonary alveolar edema	J:100359
	pulmonary edema	J:100359
Ahr^tm1Bra/Ahr^tm1Bra (B6.129-Ahr^tm1Bra)	abnormal circulating hormone level	J:126176
Ahr^tm1Gonz/Ahr^tm1Gonz (involves: 129S4/SvJae * C57BL/6N)	abnormal atrial thrombosis	J:44690
Ahr^tm1Gonz/Ahr^tm1Gonz (involves: 129S4/SvJae * C57BL/6N)	abnormal thrombosis	J:44690
Ahr^tm1Yfk/Ahr^tm1Yfk (involves: 129S/SvEv * C57BL/6J)	increased urine uric acid level	J:179919
Ahrr^{tm1b(KOMP)Wtsi}/Ahrr⁺ (B6N(Cg)-Ahrr^{tm1b(KOMP)Wtsi}/J)	decreased circulating HDL cholesterol level	J:211773
Ahsg^tm1Mbl/Ahsg^tm1Mbl (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	abnormal blood homeostasis	J:44632
Ahsg^tm1Mbl/Ahsg^tm1Mbl (B6.129-Ahsg^tm1Mbl)	decreased circulating free fatty acids level	J:78087
	decreased circulating insulin level	J:78087
	decreased circulating triglyceride level	J:78087
	decreased susceptibility to diet-induced obesity	J:78087
	improved glucose tolerance	J:78087
	increased insulin sensitivity	J:78087
Aida^tm1.1Scli/Aida^tm1.1Scli (involves: C57BL/6 * FVB/N)	abnormal lipid homeostasis	J:262001
	hyperglycemia	J:262001
	increased circulating insulin level	J:262001
	increased circulating triglyceride level	J:262001
	increased liver glycogen level	J:262001
	increased respiratory quotient	J:262001
	increased susceptibility to diet-induced obesity	J:262001
	increased triglyceride level	J:262001
	insulin resistance	J:262001
Aif1^{tm1.1(KOMP)Wtsi}/Aif1^{tm1.1(KOMP)Wtsi} (C57BL/6N-Aif1^{tm1.1(KOMP)Wtsi}/Ieg)	decreased blood urea nitrogen level	J:211773
Aifm1^Hq/Y (B6CBACa A^w-J/A-Aifm1^Hq/J)	increased superoxide dismutase level	J:144096
Aifm1^Hq/Aifm1^Hq (B6CBACa A^w-J/A-Aifm1^Hq/J)	increased superoxide dismutase level	J:144096
Aifm1^tm2Pngr/Y Foxg1^tm1(cre)Skm/Foxg1⁺ (involves: 129P2/OlaHsd)	abnormal enzyme/coenzyme level	J:112874
Aifm1^tm2Pngr/Y Tg(Ckmm-cre)5Khn/0 (involves: 129P2/OlaHsd * FVB)	abnormal glucose homeostasis	J:113016
	abnormal hormone level	J:113016
	increased circulating lactate level	J:113016
Aifm3^{em1(IMPC)Rbrc}/Aifm3^{em1(IMPC)Rbrc} (C57BL/6NJcl-Aifm3^{em1(IMPC)Rbrc}/Rbrc)	abnormal cholesterol homeostasis	J:211773
	abnormal circulating LDL cholesterol level	J:211773
	increased circulating aspartate transaminase level	J:211773
	increased fasting circulating glucose level	J:211773
Aim2^{em1(IMPC)Ccpcz}/Aim2^{em1(IMPC)Ccpcz} (C57BL/6N-Aim2^{em1(IMPC)Ccpcz}/Ccpcz)	increased circulating serum albumin level	J:211773
	increased circulating total protein level	J:211773
Aim2^{Gt(CSG445)Byg}/Aim2^{Gt(CSG445)Byg} (involves: 129P2/OlaHsd * C57BL/6)	decreased circulating interleukin-18 level	J:158969
Aim2^tm1.2Arte/Aim2^tm1.2Arte Dnase2a^tm1Osa/Dnase2a^tm1Osa Ifnar1^tm1Agt/Ifnar1^tm1Agt (involves: 129 * BALB/c * C57BL/6 * C57BL/6J)	increased circulating interleukin-10 level	J:238323
	increased circulating tumor necrosis factor level	J:238323
Aim2^tm1Ktak/Aim2^tm1Ktak (involves: 129S4/SvJae * C57BL/6)	decreased circulating interleukin-18 level	J:188013
Aip^tm1Bra/Aip^tm1Bra (involves: 129S4/SvJaeSor * C57BL/6)	pericardial edema	J:141575
Aire^{tm1.1(NCOM)Mfgc}/Aire⁺ (C57BL/6N-Aire^{tm1.1(NCOM)Mfgc}/Tcp)	abnormal cholesterol homeostasis	J:211773
Aire^tm1Mand/Aire⁺ (NOD.129P2-Aire^tm1Mand)	abnormal chemokine level	J:188686
Aire^tm1Mand/Aire⁺ (NOD.129P2-Aire^tm1Mand)	increased CXCL10 level	J:188686
Aire^tm1Ptsn/Aire^tm1Ptsn (C.B6-Aire^tm1Ptsn)	abnormal cytokine level	J:174653
Ajap1^{tm1b(EUCOMM)Hmgu}/Ajap1^{tm1b(EUCOMM)Hmgu} (B6N(Cg)-Ajap1^{tm1b(EUCOMM)Hmgu}/J)	increased circulating alanine transaminase level	J:211773
	increased circulating aspartate transaminase level	J:211773
	increased circulating chloride level	J:211773
	increased circulating potassium level	J:211773
	increased circulating sodium level	J:211773
	increased circulating total protein level	J:211773
Ak1^tm1Bew/Ak1^tm1Bew (involves: 129P2/OlaHsd * C57BL/6)	abnormal energy expenditure	J:66101
Ak1^tm1Bew/Ak1^tm1Bew (involves: 129P2/OlaHsd * C57BL/6)	abnormal glucose homeostasis	J:66101
Ak4^{em1(IMPC)Kmpc}/Ak4^{em1(IMPC)Kmpc} (C57BL/6NTac-Ak4^{em1(IMPC)Kmpc}/Kmpc)	increased circulating cholesterol level	J:211773
	increased circulating LDL cholesterol level	J:211773
Ak7^{em1(IMPC)Ccpcz}/Ak7⁺ (C57BL/6NCrl-Ak7^{em1(IMPC)Ccpcz}/Ccpcz)	decreased circulating potassium level	J:211773
Akap5^tm1.1Jsco/Akap5^tm1.1Jsco (involves: 129S * C57BL/6)	decreased circulating insulin level	J:190017
	decreased insulin secretion	J:190017
	improved glucose tolerance	J:190017
	increased insulin sensitivity	J:190017
Akap5^tm1Gsm/Akap5^tm1Gsm (involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)	decreased circulating insulin level	J:190017
Akap5^tm1Jsco/Akap5^tm1Jsco Tg(Ins2-cre)25Mgn/0 (involves: 129S * C57BL/6 * DBA)	decreased circulating insulin level	J:190017
	impaired glucose tolerance	J:190017
	increased insulin secretion	J:190017
Akap5^tm1Mdaq/Akap5^tm1Mdaq (involves: 129 * C57BL/6 * C57BL/6J)	decreased circulating insulin level	J:190017
	decreased insulin secretion	J:190017
	improved glucose tolerance	J:190017
	increased insulin sensitivity	J:190017
Akap8^Gt(XG068)Byg/Akap8^Gt(XG068)Byg Fign^fi/Fign^fi (involves: 129P2/OlaHsd * 129S1/SvImJ * C57BL/6)	cyanosis	J:116474
Akap8l^em1(IMPC)J/Akap8l^em1(IMPC)J (C57BL/6NJ-Akap8l^em1(IMPC)J/Mmjax)	increased circulating alanine transaminase level	J:211773
Akap9^{tm1a(KOMP)Wtsi}/Akap9⁺ (B6JTyr;B6N-Akap9^{tm1a(KOMP)Wtsi}/Wtsi)	decreased circulating calcium level	J:175295
	decreased circulating cholesterol level	J:175295
	decreased circulating fructosamine level	J:175295
	decreased circulating HDL cholesterol level	J:175295
	decreased circulating LDL cholesterol level	J:175295
	decreased circulating serum albumin level	J:175295
	decreased circulating total protein level	J:175295
	increased circulating fructosamine level	J:175295
Akap9^{tm1a(KOMP)Wtsi}/Akap9⁺ (involves: C57BL/6 * C57BL/6N)	decreased circulating cholesterol level	J:213427
	decreased circulating glucose level	J:213427
	decreased circulating HDL cholesterol level	J:213427
	decreased circulating LDL cholesterol level	J:213427
	decreased circulating serum albumin level	J:213427
	decreased circulating total protein level	J:213427
	increased carbon dioxide production	J:213427
	increased circulating alkaline phosphatase level	J:213427
	increased energy expenditure	J:213427
	increased oxygen consumption	J:213427
Akap11^tm1.2Jsco/Akap11^tm1.2Jsco (B6.Cg-Akap11^tm1.2Jsco)	increased urine osmolality	J:234905
Akap13^em1(IMPC)Mbp/Akap13^em1(IMPC)Mbp (C57BL/6N-Akap13^em1(IMPC)Mbp/MbpMmucd)	improved glucose tolerance	J:211773
Akap13^tm1Segj/Akap13^tm1Segj (involves: 129 * C57BL/6)	pericardial effusion	J:181087
Akip1^em1Cya/Akip1^em1Cya (C57BL/6N-Akip1^em1Cya)	decreased bleeding time	J:326919
Akip1^em1Cya/Akip1^em1Cya (C57BL/6N-Akip1^em1Cya)	decreased prothrombin time	J:326919
Akp3^tm1Jlm/Akp3^tm1Jlm (involves: 129S2/SvPas * C57BL/6)	abnormal intestinal lipid absorption	J:86263
	abnormal lipid level	J:86263
	increased circulating triglyceride level	J:86263
Akr1a1^{Gt(OST222400)Lex}/Akr1a1^{Gt(OST222400)Lex} (B6.129S5-Akr1a1^{Gt(OST222400)Lex})	abnormal vitamin C level	J:164548
	aminoaciduria	J:164548
Akr1a1^tm1Maka/Akr1a1^tm1Maka (B6.Cg-Akr1a1^tm1Maka)	abnormal vitamin C level	J:188043
Akr1b1^tm1.1Kgab/Akr1b1^tm1.1Kgab (B6.Cg-Akr1b1^tm1.1Kgab)	abnormal vitamin C level	J:164548
Akr1b1^tm1Skc/Akr1b1^tm1Skc (either: B6.129S7-Akr1b3^tm1Skc or (involves: 129S7/SvEvBrd * C57BL/6N))	abnormal renal water reabsorption	J:77647
	decreased urine calcium level	J:77647
	decreased urine chloride ion level	J:77647
	decreased urine creatinine level	J:77647
	decreased urine osmolality	J:77647
	decreased urine potassium level	J:77647
	decreased urine sodium level	J:77647
	decreased urine urea nitrogen level	J:77647
Akr1b1^tm1Tona/Akr1b1^tm1Tona (involves: 129S/SvEv * C57BL/6)	decreased urine osmolality	J:114187
	increased circulating calcium level	J:114187
	increased circulating magnesium level	J:114187
	increased urine calcium level	J:114187
Akr1b7^tm1.1Anm/Akr1b7^tm1.1Anm (involves: 129)	decreased energy expenditure	J:208505
	decreased respiratory quotient	J:208505
	increased circulating adiponectin level	J:208505
	increased circulating glycerol level	J:208505
	increased circulating insulin level	J:208505
	increased circulating leptin level	J:208505
	increased circulating triglyceride level	J:208505
	increased liver triglyceride level	J:208505
	increased susceptibility to diet-induced obesity	J:208505
	insulin resistance	J:208505
Akr1b7^tm1.1Fth/Akr1b7^tm1.1Fth (involves: 129P2/OlaHsd * C57BL/6)	decreased circulating progesterone level	J:123295
	increased circulating progesterone level	J:123295
Akr1b8^{tm1.1(KOMP)Vlcg}/Akr1b8^{tm1.1(KOMP)Vlcg} (B6N(Cg)-Akr1b8^{tm1.1(KOMP)Vlcg}/J)	decreased fasting circulating glucose level	J:211773
Akr1b8^tm1Dgen/Akr1b8^tm1Dgen (Not Specified)	abnormal interferon level	J:301852
Akr1b8^tm1Dgen/Akr1b8^tm1Dgen (Not Specified)	abnormal interleukin level	J:301852
Akr1c18^tm1Mni/Akr1c18^tm1Mni (involves: 129P2/OlaHsd * C57BL/6J)	increased circulating progesterone level	J:129608
Akr1d1^{tm1.1(KOMP)Vlcg}/Akr1d1^{tm1.1(KOMP)Vlcg} (B6N(Cg)-Akr1d1^{tm1.1(KOMP)Vlcg}/J)	decreased fasting circulating glucose level	J:211773
Akt1^tm1Mbb/Akt1^tm1Mbb (B6.129P2-Akt1^tm1Mbb)	decreased susceptibility to diet-induced obesity	J:182721
	increased carbon dioxide production	J:182721
	increased oxygen consumption	J:182721
Akt1^tm1Nhy/Akt1⁺ Akt2^tm1Rsg/Akt2^tm1Rsg (involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * DBA/1LacJ)	decreased circulating leptin level	J:149156
	decreased insulin secretion	J:149156
	hyperglycemia	J:149156
	impaired glucose tolerance	J:149156
	increased circulating insulin level	J:149156
Akt1^tm1Nhy/Akt1⁺ Akt2^tm1Rsg/Akt2^tm1Rsg Akt3^tm1Nhy/Akt3^tm1Nhy (involves: 129/Sv * C57BL/6 * DBA/1LacJ)	hyperglycemia	J:149156
Akt1^tm1Nhy/Akt1⁺ Akt2^tm1Rsg/Akt2^tm1Rsg Pten^tm1Ppp/Pten⁺ (involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * DBA/1LacJ)	impaired glucose tolerance	J:149156
	increased circulating insulin level	J:149156
Akt1^tm1Nhy/Akt1^tm1Nhy Akt2^tm1Rsg/Akt2^tm1Rsg (involves: 129/Sv * C57BL/6 * DBA/1LacJ)	abnormal lipid homeostasis	J:83741
Akt1^tm2.1Mbb/Akt1^tm2.1Mbb (involves: 129S4/SvJae * C57BL/6J * FVB/N)	abnormal gluconeogenesis	J:182721
	abnormal glucose homeostasis	J:182721
	decreased circulating leptin level	J:182721
	decreased circulating thyroxine level	J:182721
	decreased liver triglyceride level	J:182721
	decreased respiratory quotient	J:182721
	decreased susceptibility to diet-induced obesity	J:182721
	improved glucose tolerance	J:182721
	increased carbon dioxide production	J:182721
	increased circulating adiponectin level	J:182721
	increased fatty acid oxidation	J:182721
	increased insulin sensitivity	J:182721
	increased oxygen consumption	J:182721
Akt2^tm1.1Mbb/Akt2⁺ Lep^ob/Lep^ob (B6.Cg-Lep^ob Akt2^tm1.1Mbb)	decreased liver triglyceride level	J:155432
Akt2^tm1.1Mbb/Akt2^tm1.1Mbb (involves: 129P2/OlaHsd * C57BL/6)	hyperglycemia	J:71491
	impaired glucose tolerance	J:71491
	increased circulating insulin level	J:71491
	insulin resistance	J:71491
Akt2^tm1.1Mbb/Akt2^tm1.1Mbb (involves: 129P2/OlaHsd)	decreased liver triglyceride level	J:160759
	hyperglycemia	J:160759
	impaired glucose tolerance	J:160759
Akt2^tm1.1Mbb/Akt2^tm1.1Mbb (B6.129P2-Akt2^tm1.1Mbb)	decreased circulating glucose level	J:155432
	decreased liver triglyceride level	J:155432
	decreased susceptibility to diet-induced obesity	J:155432
	increased circulating insulin level	J:155432
Akt2^tm1.1Mbb/Akt2^tm1.1Mbb Lep^ob/Lep^ob (B6.Cg-Lep^ob Akt2^tm1.1Mbb)	abnormal lipid homeostasis	J:155432
	decreased circulating cholesterol level	J:155432
	decreased liver triglyceride level	J:155432
	increased circulating glucose level	J:155432
	increased circulating insulin level	J:155432
Akt2^tm1.1Mbb/Akt2^tm1.1Mbb Pten^tm1Hwu/Pten^tm1Hwu Speer6-ps1^{Tg(Alb-cre)21Mgn}/Speer6-ps1⁺ (involves: 129P2/OlaHsd * 129S4/SvJae * C57BL/6 * DBA)	hyperglycemia	J:160759
	impaired glucose tolerance	J:160759
Akt2^tm1.2Mbb/Akt2^tm1.2Mbb Lep^ob/Lep^ob Tg(Alb1-cre)1Khk/0 (involves: 129P2/OlaHsd * 129S4/SvJaeSor * C57BL/6 * SJL)	abnormal lipid homeostasis	J:155432
	decreased liver triglyceride level	J:155432
	increased circulating glucose level	J:155432
Akt2^tm1.2Mbb/Akt2^tm1.2Mbb Tg(Alb1-cre)1Khk/0 (involves: 129P2/OlaHsd * 129S4/SvJaeSor * C57BL/6 * SJL)	decreased liver triglyceride level	J:155432
Akt2^tm1Hem/Akt2^tm1Hem (involves: 129P2/OlaHsd * C57BL/6)	hyperglycemia	J:114675
	impaired glucose tolerance	J:114675
	increased circulating insulin level	J:114675
	insulin resistance	J:114675
Akt2^tm1Hem/Akt2^tm1Hem (involves: 129P2/OlaHsd)	increased circulating testosterone level	J:185012
Akt2^tm1Hem/Akt2^tm1Hem Akt3^tm1Hem/Akt3^tm1Hem (involves: 129P2/OlaHsd * C57BL/6)	decreased circulating testosterone level	J:114675
	hyperglycemia	J:114675
	impaired glucose tolerance	J:114675
	increased circulating insulin level	J:114675
	insulin resistance	J:114675
Akt2^tm1Rsg/Akt2^tm1Rsg (DBA/1LacJ-Akt2^tm1Rsg)	abnormal glucose homeostasis	J:84606
	decreased circulating insulin level	J:84606
	hyperglycemia	J:84606
	impaired glucose tolerance	J:84606
	increased circulating insulin level	J:84606
	insulin resistance	J:84606
Akt2^tm1Rsg/Akt2^tm1Rsg (involves: C57BL/6 * DBA/1LacJ)	decreased circulating leptin level	J:149156
	impaired glucose tolerance	J:149156
	increased circulating insulin level	J:149156
	insulin resistance	J:149156
Akt2^tm1Rsg/Akt2^tm1Rsg Akt3^tm1Nhy/Akt3^tm1Nhy (involves: 129/Sv * C57BL/6 * DBA/1LacJ)	impaired glucose tolerance	J:149156
Akt2^tm1Rsg/Akt2^tm1Rsg Pten^tm1Ppp/Pten⁺ (involves: 129S1/Sv * C57BL/6 * DBA/1LacJ)	decreased circulating insulin level	J:149156
	impaired glucose tolerance	J:149156
Aktip^{tm1b(EUCOMM)Hmgu}/Aktip^{tm1b(EUCOMM)Hmgu} (C57BL/6N-Aktip^{tm1b(EUCOMM)Hmgu}/Tcp)	increased circulating aspartate transaminase level	J:211773
Alas2^tm1Mym/Y (involves: 129P2/OlaHsd * C57BL/6)	abnormal iron level	J:58508
Alb^em8Mvw/Alb^em8Mvw (C57BL/6J-Alb^em8Mvw/MvwJ)	decreased circulating serum albumin level	J:101977
Alb^em12Mvw/Alb^em12Mvw Fcgrt^tm1Dcr/Fcgrt^tm1Dcr Tg(FCGRT)32Dcr/Tg(FCGRT)32Dcr (B6.Cg-Tg(FCGRT)32Dcr Alb^em12Mvw Fcgrt^tm1Dcr/MvwJ)	decreased circulating serum albumin level	J:101977
Alb^Mhdabcl002/Alb⁺ (C3HeB/FeJ-Alb^Mhdabcl002)	decreased circulating calcium level	J:183993
Alb^Mhdabcl002/Alb⁺ (C3HeB/FeJ-Alb^Mhdabcl002)	decreased circulating serum albumin level	J:82809
Alb^{tm1(cre/ERT2)Mtz}/Alb⁺ Fth1^tm1.1Lck/Fth1^tm1.1Lck (involves: 129/Sv * C57BL/6 * SJL)	abnormal liver iron level	J:166515
Alb^{tm1(cre/ERT2)Mtz}/Alb⁺ Nr5a2^tm1Sjns/Nr5a2^tm1Sjns (involves: 129/Sv * 129S2/SvPas * C57BL/6 * SJL)	abnormal bile salt level	J:129068
	abnormal intestinal lipid absorption	J:129068
	increased bile salt level	J:129068
Alb^{tm1(cre/ERT2)Mtz}/Alb^{tm1(cre/ERT2)Mtz} Slc2a2^tm2Thor/Slc2a2^tm2Thor (involves: 129P2/OlaHsd * 129S2/SvPas * C57BL/6)	abnormal bile salt level	J:197607
	abnormal circulating glucose level	J:197607
	abnormal glucose homeostasis	J:197607
	abnormal glycogen homeostasis	J:197607
	abnormal lipid homeostasis	J:197607
	decreased insulin secretion	J:197607
	decreased liver cholesterol level	J:197607
	decreased liver triglyceride level	J:197607
	impaired glucose tolerance	J:197607
	increased liver glycogen level	J:197607
Albq1^A/J/Albq1^A/J (involves: A/J * C57BL/6J)	albuminuria	J:135073
Albq2^A/J/Albq2^C57BL/6J (involves: A/J * C57BL/6J)	albuminuria	J:135073
Albq3^A/J/Albq3^C57BL/6J (involves: A/J * C57BL/6J)	albuminuria	J:135073
Albq4^A/J/Albq4^A/J Apoe^tm1Unc/Apoe^tm1Unc (involves: A/J * C57BL/6J)	albuminuria	J:135073
Albq4^A/J/Albq4^C57BL/6J Apoe^tm1Unc/Apoe^tm1Unc (involves: A/J * C57BL/6J)	albuminuria	J:135073
Albq5^DBA/2J/Albq5^DBA/2J (involves: C57BL/6J * DBA/2J)	albuminuria	J:126352
Albq6^C57BL/6J/Albq6^DBA/2J (involves: C57BL/6J * DBA/2J)	albuminuria	J:126352
Albq6^C57BL/6J/Albq6^DBA/2J Albq8^DBA/2J/Albq8^DBA/2J (involves: C57BL/6J * DBA/2J)	albuminuria	J:126352
Albq6^DBA/2J/Albq6^DBA/2J (involves: C57BL/6J * DBA/2J)	albuminuria	J:126352
Albq7^C57BL/6J/Albq7^DBA/2J (involves: C57BL/6J * DBA/2J)	albuminuria	J:126352
Albq7^DBA/2J/Albq7^DBA/2J (involves: C57BL/6J * DBA/2J)	albuminuria	J:126352
Albq7^DBA/2J/Albq7^DBA/2J Albq9^C57BL/6J/Albq9^C57BL/6J (involves: C57BL/6J * DBA/2J)	albuminuria	J:126352
Aldh1a2^tm1Dll/Aldh1a2^tm1Dll (Not Specified)	cyanosis	J:81969
Aldh1a2^tm1Dll/Aldh1a2^tm1Ipc (involves: CD-1)	cyanosis	J:81969
Aldh1a2^tm1Soc/Aldh1a2^tm2Soc Tg(Dll1-cre)1Gos/0 (Not Specified)	abnormal vitamin A level	J:112635
Aldh1a3^tm1.1Pcn/Aldh1a3^tm1.1Pcn (involves: 129/Sv * C57BL/6)	cyanosis	J:90261
Aldh1a3^{tm1b(KOMP)Wtsi}/Aldh1a3⁺ (B6N(Cg)-Aldh1a3^{tm1b(KOMP)Wtsi}/J)	increased circulating alkaline phosphatase level	J:211773
Aldh1b1^{tm1.1(KOMP)Vlcg}/Aldh1b1^{tm1.1(KOMP)Vlcg} (involves: C57BL/6J * C57BL/6NTac * CBA)	abnormal calcium ion homeostasis	J:232360
	decreased insulin secretion	J:232360
	hyperglycemia	J:232360
	impaired glucose tolerance	J:232360
	increased glucagon secretion	J:232360
	increased insulin secretion	J:232360
	insulin resistance	J:232360
Aldh1b1^tm1Vvas/Aldh1b1^tm1Vvas (B6J.Cg-Aldh1b1^tm1Vvas)	increased fasting circulating glucose level	J:228677
Aldh1l1^{tm1a(KOMP)Wtsi}/Aldh1l1^{tm1a(KOMP)Wtsi} (C57BL/6-Aldh1l1^{tm1a(KOMP)Wtsi})	abnormal folic acid level	J:280537
	abnormal homeostasis	J:280537
	decreased glycine level	J:280537
	increased serine level	J:280537
Aldh1l2^{tm2e(KOMP)Wtsi}/Aldh1l2^{tm2e(KOMP)Wtsi} (involves: C57BL/6 * C57BL/6N)	abnormal amino acid level	J:299012
	abnormal enzyme/coenzyme level	J:299012
	abnormal folic acid level	J:299012
	abnormal vitamin C level	J:299012
	decreased cystathionine level	J:299012
	decreased cysteine level	J:299012
	decreased fatty acid beta-oxidation	J:299012
	decreased glutathione level	J:299012
Aldh2^{tm1a(EUCOMM)Wtsi}/Aldh2^{tm1a(EUCOMM)Wtsi} (Not Specified)	decreased circulating alkaline phosphatase level	J:165965
	decreased circulating cholesterol level	J:165965
	decreased circulating HDL cholesterol level	J:165965
	decreased circulating LDL cholesterol level	J:165965
	decreased circulating total protein level	J:165965
Aldh2^{tm1a(EUCOMM)Wtsi}/Aldh2^{tm1a(EUCOMM)Wtsi} (C57BL/6N-Aldh2^{tm1a(EUCOMM)Wtsi}/Ieg)	increased circulating free fatty acids level	J:165965
Aldh2^tm1Dmro/Aldh2⁺ (B6.129-Aldh2^tm1Dmro)	abnormal circulating hormone level	J:261952
Aldh3a2^{tm1a(EUCOMM)Wtsi}/Aldh3a2^{tm1a(EUCOMM)Wtsi} Aldh3b2^em1Akih/Aldh3b2^em1Akih (involves: C57BL/6J * C57BL/6N)	abnormal triglyceride level	J:330263
	decreased ceramide level	J:330263
	impaired skin barrier function	J:330263
Aldh3a2^{tm1b(EUCOMM)Wtsi}/Aldh3a2^{tm1b(EUCOMM)Wtsi} (involves: C57BL * C57BL/6J * C57BL/6N * DBA)	abnormal phospholipid level	J:234695
Aldh5a1^tm1Kmg/Aldh5a1^tm1Kmg (involves: 129/Sv * C57BL/6)	abnormal amino acid level	J:91856
	decreased glutamine level	J:91856, J:75773
	increased beta-alanine level	J:75773
	increased gamma-aminobutyric acid level	J:71949, J:91856, J:75773
	increased urine gamma-aminobutyric acid level	J:71949
Aldh7a1^{tm1d(EUCOMM)Hmgu}/Aldh7a1^{tm1d(EUCOMM)Hmgu} (B6(FVB)-Aldh7a1^{tm1d(EUCOMM)Hmgu})	abnormal amino acid level	J:298561
	abnormal vitamin level	J:298561
	decreased glycine level	J:298561
	decreased lysine level	J:298561
	increased circulating noradrenaline level	J:298561
	increased leucine level	J:298561
	increased ornithine level	J:298561
	increased phenylalanine level	J:298561
	increased proline level	J:298561
	increased serine level	J:298561
Aldh16a1^{tm1a(EUCOMM)Wtsi}/Aldh16a1^{tm1a(EUCOMM)Wtsi} (C57BL/6N-Aldh16a1^{tm1a(EUCOMM)Wtsi}/Wtsi)	decreased circulating chloride level	J:211773
	decreased circulating sodium level	J:211773
Aldh16a1^{tm1a(EUCOMM)Wtsi}/Aldh16a1^{tm1a(EUCOMM)Wtsi} (C57BL/6NTac-Aldh16a1^{tm1a(EUCOMM)Wtsi}/WtsiH)	abnormal ion homeostasis	J:255311
	abnormal lipid homeostasis	J:255311
Aldoc^{tm1.1(KOMP)Vlcg}/Aldoc^{tm1.1(KOMP)Vlcg} (C57BL/6N-Aldoc^{tm1.1(KOMP)Vlcg})	decreased circulating cholesterol level	J:346664
	decreased circulating HDL cholesterol level	J:346664
	decreased circulating triglyceride level	J:346664
	increased circulating triglyceride level	J:346664
Aldoc^{tm1.1(KOMP)Vlcg}/Aldoc^{tm1.1(KOMP)Vlcg} Ldlr^tm1Her/Ldlr^tm1Her (involves: 129S7/SvEvBrd * C57BL/6J * C57BL/6N)	decreased circulating cholesterol level	J:346664
	decreased circulating LDL cholesterol level	J:346664
	decreased circulating triglyceride level	J:346664
	decreased liver cholesterol level	J:346664
	decreased liver triglyceride level	J:346664
Alg1^{tm1b(KOMP)Wtsi}/Alg1⁺ (C57BL/6N-Alg1^{tm1b(KOMP)Wtsi}/Nju)	abnormal cholesterol homeostasis	J:211773
Alg2^{tm1.1(KOMP)Vlcg}/Alg2⁺ (B6N(Cg)-Alg2^{tm1.1(KOMP)Vlcg}/J)	decreased fasting circulating glucose level	J:211773
	increased circulating insulin level	J:211773
Alg8^em1(IMPC)J/Alg8⁺ (C57BL/6NJ-Alg8^em1(IMPC)J/Mmjax)	increased circulating cholesterol level	J:211773
Alg8^em1(IMPC)J/Alg8⁺ (C57BL/6NJ-Alg8^em1(IMPC)J/Mmjax)	increased circulating HDL cholesterol level	J:211773
Alg10b^{tm1(KOMP)Vlcg}/Alg10b⁺ (C57BL/6N-Alg10b^{tm1(KOMP)Vlcg}/Bay)	increased body temperature	J:211773
Alg10b^{tm1.1(KOMP)Vlcg}/Alg10b^{tm1.1(KOMP)Vlcg} (C57BL/6N-Alg10b^{tm1.1(KOMP)Vlcg}/Bay)	edema	J:211773
Alk^tm1.1Rhp/Alk^tm1.1Rhp (involves: 129 * C57BL/6N)	decreased circulating testosterone level	J:226955
Alk^tm2.1Ics/Alk⁺ (B6N.129S2(Cg)-Alk^tm2.1Ics)	increased circulating alkaline phosphatase level	J:226655
Alk^tm2.1Ics/Alk⁺ (B6N.129S2(Cg)-Alk^tm2.1Ics)	increased circulating chloride level	J:226655
Alkbh6^{tm1b(EUCOMM)Hmgu}/Alkbh6^{tm1b(EUCOMM)Hmgu} (C57BL/6N-Alkbh6^{tm1b(EUCOMM)Hmgu}/Ieg)	increased circulating alanine transaminase level	J:211773
	increased circulating creatinine level	J:211773
Alkbh7^tm1.1Klng/Alkbh7^tm1.1Klng (involves: 129S2/SvPas * C57BL/6J)	abnormal fatty acid oxidation	J:198968
	abnormal glucose homeostasis	J:298649
	abnormal homeostasis	J:298649
	decreased circulating adiponectin level	J:198968
	decreased fasting circulating glucose level	J:198968
	increased circulating insulin level	J:198968
	increased circulating leptin level	J:198968
	increased hepatic glucose production	J:198968
	increased insulin sensitivity	J:198968
	increased susceptibility to diet-induced obesity	J:198968
Alkbh8^{tm1b(EUCOMM)Hmgu}/Alkbh8^{tm1b(EUCOMM)Hmgu} (C57BL/6N-Alkbh8^{tm1b(EUCOMM)Hmgu}/Ieg)	increased circulating alkaline phosphatase level	J:211773
Alms1^bbb/Alms1^bbb (C57BL/6JSfdAnu-Alms1^bbb/Anu)	hyperglycemia	J:104190
Alms1^bbb/Alms1^bbb (C57BL/6JSfdAnu-Alms1^bbb/Anu)	increased circulating insulin level	J:104190
Alms1^foz/Alms1^foz (involves: NOD)	hyperglycemia	J:107058
	increased circulating insulin level	J:107058
	insulin resistance	J:107058
Alms1^Gt(XH152)Byg/Alms1^Gt(XH152)Byg (involves: 129P2/OlaHsd * C57BL/6J)	albuminuria	J:100403
	crystalluria	J:100403
	hyperglycemia	J:100403
	increased circulating cholesterol level	J:100403
	increased circulating insulin level	J:100403
Alms1^L2131X/Alms1^L2131X (involves: C57BL/6 * NOD)	abnormal circulating cholesterol level	J:118221
	increased circulating HDL cholesterol level	J:118221
	increased circulating insulin level	J:118221
	increased circulating leptin level	J:118221
	increased circulating triglyceride level	J:118221
	increased urine protein level	J:118221
Alms1^m2Btlr/Alms1^m2Btlr (C57BL/6J-Alms1^m2Btlr)	impaired glucose tolerance	J:264648
Alms1^m3Btlr/Alms1^m3Btlr (C57BL/6J-Alms1^m3Btlr)	impaired glucose tolerance	J:264649
	increased circulating insulin level	J:264649
	increased fasting circulating glucose level	J:264649
Alms1^{tm1b(EUCOMM)Hmgu}/Alms1^{tm1b(EUCOMM)Hmgu} (C57BL/6N-Alms1^{tm1b(EUCOMM)Hmgu}/H)	increased circulating amylase level	J:211773
Alox5^tm1Bhk/Alox5^tm1Bhk (either: (involves: 129P2/OlaHsd * C57BL/6) or (involves: 129P2/OlaHsd * C57BL/6 * DBA/2))	abnormal thromboxane level	J:68714
	decreased leukotriene level	J:68714
	increased prostaglandin level	J:68714
Alox5^tm1Fun/Alox5^tm1Fun (B6.129S2-Alox5^tm1Fun/J)	increased circulating leptin level	J:104825
Alox5^tm1Fun/Alox5^tm1Fun (B6.129S2-Alox5^tm1Fun/J)	increased circulating VLDL cholesterol level	J:104825
Alox5ap^tm1Bhk/Alox5ap^tm1Bhk (involves: 129P2/OlaHsd * 129S/SvEv)	abnormal thromboxane level	J:39229
	decreased leukotriene level	J:39229
	increased prostaglandin level	J:39229
Alox5ap^tm1Jdm/Alox5ap⁺ (DBA/1LacJ-Alox5ap^tm1Jdm)	decreased leukotriene level	J:100736
Alox5ap^tm1Jdm/Alox5ap^tm1Jdm (DBA/1LacJ-Alox5ap^tm1Jdm)	abnormal leukotriene level	J:100736
Alox5ap^tm1Jdm/Alox5ap^tm1Jdm (DBA/1LacJ-Alox5ap^tm1Jdm)	abnormal prostaglandin level	J:100736
Alox8^{tm1a(KOMP)Wtsi}/Alox8^{tm1a(KOMP)Wtsi} (C57BL/6N-Alox8^{tm1a(KOMP)Wtsi}/MbpMmucd)	decreased body temperature	J:277623
Alox12^tm1Fun/Alox12^tm1Fun (involves: 129S2/SvPas * C57BL/6)	impaired skin barrier function	J:55741
	increased platelet aggregation	J:46896
	increased susceptibility to induced thrombosis	J:46896
Alox12b^mmy/Alox12b^mmy (involves: A/J * C57BL/6 * FVB/N)	dehydration	J:119554
Alox12b^mmy/Alox12b^mmy (involves: A/J * C57BL/6 * FVB/N)	impaired skin barrier function	J:119554
Alox12b^tm1.1Krie/Alox12b^tm1.1Krie (involves: 129P2/OlaHsd * 129S6/SvEvTac * BALB/cJ * C57BL/6)	dehydration	J:134709
	impaired skin barrier function	J:134709
Alox12b^tm1.1Krie/Alox12b^tm1.1Krie (involves: 129P2/OlaHsd)	abnormal lipid level	J:196489
Alox15^tm1.1Nadl/Alox15^tm1.1Nadl Tg(Pdx1-cre)89.1Dam/0 (involves: C57BL/6 * CBA)	abnormal enzyme/coenzyme level	J:224344
	decreased susceptibility to non-insulin-dependent diabetes	J:224344
	improved glucose tolerance	J:224344
	increased insulin secretion	J:224344
Aloxe3^tm1.2Krie/Aloxe3^tm1.2Krie (involves: 129P2/OlaHsd * 129S6/SvEvTac * C57BL/6J)	abnormal lipid level	J:196489
	dehydration	J:196489
	impaired skin barrier function	J:196489
alp/alp (Not Specified)	impaired adaptive thermogenesis	J:14855
Alpk1^em1Dlka/Alpk1^em1Dlka Crb1^rd8/Crb1^rd8 (involves: C57BL/6N)	abnormal circulating chemokine level	J:344848
	increased circulating CXCL10 level	J:344848
Alpl^ALPLD1/? (involves: C3HeB/FeJ)	decreased circulating alkaline phosphatase level	J:68708, J:187875
Alpl^BAP023/Alpl^BAP023 (C3HeB/FeJ-Alpl^BAP023)	decreased circulating alkaline phosphatase level	J:183993
Alpl^Hpp/Alpl⁺ (involves: BALB/cAnN * C3H/HeH)	decreased circulating alkaline phosphatase level	J:82809, J:122319
Alpl^Hpp/Alpl^Hpp (involves: BALB/cAnN * C3H/HeH)	decreased circulating alkaline phosphatase level	J:122319
Alpl^Mhdabap020/Alpl^Mhdabap020 (C3HeB/FeJ-Alpl^Mhdabap020/Ieg)	decreased circulating alkaline phosphatase level	J:183993
Alpl^Mhdabap26/Alpl^Mhdabap26 (C3HeB/FeJ-Alpl^Mhdabap26)	decreased circulating alkaline phosphatase level	J:183993
Alpl^Mhdabap27/Alpl^Mhdabap27 (C3HeB/FeJ-Alpl^Mhdabap27)	decreased circulating alkaline phosphatase level	J:183993
Alpl^Mhdabap32/Alpl^Mhdabap32 (C3HeB/FeJ-Alpl^Mhdabap32)	decreased circulating alkaline phosphatase level	J:183993
Alpl^SAP007/Alpl^SAP007 (C3HeB/FeJ-Alpl^SAP007)	decreased circulating alkaline phosphatase level	J:183993
Alpl^tm1Jlm/Alpl^tm1Jlm (either: (involves: 129S2/SvPas) or (involves: 129S2/SvPas * C57BL/6J))	decreased circulating alkaline phosphatase level	J:39015
Alpl^tm1Sor/Alpl^tm1Sor (either: (involves: 129S7/SvEvBrd-Alpl^tm1Sor) or (involves: 129S7/SvEvBrd * C57BL/6))	abnormal blood homeostasis	J:28394
Als2cl^em1(IMPC)J/Als2cl^em1(IMPC)J (C57BL/6NJ-Als2cl^em1(IMPC)J/Mmjax)	increased circulating alanine transaminase level	J:211773
Altre^tm1.1Hbgl/Altre^tm1.1Hbgl Foxp3^{tm4(YFP/icre)Ayr}/Y (involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)	increased circulating alanine transaminase level	J:342907
Alx1^tm1Crm/Alx1^tm1Crm (involves: 129S7/SvEvBrd * C57BL/6J)	cyanosis	J:33716
Alx3^tm1Hubr/Alx3⁺ (involves: 129P2/OlaHsd)	impaired glucose tolerance	J:166436
Alx3^tm1Hubr/Alx3⁺ (involves: 129P2/OlaHsd)	increased circulating glucose level	J:166436
Alx3^tm1Hubr/Alx3^tm1Hubr (involves: 129P2/OlaHsd)	decreased insulin secretion	J:166436
	impaired glucose tolerance	J:166436
	increased circulating insulin level	J:166436
	increased fasting circulating glucose level	J:166436
	insulin resistance	J:166436
am/am (Not Specified)	edema	J:13423
Amacr^tm1Jkh/Amacr^tm1Jkh (involves: 129S1/Sv * 129X1/SvJ)	abnormal circulating cholesterol level	J:90370
	decreased fatty acids level	J:90370
	decreased triglyceride level	J:90370
	increased circulating alkaline phosphatase level	J:90370
	increased fatty acids level	J:90370
Amelx^{em1(IMPC)Ccpcz}/Amelx^{em1(IMPC)Ccpcz} (C57BL/6N-Amelx^{em1(IMPC)Ccpcz}/Ccpcz)	decreased circulating alkaline phosphatase level	J:211773
Amer1^tm1.2Nbar/Y (involves: 129S4/SvJae * C57BL/6 * CD-1 * SJL)	cyanosis	J:173242
Amfr^{tm1a(KOMP)Wtsi}/Amfr^{tm1a(KOMP)Wtsi} (B6JTyr;B6N-Amfr^{tm1a(KOMP)Wtsi}/Wtsi)	decreased circulating alanine transaminase level	J:175295
	decreased circulating alkaline phosphatase level	J:175295
	decreased circulating aspartate transaminase level	J:175295
	decreased circulating fructosamine level	J:175295
	decreased circulating total protein level	J:175295
	decreased lactate dehydrogenase level	J:175295
Amh^tm1Bhr/Amh^tm1Bhr (involves: 129S7/SvEvBrd * C57BL/6)	suppressed circulating follicle stimulating hormone level	J:58577
Amhr2^tm3(cre)Bhr/Amhr2⁺ Ar^tm1Chc/Y (involves: 129S/SvEv * C57BL/6)	decreased circulating testosterone level	J:118270
Amhr2^tm3(cre)Bhr/Amhr2⁺ Fst^tm1Zuk/Fst^tm2Zuk (involves: 129S/SvEv * C57BL/6J)	decreased circulating testosterone level	J:89081
	increased circulating follicle stimulating hormone level	J:89081
	increased circulating luteinizing hormone level	J:89081
Amhr2^tm3(cre)Bhr/Amhr2⁺ Nr2f2^tm2.1Tsa/Nr2f2^tm2.1Tsa (involves: 129S7/SvEvBrd)	edema	J:120852
Amhr2^tm3(cre)Bhr/Amhr2⁺ Nr5a1^tm1Klp/Nr5a1^tm2Klp (involves: 129P2/OlaHsd * 129S7/SvEvBrd)	decreased circulating estradiol level	J:145805
	decreased circulating testosterone level	J:91352
	increased circulating follicle stimulating hormone level	J:145805
Amhr2^tm3(cre)Bhr/Amhr2⁺ Smad1^tm2Rob/Smad1^tm2.1Rob Smad5^tm1Huy/Smad5^tm1Huy (involves: 129P2/OlaHsd * 129S/SvEv * C57BL/6J)	suppressed circulating follicle stimulating hormone level	J:157310
Amhr2^tm3(cre)Bhr/Amhr2⁺ Smad1^tm2Rob/Smad1^tm2Rob Smad5^tm1Huy/Smad5^tm1Huy (involves: 129P2/OlaHsd * 129S/SvEv * C57BL/6J)	suppressed circulating follicle stimulating hormone level	J:157310
Amhr2^tm3(cre)Bhr/Amhr2⁺ Smad1^tm2Rob/Smad1^tm2Rob Smad5^tm1Huy/Smad5^tm1Zuk (involves: 129P2/OlaHsd * 129S/SvEv * C57BL/6J)	suppressed circulating follicle stimulating hormone level	J:157310
Amhr2^tm3(cre)Bhr/Amhr2⁺ Smad2^tm1Cxd/Smad2^tm1.1Mwst Smad3^tm1Par/Smad3^tm1Zuk (involves: 129S/SvEv * 129S1/Sv * 129X1/SvJ * C57BL/6)	increased circulating follicle stimulating hormone level	J:142827
	increased circulating luteinizing hormone level	J:142827
Amhr2^tm3(cre)Bhr/Amhr2⁺ Smad4^tm1Rob/Smad4^tm1.1Rob (involves: 129S/SvEv * C57BL/6J)	increased circulating progesterone level	J:108954
Ampd1^tm1Tm/Ampd1^tm1Tm (B6.129S2-Ampd1^tm1Tm)	abnormal ammonia homeostasis	J:260685
Ampd2^m4521Dajl/Ampd2^m4521Dajl (involves: C3H/HeSnJ * C57BL/6J * SWR)	increased circulating cholesterol level	J:149088
	increased circulating LDL cholesterol level	J:149088
	increased circulating triglyceride level	J:149088
Ampd2^{tm1b(EUCOMM)Hmgu}/Ampd2⁺ (C57BL/6N-Ampd2^{tm1b(EUCOMM)Hmgu}/H)	increased circulating potassium level	J:211773
Ampd2^{tm1b(EUCOMM)Hmgu}/Ampd2^{tm1b(EUCOMM)Hmgu} (C57BL/6N-Ampd2^{tm1b(EUCOMM)Hmgu}/H)	decreased circulating fructosamine level	J:211773
	increased circulating amylase level	J:211773
	increased circulating cholesterol level	J:211773
	increased circulating HDL cholesterol level	J:211773
Ampd2^tm1Tm/Ampd2^tm1Tm (B6.129S2-Ampd2^tm1Tm)	increased urine protein level	J:196782
Ampd3^{tm2a(KOMP)Wtsi}/Ampd3^{tm2a(KOMP)Wtsi} (involves: C57BL/6N * C57BL/6NHsd)	abnormal enzyme/coenzyme level	J:206035
	abnormal oxygen consumption	J:206035
Amt^em1(IMPC)Tcp/Amt⁺ (C57BL/6NCrl-Amt^em1(IMPC)Tcp/Tcp)	improved glucose tolerance	J:211773
Anapc1^em1(IMPC)J/Anapc1⁺ (C57BL/6NJ-Anapc1^em1(IMPC)J/Mmjax)	increased circulating alkaline phosphatase level	J:211773
Anapc2^tm1Kna/Anapc2^tm2Kna Tg(Mx1-cre)1Cgn/0 (involves: 129P2/OlaHsd * C57BL/6 * CBA)	abnormal enzyme/coenzyme level	J:87782
	decreased liver glycogen level	J:87782
	increased circulating bilirubin level	J:87782
Anapc7^em1(IMPC)J/Anapc7^em1(IMPC)J (C57BL/6NJ-Anapc7^em1(IMPC)J/Mmjax)	impaired glucose tolerance	J:211773
Anapc13^{tm2b(EUCOMM)Wtsi}/Anapc13⁺ (C57BL/6N-Anapc13^{tm2b(EUCOMM)Wtsi}/Bay)	decreased circulating serum albumin level	J:211773
Anapc15^{tm1.1(KOMP)Vlcg}/Anapc15⁺ (B6N(Cg)-Anapc15^{tm1.1(KOMP)Vlcg}/J)	increased circulating HDL cholesterol level	J:211773
Anapc15^{tm1.1(KOMP)Vlcg}/Anapc15^{tm1.1(KOMP)Vlcg} (B6N(Cg)-Anapc15^{tm1.1(KOMP)Vlcg}/J)	edema	J:211773
Ang6^{tm1.1(KOMP)Vlcg}/Ang6^{tm1.1(KOMP)Vlcg} (C57BL/6N-Ang6^{tm1.1(KOMP)Vlcg}/Ucd)	increased respiratory quotient	J:211773
Angel1^{tm1(NCOM)Cmhd}/Angel1^{tm1(NCOM)Cmhd} (C57BL/6N-Angel1^{tm1(NCOM)Cmhd}/2Tcp)	decreased circulating creatinine level	J:165965
Angpt2^tm1Gdy/Angpt2^tm1Gdy (involves: 129P2/OlaHsd * C57BL/6)	ascites	J:89618
	chylous ascites	J:89618
	skin edema	J:89618
Angptl1^{tm4b(KOMP)Wtsi}/Angptl1^{tm4b(KOMP)Wtsi} (C57BL/6N-Angptl1^{tm4b(KOMP)Wtsi}/Kmpc)	increased blood urea nitrogen level	J:211773
Angptl2^tm1Yo/Angptl2^tm1Yo (B6.Cg-Angptl2^tm1Yo)	decreased respiratory quotient	J:152387
	improved glucose tolerance	J:152387
	increased insulin sensitivity	J:152387
Angptl3^hypl/Angptl3^hypl (involves: KK/Snk)	decreased circulating cholesterol level	J:75358
	decreased circulating free fatty acids level	J:75358
	decreased circulating HDL cholesterol level	J:75358
	decreased circulating LDL cholesterol level	J:75358
	decreased circulating triglyceride level	J:75358
	decreased circulating VLDL cholesterol level	J:75358
	decreased triglyceride level	J:75358
Angptl3^tm1Akos/Angptl3^tm1Akos (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	decreased circulating cholesterol level	J:103363
	decreased circulating triglyceride level	J:103363
Angptl3^tm1Akos/Angptl3^tm1Akos Angptl4^tm1Akos/Angptl4^tm1Akos (involves: 129P2/OlaHsd * 129S1/Sv * 129X1/SvJ * C57BL/6)	decreased circulating cholesterol level	J:103363
	decreased circulating triglyceride level	J:103363
Angptl3^tm1Kfuj/Angptl3^tm1Kfuj (B6.129S1-Angptl3^tm1Kfuj)	decreased circulating cholesterol level	J:107479
	decreased circulating free fatty acids level	J:107479
	decreased circulating triglyceride level	J:107479
	decreased circulating VLDL cholesterol level	J:107479
Angptl3^tm1Lex/Angptl3^tm1Lex (involves: 129S5/SvEvBrd * C57BL/6)	decreased circulating triglyceride level	J:149912
Angptl3^tm1Lex/Angptl3^tm1Lex Apoe^tm1Unc/Apoe^tm1Unc (involves: 129P2/OlaHsd * 129S5/SvEvBrd * C57BL/6)	decreased circulating cholesterol level	J:149912
	decreased circulating triglyceride level	J:149912
Angptl3^tm1Lex/Angptl3^tm1Lex Ldlr^tm1Her/Ldlr^tm1Her (involves: 129S5/SvEvBrd * 129S7/SvEvBrd * C57BL/6)	decreased circulating cholesterol level	J:149912
	decreased circulating triglyceride level	J:149912
Angptl3^{tm2b(KOMP)Wtsi}/Angptl3^{tm2b(KOMP)Wtsi} (C57BL/6N-Angptl3^{tm2b(KOMP)Wtsi}/Ccpcz)	decreased circulating cholesterol level	J:211773
	decreased circulating HDL cholesterol level	J:211773
	decreased circulating triglyceride level	J:211773
	increased fasting circulating glucose level	J:211773
Angptl4^{Gt(OST352973)Lex}/Angptl4^{Gt(OST352973)Lex} (involves: 129S5/SvEvBrd * C57BL/6)	abnormal lipid homeostasis	J:122968
	chylous ascites	J:122968
	decreased circulating HDL cholesterol level	J:122968
	decreased circulating VLDL cholesterol level	J:122968
	decreased triglyceride level	J:122968
	enhanced lipolysis	J:122968
Angptl4^tm1Akos/Angptl4^tm1Akos (involves: 129P2/OlaHsd * C57BL/6)	decreased circulating cholesterol level	J:103363
	decreased circulating triglyceride level	J:103363
Angptl4^{tm1b(EUCOMM)Hmgu}/Angptl4^{tm1b(EUCOMM)Hmgu} (C57BL/6N-Angptl4^{tm1b(EUCOMM)Hmgu}/H)	decreased circulating triglyceride level	J:211773
Angptl4^tm1Lex/Angptl4⁺ (involves: 129S5/SvEvBrd * C57BL/6)	decreased circulating triglyceride level	J:149912
Angptl4^tm1Lex/Angptl4^tm1Lex (involves: 129S5/SvEvBrd * C57BL/6)	chylous ascites	J:122968
	decreased circulating HDL cholesterol level	J:122968
	decreased circulating triglyceride level	J:149912
	decreased circulating VLDL cholesterol level	J:122968
	decreased triglyceride level	J:122968
	enhanced lipolysis	J:122968
Angptl4^tm2Lex/Angptl4^tm2Lex (involves: 129S5/SvEvBrd * C57BL/6J)	decreased triglyceride level	J:149912
Angptl6^tm1Yo/Angptl6^tm1Yo (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	abnormal lipid homeostasis	J:97552
	decreased core body temperature	J:97552
	decreased oxygen consumption	J:97552
	hyperglycemia	J:97552
	increased circulating cholesterol level	J:97552
	increased circulating free fatty acids level	J:97552
	increased circulating insulin level	J:97552
	increased circulating leptin level	J:97552
	insulin resistance	J:97552
Angptl8^{tm1(KOMP)Vlcg}/Angptl8⁺ (involves: C57BL/6NTac)	decreased circulating triglyceride level	J:217262
Angptl8^{tm1(KOMP)Vlcg}/Angptl8^{tm1(KOMP)Vlcg} (involves: C57BL/6NTac)	decreased circulating triglyceride level	J:217262
	decreased circulating VLDL triglyceride level	J:217262
	decreased fatty acids level	J:217262
Angptl8^tm1Lex/Angptl8^tm1Lex (involves: 129S5/SvEvBrd * C57BL/6)	decreased circulating triglyceride level	J:161922, J:187261
Ank1^ity16/Ank1⁺ (involves: 129S1/Sv * 129X1/SvJ * DBA/2J)	increased kidney iron level	J:199427
Ank1^ity16/Ank1⁺ (involves: 129S1/Sv * 129X1/SvJ * DBA/2J)	increased liver iron level	J:199427
Ank1^ity16/Ank1^ity16 (involves: 129S1/Sv * 129X1/SvJ * DBA/2J)	decreased spleen iron level	J:199427
	increased blood urea nitrogen level	J:199427
	increased circulating alanine transaminase level	J:199427
	increased circulating aspartate transaminase level	J:199427
	increased circulating bilirubin level	J:199427
	increased kidney iron level	J:199427
	increased liver iron level	J:199427
Ank1^M1Btlr/Ank1⁺ (C57BL/6J-Ank1^m1Btlr)	increased circulating bilirubin level	J:203831
Ank1^M1Btlr/Ank1^M1Btlr (C57BL/6J-Ank1^m1Btlr)	increased circulating bilirubin level	J:203831
	increased circulating erythropoietin level	J:203831
	increased spleen iron level	J:203831
Ank1^MRI23420/Ank1⁺ (SJL/J-Ank1^MRI23420)	increased spleen iron level	J:187820
Ank1^nb/Ank1⁺ (involves: C57BL/6J * WB/Re)	increased erythrocyte protoporphyrin level	J:5985
Ank1^nb/Ank1^nb (either: (involves: non-inbred stock) or (involves: C57BL/6) or (involves: WB/Re))	abnormal iron homeostasis	J:30699
Ank1^nb/Ank1^nb (involves: C57BL/6J * WB/Re)	abnormal iron homeostasis	J:3122
	abnormal kidney iron level	J:3122
	hemosiderosis	J:3122
	increased erythrocyte protoporphyrin level	J:5985
	increased liver iron level	J:3122
Ank1^nb/Ank1^nb ((WB.Cg-Ank1^nb/BrkJ x B6.Cg-Ank1^nb/BrkJ)F1)	abnormal cardiac thrombosis	J:62355
	increased circulating bilirubin level	J:162532
Ank1^Rbc2/Ank1^Rbc2 (involves: 129S1/Sv * BALB/c)	increased circulating bilirubin level	J:148127
Ank1^Rbc2/Ank1^Rbc2 (involves: 129S1/Sv * BALB/c)	increased liver iron level	J:148127
Ank1^tm1Vso/Ank1^tm1Vso (B6J.129S4-Ank1^tm1Vso)	abnormal calcium ion homeostasis	J:223673
Ank2^tm2.1Bnt/Ank2⁺ (STOCK Ank2^tm2Bnt/J)	impaired glucose tolerance	J:222913
Ank2^tm2.1Bnt/Ank2^tm2.1Bnt (STOCK Ank2^tm2Bnt/J)	abnormal gluconeogenesis	J:222913
	impaired glucose tolerance	J:222913
	increased circulating free fatty acids level	J:222913
	increased circulating glucose level	J:222913
	increased susceptibility to diet-induced obesity	J:222913
	insulin resistance	J:222913
Ank2^tm3.1Bnt/Ank2⁺ (B6.129(C)-Ank2^tm3.1Bnt/J)	impaired glucose tolerance	J:222913
Ank2^tm3.1Bnt/Ank2⁺ (B6.129(C)-Ank2^tm3.1Bnt/J)	increased circulating glucose level	J:222913
Ank2^tm3.1Bnt/Ank2^tm3.1Bnt (B6.129(C)-Ank2^tm3.1Bnt/J)	abnormal gluconeogenesis	J:222913
	abnormal glucose homeostasis	J:222913
	decreased circulating insulin level	J:222913
	decreased insulin secretion	J:222913
	impaired glucose tolerance	J:222913
	increased circulating free fatty acids level	J:222913
	increased circulating glucose level	J:222913
	increased susceptibility to diet-induced obesity	J:222913
	insulin resistance	J:222913
Ank^ank/Ank^ank (involves: C3HeB/FeJ * C57BL/6J * JGBF/LeJ)	abnormal ion homeostasis	J:63420
Ank^tm1.1Ejr/Ank^tm1.1Ejr (B6.129-Ank^tm1.1Ejr)	abnormal circulating enzyme level	J:168526
Ank^tm1.1Ejr/Ank^tm1.1Ejr (B6.129-Ank^tm1.1Ejr)	increased circulating alkaline phosphatase level	J:168526
Ankhd1^{tm1a(KOMP)Wtsi}/Ankhd1^{tm1a(KOMP)Wtsi} (C57BL/6N-Ankhd1^{tm1a(KOMP)Wtsi}/Wtsi)	increased circulating amylase level	J:211773
	increased circulating insulin level	J:211773
Ankib1^{tm1b(EUCOMM)Hmgu}/Ankib1^{tm1b(EUCOMM)Hmgu} (C57BL/6N-Ankib1^{tm1b(EUCOMM)Hmgu}/H)	increased circulating alkaline phosphatase level	J:211773
	increased circulating phosphate level	J:211773
	increased fasting circulating glucose level	J:211773
Ankmy2^{tm1b(EUCOMM)Hmgu}/Ankmy2^{tm1b(EUCOMM)Hmgu} Ift88^tm1Bky/Ift88^tm1Bky (involves: 129P2/OlaHsd * C57BL/6 * C57BL/6N)	pericardial effusion	J:297055
Ankrd11^{tm1b(EUCOMM)Wtsi}/Ankrd11⁺ (C57BL/6N-Ankrd11^{tm1b(EUCOMM)Wtsi}/Ics)	increased circulating cholesterol level	J:211773
	increased circulating HDL cholesterol level	J:211773
Ankrd11^Yod/Ankrd11⁺ (involves: BALB/cAnNCrl * C3H/HeH)	decreased circulating leptin level	J:136455
Ankrd17^tm1.1Yty/Ankrd17^tm1.1Yty (B6.129P2-Ankrd17^tm1.1Yty)	hemopericardium	J:152840
Ankrd26^Gt(XK525)Byg/Ankrd26^Gt(XK525)Byg (involves: 129P2/OlaHsd * C57BL/6)	abnormal energy expenditure	J:130984
	increased circulating free fatty acids level	J:130984
	increased circulating insulin level	J:130984
	increased circulating leptin level	J:130984
	increased circulating triglyceride level	J:130984
	insulin resistance	J:130984
Ano1^tm1Bdh/Ano1^tm1Bdh (involves: 129S1/Sv)	cyanosis	J:138613
Ano1^tm1Jrr/Ano1^tm1Jrr (involves: 129S6/SvEvTac)	increased urine protein level	J:210158
Ano1^tm2Jrr/Ano1^tm2Jrr Tg(Cdh16-cre)91Igr/0 (involves: 129S6/SvEvTac * ICR)	albuminuria	J:210158
	decreased urine chloride ion level	J:210158
	decreased urine potassium level	J:210158
	decreased urine sodium level	J:210158
	increased circulating aldosterone level	J:210158
	increased circulating renin level	J:210158
	increased urine protein level	J:210158
Ano3^em2(IMPC)Mbp/Ano3^em2(IMPC)Mbp (C57BL/6N-Ano3^em2(IMPC)Mbp/Mmucd)	decreased circulating alanine transaminase level	J:211773
Ano3^tm1.1Lyj/Ano3^tm1.1Lyj Ptgds^{tm1.1(cre)Gvn}/Ptgds⁺ (involves: 129X1/SvJ * C57BL/6 * FVB/N)	abnormal body temperature homeostasis	J:310618
Ano3^tm1.1Lyj/Ano3^tm1.1Lyj Tg(Nes-cre)1Kln/0 (involves: 129X1/SvJ * C57BL/6)	abnormal body temperature homeostasis	J:310618
Ano4^{em1(IMPC)Kmpc}/Ano4^{em1(IMPC)Kmpc} (C57BL/6NTac-Ano4^{em1(IMPC)Kmpc}/Kmpc)	abnormal cholesterol homeostasis	J:211773
Ano5^em1Huyi/Ano5⁺ (C57BL/6N-Ano5^em1Huyi)	increased circulating alkaline phosphatase level	J:294237
Ano5^em1Huyi/Ano5^em1Huyi (C57BL/6N-Ano5^em1Huyi)	increased circulating alkaline phosphatase level	J:294237
Ano5^em1Huyi/Ano5^em1Huyi (C57BL/6N-Ano5^em1Huyi)	increased circulating creatine kinase level	J:294237
Ano5^em2Huyi/Ano5^em2Huyi (C57BL/6-Ano5^em2Huyi)	increased circulating alkaline phosphatase level	J:336715
Ano5^tm1Lrk/Ano5^tm1Lrk (involves: C57BL/6)	increased circulating creatine kinase level	J:235810
Ano6^em3(IMPC)Tcp/Ano6⁺ (C57BL/6NCrl-Ano6^em3(IMPC)Tcp/Tcp)	abnormal cholesterol homeostasis	J:211773
Ano6^tm1.2Lyj/Ano6^tm1.2Lyj (involves: 129X1/SvJ * C57BL/6)	abnormal platelet physiology	J:188263
	decreased susceptibility to induced thrombosis	J:188263
	increased bleeding time	J:188263
Ano6^tm1Avor/Ano6^tm1Avor (involves: 129)	increased bleeding time	J:260534
Anp32b^tm1Mak/Anp32b^tm1Mak (C.129P2(B6)-Anp32b^tm1Mak)	decreased circulating bilirubin level	J:227403
	decreased circulating cholesterol level	J:227403
	decreased circulating HDL cholesterol level	J:227403
	decreased circulating total protein level	J:227403
Antkmt^{tm1.1(KOMP)Vlcg}/Antkmt^{tm1.1(KOMP)Vlcg} (C57BL/6N-Antkmt^{tm1.1(KOMP)Vlcg}/Ucd)	increased circulating alanine transaminase level	J:211773
	increased circulating aspartate transaminase level	J:211773
Antxr2^{em1(IMPC)Wtsi}/Antxr2^{em1(IMPC)Wtsi} (C57BL/6N-Antxr2^{em1(IMPC)Wtsi}/Wtsi)	increased circulating alkaline phosphatase level	J:211773
anx/anx (B6C3Fe a/a-anx/J)	decreased body temperature	J:7689
	hypoglycemia	J:7689
	increased blood urea nitrogen level	J:7689
	increased blood uric acid level	J:7689
	increased circulating alkaline phosphatase level	J:7689
	increased circulating cholesterol level	J:7689
anx/anx (involves: DW/J * M. m. domesticus poschiavinus * Swiss)	decreased body temperature	J:13936
anx/anx Tyro3^m1/Tyro3^m1 (involves: C3HeB/FeJLe * C57BL/6J)	abnormal platelet activation	J:241666
Anxa1^{em1(IMPC)Ccpcz}/Anxa1^{em1(IMPC)Ccpcz} (C57BL/6NCrl-Anxa1^{em1(IMPC)Ccpcz}/Ccpcz)	decreased circulating iron level	J:211773
	increased circulating alanine transaminase level	J:211773
	increased circulating aspartate transaminase level	J:211773
Anxa1^tm1Rjf/Anxa1^tm1Rjf (Not Specified)	increased circulating insulin level	J:115806
Anxa1^tm1Rjf/Anxa1^tm1Rjf (involves: 129 * C57BL)	increased adrenocorticotropin level	J:135972
Anxa2^tm1Kah/Anxa2^tm1Kah (involves: 129X1/SvJ * C57BL/6)	abnormal blood coagulation	J:87621
Anxa2^tm1Kah/Anxa2^tm1Kah (involves: 129X1/SvJ * C57BL/6)	increased susceptibility to induced thrombosis	J:87621
Anxa6^{tm1(NCOM)Cmhd}/Anxa6^{tm1(NCOM)Cmhd} (C57BL/6N-Anxa6^{tm1(NCOM)Cmhd}/Tcp)	increased circulating sodium level	J:165965
Anxa7^tm1Ngl/Anxa7^tm1Ngl (involves: 129S2/SvPas)	abnormal ion homeostasis	J:69979, J:86832
Anxa7^tm1Ngl/Anxa7^tm1Ngl (involves: 129S2/SvPas)	abnormal platelet aggregation	J:91188
Anxa7^tm1Pll/Anxa7⁺ (Not Specified)	abnormal ion homeostasis	J:58572
Anxa7^tm1Pll/Anxa7⁺ (Not Specified)	decreased insulin secretion	J:58572
Aoc1^{tm1b(EUCOMM)Hmgu}/Aoc1^{tm1b(EUCOMM)Hmgu} (C57BL/6N-Aoc1^{tm1b(EUCOMM)Hmgu}/Ieg)	decreased circulating phosphate level	J:211773
	increased circulating alanine transaminase level	J:211773
aol/aol (involves: C3H * C57BL/6)	joint swelling	J:115238
Aopep^{tm1b(KOMP)Wtsi}/Aopep^{tm1b(KOMP)Wtsi} (C57BL/6N-Aopep^{tm1b(KOMP)Wtsi}/Ccpcz)	increased circulating alkaline phosphatase level	J:211773
Ap1g1^fgt/Ap1g1^fgt (C57BL/6-Ap1g1^fgt/KjnBoc)	decreased circulating thyroxine level	J:230572
Ap1m2^tm1.1Ohno/Ap1m2^tm1.1Ohno (involves: 129P2/OlaHsd * C57BL/6 * CD-1)	decreased circulating glucose level	J:226582
	decreased circulating serum albumin level	J:226582
	increased circulating cholesterol level	J:226582
Ap1s2^em1(IMPC)Mbp/Ap1s2^em1(IMPC)Mbp (C57BL/6N-Ap1s2^em1(IMPC)Mbp/MbpMmucd)	decreased fasting circulating glucose level	J:211773
Ap2a1^em1(IMPC)J/Ap2a1^em1(IMPC)J (C57BL/6NJ-Ap2a1^em1(IMPC)J/Mmjax)	decreased circulating creatinine level	J:211773
	improved glucose tolerance	J:211773
Ap2a2^{em1(IMPC)Wtsi}/Ap2a2⁺ (C57BL/6N-Ap2a2^{em1(IMPC)Wtsi}/Wtsi)	increased circulating cholesterol level	J:211773
	increased circulating HDL cholesterol level	J:211773
	increased circulating LDL cholesterol level	J:211773
Ap2a2^{tm1b(EUCOMM)Wtsi}/Ap2a2⁺ (C57BL/6N-Ap2a2^{tm1b(EUCOMM)Wtsi}/Wtsi)	increased circulating free fatty acids level	J:211773
Ap2a2^{tm1b(EUCOMM)Wtsi}/Ap2a2^{tm1b(EUCOMM)Wtsi} (C57BL/6N-Ap2a2^{tm1b(EUCOMM)Wtsi}/Wtsi)	decreased circulating fructosamine level	J:211773
	decreased circulating serum albumin level	J:211773
	increased circulating alkaline phosphatase level	J:211773
	increased circulating cholesterol level	J:211773
	increased circulating HDL cholesterol level	J:211773
	increased circulating iron level	J:211773
	increased circulating LDL cholesterol level	J:211773
Ap3b1^pe-rim2/Ap3b1^pe-rim2 (involves: B10.A(R201) * C57BL/10Slc)	abnormal platelet dense granule physiology	J:42685
	decreased platelet aggregation	J:42685
	decreased platelet ATP level	J:42685
Ap3b1^pe/Ap3b1^pe (involves: C3H/He)	abnormal blood coagulation	J:7327
	abnormal platelet dense granule physiology	J:7327
	decreased platelet serotonin level	J:7327
	increased bleeding time	J:7327
Ap3b1^pe/Ap3b1^pe (involves: C3H/He * C57BL/6J)	abnormal enzyme/coenzyme level	J:6219
Ap3b1^pe/Ap3b1^pe (B6.C3-Ap3b1^pe/J)	abnormal platelet activation	J:221384
	decreased platelet aggregation	J:221384
	decreased platelet ATP level	J:7327
	decreased platelet serotonin level	J:7327
	increased bleeding time	J:7327
Ap3b1^tm1Sms/Ap3b1^tm1Sms (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	abnormal mineral homeostasis	J:66256
	increased bleeding time	J:66256
Ap3d1^mh/Ap3d1^mh (STOCK Mfsd12^gr +/+ Ap3d1^mh/J)	decreased platelet aggregation	J:29151
	decreased platelet serotonin level	J:29151
	increased bleeding time	J:29151
Ap3d1^mh/Ap3d1^mh (B6.C3-Grxcr1^pi)	abnormal mineral level	J:50662
Ap3d1^mh/Ap3d1^mh (B6.C3-Grxcr1^pi)	increased bleeding time	J:88018
Ap3s1^{tm1b(EUCOMM)Hmgu}/Ap3s1^{tm1b(EUCOMM)Hmgu} (C57BL/6N-Ap3s1^{tm1b(EUCOMM)Hmgu}/Ieg)	increased circulating alkaline phosphatase level	J:211773
	increased fasting circulating glucose level	J:211773
Ap3s2^{tm1b(EUCOMM)Hmgu}/Ap3s2^{tm1b(EUCOMM)Hmgu} (C57BL/6N-Ap3s2^{tm1b(EUCOMM)Hmgu}/Cnrm)	decreased circulating fructosamine level	J:211773
Ap4e1^em1(IMPC)J/Ap4e1⁺ (C57BL/6NJ-Ap4e1^em1(IMPC)J/J)	decreased circulating glucose level	J:211773
	increased circulating free fatty acids level	J:211773
	increased circulating sodium level	J:211773
Ap4e1^em1(IMPC)J/Ap4e1^em1(IMPC)J (C57BL/6NJ-Ap4e1^em1(IMPC)J/J)	decreased circulating free fatty acids level	J:211773
	decreased circulating triglyceride level	J:211773
Ap4e1^em2(IMPC)Mbp/Ap4e1^em2(IMPC)Mbp (C57BL/6NCrl-Ap4e1^em2(IMPC)Mbp/Mmucd)	abnormal cholesterol homeostasis	J:211773
	increased circulating aspartate transaminase level	J:211773
Ap4e1^{tm1b(KOMP)Wtsi}/Ap4e1^{tm1b(KOMP)Wtsi} (C57BL/6N-Ap4e1^{tm1b(KOMP)Wtsi}/Wtsi)	decreased respiratory quotient	J:211773
	increased circulating alkaline phosphatase level	J:211773
	increased circulating aspartate transaminase level	J:211773
	increased circulating creatine kinase level	J:211773
Ap4e1^{tm1b(KOMP)Wtsi}/Ap4e1^{tm1b(KOMP)Wtsi} (C57BL/6N-Ap4e1^{tm1b(KOMP)Wtsi}/Ieg)	impaired glucose tolerance	J:211773
	increased circulating amylase level	J:211773
Ap4e1^{tm1b(KOMP)Wtsi}/Ap4e1^{tm1b(KOMP)Wtsi} (C57BL/6N-Ap4e1^{tm1b(KOMP)Wtsi}/J)	decreased circulating glucose level	J:211773
Ap4e1^{tm1b(KOMP)Wtsi}/Ap4e1^{tm1b(KOMP)Wtsi} (C57BL/6N-Ap4e1^{tm1b(KOMP)Wtsi}/Ccpcz)	abnormal cholesterol homeostasis	J:211773
	decreased circulating chloride level	J:211773
	increased fasting circulating glucose level	J:211773
Ap4m1^{tm1b(EUCOMM)Wtsi}/Ap4m1^{tm1b(EUCOMM)Wtsi} (C57BL/6N-Ap4m1^{tm1b(EUCOMM)Wtsi}/Wtsi)	decreased circulating serum albumin level	J:211773
	increased circulating alanine transaminase level	J:211773
	increased circulating alkaline phosphatase level	J:211773
	increased circulating aspartate transaminase level	J:211773
	increased circulating cholesterol level	J:211773
	increased circulating iron level	J:211773
Ap5m1^em1(IMPC)Mbp/Ap5m1^em1(IMPC)Mbp (C57BL/6N-Ap5m1^em1(IMPC)Mbp/MbpMmucd)	increased circulating serum albumin level	J:211773
	increased circulating total protein level	J:211773
Apba1^tm1Amor/Apba1^tm1Amor (involves: 129 * C57BL/6J)	abnormal dopamine level	J:102794
Apba2^tm1Tsuz/Apba2^tm1Tsuz (C57BL/6-Apba2^tm1Tsuz)	abnormal body temperature homeostasis	J:148481
Apba2^tm1Tsuz/Apba2^tm1Tsuz (C57BL/6-Apba2^tm1Tsuz)	increased serotonin level	J:148481
Apba3^tm1.2Ski/Apba3^tm1.2Ski (B6.129-Apba3^tm1.2Ski)	decreased circulating interleukin-12 level	J:176742
Apba3^tm1.2Ski/Apba3^tm1.2Ski (B6.129-Apba3^tm1.2Ski)	decreased circulating tumor necrosis factor level	J:176742
Apbb1ip^{em1(IMPC)Ccpcz}/Apbb1ip^{em1(IMPC)Ccpcz} (C57BL/6N-Apbb1ip^{em1(IMPC)Ccpcz}/Ccpcz)	decreased blood urea nitrogen level	J:211773
	increased circulating iron level	J:211773
Apbb2^M1Btlr/Apbb2^M1Btlr (C57BL/6J-Apbb2^M1Btlr)	impaired glucose tolerance	J:265064
Apbb2^m2Btlr/Apbb2^m2Btlr (C57BL/6J-Apbb2^m2Btlr)	impaired glucose tolerance	J:265072
Apbb2^{tm1.1(KOMP)Vlcg}/Apbb2⁺ (C57BL/6N-Apbb2^{tm1.1(KOMP)Vlcg}/Ucd)	increased circulating alanine transaminase level	J:211773
	increased circulating aspartate transaminase level	J:211773
Apc^Min/Apc⁺ (involves: AKR/J * C57BL/6J)	hyperlipidemia	J:10209
Apc^Min/Apc⁺ (C57BL/6J-Apc^Min)	increased circulating free fatty acids level	J:86036
	increased circulating triglyceride level	J:86036
	increased prostaglandin level	J:85142
Apc^Min/Apc⁺ Hsd11b2^tm1.1Mzz/Hsd11b2^tm1.1Mzz Tg(Vil1-cre)997Gum/0 (involves: 129 * C57BL/6 * C57BL/6J)	abnormal corticosterone level	J:205456
Apc^Min/Apc⁺ Ptgs1^tm1Unc/Ptgs1^tm1Unc (involves: 129P2/OlaHsd * C57BL/6J)	decreased prostaglandin level	J:64401
Apc^Min/Apc⁺ Ptgs2^tm1Unc/Ptgs2^tm1Unc (involves: 129P2/OlaHsd * C57BL/6J)	decreased prostaglandin level	J:64401
Apc^tm1Kk/Apc^tm1Kk Tg(Lck-cre)1Cwi/? (involves: 129S6/SvEvTac * C57BL/6 * DBA/2)	increased circulating tumor necrosis factor level	J:128606
Apc^tm1Tno/Apc^tm1Tno Pten^tm2Mak/Pten^tm2Mak (involves: 129P2/OlaHsd * 129S4/SvJae)	hemorrhagic ascites	J:120955
Apc^tm1Tno/Apc^tm1Tno Tg(Cdh16-cre)91Igr/0 (involves: 129S4/SvJae * ICR)	increased blood urea nitrogen level	J:95502
Apc^tm2.1Cip/Apc^tm2.1Cip Lect2^tm1Ymg/Lect2^tm1Ymg Tg(Ttr-cre/Esr1)1Vco/0 (B6.Cg-Lect2^tm1Ymg Apc^tm2.1Cip Tg(Ttr-cre/Esr1)1Vco)	abnormal chemokine level	J:184496
	abnormal circulating enzyme level	J:184496
Apc^tm2Rak/Apc⁺ Trp53^tm1Brn/Trp53^tm1Brn Tg(Pdx1-cre)6Tuv/0 (involves: 129/Sv * 129P2/OlaHsd * C57BL/6J * FVB/N * SJL)	abnormal cytokine level	J:234310
	increased circulating cholesterol level	J:234310
	increased circulating triglyceride level	J:234310
Apc^tm2Tno/Apc⁺ (involves: C57BL/6J)	hyperlipidemia	J:86036
	increased circulating cholesterol level	J:86036
	increased circulating free fatty acids level	J:86036
	increased circulating triglyceride level	J:86036
Apela^tm1.2Brre/Apela^tm1.2Brre (B6(Cg)-Apela^tm1.2Brre)	increased urine protein level	J:244834
Apela^tm1.2Brre/Apela^tm1.2Brre (B6(Cg)-Apela^tm1.2Brre)	pericardial edema	J:244834
Apex1^tm1Cur/Apex1⁺ (involves: 129S1/Sv)	abnormal nitric oxide homeostasis	J:102294
	increased circulating interleukin-1 alpha level	J:119957
	increased circulating interleukin-10 level	J:119957
Apip^{tm1b(EUCOMM)Wtsi}/Apip^{tm1b(EUCOMM)Wtsi} (C57BL/6N-Apip^{tm1b(EUCOMM)Wtsi}/Wtsi)	decreased circulating serum albumin level	J:211773
Apln^tm1Tq/Y (B6.129S6-Apln^tm1Tq)	decreased oxygen consumption	J:154303
Apln^tm1Tq/Apln^tm1Tq (B6.129S6-Apln^tm1Tq)	decreased oxygen consumption	J:154303
Aplnr^tm1.1Path/Aplnr^tm1.1Path (Not Specified)	pulmonary edema	J:227456
Aplnr^tm1Dgen/Aplnr^tm1Dgen (involves: 129X1/SvJ * C57BL/6J)	decreased urine osmolality	J:186909
Aplnr^tm1Path/Aplnr^tm1Path Tg(Kdr-cre)#Brei/0 (involves: C57BL/6)	pulmonary edema	J:227456
Apmap^em1(IMPC)J/Apmap^em1(IMPC)J (C57BL/6NJ-Apmap^em1(IMPC)J/Mmjax)	increased circulating alanine transaminase level	J:211773
	increased circulating HDL cholesterol level	J:211773
	increased circulating phosphate level	J:211773
Apmap^tm1.2Jgbs/Apmap^tm1.2Jgbs (B6.129P2-Apmap^tm1.2Jgbs)	decreased circulating glucose level	J:247647
	decreased circulating leptin level	J:247647
	decreased collagen level	J:247647
	improved glucose tolerance	J:247647
	increased circulating leptin level	J:247647
	increased insulin sensitivity	J:247647
	increased respiratory quotient	J:247647
Apoa1^{tm1(APOA1)Prli}/Apoa1^{tm2(APOA1)Prli} (involves: 129X1/SvJ * C57BL/6J)	decreased circulating cholesterol level	J:81908
Apoa1^tm1Bres/Apoa1⁺ (involves: 129S4/SvJae * C57BL/6)	decreased circulating HDL cholesterol level	J:40819
Apoa1^tm1Bres/Apoa1^tm1Bres (involves: 129S4/SvJae * C57BL/6)	decreased circulating cholesterol level	J:40819
	decreased circulating HDL cholesterol level	J:40819
	decreased circulating LDL cholesterol level	J:40819
	decreased circulating VLDL cholesterol level	J:40819
	increased circulating triglyceride level	J:40819
Apoa1^tm1Bres/Apoa1^tm1Bres Apoa2^tm1Bres/Apoa2^tm1Bres (involves: 129S4/SvJae * C57BL/6)	decreased circulating HDL cholesterol level	J:40819
Apoa1^tm1Bres/Apoa1^tm1Bres Tg(Mt1-CETP)#Tall/0 (involves: 129S4/SvJae * C57BL/6 * CBA/J)	decreased circulating HDL cholesterol level	J:40819
Apoa1^tm1Unc/Apoa1⁺ (involves: 129P2/OlaHsd * C57BL/6J)	decreased circulating cholesterol level	J:2109
Apoa1^tm1Unc/Apoa1⁺ (involves: 129P2/OlaHsd * C57BL/6J)	decreased circulating HDL cholesterol level	J:2109
Apoa1^tm1Unc/Apoa1⁺ (B6.129P2-Apoa1^tm1Unc)	decreased circulating cholesterol level	J:22986
Apoa1^tm1Unc/Apoa1^tm1Unc (B6.129P2-Apoa1^tm1Unc/J)	decreased circulating cholesterol level	J:114205
	decreased circulating HDL cholesterol level	J:114205
	decreased circulating phospholipid level	J:114205
	increased circulating cholesterol level	J:114205
	increased circulating triglyceride level	J:114205
Apoa1^tm1Unc/Apoa1^tm1Unc (involves: 129P2/OlaHsd * C57BL/6J)	decreased circulating cholesterol level	J:2109
	decreased circulating HDL cholesterol level	J:2109
Apoa1^tm1Unc/Apoa1^tm1Unc (B6.129P2-Apoa1^tm1Unc)	decreased circulating cholesterol level	J:22986
Apoa1^tm1Unc/Apoa1^tm1Unc (involves: 129P2/OlaHsd)	decreased circulating cholesterol level	J:129136
	decreased circulating HDL cholesterol level	J:129136
	decreased circulating phospholipid level	J:129136
Apoa1^tm1Unc/Apoa1^tm1Unc Ldlr^tm1Her/Ldlr^tm1Her (B6.129-Ldlr^tm1Her Apoa1^tm1Unc)	decreased cholesterol level	J:85174
	decreased circulating cholesterol level	J:85174
	decreased circulating HDL cholesterol level	J:85174
	decreased circulating LDL cholesterol level	J:85174
	decreased circulating VLDL cholesterol level	J:85174
	decreased liver cholesterol level	J:85174
	increased circulating triglyceride level	J:85174
	xanthoma	J:85174
Apoa1^tm1Unc/Apoa1^tm1Unc Tg(APOA1)1Rub/0 (involves: 129P2/OlaHsd * C57BL/6)	increased circulating cholesterol level	J:129136
	increased circulating HDL cholesterol level	J:129136
	increased circulating triglyceride level	J:129136
Apoa1^tm1Unc/Apoa1^tm1Unc Tg(APOA2)3Rub/0 (involves: 129P2/OlaHsd * C57BL/6)	decreased circulating cholesterol level	J:129136
	increased circulating triglyceride level	J:129136
Apoa1^{tm2(APOA1)Prli}/Apoa1^{tm2(APOA1)Prli} (involves: 129X1/SvJ * C57BL/6J)	abnormal cholesterol homeostasis	J:81908
	decreased circulating cholesterol level	J:81908
	decreased circulating HDL cholesterol level	J:81908
Apoa2^b/? (involves: KK * RR)	increased circulating cholesterol level	J:99474
Apoa2^tm1Bres/Apoa2⁺ Apoe^tm1Bres/Apoe^tm1Bres (involves: 129P2/OlaHsd * 129S4/SvJae)	decreased circulating cholesterol level	J:37250
Apoa2^tm1Bres/Apoa2^tm1Bres (involves: 129S4/SvJae)	abnormal cholesterol homeostasis	J:37250
	decreased circulating cholesterol level	J:37250
	decreased circulating free fatty acids level	J:37250
	decreased circulating glucose level	J:37250
	decreased circulating HDL cholesterol level	J:37250
	decreased circulating insulin level	J:37250
Apoa2^tm1Bres/Apoa2^tm1Bres Apoe^tm1Bres/Apoe^tm1Bres (involves: 129P2/OlaHsd * 129S4/SvJae)	decreased circulating cholesterol level	J:37250
	decreased circulating HDL cholesterol level	J:37250
Apoa4^tm1Bres/Apoa4^tm1Bres (either: 129S4/SvJae or (involves: 129S4/SvJae * C57BL/6))	abnormal cholesterol homeostasis	J:43015
	abnormal lipid homeostasis	J:43015
	decreased circulating cholesterol level	J:43015
	decreased circulating HDL cholesterol level	J:43015
	decreased circulating triglyceride level	J:43015
	decreased circulating VLDL triglyceride level	J:43015
Apoa5^tm1Hgc/Apoa5⁺ (involves: 129X1/SvJ * C57BL/6)	increased circulating VLDL cholesterol level	J:72092
Apoa5^tm1Hgc/Apoa5^tm1Hgc (involves: 129X1/SvJ * C57BL/6)	increased circulating triglyceride level	J:72092
Apoa5^tm1Hgc/Apoa5^tm1Hgc (involves: 129X1/SvJ * C57BL/6)	increased circulating VLDL cholesterol level	J:72092
Apob^tm1.1Zc/Apob⁺ (involves: 129X1/SvJ * C57BL/6)	decreased circulating LDL cholesterol level	J:65191
Apob^tm1.1Zc/Apob⁺ (involves: 129X1/SvJ * C57BL/6)	decreased circulating VLDL cholesterol level	J:65191
Apob^tm1.1Zc/Apob^tm1.1Zc (involves: 129X1/SvJ * C57BL/6)	decreased circulating HDL cholesterol level	J:65191
	decreased circulating LDL cholesterol level	J:65191
	decreased circulating triglyceride level	J:65191
	decreased circulating VLDL cholesterol level	J:65191
Apob^tm1Mae/Apob⁺ (involves: 129P2/OlaHsd * C57BL/6J)	abnormal circulating apolipoprotein level	J:113171, J:36426
	abnormal triglyceride level	J:113171
	decreased circulating cholesterol level	J:113171
Apob^tm1Mae/Apob^tm1Mae (involves: 129P2/OlaHsd * C57BL/6J)	abnormal circulating apolipoprotein level	J:36426
	abnormal circulating HDL cholesterol level	J:36426
	decreased circulating cholesterol level	J:36426
	decreased circulating LDL cholesterol level	J:36426
	decreased circulating VLDL cholesterol level	J:36426
Apob^tm1Sgy/Apob^tm1Sgy (involves: 129/Sv * C57BL/6)	decreased circulating LDL cholesterol level	J:33830
Apob^tm1Sgy/Apob^tm1Sgy (involves: 129/Sv * C57BL/6)	decreased circulating triglyceride level	J:33830
Apob^tm1Sgy/Apob^tm1Sgy Apoe^tm1Unc/Apoe^tm1Unc (involves: 129P2/OlaHsd * 129S7/SvEvBrd * C57BL/6)	increased circulating cholesterol level	J:41510
	increased circulating triglyceride level	J:41510
	increased circulating VLDL cholesterol level	J:41510
Apob^tm1Unc/Apob⁺ (involves: 129P2/OlaHsd * C57BL/6J)	abnormal circulating cholesterol level	J:16352
	decreased circulating HDL cholesterol level	J:16352
	decreased circulating triglyceride level	J:16352
Apob^tm1Unc/Apob^tm1Unc (involves: 129P2/OlaHsd * C57BL/6J)	abnormal circulating cholesterol level	J:16352
	decreased circulating HDL cholesterol level	J:16352
	decreased circulating triglyceride level	J:16352
Apob^tm1Zc/Apob⁺ (involves: 129/Sv * C57BL/6)	decreased circulating cholesterol level	J:76047
	decreased circulating HDL cholesterol level	J:76047
	decreased circulating LDL cholesterol level	J:76047
	decreased circulating triglyceride level	J:76047
	decreased circulating VLDL cholesterol level	J:76047
Apob^tm1Zc/Apob^tm1.1Zc (involves: 129/Sv * C57BL/6)	decreased circulating cholesterol level	J:76047
	decreased circulating HDL cholesterol level	J:76047
	decreased circulating LDL cholesterol level	J:76047
	decreased circulating triglyceride level	J:76047
	decreased circulating VLDL cholesterol level	J:76047
Apob^tm1Zc/Apob^tm1Zc (involves: 129/Sv * C57BL/6)	decreased circulating cholesterol level	J:76047
Apob^tm1Zc/Apob^tm1Zc (involves: 129/Sv * C57BL/6)	decreased circulating triglyceride level	J:76047
Apob^tm2Sgy/Apob^tm2Sgy (involves: 129/Sv * C57BL/6)	increased circulating LDL cholesterol level	J:33830
Apob^tm2Sgy/Apob^tm2Sgy (involves: 129/Sv * C57BL/6)	increased circulating triglyceride level	J:33830
Apob^tm2Sgy/Apob^tm2Sgy Apoe^tm1Unc/Apoe^tm1Unc (involves: 129P2/OlaHsd * 129S7/SvEvBrd * C57BL/6)	abnormal cholesterol homeostasis	J:41510
	decreased circulating cholesterol level	J:41510
	increased circulating HDL cholesterol level	J:41510
	increased circulating triglyceride level	J:41510
	increased circulating VLDL cholesterol level	J:41510
	increased circulating VLDL triglyceride level	J:41510
Apob^tm2Sgy/Apob^tm2Sgy Apoe^tm1Unc/Apoe^tm1Unc Lep^ob/Lep^ob (involves: 129P2/OlaHsd * 129S7/SvEvBrd * C57BL/6)	abnormal circulating cholesterol level	J:133453
	decreased circulating HDL cholesterol level	J:133453
	hyperglycemia	J:133453
	impaired glucose tolerance	J:133453
	increased circulating cholesterol level	J:133453
	increased circulating free fatty acids level	J:133453
	increased circulating insulin level	J:133453
	increased circulating triglyceride level	J:133453
	increased circulating VLDL cholesterol level	J:133453
Apob^tm2Sgy/Apob^tm2Sgy Ldlr^tm1Her/Ldlr^tm1Her (involves: 129S7/SvEvBrd * C57BL/6J)	increased circulating cholesterol level	J:227165
	increased circulating insulin level	J:227165
Apob^tm2Sgy/Apob^tm2Sgy Ldlr^tm1Her/Ldlr^tm1Her Lep^ob/Lep^ob (involves: 129S7/SvEvBrd * C57BL/6)	abnormal circulating cholesterol level	J:133453
	decreased circulating HDL cholesterol level	J:133453
	increased circulating cholesterol level	J:133453
	increased circulating free fatty acids level	J:133453
	increased circulating insulin level	J:133453
	increased circulating LDL cholesterol level	J:133453
	increased circulating triglyceride level	J:133453
Apob^tm2Sgy/Apob^tm2Sgy Ldlr^tm1Her/Ldlr^tm1Her Tg(Ins-Igf2)1Fbos/? (involves: 129S7/SvEvBrd * C57BL/6 * SJL)	impaired glucose tolerance	J:141333
	increased circulating glucose level	J:141333
	increased circulating insulin level	J:141333
Apob^tm2Sgy/Apob^tm2Sgy Ldlr^tm1Her/Ldlr^tm1Her Tg(Ins-Igf2)1Fbos/? (involves: 129S7/SvEvBrd * C57BL/6 * C57BL/6J * SJL)	abnormal fasting circulating glucose level	J:227165
	increased circulating cholesterol level	J:227165
	increased circulating insulin level	J:227165
Apob^tm2Sgy/Apob^tm4Sgy (involves: 129/Sv * 129S4/SvJae * C57BL/6)	decreased circulating cholesterol level	J:46549
Apob^tm3Sgy/Apob⁺ (involves: 129S7/SvEvBrd * C57BL/6)	abnormal cholesterol homeostasis	J:23315
	decreased circulating cholesterol level	J:23315
	decreased circulating HDL cholesterol level	J:23315
Apob^tm5Sgy/Apob^tm5Sgy (involves: 129S4/SvJae * C57BL/6)	decreased circulating LDL cholesterol level	J:51549
Apob^tm5Sgy/Apob^tm5Sgy (involves: 129S4/SvJae * C57BL/6)	decreased circulating VLDL cholesterol level	J:51549
Apobec1^tm1Chan/Apobec1^tm1Chan (involves: 129S4/SvJae * C57BL/6)	decreased circulating HDL cholesterol level	J:36051
Apobec1^tm1Chan/Apobec1^tm1Chan Apoe^tm1Unc/Apoe^tm1Unc (involves: 129P2/OlaHsd * 129S4/SvJae)	abnormal circulating cholesterol level	J:48202
	decreased circulating cholesterol level	J:48202
	increased circulating cholesterol level	J:48202
	increased circulating triglyceride level	J:48202
Apobec1^tm1Chan/Apobec1^tm1Chan Ldlr^tm1Her/Ldlr^tm1Her (involves: 129S4/SvJae * 129S7/SvEvBrd)	abnormal circulating cholesterol level	J:48202
	decreased circulating triglyceride level	J:48202
	increased circulating cholesterol level	J:48202
	increased circulating triglyceride level	J:48202
Apobec1^tm1Chan/Apobec1^tm1Chan Tg(CETP)5203Tall/0 (involves: 129S4/SvJae * C57BL/6J * CBA/J)	abnormal circulating cholesterol level	J:48202
	decreased circulating HDL cholesterol level	J:48202
	decreased circulating triglyceride level	J:48202
	increased circulating cholesterol level	J:48202
	increased circulating triglyceride level	J:48202
Apobec1^tm1Ddsn/Apobec1^tm1Ddsn (B6.129S4-Apobec1^tm1Ddsn)	abnormal lipid homeostasis	J:108052
Apobec1^tm1Ddsn/Apobec1^tm1Ddsn (B6.129S4-Apobec1^tm1Ddsn)	abnormal triglyceride level	J:108052
Apobec1^tm1Ddsn/Apobec1^tm1Ddsn Fgg^tm1Fjc/Fgg^tm1Fjc Ldlr^tm1Her/Ldlr^tm1Her (B6.129-Fgg^tm1Fjc Apobec1^tm1Ddsn Ldlr^tm1Her)	abnormal blood coagulation	J:132734
	increased circulating LDL cholesterol level	J:132734
Apobec1^tm1Ddsn/Apobec1^tm1Ddsn Ldlr^tm1Her/Ldlr^tm1Her (involves: 129S4/SvJae * 129S7/SvEvBrd * C57BL/6)	increased circulating cholesterol level	J:49125
	increased circulating LDL cholesterol level	J:49125
	increased circulating triglyceride level	J:49125
Apobec1^tm1Ddsn/Apobec1^tm1Ddsn Ldlr^tm1Her/Ldlr^tm1Her (B6.129-Apobec1^tm1Ddsn Ldlr^tm1Her)	abnormal blood coagulation	J:132734
	decreased partial thromboplastin time	J:132734
	decreased prothrombin time	J:132734
	increased circulating antithrombin level	J:132734
	increased circulating LDL cholesterol level	J:132734
	increased circulating prothrombin level	J:132734
Apobec1^tm1Ishi/Apobec1^tm1Ishi (involves: 129S7/SvEvBrd * C57BL/6)	decreased cholesterol level	J:41982
	increased cholesterol level	J:41982
Apobec1^tm1Ishi/Apobec1^tm1Ishi Apoe^tm1Unc/Apoe^tm1Unc (involves: 129P2/OlaHsd * 129S7/SvEvBrd * C57BL/6)	decreased cholesterol level	J:41982
	increased circulating triglyceride level	J:41982
Apobec1^tm1Rub/Apobec1^tm1Rub (involves: C57BL/6 * DBA)	abnormal lipid homeostasis	J:74021
	decreased circulating HDL cholesterol level	J:74021
	increased circulating LDL cholesterol level	J:74021
Apobec1^tm1Rub/Apobec1^tm1Rub Apoe^{tm1(APOE2)Mae}/Apoe^{tm1(APOE2)Mae} (involves: 129P2/OlaHsd * C57BL/6)	decreased circulating cholesterol level	J:79196
	decreased circulating LDL cholesterol level	J:79196
	increased circulating HDL cholesterol level	J:79196
	increased circulating triglyceride level	J:79196
	increased circulating VLDL triglyceride level	J:79196
Apoc1^tm1Lmh/Apoc1^tm1Lmh (involves: 129P2/OlaHsd * C57BL/6)	abnormal circulating cholesterol level	J:22858
	abnormal lipid level	J:117482
	increased cholesterol level	J:117482
	increased circulating cholesterol level	J:22858
	increased circulating triglyceride level	J:22858
	increased liver triglyceride level	J:117482
Apoc1^tm1Lmh/Apoc1^tm1Lmh Tg(CETP)5203Tall/0 (involves: 129P2/OlaHsd * C57BL/6 * CBA/J)	abnormal lipid level	J:117482
	abnormal phospholipid level	J:117482
	increased bile salt level	J:117482
	increased cholesterol level	J:117482
	increased liver triglyceride level	J:117482
Apoc1^tm2Lmh/Apoc1^tm2Lmh Apoe^tm1Bres/Apoe^tm1Bres (involves: 129P2/OlaHsd * C57BL/6)	abnormal cholesterol homeostasis	J:28261
	increased circulating cholesterol level	J:28261
Apoc2^em1Arem/Apoc2⁺ (involves: C57BL/6 * FVB/NJ)	increased circulating HDL cholesterol level	J:227332
	increased circulating triglyceride level	J:227332
	increased circulating VLDL triglyceride level	J:227332
Apoc2^em1Arem/Apoc2^em1Arem (involves: C57BL/6 * FVB/NJ)	abnormal blood homeostasis	J:227332
	abnormal circulating cholesterol level	J:227332
	abnormal lipoprotein level	J:227332
	decreased circulating HDL cholesterol level	J:227332
	increased circulating triglyceride level	J:227332
	increased circulating VLDL triglyceride level	J:227332
Apoc2^em2Arem/Apoc2⁺ (involves: C57BL/6 * CBA)	increased circulating HDL cholesterol level	J:227332
	increased circulating triglyceride level	J:227332
	increased circulating VLDL triglyceride level	J:227332
Apoc2^em2Arem/Apoc2^em2Arem (involves: C57BL/6 * CBA)	abnormal blood homeostasis	J:227332
	abnormal circulating cholesterol level	J:227332
	abnormal lipoprotein level	J:227332
	decreased circulating HDL cholesterol level	J:227332
	increased circulating triglyceride level	J:227332
	increased circulating VLDL triglyceride level	J:227332
Apoc3^tm1Unc/Apoc3⁺ (involves: 129P2/OlaHsd * C57BL/6J)	decreased circulating cholesterol level	J:21750
	decreased circulating HDL cholesterol level	J:21750
	decreased circulating triglyceride level	J:21750
Apoc3^tm1Unc/Apoc3⁺ (involves: 129)	decreased circulating cholesterol level	J:21750
	decreased circulating LDL cholesterol level	J:21750
	decreased circulating triglyceride level	J:21750
	decreased circulating VLDL cholesterol level	J:21750
Apoc3^tm1Unc/Apoc3^tm1Unc (involves: 129P2/OlaHsd * C57BL/6J)	abnormal lipid homeostasis	J:21750
	decreased circulating cholesterol level	J:21750
	decreased circulating HDL cholesterol level	J:21750
	decreased circulating LDL cholesterol level	J:21750
	decreased circulating triglyceride level	J:21750
	decreased circulating VLDL cholesterol level	J:21750
Apoc3^tm1Unc/Apoc3^tm1Unc (involves: 129)	decreased circulating cholesterol level	J:21750
	decreased circulating LDL cholesterol level	J:21750
	decreased circulating triglyceride level	J:21750
	decreased circulating VLDL cholesterol level	J:21750
Apoc3^tm1Unc/Apoc3^tm1Unc (B6.129-Apoc3^tm1Unc/J)	abnormal blood homeostasis	J:105136
	decreased circulating triglyceride level	J:105136
	decreased energy expenditure	J:105136
	increased circulating glucose level	J:105136
	increased circulating ketone body level	J:105136
	increased circulating leptin level	J:105136
	increased susceptibility to diet-induced obesity	J:105136
	insulin resistance	J:105136
	lipidosis	J:105136
Apoc4^{tm1.1(KOMP)Mbp}/Apoc4^{tm1.1(KOMP)Mbp} (C57BL/6N-Apoc4^{tm1.1(KOMP)Mbp}/Ieg)	decreased circulating chloride level	J:211773
	decreased circulating cholesterol level	J:211773
	decreased circulating HDL cholesterol level	J:211773
	impaired glucose tolerance	J:211773
	increased circulating alanine transaminase level	J:211773
	increased circulating alkaline phosphatase level	J:211773
	increased circulating triglyceride level	J:211773
Apod^tm1Dsan/Apod^tm1Dsan (either: B6.129X1-Apod^tm1Dsan or C.129X1-Apod^tm1Dsan)	abnormal lipid homeostasis	J:143809
Apoe^shl/Apoe^shl (KOR-Apoe^shl)	increased circulating cholesterol level	J:75488
Apoe^shl/Apoe^shl (KOR-Apoe^shl)	xanthoma	J:75488
Apoe^shl/Apoe^shl (C3.KOR-Apoe^shl)	increased circulating cholesterol level	J:75488
Apoe^shl/Apoe^shl (C3.KOR-Apoe^shl)	xanthoma	J:75488
Apoe^shl/Apoe^shl (C.KOR-Apoe^shl)	increased circulating cholesterol level	J:75488
Apoe^shl/Apoe^shl (C.KOR-Apoe^shl)	xanthoma	J:75488
Apoe^shl/Apoe^shl (B6.KOR-Apoe^shl)	increased circulating cholesterol level	J:75488
Apoe^shl/Apoe^shl (B6.KOR-Apoe^shl)	xanthoma	J:75488
Apoe^shl/Apoe^shl (involves: C3H/He * KOR)	increased circulating cholesterol level	J:54051
Apoe^shl/Apoe^shl (involves: C3H/He * KOR)	xanthoma	J:54051
Apoe^shl/Apoe^shl (involves: BALB/c * KOR)	increased circulating cholesterol level	J:54051
Apoe^shl/Apoe^shl (involves: BALB/c * KOR)	xanthoma	J:54051
Apoe^shl/Apoe^shl (involves: C57BL/6 * KOR)	increased circulating cholesterol level	J:54051
Apoe^shl/Apoe^shl (involves: C57BL/6 * KOR)	xanthoma	J:54051
Apoe^shl/Apoe^tm1Unc (involves: 129P2/OlaHsd * KOR)	increased circulating cholesterol level	J:54051
Apoe^shl/Apoe^tm1Unc (involves: 129P2/OlaHsd * KOR)	xanthoma	J:54051
Apoe^{Tg(rtTA)1Gaga}/Apoe^{Tg(rtTA)1Gaga} (involves: 129S1/Sv * C57BL/6J)	increased circulating cholesterol level	J:136987
Apoe^{Tg(rtTA)1Gaga}/Apoe^{Tg(rtTA)1Gaga} Igs7^{tm1(tetO-Apoe)Gaga}/0 (involves: 129S1/Sv * C57BL/6J)	increased circulating cholesterol level	J:136987
Apoe^{tm1(APOE2)Mae}/Apoe^{tm1(APOE2)Mae} (involves: 129P2/OlaHsd * C57BL/6)	abnormal lipid homeostasis	J:67282, J:48565
	abnormal lipid level	J:67282, J:48565
	hyperlipidemia	J:48565
	increased circulating cholesterol level	J:67282, J:48565
	increased circulating triglyceride level	J:67282, J:48565
	xanthoma	J:48565
Apoe^{tm1(APOE2)Mae}/Apoe^{tm1(APOE2)Mae} Ldlr^tm1(LDLR)Mae/Ldlr⁺ (involves: 129P2/OlaHsd * 129S6/SvEvTac * C57BL/6)	abnormal lipid homeostasis	J:67282
	decreased susceptibility to hyperlipidemia	J:67282
Apoe^{tm1(APOE_i4)Sfu}/Apoe^{tm1(APOE_i4)Sfu} (involves: 129P2/OlaHsd * C57BL/6N)	abnormal phospholipid level	J:60590
	decreased brain cholesterol level	J:60590
	increased circulating cholesterol level	J:60590
	increased circulating LDL cholesterol level	J:60590
	increased circulating VLDL cholesterol level	J:60590
Apoe^{tm1(APOE_i4)Sfu}/Apoe^{tm1(APOE_i4)Sfu} (involves: 129P2/OlaHsd)	abnormal circulating cholesterol level	J:104859
Apoe^tm1.1Mae/Apoe^tm1.1Mae Tg(Fabp4-cre)1Rev/0 (B6.Cg-Apoe^tm1.1Mae Tg(Fabp4-cre)1Rev)	decreased cardiac muscle triglyceride level	J:219838
	decreased cholesterol level	J:219838
	decreased circulating cholesterol level	J:219838
	decreased circulating glucose level	J:219838
	decreased circulating insulin level	J:219838
	decreased circulating triglyceride level	J:219838
	decreased liver cholesterol level	J:219838
	decreased liver triglyceride level	J:219838
	decreased skeletal muscle triglyceride level	J:219838
	decreased triglyceride level	J:219838
	improved glucose tolerance	J:219838
	increased cholesterol level	J:219838
	increased insulin sensitivity	J:219838
Apoe^tm1Bres/Apoe⁺ (either: (involves: 129P2/OlaHsd * BALB/c) or (involves: 129P2/OlaHsd * C57BL/6J))	increased circulating cholesterol level	J:2809
Apoe^tm1Bres/Apoe^tm1Bres (either: (involves: 129P2/OlaHsd * BALB/c) or (involves: 129P2/OlaHsd * C57BL/6J))	abnormal circulating LDL cholesterol level	J:2809
	increased circulating cholesterol level	J:2809, J:42426
	increased circulating VLDL cholesterol level	J:2809
	increased triglyceride level	J:2809
Apoe^tm1Bres/Apoe^tm1Bres (involves: 129P2/OlaHsd * C57BL/6 * NIH Black Swiss)	decreased circulating HDL cholesterol level	J:42927
	increased circulating cholesterol level	J:42927
	increased circulating triglyceride level	J:42927
Apoe^tm1Bres/Apoe^tm1Bres (involves: 129P2/OlaHsd * C57BL/6)	increased circulating cholesterol level	J:29950
	xanthoma	J:43846
Apoe^tm1Bres/Apoe^tm1Bres (B6.129P2-Apoe^tm1Bres)	abnormal circulating cholesterol level	J:68574
Apoe^tm1Bres/Apoe^tm1Bres (B6.129P2-Apoe^tm1Bres)	xanthoma	J:68574
Apoe^tm1Bres/Apoe^tm1Bres Esr1^tm1Ksk/Esr1^tm1Ksk (B6.129P2-Apoe^tm1Bres Esr1^tm1Ksk)	abnormal circulating cholesterol level	J:68574
Apoe^tm1Bres/Apoe^tm1Bres Fn1^tm1Bwg/Fn1^tm1Bwg (involves: 129S4/SvJae * C57BL/6)	abnormal cholesterol homeostasis	J:90917
	decreased circulating VLDL cholesterol level	J:90917
Apoe^tm1Bres/Apoe^tm1Bres Ifngr1^tm1Agt/Ifngr1^tm1Agt (involves: 129P2/OlaHsd * 129S7/SvEvBrd * C57BL/6J)	abnormal apolipoprotein level	J:40921
	increased circulating cholesterol level	J:40921
	increased circulating phospholipid level	J:40921
Apoe^tm1Bres/Apoe^tm1Bres Plg^tm1Jld/Plg^tm1Jld (involves: 129P2/OlaHsd * C57BL/6 * NIH Black Swiss)	decreased circulating HDL cholesterol level	J:42927
Apoe^tm1Khw/Apoe^tm1Khw (involves: 129S4/SvJae * C57BL/6)	increased circulating cholesterol level	J:75681
	increased circulating LDL cholesterol level	J:75681
	increased circulating triglyceride level	J:75681
	increased circulating VLDL cholesterol level	J:75681
Apoe^tm1Khw/Apoe^tm1Khw Tg(Mx1-cre)29-4Her/? (involves: 129S4/SvJae * C57BL/6 * SJL)	increased circulating cholesterol level	J:75681
	increased circulating LDL cholesterol level	J:75681
	increased circulating triglyceride level	J:75681
	increased circulating VLDL cholesterol level	J:75681
Apoe^tm1Khw/Apoe^tm1Khw Tg(Mx1-cre)29-4Her/0 (B6.Cg-Apoe^tm1Khw Tg(Mx1-cre)29-4Her)	abnormal apolipoprotein level	J:196923
	abnormal circulating lipid level	J:196923
	hyperlipidemia	J:196923
	increased circulating cholesterol level	J:196923
	increased circulating VLDL cholesterol level	J:196923
Apoe^tm1Lmh/Apoe⁺ (involves: 129S7/SvEvBrd * C57BL/6)	abnormal lipid homeostasis	J:22347
	increased circulating cholesterol level	J:22347
	increased circulating HDL cholesterol level	J:22347
	increased circulating VLDL cholesterol level	J:22347
Apoe^tm1Lmh/Apoe^tm1Lmh (involves: 129S7/SvEvBrd * C57BL/6)	abnormal lipid homeostasis	J:22347
	increased circulating cholesterol level	J:22347
	increased circulating HDL cholesterol level	J:22347
	increased circulating VLDL cholesterol level	J:22347
	xanthoma	J:24054
Apoe^tm1Lmh/Apoe^tm1Lmh Ldlr^tm1Her/Ldlr^tm1Her (involves: 129S7/SvEvBrd * C57BL/6)	increased circulating cholesterol level	J:117317
	increased circulating HDL cholesterol level	J:117317
	increased circulating LDL cholesterol level	J:117317
	increased circulating triglyceride level	J:117317
Apoe^tm1Lmh/Apoe^tm1Lmh Ldlr^tm1Her/Ldlr^tm1Her Lrp1^tm2Her/Lrp1^tm2Her Tg(Mx1-cre)29-4Her/0 (involves: 129S7/SvEvBrd * C57BL/6J * SJL)	abnormal circulating enzyme level	J:90547
	abnormal circulating protein level	J:90547
	decreased circulating cholesterol level	J:90547
	decreased circulating LDL cholesterol level	J:90547
	decreased circulating triglyceride level	J:90547
	decreased circulating VLDL cholesterol level	J:90547
	increased circulating cholesterol level	J:117317
	increased circulating factor VIII level	J:90547, J:117317
	increased circulating HDL cholesterol level	J:117317
	increased circulating LDL cholesterol level	J:117317
	increased circulating triglyceride level	J:117317
	increased circulating von Willebrand factor level	J:90547
Apoe^tm1Rraf/Apoe^tm1Rraf Tg(Mx1-cre)29-4Her/0 (B6.Cg-Apoe^tm1Rraf Tg(Mx1-cre)29-4Her)	abnormal apolipoprotein level	J:196923
	abnormal circulating cholesterol level	J:196923
	decreased circulating VLDL cholesterol level	J:196923
	hyperlipidemia	J:196923
	increased circulating cholesterol level	J:196923
Apoe^tm1Unc/Apoe⁺ (involves: 129P2/OlaHsd * C57BL/6)	increased circulating triglyceride level	J:16573
Apoe^tm1Unc/Apoe^tm1Unc (B6.129P2-Apoe^tm1Unc/J)	abnormal circulating cholesterol level	J:73202
	abnormal glomerular capillary thrombosis	J:125978
	abnormal nitric oxide homeostasis	J:298071
	decreased circulating glucose level	J:73202
	decreased circulating HDL cholesterol level	J:91058
	decreased circulating homocysteine level	J:73202
	decreased circulating triglyceride level	J:93987
	hyperlipidemia	J:101576
	increased circulating cholesterol level	J:104609, J:97385, J:125978, J:91058, J:101576, J:73202, J:133606
	increased circulating HDL cholesterol level	J:226403
	increased circulating LDL cholesterol level	J:91058, J:101576, J:93987
	increased circulating triglyceride level	J:91058, J:101576, J:73202
	increased circulating VLDL cholesterol level	J:91058, J:101576, J:93987
	xanthoma	J:43846, J:73202
Apoe^tm1Unc/Apoe^tm1Unc (involves: 129P2/OlaHsd * C57BL/6)	decreased circulating HDL cholesterol level	J:16573
	hyperlipidemia	J:80689
	increased circulating cholesterol level	J:40136, J:41510, J:16573, J:80689
	increased circulating LDL cholesterol level	J:16573
	increased circulating triglyceride level	J:16573, J:80689
	increased circulating VLDL cholesterol level	J:41510, J:16573
	increased prostaglandin level	J:125376
Apoe^tm1Unc/Apoe^tm1Unc (involves: 129P2/OlaHsd)	abnormal circulating cholesterol level	J:48202
	increased circulating cholesterol level	J:48202
	increased circulating corticosterone level	J:101973
Apoe^tm1Unc/Apoe^tm1Unc (B6.129P2-Apoe^tm1Unc)	abnormal lipid level	J:125366
	decreased circulating leptin level	J:60585
	increased circulating cholesterol level	J:61287
Apoe^tm1Unc/Apoe^tm1Unc (B6.Cg-Apoe^tm1Unc Fas^lpr)	increased circulating cholesterol level	J:133606
Apoe^tm1Unc/Apoe^tm1Unc (involves: 129P2/OlaHsd * C57BL/6 * DBA)	abnormal cholesterol homeostasis	J:75567
	abnormal circulating protein level	J:75567
	abnormal lipid homeostasis	J:75567
	decreased circulating HDL cholesterol level	J:75567
	increased circulating cholesterol level	J:75567
	increased circulating phospholipid level	J:75567
Apoe^tm1Unc/Apoe^tm1Unc Atic^{tm1c(EUCOMM)Hmgu}/Atic^{tm1c(EUCOMM)Hmgu} Gt(ROSA)26Sor^{tm1(cre/ERT2)Tyj}/Gt(ROSA)26Sor⁺ (involves: 129P2/OlaHsd * 129S4/SvJae * C57BL/6J * C57BL/6N)	decreased circulating cholesterol level	J:338121
	increased circulating triglyceride level	J:338121
Apoe^tm1Unc/Apoe^tm1Unc Cav1^tm1Mls/Cav1^tm1Mls (involves: 129/Sv * 129P2/OlaHsd * C57BL/6J * SJL)	increased circulating cholesterol level	J:101788
	increased circulating LDL cholesterol level	J:101788
	increased circulating triglyceride level	J:101788
	increased circulating VLDL cholesterol level	J:101788
Apoe^tm1Unc/Apoe^tm1Unc Cbs^tm1Unc/Cbs^tm1Unc Tg(Mt1-CBS)25Waku/0 (involves: 129P2/OlaHsd * C3H * C57BL/6)	increased circulating homocysteine level	J:168131
	increased circulating methionine level	J:168131
	increased circulating tumor necrosis factor level	J:168131
Apoe^tm1Unc/Apoe^tm1Unc Cd36^tm1Mfe/Cd36^tm1Mfe (involves: 129P2/OlaHsd * 129S1/Sv * C57BL/6)	abnormal lipid level	J:61672
	decreased circulating triglyceride level	J:61672
	increased cholesterol level	J:61672
	xanthoma	J:61672
Apoe^tm1Unc/Apoe^tm1Unc Clu^tm1Jakh/Clu^tm1Jakh Tg(APPV717F)109Ili/Tg(APPV717F)109Ili (involves: 129P2/OlaHsd * 129S2/SvPas)	increased cerebrospinal fluid amyloid beta 40 isoform level	J:107702
	increased cerebrospinal fluid amyloid beta 42 isoform level	J:107702
Apoe^tm1Unc/Apoe^tm1Unc Crp^tm1Hjf/Crp^tm1Hjf (B6.Cg-Crp^tm1Hjf Apoe^tm1Unc)	decreased circulating HDL cholesterol level	J:170409
	decreased circulating triglyceride level	J:170409
	increased circulating HDL cholesterol level	J:170409
Apoe^tm1Unc/Apoe^tm1Unc Csf1^op/Csf1^op (involves: 129P2/OlaHsd * C3HeB/Fe * C57BL/6)	increased circulating cholesterol level	J:40136
Apoe^tm1Unc/Apoe^tm1Unc Cst3^tm1Karl/Cst3^tm1Karl (involves: 129S/SvEv * C57BL/6)	abnormal enzyme/coenzyme level	J:106879
Apoe^tm1Unc/Apoe^tm1Unc Cyp4f13^{Gt(OST14770)Lex}/Cyp4f13^{Gt(OST14770)Lex} (involves: 129P2/OlaHsd * 129S5/SvEvBrd * C57BL/6)	decreased cholesterol level	J:289999
Apoe^tm1Unc/Apoe^tm1Unc Cyp19a1^tm1Esi/Cyp19a1^tm1Esi (involves: 129P2/OlaHsd * 129S6/SvEvTac * C57BL/6)	decreased circulating HDL cholesterol level	J:184647
	decreased circulating insulin level	J:184647
	impaired glucose tolerance	J:184647
	increased circulating C-reactive protein level	J:184647
	increased circulating cholesterol level	J:184647
	increased circulating glucose level	J:184647
	increased circulating interleukin-6 level	J:184647
	increased circulating LDL cholesterol level	J:184647
	increased circulating triglyceride level	J:184647
	increased circulating tumor necrosis factor level	J:184647
	increased circulating VLDL cholesterol level	J:184647
	insulin resistance	J:184647
Apoe^tm1Unc/Apoe^tm1Unc Fabp4^tm1Brsp/Fabp4^tm1Brsp Fabp5^tm1Hota/Fabp5^tm1Hota (B6.Cg-Fabp4^tm1Brsp Fabp5^tm1Hota Apoe^tm1Unc)	decreased circulating cholesterol level	J:102223
	decreased circulating glucose level	J:102223
	decreased circulating triglyceride level	J:102223
	improved glucose tolerance	J:102223
	increased insulin sensitivity	J:102223
Apoe^tm1Unc/Apoe^tm1Unc Fas^lpr/Fas^lpr (MRL.Cg-Apoe^tm1Unc Fas^lpr)	increased circulating cholesterol level	J:133606
Apoe^tm1Unc/Apoe^tm1Unc Fas^lpr/Fas^lpr (B6.Cg-Apoe^tm1Unc Fas^lpr)	decreased circulating cholesterol level	J:121671
	increased urine protein level	J:121671
Apoe^tm1Unc/Apoe^tm1Unc Fasl^gld/Fasl^gld (B6.Cg-Fasl^gld Apoe^tm1Unc)	decreased circulating HDL cholesterol level	J:91058
	increased circulating cholesterol level	J:200141, J:91058
	increased circulating LDL cholesterol level	J:91058
	increased circulating triglyceride level	J:91058
	increased circulating VLDL cholesterol level	J:91058
	increased urine protein level	J:91058
Apoe^tm1Unc/Apoe^tm1Unc Glg1^{Gt(RST092)Byg}/Glg1⁺ (B6J.129P2-Apoe^tm1Unc Glg1^{Gt(RST092)Byg})	increased collagen level	J:226586
Apoe^tm1Unc/Apoe^tm1Unc Hdl5^C57BL/6J/Hdl5^C57BL/6J (involves: C3H/HeJ * C57BL/6J)	increased circulating LDL cholesterol level	J:129301
	increased circulating VLDL cholesterol level	J:129301
Apoe^tm1Unc/Apoe^tm1Unc Hdlq19^C57BL/6J/Hdlq19^C57BL/6J (involves: C3H/HeJ * C57BL/6J)	increased circulating HDL cholesterol level	J:129301
Apoe^tm1Unc/Apoe^tm1Unc Hdlq86^C3H/HeJ/? (involves: C3H/HeJ * C57BL/6J)	increased circulating HDL cholesterol level	J:129301
	increased circulating LDL cholesterol level	J:129301
	increased circulating VLDL cholesterol level	J:129301
	increased triglyceride level	J:129301
Apoe^tm1Unc/Apoe^tm1Unc Hdlq86^C3H/HeJ/Hdlq86^C3H/HeJ (involves: C3H/HeJ * C57BL/6J)	increased circulating HDL cholesterol level	J:129301
	increased circulating LDL cholesterol level	J:129301
	increased circulating VLDL cholesterol level	J:129301
	increased triglyceride level	J:129301
Apoe^tm1Unc/Apoe^tm1Unc Hdlq91^C3H/HeJ/? (involves: C3H/HeJ * C57BL/6J)	increased circulating HDL cholesterol level	J:129301
Apoe^tm1Unc/Apoe^tm1Unc Hsd11b1^tm1Lex/Hsd11b1^tm1Lex (B6.129-Hsd11b1^tm1Lex Apoe^tm1Unc)	decreased cholesterol level	J:199430
	hyperlipidemia	J:199430
Apoe^tm1Unc/Apoe^tm1Unc Il1r1^tm1Imx/Il1r1^tm1Imx (B6.129-Il1r1^tm1Imx Apoe^tm1Unc)	decreased circulating interleukin-6 level	J:148173
Apoe^tm1Unc/Apoe^tm1Unc Il1rn^tm1Dih/Il1rn^tm1Dih (involves: 129P2/OlaHsd * 129S/SvEv * C57BL/6)	decreased circulating cholesterol level	J:132570
Apoe^tm1Unc/Apoe^tm1Unc Il10^tm1Cgn/Il10^tm1Cgn (involves: 129P2/OlaHsd * C57BL/6)	abnormal arterial thrombosis	J:105858
	abnormal blood coagulation	J:105858
	abnormal circulating cholesterol level	J:105858
	abnormal circulating cytokine level	J:105858
	decreased circulating VLDL cholesterol level	J:105858
	increased circulating interferon-gamma level	J:105858
	increased circulating interleukin-12 level	J:105858
	increased circulating LDL cholesterol level	J:105858
Apoe^tm1Unc/Apoe^tm1Unc Itgb3^tm1Hyn/Itgb3^tm1Hyn (involves: 129P2/OlaHsd * 129S2/SvPas * C57BL/6)	decreased susceptibility to diet-induced obesity	J:83615
Apoe^tm1Unc/Apoe^tm1Unc Klf15^tm1Jain/Klf15^tm1Jain (involves: 129P2/OlaHsd * 129X1/SvJ)	increased circulating cholesterol level	J:203920
	increased circulating triglyceride level	J:203920
Apoe^tm1Unc/Apoe^tm1Unc Lcat^tm1Hgc/Lcat^tm1Hgc (involves: 129P2/OlaHsd * C57BL/6 * DBA)	abnormal cholesterol homeostasis	J:75567
	abnormal circulating protein level	J:75567
	abnormal lipid homeostasis	J:75567
Apoe^tm1Unc/Apoe^tm1Unc Ldlr^tm1Her/Ldlr^tm1Her (involves: 129P2/OlaHsd * 129S7/SvEvBrd * C57BL/6J)	abnormal thrombosis	J:95598
	decreased circulating troponin level	J:95598
Apoe^tm1Unc/Apoe^tm1Unc Ldlr^tm1Her/Ldlr^tm1Her (involves: 129P2/OlaHsd * 129S7/SvEvBrd)	increased circulating cholesterol level	J:59491
Apoe^tm1Unc/Apoe^tm1Unc Lgals3^tm1Poi/Lgals3^tm1Poi (involves: 129/Sv * C57BL/6 * SJL)	increased circulating cholesterol level	J:130923
Apoe^tm1Unc/Apoe^tm1Unc Lipg^tm1Tq/Lipg^tm1Tq (involves: 129P2/OlaHsd * 129S6/SvEvTac * C57BL/6J)	increased circulating cholesterol level	J:93987
	increased circulating HDL cholesterol level	J:93987
	increased circulating LDL cholesterol level	J:93987
	increased circulating phospholipid level	J:93987
	increased circulating triglyceride level	J:93987
	increased circulating VLDL cholesterol level	J:93987
Apoe^tm1Unc/Apoe^tm1Unc Lpl^tm1Sem/Lpl^tm1Sem (involves: 129P2/OlaHsd)	abnormal circulating cholesterol level	J:151434
	abnormal circulating lipid level	J:151434
	hyperlipidemia	J:151434
	increased circulating cholesterol level	J:151434
	increased circulating triglyceride level	J:151434
	increased susceptibility to induced thrombosis	J:151434
Apoe^tm1Unc/Apoe^tm1Unc Msr1^tm1Csk/Msr1^tm1Csk (either: (involves: 129P2/OlaHsd * 129X1/SvJ * C57BL/6J * ICR) or (involves: 129P2/OlaHsd * 129X1/SvJ * 129/Sv * ICR))	increased circulating cholesterol level	J:39079
Apoe^tm1Unc/Apoe^tm1Unc Nceh1^tm1Ishi/Nceh1^tm1Ishi (B6.129-Nceh1^tm1Ishi Apoe^tm1Unc)	abnormal cholesterol homeostasis	J:152385
Apoe^tm1Unc/Apoe^tm1Unc Nfe2l2^tm1Mym/Nfe2l2^tm1Mym (involves: 129P2/OlaHsd * C57BL/6J)	increased circulating glucose level	J:143903
	increased circulating triglyceride level	J:143903
Apoe^tm1Unc/Apoe^tm1Unc Nhdlq11^C3H/HeJ/Nhdlq11^C3H/HeJ (involves: C3H/HeJ * C57BL/6J)	increased circulating LDL cholesterol level	J:129301
	increased circulating VLDL cholesterol level	J:129301
	increased triglyceride level	J:129301
Apoe^tm1Unc/Apoe^tm1Unc Nhdlq11^C3H/HeJ/Nhdlq11^C57BL/6J (involves: C3H/HeJ * C57BL/6J)	increased circulating LDL cholesterol level	J:129301
	increased circulating VLDL cholesterol level	J:129301
	increased triglyceride level	J:129301
Apoe^tm1Unc/Apoe^tm1Unc Nhdlq12^C3H/HeJ/Nhdlq12^C57BL/6J (involves: C3H/HeJ * C57BL/6J)	increased circulating LDL cholesterol level	J:129301
	increased circulating VLDL cholesterol level	J:129301
Apoe^tm1Unc/Apoe^tm1Unc Nhdlq12^C57BL/6J/Nhdlq12^C57BL/6J (involves: C3H/HeJ * C57BL/6J)	increased circulating LDL cholesterol level	J:129301
	increased circulating VLDL cholesterol level	J:129301
Apoe^tm1Unc/Apoe^tm1Unc Nos2^tm1Mrl/Nos2^tm1Mrl (involves: 129P2/OlaHsd * 129S7/SvEvBrd * C57BL/6)	decreased cholesterol level	J:64566
Apoe^tm1Unc/Apoe^tm1Unc Nos3^tm1Unc/Nos3^tm1Unc (B6.129P2-Nos3^tm1Unc Apoe^tm1Unc)	increased circulating creatinine level	J:60670
Apoe^tm1Unc/Apoe^tm1Unc Npc1^m1N/Npc1^m1N (involves: 129P2/OlaHsd * BALB/c)	increased circulating VLDL cholesterol level	J:104996
Apoe^tm1Unc/Apoe^tm1Unc Pik3cg^tm1Dwu/Pik3cg^tm1Dwu (B6.Cg-Apoe^tm1Unc Pik3cg^tm1Dwu)	decreased circulating cholesterol level	J:121582
Apoe^tm1Unc/Apoe^tm1Unc Pla2g15^tm1Ytan/Pla2g15^tm1Ytan (involves: 129S/SvEv * B6.129P2-Apoe^tm1Unc/J)	increased circulating cholesterol level	J:97471
Apoe^tm1Unc/Apoe^tm1Unc Pnhdlc1^C57BL/6J/Pnhdlc1^C57BL/6J (involves: C3H/HeJ * C57BL/6J)	increased circulating LDL cholesterol level	J:129301
	increased circulating VLDL cholesterol level	J:129301
Apoe^tm1Unc/Apoe^tm1Unc Pnhdlc6^C3H/HeJ/? (involves: C3H/HeJ * C57BL/6J)	increased circulating LDL cholesterol level	J:129301
	increased circulating VLDL cholesterol level	J:129301
Apoe^tm1Unc/Apoe^tm1Unc Ptgdr^tm1Dgen/Ptgdr^tm1Dgen (involves: 129P2/OlaHsd * C57BL/6)	increased cholesterol level	J:192168
	increased circulating cholesterol level	J:192168
	increased circulating triglyceride level	J:192168
Apoe^tm1Unc/Apoe^tm1Unc Rag2^tm1Fwa/Rag2⁺ (involves: 129P2/OlaHsd * 129S/SvEv)	decreased circulating cholesterol level	J:59156
	decreased circulating HDL cholesterol level	J:59156
Apoe^tm1Unc/Apoe^tm1Unc Rag2^tm1Fwa/Rag2^tm1Fwa (involves: 129P2/OlaHsd * 129S/SvEv)	decreased circulating cholesterol level	J:59156
	decreased circulating HDL cholesterol level	J:59156
Apoe^tm1Unc/Apoe^tm1Unc Serpind1^tm1Moto/Serpind1⁺ (involves: 129P2/OlaHsd * C57BL/6 * CBA)	abnormal urine nucleoside level	J:122173
Apoe^tm1Unc/Apoe^tm1Unc Serpine1^tm1Mlg/Serpine1^tm1Mlg (B6.129-Serpine1^tm1Mlg Apoe^tm1Unc)	increased circulating cholesterol level	J:61287
Apoe^tm1Unc/Apoe^tm1Unc Smarcd1^tm1.1Jddl/Smarcd1^tm1.1Jddl Speer6-ps1^{Tg(Alb-cre)21Mgn}/Speer6-ps1⁺ (involves: 129P2/OlaHsd * C57BL/6 * DBA)	abnormal bile salt homeostasis	J:228944
	decreased circulating cholesterol level	J:228944
Apoe^tm1Unc/Apoe^tm1Unc Soat1^tm1Far/Soat1^tm1Far (involves: 129P2/OlaHsd * 129S4/SvJae * C57BL/6J)	abnormal cholesterol homeostasis	J:61147
	abnormal cholesterol level	J:61147
	decreased circulating cholesterol level	J:61147
	decreased circulating VLDL cholesterol level	J:61147
	xanthoma	J:61147
Apoe^tm1Unc/Apoe^tm1Unc Soat2^tm1Far/Soat2^tm1Far (involves: 129P2/OlaHsd * 129S4/SvJae * C57BL/6J)	decreased circulating cholesterol level	J:81836
	increased circulating HDL cholesterol level	J:81836
	increased circulating triglyceride level	J:81836
Apoe^tm1Unc/Apoe^tm1Unc Spp1^tm1Rit/Spp1⁺ (involves: 129P2/OlaHsd * 129S7/SvEvBrd * C57BL/6)	increased circulating cholesterol level	J:103051
	increased circulating triglyceride level	J:103051
Apoe^tm1Unc/Apoe^tm1Unc Spp1^tm1Rit/Spp1^tm1Rit (involves: 129P2/OlaHsd * 129S7/SvEvBrd * C57BL/6)	increased circulating cholesterol level	J:103051
	increased circulating triglyceride level	J:103051
Apoe^tm1Unc/Apoe^tm1Unc Tg(APOC1)1Bres/0 (involves: 129P2/OlaHsd * C57BL/6J * CBA/J)	hyperlipidemia	J:80689
	impaired lipolysis	J:80689
	increased circulating cholesterol level	J:80689
	increased circulating LDL cholesterol level	J:80689
	increased circulating triglyceride level	J:80689
	increased circulating VLDL cholesterol level	J:80689
	increased circulating VLDL triglyceride level	J:80689
Apoe^tm1Unc/Apoe^tm1Unc Tg(APPV717F)109Ili/Tg(APPV717F)109Ili (involves: 129P2/OlaHsd)	increased cerebrospinal fluid amyloid beta 40 isoform level	J:107702
	increased cerebrospinal fluid amyloid beta 42 isoform level	J:107702
Apoe^tm1Unc/Apoe^tm1Unc Tg(CAG-IL1RN)1Cga/? (involves: 129P2/OlaHsd * C57BL/6 * DBA/1 * FVB)	decreased circulating serum amyloid protein level	J:132570
Apoe^tm1Unc/Apoe^tm1Unc Tg(CAG-IL1RN)2Cga/? (involves: 129P2/OlaHsd * C57BL/6 * DBA/1 * FVB)	decreased circulating serum amyloid protein level	J:132570
Apoe^tm1Unc/Apoe^tm1Unc Tg(CMV-Serpine1)1Dgi/0 (B6.Cg-Apoe^tm1Unc Tg(CMV-Serpine1)1Dgi)	increased circulating cholesterol level	J:61287
Apoe^tm1Unc/Apoe^tm1Unc Tg(Cyp21a1-Apoe)614Fet/0 (involves: 129P2/OlaHsd * C57BL/6 * FVB/N)	abnormal circulating cholesterol level	J:130658
	abnormal circulating protein level	J:130658
Apoe^tm1Unc/Apoe^tm1Unc Tg(Cyp21a1-Apoe)619Fet/0 (involves: 129P2/OlaHsd * C57BL/6 * FVB/N)	abnormal circulating apolipoprotein E level	J:130658
	abnormal lipid level	J:130658
	increased circulating cholesterol level	J:130658
Apoe^tm1Unc/Apoe^tm1Unc Tg(NOS3)2Crom/0 (involves: 129P2/OlaHsd * C57BL/6 * FVB)	decreased circulating cholesterol level	J:80701
Apoe^tm1Unc/Apoe^tm1Unc Tg(NOS3)3Crom/0 (involves: 129P2/OlaHsd * C57BL/6 * FVB)	decreased circulating cholesterol level	J:80701
Apoe^tm1Unc/Apoe^tm1Unc Trigq3^C3H/HeJ/? (involves: C3H/HeJ * C57BL/6J)	increased triglyceride level	J:129301
Apoe^tm1Unc/Apoe^tm1Unc Trigq3^C3H/HeJ/Trigq3^C3H/HeJ (involves: C3H/HeJ * C57BL/6J)	increased triglyceride level	J:129301
Apoe^tm1Unc/Apoe^tm1Unc Trigq4^C3H/HeJ/Trigq4^C3H/HeJ (involves: C3H/HeJ * C57BL/6J)	increased triglyceride level	J:129301
Apoe^tm1Unc/Apoe^tm1Unc Trigq4^C3H/HeJ/Trigq4^C57BL/6J (involves: C3H/HeJ * C57BL/6J)	increased triglyceride level	J:129301
Apoe^tm1Unc/Apoe^tm1Unc Ttpa^tm1Far/Ttpa⁺ (involves: 129P2/OlaHsd * 129S4/SvJae * C57BL/6)	abnormal vitamin E level	J:66419
Apoe^tm1Unc/Apoe^tm1Unc Ttpa^tm1Far/Ttpa^tm1Far (involves: 129P2/OlaHsd * 129S4/SvJae * C57BL/6)	abnormal lipid homeostasis	J:66419
Apoe^{tm2(APOE3)Mae}/Apoe^{tm2(APOE3)Mae} (involves: 129P2/OlaHsd * C57BL/6J)	abnormal lipid homeostasis	J:41705
	abnormal lipid level	J:41705
	abnormal triglyceride level	J:41705
	decreased circulating LDL cholesterol level	J:41705
	decreased circulating VLDL cholesterol level	J:74417
	decreased circulating VLDL triglyceride level	J:74417
	increased circulating cholesterol level	J:41705
	increased circulating HDL cholesterol level	J:74417
	increased circulating triglyceride level	J:74417
Apoe^{tm2(APOE3)Mae}/Apoe^{tm2(APOE3)Mae} Ldlr^tm1(LDLR)Mae/Ldlr⁺ (involves: 129P2/OlaHsd * 129S7/SvEvBrd * C57BL/6)	abnormal circulating lipid level	J:146721
Apoe^{tm2(APOE3)Mae}/Apoe^{tm2(APOE3)Mae} Tg(APPSWE)2576Kha/? (involves: 129P2/OlaHsd * C57BL/6 * SJL)	abnormal cerebrospinal fluid amyloid beta 40 isoform level	J:98636
	abnormal cerebrospinal fluid amyloid beta 42 isoform level	J:98636
Apoe^{tm2(APOE_i2)Sfu}/Apoe^{tm2(APOE_i2)Sfu} (involves: 129P2/OlaHsd)	decreased circulating cholesterol level	J:104859
Apoe^{tm3(APOE4)Mae}/Apoe^{tm3(APOE4)Mae} (involves: 129P2/OlaHsd * C57BL/6)	abnormal circulating lipid level	J:151284
	abnormal glucose homeostasis	J:151284
	abnormal lipid level	J:74417
	decreased circulating HDL cholesterol level	J:74417
	decreased circulating triglyceride level	J:74417
	impaired glucose tolerance	J:151284
	increased circulating VLDL cholesterol level	J:74417
	increased circulating VLDL triglyceride level	J:74417
Apoe^{tm3(APOE4)Mae}/Apoe^{tm3(APOE4)Mae} Ldlr^tm1(LDLR)Mae/Ldlr⁺ (involves: 129P2/OlaHsd * 129S7/SvEvBrd * C57BL/6)	abnormal circulating lipid level	J:146721
	increased circulating cholesterol level	J:146721
	increased circulating triglyceride level	J:146721
Apoe^{tm3(APOE4)Mae}/Apoe^{tm3(APOE4)Mae} Tg(APPSWE)2576Kha/? (involves: 129P2/OlaHsd * C57BL/6 * SJL)	abnormal cerebrospinal fluid amyloid beta 40 isoform level	J:98636
	abnormal cerebrospinal fluid amyloid beta 42 isoform level	J:98636
Apoe^{tm3(APOE_i3)Sfu}/Apoe^{tm3(APOE_i3)Sfu} (involves: 129P2/OlaHsd)	decreased circulating cholesterol level	J:104859
Apoe^tm4Mae/Apoe^tm4Mae (129S6/SvEvTac-Apoe^tm4Mae)	abnormal circulating lipid level	J:172417
	increased circulating cholesterol level	J:172417
	increased circulating HDL cholesterol level	J:172417
	increased circulating triglyceride level	J:172417
	increased circulating VLDL cholesterol level	J:172417
Apof^{tm1(KOMP)Vlcg}/Apof⁺ (involves: C57BL/6J * C57BL/6NTac)	abnormal cholesterol homeostasis	J:185314
	decreased circulating triglyceride level	J:185314
	increased circulating HDL cholesterol level	J:185314
Apof^{tm1(KOMP)Vlcg}/Apof^{tm1(KOMP)Vlcg} (involves: C57BL/6J * C57BL/6NTac)	abnormal cholesterol homeostasis	J:185314
	decreased circulating triglyceride level	J:185314
	increased liver cholesterol level	J:185314
Apoh^tm1Krl/Apoh^tm1Krl (involves: 129/Sv * C57BL/6)	abnormal blood homeostasis	J:68990
Apol6^em1Hsul/Apol6^em1Hsul (Not Specified)	decreased circulating cholesterol level	J:344362
	decreased circulating HDL cholesterol level	J:344362
	decreased circulating triglyceride level	J:344362
	decreased susceptibility to diet-induced obesity	J:344362
	enhanced lipolysis	J:344362
	improved glucose tolerance	J:344362
	increased circulating free fatty acids level	J:344362
	increased insulin sensitivity	J:344362
Apom^{tm1.1(KOMP)Vlcg}/Apom^{tm1.1(KOMP)Vlcg} (C57BL/6N-Apom^{tm1.1(KOMP)Vlcg}/Ucd)	increased circulating alanine transaminase level	J:211773
Apom^tm1Cchr/Apom^tm1Cchr (involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)	decreased cholesterol level	J:130647
	decreased circulating triglyceride level	J:130647
Apom^tm1Stf/Apom^tm1Stf (Not Specified)	decreased circulating HDL cholesterol level	J:138581
Apoo^{tm1b(KOMP)Wtsi}/Y (C57BL/6N-Apoo^{tm1b(KOMP)Wtsi}/Wtsi)	increased circulating iron level	J:211773
App^tm1.1Wevn/App^tm1.1Wevn (B6.129S6(FVB)-App^tm1.1Wevn)	increased susceptibility to induced thrombosis	J:241632
App^{tm1b(KOMP)Wtsi}/App⁺ (C57BL/6N-App^{tm1b(KOMP)Wtsi}/Ics)	increased blood urea nitrogen level	J:211773
	increased circulating calcium level	J:211773
App^tm1Ck/App^tm1Ck Psen1^tm1Mpm/Psen1^tm1Mpm (involves: 129 * 129S1/Sv * 129X1/SvJ)	increased circulating corticosterone level	J:191170
App^tm1Dbo/App^tm1Dbo (involves: 129S7/SvEvBrd * C57BL/6J)	increased susceptibility to induced thrombosis	J:241632
App^tm1Dbo/App^tm1Dbo Npc1^m1N/Npc1^m1N (C.Cg-App^tm1Dbo Npc1^m1N)	increased brain cholesterol level	J:172769
Appl1^{Gt(RRS819)Byg}/Appl1^{Gt(RRS819)Byg} (involves: 129P2/OlaHsd * C57BL/6)	abnormal hepatic glucose production	J:211794
	impaired glucose tolerance	J:211794
	increased circulating insulin level	J:211794
	increased core body temperature	J:211794
	increased fasting circulating glucose level	J:211794
	insulin resistance	J:211794
Appl2^tm1Smoc/Appl2^tm1Smoc Tg(Ckmm-cre)5Khn/0 (involves: FVB)	improved glucose tolerance	J:230004
	increased insulin sensitivity	J:230004
Aprt^{em1(IMPC)Hmgu}/Aprt⁺ (C57BL/6NCrl-Aprt^{em1(IMPC)Hmgu}/Ieg)	increased respiratory quotient	J:211773
Aprt^tm1Dwm/Aprt^tm1Dwm (involves: 129P2/OlaHsd * BALB/c)	abnormal urine homeostasis	J:38450
Aprt^tm1Dwm/Aprt^tm1Dwm (involves: 129P2/OlaHsd * BALB/c)	abnormal urine nucleoside level	J:38450
Aprt^tm1Dwm/Aprt^tm1Dwm (129P2/OlaHsd-Aprt^tm1Dwm)	aminoaciduria	J:38450
Aprt^tm1Dwm/Aprt^tm1Dwm (129P2/OlaHsd-Aprt^tm1Dwm)	colorless urine	J:38450
Aprt^tm1Jat/Aprt^tm1Jat (involves: 129S2/SvPas * Black Swiss)	abnormal urine nucleoside level	J:33255
	crystalluria	J:111451
	decreased urine uric acid level	J:33255
	increased blood urea nitrogen level	J:111451
Aprt^tm1Jat/Aprt^tm1Jat (involves: 129S2/SvPas * C57BL/6J)	abnormal urine nucleoside level	J:33255
Aprt^tm1Jat/Aprt^tm1Jat (involves: 129S2/SvPas * C57BL/6J)	decreased urine uric acid level	J:33255
Aprt^tm1Jat/Aprt^tm1Jat Spp1^tm1Rit/Spp1^tm1Rit (involves: 129S2/SvPas * 129S7/SvEvBrd)	abnormal urine nucleoside level	J:114314
Aprt^tm1Vri/Aprt^tm1Vri (involves: 129P2/OlaHsd * C57BL/6)	dehydration	J:50874
Aptx^{tm1b(EUCOMM)Hmgu}/Aptx^{tm1b(EUCOMM)Hmgu} (B6N(Cg)-Aptx^{tm1b(EUCOMM)Hmgu}/J)	increased circulating alanine transaminase level	J:211773
Aqp1^tm1Ask/Aqp1^tm1Ask (involves: C57BL/6J)	decreased urine osmolality	J:45888
	decreased urine sodium level	J:45888
	dehydration	J:45888
	increased blood osmolality	J:45888
Aqp1^tm1Ask/Aqp1^tm1Ask Aqp7^tm1.1Suc/Aqp7^tm1.1Suc (involves: 129S2/SvPas * C57BL/6J)	decreased urine osmolality	J:102454
	increased urine glucose level	J:102454
Aqp1^tm1Ask/Aqp1^tm1Ask Aqp8^tm1Ask/Aqp8^tm1Ask (involves: 129/Sv * C57BL/6 * CD-1)	decreased urine osmolality	J:104681
Aqp1^{tm1b(EUCOMM)Wtsi}/Aqp1^{tm1b(EUCOMM)Wtsi} (C57BL/6N-Aqp1^{tm1b(EUCOMM)Wtsi}/H)	decreased circulating chloride level	J:211773
	impaired glucose tolerance	J:211773
	increased circulating alkaline phosphatase level	J:211773
	increased circulating amylase level	J:211773
	increased circulating cholesterol level	J:211773
	increased circulating creatinine level	J:211773
	increased circulating HDL cholesterol level	J:211773
	increased circulating total protein level	J:211773
Aqp2^cph/Aqp2^cph (C57BL/6J-Aqp2^cph)	abnormal urine homeostasis	J:109463
	colorless urine	J:9451
	increased blood osmolality	J:109463
	increased blood urea nitrogen level	J:9451, J:109463
Aqp2^F204V/Aqp2^F204V (C57BL/6-Aqp2^F204V)	decreased urine osmolality	J:105809
Aqp2^tm1(AQP2)Suc/Aqp2⁺ (involves: 129S4/SvJae * C57BL/6)	decreased urine osmolality	J:113716
Aqp2^tm1(cre)Blyg/Aqp2^tm1(cre)Blyg (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	abnormal urine osmolality	J:121445
	decreased urine osmolality	J:121445
	dehydration	J:121445
	increased blood urea nitrogen level	J:121445
Aqp2^tm1.1Ask/Aqp2^tm1.1Ask (involves: C57BL/6J * FVB/N)	decreased urine osmolality	J:94003
Aqp2^tm1.1Ask/Aqp2^tm1.1Ask (involves: C57BL/6J * FVB/N)	increased blood urea nitrogen level	J:94003
Aqp2^tm1Ask/Aqp2^tm1Ask (involves: C57BL/6J)	decreased urine osmolality	J:94003
	dehydration	J:94003
	increased blood osmolality	J:94003
	increased blood urea nitrogen level	J:94003
Aqp2^tm1Bxy/Aqp2^tm1Bxy Tg(CAG-cre/Esr1)5Amc/0 (involves: C57BL/6 CBA)	abnormal urine osmolality	J:110648
	decreased urine osmolality	J:110648
Aqp2^tm1Nlsn/Aqp2^tm1Nlsn Tg(Hoxb7-cre)13Amc/0 (involves: 129/Sv * C57BL/6)	decreased urine osmolality	J:108291
Aqp3^tm1Ask/Aqp3^tm1Ask (involves: C57BL/6J)	decreased circulating triglyceride level	J:61675
	decreased urine osmolality	J:61675
	increased blood osmolality	J:61675
Aqp3^tm1Ask/Aqp3^tm1Ask Aqp4^tm1Ask/Aqp4^tm1Ask (involves: C57BL/6J)	decreased urine osmolality	J:61675
Aqp3^{tm2b(EUCOMM)Wtsi}/Aqp3^{tm2b(EUCOMM)Wtsi} (C57BL/6N-Aqp3^{tm2b(EUCOMM)Wtsi}/H)	increased blood urea nitrogen level	J:211773
	increased circulating alkaline phosphatase level	J:211773
	increased circulating calcium level	J:211773
	increased circulating cholesterol level	J:211773
	increased circulating creatinine level	J:211773
	increased circulating HDL cholesterol level	J:211773
	increased circulating serum albumin level	J:211773
	increased circulating total protein level	J:211773
Aqp4^tm1.1Lmno/Aqp4^tm1.1Lmno (B6.Cg-Aqp4^tm1.1Lmno)	cerebral edema	J:193622
Aqp4^tm1Ask/Aqp4^tm1Ask (involves: C57BL/6J)	decreased urine osmolality	J:46296, J:42704
Aqp4^tm1Ask/Aqp4^tm1Ask (involves: C57BL/6J * CD-1)	abnormal fluid regulation	J:111923
Aqp4^tm1Gghu/Aqp4^tm1Gghu (involves: 129P2/OlaHsd * C57BL/6J)	increased dopamine level	J:111202
Aqp5^tm1Amn/Aqp5^tm1Amn (involves: 129X1/SvJ * Black Swiss)	abnormal fluid regulation	J:82588
Aqp5^tm1Amn/Aqp5^tm1Amn (involves: 129X1/SvJ * Black Swiss)	decreased salivation	J:82588
Aqp5^tm1Ask/Aqp5^tm1Ask (involves: C57BL/6J)	decreased salivation	J:56302
Aqp5^tm1Ask/Aqp5^tm1Ask Aqp8^tm1Ask/Aqp8^tm1Ask (involves: 129/Sv * C57BL/6 * CD-1)	decreased salivation	J:104681
Aqp6^{tm1b(EUCOMM)Hmgu}/Aqp6^{tm1b(EUCOMM)Hmgu} (C57BL/6N-Aqp6^{tm1b(EUCOMM)Hmgu}/Ieg)	increased circulating chloride level	J:211773
Aqp7^tm1.1Suc/Aqp7^tm1.1Suc (involves: 129S2/SvPas * C57BL/6J)	increased urine glucose level	J:102454
Aqp7^tm1Chan/Aqp7^tm1Chan (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	increased circulating insulin level	J:125011
	increased glycerol level	J:125011
	increased insulin secretion	J:125011
Aqp7^tm1Nlsn/Aqp7^tm1Nlsn (involves: 129S1/Sv * C57BL/6)	decreased urine glycerol level	J:147631
Aqp7^tm1Tfun/Aqp7^tm1Tfun (B6N.129X1-Aqp7^tm1Tfun)	decreased circulating glycerol level	J:95278
	hypoglycemia	J:95278
	increased glycerol level	J:95278
Aqp8^tm1Ask/Aqp8^tm1Ask (involves: 129/Sv * C57BL/6 * CD-1)	abnormal fluid regulation	J:104681
	increased circulating cholesterol level	J:104681
	increased circulating triglyceride level	J:104681
Aqp8^tm1Ask/Aqp8^tm1Ask (involves: C57BL/6)	abnormal fluid regulation	J:323121
Aqp9^tm1Nlsn/Aqp9^tm1Nlsn (involves: 129S1/Sv * C57BL/6)	increased circulating glycerol level	J:123742
Aqp9^tm1Nlsn/Aqp9^tm1Nlsn (involves: 129S1/Sv * C57BL/6)	increased circulating triglyceride level	J:123742
Aqp9^tm1Nlsn/Aqp9^tm1Nlsn Lepr^db/Lepr^db (involves: 129S1/Sv * C57BL/6 * C57BLKS/J)	decreased circulating glucose level	J:123742
	increased circulating glycerol level	J:123742
Aqp11^sjds/Aqp11^sjds (involves: BALB/cRl)	decreased urine osmolality	J:169660
	increased blood urea nitrogen level	J:169660
	increased circulating creatinine level	J:169660
Aqp11^sjds/Aqp11^tm1Lex (involves: 129S5/SvEvBrd * BALB/cRl * C57BL/6 * CD-1)	increased blood urea nitrogen level	J:169660
Aqp11^{tm1.1(KOMP)Vlcg}/Aqp11⁺ (B6N(Cg)-Aqp11^{tm1.1(KOMP)Vlcg}/J)	decreased urine magnesium level	J:211773
Aqp11^tm1.1Nlsn/Aqp11^tm1.1Nlsn Speer6-ps1^{Tg(Alb-cre)21Mgn}/Speer6-ps1⁺ (involves: 129S1/Sv * C57BL/6 * DBA)	decreased blood urea nitrogen level	J:194939
	decreased circulating free fatty acids level	J:194939
	decreased circulating glycerol level	J:194939
	decreased circulating ketone body level	J:194939
	decreased circulating triglyceride level	J:194939
	increased circulating aspartate transaminase level	J:194939
	increased circulating HDL cholesterol level	J:194939
Aqp11^tm1Lex/Aqp11^tm1Lex (129S5/SvEvBrd-Aqp11^tm1Lex)	increased blood urea nitrogen level	J:100522
Aqp11^tm1Lex/Aqp11^tm1Lex (involves: 129S5/SvEvBrd * C57BL/6 * CD-1)	decreased urine osmolality	J:169660
	increased blood urea nitrogen level	J:169660
Aqp12^{tm1.1(KOMP)Vlcg}/Aqp12^{tm1.1(KOMP)Vlcg} (C57BL/6N-Aqp12^{tm1.1(KOMP)Vlcg}/Ucd)	increased circulating aspartate transaminase level	J:211773
Aqp12^tm1Rai/Aqp12^tm1Rai (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	increased cholesterol level	J:155920
Ar^tm1.1Chc/Y (involves: 129S/SvEv * C57BL/6 * FVB/N)	decreased circulating testosterone level	J:89886
Ar^tm1.1Chc/Y (involves: 129S/SvEv * C57BL/6 * FVB/N)	increased circulating luteinizing hormone level	J:89886
Ar^tm1.1Jdz/Y (B6.129X1-Ar^tm1.1Jdz)	decreased circulating testosterone level	J:123057
Ar^tm1.1Jdz/Y (involves: 129X1/SvJ * C57BL/6)	decreased circulating testosterone level	J:122327
Ar^tm1.1Verh/Y (involves: 129S1/Sv * 129X1/SvJ * Black Swiss * C57BL/6)	increased circulating luteinizing hormone level	J:100799
Ar^tm1Chc/Y Plekha5^{Tg(AMH-cre)1Flor}/Plekha5⁺ (involves: 129S/SvEv * C57BL/6 * SJL)	decreased circulating testosterone level	J:89886, J:118270
	increased circulating follicle stimulating hormone level	J:89886
	increased circulating luteinizing hormone level	J:89886
Ar^tm1Chc/Y Tmem163^{Tg(ACTB-cre)2Mrt}/0 (involves: 129S/SvEv * C57BL/6J * FVB/N)	abnormal homeostasis	J:81789
	decreased adiponectin level	J:98775
	decreased circulating testosterone level	J:98775, J:118270, J:81789
	hyperglycemia	J:98775
	impaired glucose tolerance	J:98775
	increased circulating glucose level	J:98775
	increased circulating insulin level	J:98775
	increased circulating leptin level	J:98775
	increased circulating triglyceride level	J:98775
	increased liver triglyceride level	J:98775
	increased skeletal muscle triglyceride level	J:98775
	insulin resistance	J:98775
Ar^tm1Reb/Y (involves: 129S4/SvJaeSor)	increased circulating follicle stimulating hormone level	J:90393
	increased circulating luteinizing hormone level	J:90393
	increased circulating pituitary hormone level	J:90393
	increased circulating testosterone level	J:90393
Ar^tm1Reb/Y Tg(Amh-cre)8815Reb/? (involves: 129S4/SvJaeSor * FVB/N)	increased circulating follicle stimulating hormone level	J:90393
	increased circulating luteinizing hormone level	J:90393
	increased circulating pituitary hormone level	J:90393
	increased circulating testosterone level	J:90393
Ar^tm1Verh/Y Plekha5^{Tg(AMH-cre)1Flor}/Plekha5⁺ (involves: 129S1/Sv * 129X1/SvJ * Black Swiss * C57BL/6)	increased circulating follicle stimulating hormone level	J:88169
Ar^tm1Verh/Y Tg(Fabp4-cre)1Rev/0 (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	hyperglycemia	J:196857
	impaired glucose tolerance	J:196857
	increased circulating insulin level	J:196857
	increased circulating triglyceride level	J:196857
	insulin resistance	J:196857
Ar^tm3.1(AR)Ska/Y (involves: C57BL/6 * C57BL/6J * CBA)	increased circulating testosterone level	J:170092
Ar^tm3.1(AR)Ska/Y Tg(KLKB1-cre/ERT2)1Pcn/0 (involves: C57BL/6 * C57BL/6J * CBA)	increased circulating testosterone level	J:170092
Ar^tm4(AR)Dmr/Y (involves: 129S1/Sv * C57BL/6J)	abnormal blood homeostasis	J:114552
	decreased circulating follicle stimulating hormone level	J:104360
	decreased circulating testosterone level	J:114552
	decreased urine major urinary protein level	J:104360
	increased blood urea nitrogen level	J:114552
	increased circulating creatinine level	J:114552
	increased circulating luteinizing hormone level	J:104360
	increased circulating potassium level	J:114552
Ar^tm4(AR)Dmr/Ar⁺ (involves: 129S1/Sv * C57BL/6J)	increased circulating testosterone level	J:114552
Ar^tm4(AR)Dmr/Ar⁺ (involves: 129S1/Sv * C57BL/6J)	increased urine major urinary protein level	J:114552
Arb2a^{em2(IMPC)Ccpcz}/Arb2a^{em2(IMPC)Ccpcz} (C57BL/6NCrl-Arb2a^{em2(IMPC)Ccpcz}/Ph)	increased circulating aspartate transaminase level	J:211773
Areg^{tm2c(EUCOMM)Hmgu}/Areg^{tm2c(EUCOMM)Hmgu} Foxp3^{tm4(YFP/icre)Ayr}/Foxp3⁺ (involves: 129S1/Sv * 129X1/SvJ * C57BL/6N)	decreased blood oxygen saturation level	J:224904
	decreased body surface temperature	J:224904
Areg^{tm2c(EUCOMM)Hmgu}/Areg^{tm2c(EUCOMM)Hmgu} Tg(Cd4-cre)1Cwi/0 (involves: C57BL/6 * C57BL/6N * DBA/2)	decreased blood oxygen saturation level	J:224904
	decreased body surface temperature	J:224904
Arel1^{tm1b(EUCOMM)Hmgu}/Arel1^{tm1b(EUCOMM)Hmgu} (C57BL/6N-Arel1^{tm1b(EUCOMM)Hmgu}/Mhzh)	increased fasting circulating glucose level	J:211773
Arf2^{tm1.1(KOMP)Wtsi}/Arf2^{tm1.1(KOMP)Wtsi} (B6N(Cg)-Arf2^{tm1.1(KOMP)Wtsi}/J)	decreased fasting circulating glucose level	J:211773
Arf6^tm1Yaka/Arf6^tm1Yaka (involves: 129P2/OlaHsd * C57BL/6)	hydrops fetalis	J:111404
Arfgef3^tm1Hong/Arfgef3^tm1Hong (129.129P2(B6)-Arfgef3^tm1Hong)	abnormal glucose homeostasis	J:216529
	hyperglycemia	J:216529
	impaired glucose tolerance	J:216529
	increased circulating insulin level	J:216529
	increased insulin secretion	J:216529
	insulin resistance	J:216529
Arfip2^{tm1d(EUCOMM)Wtsi}/Arfip2^{tm1d(EUCOMM)Wtsi} (involves: 129S4/SvJaeSor * C57BL/6 * C57BL/6N * CBA)	albuminuria	J:345639
Arg1^tm1.1Pmu/Arg1^tm1.1Pmu (involves: C57BL/6 * NZB)	increased macrophage nitric oxide production	J:143229
Arg1^tm1Ekoe/Arg1^tm1Ekoe (involves: 129P2/OlaHsd)	abnormal blood homeostasis	J:183882
Arg1^tm1Pmu/Arg1^tm1Pmu Tg(Tek-cre)1Ywa/? (B6.Cg-Tg(Tek-cre)1Ywa Arg1^tm1Pmu)	abnormal nitric oxide homeostasis	J:143229
	increased macrophage nitric oxide production	J:143229
Arg1^tm1Rki/Arg1^tm1Rki (Not Specified)	abnormal circulating amino acid level	J:83263
	abnormal homeostasis	J:83263
	decreased circulating ornithine level	J:83263
	decreased circulating proline level	J:83263
	increased circulating ammonia level	J:83263
	increased circulating arginine level	J:83263
	increased circulating citrulline level	J:83263
	increased circulating histidine level	J:83263
Arg2^tm1Weo/Arg2⁺ (involves: C57BL/6J)	increased circulating arginine level	J:67353
Arg2^tm1Weo/Arg2^tm1Weo (involves: C57BL/6J)	increased circulating arginine level	J:67353
Arhgap17^{tm1b(EUCOMM)Wtsi}/Arhgap17^{tm1b(EUCOMM)Wtsi} (C57BL/6N-Arhgap17^{tm1b(EUCOMM)Wtsi}/Wtsi)	decreased circulating fructosamine level	J:211773
	decreased circulating glucose level	J:211773
	improved glucose tolerance	J:211773
Arhgap18^{tm1a(KOMP)Wtsi}/Arhgap18^{tm1a(KOMP)Wtsi} (B6JTyr;B6N-Arhgap18^{tm1a(KOMP)Wtsi}/Wtsi)	increased circulating calcium level	J:175295
Arhgap20^em1(IMPC)J/Arhgap20^em1(IMPC)J (C57BL/6NJ-Arhgap20^em1(IMPC)J/Mmjax)	abnormal cholesterol homeostasis	J:211773
Arhgap22^{tm1a(KOMP)Wtsi}/Arhgap22^{tm1a(KOMP)Wtsi} (C57BL/6N-Arhgap22^{tm1a(KOMP)Wtsi}/Wtsi)	decreased circulating calcium level	J:211773
	decreased circulating LDL cholesterol level	J:211773
Arhgap23^{tm1b(EUCOMM)Wtsi}/Arhgap23^{tm1b(EUCOMM)Wtsi} (C57BL/6N-Arhgap23^{tm1b(EUCOMM)Wtsi}/Bay)	decreased circulating phosphate level	J:211773
	decreased circulating serum albumin level	J:211773
Arhgap26^{tm1b(EUCOMM)Hmgu}/Arhgap26^{tm1b(EUCOMM)Hmgu} (C57BL/6N-Arhgap26^{tm1b(EUCOMM)Hmgu}/Ieg)	increased circulating phosphate level	J:211773
Arhgap29^em1(IMPC)J/Arhgap29⁺ (C57BL/6NJ-Arhgap29^em1(IMPC)J/J)	increased circulating alanine transaminase level	J:211773
	increased circulating aspartate transaminase level	J:211773
Arhgap30^{tm1a(EUCOMM)Wtsi}/Arhgap30^{tm1a(EUCOMM)Wtsi} (C57BL/6N-Arhgap30^{tm1a(EUCOMM)Wtsi}/Wtsi)	decreased circulating fructosamine level	J:211773
	decreased circulating serum albumin level	J:211773
	increased circulating amylase level	J:211773
Arhgap31^em1(IMPC)Bay/Arhgap31^em1(IMPC)Bay (C57BL/6N-Arhgap31^em1(IMPC)Bay/Bay)	edema	J:211773
Arhgap31^tm1.2Itl/Arhgap31^tm1.2Itl (involves: 129/SvEv * C57BL/6)	subcutaneous edema	J:253757
Arhgap42^em1(IMPC)H/Arhgap42^em1(IMPC)H (C57BL/6NTac-Arhgap42^em1(IMPC)H/H)	decreased circulating total protein level	J:211773
	increased circulating creatinine level	J:211773
Arhgdia^tm1Ytk/Arhgdia^tm1Ytk (involves: 129S/SvEv * C57BL/6 * DBA)	abnormal blood homeostasis	J:57995
	decreased circulating serum albumin level	J:57995
	increased blood urea nitrogen level	J:57995
	increased circulating cholesterol level	J:57995
	increased circulating creatinine level	J:57995
	increased urine protein level	J:57995
Arhgdia^tm1Ytk/Arhgdia^tm1Ytk Arhgdib^tm1Miyo/Arhgdib^tm1Miyo (involves: 129S/SvEv)	increased circulating interleukin-5 level	J:140671
Arhgef2^em1(IMPC)Mbp/Arhgef2^em1(IMPC)Mbp (C57BL/6N-Arhgef2^em1(IMPC)Mbp/MbpMmucd)	increased circulating alkaline phosphatase level	J:211773
	increased circulating serum albumin level	J:211773
	increased circulating total protein level	J:211773
Arhgef3^{tm1(KOMP)Wtsi}/Arhgef3^{tm1(KOMP)Wtsi} (C57BL/6N-Arhgef3^{tm1(KOMP)Wtsi}/DkrsJ)	abnormal platelet physiology	J:241286
Arhgef4^{tm1a(KOMP)Wtsi}/Arhgef4^{tm1a(KOMP)Wtsi} (C57BL/6N-Arhgef4^{tm1a(KOMP)Wtsi}/Wtsi)	decreased circulating triglyceride level	J:165965
	increased circulating alkaline phosphatase level	J:165965
	increased circulating total protein level	J:165965
Arhgef6^{tm2e.1(EUCOMM)Wtsi}/Arhgef6^{tm2e.1(EUCOMM)Wtsi} (C57BL/6N-Arhgef6^{tm2e.1(EUCOMM)Wtsi}/Tcp)	increased circulating aspartate transaminase level	J:211773
	increased circulating potassium level	J:211773
Arhgef10^{tm1.1(KOMP)Vlcg}/Arhgef10^{tm1.1(KOMP)Vlcg} (B6N(Cg)-Arhgef10^{tm1.1(KOMP)Vlcg}/J)	decreased circulating glucose level	J:211773
	increased circulating alanine transaminase level	J:211773
	increased circulating potassium level	J:211773
Arhgef10^tm1.1Ssfg/Arhgef10^tm1.1Ssfg (B6.129S1-Arhgef10^tm1.1Ssfg)	increased dopamine level	J:271943
	increased noradrenaline level	J:271943
	increased serotonin level	J:271943
Arhgef11^tm1.1Mak/Arhgef11^tm1.1Mak (B6.129P2(C)-Arhgef11^tm1.1Mak)	abnormal glucose homeostasis	J:233950
	decreased susceptibility to diet-induced non-insulin dependent diabetes	J:233950
	decreased susceptibility to diet-induced obesity	J:233950
	increased oxygen consumption	J:233950
	increased respiratory quotient	J:233950
Arhgef18^{tm1b(KOMP)Mbp}/Arhgef18⁺ (C57BL/6N-Arhgef18^{tm1b(KOMP)Mbp}/H)	increased circulating amylase level	J:211773
Arhgef38^{tm1a(KOMP)Wtsi}/Arhgef38^{tm1a(KOMP)Wtsi} (C57BL/6N-Arhgef38^{tm1a(KOMP)Wtsi}/Wtsi)	increased circulating cholesterol level	J:211773
Arid1a^m1Mag/Arid1a^m1Mag (involves: 129 * CD-1)	pericardial effusion	J:192829
Arid1a^tm1.1Mag/Arid1a^tm1.1Mag Gt(ROSA)26Sor^{tm1(Pik3caH1047R)Egan}/Gt(ROSA)26Sor⁺ (involves: 129S6/SvEvTac CD-1)	hemorrhagic ascites	J:219794
Arid1b^em1(IMPC)Tcp/Arid1b⁺ (C57BL/6NCrl-Arid1b^em1(IMPC)Tcp/Tcp)	decreased fasting circulating glucose level	J:211773
	increased circulating creatinine level	J:211773
Arid1b^em1(IMPC)Tcp/Arid1b^em1(IMPC)Tcp (C57BL/6NCrl-Arid1b^em1(IMPC)Tcp/Tcp)	edema	J:211773
Arid1b^em1Hzhu/Arid1b⁺ (C57BL/6J-Arid1b^em1Hzhu)	abnormal homeostasis	J:256668
	abnormal insulin-like growth factor I level	J:256668
	decreased circulating insulin-like growth factor I level	J:256668
Arid2^{tm1a(EUCOMM)Wtsi}/Arid2^{tm1a(EUCOMM)Wtsi} (involves: C57BL/6J * C57BL/6N)	subcutaneous edema	J:223458
Arid3a^{tm1b(KOMP)Wtsi}/Arid3a⁺ (B6N(Cg)-Arid3a^{tm1b(KOMP)Wtsi}/J)	increased circulating insulin level	J:211773
	increased circulating triglyceride level	J:211773
Arid4b^tm1Alb/Arid4b^tm1.1Mywu Tg(Amh-cre)8815Reb/0 (involves: 129S7/SvEvBrd * C57BL/6J * FVB/N)	increased circulating follicle stimulating hormone level	J:233398
	increased circulating luteinizing hormone level	J:233398
Arid5a^tm1Rnis/Arid5a^tm1Rnis (B6.Cg-Arid5a^tm1Rnis)	decreased circulating interleukin-6 level	J:197418
Arid5a^tm1Rnis/Arid5a^tm1Rnis (B6.Cg-Arid5a^tm1Rnis)	decreased circulating tumor necrosis factor level	J:197418
Arid5b^{Gt(ROSA)75Sor}/Arid5b^{Gt(ROSA)75Sor} (involves: 129S4/SvJaeSor)	increased blood urea nitrogen level	J:117491
Arid5b^tm1Whit/Arid5b⁺ (involves: 129S1/Sv * C57BL/6J)	decreased susceptibility to diet-induced obesity	J:130390
Arid5b^tm1Whit/Arid5b^tm1Whit (involves: 129S1/Sv * C57BL/6J)	decreased susceptibility to diet-induced obesity	J:130390
Arih1^em3Gpt/Arih1^em3Gpt Lyz2^em1(icre)Gpt/Lyz2⁺ (C57BL/6JGpt-Arih1^em3Gpt Lyz2^em1(icre)Gpt)	decreased circulating interferon-beta level	J:330879
	decreased circulating interleukin-6 level	J:330879
Ark2c^Gt(P9-3F)Sor/Ark2c^Gt(P9-3F)Sor Tg(Hlxb9-GFP)1Tmj/0 (involves: 129S4/SvJaeSor * C57BL/6 * CBA)	cyanosis	J:198828
	dehydration	J:198828
	hypoxia	J:198828
	increased circulating lactate level	J:198828
Arl5c^{tm1.1(KOMP)Vlcg}/Arl5c^{tm1.1(KOMP)Vlcg} (C57BL/6N-Arl5c^{tm1.1(KOMP)Vlcg}/Ucd)	decreased circulating calcium level	J:211773
	decreased circulating creatinine level	J:211773
	decreased circulating serum albumin level	J:211773
	decreased circulating total protein level	J:211773
Arl6^tm2Vcs/Arl6^tm2Vcs (B6.129-Arl6^tm2Vcs)	cyanosis	J:257068
Arl8b^{tm1.1(NCOM)Mfgc}/Arl8b⁺ (C57BL/6N-Arl8b^{tm1.1(NCOM)Mfgc}/Tcp)	increased blood urea nitrogen level	J:211773
Arl8b^tm1Kkon/Arl8b^tm1Kkon Tg(Ttr-cre)1Hadj/0 (involves: C57BL/6J * C57BL/6N * CBA/J)	abnormal amino acid level	J:245627
Arl13b^{tm1c(EUCOMM)Wtsi}/Arl13b^{tm1c(EUCOMM)Wtsi} Tg(Cdh16-cre)91Igr/0 (involves: C57BL/6J * C57BL/6N * ICR)	increased blood urea nitrogen level	J:240795
Arl14^em1(IMPC)J/Arl14^em1(IMPC)J (C57BL/6NJ-Arl14^em1(IMPC)J/Mmjax)	decreased circulating aspartate transaminase level	J:211773
Arl15^em1(IMPC)H/Arl15⁺ (C57BL/6N-Arl15^em1(IMPC)H/H)	increased circulating creatinine level	J:211773
Armc2^{tm1b(EUCOMM)Hmgu}/Armc2⁺ (C57BL/6N-Armc2^{tm1b(EUCOMM)Hmgu}/H)	decreased circulating fructosamine level	J:211773
	decreased circulating serum albumin level	J:211773
	increased circulating alanine transaminase level	J:211773
	increased circulating aspartate transaminase level	J:211773
Armc3^em1(IMPC)J/Armc3⁺ (C57BL/6NJ-Armc3^em1(IMPC)J/Mmjax)	increased circulating cholesterol level	J:211773
Armc5^tm1Stra/Armc5⁺ (involves: 129 * C57BL/6N * Swiss)	decreased circulating corticosterone level	J:244906
	increased adrenocorticotropin level	J:244906
	increased circulating corticosterone level	J:244906
Armcx3^tm1.1Eso/Y Ndor1^{Tg(UBC-cre/ERT2)1Ejb}/Ndor1⁺ (involves: 129S/SvEv * C57BL/6)	decreased circulating alanine transaminase level	J:345411
	decreased circulating glucose level	J:345411
	decreased susceptibility to diet-induced obesity	J:345411
	improved glucose tolerance	J:345411
	increased circulating insulin level	J:345411
	increased insulin sensitivity	J:345411
Arnt2^em1Btlr/Arnt2^em1Btlr (C57BL/6J-Arnt2^em1Btlr)	impaired glucose tolerance	J:268298
	increased circulating insulin level	J:268298
	increased fasting circulating glucose level	J:268298
Arnt2^tm1Yfk/Arnt2^tm1Yfk (involves: 129P2/OlaHsd * C57BL/6)	abnormal pituitary hormone level	J:74118
Arnt^tm1.1Gonz/Arnt^tm1.1Gonz Tg(Vil1-cre)20Syr/0 (involves: 129X1/SvJ * C57BL/6 * DBA/2)	decreased circulating iron level	J:189504
Arnt^tm1.1Gonz/Arnt^tm1.2Gonz Tg(KRT5-cre)1Tak/0 (involves: 129X1/SvJ * C3H * C57BL/6)	dehydration	J:86533, J:85934
	impaired skin barrier function	J:86533
Arpc1b^{tm1a(EUCOMM)Wtsi}/Arpc1b^{tm1a(EUCOMM)Wtsi} (C57BL/6N-Arpc1b^{tm1a(EUCOMM)Wtsi}/Wtsi)	decreased circulating alkaline phosphatase level	J:211773
	decreased circulating fructosamine level	J:211773
	decreased circulating serum albumin level	J:211773
	increased circulating calcium level	J:211773
	increased circulating total protein level	J:211773
Arpc4^{tm1a(EUCOMM)Wtsi}/Arpc4⁺ (B6JTyr;B6N-Arpc4^{tm1a(EUCOMM)Wtsi}/Wtsi)	decreased circulating fructosamine level	J:175295
	decreased circulating total protein level	J:175295
Arpc5l^{tm1.1(KOMP)Vlcg}/Arpc5l⁺ (B6N(Cg)-Arpc5l^{tm1.1(KOMP)Vlcg}/J)	decreased fasting circulating glucose level	J:211773
	increased circulating alanine transaminase level	J:211773
Arr3^em1(IMPC)J/Arr3^em1(IMPC)J (C57BL/6NJ-Arr3^em1(IMPC)J/J)	decreased circulating triglyceride level	J:211773
	increased circulating alkaline phosphatase level	J:211773
Arrb1^tm1Jse/Arrb1^tm1Jse Arrb2^tm1Rjl/Arrb2^tm1Rjl (involves: 129X1/SvJ * C57BL/6)	cyanosis	J:159121
Arrb2^{tm1.1(KOMP)Vlcg}/Arrb2⁺ (B6N(Cg)-Arrb2^{tm1.1(KOMP)Vlcg}/J)	increased circulating free fatty acids level	J:211773
Arrb2^{tm1.1(KOMP)Vlcg}/Arrb2^{tm1.1(KOMP)Vlcg} (B6N(Cg)-Arrb2^{tm1.1(KOMP)Vlcg}/J)	increased circulating alkaline phosphatase level	J:211773
	increased circulating cholesterol level	J:211773
	increased circulating HDL cholesterol level	J:211773
	increased circulating phosphate level	J:211773
Arrb2^tm1Rjl/Arrb2^tm1Rjl (involves: 129X1/SvJ * C57BL/6)	abnormal body temperature homeostasis	J:59162
	abnormal circulating tumor necrosis factor level	J:112607
	increased circulating interleukin-6 level	J:112607
Arrdc1^{tm1.1(KOMP)Vlcg}/Arrdc1^{tm1.1(KOMP)Vlcg} (B6N(Cg)-Arrdc1^{tm1.1(KOMP)Vlcg}/J)	increased circulating alanine transaminase level	J:211773
Arrdc3^{Gt(CSE151)Byg}/Arrdc3⁺ (involves: 129P2/OlaHsd * C57BL/6)	decreased circulating adrenaline level	J:179646
	decreased circulating glucose level	J:179646
	increased circulating ketone body level	J:179646
	increased oxygen consumption	J:179646
Arrdc3^{Gt(CSE151)Byg}/Arrdc3^{Gt(CSE151)Byg} (involves: 129P2/OlaHsd * C57BL/6)	abnormal energy homeostasis	J:179646
	abnormal glucose homeostasis	J:179646
	abnormal hormone level	J:179646
	abnormal lipid homeostasis	J:179646
	decreased circulating glucose level	J:179646
	decreased circulating insulin level	J:179646
	decreased circulating leptin level	J:179646
	decreased circulating triglyceride level	J:179646
	decreased circulating triiodothyronine level	J:179646
	decreased susceptibility to induced hypothermia	J:179646
	increased circulating ketone body level	J:179646
	increased insulin sensitivity	J:179646
Arrdc5^{tm1b(EUCOMM)Wtsi}/Arrdc5^{tm1b(EUCOMM)Wtsi} (C57BL/6N-Arrdc5^{tm1b(EUCOMM)Wtsi}/Wtsi)	increased circulating alkaline phosphatase level	J:211773
	increased circulating fructosamine level	J:211773
Arsa^tm1Gie/Arsa^tm1Gie (involves: 129P2/OlaHsd * C57BL/6J)	abnormal lipid homeostasis	J:37978, J:52310
Arsb^tm1Cptr/Arsb^tm1Cptr (involves: 129P2/OlaHsd * C57BL/6J)	increased urine glycosaminoglycan level	J:34831
Arsg^tm1Tdi/Arsg^tm1Tdi (involves: 129S2/SvPas * C57BL/6)	abnormal glycosaminoglycan level	J:185592
Arsk^{tm1b(KOMP)Wtsi}/Arsk^{tm1b(KOMP)Wtsi} (B6N(Cg)-Arsk^{tm1b(KOMP)Wtsi}/J)	abnormal glycosaminoglycan level	J:302659
Art1^{tm1b(EUCOMM)Wtsi}/Art1^{tm1b(EUCOMM)Wtsi} (C57BL/6N-Art1^{tm1b(EUCOMM)Wtsi}/Tcp)	decreased circulating calcium level	J:211773
	decreased circulating sodium level	J:211773
Artles^C57BL/6J/? (involves: C57BL/6J * CAST/Ei)	increased circulating insulin level	J:70961
Artles^CAST/EiJ/? (involves: C57BL/6J * CAST/Ei)	decreased circulating insulin level	J:70961
Artmd1^DBA/1Crlj/Artmd1^MRL/MpJ (involves: DBA/1Crlj * MRL/MpJ)	joint swelling	J:97911
Artmd1^MRL/MpJ/Artmd1^MRL/MpJ (involves: DBA/1Crlj * MRL/MpJ)	joint swelling	J:97911
Artmd1^MRL/MpJ/Artmd1^MRL/MpJ Artmd2^DBA/1Crlj/Artmd2^DBA/1Crlj (involves: DBA/1Crlj * MRL/MpJ)	joint swelling	J:97911
Artmd2^DBA/1Crlj/Artmd2^DBA/1Crlj (involves: DBA/1Crlj * MRL/MpJ)	joint swelling	J:97911
Artmd2^DBA/1Crlj/Artmd2^MRL/MpJ (involves: DBA/1Crlj * MRL/MpJ)	joint swelling	J:97911
Arv1^tm1.2Geno/Arv1⁺ (involves: C57BL/6 * C57BL/6J)	increased circulating cholesterol level	J:263695
Arv1^tm1.2Geno/Arv1⁺ (involves: C57BL/6 * C57BL/6J)	increased circulating HDL cholesterol level	J:263695
Arv1^tm1.2Geno/Arv1^tm1.2Geno (involves: C57BL/6 * C57BL/6J)	abnormal bile salt homeostasis	J:263695
	abnormal enzyme/coenzyme level	J:263695
	decreased circulating cholesterol level	J:263695
	decreased circulating HDL cholesterol level	J:263695
	decreased circulating lactate dehydrogenase level	J:263695
	decreased circulating leptin level	J:263695
	decreased circulating triglyceride level	J:263695
	decreased fasting circulating glucose level	J:263695
	decreased liver cholesterol level	J:263695
	decreased liver free fatty acids level	J:263695
	decreased liver triglyceride level	J:263695
	decreased susceptibility to diet-induced obesity	J:263695
	decreased unsaturated fatty acids level	J:263695
	improved glucose tolerance	J:263695
	increased bile salt level	J:263695
	increased blood urea nitrogen level	J:263695
	increased carbon dioxide production	J:263695
	increased circulating adiponectin level	J:263695
	increased circulating alkaline phosphatase level	J:263695
	increased circulating ghrelin level	J:263695
	increased energy expenditure	J:263695
	increased insulin sensitivity	J:263695
	increased oxygen consumption	J:263695
	increased saturated fatty acids level	J:263695
	increased unsaturated fatty acids level	J:263695
Arv1^tm1.2Radr/Arv1^tm1.2Radr (involves: 129S1/Sv * 129X1/SvJ * BALB/cJ)	abnormal circulating lipid level	J:241193
	decreased circulating cholesterol level	J:241193
	decreased circulating HDL cholesterol level	J:241193
	decreased circulating leptin level	J:241193
	decreased fasting circulating glucose level	J:241193
	decreased respiratory quotient	J:241193
	hypoglycemia	J:241193
	improved glucose tolerance	J:241193
	increased carbon dioxide production	J:241193
	increased circulating adiponectin level	J:241193
	increased fatty acid oxidation	J:241193
	increased oxygen consumption	J:241193
Arvcf^{tm1e(EUCOMM)Wtsi}/Arvcf^{tm1e(EUCOMM)Wtsi} (C57BL/6N-Arvcf^{tm1e(EUCOMM)Wtsi}/Ieg)	increased circulating alkaline phosphatase level	J:211773
Arx^tm1Gldn/Arx^tm1Gldn Nkx2-2^tm2.1Suss/Nkx2-2^tm2.1Suss Tg(Ins2-cre)23Herr/0 (involves: 129 * Black Swiss * C57BL/6 * CBA/J * SJL)	hyperglycemia	J:177838
Arx^tm1Pgr/Y (involves: 129/Sv * NMRI)	dehydration	J:86206
Arx^tm1Pgr/Y (involves: 129/Sv * NMRI)	hypoglycemia	J:86206
Asah1^tm1.1Jhkh/Asah1⁺ Smpd1^tm1Esc/Smpd1⁺ (involves: 129S1/Sv)	abnormal ceramide level	J:199833
Asah1^tm1.1Jhkh/Asah1^tm1.1Jhkh (Not Specified)	abnormal ceramide level	J:199833
Asah1^tm1.2Geno/Asah1^tm1.2Geno (involves: C57BL/6)	abnormal circulating cytokine level	J:285931
	abnormal sphingomyelin level	J:285931
	increased blood urea nitrogen level	J:285931
	increased ceramide level	J:285931
	increased circulating alanine transaminase level	J:285931
	increased circulating aspartate transaminase level	J:285931
	increased circulating creatine kinase level	J:285931
	increased circulating CXCL10 level	J:285931
	increased circulating lactate dehydrogenase level	J:285931
	increased sphingosine level	J:285931
Asah1^tm1Esc/Asah1⁺ (involves: 129S1/Sv * C57BL/6)	abnormal lipid homeostasis	J:74647
Asah1^tm1Medin/Asah1^tm1Medin (involves: 129S6/SvEvTac * CD-1)	abnormal ceramide level	J:232306
	abnormal circulating chemokine level	J:232306
	increased circulating interleukin-12b level	J:232306
	pulmonary alveolar edema	J:232306
Asah2^tm1Rlp/Asah2^tm1Rlp (involves: 129S6/SvEvTac * C57BL/6)	abnormal lipid level	J:110485
Asb1^{em1(IMPC)Ccpcz}/Asb1^{em1(IMPC)Ccpcz} (C57BL/6N-Asb1^{em1(IMPC)Ccpcz}/Ccpcz)	decreased circulating chloride level	J:211773
	decreased circulating creatinine level	J:211773
	increased circulating potassium level	J:211773
Asb2^{tm2b(KOMP)Wtsi}/Asb2⁺ (C57BL/6N-Asb2^{tm2b(KOMP)Wtsi}/Kmpc)	increased circulating aspartate transaminase level	J:211773
Asb4^tm1.2Cpat/Asb4^tm1.2Cpat (involves: 129/SvEv)	abnormal urine albumin level	J:213825
Asb4^tm1.2Cpat/Asb4^tm1.2Cpat (involves: 129/SvEv)	albuminuria	J:238841
Asb5^{em1(IMPC)Ccpcz}/Asb5^{em1(IMPC)Ccpcz} (C57BL/6N-Asb5^{em1(IMPC)Ccpcz}/Ccpcz)	decreased circulating sodium level	J:211773
	increased circulating potassium level	J:211773
Asb7^{em1(IMPC)Ccpcz}/Asb7^{em1(IMPC)Ccpcz} (C57BL/6N-Asb7^{em1(IMPC)Ccpcz}/Ccpcz)	increased circulating alkaline phosphatase level	J:211773
	increased fasting circulating glucose level	J:211773
Asb18^em1(IMPC)J/Asb18^em1(IMPC)J (C57BL/6NJ-Asb18^em1(IMPC)J/J)	increased circulating bilirubin level	J:211773
Ascc3^{tm1a(EUCOMM)Hmgu}/Ascc3⁺ (C57BL/6N-Ascc3^{tm1a(EUCOMM)Hmgu}/Ics)	decreased circulating phosphate level	J:165965
	increased circulating phosphate level	J:165965
Ascl5^{em1(IMPC)Ccpcz}/Ascl5^{em1(IMPC)Ccpcz} (C57BL/6NCrl-Ascl5^{em1(IMPC)Ccpcz}/Ccpcz)	increased circulating creatine kinase level	J:211773
	increased circulating total protein level	J:211773
Asf1a^{tm1b(KOMP)Wtsi}/Asf1a⁺ (B6N(Cg)-Asf1a^{tm1b(KOMP)Wtsi}/2J)	increased circulating alkaline phosphatase level	J:211773
	increased circulating insulin level	J:211773
Asgr1^Mhdabap005/Asgr1^Mhdabap005 (C3HeB/FeJ-Asgr1^Mhdabap005/Ieg)	increased circulating alkaline phosphatase level	J:183993
Asgr1^tm1Sau/Asgr1^tm1Sau (B6.129S4-Asgr1^tm1Sau)	decreased bleeding time	J:136946
Asgr2^tm1Her/Asgr2⁺ (involves: 129S7/SvEvBrd * C57BL/6)	abnormal homeostasis	J:21380
Asgr2^tm1Her/Asgr2^tm1Her (involves: 129S7/SvEvBrd * C57BL/6)	abnormal homeostasis	J:35142, J:21380
Asgr2^tm1Her/Asgr2^tm1Her Ldlr^tm1Her/Ldlr^tm1Her (involves: 129S7/SvEvBrd * C57BL/6)	abnormal lipid homeostasis	J:21380
Asgr2^tm1Her/Asgr2^tm1Her St3gal4^tm1.1Jxm/St3gal4^tm1.1Jxm (B6.129-St3gal4^tm1.1Jxm Asgr2^tm1Her)	abnormal blood coagulation	J:136946
Ash1l^{tm2b(EUCOMM)Hmgu}/Ash1l⁺ (C57BL/6N-Ash1l^{tm2b(EUCOMM)Hmgu}/Nju)	increased fasting circulating glucose level	J:211773
Ash1l^{Tn(pb-Act-RFP)1.AF0-180T25Zhu}/Ash1l^{Tn(pb-Act-RFP)1.AF0-180T25Zhu} (B6.FVB-Ash1l^{Tn(pb-Act-RFP)1.AF0-180T25Zhu})	increased circulating interleukin-6 level	J:208213
	increased circulating tumor necrosis factor level	J:208213
Asic1^em1(IMPC)Mbp/Asic1^em1(IMPC)Mbp (C57BL/6N-Asic1^em1(IMPC)Mbp/MbpMmucd)	increased circulating triglyceride level	J:211773
Asl^tm1Brle/Asl^tm1Brle (involves: 129S7/SvEvBrd)	abnormal nitric oxide homeostasis	J:180208
	decreased circulating alanine transaminase level	J:180208
	decreased circulating arginine level	J:180208
	decreased circulating aspartate transaminase level	J:180208
	increased circulating ammonia level	J:180208
	increased circulating citrulline level	J:180208
Asl^tm1Wjc/Asl^tm1Wjc (involves: 129S7/SvEvBrd)	abnormal circulating amino acid level	J:101658
	decreased circulating arginine level	J:101658
	increased circulating ammonia level	J:101658
	increased circulating citrulline level	J:101658
	increased circulating glutamine level	J:101658
Asnsd1^{Gt(OST460318)Lex}/Asnsd1^{Gt(OST460318)Lex} (involves: 129S5/SvEvBrd * C57BL/6J)	increased circulating alanine transaminase level	J:320329
Aspa^nur7/Aspa^nur7 (involves: C57BL/6J)	abnormal enzyme/coenzyme level	J:226682
Aspa^nur7/Aspa^nur7 (involves: C57BL/6J)	abnormal sphingolipid level	J:226682
Aspa^nur7/Aspa^nur7 Nat8l^tm1.2Meck/Nat8l⁺ (involves: 129P2/OlaHsd * C57BL/6 * C57BL/6J)	abnormal enzyme/coenzyme level	J:226682
Aspa^nur7/Aspa^nur7 Nat8l^tm1.2Meck/Nat8l^tm1.2Meck (involves: 129P2/OlaHsd * C57BL/6 * C57BL/6J)	abnormal enzyme/coenzyme level	J:226682
Aspa^{tm1b(EUCOMM)Wtsi}/Aspa^{tm1b(EUCOMM)Wtsi} (C57BL/6N-Aspa^{tm1b(EUCOMM)Wtsi}/Ieg)	increased circulating alkaline phosphatase level	J:211773
	increased fasting circulating glucose level	J:211773
Aspa^tm1Mata/Aspa^tm1Mata (involves: 129S5/SvEvBrd)	decreased gamma-aminobutyric acid level	J:89099
	decreased glutamic acid level	J:89099
	increased aspartic acid level	J:89099
Asphd1^{em1(IMPC)Ccpcz}/Asphd1^{em1(IMPC)Ccpcz} (C57BL/6NCrl-Asphd1^{em1(IMPC)Ccpcz}/Ccpcz)	decreased circulating alkaline phosphatase level	J:211773
	increased circulating creatinine level	J:211773
Aspm^{tm1a(KOMP)Wtsi}/Aspm^{tm1a(KOMP)Wtsi} (C57BL/6N-Aspm^{tm1a(KOMP)Wtsi}/Wtsi)	increased circulating cholesterol level	J:211773
	increased circulating glycerol level	J:211773
	increased circulating HDL cholesterol level	J:211773
Aspn^tm1.2Mmac/Aspn^tm1.2Mmac (B6.129(Cg)-Aspn^tm1.2Mmac)	abnormal glycosaminoglycan level	J:341806
Aspn^{tm1b(EUCOMM)Hmgu}/Aspn^{tm1b(EUCOMM)Hmgu} (C57BL/6N-Aspn^{tm1b(EUCOMM)Hmgu}/Ieg)	decreased circulating phosphate level	J:211773
	increased circulating cholesterol level	J:211773
	increased circulating HDL cholesterol level	J:211773
Ass1^bar/Ass1^bar (FVB.BAR-Ass1^bar)	abnormal circulating amino acid level	J:165341
Ass1^bar/Ass1^bar (FVB.BAR-Ass1^bar)	increased circulating ammonia level	J:165341
Ass1^bar/Ass1^bar (B6.BAR-Ass1^bar)	abnormal circulating amino acid level	J:165341
	increased circulating ammonia level	J:165341
	increased circulating citrulline level	J:165341
Ass1^bar/Ass1^fold (involves: C57BL/6Ei * C57BL/6J * OF1 * P/J)	abnormal circulating amino acid level	J:165341
	increased circulating ammonia level	J:165341
	increased circulating citrulline level	J:165341
Ass1^fold/Ass1^fold (B6Ei.P-Ass1^fold/GrsrJ)	abnormal circulating amino acid level	J:165341
	increased circulating ammonia level	J:165341
	increased circulating citrulline level	J:165341
Ass1^tm1.1Ekoe/Ass1^tm1.1Ekoe Tg(Vil1-cre)997Gum/0 (involves: 129P2/OlaHsd * C57BL/6 * SJL)	abnormal amino acid level	J:203474
	abnormal circulating amino acid level	J:203474
	decreased circulating arginine level	J:203474
	decreased circulating ornithine level	J:203474
	decreased circulating taurine level	J:203474
	increased circulating citrulline level	J:203474
	increased circulating ornithine level	J:203474
	increased circulating taurine level	J:203474
Ass1^tm1Bay/Ass1⁺ (involves: 129S7/SvEvBrd * C57BL/6J)	increased circulating citrulline level	J:18326
Ass1^tm1Bay/Ass1^tm1Bay (involves: 129S7/SvEvBrd * C57BL/6J)	abnormal circulating amino acid level	J:18326
	decreased circulating arginine level	J:18326
	increased circulating ammonia level	J:18326
	increased circulating citrulline level	J:18326
Asxl1^{tm1a(EUCOMM)Wtsi}/Asxl1⁺ (B6Dnk;B6Brd;B6N-Asxl1^{tm1a(EUCOMM)Wtsi} Tyr^c-Brd/WtsiH)	decreased circulating glucose level	J:175295
	increased blood uric acid level	J:175295
Asxl1^{tm1a(EUCOMM)Wtsi}/Asxl1⁺ (C57BL/6N-Asxl1^{tm1a(EUCOMM)Wtsi}/Cnrm)	decreased circulating free fatty acids level	J:165965
	decreased circulating triglyceride level	J:165965
	increased circulating alkaline phosphatase level	J:165965
	increased circulating iron level	J:165965
Asxl2^{tm1b(EUCOMM)Hmgu}/Asxl2^{tm1b(EUCOMM)Hmgu} (C57BL/6N-Asxl2^{tm1b(EUCOMM)Hmgu}/Tcp)	increased circulating alkaline phosphatase level	J:211773
	increased circulating cholesterol level	J:211773
Atad2b^{tm1b(EUCOMM)Hmgu}/Atad2b^{tm1b(EUCOMM)Hmgu} (C57BL/6N-Atad2b^{tm1b(EUCOMM)Hmgu}/Ics)	decreased circulating cholesterol level	J:211773
	decreased circulating HDL cholesterol level	J:211773
Atad3a^{tm1a(KOMP)Wtsi}/Atad3a⁺ (C57BL/6N-Atad3a^{tm1a(KOMP)Wtsi}/Wtsi)	decreased circulating cholesterol level	J:211773
	decreased circulating HDL cholesterol level	J:211773
Atad3a^{tm1c(KOMP)Wtsi}/Atad3a^{tm1c(KOMP)Wtsi} Myl1^tm1(cre)Sjb/Myl1⁺ (B6J.Cg-Myl1^tm1(cre)Sjb Atad3a^{tm1c(KOMP)Wtsi})	abnormal cholesterol homeostasis	J:263681
Atcay^ji/Atcay^ji (JIGR)	dehydration	J:85793
Ate1^tm1Avar/Ate1^tm1Avar (either: (involves: 129S1/Sv) or (involves: 129S1/Sv * C57BL/6J))	skin edema	J:77750
Ate1^tm1Avar/Ate1^tm2.1Avar Tg(CAG-cre/Esr1)5Amc/0 (involves: 129S1/Sv C57BL/6 * CBA)	cerebral edema	J:155421
	decreased circulating glucose level	J:155421
	decreased core body temperature	J:155421
	decreased susceptibility to diet-induced obesity	J:155421
	impaired adaptive thermogenesis	J:155421
Atf2^{Tg(Gzma-Klra1)7Wum}/Atf2⁺ (involves: C57BL/6)	decreased circulating interferon-gamma level	J:61178
Atf2^{tm1b(EUCOMM)Hmgu}/Atf2⁺ (C57BL/6N-Atf2^{tm1b(EUCOMM)Hmgu}/Ccpcz)	decreased circulating chloride level	J:211773
	increased blood urea nitrogen level	J:211773
	increased circulating potassium level	J:211773
	increased fasting circulating glucose level	J:211773
Atf2^tm1Nicj/Atf2^tm1Nicj (B6.129P2-Atf2^tm1Nicj)	cyanosis	J:123909
Atf2^tm1Sis/Atf2⁺ Creb5^tm1Sis/Creb5⁺ (involves: C57BL/6 * CBA)	improved glucose tolerance	J:156376
	increased insulin sensitivity	J:156376
	increased oxygen consumption	J:156376
Atf2^tm1Sis/Atf2^tm1Sis (either: (involves: C57BL/6 * CBA) or (involves: BALB/c * C57BL/6 * CBA) or (involves: C57BL/6 * CBA * ICR))	cyanosis	J:55657
	hypoxia	J:55657
Atf2^tm2Nicj/Atf2^tm2Nicj (B6.129P2-Atf2^tm2Nicj)	cyanosis	J:123909
Atf2^tm2Nicj/Atf2^tm2Nicj Atf7^tm1Nicj/Atf7^tm1Nicj (involves: 129P2/OlaHsd * C57BL/6)	hemopericardium	J:123909
Atf3^tm1.2Kitab/Atf3^tm1.2Kitab Tg(Pdx1-cre)89.1Dam/0 (involves: 129X1/SvJ * C57BL/6 * C57BL/6J * CBA)	decreased circulating glucose level	J:231262
	improved glucose tolerance	J:231262
	increased body temperature	J:231262
	increased carbon dioxide production	J:231262
	increased energy expenditure	J:231262
	increased insulin sensitivity	J:231262
	increased oxygen consumption	J:231262
	increased respiratory quotient	J:231262
Atf4^tm1(KOMP)Mbp/Atf4⁺ (C57BL/6NCrl-Atf4^tm1(KOMP)Mbp/MbpMmucd)	increased circulating alanine transaminase level	J:211773
	increased circulating aspartate transaminase level	J:211773
Atf4^tm1.1Cmad/Atf4^tm1.1Cmad Tg(Myh11-icre/ERT2)1Soff/? (D2.Cg-Atf4^tm1.1Cmad Tg(Myh11-icre/ERT2)1Soff)	abnormal calcium ion homeostasis	J:237331
Atf4^tm1Kry/Atf4^tm1Kry Tg(Col1a1-cre)1Kry/0 (involves: C57BL/6J * FVB)	abnormal glucose homeostasis	J:152695
	abnormal glycogen homeostasis	J:152695
	decreased circulating glucose level	J:152695
	impaired gluconeogenesis	J:152695
	improved glucose tolerance	J:152695
	increased insulin secretion	J:152695
	increased insulin sensitivity	J:152695
Atf4^tm1Tow/Atf4⁺ Ptprv^tm1Asmi/Ptprv⁺ (either: (involves: 129P2/OlaHsd * 129S1/Sv * 129X1/SvJ * C57BL/6J * NIH Black Swiss) or (involves: 129P2/OlaHsd * C57BL/6J * NIH Black Swiss))	decreased circulating glucose level	J:152695
	increased circulating insulin level	J:152695
Atf4^tm1Tow/Atf4^tm1Tow (either: (involves: 129P2/OlaHsd * 129S1/Sv * 129X1/SvJ * C57BL/6J * NIH Black Swiss) or (involves: 129P2/OlaHsd * C57BL/6J * NIH Black Swiss))	decreased circulating glucose level	J:152695
	impaired gluconeogenesis	J:152695
	improved glucose tolerance	J:152695
	increased circulating insulin level	J:152695
	increased insulin secretion	J:152695
	increased insulin sensitivity	J:152695
Atf6^tm1Hota/Atf6^tm1Hota Tg(Ins2-cre)25Mgn/0 (B6.Cg-Atf6^tm1Hota Tg(Ins2-cre)25Mgn)	increased insulin sensitivity	J:213542
Atg2b^em1(IMPC)J/Atg2b^em1(IMPC)J (C57BL/6NJ-Atg2b^em1(IMPC)J/Mmjax)	increased circulating cholesterol level	J:211773
Atg3^tm1Kmts/Atg3^tm1Kmts (involves: C57BL/6NCrlj * CBA/JNCrlj)	abnormal circulating amino acid level	J:215884
Atg4b^{Gt(A029E06)Wrst}/Atg4b^{Gt(A029E06)Wrst} (involves: 129S2/SvPas * C57BL/6)	abnormal lipid homeostasis	J:163712
Atg4b^{tm1b(EUCOMM)Hmgu}/Atg4b^{tm1b(EUCOMM)Hmgu} (C57BL/6N-Atg4b^{tm1b(EUCOMM)Hmgu}/H)	decreased circulating cholesterol level	J:211773
	decreased circulating HDL cholesterol level	J:211773
	decreased circulating serum albumin level	J:211773
	decreased circulating total protein level	J:211773
	increased circulating alanine transaminase level	J:211773
	increased circulating alkaline phosphatase level	J:211773
Atg5^tm1Myok/Atg5^tm1Myok Lyz2^tm1(cre)Ifo/Lyz2⁺ (involves: 129P2/OlaHsd * 129S/SvEv)	abnormal circulating chemokine level	J:235399
	decreased circulating interleukin-10 level	J:235399
	increased blood urea nitrogen level	J:235399
	increased circulating creatinine level	J:235399
	increased circulating interleukin-1 beta level	J:235399
	increased circulating interleukin-6 level	J:235399
	increased circulating interleukin-12b level	J:235399
	increased urine protein level	J:235399
Atg5^tm1Myok/Atg5^tm1Myok Tg(Kap-cre)1Isa/0 (involves: 129S/SvEv * C57BL/6 * DBA)	aminoaciduria	J:179961
	hyperthreoninuria	J:179961
	increased urine glucose level	J:179961
	tryptophanuria	J:179961
	valinuria	J:179961
Atg5^tm1Nmz/Atg5^tm1Nmz (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	abnormal amino acid level	J:104491
	abnormal circulating amino acid level	J:104491
Atg7^{em1(IMPC)Ccpcz}/Atg7⁺ (C57BL/6N-Atg7^{em1(IMPC)Ccpcz}/Ccpcz)	increased circulating serum albumin level	J:211773
	increased circulating total protein level	J:211773
Atg7^tm1.1Tchi/Atg7^tm1.1Tchi (involves: C57BL/6 * CBA * FVB/N)	abnormal circulating amino acid level	J:100199
Atg7^tm1Tchi/Atg7^tm1Tchi En1^tm2(cre)Wrst/En1⁺ (involves: 129S1/Sv * 129X1/SvJ * C57BL/6NCrlj * CBA/JNCrlj)	decreased dopamine level	J:192452
Atg7^tm1Tchi/Atg7^tm1Tchi Lyz2^tm1(cre)Ifo/Lyz2⁺ (involves: 129P2/OlaHsd * C57BL/6NCrlj * CBA/JNCrlj)	abnormal circulating chemokine level	J:235399
	decreased circulating interleukin-10 level	J:235399
	increased blood urea nitrogen level	J:235399
	increased circulating creatinine level	J:235399
	increased circulating interleukin-1 beta level	J:235399
	increased circulating interleukin-6 level	J:235399
	increased circulating interleukin-12b level	J:235399
	increased urine protein level	J:235399
Atg7^tm1Tchi/Atg7^tm1Tchi Lyz2^tm1(cre)Ifo/Lyz2⁺ Tg(CAG-EGFP/Map1lc3b)53Nmz/0 (involves: 129P2/OlaHsd * C57BL/6 * C57BL/6NCrlj * CBA/JNCrlj * DBA/2)	abnormal circulating chemokine level	J:235399
	decreased circulating interleukin-10 level	J:235399
	increased circulating interleukin-1 beta level	J:235399
	increased circulating interleukin-6 level	J:235399
Atg7^tm1Tchi/Atg7^tm1Tchi Slc6a3^tm1(cre)Xz/Slc6a3⁺ (involves: 129S1/Sv * C57BL/6NCrlj * CBA/JNCrlj)	decreased dopamine level	J:192452
Atg7^tm1Tchi/Atg7^tm1Tchi Sqstm1^tm1Keta/Sqstm1^tm1Keta Tg(Mx1-cre)1Cgn/0 (involves: 129 * C57BL/6 * C57BL/6NCrlj * CBA * CBA/JNCrlj)	increased circulating alanine transaminase level	J:130839
	increased circulating alkaline phosphatase level	J:130839
	increased circulating aspartate transaminase level	J:130839
Atg7^tm1Tchi/Atg7^tm1Tchi Tg(Mx1-cre)1Cgn/0 (involves: C57BL/6 * CBA)	abnormal amino acid level	J:100199
	abnormal circulating enzyme level	J:100199
	increased circulating alanine transaminase level	J:130839, J:100199
	increased circulating alkaline phosphatase level	J:130839, J:100199
	increased circulating aspartate transaminase level	J:130839, J:100199
Atg9b^{tm1b(KOMP)Mbp}/Atg9b^{tm1b(KOMP)Mbp} (C57BL/6N-Atg9b^{tm1b(KOMP)Mbp}/Ucd)	increased circulating alanine transaminase level	J:211773
Atg12^tm1.1Jdth/Atg12^tm1.1Jdth Tg(Pomc1-cre)1Gsb/0 (involves: C57BL/6 * FVB/N)	impaired glucose tolerance	J:232686
	increased susceptibility to diet-induced obesity	J:232686
Atg16l1^tm1.1Mvlc/Atg16l1^tm1.1Mvlc (C57BL/6-Atg16l1^tm1.1Mvlc)	increased circulating interleukin-1 beta level	J:206931
Atg16l1^{tm1a(EUCOMM)Wtsi}/Atg16l1⁺ (C57BL/6N-Atg16l1^{tm1a(EUCOMM)Wtsi}/Wtsi)	increased circulating serum albumin level	J:175295
Atg16l1^{tm1a(EUCOMM)Wtsi}/Atg16l1^{tm1a(EUCOMM)Wtsi} (C57BL/6N-Atg16l1^{tm1a(EUCOMM)Wtsi}/Wtsi)	subcutaneous edema	J:239583
Atg16l1^{tm1c(EUCOMM)Wtsi}/Atg16l1^{tm1c(EUCOMM)Wtsi} Tcrd^tm1Mom/Tcrd^tm1Mom Tg(Vil1-cre)997Gum/0 (involves: 129P2/OlaHsd * C57BL/6J * C57BL/6N * SJL)	abnormal cytokine level	J:340266
Atg16l1^{tm1c(EUCOMM)Wtsi}/Atg16l1^{tm1c(EUCOMM)Wtsi} Tg(Vil1-cre)997Gum/? (involves: C57BL/6J * C57BL/6N * SJL)	abnormal chemokine level	J:221019
	abnormal circulating interleukin level	J:221019
	abnormal cytokine level	J:221019
	increased circulating interleukin-1 beta level	J:221019
	increased circulating interleukin-6 level	J:221019
Atg101^em1Nmz/Atg101^em1Nmz (involves: C57BL/6JJcl)	abnormal lipid homeostasis	J:300057
Ath9^FVB/NCr/Ath9^C57BL/6J (involves: C57BL/6J * FVB/NCr)	increased circulating HDL cholesterol level	J:76127
Ath9^FVB/NCr/Ath9^FVB/NCr (involves: C57BL/6J * FVB/NCr)	increased circulating HDL cholesterol level	J:76127
Atm^tm1Pmc/Atm⁺ (B6.Cg-Atm^tm1Pmc)	impaired glucose tolerance	J:222034
Atm^tm1Pmc/Atm⁺ (B6.Cg-Atm^tm1Pmc)	insulin resistance	J:222034
Atm^tm1Pmc/Atm^tm1Pmc (B6.Cg-Atm^tm1Pmc)	decreased circulating adiponectin level	J:222034
	decreased circulating leptin level	J:222034
	impaired glucose tolerance	J:222034
	insulin resistance	J:222034
Atmin^gpg6/Atmin^gpg6 (involves: BALB/cAnN * C3H/HeH)	edema	J:145068
Atmin^gpg6/Atmin^gpg6 (C3H.C-Atmin^gpg6)	edema	J:217609
Atmin^gpg6/Atmin^m1H (C3.C-Atmin^gpg6/Atmin^m1H)	edema	J:217609
Atmin^m1H/Atmin^m1H (C3H.C-Atmin^m1H)	edema	J:217609
Atn1^{tm1b(EUCOMM)Wtsi}/Atn1^{tm1b(EUCOMM)Wtsi} (C57BL/6N-Atn1^{tm1b(EUCOMM)Wtsi}/Cnrm)	decreased circulating serum albumin level	J:211773
	increased circulating triglyceride level	J:211773
Atoh1^tm1Hzo/Atoh1^tm1Hzo (involves: 129S7/SvEvBrd)	cyanosis	J:44241
Atoh1^tm2Hzo/Atoh1^tm2Hzo (Not Specified)	cyanosis	J:60393
Atox1^{Gt(IRESBetageo)3Pgr}/Atox1^{Gt(IRESBetageo)3Pgr} (B6.129(Cg)-Atox1^{Gt(IRESBetageo)3Pgr}/Mmucd)	abnormal copper homeostasis	J:74249
	decreased body temperature	J:74249
	decreased brain copper level	J:74249
	decreased liver copper level	J:74249
Atp1a1^tm1Ling/Atp1a1⁺ (involves: 129P2/OlaHsd * Black Swiss)	increased circulating corticosterone level	J:117414
Atp1a2^tm1.1Tmklh/Atp1a2⁺ (B6.129S1(Cg)-Atp1a2^tm1.1Tmklh)	increased glutamic acid level	J:259556
Atp1a2^tm2Kwk/Atp1a2^tm2Kwk (B6.129X1-Atp1a2^tm2Kwk)	increased gamma-aminobutyric acid level	J:94810
Atp1a3^{tm1b(EUCOMM)Hmgu}/Atp1a3⁺ (C57BL/6N-Atp1a3^{tm1b(EUCOMM)Hmgu}/H)	improved glucose tolerance	J:211773
Atp2a1^tm1Dhm/Atp2a1^tm1Dhm (involves: CD-1)	cyanosis	J:82947
Atp2a2^tm1.1Iemr/Atp2a2^tm1.1Iemr A1cf^{Tg(Myh6-cre/Esr1)1Jmk}/A1cf⁺ (involves: 129P2/OlaHsd C57BL/6J * FVB/N)	increased circulating noradrenaline level	J:157143
Atp2a2^tm1.1Raco/Atp2a2⁺ (C57BL/6J-Atp2a2^tm1.1Raco/Raco)	abnormal calcium ion homeostasis	J:216004
Atp2a2^{tm1b(EUCOMM)Hmgu}/Atp2a2⁺ (C57BL/6N-Atp2a2^{tm1b(EUCOMM)Hmgu}/H)	decreased circulating alkaline phosphatase level	J:211773
	increased fasting circulating glucose level	J:211773
Atp2a2^tm1Fwuy/Atp2a2^tm1Fwuy (involves: 129S1/Sv * 129X1/SvJ * Swiss)	abnormal calcium ion homeostasis	J:111247
Atp2a2^tm1Fwuy/Atp2a2^tm1Fwuy Pln^tm1Egk/Pln^tm1Egk (involves: 129 * FVB/N * Swiss)	abnormal calcium ion homeostasis	J:110974
Atp2a2^tm1Ges/Atp2a2⁺ (involves: 129X1/SvJ * Black Swiss)	abnormal calcium ion homeostasis	J:52186, J:66006
Atp2a2^tm1Ges/Atp2a2⁺ (involves: 129X1/SvJ * Black Swiss)	pulmonary edema	J:95608
Atp2b1^tm1.1Hiraw/Atp2b1^tm1.1Hiraw Tg(Tagln-cre)1Her/0 (B6J.Cg-Atp2b1^tm1.1Hiraw Tg(Tagln-cre)1Her)	abnormal calcium ion homeostasis	J:225010
Atp2b1^tm1.1Raku/Atp2b1^tm1.1Raku Tg(Vil1-cre)997Gum/0 (involves: C57BL/6 * C57BL/6J)	abnormal urine phosphate level	J:232942
	decreased urine calcium level	J:232942
Atp2b1^{tm1b(KOMP)Wtsi}/Atp2b1⁺ (C57BL/6N-Atp2b1^{tm1b(KOMP)Wtsi}/Tcp)	decreased circulating calcium level	J:211773
Atp2b2^dfw/Atp2b2^dfw (C3H/HeJ-Atp2b2^dfw/J)	abnormal calcium ion homeostasis	J:119503
Atp2b2^tm1Ges/Atp2b2^tm1Ges (involves: 129/Sv * 129X1/SvJ * Black Swiss)	abnormal calcium ion homeostasis	J:119503, J:108937
Atp4a^m1Btlr/Atp4a^m1Btlr (involves: C57BL/6J)	abnormal iron homeostasis	J:179090
	decreased circulating iron level	J:179090
	increased circulating erythropoietin level	J:179090
Atp4a^m1Btlr/Atp4a^tm1Ges (involves: 129X1/SvJ * Black Swiss * C57BL/6J)	decreased circulating iron level	J:179090
Atp4a^tm1.1Ocalv/Atp4a^tm1.1Ocalv (involves: 129S6/SvEv * C57BL/6J * C57BL/6NCrl)	decreased circulating ferritin level	J:235360
	increased circulating gastrin level	J:235360
Atp4a^tm1Ges/Atp4a^tm1Ges (involves: 129X1/SvJ * Black Swiss)	increased circulating gastrin level	J:63470
Atp4b^tm1Ird/Atp4b^tm1Ird (either: (involves: 129S4/SvJae * BALB/cCrSlc) or (involves: 129S4/SvJae * C57BL/6))	increased circulating gastrin level	J:74022
Atp5if1^em1Jpy/Atp5if1^em1Jpy (C57BL/6J-Atp5if1^em1Jpy)	decreased energy expenditure	J:313048
	improved glucose tolerance	J:313048
	increased susceptibility to diet-induced obesity	J:313048
	insulin resistance	J:313048
Atp5if1^{tm1a(EUCOMM)Wtsi}/Atp5if1^{tm1a(EUCOMM)Wtsi} (C57BL/6N-Atp5if1^{tm1a(EUCOMM)Wtsi}/Wtsi)	decreased circulating alanine transaminase level	J:175295
	decreased circulating alkaline phosphatase level	J:175295
Atp5mc2^{tm2b(EUCOMM)Hmgu}/Atp5mc2⁺ (C57BL/6N-Atp5mc2^{tm2b(EUCOMM)Hmgu}/Ieg)	increased fasting circulating glucose level	J:211773
Atp5mg^{tm1b(EUCOMM)Hmgu}/Atp5mg⁺ (C57BL/6N-Atp5mg^{tm1b(EUCOMM)Hmgu}/H)	increased blood urea nitrogen level	J:211773
	increased circulating serum albumin level	J:211773
Atp5mk^{tm1b(EUCOMM)Wtsi}/Atp5mk^{tm1b(EUCOMM)Wtsi} (C57BL/6N-Atp5mk^{tm1b(EUCOMM)Wtsi}/H)	decreased circulating glucose level	J:211773
	decreased circulating serum albumin level	J:211773
	decreased circulating total protein level	J:211773
	increased blood urea nitrogen level	J:211773
	increased circulating alanine transaminase level	J:211773
	increased circulating amylase level	J:211773
	increased circulating aspartate transaminase level	J:211773
	increased circulating phosphate level	J:211773
Atp5po^{tm1.1(KOMP)Vlcg}/Atp5po⁺ (B6N(Cg)-Atp5po^{tm1.1(KOMP)Vlcg}/J)	improved glucose tolerance	J:211773
Atp6ap2^em1Nira/Y (C57BL/6J-Atp6ap2^em1Nira)	decreased circulating angiotensinogen level	J:324587
Atp6ap2^tm1.1Aich/Atp6ap2⁺ Tg(Six2-EGFP/cre)1Amc/0 (involves: C57BL/6 * CD-1)	albuminuria	J:228872
	increased circulating creatinine level	J:228872
Atp6ap2^tm1.1Aich/Atp6ap2^tm1.1Aich Tg(Hoxb7-cre)5526Cmb/0 (involves: C57BL/6)	decreased urine osmolality	J:223201
	increased circulating creatinine level	J:223201
	increased urine pH	J:223201
Atp6ap2^tm1.1Ics/Y Tg(NPHS2-cre)295Lbh/0 (involves: C57BL/6 * C57BL/6N * SJL)	albuminuria	J:232697
	decreased circulating serum albumin level	J:232697
	increased blood urea nitrogen level	J:232697
	increased circulating cholesterol level	J:232697
	increased circulating creatinine level	J:232697
	increased urine protein level	J:232697
Atp6v0a1^{tm1b(EUCOMM)Hmgu}/Atp6v0a1⁺ (C57BL/6N-Atp6v0a1^{tm1b(EUCOMM)Hmgu}/Tcp)	increased circulating potassium level	J:211773
Atp6v0a4^tm1.1Fekf/Atp6v0a4⁺ (involves: C57BL/6)	acidosis	J:188593
Atp6v0a4^tm1.1Fekf/Atp6v0a4^tm1.1Fekf (involves: C57BL/6)	abnormal urine homeostasis	J:188593
	acidosis	J:188593
	decreased urine pH	J:188593
	dehydration	J:188593
	hypokalemia	J:188593
	increased blood osmolality	J:188593
	increased blood urea nitrogen level	J:188593
	increased circulating chloride level	J:188593
Atp6v0d1^em1Nju/Atp6v0d1^em1Nju Tg(Adipoq-cre)1Evdr/0 (involves: FVB/NJ)	decreased circulating adiponectin level	J:346448
	decreased circulating leptin level	J:346448
	decreased circulating triglyceride level	J:346448
	improved glucose tolerance	J:346448
	increased circulating aspartate transaminase level	J:346448
	increased circulating cholesterol level	J:346448
	increased circulating free fatty acids level	J:346448
	increased liver cholesterol level	J:346448
	increased liver free fatty acids level	J:346448
	increased liver triglyceride level	J:346448
	insulin resistance	J:346448
Atp6v0d2^tm1Ywc/Atp6v0d2^tm1Ywc (involves: 129P2/OlaHsd * C57BL/6)	decreased circulating type I collagen C-terminal telopeptide level	J:117744
Atp6v1b1^{tm1.1(KOMP)Vlcg}/Atp6v1b1^{tm1.1(KOMP)Vlcg} (C57BL/6N-Atp6v1b1^{tm1.1(KOMP)Vlcg}/Ucd)	increased circulating alanine transaminase level	J:211773
Atp6v1b1^tm1Choo/Atp6v1b1^tm1Choo (involves: 129S1/Sv * C57BL/6)	abnormal urine calcium level	J:101414
	acidosis	J:101414
	decreased circulating bicarbonate level	J:101414
	decreased urine osmolality	J:101414
	increased urine pH	J:101414
Atp6v1b1^tm1Choo/Atp6v1b1^tm1Choo (involves: 129S1/Sv)	abnormal pH regulation	J:192002
Atp6v1b1^vtx/Atp6v1b1^vtx (MRL/MpJ-Atp6v1b1^vtx/Kjn)	decreased urine calcium level	J:243701
Atp6v1b1^vtx/Atp6v1b1^vtx (B6.MRL-Atp6v1b1^vtx/Kjn)	decreased urine calcium level	J:243701
Atp6v1b1^vtx/Atp6v1b1^vtx (B6.MRL-Atp6v1b1^vtx/Kjn)	increased urine pH	J:243701
Atp6v1b2^{tm1b(KOMP)Wtsi}/Atp6v1b2⁺ (C57BL/6N-Atp6v1b2^{tm1b(KOMP)Wtsi}/Tcp)	increased circulating alkaline phosphatase level	J:211773
Atp6v1h^em1Xhd/Atp6v1h⁺ (involves: C57BL/6)	decreased circulating phosphate level	J:239439
	increased circulating alkaline phosphatase level	J:239439
	increased circulating calcium level	J:239439
Atp7a^Mo-3Btlr/Y (C57BL/6J-Atp7a^Mo-3Btlr)	decreased brain copper level	J:188598
Atp7a^Mo-blo/Y (Not Specified)	abnormal noradrenaline level	J:5462
Atp7a^Mo-blo/Y (involves: C57BL/6J)	abnormal copper homeostasis	J:36268
	decreased liver copper level	J:36268
	increased intestine copper level	J:36268
	increased kidney copper level	J:36268
Atp7a^Mo-blo/Atp7a⁺ (involves: C57BL/6J)	abnormal copper homeostasis	J:36268
	abnormal ion homeostasis	J:36268
	decreased brain copper level	J:36268
	decreased liver copper level	J:36268
	increased kidney copper level	J:36268
Atp7a^Mo-br/Y (involves: C57BL)	abnormal liver copper level	J:5462
	abnormal noradrenaline level	J:5462
	decreased brain copper level	J:5462
	decreased circulating copper level	J:5462
	increased intestine copper level	J:5462
Atp7a^Mo-brJ/Y (involves: C3H/HeJ * C57BL/6J)	decreased liver copper level	J:33276
Atp7a^Mo-brJ/Y (involves: C3H/HeJ * C57BL/6J)	increased intestine copper level	J:33276
Atp7a^Mo-dp/Atp7a⁺ (involves: 101/H * C3H/HeH)	decreased brain copper level	J:220263
Atp7a^Mo-dp/Atp7a⁺ (involves: 101/H * C3H/HeH)	decreased noradrenaline level	J:220263
Atp7a^Mo-ml/Y (involves: C3Hf/He)	abnormal copper level	J:12745
	decreased brain copper level	J:12745
	decreased brainstem copper level	J:12745
	decreased liver copper level	J:1132, J:12745
	increased intestine copper level	J:12745
	increased kidney copper level	J:12745
Atp7a^Mo-ml/Atp7a⁺ (involves: C3Hf/He)	decreased brain copper level	J:12745
Atp7a^Mo-ml/Atp7a⁺ (involves: C3Hf/He)	increased intestine copper level	J:12745
Atp7a^Mo-ms/Y (Not Specified)	abnormal copper level	J:168658
	decreased brain copper level	J:168658
	decreased liver copper level	J:168658
	increased kidney copper level	J:168658
Atp7a^Mo-ms/Y (involves: CBA)	increased kidney copper level	J:80157
Atp7a^Mo-ms/Y (involves: CBA/Kw)	abnormal copper homeostasis	J:14875
	decreased brain copper level	J:14875
	decreased circulating ceruloplasmin level	J:14875
	decreased liver copper level	J:14875
	increased intestine copper level	J:14875
Atp7a^Mo-to/Atp7a⁺ (B6.Cg-Atp7a^Mo-to/J)	increased intestine copper level	J:79328
Atp7a^Mo-Tohm/Y (involves: AA * C3H/He * C57BL/6 * ICR)	abnormal copper level	J:105797
Atp7a^Mo-Tohm/Atp7a⁺ (B6.Cg-Atp7a^Mo-Tohm)	decreased brain copper level	J:105797
Atp7a^Mo-vbr/Y (Not Specified)	abnormal pH regulation	J:44695
Atp7a^Mo-vbr/Y (Not Specified)	decreased creatine level	J:44695
Atp7a^tm1.1Mjp/Y Mnx1^tm4(cre)Tmj/Mnx1⁺ (involves: 129S1/Sv * C57BL/6)	abnormal copper level	J:221066
Atp7a^tm1.2Mlke/Y (involves: C57BL/6J)	abnormal copper level	J:266704
Atp7a^tm1.2Mlke/Y (involves: C57BL/6J)	increased brain copper level	J:266704
Atp7b^m1Btlr/Atp7b^m1Btlr (C57BL/6J-Atp7b^m1Btlr)	abnormal circulating bilirubin level	J:255002
Atp7b^tm1Tcg/Atp7b^tm1Tcg (involves: 129S1/Sv)	abnormal copper level	J:57632
Atp7b^tm1Tcg/Atp7b^tm1Tcg (involves: 129S1/Sv)	abnormal liver copper level	J:57632
Atp7b^tx-J/Atp7b^tx-J (C3H/HeJ-Atp7b^tx-J/J)	increased brain copper level	J:86701
Atp7b^tx-J/Atp7b^tx-J Tg(PRNP-APPSweInd)8Dwst/0 (involves: C3H/HeJ * C57BL/6)	abnormal copper level	J:86701
Atp7b^tx/Atp7b^tx (DL-Atp7b^tx)	abnormal copper level	J:19226
	abnormal mineral level	J:19226
	decreased circulating copper level	J:7102
	decreased liver copper level	J:7102
	increased brain copper level	J:19226
	increased circulating copper level	J:19226
	increased kidney copper level	J:19226
	increased liver copper level	J:40104, J:7102, J:19226
Atp7b^tx/Atp7b^tx (involves: C57BL/6 * DL)	decreased circulating copper level	J:7102
	decreased liver copper level	J:7102
	increased liver copper level	J:7102
Atp8a1^{tm1a(EUCOMM)Wtsi}/Atp8a1^{tm1a(EUCOMM)Wtsi} (C57BL/6N-Atp8a1^{tm1a(EUCOMM)Wtsi}/H)	increased blood urea nitrogen level	J:165965
Atp8a2^em1(IMPC)J/Atp8a2⁺ (C57BL/6NJ-Atp8a2^em1(IMPC)J/Mmjax)	increased circulating glucose level	J:211773
Atp8a2^wl/Atp8a2^wl (Not Specified)	abnormal circulating amino acid level	J:5108
	abnormal enzyme/coenzyme level	J:5108
	hypoglycemia	J:14851
	increased circulating tyrosine level	J:5108
Atp8b1^em1(IMPC)Tcp/Atp8b1^em1(IMPC)Tcp (C57BL/6NCrl-Atp8b1^em1(IMPC)Tcp/Tcp)	decreased circulating glucose level	J:211773
	decreased circulating HDL cholesterol level	J:211773
	decreased circulating triglyceride level	J:211773
	decreased fasting circulating glucose level	J:211773
	improved glucose tolerance	J:211773
	increased circulating alanine transaminase level	J:211773
	increased circulating alkaline phosphatase level	J:211773
	increased circulating aspartate transaminase level	J:211773
	increased circulating bilirubin level	J:211773
	increased circulating potassium level	J:211773
Atp8b1^tm1Nbf/Atp8b1^tm1Nbf (involves: 129S1/SvImJ * 129S4/SvJae)	abnormal bile salt level	J:89817
	increased circulating aspartate transaminase level	J:89817
	increased circulating bilirubin level	J:89817
Atp8b1^tm1Nbf/Atp8b1^tm1Nbf Por^tm1Wolf/Por^tm1Wolf Speer6-ps1^{Tg(Alb-cre)21Mgn}/Speer6-ps1⁺ (involves: 129P2/OlaHsd * 129S4/SvJae * C57BL/6 * DBA)	abnormal bile salt homeostasis	J:215915
	increased bile salt level	J:215915
	increased circulating alanine transaminase level	J:215915
	increased circulating alkaline phosphatase level	J:215915
	increased circulating bilirubin level	J:215915
Atp8b2^{tm1a(KOMP)Wtsi}/Atp8b2^{tm1a(KOMP)Wtsi} (C57BL/6N-Atp8b2^{tm1a(KOMP)Wtsi}/Wtsi)	decreased circulating serum albumin level	J:211773
	increased circulating alkaline phosphatase level	J:211773
Atp11a^{tm1a(KOMP)Wtsi}/Atp11a^{tm1a(KOMP)Wtsi} (C57BL/6N-Atp11a^{tm1a(KOMP)Wtsi}/Wtsi)	subcutaneous edema	J:239583
Atp11c^ambr/Y (C57BL/6-Atp11c^ambr)	increased circulating bilirubin level	J:171924
Atp11c^em1(IMPC)J/Y (C57BL/6NJ-Atp11c^em1(IMPC)J/Mmjax)	abnormal cholesterol homeostasis	J:211773
	increased circulating bilirubin level	J:211773
	increased circulating cholesterol level	J:211773
	increased circulating HDL cholesterol level	J:211773
Atp11c^em1(IMPC)J/Atp11c^em1(IMPC)J (C57BL/6NJ-Atp11c^em1(IMPC)J/Mmjax)	abnormal cholesterol homeostasis	J:211773
	increased circulating alkaline phosphatase level	J:211773
	increased circulating bilirubin level	J:211773
	increased circulating cholesterol level	J:211773
	increased circulating HDL cholesterol level	J:211773
Atp11c^m1Btlr/Y (involves: C57BL/6J)	increased circulating bilirubin level	J:171925
Atp12a^tm1Ges/Atp12a^tm1Ges (involves: Black Swiss)	decreased circulating potassium level	J:45707
Atp12a^tm1Ges/Atp12a^tm1Ges (involves: Black Swiss)	increased urine potassium level	J:45707
Atp13a1^em1(IMPC)Tcp/Atp13a1^em1(IMPC)Tcp (C57BL/6N-Atp13a1^em1(IMPC)Tcp/Tcp)	edema	J:211773
Atp13a3^em1(IMPC)J/Atp13a3^em1(IMPC)J (C57BL/6NJ-Atp13a3^em1(IMPC)J/Mmjax)	abnormal cholesterol homeostasis	J:211773
	decreased blood urea nitrogen level	J:211773
	decreased circulating cholesterol level	J:211773
	decreased circulating glucose level	J:211773
	decreased circulating HDL cholesterol level	J:211773
	decreased circulating serum albumin level	J:211773
	decreased circulating total protein level	J:211773
	decreased circulating triglyceride level	J:211773
	decreased fasting circulating glucose level	J:211773
	improved glucose tolerance	J:211773
	increased circulating alanine transaminase level	J:211773
	increased circulating alkaline phosphatase level	J:211773
	increased circulating aspartate transaminase level	J:211773
	increased circulating bilirubin level	J:211773
Atpsckmt^em1(IMPC)J/Atpsckmt⁺ (C57BL/6NJ-Atpsckmt^em1(IMPC)J)	abnormal calcium level	J:343227
Atr^{tm1b(KOMP)Wtsi}/Atr⁺ (B6N(Cg)-Atr^{tm1b(KOMP)Wtsi}/2J)	decreased circulating glucose level	J:211773
Atrip^{tm1b(KOMP)Wtsi}/Atrip⁺ (B6N(Cg)-Atrip^{tm1b(KOMP)Wtsi}/J)	decreased fasting circulating glucose level	J:211773
	increased circulating chloride level	J:211773
	increased circulating sodium level	J:211773
Atxn1^tm1Hzo/Atxn1⁺ Atxn1l^tm2.1Hzo/Atxn1l^tm2.1Hzo (involves: 129S7/SvEvBrd * C57BL/6J)	cyanosis	J:178303
Atxn1^tm1Hzo/Atxn1^tm1Hzo Atxn1l^tm2.1Hzo/Atxn1l⁺ (involves: 129S7/SvEvBrd * C57BL/6J)	cyanosis	J:178303
Atxn1^tm1Hzo/Atxn1^tm1Hzo Atxn1l^tm2.1Hzo/Atxn1l^tm2.1Hzo (involves: 129S7/SvEvBrd * C57BL/6J)	cyanosis	J:178303
Atxn1l^tm2.1Hzo/Atxn1l^tm2.1Hzo (involves: 129S7/SvEvBrd * C57BL/6J)	cyanosis	J:178303
Atxn2^tm1.1Aub/Atxn2^tm1.1Aub (involves: 129P2/OlaHsd * C57BL/6)	abnormal lipid level	J:135320
	decreased circulating glucose level	J:135320
	increased circulating cholesterol level	J:135320
	increased circulating insulin level	J:135320
	increased insulin secretion	J:135320
	increased liver glycogen level	J:135320
Atxn3^{tm1a(KOMP)Wtsi}/Atxn3^{tm1a(KOMP)Wtsi} (C57BL/6N-Atxn3^{tm1a(KOMP)Wtsi}/Wtsi)	decreased circulating fructosamine level	J:211773
	increased circulating aspartate transaminase level	J:211773
Atxn7l2^em1(IMPC)Mbp/Atxn7l2^em1(IMPC)Mbp (C57BL/6NCrl-Atxn7l2^em1(IMPC)Mbp/Mmucd)	increased circulating HDL cholesterol level	J:211773
AU021092^{tm1b(KOMP)Wtsi}/AU021092⁺ (C57BL/6N-AU021092^{tm1b(KOMP)Wtsi}/Ucd)	decreased circulating calcium level	J:211773
AU021092^{tm1b(KOMP)Wtsi}/AU021092^{tm1b(KOMP)Wtsi} (C57BL/6N-AU021092^{tm1b(KOMP)Wtsi}/Ucd)	decreased circulating glucose level	J:211773
Auh^em1(IMPC)Tcp/Auh^em1(IMPC)Tcp (C57BL/6NCrl-Auh^em1(IMPC)Tcp/Tcp)	increased circulating alanine transaminase level	J:211773
Aurkb^tm1.2Mama/Aurkb^tm2.2Mama (involves: 129/Sv * BALB/cJ * C57BL/6 * CD-1 * SJL)	edema	J:173575
Avp^{tm1b(EUCOMM)Wtsi}/Avp⁺ (C57BL/6N-Avp^{tm1b(EUCOMM)Wtsi}/H)	increased circulating total protein level	J:211773
Avp^tm1Hari/Avp⁺ (involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)	abnormal hormone level	J:147993
	decreased urine osmolality	J:147993
Avp^tm1Hari/Avp^tm1Hari (involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)	dehydration	J:147993
Avp^tm1Lja/Avp⁺ (involves: 129S1/Sv * 129X1/SvJ)	abnormal circulating hormone level	J:148012
Avpr1a^tm1Gzt/Avpr1a^tm1Gzt (involves: 129 * C57BL/6J)	abnormal circulating corticosterone level	J:110099
Avpr1a^tm1Gzt/Avpr1a^tm1Gzt (involves: 129 * C57BL/6J)	decreased circulating atrial natriuretic factor	J:110099
Avpr1b^tm1Gzt/Avpr1b^tm1Gzt (involves: 129 * C57BL/6J)	decreased circulating adrenocorticotropin level	J:87707
Avpr1b^tm1Gzt/Avpr1b^tm1Gzt (involves: 129 * C57BL/6J)	decreased circulating corticosterone level	J:87707
Avpr1b^tm1Wsy/Avpr1b^tm1Wsy (involves: 129S4/SvJae * C57BL/6)	increased circulating testosterone level	J:94939
Avpr2^tm1Jwe/Y (involves: 129S1/Sv * 129X1/SvJ * CF-1)	decreased urine osmolality	J:66094
	hypoglycemia	J:66094
	increased circulating chloride level	J:66094
	increased circulating sodium level	J:66094
Avpr2^tm1Jwe/Avpr2⁺ (involves: 129S1/Sv * 129X1/SvJ * CF-1)	decreased urine osmolality	J:66094
Avpr2^tm2.1Jwe/Y Tg(CAG-cre/Esr1)5Amc/0 (involves: 129 C57BL/6)	decreased urine creatinine level	J:324922
	decreased urine osmolality	J:324922
	decreased urine potassium level	J:324922
	decreased urine sodium level	J:324922
	decreased urine urea nitrogen level	J:324922
AW112010^em2Flv/AW112010^em2Flv (involves: C57BL/6N)	decreased circulating interleukin-6 level	J:267975
AW112010^em2Flv/AW112010^em2Flv (involves: C57BL/6N)	decreased circulating interleukin-12b level	J:267975
Awat2^em1(IMPC)Mbp/Awat2^em1(IMPC)Mbp (C57BL/6NCrl-Awat2^em1(IMPC)Mbp/Mmucd)	increased circulating alanine transaminase level	J:211773
	increased circulating aspartate transaminase level	J:211773
Axl^tm1Grl/Axl^tm1Grl Mertk^tm1Grl/Mertk^tm1Grl Tyro3^tm1Grl/Tyro3^tm1Grl (involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)	abnormal brain thrombosis	J:70420
	abnormal thrombosis	J:70420
	increased circulating tumor necrosis factor level	J:70420
Azgp1^tm1.1Sbah/Azgp1^tm1.1Sbah (involves: 129P2/OlaHsd * C57BL/6)	impaired lipolysis	J:118213
Azin2^{Gt(IST12418H6)Tigm}/Azin2^{Gt(IST12418H6)Tigm} (involves: C57BL/6N)	decreased circulating insulin level	J:204392
b2b1702Clo/b2b1702Clo (C57BL/6J-b2b1702Clo)	hydrops fetalis	J:175213
B2m^{tm1b(EUCOMM)Wtsi}/B2m⁺ (C57BL/6N-B2m^{tm1b(EUCOMM)Wtsi}/Tcp)	increased circulating phosphate level	J:211773
B2m^tm1Jae/B2m^tm1Jae (involves: 129S2/SvPas)	hemochromatosis	J:17527
B2m^tm1Jae/B2m^tm1Jae Foxp3^sf Otc^spf/Y (involves: 129/Rl * 129S2/SvPas)	abnormal interleukin level	J:20865
	abnormal tumor necrosis factor level	J:20865
B2m^tm1Jae/B2m^tm1Jae Tg(B2m)1Rms/0 Tg(INS-cre)2Rms/0 (involves: 129S2/SvPas * NOD)	abnormal glucose homeostasis	J:83635
B2m^tm1Unc/B2m^tm1Unc (B6.129P2-B2m^tm1Unc/DcrJ)	abnormal interleukin level	J:123934
	abnormal tumor necrosis factor level	J:123934
	decreased circulating serum albumin level	J:110885
B2m^tm1Unc/B2m^tm1Unc Ciita^tm1Ccum/Ciita^tm1Ccum (NOD.Cg-B2m^tm1Unc Ciita^tm1Ccum)	abnormal glucose homeostasis	J:107051
B2m^tm1Unc/B2m^tm1Unc Hfe^tm2Nca/Hfe^tm2Nca (involves: 129S6/SvEvTac * C57BL/6J)	increased liver iron level	J:62112
B2m^tm1Unc/B2m^tm1Unc Prkdc^scid/Prkdc^scid (NOD.Cg-B2m^tm1Unc Prkdc^scid)	increased liver iron level	J:102141
B3gat3^tm1Hkit/B3gat3^tm1Hkit (involves: 129P2/OlaHsd * C57BL/6J)	abnormal glycosaminoglycan level	J:225032
B4galnt1^tm1Rlp/B4galnt1^tm1Rlp St3gal5^tm1Rlp/St3gal5^tm1Rlp (involves: 129S6/SvEvTac * C57BL/6)	abnormal ganglioside level	J:96830
	abnormal lipid homeostasis	J:96830
B4galnt2^tm1Jbl/B4galnt2^tm1Jbl (involves: 129S1/Sv)	increased circulating alkaline phosphatase level	J:217719
B4galt1^tm1Shur/B4galt1^tm1Shur (involves: 129S7/SvEvBrd * C57BL/6J)	decreased circulating thyroxine level	J:37846
	dehydration	J:37846
B4galt1^tm1Yiw/B4galt1^tm1Yiw (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	albuminuria	J:117891
	hematuria	J:117891
B4galt5^em1(IMPC)Tcp/B4galt5⁺ (C57BL/6NCrl-B4galt5^em1(IMPC)Tcp/Tcp)	increased circulating alanine transaminase level	J:211773
B4galt5^{Gt(OST202518)Lex}/B4galt5⁺ (involves: 129S5/SvEvBrd)	increased response to stress-induced hyperthermia	J:103485
B9d2/Tgfb1^tm1Flv/Tgfb1^tm2Flv Tg(Cd4-cre)1Cwi/0 (involves: 129S6/SvEvTac * C57BL/6 * DBA/2)	abnormal interferon level	J:123547
	abnormal interleukin level	J:123547
B9d2^{tm1a(EUCOMM)Wtsi}/B9d2^{tm1a(EUCOMM)Wtsi} (C57BL/6N-B9d2^{tm1a(EUCOMM)Wtsi}/Wtsi)	subcutaneous edema	J:239583
Baat^em1(IMPC)Mbp/Baat^em1(IMPC)Mbp (C57BL/6NCrl-Baat^em1(IMPC)Mbp/Mmucd)	decreased circulating cholesterol level	J:211773
	decreased circulating HDL cholesterol level	J:211773
	improved glucose tolerance	J:211773
	increased circulating alkaline phosphatase level	J:211773
	increased circulating triglyceride level	J:211773
Babam1^{em1(IMPC)Ccpcz}/Babam1^{em1(IMPC)Ccpcz} (C57BL/6NCrl-Babam1^{em1(IMPC)Ccpcz}/Ccpcz)	increased circulating alanine transaminase level	J:211773
Babam1^{Gt(IST11207B9)Tigm}/Babam1^{Gt(IST11207B9)Tigm} (involves: C57BL/6N)	abnormal platelet physiology	J:223526
Bace2^{tm1b(EUCOMM)Wtsi}/Bace2^{tm1b(EUCOMM)Wtsi} (C57BL/6N-Bace2^{tm1b(EUCOMM)Wtsi}/Orl)	increased circulating calcium level	J:211773
Bach1^{tm1.1(KOMP)Vlcg}/Bach1⁺ (B6N(Cg)-Bach1^{tm1.1(KOMP)Vlcg}/J)	increased circulating sodium level	J:211773
	increased fasting circulating glucose level	J:211773
Bach2^{tm1a(EUCOMM)Wtsi}/Bach2^{tm1a(EUCOMM)Wtsi} (C57BL/6N-Bach2^{tm1a(EUCOMM)Wtsi}/Wtsi)	decreased circulating creatinine level	J:211773
	increased circulating iron level	J:211773
Bach2^{tm1b(EUCOMM)Wtsi}/Bach2^{tm1b(EUCOMM)Wtsi} (C57BL/6N-Bach2^{tm1b(EUCOMM)Wtsi}/Ieg)	decreased circulating creatinine level	J:211773
	decreased circulating glucose level	J:211773
	decreased respiratory quotient	J:211773
	increased circulating alkaline phosphatase level	J:211773
	increased circulating amylase level	J:211773
	increased circulating aspartate transaminase level	J:211773
	increased circulating unsaturated transferrin level	J:211773
Bad^tm1Meg/Bad^tm1Meg (involves: 129S4/SvJae)	decreased circulating insulin level	J:133563
	decreased insulin secretion	J:133563
	increased circulating glucose level	J:133563
Bad^tm1Sjk/Bad^tm1Sjk (involves: 129X1/SvJ)	abnormal circulating glucose level	J:133563
	decreased insulin secretion	J:133563
	increased circulating insulin level	J:133563
Bad^tm1Sjk/Bad^tm1Sjk Tg(Ins2-Mirc13)E4Biat/0 (involves: 129X1/SvJ * C57BL/6N)	hyperglycemia	J:314874
Bad^tm2Meg/Bad^tm2Meg (involves: 129S4/SvJae * C57BL/6 * SJL)	decreased insulin secretion	J:133563
	impaired glucose tolerance	J:133563
Bag2^em1(IMPC)J/Bag2^em1(IMPC)J (C57BL/6NJ-Bag2^em1(IMPC)J/Mmjax)	increased circulating phosphate level	J:211773
	increased fasting circulating glucose level	J:211773
Bag3^{Gt(OST16086)Lex}/Bag3^{Gt(OST16086)Lex} (involves: 129S5/SvEvBrd * C57BL/6)	pulmonary edema	J:112361
Bag3^tm1.1Jhl/Bag3^tm1.1Jhl (B6.129S2-Bag3^tm1.1Jhl)	decreased circulating cholesterol level	J:144416
	decreased circulating insulin level	J:144416
	decreased circulating triglyceride level	J:144416
	hypoglycemia	J:144416
	increased circulating ketone body level	J:144416
Bag3^{tm1b(EUCOMM)Hmgu}/Bag3⁺ (C57BL/6N-Bag3^{tm1b(EUCOMM)Hmgu}/H)	decreased blood urea nitrogen level	J:211773
Bag4^tm1Yeh/Bag4^tm1Yeh (involves: 129P2/OlaHsd * C57BL/6)	increased circulating interleukin-6 level	J:83559
Bag6^tm1Pmc/Bag6^tm1Pmc (involves: 129S1/Sv * C57BL/6)	edema	J:119857
Baiap2^Gt(XG757)Byg/Baiap2^Gt(XG757)Byg (B6.129P2-Baiap2^Gt(XG757)Byg)	pericardial edema	J:275147
	subcutaneous edema	J:275147
Baiap2^Gt(XG757)Byg/Baiap2^Gt(XG757)Byg Baiap2l1^tm1.1Arte/Baiap2l1^tm1.1Arte (involves: 129P2/OlaHsd * C57BL/6J * C57BL/6NTac)	pericardial edema	J:275147
	subcutaneous edema	J:275147
Baiap2^{tm1b(KOMP)Wtsi}/Baiap2⁺ (C57BL/6N-Baiap2^{tm1b(KOMP)Wtsi}/Tcp)	decreased circulating calcium level	J:211773
Baiap2^{tm1b(KOMP)Wtsi}/Baiap2^{tm1b(KOMP)Wtsi} (C57BL/6N-Baiap2^{tm1b(KOMP)Wtsi}/Tcp)	edema	J:211773
Baiap2l1^tm1Zgh/Baiap2l1^tm1Zgh (B6.Cg-Baiap2l1^tm1Zgh)	impaired glucose tolerance	J:238622
	increased circulating insulin level	J:238622
	increased fasting circulating glucose level	J:238622
	increased hepatic glucose production	J:238622
	insulin resistance	J:238622
Baiap2l2^{tm1a(EUCOMM)Hmgu}/Baiap2l2^{tm1a(EUCOMM)Hmgu} (C57BL/6N-Baiap2l2^{tm1a(EUCOMM)Hmgu}/Ics)	increased circulating bilirubin level	J:211773
Bak1^tm1Thsn/Bak1^tm1Thsn (B6.129-Bak1^tm1Thsn)	abnormal platelet physiology	J:149205
Bak1^tm1Thsn/Bak1^tm1Thsn Bcl2l1^tm1Dlo/Bcl2l1⁺ (B6.Cg-Bcl2l1^tm1Dlo Bak1^tm1Thsn)	abnormal platelet physiology	J:149205
Banp^em1(IMPC)J/Banp⁺ (C57BL/6NJ-Banp^em1(IMPC)J/Mmjax)	increased circulating cholesterol level	J:211773
Bap1^tm1.1Geno/Bap1^tm1.1Geno Gt(ROSA)26Sor^{tm9(cre/ESR1)Arte}/Gt(ROSA)26Sor⁺ (involves: C57BL/6 * C57BL/6NTac)	abnormal cardiac thrombosis	J:187380
BAP008/BAP008 (C3HeB/FeJ-BAP008)	increased circulating alkaline phosphatase level	J:183993
BAP011/BAP011 (C3HeB/FeJ-BAP011)	increased circulating alkaline phosphatase level	J:183993
BAP013/BAP013 (C3HeB/FeJ-BAP013)	increased circulating alkaline phosphatase level	J:183993
BAP028/BAP028 (C3HeB/FeJ-BAP028)	decreased circulating alkaline phosphatase level	J:183993
BAP029/BAP029 (C3HeB/FeJ-BAP029)	decreased circulating alkaline phosphatase level	J:183993
BAP030/BAP030 (C3HeB/FeJ-BAP030)	decreased circulating alkaline phosphatase level	J:183993
BAP031/BAP031 (C3HeB/FeJ-BAP031)	decreased circulating alkaline phosphatase level	J:183993
Barx2^{tm1b(EUCOMM)Hmgu}/Barx2^{tm1b(EUCOMM)Hmgu} (C57BL/6N-Barx2^{tm1b(EUCOMM)Hmgu}/H)	increased circulating amylase level	J:211773
	increased circulating aspartate transaminase level	J:211773
	increased circulating bilirubin level	J:211773
	increased circulating creatine kinase level	J:211773
Baz1b^tm1Ska/Baz1b⁺ (involves: C57BL/6 * CBA)	increased circulating calcium level	J:149990
Baz1b^{tm2a(KOMP)Wtsi}/Baz1b⁺ (Not Specified)	decreased circulating cholesterol level	J:165965
	decreased circulating glucose level	J:165965
	decreased circulating HDL cholesterol level	J:165965
	decreased circulating total protein level	J:165965
Baz2a^em1(IMPC)Tcp/Baz2a^em1(IMPC)Tcp (C57BL/6NCrl-Baz2a^em1(IMPC)Tcp/Tcp)	decreased fasting circulating glucose level	J:211773
	increased blood urea nitrogen level	J:211773
	increased circulating sodium level	J:211773
Baz2b^{em1(IMPC)Wtsi}/Baz2b^{em1(IMPC)Wtsi} (C57BL/6N-Baz2b^{em1(IMPC)Wtsi}/Wtsi)	decreased circulating glucose level	J:211773
	increased circulating alkaline phosphatase level	J:211773
Baz2b^em1Hzhu/Baz2b^em1Hzhu (involves: 129 * C57BL/6)	decreased circulating alanine transaminase level	J:326413
Baz2b^em1Hzhu/Baz2b^em1Hzhu (involves: 129 * C57BL/6)	decreased circulating aspartate transaminase level	J:326413
Bbc3^tm1Gpz/Bbc3^tm1Gpz (involves: 129P2/OlaHsd)	decreased lactate dehydrogenase level	J:116287
Bbip1^{em1(IMPC)Ccpcz}/Bbip1⁺ (C57BL/6N-Bbip1^{em1(IMPC)Ccpcz}/Ccpcz)	decreased respiratory quotient	J:211773
Bbs1^em1(IMPC)Mbp/Bbs1⁺ (C57BL/6N-Bbs1^em1(IMPC)Mbp/MbpMmucd)	edema	J:211773
Bbs1^em1(IMPC)Mbp/Bbs1^em1(IMPC)Mbp (C57BL/6N-Bbs1^em1(IMPC)Mbp/MbpMmucd)	edema	J:211773
Bbs1^tm1Vcs/Bbs1^tm1Vcs (involves: 129S1/Sv * 129X1/SvJ)	increased circulating leptin level	J:128532
Bbs2^tm1.1Huss/Bbs2^tm1.1Huss (involves: 129S6/SvEv * C57BL/6)	increased ceramide level	J:296033
	increased circulating alanine transaminase level	J:296033
	increased circulating leptin level	J:296033
	increased circulating triglyceride level	J:296033
Bbs2^tm1Vcs/Bbs2^tm1Vcs (either: (involves: 129S1/Sv * 129X1/SvJ) or (involves: 129S1/Sv * 129X1/SvJ * C57BL/6J))	decreased salivation	J:94467
Bbs4^Gt1Nk/Bbs4^Gt1Nk (involves: 129S7/SvEvBrd)	abnormal blood homeostasis	J:134093
	abnormal circulating hormone level	J:134093
	abnormal circulating lipid level	J:134093
	abnormal circulating mineral level	J:134093
	increased blood urea nitrogen level	J:134093
	increased circulating alanine transaminase level	J:134093
	increased circulating alkaline phosphatase level	J:134093
	increased circulating aspartate transaminase level	J:134093
	increased circulating bilirubin level	J:134093
	increased circulating cholesterol level	J:134093
	increased circulating creatine kinase level	J:134093
	increased circulating glucose level	J:134093
	increased circulating HDL cholesterol level	J:134093
	increased circulating insulin level	J:134093
	increased circulating lactate dehydrogenase level	J:134093
	increased circulating LDL cholesterol level	J:134093
	increased circulating leptin level	J:134093
	increased circulating magnesium level	J:134093
	increased circulating sodium level	J:134093
	increased circulating VLDL cholesterol level	J:134093
Bbs4^tm1Vcs/Bbs4^tm1Vcs (involves: 129S1/Sv * 129X1/SvJ)	decreased salivation	J:94467
Bbs5^{tm1b(EUCOMM)Wtsi}/Bbs5^{tm1b(EUCOMM)Wtsi} (C57BL/6NTac-Bbs5^{tm1b(EUCOMM)Wtsi}/H)	decreased circulating triglyceride level	J:211773
	decreased respiratory quotient	J:211773
	impaired glucose tolerance	J:211773
	increased circulating alanine transaminase level	J:211773
	increased circulating alkaline phosphatase level	J:211773
	increased circulating aspartate transaminase level	J:211773
	increased circulating fructosamine level	J:211773
	increased circulating glucose level	J:211773
	increased fasting circulating glucose level	J:211773
Bbs7^{tm1b(EUCOMM)Wtsi}/Bbs7⁺ (B6N(Cg)-Bbs7^{tm1b(EUCOMM)Wtsi}/J)	increased circulating alanine transaminase level	J:211773
	increased circulating sodium level	J:211773
Bbs7^tm1Vcs/Bbs7^tm1Vcs Ift88^Tg737Rpw/Ift88^Tg737Rpw (involves: FVB/N)	pericardial edema	J:181886
Bbs10^{tm1.1(KOMP)Vlcg}/Bbs10⁺ (B6N(Cg)-Bbs10^{tm1.1(KOMP)Vlcg}/J)	increased circulating sodium level	J:211773
Bbs10^tm1.2Vmar/Bbs10^tm1.2Vmar (involves: 129P2/OlaHsd * C57BL/6)	abnormal glucose tolerance	J:227230
	increased circulating antidiuretic hormone level	J:227230
	increased circulating leptin level	J:227230
	increased urine microalbumin level	J:227230
Bbs12^tm1.1Vmar/Bbs12^tm1.1Vmar (involves: 129S6/SvEvTac * C57BL/6)	decreased circulating free fatty acids level	J:189019
	decreased circulating interleukin-6 level	J:189019
	decreased circulating tumor necrosis factor level	J:189019
	increased circulating adiponectin level	J:189019
	increased circulating glucose level	J:189019
	increased circulating leptin level	J:189019
	increased insulin sensitivity	J:189019
	increased susceptibility to diet-induced obesity	J:189019
BC004004^em1Nju/BC004004^em1Nju (C57BL/6J-BC004004^em1Nju)	decreased collagen level	J:328326
BC004004^em1Nju/BC004004^em1Nju (C57BL/6J-BC004004^em1Nju)	decreased hydroxyproline level	J:328326
BC048562^{tm1b(KOMP)Wtsi}/BC048562^{tm1b(KOMP)Wtsi} (C57BL/6N-BC048562^{tm1b(KOMP)Wtsi}/Bay)	decreased fasting circulating glucose level	J:211773
Bcap31^tm1.1Bwang/Bcap31^tm1.1Bwang Lyz2^tm1(cre)Ifo/Lyz2⁺ (involves: 129P2/OlaHsd * C57BL/6)	abnormal enzyme/coenzyme level	J:292505
Bcar3^em1(IMPC)Mbp/Bcar3^em1(IMPC)Mbp (C57BL/6N-Bcar3^em1(IMPC)Mbp/MbpMmucd)	increased circulating calcium level	J:211773
	increased circulating insulin level	J:211773
Bcat2^m1Ytc/Bcat2^m1Ytc (C57BL/6J-Bcat2^m1Ytc)	abnormal circulating amino acid level	J:87589
Bcat2^m1Ytc/Bcat2^m1Ytc (C57BL/6J-Bcat2^m1Ytc)	ketoaciduria	J:87589
Bcat2^tm1.2Clyn/Bcat2^tm1.2Clyn (involves: BALB/cJ * C57BL/6J * C57BL/6N)	abnormal circulating amino acid level	J:129967
	abnormal circulating hormone level	J:129967
	abnormal glucose homeostasis	J:129967
	abnormal homeostasis	J:129967
	abnormal lipid homeostasis	J:129967
	abnormal urine amino acid level	J:129967
	decreased circulating adiponectin level	J:129967
	decreased circulating free fatty acids level	J:129967
	decreased circulating glucose level	J:129967
	decreased circulating insulin level	J:129967
	decreased circulating ketone body level	J:129967
	decreased circulating leptin level	J:129967
	decreased susceptibility to diet-induced obesity	J:129967
	decreased urine creatinine level	J:129967
	improved glucose tolerance	J:129967
	increased core body temperature	J:129967
	increased energy expenditure	J:129967
	increased insulin sensitivity	J:129967
BCH001/BCH001 (C3HeB/FeJ-BCH001)	increased circulating calcium level	J:183993
BCH005/BCH005 (C3HeB/FeJ-BCH005)	increased circulating calcium level	J:183993
BCH012/BCH012 (C3HeB/FeJ-BCH012)	increased circulating calcium level	J:183993
Bckdha^{tm1a(EUCOMM)Hmgu}/Bckdha^{tm1a(EUCOMM)Hmgu} Tg(Ucp1-cre)1Evdr/0 (involves: C57BL/6N * FVB)	decreased core body temperature	J:278806
	decreased fatty acid oxidation	J:278806
	impaired adaptive thermogenesis	J:278806
	impaired febrile response	J:345254
	impaired glucose tolerance	J:278806
	increased liver triglyceride level	J:278806
	insulin resistance	J:278806
Bckdhb^em1(IMPC)J/Bckdhb^em1(IMPC)J (CByJ.B6-Bckdhb^em1(IMPC)J)	abnormal circulating amino acid level	J:344897
	decreased circulating alanine level	J:344897
	increased circulating leucine level	J:344897
	increased circulating valine level	J:344897
Bckdk^{Gt(OST79912)Lex}/Bckdk^{Gt(OST79912)Lex} (involves: 129S5/SvEvBrd)	abnormal amino acid level	J:238065
	abnormal circulating amino acid level	J:238065
Bckdk^{Gt(VICT48)710Lex}/Bckdk^{Gt(VICT48)710Lex} (B6.129S5/SvEvBrd-Bckdk^{Gt(VICT48)710Lex})	abnormal amino acid level	J:117564
	abnormal carbon dioxide level	J:117564
	abnormal circulating amino acid level	J:117564
BCL001/BCL001 (C3HeB/FeJ-BCL001)	decreased circulating calcium level	J:183993
BCL001/BCL001 (C3HeB/FeJ-BCL001)	increased circulating alkaline phosphatase level	J:183993
Bcl2^tm1.1Sjk/Bcl2^tm1.1Sjk Tg(CAG-EGFP/Map1lc3b)53Nmz/0 (involves: 129X1/SvJ * C57BL/6 * C57BL/6NCrj * SJL)	abnormal carbon dioxide production	J:181308
	abnormal cholesterol homeostasis	J:181308
	abnormal circulating adiponectin level	J:181308
	abnormal circulating glucose level	J:181308
	abnormal circulating insulin level	J:181308
	abnormal glucose homeostasis	J:181308
	abnormal glucose tolerance	J:181308
	abnormal oxygen consumption	J:181308
	abnormal triglyceride level	J:181308
	increased circulating leptin level	J:181308
Bcl2^tm1Mpin/Bcl2^tm1Mpin (involves: 129S2/SvPas * C57BL/6)	increased blood urea nitrogen level	J:34326
Bcl2^tm1Mpin/Bcl2^tm1Mpin (involves: 129S2/SvPas * C57BL/6)	increased circulating creatinine level	J:34326
Bcl2^tm1Sjk/Bcl2^tm1Sjk (involves: 129S2/SvPas * C57BL/6)	increased blood urea nitrogen level	J:15224, J:22552
Bcl2^tm1Sjk/Bcl2^tm1Sjk (involves: 129S2/SvPas * C57BL/6)	increased circulating creatinine level	J:15224, J:22552
Bcl2l1^Plt16/Bcl2l1⁺ (involves: BALB/c * C57BL/6)	abnormal platelet physiology	J:149205
Bcl2l1^Plt20/Bcl2l1⁺ (involves: BALB/c * C57BL/6)	abnormal platelet physiology	J:149205
Bcl2l1^Plt20/Bcl2l1^Plt20 (involves: BALB/c * C57BL/6)	abnormal platelet physiology	J:149205
Bcl2l1^tm1.1Mam/Bcl2l1^tm1.1Mam 7630403G23Rik^{Tg(Th-cre)1Tmd}/? (involves: 129S6/SvEvTac * C57BL/6 * SJL)	decreased dopamine level	J:99848
Bcl2l1^tm1Dlo/Bcl2l1⁺ (B6.Cg-Bcl2l1^tm1Dlo)	abnormal platelet physiology	J:149205
Bcl2l2^{Gt(ROSA)41Sor}/Bcl2l2^{Gt(ROSA)41Sor} (involves: 129S5/SvEvBrd)	increased circulating follicle stimulating hormone level	J:46386
Bcl2l11^em1(IMPC)H/Bcl2l11^em1(IMPC)H (C57BL/6NTac-Bcl2l11^em1(IMPC)H/H)	increased circulating potassium level	J:211773
Bcl2l11^tm1.1Ast/Bcl2l11^tm1.1Ast (involves: 129S1/Sv * C57BL/6)	increased blood urea nitrogen level	J:58641
Bcl2l15^{tm1b(EUCOMM)Hmgu}/Bcl2l15^{tm1b(EUCOMM)Hmgu} (C57BL/6N-Bcl2l15^{tm1b(EUCOMM)Hmgu}/Ieg)	increased circulating bilirubin level	J:211773
	increased circulating total protein level	J:211773
Bcl3^tm1Sbn/Bcl3^tm1Sbn (involves: 129S4/SvJae * C57BL/6)	abnormal nitric oxide homeostasis	J:39747
Bcl6^tm1Gdba/Bcl6^tm1Gdba Tg(Adipoq-cre)1Evdr/0 (involves: C57BL/6 * FVB/NJ)	abnormal lipid level	J:271078
	decreased ceramide level	J:271078
	decreased circulating free fatty acids level	J:271078
	decreased circulating insulin level	J:271078
	decreased circulating triglyceride level	J:271078
	decreased fasting circulating glucose level	J:271078
	decreased liver triglyceride level	J:271078
	decreased respiratory quotient	J:271078
	impaired gluconeogenesis	J:271078
	increased circulating adiponectin level	J:271078
	increased circulating leptin level	J:271078
	increased insulin sensitivity	J:271078
	increased susceptibility to diet-induced obesity	J:271078
Bcl6^tm1Sdt/Bcl6^tm1Sdt (involves: 129/Sv * C57BL/6)	abnormal chemokine level	J:123621
Bcl7c^em1(IMPC)J/Bcl7c^em1(IMPC)J (C57BL/6NJ-Bcl7c^em1(IMPC)J/Mmjax)	decreased circulating calcium level	J:211773
	increased circulating creatinine level	J:211773
Bcl11a^tm1Mbu/Bcl11a^tm1Mbu Epor^{tm1.1(EGFP/icre)Uk}/Epor⁺ Tg(HBB)8.1Gvs/0 (involves: 129 * BALB/cJ * FVB/N)	increased circulating erythropoietin level	J:196405
Bcl11a^tm1Mbu/Bcl11a^tm1Mbu Klf1^tm1Nimr/Klf1⁺ Tg(HBB)8.1Gvs/0 (involves: 129P2/OlaHsd * FVB)	increased circulating erythropoietin level	J:196405
Bcl11a^tm1Pwt/Bcl11a^tm1Pwt Commd10^{Tg(Vav1-icre)A2Kio}/Commd10⁺ (involves: C57BL/6 * C57BL/10 * CBA/Ca)	decreased circulating interferon-alpha level	J:207383
Bcl11b^{tm1.1(KOMP)Vlcg}/Bcl11b⁺ (B6N(Cg)-Bcl11b^{tm1.1(KOMP)Vlcg}/J)	increased fasting circulating glucose level	J:211773
Bcl11b^tm1.1Leid/Bcl11b^tm1.1Leid Tg(KRT14-cre)1Ipc/0 (involves: C57BL/6 * SJL)	impaired skin barrier function	J:147182
Bcl11b^tm1.2Leid/Bcl11b^tm1.2Leid (involves: C57BL/6 * SJL)	impaired skin barrier function	J:147182
Bclaf1^{tm1b(EUCOMM)Wtsi}/Bclaf1^{tm1b(EUCOMM)Wtsi} (B6N(Cg)-Bclaf1^{tm1b(EUCOMM)Wtsi}/J)	cyanosis	J:211773
Bco1^tm1Dnp/Bco1^tm1Dnp (involves: 129S6/SvEvTac * C57BL/6)	abnormal vitamin A level	J:128383
	abnormal vitamin homeostasis	J:128383
	increased circulating alanine transaminase level	J:128383
	increased circulating cholesterol level	J:128383
	increased circulating free fatty acids level	J:128383
	increased susceptibility to diet-induced obesity	J:128383
Bco2^tm1Dnp/Bco2⁺ (involves: 129S6/SvEvTac * C57BL/6)	increased liver triglyceride level	J:170742
Bco2^tm1Dnp/Bco2^tm1Dnp (involves: 129S6/SvEvTac * C57BL/6)	abnormal blood homeostasis	J:166153
	abnormal homeostasis	J:166153
	increased liver triglyceride level	J:170742
Bcorl1^em1(IMPC)Tcp/Y (C57BL/6N-Bcorl1^em1(IMPC)Tcp/Tcp)	decreased circulating cholesterol level	J:211773
	decreased circulating HDL cholesterol level	J:211773
	increased circulating alkaline phosphatase level	J:211773
	increased circulating bilirubin level	J:211773
Bcorl1^em1(IMPC)Tcp/Bcorl1^em1(IMPC)Tcp (C57BL/6N-Bcorl1^em1(IMPC)Tcp/Tcp)	decreased circulating cholesterol level	J:211773
Bcr^tm1Hkp/Bcr^tm1Hkp (involves: 129S2/SvPas)	increased blood urea nitrogen level	J:23804
	increased circulating alanine transaminase level	J:23804
	increased circulating aspartate transaminase level	J:23804
	increased circulating lactate dehydrogenase level	J:23804
	intestinal edema	J:23804
Bcs1l^tm1.1Levp/Bcs1l^tm1.1Levp (involves: 129 * 129S6/SvEvTac * C57BL/6)	decreased liver glycogen level	J:189652
	increased circulating lactate level	J:189652
	increased liver iron level	J:189652
Bcs1l^tm1.1Levp/Bcs1l^tm1.1Levp (B6.129-Bcs1l^tm1.1Levp)	abnormal enzyme/coenzyme level	J:273501
	decreased circulating arginine level	J:273501
	decreased circulating glucose level	J:273501
	increased circulating alanine transaminase level	J:273501
	increased circulating alkaline phosphatase level	J:273501
	increased circulating citrulline level	J:273501
	increased circulating ornithine level	J:273501
	ketosis	J:273501
Bdkrb1^em1(IMPC)H/Bdkrb1^em1(IMPC)H (B6N;B6NTac-Bdkrb1^em1(IMPC)H/H)	increased circulating alkaline phosphatase level	J:211773
Bdkrb2^tm1Jfh/Bdkrb2^tm1Jfh (B6.129S7-Bdkrb2^tm1Jfh)	decreased blood urea nitrogen level	J:121339
	decreased urine nitrite level	J:83895
	increased blood urea nitrogen level	J:121339
	increased circulating creatinine level	J:121339
Bdnf^tm1Par/Bdnf⁺ (B6.129S1-Bdnf^tm1Par)	abnormal serotonin level	J:59077
Bdnf^tm1Par/Bdnf⁺ (B6.129S1-Bdnf^tm1Par)	increased circulating insulin level	J:59077
Bdnf^tm3Jae/Bdnf^tm3Jae Tg(Camk2a-cre)93Kln/0 (involves: 129S4/SvJae * CBA/J)	abnormal homeostasis	J:71969
	increased cholesterol level	J:71969
	increased circulating glucose level	J:71969
	increased circulating insulin level	J:71969
	increased circulating leptin level	J:71969
	insulin resistance	J:71969
Bdt3^DBA/2J/Bdt3^DBA/2J (involves: C57BL/6J * DBA/2J)	increased circulating leptin level	J:104825
Bdt3^DBA/2J/Bdt3^DBA/2J (involves: C57BL/6J * DBA/2J)	increased circulating VLDL cholesterol level	J:104825
Becn1^{tm1b(KOMP)Wtsi}/Becn1⁺ (C57BL/6N-Becn1^{tm1b(KOMP)Wtsi}/Ieg)	decreased circulating HDL cholesterol level	J:211773
	increased circulating bilirubin level	J:211773
Becn1^tm1Ebr/Becn1^tm1Ebr Lyz2^tm1(cre)Ifo/Lyz2⁺ (involves: 129P2/OlaHsd)	abnormal circulating chemokine level	J:235399
	decreased circulating interleukin-10 level	J:235399
	increased blood urea nitrogen level	J:235399
	increased circulating creatinine level	J:235399
	increased circulating interleukin-1 beta level	J:235399
	increased circulating interleukin-6 level	J:235399
	increased circulating interleukin-12b level	J:235399
	increased urine protein level	J:235399
Becn2^tm1.1Blev/Becn2⁺ (B6.Cg-Becn2^tm1.1Blev)	impaired glucose tolerance	J:203842
	increased circulating glucose level	J:203842
	increased susceptibility to diet-induced obesity	J:203842
	insulin resistance	J:203842
Betalinc1^tm1Suss/Betalinc1^tm1Suss (involves: 129 * C57BL/6)	impaired glucose tolerance	J:231585
	increased circulating insulin level	J:231585
	insulin resistance	J:231585
Bfq1^LP/J/Bfq1^LP/J (involves: C57BL/10SnJ * LP/J)	decreased circulating insulin level	J:42700
Bglap/Bglap2^tm1Kry/Bglap/Bglap2^tm1Kry (involves: 129S7/SvEvBrd)	abnormal glucose homeostasis	J:126780
	decreased circulating insulin level	J:126780
	decreased circulating testosterone level	J:170888
	decreased energy expenditure	J:126780
	decreased insulin secretion	J:126780
	impaired glucose tolerance	J:126780
	increased circulating estradiol level	J:170888
	increased circulating glucose level	J:126780
	increased circulating luteinizing hormone level	J:170888
	increased circulating triglyceride level	J:126780
	insulin resistance	J:126780
Bglap/Bglap2^tm1Kry/Bglap/Bglap2^tm1Kry Tg(AZIP/F)1Vsn/0 (involves: 129S7/SvEvBrd * FVB/N)	increased circulating insulin level	J:145998
Bglap/Bglap2^tm1Kry/Bglap/Bglap2^tm1Kry (involves: 129S7/SvEvBrd)	abnormal glucose homeostasis	J:126780
	decreased circulating insulin level	J:126780
	decreased circulating testosterone level	J:170888
	decreased energy expenditure	J:126780
	decreased insulin secretion	J:126780
	impaired glucose tolerance	J:126780
	increased circulating estradiol level	J:170888
	increased circulating glucose level	J:126780
	increased circulating luteinizing hormone level	J:170888
	increased circulating triglyceride level	J:126780
	insulin resistance	J:126780
Bglap/Bglap2^tm1Kry/Bglap/Bglap2^tm1Kry Tg(AZIP/F)1Vsn/0 (involves: 129S7/SvEvBrd * FVB/N)	increased circulating insulin level	J:145998
Bglap/Bglap2^tm3.1Kry/Bglap/Bglap2^tm3.1Kry Tg(Col1a1-cre)1Kry/0 (involves: FVB)	decreased circulating testosterone level	J:170888
Bglap/Bglap2^tm3.1Kry/Bglap/Bglap2^tm3.1Kry Tg(Col1a1-cre)1Kry/0 (involves: FVB)	decreased circulating testosterone level	J:170888
Bglu1^C57BL/6Slc/Bglu1^C3H/HeSlc (involves: C3H/HeSlc * C57BL/6Slc)	hyperglycemia	J:62933
Bglu1^C57BL/6Slc/Bglu1^C57BL/6Slc (involves: C3H/HeSlc * C57BL/6Slc)	hyperglycemia	J:62933
Bglu2^C57BL/6Slc/Bglu2^C3H/HeSlc (involves: C3H/HeSlc * C57BL/6Slc)	hyperglycemia	J:62933
Bglu2^C57BL/6Slc/Bglu2^C57BL/6Slc (involves: C3H/HeSlc * C57BL/6Slc)	hyperglycemia	J:62933
Bglu3^C3H/HeJ/Bglu3^C3H/HeJ (involves: C3H/HeJ * C57BL/6J)	increased circulating glucose level	J:108422
Bglu3^C3H/HeJ/Bglu3^C57BL/6J (involves: C3H/HeJ * C57BL/6J)	increased circulating glucose level	J:108422
Bglu4^NZB/BlNJ/? (involves: NZB/BlNJ * NZW/LacJ)	increased circulating glucose level	J:138463
Bglu5^NZW/LacJ/? (involves: NZB/BlNJ * NZW/LacJ)	increased circulating glucose level	J:138463
Bglu6^NZB/BlNJ/? (involves: NZB/BlNJ * NZW/LacJ)	increased circulating glucose level	J:138463
Bglu7^NZW/LacJ/? (involves: NZB/BlNJ * NZW/LacJ)	increased circulating glucose level	J:138463
Bglu8^NZB/BlNJ/Bglu8^NZB/BlNJ (involves: NZB/BlNJ * NZW/LacJ)	increased circulating glucose level	J:138463
Bglu8^NZW/LacJ/Bglu8^NZW/LacJ (involves: NZB/BlNJ * NZW/LacJ)	increased circulating glucose level	J:138463
Bglu10^NZB/BlNJ/? (involves: NZB/BlNJ * NZW/LacJ)	increased circulating glucose level	J:138463
Bglu11^NZB/BlNJ/Bglu11^NZB/BlNJ Bglu9^NZB/BlNJ/Bglu9^NZB/BlNJ (involves: NZB/BlNJ * NZW/LacJ)	increased circulating glucose level	J:138463
Bgn^tm1Mfy/Bgn^tm1Mfy (involves: 129S4/SvJae)	decreased collagen level	J:222369
Bgn^tm1Mfy/Bgn^tm1Mfy Epyc^tm1Mhok/Epyc^tm1Mhok (involves: 129S4/SvJae * 129S7/SvEvBrd * C57BL/6J)	decreased collagen level	J:222369
bh/bh (AKR-T)	aminoaciduria	J:12172
bh/bh (AKR-T)	increased urine protein level	J:12172
Bhlha15^tm2(Kras)Skz/Bhlha15⁺ (involves: 129S6/SvEvTac * C57BL/6)	hemorrhagic ascites	J:105076
Bhlhe40^{tm1b(KOMP)Wtsi}/Bhlhe40^{tm1b(KOMP)Wtsi} (B6N(Cg)-Bhlhe40^{tm1b(KOMP)Wtsi}/J)	decreased fasting circulating glucose level	J:211773
Bhlhe40^{tm1b(KOMP)Wtsi}/Bhlhe40^{tm1b(KOMP)Wtsi} (C57BL/6N-Bhlhe40^{tm1b(KOMP)Wtsi}/Wtsi)	decreased circulating calcium level	J:211773
	decreased circulating cholesterol level	J:211773
	decreased circulating glycerol level	J:211773
	decreased circulating HDL cholesterol level	J:211773
	increased blood urea nitrogen level	J:211773
	increased circulating chloride level	J:211773
	increased circulating fructosamine level	J:211773
	increased circulating iron level	J:211773
Bhmt^tm1.2Zei/Bhmt^tm1.2Zei (involves: 129P2/OlaHsd * C57BL/6)	abnormal circulating lipid level	J:177569
	abnormal lipid level	J:177569
	abnormal phospholipid level	J:177569
	abnormal urine homeostasis	J:177569
	decreased choline level	J:177569
	decreased circulating cholesterol level	J:177569
	decreased circulating HDL cholesterol level	J:177569
	decreased circulating phospholipid level	J:177569
	increased amino acid betaine level	J:177569
	increased circulating alanine transaminase level	J:177569
	increased triglyceride level	J:177569
Bhmt^{tm1b(EUCOMM)Hmgu}/Bhmt^{tm1b(EUCOMM)Hmgu} (C57BL/6N-Bhmt^{tm1b(EUCOMM)Hmgu}/Bay)	decreased blood urea nitrogen level	J:211773
Bicc1^em1(IMPC)Mbp/Bicc1^em1(IMPC)Mbp (C57BL/6N-Bicc1^em1(IMPC)Mbp/MbpMmucd)	edema	J:211773
Bicc1^jcpk-bpk/Bicc1^jcpk-bpk (BALB/c-Bicc1^jcpk-bpk)	increased blood urea nitrogen level	J:13276
Bicc1^m1Btlr/Bicc1^m1Btlr (C57BL/6J-Bicc1^m1Btlr)	increased blood urea nitrogen level	J:132744
Bicra^em1Hzhg/Bicra⁺ (Not Specified)	decreased growth hormone level	J:335098
Bicra^em1Hzhg/Bicra^em1Hzhg (Not Specified)	pericardial edema	J:335098
Bicra^em2Hzhg/Bicra⁺ (Not Specified)	decreased growth hormone level	J:335098
Bicra^em2Hzhg/Bicra^em2Hzhg (Not Specified)	pericardial edema	J:335098
Bin2^tm1.1Beni/Bin2^tm1.1Beni Tg(Pf4-icre)Q3Rsko/0 (involves: 129S6/SvEvTac * C57BL/6 * C57BL/6NTac)	abnormal platelet activation	J:302510
	abnormal platelet calcium level	J:302510
	abnormal platelet physiology	J:302510
	decreased platelet aggregation	J:302510
	decreased susceptibility to induced thrombosis	J:302510
	increased bleeding time	J:302510
Birc2^tm1.1Rbr/Birc2^tm1.1Rbr Birc3^tm1.1Rbr/Birc3^tm1.1Rbr (involves: BALB/cJ * C57BL/6 * SJL)	hemopericardium	J:182515
Birc2^tm1.1Rbr/Birc2^tm1.1Rbr Xiap^tm1Vdr/Xiap^tm1Vdr (involves: 129S1/Sv * BALB/cJ * C57BL/6)	hemopericardium	J:182515
Birc6^{em1(IMPC)Ccpcz}/Birc6⁺ (C57BL/6N-Birc6^{em1(IMPC)Ccpcz}/Ccpcz)	increased circulating creatine kinase level	J:211773
Birc6^{em1(IMPC)Ccpcz}/Birc6^{em1(IMPC)Ccpcz} (C57BL/6N-Birc6^{em1(IMPC)Ccpcz}/Ccpcz)	edema	J:211773
Birc6^tm1Nai/Birc6^tm1Nai (involves: 129S4/SvJae * C57BL/6J)	edema	J:96768
Bivm^{tm1b(KOMP)Wtsi}/Bivm^{tm1b(KOMP)Wtsi} (C57BL/6N-Bivm^{tm1b(KOMP)Wtsi}/Wtsi)	decreased circulating glucose level	J:211773
Blcap^em1(IMPC)J/Blcap^em1(IMPC)J (C57BL/6NJ-Blcap^em1(IMPC)J/J)	decreased circulating alkaline phosphatase level	J:211773
	increased fasting circulating glucose level	J:211773
Blite/Blite (C57BL/6J-Blite/H)	hydrops fetalis	J:148828
Bloc1s1^{tm1a(EUCOMM)Hmgu}/Bloc1s1⁺ (C57BL/6N-Bloc1s1^{tm1a(EUCOMM)Hmgu}/Ics)	increased circulating cholesterol level	J:165965
Bloc1s2^{tm1.1(KOMP)Mbp}/Bloc1s2⁺ (B6N(Cg)-Bloc1s2^{tm1.1(KOMP)Mbp}/J)	decreased circulating free fatty acids level	J:211773
	increased circulating alanine transaminase level	J:211773
Bloc1s2^{tm1.1(KOMP)Mbp}/Bloc1s2^{tm1.1(KOMP)Mbp} (B6N(Cg)-Bloc1s2^{tm1.1(KOMP)Mbp}/J)	edema	J:211773
Bloc1s4^cno/Bloc1s4^cno (C3H/HeJ-Bloc1s4^cno)	abnormal platelet dense granule physiology	J:61187
	decreased platelet aggregation	J:61187
	decreased platelet ATP level	J:61187
	decreased platelet calcium level	J:61187
	decreased platelet serotonin level	J:61187
	increased bleeding time	J:61187
Bloc1s5^mu/Bloc1s5^mu (involves: STOCK t)	abnormal platelet physiology	J:29151
	decreased platelet aggregation	J:29151
	decreased platelet ATP level	J:29151
	decreased platelet serotonin level	J:29151
	decreased urine protein level	J:29151
	increased bleeding time	J:29151
Bloc1s5^mu/Bloc1s5^mu (CHMU/Le)	abnormal platelet dense granule physiology	J:29151
	decreased platelet aggregation	J:29151
	decreased platelet serotonin level	J:29151
	increased bleeding time	J:29151
Bloc1s6^em1(IMPC)Mbp/Bloc1s6^em1(IMPC)Mbp (C57BL/6N-Bloc1s6^em1(IMPC)Mbp/MbpMmucd)	increased circulating serum albumin level	J:211773
Bloc1s6^pa/Bloc1s6^pa (B6.Cg-Bloc1s6^pa/J)	abnormal blood homeostasis	J:4098
	abnormal platelet activation	J:7327, J:221384
	abnormal platelet physiology	J:221384
	abnormal urine enzyme level	J:6219
	decreased platelet aggregation	J:221384
	decreased platelet ATP level	J:7327
	decreased platelet serotonin level	J:7327
	increased bleeding time	J:7327
	pulmonary edema	J:4098
Bltp1^{tm1b(EUCOMM)Hmgu}/Bltp1⁺ (C57BL/6N-Bltp1^{tm1b(EUCOMM)Hmgu}/Ieg)	impaired glucose tolerance	J:211773
	increased circulating glucose level	J:211773
Bltp3b^em1(IMPC)J/Bltp3b^em1(IMPC)J (C57BL/6NJ-Bltp3b^em1(IMPC)J/Mmjax)	increased circulating aspartate transaminase level	J:211773
Blvra^{tm1c(EUCOMM)Hmgu}/Blvra^{tm1c(EUCOMM)Hmgu} Speer6-ps1^{Tg(Alb-cre)21Mgn}/Speer6-ps1⁺ (involves: C57BL/6J * C57BL/6N)	decreased fatty acid beta-oxidation	J:237631
	decreased liver glycogen level	J:237631
	impaired glucose tolerance	J:237631
	increased circulating insulin level	J:237631
	increased fasting circulating glucose level	J:237631
	increased fatty acids level	J:237631
	increased liver triglyceride level	J:237631
	insulin resistance	J:237631
Blvrb^{tm1(KOMP)Wtsi}/Blvrb^{tm1(KOMP)Wtsi} (C57BL/6N-Blvrb^{tm1(KOMP)Wtsi}/Nju)	increased circulating creatinine level	J:211773
Bmal1^tm1.2Shbi/Bmal1^tm1.2Shbi (involves: C57BL/6J)	abnormal gluconeogenesis	J:177865
	abnormal glucose homeostasis	J:177865
	abnormal lipid level	J:177865
	decreased circulating HDL cholesterol level	J:177865
	decreased circulating insulin level	J:177865
	decreased circulating VLDL triglyceride level	J:177865
	decreased insulin secretion	J:177865
	decreased susceptibility to diet-induced obesity	J:177865
	hyperglycemia	J:177865
	impaired glucose tolerance	J:177865
	increased circulating cholesterol level	J:177865
	increased circulating free fatty acids level	J:177865
	increased circulating HDL cholesterol level	J:177865
	increased circulating LDL cholesterol level	J:177865
	increased circulating triglyceride level	J:177865
	increased circulating VLDL cholesterol level	J:177865
	increased liver triglyceride level	J:177865
	increased respiratory quotient	J:177865
	increased skeletal muscle triglyceride level	J:177865
Bmal1^tm1Bra/Bmal1^tm1Bra (involves: 129)	abnormal circulating protein level	J:155089
	abnormal glucose homeostasis	J:131694
	abnormal lipid homeostasis	J:131694
	decreased circulating progesterone level	J:151819
	impaired gluconeogenesis	J:131694
	increased insulin sensitivity	J:131694
Bmal1^tm1Bra/Bmal1^tm1Bra (B6.129-Bmal1^tm1Bra)	abnormal circulating adrenaline level	J:125921
	abnormal circulating protein level	J:191844
	abnormal nitric oxide homeostasis	J:191844
	abnormal venous thrombosis	J:191844
	decreased circulating adrenaline level	J:125921
	decreased circulating noradrenaline level	J:125921
	decreased prothrombin time	J:191844
	dehydration	J:97108
	hypercoagulability	J:191844
	increased circulating factor VIII level	J:191844
	increased circulating fibrinogen level	J:191844
	increased circulating osteocalcin level	J:97108
	increased partial thromboplastin time	J:191844
	increased susceptibility to induced thrombosis	J:191844
Bmal1^tm1Bra/Bmal1^tm1Bra (involves: 129/Sv * C57BL/6)	decreased circulating glucose level	J:135933
	decreased insulin secretion	J:162641
	decreased plasma anion gap	J:135933
	increased blood urea nitrogen level	J:135933
	increased circulating alanine transaminase level	J:135933
	increased circulating aspartate transaminase level	J:135933
Bmal1^tm2Bra/Bmal1^tm2Bra Tg(Pdx1-cre)89.1Dam/0 (involves: 129 * C57BL/6 * C57BL/6J * CBA * ICR)	decreased insulin secretion	J:162641
	hyperglycemia	J:162641
	impaired glucose tolerance	J:162641
Bmal1^tm2Bra/Bmal1^tm2Bra Tg(Tek-cre)12Flv/0 (involves: C3H * C57BL/6 * C57BL/6J)	abnormal protein level	J:155089
Bmi1^{tm1.1(KOMP)Vlcg}/Bmi1⁺ (C57BL/6N-Bmi1^{tm1.1(KOMP)Vlcg}/MbpMmucd)	edema	J:211773
Bmi1^{tm1.1(KOMP)Vlcg}/Bmi1^{tm1.1(KOMP)Vlcg} (C57BL/6N-Bmi1^{tm1.1(KOMP)Vlcg}/MbpMmucd)	edema	J:211773
Bmi1^tm1Brn/Bmi1^tm1Brn (involves: 129P2/OlaHsd)	abnormal enzyme/coenzyme level	J:286451
Bmi1^tm1Brn/Bmi1^tm1Brn (involves: 129P2/OlaHsd)	decreased circulating testosterone level	J:286451
Bmi1^tm1Brn/Bmi1^tm1Brn (involves: 129P2/OlaHsd * C57BL/6J * FVB/N)	abnormal enzyme/coenzyme level	J:287217
	decreased superoxide dismutase level	J:287217
Bmp2^tm1Jfm/Bmp2^tm1Jfm Bmp4^tm1Jfm/Bmp4^tm1Jfm Tg(Mef2c-cre)2Blk/0 (involves: 129S4/SvJaeSor)	pericardial edema	J:169047
Bmp2^tm1Jfm/Bmp2^tm1Jfm Nkx2-5^tm1(cre)Rjs/Nkx2-5⁺ (involves: 129S4/SvJaeSor)	pericardial effusion	J:104417
Bmp2^tm1Vrs/Bmp2^tm1Vrs Nkx2-5^tm2(cre)Rph/Nkx2-5⁺ (involves: 129S1/Sv * C57BL/6)	cardiac edema	J:110615
	pericardial effusion	J:110615
Bmp2k^em1(IMPC)J/Bmp2k^em1(IMPC)J (C57BL/6NJ-Bmp2k^em1(IMPC)J/J)	decreased urine magnesium level	J:211773
Bmp4^tm1Blh/Bmp4⁺ (involves: 129S2/SvPas * C57BL/6)	increased circulating glucose level	J:173500
Bmp4^tm1Jfm/Bmp4^tm1.1Jfm Nkx2-5^tm1(cre)Rjs/Nkx2-5⁺ (involves: 129S4/SvJaeSor * 129S7/SvEvBrd)	hydrops fetalis	J:89237
	pericardial effusion	J:89237
Bmp4^tm2.1Blh/Bmp4⁺ Slc27a4^pskn/Slc27a4^pskn (involves: 129S6/SvEvTac * FVB/N)	impaired skin barrier function	J:194779
Bmp6^{em1(IMPC)Ccpcz}/Bmp6^{em1(IMPC)Ccpcz} (C57BL/6N-Bmp6^{em1(IMPC)Ccpcz}/Ccpcz)	increased circulating alanine transaminase level	J:211773
	increased circulating aspartate transaminase level	J:211773
	increased circulating iron level	J:211773
Bmp7^tm1.1Dgra/Bmp7^tm1.1Dgra H2az2^{Tg(Wnt1-cre)11Rth}/H2az2⁺ (involves: 129S6/SvEvTac * C57BL/6J * C57BL/6NTac * CBA/J)	decreased body temperature	J:302309
	decreased oxygen consumption	J:302309
	increased circulating hydroxyproline level	J:302309
Bmp10^{tm1.1(Gdf2)Minh}/Bmp10^{tm1.1(Gdf2)Minh} (C57BL/6N-Bmp10^{tm1.1(Gdf2)Minh})	hydrops fetalis	J:222016
	pericardial edema	J:222016
Bmp10^{tm3b(EUCOMM)Hmgu}/Bmp10⁺ (C57BL/6N-Bmp10^{tm3b(EUCOMM)Hmgu}/Ics)	decreased circulating creatinine level	J:211773
	improved glucose tolerance	J:211773
Bmpr1a^tm2.1Bhr/Bmpr1a^tm2.1Bhr Kdr^tm1(cre)Sato/Kdr⁺ (involves: 129S1/Sv * 129S7/SvEvBrd)	pericardial effusion	J:112269
Bmpr1b^em1(IMPC)Mbp/Bmpr1b^em1(IMPC)Mbp (C57BL/6NCrl-Bmpr1b^em1(IMPC)Mbp/MbpMmucd)	increased circulating phosphate level	J:211773
Bmpr2^tm1.1Enl/Bmpr2^tm1.1Enl Tg(Acvrl1-cre)L1Spo/0 (involves: 129S4/SvJae * FVB)	abnormal lung thrombosis	J:158116
Bms1^{tm1b(EUCOMM)Hmgu}/Bms1⁺ (C57BL/6N-Bms1^{tm1b(EUCOMM)Hmgu}/Ieg)	decreased circulating sodium level	J:211773
Bmyc^tm1Mpo/Bmyc^tm1Mpo (involves: 129S7/SvEvBrd * C57BL/6N)	abnormal testosterone level	J:191587
	increased circulating luteinizing hormone level	J:191587
Bnc1^em1(IMPC)H/Bnc1^em1(IMPC)H (C57BL/6NTac-Bnc1^em1(IMPC)H/H)	increased circulating alanine transaminase level	J:211773
Bnip2^{tm1b(EUCOMM)Wtsi}/Bnip2^{tm1b(EUCOMM)Wtsi} (C57BL/6N-Bnip2^{tm1b(EUCOMM)Wtsi}/Wtsi)	increased circulating alkaline phosphatase level	J:211773
Bnip3^em1(IMPC)Mbp/Bnip3^em1(IMPC)Mbp (C57BL/6N-Bnip3^em1(IMPC)Mbp/MbpMmucd)	impaired glucose tolerance	J:211773
	increased circulating cholesterol level	J:211773
	increased circulating insulin level	J:211773
Bnip5^{tm1.1(KOMP)Vlcg}/Bnip5^{tm1.1(KOMP)Vlcg} (C57BL/6N-Bnip5^{tm1.1(KOMP)Vlcg}/MbpMmucd)	increased circulating alanine transaminase level	J:211773
Boc^{tm1b(KOMP)Wtsi}/Boc^{tm1b(KOMP)Wtsi} (C57BL/6N-Boc^{tm1b(KOMP)Wtsi}/H)	decreased circulating serum albumin level	J:211773
	decreased circulating total protein level	J:211773
	increased circulating triglyceride level	J:211773
Bodwt1^C3H/HeJ/Bodwt1^C3H/HeJ (involves: C3H/HeJ * C57BL/6J)	abnormal circulating cholesterol level	J:106521
	increased circulating HDL cholesterol level	J:106521
	increased circulating triglyceride level	J:106521
Bodwt1^C3H/HeJ/Bodwt1^C57BL/6J (involves: C3H/HeJ * C57BL/6J)	abnormal circulating cholesterol level	J:106521
	increased circulating HDL cholesterol level	J:106521
	increased circulating triglyceride level	J:106521
Bok^{tm1b(EUCOMM)Hmgu}/Bok^{tm1b(EUCOMM)Hmgu} (C57BL/6N-Bok^{tm1b(EUCOMM)Hmgu}/Tcp)	abnormal cholesterol homeostasis	J:211773
Bola2^{tm1(KOMP)Wtsi}/Bola2^{tm1(KOMP)Wtsi} (C57BL/6N-Bola2^{tm1(KOMP)Wtsi}/Nju)	decreased circulating iron level	J:211773
	improved glucose tolerance	J:211773
Bola3^{tm1a(EUCOMM)Wtsi}/Bola3^{tm1a(EUCOMM)Wtsi} Tg(Adipoq-cre)1Evdr/0 (involves: C57BL/6 * C57BL/6N * FVB/NJ)	decreased energy expenditure	J:287367
	decreased oxygen consumption	J:287367
	impaired glucose tolerance	J:287367
Borcs6^{tm1.1(KOMP)Vlcg}/Borcs6⁺ (B6N(Cg)-Borcs6^{tm1.1(KOMP)Vlcg}/J)	increased circulating calcium level	J:211773
bpck/bpck (B6C3Fe a/a-bpck/J)	increased blood urea nitrogen level	J:144929
Bpgm^m1Pgrs/Bpgm^m1Pgrs (involves: C57BL/6 * C57BL/10J)	increased blood oxygen capacity	J:301620
Bpgm^m1Pgrs/Bpgm^m1Pgrs (involves: C57BL/6 * C57BL/10J)	increased circulating erythropoietin level	J:301620
Bpgm^{tm1a(KOMP)Wtsi}/Bpgm^{tm1a(KOMP)Wtsi} (C57BL/6N-Bpgm^{tm1a(KOMP)Wtsi}/Wtsi)	increased circulating creatinine level	J:211773
Bpifb1^{tm1b(KOMP)Wtsi}/Bpifb1^{tm1b(KOMP)Wtsi} (C57BL/6N-Bpifb1^{tm1b(KOMP)Wtsi}/Ucd)	increased circulating aspartate transaminase level	J:211773
Bpifc^em1(IMPC)J/Bpifc^em1(IMPC)J (C57BL/6NJ-Bpifc^em1(IMPC)J/Mmjax)	impaired glucose tolerance	J:211773
BPL001/BPL001 (C3HeB/FeJ-BPL001)	decreased circulating phosphate level	J:183993
BPL002/BPL002 (C3HeB/FeJ-BPL002)	decreased circulating phosphate level	J:183993
BPL003/BPL003 (C3HeB/FeJ-BPL003)	decreased circulating phosphate level	J:183993
BPL004/BPL004 (C3HeB/FeJ-BPL004)	decreased circulating phosphate level	J:183993
BPL005/BPL005 (C3HeB/FeJ-BPL005)	decreased circulating phosphate level	J:183993
BPL006/BPL006 (C3HeB/FeJ-BPL006)	decreased circulating phosphate level	J:183993
BPL007/BPL007 (C3HeB/FeJ-BPL007)	decreased circulating phosphate level	J:183993
BPL008/BPL008 (C3HeB/FeJ-BPL008)	decreased circulating phosphate level	J:183993
BPL009/BPL009 (C3HeB/FeJ-BPL009)	decreased circulating phosphate level	J:183993
BPL010/BPL010 (C3HeB/FeJ-BPL010)	decreased circulating phosphate level	J:183993
BPL011/BPL011 (C3HeB/FeJ-BPL011)	decreased circulating phosphate level	J:183993
BPL012/BPL012 (C3HeB/FeJ-BPL012)	decreased circulating phosphate level	J:183993
BPL013/BPL013 (C3HeB/FeJ-BPL013)	decreased circulating phosphate level	J:183993
BPL014/BPL014 (C3HeB/FeJ-BPL014)	decreased circulating phosphate level	J:183993
Bpnt1^tm1Yrk/Bpnt1^tm1Yrk (involves: 129S/SvEv * C57BL/6)	abnormal circulating apolipoprotein E level	J:194247
	abnormal circulating apolipoprotein level	J:194247
	abnormal circulating enzyme level	J:194247
	abnormal circulating protein level	J:194247
	anasarca	J:194247
	decreased cholesterol level	J:194247
	decreased circulating serum albumin level	J:194247
	increased circulating alanine transaminase level	J:194247
	increased circulating alkaline phosphatase level	J:194247
	increased circulating aspartate transaminase level	J:194247
Braf^tm1Bbd/Braf⁺ (involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)	increased circulating noradrenaline level	J:170095
Braf^tm1Cpri/Braf^tm1Cpri Tg(TPO-cre)1Shk/0 (involves: 129P2/OlaHsd * FVB/NCr)	increased circulating thyroid-stimulating hormone level	J:168249
	increased circulating thyroxine level	J:168249
Braf^tm1Mmcm/Braf⁺ Tg(Tg-cre/ERT2)#Mmcm/0 (involves: 129P2/OlaHsd)	decreased circulating thyroxine level	J:172205
	increased circulating thyroid-stimulating hormone level	J:172205
Braf^tm1Mmcm/Braf⁺ Tg(TPO-cre/ERT2)1139Tyj/0 Trp53^tm1Brn/Trp53^tm1Brn (involves: 129P2/OlaHsd * 129S4/SvJae * C57BL/6 * C57BL/6NTac)	increased thyroid-stimulating hormone level	J:208854
Braf^tm1Sva/Braf^tm1.1Sva Tg(Nes-cre)1Kln/0 (involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * SJL)	abnormal body temperature homeostasis	J:121660
	abnormal growth hormone level	J:121660
	hypoglycemia	J:121660
Braf^tm1Tumg/Braf⁺ Tg(CAG-cre)2Osb/0 (involves: C57BL * C57BL/6J * DBA)	cyanosis	J:216228
	edema	J:216228
Braf^tm1Wds/Braf^tm1.1Wds Tg(Nes-cre)1Kln/0 (involves: 129P2/OlaHsd * C57BL/6 * SJL)	abnormal body temperature homeostasis	J:121660
	abnormal growth hormone level	J:121660
	hypoglycemia	J:121660
Braf^tm1Zim/Braf^tm1Zim (involves: 129)	hemopericardium	J:41257
Brap^em1(IMPC)Mbp/Brap⁺ (C57BL/6NCrl-Brap^em1(IMPC)Mbp/Mmucd)	edema	J:211773
Brca1^tm1Brn/Brca1^tm1Brn Tg(Krt18-EGFP,-TAg121)36Ysng/0 Trp53^tm1Brn/Trp53^tm2Tyj (involves: 129P2/OlaHsd * 129S4/SvJae * C57BL/6 * DBA/2 * FVB/N)	hemorrhagic ascites	J:189304
Brcc3dc^em1(IMPC)J/Brcc3dc^em1(IMPC)J (C57BL/6NJ-Brcc3dc^em1(IMPC)J/Mmjax)	impaired glucose tolerance	J:211773
Brd2^{em1(IMPC)Wtsi}/Brd2^{em1(IMPC)Wtsi} (C57BL/6N-Brd2^{em1(IMPC)Wtsi}/WtsiIeg)	retropleural edema	J:239583
	subcutaneous edema	J:239583
Brd2^{Gt(RRT234)Byg}/Brd2⁺ (B6.129P2-Brd2^{Gt(RRT234)Byg})	abnormal blood homeostasis	J:159964
	abnormal circulating lipid level	J:159964
	abnormal respiratory quotient	J:159964
	decreased circulating glucose level	J:159964
	improved glucose tolerance	J:159964
	increased circulating adiponectin level	J:159964
	increased circulating cholesterol level	J:159964
	increased circulating glucagon level	J:159964
	increased circulating insulin level	J:159964
	increased circulating interleukin-1 beta level	J:159964
	increased circulating leptin level	J:159964
	increased circulating triglyceride level	J:159964
	increased circulating tumor necrosis factor level	J:159964
Brd7^{tm2a(EUCOMM)Wtsi}/Brd7⁺ (Not Specified)	decreased circulating LDL cholesterol level	J:175295
Brd7^{tm2a(EUCOMM)Wtsi}/Brd7⁺ (Not Specified)	increased blood uric acid level	J:175295
Brdt^{tm1a(EUCOMM)Wtsi}/Brdt^{tm1a(EUCOMM)Wtsi} (C57BL/6-Brdt^{tm1a(EUCOMM)Wtsi})	decreased circulating testosterone level	J:232496
Brf1^tm1Arte/Brf1^tm1Arte (Not Specified)	increased circulating alanine transaminase level	J:285667
	increased circulating alkaline phosphatase level	J:285667
	increased circulating bilirubin level	J:285667
Brms1^{tm1.1(KOMP)Vlcg}/Brms1⁺ (B6N(Cg)-Brms1^{tm1.1(KOMP)Vlcg}/J)	increased circulating chloride level	J:211773
	increased circulating sodium level	J:211773
Brpf3^{tm1a(EUCOMM)Wtsi}/Brpf3⁺ (B6JTyr;B6N-Brpf3^{tm1a(EUCOMM)Wtsi}/Wtsi)	decreased circulating glucose level	J:175295
	decreased circulating potassium level	J:175295
Brs3^tm1Hoh/Brs3^tm1Hoh (involves: 129P2/OlaHsd * C57BL/6J)	abnormal glucose homeostasis	J:44242
	decreased circulating growth hormone level	J:44242
	decreased oxygen consumption	J:44242
	increased circulating insulin level	J:44242
	increased circulating leptin level	J:44242
Brs3^tm1Jfb/Brs3^tm1Jfb (B6.129X1-Brs3^tm1Jfb)	increased circulating insulin level	J:134021
Brs3^tm1Jfb/Brs3^tm1Jfb (B6.129X1-Brs3^tm1Jfb)	increased circulating leptin level	J:134021
Brwd1^em1(IMPC)Tcp/Brwd1^em1(IMPC)Tcp (C57BL/6NCrl-Brwd1^em1(IMPC)Tcp/Tcp)	increased circulating cholesterol level	J:211773
	increased circulating HDL cholesterol level	J:211773
Bsbob3^SPRET/EiJ/? Bsbob4^SPRET/EiJ/? (involves: B6.129P2-Lipc^tm1Unc/J * SPRET/EiJ)	increased circulating cholesterol level	J:90614
Bsbob^SPRET/EiJ/Bsbob^SPRET/EiJ (involves: B6.129P2-Lipc^tm1Unc/J * SPRET/EiJ)	abnormal energy expenditure	J:127206
Bscl2^tm1.1Gliu/Bscl2^tm1.1Gliu Tg(Ddx4-cre)1Dcas/0 (involves: 129 * 129S4/SvJaeSor * FVB/N)	abnormal phospholipid level	J:211072
Bscl2^tm1.1Gliu/Bscl2^tm1.1Gliu Tg(Fabp4-cre)1Rev/0 (involves: 129 * 129S4/SvJaeSor)	increased circulating cholesterol level	J:211072
	increased circulating insulin level	J:211072
Bscl2^tm1.1Lchan/Bscl2^tm1.1Lchan (involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)	abnormal glucose homeostasis	J:183701
	abnormal lipid homeostasis	J:183701
	decreased circulating adiponectin level	J:183701
	decreased circulating free fatty acids level	J:183701
	decreased circulating glucose level	J:183701
	decreased circulating glycerol level	J:183701
	decreased circulating leptin level	J:183701
	decreased circulating triglyceride level	J:183701
	enhanced lipolysis	J:183701
	increased circulating free fatty acids level	J:183701
	increased circulating glucose level	J:183701
	increased circulating glycerol level	J:183701
	increased circulating insulin level	J:183701
	increased circulating triglyceride level	J:183701
	insulin resistance	J:183701
Bscl2^tm1.2Gliu/Bscl2^tm1.2Gliu (involves: 129 * 129S4/SvJaeSor * C57BL/6 * FVB/N)	abnormal phospholipid level	J:211072
	decreased circulating adiponectin level	J:173404
	decreased circulating leptin level	J:173404
	impaired glucose tolerance	J:173404
	increased body temperature	J:173404
	increased circulating cholesterol level	J:211072, J:173404
	increased circulating glucose level	J:173404
	increased circulating insulin level	J:211072, J:173404
	increased circulating triglyceride level	J:173404
	increased liver triglyceride level	J:173404
	insulin resistance	J:173404
Bscl2^{tm1b(EUCOMM)Hmgu}/Bscl2^{tm1b(EUCOMM)Hmgu} (C57BL/6N-Bscl2^{tm1b(EUCOMM)Hmgu}/Ics)	decreased respiratory quotient	J:211773
	improved glucose tolerance	J:211773
	increased circulating alanine transaminase level	J:211773
	increased circulating alkaline phosphatase level	J:211773
	increased circulating aspartate transaminase level	J:211773
	increased circulating calcium level	J:211773
	increased circulating cholesterol level	J:211773
	increased circulating glucose level	J:211773
	increased circulating HDL cholesterol level	J:211773
	increased circulating phosphate level	J:211773
	increased circulating serum albumin level	J:211773
	increased circulating total protein level	J:211773
	increased fasting circulating glucose level	J:211773
Bscl2^{tm1c(EUCOMM)Hmgu}/Bscl2^{tm1c(EUCOMM)Hmgu} Tg(Adipoq-cre)1Evdr/0 (involves: C57BL/6N * FVB/NJ)	abnormal triglyceride level	J:260853
	decreased circulating adiponectin level	J:260853
	decreased respiratory quotient	J:260853
	decreased susceptibility to diet-induced obesity	J:260853
	increased liver triglyceride level	J:260853
	increased respiratory quotient	J:260853
Bscl2^tm1Geno/Bscl2^tm1Geno (B6.129P2-Bscl2^tm1Geno)	abnormal lipid homeostasis	J:200947
	decreased carbon dioxide production	J:200947
	decreased circulating adiponectin level	J:200947
	decreased circulating free fatty acids level	J:200947
	decreased circulating leptin level	J:200947
	decreased circulating triglyceride level	J:200947
	decreased energy expenditure	J:200947
	decreased oxygen consumption	J:200947
	enhanced lipolysis	J:200947
	hyperglycemia	J:200947
	impaired glucose tolerance	J:200947
	increased circulating glucose level	J:200947
	increased circulating HDL cholesterol level	J:200947
	increased circulating insulin level	J:200947
	increased liver triglyceride level	J:200947
	insulin resistance	J:200947
Bsg^tm1Tmu/Bsg^tm1Tmu (involves: 129S2/SvPas)	albuminuria	J:287636
Bsg^tm1Tmu/Bsg^tm1Tmu (involves: 129S2/SvPas)	decreased circulating complement protein level	J:287636
Bsnd^tm1.1Suc/Bsnd^tm1.1Suc (involves: 129S4/SvJae * C57BL/6)	alkalosis	J:175265
	decreased circulating chloride level	J:175265
	decreased circulating sodium level	J:175265
	decreased urine sodium level	J:175265
	hypokalemia	J:175265
	increased circulating bicarbonate level	J:175265
Bsnd^tm1.1Tjj/Bsnd^tm1.1Tjj (involves: 129/Sv * 129X1/SvJ * BALB/cJ * C57BL/6)	dehydration	J:143314
Bsnd^tm1Suc/Bsnd^tm1Suc (involves: 129S4/SvJae * C57BL/6)	alkalosis	J:175265
	decreased circulating chloride level	J:175265
	decreased circulating creatinine level	J:175265
	decreased urine osmolality	J:175265
	hypokalemia	J:175265
	increased circulating aldosterone level	J:175265
	increased circulating bicarbonate level	J:175265
Bsnd^tm1Tjj/Bsnd^tm1Tjj Foxg1^tm1(cre)Skm/Foxg1⁺ (involves: 129/Sv * 129P2/OlaHsd * 129X1/SvJ * C57BL/6)	dehydration	J:143314
Bsx^tm1Tre/Bsx^tm1Tre (B6.129-Bsx^tm1Tre)	abnormal circadian temperature homeostasis	J:122746
Bsx^tm1Tre/Bsx^tm1Tre (B6.129-Bsx^tm1Tre)	decreased respiratory quotient	J:122746
Bsx^tm1Tre/Bsx^tm1Tre Lep^ob/Lep^ob (B6.Cg-Lep^ob Bsx^tm1Tre)	decreased core body temperature	J:122746
	hyperglycemia	J:122746
	increased circulating insulin level	J:122746
Btaf1^m1Fme/Btaf1^{Gt(RRF308)Byg} (involves: 129P2/OlaHsd * C57BL/6 * FVB/N)	edema	J:173663
Btaf1^m1Fme/Btaf1^m1Fme (involves: C57BL/6J * FVB/NJ)	edema	J:173663
Btbd1^{tm1a(KOMP)Wtsi}/Btbd1^{tm1a(KOMP)Wtsi} (C57BL/6N-Btbd1^{tm1a(KOMP)Wtsi}/Wtsi)	decreased circulating total protein level	J:211773
Btbd8^{em1(IMPC)Ccpcz}/Btbd8^{em1(IMPC)Ccpcz} (C57BL/6N-Btbd8^{em1(IMPC)Ccpcz}/Ccpcz)	decreased circulating chloride level	J:211773
Btbd9^{Gt(RRE078)Byg}/Btbd9^{Gt(RRE078)Byg} (involves: 129P2/OlaHsd * C57BL/6)	increased circulating iron level	J:187433
Btbd9^{tm1b(EUCOMM)Wtsi}/Btbd9^{tm1b(EUCOMM)Wtsi} (C57BL/6N-Btbd9^{tm1b(EUCOMM)Wtsi}/Ieg)	increased circulating cholesterol level	J:211773
	increased circulating HDL cholesterol level	J:211773
	increased fasting circulating glucose level	J:211773
Btbd16^{tm2b(EUCOMM)Hmgu}/Btbd16^{tm2b(EUCOMM)Hmgu} (C57BL/6N-Btbd16^{tm2b(EUCOMM)Hmgu}/Bay)	decreased circulating triglyceride level	J:211773
Btc^tm1Dcl/Btc^tm1Dcl Hbegf^tm1Dcl/Hbegf^tm1Dcl (involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)	abnormal atrial thrombosis	J:83820
Btd^tm1Bwol/Btd^tm1Bwol (B6.Cg-Btd^tm1Bwol)	abnormal urine homeostasis	J:168391
Btd^tm1Bwol/Btd^tm1Bwol (B6.Cg-Btd^tm1Bwol)	increased circulating ammonia level	J:168391
Btg2^{tm1b(KOMP)Mbp}/Btg2^{tm1b(KOMP)Mbp} (B6N(Cg)-Btg2^{tm1b(KOMP)Mbp}/2J)	increased fasting circulating glucose level	J:211773
Btk^tm1Wk/Btk^tm1Wk Tec^tm1Welm/Tec^tm1Welm (involves: 129P2/OlaHsd * C57BL/6)	abnormal platelet physiology	J:86448
	decreased platelet aggregation	J:86448
Btnl2^em1Wche/Btnl2^em1Wche (C57BL/6-Btnl2^em1Wche)	abnormal cytokine level	J:321348
Btrc^{tm1b(KOMP)Wtsi}/Btrc^{tm1b(KOMP)Wtsi} (C57BL/6N-Btrc^{tm1b(KOMP)Wtsi}/H)	increased circulating alanine transaminase level	J:211773
Btrc^tm1Paga/Btrc^tm1Paga Fbxw11^tm1Ybn/Fbxw11^tm1Ybn Tg(Vil1-cre/ERT2)23Syr/? (involves: 129S1/Sv * 129S2/SvPas * 129X1/SvJ * C57BL/6 * DBA/2)	increased circulating interleukin-1 beta level	J:206654
Bub1b^tm1Jvd/Bub1b^tm1Jvd (involves: 129S6/SvEvTac * C57BL/6 * FVB)	hypoglycemia	J:234643
	improved glucose tolerance	J:234643
	increased insulin sensitivity	J:234643
Bub1b^tm1Jvd/Bub1b^tm1Jvd Mad2l1bp^tm1.1Itl/Mad2l1bp^tm1.1Itl Speer6-ps1^{Tg(Alb-cre)21Mgn}/Speer6-ps1⁺ (involves: 129S6/SvEvTac * C57BL/6 * FVB)	hypoglycemia	J:234643
	improved glucose tolerance	J:234643
	increased insulin sensitivity	J:234643
Bud23^em2(IMPC)H/Bud23⁺ (C57BL/6N-Bud23^em2(IMPC)H/H)	decreased circulating glucose level	J:211773
Bud23^em2Asil/Bud23^em2Asil Tg(Ckmm-cre)5Khn/0 (involves: C57BL/6 * C57BL/6J * DBA/2)	abnormal enzyme/coenzyme level	J:290738
	abnormal protein level	J:290738
Bves^{tm1.1(KOMP)Vlcg}/Bves^{tm1.1(KOMP)Vlcg} (C57BL/6N-Bves^{tm1.1(KOMP)Vlcg}/Ucd)	improved glucose tolerance	J:211773
Bwt1^HRS/J/Bwt1^HRS/J Find1^C57BLKS/J/Find1^C57BLKS/J (involves: C57BLKS/J * HRS/J)	increased circulating glucose level	J:100832
Bysl^{em1(IMPC)Ccpcz}/Bysl⁺ (C57BL/6N-Bysl^{em1(IMPC)Ccpcz}/Ccpcz)	increased circulating alanine transaminase level	J:211773
Bzw2^{tm1b(KOMP)Mbp}/Bzw2^{tm1b(KOMP)Mbp} (B6N(Cg)-Bzw2^{tm1b(KOMP)Mbp}/J)	decreased circulating cholesterol level	J:211773
	decreased circulating glucose level	J:211773
	decreased circulating iron level	J:211773
	increased circulating alkaline phosphatase level	J:211773
C1d^em1(IMPC)H/C1d⁺ (C57BL/6NTac-C1d^em1(IMPC)H/H)	increased circulating serum albumin level	J:211773
C1galt1^ptl1/C1galt1^ptl1 (C57BL/6-C1galt1^ptl1)	albuminuria	J:115272
	increased blood urea nitrogen level	J:115272
	increased circulating creatinine level	J:115272
	increased urine protein level	J:115272
C1galt1^ptl1/C1galt1^ptl1 Rag1^tm1Bal/Rag1^tm1Bal (involves: 129S4/SvJae * C57BL/6)	increased urine protein level	J:115272
C1galt1^tm1.1Rpmc/C1galt1^tm1.1Rpmc Mgat1^tm2Jxm/Mgat1^tm2Jxm Tg(Zp3-cre)1Gwh/0 (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	abnormal hormone level	J:173879
	decreased circulating testosterone level	J:173879
	increased circulating follicle stimulating hormone level	J:173879
C1galt1^tm1.1Staka/C1galt1^tm1.2Staka Tg(Mx1-cre)1Cgn/0 (involves: C57BL/6 * C57BL/6J * CBA * DBA/2)	increased bleeding time	J:202276
C1qa^{tm1b(EUCOMM)Wtsi}/C1qa^{tm1b(EUCOMM)Wtsi} (B6N(Cg)-C1qa^{tm1b(EUCOMM)Wtsi}/3J)	decreased blood urea nitrogen level	J:211773
	decreased circulating glucose level	J:211773
	increased circulating chloride level	J:211773
C1qc^em1(IMPC)J/C1qc^em1(IMPC)J (C57BL/6NJ-C1qc^em1(IMPC)J/J)	increased circulating alanine transaminase level	J:211773
	increased circulating aspartate transaminase level	J:211773
	increased circulating calcium level	J:211773
	increased circulating total protein level	J:211773
C1ql3^em1(IMPC)H/C1ql3^em1(IMPC)H (C57BL/6NTac-C1ql3^em1(IMPC)H/H)	increased blood urea nitrogen level	J:211773
C1ql4^tm1Lex/C1ql4^tm1Lex (B6.129S5-C1ql4^tm1Lex)	impaired glucose tolerance	J:344722
	increased circulating cholesterol level	J:344722
	increased circulating ketone body level	J:344722
	increased energy expenditure	J:344722
	increased oxygen consumption	J:344722
	increased susceptibility to diet-induced obesity	J:344722
	insulin resistance	J:344722
C1qtnf1^em1(IMPC)Mbp/C1qtnf1^em1(IMPC)Mbp (C57BL/6N-C1qtnf1^em1(IMPC)Mbp/MbpMmucd)	decreased circulating cholesterol level	J:211773
	decreased circulating HDL cholesterol level	J:211773
	decreased circulating triglyceride level	J:211773
C1qtnf1^tm1Lex/C1qtnf1^tm1Lex (B6.129S5-C1qtnf1^tm1Lex)	abnormal lipid homeostasis	J:241403
	decreased circulating free fatty acids level	J:241403
	decreased circulating triglyceride level	J:241403
	decreased liver cholesterol level	J:241403
	decreased liver triglyceride level	J:241403
	decreased susceptibility to diet-induced obesity	J:241403
	impaired glucose tolerance	J:241403
	increased circulating insulin level	J:241403
	increased liver triglyceride level	J:241403
	insulin resistance	J:241403
C1qtnf2^tm1Lex/C1qtnf2^tm1Lex (B6.129S5-C1qtnf2^tm1Lex)	abnormal phospholipid level	J:282612
	decreased cholesterol level	J:282612
	decreased circulating cholesterol level	J:282612
	decreased circulating HDL cholesterol level	J:282612
	decreased circulating LDL cholesterol level	J:282612
	decreased liver cholesterol level	J:282612
	decreased liver triglyceride level	J:282612
	decreased respiratory quotient	J:282612
	enhanced lipolysis	J:282612
	increased carbon dioxide production	J:282612
	increased circulating free fatty acids level	J:282612
	increased circulating glycerol level	J:282612
	increased circulating triglyceride level	J:282612
	increased circulating VLDL cholesterol level	J:282612
	increased circulating VLDL triglyceride level	J:282612
	increased energy expenditure	J:282612
	increased oxygen consumption	J:282612
C1qtnf3^{tm2b(EUCOMM)Wtsi}/C1qtnf3^{tm2b(EUCOMM)Wtsi} (C57BL/6N-C1qtnf3^{tm2b(EUCOMM)Wtsi}/H)	increased circulating alanine transaminase level	J:211773
	increased circulating aspartate transaminase level	J:211773
	increased circulating creatine kinase level	J:211773
C1qtnf4^em1Smoc/C1qtnf4^em1Smoc (C57BL/6J-C1qtnf4^em1Smoc/Smoc)	increased circulating interleukin-6 level	J:302282
	increased circulating interleukin-18 level	J:302282
	increased circulating tumor necrosis factor level	J:302282
C1qtnf5^{tm1(KOMP)Vlcg}/C1qtnf5^{tm1(KOMP)Vlcg} (involves: C57BL/6NTac)	decreased circulating insulin level	J:237401
	decreased fasting circulating glucose level	J:237401
	decreased liver triglyceride level	J:237401
	impaired gluconeogenesis	J:237401
	improved glucose tolerance	J:237401
	increased insulin secretion	J:237401
	increased insulin sensitivity	J:237401
C1qtnf5^{tm1.1(KOMP)Vlcg}/C1qtnf5⁺ (B6N(Cg)-C1qtnf5^{tm1.1(KOMP)Vlcg}/J)	increased fasting circulating glucose level	J:211773
C1qtnf6^tm1Yiw/C1qtnf6^tm1Yiw (B6.129P2-C1qtnf6^tm1Yiw)	abnormal complement protein level	J:227217
C1qtnf6^tm1Yiw/C1qtnf6^tm1Yiw (B6.129P2-C1qtnf6^tm1Yiw)	increased circulating complement protein level	J:227217
C1qtnf7^{tm1(KOMP)Vlcg}/C1qtnf7^{tm1(KOMP)Vlcg} (C57BL/6N-C1qtnf7^{tm1(KOMP)Vlcg})	decreased circulating glucose level	J:244352
	improved glucose tolerance	J:244352
C1qtnf9^{tm1(KOMP)Vlcg}/C1qtnf9^{tm1(KOMP)Vlcg} (C57BL/6-C1qtnf9^{tm1(KOMP)Vlcg})	abnormal circulating hormone level	J:212299
	increased circulating insulin level	J:212299
	increased circulating leptin level	J:212299
	increased insulin secretion	J:212299
	increased liver triglyceride level	J:212299
	insulin resistance	J:212299
C2cd2^em1(IMPC)J/C2cd2^em1(IMPC)J (C57BL/6NJ-C2cd2^em1(IMPC)J/Mmjax)	decreased circulating calcium level	J:211773
C2cd3^em1Brgm/C2cd3^em1Brgm (involves: C57BL/6NCrl * CD-1)	pericardial edema	J:308674
C2cd3^em1Brgm/C2cd3^em1Brgm (involves: C57BL/6J * C57BL/6NCrl * CD-1)	pericardial edema	J:308674
C2cd3^hty/C2cd3^{Gt(AG0177)Wtsi} (involves: 129P2/OlaHsd * C3H/He * C57BL/6)	pericardial edema	J:142506
C2cd3^hty/C2cd3^hty (involves: C3H/He * C57BL/6)	pericardial edema	J:142506
C2cd4b^{em1(IMPC)Wtsi}/C2cd4b^{em1(IMPC)Wtsi} (C57BL/6N-C2cd4b^{em1(IMPC)Wtsi}/Wtsi)	decreased circulating cholesterol level	J:211773
	decreased circulating HDL cholesterol level	J:211773
	decreased circulating triglyceride level	J:211773
	increased circulating bilirubin level	J:211773
C2cd5^{Gt(IST12020E4)Tigm}/C2cd5^{Gt(IST12020E4)Tigm} (C57BL/6N-C2cd5^{Gt(IST12020E4)Tigm})	abnormal glucose homeostasis	J:284780
	decreased circulating adrenaline level	J:284780
	decreased circulating free fatty acids level	J:284780
	decreased core body temperature	J:284780
	decreased energy expenditure	J:284780
	decreased fatty acid oxidation	J:284780
	decreased hepatic glucose production	J:284780
	decreased oxygen consumption	J:284780
	impaired adaptive thermogenesis	J:284780
	impaired glucose tolerance	J:284780
	impaired lipolysis	J:284780
	increased adrenaline level	J:284780
	increased fasting circulating glucose level	J:284780
	increased liver triglyceride level	J:284780
	increased noradrenaline level	J:284780
	increased susceptibility to diet-induced obesity	J:284780
	insulin resistance	J:284780
C3^tm1Crr/C3^tm1Crr (involves: 129S4/SvJae * C57BL/6)	abnormal enzyme/coenzyme level	J:152533
	abnormal tumor necrosis factor level	J:44240
	decreased circulating alanine transaminase level	J:152533
	decreased circulating interleukin-6 level	J:166640, J:152533
	decreased circulating tumor necrosis factor level	J:152533
	increased circulating alanine transaminase level	J:152533
	increased circulating bilirubin level	J:152533
C3^tm1Crr/C3^tm1Crr (B6.129S4-C3^tm1Crr)	abnormal blood homeostasis	J:113463
C3^tm1Crr/C3^tm1Crr (B6;129S4-C3^tm1Crr/J)	decreased circulating free fatty acids level	J:214214
C3^tm1Crr/C3^tm1Crr (involves: 129S4/SvJae)	abnormal blood coagulation	J:44715
C3^tm1Crr/C3^tm1Crr (involves: 129S4/SvJae)	decreased urine albumin level	J:44715
C3^tm1Hrc/C3^tm1Hrc (involves: 129/Sv * C57BL/6)	abnormal energy expenditure	J:60633, J:58966
	abnormal glucose homeostasis	J:60633, J:58966
	abnormal lipid homeostasis	J:60633, J:58966
	decreased circulating glucose level	J:60633, J:58966
	decreased circulating insulin level	J:60633
	decreased circulating leptin level	J:60633, J:58966
	decreased circulating triglyceride level	J:60633
	increased circulating free fatty acids level	J:60633, J:58966
	increased triglyceride level	J:58966
C3^tm1Hrc/C3^tm1Hrc (involves: 129)	abnormal intestinal lipid absorption	J:87945
	decreased circulating insulin level	J:87945
	decreased circulating leptin level	J:87945
	increased circulating free fatty acids level	J:87945
	increased triglyceride level	J:87945
C3^tm1Hrc/C3^tm1Hrc Cd55^tm1Song/Cd55^tm1Song Cr1l^tm1Hmo/Cr1l^tm1Hmo (involves: 129/Sv * 129S6/SvEvTac * 129X1/SvJ)	abnormal platelet physiology	J:138410
C3^tm1Hrc/C3^tm1Hrc Cd55^tm1Song/Cd55^tm1Song Cr1l^tm1Hmo/Cr1l^tm1Hmo Vsig4^tm1Gne/Vsig4^tm1Gne (involves: 129/Sv * 129S6/SvEvTac * 129X1/SvJ * C57BL/6N)	abnormal platelet physiology	J:138410
C3^tm1Hrc/C3^tm1Hrc Lep^ob/Lep^ob (involves: 129 * C57BL/6)	abnormal energy expenditure	J:80546
	abnormal glucose homeostasis	J:80546
	abnormal lipid homeostasis	J:80546
	abnormal oxygen consumption	J:80546
	decreased circulating insulin level	J:80546
	increased circulating free fatty acids level	J:80546
	increased triglyceride level	J:80546
C3ar1^tm1Cge/C3ar1^tm1Cge (involves: 129S4/SvJae * C57BL/6)	decreased circulating interleukin-6 level	J:166640
C3ar1^tm1Cge/C3ar1^tm1Cge (B6.129S4(C)-C3ar1^tm1Cge)	decreased circulating free fatty acids level	J:214214
C3ar1^tm1Cge/C3ar1^tm1Cge (B6.129S4(C)-C3ar1^tm1Cge)	decreased circulating phospholipid level	J:214214
C3ar1^tm1Cge/C3ar1^tm1Cge C5ar1^tm1Cge/C5ar1^tm1Cge (B6.Cg-C3ar1^tm1Cge C5ar1^tm1Cge)	decreased circulating free fatty acids level	J:214214
	decreased circulating phospholipid level	J:214214
C3ar1^tm1Raw/C3ar1^tm1Raw (involves: 129X1/SvJ * C57BL/6)	increased circulating interleukin-1 beta level	J:68807
C3ar1^tm1Raw/C3ar1^tm1Raw (B6.129X1(B6)-C3ar1^tm1Raw)	abnormal interleukin level	J:80071
C3ar1^tm1Raw/C3ar1^tm1Raw (B6.129X1(B6)-C3ar1^tm1Raw)	increased circulating interleukin-1 beta level	J:93791
C4b^tm1Crr/C4b^tm1Crr (involves: 129S4/SvJae)	abnormal blood coagulation	J:44715
C4bp^{tm1b(KOMP)Wtsi}/C4bp^{tm1b(KOMP)Wtsi} (C57BL/6N-C4bp^{tm1b(KOMP)Wtsi}/Ieg)	increased circulating cholesterol level	J:211773
	increased circulating HDL cholesterol level	J:211773
C4bp^tm1Raw/C4bp^tm1Raw (B6.129-C4bp^tm1Raw)	increased circulating interleukin-6 level	J:244020
C5ar1^tm1Cge/C5ar1^tm1Cge (involves: 129S4/SvJae * C57BL/6)	decreased circulating interleukin-6 level	J:166640
C5ar1^tm1Cge/C5ar1^tm1Cge (B6.129S4(Cg)-C5ar1^tm1Cge)	decreased circulating free fatty acids level	J:214214
C5ar2^tm1Gdy/C5ar2^tm1Gdy (involves: 129 * C57BL/6)	abnormal glucose homeostasis	J:123294
	increased circulating alanine transaminase level	J:152533
	increased circulating bilirubin level	J:152533
	increased circulating insulin level	J:123294
	increased fatty acid oxidation	J:123294
C9^{tm1.1(KOMP)Vlcg}/C9^{tm1.1(KOMP)Vlcg} (B6N(Cg)-C9^{tm1.1(KOMP)Vlcg}/J)	increased circulating sodium level	J:211773
C9orf72^{tm1.1(KOMP)Mbp}/C9orf72^{tm1.1(KOMP)Mbp} (C57BL/6N-C9orf72^{tm1.1(KOMP)Mbp}/Ucd)	increased circulating alkaline phosphatase level	J:211773
C9orf72^tm1.1Eggn/C9orf72⁺ (involves: C57BL/6 * C57BL/6N)	abnormal circulating interleukin level	J:240357
C9orf72^tm1.1Eggn/C9orf72⁺ (involves: C57BL/6 * C57BL/6N)	decreased circulating interleukin-2 level	J:240357
C9orf72^tm1.1Eggn/C9orf72^tm1.1Eggn (involves: C57BL/6 * C57BL/6N)	abnormal circulating cytokine level	J:240357
C9orf72^tm1Eggn/C9orf72^tm1Eggn (involves: C57BL/6 * C57BL/6N)	abnormal circulating cytokine level	J:240357
CA001/CA001⁺ (C3HeB/FeJ-CA001)	decreased circulating calcium level	J:163957
cab/cab (STOCK Cacna1s^mdg)	abnormal glucose homeostasis	J:7797
	cyanosis	J:6195
	decreased glycogen level	J:6195, J:7797
	hypoglycemia	J:7797
Cabcoco1^{tm1a(KOMP)Wtsi}/Cabcoco1^{tm1a(KOMP)Wtsi} (C57BL/6N-Cabcoco1^{tm1a(KOMP)Wtsi}/MbpMmucd)	increased circulating alanine transaminase level	J:211773
	increased circulating aspartate transaminase level	J:211773
Cabp1^{tm1b(EUCOMM)Wtsi}/Cabp1^{tm1b(EUCOMM)Wtsi} (C57BL/6N-Cabp1^{tm1b(EUCOMM)Wtsi}/H)	decreased circulating fructosamine level	J:211773
Cabp5^{tm1b(KOMP)Wtsi}/Cabp5^{tm1b(KOMP)Wtsi} (C57BL/6N-Cabp5^{tm1b(KOMP)Wtsi}/BayMmucd)	impaired glucose tolerance	J:211773
Cacfd1^tm1Lex/Cacfd1^tm1Lex (B6;129S5-Cacfd1^tm1Lex/Mmucd)	increased circulating cholesterol level	J:171883
Cacfd1^tm1Lex/Cacfd1^tm1Lex (B6;129S5-Cacfd1^tm1Lex/Mmucd)	increased circulating triglyceride level	J:171883
Cachd1^em1(IMPC)J/Cachd1⁺ (C57BL/6NJ-Cachd1^em1(IMPC)J/J)	increased circulating calcium level	J:211773
Cacna1a^tg-rol/Cacna1a⁺ (involves: C3Hf/Nga * C57BL/6 * SIII)	abnormal glucose homeostasis	J:3611
Cacna1a^tg-rol/Cacna1a^tg-rol (involves: C57BL/6 * SIII)	decreased glutamic acid level	J:6553
	increased glycine level	J:6553
	increased taurine level	J:6553
Cacna1a^tg-rol/Cacna1a^tg-rol (involves: C3Hf/Nga * C57BL/6 * SIII)	abnormal glucose homeostasis	J:3611
	increased noradrenaline level	J:164122
Cacna1b^{tm1b(KOMP)Wtsi}/Cacna1b^{tm1b(KOMP)Wtsi} (C57BL/6N-Cacna1b^{tm1b(KOMP)Wtsi}/H)	decreased fasting circulating glucose level	J:211773
Cacna1b^tm1Ksw/Cacna1b^tm1Ksw (involves: C57BL/6 * CBA)	abnormal lipid level	J:105212
	decreased circulating glucagon level	J:105212
	decreased circulating insulin level	J:105212
	decreased circulating leptin level	J:105212
	decreased circulating triglyceride level	J:105212
	decreased susceptibility to diet-induced obesity	J:105212
	improved glucose tolerance	J:105212
Cacna1c^tm2.1Wac/Cacna1c^tm2.1Wac (involves: C57BL/6)	abnormal calcium ion homeostasis	J:216746
Cacna1c^tm3Hfm/Cacna1c^tm3Hfm Tg(Ins2-cre)25Mgn/0 (involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * DBA)	decreased circulating insulin level	J:84919
	decreased insulin secretion	J:84919
	impaired glucose tolerance	J:84919
	increased circulating glucose level	J:84919
Cacna1d^tm1Hssh/Cacna1d^tm1Hssh (involves: 129S4/SvJae * C57BL/6J)	abnormal calcium ion homeostasis	J:72316
	decreased circulating insulin level	J:72316
	decreased insulin secretion	J:72316
	impaired glucose tolerance	J:72316
	increased insulin sensitivity	J:72316
Cacna1d^tm1Jst/Cacna1d^tm1Jst (involves: 129S7/SvEvBrd * C57BL/6J)	abnormal calcium ion homeostasis	J:63515
Cacna1e^tm1.1Tsch/Cacna1e^tm1.1Tsch (involves: C57BL/6)	abnormal glucagon secretion	J:95377
	decreased circulating glucagon level	J:95377
	decreased insulin secretion	J:95377
	impaired glucose tolerance	J:95377
	increased circulating glucose level	J:95377
Cacna1e^tm1.1Tsch/Cacna1e^tm1.1Tsch (involves: BALB/cJ * C57BL/6)	decreased glucagon secretion	J:101873
	decreased insulin secretion	J:95636
	hyperglycemia	J:95636
	impaired glucose tolerance	J:95636
	increased circulating glucose level	J:101873
Cacna1f^{tm1.1(KOMP)Vlcg}/Y (C57BL/6N-Cacna1f^{tm1.1(KOMP)Vlcg}/Ucd)	increased circulating creatinine level	J:211773
Cacna1f^{tm1.1(KOMP)Vlcg}/Cacna1f^{tm1.1(KOMP)Vlcg} (C57BL/6N-Cacna1f^{tm1.1(KOMP)Vlcg}/Ucd)	increased circulating insulin level	J:211773
Cacna1g^tm1Dgen/Cacna1g^tm1Dgen (involves: 129/Sv * C57BL/6)	decreased susceptibility to diet-induced obesity	J:150571
Cacna1i^{tm1b(KOMP)Wtsi}/Cacna1i^{tm1b(KOMP)Wtsi} (C57BL/6N-Cacna1i^{tm1b(KOMP)Wtsi}/Bay)	increased circulating chloride level	J:211773
Cacna1s^mdg/Cacna1s^mdg (involves: STOCK T/t⁴)	edema	J:4466, J:14970
Cacna1s^mdg/Cacna1s^mdg (involves: STOCK T/t⁴)	extremity edema	J:4466, J:14970
Cacna1s^{tm1.1(KOMP)Vlcg}/Cacna1s⁺ (B6N(Cg)-Cacna1s^{tm1.1(KOMP)Vlcg}/J)	decreased circulating glucose level	J:211773
Cacna1s^{tm1.1(KOMP)Vlcg}/Cacna1s^{tm1.1(KOMP)Vlcg} (B6N(Cg)-Cacna1s^{tm1.1(KOMP)Vlcg}/J)	cyanosis	J:211773
	edema	J:211773
Cacna1s^tm1.1Arte/Cacna1s^tm1.1Arte (involves: C57BL/6N)	abnormal calcium ion homeostasis	J:235534
Cacna2d1^em1(IMPC)Mbp/Cacna2d1^em1(IMPC)Mbp (C57BL/6N-Cacna2d1^em1(IMPC)Mbp/MbpMmucd)	impaired glucose tolerance	J:211773
	increased circulating alkaline phosphatase level	J:211773
	increased fasting circulating glucose level	J:211773
Cacna2d2^tm1Svi/Cacna2d2^tm1Svi (involves: 129S1/Sv * C57BL/6J)	dehydration	J:92396
Cacna2d3^{tm1b(KOMP)Wtsi}/Cacna2d3⁺ (B6N(Cg)-Cacna2d3^{tm1b(KOMP)Wtsi}/J)	decreased circulating glucose level	J:211773
	increased circulating sodium level	J:211773
Cacnb2^{tm1.1(KOMP)Vlcg}/Cacnb2^{tm1.1(KOMP)Vlcg} (C57BL/6N-Cacnb2^{tm1.1(KOMP)Vlcg}/Tcp)	impaired glucose tolerance	J:211773
	increased circulating glucose level	J:211773
Cacnb2^tm1.1Mfre/Cacnb2^tm1.1Mfre Tg(CAG-Bgeo/GFP)21Lbe/? (involves: 129S1/Sv * 129S4/SvJae * 129X1/SvJ * C57BL/6N * FVB/N)	pericardial effusion	J:126506
Cacnb3^tm1Acv/Cacnb3^tm1Acv (involves: 129S1/Sv * 129X1/SvJ)	abnormal calcium ion homeostasis	J:86381
Cacng3^tm1Dgen/Cacng3^tm1Dgen (involves: 129P2/OlaHsd * C57BL/6)	increased circulating cholesterol level	J:101679
	increased circulating HDL cholesterol level	J:101679
Cacybp^{tm1b(EUCOMM)Wtsi}/Cacybp⁺ (C57BL/6N-Cacybp^{tm1b(EUCOMM)Wtsi}/Tcp)	increased circulating alanine transaminase level	J:211773
Cadps2^{em1(IMPC)Rbrc}/Cadps2^{em1(IMPC)Rbrc} (C57BL/6NJcl-Cadps2^{em1(IMPC)Rbrc}/Rbrc)	abnormal circulating alkaline phosphatase level	J:211773
	increased circulating amylase level	J:211773
Cadps2^tm1Bros/Cadps2^tm1Bros (Not Specified)	decreased insulin secretion	J:131014
	impaired glucose tolerance	J:131014
	increased glucagon secretion	J:131014
	increased insulin sensitivity	J:131014
Cadps^tm1Bros/Cadps⁺ Cadps2^tm1Bros/Cadps2^tm1Bros (Not Specified)	abnormal glucose homeostasis	J:131014
	abnormal hormone level	J:131014
	decreased insulin secretion	J:131014
	impaired glucose tolerance	J:131014
	increased glucagon secretion	J:131014
	increased insulin sensitivity	J:131014
Calca^tm1Hku/Calca^tm1Hku (involves: 129S6/SvEvTac * C57BL/6)	abnormal urine catecholamine level	J:80225
Calca^tm1Rfg/Calca^tm1Rfg (involves: 129S7/SvEvBrd * C57BL/6)	abnormal circulating calcium level	J:80827
	abnormal urine homeostasis	J:80827
Calca^tm1Rfg/Calca^tm1Rfg (involves: Black Swiss)	abnormal circulating magnesium level	J:80827
Calcoco1^em1(IMPC)H/Calcoco1^em1(IMPC)H (C57BL/6N-Calcoco1^em1(IMPC)H/H)	decreased circulating total protein level	J:211773
Calcr^{em1(IMPC)Rbrc}/Calcr^{em1(IMPC)Rbrc} (C57BL/6NJcl-Calcr^{em1(IMPC)Rbrc}/Rbrc)	abnormal circulating alkaline phosphatase level	J:211773
	abnormal circulating calcium level	J:211773
Calcr^tm1Rda/Calcr^tm1Rda Tg(CMV-cre)1Cgn/0 (B6.Cg-Calcr^tm1Rda Tg(CMV-cre)1Cgn)	abnormal circulating calcium level	J:150982
	abnormal circulating hormone level	J:150982
Calcrl^tm1Kmca/Calcrl^tm1Kmca (129S6/SvEvTac-Calcrl^tm1Kmca)	edema	J:130930
	hydrops fetalis	J:106927
	intestinal edema	J:106927
	lymphedema	J:130930
Calcrl^tm1Kmca/Calcrl^tm2Kmca Tg(Tek-cre)12Flv/0 (involves: 129P2/OlaHsd * 129S6/SvEvTac * C3H * C57BL/6 * C57BL/6J)	edema	J:130930
Calr^tm1Mlk/Calr^tm1Mlk (involves: 129S4/SvJae * C57BL/6J)	abnormal calcium ion homeostasis	J:53466
Calr^tm1Mlk/Calr^tm1Mlk (involves: 129S4/SvJae * C57BL/6J)	increased cardiac muscle glycogen level	J:119647
Camk1^{tm2b(EUCOMM)Hmgu}/Camk1^{tm2b(EUCOMM)Hmgu} (C57BL/6N-Camk1^{tm2b(EUCOMM)Hmgu}/Bay)	decreased circulating alanine transaminase level	J:211773
	decreased fasting circulating glucose level	J:211773
Camk1d^em1(IMPC)Mbp/Camk1d^em1(IMPC)Mbp (C57BL/6NCrl-Camk1d^em1(IMPC)Mbp/Mmucd)	increased blood urea nitrogen level	J:211773
Camk2b^{tm1b(EUCOMM)Hmgu}/Camk2b⁺ (C57BL/6N-Camk2b^{tm1b(EUCOMM)Hmgu}/Ieg)	improved glucose tolerance	J:211773
Camkk2^tm1.1Arm/Camkk2^tm1.1Arm (involves: C57BL/6)	abnormal glucose homeostasis	J:136219
	decreased circulating leptin level	J:136219
	decreased susceptibility to diet-induced obesity	J:136219
	improved glucose tolerance	J:136219
	increased body temperature	J:136219
Camkmt^{tm1b(EUCOMM)Wtsi}/Camkmt^{tm1b(EUCOMM)Wtsi} (C57BL/6N-Camkmt^{tm1b(EUCOMM)Wtsi}/Wtsi)	increased blood urea nitrogen level	J:211773
	increased circulating creatinine level	J:211773
	increased circulating sodium level	J:211773
Camsap1^em1(IMPC)J/Camsap1⁺ (C57BL/6NJ-Camsap1^em1(IMPC)J/Mmjax)	increased circulating phosphate level	J:211773
Camsap3^{tm1a(EUCOMM)Wtsi}/Camsap3⁺ (C57BL/6N-Camsap3^{tm1a(EUCOMM)Wtsi}/Wtsi)	decreased circulating cholesterol level	J:211773
	decreased circulating HDL cholesterol level	J:211773
Camsap3^{tm1a(EUCOMM)Wtsi}/Camsap3^{tm1a(EUCOMM)Wtsi} (C57BL/6N-Camsap3^{tm1a(EUCOMM)Wtsi}/Wtsi)	decreased blood urea nitrogen level	J:211773
	decreased circulating cholesterol level	J:211773
	decreased circulating glucose level	J:211773
	decreased circulating HDL cholesterol level	J:211773
	increased circulating alkaline phosphatase level	J:211773
	increased circulating chloride level	J:211773
	increased circulating glycerol level	J:211773
	increased circulating sodium level	J:211773
	increased circulating thyroxine level	J:211773
Cand1^em1(IMPC)Mbp/Cand1⁺ (C57BL/6NCrl-Cand1^em1(IMPC)Mbp/Mmucd)	edema	J:211773
	increased fasting circulating glucose level	J:211773
Cand1^em1(IMPC)Mbp/Cand1^em1(IMPC)Mbp (C57BL/6NCrl-Cand1^em1(IMPC)Mbp/Mmucd)	edema	J:211773
Cand2^{tm1a(EUCOMM)Wtsi}/Cand2^{tm1a(EUCOMM)Wtsi} (C57BL/6N-Cand2^{tm1a(EUCOMM)Wtsi}/Wtsi)	decreased circulating iron level	J:211773
	decreased circulating thyroxine level	J:211773
Candy/Candy (involves: C3H/HeH * C57BL/6J)	hyperglycemia	J:169366
Candy/Candy (involves: C3H/HeH * C57BL/6J)	increased urine glucose level	J:169366
Candy2/Candy2 (involves: C3H/HeH * C57BL/6J)	hyperglycemia	J:169366
Candy2/Candy2 (involves: C3H/HeH * C57BL/6J)	increased urine glucose level	J:169366
Candy3/Candy3 (involves: C3H/HeH * C57BL/6J)	hyperglycemia	J:169366
Candy3/Candy3 (involves: C3H/HeH * C57BL/6J)	increased urine glucose level	J:169366
Candy4/Candy4 (involves: C3H/HeH * C57BL/6J)	hyperglycemia	J:169366
Candy4/Candy4 (involves: C3H/HeH * C57BL/6J)	increased urine glucose level	J:169366
Candy5/Candy5 (involves: C3H/HeH * C57BL/6J)	hyperglycemia	J:163957
Candy5/Candy5 (involves: C3H/HeH * C57BL/6J)	increased circulating phosphate level	J:163957
Cant1^{tm1b(EUCOMM)Hmgu}/Cant1⁺ (C57BL/6N-Cant1^{tm1b(EUCOMM)Hmgu}/Ieg)	increased circulating alkaline phosphatase level	J:211773
	increased circulating amylase level	J:211773
	increased circulating lipase level	J:211773
Canx^{em1(IMPC)Ccpcz}/Canx⁺ (C57BL/6NCrl-Canx^{em1(IMPC)Ccpcz}/Ccpcz)	increased circulating creatine kinase level	J:211773
Cap2^{tm1a(EUCOMM)Wtsi}/Cap2^{tm1a(EUCOMM)Wtsi} (C57BL/6N-Cap2^{tm1a(EUCOMM)Wtsi}/Ieg)	decreased circulating triglyceride level	J:165965
Capn1^tm1.1Arte/Capn1^tm1.1Arte Tg(Pf4-icre)Q3Rsko/0 (involves: C57BL/6)	abnormal platelet physiology	J:189100
Capn1^tm1Ahc/Capn1^tm1Ahc (involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)	abnormal blood coagulation	J:67798
	abnormal platelet dense granule physiology	J:67798
	abnormal platelet physiology	J:67798
	decreased platelet aggregation	J:67798
Capn3^tm1.1Hiso/Capn3^tm1.1Hiso (B6.129P2-Capn3^tm1.1Hiso)	increased circulating creatine kinase level	J:163711
Capn10^{tm1b(EUCOMM)Wtsi}/Capn10^{tm1b(EUCOMM)Wtsi} (C57BL/6N-Capn10^{tm1b(EUCOMM)Wtsi}/Ics)	abnormal cholesterol homeostasis	J:211773
	increased circulating bilirubin level	J:211773
	increased circulating phosphate level	J:211773
Capn11^{tm1b(EUCOMM)Wtsi}/Capn11^{tm1b(EUCOMM)Wtsi} (C57BL/6N-Capn11^{tm1b(EUCOMM)Wtsi}/Wtsi)	impaired glucose tolerance	J:211773
Capn12^{tm1b(EUCOMM)Hmgu}/Capn12^{tm1b(EUCOMM)Hmgu} (C57BL/6N-Capn12^{tm1b(EUCOMM)Hmgu}/Ieg)	increased circulating amylase level	J:211773
	increased circulating glucose level	J:211773
	increased circulating lipase level	J:211773
Caprin1^tm1Mtok/Caprin1^tm1Mtok (involves: 129S6/SvEvTac * C57BL/6)	cyanosis	J:164650
Capza2^{tm1b(KOMP)Wtsi}/Capza2⁺ (C57BL/6N-Capza2^{tm1b(KOMP)Wtsi}/Wtsi)	increased circulating creatinine level	J:211773
Car2ⁿ/Car2ⁿ (involves: C57BL/6J * DBA/2J)	decreased circulating bicarbonate level	J:19268
	renal tubular acidosis	J:19268
	respiratory acidosis	J:102478
Car2^{tm1(KOMP)Vlcg}/Car2^{tm1(KOMP)Vlcg} (involves: C57BL/6 * C57BL/6NTac)	abnormal blood pH regulation	J:216402
	decreased circulating bicarbonate level	J:216402
	hypokalemia	J:216402
	increased urine pH	J:216402
	metabolic acidosis	J:216402
	renal tubular acidosis	J:216402
Car4^{tm1b(EUCOMM)Wtsi}/Car4⁺ (C57BL/6N-Car4^{tm1b(EUCOMM)Wtsi}/Ieg)	increased circulating calcium level	J:211773
Car5a^tm1Sly/Car5a^tm1Sly (involves: 129X1/SvJ * C57BL/6)	abnormal homeostasis	J:196135
Car5a^tm1Sly/Car5a^tm1Sly (involves: 129X1/SvJ * C57BL/6)	increased circulating ammonia level	J:196135
Car5a^tm1Sly/Car5a^tm1Sly Car5b^tm1Sly/Y (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	decreased circulating glucose level	J:196135
	increased circulating ammonia level	J:196135
Car5a^tm1Sly/Car5a^tm1Sly Car5b^tm1Sly/Car5b^tm1Sly (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	decreased circulating glucose level	J:196135
	increased circulating ammonia level	J:196135
Car7^{tm1b(KOMP)Wtsi}/Car7⁺ (B6N(Cg)-Car7^{tm1b(KOMP)Wtsi}/J)	increased circulating free fatty acids level	J:211773
	increased circulating sodium level	J:211773
Car13^{tm1b(KOMP)Wtsi}/Car13^{tm1b(KOMP)Wtsi} (C57BL/6N-Car13^{tm1b(KOMP)Wtsi}/Bay)	impaired glucose tolerance	J:211773
Car14^{tm1b(EUCOMM)Hmgu}/Car14^{tm1b(EUCOMM)Hmgu} (C57BL/6N-Car14^{tm1b(EUCOMM)Hmgu}/Ieg)	decreased respiratory quotient	J:211773
Car14^tm1Sly/Car14^tm1Sly Car4^tm1Sly/Car4^tm1Sly (involves: 129S1/Sv * C57BL/6)	abnormal pH regulation	J:103742
Card9^tm1Xlin/Card9^tm1Xlin (involves: 129/Sv * C57BL/6)	abnormal cytokine level	J:117799
Card11^{em1(IMPC)Ccpcz}/Card11^{em1(IMPC)Ccpcz} (C57BL/6NCrl-Card11^{em1(IMPC)Ccpcz}/Ccpcz)	decreased circulating alkaline phosphatase level	J:211773
Card11^tm1Xav/Card11^tm1Xav (involves: 129 * C57BL/6)	decreased circulating interleukin-4 level	J:132226
Card11^tm1Xav/Card11^tm1Xav (involves: 129 * C57BL/6)	decreased circulating interleukin-5 level	J:132226
Carf^{tm1.1(KOMP)Vlcg}/Carf^{tm1.1(KOMP)Vlcg} (B6N(Cg)-Carf^{tm1.1(KOMP)Vlcg}/J)	increased circulating chloride level	J:211773
	increased circulating sodium level	J:211773
Carmil2^{tm1b(KOMP)Mbp}/Carmil2^{tm1b(KOMP)Mbp} (C57BL/6N-Carmil2^{tm1b(KOMP)Mbp}/Orl)	abnormal cholesterol homeostasis	J:211773
	increased circulating glucose level	J:211773
Cartpt^tm1Amgn/Cartpt^tm1Amgn (involves: 129X1/SvJ * Black Swiss)	decreased insulin secretion	J:103911
	impaired glucose tolerance	J:103911
	increased circulating insulin level	J:103911
Cartpt^tm1Hmh/Cartpt⁺ (involves: 129P2/OlaHsd * C57BL/6)	increased susceptibility to diet-induced obesity	J:97913
Cartpt^tm1Hmh/Cartpt^tm1Hmh (involves: 129P2/OlaHsd * C57BL/6)	increased susceptibility to diet-induced obesity	J:97913
Casc3^{tm1.1(KOMP)Vlcg}/Casc3⁺ (C57BL/6N-Casc3^{tm1.1(KOMP)Vlcg}/Ucd)	decreased blood urea nitrogen level	J:211773
Caskin1^tm1.1Tayk/Caskin1^tm1.1Tayk (involves: C57BL/6N * C57BL/6NCrlj * CBA/JNCrlj)	decreased body temperature	J:279657
Caskin1^{tm1b(KOMP)Wtsi}/Caskin1⁺ (C57BL/6N-Caskin1^{tm1b(KOMP)Wtsi}/Ucd)	increased respiratory quotient	J:211773
Casp1^tm1Flv/Casp1^tm1Flv Casp4^del/Casp4^del (involves: 129S2/SvPas * C57BL/6)	decreased circulating interferon-gamma level	J:115310
Casp1^tm1Sesh/Casp1^tm1Sesh Casp4^del/Casp4^del (involves: 129S2/SvPas * C57BL/6)	decreased circulating interleukin-1 alpha level	J:22964
	decreased circulating interleukin-1 beta level	J:22964
	decreased circulating interleukin-6 level	J:22964
	decreased circulating tumor necrosis factor level	J:22964
Casp1^tm1Sesh/Casp1^tm1Sesh Casp4^del/Casp4^del (B6.129S2(NOD)-Casp1^tm1Sesh Casp4^del)	decreased circulating interleukin-1 alpha level	J:193522
	decreased circulating interleukin-1 beta level	J:193522
	decreased circulating interleukin-18 level	J:193522
Casp1^tm1Sesh/Casp1^tm1Sesh Casp4^del/Casp4^del Tg(Casp4)#Gne/0 (involves: 129S2/SvPas * C57BL/6 * NOD/ShiLtJ)	decreased circulating interleukin-1 beta level	J:193522
	decreased circulating interleukin-18 level	J:193522
Casp1^tm1Sesh/Casp1^tm1Sesh Nlrp1a^Neut1/Nlrp1a^Neut1 (involves: 129S2/SvPas * C57BL/6)	increased circulating interleukin-18 level	J:191055
Casp4^tm1.1Vmd/Casp4^tm1.1Vmd (involves: C57BL/6)	decreased circulating interleukin-1 alpha level	J:193522
	decreased circulating interleukin-1 beta level	J:193522
	decreased circulating interleukin-18 level	J:193522
Casp4^{tm1b(KOMP)Wtsi}/Casp4^{tm1b(KOMP)Wtsi} (C57BL/6N-Casp4^{tm1b(KOMP)Wtsi}/Ucd)	increased circulating bilirubin level	J:211773
	increased circulating calcium level	J:211773
	increased circulating glucose level	J:211773
	increased circulating insulin level	J:211773
Casp4^tm1Yuan/Casp4^tm1Yuan (involves: 129S4/SvJae * C57BL/6J * DBA/2)	decreased circulating interleukin-1 alpha level	J:46167
	decreased circulating interleukin-1 beta level	J:46167
Casp8^em1Hbz/Casp8^em1Hbz (involves: C57BL/6)	decreased circulating alanine transaminase level	J:342732
Casp8^em1Hbz/Casp8^em1Hbz (involves: C57BL/6)	decreased circulating aspartate transaminase level	J:342732
Casp8^tm1Clie/Casp8^tm1Clie Ikbkg^tm1.1Chtr/Ikbkg^tm1.1Chtr Tg(Alb1-cre)7Gsc/0 (involves: 129P2/OlaHsd * C57BL/6 * FVB/N)	abnormal circulating enzyme level	J:218665
	increased bile salt level	J:218665
	increased circulating alkaline phosphatase level	J:218665
	increased circulating bilirubin level	J:218665
Casp8^tm1Clie/Casp8^tm1Clie Map3k7^tm1Aki/Map3k7^tm1Aki Tg(Alb1-cre)7Gsc/0 (involves: 129P2/OlaHsd * FVB/N)	increased circulating alanine transaminase level	J:160521
	increased circulating aspartate transaminase level	J:160521
	increased circulating bilirubin level	J:160521
Casp8^tm1Clie/Casp8^tm1Clie Tg(Alb1-cre)7Gsc/0 (involves: 129P2/OlaHsd * C57BL/6 * FVB/N)	abnormal circulating enzyme level	J:218665
Casp8^tm1Hed/Casp8^tm1Hed Tg(KRT14-cre)1Efu/0 (Not Specified)	epidermal spongiosis	J:167299
	impaired skin barrier function	J:167299
	skin edema	J:167299
Casp8^tm1Syon/Casp8^tm1Syon (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	hemopericardium	J:103506
Casp8^tm1Syon/Casp8^tm1Syon Tg(Myh7-BVp35-EGFP)#Ksa/? (involves: 129S1/Sv * 129X1/SvJ * C3H * C57BL/6)	hemopericardium	J:102279
Casp8^tm1Wll/Casp8^tm1.1Yuan Tg(Tie1-cre)9Ref/0 (involves: 129S1/Sv * 129X1/SvJ * MF1)	pericardial edema	J:92722
Casp12^tm1Dwni/Casp12^tm1Dwni (involves: 129S1/SvImJ * C57BL/6)	increased circulating interleukin-18 level	J:144912
Casp14^{em1(IMPC)Ccpcz}/Casp14^{em1(IMPC)Ccpcz} (C57BL/6N-Casp14^{em1(IMPC)Ccpcz}/Ccpcz)	increased circulating potassium level	J:211773
Casp14^tm1Wdec/Casp14^tm1Wdec (Not Specified)	dehydration	J:129490
Casp14^tm1Wdec/Casp14^tm1Wdec (Not Specified)	impaired skin barrier function	J:129490
Casq1^{tm1b(EUCOMM)Wtsi}/Casq1^{tm1b(EUCOMM)Wtsi} (C57BL/6N-Casq1^{tm1b(EUCOMM)Wtsi}/Ics)	abnormal cholesterol homeostasis	J:211773
	decreased circulating creatinine level	J:211773
	increased circulating total protein level	J:211773
Casq2^{tm1b(KOMP)Wtsi}/Casq2^{tm1b(KOMP)Wtsi} (C57BL/6N-Casq2^{tm1b(KOMP)Wtsi}/Ucd)	edema	J:211773
Casr^BCH002/Casr^BCH002 (C3HeB/FeJ-Casr^BCH002)	decreased circulating phosphate level	J:183993
Casr^BCH002/Casr^BCH002 (C3HeB/FeJ-Casr^BCH002)	increased circulating calcium level	J:183993
Casr^BCH003/Casr^BCH003 (C3HeB/FeJ-Casr^BCH003)	increased circulating calcium level	J:183993
Casr^BCH004/Casr^BCH004 (C3HeB/FeJ-Casr^BCH004)	increased circulating calcium level	J:183993
Casr^BCH007/Casr^BCH007 (C3HeB/FeJ-Casr^BCH007)	increased circulating calcium level	J:183993
Casr^BCH011/Casr^BCH011 (C3HeB/FeJ-Casr^BCH011)	increased circulating calcium level	J:183993
Casr^BCH013/Casr^BCH013 (C3HeB/FeJ-Casr^BCH013)	increased circulating calcium level	J:183993
Casr^Nuf/Casr⁺ (either: (involves: 102/El * 102/H * C3H/He) or (involves: 102/El * C3H/He * C3H/HeH))	decreased circulating calcium level	J:92612
	decreased circulating parathyroid hormone level	J:92612
	increased circulating phosphate level	J:92612
Casr^Nuf/Casr^Nuf (involves: 102/El * C3H/He)	calcinosis	J:92612
	decreased circulating calcium level	J:92612
	decreased circulating parathyroid hormone level	J:92612
	decreased urine calcium level	J:92612
	decreased urine phosphate level	J:92612
	increased circulating phosphate level	J:92612
Casr^{tm1b(KOMP)Mbp}/Casr⁺ (C57BL/6N-Casr^{tm1b(KOMP)Mbp}/Tcp)	edema	J:211773
	increased circulating calcium level	J:211773
	increased circulating phosphate level	J:211773
Casr^tm1Ces/Casr⁺ (involves: 129X1/SvJ * Black Swiss)	decreased urine calcium level	J:29900
	increased circulating calcium level	J:29900
	increased circulating magnesium level	J:29900
	increased circulating parathyroid hormone level	J:29900
Casr^tm1Ces/Casr^tm1Ces (involves: 129X1/SvJ * Black Swiss)	decreased circulating phosphate level	J:71056
	decreased urine calcium level	J:29900
	dehydration	J:29900
	increased circulating calcium level	J:29900
	increased circulating magnesium level	J:29900
	increased circulating parathyroid hormone level	J:29900
Casr^tm1Wch/Casr⁺ Tg(PTH-cre)4167Slib/0 (involves: 129S4/SvJae * C57BL/6 * FVB)	increased circulating calcium level	J:180651
	increased circulating parathyroid hormone level	J:180651
	increased urine calcium level	J:180651
Casr^tm1Wch/Casr^tm1Wch Tg(PTH-cre)4167Slib/0 (involves: 129S4/SvJae * C57BL/6 * FVB)	increased circulating calcium level	J:180651
	increased circulating parathyroid hormone level	J:180651
	increased urine calcium level	J:180651
Cast^{tm1.1(KOMP)Vlcg}/Cast^{tm1.1(KOMP)Vlcg} (B6N(Cg)-Cast^{tm1.1(KOMP)Vlcg}/2J)	decreased fasting circulating glucose level	J:211773
	increased circulating alanine transaminase level	J:211773
	increased circulating phosphate level	J:211773
	increased circulating sodium level	J:211773
Casz1^{Gt(CJ0565)Wtsi}/Casz1^{Gt(CJ0565)Wtsi} (involves: 129P2/OlaHsd * C57BL/6)	nuchal edema	J:242127
	subcutaneous edema	J:242127
Casz1^tm1.1Flc/Casz1^tm1.1Flc Nkx2-5^tm1(cre)Rjs/Nkx2-5⁺ (involves: 129P2/OlaHsd * 129S7/SvEvBrd * C57BL/6 * C57BL/6J * SJL)	edema	J:221324
Cat^b/Cat^b (Not Specified)	decreased circulating cholesterol level	J:5205, J:5351
Cat^b/Cat^b (Not Specified)	decreased circulating triglyceride level	J:5205, J:5351
Catsper1^tm1Clph/Catsper1^tm1Clph (involves: 129S4/SvJae * C57BL/6J)	abnormal calcium ion homeostasis	J:72046
Cav1^em2(IMPC)Ics/Cav1^em2(IMPC)Ics (C57BL/6N-Cav1^em2(IMPC)Ics/Ics)	increased circulating cholesterol level	J:211773
	increased circulating HDL cholesterol level	J:211773
Cav1^tm1Krc/Cav1^tm1Krc (involves: 129S4/SvJae * Black Swiss)	abnormal nitric oxide homeostasis	J:78603
Cav1^tm1Kur/Cav1^tm1Kur (involves: 129X1/SvJ * C57BL/6)	abnormal lipid level	J:112452
Cav1^tm1Kur/Cav1^tm1Kur (involves: 129X1/SvJ * C57BL/6)	decreased liver triglyceride level	J:112452
Cav1^tm1Mls/Cav1^tm1Mls (involves: 129/Sv * C57BL/6 * SJL)	abnormal blood homeostasis	J:75192
	abnormal circulating free fatty acids level	J:75192
	abnormal cytokine level	J:115914
	abnormal homeostasis	J:116286
	abnormal lipid homeostasis	J:75192
	abnormal nitric oxide homeostasis	J:139304
	decreased circulating leptin level	J:75192
	decreased susceptibility to diet-induced obesity	J:75192
	increased circulating CXCL10 level	J:115914
	increased circulating interferon-gamma level	J:115914
	increased circulating interleukin-6 level	J:115914
	increased circulating triglyceride level	J:75192
	increased circulating tumor necrosis factor level	J:115914
	increased circulating VLDL triglyceride level	J:75192
Cav1^tm1Mls/Cav1^tm1Mls (involves: 129/Sv * C57BL/6J * SJL)	abnormal nitric oxide homeostasis	J:114334
	impaired lipolysis	J:89326
	increased circulating insulin level	J:84260
	insulin resistance	J:84260
Cav1^tm1Mls/Cav1^tm1Mls (B6.Cg-Cav1^tm1Mls)	abnormal triglyceride level	J:105133
	decreased core body temperature	J:105133
	decreased fatty acids level	J:105133
	impaired adaptive thermogenesis	J:105133
	impaired lipolysis	J:105133
Cav1^tm1Mls/Cav1^tm1Mls (B6.Cg-Cav1^tm1Mls/J)	pulmonary edema	J:143600
Cav1^tm1Mls/Cav1^tm1Mls (FVB.Cg-Cav1^tm1Mls)	abnormal circulating amino acid level	J:182288
	abnormal free fatty acids level	J:182288
	abnormal glucose homeostasis	J:182288
	abnormal homeostasis	J:182288
	abnormal respiratory quotient	J:182288
	decreased circulating adiponectin level	J:182288
	decreased liver glycogen level	J:182288
	decreased susceptibility to diet-induced obesity	J:182288
	enhanced gluconeogenesis	J:182288
	enhanced lipolysis	J:182288
	hyperglycemia	J:182288
	increased blood urea nitrogen level	J:182288
	increased circulating glycerol level	J:182288
	increased circulating insulin level	J:182288
	increased liver glycogen level	J:182288
	increased oxygen consumption	J:182288
	increased respiratory quotient	J:182288
	increased triglyceride level	J:182288
	insulin resistance	J:182288
Cav1^tm1Pesch/Cav1^tm1Pesch Speer6-ps1^{Tg(Alb-cre)21Mgn}/Speer6-ps1⁺ (FVB.Cg-Cav1^tm1Pesch Speer6-ps1^{Tg(Alb-cre)21Mgn})	decreased circulating glucose level	J:182288
	decreased circulating glycerol level	J:182288
Cav1^tm1Tt/Cav1^tm1Tt (involves: 129S7/SvEvBrd * C57BL/6J)	abnormal renal calcium reabsorption	J:82490
Cav1^tm1Tt/Cav1^tm1Tt (involves: 129S7/SvEvBrd * C57BL/6J)	increased urine calcium level	J:82490
Cav2^{em1(IMPC)Kmpc}/Cav2^{em1(IMPC)Kmpc} (C57BL/6NTac-Cav2^{em1(IMPC)Kmpc}/Kmpc)	increased circulating alanine transaminase level	J:211773
	increased circulating total protein level	J:211773
Cav3^{em1(IMPC)Kmpc}/Cav3^{em1(IMPC)Kmpc} (C57BL/6NTac-Cav3^{em1(IMPC)Kmpc}/Kmpc)	increased circulating LDL cholesterol level	J:211773
Cav3^tm1Mls/Cav3^tm1Mls (involves: 129/Sv * C57BL/6J * SJL)	increased circulating creatine kinase level	J:69965
Cavin1^tm1Pfp/Cavin1^tm1Pfp (involves: 129S6/SvEvTac * C57BL/6)	abnormal circulating hormone level	J:143425
	abnormal circulating lipid level	J:143425
	decreased circulating leptin level	J:143425
	hyperlipidemia	J:143425
	impaired glucose tolerance	J:143425
	increased circulating free fatty acids level	J:143425
	increased circulating insulin level	J:143425
	increased circulating triglyceride level	J:143425
	insulin resistance	J:143425
Cbfb^tm1Ppl/Cbfb⁺ (either: (involves: 129/Sv * 129S6/SvEvTac) or (involves: 129S6/SvEvTac * Black Swiss) or (involves: 129S6/SvEvTac * C57BL/6))	hemopericardium	J:36594
Cbfb^tm1Spe/Cbfb^tm1Spe (either: (involves: 129S4/SvJae * BALB/c) or (involves: 129S4/SvJae * C57BL/6))	edema	J:36593
Cbl^tm1Ddlb/Cbl⁺ (involves: 129S1/Sv * C57BL/6)	improved glucose tolerance	J:121012
Cbl^tm1Ddlb/Cbl⁺ (involves: 129S1/Sv * C57BL/6)	increased susceptibility to diet-induced obesity	J:121012
Cbl^tm1Ddlb/Cbl^tm1Ddlb (involves: 129S1/Sv * C57BL/6)	abnormal gas homeostasis	J:94416
	abnormal glucose homeostasis	J:94416
	abnormal lipid homeostasis	J:94416
	decreased circulating free fatty acids level	J:94416
	decreased circulating insulin level	J:94416
	decreased circulating leptin level	J:94416
	decreased liver triglyceride level	J:94416
	decreased respiratory quotient	J:94416
	improved glucose tolerance	J:94416
	increased body temperature	J:94416
	increased insulin sensitivity	J:94416
	increased oxygen consumption	J:94416
Cbl^tm1Ddlb/Cbl^tm2Wlan (involves: 129S1/Sv * C57BL/6)	decreased circulating free fatty acids level	J:121012
	decreased circulating insulin level	J:121012
	decreased circulating leptin level	J:121012
	decreased circulating triglyceride level	J:121012
	decreased susceptibility to diet-induced obesity	J:121012
	improved glucose tolerance	J:121012
	increased insulin sensitivity	J:121012
	increased oxygen consumption	J:121012
Cblif^{tm1a(KOMP)Wtsi}/Cblif^{tm1a(KOMP)Wtsi} (C57BL/6N-Cblif^{tm1a(KOMP)Wtsi})	abnormal circulating lipoprotein level	J:236022
	abnormal vitamin B12 level	J:236022
	decreased circulating cholesterol level	J:236022
	decreased circulating glucose level	J:236022
	decreased circulating glycerol level	J:236022
	decreased circulating iron level	J:236022
	decreased circulating serum albumin level	J:236022
	increased blood urea nitrogen level	J:236022
Cbr2^{tm1b(EUCOMM)Hmgu}/Cbr2^{tm1b(EUCOMM)Hmgu} (C57BL/6N-Cbr2^{tm1b(EUCOMM)Hmgu}/Wtsi)	decreased circulating amylase level	J:211773
	decreased circulating fructosamine level	J:211773
Cbs^tm1Unc/Cbs⁺ (involves: 129P2/OlaHsd * C57BL/6J)	abnormal circulating homocysteine level	J:23321
Cbs^tm1Unc/Cbs⁺ (B6.129P2-Cbs^tm1Unc/J)	increased circulating homocysteine level	J:64885, J:166184
Cbs^tm1Unc/Cbs⁺ (involves: 129P2/OlaHsd)	increased circulating homocysteine level	J:112538
Cbs^tm1Unc/Cbs^tm1Unc (involves: 129P2/OlaHsd * C57BL/6J)	abnormal amino acid level	J:101303
	abnormal interleukin level	J:101303
	abnormal tumor necrosis factor level	J:101303
	hemosiderosis	J:23321
	increased circulating homocysteine level	J:105571, J:23321
	increased circulating progesterone level	J:114850
Cbs^tm1Unc/Cbs^tm1Unc (involves: 129P2/OlaHsd * C57BL/6)	increased circulating homocysteine level	J:150548
Cbs^tm1Unc/Cbs^tm1Unc (B6.129P2-Cbs^tm1Unc/J)	abnormal circulating amino acid level	J:166184
	decreased circulating taurine level	J:166184
	increased circulating homocysteine level	J:166184
Cbs^tm1Unc/Cbs^tm1Unc (involves: 129P2/OlaHsd)	increased circulating homocysteine level	J:112538
Cbs^tm1Unc/Cbs^tm1Unc Tg(CBS)11181Eri/0 (involves: 129P2/OlaHsd * C57BL/6J)	abnormal blood homeostasis	J:165612
	abnormal circulating amino acid level	J:165612
	abnormal circulating homocysteine level	J:165612
	decreased bleeding time	J:165612
	hypercoagulability	J:165612
Cbs^tm1Unc/Cbs^tm1Unc Tg(Mt1-CBS)25Waku/0 (involves: 129P2/OlaHsd * C3H * C57BL/6)	abnormal amino acid level	J:150548
	abnormal circulating homocysteine level	J:150548
Cbs^tm1Unc/Cbs^tm1Unc Tg(Mt1-CBSI278T)1Waku/0 (involves: 129P2/OlaHsd C3H * C57BL/6)	abnormal amino acid level	J:150548
	abnormal circulating homocysteine level	J:150548
Cbs^tm1Unc/Cbs^tm1Unc Tg(Mt1-CBSS466L)EB86Waku/0 (involves: 129P2/OlaHsd C3H * C57BL/6)	increased circulating homocysteine level	J:150548, J:168131
	increased circulating methionine level	J:168131
Cbx5^{tm1a(EUCOMM)Wtsi}/Cbx5^{tm1a(EUCOMM)Wtsi} (C57BL/6N-Cbx5^{tm1a(EUCOMM)Wtsi}/Wtsi)	decreased circulating glucose level	J:211773
Cbx6^{tm1a(EUCOMM)Wtsi}/Cbx6^{tm1a(EUCOMM)Wtsi} (C57BL/6N-Cbx6^{tm1a(EUCOMM)Wtsi}/Wtsi)	decreased circulating cholesterol level	J:211773
	decreased circulating glucose level	J:211773
	decreased circulating HDL cholesterol level	J:211773
	decreased fasting circulating glucose level	J:211773
	increased blood urea nitrogen level	J:211773
	increased circulating amylase level	J:211773
	increased circulating chloride level	J:211773
	increased circulating creatinine level	J:211773
	increased circulating sodium level	J:211773
Cc2d1a^tm1.1Thkn/Cc2d1a^tm1.1Thkn Tg(Nes-cre)1Kln/0 (involves: 129S4/SvJae * C57BL/6 * SJL)	cyanosis	J:236761
Cc2d1a^tm1.2Thkn/Cc2d1a^tm1.2Thkn (involves: 129S4/SvJae * BALB/cJ * C57BL/6 * SJL)	cyanosis	J:236761
Cc2d1b^{tm1a(KOMP)Wtsi}/Cc2d1b⁺ (Not Specified)	decreased circulating free fatty acids level	J:165965
Cc2d1b^{tm1a(KOMP)Wtsi}/Cc2d1b⁺ (Not Specified)	decreased circulating phosphate level	J:165965
Cc2d1b^{tm1a(KOMP)Wtsi}/Cc2d1b^{tm1a(KOMP)Wtsi} (Not Specified)	decreased circulating free fatty acids level	J:165965
Ccar2^tm1Dac/Ccar2^tm1Dac (involves: 129 * C57BL/6J)	decreased energy expenditure	J:228688
	decreased oxygen consumption	J:228688
	impaired glucose tolerance	J:228688
	increased circulating insulin level	J:228688
	increased hepatic glucose production	J:228688
	increased susceptibility to diet-induced obesity	J:228688
	increased unsaturated fatty acids level	J:228688
	insulin resistance	J:228688
Ccar2^tm1Dac/Ccar2^tm1Dac Lep^ob/Lep^ob (involves: 129 * C57BL/6J)	impaired glucose tolerance	J:228688
Ccar2^tm1Dac/Ccar2^tm1Dac Sirt1^tm1Ygu/Sirt1^tm1Ygu Tg(SERPINA1-cre)1Arge/0 (involves: 129 * 129S1/Sv * 129X1/SvJ * C57BL/6J)	decreased susceptibility to diet-induced obesity	J:228688
Ccbe1^em1(IMPC)Mbp/Ccbe1^em1(IMPC)Mbp (C57BL/6NCrl-Ccbe1^em1(IMPC)Mbp/MbpMmucd)	edema	J:211773
Ccbe1^tm1Lex/Ccbe1^tm1Lex (involves: 129S5/SvEvBrd)	edema	J:186594
Ccbe1^tm1Mlkn/Ccbe1^tm1Mlkn (either: B6.129-Ccbe1^tm1Mlkn or (involves: 129 * C57BL/6))	edema	J:196696
Ccdc3^tm1Ish/Ccdc3^tm1Ish (involves: C57BL/6J)	abnormal glucose homeostasis	J:220560
	decreased circulating leptin level	J:220560
	decreased liver triglyceride level	J:220560
	increased circulating glucose level	J:220560
	increased insulin sensitivity	J:220560
Ccdc6^tm1Afus/Ccdc6^tm1Afus (involves: 129 * C57BL/6J)	decreased thyroid-stimulating hormone level	J:301625
	increased thyroxine level	J:301625
	increased triiodothyronine level	J:301625
Ccdc7a^{Tg(Prnp-Sirt1)10Imai}/? (B6.Cg-Ccdc7a^{Tg(Prnp-Sirt1)10Imai})	increased body temperature	J:162852, J:203814
	increased energy expenditure	J:203814
	increased oxygen consumption	J:203814
Ccdc18^{tm1a(EUCOMM)Wtsi}/Ccdc18^{tm1a(EUCOMM)Wtsi} (C57BL/6N-Ccdc18^{tm1a(EUCOMM)Wtsi}/Wtsi)	increased circulating alkaline phosphatase level	J:211773
	increased circulating free fatty acids level	J:211773
	increased circulating glycerol level	J:211773
	increased circulating sodium level	J:211773
	increased circulating total protein level	J:211773
	increased circulating triglyceride level	J:211773
Ccdc25^em1(IMPC)Mbp/Ccdc25⁺ (C57BL/6N-Ccdc25^em1(IMPC)Mbp/MbpMmucd)	impaired glucose tolerance	J:211773
Ccdc28b^em1Jlba/Ccdc28b^em1Jlba (C57BL/6J-Ccdc28b^em1Jlba)	abnormal glucose tolerance	J:325766
Ccdc28b^em1Jlba/Ccdc28b^em1Jlba (C57BL/6J-Ccdc28b^em1Jlba)	increased circulating glucose level	J:325766
Ccdc50^{tm1b(EUCOMM)Hmgu}/Ccdc50^{tm1b(EUCOMM)Hmgu} (C57BL/6N-Ccdc50^{tm1b(EUCOMM)Hmgu}/H)	increased circulating alkaline phosphatase level	J:211773
Ccdc51^em1(IMPC)J/Ccdc51^em1(IMPC)J (C57BL/6NJ-Ccdc51^em1(IMPC)J/Mmjax)	increased fasting circulating glucose level	J:211773
Ccdc57^{tm1a(EUCOMM)Wtsi}/Ccdc57⁺ (B6JTyr;B6N-Ccdc57^{tm1a(EUCOMM)Wtsi}/Wtsi)	decreased circulating glucose level	J:175295
	decreased circulating potassium level	J:175295
	increased circulating sodium level	J:175295
Ccdc77^{tm1a(EUCOMM)Wtsi}/Ccdc77^{tm1a(EUCOMM)Wtsi} (C57BL/6N-Ccdc77^{tm1a(EUCOMM)Wtsi}/Wtsi)	increased circulating LDL cholesterol level	J:211773
Ccdc78^em1(IMPC)J/Ccdc78^em1(IMPC)J (C57BL/6NJ-Ccdc78^em1(IMPC)J/J)	decreased circulating calcium level	J:211773
Ccdc80^tm1Ftrm/Ccdc80^tm1Ftrm (C57BL/6-Ccdc80^tm1Ftrm)	decreased circulating insulin level	J:189183
	decreased oxygen consumption	J:189183
	enhanced lipolysis	J:189183
	impaired glucose tolerance	J:189183
	increased circulating free fatty acids level	J:189183
	increased circulating glucose level	J:189183
	increased circulating leptin level	J:189183
	increased insulin secretion	J:189183
Ccdc88b^em1(IMPC)Tcp/Ccdc88b^em1(IMPC)Tcp (C57BL/6NCrl-Ccdc88b^em1(IMPC)Tcp/Tcp)	decreased fasting circulating glucose level	J:211773
Ccdc92^{tm1a(KOMP)Mbp}/Ccdc92^{tm1a(KOMP)Mbp} (C57BL/6NCrl-Ccdc92^{tm1a(KOMP)Mbp}/MbpMmucd)	increased blood urea nitrogen level	J:211773
	increased circulating serum albumin level	J:211773
Ccdc92^{tm1a(KOMP)Mbp}/Ccdc92^{tm1a(KOMP)Mbp} (C57BL/6N-Ccdc92^{tm1a(KOMP)Mbp})	decreased circulating cholesterol level	J:332421
	decreased circulating interleukin-1 beta level	J:332421
	decreased circulating interleukin-18 level	J:332421
	decreased circulating LDL cholesterol level	J:332421
	decreased circulating leptin level	J:332421
	decreased circulating triglyceride level	J:332421
	decreased liver triglyceride level	J:332421
	decreased susceptibility to diet-induced obesity	J:332421
	improved glucose tolerance	J:332421
	increased circulating adiponectin level	J:332421
	increased energy expenditure	J:332421
	increased insulin sensitivity	J:332421
	increased oxygen consumption	J:332421
Ccdc92^{tm1b(KOMP)Mbp}/Ccdc92^{tm1b(KOMP)Mbp} (C57BL/6N-Ccdc92^{tm1b(KOMP)Mbp}/Ucd)	decreased circulating cholesterol level	J:211773
Ccdc103^em4(IMPC)H/Ccdc103⁺ (C57BL/6N-Ccdc103^em4(IMPC)H/H)	increased circulating amylase level	J:211773
Ccdc116^{tm1.1(KOMP)Vlcg}/Ccdc116^{tm1.1(KOMP)Vlcg} (C57BL/6N-Ccdc116^{tm1.1(KOMP)Vlcg}/Ucd)	impaired glucose tolerance	J:211773
Ccdc117^em1(IMPC)J/Ccdc117^em1(IMPC)J (C57BL/6NJ-Ccdc117^em1(IMPC)J/Mmjax)	increased circulating alkaline phosphatase level	J:211773
Ccdc120^{tm1.1(KOMP)Vlcg}/Y (B6N(Cg)-Ccdc120^{tm1.1(KOMP)Vlcg}/J)	decreased circulating glucose level	J:211773
	increased circulating free fatty acids level	J:211773
Ccdc120^{tm1.1(KOMP)Vlcg}/Ccdc120^{tm1.1(KOMP)Vlcg} (B6N(Cg)-Ccdc120^{tm1.1(KOMP)Vlcg}/J)	increased fasting circulating glucose level	J:211773
Ccdc122^{tm1a(KOMP)Wtsi}/Ccdc122^{tm1a(KOMP)Wtsi} (C57BL/6N-Ccdc122^{tm1a(KOMP)Wtsi}/Wtsi)	decreased circulating fructosamine level	J:211773
	increased respiratory quotient	J:211773
Ccdc127^{tm1b(EUCOMM)Wtsi}/Ccdc127^{tm1b(EUCOMM)Wtsi} (C57BL/6N-Ccdc127^{tm1b(EUCOMM)Wtsi}/Wtsi)	decreased circulating fructosamine level	J:211773
Ccdc186^em1(IMPC)Mbp/Ccdc186^em1(IMPC)Mbp (C57BL/6NCrl-Ccdc186^em1(IMPC)Mbp/MbpMmucd)	edema	J:211773
Cck^tm1Lcs/Cck^tm1Lcs (involves: 129S1/Sv * 129X1/SvJ)	abnormal enzyme/coenzyme level	J:76894
Cckar^{tm1b(EUCOMM)Hmgu}/Cckar^{tm1b(EUCOMM)Hmgu} (C57BL/6N-Cckar^{tm1b(EUCOMM)Hmgu}/Ieg)	increased circulating aspartate transaminase level	J:211773
Cckar^tm1Kpn/Cckar^tm1Kpn (involves: 129S/SvEv)	abnormal bile salt homeostasis	J:91998
	abnormal cholesterol homeostasis	J:91998
	increased intestinal cholesterol absorption	J:91998
Cckar^tm1Kym/Cckar^tm1Kym (B6.129S4-Cckar^tm1Kym)	abnormal body temperature homeostasis	J:95791
Cckar^tm1Kym/Cckar^tm1Kym Cckbr^tm1Tom/Cckbr^tm1Tom (involves: 129S4/SvJae * C57BL/6J)	abnormal body temperature homeostasis	J:95791
Cckar^tm1Kym/Cckar^tm1Kym Cckbr^tm1Tom/Cckbr^tm1Tom (involves: 129S4/SvJae)	increased energy expenditure	J:96087
Cckbr^em1(IMPC)H/Cckbr^em1(IMPC)H (C57BL/6N-Cckbr^em1(IMPC)H/H)	increased circulating iron level	J:211773
Cckbr^tm1Kpn/Cckbr^tm1Kpn (involves: 129S2/SvPas)	increased circulating gastrin level	J:49320
Cckbr^tm1Tom/Cckbr^tm1Tom (involves: 129S4/SvJae * C57BL/6J)	abnormal circulating iron level	J:142455
	decreased circulating ferritin level	J:142455
	decreased circulating unsaturated transferrin level	J:142455
	impaired febrile response	J:143853
	increased circulating gastrin level	J:142455, J:35876
	increased liver iron level	J:142455
Cckbr^tm1Tom/Cckbr^tm1Tom (involves: 129S4/SvJae)	increased circulating gastrin level	J:101985
Cckbr^tm1Tom/Cckbr^tm1Tom (involves: 129S4/SvJae)	increased energy expenditure	J:96087
Ccl2^tm1.1Tyos/Ccl2^tm1.1Tyos (involves: 129S1/Sv * C57BL/6)	abnormal chemokine level	J:151874
Ccl2^tm1Rol/Ccl2^tm1Rol (involves: 129S4/SvJae)	increased circulating interferon-gamma level	J:155025
	increased circulating interleukin-10 level	J:155025
	increased circulating tumor necrosis factor level	J:155025
Ccl2^tm1Rol/Ccl2^tm1Rol (B6.129S4-Ccl2^tm1Rol)	abnormal chemokine level	J:151874, J:118606
Ccl2^tm1Rol/Ccl2^tm1Rol (B6.129S4-Ccl2^tm1Rol/J)	abnormal gluconeogenesis	J:110277
	abnormal glucose homeostasis	J:126512
	decreased adiponectin level	J:126512
	decreased circulating free fatty acids level	J:110277
	decreased circulating insulin level	J:110277
	impaired glucose tolerance	J:126512
	improved glucose tolerance	J:110277
	increased adiponectin level	J:110277
	increased circulating glucose level	J:126512
	increased circulating insulin level	J:126512
	increased circulating leptin level	J:126512
	increased insulin sensitivity	J:110277
	increased susceptibility to diet-induced obesity	J:126512
Ccl2^tm1Rol/Ccl2^tm1Rol Ldlr^tm1Her/Ldlr^tm1Her (involves: 129S4/SvJae * 129S7/SvEvBrd * C57BL/6)	increased circulating triglyceride level	J:75837
	increased circulating VLDL cholesterol level	J:75837
Ccl2^tm1Rol/Ccl2^tm1Rol Mpz^tm1Msch/Mpz⁺ (involves: 129S4/SvJae * 129S7/SvEvBrd)	abnormal cytokine level	J:133028
Ccl2^tm1Tyos/Ccl2^tm1Tyos (involves: 129S1/Sv * C57BL/6)	abnormal chemokine level	J:151874
Ccl3^em1(IMPC)H/Ccl3^em1(IMPC)H (C57BL/6N-Ccl3^em1(IMPC)H/H)	decreased circulating serum albumin level	J:211773
	decreased circulating total protein level	J:211773
Ccl3^tm1Unc/Ccl3^tm1Unc Hexb^tm1Rlp/Hexb^tm1Rlp (involves: 129P2/OlaHsd * 129S4/SvJae * C57BL/6)	abnormal tumor necrosis factor level	J:90687
Ccl9^{tm1(KOMP)Vlcg}/Ccl9^{tm1(KOMP)Vlcg} (C57BL/6N-Ccl9^{tm1(KOMP)Vlcg}/Ucd)	increased circulating cholesterol level	J:211773
	increased circulating HDL cholesterol level	J:211773
Ccl25^em1(IMPC)H/Ccl25^em1(IMPC)H (C57BL/6N-Ccl25^em1(IMPC)H/H)	decreased fasting circulating glucose level	J:211773
Ccl26^{tm1.1(KOMP)Vlcg}/Ccl26^{tm1.1(KOMP)Vlcg} (B6N(Cg)-Ccl26^{tm1.1(KOMP)Vlcg}/J)	improved glucose tolerance	J:211773
Ccl28^{em1(IMPC)Ccpcz}/Ccl28^{em1(IMPC)Ccpcz} (C57BL/6NCrl-Ccl28^{em1(IMPC)Ccpcz}/Ccpcz)	increased circulating alanine transaminase level	J:211773
Ccm2^{Gt(RRG051)Byg}/Ccm2⁺ Heg1^tm1Mlkn/Heg1⁺ (involves: 129/Sv * 129P2/OlaHsd * C57BL/6)	hemopericardium	J:146528
	pericardial edema	J:146528
Ccm2^{Gt(RRG051)Byg}/Ccm2^{Gt(RRG051)Byg} (involves: 129P2/OlaHsd)	hemopericardium	J:146528
	pericardial edema	J:146528
Ccm2^tm1.1Etl/Ccm2^tm1.1Etl (B6.129-Ccm2^tm1.1Etl)	pericardial edema	J:146210
Ccm2^tm1Etl/Ccm2^tm1Etl Tg(Tek-cre)1Ywa/0 (B6.Cg-Tg(Tek-cre)1Ywa Ccm2^tm1Etl)	pericardial edema	J:146210
Ccm2^tm1Sbn/Ccm2^tm1Sbn (involves: C57BL/6)	pericardial edema	J:174085
Ccnd1^tm1Dsn/Ccnd1^tm1Dsn Ccnd2^tm1Wbg/Ccnd2^tm1Wbg Ccnd3^tm1Pisc/Ccnd3^tm1Pisc (involves: 129P2/OlaHsd * 129S2/SvPas)	hydrops fetalis	J:92563
Ccnd2^{tm1b(KOMP)Mbp}/Ccnd2^{tm1b(KOMP)Mbp} (C57BL/6N-Ccnd2^{tm1b(KOMP)Mbp}/H)	impaired glucose tolerance	J:211773
	increased circulating alkaline phosphatase level	J:211773
	increased circulating glucose level	J:211773
	increased circulating iron level	J:211773
	increased circulating phosphate level	J:211773
	increased fasting circulating glucose level	J:211773
Ccni^tm1Jro/Ccni^tm1Jro (involves: 129S4/SvJaeSor)	increased circulating creatinine level	J:115356
Ccni^tm1Jro/Ccni^tm1Jro (involves: 129S4/SvJaeSor)	increased urine protein level	J:115356
Ccnq^{tm1.1(KOMP)Vlcg}/Ccnq⁺ (C57BL/6N-Ccnq^{tm1.1(KOMP)Vlcg}/Ucd)	increased circulating triglyceride level	J:211773
Ccnt1^em1(IMPC)J/Ccnt1^em1(IMPC)J (C57BL/6NJ-Ccnt1^em1(IMPC)J/Mmjax)	decreased circulating total protein level	J:211773
	increased circulating alkaline phosphatase level	J:211773
Ccny^tm1.1Smoc/Ccny^tm1.1Smoc (involves: C57BL/6)	decreased circulating cholesterol level	J:224589
	decreased circulating free fatty acids level	J:224589
	decreased circulating triglyceride level	J:224589
	decreased liver triglyceride level	J:224589
	increased carbon dioxide production	J:224589
	increased energy expenditure	J:224589
	increased oxygen consumption	J:224589
	increased respiratory quotient	J:224589
Ccpg1^{tm1b(EUCOMM)Hmgu}/Ccpg1^{tm1b(EUCOMM)Hmgu} (C57BL/6N-Ccpg1^{tm1b(EUCOMM)Hmgu}/Ieg)	increased circulating amylase level	J:211773
	increased circulating lipase level	J:211773
Ccr1^tm1Cge/Ccr1^tm1Cge (involves: 129S4/SvJae)	increased blood urea nitrogen level	J:115119
Ccr1^tm1Cge/Ccr1^tm1Cge (involves: 129S4/SvJae)	increased urine protein level	J:115119
Ccr1^tm1Cge/Ccr1^tm1Cge (involves: 129S4/SvJae * BALB/c)	abnormal circulating chemokine level	J:169909
	decreased circulating interferon-gamma level	J:169909
	increased macrophage nitric oxide production	J:169909
Ccr2^{tm1.1(CCR2)Rodb}/Ccr2^{tm1.1(CCR2)Rodb} (involves: C57BL/6)	abnormal glucose homeostasis	J:203000
	abnormal urine protein level	J:203000
Ccr2^{tm1.1(CCR2)Rodb}/Ccr2^{tm1.1(CCR2)Rodb} Lepr^db/Lepr^db (involves: C57BL/6 * C57BLKS/J)	abnormal urine protein level	J:203000
Ccr2^tm1Blck/Ccr2^tm1Blck Fas^lpr/Fas^lpr (MRL.Cg-Ccr2^tm1Blck Fas^lpr)	abnormal interferon level	J:113343
	abnormal tumor necrosis factor level	J:113343
	albuminuria	J:113343
Ccr2^tm1Ifc/Ccr2^tm1Ifc (involves: 129S4/SvJae * C57BL/6)	abnormal cholesterol homeostasis	J:81363
	abnormal lipid homeostasis	J:81363
	increased circulating alanine transaminase level	J:61542
Ccr2^tm1Mae/Ccr2^tm1Mae (involves: 129P2/OlaHsd)	decreased circulating alanine transaminase level	J:311042
Ccr2^tm1Mae/Ccr2^tm1Mae (involves: 129P2/OlaHsd * BALB/c)	decreased circulating creatinine level	J:162714
Ccr2^tm1Mae/Ccr2^tm1Mae Msmp^em1Jzx/Msmp^em1Jzx (involves: 129P2/OlaHsd * C57BL/6)	decreased circulating alanine transaminase level	J:311042
Ccr3^tm1Cge/Ccr3^tm1Cge (involves: 129S4/SvJae * BALB/c)	abnormal hemostasis	J:115273
Ccr3^tm1Cge/Ccr3^tm1Cge (involves: 129S4/SvJae * BALB/c)	decreased circulating interleukin-4 level	J:115273
Ccr5^tm1Kuz/Ccr5^tm1Kuz (involves: 129P2/OlaHsd * C57BL/6)	abnormal cytokine level	J:110814
Ccr5^tm1Kuz/Ccr5^tm1Kuz (B6.129P2-Ccr5^tm1Kuz/J)	decreased skeletal muscle glycogen level	J:264446
Ccr6^tm1Lira/Ccr6^tm1Lira (involves: 129 * C57BL/6)	decreased macrophage nitric oxide production	J:124358
Ccr9^em1(IMPC)H/Ccr9^em1(IMPC)H (C57BL/6N-Ccr9^em1(IMPC)H/H)	impaired glucose tolerance	J:211773
Ccs^tm1Pcw/Ccs^tm1Pcw (involves: 129S1/Sv)	abnormal copper homeostasis	J:80627
Cd1d1^em1(IMPC)H/Cd1d1^em1(IMPC)H (C57BL/6NTac-Cd1d1^em1(IMPC)H/H)	increased circulating amylase level	J:211773
Cd1d1^tm1Luc/Cd1d1^tm1Luc (C.129S6-Cd1d1^tm1Luc)	increased blood urea nitrogen level	J:121187
Cd1d1^tm1Luc/Cd1d1^tm1Luc (C.129S6-Cd1d1^tm1Luc)	increased urine protein level	J:121187
Cd1d1^tm1Luc/Cd1d1^tm1Luc Ldlr^tm1Her/Ldlr^tm1Her (B6.129S-Cd1d1^tm1Luc Ldlr^tm1Her)	decreased circulating VLDL cholesterol level	J:110061
Cd2ap^em1Irgu/Cd2ap^em1Irgu (C57BL/6-Cd2ap^em1Irgu)	albuminuria	J:294238
	decreased circulating serum albumin level	J:294238
	increased blood urea nitrogen level	J:294238
	increased circulating creatinine level	J:294238
	increased urine protein level	J:294238
Cd2ap^tm1Shaw/Cd2ap^tm1Shaw (involves: 129X1/SvJ)	ascites	J:57971
	decreased circulating serum albumin level	J:57971
	increased blood urea nitrogen level	J:57971
	increased circulating creatinine level	J:57971
	increased urine protein level	J:57971
Cd2bp2^tm1.1Tbh/Cd2bp2^tm1.1Tbh Tg(NPHS2-cre)295Lbh/0 (involves: 129S1/Sv * 129X1/SvJ * C57BL/6N * SJL)	increased urine protein level	J:283435
Cd4^tm1Mak/Cd4^tm1Mak (B6.129S2-Cd4^tm1Mak/J)	abnormal bile salt level	J:133047
Cd5l^{tm1b(KOMP)Mbp}/Cd5l^{tm1b(KOMP)Mbp} (C57BL/6N-Cd5l^{tm1b(KOMP)Mbp}/H)	decreased circulating glucose level	J:211773
Cd9^{tm1c(EUCOMM)Hmgu}/Cd9⁺ Kras^tm4Tyj/Kras⁺ Tg(Pdx1-cre)6Tuv/0 Trp53^tm1Brn/Trp53⁺ (involves: 129P2/OlaHsd * 129S4/SvJae * C57BL/6N * FVB/N)	decreased glutamic acid level	J:280854
Cd14^tm1Frm/Cd14^tm1Frm (B6.129S4-Cd14^tm1Frm)	abnormal cytokine level	J:96680
	abnormal interleukin level	J:96680
	abnormal tumor necrosis factor level	J:96680
	pulmonary edema	J:96680
Cd14^tm1Smg/Cd14^tm1Smg (involves: 129S1/Sv * C57BL/6)	decreased circulating interleukin-6 level	J:32729
Cd14^tm1Smg/Cd14^tm1Smg (involves: 129S1/Sv * C57BL/6)	decreased circulating tumor necrosis factor level	J:32729
Cd14^tm1Smg/Cd14^tm1Smg (involves: 129S1/Sv)	abnormal tumor necrosis factor level	J:103464
Cd19^tm1(cre)Cgn/Cd19⁺ Il10^tm1Roer/Il10^tm1Roer (involves: 129P2/OlaHsd)	decreased circulating interleukin-10 level	J:151551
Cd19^tm1Tft/Cd19^tm1Tft (B6.Cg-Cd19^tm1Tft)	decreased circulating interferon-gamma level	J:136210
	decreased circulating interleukin-4 level	J:136210
	decreased circulating interleukin-6 level	J:136210
	decreased circulating interleukin-10 level	J:136210
	decreased circulating tumor necrosis factor level	J:136210
Cd22^{tm1b(EUCOMM)Wtsi}/Cd22^{tm1b(EUCOMM)Wtsi} (C57BL/6N-Cd22^{tm1b(EUCOMM)Wtsi}/Tcp)	increased circulating cholesterol level	J:211773
Cd24a^tm1Pjln/Cd24a^tm1Pjln (C57BL/6-Cd24a^tm1Pjln)	increased erythrocyte sedimentation rate	J:76695
Cd28^tm1Mak/Cd28^tm1Mak (involves: 129S2/SvPas * C57BL/6)	decreased circulating interferon-gamma level	J:95353
Cd28^tm1Mak/Cd28^tm1Mak (involves: 129S2/SvPas * C57BL/6)	decreased circulating interleukin-4 level	J:95353
Cd28^tm1Shr/Cd28^tm1Shr Ctla4^tm1Shr/Ctla4^tm1Shr (C.129S4-Cd28^tm1Shr Ctla4^tm1Shr)	abnormal interferon level	J:68642
Cd33^{tm1.1(KOMP)Vlcg}/Cd33^{tm1.1(KOMP)Vlcg} (B6N(Cg)-Cd33^{tm1.1(KOMP)Vlcg}/J)	increased fasting circulating glucose level	J:211773
Cd33^tm1Avrk/Cd33^tm1Avrk (involves: 129X1/SvJ * C57BL/6)	increased circulating aspartate transaminase level	J:83728
Cd36^em1(IMPC)Mbp/Cd36^em1(IMPC)Mbp (C57BL/6N-Cd36^em1(IMPC)Mbp/MbpMmucd)	decreased circulating triglyceride level	J:211773
	decreased fasting circulating glucose level	J:211773
Cd36^tm1Frm/Cd36^tm1Frm (involves: 129S4/SvJae * C57BL/6J)	abnormal chemokine level	J:80658
Cd36^tm1Mfe/Cd36^tm1Mfe (involves: 129S1/Sv * C57BL/6)	abnormal cholesterol homeostasis	J:56081
	abnormal homeostasis	J:123605
	abnormal hormone level	J:126461
	abnormal intestinal lipid absorption	J:123605
	abnormal lipid homeostasis	J:56081
	abnormal triglyceride level	J:123605
	decreased cardiac muscle glycogen level	J:83611
	decreased cardiac muscle triglyceride level	J:83611
	decreased circulating adiponectin level	J:126461
	decreased fasting circulating glucose level	J:56081
	decreased intestinal cholesterol absorption	J:123605
	increased circulating cholesterol level	J:56081
	increased circulating HDL cholesterol level	J:56081
	increased circulating ketone body level	J:126461
	increased circulating leptin level	J:126461
	increased circulating triglyceride level	J:56081
	increased circulating VLDL triglyceride level	J:56081
	increased fatty acids level	J:56081
Cd36^tm1Mfe/Cd36^tm1Mfe (B6.129S1-Cd36^tm1Mfe)	abnormal circulating lipid level	J:87372
	abnormal fatty acids level	J:87372
	abnormal gluconeogenesis	J:87372
	abnormal glucose homeostasis	J:87372
	abnormal lipid level	J:87372
	decreased fatty acids level	J:87372
	decreased liver free fatty acids level	J:135594
	decreased liver triglyceride level	J:135594
	decreased susceptibility to induced thrombosis	J:136325
	increased circulating free fatty acids level	J:87372
	increased circulating ketone body level	J:87372
	increased circulating triglyceride level	J:87372
	increased fatty acids level	J:87372
	increased liver triglyceride level	J:87372
Cd36^tm1Mfe/Cd36^tm1Mfe (involves: 129S1/Sv)	abnormal triglyceride level	J:220343
	decreased circulating glucose level	J:220343
	decreased circulating triglyceride level	J:220343
	decreased skeletal muscle glycogen level	J:220343
	impaired adaptive thermogenesis	J:220343
Cd36^tm2.1Mfe/Cd36^tm2.1Mfe A1cf^{Tg(Myh6-cre/Esr1)1Jmk}/A1cf⁺ (B6.Cg-Cd36^tm2.1Mfe A1cf^{Tg(Myh6-cre/Esr1)1Jmk})	abnormal glucose homeostasis	J:225392
	decreased cardiac muscle triglyceride level	J:225392
	decreased fatty acid oxidation	J:225392
	decreased fatty acids level	J:225392
Cd38^tm1Lnd/Cd38^tm1Lnd (B6.129P2-Cd38^tm1Lnd)	insulin resistance	J:116576
Cd38^tm1Okam/Cd38^tm1Okam (involves: C57BL/6 * CBA)	decreased circulating insulin level	J:52933
Cd38^tm1Okam/Cd38^tm1Okam (involves: C57BL/6 * CBA)	impaired glucose tolerance	J:52933
Cd40^tm1Kik/Cd40^tm1Kik (B6.129P2-Cd40^tm1Kik/J)	decreased platelet aggregation	J:108988
Cd40^tm1Kik/Cd40^tm1Kik Tg(Tnfsf13b)1Fma/? (B6.Cg-Cd40^tm1Kik Tg(Tnfsf13b)1Fma)	increased urine protein level	J:113556
Cd40lg^tm1Imx/Y (B6.129S2-Cd40lg^tm1Imx/J)	decreased platelet aggregation	J:108988
Cd40lg^tm1Imx/? (involves: 129S2/SvPas * C57BL/6)	abnormal thrombosis	J:103954
	decreased platelet aggregation	J:103954
	increased bleeding time	J:103954
Cd40lg^tm1Imx/Cd40lg^tm1Imx (involves: 129S2/SvPas * C57BL/6)	abnormal blood coagulation	J:75152
Cd44^tm1Hbg/Cd44^tm1Hbg (involves: 129S1/Sv * 129X1/SvJ)	abnormal lipid level	J:108938
	decreased cholesterol level	J:108938
	impaired skin barrier function	J:108938
Cd44^tm1Hbg/Cd44^tm1Hbg Tg(TNF)197Gkl/0 (involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * CBA)	increased circulating interleukin-1 level	J:97992
	increased circulating interleukin-6 level	J:97992
	joint swelling	J:97992
Cd44^tm1Mak/Cd44^tm1Mak (B6.129P2-Cd44^tm1Mak)	abnormal circulating cytokine level	J:69351
	decreased transforming growth factor beta level	J:111216
	increased circulating interferon-gamma level	J:69351
	increased circulating interleukin-2 level	J:69351
	increased circulating tumor necrosis factor level	J:69351
Cd44^tm1Mak/Cd44^tm1Mak (involves: 129P2/OlaHsd * C57BL/6)	abnormal circulating chemokine level	J:155691
	decreased blood urea nitrogen level	J:114341
	decreased circulating creatinine level	J:114341
	decreased circulating tumor necrosis factor level	J:155691
Cd47^tm1Fpl/Cd47^tm1Fpl (B6.129S7-Cd47^tm1Fpl)	abnormal platelet physiology	J:98979
Cd47^tm1Fpl/Cd47^tm1Fpl (C.129S7-Cd47^tm1Fpl)	abnormal platelet physiology	J:98979
Cd47^tm1Fpl/Cd47^tm1Fpl (involves: 129S7/SvEvBrd * C57BL/6)	abnormal cytokine level	J:134866
	abnormal tumor necrosis factor level	J:134866
	pleural effusion	J:134866
Cd55^tm1Mme/Cd55^tm1Mme (involves: 129P2/OlaHsd * C57BL/6)	albuminuria	J:76756
Cd55b^{tm1a(KOMP)Wtsi}/Cd55b^{tm1a(KOMP)Wtsi} (C57BL/6N-Cd55b^{tm1a(KOMP)Wtsi}/Wtsi)	increased circulating creatinine level	J:211773
Cd59a^tm1Bpm/Cd59a^tm1Bpm (involves: 129/Sv * C57BL/6)	hemoglobinemia	J:70419
Cd59a^tm1Bpm/Cd59a^tm1Bpm (involves: 129/Sv * C57BL/6)	hemoglobinuria	J:70419
Cd59b^tm1Jha/Cd59b^tm1Jha (involves: 129/Sv * C57BL/6)	abnormal platelet physiology	J:82330
	hemoglobinemia	J:82330
	hemoglobinuria	J:82330
	hemosiderinuria	J:82330
Cd63^tm1Psa/Cd63^tm1Psa (involves: 129P2/OlaHsd * C57BL/6J)	abnormal fluid regulation	J:145741
	abnormal urine homeostasis	J:145741
	decreased urine osmolality	J:145741
Cd72^b/Cd72^b Fas^lpr/Fas^lpr (involves: C57BL/6 * C57BL/6JJmsSlc * MRL/Mp)	abnormal urine protein level	J:204782
Cd81^tm1Geha/Cd81^tm1Geha (involves: 129S4/SvJae * C57BL/6)	increased dopamine level	J:69590
Cd84^{tm1b(KOMP)Mbp}/Cd84^{tm1b(KOMP)Mbp} (B6N(Cg)-Cd84^{tm1b(KOMP)Mbp}/J)	increased circulating sodium level	J:211773
Cd86^tm2Shr/Cd86^tm2Shr Icos^tm1Flv/Icos^tm1Flv (involves: 129S1/Sv * 129S4/SvJaeSor)	abnormal cytokine level	J:112600
Cd151^tm1Lka/Cd151^tm1Lka (C57BL/6-Cd151^tm1Lka)	increased bleeding time	J:91605
Cd151^tm1Lka/Cd151^tm1Lka (FVB.B6-CD151^tm1Lka)	edema	J:139653
Cd151^tm1Lka/Cd151^tm1Lka (FVB.B6-CD151^tm1Lka)	increased urine protein level	J:139653
Cd151^tm1Nki/Cd151^tm1Nki (involves: 129P2/OlaHsd * FVB/N)	albuminuria	J:114988
Cd151^tm1Nki/Cd151^tm1Nki (involves: 129P2/OlaHsd * FVB/N)	increased urine protein level	J:114988
Cd163^{tm1(KOMP)Vlcg}/Cd163^{tm1(KOMP)Vlcg} (involves: C57BL/6NTac)	abnormal circulating cytokine level	J:224919
Cd180^tm1Kmiy/Cd180^tm1Kmiy Fas^lpr/Fas^lpr (MRL.Cg-Cd180^tm1Kmiy Fas^lpr)	abnormal blood urea nitrogen level	J:137066
Cd200^{tm1a(KOMP)Wtsi}/Cd200^{tm1a(KOMP)Wtsi} (C57BL/6N-Cd200^{tm1a(KOMP)Wtsi}/H)	decreased circulating calcium level	J:165965
Cd200^tm1Jods/Cd200^tm1Jods (C57BL/6-Cd200^tm1Jods)	abnormal cytokine level	J:95862
Cd209a^tm1.1Cfg/Cd209a^tm1.1Cfg (involves: C57BL/6)	decreased blood urea nitrogen level	J:217719
Cd209b^tm1.1Cfg/Cd209b^tm1.1Cfg (involves: C57BL/6)	decreased circulating bilirubin level	J:217719
Cd209d^tm1.1Cfg/Cd209d^tm1.1Cfg (involves: C57BL/6 * C57BL/6J)	increased circulating tumor necrosis factor level	J:153503
Cd209e^{tm1b(KOMP)Wtsi}/Cd209e^{tm1b(KOMP)Wtsi} (C57BL/6N-Cd209e^{tm1b(KOMP)Wtsi}/Wtsi)	increased circulating serum albumin level	J:211773
Cd248^{tm1.1(KOMP)Vlcg}/Cd248^{tm1.1(KOMP)Vlcg} (C57BL/6N-Cd248^{tm1.1(KOMP)Vlcg}/Ucd)	increased circulating insulin level	J:211773
Cd276^{tm2b(EUCOMM)Hmgu}/Cd276^{tm2b(EUCOMM)Hmgu} (C57BL/6N-Cd276^{tm2b(EUCOMM)Hmgu}/Orl)	increased circulating total protein level	J:211773
Cd300e^{tm1.1(KOMP)Vlcg}/Cd300e^{tm1.1(KOMP)Vlcg} (C57BL/6N-Cd300e^{tm1.1(KOMP)Vlcg}/Ucd)	decreased circulating glucose level	J:211773
Cd300ld2^{em1(IMPC)Wtsi}/Cd300ld2^{em1(IMPC)Wtsi} (C57BL/6N-Cd300ld2^{em1(IMPC)Wtsi}/Wtsi)	increased circulating alanine transaminase level	J:211773
	increased circulating aspartate transaminase level	J:211773
	increased circulating creatine kinase level	J:211773
Cd300ld^{em1(IMPC)Wtsi}/Cd300ld^{em1(IMPC)Wtsi} (C57BL/6N-Cd300ld^{em1(IMPC)Wtsi}/WtsiIeg)	increased circulating aspartate transaminase level	J:211773
Cd300lf^tm1Gne/Cd300lf^tm1Gne (involves: C57BL/6N)	abnormal nitric oxide homeostasis	J:156819
Cd320^{Gt(CC0426)Wtsi}/Cd320^{Gt(CC0426)Wtsi} (involves: 129P2/OlaHsd * C57BL/6)	abnormal vitamin B12 level	J:199961
	abnormal vitamin homeostasis	J:199961
	increased circulating homocysteine level	J:199961
	increased circulating methylmalonic acid level	J:199961
	increased methylmalonic acid level	J:199961
Cdan1^{tm1b(KOMP)Wtsi}/Cdan1⁺ (C57BL/6N-Cdan1^{tm1b(KOMP)Wtsi}/Ucd)	increased circulating alanine transaminase level	J:211773
Cdc20^{tm1.1(KOMP)Vlcg}/Cdc20⁺ (B6N(Cg)-Cdc20^{tm1.1(KOMP)Vlcg}/J)	decreased circulating glucose level	J:211773
	improved glucose tolerance	J:211773
	increased circulating glucose level	J:211773
	increased fasting circulating glucose level	J:211773
Cdc20b^{em1(IMPC)Wtsi}/Cdc20b^{em1(IMPC)Wtsi} (C57BL/6N-Cdc20b^{em1(IMPC)Wtsi}/Wtsi)	increased circulating triglyceride level	J:211773
Cdc34^{tm1.1(KOMP)Mbp}/Cdc34⁺ (B6N(Cg)-Cdc34^{tm1.1(KOMP)Mbp}/J)	increased fasting circulating glucose level	J:211773
Cdc37^em1(IMPC)J/Cdc37⁺ (C57BL/6NJ-Cdc37^em1(IMPC)J/Mmjax)	increased circulating alkaline phosphatase level	J:211773
Cdc42^{tm1b(EUCOMM)Hmgu}/Cdc42⁺ (C57BL/6N-Cdc42^{tm1b(EUCOMM)Hmgu}/H)	decreased circulating serum albumin level	J:211773
	increased circulating alkaline phosphatase level	J:211773
	increased circulating aspartate transaminase level	J:211773
	increased circulating cholesterol level	J:211773
	increased circulating HDL cholesterol level	J:211773
Cdc42^tm1Brak/Cdc42⁺ Rab8a^tm1.1Aha/Rab8a⁺ Tg(Vil1-cre)997Gum/0 (involves: C57BL/6J * SJL)	intestinal edema	J:184563
Cdc42^tm1Brak/Cdc42^tm1Brak Tg(Pf4-icre)Q3Rsko/0 (involves: 129 * C57BL/6)	abnormal platelet activation	J:160792
	abnormal platelet dense granule physiology	J:160792
	abnormal platelet physiology	J:160792
	increased bleeding time	J:160792
	increased platelet aggregation	J:160792
	increased susceptibility to induced thrombosis	J:160792
Cdc42^tm1Brak/Cdc42^tm1Brak Tg(Vil1-cre)997Gum/0 (involves: C57BL/6J * SJL)	intestinal edema	J:184563
Cdc42ep3^em1(IMPC)Mbp/Cdc42ep3^em1(IMPC)Mbp (C57BL/6NCrl-Cdc42ep3^em1(IMPC)Mbp/Mmucd)	increased circulating aspartate transaminase level	J:211773
Cdc73^{Gt(RRE190)Byg}/Cdc73⁺ (B6.129P2-Cdc73^{Gt(RRE190)Byg})	increased circulating calcium level	J:243366
	increased circulating parathyroid hormone level	J:243366
Cdc73^tm1Btt/Cdc73⁺ Tg(PTH-cre)4167Slib/0 (Not Specified)	increased circulating calcium level	J:243366
Cdc73^tm1Btt/Cdc73^tm1Btt Tg(CAG-cre/Esr1)5Amc/0 (involves: 129S4/SvJae C57BL/6 * CBA)	ascites	J:135255
Cdc73^tm1Btt/Cdc73^tm1Btt Tg(PTH-cre)4167Slib/0 (Not Specified)	increased circulating calcium level	J:243366
Cdca5^{tm1.1(KOMP)Vlcg}/Cdca5⁺ (B6N(Cg)-Cdca5^{tm1.1(KOMP)Vlcg}/J)	increased circulating alanine transaminase level	J:211773
	increased circulating chloride level	J:211773
	increased circulating sodium level	J:211773
Cdca7l^em1(IMPC)Mbp/Cdca7l^em1(IMPC)Mbp (C57BL/6NCrl-Cdca7l^em1(IMPC)Mbp/Mmucd)	increased circulating cholesterol level	J:211773
Cdca8^{tm1a(KOMP)Wtsi}/Cdca8⁺ (C57BL/6N-Cdca8^{tm1a(KOMP)Wtsi}/Wtsi)	decreased circulating chloride level	J:175295
	increased circulating alkaline phosphatase level	J:175295
	increased circulating chloride level	J:175295
	increased circulating HDL cholesterol level	J:175295
	increased circulating LDL cholesterol level	J:175295
Cdh1^tm2Kem/Cdh1^tm2Kem Tg(Ins2-cre)23Herr/0 (involves: 129S1/Sv * 129X1/SvJ * C57BL/6J * CBA/J)	decreased insulin secretion	J:196410
	impaired glucose tolerance	J:196410
Cdh1^tm2Kem/Cdh1^tm2Kem Tg(KRT14-cre)1Efu/0 Tg(Krt14-RNAi:Cdh3)1Efu/0 (involves: 129S1/Sv * 129X1/SvJ)	impaired skin barrier function	J:144091
Cdh2^em1Obir/Cdh2^em1Obir (C57BL/6JRcc-Cdh2^em1Obir)	decreased nervous system dopamine level	J:331911
Cdh2^{Gt(OST49160)Lex}/Cdh2^{Gt(OST49160)Lex} (involves: 129S5/SvEvBrd)	pericardial edema	J:95209
Cdh4^{tm1b(EUCOMM)Wtsi}/Cdh4^{tm1b(EUCOMM)Wtsi} (B6N(Cg)-Cdh4^{tm1b(EUCOMM)Wtsi}/J)	increased circulating sodium level	J:211773
	increased circulating total protein level	J:211773
Cdh5^tm1.1Ics/Cdh5^tm1.1Ics (B6.129(Cg)-Cdh5^tm1.1Ics)	edema	J:214298
Cdh5^{tm3(Cdh5/Ctnna1)Dvst}/Cdh5^{tm3(Cdh5/Ctnna1)Dvst} (B6.Cg-Cdh5^{tm3(Cdh5/Ctnna1)Dvst})	lymphedema	J:213676
Cdh9^{tm1b(KOMP)Wtsi}/Cdh9^{tm1b(KOMP)Wtsi} (C57BL/6N-Cdh9^{tm1b(KOMP)Wtsi}/Ics)	increased circulating cholesterol level	J:211773
Cdh11^em1(IMPC)Mbp/Cdh11^em1(IMPC)Mbp (C57BL/6N-Cdh11^em1(IMPC)Mbp/MbpMmucd)	increased circulating alkaline phosphatase level	J:211773
Cdh13^tm1Brns/Cdh13^tm1Brns (involves: 129)	increased circulating adiponectin level	J:132759
Cdh18^em1(IMPC)J/Cdh18^em1(IMPC)J (C57BL/6NJ-Cdh18^em1(IMPC)J/Mmjax)	decreased circulating calcium level	J:211773
Cdh20^em1(IMPC)J/Cdh20^em1(IMPC)J (C57BL/6NJ-Cdh20^em1(IMPC)J/Mmjax)	decreased circulating bilirubin level	J:211773
Cdh23^{tm2b(EUCOMM)Wtsi}/Cdh23^{tm2b(EUCOMM)Wtsi} (C57BL/6N-Cdh23^{tm2b(EUCOMM)Wtsi}/Wtsi)	decreased circulating calcium level	J:211773
	decreased circulating glucose level	J:211773
	decreased fasting circulating glucose level	J:211773
	increased circulating chloride level	J:211773
	increased circulating sodium level	J:211773
Cdin1^em1(IMPC)J/Cdin1⁺ (C57BL/6NJ-Cdin1^em1(IMPC)J/J)	increased circulating alanine transaminase level	J:211773
Cdipt^{tm1b(EUCOMM)Wtsi}/Cdipt⁺ (C57BL/6N-Cdipt^{tm1b(EUCOMM)Wtsi}/Bay)	decreased circulating lactate dehydrogenase level	J:211773
Cdk2^tm1Kald/Cdk2^tm1Kald Cdk4^tm1Kiyo/Cdk4^tm1Kiyo (involves: 129S1/Sv * C57BL/6)	edema	J:108720
Cdk4^{tm1b(NCOM)Mfgc}/Cdk4^{tm1b(NCOM)Mfgc} (C57BL/6N-Cdk4^{tm1b(NCOM)Mfgc}/Tcp)	edema	J:211773
Cdk4^tm1Bbd/Cdk4^tm1Bbd (involves: 129S1/Sv * 129X1/SvJ * ICR)	decreased circulating follicle stimulating hormone level	J:54534
	decreased circulating insulin level	J:54534
	decreased circulating progesterone level	J:54534
	hyperglycemia	J:54534
	increased urine glucose level	J:54534
	ketoaciduria	J:54534
Cdk4^tm1Kiyo/Cdk4^tm1Kiyo (involves: 129S1/Sv * C57BL/6)	increased urine glucose level	J:57854
Cdk4^wnch/Cdk4^wnch (C57BL/6JAnu-Cdk4^wnch)	abnormal glucose homeostasis	J:104190
Cdk5^tm1Kul/Cdk5^tm1Kul (involves: 129S4/SvJae * C57BL/6)	cyanosis	J:64289
Cdk5r1^tm1Lht/Cdk5r1^tm1Lht (involves: 129S4/SvJae)	increased serotonin level	J:204269
Cdk5rap1^tm1.2Tomik/Cdk5rap1^tm1.2Tomik (B6J.Cg-Cdk5rap1^tm1.2Tomik)	decreased circulating glucose level	J:220703
	decreased oxygen consumption	J:220703
Cdk5rap3^{tm1b(EUCOMM)Hmgu}/Cdk5rap3⁺ (C57BL/6N-Cdk5rap3^{tm1b(EUCOMM)Hmgu}/Ieg)	increased fasting circulating glucose level	J:211773
Cdk5rap3^{tm1c(EUCOMM)Hmgu}/Cdk5rap3^{tm1c(EUCOMM)Hmgu} Tg(Foxa3-cre)1Khk/0 (involves: 129S4/SvJaeSor * C57BL/6N * DBA)	decreased circulating cholesterol level	J:272566
	decreased circulating triglyceride level	J:272566
	decreased fasting circulating glucose level	J:272566
	hypoglycemia	J:272566
	increased circulating alanine transaminase level	J:272566
	increased circulating bilirubin level	J:272566
Cdk8^{tm1a(EUCOMM)Hmgu}/Cdk8^{tm1a(EUCOMM)Hmgu} Tg(Ins2-cre)23Herr/0 (involves: C57BL/6J * C57BL/6N * CBA/J)	decreased circulating insulin level	J:281075
	improved glucose tolerance	J:281075
	increased circulating glucose level	J:281075
	increased insulin secretion	J:281075
Cdk8^{tm1a(EUCOMM)Hmgu}/Cdk8^{tm1a(EUCOMM)Hmgu} Tg(Pdx1-cre)6Tuv/0 (involves: C57BL/6N * FVB/N)	improved glucose tolerance	J:281075
	increased insulin secretion	J:281075
Cdk12^em1(IMPC)Tcp/Cdk12⁺ (C57BL/6NCrl-Cdk12^em1(IMPC)Tcp/Tcp)	decreased circulating HDL cholesterol level	J:211773
Cdk13^{tm1a(EUCOMM)Hmgu}/Cdk13^{tm1a(EUCOMM)Hmgu} (involves: C57BL/6N)	nuchal edema	J:291583
	pericardial effusion	J:291583
Cdk13^{tm1d(EUCOMM)Hmgu}/Cdk13^{tm1d(EUCOMM)Hmgu} (involves: C57BL/6N * C57BL/6NTac)	pericardial effusion	J:291583
Cdk14^{tm1a(KOMP)Wtsi}/Cdk14^{tm1a(KOMP)Wtsi} (C57BL/6N-Cdk14^{tm1a(KOMP)Wtsi}/Wtsi)	decreased circulating magnesium level	J:211773
Cdk18^em1(IMPC)J/Cdk18^em1(IMPC)J (C57BL/6NJ-Cdk18^em1(IMPC)J/Mmjax)	increased circulating creatinine level	J:211773
Cdkal1^Gt(6062)Tgen/Cdkal1^Gt(6062)Tgen (involves: C57BL/6 * C57BL/6J * CBA/JNCrj)	abnormal glucose homeostasis	J:195460
	decreased circulating glucose level	J:195460
	decreased circulating insulin level	J:195460
	decreased insulin secretion	J:195460
	decreased liver triglyceride level	J:195460
	decreased skeletal muscle triglyceride level	J:195460
	increased circulating leptin level	J:195460
	increased liver triglyceride level	J:195460
	increased skeletal muscle triglyceride level	J:195460
Cdkal1^tm1.1Tomik/Cdkal1^tm1.1Tomik Tg(Ins2-cre)25Mgn/0 (B6.Cg-Cdkal1^tm1.1Tomik Tg(Ins2-cre)25Mgn)	abnormal insulin secretion	J:178248
	decreased insulin secretion	J:178248
	impaired glucose tolerance	J:178248
	increased circulating glucose level	J:178248
Cdkl2^{tm1b(EUCOMM)Hmgu}/Cdkl2^{tm1b(EUCOMM)Hmgu} (C57BL/6N-Cdkl2^{tm1b(EUCOMM)Hmgu}/Bay)	decreased circulating aspartate transaminase level	J:211773
	decreased circulating phosphate level	J:211773
	decreased circulating potassium level	J:211773
Cdkl4^{tm1.1(KOMP)Vlcg}/Cdkl4^{tm1.1(KOMP)Vlcg} (B6N(Cg)-Cdkl4^{tm1.1(KOMP)Vlcg}/J)	increased circulating alkaline phosphatase level	J:211773
Cdkl5^tm1dIcs/Y (C57BL/6N-Cdkl5^tm1dIcs/Ics)	decreased respiratory quotient	J:211773
Cdkn1a^tm1Led/Cdkn1a^tm1Led Gadd45a^tm1Ajf/Gadd45a^tm1Ajf (either: (involves: 129P2/OlaHsd * 129S6/SvEvTac * C57BL/6) or (involves: 129S6/SvEvTac * 129X1/SvJ * C57BL/6))	increased urine protein level	J:76041
Cdkn1a^tm1Tyj/Cdkn1a^tm1Tyj (involves: 129S2/SvPas)	increased circulating cholesterol level	J:118516
Cdkn1a^tm1Tyj/Cdkn1a^tm1Tyj (involves: 129S2/SvPas * C57BL/6)	increased urine protein level	J:60292
Cdkn1a^tm1Tyj/Cdkn1a^tm1Tyj Cdkn1b^tm1Ako/Cdkn1b^tm1Ako (involves: 129S1/Sv * 129S2/SvPas)	decreased circulating testosterone level	J:115443
	impaired glucose tolerance	J:118516
	increased circulating cholesterol level	J:118516
	insulin resistance	J:118516
Cdkn1b^tm1Ako/Cdkn1b^tm1Ako (involves: 129S1/Sv)	decreased circulating testosterone level	J:115443
Cdkn1b^tm1Ako/Cdkn1b^tm1Ako (involves: 129S1/Sv)	increased circulating cholesterol level	J:118516
Cdkn1b^tm1Ako/Cdkn1b^tm1Ako Cdkn2c^tm1Yxi/Cdkn2c^tm1Yxi (involves: 129/Sv * 129S1/Sv * C57BL/6 * DBA/2)	dehydration	J:50053
Cdkn1b^tm1Kin/Cdkn1b⁺ Irs2^tm1Mfw/Irs2^tm1Mfw (involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)	increased circulating glucose level	J:96047
	increased circulating insulin level	J:96047
Cdkn1b^tm1Kin/Cdkn1b⁺ Lepr^db/Lepr^db (involves: C57BL/6J * C57BLKS/J)	decreased body temperature	J:96047
	hyperglycemia	J:96047
	hyperlipidemia	J:96047
	increased circulating insulin level	J:96047
Cdkn1b^tm1Kin/Cdkn1b^tm1Kin Irs2^tm1Mfw/Irs2^tm1Mfw (involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)	increased circulating glucose level	J:96047
	increased circulating insulin level	J:96047
Cdkn1b^tm1Kin/Cdkn1b^tm1Kin Lepr^db/Lepr^db (involves: C57BL/6J * C57BLKS/J)	decreased body temperature	J:96047
	hyperlipidemia	J:96047
	increased circulating insulin level	J:96047
Cdkn1b^tm1Mlf/Cdkn1b^tm1Mlf Cdkn2d^tm1Maro/Cdkn2d^tm1Maro (involves: 129X1/SvJ * C57BL/6)	dehydration	J:58522
	photosensitivity	J:58522
Cdkn1b^tm2Kin/Cdkn1b^tm2Kin Rassf5^tm1Kina/Rassf5^tm1Kina (involves: C57BL/6 * CBA)	increased urine protein level	J:168749
Cdkn1c^{tm1.1(KOMP)Vlcg}/Cdkn1c⁺ (C57BL/6N-Cdkn1c^{tm1.1(KOMP)Vlcg}/MbpMmucd)	edema	J:211773
Cdkn1c^{tm1.1(KOMP)Vlcg}/Cdkn1c^{tm1.1(KOMP)Vlcg} (C57BL/6N-Cdkn1c^{tm1.1(KOMP)Vlcg}/MbpMmucd)	edema	J:211773
Cdkn1c^tm1Kat/Cdkn1c⁺ (involves: 129P2/OlaHsd * C57BL/6)	cyanosis	J:61190
Cdkn1c^tm1Kat/Cdkn1c⁺ (involves: 129P2/OlaHsd * C57BL/6)	increased urine protein level	J:102331
Cdkn1c^tm1Kat/Cdkn1c⁺ (involves: 129P2/OlaHsd)	increased urine protein level	J:102331
Cdkn1c^tm1Kat/Cdkn1c^tm1Kat (involves: 129P2/OlaHsd * C57BL/6)	cyanosis	J:61190
Cdkn1c^tm1Kat/Cdkn1c^tm1Kat (involves: 129P2/OlaHsd)	increased urine protein level	J:102331
Cdkn2a^tm1.1Brn/Cdkn2a⁺ Nf2^tm2Gth/Nf2^tm2Gth Trp53^tm1Brn/Trp53^tm1Brn (involves: 129P2/OlaHsd * 129S7/SvEvBrd)	pleural effusion	J:132943
Cdkn2a^tm1.1Gsu/Cdkn2a^tm1.1Gsu Kras^tm4Tyj/Kras⁺ Tg(Pdx1-cre)6Tuv/0 (involves: 129S4/SvJae * 129S4/SvJaeSor * C57BL/6J * FVB/N)	ascites	J:198619
Cdkn2a^tm2.1Rdp/Cdkn2a^tm2.1Rdp Kras^tm4Tyj/Kras⁺ Tg(Pdx1-cre)6Tuv/0 (involves: 129S4/SvJae * 129S6/SvEvTac * FVB/N)	ascites	J:198619
Cdkn2aip^em1(IMPC)J/Cdkn2aip^em1(IMPC)J (C57BL/6NJ-Cdkn2aip^em1(IMPC)J/Mmjax)	increased blood urea nitrogen level	J:211773
	increased circulating alkaline phosphatase level	J:211773
Cdkn2c^tm1Bbd/Cdkn2c^tm1Bbd (involves: 129S1/Sv * C57BL/6)	decreased circulating testosterone level	J:68829
Cdkn2c^tm1Bbd/Cdkn2c^tm1Bbd Cdkn2d^tm1Maro/Cdkn2d^tm1Maro (involves: 129P2/OlaHsd * 129S1/Sv * C57BL/6)	decreased circulating testosterone level	J:68829
	increased circulating follicle stimulating hormone level	J:68829
Cdkn2c^tm1Yxi/Cdkn2c^tm1Yxi (involves: 129/Sv * C57BL/6 * DBA/2)	dehydration	J:50053
Cdkn2d^tm1Maro/Cdkn2d^tm1Maro (involves: 129X1/SvJ * C57BL/6)	increased circulating follicle stimulating hormone level	J:68829
Cdkn3^em1(IMPC)J/Cdkn3^em1(IMPC)J (C57BL/6NJ-Cdkn3^em1(IMPC)J/J)	increased circulating alkaline phosphatase level	J:211773
Cdnf^tm1.1Uhb/Cdnf^tm1.1Uhb (either: B6JRcc.129P2(Cg)-Cdnf^tm1.1Uhb or (involves: 129P2/OlaHsd * C57BL/6JRcc * ICR))	abnormal dopamine level	J:285339
	increased nervous system dopamine level	J:285339
Cdnf^tm1Uhb/Cdnf^tm1Uhb (involves: 129P2/OlaHsd)	hydropic allantois	J:285339
Cdo1^tm1.1Mhst/Cdo1^tm1.1Mhst (involves: C57BL/6)	decreased circulating glucose level	J:182195
	decreased circulating insulin-like growth factor I level	J:182195
	decreased taurine level	J:182195
	increased circulating cysteine level	J:182195
	increased cysteine level	J:182195
Cdo1^tm1Mhst/Cdo1^tm1Mhst Speer6-ps1^{Tg(Alb-cre)21Mgn}/Speer6-ps1⁺ (involves: C57BL/6 * DBA)	abnormal blood homeostasis	J:186922
	abnormal homeostasis	J:186922
	decreased circulating cysteine level	J:186922
	decreased cysteine level	J:186922
Cdsn^tm1.1Ics/Cdsn^tm1.1Ics Tg(KRT14-cre)1Ipc/0 (involves: 129S2/SvPas * C57BL/6 * SJL)	impaired skin barrier function	J:153292
Cdsn^tm1.1Ics/Cdsn^tm1.1Ics Tg(KRT14-cre/ERT2)1Ipc/0 (involves: 129S2/SvPas)	impaired skin barrier function	J:153292
Cdx2^tm1Fbe/Cdx2⁺ Cdx4^tm1.1Jdes/Y (involves: 129 * C57BL/6 * CBA * FVB)	edema	J:104372
Ceacam2^tm1Snaj/Ceacam2^tm1Snaj (involves: 129S4/SvJae * C57BL/6)	abnormal glucose homeostasis	J:181979
	abnormal glycogen homeostasis	J:181979
	decreased carbon dioxide production	J:181979
	decreased circulating triglyceride level	J:181979
	decreased energy expenditure	J:181979
	decreased fatty acid oxidation	J:181979
	decreased oxygen consumption	J:181979
	decreased respiratory quotient	J:181979
	impaired glucose tolerance	J:181979
	increased circulating insulin level	J:181979
	increased circulating leptin level	J:181979
	increased insulin secretion	J:181979
	increased skeletal muscle triglyceride level	J:181979
	insulin resistance	J:181979
Ceacam3^{em1(IMPC)Wtsi}/Ceacam3^{em1(IMPC)Wtsi} (C57BL/6N-Ceacam3^{em1(IMPC)Wtsi}/WtsiCnrm)	decreased circulating fructosamine level	J:211773
	decreased circulating total protein level	J:211773
	increased circulating amylase level	J:211773
Ceacam16^{tm1.1(KOMP)Wtsi}/Ceacam16^{tm1.1(KOMP)Wtsi} (B6N(Cg)-Ceacam16^{tm1.1(KOMP)Wtsi}/J)	decreased circulating free fatty acids level	J:211773
	increased circulating sodium level	J:211773
Ceacam23^{em1(IMPC)Wtsi}/Ceacam23^{em1(IMPC)Wtsi} (C57BL/6N-Ceacam23^{em1(IMPC)Wtsi}/WtsiOulu)	increased circulating HDL cholesterol level	J:211773
Cebpa^m4443Dajl/Cebpa^m4443Dajl (involves: C3H/HeSnJ * C57BL/6J * SWR)	increased circulating cholesterol level	J:149088
	increased circulating HDL cholesterol level	J:149088
	increased circulating LDL cholesterol level	J:149088
	increased circulating triglyceride level	J:149088
Cebpa^{tm1.1(Cebpb)Ylee}/Cebpa^{tm1.1(Cebpb)Ylee} (involves: 129X1/SvJ * C57BL/6 * FVB/N)	decreased circulating leptin level	J:77646
Cebpa^tm1Gjd/Cebpa^tm1Gjd (involves: 129S7/SvEvBrd * C57BL/6)	abnormal energy expenditure	J:28320
	abnormal gluconeogenesis	J:28320
	abnormal glucose homeostasis	J:28320
	abnormal glycogen homeostasis	J:28320
	abnormal lipid homeostasis	J:28320
	decreased circulating serum albumin level	J:28320
	decreased liver glycogen level	J:28320
	hypoglycemia	J:28320
	increased circulating tyrosine level	J:28320
Cebpa^tm1Gonz/Cebpa^tm1Gonz Lep^ob/Lep^ob Tg(Alb1-cre)1Dlr/0 (involves: 129X1/SvJ * C57BL/6J * FVB/N)	abnormal lipid homeostasis	J:93579
	decreased circulating cholesterol level	J:93579
	decreased circulating HDL cholesterol level	J:93579
	decreased circulating insulin level	J:93579
	decreased circulating LDL cholesterol level	J:93579
	decreased liver cholesterol level	J:93579
	decreased liver triglyceride level	J:93579
	decreased susceptibility to diet-induced obesity	J:93579
	impaired glucose tolerance	J:93579
	increased circulating free fatty acids level	J:93579
	increased circulating glucose level	J:93579
	increased circulating VLDL cholesterol level	J:93579
	increased liver glycogen level	J:93579
	insulin resistance	J:93579
Cebpa^tm1Gonz/Cebpa^tm1Gonz Tg(Alb1-cre)1Dlr/0 (involves: 129X1/SvJ * FVB/N)	increased circulating free fatty acids level	J:93579
Cebpa^tm1Kgx/Cebpa^tm1Kgx (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	abnormal glucose homeostasis	J:35795
	abnormal lipid homeostasis	J:89611, J:35795
	decreased liver glycogen level	J:35795
	hypoglycemia	J:35795
Cebpa^tm1Timc/Cebpa^tm1Timc (Not Specified)	decreased circulating glucose level	J:163725
	increased circulating alanine transaminase level	J:163725
	increased circulating aspartate transaminase level	J:163725
	increased circulating triglyceride level	J:163725
Cebpa^tm5Nerl/Cebpa^tm5Nerl (involves: 129P2/OlaHsd * C57BL/6)	increased liver triglyceride level	J:120098
Cebpa^tm6Nerl/Cebpa^tm6Nerl (involves: 129P2/OlaHsd * C57BL/6)	abnormal circulating insulin level	J:120098
	decreased liver glycogen level	J:120098
	impaired glucose tolerance	J:120098
	increased circulating glucose level	J:120098
Cebpa^tm8.1Nerl/Cebpa^tm8.1Nerl (involves: 129P2/OlaHsd * BALB/cJ * C57BL/6)	hypoglycemia	J:136134
Cebpb^tm1.1Elgaz/Cebpb^tm1.1Elgaz Lyz2^{em1.1(cre)Elgaz}/Lyz2⁺ (BALB/cJ-Cebpb^tm1.1Elgaz Lyz2^em1.1Elgaz/Elgaz)	decreased circulating interleukin-10 level	J:247885
	decreased transforming growth factor beta level	J:247885
	increased circulating interleukin-6 level	J:247885
	increased circulating tumor necrosis factor level	J:247885
Cebpb^tm1.1Maka/Cebpb^tm1.1Maka Ins2^Akita/Ins2^Akita Tg(Ins2-cre)23Herr/0 (involves: 129P2/OlaHsd * C57BL/6J * C57BL/6NSlc * CBA/J)	decreased circulating insulin level	J:156725
	decreased insulin secretion	J:156725
	increased circulating glucose level	J:156725
Cebpb^tm1.1Maka/Cebpb^tm1.1Maka Lepr^db/Lepr^db Tg(Ins2-cre)23Herr/0 (involves: 129P2/OlaHsd * C57BL/6J * C57BLKS/J * CBA/J)	hyperglycemia	J:156725
	increased circulating insulin level	J:156725
Cebpb^tm1.1Maka/Cebpb^tm1.1Maka Tg(Ins2-cre)23Herr/0 (involves: 129P2/OlaHsd * C57BL/6J * CBA/J)	increased insulin secretion	J:156725
Cebpb^tm1Pfj/Cebpb^tm1Pfj (involves: 129S1/Sv * C57BL/6)	abnormal tumor necrosis factor level	J:192313
Cebpb^tm1Vpo/Cebpb^tm1Vpo (involves: 129S/SvEv * MF1)	abnormal circulating free fatty acids level	J:52286
	abnormal enzyme/coenzyme level	J:52286
	abnormal gluconeogenesis	J:52286
	abnormal glucose homeostasis	J:62132, J:52286
	abnormal lipid homeostasis	J:62132, J:52286
	decreased circulating free fatty acids level	J:62132, J:52286
	decreased circulating insulin level	J:62132
	decreased circulating interleukin-12 level	J:25215
	decreased circulating leptin level	J:62132
	decreased circulating triglyceride level	J:52286
	decreased glycogen catabolism rate	J:52286
	hemosiderosis	J:25215
	hypoglycemia	J:62132, J:52286
	impaired lipolysis	J:62132
	increased circulating corticosterone level	J:52286
	increased circulating interleukin-6 level	J:25215
	increased insulin sensitivity	J:62132
Cebpb^tm1Vpo/Cebpb^tm1Vpo (involves: 129S/SvEv * C57BL/6 * MF1)	abnormal gluconeogenesis	J:49673
	abnormal glucose homeostasis	J:49673
	hypoglycemia	J:49673
Cebpb^tm1Vpo/Cebpb^tm1Vpo (involves: 129S/SvEv * C57BL/6)	decreased triglyceride level	J:117502
	impaired adaptive thermogenesis	J:117502
	increased circulating glucose level	J:117502
	increased circulating triglyceride level	J:117502
Cebpb^tm2.1Acle/Cebpb^tm2.1Acle (involves: 129P2/OlaHsd * BALB/cJ * C57BL/6)	increased circulating interleukin-6 level	J:155795
Cebpd^tm1Pfj/Cebpd⁺ (involves: 129S1/Sv)	abnormal urine homeostasis	J:116932
	decreased circulating lactate level	J:116932
	increased urine uric acid level	J:116932
Cebpd^tm1Pfj/Cebpd^tm1Pfj (involves: 129S1/Sv * C57BL/6)	abnormal cytokine level	J:192313
Cebpd^tm1Pfj/Cebpd^tm1Pfj (involves: 129S1/Sv)	abnormal urine homeostasis	J:116932
	decreased blood uric acid level	J:116932
	decreased circulating lactate level	J:116932
	increased urine uric acid level	J:116932
Cecr2^{tm2b(EUCOMM)Hmgu}/Cecr2⁺ (C57BL/6N-Cecr2^{tm2b(EUCOMM)Hmgu}/Tcp)	increased circulating alkaline phosphatase level	J:211773
Cel^tm1Dyh/Cel^tm1Dyh (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	abnormal intestinal lipid absorption	J:124658
Cel^tm1Dyh/Cel^tm1Dyh (involves: 129S1/Sv * 129X1/SvJ * Black Swiss)	abnormal intestinal lipid absorption	J:32099
Cel^tm1Dyh/Cel^tm1Dyh Pnlip^tm1Dyh/Pnlip^tm1Dyh (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	abnormal intestinal lipid absorption	J:124658
	decreased circulating cholesterol level	J:124658
	decreased circulating insulin level	J:124658
	decreased intestinal cholesterol absorption	J:124658
	decreased susceptibility to diet-induced obesity	J:124658
	insulin resistance	J:124658
Cel^tm1Eaf/Cel^tm1Eaf (involves: 129S4/SvJae)	abnormal intestinal lipid absorption	J:54090
Celf4^{tm1a(EUCOMM)Wtsi}/Celf4⁺ (C57BL/6N-Celf4^{tm1a(EUCOMM)Wtsi}/Wtsi)	decreased circulating calcium level	J:211773
	decreased circulating cholesterol level	J:211773
	impaired glucose tolerance	J:211773
	increased circulating insulin level	J:211773
Celf6^tm1.2Jdd/Celf6^tm1.2Jdd (involves: C57BL/6)	decreased dopamine level	J:194266
	decreased noradrenaline level	J:194266
	decreased serotonin level	J:194266
Celsr3^tm1Agof/Celsr3^tm1Agof (either: CD-1.129P2-Celsr3^tm1Agof or (involves: 129P2/OlaHsd * C57BL/6 * CD-1))	cyanosis	J:98367
Cemip2^tm1.1Cya/Cemip2^tm1.1Cya Tg(CAG-cre/Esr1)5Amc/0 (involves: C57BL/6 CBA)	increased circulating hyaluronic acid level	J:317425
	increased hyaluronic acid level	J:317425
Cenpe^{tm1b(EUCOMM)Hmgu}/Cenpe⁺ (C57BL/6N-Cenpe^{tm1b(EUCOMM)Hmgu}/Cnrm)	increased circulating lipase level	J:211773
	increased fasting circulating glucose level	J:211773
Cenph^{tm1b(EUCOMM)Hmgu}/Cenph⁺ (C57BL/6N-Cenph^{tm1b(EUCOMM)Hmgu}/Ieg)	decreased circulating HDL cholesterol level	J:211773
Cenpj^{tm1a(EUCOMM)Wtsi}/Cenpj^{tm1a(EUCOMM)Wtsi} (B6Brd;B6N-Tyr^c-Brd Cenpj^{tm1a(EUCOMM)Wtsi}/Wtsi)	abnormal glucose tolerance	J:194085
	decreased circulating serum albumin level	J:194085
Cenpj^{tm1a(EUCOMM)Wtsi}/Cenpj^{tm1a(EUCOMM)Wtsi} (B6JTyr;B6N-Cenpj^{tm1a(EUCOMM)Wtsi}/Wtsi)	decreased circulating calcium level	J:175295
	decreased circulating serum albumin level	J:175295
	decreased circulating total protein level	J:175295
Cenpo^{tm1b(KOMP)Mbp}/Cenpo⁺ (B6N(Cg)-Cenpo^{tm1b(KOMP)Mbp}/J)	decreased blood urea nitrogen level	J:211773
	decreased circulating calcium level	J:211773
	decreased circulating cholesterol level	J:211773
	decreased circulating free fatty acids level	J:211773
	decreased circulating glucose level	J:211773
	decreased circulating HDL cholesterol level	J:211773
	decreased circulating iron level	J:211773
	decreased circulating triglyceride level	J:211773
Cep19^tm1.1Jmgi/Cep19^tm1.1Jmgi (involves: 129S2/SvPas * C57BL/6J)	decreased oxygen consumption	J:206667
	increased respiratory quotient	J:206667
Cep19^tm2.1Jmgi/Cep19^tm2.1Jmgi (involves: C57BL/6NTac)	impaired glucose tolerance	J:206667
	increased circulating glucose level	J:206667
	increased circulating triglyceride level	J:206667
	insulin resistance	J:206667
Cep20^{tm1.1(KOMP)Vlcg}/Cep20^{tm1.1(KOMP)Vlcg} (B6(Cg)-Cep20^{tm1.1(KOMP)Vlcg})	pericardial edema	J:308526
Cep43^{tm1b(EUCOMM)Hmgu}/Cep43⁺ (C57BL/6N-Cep43^{tm1b(EUCOMM)Hmgu}/Ieg)	increased circulating alkaline phosphatase level	J:211773
Cep57l1^{tm1b(KOMP)Wtsi}/Cep57l1⁺ (B6N(Cg)-Cep57l1^{tm1b(KOMP)Wtsi}/2J)	increased fasting circulating glucose level	J:211773
Cep83^{tm1.1(KOMP)Vlcg}/Cep83^{tm1.1(KOMP)Vlcg} (C57BL/6N-Cep83^{tm1.1(KOMP)Vlcg}/Tcp)	edema	J:211773
Cep126^{tm1b(KOMP)Mbp}/Cep126^{tm1b(KOMP)Mbp} (C57BL/6N-Cep126^{tm1b(KOMP)Mbp}/J)	increased fasting circulating glucose level	J:211773
Cep135^em1(IMPC)J/Cep135⁺ (C57BL/6NJ-Cep135^em1(IMPC)J/J)	decreased circulating serum albumin level	J:211773
Cep135^em1(IMPC)J/Cep135⁺ (C57BL/6NJ-Cep135^em1(IMPC)J/J)	increased circulating total protein level	J:211773
Cep135^em1(IMPC)J/Cep135^em1(IMPC)J (C57BL/6NJ-Cep135^em1(IMPC)J/J)	edema	J:211773
Cep164^{tm1a(EUCOMM)Wtsi}/Cep164^{tm1a(EUCOMM)Wtsi} (involves: C57BL/6N)	pericardial edema	J:255142
Cep295nl^{tm1.1(KOMP)Vlcg}/Cep295nl^{tm1.1(KOMP)Vlcg} (B6N(Cg)-Cep295nl^{tm1.1(KOMP)Vlcg}/J)	increased circulating sodium level	J:211773
Cept1^tm1.1Sem/Cept1^tm1.1Sem Tg(ACTA1-cre)79Jme/0 (involves: C57BL/6J * SJL)	decreased circulating glucose level	J:249456
	improved glucose tolerance	J:249456
	increased insulin sensitivity	J:249456
	increased respiratory quotient	J:249456
cerbo/cerbo (involves: C57BL/6 * FVB/N)	cardiac edema	J:173681
cerbo/cerbo (involves: C57BL/6 * FVB/N)	nuchal edema	J:173681
Cerk^tm1Fbor/Cerk^tm1Fbor (involves: BALB/c)	abnormal ceramide level	J:137892
Cers1^fln/Cers1^fln (NOD.Cg-Cers1^fln/Sz)	abnormal lipid homeostasis	J:172719
Cers1^fln/Cers1^fln (NOD.Cg-Cers1^fln/Sz)	abnormal lipid level	J:172719
Cers1^tm1.1Kwi/Cers1^tm1.1Kwi (involves: 129P2/OlaHsd * C57BL/6)	abnormal lipid homeostasis	J:193419
	abnormal lipid level	J:193419
Cers2^{Gt(S16-4B1)Sor}/Cers2^{Gt(S16-4B1)Sor} (involves: 129S4/SvJaeSor * C57BL/6)	abnormal lipid homeostasis	J:156841
Cers3^tm1.1Rsnd/Cers3^tm1.1Rsnd (involves: 129P2/OlaHsd * C57BL/6)	abnormal lipid level	J:179754
	dehydration	J:179754
	impaired skin barrier function	J:179754
Cers4^tm1.1Kwi/Cers4^tm1.1Kwi (involves: 129P2/OlaHsd * C57BL/6)	abnormal ceramide level	J:213606
	abnormal sphingomyelin level	J:213606
Cers5^{tm2b(KOMP)Mbp}/Cers5^{tm2b(KOMP)Mbp} (B6N(Cg)-Cers5^{tm2b(KOMP)Mbp}/J)	increased circulating sodium level	J:211773
Cers6^tm1.1Arte/Cers6^tm1.1Arte (involves: BALB/cJ * C57BL/6N)	abnormal ceramide level	J:215519
	decreased circulating insulin level	J:215519
	decreased circulating leptin level	J:215519
	decreased susceptibility to diet-induced obesity	J:215519
	enhanced lipolysis	J:215519
	improved glucose tolerance	J:215519
	increased energy expenditure	J:215519
	increased fatty acid oxidation	J:215519
Cers6^tm1.1Kwi/Cers6^tm1.1Kwi (involves: 129P2/OlaHsd * C57BL/6)	abnormal lipid homeostasis	J:201327
Cers6^tm1Arte/Cers6^tm1Arte Tg(Alb1-cre)7Gsc/0 (involves: C57BL/6N * FVB/N)	abnormal ceramide level	J:215519
	decreased susceptibility to diet-induced obesity	J:215519
	improved glucose tolerance	J:215519
Cert1^{Gt(RRF047)Byg}/Cert1^{Gt(RRF047)Byg} (involves: 129P2/OlaHsd * C57BL/6)	abnormal lipid homeostasis	J:146172
Ces1c^b/Ces1c^b Ces1e^h/Ces1e^h (B6.YBR-Ces1c^b Ces1e^h)	abnormal enzyme/coenzyme level	J:111387, J:109947
Ces1c^tm1.1Loc/Ces1c^tm1.1Loc (C57BL/6-Ces1c^tm1.1Loc)	decreased body temperature	J:168821
Ces1d^em1(IMPC)Mbp/Ces1d^em1(IMPC)Mbp (C57BL/6NCrl-Ces1d^em1(IMPC)Mbp/Mmucd)	increased circulating alanine transaminase level	J:211773
	increased circulating aspartate transaminase level	J:211773
Ces1d^tm1Reli/Ces1d^tm1Reli (involves: 129S6/SvEvTac)	abnormal circulating lipid level	J:158743
	decreased circulating adiponectin level	J:158743
	decreased circulating cholesterol level	J:158743
	decreased circulating free fatty acids level	J:158743
	decreased circulating glucose level	J:158743
	decreased circulating glycerol level	J:158743
	decreased circulating triglyceride level	J:158743
	decreased circulating VLDL cholesterol level	J:158743
	decreased circulating VLDL triglyceride level	J:158743
	decreased liver triglyceride level	J:158743
	improved glucose tolerance	J:158743
	increased insulin sensitivity	J:158743
	increased oxygen consumption	J:158743
	increased respiratory quotient	J:158743
Ces1g^tm1Reli/Ces1g^tm1Reli (involves: 129S/SvEv * C57BL/6)	abnormal apolipoprotein level	J:262803
	abnormal circulating apolipoprotein E level	J:262803
	abnormal circulating apolipoprotein level	J:262803
	abnormal glucose homeostasis	J:262803
	abnormal lipid homeostasis	J:262803
	decreased carbon dioxide production	J:262803
	decreased energy expenditure	J:262803
	decreased fasting circulating glucose level	J:262803
	decreased oxygen consumption	J:262803
	decreased respiratory quotient	J:262803
	decreased saturated fatty acids level	J:262803
	hyperlipidemia	J:262803
	impaired adaptive thermogenesis	J:262803
	increased circulating cholesterol level	J:262803
	increased circulating free fatty acids level	J:262803
	increased circulating insulin level	J:262803
	increased circulating phospholipid level	J:262803
	increased circulating triglyceride level	J:262803
	increased circulating VLDL cholesterol level	J:262803
	increased circulating VLDL triglyceride level	J:262803
	increased insulin sensitivity	J:262803
	increased liver cholesterol level	J:262803
	increased liver triglyceride level	J:262803
	increased respiratory quotient	J:262803
	increased unsaturated fatty acids level	J:262803
	insulin resistance	J:262803
Ces2c^em1(IMPC)J/Ces2c^em1(IMPC)J (C57BL/6NJ-Ces2c^em1(IMPC)J/Mmjax)	decreased circulating calcium level	J:211773
Ces3b^em1(IMPC)J/Ces3b^em1(IMPC)J (C57BL/6NJ-Ces3b^em1(IMPC)J/Mmjax)	abnormal cholesterol homeostasis	J:211773
Cfap36^{tm1a(EUCOMM)Wtsi}/Cfap36^{tm1a(EUCOMM)Wtsi} (C57BL/6N-Cfap36^{tm1a(EUCOMM)Wtsi}/Wtsi)	decreased circulating alkaline phosphatase level	J:175295
	increased circulating sodium level	J:175295
Cfap44^{tm1a(EUCOMM)Wtsi}/Cfap44^{tm1a(EUCOMM)Wtsi} (C57BL/6N-Cfap44^{tm1a(EUCOMM)Wtsi}/Wtsi)	decreased circulating serum albumin level	J:211773
Cfap53^{em1(IMPC)Wtsi}/Cfap53^{em1(IMPC)Wtsi} (C57BL/6N-Cfap53^{em1(IMPC)Wtsi}/Wtsi)	retropleural edema	J:239583
	subcutaneous edema	J:239583
Cfap61^{tm2a(EUCOMM)Wtsi}/Cfap61^{tm2a(EUCOMM)Wtsi} (C57BL/6N-Cfap61^{tm2a(EUCOMM)Wtsi}/Wtsi)	increased blood urea nitrogen level	J:211773
Cfap119^{tm1b(EUCOMM)Hmgu}/Cfap119^{tm1b(EUCOMM)Hmgu} (C57BL/6N-Cfap119^{tm1b(EUCOMM)Hmgu}/Ics)	increased circulating cholesterol level	J:211773
	increased circulating HDL cholesterol level	J:211773
Cfb^{tm1.1(KOMP)Wtsi}/Cfb^{tm1.1(KOMP)Wtsi} (C57BL/6N-Cfb^{tm1.1(KOMP)Wtsi}/J)	decreased circulating phosphate level	J:211773
	increased fasting circulating glucose level	J:211773
Cfb^tm1Hrc/Cfb⁺ Cfh^tm1Mbo/Cfh^tm1Mbo (involves: 129S/Sv * C57BL/6)	decreased circulating complement protein level	J:78193
Cfh^tm1.1Song/Cfh^tm1.1Song (involves: C57BL/6)	abnormal blood coagulation	J:240426
	abnormal blood homeostasis	J:240426
	abnormal brain thrombosis	J:240426
	abnormal glomerular capillary thrombosis	J:240426
	abnormal hepatic portal vein thrombosis	J:240426
	abnormal kidney thrombosis	J:240426
	abnormal kidney venous thrombosis	J:240426
	abnormal lung thrombosis	J:240426
	abnormal thrombosis	J:240426
	decreased circulating complement protein level	J:240426
	decreased complement C5 level	J:240426
	increased blood urea nitrogen level	J:240426
	increased creatine level	J:240426
Cfh^tm1Mbo/Cfh⁺ (involves: 129/Sv * C57BL/6)	decreased circulating complement protein level	J:78193
Cfh^tm1Mbo/Cfh^tm1Mbo (involves: 129/Sv * C57BL/6)	albuminuria	J:78193
	decreased circulating complement protein level	J:78193
	hematuria	J:78193
	increased urine protein level	J:78193
Cfh^tm1Mbo/Cfh^tm1Mbo (involves: 129)	abnormal complement protein level	J:125860
Cfh^tm1Mbo/Cfh^tm1Mbo (involves: 129)	decreased circulating complement protein level	J:125860, J:131403
Cfh^tm1Mbo/Cfh^tm1Mbo Cfi^tm1Mcp/Cfi^tm1Mcp (involves: 129/Sv * C57BL/6)	abnormal circulating protein level	J:131403
Cfh^tm1Mbo/Cfh^tm1Mbo Tg(CAG-Cfh)#Mcp/0 (involves: 129/Sv C57BL/6 * CBA)	abnormal circulating complement protein level	J:125860
	abnormal complement protein level	J:125860
	abnormal kidney thrombosis	J:125860
	anasarca	J:125860
	hematuria	J:125860
	increased blood urea nitrogen level	J:125860
Cfi^em1Jiwe/Cfi^em1Jiwe (involves: C57BL/6J)	abnormal complement protein level	J:308307
Cfi^{tm1b(EUCOMM)Hmgu}/Cfi^{tm1b(EUCOMM)Hmgu} (C57BL/6N-Cfi^{tm1b(EUCOMM)Hmgu}/H)	increased circulating alanine transaminase level	J:211773
Cfi^tm1Mcp/Cfi^tm1Mcp (involves: 129/Sv * C57BL/6)	decreased circulating complement protein level	J:131403
Cfl1^c5/Cfl1^c5 (involves: C57BL/6J)	pericardial edema	J:194042
Cfl1^tm1.1Wit/Cfl1^tm1.1Wit Tg(NPHS2-cre)295Lbh/0 (involves: 129 * C57BL/6 * SJL)	ascites	J:165315
	increased circulating creatinine level	J:165315
	increased urine protein level	J:165315
Cflar^tm1Mak/Cflar^tm1Mak (either: (involves: 129P2/OlaHsd * C57BL/6J) or (involves: 129P2/OlaHsd * CD-1))	pericardial edema	J:63049
Cftr^tm1Kth/Cftr^tm1Kth (involves: 129S7/SvEvBrd * C57BL/6J)	abnormal fluid regulation	J:29074
	abnormal ion homeostasis	J:29074
Cftr^tm1Unc/Cftr^tm1Unc (B6.129P2-Cftr^tm1Unc/J)	abnormal phospholipid level	J:58571
Cga^tm1Sac/Cga^tm1Sac (involves: 129S2/SvPas * C57BL/6J)	decreased circulating follicle stimulating hormone level	J:28450
	decreased circulating luteinizing hormone level	J:28450
	decreased circulating testosterone level	J:28450
	decreased circulating thyroid-stimulating hormone level	J:28450
Cgas^{tm1a(EUCOMM)Hmgu}/Cgas^{tm1a(EUCOMM)Hmgu} (C57BL/6N-Cgas^{tm1a(EUCOMM)Hmgu})	decreased circulating interferon-alpha level	J:201167
	decreased circulating interferon-beta level	J:201167
Cgn^{tm1b(KOMP)Wtsi}/Cgn^{tm1b(KOMP)Wtsi} (B6N(Cg)-Cgn^{tm1b(KOMP)Wtsi}/J)	cyanosis	J:211773
Cgnl1^em1(IMPC)Mbp/Cgnl1^em1(IMPC)Mbp (C57BL/6NCrl-Cgnl1^em1(IMPC)Mbp/Mmucd)	increased blood urea nitrogen level	J:211773
Cgref1^em1(IMPC)J/Cgref1^em1(IMPC)J (C57BL/6NJ-Cgref1^em1(IMPC)J/Mmjax)	decreased circulating alkaline phosphatase level	J:211773
Cgrrf1^{tm1b(KOMP)Wtsi}/Cgrrf1^{tm1b(KOMP)Wtsi} (C57BL/6N-Cgrrf1^{tm1b(KOMP)Wtsi}/Wtsi)	decreased circulating serum albumin level	J:211773
Chab1^AKR/J/Chab1^AKR/J (involves: AKR/J * DBA/2J)	increased intestinal cholesterol absorption	J:72737
Chab1^AKR/J/Chab1^DBA/2J (involves: AKR/J * DBA/2J)	increased intestinal cholesterol absorption	J:72737
Chab2^AKR/J/Chab2^AKR/J (involves: AKR/J * DBA/2J)	increased intestinal cholesterol absorption	J:72737
Chab2^AKR/J/Chab2^DBA/2J (involves: AKR/J * DBA/2J)	increased intestinal cholesterol absorption	J:72737
Chab3^AKR/J/Chab3^AKR/J (involves: AKR/J * DBA/2J)	increased intestinal cholesterol absorption	J:72737
Chab3^AKR/J/Chab3^DBA/2J (involves: AKR/J * DBA/2J)	increased intestinal cholesterol absorption	J:72737
Chab4^AKR/J/Chab4^AKR/J (involves: AKR/J * DBA/2J)	increased intestinal cholesterol absorption	J:72737
Chab4^AKR/J/Chab4^DBA/2J (involves: AKR/J * DBA/2J)	increased intestinal cholesterol absorption	J:72737
Chab5^AKR/J/Chab5^AKR/J (involves: AKR/J * DBA/2J)	increased intestinal cholesterol absorption	J:72737
Chab5^AKR/J/Chab5^DBA/2J (involves: AKR/J * DBA/2J)	increased intestinal cholesterol absorption	J:72737
Chab6^129P3/J/Chab6^SJL/J (involves: 129P3/J * SJL/J)	decreased intestinal cholesterol absorption	J:72737
Chab6^SJL/J/Chab6^SJL/J (involves: 129P3/J * SJL/J)	decreased intestinal cholesterol absorption	J:72737
Chab7^129P3/J/Chab7^SJL/J (involves: 129P3/J * SJL/J)	decreased intestinal cholesterol absorption	J:72737
Chab7^SJL/J/Chab7^SJL/J (involves: 129P3/J * SJL/J)	decreased intestinal cholesterol absorption	J:72737
Chaf1b^{tm1b(EUCOMM)Hmgu}/Chaf1b⁺ (C57BL/6N-Chaf1b^{tm1b(EUCOMM)Hmgu}/Ieg)	decreased circulating calcium level	J:211773
	decreased circulating serum albumin level	J:211773
	increased circulating amylase level	J:211773
	increased circulating lipase level	J:211773
Champ1^em1(IMPC)Mbp/Champ1⁺ (C57BL/6NCrl-Champ1^em1(IMPC)Mbp/MbpMmucd)	edema	J:211773
Champ1^em1(IMPC)Mbp/Champ1^em1(IMPC)Mbp (C57BL/6NCrl-Champ1^em1(IMPC)Mbp/MbpMmucd)	edema	J:211773
Chat/Slc18a3^tm1.1Vpra/Chat/Slc18a3^tm1.1Vpra (involves: 129S4/SvJae * C57BL/6J)	cyanosis	J:153908
	increased acetylcholine level	J:153908
Chat/Slc18a3^tm1.1Vpra/Chat⁺ (involves: 129S4/SvJae * C57BL/6J)	increased acetylcholine level	J:153908
Chat/Slc18a3^tm1.1Vpra/Chat/Slc18a3^tm1.1Vpra (involves: 129S4/SvJae * C57BL/6J)	cyanosis	J:153908
	increased acetylcholine level	J:153908
Chat/Slc18a3^tm1.1Vpra/Slc18a3⁺ (involves: 129S4/SvJae * C57BL/6J)	increased acetylcholine level	J:153908
Chat^tm2(cre)Lowl/Chat⁺ Cpeb2^tm1.1Yshu/Cpeb2^tm1.1Yshu (involves: C57BL/6 * C57BL/6J * C57BL/6NJ * SJL/J)	increased acetylcholine level	J:237513
Chchd4^{Gt(IST11943B12)Tigm}/Chchd4⁺ (involves: C57BL/6N)	decreased susceptibility to diet-induced obesity	J:250035
Chchd10^em1(IMPC)H/Chchd10^em1(IMPC)H (C57BL/6N-Chchd10^em1(IMPC)H/H)	increased blood urea nitrogen level	J:211773
	increased circulating creatinine level	J:211773
	increased circulating potassium level	J:211773
Chchd10^em1(IMPC)Mbp/Chchd10^em1(IMPC)Mbp (C57BL/6NCrl-Chchd10^em1(IMPC)Mbp/Mmucd)	increased circulating phosphate level	J:211773
Chct1^{tm1b(EUCOMM)Wtsi}/Chct1^{tm1b(EUCOMM)Wtsi} (C57BL/6N-Chct1^{tm1b(EUCOMM)Wtsi}/Bay)	increased circulating calcium level	J:211773
Chd2^{Gt(RRBO46)Byg}/Chd2⁺ (involves: 129P2/OlaHsd * C57BL/6)	lipidosis	J:146743
	pulmonary alveolar edema	J:146743
Chd2^{tm1b(EUCOMM)Hmgu}/Chd2^{tm1b(EUCOMM)Hmgu} (C57BL/6N-Chd2^{tm1b(EUCOMM)Hmgu}/Tcp)	increased circulating alanine transaminase level	J:211773
	increased circulating aspartate transaminase level	J:211773
Chd3^em1(IMPC)J/Chd3^em1(IMPC)J (C57BL/6NJ-Chd3^em1(IMPC)J/Mmjax)	decreased circulating phosphate level	J:211773
Chd6^em1(IMPC)Mbp/Chd6^em1(IMPC)Mbp (C57BL/6N-Chd6^em1(IMPC)Mbp/MbpMmucd)	abnormal cholesterol homeostasis	J:211773
Chd7^{Gt(S20-7E1)Sor}/Chd7⁺ (129S1.129S4(B6)-Chd7^{Gt(S20-7E1)Sor})	decreased circulating follicle stimulating hormone level	J:174086
	decreased circulating luteinizing hormone level	J:174086
Chd7^Looper/Chd7⁺ (BALB/c-Chd7^Looper)	eyelid edema	J:252089
Chd7^{tm2a(EUCOMM)Wtsi}/Chd7⁺ (involves: 129S5/SvEvBrd * C57BL/6N)	abnormal circulating enzyme level	J:330596
	abnormal circulating lipoprotein level	J:330596
	abnormal response to stress-induced hyperthermia	J:330596
	decreased circulating alanine transaminase level	J:330596
	decreased circulating total protein level	J:330596
	increased blood uric acid level	J:330596
	increased circulating alkaline phosphatase level	J:330596
Chd7^{tm2a(EUCOMM)Wtsi}/Chd7^{tm2a(EUCOMM)Wtsi} Mesp1^tm2(cre)Ysa/Mesp1⁺ (involves: C57BL/6J * C57BL/6N * C57BL/6NCrlj * CBA/JNCrlj)	edema	J:225736
Chd7^{tm2a(EUCOMM)Wtsi}/Chd7^{tm2a(EUCOMM)Wtsi} Tg(Tek-cre)1Ywa/0 (involves: C57BL/6 * C57BL/6J * C57BL/6N * SJL)	edema	J:225736
Chd7^Whi/Chd7⁺ (C3HeB/FeJ-Chd7^Whi)	abnormal circulating lipid level	J:330596
	abnormal circulating lipoprotein level	J:330596
	abnormal circulating mineral level	J:330596
	abnormal circulating protein level	J:330596
	abnormal glucose tolerance	J:330596
	abnormal response to stress-induced hyperthermia	J:330596
	decreased circulating aspartate transaminase level	J:330596
	decreased circulating calcium level	J:330596
	decreased circulating cholesterol level	J:330596
	decreased circulating free fatty acids level	J:330596
	decreased circulating glycerol level	J:330596
	decreased circulating insulin level	J:330596
	decreased circulating magnesium level	J:330596
	decreased circulating potassium level	J:330596
	decreased circulating serum albumin level	J:330596
	decreased circulating triglyceride level	J:330596
	increased blood urea nitrogen level	J:330596
	increased carbon dioxide production	J:330596
	increased oxygen consumption	J:330596
Chd7^Whi/Chd7⁺ (involves: C3HeB/FeJ)	edema	J:104123
Chd9^{tm1a(EUCOMM)Wtsi}/Chd9^{tm1a(EUCOMM)Wtsi} (C57BL/6N-Chd9^{tm1a(EUCOMM)Wtsi}/Wtsi)	decreased circulating amylase level	J:211773
	decreased circulating serum albumin level	J:211773
	increased circulating alkaline phosphatase level	J:211773
Chdh^em1Rmps/Chdh^em1Rmps (C57BL/6N-Chdh^em1Rmps)	decreased amino acid betaine level	J:286033
Chdh^em1Rmps/Chdh^em1Rmps (C57BL/6N-Chdh^em1Rmps)	increased circulating homocysteine level	J:286033
Chdh^{tm1b(KOMP)Mbp}/Chdh^{tm1b(KOMP)Mbp} (C57BL/6N-Chdh^{tm1b(KOMP)Mbp}/Tcp)	decreased circulating alanine transaminase level	J:211773
Chga^tm1Gnh/Chga^tm1Gnh (involves: 129S1/Sv * 129X1/SvJ * BALB/c)	abnormal urine catecholamine level	J:111025
Chga^tm1Skmt/Chga⁺ (involves: 129S1/Sv * C57BL/6J)	decreased adrenaline level	J:99805
	decreased noradrenaline level	J:99805
	increased circulating adrenaline level	J:99805
	increased circulating noradrenaline level	J:99805
Chga^tm1Skmt/Chga^tm1Skmt (involves: 129S1/Sv * C57BL/6J)	abnormal corticosterone level	J:99805
	decreased adrenaline level	J:99805
	decreased noradrenaline level	J:99805
	increased circulating adrenaline level	J:99805
	increased circulating noradrenaline level	J:99805
Chgb^tm1Ribo/Chgb^tm1Ribo (involves: 129P2/OlaHsd * C57BL/6J)	decreased adrenaline level	J:157697
Chgb^tm1Ribo/Chgb^tm1Ribo (involves: 129P2/OlaHsd * C57BL/6)	decreased insulin secretion	J:157614
	impaired glucose tolerance	J:157614
Chic2^{tm1b(EUCOMM)Wtsi}/Chic2⁺ (C57BL/6N-Chic2^{tm1b(EUCOMM)Wtsi}/H)	increased circulating alanine transaminase level	J:211773
	increased circulating amylase level	J:211773
Chka^Gt(XH252)Byg/Chka⁺ (involves: 129P2/OlaHsd * C57BL/6)	increased liver triglyceride level	J:130726
Chkb^rmd/Chkb^rmd (involves: BALB/cByJ * C57BL/6J)	abnormal enzyme/coenzyme level	J:108320
Chkb^rmd/Chkb^rmd (involves: BALB/cByJ * C57BL/6J)	abnormal lipid level	J:108320
Chldq1^MRL/MpJ/Chldq1^MRL/MpJ (involves: MRL/MpJ * SJL/J)	increased circulating cholesterol level	J:106033
Chldq1^MRL/MpJ/Chldq1^MRL/MpJ (involves: MRL/MpJ * SJL/J)	increased circulating HDL cholesterol level	J:106033
Chldq1^MRL/MpJ/Chldq1^SJL/J (involves: MRL/MpJ * SJL/J)	increased circulating cholesterol level	J:106033
Chldq1^MRL/MpJ/Chldq1^SJL/J (involves: MRL/MpJ * SJL/J)	increased circulating HDL cholesterol level	J:106033
Chldq2^MRL/MpJ/Chldq2^MRL/MpJ (involves: MRL/MpJ * SJL/J)	increased circulating cholesterol level	J:106033
Chldq2^MRL/MpJ/Chldq2^MRL/MpJ (involves: MRL/MpJ * SJL/J)	increased circulating HDL cholesterol level	J:106033
Chldq2^MRL/MpJ/Chldq2^SJL/J (involves: MRL/MpJ * SJL/J)	increased circulating cholesterol level	J:106033
Chldq2^MRL/MpJ/Chldq2^SJL/J (involves: MRL/MpJ * SJL/J)	increased circulating HDL cholesterol level	J:106033
Chldq3^MRL/MpJ/Chldq3^MRL/MpJ (involves: MRL/MpJ * SJL/J)	increased circulating cholesterol level	J:106033, J:123776
Chldq3^MRL/MpJ/Chldq3^MRL/MpJ (involves: MRL/MpJ * SJL/J)	increased circulating HDL cholesterol level	J:106033, J:123776
Chldq3^MRL/MpJ/Chldq3^SJL/J (involves: MRL/MpJ * SJL/J)	increased circulating cholesterol level	J:106033
Chldq3^MRL/MpJ/Chldq3^SJL/J (involves: MRL/MpJ * SJL/J)	increased circulating HDL cholesterol level	J:106033
Chldq4^MRL/MpJ/Chldq4^MRL/MpJ (involves: MRL/MpJ * SJL/J)	increased circulating cholesterol level	J:106033
Chldq4^MRL/MpJ/Chldq4^MRL/MpJ (involves: MRL/MpJ * SJL/J)	increased circulating HDL cholesterol level	J:106033
Chldq4^MRL/MpJ/Chldq4^SJL/J (involves: MRL/MpJ * SJL/J)	increased circulating cholesterol level	J:106033
Chldq4^MRL/MpJ/Chldq4^SJL/J (involves: MRL/MpJ * SJL/J)	increased circulating HDL cholesterol level	J:106033
Chldq7^NZB/BlNJ/Chldq7^NZB/BlNJ (involves: NZB/BlNJ * RF/J)	increased circulating HDL cholesterol level	J:123776
Chldq7^NZB/BlNJ/Chldq7^RF/J (involves: NZB/BlNJ * RF/J)	increased circulating HDL cholesterol level	J:123776
Chldq9^NZB/BlNJ/Chldq9^RF/J (involves: NZB/BlNJ * RF/J)	decreased circulating HDL cholesterol level	J:123776
Chldq9^RF/J/Chldq9^RF/J (involves: NZB/BlNJ * RF/J)	decreased circulating HDL cholesterol level	J:123776
Chldq12^NZB/BlNJ/Chldq12^NZB/BlNJ (involves: NZB/BlNJ * RF/J)	increased circulating cholesterol level	J:123776
	increased circulating HDL cholesterol level	J:123776
Chldq12^NZB/BlNJ/Chldq12^RF/J (involves: NZB/BlNJ * RF/J)	increased circulating cholesterol level	J:123776
Chldq12^NZB/BlNJ/Chldq12^RF/J (involves: NZB/BlNJ * RF/J)	increased circulating HDL cholesterol level	J:123776
Chlq1^BALB/cJ/? (involves: BALB/cJ * C3H/HeJ * C57BL/6J * DBA/2J)	increased circulating insulin-like growth factor I level	J:104331
Chlq1^DBA/2J/? (involves: BALB/cJ * C3H/HeJ * C57BL/6J * DBA/2J)	abnormal circulating corticosterone level	J:104331
Chlq2^C57BL/6J/? (involves: BALB/cJ * C3H/HeJ * C57BL/6J * DBA/2J)	increased circulating insulin-like growth factor I level	J:104331
Chlq3^C3H/HeJ/? (involves: BALB/cJ * C3H/HeJ * C57BL/6J * DBA/2J)	increased circulating leptin level	J:104331
Chlq4^C3H/HeJ/? (involves: BALB/cJ * C3H/HeJ * C57BL/6J * DBA/2J)	increased circulating thyroxine level	J:104331
Chlq5^C57BL/6J/? (involves: BALB/cJ * C3H/HeJ * C57BL/6J * DBA/2J)	increased circulating insulin-like growth factor I level	J:104331
Chlq6^C3H/HeJ/? (involves: BALB/cJ * C3H/HeJ * C57BL/6J * DBA/2J)	increased circulating insulin-like growth factor I level	J:104331
Chlq7^BALB/cJ/? (involves: BALB/cJ * C3H/HeJ * C57BL/6J * DBA/2J)	increased circulating thyroxine level	J:104331
Chlq8^C3H/HeJ/? (involves: BALB/cJ * C3H/HeJ * C57BL/6J * DBA/2J)	increased circulating thyroxine level	J:104331
Chlq10^C3H/HeJ/? Chlq11^C3H/HeJ/? Chlq9^BALB/cJ/? (involves: BALB/cJ * C3H/HeJ * C57BL/6J * DBA/2J)	increased circulating insulin-like growth factor I level	J:111693
Chlq10^DBA/2J/? Chlq11^DBA/2J/? Chlq9^BALB/cJ/? (involves: BALB/cJ * C3H/HeJ * C57BL/6J * DBA/2J)	increased circulating insulin-like growth factor I level	J:111693
Chlq10^DBA/2J/? Chlq11^DBA/2J/? Chlq9^C57BL/6J/? (involves: BALB/cJ * C3H/HeJ * C57BL/6J * DBA/2J)	increased circulating insulin-like growth factor I level	J:111693
Chlq11^DBA/2J/? Chlq12^DBA/2J/? Chlq5^BALB/cJ/? Chlq9^C57BL/6J/? (involves: BALB/cJ * C3H/HeJ * C57BL/6J * DBA/2J)	decreased circulating insulin-like growth factor I level	J:111693
Chlq13^DBA/2J/? Chlq14^DBA/2J/? Chlq15^C3H/HeJ/? Chlq5^C57BL/6J/? (involves: BALB/cJ * C3H/HeJ * C57BL/6J * DBA/2J)	increased circulating insulin-like growth factor I level	J:111693
Chlq15^C3H/HeJ/? Chlq16^BALB/cJ/? Chlq17^BALB/cJ/? Chlq18^C3H/HeJ/? (involves: BALB/cJ * C3H/HeJ * C57BL/6J * DBA/2J)	increased circulating insulin-like growth factor I level	J:111693
Chmp1a^Gt(XC472)Byg/Chmp1a^Gt(XC472)Byg (B6.129P2-Chmp1a^Gt(XC472)Byg)	abnormal protein level	J:271138
Chmp3^{tm1b(EUCOMM)Hmgu}/Chmp3⁺ (C57BL/6N-Chmp3^{tm1b(EUCOMM)Hmgu}/Bay)	impaired glucose tolerance	J:211773
Chmp4c^{tm1b(EUCOMM)Wtsi}/Chmp4c^{tm1b(EUCOMM)Wtsi} (C57BL/6N-Chmp4c^{tm1b(EUCOMM)Wtsi}/H)	increased circulating alanine transaminase level	J:211773
Chn1^em1(IMPC)J/Chn1⁺ (C57BL/6NJ-Chn1^em1(IMPC)J/J)	decreased circulating glucose level	J:211773
	decreased circulating iron level	J:211773
	increased circulating alkaline phosphatase level	J:211773
	increased circulating sodium level	J:211773
Chn1^{tm1.1(KOMP)Vlcg}/Chn1^{tm1.1(KOMP)Vlcg} (B6N(Cg)-Chn1^{tm1.1(KOMP)Vlcg}/J)	decreased circulating chloride level	J:211773
	decreased circulating free fatty acids level	J:211773
	decreased circulating glucose level	J:211773
	increased circulating alkaline phosphatase level	J:211773
	increased circulating sodium level	J:211773
Chohd2/Chohd2⁺ (C3HeB/FeJ-Chohd2/Ieg)	increased circulating cholesterol level	J:94145
Chohd3/Chohd3⁺ (C3HeB/FeJ-Chohd3/Ieg)	increased circulating cholesterol level	J:94145
Chohd4/Chohd4⁺ (C3HeB/FeJ-Chohd4/Ieg)	increased circulating cholesterol level	J:94145
Chohd5/Chohd5⁺ (C3HeB/FeJ-Chohd5/Ieg)	increased circulating cholesterol level	J:94145
	increased circulating HDL cholesterol level	J:94145
	increased circulating LDL cholesterol level	J:94145
Chohd6/Chohd6⁺ (C3HeB/FeJ-Chohd6/Ieg)	increased circulating cholesterol level	J:94145
	increased circulating HDL cholesterol level	J:94145
	increased circulating LDL cholesterol level	J:94145
chohr1/chohr1 (C3HeB/FeJ-chohr1/Ieg)	increased circulating cholesterol level	J:94145
chohr1/chohr1 (C3HeB/FeJ-chohr1/Ieg)	increased circulating HDL cholesterol level	J:94145
chohr2/chohr2 (C3HeB/FeJ-chohr2/Ieg)	increased circulating cholesterol level	J:94145
	increased circulating HDL cholesterol level	J:94145
	increased circulating LDL cholesterol level	J:94145
chohr3/chohr3 (C3HeB/FeJ-chohr3/Ieg)	abnormal urine homeostasis	J:94145
	albuminuria	J:94145
	increased blood urea nitrogen level	J:94145
	increased circulating cholesterol level	J:94145
	increased circulating creatinine level	J:94145
	increased circulating HDL cholesterol level	J:94145
	increased circulating LDL cholesterol level	J:94145
Chol6^CAST/Ei/Chol6^CAST/Ei (involves: CAST/Ei * DBA/2J)	abnormal circulating cholesterol level	J:83460
Chol6^CAST/Ei/Chol6^CAST/Ei (involves: CAST/Ei * DBA/2J)	increased circulating cholesterol level	J:83460
Chol7^129S1/SvImJ/Chol7^129S1/SvImJ (involves: 129S1/SvImJ * CAST/Ei)	increased circulating cholesterol level	J:88732
Chol7^129S1/SvImJ/Chol7^CAST/Ei (involves: 129S1/SvImJ * CAST/Ei)	increased circulating cholesterol level	J:88732
Chol8^129S1/SvImJ/Chol8^CAST/Ei (involves: 129S1/SvImJ * CAST/Ei)	increased circulating cholesterol level	J:88732
Chol8^CAST/Ei/Chol8^CAST/Ei (involves: 129S1/SvImJ * CAST/Ei)	increased circulating cholesterol level	J:88732
Chol9^129S1/SvImJ/Chol9^CAST/Ei (involves: 129S1/SvImJ * CAST/Ei)	increased circulating cholesterol level	J:88732
Chol9^CAST/Ei/Chol9^CAST/Ei (involves: 129S1/SvImJ * CAST/Ei)	increased circulating cholesterol level	J:88732
Chol10^129S1/SvImJ/Chol10^129S1/SvImJ (involves: 129S1/SvImJ * RIIIS/J)	increased circulating cholesterol level	J:89282
Chol10^129S1/SvImJ/Chol10^RIIIS/J (involves: 129S1/SvImJ * RIIIS/J)	increased circulating cholesterol level	J:89282
Chol11^129S1/SvImJ/Chol11^129S1/SvImJ (involves: 129S1/SvImJ * RIIIS/J)	increased circulating cholesterol level	J:89282
Chol11^129S1/SvImJ/Chol11^RIIIS/J (involves: 129S1/SvImJ * RIIIS/J)	increased circulating cholesterol level	J:89282
Chp2^{tm1b(KOMP)Mbp}/Chp2⁺ (B6N(Cg)-Chp2^{tm1b(KOMP)Mbp}/J)	decreased fasting circulating glucose level	J:211773
Chrd^tm1Emdr/Chrd^tm1Emdr (either: B6SJL.129-Chrd^tm1Emdr or (involves: 129S1/Sv * 129X1/SvJ * C57BL/6J * SJL/J))	cyanosis	J:83662
	hydrops fetalis	J:83662
Chrdl1^em1(IMPC)H/Chrdl1^em1(IMPC)H (C57BL/6NTac-Chrdl1^em1(IMPC)H/H)	increased fasting circulating glucose level	J:211773
Chrm1^tm1Kano/Chrm1^tm1Kano Chrm3^tm1Mmt/Chrm3^tm1Mmt (involves: 129X1/SvJ * C57BL/6)	decreased salivation	J:105126
Chrm1^tm1Stl/Chrm1^tm1Stl (C57BL/6-Chrm1^tm1Stl)	increased dopamine level	J:73448
Chrm3^tm1Jwe/Chrm3⁺ (involves: 129S6/SvEvTac * C57BL/6J)	decreased circulating insulin level	J:91888
Chrm3^tm1Jwe/Chrm3⁺ (involves: 129S6/SvEvTac * C57BL/6J)	decreased insulin secretion	J:91888
Chrm3^tm1Jwe/Chrm3^tm1Jwe (involves: 129S6/SvEvTac * C57BL/6J)	abnormal glucose homeostasis	J:67919
	decreased body temperature	J:67919
	decreased circulating glucagon level	J:91888
	decreased circulating glucose level	J:91888
	decreased circulating insulin level	J:91888, J:67919
	decreased circulating leptin level	J:67919
	decreased circulating triglyceride level	J:67919
	decreased glucagon secretion	J:91888
	decreased insulin secretion	J:91888
	improved glucose tolerance	J:91888
	increased insulin sensitivity	J:67919
Chrm3^tm1Mmt/Chrm3^tm1Mmt (involves: 129X1/SvJ)	decreased salivation	J:105126
Chrm3^tm1Mmt/Chrm3^tm1Mmt (involves: 129X1/SvJ * C57BL/6)	decreased salivation	J:64069
Chrm3^tm1Mmt/Chrm3^tm1Mmt (B6.129X1-Chrm3^tm1Mmt)	abnormal histamine physiology	J:104782
Chrm3^tm2.1Jwe/Chrm3^tm2.1Jwe Speer6-ps1^{Tg(Alb-cre)21Mgn}/Speer6-ps1⁺ (involves: 129S6/SvEvTac * C57BL/6 * DBA * FVB/N)	decreased circulating glucose level	J:158245
Chrm3^tm2Jwe/Chrm3^tm2Jwe Tg(Ins2-cre)25Mgn/0 (involves: 129S6/SvEvTac * C57BL/6 * DBA)	decreased insulin secretion	J:129643
	impaired glucose tolerance	J:129643
Chrm4^tm2.1Jwe/Chrm4^tm2.1Jwe Tg(Drd1a-cre)AGsc/0 (involves: 129S6/SvEvTac * C57BL/6 * FVB/N)	increased dopamine level	J:157841
Chrm5^tm1Jwe/Chrm5^tm1Jwe (involves: 129S6/SvEvTac * CF-1)	abnormal dopamine level	J:72953
Chrm5^tm1Minm/Chrm5^tm1Minm (B6.129X1-Chrm5^tm1Minm)	abnormal histamine physiology	J:104782
Chrm5^tm1Yeo/Chrm5^tm1Yeo (Not Specified)	decreased salivation	J:83217
Chrna3^tm1Bay/Chrna3^tm1Bay (involves: 129S7/SvEvBrd * C57BL/6)	abnormal urine color	J:54994
Chrna4^tm1.1Stit/Chrna4^tm1.1Stit (B6.129X1-Chrna4^tm1.1Stit)	decreased body temperature	J:180872
Chrna7^{tm1b(EUCOMM)Hmgu}/Chrna7^{tm1b(EUCOMM)Hmgu} (C57BL/6N-Chrna7^{tm1b(EUCOMM)Hmgu}/H)	increased circulating cholesterol level	J:211773
	increased circulating HDL cholesterol level	J:211773
Chrna7^tm1Bay/Chrna7^tm1Bay (B6.Cg-Chrna7^tm1Bay)	abnormal interleukin level	J:89610
Chrna7^tm1Bay/Chrna7^tm1Bay (B6.Cg-Chrna7^tm1Bay)	abnormal tumor necrosis factor level	J:89610
Chrnb2^{tm1b(EUCOMM)Hmgu}/Chrnb2⁺ (C57BL/6N-Chrnb2^{tm1b(EUCOMM)Hmgu}/H)	increased circulating aspartate transaminase level	J:211773
Chrng^tm1Mtak/Chrng^tm1Mtak (involves: 129X1/SvJ * C57BL/6)	cyanosis	J:99894
Chrng^tm1Mtak/Chrng^tm1Mtak (involves: 129X1/SvJ * C57BL/6)	dehydration	J:99894
Chst2^em1(IMPC)Mbp/Chst2^em1(IMPC)Mbp (C57BL/6N-Chst2^em1(IMPC)Mbp/MbpMmucd)	increased circulating aspartate transaminase level	J:211773
Chst8^tm1.1Jub/Chst8^tm1.1Jub (B6.129X1-Chst8^tm1.1Jub)	increased circulating follicle stimulating hormone level	J:135143
	increased circulating luteinizing hormone level	J:135143
	increased circulating testosterone level	J:135143
Chst8^{tm1b(KOMP)Mbp}/Chst8^{tm1b(KOMP)Mbp} (C57BL/6N-Chst8^{tm1b(KOMP)Mbp}/Ucd)	increased circulating alanine transaminase level	J:211773
Chst10^tm1Mifu/Chst10^tm1Mifu (involves: 129)	increased circulating estrogen level	J:195651
Chtf18^{tm1b(KOMP)Wtsi}/Chtf18⁺ (B6N(Cg)-Chtf18^{tm1b(KOMP)Wtsi}/J)	increased circulating bilirubin level	J:211773
	increased circulating chloride level	J:211773
Chtop^{tm1a(EUCOMM)Wtsi}/Chtop^{tm1a(EUCOMM)Wtsi} (C57BL/6N-Chtop^{tm1a(EUCOMM)Wtsi}/Wtsi)	subcutaneous edema	J:239583
Chuk^{em1(IMPC)Ccpcz}/Chuk⁺ (C57BL/6NCrl-Chuk^{em1(IMPC)Ccpcz}/Ccpcz)	increased circulating HDL cholesterol level	J:211773
Chuk^tm1Aki/Chuk^tm1Aki (involves: 129P2/OlaHsd)	impaired skin barrier function	J:54315
Chuk^tm1Mpa/Chuk^tm1Mpa Ikbkb^tm2Cgn/Ikbkb^tm2Cgn Tg(Alb1-cre)7Gsc/0 (involves: C57BL/6 * FVB/N)	increased circulating alanine transaminase level	J:137861
	increased circulating bilirubin level	J:137861
Chuk^tm1Mpa/Chuk^tm1Mpa Tg(KRT14-cre)1Cgn/? (involves: C57BL/6)	decreased circulating free fatty acids level	J:122320
	impaired skin barrier function	J:122320
	increased cholesterol level	J:122320
Chuk^tm1Ver/Chuk^tm1Ver (involves: 129S4/SvJae * C57BL/6J)	impaired skin barrier function	J:55415
Chuk^tm2Mka/Chuk^tm2Mka Tg(Tnfsf13b)1Fma/? (B6.Cg-Chuk^tm2Mka Tg(Tnfsf13b)1Fma)	increased urine protein level	J:113556
Chy2/Chy2⁺ (involves: 101/H * C3H/HeH)	chylous ascites	J:90559
Chy2/Chy2⁺ (involves: 101/H * C3H/HeH)	edema	J:90559
Chy5/Chy5⁺ (involves: C3H/HeH)	chylous ascites	J:181531
Chy6/Chy6⁺ (involves: C3H/HeH)	chylous ascites	J:181531
Chy6/Chy6⁺ (involves: C3H/HeH)	edema	J:181531
Chy7/Chy7⁺ (involves: 101/H * C3H/HeH)	chylous ascites	J:169366
Chy8/Chy8⁺ (involves: 101/H * C3H/HeH)	chylous ascites	J:90559
Chy8/Chy8⁺ (involves: 101/H * C3H/HeH)	edema	J:90559
Chy9/Chy9⁺ (involves: 101/H * C3H/HeH)	chylous ascites	J:90559
Chy9/Chy9⁺ (involves: 101/H * C3H/HeH)	edema	J:90559
Chy10/Chy10⁺ (involves: 101/H * C3H/HeH)	chylous ascites	J:90559
Chy10/Chy10⁺ (involves: 101/H * C3H/HeH)	edema	J:90559
Chy11/Chy11⁺ (involves: 101/H * C3H/HeH)	chylous ascites	J:90559
Chy12/Chy12⁺ (involves: 101/H * C3H/HeH)	chylous ascites	J:90559
Chy12/Chy12⁺ (involves: 101/H * C3H/HeH)	edema	J:90559
Chy13/Chy13⁺ (involves: 101/H * C3H/HeH)	chylous ascites	J:90559
Chy13/Chy13⁺ (involves: 101/H * C3H/HeH)	edema	J:90559
Ciart^{Gt(IST11761C7)Tigm}/Ciart^{Gt(IST11761C7)Tigm} (C57BL/6-Ciart^{Gt(IST11761C7)Tigm})	increased circulating corticosterone level	J:209571
Ciart^{tm1e(KOMP)Wtsi}/Ciart^{tm1e(KOMP)Wtsi} (involves: C57BL/6N)	abnormal homeostasis	J:205586
Ciart^{tm1e(KOMP)Wtsi}/Ciart^{tm1e(KOMP)Wtsi} Cry1^tm1Asn/Cry1^tm1Asn (involves: 129P2/OlaHsd * C57BL/6N)	abnormal homeostasis	J:205586
Cib2^{tm1b(EUCOMM)Wtsi}/Cib2^{tm1b(EUCOMM)Wtsi} (C57BL/6N-Cib2^{tm1b(EUCOMM)Wtsi}/H)	increased circulating cholesterol level	J:211773
	increased circulating fructosamine level	J:211773
	increased circulating HDL cholesterol level	J:211773
	increased circulating triglyceride level	J:211773
Cib3^em1(IMPC)H/Cib3^em1(IMPC)H (C57BL/6N-Cib3^em1(IMPC)H/H)	increased circulating amylase level	J:211773
Cibar1^{tm1b(KOMP)Wtsi}/Cibar1^{tm1b(KOMP)Wtsi} (C57BL/6N-Cibar1^{tm1b(KOMP)Wtsi}/Wtsi)	decreased circulating glycerol level	J:211773
	improved glucose tolerance	J:211773
	increased circulating alkaline phosphatase level	J:211773
	increased circulating amylase level	J:211773
Cidea^{tm1b(EUCOMM)Hmgu}/Cidea^{tm1b(EUCOMM)Hmgu} (C57BL/6N-Cidea^{tm1b(EUCOMM)Hmgu}/Ics)	increased circulating alkaline phosphatase level	J:211773
	increased circulating serum albumin level	J:211773
Cidea^tm1Pli/Cidea^tm1Pli (involves: 129X1/SvJ)	abnormal body temperature homeostasis	J:215366
	abnormal circulating glucose level	J:85229
	abnormal glucose homeostasis	J:85229
	abnormal lipid homeostasis	J:85229
	decreased circulating triglyceride level	J:85229
	decreased fatty acids level	J:85229
	decreased susceptibility to induced hypothermia	J:85229
	enhanced lipolysis	J:85229
Cideb^tm1Pli/Cideb^tm1Pli (Not Specified)	decreased circulating free fatty acids level	J:126556
	decreased circulating leptin level	J:126556
	decreased circulating triglyceride level	J:126556
	increased circulating adiponectin level	J:126556
	increased insulin sensitivity	J:126556
	increased oxygen consumption	J:126556
Cidec^tm1.1Gonz/Cidec^tm1.2Gonz Tg(Fabp4-cre)#Abel/? (B6N.Cg-Cidec^tm1.1Gonz/Cidec^tm1.2Gonz Tg(Fabp4-cre)#Abel)	abnormal adaptive thermogenesis	J:226899
	abnormal circulating lipid level	J:226899
	decreased respiratory quotient	J:226899
	decreased susceptibility to diet-induced obesity	J:226899
	increased circulating alanine transaminase level	J:226899
	increased circulating free fatty acids level	J:226899
	increased circulating insulin level	J:226899
	increased circulating triglyceride level	J:226899
	increased energy expenditure	J:226899
	increased oxygen consumption	J:226899
	insulin resistance	J:226899
Cidec^{tm1b(EUCOMM)Wtsi}/Cidec^{tm1b(EUCOMM)Wtsi} (C57BL/6N-Cidec^{tm1b(EUCOMM)Wtsi}/Ieg)	decreased circulating alkaline phosphatase level	J:211773
	increased circulating cholesterol level	J:211773
	increased fasting circulating glucose level	J:211773
Cidec^tm1Maka/Cidec^tm1Maka (B6.129P2-Cidec^tm1Maka)	decreased circulating glucose level	J:140863
	decreased circulating leptin level	J:140863
	decreased susceptibility to diet-induced obesity	J:140863
	enhanced lipolysis	J:140863
	improved glucose tolerance	J:140863
	increased energy expenditure	J:140863
	increased oxygen consumption	J:140863
	increased respiratory quotient	J:140863
Cidec^tm1Pli/Cidec^tm1Pli (Not Specified)	abnormal blood homeostasis	J:140122
	decreased circulating free fatty acids level	J:140122
	decreased circulating ketone body level	J:140122
	decreased circulating leptin level	J:140122
	decreased circulating triglyceride level	J:140122
	enhanced lipolysis	J:140122
	impaired adaptive thermogenesis	J:140122
	improved glucose tolerance	J:140122
	increased body temperature	J:140122
	increased insulin sensitivity	J:140122
	increased oxygen consumption	J:140122
Cidec^tm1Pli/Cidec^tm1Pli Lep^ob/Lep^ob (involves: C57BL/10J)	decreased circulating free fatty acids level	J:140122
	decreased circulating triglyceride level	J:140122
	improved glucose tolerance	J:140122
	increased insulin sensitivity	J:140122
Ciita^tm1Ccum/Ciita^tm1Ccum (NOD.129S2(B6)-Ciita^tm1Ccum)	abnormal circulating glucose level	J:106081
Ciita^tm1Wrth/Ciita^tm1Wrth (involves: 129P2/OlaHsd * C57BL/6)	increased circulating type I collagen C-terminal telopeptide level	J:233241
Cilk1^{tm1a(KOMP)Mbp}/Cilk1^{tm1a(KOMP)Mbp} (C57BL/6N-Cilk1^{tm1a(KOMP)Mbp})	edema	J:211652
Cimip2b^{tm1(KOMP)Wtsi}/Cimip2b^{tm1(KOMP)Wtsi} (C57BL/6N-Cimip2b^{tm1(KOMP)Wtsi}/Nju)	increased blood urea nitrogen level	J:211773
Cinp^{tm1.1(KOMP)Vlcg}/Cinp⁺ (B6N(Cg)-Cinp^{tm1.1(KOMP)Vlcg}/J)	increased fasting circulating glucose level	J:211773
Cir1^{tm3a(KOMP)Wtsi}/Cir1^{tm3a(KOMP)Wtsi} (C57BL/6N-Cir1^{tm3a(KOMP)Wtsi}/Wtsi)	subcutaneous edema	J:239583
Cirbil^em1Cya/Cirbil^em1Cya (Not Specified)	increased circulating lactate dehydrogenase level	J:301260
Cisd1^{em1(IMPC)Hmgu}/Cisd1^{em1(IMPC)Hmgu} (C57BL/6N-Cisd1^{em1(IMPC)Hmgu}/Ieg)	decreased circulating triglyceride level	J:211773
	increased circulating chloride level	J:211773
Cisd2^{Gt(XS0445)Wtsi}/Cisd2^{Gt(XS0445)Wtsi} (B6.129P2-Cisd2^{Gt(XS0445)Wtsi})	abnormal calcium ion homeostasis	J:183788
Cisd2^{tm1a(EUCOMM)Wtsi}/Cisd2^{tm1a(EUCOMM)Wtsi} (C57BL/6N-Cisd2^{tm1a(EUCOMM)Wtsi}/H)	abnormal glucose homeostasis	J:165965
	decreased circulating amylase level	J:165965
	decreased circulating triglyceride level	J:165965
	increased circulating aspartate transaminase level	J:165965
	increased circulating phosphate level	J:165965
Cisd2^tm1Tfts/Cisd2^tm1Tfts (B6.129S7-Cisd2^tm1Tfts)	abnormal glucose homeostasis	J:148467
	decreased insulin secretion	J:148467
	decreased oxygen consumption	J:148467
	impaired glucose tolerance	J:148467
	increased insulin sensitivity	J:148467
Cit^{tm1a(KOMP)Wtsi}/Cit⁺ (B6JTyr;B6N-Cit^{tm1a(KOMP)Wtsi}/Wtsi)	decreased circulating creatinine level	J:165965
Cited2^tm1.2Dunw/Cited2^tm1.2Dunw (involves: 129S1/Sv * C57BL/6J)	hydrops fetalis	J:117087
Cited2^tm1Bha/Cited2⁺ (involves: 129P2/OlaHsd)	edema	J:137951
Cited2^tm1Jpmb/Cited2^tm1Jpmb (involves: 129P2/OlaHsd * C57BL/6)	edema	J:74736
Ckap5^{tm2b(EUCOMM)Hmgu}/Ckap5⁺ (C57BL/6N-Ckap5^{tm2b(EUCOMM)Hmgu}/Bay)	decreased body temperature	J:211773
Ckb^{tm1.1(KOMP)Wtsi}/Ckb^{tm1.1(KOMP)Wtsi} (C57BL/6N-Ckb^{tm1.1(KOMP)Wtsi}/Ucd)	decreased circulating creatinine level	J:211773
Ckdbp2^{129S6/SvEvTac}/Ckdbp2^{129S6/SvEvTac} (involves: 129S6/SvEvTac * C57BL/6J)	albuminuria	J:127712
Ckm^tm1Bew/Ckm^tm1Bew (involves: 129S7/SvEvBrd * C57BL/6)	increased glycogen catabolism rate	J:76699
Ckm^tm1Bew/Ckm^tm1Bew (involves: 129S7/SvEvBrd * C57BL/6)	increased skeletal muscle glycogen level	J:76699
Clca1^tm1.1Lex/Clca1^tm1.1Lex (involves: 129S/SvEvBrd)	abnormal chemokine level	J:125158
Clca2^em1(IMPC)Mbp/Clca2^em1(IMPC)Mbp (C57BL/6NCrl-Clca2^em1(IMPC)Mbp/MbpMmucd)	increased circulating alanine transaminase level	J:211773
Clcn2^em1Uis/Clcn2⁺ (C57BL/6N-Clcn2^em1Uis)	decreased urine chloride ion level	J:282228
	decreased urine sodium level	J:282228
	increased circulating aldosterone level	J:282228
Clcn2^tm1Tjj/Clcn2^tm1Tjj (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	increased circulating renin level	J:282228
Clcn3^tm1Lamb/Clcn3^tm1Lamb (involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)	decreased circulating glucose level	J:80901
Clcn3^tm1Tjj/Clcn3^tm1Tjj Clcn5^tm6.1Tjj/Y Tg(Vil1-cre)20Syr/0 (involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * DBA/2)	abnormal renal protein reabsorption	J:164474
Clcn4^tm1Tjj/Clcn4^tm1Tjj Clcn5^tm6.1Tjj/Y Tg(Vil1-cre)20Syr/0 (involves: 129/Sv * C57BL/6 * DBA/2)	abnormal renal protein reabsorption	J:164474
Clcn5^tm1Gug/Y (involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)	abnormal renal protein reabsorption	J:66560, J:84433
	aminoaciduria	J:66560
	cystinuria	J:66560
	hydroxyprolinuria	J:66560
	hyperglutaminuria	J:66560
	hyperthreoninuria	J:66560
	increased urine calcium level	J:66560
	increased urine glucose level	J:66560
	increased urine phosphate level	J:66560
	increased urine protein level	J:66560
Clcn5^tm1Tjj/Y (B6.129-Clcn5^tm1Tjj)	decreased urine pH	J:77111
	increased urine beta2-microglobulin level	J:77111
	increased urine phosphate level	J:77111
	increased urine protein level	J:77111
Clcn5^tm1Tjj/Y (involves: 129)	decreased urine pH	J:160701
	increased urine calcium level	J:160701
	increased urine glucose level	J:160701
	increased urine insulin level	J:160701
	increased urine phosphate level	J:160701
Clcn5^tm2.1Tjj/Y (involves: 129P2/OlaHsd * 129X1/SvJ * BALB/cJ * C57BL/6)	decreased urine creatinine level	J:160701
	decreased urine pH	J:160701
	increased urine calcium level	J:160701
	increased urine glucose level	J:160701
	increased urine insulin level	J:160701
	increased urine phosphate level	J:160701
	increased urine protein level	J:160701
Clcn7^tm1.1Mjec/Clcn7⁺ (involves: 129S/SvEv * C57BL/6 * DBA/2J)	increased circulating alkaline phosphatase level	J:203761
Clcn7^tm1.1Teti/Clcn7⁺ (involves: 129S2/SvPas * C57BL/6)	increased circulating parathyroid hormone level	J:203761
Clcn7^tm5.1Tjj/Clcn7^tm5.1Tjj (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	abnormal chloride level	J:217031
Clcnka^{tm1b(EUCOMM)Hmgu}/Clcnka^{tm1b(EUCOMM)Hmgu} (C57BL/6N-Clcnka^{tm1b(EUCOMM)Hmgu}/H)	increased circulating alkaline phosphatase level	J:211773
Clcnka^tm1Suc/Clcnka^tm1Suc (involves: 129P2/OlaHsd * C57BL/6)	decreased urine osmolality	J:51917
Clcnkb^em1(IMPC)Mbp/Clcnkb^em1(IMPC)Mbp (C57BL/6NCrl-Clcnkb^em1(IMPC)Mbp/MbpMmucd)	abnormal cholesterol homeostasis	J:211773
	improved glucose tolerance	J:211773
	increased blood urea nitrogen level	J:211773
	increased circulating alkaline phosphatase level	J:211773
	increased circulating calcium level	J:211773
	increased circulating cholesterol level	J:211773
	increased circulating creatinine level	J:211773
	increased fasting circulating glucose level	J:211773
Clcnkb^em1Haca/Clcnkb^em1Haca (C57BL/6-Clcnkb^em1Haca)	decreased circulating chloride level	J:259681
	decreased circulating potassium level	J:259681
	decreased urine osmolality	J:259681
	increased circulating renin level	J:259681
	increased urine chloride ion level	J:259681
	increased urine potassium level	J:259681
	increased urine prostaglandin level	J:259681
	increased urine sodium level	J:259681
Clcnkb^tm1.1Doel/Clcnkb^tm1.1Doel (involves: 129S1/Sv * 129X1/SvJ)	abnormal urine homeostasis	J:259639
	alkalemia	J:259639
	alkalosis	J:259639
	decreased urine osmolality	J:259639
	hypokalemia	J:259639
	increased urine magnesium level	J:259639
	increased urine prostaglandin level	J:259639
Cldn1^tm1Sts/Cldn1^tm1Sts (involves: 129S4/SvJae * C57BL/6)	dehydration	J:75447
Cldn1^tm1Sts/Cldn1^tm1Sts (involves: 129S4/SvJae * C57BL/6)	impaired skin barrier function	J:75447
Cldn2^tm1Lex/Y (B6J.129S5-Cldn2^tm1Lex)	abnormal enzyme/coenzyme level	J:237065
	abnormal renal sodium reabsorption	J:237065
	hypoxia	J:237065
	increased blood urea nitrogen level	J:237065
	increased circulating creatinine level	J:237065
	increased oxygen consumption	J:237065
	increased urine sodium level	J:237065
Cldn2^tm1Muto/Cldn2^tm1Muto (involves: 129S4/SvJae * C57BL/6)	abnormal renal sodium reabsorption	J:159379
	abnormal renal water reabsorption	J:159379
	decreased urine osmolality	J:159379
	increased urine calcium level	J:159379
	increased urine sodium level	J:159379
Cldn4^tm1.1Jhou/Cldn4^tm1.1Jhou Tg(Aqp2-cre)1Dek/0 (B6.Cg-Cldn4^tm1.1Jhou Tg(Aqp2-cre)1Dek)	abnormal renal sodium reabsorption	J:216399
	alkalosis	J:216399
	decreased circulating chloride level	J:216399
	increased circulating aldosterone level	J:216399
	increased circulating bicarbonate level	J:216399
	increased circulating potassium level	J:216399
	increased urine chloride ion level	J:216399
	increased urine sodium level	J:216399
Cldn4^tm1.1Yham/Cldn4^tm1.1Yham (B6.129S2-Cldn4^tm1.1Yham)	abnormal renal calcium reabsorption	J:195766
	decreased circulating calcium level	J:195766
	increased urine calcium level	J:195766
	increased urine chloride ion level	J:195766
Cldn7^tm1Yche/Cldn7^tm1Yche (involves: C57BL/6)	abnormal urine homeostasis	J:155363
	dehydration	J:155363
	increased blood urea nitrogen level	J:155363
	increased circulating aldosterone level	J:155363
	increased urine chloride ion level	J:155363
	increased urine potassium level	J:155363
	increased urine sodium level	J:155363
Cldn8^tm1.1Jhou/Cldn8^tm1.1Jhou Tg(Aqp2-cre)1Dek/0 (B6.Cg-Cldn8^tm1.1Jhou Tg(Aqp2-cre)1Dek)	alkalosis	J:220813
	decreased circulating chloride level	J:220813
	decreased circulating potassium level	J:220813
	hypokalemia	J:220813
	increased circulating aldosterone level	J:220813
	increased circulating bicarbonate level	J:220813
	increased urine chloride ion level	J:220813
	increased urine potassium level	J:220813
	increased urine sodium level	J:220813
Cldn10^tm1.1Dmu/Cldn10^tm1.1Dmu Tg(Cdh16-cre)91Igr/0 (involves: C57BL/6 * ICR * SJL)	abnormal circulating mineral level	J:188580
	abnormal renal calcium reabsorption	J:188580
	abnormal urine homeostasis	J:188580
	decreased urine calcium level	J:188580
	decreased urine magnesium level	J:188580
	decreased urine osmolality	J:188580
	decreased urine pH	J:188580
	decreased urine urea nitrogen level	J:188580
	increased blood urea nitrogen level	J:188580
	increased circulating magnesium level	J:188580
	increased circulating phosphate level	J:188580
	increased urine potassium level	J:188580
Cldn11^em1(IMPC)H/Cldn11^em1(IMPC)H (C57BL/6N-Cldn11^em1(IMPC)H/H)	increased blood urea nitrogen level	J:211773
Cldn12^{tm1.1(KOMP)Vlcg}/Cldn12^{tm1.1(KOMP)Vlcg} (B6J.B6N-Cldn12^{tm1.1(KOMP)Vlcg})	abnormal circulating non-HDL cholesterol level	J:279934
	decreased circulating free fatty acids level	J:279934
	decreased circulating total protein level	J:279934
	decreased circulating triglyceride level	J:279934
	decreased fasting circulating glucose level	J:279934
	decreased respiratory quotient	J:279934
	increased circulating creatinine level	J:279934
	increased circulating glucose level	J:279934
Cldn13^em1(IMPC)J/Cldn13^em1(IMPC)J (C57BL/6NJ-Cldn13^em1(IMPC)J/J)	decreased fasting circulating glucose level	J:211773
	increased circulating alanine transaminase level	J:211773
Cldn13^{tm1.1(KOMP)Vlcg}/Cldn13^{tm1.1(KOMP)Vlcg} (B6N(Cg)-Cldn13^{tm1.1(KOMP)Vlcg}/J)	decreased blood urea nitrogen level	J:211773
	decreased fasting circulating glucose level	J:211773
	increased circulating potassium level	J:211773
	increased circulating sodium level	J:211773
Cldn16^tm1.1Dmu/Cldn16^tm1.1Dmu (involves: 129 * BALB/cJ * C57BL/6)	abnormal renal calcium reabsorption	J:159706
	abnormal vitamin D level	J:159706
	decreased circulating magnesium level	J:159706
	decreased urine pH	J:159706
	increased circulating parathyroid hormone level	J:159706
	increased urine calcium level	J:159706
Cldn17^em#Prso/Cldn17^em#Prso (C57BL/6-Cldn17^em#Prso)	abnormal circulating protein level	J:325994
	abnormal urine homeostasis	J:325994
	decreased circulating sodium level	J:325994
	increased circulating bicarbonate level	J:325994
	increased circulating chloride level	J:325994
Cldn19^{tm1.1(KOMP)Vlcg}/Cldn19^{tm1.1(KOMP)Vlcg} (B6N(Cg)-Cldn19^{tm1.1(KOMP)Vlcg}/J)	increased circulating sodium level	J:211773
Cldn23^em1(IMPC)J/Cldn23^em1(IMPC)J (C57BL/6NJ-Cldn23^em1(IMPC)J/Mmjax)	decreased circulating aspartate transaminase level	J:211773
Cldn34b2^{tm1a(KOMP)Wtsi}/Cldn34b2^{tm1a(KOMP)Wtsi} (C57BL/6N-Cldn34b2^{tm1a(KOMP)Wtsi}/Wtsi)	increased circulating chloride level	J:211773
Cldnd2^{tm1b(EUCOMM)Hmgu}/Cldnd2^{tm1b(EUCOMM)Hmgu} (C57BL/6N-Cldnd2^{tm1b(EUCOMM)Hmgu}/Orl)	abnormal cholesterol homeostasis	J:211773
	increased circulating calcium level	J:211773
	increased circulating serum albumin level	J:211773
	increased circulating total protein level	J:211773
	increased fasting circulating glucose level	J:211773
Clec1b^tm1.1Arte/Clec1b^tm1.1Arte Tg(Pf4-icre)Q3Rsko/0 (involves: C57BL/6)	abnormal blood coagulation	J:217963
	abnormal platelet physiology	J:181715
	ascites	J:181715
	edema	J:181715
Clec1b^tm1.1Ksi/Clec1b^tm1.1Ksi (involves: C57BL/6)	abnormal platelet activation	J:165898
	decreased platelet aggregation	J:165898
	skin edema	J:165898
Clec1b^tm1.2Arte/Clec1b^tm1.2Arte (involves: 129 * C57BL/6)	abnormal platelet physiology	J:181754
Clec1b^tm1.2Arte/Clec1b^tm1.2Arte (Not Specified)	chylous ascites	J:181715
	decreased platelet aggregation	J:181715
	edema	J:181715
Clec1b^tm1Ksi/Clec1b^tm1Ksi Tg(Pf4-icre)Q3Rsko/0 (involves: C57BL/6)	intestinal edema	J:187533
Clec1b^tm1Mlkn/Clec1b^tm1Mlkn (involves: 129S4/SvJae * C57BL/6)	abnormal platelet activation	J:162815
	intestinal edema	J:162815
Clec2d^tm1.1Mgil/Clec2d^tm1.1Mgil (C57BL/6-Clec2d^tm1.1Mgil)	decreased circulating parathyroid hormone level	J:143122
	increased circulating calcium level	J:143122
Clec2h^tm1.1Apma/Clec2h^tm1.1Apma (B6(Cg)-Clec2h^tm1.1Apma)	increased circulating creatinine level	J:322835
Clec4a2^tm1Yiw/Clec4a2^tm1Yiw (involves: 129P2/OlaHsd * C57BL/6J)	abnormal circulating interleukin level	J:217720
	increased circulating interleukin-4 level	J:217720
	increased circulating interleukin-10 level	J:217720
	increased circulating interleukin-17 level	J:217720
	increased circulating interleukin-23 level	J:217720
Clec4b1^em#Tsak/Clec4b1^em#Tsak (involves: C57BL/6N)	abnormal cytokine level	J:258645
Clec4d^tm1.1Shoy/Clec4d^tm1.1Shoy (involves: 129P2/OlaHsd * C57BL/6)	decreased circulating interleukin-17 level	J:203159
Clec4e^tm1Tks/Clec4e^tm1Tks (involves: 129S1/Sv * 129X1/SvJ)	decreased circulating interleukin-17 level	J:203159
Clec4g^tm1.1Fhe/Clec4g^tm1.1Fhe (B6.129-Clec4g^tm1.1Fhe)	increased circulating alanine transaminase level	J:200968
Clec4g^tm1.1Fhe/Clec4g^tm1.1Fhe (B6.129-Clec4g^tm1.1Fhe)	increased circulating aspartate transaminase level	J:200968
Clec7a^tm1Gdb/Clec7a^tm1Gdb (B6.129S6-Clec7a^tm1Gdb)	abnormal circulating interleukin level	J:179011
Clec7a^tm1Gdb/Clec7a^tm1Gdb (B6.129S6-Clec7a^tm1Gdb)	decreased circulating interleukin-17 level	J:179011
Clec16a^tm1.1Hhak/Clec16a^tm1.1Hhak Ndor1^{Tg(UBC-cre/ERT2)1Ejb}/0 (involves: 129S/SvEv * C57BL/6 * SJL)	decreased oxygen consumption	J:214528
Clec16a^tm1.1Hhak/Clec16a^tm1.1Hhak Tg(Pdx1-cre)1Herr/0 (involves: C57BL/6 * C57BL/6J * CBA/J * SJL)	decreased insulin secretion	J:214528
	decreased oxygen consumption	J:214528
	hyperglycemia	J:214528
	impaired glucose tolerance	J:214528
Clic1^tm1.1Breit/Clic1^tm1.1Breit (involves: 129 * C57BL/6J)	abnormal platelet activation	J:158394
	decreased platelet aggregation	J:158394
	increased bleeding time	J:158394
Clic4^tm1.1Aidi/Clic4^tm1.1Aidi (involves: C57BL/6 * C57BL/6J)	decreased circulating interleukin-6 level	J:175404
	decreased circulating tumor necrosis factor level	J:175404
Clic5^jbg/Clic5^jbg (C3H/HeJ-Clic5^jbg/J)	albuminuria	J:243805
Clic5^jbg/Clic5^jbg (C3H/HeJ-Clic5^jbg/J)	increased urine protein level	J:184254
Clic5^jbg/Clic5^jbg (involves: C3H/HeJ * C57BL/6)	decreased body temperature	J:160186
	decreased circulating glucose level	J:160186
	decreased circulating insulin level	J:160186
	decreased circulating leptin level	J:160186
	increased circulating glucagon level	J:160186
	increased respiratory quotient	J:160186
Clip3^tm1.1Ics/Clip3^tm1.1Ics (involves: C57BL/6)	cyanosis	J:194894
Clk1^{tm1a(EUCOMM)Wtsi}/Clk1^{tm1a(EUCOMM)Wtsi} (C57BL/6N-Clk1^{tm1a(EUCOMM)Wtsi}/Ics)	decreased circulating calcium level	J:165965
	increased circulating chloride level	J:165965
Clk2^tm1.1Ppgr/Clk2^tm1.1Ppgr Speer6-ps1^{Tg(Alb-cre)21Mgn}/Speer6-ps1⁺ (involves: C57BL/6NTac * FVB/N)	abnormal fatty acid oxidation	J:229283
	decreased liver triglyceride level	J:229283
	decreased respiratory quotient	J:229283
Clmp^tm1.1Fgr/Clmp^tm1.1Fgr (involves: 129P2/OlaHsd * 129S1/Sv * C57BL/6)	increased urine lipocalin 2 level	J:258315
Clmp^tm1Lex/Clmp^tm1Lex (B6;129S5-Clmp^tm1Lex/Mmucd)	abnormal blood homeostasis	J:171883
Cln3^tm1Blda/Cln3^tm1Blda (B6.129-Cln3^tm1Blda)	decreased urine osmolality	J:160849
	decreased urine potassium level	J:160849
	increased blood osmolality	J:160849
	increased circulating potassium level	J:160849
Cln6^{tm1b(EUCOMM)Hmgu}/Cln6^{tm1b(EUCOMM)Hmgu} (C57BL/6N-Cln6^{tm1b(EUCOMM)Hmgu}/Tcp)	impaired glucose tolerance	J:211773
Cln8^em1(IMPC)Mbp/Cln8^em1(IMPC)Mbp (C57BL/6N-Cln8^em1(IMPC)Mbp/MbpMmucd)	increased circulating phosphate level	J:211773
	increased circulating serum albumin level	J:211773
Clock^{em1(IMPC)Ccpcz}/Clock^{em1(IMPC)Ccpcz} (C57BL/6NCrl-Clock^{em1(IMPC)Ccpcz}/Ccpcz)	decreased circulating serum albumin level	J:211773
	decreased circulating total protein level	J:211773
	increased circulating alkaline phosphatase level	J:211773
	increased circulating HDL cholesterol level	J:211773
	increased circulating triglyceride level	J:211773
Clock^m1Jt/Clock⁺ (involves: C57BL/6)	abnormal circulating protein level	J:155089
Clock^m1Jt/Clock^m1Jt (C57BL/6-Clock^m1Jt)	decreased circulating corticosterone level	J:98343
	decreased energy expenditure	J:98343
	increased circulating cholesterol level	J:98343
	increased circulating glucose level	J:98343
	increased circulating leptin level	J:98343
	increased circulating triglyceride level	J:98343
	increased susceptibility to diet-induced obesity	J:98343
Clock^m1Jt/Clock^m1Jt (involves: C57BL/6)	abnormal glucose homeostasis	J:131694
	abnormal lipid homeostasis	J:131694
	abnormal luteinizing hormone level	J:92343
	decreased circulating estradiol level	J:92343
	decreased circulating luteinizing hormone level	J:92343
	decreased circulating progesterone level	J:92343
	impaired gluconeogenesis	J:131694
	increased circulating estradiol level	J:92343
	increased circulating progesterone level	J:92343
	increased insulin sensitivity	J:131694
Clock^m1Jt/Clock^m1Jt (involves: C57BL/6 * Jcl:ICR)	abnormal circadian temperature homeostasis	J:116792, J:103663
Clock^m1Jt/Clock^m1Jt (C57BL/6J-Clock^m1Jt/J)	abnormal intestinal lipid absorption	J:153782
Clock^m1Jt/Clock^m1Jt (involves: C57BL/6J)	decreased insulin secretion	J:162641
	hyperglycemia	J:162641
	impaired glucose tolerance	J:162641
	increased insulin sensitivity	J:162641
	insulin resistance	J:162641
Clock^m1Jt/Clock^m1Jt Lep^ob/Lep^ob (involves: BALB/c * C57BL/6 * C57BL/6J * Jcl:ICR)	decreased circulating glucose level	J:135847
	decreased circulating insulin level	J:135847
	increased circulating cholesterol level	J:135847
	increased circulating free fatty acids level	J:135847
	increased circulating glucose level	J:135847
	increased circulating insulin level	J:135847
	increased circulating triglyceride level	J:135847
Clpp^{tm1a(EUCOMM)Wtsi}/Clpp^{tm1a(EUCOMM)Wtsi} (C57BL/6N-Clpp^{tm1a(EUCOMM)Wtsi}/Wtsi)	decreased circulating fructosamine level	J:211773
	decreased circulating glucose level	J:211773
	increased circulating alkaline phosphatase level	J:211773
	increased circulating aspartate transaminase level	J:211773
	increased circulating bilirubin level	J:211773
	increased circulating cholesterol level	J:211773
	increased circulating glycerol level	J:211773
	increased circulating iron level	J:211773
	increased circulating serum albumin level	J:211773
Clps^tm1Lowe/Clps^tm1Lowe (involves: 129S6/SvEvTac * Black Swiss)	decreased circulating triglyceride level	J:75167
	increased circulating cholesterol level	J:75167
	steatorrhea	J:75167
Clps^tm2.1Lowe/Clps^tm2.1Lowe (B6.129X1-Clps^tm2.1Lowe)	decreased circulating HDL cholesterol level	J:159587
Clps^tm2.1Lowe/Clps^tm2.1Lowe (B6.129X1-Clps^tm2.1Lowe)	increased circulating cholesterol level	J:159587
Clptm1l^em1(IMPC)J/Clptm1l^em1(IMPC)J (C57BL/6NJ-Clptm1l^em1(IMPC)J/Mmjax)	decreased circulating alkaline phosphatase level	J:211773
Clstn3^{tm1b(EUCOMM)Hmgu}/Clstn3^{tm1b(EUCOMM)Hmgu} (involves: BALB/cJ * C57BL/6N)	abnormal homeostasis	J:293885
	decreased circulating glucose level	J:293885
	decreased susceptibility to diet-induced obesity	J:293885
	increased carbon dioxide production	J:293885
	increased energy expenditure	J:293885
	increased insulin sensitivity	J:293885
	increased oxygen consumption	J:293885
Cltrn^tm1.1Pngr/Cltrn^tm1.1Pngr (involves: 129P2/OlaHsd * C57BL/6J)	abnormal homeostasis	J:117490
	increased urine osmolality	J:117490
Cltrn^tm1Thu/Y (involves: 129S/SvEv * C57BL/6)	abnormal amino acid level	J:148522
	abnormal urine homeostasis	J:148522
	aminoaciduria	J:148752
	crystalluria	J:148752
	decreased circulating carnitine level	J:148522
	decreased urine osmolality	J:148752
	decreased urine sodium level	J:148752
	decreased urine urea nitrogen level	J:148752
	increased circulating ketone body level	J:148522
	increased circulating methionine level	J:148752
	increased circulating sodium level	J:148752
	increased circulating tyrosine level	J:148752
	increased insulin sensitivity	J:148522
Clu^{tm1b(EUCOMM)Hmgu}/Clu^{tm1b(EUCOMM)Hmgu} (C57BL/6N-Clu^{tm1b(EUCOMM)Hmgu}/H)	decreased fasting circulating glucose level	J:211773
Clu^tm1Jakh/Clu^tm1Jakh (involves: Black Swiss * FVB/N)	cardiac edema	J:65660
Clu^tm1Jakh/Clu^tm1Jakh (involves: 129S2/SvPas * Black Swiss)	hematuria	J:74983
Cluap1^tm1.2Hmd/Cluap1^tm1.2Hmd (involves: 129S6/SvEvTac * C57BL/6NCr)	cardiac edema	J:200709
Cluh^tm1.1Eir/Cluh^tm1.1Eir Speer6-ps1^{Tg(Alb-cre)21Mgn}/Speer6-ps1⁺ (involves: BALB/cJ * C57BL/6 * DBA * SJL)	abnormal circulating amino acid level	J:249661
	abnormal homeostasis	J:249661
	decreased fasting circulating glucose level	J:249661
	hypoglycemia	J:249661
	increased circulating alanine transaminase level	J:249661
	increased circulating lysine level	J:249661
	increased circulating methionine level	J:249661
	increased circulating proline level	J:249661
	increased circulating serine level	J:249661
	increased circulating threonine level	J:249661
Cluh^tm1.2Eir/Cluh^tm1.2Eir (involves: BALB/cJ * C57BL/6 * SJL)	abnormal homeostasis	J:249661
	decreased fasting circulating glucose level	J:249661
Clvs1^{tm1.1(KOMP)Vlcg}/Clvs1^{tm1.1(KOMP)Vlcg} (B6N(Cg)-Clvs1^{tm1.1(KOMP)Vlcg}/J)	decreased fasting circulating glucose level	J:211773
	increased circulating chloride level	J:211773
Cm/+ (C3Sn.Cg-Cm/J)	increased dopamine level	J:156905
Cm/+ Drd2^tm1Low/Drd2^tm1Low (involves: 101/H * 129S2/SvPas * C3H/HeH * C3H/HeSn * C57BL/6J)	decreased dopamine level	J:156905
Cmas^tm1.1Bwei/Cmas^tm1.1Bwei Tg(NPHS2-cre)295Lbh/0 (involves: 129P2/OlaHsd * C57BL/6 * SJL)	increased urine protein level	J:286022
Cmklr2^tm1.1Dgen/Cmklr2^tm1.1Dgen (involves: C57BL/6J)	increased circulating estradiol level	J:273922
Cmklr2^tm1.1Dgen/Cmklr2^tm1.1Dgen (involves: C57BL/6J)	increased circulating LDL cholesterol level	J:273922
Cmpk1^{tm1b(EUCOMM)Wtsi}/Cmpk1⁺ (C57BL/6N-Cmpk1^{tm1b(EUCOMM)Wtsi}/Ieg)	increased circulating iron level	J:211773
Cmpk2^{tm1b(KOMP)Wtsi}/Cmpk2^{tm1b(KOMP)Wtsi} (C57BL/6N-Cmpk2^{tm1b(KOMP)Wtsi}/H)	increased circulating cholesterol level	J:211773
Cmtm3^em1Wlh/Cmtm3^em1Wlh (involves: C57BL/6)	abnormal hormone level	J:338327
Cmtm7^em1(IMPC)J/Cmtm7^em1(IMPC)J (C57BL/6NJ-Cmtm7^em1(IMPC)J/Mmjax)	increased circulating alkaline phosphatase level	J:211773
Cmtr2^{tm1.1(KOMP)Vlcg}/Cmtr2⁺ (B6N(Cg)-Cmtr2^{tm1.1(KOMP)Vlcg}/2J)	decreased circulating creatinine level	J:211773
Cmya5^tm1Cap/Cmya5^tm1Cap (129-Cmya5^tm1Cap)	abnormal nervous system dopamine level	J:322761
Cmya5^tm1Cap/Cmya5^tm1Cap (129-Cmya5^tm1Cap)	increased serotonin level	J:322761
Cnbp^{tm1b(KOMP)Wtsi}/Cnbp⁺ (B6N(Cg)-Cnbp^{tm1b(KOMP)Wtsi}/J)	decreased blood urea nitrogen level	J:211773
	decreased circulating serum albumin level	J:211773
	increased circulating chloride level	J:211773
	increased circulating potassium level	J:211773
Cnga2^tm1.1Kob/Y Gucy1b2^{tm4.1(cre)Mom}/Gucy1b2^{tm4.1(cre)Mom} (involves: 129P2/OlaHsd * 129S2/SvPas * 129S4/SvJaeSor * C57BL/6J)	abnormal homeostasis	J:307157
Cnga2^tm1.1Kob/Cnga2^tm1.1Kob Gucy1b2^{tm4.1(cre)Mom}/Gucy1b2^{tm4.1(cre)Mom} (involves: 129P2/OlaHsd * 129S2/SvPas * 129S4/SvJaeSor * C57BL/6J)	abnormal homeostasis	J:307157
Cnga3^{tm1.1(KOMP)Vlcg}/Cnga3^{tm1.1(KOMP)Vlcg} (C57BL/6N-Cnga3^{tm1.1(KOMP)Vlcg}/Ucd)	increased circulating alanine transaminase level	J:211773
Cnih2^{tm1b(KOMP)Wtsi}/Cnih2^{tm1b(KOMP)Wtsi} (B6N(Cg)-Cnih2^{tm1b(KOMP)Wtsi}/J)	decreased circulating calcium level	J:211773
	increased circulating alkaline phosphatase level	J:211773
Cnmd^tm1Ska/Cnmd^tm1Ska (involves: C57BL/6 * CBA)	decreased circulating alkaline phosphatase level	J:81137
Cnn1^tm1Tkhi/Cnn1^tm1Tkhi (involves: 129S/SvEv * C57BL/6)	increased circulating alkaline phosphatase level	J:77112
Cnnm2^tm1.1Hmik/Cnnm2⁺ (involves: C57BL * C57BL/6J * DBA)	abnormal homeostasis	J:303151
Cnnm2^tm1.1Hmik/Cnnm2⁺ (involves: C57BL * C57BL/6J * DBA)	decreased circulating magnesium level	J:303151
Cnnm2^tm1Hmik/Cnnm2^tm1Hmik Tg(Six2-EGFP/cre)1Amc/0 (involves: C57BL/6J * CD-1)	decreased circulating magnesium level	J:303151
Cnnm4^{tm1a(EUCOMM)Wtsi}/Cnnm4^{tm1a(EUCOMM)Wtsi} (involves: C57BL/6J * C57BL/6N)	decreased circulating magnesium level	J:207520
	decreased urine magnesium level	J:207520
Cnnm4^{tm1b(EUCOMM)Wtsi}/Cnnm4^{tm1b(EUCOMM)Wtsi} (involves: C57BL * C57BL/6N * DBA)	decreased circulating magnesium level	J:303151
Cnot3^{em1(IMPC)Rbrc}/Cnot3⁺ (C57BL/6NJcl-Cnot3^{em1(IMPC)Rbrc}/Rbrc)	decreased circulating triglyceride level	J:211773
	improved glucose tolerance	J:211773
	increased circulating bilirubin level	J:211773
Cnot3^tm1.1Tya/Cnot3⁺ (B6.129P2(Cg)-Cnot3^tm1.1Tya)	decreased circulating glucose level	J:180033
	decreased circulating triglyceride level	J:180033
	decreased fasting circulating glucose level	J:180033
	decreased susceptibility to diet-induced obesity	J:180033
	improved glucose tolerance	J:180033
	increased insulin sensitivity	J:180033
	increased oxygen consumption	J:180033
Cnot3^tm1.1Tya/Cnot3⁺ Lep^ob/Lep^ob (involves: 129P2/OlaHsd * C57BL/6J)	decreased respiratory quotient	J:180033
	improved glucose tolerance	J:180033
	increased insulin sensitivity	J:180033
	increased oxygen consumption	J:180033
Cnot4^{tm1b(EUCOMM)Wtsi}/Cnot4⁺ (C57BL/6N-Cnot4^{tm1b(EUCOMM)Wtsi}/Wtsi)	decreased circulating alkaline phosphatase level	J:211773
Cnot6l^tm1Tya/Cnot6l^tm1Tya (B6.Cg-Cnot6l^tm1Tya)	abnormal circulating glucose level	J:274297
	abnormal circulating insulin level	J:274297
	abnormal circulating lipid level	J:274297
	abnormal homeostasis	J:274297
	decreased respiratory quotient	J:274297
	decreased susceptibility to diet-induced obesity	J:274297
	increased circulating ketone body level	J:274297
	increased oxygen consumption	J:274297
Cnot9^m1Tc/Cnot9^m1Tc (involves: C57BL/6J * FVB/N)	edema	J:186861
Cnpy1^{tm1(KOMP)Wtsi}/Cnpy1^{tm1(KOMP)Wtsi} (C57BL/6N-Cnpy1^{tm1(KOMP)Wtsi}/Nju)	decreased circulating serum albumin level	J:211773
Cnpy2^tm1.2Zhli/Cnpy2^tm1.2Zhli (B6.Cg-Cnpy2^tm1.2Zhli)	decreased circulating alanine transaminase level	J:277868
	decreased circulating triglyceride level	J:277868
	decreased susceptibility to diet-induced obesity	J:277868
Cnr1^{tm1.1(KOMP)Vlcg}/Cnr1⁺ (C57BL/6N-Cnr1^{tm1.1(KOMP)Vlcg}/MbpMmucd)	edema	J:211773
Cnr1^{tm1.1(KOMP)Vlcg}/Cnr1^{tm1.1(KOMP)Vlcg} (C57BL/6N-Cnr1^{tm1.1(KOMP)Vlcg}/MbpMmucd)	edema	J:211773
Cnr1^tm1Map/Cnr1^tm1Map (involves: 129S1/Sv * 129X1/SvJ * CD-1)	increased circulating adrenocorticotropin level	J:89722
Cnr1^tm1Ojm/Cnr1^tm1Ojm (involves: 129P2/OlaHsd * C57BL/6)	decreased circulating insulin level	J:93697
	decreased circulating leptin level	J:93697
	decreased susceptibility to diet-induced obesity	J:93697
	increased insulin sensitivity	J:93697
Cnr1^tm1Zim/Cnr1^tm1Zim (involves: 129 * C57BL/6J)	decreased circulating progesterone level	J:144423
	increased circulating corticosterone level	J:144423
	increased circulating estradiol level	J:144423
	increased follicle stimulating hormone level	J:144423
Cntn5^em1(IMPC)Mbp/Cntn5^em1(IMPC)Mbp (C57BL/6N-Cntn5^em1(IMPC)Mbp/MbpMmucd)	increased circulating alanine transaminase level	J:211773
Cntnap4^tm1Pele/Cntnap4⁺ (involves: 129S1/Sv * 129X1/SvJ * ICR)	increased dopamine level	J:211338
Cntnap4^tm1Pele/Cntnap4^tm1Pele (involves: 129S1/Sv * 129X1/SvJ * ICR)	increased dopamine level	J:211338
Coasy^em1(IMPC)H/Coasy⁺ (C57BL/6NTac-Coasy^em1(IMPC)H/H)	increased circulating potassium level	J:211773
Coasy^tm1.1Vtr/Coasy^tm1.1Vtr Tg(Syn1-cre)671Jxm/0 (involves: 129 * C57BL/6N * CBA)	abnormal calcium level	J:299154
	abnormal magnesium level	J:299154
	increased brain iron level	J:299154
Cog2^{tm1a(KOMP)Wtsi}/Cog2⁺ (B6JTyr;B6N-Cog2^{tm1a(KOMP)Wtsi}/Wtsi)	decreased circulating alanine transaminase level	J:175295
	decreased circulating aspartate transaminase level	J:175295
	decreased circulating creatinine level	J:175295
	decreased lactate dehydrogenase level	J:175295
	increased circulating triglyceride level	J:175295
Cog3^{tm1b(EUCOMM)Hmgu}/Cog3⁺ (C57BL/6N-Cog3^{tm1b(EUCOMM)Hmgu}/Ieg)	increased circulating insulin level	J:211773
Cog5^{em1(IMPC)Ccpcz}/Cog5⁺ (C57BL/6NCrl-Cog5^{em1(IMPC)Ccpcz}/Ccpcz)	increased circulating creatine kinase level	J:211773
Cog6^{tm1a(EUCOMM)Wtsi}/Cog6^{tm1a(EUCOMM)Wtsi} (C57BL/6N-Cog6^{tm1a(EUCOMM)Wtsi}/Wtsi)	increased circulating alkaline phosphatase level	J:211773
	increased circulating amylase level	J:211773
	increased circulating aspartate transaminase level	J:211773
	increased circulating bilirubin level	J:211773
	increased circulating total protein level	J:211773
Cog8^em1(IMPC)J/Cog8⁺ (C57BL/6NJ-Cog8^em1(IMPC)J/Mmjax)	decreased circulating bilirubin level	J:211773
Col1a1^Aga2/Col1a1⁺ (involves: C3HeB/FeJ * C57BL/6J)	abnormal enzyme/coenzyme level	J:129569
	abnormal hormone level	J:129569
	decreased circulating alkaline phosphatase level	J:129569
	increased circulating parathyroid hormone level	J:129569
Col1a1^Aga2/Col1a1⁺ (C3HeB/FeJ-Col1a1^Aga2)	abnormal blood gas level	J:185988
Col1a1^m1Btlr/Col1a1^m1Btlr (C57BL/6J-Col1a1^m1Btlr)	decreased hydroxyproline level	J:253622
Col1a1^M1Jrt/Col1a1⁺ (involves: C3H/HeJ * C57BL/6J * FVB/NJ)	decreased collagen level	J:216423
Col1a1^{tm1(tetO-Deptor)Dmsa}/Col1a1⁺ Gt(ROSA)26Sor^{tm1(rtTAM2)Jae}/? (involves: 129S4/SvJae C57BL/6 * C57BL/6J)	increased circulating leptin level	J:187378
	increased susceptibility to diet-induced obesity	J:187378
	increased triglyceride level	J:187378
Col1a1^{tm1(tetO-Lin28a)Gqda}/Col1a1⁺ (involves: 129S4/SvJae * C57BL/6 * CD-1)	decreased circulating glucose level	J:166568
	decreased circulating insulin level	J:166568
	decreased susceptibility to diet-induced obesity	J:177113
	improved glucose tolerance	J:166568, J:177113
	increased insulin sensitivity	J:166568, J:177113
Col1a1^{tm1(tetO-Tcfap2c)Hsc}/Col1a1⁺ Gt(ROSA)26Sor^{tm1(rtTAM2)Jae}/Gt(ROSA)26Sor⁺ (involves: 129S4/SvJae C57BL/6)	abnormal circulating enzyme level	J:174049
	decreased liver glycogen level	J:174049
	dehydration	J:174049
	increased circulating alanine transaminase level	J:174049
	increased circulating alkaline phosphatase level	J:174049
	increased circulating amylase level	J:174049
	increased circulating aspartate transaminase level	J:174049
	increased circulating lactate dehydrogenase level	J:174049
Col1a1^{tm1(tetO-URI1)Ndj}/Col1a1⁺ Tg(Cebpb-tTA)#Bjd/0 (B6.Cg-Col1a1^{tm1(tetO-URI1)Ndj} Tg(Cebpb-tTA)#Bjd)	abnormal enzyme/coenzyme level	J:217463
	decreased circulating glucose level	J:217463
	increased bile salt level	J:217463
	increased circulating alanine transaminase level	J:217463
	increased circulating serum albumin level	J:217463
Col1a1^{tm2(CAG-IDH2R172K)Kkw}/Col1a1⁺ Ndor1^{Tg(UBC-cre/ERT2)1Ejb}/0 (involves: 129S/SvEv 129S4/SvJae * BALB/c * C57BL/6)	increased cardiac muscle glycogen level	J:209629
	increased skeletal muscle glycogen level	J:209629
Col1a1^{tm2(tetO-Fosl2,-DsRed)Wag}/Col1a1⁺ Tg(Cebpb-tTA)5Bjd/0 (involves: 129S4/SvJae * C57BL/6 * NMRI)	decreased liver triglyceride level	J:210545
Col1a1^{tm2(tetO-Fosl2,-DsRed)Wag}/Col1a1⁺ Tg(Sp7-tTA,tetO-EGFP/cre)1Amc/0 (involves: 129S4/SvJae * C57BL/6 * CD-1)	decreased circulating adiponectin level	J:211215
	decreased circulating glucose level	J:211215
	decreased circulating insulin level	J:211215
	decreased insulin secretion	J:211215
	improved glucose tolerance	J:211215
	increased circulating osteocalcin level	J:211215
	increased insulin sensitivity	J:211215
Col1a1^{tm2(tetO-LIN28B)Gqda}/Col1a1⁺ Gt(ROSA)26Sor^{tm1(rtTAM2)Jae}/Gt(ROSA)26Sor⁺ (involves: 129S4/SvJae C57BL/6 * CD-1)	decreased susceptibility to diet-induced obesity	J:177113
	hypoglycemia	J:177113
	improved glucose tolerance	J:177113
	increased insulin sensitivity	J:177113
Col1a1^{tm2(tetO-Pou5f1)Jae}/Col1a1⁺ Gt(ROSA)26Sor^{tm1(rtTAM2)Jae}/Gt(ROSA)26Sor⁺ (involves: 129S4/SvJae C57BL/6)	dehydration	J:98920
Col1a1^{tm3(CAG-IDH2R140Q)Kkw}/Col1a1⁺ Ndor1^{Tg(UBC-cre/ERT2)1Ejb}/0 (involves: 129S/SvEv 129S4/SvJae * BALB/c * C57BL/6)	increased skeletal muscle glycogen level	J:209629
Col1a1^{tm3(tetO-Fosl1,-DsRed)Wag}/Col1a1⁺ Gt(ROSA)26Sor^{tm1(rtTAM2)Jae}/Gt(ROSA)26Sor⁺ (involves: 129S4/SvJae C57BL/6)	ascites	J:213764
Col1a1^{tm3(tetO-Fosl1,-DsRed)Wag}/Col1a1⁺ Tg(Cebpb-tTA)5Bjd/0 (involves: 129S4/SvJae * C57BL/6 * NMRI)	decreased circulating alanine transaminase level	J:213764, J:210545
	decreased circulating cholesterol level	J:213764
	decreased circulating interleukin-6 level	J:210545
	decreased liver triglyceride level	J:210545
	impaired glucose tolerance	J:210545
	increased bile salt level	J:213764
	increased circulating cholesterol level	J:210545
	increased circulating triglyceride level	J:210545
	insulin resistance	J:210545
Col1a1^{tm3(tetO-GFP/RNAi:Apc)Slowe}/Col1a1⁺ Gt(ROSA)26Sor^{tm1(rtTAM2)Jae}/Gt(ROSA)26Sor⁺ (involves: 129S4/SvJae C57BL/6)	hydrops fetalis	J:171191
Col1a1^{tm3(tetO-Mirlet7g/Mir21)Gqda}/Col1a1⁺ Gt(ROSA)26Sor^{tm1(rtTAM2)Jae}/Gt(ROSA)26Sor⁺ (involves: 129S4/SvJae C57BL/6 * CD-1)	impaired glucose tolerance	J:177113
	increased circulating glucose level	J:177113
	increased circulating insulin level	J:177113
Col1a1^{tm4(tetO-Jun/Fosl2)Wag}/Col1a1⁺ Tg(Cebpb-tTA)5Bjd/0 (involves: 129S4/SvJae * C57BL/6 * NMRI)	decreased liver triglyceride level	J:210545
Col1a2^{tm1b(EUCOMM)Wtsi}/Col1a2^{tm1b(EUCOMM)Wtsi} (C57BL/6N-Col1a2^{tm1b(EUCOMM)Wtsi}/Bay)	decreased blood urea nitrogen level	J:211773
	increased circulating alkaline phosphatase level	J:211773
Col1a2^{tm1b(EUCOMM)Wtsi}/Col1a2^{tm1b(EUCOMM)Wtsi} (C57BL/6N-Col1a2^{tm1b(EUCOMM)Wtsi}/BayMmucd)	decreased circulating amylase level	J:211773
	increased circulating alkaline phosphatase level	J:211773
Col2a1^tm1Dshh/Col2a1^tm1Dshh (involves: 129S6/SvEvTac * C57BL/6J)	cyanosis	J:212712
Col2a1^tm1Prc/Col2a1⁺ (involves: 129/Sv * C57BL/6)	decreased hyaluronic acid level	J:144313
Col4a1^deltaex40/Col4a1⁺ (B6.129S-Col4a1^deltaex40)	cyanosis	J:215446
Col4a1^deltaex40/Col4a1⁺ (B6.129S-Col4a1^deltaex40)	increased urine microalbumin level	J:215446
Col4a1^deltaex40/Col4a1⁺ (involves: 129S/SvEv * C57BL/6J)	increased circulating creatine kinase level	J:172720
Col4a1^tm1.1Ics/Col4a1⁺ (involves: 129S2/SvPas * C57BL/6)	abnormal urine albumin level	J:240798
	albuminuria	J:240798
	erythrocyturia	J:240798
	hematuria	J:240798
Col4a1^tm1.1Ics/Col4a1^tm1.1Ics (involves: 129S2/SvPas * C57BL/6)	abnormal urine albumin level	J:240798
	albuminuria	J:240798
	decreased collagen level	J:240798
	decreased urine osmolality	J:240798
	erythrocyturia	J:240798
	hematuria	J:240798
	increased blood urea nitrogen level	J:240798
Col4a2^{em1(IMPC)Wtsi}/Col4a2⁺ (C57BL/6N-Col4a2^{em1(IMPC)Wtsi}/WtsiOulu)	decreased circulating fructosamine level	J:211773
	decreased circulating serum albumin level	J:211773
	decreased circulating total protein level	J:211773
Col4a2^{em1(IMPC)Wtsi}/Col4a2^{em1(IMPC)Wtsi} (C57BL/6N-Col4a2^{em1(IMPC)Wtsi}/WtsiOulu)	subcutaneous edema	J:239583
Col4a3^tm1.1Rkl/Col4a3⁺ (involves: C57BL/6)	increased circulating creatinine level	J:167404
Col4a3^tm1.1Rkl/Col4a3⁺ (involves: C57BL/6)	increased urine protein level	J:167404
Col4a3^{tm1b(EUCOMM)Wtsi}/Col4a3^{tm1b(EUCOMM)Wtsi} (C57BL/6N-Col4a3^{tm1b(EUCOMM)Wtsi}/H)	decreased circulating amylase level	J:211773
Col4a3^tm1Dec/Col4a3^tm1Dec (involves: 129X1/SvJ * C57BL/6)	albuminuria	J:37963
	hematuria	J:37963
	increased blood urea nitrogen level	J:37963
Col4a3^tm1Dec/Col4a3^tm1Dec (129-Col4a3^tm1Dec/J)	albuminuria	J:158731
	increased blood urea nitrogen level	J:158731
	increased circulating creatinine level	J:158731
	increased urine protein level	J:158731
Col4a3^tm1Dec/Col4a3^tm1Dec (B6.129X1-Col4a3^tm1Dec)	increased circulating creatinine level	J:167404
Col4a3^tm1Dec/Col4a3^tm1Dec (B6.129X1-Col4a3^tm1Dec)	increased urine protein level	J:167404
Col4a3^tm1Dec/Col4a3^tm1Dec Itga1^tm1Gdnr/Itga1^tm1Gdnr (involves: 129S4/SvJae * 129X1/SvJ * BALB/c)	increased circulating total protein level	J:91620
Col4a3^tm1Dec/Col4a3^tm1Dec Sostdc1^tm1Myan/Sostdc1^tm1Myan (involves: 129X1/SvJ)	albuminuria	J:158731
	increased blood urea nitrogen level	J:158731
	increased circulating creatinine level	J:158731
Col4a3^tm1Jhm/Col4a3^tm1Jhm (involves: 129S1/Sv * 129X1/SvJ)	albuminuria	J:37017
	increased blood urea nitrogen level	J:37017
	increased circulating creatinine level	J:37017
	increased urine protein level	J:207595, J:37017
	uremia	J:37017
Col4a3^tm1Jhm/Col4a3^tm1Jhm Lamb2^em1Jhm/Lamb2⁺ (involves: 129S1/Sv * 129X1/SvJ * C57BL/6J * CBA/J)	albuminuria	J:280129
	increased blood urea nitrogen level	J:280129
Col4a4^bwk/Col4a4^bwk (NON;NZO-Col4a4^bwk/J)	albuminuria	J:223185
Col4a4^bwk/Col4a4^bwk (D2.NON(NZO)-Col4a4^bwk/GrsrJ)	albuminuria	J:223185
Col4a4^bwk/Col4a4^bwk (129S1.NON(NZO)-Col4a4^bwk/PgnJ)	albuminuria	J:223185
Col4a4^m1Btlr/Col4a4^m1Btlr (C57BL/6J-Col4a4^m1Btlr)	hematuria	J:170552
	increased blood urea nitrogen level	J:170552, J:158794
	increased circulating creatinine level	J:158794
	increased urine protein level	J:170552
	leukocyturia	J:170552
	uremia	J:158794
Col4a4^m1H/Col4a4^m1H (involves: C3H/HeH * C57BL/6J)	decreased circulating serum albumin level	J:285510
	decreased urine potassium level	J:285510
	decreased urine sodium level	J:285510
	hematuria	J:285510
	increased blood urea nitrogen level	J:285510
	increased circulating creatinine level	J:285510
	increased urine protein level	J:285510
Col4a5^em1Keha/Y (C57BL/6J-Col4a5^em1Keha)	albuminuria	J:283613
	decreased circulating total protein level	J:283613
	hematuria	J:283613
	increased blood urea nitrogen level	J:283613
	increased circulating creatinine level	J:283613
Col4a5^{tm1b(EUCOMM)Wtsi}/Y (C57BL/6N-Col4a5^{tm1b(EUCOMM)Wtsi}/Cnrm)	decreased circulating fructosamine level	J:211773
	decreased circulating serum albumin level	J:211773
	decreased circulating total protein level	J:211773
	increased blood urea nitrogen level	J:211773
	increased circulating amylase level	J:211773
	increased circulating calcium level	J:211773
	increased circulating cholesterol level	J:211773
	increased circulating creatinine level	J:211773
	increased circulating HDL cholesterol level	J:211773
	increased circulating triglyceride level	J:211773
Col4a5^{tm1b(EUCOMM)Wtsi}/Col4a5^{tm1b(EUCOMM)Wtsi} (C57BL/6N-Col4a5^{tm1b(EUCOMM)Wtsi}/Cnrm)	decreased circulating fructosamine level	J:211773
	decreased circulating serum albumin level	J:211773
	decreased circulating total protein level	J:211773
	impaired glucose tolerance	J:211773
	increased blood urea nitrogen level	J:211773
	increased circulating amylase level	J:211773
	increased circulating calcium level	J:211773
	increased circulating cholesterol level	J:211773
	increased circulating creatinine level	J:211773
	increased circulating HDL cholesterol level	J:211773
	increased circulating phosphate level	J:211773
	increased circulating triglyceride level	J:211773
Col4a5^tm1Yseg/Y (B6.Cg-Col4a5^tm1Yseg)	increased blood urea nitrogen level	J:102306
Col4a5^tm1Yseg/Y (B6.Cg-Col4a5^tm1Yseg)	increased urine protein level	J:102306
Col4a5^tm1Yseg/Col4a5⁺ (B6.Cg-Col4a5^tm1Yseg)	increased blood urea nitrogen level	J:102306
Col4a5^tm1Yseg/Col4a5⁺ (B6.Cg-Col4a5^tm1Yseg)	increased urine protein level	J:102306
Col4a5^tm1Yseg/Col4a5⁺ Lamb2^em1Jhm/Lamb2⁺ (involves: 129X1/SvJ * C57BL/6J * CBA/J)	albuminuria	J:280129
Col5a3^tm1Dgr/Col5a3^tm1Dgr (involves: 129S1/Sv * 129X1/SvJ * ICR)	abnormal glucose homeostasis	J:171817
	decreased circulating insulin level	J:171817
	decreased insulin secretion	J:171817
	decreased susceptibility to diet-induced obesity	J:171817
	hyperglycemia	J:171817
	impaired glucose tolerance	J:171817
	insulin resistance	J:171817
Col6a1^tm1Sngi/Col6a1^tm1Sngi (B6.Cg-Col6a1^tm1Sngi)	decreased circulating insulin-like growth factor I level	J:278926
Col6a1^tm1Sngi/Col6a1^tm1Sngi (B6.Cg-Col6a1^tm1Sngi)	impaired glucose tolerance	J:278926
Col6a3^{em1(IMPC)Kmpc}/Col6a3^{em1(IMPC)Kmpc} (C57BL/6NTac-Col6a3^{em1(IMPC)Kmpc}/Kmpc)	abnormal cholesterol homeostasis	J:211773
	increased circulating LDL cholesterol level	J:211773
Col9a2^{tm1b(EUCOMM)Wtsi}/Col9a2^{tm1b(EUCOMM)Wtsi} (C57BL/6N-Col9a2^{tm1b(EUCOMM)Wtsi}/H)	increased circulating alkaline phosphatase level	J:211773
	increased circulating triglyceride level	J:211773
Col9a3^em1(IMPC)Tcp/Col9a3^em1(IMPC)Tcp (C57BL/6N-Col9a3^em1(IMPC)Tcp/Tcp)	increased circulating triglyceride level	J:211773
Col11a2^{tm1b(KOMP)Wtsi}/Col11a2⁺ (C57BL/6N-Col11a2^{tm1b(KOMP)Wtsi}/Ieg)	decreased circulating triglyceride level	J:211773
	increased circulating bilirubin level	J:211773
	increased circulating unsaturated transferrin level	J:211773
Col14a1^{tm1b(KOMP)Wtsi}/Col14a1^{tm1b(KOMP)Wtsi} (C57BL/6N-Col14a1^{tm1b(KOMP)Wtsi}/Bay)	impaired glucose tolerance	J:211773
Col16a1^em1(IMPC)J/Col16a1^em1(IMPC)J (C57BL/6NJ-Col16a1^em1(IMPC)J/J)	decreased circulating calcium level	J:211773
	decreased circulating total protein level	J:211773
Col17a1^em1(IMPC)Mbp/Col17a1^em1(IMPC)Mbp (C57BL/6N-Col17a1^em1(IMPC)Mbp/MbpMmucd)	decreased circulating calcium level	J:211773
	decreased circulating serum albumin level	J:211773
Col18a1^{tm1.1(KOMP)Vlcg}/Col18a1^{tm1.1(KOMP)Vlcg} (B6N(Cg)-Col18a1^{tm1.1(KOMP)Vlcg}/J)	decreased circulating glucose level	J:211773
	decreased circulating HDL cholesterol level	J:211773
	increased circulating free fatty acids level	J:211773
	increased circulating triglyceride level	J:211773
	increased fasting circulating glucose level	J:211773
Col18a1^tm1Hms/Col18a1^tm1Hms (B6.129S4-Col18a1^tm1Hms)	abnormal circulating enzyme level	J:167008
	abnormal enzyme/coenzyme level	J:167008
	impaired lipolysis	J:167008
	increased circulating triglyceride level	J:167008
	increased circulating VLDL triglyceride level	J:167008
Col18a1^tm1Hms/Col18a1^tm1Hms (involves: 129S4/SvJae * C57BL/6J * C57BL/6JOlaHsd)	increased circulating creatinine level	J:92842
Col25a1^tm1.1Tiwa/Col25a1^tm1.1Tiwa (B6.Cg-Col25a1^tm1.1Tiwa)	cyanosis	J:206855
Col27a1^em1(IMPC)Mbp/Col27a1⁺ (C57BL/6N-Col27a1^em1(IMPC)Mbp/MbpMmucd)	edema	J:211773
Col27a1^em1(IMPC)Mbp/Col27a1^em1(IMPC)Mbp (C57BL/6N-Col27a1^em1(IMPC)Mbp/MbpMmucd)	edema	J:211773
Colec10^em2(IMPC)Tcp/Colec10^em2(IMPC)Tcp (C57BL/6NCrl-Colec10^em2(IMPC)Tcp/Tcp)	increased circulating phosphate level	J:211773
	increased circulating triglyceride level	J:211773
Colec11^tm1Lex/Colec11^tm1Lex (involves: 129S5/SvEvBrd * C57BL/6)	abnormal blood urea nitrogen level	J:234934
	abnormal complement protein level	J:234934
Colgalt2^tm1.1Hwei/Colgalt2^tm1.1Hwei (involves: C57BL/6J)	increased circulating alanine transaminase level	J:310468
	increased circulating interleukin-1 beta level	J:310468
	increased circulating interleukin-4 level	J:310468
	increased circulating interleukin-6 level	J:310468
	increased circulating interleukin-9 level	J:310468
Commd1^tm2.1Bvds/Commd1^tm2.1Bvds Speer6-ps1^{Tg(Alb-cre)21Mgn}/Speer6-ps1⁺ (involves: 129S/SvEv * C57BL/6 * DBA * SJL)	increased liver copper level	J:182331
Commd9^{Gt(AQ0362)Wtsi}/Commd9^{Gt(AQ0362)Wtsi} (involves: 129P2/OlaHsd)	edema	J:230747
	hemopericardium	J:230747
Commd9^{tm1b(KOMP)Wtsi}/Commd9⁺ (C57BL/6N-Commd9^{tm1b(KOMP)Wtsi}/H)	decreased circulating fructosamine level	J:211773
	decreased circulating serum albumin level	J:211773
	impaired glucose tolerance	J:211773
Comt^{tm1b(EUCOMM)Wtsi}/Comt^{tm1b(EUCOMM)Wtsi} (C57BL/6N-Comt^{tm1b(EUCOMM)Wtsi}/H)	decreased circulating fructosamine level	J:211773
	decreased circulating serum albumin level	J:211773
	decreased circulating total protein level	J:211773
	increased circulating alanine transaminase level	J:211773
	increased circulating phosphate level	J:211773
Comt^tm1Kara/Comt^tm1Kara (involves: 129S4/SvJaeSor)	abnormal blood homeostasis	J:137276
	abnormal homeostasis	J:137276
	albuminuria	J:137276
	hypoxia	J:137276
	increased dopamine level	J:49475
Comt^tm1Kara/Comt^tm1Kara (B6.129S4-Comt^tm1Kara)	increased dopamine level	J:164057
Cop1^{Gt(XR0653)Wtsi}/Cop1^{Gt(XR0653)1.1Wtsi} (involves: 129P2/OlaHsd * C57BL/6 * CBA)	hydrops fetalis	J:178271
Copa^tm1.1Shum/Copa⁺ (B6(CBA)-Copa^tm1.1Shum)	pulmonary alveolar proteinosis	J:288425
Copa^tm1.1Shum/Copa⁺ (B6(CBA)-Copa^tm1.1Shum)	pulmonary edema	J:288425
Copg1^em1Geha/Copg1^em1Geha (involves: C57BL/6)	decreased circulating interferon-gamma level	J:345528
Copg1^{tm1a(EUCOMM)Wtsi}/Copg1⁺ (C57BL/6N-Copg1^{tm1a(EUCOMM)Wtsi}/Wtsi)	decreased circulating cholesterol level	J:175295
Cops7a^{tm1b(KOMP)Mbp}/Cops7a^{tm1b(KOMP)Mbp} (C57BL/6N-Cops7a^{tm1b(KOMP)Mbp}/Ucd)	decreased blood urea nitrogen level	J:211773
	improved glucose tolerance	J:211773
Coq6^{tm1b(EUCOMM)Hmgu}/Coq6⁺ (C57BL/6N-Coq6^{tm1b(EUCOMM)Hmgu}/Ics)	increased fasting circulating glucose level	J:211773
Coq6^{tm1b(EUCOMM)Hmgu}/Coq6⁺ (B6N(Cg)-Coq6^{tm1b(EUCOMM)Hmgu}/J)	increased circulating sodium level	J:211773
Coq6^{tm1c(EUCOMM)Hmgu}/Coq6^{tm1c(EUCOMM)Hmgu} Tg(NPHS2-cre)295Lbh/0 (involves: C57BL/6 * C57BL/6N * SJL)	albuminuria	J:278754
	increased urine protein level	J:278754
Coq8a^tm1.1Ics/Coq8a^tm1.1Ics (involves: 129S2/SvPas * C57BL/6J * C57BL/6N)	abnormal enzyme/coenzyme level	J:249129
	hyperlipidemia	J:249129
Coq8b^{tm1b(EUCOMM)Hmgu}/Coq8b⁺ (B6N(Cg)-Coq8b^{tm1b(EUCOMM)Hmgu}/J)	decreased fasting circulating glucose level	J:211773
	impaired glucose tolerance	J:211773
Coq8b^{tm1c(EUCOMM)Hmgu}/Coq8b^{tm1c(EUCOMM)Hmgu} Tg(NPHS2-cre)295Lbh/0 (involves: C3H * C57BL/6 * C57BL/6N * SJL)	decreased circulating serum albumin level	J:294296
	increased blood urea nitrogen level	J:294296
	increased circulating serum albumin level	J:294296
Coq9^tm1.1Lcl/Coq9^tm1.1Lcl (involves: C57BL/6 * C57BL/6NTac * SJL)	abnormal enzyme/coenzyme level	J:193288
Corin^tm1Qwu/Corin^tm1Qwu (involves: 129X1/SvJ * C57BL/6)	increased urine protein level	J:96458
Coro1c^{tm1a(KOMP)Wtsi}/Coro1c^{tm1a(KOMP)Wtsi} (C57BL/6N-Coro1c^{tm1a(KOMP)Wtsi}/Wtsi)	subcutaneous edema	J:239583
Coro1c^{tm1d(KOMP)Wtsi}/Coro1c^{tm1d(KOMP)Wtsi} (involves: C57BL/6N)	increased circulating alkaline phosphatase level	J:290447
Coro2b^{tm1(KOMP)Wtsi}/Coro2b^{tm1(KOMP)Wtsi} (C57BL/6-Coro2b^{tm1(KOMP)Wtsi})	abnormal urine protein level	J:254431
Cort^tm1Ldl/Cort^tm1Ldl (involves: C57BL/6J)	abnormal somatostatin level	J:179095
	decreased circulating prolactin level	J:179095
	decreased prolactin level	J:179095
	increased adrenocorticotropin level	J:179095
	increased circulating adrenocorticotropin level	J:179095
	increased circulating ghrelin level	J:179095
	increased circulating glucose level	J:179095
	increased circulating growth hormone level	J:179095
	insulin resistance	J:179095
Cox4i2^tm1Hutt/Cox4i2^tm1Hutt (B6.129-Cox4i2^tm1Hutt)	improved glucose tolerance	J:187640
Cox7a2l^{Gt(OST241316)Lex}/Cox7a2l^{Gt(OST241316)Lex} (B6.129S5-Cox7a2l^{Gt(OST241316)Lex})	decreased carbon dioxide production	J:215964
	decreased oxygen consumption	J:215964
	impaired adaptive thermogenesis	J:215964
	increased respiratory quotient	J:215964
Cox7c^{tm1b(KOMP)Mbp}/Cox7c⁺ (B6N(Cg)-Cox7c^{tm1b(KOMP)Mbp}/J)	increased fasting circulating glucose level	J:211773
Cox10^tm1Ctm/Cox10^tm1Ctm Slc6a3^{tm1.1(cre)Bkmn}/? (B6.Cg-Cox10^tm1Ctm Slc6a3^{tm1.1(cre)Bkmn})	decreased dopamine level	J:231810
Cox15^{tm1.1(KOMP)Vlcg}/Cox15⁺ (C57BL/6N-Cox15^{tm1.1(KOMP)Vlcg}/Ucd)	increased circulating alanine transaminase level	J:211773
	increased circulating aspartate transaminase level	J:211773
Cox19^{tm1b(EUCOMM)Hmgu}/Cox19⁺ (C57BL/6N-Cox19^{tm1b(EUCOMM)Hmgu}/Tcp)	decreased circulating creatinine level	J:211773
	increased circulating phosphate level	J:211773
Cp^m1Btlr/Cp^m1Btlr (C57BL/6J-Cp^m1Btlr)	decreased circulating iron level	J:173078
Cp^m1Btlr/Cp^m1Btlr (C57BL/6J-Cp^m1Btlr)	increased liver iron level	J:173078
Cp^m1Cbea/Cp^m1Cbea (involves: C3H/DiSnA * C57BL/10ScSnA)	hemochromatosis	J:122133
Cp^m1Cbea/Cp^m1Cbea Hfe^tm1Sly/Hfe^tm1Sly (involves: C3H/DiSnA * C57BL/10ScSnA)	hemochromatosis	J:122133
Cp^{tm1b(KOMP)Wtsi}/Cp^{tm1b(KOMP)Wtsi} (B6N(Cg)-Cp^{tm1b(KOMP)Wtsi}/J)	decreased circulating iron level	J:211773
Cp^tm1Hrs/Cp^tm1Hrs (involves: 129X1/SvJ * Black Swiss)	abnormal iron homeostasis	J:57730
	abnormal iron level	J:57730
	abnormal liver copper level	J:71807
	decreased circulating ceruloplasmin level	J:57730
	increased circulating ferritin level	J:57730
	increased liver iron level	J:71807, J:57730
	increased spleen iron level	J:57730
Cp^tm1Hrs/Cp^tm1Hrs Heph^sla/Y (involves: 129X1/SvJ * C57BL/6)	abnormal iron level	J:92620, J:136925
Cp^tm1Hrs/Cp^tm1Hrs Heph^sla/Heph^sla (involves: 129X1/SvJ)	abnormal iron level	J:196540
Cp^tm1Hrs/Cp^tm1Hrs Heph^sla/Heph^sla (involves: 129X1/SvJ)	decreased circulating iron level	J:196540
Cp^tm1Hrs/Cp^tm1Hrs Heph^tm1.1Jdun/Heph^tm1.1Jdun Tg(BEST1-cre)1Jdun/0 (involves: 129X1/SvJ * C57BL/6 * C57BL/6NTac)	abnormal iron level	J:196540
Cp^tm1Hrs/Cp^tm1Hrs Heph^tm1.1Jdun/Heph^tm1.1Jdun Tg(BEST1-cre)1Jdun/0 Tg(Rho-cre)#Yzl/0 (involves: 129X1/SvJ * C57BL/6 * C57BL/6NTac)	abnormal iron level	J:196540
	abnormal protein level	J:196540
Cp^tm1Hrs/Cp^tm1Hrs Heph^tm1.2Jdun/Heph^tm1.2Jdun (involves: 129X1/SvJ * C57BL/6 * C57BL/6NTac)	abnormal iron level	J:196540
Cp^tm1Samd/Cp^tm1Samd (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	abnormal brain iron level	J:78092, J:112703
	abnormal lipid homeostasis	J:78092
	decreased circulating iron level	J:78092
	increased circulating unsaturated transferrin level	J:78092
	increased liver iron level	J:78092
Cp^tm1Yos/Cp^tm1Yos (involves: 129P2/OlaHsd * BALB/c)	decreased circulating iron level	J:79916
Cp^tm1Yos/Cp^tm1Yos (involves: 129P2/OlaHsd * BALB/c)	increased liver iron level	J:79916
Cp^tm1Yos/Cp^tm1Yos (C.129P2-Cp^tm1Yos)	abnormal lipid homeostasis	J:142713
Cpa1^tm1.1Satom/Cpa1^tm1.1Satom (involves: C57BL/6NCrl * FVB/N)	increased circulating amylase level	J:300042
	increased circulating hydroxyproline level	J:300042
Cpa1^tm1Satom/Cpa1^tm1Satom (involves: C57BL/6NCrl)	decreased circulating amylase level	J:300042
Cpa2^{tm1b(EUCOMM)Hmgu}/Cpa2^{tm1b(EUCOMM)Hmgu} (C57BL/6N-Cpa2^{tm1b(EUCOMM)Hmgu}/Ieg)	decreased circulating chloride level	J:211773
Cpa3^tm3(icre)Hrr/Cpa3⁺ Fgfr1^tm1Upir/Fgfr1^tm1Upir Fgfr2^tm1Dor/Fgfr2^tm1Dor Tg(KRT5-cre)5132Jlj/0 (involves: 129P2/OlaHsd * 129X1/SvJ * C57BL/6 * C57BL/6J * DBA/2J)	impaired skin barrier function	J:221184
Cpa5^em1(IMPC)J/Cpa5^em1(IMPC)J (C57BL/6NJ-Cpa5^em1(IMPC)J/Mmjax)	decreased circulating bilirubin level	J:211773
Cpb1^{tm1.1(KOMP)Vlcg}/Cpb1^{tm1.1(KOMP)Vlcg} (B6N(Cg)-Cpb1^{tm1.1(KOMP)Vlcg}/J)	decreased circulating glucose level	J:211773
	increased circulating total protein level	J:211773
Cpb2^tm1Efp/Cpb2⁺ Plg^tm1Dco/Plg⁺ (involves: 129S1/Sv * 129S2/SvPas * 129X1/SvJ * C57BL/6)	abnormal blood coagulation	J:80114
Cpb2^tm1Efp/Cpb2⁺ Plg^tm1Dco/Plg^tm1Dco (involves: 129S1/Sv * 129S2/SvPas * 129X1/SvJ * C57BL/6)	abnormal blood coagulation	J:80114
Cpb2^tm1Efp/Cpb2^tm1Efp (B6.129-Cpb2^tm1Efp)	abnormal blood coagulation	J:80114
Cpb2^tm1Efp/Cpb2^tm1Efp Plg^tm1Dco/Plg⁺ (involves: 129S1/Sv * 129S2/SvPas * 129X1/SvJ * C57BL/6)	abnormal blood coagulation	J:80114
Cpb2^tm1Efp/Cpb2^tm1Efp Plg^tm1Dco/Plg^tm1Dco (involves: 129S1/Sv * 129S2/SvPas * 129X1/SvJ * C57BL/6)	abnormal blood coagulation	J:80114
Cpb2^tm1Jcmm/Cpb2^tm1Jcmm (involves: 129P2/OlaHsd * C57BL/6J)	abnormal thrombolysis	J:102729
Cpb2^tm1Mng/Cpb2^tm1Mng (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	abnormal blood coagulation	J:73713, J:107340
	abnormal chemokine level	J:107340
	abnormal tumor necrosis factor level	J:107340
	decreased lactate dehydrogenase level	J:107340
Cpd^em1(IMPC)J/Cpd⁺ (C57BL/6NJ-Cpd^em1(IMPC)J/Mmjax)	abnormal cholesterol homeostasis	J:211773
	impaired glucose tolerance	J:211773
	increased circulating aspartate transaminase level	J:211773
	increased circulating creatinine level	J:211773
Cpe^fat/Cpe^fat (involves: HRS/J)	hyperglycemia	J:10872
	hypoglycemia	J:13651
	increased circulating insulin level	J:13651, J:10872
Cpe^fat/Cpe^fat (BKSChpLt.HRS-Cpe^fat/J)	abnormal hormone level	J:80698
	decreased circulating adrenocorticotropin level	J:40372
	decreased circulating gastrin level	J:52393
	hyperglycemia	J:10872
	impaired adaptive thermogenesis	J:80698
	increased circulating cholesterol level	J:19043, J:18161
	increased circulating growth hormone level	J:40372
	increased circulating HDL cholesterol level	J:19043, J:18161
	increased circulating insulin level	J:24436, J:10872
	increased circulating LDL cholesterol level	J:19043
	increased circulating pituitary hormone level	J:40372, J:38227
	increased circulating triglyceride level	J:19043
	increased circulating triiodothyronine level	J:80698
	increased circulating VLDL cholesterol level	J:19043
	increased growth hormone level	J:40372
	increased pituitary hormone level	J:40372
Cpe^fat/Cpe^fat Find1^HRS/J/Find1^HRS/J (involves: C57BLKS/J * HRS/J)	increased circulating glucose level	J:100832
Cpe^fat/Cpe^fat Find2^C57BLKS/J/Find2^C57BLKS/J (involves: C57BLKS/J * HRS/J)	decreased circulating insulin level	J:100832
	increased circulating cholesterol level	J:100832
	increased circulating glucose level	J:100832
Cpe^{tm1b(EUCOMM)Hmgu}/Cpe^{tm1b(EUCOMM)Hmgu} (C57BL/6N-Cpe^{tm1b(EUCOMM)Hmgu}/Ieg)	decreased circulating chloride level	J:211773
	impaired glucose tolerance	J:211773
	increased circulating alanine transaminase level	J:211773
	increased circulating alkaline phosphatase level	J:211773
	increased circulating aspartate transaminase level	J:211773
	increased circulating calcium level	J:211773
	increased circulating glucose level	J:211773
	increased fasting circulating glucose level	J:211773
Cpe^tm1Yplo/Cpe^tm1Yplo (involves: 129S1/Sv * C57BL/6)	abnormal energy expenditure	J:95741
	abnormal glucose homeostasis	J:95741
	impaired glucose tolerance	J:95741
	increased circulating glucose level	J:95741
	increased circulating insulin level	J:95741
	increased circulating leptin level	J:95741
	increased respiratory quotient	J:95741
	insulin resistance	J:95741
Cpeb2^tm1.1Yshu/Cpeb2^tm1.1Yshu Tg(Nes-cre)1Kln/0 (involves: C57BL/6 * C57BL/6J * SJL/J)	increased acetylcholine level	J:237513
Cpeb2^tm1.2Yshu/Cpeb2^tm1.2Yshu (involves: 129S/Sv * C57BL/6 * C57BL/6J * SJL/J)	increased acetylcholine level	J:237513
Cpeb3^em1Gaoxu/Cpeb3^em1Gaoxu (C57BL/6J-Cpeb3^em1Gaoxu)	decreased circulating estradiol level	J:323073
Cpeb3^em1Gaoxu/Cpeb3^em1Gaoxu (C57BL/6J-Cpeb3^em1Gaoxu)	increased circulating follicle stimulating hormone level	J:323073
Cpeb3^tm1.2Yshu/Cpeb3^tm1.2Yshu (involves: 129S4/SvJae * C57BL/6)	abnormal calcium ion homeostasis	J:202741
Cpeb4^{tm1b(EUCOMM)Wtsi}/Cpeb4⁺ (C57BL/6N-Cpeb4^{tm1b(EUCOMM)Wtsi}/Ieg)	decreased circulating calcium level	J:211773
Cpgi5563^{tm1.1(NCC)Wcs}/Cpgi5563^{tm1.1(NCC)Wcs} (C57BL/6N-Cpgi5563^{tm1.1(NCC)Wcs}/Wtsi)	decreased circulating amylase level	J:277622
	decreased circulating cholesterol level	J:277622
	decreased circulating triglyceride level	J:277622
Cplane1^b2b012Clo/Cplane1^b2b012Clo (C57BL/6J-Cplane1^b2b012Clo)	hydrops fetalis	J:223340
Cplx4^em1(IMPC)H/Cplx4^em1(IMPC)H (C57BL/6NTac-Cplx4^em1(IMPC)H/H)	increased circulating alanine transaminase level	J:211773
	increased circulating total protein level	J:211773
Cpm^{em1(IMPC)Ccpcz}/Cpm^{em1(IMPC)Ccpcz} (C57BL/6NCrl-Cpm^{em1(IMPC)Ccpcz}/Ccpcz)	increased circulating calcium level	J:211773
	increased circulating creatinine level	J:211773
	increased circulating glucose level	J:211773
Cpn1^{tm1b(KOMP)Wtsi}/Cpn1^{tm1b(KOMP)Wtsi} (B6N(Cg)-Cpn1^{tm1b(KOMP)Wtsi}/2J)	increased circulating calcium level	J:211773
Cpox^Rbc16/Cpox⁺ (involves: C57BL/6)	increased circulating ferritin level	J:244493
Cpox^Rbc16/Cpox⁺ (involves: C57BL/6)	porphyria	J:244493
Cps1^em1(IMPC)H/Cps1⁺ (C57BL/6NTac-Cps1^em1(IMPC)H/H)	decreased circulating potassium level	J:211773
	increased circulating cholesterol level	J:211773
	increased circulating HDL cholesterol level	J:211773
Cps1^tm1Mw/Cps1^tm1Mw (involves: 129S7/SvEvBrd * C57BL/6)	increased circulating ammonia level	J:52334
Cpt1a^tm1Pwo/Cpt1a⁺ (either: 129S6/SvEvTac-Cpt1a^tm1Pwo or (involves: 129S6/SvEvTac * C57BL/6NTac))	decreased circulating glucose level	J:101934
	increased circulating free fatty acids level	J:101934
Cpt1b^tm1You/Cpt1b⁺ (involves: 129X1/SvJ * C57BL/6J)	impaired adaptive thermogenesis	J:131341
Cpt1c^tm1Dhwu/Cpt1c^tm1Dhwu (involves: 129 * C57BL/6J)	enhanced gluconeogenesis	J:148205
	increased circulating glucose level	J:148205
	increased circulating insulin level	J:148205
	increased glycerol level	J:148205
	insulin resistance	J:148205
Cpt1c^tm1Fghe/Cpt1c^tm1Fghe (B6.129S-Cpt1c^tm1Fghe)	abnormal lipid level	J:186508
Cpt1c^tm1Mdln/Cpt1c^tm1Mdln (involves: C57BL/6)	hyperlipidemia	J:109455
	increased circulating triglyceride level	J:109455
	insulin resistance	J:109455
Cpt2^{tm1b(KOMP)Wtsi}/Cpt2⁺ (C57BL/6N-Cpt2^{tm1b(KOMP)Wtsi}/Wtsi)	increased circulating phosphate level	J:211773
Cpt2^{tm1b(KOMP)Wtsi}/Cpt2^{tm1b(KOMP)Wtsi} (C57BL/6N-Cpt2^{tm1b(KOMP)Wtsi}/Wtsi)	hemopericardium	J:239583
Cq1^C57BL/6J/Cq1^C57BL/6J (involves: C57BL/6J * KK-A^y)	increased circulating cholesterol level	J:54322
Cq1^KK/Cq1^C57BL/6J (involves: C57BL/6J * KK-A^y)	increased circulating cholesterol level	J:54322
Cq1^KK/Cq1^KK (involves: C57BL/6J * KK-A^y)	increased circulating cholesterol level	J:54322
Cq2^KK/Cq2^C57BL/6J (involves: C57BL/6J * KK-A^y)	increased circulating cholesterol level	J:54322
Cq2^KK/Cq2^KK (involves: C57BL/6J * KK-A^y)	increased circulating cholesterol level	J:54322
Cq2^KK/Cq2^KK Cq3^C57BL/6J/Cq3^C57BL/6J (involves: C57BL/6J * KK-A^y)	increased circulating cholesterol level	J:108417
Cq3^C57BL/6J/? (involves: C57BL/6J * KK-A^y)	increased circulating cholesterol level	J:108417
Cq4^C57BL/6J/Cq4^KK-A(y) (involves: C57BL/6J * KK-A^y)	increased circulating cholesterol level	J:87328
Cq4^KK-A(y)/Cq4^KK-A(y) (involves: C57BL/6J * KK-A^y)	increased circulating cholesterol level	J:87328
Cq5^KK-A(y)/Cq5^KK-A(y) (involves: KK-A^y * RR)	increased circulating cholesterol level	J:87328
Cq6^C57BL/6J/Cq6^RR (involves: C57BL/6J * RR)	increased circulating cholesterol level	J:94251
Cq6^RR/Cq6^RR (involves: C57BL/6J * RR)	increased circulating cholesterol level	J:94251
Cr1l^tm1Hmo/Cr1l⁺ (involves: 129X1/SvJ)	increased blood urea nitrogen level	J:105466
Cracdl^{tm1b(KOMP)Wtsi}/Cracdl^{tm1b(KOMP)Wtsi} (C57BL/6N-Cracdl^{tm1b(KOMP)Wtsi}/Wtsi)	decreased circulating calcium level	J:211773
	decreased circulating cholesterol level	J:211773
	decreased circulating HDL cholesterol level	J:211773
	decreased circulating serum albumin level	J:211773
	decreased circulating total protein level	J:211773
Crat^tm1.1Pbrc/Crat^tm1.1Pbrc Tg(Ckmm-cre)5Khn/0 (involves: C57BL/6J * FVB)	abnormal glucose homeostasis	J:184778
	decreased circulating free fatty acids level	J:184778
	decreased circulating triglyceride level	J:184778
	impaired glucose tolerance	J:184778
	increased circulating glucose level	J:184778
	increased susceptibility to diet-induced obesity	J:184778
	insulin resistance	J:184778
Crb1^tm1Wij/Crb1^tm1Wij (involves: 129P2/OlaHsd * C57BL/6)	photosensitivity	J:92068
Crb3^tm1.2Lprs/Crb3^tm1.2Lprs (B6(Cg)-Crb3^tm1.2Lprs)	cyanosis	J:228786
Crbn^tm1Csp/Crbn^tm1Csp (B6N.Cg-Crbn^tm1Csp)	decreased circulating free fatty acids level	J:208570
	decreased circulating glucose level	J:208570
	decreased circulating insulin level	J:208570
	decreased circulating leptin level	J:208570
	decreased liver triglyceride level	J:208570
	decreased susceptibility to diet-induced obesity	J:208570
	improved glucose tolerance	J:208570
	increased insulin sensitivity	J:208570
Creb1^tm3Gsc/Creb1⁺ Gprc6a^tm1.1Kry/Gprc6a⁺ Tg(Cyp17a1-icre)AJako/0 (involves: 129P2/OlaHsd * C57BL/6 * SJL)	decreased circulating testosterone level	J:170888
Creb1^tm3Gsc/Creb1^tm3Gsc Tg(Cyp17a1-icre)AJako/0 (involves: 129P2/OlaHsd * C57BL/6 * SJL)	decreased circulating testosterone level	J:170888
Creb3^Gt1Mbac/Creb3⁺ (B6NTac.Cg-Creb3^Gt1Mbac)	abnormal lipid level	J:345514
	abnormal phospholipid level	J:345514
	decreased circulating insulin level	J:345514
	decreased circulating leptin level	J:345514
	decreased fasting circulating glucose level	J:345514
	decreased liver triglyceride level	J:345514
	decreased skeletal muscle triglyceride level	J:345514
	decreased susceptibility to diet-induced obesity	J:345514
	improved glucose tolerance	J:345514
	increased energy expenditure	J:345514
	increased respiratory quotient	J:345514
Creb3l1^{tm1e(EUCOMM)Wtsi}/Creb3l1⁺ (C57BL/6N-Creb3l1^{tm1e(EUCOMM)Wtsi}/Wtsi)	increased circulating alkaline phosphatase level	J:211773
Creb3l3^tm1.1Sad/Creb3l3^tm1.1Sad (involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * FVB/N)	decreased circulating serum amyloid protein level	J:140018
Crebbp^{Gt(U-San)112Imeg}/Crebbp⁺ (involves: C57BL/6 * CBA)	abnormal tumor necrosis factor level	J:75361
	decreased circulating free fatty acids level	J:75361
	decreased susceptibility to diet-induced obesity	J:75361
	decreased triglyceride level	J:75361
	improved glucose tolerance	J:75361
	increased circulating adiponectin level	J:75361
	increased circulating insulin level	J:75361
	increased circulating leptin level	J:75361
	increased insulin sensitivity	J:75361
	increased oxygen consumption	J:75361
Crebbp^tm1Few/Crebbp⁺ (Not Specified)	abnormal glucose homeostasis	J:91133
	decreased circulating glucagon level	J:91133
	impaired glucose tolerance	J:91133
	increased circulating glucose level	J:91133
	increased circulating insulin level	J:91133
	increased liver glycogen level	J:91133
	insulin resistance	J:91133
Crebbp^tm1Few/Crebbp^tm1Few (Not Specified)	abnormal glucose homeostasis	J:91133
	decreased circulating glucagon level	J:91133
	impaired glucose tolerance	J:91133
	increased circulating glucose level	J:91133
	increased circulating insulin level	J:91133
	increased liver glycogen level	J:91133
Crebrf^{Gt(YHD319)Byg}/Crebrf^{Gt(YHD319)Byg} (B6.129P2-Crebrf^{Gt(YHD319)Byg})	decreased circulating corticosterone level	J:192857
	decreased circulating prolactin level	J:192857
Creg1^em1Yal/Creg1^em1Yal Speer6-ps1^{Tg(Alb-cre)21Mgn}/Speer6-ps1⁺ (involves: C57BL/6 * DBA)	abnormal circulating enzyme level	J:263073
	abnormal glucose homeostasis	J:263073
	abnormal lipid homeostasis	J:263073
	decreased glycogen level	J:263073
	impaired glucose tolerance	J:263073
	increased circulating alanine transaminase level	J:263073
	increased circulating alkaline phosphatase level	J:263073
	increased circulating aspartate transaminase level	J:263073
	increased circulating insulin level	J:263073
	increased fasting circulating glucose level	J:263073
	increased liver cholesterol level	J:263073
	increased liver free fatty acids level	J:263073
	insulin resistance	J:263073
Creg2^em1(IMPC)J/Creg2^em1(IMPC)J (C57BL/6NJ-Creg2^em1(IMPC)J/Mmjax)	decreased fasting circulating glucose level	J:211773
Creld2^tm1.1Emass/Creld2^tm1.1Emass (B6.129P2(SJL)-Creld2^tm1.1Emass)	increased ceramide level	J:316411
	insulin resistance	J:316411
Crh^m1H/Crh⁺ (involves: C3H/HeH * C57BL/6J)	abnormal blood homeostasis	J:208708
	abnormal corticosterone level	J:208708
	abnormal glucose homeostasis	J:208708
	abnormal homeostasis	J:208708
	abnormal urine homeostasis	J:208708
	decreased circulating osteocalcin level	J:208708
	decreased circulating parathyroid hormone level	J:208708
	hyperglycemia	J:208708
	impaired glucose tolerance	J:208708
	increased blood uric acid level	J:208708
	increased circulating alanine transaminase level	J:208708
	increased circulating alkaline phosphatase level	J:208708
	increased circulating aspartate transaminase level	J:208708
	increased circulating calcium level	J:208708
	increased circulating cholesterol level	J:208708
	increased circulating corticosterone level	J:208708
	increased circulating creatinine level	J:208708
	increased circulating glucagon level	J:208708
	increased circulating insulin level	J:208708
	increased circulating leptin level	J:208708
	increased circulating total protein level	J:208708
	increased circulating triglyceride level	J:208708
	increased urine calcium level	J:208708
	increased urine corticosterone level	J:208708
	increased urine glucose level	J:208708
	increased urine protein level	J:208708
	insulin resistance	J:208708
Crh^tm1Maj/Crh⁺ Tg(MECP2)1Hzo/0 (involves: 129S2/SvPas * 129S6/SvEvTac * C57BL/6 * FVB/N)	abnormal corticosterone level	J:181213
Crh^tm1Maj/Crh^tm1Maj (involves: 129S2/SvPas * C57BL/6J)	abnormal circulating corticosterone level	J:23082
Crh^tm1Maj/Crh^tm1Maj (involves: 129S2/SvPas * C57BL/6J)	abnormal circulating glucose level	J:23082
Crh^tm1Maj/Crh^tm1Maj (involves: 129S2/SvPas * C57BL/6)	abnormal adrenocorticotropin level	J:72196, J:102987
	abnormal circulating adrenaline level	J:105629
	abnormal circulating corticosterone level	J:90690, J:72196, J:102987, J:105629, J:54256
	abnormal circulating glucose level	J:102987, J:105629
	abnormal circulating hormone level	J:90690
	abnormal circulating noradrenaline level	J:105629
	decreased circulating adrenaline level	J:102987
	decreased circulating corticosterone level	J:105629
	decreased circulating leptin level	J:105629
	increased circulating interleukin-6 level	J:72196
Crh^tm2.1Maj/Crh^tm2.1Maj Tg(Sim1-cre)1Lowl/? (involves: 129S4/SvJae * C57BL/6 * FVB/N)	decreased circulating adrenocorticotropin level	J:238330
	decreased circulating corticosterone level	J:238330
Crh^tm2.2Maj/Crh^tm2.2Maj (involves: 129S4/SvJae * C57BL/6 * FVB/N)	decreased circulating corticosterone level	J:238330
Crhr1^tm1Jde/Crhr1^tm1Jde (involves: 129S2/SvPas * C57BL/6J)	abnormal corticosterone level	J:176339
Crhr1^tm1Klee/Crhr1^tm1Klee (involves: 129S4/SvJae * C57BL/6)	abnormal hormone level	J:48280
Crhr1^tm1Klee/Crhr1^tm1Klee Crhr2^tm1Klee/Crhr2^tm1Klee (involves: 129S4/SvJae * C57BL/6)	abnormal hormone level	J:77641
Crhr1^tm1Wrst/Crhr1^tm1Wrst (either: (involves: 129P2/OlaHsd * 129P/Ola) or (involves: 129P2/OlaHsd * CD-1))	abnormal hormone level	J:76022
Crhr1^tm2.3Jde/Crhr1^tm2.3Jde (involves: 129S2/SvPas * C57BL/6 * C57BL/6NTac)	decreased circulating corticosterone level	J:187372
Crhr1^tm2Jde/Crhr1^tm2Jde (involves: 129S2/SvPas * C57BL/6)	decreased circulating corticosterone level	J:187372
Crhr1^tm2Wrst/Crhr1^tm2Wrst Tg(Camk2a-cre)159Kln/0 (involves: 129S2/SvPas * C57BL/6)	increased circulating adrenocorticotropin level	J:85745
	increased circulating corticosterone level	J:85745
Crhr2^tm1Klee/Crhr2^tm1Klee (involves: 129S4/SvJae * C57BL/6)	abnormal glucose homeostasis	J:83683
	abnormal hormone level	J:61484
	decreased circulating cholesterol level	J:83683
	decreased circulating free fatty acids level	J:83683
	decreased circulating triglyceride level	J:83683
	increased insulin sensitivity	J:83683
Crhr2^tm1Mpsp/Crhr2^tm1Mpsp (involves: 129X1/SvJ * C57BL/6J)	abnormal hormone level	J:61510
cri/cri (involves: DBA/2J)	abnormal circulating mineral level	J:15349
	abnormal circulating potassium level	J:15349
	abnormal homeostasis	J:15349
	abnormal urine homeostasis	J:15349
	decreased circulating potassium level	J:15349
	decreased urine potassium level	J:15349
	decreased urine sodium level	J:15349
Crim1^{em1(IMPC)Wtsi}/Crim1^{em1(IMPC)Wtsi} (C57BL/6N-Crim1^{em1(IMPC)Wtsi}/WtsiOrl)	subcutaneous edema	J:239583
Crim1^{Gt(KST264)Byg}/Crim1^{Gt(KST264)Byg} (involves: 129P2/OlaHsd * C57BL/6)	cerebral edema	J:117237
Crim1^{Gt(KST264)Byg}/Crim1^{Gt(KST264)Byg} (involves: 129P2/OlaHsd * C57BL/6 * CD-1)	albuminuria	J:147543
Crim1^tm1.1Dpen/Crim1^tm1.1Dpen (either: (B6.129P2(129S7)-Crim1^tm1.1Dpen) or (involves: 129P2/OlaHsd * 129S7/SvEvBrd * C57BL/6 * CD-1))	edema	J:187855
Crispld2^{tm1.1(KOMP)Vlcg}/Crispld2⁺ (C57BL/6N-Crispld2^{tm1.1(KOMP)Vlcg}/Ucd)	decreased circulating triglyceride level	J:211773
Crispld2^tm1Lex/Crispld2^tm1Lex (B6;129S5-Crispld2^tm1Lex/Mmucd)	improved glucose tolerance	J:171883
Crk^tm1.1Cur/Crk^tm1.1Cur (involves: 129S/SvEv * C57BL/6)	hydrops fetalis	J:111399
Crlf2^em1(IMPC)Mbp/Crlf2^em1(IMPC)Mbp (C57BL/6N-Crlf2^em1(IMPC)Mbp/MbpMmucd)	increased circulating bilirubin level	J:211773
Crls1^tm1Geno/Crls1^tm1Geno Gt(ROSA)26Sor^{tm1(cre/ERT2)Tyj}/Gt(ROSA)26Sor⁺ (involves: 129S4/SvJae * C57BL/6)	decreased oxygen consumption	J:266083
Crls1^tm1Geno/Crls1^tm1Geno Tg(Adipoq-cre)1Evdr/0 (involves: C57BL/6 * FVB/NJ)	decreased oxygen consumption	J:266083
	decreased respiratory quotient	J:266083
	decreased susceptibility to diet-induced obesity	J:266083
	impaired adaptive thermogenesis	J:266083
	increased fasting circulating glucose level	J:266083
	insulin resistance	J:266083
Crls1^tm1Geno/Crls1^tm1Geno Tg(Ucp1-cre/ERT2)426Biat/0 (involves: C57BL/6N)	insulin resistance	J:266083
Crp^em1Wuy/Crp^em1Wuy (C57BL/6-Crp^em1Wuy)	abnormal circulating aspartate transaminase level	J:341658
Crp^em1Wuy/Crp^em1Wuy (C57BL/6-Crp^em1Wuy)	increased circulating alanine transaminase level	J:341658
Crp^tm1Hjf/Crp⁺ (C57BL/6-Crp^tm1Hjf)	decreased circulating C-reactive protein level	J:170409
Crp^tm1Hjf/Crp^tm1Hjf (C57BL/6-Crp^tm1Hjf)	decreased circulating C-reactive protein level	J:170409
Crp^tm1Hjf/Crp^tm1Hjf Ldlr^tm1Her/Ldlr^tm1Her (B6.Cg-Crp^tm1Hjf Ldlr^tm1Her)	decreased circulating LDL cholesterol level	J:170409
	decreased circulating VLDL cholesterol level	J:170409
	increased circulating cholesterol level	J:170409
	increased circulating triglyceride level	J:170409
Crppa^em2Mbp/Crppa^em2Mbp Myf5^tm3(cre)Sor/Myf5⁺ (B6.Cg-Myf5^tm3(cre)Sor Crppa^em2Mbp)	increased circulating creatine kinase level	J:324289
Crtac1^em1(IMPC)H/Crtac1^em1(IMPC)H (C57BL/6NTac-Crtac1^em1(IMPC)H/H)	increased blood urea nitrogen level	J:211773
Crtc1^Gt(XK522)Byg/Crtc1^Gt(XK522)Byg (involves: 129P2/OlaHsd * C57BL/6)	decreased circulating luteinizing hormone level	J:142448
	decreased energy expenditure	J:142448
	hyperglycemia	J:142448
	impaired glucose tolerance	J:142448
	increased circulating insulin level	J:142448
	increased circulating triglyceride level	J:142448
Crtc1^Gt(XK522)Byg/Crtc1^Gt(XK522)Byg (B6N.129P2-Crtc1^Gt(XK522)Byg)	abnormal homeostasis	J:244400
	decreased serotonin level	J:244400
Crtc2^tm1.1Khk/Crtc2^tm1.1Khk (involves: C57BL/6 * C57BL/6J * FVB/N)	abnormal glucose homeostasis	J:151618
	decreased circulating corticosterone level	J:151618
	decreased glycogen level	J:151618
Crtc2^tm1Mmy/Crtc2^tm1Mmy (involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)	decreased circulating insulin level	J:157556
	decreased fasting circulating glucose level	J:157556
	decreased hepatic glucose production	J:157556
	impaired gluconeogenesis	J:157556
	increased insulin sensitivity	J:157556
Crtc3^tm1Mmy/Crtc3⁺ (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	decreased susceptibility to diet-induced obesity	J:167211
Crtc3^tm1Mmy/Crtc3^tm1Mmy (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	abnormal glucose homeostasis	J:167211
	decreased circulating free fatty acids level	J:167211
	decreased circulating insulin level	J:167211
	decreased circulating leptin level	J:167211
	decreased susceptibility to diet-induced obesity	J:167211
	increased body temperature	J:167211
	increased energy expenditure	J:167211
	increased insulin sensitivity	J:167211
	increased oxygen consumption	J:167211
Crx^{em1(IMPC)Ccpcz}/Crx^{em1(IMPC)Ccpcz} (C57BL/6N-Crx^{em1(IMPC)Ccpcz}/Ccpcz)	increased fasting circulating glucose level	J:211773
Cry1^em1(IMPC)H/Cry1^em1(IMPC)H (C57BL/6N-Cry1^em1(IMPC)H/H)	decreased fasting circulating glucose level	J:211773
Cry1^tm1Asn/Cry1^tm1Asn Cry2^tm1Asn/Cry2^tm1Asn (involves: 129P2/OlaHsd * C57BL/6)	abnormal circadian temperature homeostasis	J:128437
	impaired glucose tolerance	J:128437
	increased insulin sensitivity	J:128437
	increased oxygen consumption	J:128437
Cry1^tm1Jhjh/Cry1^tm1Jhjh Cry2^tm1Jhjh/Cry2^tm1Jhjh (involves: 129P2/OlaHsd * C57BL/6)	increased circulating interleukin-1 beta level	J:159504
	increased circulating interleukin-6 level	J:159504
	increased circulating tumor necrosis factor level	J:159504
Cryba1^{tm1a(EUCOMM)Hmgu}/Cryba1^{tm1a(EUCOMM)Hmgu} (involves: C57BL/6J * C57BL/6N)	abnormal calcium ion homeostasis	J:235696
Crybb2^tm1Itl/Crybb2^tm1Itl (C57BL/6-Crybb2^tm1Itl)	decreased circulating progesterone level	J:220082
Crybb2^tm1Itl/Crybb2^tm1Itl (C57BL/6-Crybb2^tm1Itl)	increased circulating estradiol level	J:220082
Crybg1^{tm1b(KOMP)Wtsi}/Crybg1⁺ (C57BL/6N-Crybg1^{tm1b(KOMP)Wtsi}/Tcp)	increased blood urea nitrogen level	J:211773
Crym^tm1Sasu/Crym^tm1Sasu (129S6.Cg-Crym^tm1Sasu)	abnormal triiodothyronine level	J:119707
	decreased circulating thyroxine level	J:119707
	decreased circulating triiodothyronine level	J:119707
Cs^{tm1.1(KOMP)Wtsi}/Cs⁺ (C57BL/6N-Cs^{tm1.1(KOMP)Wtsi}/Ieg)	impaired glucose tolerance	J:211773
Csf1^Mhdabap25/Csf1^Mhdabap25 (C3HeB/FeJ-Csf1^Mhdabap25)	decreased circulating alkaline phosphatase level	J:183993
Csf1^op/Csf1^op (C57BL/6J-Csf1^op)	decreased circulating phosphate level	J:5634
Csf1^op/Csf1^op (B6C3Fe a/a-Csf1^op/J)	decreased circulating testosterone level	J:34371
Csf1^op/Csf1^op (involves: C3HeB/FeJ * C57BL/6J)	abnormal circulating calcium level	J:5634
	decreased circulating phosphate level	J:5634
	decreased circulating testosterone level	J:34371
Csf1^op/Csf1^op Csf2^tm1Ard/Csf2^tm1Ard (involves: 129P2/OlaHsd * C57BL/6)	pulmonary alveolar proteinosis	J:19089
Csf1^op/Csf1^op Sh3bp2^tm1Bjro/Sh3bp2^tm1Bjro (involves: 129S4/SvJae * BALB/cJ * C57BL/6J)	increased circulating tumor necrosis factor level	J:117880
Csf1r^tm1Ers/Csf1r^tm1Ers (involves: 129X1/SvJ * C3Heb/FeJ * C57BL/6J)	abnormal circulating cytokine level	J:73663
Csf2^tm1Ard/Csf2^tm1Ard (involves: 129P2/OlaHsd * C57BL/6)	decreased circulating progesterone level	J:86386
Csf2^tm1Ard/Csf2^tm1Ard (involves: 129P2/OlaHsd * C57BL/6)	pulmonary alveolar proteinosis	J:18747
Csf2^tm1Mlg/Csf2^tm1Mlg (B6.129S2-Csf2^tm1Mlg)	abnormal lipid level	J:102499
	decreased energy expenditure	J:102499
	increased circulating free fatty acids level	J:102499
	increased circulating glucose level	J:145518
	increased circulating leptin level	J:102499
	increased circulating triglyceride level	J:102499
Csf2^tm1Mlg/Csf2^tm1Mlg (involves: 129S2/SvPas * C57BL/6)	abnormal circulating glucose level	J:142440
	decreased circulating insulin level	J:142440
	enhanced gluconeogenesis	J:142440
Csf2^tm1Mlg/Csf2^tm1Mlg Il3^tm1Glli/Il3^tm1Glli (B6.129S2-Csf2^tm1Mlg Il3^tm1Glli)	hyperglycemia	J:145518
	impaired glucose tolerance	J:145518
Csf2ra^em1Szut/Csf2ra^em1Szut (C57BL/6-Csf2ra^em1Szut)	increased cholesterol level	J:322934
Csf2rb^tm1Cgb/Csf2rb^tm1Cgb (involves: 129S1/Sv * C57BL/6)	pulmonary alveolar proteinosis	J:29737
Csf3^em1(IMPC)H/Csf3^em1(IMPC)H (C57BL/6NTac-Csf3^em1(IMPC)H/H)	increased circulating alanine transaminase level	J:211773
Csgalnact1^tm1.1Migar/Csgalnact1^tm1.1Migar (involves: C57BL/6N * C57BL/6NCrlj * CBA/JNCrlj)	abnormal glycosaminoglycan level	J:269621
Csgalnact1^tm1.1Nari/Csgalnact1^tm1.1Nari Csgalnact2^tm1.2Staka/Csgalnact2^tm1.2Staka (involves: C57BL/6J)	cyanosis	J:256718
Csmd1^{em1(IMPC)Wtsi}/Csmd1^{em1(IMPC)Wtsi} (C57BL/6N-Csmd1^{em1(IMPC)Wtsi}/WtsiIeg)	increased circulating creatinine level	J:211773
Csmd1^tm1Lex/Csmd1^tm1Lex (involves: 129S5/SvEvBrd * C57BL/6NTac)	improved glucose tolerance	J:209700
Csmd3^em1(IMPC)Mbp/Csmd3^em1(IMPC)Mbp (C57BL/6NCrl-Csmd3^em1(IMPC)Mbp/Mmucd)	decreased circulating HDL cholesterol level	J:211773
	increased circulating bilirubin level	J:211773
Csn1s1^tm1Afk/Csn1s1^tm1Afk (involves: 129 * C57BL/6)	abnormal milk calcium level	J:174932
Csn1s1^tm1Afk/Csn1s1^tm1Afk (involves: 129 * C57BL/6)	abnormal milk phosphate level	J:174932
Csnk1g2^em1Xidw/Csnk1g2^em1Xidw (Not Specified)	abnormal circulating protein level	J:298682
	decreased circulating testosterone level	J:298682
	increased circulating follicle stimulating hormone level	J:298682
	increased circulating luteinizing hormone level	J:298682
Csnk1g2^{tm1b(EUCOMM)Wtsi}/Csnk1g2^{tm1b(EUCOMM)Wtsi} (C57BL/6N-Csnk1g2^{tm1b(EUCOMM)Wtsi}/Ieg)	increased circulating aspartate transaminase level	J:211773
	increased circulating glucose level	J:211773
	increased circulating phosphate level	J:211773
	increased circulating potassium level	J:211773
Csnk1g3^{tm1a(EUCOMM)Wtsi}/Csnk1g3^{tm1a(EUCOMM)Wtsi} (C57BL/6N-Csnk1g3^{tm1a(EUCOMM)Wtsi}/Wtsi)	decreased circulating alkaline phosphatase level	J:211773
	decreased circulating fructosamine level	J:211773
	increased circulating LDL cholesterol level	J:211773
Csnk2a1^tm1Dcs/Csnk2a1^tm1Dcs (involves: 129S6/SvEvTac * C57BL/6)	hydrops fetalis	J:129208
	pericardial edema	J:129208
Csnk2a2^em1(IMPC)Mbp/Csnk2a2^em1(IMPC)Mbp (C57BL/6N-Csnk2a2^em1(IMPC)Mbp/MbpMmucd)	decreased circulating glucose level	J:211773
	decreased circulating HDL cholesterol level	J:211773
	decreased circulating triglyceride level	J:211773
	increased circulating alkaline phosphatase level	J:211773
	increased circulating bilirubin level	J:211773
Csnk2b^tm1.1Bb/Csnk2b^tm1.2Bb Tg(Stra8-icre)1Reb/0 (involves: 129S2/SvPasCrl * C57BL/6 * FVB/NJ)	abnormal protein level	J:289955
Cspg4^tm1Wbst/Cspg4^tm1Wbst (involves: 129S1/Sv * 129X1/SvJ)	decreased body temperature	J:184220
	decreased carbon dioxide production	J:184220
	decreased oxygen consumption	J:184220
	impaired adaptive thermogenesis	J:184220
	impaired glucose tolerance	J:184220
	increased circulating cholesterol level	J:184220
	increased circulating HDL cholesterol level	J:184220
	increased circulating LDL cholesterol level	J:184220
	insulin resistance	J:184220
Cspp1^em1(IMPC)J/Cspp1^em1(IMPC)J (C57BL/6NJ-Cspp1^em1(IMPC)J/Mmjax)	decreased circulating creatinine level	J:211773
Cst6^{em1(IMPC)Ccpcz}/Cst6⁺ (C57BL/6NCrl-Cst6^{em1(IMPC)Ccpcz}/Ccpcz)	decreased circulating serum albumin level	J:211773
	increased circulating creatine kinase level	J:211773
Cstb^{tm1b(EUCOMM)Wtsi}/Cstb^{tm1b(EUCOMM)Wtsi} (C57BL/6N-Cstb^{tm1b(EUCOMM)Wtsi}/Orl)	decreased circulating creatinine level	J:211773
	increased circulating triglyceride level	J:211773
Cstdc2^em1(IMPC)Tcp/Cstdc2^em1(IMPC)Tcp (C57BL/6NCrl-Cstdc2^em1(IMPC)Tcp/Tcp)	decreased circulating chloride level	J:211773
Cstf1^em1(IMPC)J/Cstf1⁺ (C57BL/6NJ-Cstf1^em1(IMPC)J/Mmjax)	abnormal cholesterol homeostasis	J:211773
Ct45a^{tm1e(KOMP)Wtsi}/Y (C57BL/6N-Ct45a^{tm1e(KOMP)Wtsi}/Wtsi)	increased circulating cholesterol level	J:211773
	increased circulating HDL cholesterol level	J:211773
	increased circulating LDL cholesterol level	J:211773
Ct45a^{tm1e(KOMP)Wtsi}/Ct45a^{tm1e(KOMP)Wtsi} (C57BL/6N-Ct45a^{tm1e(KOMP)Wtsi}/Wtsi)	increased circulating cholesterol level	J:211773
	increased circulating HDL cholesterol level	J:211773
Ctbp2^em1(IMPC)Bay/Ctbp2^em1(IMPC)Bay (C57BL/6N-Ctbp2^em1(IMPC)Bay/BayMmucd)	edema	J:211773
Ctbs^em1(IMPC)J/Ctbs^em1(IMPC)J (C57BL/6NJ-Ctbs^em1(IMPC)J/J)	impaired glucose tolerance	J:211773
Ctbs^tm1Tbec/Ctbs^tm1Tbec (involves: 129S2/SvPas * C57BL/6N)	abnormal urine homeostasis	J:185162
Ctdsp1^{tm1b(EUCOMM)Wtsi}/Ctdsp1^{tm1b(EUCOMM)Wtsi} (C57BL/6N-Ctdsp1^{tm1b(EUCOMM)Wtsi}/H)	increased circulating alkaline phosphatase level	J:211773
Ctdspl^{tm1.1(KOMP)Mbp}/Ctdspl^{tm1.1(KOMP)Mbp} (C57BL/6N-Ctdspl^{tm1.1(KOMP)Mbp}/Ucd)	decreased circulating serum albumin level	J:211773
	decreased circulating total protein level	J:211773
	impaired glucose tolerance	J:211773
	increased circulating aspartate transaminase level	J:211773
Ctf1^tm1Msd/Ctf1^tm1Msd (B6.Cg-Ctf1^tm1Msd)	decreased circulating free fatty acids level	J:176727
	decreased energy expenditure	J:176727
	decreased oxygen consumption	J:176727
	enhanced lipolysis	J:176727
	hyperglycemia	J:176727
	increased circulating cholesterol level	J:176727
	increased circulating insulin level	J:176727
	increased circulating leptin level	J:176727
	increased respiratory quotient	J:176727
	increased susceptibility to diet-induced obesity	J:176727
	insulin resistance	J:176727
Cth^tm1Iish/Cth⁺ (B6.129-Cth^tm1Iish/Iish)	increased circulating homocysteine level	J:166184
Cth^tm1Iish/Cth^tm1Iish (B6.129-Cth^tm1Iish/Iish)	abnormal circulating amino acid level	J:166184
	cystathioninuria	J:166184
	decreased circulating creatinine level	J:166184
	decreased circulating taurine level	J:166184
	decreased glutathione level	J:166184
	decreased lactate dehydrogenase level	J:166184
	increased blood urea nitrogen level	J:166184
	increased circulating alanine transaminase level	J:166184
	increased circulating alkaline phosphatase level	J:166184
	increased circulating aspartate transaminase level	J:166184
	increased circulating homocysteine level	J:166184
	increased circulating serum albumin level	J:166184
	increased circulating triglyceride level	J:166184
Cth^tm1Liwu/Cth⁺ (involves: 129S/SvEvBrd * C57BL/6J)	decreased circulating cysteine level	J:140705
Cth^tm1Liwu/Cth⁺ (involves: 129S/SvEvBrd * C57BL/6J)	increased circulating homocysteine level	J:140705
Cth^tm1Liwu/Cth^tm1Liwu (involves: 129S/SvEvBrd * C57BL/6J)	decreased circulating cysteine level	J:140705
Cth^tm1Liwu/Cth^tm1Liwu (involves: 129S/SvEvBrd * C57BL/6J)	increased circulating homocysteine level	J:140705
Cthrc1^tm1Vli/Cthrc1^tm1Vli (129S6.Cg-Cthrc1^tm1Vli)	increased circulating glucose level	J:192096
	increased liver glycogen level	J:192096
	increased skeletal muscle glycogen level	J:192096
	insulin resistance	J:192096
Ctif^em1(IMPC)J/Ctif^em1(IMPC)J (C57BL/6NJ-Ctif^em1(IMPC)J/Mmjax)	improved glucose tolerance	J:211773
Ctnnb1^{tm1(Nfkbia)Rsu}/Ctnnb1⁺ (involves: 129P2/OlaHsd * C57BL/6)	abnormal nitric oxide homeostasis	J:71744
Ctnnb1^tm1Mmt/Ctnnb1⁺ Kras^tm4Tyj/Kras⁺ Tg(CYP19A1-cre)1Jri/0 (involves: 129S4/SvJae * 129X1/SvJ * C57BL/6)	decreased circulating estradiol level	J:186144
	decreased circulating progesterone level	J:186144
	increased circulating follicle stimulating hormone level	J:186144
	increased circulating luteinizing hormone level	J:186144
Ctnnb1^tm1Mmt/Ctnnb1⁺ Pten^tm1Hwu/Pten^tm1Hwu Tg(CYP19A1-cre)1Jri/0 (involves: 129S4/SvJae * 129X1/SvJ * C57BL/6)	decreased circulating estradiol level	J:186144
	decreased circulating progesterone level	J:186144
	increased circulating follicle stimulating hormone level	J:186144
	increased circulating luteinizing hormone level	J:186144
Ctnnb1^tm1Mmt/Ctnnb1^tm1Mmt Tg(Upk2-cre)6Xrw/0 Tg(Upk2-HRASQ61L)5Xrw/0 (involves: 129X1/SvJ FVB/N)	hematuria	J:234236
Ctnnb1^tm2Kem/Ctnnb1^tm2.1Kem Tg(Tek-cre)1Ywa/0 (involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * SJL)	pericardial edema	J:85505
Ctns^tm1Antc/Ctns^tm1Antc (involves: 129/Sv * C57BL/6)	increased cysteine level	J:79610
Ctr9^{tm1b(EUCOMM)Wtsi}/Ctr9⁺ (C57BL/6N-Ctr9^{tm1b(EUCOMM)Wtsi}/Wtsi)	increased circulating alanine transaminase level	J:211773
Ctrb1^em1Toth/Ctrb1^em1Toth (C57BL/6N-Ctrb1^em1Toth)	edema	J:294171
Ctsa^tm1Adz/Ctsa^tm1Adz (either: (involves: 129P2/OlaHsd * C57BL/6) or (involves: 129P2/OlaHsd * FVB/NJ))	edema	J:29674
Ctsa^{tm2b(EUCOMM)Hmgu}/Ctsa^{tm2b(EUCOMM)Hmgu} (C57BL/6N-Ctsa^{tm2b(EUCOMM)Hmgu}/H)	decreased circulating calcium level	J:211773
	decreased circulating cholesterol level	J:211773
	decreased circulating glucose level	J:211773
	decreased circulating HDL cholesterol level	J:211773
	decreased circulating serum albumin level	J:211773
	decreased circulating total protein level	J:211773
	decreased circulating triglyceride level	J:211773
	increased circulating alanine transaminase level	J:211773
	increased circulating alkaline phosphatase level	J:211773
	increased circulating aspartate transaminase level	J:211773
	increased circulating bilirubin level	J:211773
	increased circulating iron level	J:211773
Ctsb^tm1Jde/Ctsb⁺ (NOD.129P2-Ctsb^tm1Jde)	hyperglycemia	J:153355
Ctsb^tm1Jde/Ctsb^tm1Jde (involves: 129P2/OlaHsd * C57BL/6J)	abnormal thyroid hormone level	J:83877
Ctsb^tm1Jde/Ctsb^tm1Jde (NOD.129P2-Ctsb^tm1Jde)	hyperglycemia	J:153355
Ctsb^tm1Jde/Ctsb^tm1Jde Ctsk^tm1Psa/Ctsk^tm1Psa (involves: 129P2/OlaHsd * 129X1/SvJ * C57BL/6J)	abnormal thyroid hormone level	J:83877
Ctsc^tm1Ley/Ctsc^tm1Ley (B6.129X1-Ctsc^tm1Ley)	abnormal chemokine level	J:131520
	decreased circulating interleukin-6 level	J:131520
	increased circulating interleukin-6 level	J:88160
Ctsd^{tm1b(EUCOMM)Wtsi}/Ctsd⁺ (C57BL/6N-Ctsd^{tm1b(EUCOMM)Wtsi}/Ics)	increased circulating aspartate transaminase level	J:211773
Ctsd^tm1Cptr/Ctsd^tm1Cptr (either: (involves: 129P2/OlaHsd * C57BL/6) or (involves: 129P2/OlaHsd))	abnormal thrombosis	J:28201
Ctse^tm1Kjy/Ctse^tm1Kjy (involves: C57BL/6)	increased circulating interleukin-1 beta level	J:108745
Ctse^tm1Kjy/Ctse^tm1Kjy (involves: C57BL/6)	increased circulating interleukin-18 level	J:108745
Ctsk^tm1Psa/Ctsk^tm1Psa Ctsl^tm1Cptr/Ctsl^tm1Cptr (involves: 129P2/OlaHsd * 129X1/SvJ * C57BL/6J)	abnormal thyroid hormone level	J:83877
	decreased circulating thyroxine level	J:83877
	decreased thyroxine level	J:83877
Ctsl^tm1Cptr/Ctsl⁺ (NOD.129P2-Ctsl^tm1Cptr)	hyperglycemia	J:153355
Ctsl^tm1Cptr/Ctsl^tm1Cptr (involves: 129P2/OlaHsd * C57BL/6J)	abnormal thyroid hormone level	J:83877
	decreased thyroxine level	J:83877
Ctsm^{tm1(KOMP)Wtsi}/Ctsm^{tm1(KOMP)Wtsi} (C57BL/6N-Ctsm^{tm1(KOMP)Wtsi}/Nju)	increased fasting circulating glucose level	J:211773
Ctso^{tm2b(KOMP)Wtsi}/Ctso^{tm2b(KOMP)Wtsi} (C57BL/6N-Ctso^{tm2b(KOMP)Wtsi}/Cnrm)	decreased circulating bilirubin level	J:211773
	decreased circulating calcium level	J:211773
Ctss^tm1Eae/Ctss⁺ (NOD.D1-Ctss^tm1Eae)	hyperglycemia	J:153355
Ctss^tm1Eae/Ctss^tm1Eae (NOD.D1-Ctss^tm1Eae)	hyperglycemia	J:153355
Ctss^tm1Hap/Ctss^tm1Hap Dmd^mdx/Dmd^mdx (involves: 129S2/SvPas * C57BL/10ScSn)	increased circulating creatine kinase level	J:230788
Ctss^tm1Hap/Ctss^tm1Hap Ldlr^tm1Her/Ldlr^tm1Her (B6.129S-Ctss^tm1Hap Ldlr^tm1Her)	decreased circulating cholesterol level	J:82520
	decreased circulating LDL cholesterol level	J:82520
Cttnbp2^em1Yph/Cttnbp2^em1Yph (C57BL/6-Cttnbp2^em1Yph)	decreased brain zinc level	J:300704
Cttnbp2^em2Yph/Cttnbp2⁺ (C57BL/6-Cttnbp2^em2Yph)	decreased brain zinc level	J:300704
Cttnbp2nl^em1(IMPC)J/Cttnbp2nl^em1(IMPC)J (C57BL/6NJ-Cttnbp2nl^em1(IMPC)J/Mmjax)	increased blood urea nitrogen level	J:211773
Cubn^tm1Rkoz/Cubn^tm1Rkoz Lrp2^tm1Tew/Lrp2^tm1Tew Meox2^tm1(cre)Sor/Meox2⁺ (involves: 129S4/SvJaeSor * 129X1/SvJ * C57BL/6)	albuminuria	J:164025
Cubn^tm1Rkoz/Cubn^tm1Rkoz Meox2^tm1(cre)Sor/Meox2⁺ (involves: 129S4/SvJaeSor * 129X1/SvJ * C57BL/6)	abnormal vitamin B12 level	J:164025
	albuminuria	J:164025
Cul3^tm1.1Arte/Cul3⁺ (involves: C57BL/6J * C57BL/6N)	abnormal pH regulation	J:229424
	hyperkalemia	J:229424
	increased circulating aldosterone level	J:229424
	increased circulating chloride level	J:229424
	increased circulating magnesium level	J:229424
	increased circulating phosphate level	J:229424
	metabolic acidosis	J:229424
Cul3^tm1Suc/Cul3⁺ (involves: C57BL/6)	increased circulating chloride level	J:226618
Cul4a^{tm1b(EUCOMM)Hmgu}/Cul4a^{tm1b(EUCOMM)Hmgu} (C57BL/6N-Cul4a^{tm1b(EUCOMM)Hmgu}/Ccpcz)	increased circulating potassium level	J:211773
	increased fasting circulating glucose level	J:211773
Cul9^{em1(IMPC)Ccpcz}/Cul9^{em1(IMPC)Ccpcz} (C57BL/6N-Cul9^{em1(IMPC)Ccpcz}/Ccpcz)	increased blood urea nitrogen level	J:211773
	increased circulating creatine kinase level	J:211773
	increased circulating lactate dehydrogenase level	J:211773
	increased circulating potassium level	J:211773
Cux1^tm1Ejn/Cux1^tm1Ejn Cys1^cpk/Cys1^cpk (involves: 129S4/SvJae * C57BL/6)	increased blood urea nitrogen level	J:142805
Cux1^tm1Mbu/Cux1^tm1Mbu (involves: 129P2/OlaHsd * C57BL/6)	cyanosis	J:71407
Cux1^tm1Rhsc/Cux1^tm1Rhsc (involves: 129S1/Sv * C57BL/6J)	abnormal tumor necrosis factor level	J:100055
Cux1^tm2Ejn/Cux1⁺ (involves: 129S4/SvJae * C57BL/6)	decreased circulating testosterone level	J:74660
Cux1^tm2Ejn/Cux1^tm2Ejn (involves: 129S4/SvJae * C57BL/6)	decreased circulating testosterone level	J:74660
Cwc22^em1(IMPC)Mbp/Cwc22⁺ (C57BL/6NCrl-Cwc22^em1(IMPC)Mbp/Mmucd)	increased circulating aspartate transaminase level	J:211773
Cwc27^tm1Lex/Cwc27^tm1Lex (B6;129S5-Cwc27^tm1Lex/Mmucd)	abnormal blood homeostasis	J:171883
Cx3cl1^em3(IMPC)Ics/Cx3cl1^em3(IMPC)Ics (C57BL/6N-Cx3cl1^em3(IMPC)Ics/Ics)	increased respiratory quotient	J:211773
Cx3cl1^tm1Sgs/Cx3cl1^tm1Sgs Ldlr^tm1Her/Ldlr⁺ (involves: B6.129S4-Cx3cl1^tm1Sgs * B6.129S7-Ldlr^tm1Her/J)	decreased circulating cholesterol level	J:95279
	decreased circulating LDL cholesterol level	J:95279
Cx3cl1^tm1Sgs/Cx3cl1^tm1Sgs Ldlr^tm1Her/Ldlr^tm1Her (involves: B6.129S4-Cx3cl1^tm1Sgs * B6.129S7-Ldlr^tm1Her/J)	decreased circulating cholesterol level	J:95279
	decreased circulating LDL cholesterol level	J:95279
Cx3cr1^{tm2.1(cre/ERT2)Litt}/Cx3cr1⁺ Vps35^{Gt(RRK261)Byg}/Vps35^{Gt(RRK261)Byg} (involves: 129P2/OlaHsd * C57BL/6)	increased transforming growth factor beta level	J:292365
Cxadr^tm1Dvst/Cxadr^tm1Dvst (involves: 129X1/SvJ * C57BL/6)	increased cardiac muscle glycogen level	J:100174
Cxadr^tm1Dvst/Cxadr^tm1Dvst (involves: 129X1/SvJ * C57BL/6)	pericardial edema	J:100174
Cxadr^tm1Rwf/Cxadr^tm1Rwf (involves: 129S6/SvEvTac * C57BL/6)	hemopericardium	J:99585
Cxadr^tm2Know/Cxadr^tm2Know (involves: 129 * Black Swiss)	pericardial effusion	J:140870
Cxcl5^tm1Gscw/Cxcl5^tm1Gscw (involves: 129)	abnormal circulating chemokine level	J:162629
Cxcl5^tm1Gscw/Cxcl5^tm1Gscw (involves: 129)	decreased circulating interleukin-6 level	J:162629
Cxcl5^tm1Gscw/Cxcl5^tm1Gscw Ackr1^tm1Scp/Ackr1^tm1Scp (involves: 129/Sv * 129P2/OlaHsd * C57BL/6)	abnormal circulating chemokine level	J:162629
Cxcl9^{tm1b(EUCOMM)Wtsi}/Cxcl9^{tm1b(EUCOMM)Wtsi} (C57BL/6N-Cxcl9^{tm1b(EUCOMM)Wtsi}/H)	decreased fasting circulating glucose level	J:211773
	increased circulating cholesterol level	J:211773
	increased circulating HDL cholesterol level	J:211773
Cxcl10^tm1Adl/Cxcl10^tm1Adl (involves: 129S4/SvJae * C57BL/6)	abnormal interferon level	J:75584
Cxcl14^em1(IMPC)H/Cxcl14^em1(IMPC)H (C57BL/6NTac-Cxcl14^em1(IMPC)H/H)	decreased circulating serum albumin level	J:211773
	decreased circulating total protein level	J:211773
Cxcl14^tm1Tha/Cxcl14^tm1Tha (involves: C57BL/6 * CBA)	decreased circulating cholesterol level	J:126841
	decreased circulating glucose level	J:126841
	decreased circulating insulin level	J:126841
	decreased liver triglyceride level	J:126841
	impaired glucose tolerance	J:126841
	improved glucose tolerance	J:126841
	increased insulin sensitivity	J:126841
Cxcl16^tm1Syon/Cxcl16^tm1Syon (B6.129P2-Cxcl16^tm1Syon)	decreased circulating interferon-gamma level	J:155199
Cxcl16^tm1Syon/Cxcl16^tm1Syon (B6.129P2-Cxcl16^tm1Syon)	decreased circulating interleukin-4 level	J:155199
Cxcl17^{tm1b(EUCOMM)Wtsi}/Cxcl17^{tm1b(EUCOMM)Wtsi} (C57BL/6N-Cxcl17^{tm1b(EUCOMM)Wtsi}/Ucd)	increased circulating alanine transaminase level	J:211773
Cxcr1^{tm1a(EUCOMM)Wtsi}/Cxcr1^{tm1a(EUCOMM)Wtsi} (C57BL/6N-Cxcr1^{tm1a(EUCOMM)Wtsi}/Wtsi)	increased circulating insulin level	J:211773
	increased fasting circulating glucose level	J:211773
Cxcr2^{tm1a(EUCOMM)Wtsi}/Cxcr2⁺ (C57BL/6N-Cxcr2^{tm1a(EUCOMM)Wtsi}/Wtsi)	increased circulating creatinine level	J:211773
	increased circulating magnesium level	J:211773
Cxcr2^{tm1a(EUCOMM)Wtsi}/Cxcr2^{tm1a(EUCOMM)Wtsi} (C57BL/6N-Cxcr2^{tm1a(EUCOMM)Wtsi}/Wtsi)	decreased circulating fructosamine level	J:211773
	decreased circulating serum albumin level	J:211773
	decreased circulating thyroxine level	J:211773
	improved glucose tolerance	J:211773
	increased circulating calcium level	J:211773
	increased circulating total protein level	J:211773
Cxcr2^tm1Mwm/Cxcr2^tm1Mwm (involves: 129S2/SvPas * C57BL/6J)	increased circulating interleukin-6 level	J:19570
Cxcr2^tm1Mwm/Cxcr2^tm1Mwm (C.129S2(B6)-Cxcr2^tm1Mwm/J)	abnormal chemokine level	J:73947
Cxcr2^tm1Mwm/Cxcr2^tm1Mwm (C.129S2(B6)-Cxcr2^tm1Mwm/J)	abnormal interleukin level	J:73947, J:87365
Cxcr3^tm1Dgen/Y (involves: 129P2/OlaHsd * C57BL/6)	increased circulating glucose level	J:101679
Cxcr3^tm1Raks/Cxcr3^tm1Raks (B6.129P2-Cxcr3^tm1Raks)	albuminuria	J:152790
	decreased blood urea nitrogen level	J:152790
	decreased circulating creatinine level	J:152790
Cxcr3^tm1Wwh/Y (B6.Cg-Cxcr3^tm1Wwh)	abnormal interferon level	J:91359
Cxcr3^tm1Wwh/Cxcr3^tm1Wwh (B6.Cg-Cxcr3^tm1Wwh)	abnormal interferon level	J:91359
Cxcr4^em1(IMPC)Mbp/Cxcr4⁺ (C57BL/6NCrl-Cxcr4^em1(IMPC)Mbp/MbpMmucd)	decreased circulating creatinine level	J:211773
Cxcr4^em1(IMPC)Mbp/Cxcr4^em1(IMPC)Mbp (C57BL/6NCrl-Cxcr4^em1(IMPC)Mbp/MbpMmucd)	edema	J:211773
Cxcr4^tm1Yzo/Cxcr4^tm1Yzo (Not Specified)	hydrops fetalis	J:69255
Cxcr4^tm2Yzo/Cxcr4^tm2Yzo Tg(Fabp4-cre)1Rev/0 (involves: 129P2/OlaHsd * C57BL/6)	decreased oxygen consumption	J:217569
	impaired adaptive thermogenesis	J:217569
	increased susceptibility to diet-induced obesity	J:217569
Cxxc4^em1(IMPC)J/Cxxc4^em1(IMPC)J (C57BL/6NJ-Cxxc4^em1(IMPC)J/J)	decreased circulating creatinine level	J:211773
Cyb5d1^{tm1.1(KOMP)Vlcg}/Cyb5d1^{tm1.1(KOMP)Vlcg} (B6N(Cg)-Cyb5d1^{tm1.1(KOMP)Vlcg}/J)	decreased circulating free fatty acids level	J:211773
	decreased circulating serum albumin level	J:211773
	increased circulating alkaline phosphatase level	J:211773
	increased circulating sodium level	J:211773
Cyb5d2^{tm1.1(KOMP)Wtsi}/Cyb5d2^{tm1.1(KOMP)Wtsi} (B6N(Cg)-Cyb5d2^{tm1.1(KOMP)Wtsi}/J)	increased circulating sodium level	J:211773
Cyb5r4^tm1Hfb/Cyb5r4^tm1Hfb (involves: 129S4/SvJae * BALB/cAnN)	abnormal glucose homeostasis	J:91486
	decreased circulating insulin level	J:91486
	decreased insulin secretion	J:91486
	hyperlipidemia	J:91486
	impaired glucose tolerance	J:91486
	increased circulating glucose level	J:91486
	increased insulin sensitivity	J:91486
Cyb561^{tm1a(EUCOMM)Wtsi}/Cyb561^{tm1a(EUCOMM)Wtsi} (Not Specified)	abnormal respiratory quotient	J:165965
	decreased circulating calcium level	J:165965
	decreased circulating serum albumin level	J:165965
	decreased circulating total protein level	J:165965
	increased circulating iron level	J:165965
Cyb561^{tm1a(EUCOMM)Wtsi}/Cyb561^{tm1a(EUCOMM)Wtsi} (B6JTyr;B6N-Cyb561^{tm1a(EUCOMM)Wtsi}/Wtsi)	decreased circulating LDL cholesterol level	J:175295
	increased circulating amylase level	J:175295
	increased circulating fructosamine level	J:175295
	increased circulating magnesium level	J:175295
Cyb561^{tm1b(EUCOMM)Wtsi}/Cyb561^{tm1b(EUCOMM)Wtsi} (C57BL/6N-Cyb561^{tm1b(EUCOMM)Wtsi}/H)	decreased circulating glucose level	J:211773
	decreased circulating serum albumin level	J:211773
	decreased circulating total protein level	J:211773
	decreased fasting circulating glucose level	J:211773
	increased circulating alkaline phosphatase level	J:211773
	increased circulating amylase level	J:211773
	increased circulating aspartate transaminase level	J:211773
	increased circulating triglyceride level	J:211773
Cyb561a3^{tm2b(EUCOMM)Hmgu}/Cyb561a3^{tm2b(EUCOMM)Hmgu} (C57BL/6N-Cyb561a3^{tm2b(EUCOMM)Hmgu}/Ieg)	increased fasting circulating glucose level	J:211773
Cyba^{tm1a(EUCOMM)Wtsi}/Cyba^{tm1a(EUCOMM)Wtsi} (C57BL/6N-Cyba^{tm1a(EUCOMM)Wtsi}/Wtsi)	decreased blood urea nitrogen level	J:211773
	decreased circulating amylase level	J:211773
Cybb^tm1.1Abk/Cybb^tm1.1Abk Lyz2^tm1(cre)Ifo/? (B6.Cg-Lyz2^tm1(cre)Ifo Cybb^tm1.1Abk)	decreased cholesterol level	J:245699
	decreased circulating insulin level	J:245699
	decreased circulating LDL cholesterol level	J:245699
	decreased fasting circulating glucose level	J:245699
	decreased susceptibility to diet-induced obesity	J:245699
	decreased triglyceride level	J:245699
	increased circulating HDL cholesterol level	J:245699
Cybb^tm1Din/Y (B6.129S-Cybb^tm1Din)	abnormal nitric oxide homeostasis	J:101981
	decreased urine sodium level	J:138704
	increased urine creatinine level	J:101981
	increased urine nitrite level	J:101981
	increased urine sodium level	J:101981
Cybb^tm1Din/? (B6.129S-Cybb^tm1Din/J)	abnormal glycosaminoglycan level	J:306955
Cybb^tm1Din/Cybb^tm1Din (B6.129S-Cybb^tm1Din/J)	abnormal circulating chemokine level	J:235399
	decreased circulating interleukin-10 level	J:235399
	increased blood urea nitrogen level	J:235399
	increased circulating creatinine level	J:235399
	increased circulating interleukin-1 beta level	J:235399
	increased circulating interleukin-6 level	J:235399
	increased circulating interleukin-12b level	J:235399
	increased urine protein level	J:235399
Cybc1^{tm1a(KOMP)Wtsi}/Cybc1^{tm1a(KOMP)Wtsi} (C57BL/6N-Cybc1^{tm1a(KOMP)Wtsi}/Wtsi)	decreased circulating amylase level	J:175295
	decreased circulating glucose level	J:175295
	decreased circulating potassium level	J:175295
	increased circulating sodium level	J:175295
Cybrd1^{tm1b(EUCOMM)Hmgu}/Cybrd1^{tm1b(EUCOMM)Hmgu} (C57BL/6N-Cybrd1^{tm1b(EUCOMM)Hmgu}/H)	increased circulating HDL cholesterol level	J:211773
Cybrd1^tm1Nca/Cybrd1^tm1Nca (involves: 129S4/SvJae * 129S6/SvEvTac)	decreased liver iron level	J:119528
Cyfip2^{tm1a(EUCOMM)Wtsi}/Cyfip2^{tm1a(EUCOMM)Wtsi} (C57BL/6N-Cyfip2^{tm1a(EUCOMM)Wtsi}/Wtsi)	subcutaneous edema	J:239583
Cygb^{tm1b(EUCOMM)Wtsi}/Cygb^{tm1b(EUCOMM)Wtsi} (C57BL/6N-Cygb^{tm1b(EUCOMM)Wtsi}/Tcp)	decreased circulating cholesterol level	J:211773
Cyld^tm1.1Gmos/Cyld^tm1.1Gmos (involves: BALB/cJ)	cyanosis	J:162840
Cyld^tm1Lex/Cyld^tm1Lex (involves: 129S5/SvEvBrd * C57BL/6)	abnormal circulating serum albumin level	J:114972
Cyp1a1^tm1.1Dwn/Cyp1a1^tm1.1Dwn (B6.129P2-Cyp1a1^tm1.1Dwn)	increased circulating alanine transaminase level	J:163973
Cyp1a1^tm1.1Dwn/Cyp1a1^tm1.1Dwn (B6.129P2-Cyp1a1^tm1.1Dwn)	increased circulating aspartate transaminase level	J:163973
Cyp1a1^tm1.1Dwn/Cyp1a1^tm1.1Dwn (involves: 129P2/OlaHsd * C57BL/6)	increased circulating alanine transaminase level	J:122409
	increased circulating aspartate transaminase level	J:122409
Cyp1a1^tm4.1Dwn/Cyp1a1^tm4.1Dwn (B6.129X1-Cyp1a1^tm4.1Dwn)	increased circulating alanine transaminase level	J:163973
Cyp1a1^tm4.1Dwn/Cyp1a1^tm4.1Dwn (B6.129X1-Cyp1a1^tm4.1Dwn)	increased circulating aspartate transaminase level	J:163973
Cyp1a2^tm1Gonz/Cyp1a2^tm1Gonz (involves: 129S4/SvJae)	cyanosis	J:25724
Cyp1a2^tm1Gonz/Cyp1a2^tm1Gonz (involves: 129S4/SvJae)	decreased body temperature	J:25724
Cyp1a^tm1Dwn/Cyp1a^tm1Dwn (B6.129-Cyp1a^tm1Dwn)	increased circulating alanine transaminase level	J:122409
Cyp1a^tm1Dwn/Cyp1a^tm1Dwn (B6.129-Cyp1a^tm1Dwn)	increased circulating aspartate transaminase level	J:122409
Cyp2ab1^{tm1b(KOMP)Wtsi}/Cyp2ab1^{tm1b(KOMP)Wtsi} (C57BL/6N-Cyp2ab1^{tm1b(KOMP)Wtsi}/Bay)	decreased circulating aspartate transaminase level	J:211773
	decreased circulating phosphate level	J:211773
Cyp2b10^{tm1a(KOMP)Wtsi}/Cyp2b10^{tm1a(KOMP)Wtsi} (C57BL/6N-Cyp2b10^{tm1a(KOMP)Wtsi})	abnormal blood homeostasis	J:339440
	abnormal homeostasis	J:339440
	abnormal lipid oxidation	J:339440
	increased circulating alanine transaminase level	J:339440
Cyp2c23^{Gt(OST85045)Lex}/Cyp2c23^{Gt(OST85045)Lex} (129-Cyp2c23^{Gt(OST85045)Lex})	decreased circulating aldosterone level	J:204734
	decreased urine sodium level	J:204734
	increased circulating sodium level	J:204734
Cyp2c23^tm1.1Jhc/Cyp2c23^tm1.1Jhc Tg(Hoxb7-cre)13Amc/0 (involves: C57BL/6)	decreased urine sodium level	J:213555
Cyp2c23^{tm1b(EUCOMM)Hmgu}/Cyp2c23^{tm1b(EUCOMM)Hmgu} (C57BL/6N-Cyp2c23^{tm1b(EUCOMM)Hmgu}/J)	increased circulating alkaline phosphatase level	J:211773
	increased circulating cholesterol level	J:211773
Cyp2c^tm1104Arte/Cyp2c^tm1104Arte (B6NTac(Cg)-Cyp2c^tm1104Arte/Arte)	decreased circulating cholesterol level	J:241121
	decreased circulating HDL cholesterol level	J:241121
Cyp2e1^tm1Gonz/Cyp2e1^tm1Gonz (involves: 129S4/SvJae)	abnormal blood homeostasis	J:143909
Cyp2j5^tm1Dcz/Cyp2j5^tm1Dcz (129S/SvEv-Cyp2j5^tm1Dcz)	decreased circulating estrogen level	J:146047
Cyp2r1^{tm1(KOMP)Vlcg}/Cyp2r1⁺ (involves: C57BL/6NTac)	abnormal vitamin D level	J:223194
Cyp2r1^{tm1(KOMP)Vlcg}/Cyp2r1^{tm1(KOMP)Vlcg} (involves: C57BL/6NTac)	abnormal vitamin D level	J:223194
	decreased circulating phosphate level	J:223194
Cyp4a10^tm1Jhc/Cyp4a10^tm1Jhc (involves: 129S6/SvEvTac)	abnormal renal sodium reabsorption	J:110364
Cyp4a10^tm1Jhc/Cyp4a10^tm1Jhc (involves: 129S6/SvEvTac)	decreased urine potassium level	J:110364
Cyp4a14^tm1Jhc/Cyp4a14^tm1Jhc (involves: 129S6/SvEvTac * 129X1/SvJ)	abnormal lipid homeostasis	J:77631
Cyp4b1^{tm1b(KOMP)Wtsi}/Cyp4b1^{tm1b(KOMP)Wtsi} (C57BL/6N-Cyp4b1^{tm1b(KOMP)Wtsi}/Ieg)	decreased blood urea nitrogen level	J:211773
	decreased circulating triglyceride level	J:211773
	increased circulating aspartate transaminase level	J:211773
	increased circulating bilirubin level	J:211773
	increased fasting circulating glucose level	J:211773
Cyp4f14^tm1Rspk/Cyp4f14^tm1Rspk (involves: 129S/SvEv * C57BL/6J)	abnormal enzyme/coenzyme level	J:188849
	abnormal urine homeostasis	J:188849
Cyp4f16^{tm1b(KOMP)Wtsi}/Cyp4f16^{tm1b(KOMP)Wtsi} (C57BL/6N-Cyp4f16^{tm1b(KOMP)Wtsi}/H)	increased fasting circulating glucose level	J:211773
Cyp4f18^tm1.1Pchr/Cyp4f18^tm1.1Pchr (B6.Cg-Cyp4f18^tm1.1Pchr)	abnormal fatty acid oxidation	J:212489
	decreased leukotriene level	J:212489
Cyp4f39^em1Akih/Cyp4f39^em1Akih (C57BL/6J-Cyp4f39^em1Akih)	decreased ceramide level	J:286705
Cyp4f39^em1Akih/Cyp4f39^em1Akih (C57BL/6J-Cyp4f39^em1Akih)	impaired skin barrier function	J:286705
Cyp4v3^{tm1(KOMP)Vlcg}/Cyp4v3^{tm1(KOMP)Vlcg} (B6(Cg)-Cyp4v3^{tm1(KOMP)Vlcg})	abnormal fatty acids level	J:230232
Cyp4x1^tm1.1Beld/Cyp4x1^tm1.1Beld (involves: C57BL/6)	decreased oxygen consumption	J:254435
	decreased respiratory quotient	J:254435
	increased susceptibility to diet-induced obesity	J:254435
Cyp7a1^{tm1b(EUCOMM)Wtsi}/Cyp7a1^{tm1b(EUCOMM)Wtsi} (C57BL/6N-Cyp7a1^{tm1b(EUCOMM)Wtsi}/Ieg)	decreased blood urea nitrogen level	J:211773
	decreased circulating iron level	J:211773
	decreased circulating serum albumin level	J:211773
	increased circulating alkaline phosphatase level	J:211773
	increased circulating bilirubin level	J:211773
	increased circulating cholesterol level	J:211773
	increased circulating HDL cholesterol level	J:211773
	increased circulating unsaturated transferrin level	J:211773
Cyp7a1^tm1Rus/Cyp7a1^tm1Rus (involves: 129S7/SvEvBrd * C57BL/6J)	abnormal bile salt homeostasis	J:34342
	abnormal bile salt level	J:34870
	abnormal fat-soluble vitamin level	J:34342, J:34870
	abnormal lipid homeostasis	J:34870
	decreased intestinal cholesterol absorption	J:114411
	steatorrhea	J:34342
Cyp7b1^{tm1b(EUCOMM)Wtsi}/Cyp7b1^{tm1b(EUCOMM)Wtsi} (C57BL/6N-Cyp7b1^{tm1b(EUCOMM)Wtsi}/Bay)	impaired glucose tolerance	J:211773
Cyp7b1^tm1Rus/Cyp7b1^tm1Rus (involves: 129S/SvEv * C57BL/6J)	abnormal cholesterol homeostasis	J:62589, J:62587
Cyp8b1^tm1Rus/Cyp8b1^tm1Rus (involves: 129S7/SvEvBrd * C57BL/6J)	abnormal bile salt homeostasis	J:100246, J:100206
	abnormal bile salt level	J:100206
	abnormal lipid homeostasis	J:100206
	decreased circulating cholesterol level	J:100246
	decreased intestinal cholesterol absorption	J:100206
	steatorrhea	J:100206
Cyp11a1^tm1.1Bcc/Cyp11a1^tm1.1Bcc (B6.129(FVB)-Cyp11a1^tm1.1Bcc)	abnormal corticosterone level	J:191801
	decreased adrenaline level	J:191801
	decreased noradrenaline level	J:191801
	increased circulating adrenocorticotropin level	J:191801
Cyp11a1^{tm1b(EUCOMM)Hmgu}/Cyp11a1^{tm1b(EUCOMM)Hmgu} (C57BL/6N-Cyp11a1^{tm1b(EUCOMM)Hmgu}/Wtsi)	hemopericardium	J:239583
Cyp11a1^tm1Bcc/Cyp11a1^tm1Bcc (involves: 129 * C57BL/6)	abnormal circulating potassium level	J:78062
	abnormal circulating sodium level	J:78062
	abnormal lipid level	J:78062
	decreased circulating aldosterone level	J:78062
	decreased circulating corticosterone level	J:78062
	increased circulating adrenocorticotropin level	J:78062
Cyp11a1^tm2Bcc/Cyp11a1^tm2Bcc (Not Specified)	abnormal circulating hormone level	J:133007
Cyp11a1^tm2Bcc/Cyp11a1^tm2Bcc (Not Specified)	decreased circulating corticosterone level	J:133007
Cyp11b1^tm1Chjk/Cyp11b1^tm1Chjk (involves: 129P2/OlaHsd * C57BL/6J)	decreased circulating corticosterone level	J:147610
	decreased circulating insulin level	J:147610
	decreased circulating renin level	J:147610
	decreased urine aldosterone level	J:147610
	decreased urine corticosterone level	J:147610
	hypokalemia	J:147610
	impaired glucose tolerance	J:147610
	increased circulating adrenocorticotropin level	J:147610
	increased urine deoxycorticosterone level	J:147610
	increased urine progesterone level	J:147610
Cyp11b2^tm1Hsk/Cyp11b2^tm1Hsk (involves: 129S6/SvEvTac)	decreased circulating aldosterone level	J:99269
	decreased circulating chloride level	J:99269
	increased circulating angiotensin II level	J:99269
	increased circulating corticosterone level	J:99269
	increased circulating potassium level	J:99269
	increased circulating renin level	J:99269
Cyp11b2^tm2Hsk/Cyp11b2^tm2Hsk (involves: 129S6/SvEvTac)	decreased urine osmolality	J:147672
	hypokalemia	J:147672
	increased urine osmolality	J:147672
Cyp17a1^{tm1b(EUCOMM)Wtsi}/Cyp17a1^{tm1b(EUCOMM)Wtsi} (C57BL/6N-Cyp17a1^{tm1b(EUCOMM)Wtsi}/Nju)	decreased circulating phosphate level	J:211773
	improved glucose tolerance	J:211773
	increased blood urea nitrogen level	J:211773
	increased circulating alkaline phosphatase level	J:211773
	increased circulating cholesterol level	J:211773
	increased circulating creatinine level	J:211773
	increased circulating HDL cholesterol level	J:211773
	increased fasting circulating glucose level	J:211773
Cyp17a1^tm1Vpap/Cyp17a1⁺ (chimera involves: 129X1/SvJ * C57BL/6)	abnormal testosterone level	J:100434
	decreased circulating testosterone level	J:100434
Cyp19a1^{tm1b(EUCOMM)Hmgu}/Cyp19a1^{tm1b(EUCOMM)Hmgu} (C57BL/6N-Cyp19a1^{tm1b(EUCOMM)Hmgu}/H)	decreased circulating alkaline phosphatase level	J:211773
	increased blood urea nitrogen level	J:211773
	increased circulating cholesterol level	J:211773
	increased circulating serum albumin level	J:211773
	increased fasting circulating glucose level	J:211773
Cyp19a1^tm1Esi/Cyp19a1^tm1Esi (involves: 129S6/SvEvTac * C57BL/6)	abnormal enzyme/coenzyme level	J:105620
	increased circulating dihydrotestosterone level	J:70204
	increased circulating follicle stimulating hormone level	J:48086, J:63458, J:56358
	increased circulating luteinizing hormone level	J:48086, J:63458, J:56358
	increased circulating prolactin level	J:70204
	increased circulating testosterone level	J:48086, J:70204, J:56358
	increased urine protein level	J:92438
Cyp19a1^tm1Esi/Cyp19a1^tm1Esi (involves: 129S6/SvEvTac)	abnormal glucose homeostasis	J:65805
	increased circulating cholesterol level	J:65805
	increased circulating HDL cholesterol level	J:65805
	increased circulating insulin level	J:65805
	increased circulating leptin level	J:65805
	increased circulating triglyceride level	J:65805
Cyp19a1^tm1Toda/Cyp19a1^tm1Toda (involves: 129P2/OlaHsd * C57BL/6J)	abnormal enzyme/coenzyme level	J:79603
	abnormal lipid homeostasis	J:79603
	decreased circulating estradiol level	J:114305, J:70359
	impaired glucose tolerance	J:82070
	increased circulating cholesterol level	J:82070
	increased circulating glucose level	J:82070
	increased circulating testosterone level	J:114305, J:70359, J:82070, J:68190
	increased circulating triglyceride level	J:82070
	insulin resistance	J:82070
Cyp20a1^{tm1a(EUCOMM)Wtsi}/Cyp20a1^{tm1a(EUCOMM)Wtsi} (C57BL/6N-Cyp20a1^{tm1a(EUCOMM)Wtsi}/Wtsi)	increased circulating bilirubin level	J:211773
Cyp24a1^tm1Star/Cyp24a1^tm1Star (involves: 129S4/SvJae)	abnormal vitamin D level	J:63457
	increased circulating calcium level	J:63457
	increased urine calcium level	J:63457
Cyp26b1^tm1Hmd/Cyp26b1^tm1Hmd (involves: 129S1/Sv * 129X1/SvJ)	impaired skin barrier function	J:192725
Cyp26b1^tm1Hmd/Cyp26b1^tm1Hmd Tg(Prox1-EGFP)KY221Gsat/0 (involves: 129S1/Sv * 129X1/SvJ * FVB/NTac)	skin edema	J:206581
Cyp27a1^{tm1.1(KOMP)Vlcg}/Cyp27a1^{tm1.1(KOMP)Vlcg} (C57BL/6N-Cyp27a1^{tm1.1(KOMP)Vlcg}/Ucd)	decreased circulating cholesterol level	J:211773
	decreased circulating HDL cholesterol level	J:211773
	decreased circulating serum albumin level	J:211773
	decreased circulating triglyceride level	J:211773
	improved glucose tolerance	J:211773
	increased circulating alkaline phosphatase level	J:211773
Cyp27a1^tm1Elt/Cyp27a1^tm1Elt (involves: 129/Sv * C57BL/6J)	abnormal bile salt homeostasis	J:115373
	abnormal circulating cholesterol level	J:48127
	abnormal vitamin D level	J:48127
	decreased bile salt level	J:115373
	decreased cholesterol level	J:115373
	decreased intestinal cholesterol absorption	J:115373
	increased cholesterol level	J:115373, J:48127
	increased circulating cholesterol level	J:115373
	increased circulating triglyceride level	J:115373
	increased circulating VLDL cholesterol level	J:115373
	increased circulating VLDL triglyceride level	J:115373
	increased fatty acids level	J:115373
	increased liver triglyceride level	J:115373
	increased sterol level	J:115373
Cyp27a1^tm1Elt/Cyp27a1^tm1Elt (B6.129-Cyp27a1^tm1Elt/J)	abnormal vitamin D level	J:223194
Cyp27a1^tm1Elt/Cyp27a1^tm1Elt (B6.129-Cyp27a1^tm1Elt/J)	decreased circulating phosphate level	J:223194
Cyp27a1^tm1Elt/Cyp27a1^tm1Elt Cyp2r1^{tm1(KOMP)Vlcg}/Cyp2r1^{tm1(KOMP)Vlcg} (involves: C57BL/6J * C57BL/6N * C57BL/6NTac)	abnormal vitamin D level	J:223194
	decreased circulating phosphate level	J:223194
Cyp27b1^{tm1b(EUCOMM)Hmgu}/Cyp27b1^{tm1b(EUCOMM)Hmgu} (C57BL/6N-Cyp27b1^{tm1b(EUCOMM)Hmgu}/Tcp)	decreased circulating calcium level	J:211773
	decreased circulating phosphate level	J:211773
	increased circulating alkaline phosphatase level	J:211773
	increased circulating aspartate transaminase level	J:211773
	increased circulating bilirubin level	J:211773
Cyp27b1^tm1Dgo/Cyp27b1^tm1Dgo (involves: 129S1/Sv * 129X1/SvJ * BALB/c)	abnormal blood homeostasis	J:70030
	decreased circulating calcium level	J:70030
	decreased circulating phosphate level	J:70030
	increased circulating alkaline phosphatase level	J:70030
	increased circulating parathyroid hormone level	J:70030
	increased urine phosphate level	J:70030
Cyp27b1^tm1Star/Cyp27b1^tm1Star (involves: 129S1/Sv * 129X1/SvJ)	abnormal blood homeostasis	J:71928
	decreased circulating calcium level	J:78635, J:71928
	decreased circulating phosphate level	J:71928
	increased circulating alkaline phosphatase level	J:71928
	increased circulating parathyroid hormone level	J:71928
Cyp27b1^tm1Star/Cyp27b1^tm1Star (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	impaired skin barrier function	J:89330
Cyp46a1^tm1Rus/Cyp46a1^tm1Rus (involves: 129 * C57BL/6J)	abnormal cholesterol homeostasis	J:84116
Cyp51^tm1.1Bfro/Cyp51^tm1.1Bfro (involves: 129P2/OlaHsd * C57BL/6)	pericardial effusion	J:173366
Cyria^{em1(IMPC)Hmgu}/Cyria^{em1(IMPC)Hmgu} (C57BL/6NCrl-Cyria^{em1(IMPC)Hmgu}/Ieg)	decreased circulating creatinine level	J:211773
Cyrib^m1Ivdi/Cyrib^m1Ivdi (involves: 129S1/Sv * 129X1/SvJ * DBA/2J)	increased circulating interleukin-6 level	J:282597
	increased circulating interleukin-10 level	J:282597
	increased circulating tumor necrosis factor level	J:282597
	intestinal edema	J:282597
Cyrib^{tm1b(KOMP)Wtsi}/Cyrib⁺ (C57BL/6N-Cyrib^{tm1b(KOMP)Wtsi}/Tcp)	decreased circulating sodium level	J:211773
Cyrib^{tm1b(KOMP)Wtsi}/Cyrib^{tm1b(KOMP)Wtsi} (C57BL/6N-Cyrib^{tm1b(KOMP)Wtsi}/Tcp)	edema	J:211773
Cyrib^{tm1c(KOMP)Wtsi}/Cyrib^{tm1d(KOMP)Wtsi} Lyz2^tm1(cre)Ifo/Lyz2⁺ (involves: 129P2/OlaHsd * 129S4/SvJaeSor * BcA17/Skmn * C57BL/6N)	abnormal circulating chemokine level	J:282597
	increased circulating CXCL10 level	J:282597
	increased circulating interleukin-6 level	J:282597
	increased circulating interleukin-10 level	J:282597
	increased circulating tumor necrosis factor level	J:282597
Cys1^cpk/Cys1^cpk (B6(Cg)-Cys1^cpk/J)	colorless urine	J:6718
Cys1^cpk/Cys1^cpk (B6(Cg)-Cys1^cpk/J)	increased blood urea nitrogen level	J:9290, J:6718
Cys1^cpk/Cys1^cpk (B6(Cg)-Cys1^cpk/JUnc)	colorless urine	J:7202
	increased blood urea nitrogen level	J:7202
	increased circulating creatinine level	J:7202
Cys1^cpk/Cys1^cpk (involves: C57BL/6J * CD-1)	increased blood urea nitrogen level	J:33739
Cys1^cpk/Cys1^cpk (C.B6(Cg)-Cys1^cpk)	increased blood urea nitrogen level	J:99616
Cys1^cpk/Cys1^cpk (D2J.B6(Cg)-Cys1^cpk)	increased blood urea nitrogen level	J:99620
Cys1^cpk/Cys1^cpk (D2J.B6(Cg)-Cys1^cpk)	increased circulating creatinine level	J:99620
Cysltr2^tm1Ykn/Cysltr2^tm1Ykn (C57BL/6-Cysltr2^tm1Ykn)	abnormal prostaglandin level	J:94488
Cystm1^{tm1b(EUCOMM)Hmgu}/Cystm1^{tm1b(EUCOMM)Hmgu} (C57BL/6N-Cystm1^{tm1b(EUCOMM)Hmgu}/Ieg)	decreased respiratory quotient	J:211773
	increased circulating alkaline phosphatase level	J:211773
Cyth3^{tm2a(KOMP)Wtsi}/Cyth3^{tm2a(KOMP)Wtsi} (C57BL/6N-Cyth3^{tm2a(KOMP)Wtsi})	abnormal bile salt homeostasis	J:272118
	decreased circulating glucose level	J:272118
	decreased circulating triglyceride level	J:272118
	decreased liver glycogen level	J:272118
	decreased liver triglyceride level	J:272118
	decreased susceptibility to diet-induced obesity	J:272118
	insulin resistance	J:272118
D6Wsu163e^{tm1b(EUCOMM)Wtsi}/D6Wsu163e^{tm1b(EUCOMM)Wtsi} (C57BL/6N-D6Wsu163e^{tm1b(EUCOMM)Wtsi}/Wtsi)	decreased circulating glucose level	J:211773
	increased circulating alkaline phosphatase level	J:211773
	increased circulating cholesterol level	J:211773
	increased circulating fructosamine level	J:211773
	increased circulating HDL cholesterol level	J:211773
	increased circulating LDL cholesterol level	J:211773
	increased circulating serum albumin level	J:211773
	increased circulating total protein level	J:211773
D7Ertd443e^{tm2a(KOMP)Wtsi}/D7Ertd443e^{tm2a(KOMP)Wtsi} (C57BL/6N-D7Ertd443e^{tm2a(KOMP)Wtsi}/Wtsi)	increased blood urea nitrogen level	J:211773
	increased circulating alanine transaminase level	J:211773
	increased circulating creatinine level	J:211773
D630045J12Rik^{tm1b(KOMP)Wtsi}/D630045J12Rik^{tm1b(KOMP)Wtsi} (C57BL/6N-D630045J12Rik^{tm1b(KOMP)Wtsi}/Tcp)	decreased circulating triglyceride level	J:211773
	improved glucose tolerance	J:211773
	increased fasting circulating glucose level	J:211773
D930028M14Rik^{tm1a(EUCOMM)Wtsi}/D930028M14Rik^{tm1a(EUCOMM)Wtsi} (C57BL/6N-D930028M14Rik^{tm1a(EUCOMM)Wtsi}/Wtsi)	retropleural edema	J:239583
Daam1^{Gt(RRT390)Byg}/Daam1^{Gt(RRT390)Byg} (involves: 129P2/OlaHsd * C57BL/6J)	cyanosis	J:167714
	pericardial effusion	J:167714
Daam1^{tm1b(EUCOMM)Hmgu}/Daam1⁺ (C57BL/6N-Daam1^{tm1b(EUCOMM)Hmgu}/H)	increased blood urea nitrogen level	J:211773
	increased circulating amylase level	J:211773
Daam2^{tm1a(KOMP)Wtsi}/Daam2^{tm1a(KOMP)Wtsi} (C57BL/6N-Daam2^{tm1a(KOMP)Wtsi}/Wtsi)	increased circulating alkaline phosphatase level	J:211773
	increased fasting circulating glucose level	J:211773
Daam2^{tm1b(KOMP)Wtsi}/Daam2^{tm1b(KOMP)Wtsi} (C57BL/6N-Daam2^{tm1b(KOMP)Wtsi}/Wtsi)	increased circulating alanine transaminase level	J:211773
	increased circulating amylase level	J:211773
	increased circulating aspartate transaminase level	J:211773
	increased circulating phosphate level	J:211773
Dab2^tm1Cpr/Dab2^tm1.1Cpr Meox2^tm1(cre)Sor/Meox2⁺ (involves: 129S4/SvJaeSor * C57BL/6)	increased urine protein level	J:75911
Dab2^tm2.1Xxx/Dab2^tm2.2Xxx Edil3^{Tg(Sox2-cre)1Amc}/Edil3⁺ (involves: 129S4/SvJaeSor * 129X1/SvJ * C57BL/6 * CBA)	increased circulating cholesterol level	J:205046
	increased circulating LDL cholesterol level	J:205046
Dach1^{tm1b(KOMP)Wtsi}/Dach1⁺ (B6N(Cg)-Dach1^{tm1b(KOMP)Wtsi}/J)	increased circulating alanine transaminase level	J:211773
	increased circulating chloride level	J:211773
Dach1^tm1Krs/Dach1^tm1Krs (involves: 129P2/OlaHsd)	cyanosis	J:81143
Dach1^tm1Mrd/Dach1^tm1Mrd (involves: 129S7/SvEvBrd)	cyanosis	J:67361
Dach1^tm1Mrd/Dach1^tm1Mrd (involves: 129S7/SvEvBrd * C57BL/6)	cyanosis	J:67361
Dach2^{em1(IMPC)Ccpcz}/Dach2^{em1(IMPC)Ccpcz} (C57BL/6NCrl-Dach2^{em1(IMPC)Ccpcz}/Ccpcz)	increased circulating calcium level	J:211773
Dact3^{tm1b(KOMP)Wtsi}/Dact3^{tm1b(KOMP)Wtsi} (C57BL/6N-Dact3^{tm1b(KOMP)Wtsi}/Wtsi)	decreased circulating serum albumin level	J:211773
	improved glucose tolerance	J:211773
Dad1^tm1Wnt/Dad1^tm1Wnt (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	hydropic allantois	J:77517
Dag1^tm1.1Swin/Dag1^tm1.1Swin Dmd^mdx/Y (involves: 129S4/SvJae * C57BL/6 * C57BL/10ScSn)	increased circulating creatine kinase level	J:187750
Dag1^tm1.1Swin/Dag1^tm1.1Swin Dmd^mdx/Dmd^mdx (involves: 129S4/SvJae * C57BL/6 * C57BL/10ScSn)	increased circulating creatine kinase level	J:187750
Dag1^tm2Kcam/Dag1^tm2Kcam Tg(Ckmm-cre)5Khn/0 (involves: 129S1/Sv * 129X1/SvJ * FVB)	increased circulating creatine kinase level	J:78838
Dagla^tm1Pado/Dagla^tm1Pado (C57BL/6-Dagla^tm1Pado)	abnormal lipid level	J:157850
Daglb^{Gt(OST195261)Lex}/Daglb^{Gt(OST195261)Lex} (B6.129S5-Daglb^{Gt(OST195261)Lex})	abnormal lipid level	J:157850
Dao^G181R/Dao^G181R (DDY-Dao1^G181R)	abnormal circulating amino acid level	J:21994
	decreased circulating glutamic acid level	J:21994
	decreased circulating glycine level	J:21994
	decreased circulating taurine level	J:21994
	decreased glycine level	J:21994
	increased circulating alanine level	J:21994
	increased circulating serine level	J:21994
	increased glutamic acid level	J:21994
	increased glutamine level	J:21994
Dao^tm1Ttsu/Dao^tm1Ttsu (129S/SvEv-Dao^tm1Ttsu)	increased circulating serine level	J:228710
Dao^tm1Ttsu/Dao^tm1Ttsu (129S/SvEv-Dao^tm1Ttsu)	increased serine level	J:228710
Dap3^em1(IMPC)J/Dap3⁺ (C57BL/6NJ-Dap3^em1(IMPC)J/Mmjax)	increased circulating alkaline phosphatase level	J:211773
Dap^{tm1a(KOMP)Mbp}/Dap^{tm1a(KOMP)Mbp} (C57BL/6N-Dap^{tm1a(KOMP)Mbp}/Wtsi)	increased circulating free fatty acids level	J:211773
Dars2^{tm1a(KOMP)Wtsi}/Dars2⁺ (C57BL/6N-Dars2^{tm1a(KOMP)Wtsi}/Wtsi)	increased circulating LDL cholesterol level	J:211773
Datd^DBA/2J/? (involves: C57BL/6J * DBA/2J)	abnormal circulating protein level	J:70962
Dbf/Dbf (involves: 101/H * C3H/HeH)	edema	J:39106
Dbh^tm1Rpa/Dbh^tm1Rpa (either: (involves: 129S7/SvEvBrd * 129/SvCpj) or (involves: 129S7/SvEvBrd * C57BL/6J))	absent circulating adrenaline	J:24414
	absent circulating noradrenaline	J:24414
	increased circulating corticosterone level	J:97566
	increased dopamine level	J:24414
Dbh^tm1Rpa/Dbh^tm1Rpa (involves: 129S7/SvEvBrd * 129/SvCPJ * C57BL/6J)	abnormal glucose homeostasis	J:85772
	decreased circulating glucagon level	J:85772
	decreased circulating glucose level	J:85772
	decreased glucagon secretion	J:85772
	increased circulating corticosterone level	J:85772
	increased circulating insulin level	J:85772
	insulin resistance	J:85772
Dbh^tm2(Th)Rpa/Dbh⁺ Th^tm1Rpa/Th^tm1Rpa (involves: 129S7/SvEvBrd)	decreased dopamine level	J:30404
Dbh^tm2(Th)Rpa/Dbh⁺ Th^tm5Rpa/Th^tm5Rpa (involves: 129S4/SvJaeSor * C57BL/6)	decreased dopamine level	J:110806
Dbh^tm2(Th)Rpa/Dbh⁺ Th^tm5Rpa/Th^tm5Rpa (involves: 129S4/SvJaeSor * C57BL/6)	decreased dopamine level	J:110806
Dbh^tm2(Th)Rpa/Dbh⁺ Th^tm5Rpa/Th^tm5Rpa (involves: 129S4/SvJaeSor)	decreased dopamine level	J:154773
Dbi^tm1Smdp/Dbi^tm1Smdp (B6JBomTac.129-Dbi^tm1Smdp)	abnormal cholesterol homeostasis	J:168744
	increased circulating cholesterol level	J:168744
	increased liver cholesterol level	J:168744
	increased liver triglyceride level	J:168744
Dbi^tm1Smdp/Dbi^tm1Smdp (involves: 129S1/Sv * 129X1/SvJ)	increased liver cholesterol level	J:204137
Dbi^tm1Smdp/Dbi^tm1Smdp (involves: 129S1/Sv * 129X1/SvJ)	increased liver triglyceride level	J:204137
Dbi^tm2.1Smdp/Dbi^tm2.2Smdp Tg(KRT14-cre)1Cgn/0 (involves: C57BL/6 * DBA/2 * FVB/N)	impaired skin barrier function	J:204137
	increased liver cholesterol level	J:204137
Dbil5^{tm1(KOMP)Wtsi}/Dbil5^{tm1(KOMP)Wtsi} (C57BL/6N-Dbil5^{tm1(KOMP)Wtsi}/Nju)	increased circulating alkaline phosphatase level	J:211773
	increased circulating glucose level	J:211773
	increased circulating total protein level	J:211773
Dbm1^A/J/Dbm1^A/J Ins2^Akita/Ins2⁺ (involves: A/J * C57BL/6J * C57BL/6NSlc)	increased circulating glucose level	J:112869
	increased circulating insulin level	J:112869
Dbm2^C57BL/6J/? (involves: A/J * C57BL/6J)	abnormal glucose homeostasis	J:112869
Dbm2^C57BL/6J/? (involves: A/J * C57BL/6J)	increased circulating glucose level	J:112869
Dbm3^C57BL/6J/? Ins2^Akita/Ins2⁺ (involves: A/J * C57BL/6J * C57BL/6NSlc)	abnormal circulating glucose level	J:112869
Dbm4^C57BL/6J/? Ins2^Akita/Ins2⁺ (involves: A/J * C57BL/6J * C57BL/6NSlc)	abnormal circulating glucose level	J:112869
Dbmc1^BTBR/Dbmc1^BTBR Lep^ob/Lep^ob (involves: BTBR * C57BL/6J)	abnormal enzyme/coenzyme level	J:119260
Dbmc1^BTBR/Dbmc1^C57BL/6J Lep^ob/Lep^ob (involves: BTBR * C57BL/6J)	abnormal enzyme/coenzyme level	J:119260
Dbmc2^BTBR/Dbmc2^BTBR Lep^ob/Lep^ob (involves: BTBR * C57BL/6J)	abnormal enzyme/coenzyme level	J:119260
Dbmc2^BTBR/Dbmc2^C57BL/6J Lep^ob/Lep^ob (involves: BTBR * C57BL/6J)	abnormal enzyme/coenzyme level	J:119260
Dbmc3^BTBR/Dbmc3^C57BL/6J Lep^ob/Lep^ob (involves: BTBR * C57BL/6J)	abnormal enzyme/coenzyme level	J:119260
Dbmc3^C57BL/6J/Dbmc3^C57BL/6J Lep^ob/Lep^ob (involves: BTBR * C57BL/6J)	abnormal enzyme/coenzyme level	J:119260
Dbn1^{tm1a(KOMP)Wtsi}/Dbn1^{tm1a(KOMP)Wtsi} (C57BL/6N-Dbn1^{tm1a(KOMP)Wtsi}/Wtsi)	decreased circulating alanine transaminase level	J:175295
	decreased circulating aspartate transaminase level	J:175295
	decreased circulating calcium level	J:175295
	decreased circulating cholesterol level	J:175295
	decreased circulating fructosamine level	J:175295
	decreased circulating HDL cholesterol level	J:175295
	decreased circulating LDL cholesterol level	J:175295
	decreased circulating serum albumin level	J:175295
	decreased circulating total protein level	J:175295
	increased circulating chloride level	J:175295
Dbn1^{tm1b(KOMP)Wtsi}/Dbn1⁺ (C57BL/6N-Dbn1^{tm1b(KOMP)Wtsi}/Wtsi)	increased circulating chloride level	J:211773
	increased circulating creatinine level	J:211773
	increased circulating magnesium level	J:211773
Dbn1^{tm1b(KOMP)Wtsi}/Dbn1⁺ (C57BL/6N-Dbn1^{tm1b(KOMP)Wtsi}/Ucd)	increased circulating phosphate level	J:211773
Dbn1^{tm1b(KOMP)Wtsi}/Dbn1⁺ (C57BL/6N-Dbn1^{tm1b(KOMP)Wtsi}/J)	decreased circulating free fatty acids level	J:211773
	decreased circulating serum albumin level	J:211773
Dbn1^{tm1b(KOMP)Wtsi}/Dbn1⁺ (C57BL/6N-Dbn1^{tm1b(KOMP)Wtsi}/Rbrc)	increased circulating alkaline phosphatase level	J:211773
Dbn1^{tm1b(KOMP)Wtsi}/Dbn1⁺ (C57BL/6N-Dbn1^{tm1b(KOMP)Wtsi}/Bay)	decreased circulating cholesterol level	J:211773
	decreased circulating serum albumin level	J:211773
Dbn1^{tm1b(KOMP)Wtsi}/Dbn1⁺ (C57BL/6NCrl-Dbn1^{tm1b(KOMP)Wtsi}/Wtsi)	increased fasting circulating glucose level	J:211773
Dbndd2^{tm1b(EUCOMM)Wtsi}/Dbndd2^{tm1b(EUCOMM)Wtsi} (C57BL/6N-Dbndd2^{tm1b(EUCOMM)Wtsi}/Tcp)	decreased circulating creatinine level	J:211773
	decreased circulating serum albumin level	J:211773
Dbnl^{tm1b(KOMP)Wtsi}/Dbnl^{tm1b(KOMP)Wtsi} (C57BL/6N-Dbnl^{tm1b(KOMP)Wtsi}/Orl)	decreased circulating alkaline phosphatase level	J:211773
	decreased circulating cholesterol level	J:211773
	decreased circulating HDL cholesterol level	J:211773
	decreased circulating serum albumin level	J:211773
	decreased circulating total protein level	J:211773
	decreased circulating triglyceride level	J:211773
	increased circulating glucose level	J:211773
Dbnl^tm1Jwnd/Dbnl^tm1Jwnd (involves: BALB/c)	generalized edema	J:109363
Dbp^tm1Schb/Dbp^tm1Schb Hlf^tm1Schb/Hlf^tm1Schb Tef^tm1Schb/Tef^tm1Schb (involves: 129P2/OlaHsd * 129S2/SvPas)	decreased circulating aldosterone level	J:164398
	decreased dopamine level	J:90854
	decreased serotonin level	J:90854
	increased circulating alanine transaminase level	J:129710
Dbr1^{tm1.1(KOMP)Vlcg}/Dbr1⁺ (C57BL/6N-Dbr1^{tm1.1(KOMP)Vlcg}/J)	decreased urine magnesium level	J:211773
Dbsq3^C3H/HeJ/Dbsq3^C3H/HeJ Lepr^db/Lepr⁺ (involves: C3H/HeJ * C57BLKS)	increased circulating glucose level	J:116038
Dbsq3^C57BLKS/J/Dbsq3^C3H/HeJ Lepr^db/Lepr⁺ (involves: C3H/HeJ * C57BLKS)	increased circulating glucose level	J:116038
Dbsty1^NZO/HlLt/Dbsty1^NON/ShiLtJ (involves: NON/Lt * NZO/HlLt)	hyperglycemia	J:65256
	increased circulating insulin level	J:65256
Dbsty1^NZO/HlLt/Dbsty1^NZO/HlLt (involves: NON/Lt * NZO/HlLt)	hyperglycemia	J:65256
	increased circulating insulin level	J:65256
Dbsty3^NON/ShiLtJ/Dbsty3^NZO/HlLt (involves: NON/Lt * NZO/HlLt)	insulin resistance	J:65256
Dbsty3^NZO/HlLt/Dbsty3^NZO/HlLt (involves: NON/Lt * NZO/HlLt)	insulin resistance	J:65256
Dbsty4^NZO/HlLt/Dbsty4^NON/ShiLtJ (involves: NON/Lt * NZO/HlLt)	hyperglycemia	J:65256
Dbsty4^NZO/HlLt/Dbsty4^NZO/HlLt (involves: NON/Lt * NZO/HlLt)	hyperglycemia	J:65256
Dbt^tm1Geh/Dbt^tm1Geh (involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)	abnormal circulating amino acid level	J:119973
	aminoaciduria	J:119973
	decreased circulating alanine level	J:119973
	decreased circulating glutamic acid level	J:119973
	decreased circulating glutamine level	J:119973
Dbt^tm1Geh/Dbt^tm1Geh Tg(tetO-DBT)525AGeh/0 Tg(Cebpb-tTA)5Bjd/0 (involves: 129S1/Sv * 129X1/SvJ * C57BL/6J * FVB * NMRI)	abnormal circulating amino acid level	J:119973
Dbt^tm1Geh/Dbt^tm1Geh Tg(tetO-DBT)A1Geh/0 Tg(Cebpb-tTA)5Bjd/0 (involves: 129S1/Sv * 129X1/SvJ * C57BL/6J * FVB * NMRI)	abnormal circulating amino acid level	J:119973
Dbts1^SM/J/? (involves: LG/J * SM/J)	impaired glucose tolerance	J:94605
Dbts2^SM/J/? (involves: LG/J * SM/J)	impaired glucose tolerance	J:94605
Dbx1^tm1Tmj/Dbx1^tm1Tmj (involves: 129P2/OlaHsd * C57BL/6)	cyanosis	J:165285
Dcaf7^{tm1b(EUCOMM)Wtsi}/Dcaf7⁺ (C57BL/6N-Dcaf7^{tm1b(EUCOMM)Wtsi}/Ics)	increased circulating total protein level	J:211773
Dcaf8^{em1(IMPC)Ccpcz}/Dcaf8^{em1(IMPC)Ccpcz} (C57BL/6N-Dcaf8^{em1(IMPC)Ccpcz}/Ccpcz)	increased blood urea nitrogen level	J:211773
	increased circulating potassium level	J:211773
Dcbld2^{tm1a(KOMP)Wtsi}/Dcbld2^{tm1a(KOMP)Wtsi} (C57BL/6N-Dcbld2^{tm1a(KOMP)Wtsi}/Wtsi)	decreased circulating fructosamine level	J:211773
Dclk1^{tm1a(EUCOMM)Wtsi}/Dclk1^{tm1a(EUCOMM)Wtsi} (C57BL/6N-Dclk1^{tm1a(EUCOMM)Wtsi}/Wtsi)	decreased circulating magnesium level	J:211773
	increased circulating aspartate transaminase level	J:211773
Dcp2^tm1Smoc/Dcp2^tm1Smoc Ndor1^{Tg(UBC-cre/ERT2)1Ejb}/Ndor1⁺ (involves: 129S/SvEv * C57BL/6)	decreased circulating testosterone level	J:292283
	increased circulating follicle stimulating hormone level	J:292283
	increased circulating luteinizing hormone level	J:292283
Dct^{tm1b(KOMP)Mbp}/Dct^{tm1b(KOMP)Mbp} (C57BL/6N-Dct^{tm1b(KOMP)Mbp}/Ucd)	increased circulating bilirubin level	J:211773
	increased circulating phosphate level	J:211773
Dctn1^{tm1a(EUCOMM)Wtsi}/Dctn1⁺ (C57BL/6N-Dctn1^{tm1a(EUCOMM)Wtsi}/Wtsi)	increased circulating creatinine level	J:211773
Dctn4^{em1(IMPC)Wtsi}/Dctn4⁺ (C57BL/6N-Dctn4^{em1(IMPC)Wtsi}/Wtsi)	increased circulating free fatty acids level	J:211773
Dcun1d3^{em1(IMPC)Wtsi}/Dcun1d3^{em1(IMPC)Wtsi} (C57BL/6N-Dcun1d3^{em1(IMPC)Wtsi}/WtsiIeg)	decreased circulating cholesterol level	J:211773
	decreased circulating glucose level	J:211773
	decreased circulating HDL cholesterol level	J:211773
	decreased fasting circulating glucose level	J:211773
	improved glucose tolerance	J:211773
	increased circulating alkaline phosphatase level	J:211773
	increased circulating bilirubin level	J:211773
Dcun1d5^em1(IMPC)H/Dcun1d5^em1(IMPC)H (C57BL/6N-Dcun1d5^em1(IMPC)H/H)	increased circulating serum albumin level	J:211773
	increased circulating total protein level	J:211773
Dcx^{tm1a(EUCOMM)Wtsi}/Y (C57BL/6N-Dcx^{tm1a(EUCOMM)Wtsi}/Wtsi)	increased circulating chloride level	J:211773
	increased circulating insulin level	J:211773
	increased circulating sodium level	J:211773
Ddah1^tm1.1Geno/Ddah1^tm1.1Geno (Not Specified)	abnormal amino acid level	J:234529
Ddah1^tm1.1Geno/Ddah1^tm1.1Geno (Not Specified)	abnormal circulating amino acid level	J:234529
Ddah1^tm1.1Yjch/Ddah1^tm1.1Yjch (involves: 129S1/Sv * 129S4/SvJae)	abnormal amino acid level	J:182373
	abnormal circulating amino acid level	J:182373
	abnormal nitric oxide homeostasis	J:182373
Ddah1^tm1Pval/Ddah1⁺ (involves: 129X1/SvJ * C57BL/6)	abnormal circulating amino acid level	J:121719
Ddah1^tm1Pval/Ddah1⁺ (involves: 129X1/SvJ * C57BL/6)	abnormal nitric oxide homeostasis	J:121719
Ddah1^tm1Yjch/Ddah1^tm1Yjch Tg(Tek-cre)12Flv/0 (involves: 129S1/Sv * C57BL/6J)	abnormal amino acid level	J:168130
	abnormal circulating amino acid level	J:168130
	abnormal nitric oxide homeostasis	J:168130
Ddc^tm1.1Nwlh/Ddc^tm1.1Nwlh (involves: C57BL/6)	abnormal dopamine level	J:197646
	abnormal noradrenaline level	J:197646
	decreased dopamine level	J:197646
	decreased serotonin level	J:197646
Ddc^tm1.1Rhrs/Ddc^tm1.1Rhrs Tg(Ggt1-cre)M3Egn/0 (involves: 129 * C57BL/6 * SJL)	albuminuria	J:175630
	decreased circulating aldosterone level	J:175630
	decreased dopamine level	J:175630
	increased circulating creatinine level	J:175630
Ddc^tm1.1Rhrs/Ddc^tm1.1Rhrs Tg(Ggt1-cre)M3Egn/0 (129.Cg-Ddc^tm1.1Rhrs Tg(Ggt1-cre)M3Egn)	albuminuria	J:175630
	decreased circulating aldosterone level	J:175630
	decreased dopamine level	J:175630
	increased circulating creatinine level	J:175630
Ddc^tm1Umon/Ddc^tm1Umon (involves: 129S/SvEv * C57BL/6 * FVB/N)	decreased dopamine level	J:250494
	decreased serotonin level	J:250494
	impaired adaptive thermogenesis	J:250494
Ddhd2^tm1Crv/Ddhd2^tm1Crv (involves: C57BL/6)	abnormal lipid level	J:216446
Ddhd2^tm1Crv/Ddhd2^tm1Crv (involves: C57BL/6)	increased triglyceride level	J:216446
Ddi2^{tm1b(EUCOMM)Hmgu}/Ddi2⁺ (C57BL/6N-Ddi2^{tm1b(EUCOMM)Hmgu}/Ccpcz)	impaired glucose tolerance	J:211773
Ddit3^{tm1.1(KOMP)Vlcg}/Ddit3^{tm1.1(KOMP)Vlcg} (C57BL/6N-Ddit3^{tm1.1(KOMP)Vlcg}/Ucd)	increased circulating aspartate transaminase level	J:211773
Ddit3^tm2.1Dron/Ddit3^tm2.1Dron (B6.129S(Cg)-Ddit3^tm2.1Dron/J)	decreased energy expenditure	J:214136
	impaired glucose tolerance	J:214136
	increased cholesterol level	J:214136
	increased susceptibility to diet-induced obesity	J:214136
	insulin resistance	J:214136
Ddo^tm1Rdl/Ddo^tm1Rdl (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	increased aspartic acid level	J:109184
Ddo^tm1Snyd/Ddo^tm1Snyd (involves: 129S4/SvJae)	increased aspartic acid level	J:106267
Ddr1^tm1Wfv/Ddr1^tm1Wfv (involves: 129S1/Sv * 129X1/SvJ * ICR)	erythrocyturia	J:101769
	increased urine protein level	J:101769
Ddr2^slie/Ddr2^slie (BKSChpLt.Cg-Tg(Ins2-Cpe)1Lt Cpe^fat/LtJng)	decreased blood urea nitrogen level	J:134371
	decreased circulating estradiol level	J:134371
	decreased circulating progesterone level	J:134371
	decreased circulating testosterone level	J:134371
	increased circulating glucose level	J:134371
Ddr2^{tm1.1(cre/Esr1)Rcow}/Ddr2^{tm1.1(cre/Esr1)Rcow} (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	decreased collagen level	J:214642
Ddx3x^tm1.1Lyou/Y Edil3^{Tg(Sox2-cre)1Amc}/Edil3⁺ (involves: 129 * C57BL/6 * CBA)	pericardial effusion	J:231798
Ddx3x^tm1.2Lyou/Ddx3x⁺ (involves: 129 * C57BL/6)	edema	J:231798
Ddx6^em1(IMPC)Mbp/Ddx6⁺ (C57BL/6N-Ddx6^em1(IMPC)Mbp/Ucd)	increased circulating total protein level	J:211773
Ddx20^tm1Yosa/Ddx20⁺ (involves: 129/Sv * C57BL/6)	decreased circulating adrenocorticotropin level	J:136021
Ddx39a^{tm1b(KOMP)Wtsi}/Ddx39a⁺ (C57BL/6N-Ddx39a^{tm1b(KOMP)Wtsi}/Bay)	increased circulating phosphate level	J:211773
Ddx42^{tm1b(EUCOMM)Wtsi}/Ddx42⁺ (C57BL/6N-Ddx42^{tm1b(EUCOMM)Wtsi}/Wtsi)	increased circulating thyroxine level	J:211773
Ddx46^em1Caox/Ddx46⁺ (involves: C57BL/6J)	increased circulating interferon-beta level	J:271836
Ddx51^{tm1a(KOMP)Wtsi}/Ddx51⁺ (C57BL/6N-Ddx51^{tm1a(KOMP)Wtsi}/Wtsi)	decreased circulating cholesterol level	J:211773
Ddx60^{tm1b(EUCOMM)Wtsi}/Ddx60^{tm1b(EUCOMM)Wtsi} (involves: C57BL/6N)	decreased circulating interferon-beta level	J:228452
	increased circulating interferon-alpha level	J:228452
Decr1^tm1Jkh/Decr1^tm1Jkh (B6.129X1-Decr1^tm1Jkh)	decreased circulating glucose level	J:151622
	impaired adaptive thermogenesis	J:151622
	increased fatty acids level	J:151622
Decr2^{tm1b(EUCOMM)Wtsi}/Decr2^{tm1b(EUCOMM)Wtsi} (C57BL/6N-Decr2^{tm1b(EUCOMM)Wtsi}/Ieg)	increased circulating creatinine level	J:211773
Defb14^{tm1b(KOMP)Wtsi}/Defb14^{tm1b(KOMP)Wtsi} (C57BL/6N-Defb14^{tm1b(KOMP)Wtsi}/Wtsi)	decreased circulating glycerol level	J:211773
Defb20^{tm1b(EUCOMM)Hmgu}/Defb20^{tm1b(EUCOMM)Hmgu} (C57BL/6N-Defb20^{tm1b(EUCOMM)Hmgu}/J)	decreased fasting circulating glucose level	J:211773
Degs1^{Gt(OST368559)Lex}/Degs1⁺ (involves: 129S5/SvEvBrd)	abnormal ceramide level	J:203554
Degs1^{Gt(OST368559)Lex}/Degs1⁺ (involves: 129S5/SvEvBrd)	increased insulin sensitivity	J:203554
Degs1^{Gt(OST368559)Lex}/Degs1^{Gt(OST368559)Lex} (involves: 129S5/SvEvBrd)	abnormal ceramide level	J:203554
	abnormal homeostasis	J:203554
	increased circulating alanine transaminase level	J:203554
	increased circulating alkaline phosphatase level	J:203554
	increased circulating bilirubin level	J:203554
Degs2^tm1Akih/Degs2^tm1Akih (Not Specified)	decreased ceramide level	J:335270
Del(1)1Brk/Steap3^tm1.1Mdf (involves: 129S4/SvJae * 129S6/SvEvTac * C57BL/6J * CBA/J)	abnormal iron homeostasis	J:103440
	increased liver iron level	J:103440
Del(1)1Brk/Del(1)1Brk (involves: 129S6/SvEvTac * C57BL/6J * CBA/J)	abnormal circulating iron level	J:100202
	abnormal iron homeostasis	J:100202
	abnormal iron level	J:100202
	abnormal liver iron level	J:100202
Del(1)1Brk/Del(1)1Brk (involves: 129S4/SvJae * 129S6/SvEvTac * C57BL/6J * CBA/J)	abnormal iron homeostasis	J:103440
	increased liver iron level	J:103440
Del(2Duoxa2-Duoxa1)1Sref/Del(2Duoxa2-Duoxa1)1Sref (involves: 129S6/SvEvTac * C57BL/6J)	decreased circulating thyroxine level	J:205165
	decreased circulating triiodothyronine level	J:205165
	increased circulating thyroid-stimulating hormone level	J:205165
Del(2Nespas-Gnas)1Hju/+ (either: (involves: 129S4/SvJae) or (involves: 129S4/SvJae * C57BL/6J))	skin edema	J:160293
Del(4Cyp2j13-Cyp2j5)1Brs/Del(4Cyp2j13-Cyp2j5)1Brs (involves: C57BL/6)	abnormal oxygen level	J:223128
Del(4Sdr16c5-Sdr16c6)1Nyk/Del(4Sdr16c5-Sdr16c6)1Nyk (B6.Cg-Del(4Sdr16c5-Sdr16c6)1Nyk)	eyelid edema	J:283063
Del(6Dlx6-Dlx5)1Tlu/+ Mef2c^tm1Eno/Mef2c⁺ (involves: 129S7/SvEvBrd)	cyanosis	J:122483
Del(6Ephb6-Trpv6)1Mhed/Del(6Ephb6-Trpv6)1Mhed (involves: 129S/SvEv)	abnormal calcium ion homeostasis	J:136038
	abnormal circulating calcium level	J:133151
	abnormal mineral level	J:133151
	abnormal urine osmolality	J:133151
	abnormal vitamin D level	J:133151
	increased circulating parathyroid hormone level	J:136038, J:133151
Del(6Slco1b2-Slco1a5)1Nki/+ (involves: 129P2/OlaHsd * C57BL/6)	abnormal blood homeostasis	J:163765
	abnormal urine homeostasis	J:163765
	bilirubinuria	J:163765
	decreased urine protein level	J:163765
	increased bile salt level	J:163765
	increased circulating bilirubin level	J:163765
	increased circulating HDL cholesterol level	J:163765
	increased circulating triglyceride level	J:163765
Del(6Snca)1Slab/Del(6Snca)1Slab Tg(Th-SNCA)1Mgsp/0 (involves: C57BL/6J C57BL/6JOlaHsd * CBA/Ca)	decreased dopamine level	J:108310
Del(7)Tyr^c-3H/Del(7)Tyr^c-3H (involves: 101/H * C3H/HeH)	decreased circulating glucose level	J:5063
Del(7)Tyr^c-3H/Del(7)Tyr^c-3H (involves: 101/H * C3H/HeH)	hypoglycemia	J:5063
Del(7Ffar2-Ffar3)1Soff/Del(7Ffar2-Ffar3)1Soff (involves: 129S4/SvJae * C57BL/6)	abnormal insulin secretion	J:227939
	decreased circulating free fatty acids level	J:227939
	improved glucose tolerance	J:227939
	increased circulating insulin level	J:227939
Del(7Herc2-Mkrn3)13FRdni/+ (involves: C57BL/6 * CD-1 * SJL)	dehydration	J:56614
Del(7Ins2-Tel)1Lef/+ (involves: 129S1/Sv * 129X1/SvJ * ICR)	pericardial effusion	J:130399
Del(7Saa1-Saa2)1Itl/Del(7Saa1-Saa2)1Itl (involves: 129S6/SvEvTac * C57BL/6NTac)	abnormal cholesterol homeostasis	J:165605
	increased circulating cholesterol level	J:165605
	increased circulating phospholipid level	J:165605
Del(8A4-B3)7H/+ (involves: 101/H * C3H/HeH)	chylous ascites	J:123074
	extremity edema	J:123074, J:3564
	lymphedema	J:123074
Del(8Col4a1-Col4a2)1Epo/Del(8Col4a1-Col4a2)1Epo (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	hemopericardium	J:89190
Del(8Defb1-Defb13)1Jrdo/Del(8Defb1-Defb13)1Jrdo (involves: 129P2/OlaHsd * C57BL/6N)	abnormal calcium ion homeostasis	J:204187
Del(8Npy5r-Npy1r)1Snby/Del(8Npy5r-Npy1r)1Snby (involves: 129 * C57BL/6)	decreased energy expenditure	J:225097
	decreased respiratory quotient	J:225097
	increased energy expenditure	J:225097
Del(9Apoa1-Apoa4)1Hmez/Del(9Apoa1-Apoa4)1Hmez (involves: 129P2/OlaHsd * C57BL/6)	decreased circulating cholesterol level	J:109005
	decreased circulating HDL cholesterol level	J:109005
	decreased circulating triglyceride level	J:109005
Del(9Casp1-Casp4)1Bhk/Del(9Casp1-Casp4)1Bhk (129-Del(9Casp1-Casp4)1Bhk)	decreased lactate dehydrogenase level	J:189777
Del(10Prmt2-Col6a1)1Yah/+ (involves: 129P2/OlaHsd * C57BL/6 * SJL)	abnormal cytokine level	J:167506
Del(11Irf1-D11Mit23)1Rub/+ (129/Sv-Del(11Irf1-D11Mit23)1Rub)	decreased circulating carnitine level	J:60187
	impaired lipolysis	J:60187
	increased circulating VLDL triglyceride level	J:60187
Del(11Irf1-D11Mit23)1Rub/Del(11Irf1-D11Mit23)1Rub (129/Sv-Del(11Irf1-D11Mit23)1Rub)	decreased circulating carnitine level	J:60187
	impaired lipolysis	J:60187
	increased cardiac muscle triglyceride level	J:60187
	increased cholesterol level	J:60187
	increased circulating free fatty acids level	J:60187
	increased circulating triglyceride level	J:60187
	increased circulating VLDL triglyceride level	J:60187
	increased liver cholesterol level	J:60187
	increased liver triglyceride level	J:60187
Del(11Jmjd6-Mettl23)1Flv/Del(11Jmjd6-Mettl23)1Flv (involves: 129S6/SvEvTac * C57BL/6)	abnormal blood homeostasis	J:86771
	cyanosis	J:86771
Del(11Nme2-Nme1)1Zou/Del(11Nme2-Nme1)1Zou (involves: 129 * C57BL/6)	abnormal circulating iron level	J:146219
	abnormal circulating protein level	J:146219
	decreased circulating iron level	J:146219
Del(12Bdkrb2-Bdkrb1)1Mki/Del(12Bdkrb2-Bdkrb1)1Mki (involves: C57BL/6J)	decreased blood urea nitrogen level	J:121339
	increased blood urea nitrogen level	J:121339
	increased circulating creatinine level	J:121339
Del(13Naip1-Naip5)1Vnce/Del(13Naip1-Naip5)1Vnce (involves: C57BL/6)	decreased lactate dehydrogenase level	J:294930
Del(13Naip1-Naip5)1Vnce/Del(13Naip1-Naip5)1Vnce Nlrc4^em2Vnce/Nlrc4^em2Vnce (involves: C57BL/6)	decreased lactate dehydrogenase level	J:294930
Del(13Naip1-Naip5)1Vnce/Del(13Naip1-Naip5)1Vnce Nlrp3^tm1Vmd/Nlrp3^tm1Vmd (involves: C57BL/6J * C57BL/6N)	decreased lactate dehydrogenase level	J:294930
Del(15Krt7-Krt18)1Tmm/Del(15Krt7-Krt18)1Tmm (involves: 129S7/SvEvBrd * C57BL/6)	abnormal energy homeostasis	J:153804
Del(16Lipi-Usp25)1Dja/+ (involves: 129P2/OlaHsd * C57BL/6)	increased susceptibility to diet-induced obesity	J:184302
Del(17)T^hp/+ (involves: AKR/J * C57BL/Gr * CBA/Gr)	edema	J:31524
Del(17Abcg1-Cbs)2Yah/+ (B6.129P2-Del(17Abcg1-Cbs)2Yah)	increased circulating homocysteine level	J:154298
Del(17Abcg5-Abcg8)1Hobb/Del(17Abcg5-Abcg8)1Hobb (involves: 129S6/SvEvTac * C57BL/6)	abnormal cholesterol homeostasis	J:80679
	decreased circulating cholesterol level	J:80679
	decreased liver cholesterol level	J:80679
	increased circulating cholesterol level	J:80679
	increased circulating phytosterol level	J:80679
	increased intestinal phytosterol absorption	J:80679
	increased liver cholesterol level	J:80679
Del(17Trem1-Trem3)1Jkt/Del(17Trem1-Trem3)1Jkt (involves: 129P2/OlaHsd * BALB/cJ * C57BL/6)	abnormal chemokine level	J:194295
	abnormal circulating chemokine level	J:194295
	abnormal cytokine level	J:194295
	decreased body temperature	J:194295
	increased circulating alanine transaminase level	J:194295
	increased circulating interleukin-1 alpha level	J:194295
	increased circulating interleukin-6 level	J:194295
	increased circulating interleukin-10 level	J:194295
	increased circulating tumor necrosis factor level	J:194295
Del(MTmt-Tk-mt-Nd5)1Jiha (involves: C57BL/6J * CBA * DBA/2)	increased blood urea nitrogen level	J:65025
Del(MTmt-Tk-mt-Nd5)1Jiha (involves: C57BL/6J * CBA * DBA/2)	increased circulating creatinine level	J:65025
Del(MTmt-Tk-mt-Nd5)1Jiha (involves: C57BL/6J * CBA)	decreased circulating glucose level	J:92536
	increased blood urea nitrogen level	J:103743
	increased circulating insulin level	J:92536
	increased circulating lactate level	J:103743
	increased insulin secretion	J:92536
	lactic acidosis	J:115155
Del(MTmt-Tk-mt-Nd5)1Jiha (involves: C57BL/6JJcl * C57BL/6NCrlj * CBA/JNCrlj)	decreased circulating glucose level	J:199416
Dele1^{em2(IMPC)Ccpcz}/Dele1^{em2(IMPC)Ccpcz} (C57BL/6N-Dele1^{em2(IMPC)Ccpcz}/Ccpcz)	increased circulating potassium level	J:211773
Dennd5b^em1(IMPC)Tcp/Dennd5b^em1(IMPC)Tcp (C57BL/6N-Dennd5b^em1(IMPC)Tcp/Tcp)	decreased circulating cholesterol level	J:211773
	decreased circulating glucose level	J:211773
	decreased circulating HDL cholesterol level	J:211773
	decreased circulating total protein level	J:211773
	decreased circulating triglyceride level	J:211773
	improved glucose tolerance	J:211773
	increased circulating alkaline phosphatase level	J:211773
Dennd5b^em1Smgo/Dennd5b^em1Smgo (involves: C57BL/6 * CBA)	abnormal circulating lipid level	J:276600
	decreased circulating HDL cholesterol level	J:276600
	decreased liver cholesterol level	J:276600
	decreased liver free fatty acids level	J:276600
	increased circulating VLDL triglyceride level	J:276600
Dennd6b^{em1(IMPC)Hmgu}/Dennd6b^{em1(IMPC)Hmgu} (C57BL/6NCrl-Dennd6b^{em1(IMPC)Hmgu}/Ieg)	increased circulating lipase level	J:211773
Denr^{tm1b(KOMP)Wtsi}/Denr⁺ (C57BL/6N-Denr^{tm1b(KOMP)Wtsi}/Wtsi)	increased circulating alkaline phosphatase level	J:211773
Depdc5^{tm1b(EUCOMM)Hmgu}/Depdc5⁺ (C57BL/6N-Depdc5^{tm1b(EUCOMM)Hmgu}/H)	impaired glucose tolerance	J:211773
	increased circulating alkaline phosphatase level	J:211773
Deptor^tm1.1Mala/Deptor^tm1.1Mala Speer6-ps1^{Tg(Alb-cre)21Mgn}/0 (involves: 129S1/Sv * 129X1/SvJ * C57BL/6 x DBA)	decreased fasting circulating glucose level	J:275931
	decreased liver glycogen level	J:275931
	increased insulin sensitivity	J:275931
Derl2^tm1.2Hpl/Derl2^tm1.2Hpl (involves: BALB/cJ)	hypoglycemia	J:170650
Deup1^{tm1.1(KOMP)Vlcg}/Deup1^{tm1.1(KOMP)Vlcg} (C57BL/6N-Deup1^{tm1.1(KOMP)Vlcg}/MbpMmucd)	decreased blood urea nitrogen level	J:211773
	decreased circulating calcium level	J:211773
Dgat1^tm1Far/Dgat1^tm1Far (involves: 129S4/SvJae * C57BL/6J)	abnormal vitamin A level	J:147611
	decreased circulating glucose level	J:111346
	decreased circulating leptin level	J:111346
	decreased liver cholesterol level	J:111346
	decreased liver triglyceride level	J:111346
	decreased susceptibility to diet-induced obesity	J:61885
	improved glucose tolerance	J:111346
	increased insulin sensitivity	J:61885
	increased oxygen consumption	J:111346
Dgat1^tm1Ryyo/Dgat1^tm1Ryyo (involves: C57BL/6)	decreased circulating triglyceride level	J:155626
Dgat2^tm1Far/Dgat2^tm1Far (involves: 129S4/SvJae * C57BL/6J)	abnormal lipid level	J:88742
	abnormal phospholipid level	J:88742
	decreased body surface temperature	J:88742
	decreased circulating free fatty acids level	J:88742
	decreased circulating triglyceride level	J:88742
	decreased fatty acids level	J:88742
	decreased liver glycogen level	J:88742
	decreased liver triglyceride level	J:88742
	decreased triglyceride level	J:88742
	decreased unsaturated fatty acids level	J:88742
	dehydration	J:88742
	hypoglycemia	J:88742
	impaired skin barrier function	J:88742
Dgat2^tm1Lex/Dgat2^tm1Lex (involves: 129S5/SvEvBrd * C57BL/6J)	dehydration	J:103485
Dgat2l6^{tm1b(KOMP)Wtsi}/Dgat2l6^{tm1b(KOMP)Wtsi} (C57BL/6N-Dgat2l6^{tm1b(KOMP)Wtsi}/Ucd)	increased circulating alanine transaminase level	J:211773
	increased circulating aspartate transaminase level	J:211773
Dgcr2^{tm1b(EUCOMM)Wtsi}/Dgcr2^{tm1b(EUCOMM)Wtsi} (C57BL/6N-Dgcr2^{tm1b(EUCOMM)Wtsi}/Bay)	impaired glucose tolerance	J:211773
Dgkb^{Tn(sb-lacZ,GFP)IR3.PV122Jtak}/Dgkb^{Tn(sb-lacZ,GFP)IR3.PV122Jtak} (involves: C3H * C57BL/6 * DBA/2 * ICR)	abnormal lipid level	J:163104
Dgkd^em1(IMPC)H/Dgkd⁺ (C57BL/6NTac-Dgkd^em1(IMPC)H/H)	decreased circulating glucose level	J:211773
Dgkd^em1(IMPC)H/Dgkd⁺ (C57BL/6NTac-Dgkd^em1(IMPC)H/H)	decreased fasting circulating glucose level	J:211773
Dgke^em1(IMPC)Tcp/Dgke^em1(IMPC)Tcp (C57BL/6NCrl-Dgke^em1(IMPC)Tcp/Tcp)	decreased circulating creatinine level	J:211773
Dgkh^em1(IMPC)J/Dgkh^em1(IMPC)J (C57BL/6NJ-Dgkh^em1(IMPC)J/J)	decreased blood urea nitrogen level	J:211773
	decreased circulating creatinine level	J:211773
Dgki^{em1(IMPC)Wtsi}/Dgki^{em1(IMPC)Wtsi} (C57BL/6N-Dgki^{em1(IMPC)Wtsi}/Wtsi)	increased circulating glycerol level	J:295189, J:211773
Dgkk^em1(IMPC)Ics/Y (C57BL/6N-Dgkk^em1(IMPC)Ics/Ics)	increased circulating alkaline phosphatase level	J:211773
	increased circulating cholesterol level	J:211773
	increased circulating HDL cholesterol level	J:211773
Dgkz^tm1Gak/Dgkz^tm1Gak (involves: 129X1/SvJ * C57BL/6)	abnormal cytokine level	J:293120
	abnormal interferon level	J:85149
	decreased circulating ferritin level	J:293120
Dglucy^{tm1b(KOMP)Wtsi}/Dglucy^{tm1b(KOMP)Wtsi} (involves: C57BL/6N)	increased glutamic acid level	J:241368
Dguok^tm1.1Anka/Dguok^tm1.1Anka (involves: 129 * C57BL/6N)	decreased circulating glucose level	J:294620
	decreased circulating serum albumin level	J:294620
	increased circulating alanine transaminase level	J:294620
	increased circulating aspartate transaminase level	J:294620
	increased circulating cholesterol level	J:294620
Dhcr7^em1(IMPC)Mbp/Dhcr7^em1(IMPC)Mbp (C57BL/6N-Dhcr7^em1(IMPC)Mbp/MbpMmucd)	edema	J:211773
Dhcr7^tm1.1Sbpa/Dhcr7^tm1.1Sbpa Speer6-ps1^{Tg(Alb-cre)21Mgn}/Speer6-ps1⁺ (B6.Cg-Dhcr7^tm1.1Sbpa Speer6-ps1^{Tg(Alb-cre)21Mgn})	abnormal bile salt homeostasis	J:303316
	abnormal sterol level	J:303316
	decreased liver cholesterol level	J:303316
	increased bile salt level	J:303316
Dhcr7^tm1Fdp/Dhcr7^tm1Fdp (involves: 129S4/SvJae)	abnormal cholesterol homeostasis	J:68084, J:165301
	cyanosis	J:68084
	decreased cholesterol level	J:68084
Dhcr7^tm1Fdp/Dhcr7^tm2Fdp (involves: 129S4/SvJae)	abnormal cholesterol level	J:106758
Dhcr7^tm1Fdp/Dhcr7^tm2Fdp (involves: 129S4/SvJae)	decreased cholesterol level	J:106758
Dhcr7^tm1Gst/Dhcr7^tm1Gst (involves: 129P2/OlaHsd)	abnormal cholesterol homeostasis	J:71611
	abnormal enzyme/coenzyme level	J:71611
	abnormal lipid level	J:71611
	decreased brain cholesterol level	J:71611
	decreased liver cholesterol level	J:71611
Dhcr7^tm1Gst/Dhcr7^tm1Gst (B6.129P2-Dhcr7^tm1Gst)	abnormal lipid level	J:93296
	decreased cholesterol level	J:93296
	hypoxia	J:93296
	increased circulating corticosterone level	J:93296
Dhcr7^tm1Gst/Dhcr7^tm1Gst Tg(APOE-DHCR7)2Hoyu/0 (involves: 129P2/OlaHsd * C57BL * C57BL/6J * FVB/N)	decreased brain cholesterol level	J:141730
	decreased cholesterol level	J:141730
	decreased circulating cholesterol level	J:141730
	decreased liver cholesterol level	J:141730
Dhcr7^tm2Fdp/Dhcr7^tm2Fdp (involves: 129S4/SvJae)	abnormal cholesterol level	J:106758
Dhcr7^tm2Fdp/Dhcr7^tm2Fdp (involves: 129S4/SvJae)	decreased cholesterol level	J:106758
Dhcr24^{tm1a(EUCOMM)Wtsi}/Dhcr24⁺ (B6JTyr;B6N-Dhcr24^{tm1a(EUCOMM)Wtsi}/Wtsi)	decreased circulating triglyceride level	J:175295
Dhcr24^{tm1c(EUCOMM)Wtsi}/Dhcr24^{tm1c(EUCOMM)Wtsi} Gt(ROSA)26Sor^{tm1(cre/ERT)Nat}/Gt(ROSA)26Sor⁺ (involves: 129S1/Sv * 129S4/SvJaeSor * 129X1/SvJ * C57BL/6J * C57BL/6N)	abnormal sterol level	J:304449
	decreased circulating cholesterol level	J:304449
Dhcr24^{tm1c(EUCOMM)Wtsi}/Dhcr24^{tm1c(EUCOMM)Wtsi} Speer6-ps1^{Tg(Alb-cre)21Mgn}/Speer6-ps1⁺ (B6.Cg-Dhcr24^{tm1c(EUCOMM)Wtsi} Speer6-ps1^{Tg(Alb-cre)21Mgn})	abnormal sterol level	J:304449
	decreased liver cholesterol level	J:304449
Dhcr24^tm1Lex/Dhcr24^tm1Lex (involves: 129S5/SvEvBrd * C57BL/6)	abnormal circulating cholesterol level	J:87402
	decreased circulating cholesterol level	J:87402
Dhfr^orana/Dhfr⁺ (involves: C57BL/6JAnu)	abnormal folic acid level	J:236197
Dhfr^orana/Dhfr^orana (involves: C57BL/6JAnu)	abnormal folic acid level	J:236197
Dhfr^{tm1b(EUCOMM)Wtsi}/Dhfr⁺ (C57BL/6N-Dhfr^{tm1b(EUCOMM)Wtsi}/Tcp)	decreased circulating creatinine level	J:211773
Dhh^tm1Amc/Dhh^tm1Amc (involves: 129S1/Sv * C57BL/6J * Swiss Webster)	decreased circulating testosterone level	J:65900
	increased circulating luteinizing hormone level	J:65900
Dhps^{tm2c(EUCOMM)Wtsi}/Dhps^{tm2c(EUCOMM)Wtsi} Tg(CAG-cre/Esr1)5Amc/0 (involves: C57BL/6J C57BL/6N * CBA * SJL)	increased kidney iron level	J:236582
Dhrs2^{tm1a(KOMP)Wtsi}/Dhrs2^{tm1a(KOMP)Wtsi} (C57BL/6N-Dhrs2^{tm1a(KOMP)Wtsi}/Wtsi)	increased circulating alanine transaminase level	J:211773
Dhrs3^{tm1(NCOM)Mfgc}/Dhrs3^{tm1(NCOM)Mfgc} (involves: C57BL/6 * C57BL/6N)	abnormal retinol level	J:214109
	edema	J:214109
Dhtkd1^tm1Mmgu/Dhtkd1^tm1Mmgu (involves: 129S6/SvEvTac * C57BL/6J)	decreased circulating cholesterol level	J:288186
	decreased circulating glycerol level	J:288186
	decreased circulating triglyceride level	J:288186
	increased circulating phospholipid level	J:288186
	increased respiratory quotient	J:288186
Dhtkd1^tm1Zgwg/Dhtkd1^tm1Zgwg (involves: C57BL/6)	aciduria	J:267178
	decreased circulating glucose level	J:267178
	improved glucose tolerance	J:267178
	increased circulating creatine kinase level	J:267178
	increased circulating insulin level	J:267178
	increased circulating insulin-like growth factor I level	J:267178
	increased circulating lactate dehydrogenase level	J:267178
	increased insulin secretion	J:267178
	increased insulin sensitivity	J:267178
	increased liver glycogen level	J:267178
Dhx29^{tm1.1(KOMP)Vlcg}/Dhx29⁺ (C57BL/6N-Dhx29^{tm1.1(KOMP)Vlcg}/J)	impaired glucose tolerance	J:211773
	increased urine magnesium level	J:211773
Dhx30^{tm1.1(KOMP)Vlcg}/Dhx30⁺ (C57BL/6N-Dhx30^{tm1.1(KOMP)Vlcg}/J)	decreased circulating glucose level	J:211773
	increased circulating free fatty acids level	J:211773
	increased circulating sodium level	J:211773
	increased fasting circulating glucose level	J:211773
Dhx33^{tm1b(KOMP)Wtsi}/Dhx33⁺ (C57BL/6N-Dhx33^{tm1b(KOMP)Wtsi}/Wtsi)	increased circulating thyroxine level	J:211773
Dhx40^{tm1(NCOM)Cmhd}/Dhx40^{tm1(NCOM)Cmhd} (C57BL/6N-Dhx40^{tm1(NCOM)Cmhd}/Tcp)	decreased circulating cholesterol level	J:165965
Dhx58^tm1Aki/Dhx58^tm1Aki (involves: 129/Sv * C57BL/6)	decreased circulating interferon-beta level	J:156867
Dhx58^tm1Gnb/Dhx58^tm1Gnb (involves: 129P2/OlaHsd * C57BL/6J)	increased circulating interferon-gamma level	J:146113
	increased circulating interleukin-12 level	J:146113
Diaph1^{em1(IMPC)Rbrc}/Diaph1^{em1(IMPC)Rbrc} (C57BL/6NJcl-Diaph1^{em1(IMPC)Rbrc}/Rbrc)	increased blood urea nitrogen level	J:211773
Diaph1^tm1Asal/Diaph1^tm1Asal (involves: 129S1/Sv * C57BL/6)	dehydration	J:124319
Diaph2^{tm1b(EUCOMM)Hmgu}/Y (C57BL/6N-Diaph2^{tm1b(EUCOMM)Hmgu}/Orl)	increased circulating phosphate level	J:211773
Diaph3^{tm1b(KOMP)Mbp}/Diaph3⁺ (C57BL/6N-Diaph3^{tm1b(KOMP)Mbp}/J)	decreased circulating free fatty acids level	J:211773
	decreased circulating triglyceride level	J:211773
Dibg1^{129S6/SvEvTac}/Dibg1^{129S6/SvEvTac} (involves: 129S6/SvEvTac * C57BL/6)	hyperglycemia	J:142949
Dicer1^{tm1b(EUCOMM)Wtsi}/Dicer1⁺ (C57BL/6N-Dicer1^{tm1b(EUCOMM)Wtsi}/H)	increased circulating alkaline phosphatase level	J:211773
Dicer1^tm1Bdh/Dicer1^tm1Bdh Amhr2^tm3(cre)Bhr/Amhr2⁺ (involves: 129)	decreased circulating progesterone level	J:142113
Dicer1^tm1Bdh/Dicer1^tm1Bdh Nkx2-5^tm1(cre)Rjs/Nkx2-5⁺ (involves: 129 * 129S7/SvEvBrd * C57BL/6)	pericardial edema	J:211548
Dicer1^tm1Smr/Dicer1^tm1Smr Pax8^{tm1.1(cre)Mbu}/Pax8⁺ (involves: 129P2/OlaHsd * 129S7/SvEvBrd)	albuminuria	J:229188
	decreased urine osmolality	J:229188
	increased urine protein level	J:229188
Dicer1^tm1Smr/Dicer1^tm1Smr Tg(Myh6-cre)2182Mds/0 (involves: 129S7/SvEvBrd * FVB/N)	abnormal atrial thrombosis	J:131962
	abnormal ventricular thrombosis	J:131962
Dicer1^tm1Tara/Dicer1^tm1Tara Pten^tm1Hwu/Pten^tm1Hwu Amhr2^tm3(cre)Bhr/Amhr2⁺ (involves: 129P2/OlaHsd * 129S4/SvJae * 129S7/SvEvBrd)	ascites	J:182161
Dicer1^tm1Tara/Dicer1^tm1Tara Pten^tm1Hwu/Pten^tm1Hwu Trp53^tm2Tyj/Trp53⁺ Amhr2^tm3(cre)Bhr/Amhr2⁺ (involves: 129P2/OlaHsd * 129S4/SvJae * 129S7/SvEvBrd)	ascites	J:222579
Dicer1^tm1Tara/Dicer1^tm1Tara Tg(KRT14-cre)1Efu/? (involves: 129P2/OlaHsd * CD-1)	dehydration	J:106792
Dido1^tm3Cmar/Dido1^tm3.1Cmar Ndor1^{Tg(UBC-cre/ERT2)1Ejb}/Ndor1⁺ (involves: 129S/SvEv * C57BL/6)	increased circulating alanine transaminase level	J:328215
	increased circulating aspartate transaminase level	J:328215
	increased circulating cholesterol level	J:328215
Diht^C3H/HeJArc/Diht^C3H/HeJArc (involves: C3H/HeJArc * C3.PRI-Oas1b^Flv-r)	decreased body temperature	J:94070
Diht^C3H/HeJArc/Diht^PRI (involves: C3H/HeJArc * C3.PRI-Oas1b^Flv-r)	decreased body temperature	J:94070
Diht^PRI/Diht^PRI (involves: C3H/HeJArc * C3.PRI-Oas1b^Flv-r)	decreased body temperature	J:94070
Dio1^tm1Vag/Dio1^tm1Vag (involves: 129 * C57BL/6)	abnormal thyroid hormone level	J:104508
	abnormal urine homeostasis	J:104508
	decreased circulating cholesterol level	J:104508
	increased circulating thyroxine level	J:104508
	increased circulating triiodothyronine level	J:104508
	increased thyroxine level	J:104508
	increased triiodothyronine level	J:104508
Dio2^tm1Acb/Dio2^tm1Acb Tg(Cga-cre)3Sac/0 (involves: C57BL/6J * SJL)	abnormal thyroid hormone level	J:197623
	increased circulating thyroid-stimulating hormone level	J:197623
	increased circulating thyroxine level	J:197623
Dio2^tm1Vag/Dio2^tm1Vag (involves: 129S7/SvEvBrd * C57BL/6)	abnormal thyroid-stimulating hormone level	J:72958
	abnormal urine homeostasis	J:104508
	impaired adaptive thermogenesis	J:77694
	increased circulating thyroid-stimulating hormone level	J:72958
	increased circulating thyroxine level	J:72958
	increased thyroxine level	J:77694
Dio3^tm1Dmst/Dio3^tm1Dmst Speer6-ps1^{Tg(Alb-cre)21Mgn}/Speer6-ps1⁺ (involves: C57BL/6 * DBA)	increased circulating thyroxine level	J:218350
	increased circulating triiodothyronine level	J:218350
Dio3^tm1Stg/Dio3^tm1Stg (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	abnormal pituitary hormone level	J:105434
	abnormal thyroid hormone level	J:105434
	decreased circulating thyroid-stimulating hormone level	J:105434
	decreased circulating thyroxine level	J:105434
	decreased circulating triiodothyronine level	J:105434
	increased circulating thyroid-stimulating hormone level	J:105434
	increased triiodothyronine level	J:105434
Dip2a^{tm2a(KOMP)Wtsi}/Dip2a^{tm2a(KOMP)Wtsi} (involves: C57BL/6J * C57BL/6N * CD-1)	increased susceptibility to diet-induced obesity	J:305801
Dip2a^{tm2b(KOMP)Wtsi}/Dip2a^{tm2b(KOMP)Wtsi} (C57BL/6N-Dip2a^{tm2b(KOMP)Wtsi}/Wtsi)	increased circulating iron level	J:211773
Dip2b^{tm1a(EUCOMM)Wtsi}/Dip2b⁺ (B6JTyr;B6N-Dip2b^{tm1a(EUCOMM)Wtsi}/Wtsi)	decreased circulating free fatty acids level	J:175295
Dipk1a^{tm1a(EUCOMM)Wtsi}/Dipk1a^{tm1a(EUCOMM)Wtsi} (C57BL/6N-Dipk1a^{tm1a(EUCOMM)Wtsi}/Wtsi)	increased circulating alkaline phosphatase level	J:211773
	increased circulating sodium level	J:211773
Dis3^{tm1e.1(EUCOMM)Hmgu}/Dis3⁺ (C57BL/6N-Dis3^{tm1e.1(EUCOMM)Hmgu}/Ieg)	impaired glucose tolerance	J:211773
Disc1^tm1Kozo/Disc1^tm1Kozo (B6JJmsSlc.Cg-Disc1^tm1Kozo)	decreased serotonin level	J:177560
Disp1^icb/Disp1^icb (involves: C3HeB/FeJ * C57BL/6J)	pericardial edema	J:79027
Diwg1^C57BL/6/Diwg1^C57BL/6 (involves: 129S6/SvEvTac * C57BL/6)	hyperglycemia	J:142949
Dkk1^tm1.1Svo/Dkk1^tm1.2Svo Pax8^{tm1.1(cre)Mbu}/Pax8⁺ (involves: 129P2/OlaHsd * C57BL/6 * SJL)	decreased urine creatinine level	J:173125
	decreased urine glucose level	J:173125
	decreased urine phosphate level	J:173125
	decreased urine potassium level	J:173125
	decreased urine protein level	J:173125
	decreased urine sodium level	J:173125
	increased urine calcium level	J:173125
	increased urine chloride ion level	J:173125
Dkk3^tm1Cni/Dkk3^tm1Cni (involves: 129X1/SvJ * C57BL/6)	increased circulating aldosterone level	J:188335
Dkk3^tm1Cni/Dkk3^tm1Cni Kcnk3^tm1Sgb/Kcnk3^tm1Sgb (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	increased circulating aldosterone level	J:188335
Dlec1^{tm1b(EUCOMM)Wtsi}/Dlec1^{tm1b(EUCOMM)Wtsi} (C57BL/6N-Dlec1^{tm1b(EUCOMM)Wtsi}/Ieg)	increased circulating alanine transaminase level	J:211773
Dlg1^{Gt(gt1.8geo)1Ber}/Dlg1^{Gt(gt1.8geo)1Ber} (involves: 129S1/Sv * 129X1/SvJ * ICR)	cyanosis	J:67360
Dlg4^{tm1e(EUCOMM)Wtsi}/Dlg4^{tm1e(EUCOMM)Wtsi} (C57BL/6N-Dlg4^{tm1e(EUCOMM)Wtsi}/Wtsi)	increased circulating sodium level	J:211773
Dlg4^tm2.1Grnt/Dlg4^tm2.1Grnt (involves: 129P2/OlaHsd * C57BL/6J)	increased circulating corticosterone level	J:175436
	increased response to stress-induced hyperthermia	J:175436
Dlg5^tm1Vv/Dlg5^tm1Vv (involves: 129 * C57BL/6)	increased blood urea nitrogen level	J:124940
Dlgap2^{em1(IMPC)Mhzh}/Dlgap2^{em1(IMPC)Mhzh} (C57BL/6N-Dlgap2^{em1(IMPC)Mhzh}/Mhzh)	increased fasting circulating glucose level	J:211773
Dlgap4^{tm1b(KOMP)Wtsi}/Dlgap4⁺ (C57BL/6N-Dlgap4^{tm1b(KOMP)Wtsi}/Wtsi)	decreased fasting circulating glucose level	J:211773
	increased blood urea nitrogen level	J:211773
	increased circulating creatinine level	J:211773
Dlk1^{em1(IMPC)Wtsi}/Dlk1^{em1(IMPC)Wtsi} (C57BL/6N-Dlk1^{em1(IMPC)Wtsi}/WtsiIeg)	decreased circulating glucose level	J:211773
Dlk1^tm1Hsul/Dlk1^tm1Hsul (either: (involves: 129 * BALB/c) or (involves: 129 * C57BL/6J))	hyperlipidemia	J:77909
	increased circulating cholesterol level	J:77909
Dll1^m1Mhda/Dll1⁺ (C3HeB/FeJ-Dll1^m1Mhda)	decreased circulating cholesterol level	J:150183
	decreased circulating triglyceride level	J:150183
	increased blood uric acid level	J:150183
Dll1^tm1Gos/Dll1⁺ (C3Fe.129-Dll1^tm1Gos)	decreased blood uric acid level	J:150183
	decreased circulating cholesterol level	J:150183
	decreased circulating total protein level	J:150183
	decreased circulating triglyceride level	J:150183
Dll4^tm1Grid/Dll4⁺ (either: (involves: 129X1/SvJ * Black Swiss) or (involves: 129X1/SvJ * C57BL/6J))	pericardial effusion	J:93125
Dll4^tm1Jrt/Dll4^tm1Jrt (involves: 129S1/Sv * 129X1/SvJ * ICR)	pericardial edema	J:93157
Dlx2^tm1Fsh/Dlx2^tm1Fsh (Not Specified)	cyanosis	J:102348
Dlx2^tm1Jlr/Dlx2^tm1Jlr (either: (involves: 129X1/SvJ) or (involves: 129X1/SvJ * CD-1))	cyanosis	J:29443
Dlx3^em1(IMPC)Mbp/Dlx3⁺ (C57BL/6N-Dlx3^em1(IMPC)Mbp/MbpMmucd)	edema	J:211773
	increased circulating alkaline phosphatase level	J:211773
	increased circulating calcium level	J:211773
Dmbt1^tm2Qaa/Dmbt1^tm2Qaa Tg(ATP6V1B1-cre)45Rnel/0 (involves: C57BL/6 * C57BL/6J * CBA)	decreased circulating bicarbonate level	J:167156
	increased urine pH	J:167156
	metabolic acidosis	J:167156
	renal tubular acidosis	J:167156
Dmbt1^tm2Qaa/Dmbt1^tm2Qaa Tg(Hoxb7-cre)5526Cmb/0 (involves: C57BL/6 * FVB/N)	decreased circulating bicarbonate level	J:167156
	increased urine pH	J:167156
	metabolic acidosis	J:167156
	renal tubular acidosis	J:167156
Dmbx1^tm1Sse/Dmbx1^tm1Sse (involves: ICR)	decreased circulating leptin level	J:125193
Dmbx1^tm1Sse/Dmbx1^tm1Sse Lep^ob/Lep^ob (involves: ICR)	abnormal circulating glucose level	J:125193
Dmd^{em1(IMPC)Hmgu}/Y (C57BL/6N-Dmd^{em1(IMPC)Hmgu}/Ieg)	increased circulating alanine transaminase level	J:211773
Dmd^{em1(IMPC)Hmgu}/Y (C57BL/6N-Dmd^{em1(IMPC)Hmgu}/Ieg)	increased circulating aspartate transaminase level	J:211773
Dmd^{em1(IMPC)Hmgu}/Dmd^{em1(IMPC)Hmgu} (C57BL/6N-Dmd^{em1(IMPC)Hmgu}/Ieg)	increased circulating alanine transaminase level	J:211773
	increased circulating alkaline phosphatase level	J:211773
	increased circulating aspartate transaminase level	J:211773
	increased circulating serum albumin level	J:211773
	increased circulating total protein level	J:211773
Dmd^em1Eno/Y (involves: C57BL/6J)	increased creatine kinase level	J:253191
Dmd^em4Eno/Y (C57BL/6-Dmd^em4Eno)	increased circulating creatine kinase level	J:285447
Dmd^em4Eno/Dmd^em4Eno (C57BL/6-Dmd^em4Eno)	increased circulating creatine kinase level	J:285447
Dmd^em#Tve/Y (involves: C57BL/6 * CBA)	increased circulating creatine kinase level	J:275476
Dmd^mdx/Y (C57BL/10ScSn-Dmd^mdx/J)	abnormal circulating pyruvate kinase level	J:7361
Dmd^mdx/Y (C57BL/10ScSn-Dmd^mdx/J)	increased circulating creatine kinase level	J:7361
Dmd^mdx/Y (involves: 129S4/SvJae * C57BL/10ScSn)	abnormal circulating pyruvate kinase level	J:48851
Dmd^mdx/Y Nos1^tm1Plh/Nos1^tm1Plh (involves: 129S4/SvJae * C57BL/10ScSn)	abnormal circulating pyruvate kinase level	J:48851
Dmd^mdx/Y Terc^tm1Rdp/Terc⁺ (involves: 129/Sv * C57BL/6J * C57BL/10ScSn * SJL)	increased circulating creatine kinase level	J:167294
Dmd^mdx/Y Terc^tm1Rdp/Terc^tm1Rdp (involves: 129/Sv * C57BL/6J * C57BL/10ScSn * SJL)	increased circulating creatine kinase level	J:167294
Dmd^mdx/Y Tg(DMD)#Spc/0 (involves: 129P2/OlaHsd C57BL/10ScSn * DBA/2)	abnormal calcium level	J:280218
Dmd^mdx/Dmd⁺ (involves: 129S4/SvJae * C57BL/10ScSn)	abnormal circulating pyruvate kinase level	J:48851
Dmd^mdx/Dmd⁺ Nos1^tm1Plh/Nos1^tm1Plh (involves: 129S4/SvJae * C57BL/10ScSn)	abnormal circulating pyruvate kinase level	J:48851
Dmd^mdx/Dmd^mdx (C57BL/10ScSn-Dmd^mdx/J)	abnormal circulating pyruvate kinase level	J:7361
Dmd^mdx/Dmd^mdx (C57BL/10ScSn-Dmd^mdx/J)	increased circulating creatine kinase level	J:7361, J:226314
Dmd^mdx/Dmd^mdx (C57BL/10ScSn-Dmd^mdx)	abnormal circulating pyruvate kinase level	J:7361
	increased circulating creatine kinase level	J:18080, J:7361, J:152524
	increased growth hormone level	J:18080
Dmd^mdx/Dmd^mdx (involves: BALB/c * C57BL/10ScSn * C57BL/Ka)	increased transforming growth factor beta level	J:125527
Dmd^mdx/Dmd^mdx (D2.B10-Dmd^mdx/J)	increased circulating creatine kinase level	J:226314
Dmd^mdx/Dmd^mdx Prkdc^scid/Prkdc^scid (involves: BALB/c * C57BL/10ScSn * C57BL/Ka)	decreased transforming growth factor beta level	J:125527
Dmd^mdx/Dmd^mdx Selenos^tm1.1Sfa/Selenos⁺ (involves: C57BL/6 * C57BL/10ScSn)	abnormal respiratory quotient	J:266872
	increased carbon dioxide production	J:266872
	increased oxygen consumption	J:266872
Dmd^tm1Kmf/Y (involves: C57BL/6)	increased circulating creatine kinase level	J:233298
Dmp1^{tm1.1(KOMP)Vlcg}/Dmp1^{tm1.1(KOMP)Vlcg} (C57BL/6N-Dmp1^{tm1.1(KOMP)Vlcg}/Ucd)	decreased blood urea nitrogen level	J:211773
	decreased circulating phosphate level	J:211773
	increased circulating alkaline phosphatase level	J:211773
Dmp1^tm1Mis/Dmp1^tm1Mis (involves: 129S7/SvEvBrd * CD-1)	abnormal circulating protein level	J:115339
	decreased circulating calcium level	J:115339
	decreased circulating phosphate level	J:184352, J:115339
	increased circulating parathyroid hormone level	J:115339
Dmpk^tm1Rdd/Dmpk^tm1Rdd (involves: 129S2/SvPas * C57BL/6J)	abnormal calcium ion homeostasis	J:97257
Dmwd^em1(IMPC)J/Dmwd^em1(IMPC)J (C57BL/6NJ-Dmwd^em1(IMPC)J/Mmjax)	increased fasting circulating glucose level	J:211773
Dmxl2^{tm1a(EUCOMM)Wtsi}/Dmxl2⁺ (C57BL/6N-A^tm1Brd Dmxl2^{tm1a(EUCOMM)Wtsi}/WtsiH)	decreased circulating cholesterol level	J:211773
Dmxl2^{tm1c(EUCOMM)Wtsi}/Dmxl2⁺ Tg(Nes-cre)1Atp/0 (involves: C57BL/6N * FVB/N)	decreased circulating testosterone level	J:217623
	increased circulating luteinizing hormone level	J:217623
Dnaaf2^{tm1.1(KOMP)Vlcg}/Dnaaf2^{tm1.1(KOMP)Vlcg} (B6N(Cg)-Dnaaf2^{tm1.1(KOMP)Vlcg}/J)	pericardial edema	J:278736
Dnah5^{tm1b(KOMP)Wtsi}/Dnah5⁺ (C57BL/6N-Dnah5^{tm1b(KOMP)Wtsi}/Ucd)	increased blood urea nitrogen level	J:211773
	increased circulating calcium level	J:211773
	increased circulating total protein level	J:211773
Dnah11^lrm3/Dnah11^lrm3 (involves: BALB/cAnN * C3H/HeH)	edema	J:145068
Dnah11^lrm5/Dnah11^lrm5 (involves: BALB/cAnN * C3H/HeH)	edema	J:145068
Dnaja3^tm1.1Jdl/Dnaja3^tm1.1Jdl Tg(Myhca-cre)1Abel/0 (involves: 129X1/SvJ * C57BL/6J * FVB)	pericardial effusion	J:104462
Dnaja4^{tm1b(KOMP)Wtsi}/Dnaja4^{tm1b(KOMP)Wtsi} (C57BL/6N-Dnaja4^{tm1b(KOMP)Wtsi}/J)	decreased circulating glucose level	J:211773
	increased fasting circulating glucose level	J:211773
Dnajb3^{tm1.1(KOMP)Vlcg}/Dnajb3^{tm1.1(KOMP)Vlcg} (C57BL/6N-Dnajb3^{tm1.1(KOMP)Vlcg}/J)	decreased circulating glucose level	J:211773
Dnajb7^{tm1.1(KOMP)Vlcg}/Dnajb7^{tm1.1(KOMP)Vlcg} (C57BL/6N-Dnajb7^{tm1.1(KOMP)Vlcg}/J)	increased fasting circulating glucose level	J:211773
Dnajb9^{Gt(KST256)Byg}/Dnajb9^{Gt(KST256)Byg} (129P2/OlaHsd-Dnajb9^{Gt(KST256)Byg})	decreased liver glycogen level	J:226674
	hypoglycemia	J:226674
	increased circulating glucagon level	J:226674
Dnajb9^{Gt(KST256)Byg}/Dnajb9^{Gt(KST256)Byg} (B6.129P2-Dnajb9^{Gt(KST256)Byg})	abnormal circulating glucose level	J:226674
	decreased circulating insulin level	J:226674
	decreased liver glycogen level	J:226674
	hypoglycemia	J:226674
	increased circulating glucagon level	J:226674
Dnajb11^{tm1b(EUCOMM)Wtsi}/Dnajb11⁺ (C57BL/6N-Dnajb11^{tm1b(EUCOMM)Wtsi}/Ieg)	increased circulating alkaline phosphatase level	J:211773
Dnajb12^{tm1.1(KOMP)Vlcg}/Dnajb12⁺ (C57BL/6N-Dnajb12^{tm1.1(KOMP)Vlcg}/J)	increased circulating sodium level	J:211773
Dnajb14^em1(IMPC)J/Dnajb14⁺ (C57BL/6NJ-Dnajb14^em1(IMPC)J/Mmjax)	increased circulating phosphate level	J:211773
Dnajc2^em1(IMPC)J/Dnajc2⁺ (C57BL/6NJ-Dnajc2^em1(IMPC)J/Mmjax)	decreased circulating calcium level	J:211773
Dnajc3^tm8663Wcl/Dnajc3^tm8663Wcl (C57BL/6-Dnajc3^tm8663Wcl/Mmmh)	hyperglycemia	J:98194
	increased circulating insulin level	J:98194
	increased urine glucose level	J:98194
Dnajc5g^{tm1.1(KOMP)Vlcg}/Dnajc5g⁺ (C57BL/6N-Dnajc5g^{tm1.1(KOMP)Vlcg}/J)	increased circulating insulin level	J:211773
	increased fasting circulating glucose level	J:211773
Dnajc7^tm1.2Neg/Dnajc7^tm1.2Neg (involves: 129S/SvEv * C57BL/6 * CBA)	increased circulating cholesterol level	J:225381
Dnajc9^{tm1.1(KOMP)Vlcg}/Dnajc9⁺ (C57BL/6N-Dnajc9^{tm1.1(KOMP)Vlcg}/J)	increased circulating free fatty acids level	J:211773
Dnajc13^em1(IMPC)J/Dnajc13⁺ (C57BL/6NJ-Dnajc13^em1(IMPC)J/Mmjax)	increased circulating bilirubin level	J:211773
Dnajc14^{tm1.1(KOMP)Vlcg}/Dnajc14^{tm1.1(KOMP)Vlcg} (C57BL/6N-Dnajc14^{tm1.1(KOMP)Vlcg}/J)	decreased circulating serum albumin level	J:211773
	increased circulating chloride level	J:211773
	increased circulating sodium level	J:211773
Dnajc15^{Gt(RRN226)Byg}/Dnajc15^{Gt(RRN226)Byg} (B6.129P2-Dnajc15^{Gt(RRN226)Byg})	abnormal glycogen homeostasis	J:204025
	abnormal lipid homeostasis	J:204025
	decreased circulating free fatty acids level	J:204025
	decreased circulating triglyceride level	J:204025
	decreased liver cholesterol level	J:204025
	increased glycogen level	J:204025
	increased kidney glycogen level	J:204025
	increased liver glycogen level	J:204025
Dnajc15^{tm1b(KOMP)Wtsi}/Dnajc15^{tm1b(KOMP)Wtsi} (C57BL/6N-Dnajc15^{tm1b(KOMP)Wtsi}/Bay)	increased circulating glucose level	J:211773
Dnajc17^{tm1a(EUCOMM)Hmgu}/Dnajc17⁺ (C57BL/6N-Dnajc17^{tm1a(EUCOMM)Hmgu}/Ieg)	increased circulating alkaline phosphatase level	J:165965
Dnajc17^{tm1b(EUCOMM)Hmgu}/Dnajc17⁺ (C57BL/6N-Dnajc17^{tm1b(EUCOMM)Hmgu}/Ieg)	increased circulating fructosamine level	J:211773
Dnajc19^{tm1a(EUCOMM)Hmgu}/Dnajc19^{tm1a(EUCOMM)Hmgu} (C57BL/6N-Dnajc19^{tm1a(EUCOMM)Hmgu}/H)	increased circulating glucose level	J:165965
Dnajc30^{tm1(KOMP)Vlcg}/Dnajc30^{tm1(KOMP)Vlcg} (C57BL/6N-Dnajc30^{tm1(KOMP)Vlcg})	increased energy expenditure	J:266469
Dnajc30^{tm1(KOMP)Vlcg}/Dnajc30^{tm1(KOMP)Vlcg} Tg(Thy1-YFP)HJrs/0 (involves: C57BL/6J * C57BL/6N)	decreased oxygen consumption	J:266469
Dnajc30^{tm1.1(KOMP)Vlcg}/Dnajc30^{tm1.1(KOMP)Vlcg} (C57BL/6N-Dnajc30^{tm1.1(KOMP)Vlcg}/J)	improved glucose tolerance	J:211773
	increased circulating calcium level	J:211773
	increased circulating total protein level	J:211773
	increased fasting circulating glucose level	J:211773
Dnal1^{tm1.1(KOMP)Vlcg}/Dnal1⁺ (C57BL/6N-Dnal1^{tm1.1(KOMP)Vlcg}/Ucd)	increased respiratory quotient	J:211773
Dnal1^{tm1.1(KOMP)Vlcg}/Dnal1^{tm1.1(KOMP)Vlcg} (C57BL/6N-Dnal1^{tm1.1(KOMP)Vlcg}/Ucd)	edema	J:211773
Dnase1^tm1Tmo/Dnase1^tm1Tmo (involves: 129P2/OlaHsd * CD-1)	decreased blood urea nitrogen level	J:110060
Dnase1^tm1Tmo/Dnase1^tm1Tmo (involves: 129P2/OlaHsd * CD-1)	decreased circulating creatinine level	J:110060
Dnase1^tm2092.1Arte/Dnase1^tm2092.1Arte (involves: C57BL/6)	increased circulating creatinine level	J:277126
Dnase1l2^{tm1.1(KOMP)Wtsi}/Dnase1l2^{tm1.1(KOMP)Wtsi} (C57BL/6N-Dnase1l2^{tm1.1(KOMP)Wtsi}/Wtsi)	increased circulating aspartate transaminase level	J:211773
Dnase1l2^{tm1.1(KOMP)Wtsi}/Dnase1l2^{tm1.1(KOMP)Wtsi} (C57BL/6N-Dnase1l2^{tm1.1(KOMP)Wtsi}/Ieg)	increased blood urea nitrogen level	J:211773
	increased fasting circulating glucose level	J:211773
Dnase1l2^{tm1.1(KOMP)Wtsi}/Dnase1l2^{tm1.1(KOMP)Wtsi} (C57BL/6N-Dnase1l2^{tm1.1(KOMP)Wtsi}/H)	increased blood urea nitrogen level	J:211773
Dnase1l2^{tm1.1(KOMP)Wtsi}/Dnase1l2^{tm1.1(KOMP)Wtsi} (C57BL/6N-Dnase1l2^{tm1.1(KOMP)Wtsi}/Orl)	increased circulating calcium level	J:211773
Dnase1l2^{tm1.1(KOMP)Wtsi}/Dnase1l2^{tm1.1(KOMP)Wtsi} (C57BL/6N-Dnase1l2^{tm1.1(KOMP)Wtsi}/J)	increased fasting circulating glucose level	J:211773
Dnase2a^tm1Osa/Dnase2a^tm1Osa Ifnar1^tm1Agt/Ifnar1^tm1Agt (involves: 129S1/Sv * 129S2/SvPas * 129X1/SvJ * C57BL/6)	abnormal blood homeostasis	J:114982
	abnormal cytokine level	J:114982
	increased circulating interleukin-10 level	J:238323
	increased circulating interleukin-18 level	J:114982
	increased circulating tumor necrosis factor level	J:238323, J:114982
Dnase2a^tm1Osa/Dnase2a^tm2Osa Tg(Mx1-cre)1Cgn/0 (involves: 129S1/Sv * 129S2/SvPas * 129X1/SvJ * C57BL/6 * CBA)	abnormal blood homeostasis	J:114982
	abnormal cytokine level	J:114982
	increased circulating interleukin-18 level	J:114982
	increased circulating tumor necrosis factor level	J:114982
Dnase2b^{tm1a(EUCOMM)Hmgu}/Dnase2b^{tm1a(EUCOMM)Hmgu} (C57BL/6N-Dnase2b^{tm1a(EUCOMM)Hmgu}/H)	increased circulating HDL cholesterol level	J:165965
Dner^{tm3b(EUCOMM)Hmgu}/Dner^{tm3b(EUCOMM)Hmgu} (C57BL/6N-Dner^{tm3b(EUCOMM)Hmgu}/Ieg)	increased circulating aspartate transaminase level	J:211773
Dnm1^tm1Pdc/Dnm1^tm1Pdc Dnm3^tm1.2Pdc/Dnm3^tm1.2Pdc (involves: 129S1/Sv * C57BL/6 * FVB/N)	cyanosis	J:175247
Dnm1l^Py/Dnm1l⁺ (involves: BALB/cAnNCrl * C3H/HeH)	ascites	J:161510
	increased circulating alanine transaminase level	J:161510
	increased circulating aspartate transaminase level	J:161510
	pleural effusion	J:161510
	skin edema	J:161510
Dnm2^{tm1.1(KOMP)Vlcg}/Dnm2⁺ (C57BL/6N-Dnm2^{tm1.1(KOMP)Vlcg}/Ucd)	increased circulating alkaline phosphatase level	J:211773
Dnm2^tm1.1Ics/Dnm2⁺ (involves: 129S2/SvPas * C57BL/6)	abnormal calcium ion homeostasis	J:237196
Dnmt3a^{tm1b(KOMP)Wtsi}/Dnmt3a⁺ (C57BL/6N-Dnmt3a^{tm1b(KOMP)Wtsi}/J)	decreased circulating cholesterol level	J:211773
	decreased circulating glucose level	J:211773
	decreased circulating HDL cholesterol level	J:211773
Dnmt3b^em1(IMPC)Mbp/Dnmt3b^em1(IMPC)Mbp (C57BL/6N-Dnmt3b^em1(IMPC)Mbp/Ucd)	edema	J:211773
Dnmt3l^tm1Bes/Dnmt3l^tm1Bes (involves: 129S6/SvEvTac)	pericardial edema	J:73452
Dnpep^{tm1e(EUCOMM)Wtsi}/Dnpep^{tm1e(EUCOMM)Wtsi} (C57BL/6N-Dnpep^{tm1e(EUCOMM)Wtsi}/Wtsi)	increased circulating creatinine level	J:211773
Dntt^{tm2b(KOMP)Wtsi}/Dntt^{tm2b(KOMP)Wtsi} (C57BL/6N-Dntt^{tm2b(KOMP)Wtsi}/J)	increased circulating cholesterol level	J:211773
	increased circulating HDL cholesterol level	J:211773
	increased circulating sodium level	J:211773
Dock1^b2b3190Clo/Dock1^b2b3190Clo (C57BL/6J-Dock1^b2b3190Clo)	hydrops fetalis	J:175213
Dock1^tm1.1Ysfk/Dock1^tm1.1Ysfk (B6(Cg)-Dock1^tm1.1Ysfk)	edema	J:178190
Dock1^tm1Jfco/Dock1^tm1Jfco (involves: 129/Sv * C57BL/6)	cyanosis	J:143342
Dock1^tm1Jfco/Dock1^tm1Jfco (involves: 129)	edema	J:178190
Dock7^m/Dock7^m (B6.D(Cg)-Dock7^m)	increased bleeding time	J:45425
Dock9^em1(IMPC)J/Dock9^em1(IMPC)J (C57BL/6NJ-Dock9^em1(IMPC)J/J)	abnormal cholesterol homeostasis	J:211773
	increased circulating bilirubin level	J:211773
Dohh^tm1.1Sbal/Dohh^tm1.1Sbal Tg(CAG-cre/Esr1)5Amc/0 (involves: 129S1/Sv 129X1/SvJ * BALB/cJ)	increased kidney iron level	J:236582
Dok1^tm1Yyam/Dok1^tm1Yyam (B6.129S4-Dok1^tm1Yyam)	decreased circulating insulin level	J:133566
	decreased circulating leptin level	J:133566
	improved glucose tolerance	J:133566
	increased circulating adiponectin level	J:133566
	increased insulin sensitivity	J:133566
	increased oxygen consumption	J:133566
Dop1b^{tm1a(EUCOMM)Wtsi}/Dop1b^{tm1a(EUCOMM)Wtsi} (C57BL/6N-Dop1b^{tm1a(EUCOMM)Wtsi}/Wtsi)	decreased circulating free fatty acids level	J:211773
	decreased circulating glycerol level	J:211773
	increased blood urea nitrogen level	J:211773
Dp(7Herc2-Mkrn3)1Taku/0 (involves: 129S7/SvEvBrd * C57BL/6J)	decreased serotonin level	J:190050
	increased adrenaline level	J:190050
	increased dopamine level	J:190050
	increased noradrenaline level	J:190050
Dp(17Abcg1-Cbs)1Yah/0 (B6.129P2-Dp(17Abcg1-Cbs1)1Yah)	decreased circulating homocysteine level	J:154298
Dpf2^{tm1b(EUCOMM)Hmgu}/Dpf2^{tm1b(EUCOMM)Hmgu} (C57BL/6N-Dpf2^{tm1b(EUCOMM)Hmgu}/Tcp)	edema	J:211773
Dpf3^em1(IMPC)J/Dpf3^em1(IMPC)J (C57BL/6NJ-Dpf3^em1(IMPC)J/Mmjax)	decreased circulating calcium level	J:211773
Dph1^tm1.1Cmch/Dph1^tm1.1Cmch Edil3^{Tg(Sox2-cre)1Amc}/Edil3⁺ (involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * C57BL/6J * CBA)	edema	J:214744
Dph1^tm1Bhr/Dph1^tm1Bhr (either: 129/Sv or (involves: 129/Sv * C57BL/6))	hydrops fetalis	J:88090
Dph1^tm1Bhr/Dph1^tm2Bhr (involves: 129/Sv * C57BL/6)	hydrops fetalis	J:88090
Dph1^tm2Bhr/Dph1^tm2Bhr (either: 129/Sv or (involves: 129/Sv * C57BL/6))	hydrops fetalis	J:88090
Dph6^{tm1a(KOMP)Wtsi}/Dph6^{tm1a(KOMP)Wtsi} (C57BL/6N-Dph6^{tm1a(KOMP)Wtsi}/Wtsi)	increased blood urea nitrogen level	J:211773
	increased circulating creatinine level	J:211773
	increased circulating magnesium level	J:211773
Dpm2^{tm1b(EUCOMM)Hmgu}/Dpm2⁺ (C57BL/6N-Dpm2^{tm1b(EUCOMM)Hmgu}/H)	impaired glucose tolerance	J:211773
	increased circulating total protein level	J:211773
Dpml^BALB/cJ/Dpml^BALB/cJ (involves: BALB/cJ * C57BL/6J)	abnormal dopamine level	J:85562
Dpml^BALB/cJ/Dpml^C57BL/6J (involves: BALB/cJ * C57BL/6J)	abnormal dopamine level	J:85562
Dpp4^em1Rba/Dpp4⁺ (C57BL/6J-Dpp4^em1Rba)	pulmonary alveolar edema	J:279834
Dpp4^em1Rba/Dpp4^em1Rba (C57BL/6J-Dpp4^em1Rba)	pulmonary alveolar edema	J:279834
Dpp4^{tm1(DPP4)Vlcg}/? (involves: 129S6/SvEvTac * C57BL/6 * C57BL/6NTac)	pulmonary edema	J:238079
Dpp4^{tm1.1(DPP4)Pbmj}/Dpp4^{tm1.1(DPP4)Pbmj} (involves: C57BL/6 * C57BL/6NTac)	pulmonary edema	J:242025
Dpp4^{tm1b(EUCOMM)Wtsi}/Dpp4^{tm1b(EUCOMM)Wtsi} (C57BL/6N-Dpp4^{tm1b(EUCOMM)Wtsi}/Ics)	improved glucose tolerance	J:211773
Dpp4^tm1Lex/Dpp4^tm1Lex (involves: 129S/SvEvBrd * C57BL/6J)	improved glucose tolerance	J:195941
Dpp4^tm1Nwa/Dpp4^tm1Nwa (C57BL/6-Dpp4^tm1Nwa)	improved glucose tolerance	J:62709
	increased circulating glucagon level	J:62709
	increased circulating insulin level	J:62709
	increased insulin secretion	J:62709
Dpp8^em1(IMPC)J/Dpp8^em1(IMPC)J (C57BL/6NJ-Dpp8^em1(IMPC)J/Mmjax)	decreased circulating calcium level	J:211773
	impaired glucose tolerance	J:211773
Dpp9^{tm1a(EUCOMM)Hmgu}/Dpp9⁺ (C57BL/6N-Dpp9^{tm1a(EUCOMM)Hmgu}/Cnrm)	decreased circulating phosphate level	J:165965
	decreased circulating triglyceride level	J:165965
	increased circulating alkaline phosphatase level	J:165965
Dpp9^{tm1b(EUCOMM)Hmgu}/Dpp9⁺ (C57BL/6N-Dpp9^{tm1b(EUCOMM)Hmgu}/Cnrm)	increased circulating iron level	J:211773
Dppa1^{tm1a(KOMP)Wtsi}/Dppa1^{tm1a(KOMP)Wtsi} (C57BL/6N-Dppa1^{tm1a(KOMP)Wtsi}/Wtsi)	increased respiratory quotient	J:211773
Dppa2^tm1.1Yam/Dppa2^tm1.1Yam Dppa4^tm1Yam/Dppa4^tm1Yam (involves: 129S4/SvJae)	cyanosis	J:178324
Dpy19l3^{tm1a(EUCOMM)Wtsi}/Dpy19l3^{tm1a(EUCOMM)Wtsi} (C57BL/6N-Dpy19l3^{tm1a(EUCOMM)Wtsi}/Ics)	decreased circulating free fatty acids level	J:165965
Dpy30^{tm1a(KOMP)Wtsi}/Dpy30⁺ (C57BL/6N-Dpy30^{tm1a(KOMP)Wtsi}/Wtsi)	increased circulating sodium level	J:211773
Draxin^tm1Lex/Draxin^tm1Lex (B6;129S5-Draxin^tm1Lex/Mmucd)	decreased circulating insulin level	J:171883
Drc7^em1(IMPC)J/Drc7^em1(IMPC)J (C57BL/6NJ-Drc7^em1(IMPC)J/J)	increased circulating alkaline phosphatase level	J:211773
Drd1^tm1Jcd/Drd1^tm1Jcd (B6.129S4-Drd1^tm1Jcd/J)	decreased response to stress-induced hyperthermia	J:137069
Drd2^tm1.1Mrub/Drd2^tm1.1Mrub Tg(Nes-cre)1Kln/? (involves: 129S4/SvJae * C57BL/6 * SJL)	abnormal hormone level	J:194227
	decreased circulating insulin-like growth factor I level	J:194227
	decreased growth hormone level	J:194227
	decreased urine major urinary protein level	J:194227
Drd2^tm1.1Mrub/Drd2^tm1.1Mrub Tg(Prl-cre)1Mrub/? (involves: 129S4/SvJae * C57BL/6 * CBA)	increased circulating prolactin level	J:194227
Drd2^tm1Ebo/Drd2^tm1Ebo (involves: 129S2/SvPas * C57BL/6)	decreased body temperature	J:29045
	decreased circulating estrogen level	J:41857
	decreased circulating growth hormone level	J:41857
	increased circulating adrenocorticotropin level	J:110599
	increased circulating corticosterone level	J:110599
	increased circulating pituitary hormone level	J:110599
	increased circulating prolactin level	J:41857
Drd2^tm1Low/Drd2^tm1Low (either: B6.129S2-Drd2^tm1Low or (involves: 129S2/SvPas * C57BL/6))	increased circulating prolactin level	J:41858
Drd2^tm1Low/Drd2^tm1Low (B6.129S2-Drd2^tm1Low)	increased urine sodium level	J:103181
Drd2^tm1Low/Drd2^tm1Low (B6.129S2-Drd2^tm1Low/J)	decreased circulating growth hormone level	J:106832
	decreased circulating insulin-like growth factor I level	J:106832
	decreased response to stress-induced hyperthermia	J:137069
	increased circulating prolactin level	J:106832
	increased growth hormone level	J:106832
Drd2^tm1Mok/Drd2^tm1Mok (involves: 129S/SvEv * C57BL/6J * DBA/2J)	abnormal circulating hormone level	J:97838
	increased pituitary hormone level	J:97838
Drd2^tm1Schm/Drd2^tm1Schm (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	abnormal dopamine level	J:79483
Drd2^tm1Schm/Drd2^tm1Schm Drd3^tm1Schm/Drd3⁺ (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	abnormal dopamine level	J:79483
Drd2^tm1Schm/Drd2^tm1Schm Drd3^tm1Schm/Drd3^tm1Schm (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	abnormal dopamine level	J:79483
Drd2^tm3.1Ebo/Drd2^tm3.1Ebo En1^tm2(cre)Wrst/En1⁺ (involves: 129S1/Sv * 129S2/SvPas * 129X1/SvJ * C57BL/6)	abnormal dopamine level	J:185643
	increased dopamine level	J:185643
Drd2^tm3.1Ebo/Drd2^tm3.1Ebo Tg(Drd1a-cre)AGsc/0 (involves: 129S2/SvPas * C57BL/6 * FVB/N)	abnormal dopamine level	J:185643
Drd3^tm1Dac/Drd3^tm1Dac (involves: 129S4/SvJae * C57BL/6)	decreased urine sodium level	J:115136
Drd3^tm1Rmw/Drd3^tm1Rmw (involves: 129P2/OlaHsd)	decreased dopamine level	J:117918
Drd3^tm1Stl/Drd3^tm1Stl (involves: 129S2/SvPas * C57BL/6)	increased circulating leptin level	J:89345
Drd4^tm1Dkg/Drd4^tm1Dkg (involves: 129P2/OlaHsd * C57BL/6J)	increased dopamine level	J:43061
Drg2^{tm1a(EUCOMM)Wtsi}/Drg2^{tm1a(EUCOMM)Wtsi} (C57BL/6N-Drg2^{tm1a(EUCOMM)Wtsi}/Ics)	decreased circulating phosphate level	J:165965
Drosha^tm1Litt/Drosha^tm1Litt Tg(Six2-EGFP/cre)1Amc/0 (involves: 129P2/OlaHsd * CD-1)	cyanosis	J:321428
	pulmonary edema	J:321428
Drosha^tm1Litt/Drosha^tm1Litt Wt1^{tm2(cre/ERT2)Wtp}/Wt1⁺ (involves: 129P2/OlaHsd * 129S4/SvJae)	increased urine protein level	J:321428
Drsi^C3H/HeNCrl/Drsi^C3H/HeNCrl (B6.C3-(D7Mit56-D7Mit230))	increased circulating total protein level	J:89623
Dsc1^tm1Dga/Dsc1^tm1Dga (involves: C57BL/6J)	impaired skin barrier function	J:73102
Dsc3^{tm1b(EUCOMM)Wtsi}/Dsc3⁺ (C57BL/6N-Dsc3^{tm1b(EUCOMM)Wtsi}/H)	decreased fasting circulating glucose level	J:211773
Dscc1^{tm1a(KOMP)Wtsi}/Dscc1^{tm1a(KOMP)Wtsi} (B6JTyr;B6N-Dscc1^{tm1a(KOMP)Wtsi}/Wtsi)	increased blood urea nitrogen level	J:175295
Dse^{tm1b(EUCOMM)Hmgu}/Dse⁺ (C57BL/6N-Dse^{tm1b(EUCOMM)Hmgu}/H)	increased circulating aspartate transaminase level	J:211773
Dsel^tm1Mmac/Dsel^tm1Mmac (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	abnormal mineral level	J:213195
Dsg1c^em1(IMPC)Mbp/Dsg1c^em1(IMPC)Mbp (C57BL/6N-Dsg1c^em1(IMPC)Mbp/Ucd)	increased circulating calcium level	J:211773
	increased circulating cholesterol level	J:211773
	increased circulating creatinine level	J:211773
	increased circulating HDL cholesterol level	J:211773
	increased circulating serum albumin level	J:211773
	increased circulating total protein level	J:211773
Dsg2^em1Spin/Dsg2^em1Spin (involves: C57BL/6J)	hemopericardium	J:342765
Dsg3^sqk/Dsg3^sqk (C57BL/6-Dsg3^sqk)	decreased circulating leptin level	J:219200
Dsg4^arm/Dsg4^arm (involves: C57BL/6JSfdAnu * C57BL/10Sg * C57BR/cd)	skin edema	J:104190
Dspp^{tm1.1(KOMP)Vlcg}/Dspp^{tm1.1(KOMP)Vlcg} (C57BL/6N-Dspp^{tm1.1(KOMP)Vlcg}/Ucd)	improved glucose tolerance	J:211773
Dtnbp1^sdy/Dtnbp1^sdy (involves: DBA/2J)	abnormal platelet physiology	J:85123, J:323340
	decreased platelet aggregation	J:85123
	decreased platelet serotonin level	J:85123
	increased bleeding time	J:1958
Dtnbp1^sdy/Dtnbp1^sdy (DBA/2J-Dtnbp1^sdy/J)	increased bleeding time	J:14267
Dtnbp1^{tm1b(EUCOMM)Hmgu}/Dtnbp1^{tm1b(EUCOMM)Hmgu} (C57BL/6N-Dtnbp1^{tm1b(EUCOMM)Hmgu}/Tcp)	impaired glucose tolerance	J:211773
	increased circulating phosphate level	J:211773
	increased fasting circulating glucose level	J:211773
Dtx1^em1(IMPC)H/Dtx1^em1(IMPC)H (C57BL/6N-Dtx1^em1(IMPC)H/H)	increased circulating glucose level	J:211773
Dtx1^tm1.2Mzl/Dtx1^tm1.2Mzl (B6.129-Dtx1^tm1.2Mzl)	decreased transforming growth factor beta level	J:151605
Dtx3l^em1(IMPC)H/Dtx3l^em1(IMPC)H (C57BL/6N-Dtx3l^em1(IMPC)H/H)	decreased circulating serum albumin level	J:211773
	increased circulating alkaline phosphatase level	J:211773
	increased circulating aspartate transaminase level	J:211773
Dtx4^{em1(IMPC)Ccpcz}/Dtx4⁺ (C57BL/6N-Dtx4^{em1(IMPC)Ccpcz}/Ccpcz)	impaired glucose tolerance	J:211773
	increased circulating alkaline phosphatase level	J:211773
Duox2^em1(IMPC)Mbp/Duox2^em1(IMPC)Mbp (C57BL/6N-Duox2^em1(IMPC)Mbp/MbpMmucd)	increased circulating calcium level	J:211773
	increased circulating cholesterol level	J:211773
	increased circulating creatinine level	J:211773
	increased circulating HDL cholesterol level	J:211773
	increased circulating serum albumin level	J:211773
	increased circulating total protein level	J:211773
	increased fasting circulating glucose level	J:211773
Duox2^thyd/Duox2^thyd (B6(129)-Duox2^thyd/J)	decreased circulating insulin-like growth factor I level	J:121821
	decreased circulating thyroxine level	J:121821
	increased circulating thyroid-stimulating hormone level	J:121821
Duoxa2^{tm1b(KOMP)Wtsi}/Duoxa2^{tm1b(KOMP)Wtsi} (C57BL/6N-Duoxa2^{tm1b(KOMP)Wtsi}/Wtsi)	decreased circulating amylase level	J:211773
	decreased circulating glucose level	J:211773
	decreased circulating thyroxine level	J:211773
	improved glucose tolerance	J:211773
	increased blood urea nitrogen level	J:211773
	increased circulating calcium level	J:211773
	increased circulating cholesterol level	J:211773
	increased circulating creatinine level	J:211773
	increased circulating fructosamine level	J:211773
	increased circulating HDL cholesterol level	J:211773
	increased circulating iron level	J:211773
	increased circulating LDL cholesterol level	J:211773
	increased circulating serum albumin level	J:211773
	increased circulating sodium level	J:211773
	increased circulating total protein level	J:211773
	increased fasting circulating glucose level	J:211773
Dusp1^{tm1(KOMP)Wtsi}/Dusp1^{tm1(KOMP)Wtsi} (C57BL/6N-Dusp1^{tm1(KOMP)Wtsi}/Wtsi)	decreased circulating alanine transaminase level	J:175295
Dusp1^tm1Brv/Dusp1^tm1Brv (involves: 129S2/SvPas)	abnormal circulating alanine transaminase level	J:118832
	abnormal nitric oxide homeostasis	J:118832
	increased blood urea nitrogen level	J:118832
	pulmonary edema	J:118832
Dusp1^tm1Brv/Dusp1^tm1Brv (involves: 129S2/SvPas * C57BL/6)	decreased circulating cholesterol level	J:129718
	decreased circulating free fatty acids level	J:129718
	decreased circulating triglyceride level	J:129718
	decreased susceptibility to diet-induced obesity	J:129718
	increased circulating interleukin-6 level	J:118833
	increased circulating interleukin-10 level	J:118833
	increased circulating tumor necrosis factor level	J:118833
	increased energy expenditure	J:129718
	increased hepatic glucose production	J:129718
	increased respiratory quotient	J:129718
Dusp1^tm1Brv/Dusp1^tm1Brv (involves: 129S2/SvPas * various)	decreased body temperature	J:125919
Dusp1^tm1Lex/Dusp1^tm1Lex (involves: 129S5/SvEvBrd * C57BL/6)	abnormal chemokine level	J:126383
	abnormal interleukin level	J:126383
	increased circulating interferon-gamma level	J:126383
	increased circulating interleukin-6 level	J:126383
	increased circulating interleukin-10 level	J:126383
	increased circulating tumor necrosis factor level	J:126383
	increased prostaglandin level	J:126383
Dusp3^{tm1a(KOMP)Wtsi}/Dusp3^{tm1a(KOMP)Wtsi} (B6JTyr;B6N-Dusp3^{tm1a(KOMP)Wtsi}/Wtsi)	decreased circulating creatinine level	J:175295
Dusp3^{tm1b(KOMP)Wtsi}/Dusp3^{tm1b(KOMP)Wtsi} (B6Brd;B6Dnk;B6N-Tyr^c-Brd Dusp3^{tm1b(KOMP)Wtsi}/Wtsi)	increased circulating glycerol level	J:211773
	increased circulating insulin level	J:211773
Dusp4^{tm1a(EUCOMM)Wtsi}/Dusp4^{tm1a(EUCOMM)Wtsi} (C57BL/6N-Dusp4^{tm1a(EUCOMM)Wtsi}/Wtsi)	decreased circulating glucose level	J:175295
	decreased circulating potassium level	J:175295
	decreased circulating sodium level	J:175295
	increased circulating sodium level	J:175295
Dusp7^{tm1(KOMP)Wtsi}/Dusp7^{tm1(KOMP)Wtsi} (C57BL/6N-Dusp7^{tm1(KOMP)Wtsi}/Nju)	abnormal cholesterol homeostasis	J:211773
	decreased circulating cholesterol level	J:211773
	decreased circulating HDL cholesterol level	J:211773
Dusp8^em1(IMPC)Mbp/Dusp8^em1(IMPC)Mbp (C57BL/6N-Dusp8^em1(IMPC)Mbp/MbpMmucd)	impaired glucose tolerance	J:211773
Dusp11^{Gt(BB0198)Wtsi}/Dusp11^{Gt(BB0198)Wtsi} (B6.129P2-Dusp11^{Gt(BB0198)Wtsi})	increased circulating interleukin-1 beta level	J:301503
	increased circulating interleukin-6 level	J:301503
	increased circulating tumor necrosis factor level	J:301503
Dusp11^{tm1b(EUCOMM)Wtsi}/Dusp11^{tm1b(EUCOMM)Wtsi} (C57BL/6N-Dusp11^{tm1b(EUCOMM)Wtsi}/Ics)	increased circulating aspartate transaminase level	J:211773
Dusp16^em1(IMPC)Tcp/Dusp16^em1(IMPC)Tcp (C57BL/6NCrl-Dusp16^em1(IMPC)Tcp/Tcp)	decreased circulating HDL cholesterol level	J:211773
	increased circulating bilirubin level	J:211773
Dusp22^tm1Tht/Dusp22^tm1Tht (B6.129S7-Dusp22^tm1Tht)	abnormal cytokine level	J:213253
	increased circulating interferon-gamma level	J:213253
	increased circulating interleukin-6 level	J:213253
	increased circulating interleukin-17 level	J:213253
	increased circulating tumor necrosis factor level	J:213253
Dusp26^em1Jhxia/Dusp26^em1Jhxia Speer6-ps1^{Tg(Alb-cre)21Mgn}/Speer6-ps1⁺ (involves: C57BL/6 * DBA)	decreased liver glycogen level	J:279111
	impaired glucose tolerance	J:279111
	increased circulating alanine transaminase level	J:279111
	increased circulating aspartate transaminase level	J:279111
	increased circulating glucose level	J:279111
	increased fasting circulating glucose level	J:279111
	increased liver cholesterol level	J:279111
	increased liver free fatty acids level	J:279111
	increased liver triglyceride level	J:279111
	increased susceptibility to diet-induced obesity	J:279111
	insulin resistance	J:279111
Dusp26^{tm1a(KOMP)Wtsi}/Dusp26^{tm1a(KOMP)Wtsi} (C57BL/6N-Dusp26^{tm1a(KOMP)Wtsi}/Wtsi)	decreased circulating LDL cholesterol level	J:175295
	decreased circulating magnesium level	J:175295
	decreased circulating total protein level	J:175295
Dvl2^tm1Awb/Dvl2^tm1Awb (either: 129S6/SvEvTac-Dvl2^tm1Awb or (involves: 129S6/SvEvTac * NIH Swiss))	cyanosis	J:79834
Dvl2^tm1Awb/Dvl2^tm1Awb Dvl3^tm1Awb/Dvl3⁺ (involves: 129S6/SvEvTac * Black Swiss)	pericardial effusion	J:142392
Dvl3^tm1Awb/Dvl3^tm1Awb (129S6/SvEvTac-Dvl3^tm1Awb)	cyanosis	J:142392
Dvl3^tm1Awb/Dvl3^tm1Awb (involves: 129S6/SvEvTac * Black Swiss)	cyanosis	J:142392
Dym^em1(IMPC)Tcp/Dym^em1(IMPC)Tcp (C57BL/6N-Dym^em1(IMPC)Tcp/Tcp)	decreased circulating cholesterol level	J:211773
	decreased circulating HDL cholesterol level	J:211773
	decreased circulating triglyceride level	J:211773
	increased circulating alanine transaminase level	J:211773
	increased circulating alkaline phosphatase level	J:211773
	increased circulating aspartate transaminase level	J:211773
Dync1h1^tm1dIcs/Dync1h1⁺ (C57BL/6N-Dync1h1^tm1dIcs/Ics)	impaired glucose tolerance	J:211773
Dync1i2^{tm1a(EUCOMM)Wtsi}/Dync1i2⁺ (C57BL/6N-Dync1i2^{tm1a(EUCOMM)Wtsi}/Wtsi)	decreased circulating cholesterol level	J:175295
	decreased circulating sodium level	J:175295
Dync2i1^{Tn(pb-Act-RFP)1.1Zhu}/Dync2i1^{Tn(pb-Act-RFP)1.1Zhu} (involves: FVB/NJ)	cardiac edema	J:335806
	edema	J:335806
Dync2li1^tm1Aar/Dync2li1^tm1Aar (involves: 129P2/OlaHsd)	pericardial edema	J:93573
Dynll1^{Gt(EUCE0287d04)Hmgu}/Dynll1^{Gt(EUCE0287d04)Hmgu} (involves: 129P2/OlaHsd)	edema	J:217609
Dynll1^{tm1(KOMP)Wtsi}/Dynll1⁺ (C57BL/6N-Dynll1^{tm1(KOMP)Wtsi}/Wtsi)	decreased circulating fructosamine level	J:211773
	decreased circulating glucose level	J:211773
	increased circulating alkaline phosphatase level	J:211773
	increased circulating bilirubin level	J:211773
Dynlrb2^{tm1a(KOMP)Wtsi}/Dynlrb2⁺ (C57BL/6N-Dynlrb2^{tm1a(KOMP)Wtsi}/Wtsi)	increased circulating magnesium level	J:211773
	increased circulating phosphate level	J:211773
	increased fasting circulating glucose level	J:211773
Dyrk1b^{tm1b(EUCOMM)Wtsi}/Dyrk1b⁺ (C57BL/6N-Dyrk1b^{tm1b(EUCOMM)Wtsi}/Ics)	decreased blood urea nitrogen level	J:211773
Dysf^tm1Kcam/Dysf^tm1Kcam (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	increased circulating creatine kinase level	J:83126, J:171870
Dytn^em1(IMPC)J/Dytn^em1(IMPC)J (C57BL/6NJ-Dytn^em1(IMPC)J/Mmjax)	decreased circulating phosphate level	J:211773
Dzip1l^em1(IMPC)J/Dzip1l^em1(IMPC)J (C57BL/6NJ-Dzip1l^em1(IMPC)J/Mmjax)	edema	J:211773
E2f1^{Tg(Wnt1-cre)2Sor}/E2f1⁺ Snrpb^em1Lajm/Snrpb⁺ (involves: C3H * C57BL/6 * C57BL/6J * CD1)	edema	J:326544
E2f1^tm1Meg/E2f1^tm1Meg (either: (involves: 129/Sv * 129S4/SvJae) or (involves: 129/Sv * 129S4/SvJae * C57BL/6))	decreased salivation	J:93708
E2f1^tm1Meg/E2f1^tm1Meg (NOD.Cg-E2f1^tm1Meg)	decreased salivation	J:93708
E2f1^tm1Meg/E2f1^tm1Meg E2f3^tm2.1Gle/E2f3^tm2.1Gle (involves: 129S4/SvJae * 129S6/SvEvTac * FVB/N * NIH Black Swiss)	decreased circulating growth hormone level	J:138289
	decreased circulating insulin-like growth factor I level	J:138289
	decreased circulating leptin level	J:138289
	decreased circulating triglyceride level	J:138289
E2f1^tm1Njd/E2f1^tm1Njd (involves: 129S2/SvPas * C57BL/6)	abnormal circulating insulin level	J:89720
	decreased circulating glucose level	J:89720
	decreased circulating insulin level	J:89720
	decreased insulin secretion	J:89720
	impaired glucose tolerance	J:89720
	increased insulin sensitivity	J:89720
E2f3^{tm1b(KOMP)Wtsi}/E2f3⁺ (C57BL/6N-E2f3^{tm1b(KOMP)Wtsi}/Kmpc)	impaired glucose tolerance	J:211773
E2f3^tm1Lees/E2f3^tm1Lees (involves: 129S2/SvPas * C57BL/6)	abnormal atrial thrombosis	J:75765
	abnormal cardiac thrombosis	J:75765
	pleural effusion	J:75765
	pulmonary edema	J:75765
E2f4^tm1Lees/E2f4^tm1Lees (involves: 129S2/SvPas * C57BL/6)	dehydration	J:64193
E2f5^tm1Dli/E2f5^tm1Dli (either: (involves: 129S1/Sv * BALB/c) or (involves: 129S1/Sv * C57BL/6))	dehydration	J:47283
E4f1^tm1Pisc/E4f1^tm1.1Llca Tg(KRT5-cre)5132Jlj/0 (involves: 129S4/SvJae * C57BL/6 * DBA/2J)	dehydration	J:167157
E130308A19Rik^em1(IMPC)J/E130308A19Rik^em1(IMPC)J (C57BL/6NJ-E130308A19Rik^em1(IMPC)J/Mmjax)	increased circulating cholesterol level	J:211773
E130311K13Rik^em1(IMPC)J/E130311K13Rik^em1(IMPC)J (C57BL/6NJ-E130311K13Rik^em1(IMPC)J/J)	increased circulating alanine transaminase level	J:211773
Ebf1^em1(IMPC)Mbp/Ebf1⁺ (C57BL/6N-Ebf1^em1(IMPC)Mbp/MbpMmucd)	increased circulating serum albumin level	J:211773
Ebi3^Gt716Lex/Ebi3^Gt716Lex Tg(DO11.10)10Dlo/0 (involves: 129S5/SvEvBrd * BALB/c * C3H * C57BL/6)	abnormal circulating interleukin level	J:134148
	increased circulating interleukin-17 level	J:134148
Ebi3^tm1Nkma/Ebi3^tm1Nkma Fas^lpr/Fas^lpr (MRL.Cg-Ebi3^tm1Nkma Fas^lpr)	abnormal blood homeostasis	J:181669
	abnormal cytokine level	J:181669
	abnormal renal protein reabsorption	J:181669
	decreased blood urea nitrogen level	J:181669
	decreased circulating creatine level	J:181669
	decreased circulating creatinine level	J:181669
	decreased circulating interferon-gamma level	J:181669
	increased circulating interleukin-4 level	J:181669
	increased urine protein level	J:181669
Ece1^tm1Reh/Ece1^tm1Reh (involves: 129S6/SvEvTac * C57BL/6)	hydrops fetalis	J:46640
Ece1^tm1Reh/Ece1^tm1Reh (involves: 129S6/SvEvTac * C57BL/6)	pericardial effusion	J:46640
Ecel1^em1Hiki/Ecel1^em1Hiki (involves: C57BL/6)	cyanosis	J:262090
Ecel1^tm1Jroh/Ecel1^tm1Jroh (involves: 129P2/OlaHsd * C57BL/6)	anoxia	J:56300
	cyanosis	J:56300
Echdc1^em1(IMPC)J/Echdc1^em1(IMPC)J (C57BL/6NJ-Echdc1^em1(IMPC)J/Mmjax)	increased circulating cholesterol level	J:346664
	increased circulating LDL cholesterol level	J:346664
	increased circulating triglyceride level	J:346664
	increased circulating VLDL cholesterol level	J:346664
	increased circulating VLDL triglyceride level	J:346664
Echs1^em1Jynz/Echs1⁺ (C57BL/6-Echs1^em1Jynz)	abnormal free fatty acids level	J:283707
Echs1^em1Jynz/Echs1⁺ (C57BL/6-Echs1^em1Jynz)	abnormal lipid level	J:283707
Eci1^tm1Wst/Eci1^tm1Wst (involves: 129S1/Sv * 129X1/SvJ)	abnormal lipid level	J:76763
	abnormal urine homeostasis	J:76763
	increased triglyceride level	J:76763
	increased unsaturated fatty acids level	J:76763
Eci3^{tm1b(EUCOMM)Wtsi}/Eci3^{tm1b(EUCOMM)Wtsi} (C57BL/6N-Eci3^{tm1b(EUCOMM)Wtsi}/Wtsi)	increased circulating alanine transaminase level	J:211773
Ecpas^em1(IMPC)J/Ecpas^em1(IMPC)J (C57BL/6NJ-Ecpas^em1(IMPC)J/Mmjax)	increased circulating phosphate level	J:211773
Ecrg4^{tm1b(EUCOMM)Hmgu}/Ecrg4^{tm1b(EUCOMM)Hmgu} (C57BL/6N-Ecrg4^{tm1b(EUCOMM)Hmgu}/Orl)	increased circulating cholesterol level	J:211773
Ecscr^{tm1a(KOMP)Wtsi}/Ecscr^{tm1a(KOMP)Wtsi} (involves: C57BL/6N)	enhanced lipolysis	J:236657
	increased circulating free fatty acids level	J:236657
	increased circulating glycerol level	J:236657
	increased circulating triglyceride level	J:236657
Edaradd^cr/Edaradd^cr (B6C3Fe a/a-Edaradd^cr/J)	abnormal lipid level	J:5870
Edc3^em1(IMPC)Tcp/Edc3⁺ (C57BL/6NCrl-Edc3^em1(IMPC)Tcp/Tcp)	increased circulating alkaline phosphatase level	J:211773
Edn1^tm1Utj/Edn1⁺ (involves: 129X1/SvJ * ICR)	abnormal blood gas level	J:60070
	hypercapnia	J:60070
	hypoxia	J:60070
Edn1^tm1Ywa/Edn1^tm1Ywa Tg(Aqp2-cre)1Dek/0 (involves: 129S6/SvEvTac * C57BL/6 * SJL)	abnormal urine homeostasis	J:104785
	decreased circulating antidiuretic hormone level	J:104785
	decreased circulating sodium level	J:104785
	increased urine osmolality	J:104785
Edn1^tm1Ywa/Edn1^tm1Ywa Tg(AQP2-cre)2Dek/0 (involves: C57BL/6 * CBA)	decreased urine sodium level	J:91968
Edn2^tm1.1Nat/Edn2^tm1.1Nat Tg(CAG-cre/Esr1)5Amc/0 (involves: 129S1/Sv 129X1/SvJ * C57BL/6 * CBA)	acidemia	J:201436
	acidosis	J:201436
	decreased body temperature	J:201436
	decreased circulating glucose level	J:201436
	hypercapnia	J:201436
	impaired adaptive thermogenesis	J:201436
	increased circulating bicarbonate level	J:201436
Edn2^tm1Ywa/Edn2^tm1Ywa (involves: 129S6/SvEvTac)	abnormal blood homeostasis	J:201436
	abnormal gas homeostasis	J:201436
	abnormal lipolysis	J:201436
	acidemia	J:201436
	acidosis	J:201436
	decreased body temperature	J:201436
	decreased circulating glucose level	J:201436
	decreased circulating triiodothyronine level	J:201436
	hypercapnia	J:201436
	hypoxia	J:201436
	impaired adaptive thermogenesis	J:201436
	increased blood urea nitrogen level	J:201436
	increased blood uric acid level	J:201436
	increased circulating bicarbonate level	J:201436
	increased circulating erythropoietin level	J:201436
	increased circulating ketone body level	J:201436
Edn2^tm1Ywa/Edn2^tm1Ywa (involves: 129S6/SvEvTac * C57BL/6)	decreased circulating progesterone level	J:215159
Ednra^tm1Ywa/Ednra^tm1Ywa Ednrb^tm1Ywa/Ednrb^tm1Ywa (involves: 129S7/SvEvBrd)	pericardial effusion	J:46640
Ednra^tm1Ywa/Ednra^tm1Ywa Foxc2^tm1Miu/Foxc2^tm1Miu (involves: 129P2/OlaHsd * 129S7/SvEvBrd * C57BL/6)	pericardial edema	J:102130
Ednra^tm2Ywa/Ednra^tm2Ywa Tg(Aqp2-cre)1Dek/0 (involves: 129S7/SvEvBrd * C57BL/6 * SJL)	abnormal urine osmolality	J:101241
	increased circulating antidiuretic hormone level	J:101241
Ednrb^s-24Pub/Ednrb⁺ m128-7Tpo/m128-7Tpo⁺ (involves: 101/Rl * C3H/Rl * C57BL/6J * SSL/LeJ)	hemopericardium	J:149893
Ednrb^tm1.1Nrd/Ednrb⁺ (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	abnormal blood pH regulation	J:226561
	abnormal oxygen level	J:226561
	decreased circulating lactate level	J:226561
	hypocapnia	J:226561
Ednrb^tm1Yko/Ednrb^tm1Yko Tg(AQP2-cre)2Dek/0 (involves: C57BL/6 * CBA)	abnormal urine homeostasis	J:116002
	abnormal urine sodium level	J:116002
Ednrb^tm1Yko/Ednrb^tm1Yko Tg(Tek-cre)1Ywa/0 (involves: 129P2/OlaHsd * Bkl:BKW * C57BL/6 * SJL)	abnormal blood homeostasis	J:135711
	abnormal nitric oxide homeostasis	J:135711
Ednrb^tm1Ywa/Ednrb^s (involves: 129S/SvEv)	abnormal blood gas level	J:60070
	hypercapnia	J:60070
	hypoxia	J:60070
Eea1^{tm1b(EUCOMM)Hmgu}/Eea1^{tm1b(EUCOMM)Hmgu} (C57BL/6N-Eea1^{tm1b(EUCOMM)Hmgu}/Ieg)	increased circulating alanine transaminase level	J:211773
	increased circulating aspartate transaminase level	J:211773
Eef1d^em1(IMPC)Mbp/Eef1d⁺ (C57BL/6NCrl-Eef1d^em1(IMPC)Mbp/MbpMmucd)	edema	J:211773
Eef1d^em1(IMPC)Mbp/Eef1d^em1(IMPC)Mbp (C57BL/6NCrl-Eef1d^em1(IMPC)Mbp/MbpMmucd)	edema	J:211773
Eef2kmt^{tm1b(EUCOMM)Wtsi}/Eef2kmt^{tm1b(EUCOMM)Wtsi} (C57BL/6N-Eef2kmt^{tm1b(EUCOMM)Wtsi}/Ieg)	impaired glucose tolerance	J:211773
Eepd1^em1(IMPC)J/Eepd1^em1(IMPC)J (C57BL/6NJ-Eepd1^em1(IMPC)J/Mmjax)	increased circulating phosphate level	J:211773
Efcab7^em1(IMPC)J/Efcab7^em1(IMPC)J (C57BL/6NJ-Efcab7^em1(IMPC)J/Mmjax)	decreased circulating total protein level	J:211773
Efna4^{tm1.1(KOMP)Vlcg}/Efna4^{tm1.1(KOMP)Vlcg} (C57BL/6N-Efna4^{tm1.1(KOMP)Vlcg}/J)	decreased circulating glucose level	J:211773
Efna5^{tm1b(EUCOMM)Wtsi}/Efna5^{tm1b(EUCOMM)Wtsi} (C57BL/6N-Efna5^{tm1b(EUCOMM)Wtsi}/Ieg)	increased fasting circulating glucose level	J:211773
Efnb1^tm1.1Rha/Efnb1^tm1.1Rha (involves: 129P2/OlaHsd * BALB/c * C57BL/6)	edema	J:110732
Efnb1^tm1Rha/Y Tg(Pgk1-cre)1Lni/? (involves: 129P2/OlaHsd * BALB/c * C57BL/6)	edema	J:110732
Efnb2^tm5.1Kln/Efnb2^tm5.1Kln (involves: C57BL/6)	chylothorax	J:95885
Efnb2^tm5.1Kln/Efnb2^tm5.1Kln (involves: CD-1)	chylothorax	J:95885
Efnb2^tm5Kln/Efnb2^tm5Kln (involves: C57BL/6)	chylothorax	J:95885
Efr3b^em1(IMPC)Mbp/Efr3b^em1(IMPC)Mbp (C57BL/6N-Efr3b^em1(IMPC)Mbp/Ucd)	decreased circulating creatinine level	J:211773
	impaired glucose tolerance	J:211773
Eftud2^{tm1b(KOMP)Wtsi}/Eftud2⁺ (C57BL/6N-Eftud2^{tm1b(KOMP)Wtsi}/Ics)	increased circulating calcium level	J:211773
	increased circulating cholesterol level	J:211773
	increased circulating HDL cholesterol level	J:211773
	increased circulating serum albumin level	J:211773
	increased circulating total protein level	J:211773
Egfem1^em1(IMPC)J/Egfem1^em1(IMPC)J (C57BL/6NJ-Egfem1^em1(IMPC)J/J)	decreased fasting circulating glucose level	J:211773
	impaired glucose tolerance	J:211773
Egfl7^{Gt(OST80956)Lex}/Egfl7^{Gt(OST80956)Lex} (involves: 129S5/SvEvBrd * C57BL/6)	edema	J:124110
	hypoxia	J:124110
Egfr^tm1Dwt/Egfr^tm1Dwt Sox9^tm3(cre)Crm/Sox9⁺ (involves: 129S6/SvEvTac * 129S7/SvEvBrd)	impaired skin barrier function	J:229771
Egfr^tm1Mag/Egfr^tm1Mag (involves: 129S2/SvPas * CD-1)	increased blood urea nitrogen level	J:26833
Egfr^tm1Mag/Egfr^tm1Mag (involves: 129S2/SvPas * CD-1)	increased circulating creatinine level	J:26833
Egfr^tm1Msi/Egfr^tm1Msi Tg(Alb1-cre)7Gsc/? (involves: 129P2/OlaHsd * C57BL/6 * FVB/N)	increased circulating tumor necrosis factor level	J:125912
Egfr^tm1Msi/Egfr^tm1Msi Tg(Mx1-cre)1Cgn/? (involves: 129P2/OlaHsd * C57BL/6 * CBA)	increased circulating tumor necrosis factor level	J:125912
Egfr^tm1Rdk/Egfr^tm1Rdk (involves: 129X1/SvJ * Black Swiss)	cyanosis	J:41158
Egfr^tm1Wag/Egfr^tm1Wag (involves: 129 * C57BL/6 * MF1)	dehydration	J:26834
Egln1^{Gt(RRG405)Byg}/Egln1^{Gt(RRG405)Byg} P4htm^tm1Jomy/P4htm^tm1Jomy (Not Specified)	decreased circulating erythropoietin level	J:213191
Egln1^tm1Kael/Egln1^tm1Kael Tg(CAG-cre/Esr1)5Amc/0 (involves: 129S6/SvEvTac C57BL/6 * CBA)	increased circulating erythropoietin level	J:132718
Egln1^tm2.1Fsl/Egln1^tm2.1Fsl Gt(ROSA)26Sor^{tm9(cre/ESR1)Arte}/Gt(ROSA)26Sor⁺ (B6.Cg-Gt(ROSA)26Sor^{tm9(cre/ESR1)Arte} Egln1^tm2.1Fsl)	increased erythropoietin level	J:202737
Egln1^tm2.1Fsl/Egln1^tm2.1Fsl Gt(ROSA)26Sor^{tm9(cre/ESR1)Arte}/Gt(ROSA)26Sor⁺ Hif1a^tm3Rsjo/Hif1a^tm3Rsjo (B6.Cg-Gt(ROSA)26Sor^{tm9(cre/ESR1)Arte} Egln1^tm2.1Fsl Hif1a^tm3Rsjo)	increased erythropoietin level	J:202737
Egln1^tm2Fong/Egln1^tm2Fong Gt(ROSA)26Sor^{tm1(cre/ERT2)Alj}/Gt(ROSA)26Sor⁺ (involves: 129S6/SvEvTac * C57BL/6)	increased circulating erythropoietin level	J:132720
Egln2^tm1Pec/Egln2^tm1Pec (involves: 129S/SvEv * Swiss)	decreased oxygen consumption	J:132630
Egln3^tm1Pjr/Egln3^tm1Pjr (involves: 129S/SvEv * Swiss)	decreased circulating adrenaline level	J:136034
Egln3^tm1Pjr/Egln3^tm1Pjr (involves: 129S/SvEv * Swiss)	decreased circulating noradrenaline level	J:136034
Egr1^tm1Jmi/Egr1^tm1Jmi (involves: 129)	abnormal circulating progesterone level	J:35132
Egr1^tm1Jmi/Egr1^tm1Jmi (involves: 129)	decreased luteinizing hormone level	J:35132
Egr1^tm1Jmi/Egr1^tm1Jmi (B6.129-Egr1^tm1Jmi)	abnormal circulating alanine transaminase level	J:128421
Egr1^tm1Jmi/Egr1^tm1Jmi (B6.129-Egr1^tm1Jmi)	abnormal circulating tumor necrosis factor level	J:128421
Egr1^tm1Jmi/Egr1^tm1Jmi (involves: 129 * C57BL/6)	abnormal circulating alanine transaminase level	J:105638
	abnormal homeostasis	J:105638
	abnormal tumor necrosis factor level	J:105638
	increased liver triglyceride level	J:105638
Egr1^tm1Pch/Egr1^tm1Pch (involves: 129S2/SvPas * C57BL/6J)	decreased circulating testosterone level	J:45064
Egr1^tm1Pch/Egr1^tm1Pch (involves: 129S2/SvPas * C57BL/6J)	decreased growth hormone level	J:45064
Egr2^tm2(cre)Pch/Egr2⁺ Phox2b^tm4Jbr/Phox2b⁺ (involves: 129S2/SvPas * C57BL/6 * DBA/2)	alkalemia	J:176573
Egr3^tm1.1Kfuji/Egr3^tm1.1Kfuji Tg(Cd4-cre)1Cwi/0 (involves: C57BL/6 * DBA/2)	decreased transforming growth factor beta level	J:205814
Eh/Eh (B6By.Cg-Eh/J)	cyanosis	J:121991
Ehbp1l1^{tm1a(EUCOMM)Wtsi}/Ehbp1l1^{tm1a(EUCOMM)Wtsi} (C57BL/6N-Ehbp1l1^{tm1a(EUCOMM)Wtsi}/Wtsi)	subcutaneous edema	J:239583
Ehd1^{tm1a(EUCOMM)Wtsi}/Ehd1⁺ (C57BL/6N-Ehd1^{tm1a(EUCOMM)Wtsi}/Wtsi)	increased circulating chloride level	J:175295
Ehd2^tm1.1Cbm/Ehd2^tm1.1Cbm (B6N.129(Cg)-Ehd2^tm1.1Cbm)	decreased circulating free fatty acids level	J:285350
Ehd3^tm1.2Haba/Ehd3^tm1.2Haba Ehd4^tm1.1Haba/Ehd4^tm1.1Haba (involves: 129P2/OlaHsd * C57BL/6 * C57BL/6J)	increased urine protein level	J:171715
Ehf^{em1(IMPC)Kmpc}/Ehf^{em1(IMPC)Kmpc} (C57BL/6NTac-Ehf^{em1(IMPC)Kmpc}/Kmpc)	decreased fasting circulating glucose level	J:211773
	improved glucose tolerance	J:211773
Ehhadh^{tm1b(KOMP)Wtsi}/Ehhadh^{tm1b(KOMP)Wtsi} (C57BL/6NTac-Ehhadh^{tm1b(KOMP)Wtsi}/H)	increased circulating potassium level	J:211773
Ehhadh^tm1Jkr/Ehhadh^tm1Jkr (involves: 129P2/OlaHsd * C57BL/6J)	abnormal lipid homeostasis	J:104835
Ehhadh^tm1Jkr/Ehhadh^tm1Jkr Hsd17b4^tm1Baes/Hsd17b4^tm1Baes (involves: 129P2/OlaHsd * 129S1/Sv * 129X1/SvJ * C57BL/6J)	abnormal bile salt level	J:99925
	abnormal lipid homeostasis	J:104835
	abnormal lipid level	J:89945, J:104835
	decreased fatty acids level	J:89945
Ehmt1^tm1.1Tara/Ehmt1^tm1.1Tara Tg(Adipoq-cre)1Evdr/0 (involves: 129P2/OlaHsd * FVB/NJ)	abnormal oxygen consumption	J:207678
	decreased body temperature	J:207678
	decreased fatty acid oxidation	J:207678
	impaired adaptive thermogenesis	J:207678
	impaired glucose tolerance	J:207678
	increased circulating free fatty acids level	J:207678
	increased circulating glucose level	J:207678
	increased circulating insulin level	J:207678
	increased liver triglyceride level	J:207678
	insulin resistance	J:207678
Ehmt1^{tm1b(EUCOMM)Hmgu}/Ehmt1⁺ (C57BL/6N-Ehmt1^{tm1b(EUCOMM)Hmgu}/Nju)	decreased blood urea nitrogen level	J:211773
	decreased circulating creatinine level	J:211773
	decreased circulating serum albumin level	J:211773
Ehmt1^{tm1b(EUCOMM)Hmgu}/Ehmt1⁺ (C57BL/6N-Ehmt1^{tm1b(EUCOMM)Hmgu}/Wtsi)	increased circulating cholesterol level	J:211773
	increased circulating LDL cholesterol level	J:211773
Eid2b^em1(IMPC)J/Eid2b⁺ (C57BL/6NJ-Eid2b^em1(IMPC)J/Mmjax)	decreased circulating calcium level	J:211773
Eid2b^em1(IMPC)J/Eid2b⁺ (C57BL/6NJ-Eid2b^em1(IMPC)J/Mmjax)	increased circulating glucose level	J:211773
Eif2ak1^tm1Jjch/Eif2ak1^tm1Jjch (Not Specified)	abnormal iron homeostasis	J:85896
Eif2ak2^em1(IMPC)Mbp/Eif2ak2^em1(IMPC)Mbp (C57BL/6N-Eif2ak2^em1(IMPC)Mbp/MbpMmucd)	increased circulating calcium level	J:211773
	increased circulating creatinine level	J:211773
	increased circulating serum albumin level	J:211773
Eif2ak3^tm1.1Drc/Eif2ak3^tm1.1Drc Tg(Ela1-cre)16Eps/0 (involves: 129S6/SvEvTac)	increased circulating amylase level	J:129974
Eif2ak3^tm1Drc/Eif2ak3^tm1Drc (involves: 129S6/SvEvTac)	abnormal insulin secretion	J:76661
	decreased circulating insulin level	J:76661
	hyperglycemia	J:76661
	impaired glucose tolerance	J:76661
	increased liver glycogen level	J:76661
Eif2ak3^tm1Dron/Eif2ak3⁺ (either: 129S6/SvEvTac-Eif2ak3^tm1Dron or (involves: 129S6/SvEvTac * C57BL/6))	impaired glucose tolerance	J:70005
Eif2ak3^tm1Dron/Eif2ak3^tm1Dron (involves: 129S6/SvEvTac * Swiss Webster)	decreased circulating insulin level	J:70005
	hyperglycemia	J:70005
	steatorrhea	J:70005
Eif2ak4^tm1Drc/Eif2ak4^tm1Drc (involves: 129S6/SvEvTac * C57BL/6)	abnormal circulating amino acid level	J:92545
Eif2ak4^tm1Drc/Eif2ak4^tm1Drc (B6.129S6-Eif2ak4^tm1Drc)	abnormal circulating amino acid level	J:92545
Eif2ak4^tm1Drc/Eif2ak4^tm1Drc Impact^tm1.1Casb/Impact^tm1.1Casb (involves: 129S6/SvEvTac * C57BL/6J)	decreased body temperature	J:279071
	decreased susceptibility to diet-induced obesity	J:279071
Eif2b4^tm1.1Vdk/Eif2b4^tm1.1Vdk Eif2b5^tm1.1Vdk/Eif2b5^tm1.1Vdk (involves: C57BL/6 * C57BL/6J)	increased hyaluronic acid level	J:234659
Eif2b5^tm1.1Vdk/Eif2b5^tm1.1Vdk (involves: C57BL/6 * C57BL/6J)	increased hyaluronic acid level	J:234659
Eif2b5^{tm1a(EUCOMM)Wtsi}/Eif2b5⁺ (C57BL/6N-Eif2b5^{tm1a(EUCOMM)Wtsi}/Ics)	decreased circulating glucose level	J:165965
Eif2s1^tm1Rjk/Eif2s1^tm1Rjk (involves: 129S1/Sv * 129X1/SvJ)	decreased circulating insulin level	J:70004
	decreased insulin secretion	J:70004
	hypoglycemia	J:70004
Eif2s1^tm1Rjk/Eif2s1^tm1Rjk Ppp1r15b^tm1Dron/Ppp1r15b^tm1Dron (involves: 129P2/OlaHsd)	hypoglycemia	J:144954
Eif3k^{em1(IMPC)Hmgu}/Eif3k⁺ (C57BL/6NCrl-Eif3k^{em1(IMPC)Hmgu}/Ieg)	increased circulating total protein level	J:211773
Eif4b^em1(IMPC)J/Eif4b^em1(IMPC)J (C57BL/6NJ-Eif4b^em1(IMPC)J/Mmjax)	edema	J:211773
Eif4e2^tm1.1Nso/Eif4e2^tm1.1Nso (involves: 129P2/OlaHsd * C57BL/6J)	cyanosis	J:188802
Eif4e3^{tm1a(KOMP)Wtsi}/Eif4e3^{tm1a(KOMP)Wtsi} (B6JTyr;B6N-Eif4e3^{tm1a(KOMP)Wtsi}/Wtsi)	decreased circulating alanine transaminase level	J:175295
	decreased circulating aspartate transaminase level	J:175295
	decreased circulating calcium level	J:175295
	decreased circulating cholesterol level	J:175295
	decreased circulating HDL cholesterol level	J:175295
	decreased circulating LDL cholesterol level	J:175295
	decreased lactate dehydrogenase level	J:175295
Eif4ebp1^tm1Nso/Eif4ebp1^tm1Nso (involves: 129S4/SvJae * BALB/c)	decreased circulating leptin level	J:72217
	hypoglycemia	J:72217
	increased oxygen consumption	J:72217
Eif4enif1^em1(IMPC)Tcp/Eif4enif1⁺ (C57BL/6NCrl-Eif4enif1^em1(IMPC)Tcp/Tcp)	decreased circulating chloride level	J:211773
Eif4enif1^em1(IMPC)Tcp/Eif4enif1^em1(IMPC)Tcp (C57BL/6NCrl-Eif4enif1^em1(IMPC)Tcp/Tcp)	edema	J:211773
Eif4g1^{em1(IMPC)Hmgu}/Eif4g1⁺ (C57BL/6NCrl-Eif4g1^{em1(IMPC)Hmgu}/Ieg)	increased circulating alanine transaminase level	J:211773
	increased circulating aspartate transaminase level	J:211773
	increased circulating chloride level	J:211773
	increased fasting circulating glucose level	J:211773
Eif4g2^{tm1b(KOMP)Wtsi}/Eif4g2⁺ (C57BL/6N-Eif4g2^{tm1b(KOMP)Wtsi}/J)	decreased circulating chloride level	J:211773
	decreased circulating glucose level	J:211773
	impaired glucose tolerance	J:211773
	increased circulating alkaline phosphatase level	J:211773
	increased fasting circulating glucose level	J:211773
Elapor1^{tm1b(EUCOMM)Hmgu}/Elapor1⁺ (C57BL/6N-Elapor1^{tm1b(EUCOMM)Hmgu}/Ics)	increased circulating glucose level	J:211773
Elavl1^tm1.1Dkon/Elavl1^tm1.1Dkon Lyz2^tm1(cre)Ifo/Lyz2⁺ (B6.129P2-Elavl1^tm1.1Dkon Lyz2^tm1(cre)Ifo)	increased circulating interleukin-1 beta level	J:184388
	increased circulating interleukin-6 level	J:184388
	increased circulating interleukin-12 level	J:184388
	increased circulating tumor necrosis factor level	J:184388
Elavl1^tm1.1Dkon/Elavl1^tm1.1Dkon Lyz2^tm1(cre)Ifo/Lyz2⁺ (involves: 129P2/OlaHsd * C57BL/6J)	increased circulating interleukin-1 beta level	J:184388
	increased circulating interleukin-6 level	J:184388
	increased circulating interleukin-12 level	J:184388
	increased circulating tumor necrosis factor level	J:184388
Elavl1^tm1.1Dkon/Elavl1^tm1.1Dkon Tg(MYOD1-cre)M23Glh/0 (involves: 129P2/OlaHsd * C57BL/6)	increased carbon dioxide production	J:279284
	increased oxygen consumption	J:279284
	increased respiratory quotient	J:279284
Elavl1^{tm1b(EUCOMM)Hmgu}/Elavl1⁺ (C57BL/6N-Elavl1^{tm1b(EUCOMM)Hmgu}/J)	increased circulating alanine transaminase level	J:211773
Elavl1^{tm1b(EUCOMM)Hmgu}/Elavl1^{tm1b(EUCOMM)Hmgu} (C57BL/6N-Elavl1^{tm1b(EUCOMM)Hmgu}/J)	edema	J:211773
Elavl3^tm1.1Rbd/Elavl3^tm1.1Rbd Elavl4^tm1Okn/Elavl4^tm1Okn (either: (involves: 129 * C57BL/6) or (involves: 129 * CD-1))	decreased glutamic acid level	J:188326
Elf4^em1Hdu/Elf4^em1Hdu (C57BL/6-Elf4^em1Hdu)	abnormal interferon level	J:328935
	abnormal interleukin level	J:328935
	abnormal tumor necrosis factor level	J:328935
Elk1^{tm1.1(KOMP)Vlcg}/Y (C57BL/6N-Elk1^{tm1.1(KOMP)Vlcg}/J)	increased circulating insulin level	J:211773
Elk3^em1(IMPC)Ics/Elk3⁺ (C57BL/6N-Elk3^em1(IMPC)Ics/Ics)	increased circulating alkaline phosphatase level	J:211773
	increased circulating cholesterol level	J:211773
	increased circulating HDL cholesterol level	J:211773
Elk3^tm1.2Ics/Elk3^tm1.2Ics (involves: 129S2/SvPas * C57BL/6J)	chylothorax	J:221521
Elk3^tm1Wlyk/Elk3^tm1Wlyk (either: (involves: 129/Sv) or (involves: 129/Sv * C57BL/6))	chylothorax	J:71816
Elk4^{tm1a(EUCOMM)Wtsi}/Elk4^{tm1a(EUCOMM)Wtsi} (C57BL/6N-Elk4^{tm1a(EUCOMM)Wtsi}/H)	decreased circulating cholesterol level	J:165965
	decreased circulating HDL cholesterol level	J:165965
	decreased circulating serum albumin level	J:165965
	decreased circulating total protein level	J:165965
	decreased circulating triglyceride level	J:165965
	increased circulating alkaline phosphatase level	J:165965
	increased lactate dehydrogenase level	J:165965
Elk4^{tm1a(EUCOMM)Wtsi}/Elk4^{tm1a(EUCOMM)Wtsi} (Not Specified)	decreased circulating chloride level	J:165965
	decreased circulating fructosamine level	J:165965
	decreased circulating glycerol level	J:165965
	decreased circulating serum albumin level	J:165965
	decreased circulating sodium level	J:165965
Ell2^{tm1a(EUCOMM)Wtsi}/Ell2^{tm1a(EUCOMM)Wtsi} (C57BL/6N-Ell2^{tm1a(EUCOMM)Wtsi}/Wtsi)	decreased circulating serum albumin level	J:211773
	increased circulating alkaline phosphatase level	J:211773
Ell2^{tm1b(EUCOMM)Wtsi}/Ell2^{tm1b(EUCOMM)Wtsi} (C57BL/6N-Ell2^{tm1b(EUCOMM)Wtsi}/Wtsi)	increased circulating alkaline phosphatase level	J:211773
Elmo1^{tm1a(EUCOMM)Wtsi}/Elmo1^{tm1a(EUCOMM)Wtsi} (C57BL/6N-Elmo1^{tm1a(EUCOMM)Wtsi}/Wtsi)	decreased fasting circulating glucose level	J:211773
Elmod1^{tm1a(EUCOMM)Hmgu}/Elmod1^{tm1a(EUCOMM)Hmgu} (C57BL/6N-Elmod1^{tm1a(EUCOMM)Hmgu}/H)	decreased circulating cholesterol level	J:165965
	decreased circulating glucose level	J:165965
	decreased circulating HDL cholesterol level	J:165965
	increased blood urea nitrogen level	J:165965
	increased circulating alkaline phosphatase level	J:165965
	increased circulating chloride level	J:165965
Elmod1^{tm1b(EUCOMM)Hmgu}/Elmod1^{tm1b(EUCOMM)Hmgu} (C57BL/6N-Elmod1^{tm1b(EUCOMM)Hmgu}/H)	increased blood urea nitrogen level	J:211773
	increased circulating phosphate level	J:211773
Elmod2^{tm1b(EUCOMM)Hmgu}/Elmod2⁺ (C57BL/6N-Elmod2^{tm1b(EUCOMM)Hmgu}/H)	increased circulating cholesterol level	J:211773
	increased circulating HDL cholesterol level	J:211773
Eln^tm1Dyl/Eln⁺ (B6.129-Eln^tm1Dyl)	increased circulating renin level	J:86535
Elof1^{tm1.1(KOMP)Vlcg}/Elof1⁺ (C57BL/6N-Elof1^{tm1.1(KOMP)Vlcg}/J)	decreased circulating serum albumin level	J:211773
	increased circulating sodium level	J:211773
Elovl1^tm1.1Akih/Elovl1^tm1.1Akih (involves: 129P2/OlaHsd * C57BL * C57BL/6J * DBA)	abnormal ceramide level	J:204477
	abnormal phospholipid level	J:204477
	abnormal sphingomyelin level	J:204477
	impaired skin barrier function	J:204477, J:261184
Elovl2^em1Haml/Elovl2^em1Haml (C57BL/6N-Elovl2^em1Haml)	decreased unsaturated fatty acids level	J:284063
Elovl2^em1Haml/Elovl2^em1Haml (C57BL/6N-Elovl2^em1Haml)	increased unsaturated fatty acids level	J:284063
Elovl2^tm1Jaco/Elovl2^tm1Jaco (involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)	decreased fatty acids level	J:168856
Elovl3^tm1Jaco/Elovl3^tm1Jaco (involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)	abnormal adaptive thermogenesis	J:88477
	impaired skin barrier function	J:88477
Elovl4^tm1Kzh/Elovl4^tm1Kzh (involves: C57BL/6)	impaired skin barrier function	J:161118
Elovl4^tm1Rayy/Elovl4⁺ (involves: 129 * C57BL/6J)	abnormal fatty acids level	J:114752
Elovl4^tm1Wked/Elovl4^tm1Wked (involves: 129S/SvEv * 129S1/Sv)	impaired skin barrier function	J:121481
Elovl4^tm1Wked/Elovl4^tm1Wked Tg(IVL-Elovl4)#Wked/0 Tg(KRT14-Elovl4)#Mpag/0 (involves: 129 * C57BL/6)	abnormal energy homeostasis	J:277065
Elovl4^tm2Kzh/Elovl4^tm2Kzh (involves: 129X1/SvJ * C57BL/6)	impaired skin barrier function	J:161118
Elovl4^tm3Kzh/Elovl4^tm3Kzh Tg(Rho-cre)#Yzl/? (Not Specified)	decreased unsaturated fatty acids level	J:194246
Elovl4^tm3Kzh/Elovl4^tm3Kzh Tg(Rho-icre)1Ck/? (involves: C57BL/6 * SJL)	decreased unsaturated fatty acids level	J:194246
Elovl6^{Gt(OST222498)Lex}/Elovl6^{Gt(OST222498)Lex} (B6;129S5-Elovl6^{Gt(OST222498)Lex}/Orl)	decreased circulating cholesterol level	J:82809
Elovl6^{Gt(OST222498)Lex}/Elovl6^{Gt(OST222498)Lex} (involves: 129S5/SvEvBrd * C57BL/6)	abnormal fatty acids level	J:130031
	abnormal lipid homeostasis	J:130031
	decreased circulating insulin level	J:130031
	decreased circulating leptin level	J:130031
	decreased fatty acid oxidation	J:130031
	improved glucose tolerance	J:130031
	increased insulin sensitivity	J:130031
Elovl6^{tm1b(EUCOMM)Hmgu}/Elovl6^{tm1b(EUCOMM)Hmgu} (C57BL/6N-Elovl6^{tm1b(EUCOMM)Hmgu}/H)	increased circulating alkaline phosphatase level	J:211773
	increased circulating amylase level	J:211773
	increased circulating triglyceride level	J:211773
Elp1^tm1.1Id/Elp1^tm1.1Id (involves: 129S1/Sv * C57BL/6 * CBA)	pericardial effusion	J:178070
Elp1^tm1Id/Elp1^tm1Id (involves: 129S1/Sv * C57BL/6)	pericardial effusion	J:178070
Elp6^em1(IMPC)J/Elp6⁺ (C57BL/6NJ-Elp6^em1(IMPC)J/Mmjax)	increased circulating alanine transaminase level	J:211773
Elp6^em1(IMPC)J/Elp6⁺ (C57BL/6NJ-Elp6^em1(IMPC)J/Mmjax)	increased circulating aspartate transaminase level	J:211773
Elpfm^C3H/HeJ/? (involves: C3H/HeJ * DBA/2J)	abnormal enzyme/coenzyme level	J:94275
Elpt2^C57BL/6/Elpt2^C57BL/6 (involves: 129S6/SvEvTac * C57BL/6)	increased circulating leptin level	J:142949
Elpt3^{129S6/SvEvTac}/Elpt3^{129S6/SvEvTac} (involves: 129S6/SvEvTac * C57BL/6)	increased circulating leptin level	J:142949
Elpt^C57BL/6J/? (involves: 129S6/SvEvTac * C57BL/6-Insr^tm1Dac Irs1^tm1Jos)	increased circulating leptin level	J:83539
Elpt^C57BL/6J/Elpt^C57BL/6J Hypn^C57BL/6/Hypn^C57BL/6 (involves: 129S6/SvEvTac * C57BL/6-Insr^tm1Dac Irs1^tm1Jos)	increased circulating insulin level	J:83539
Emb^tm1Heij/Emb^tm1Heij (involves: 129S6/SvEvTac * C57BL/6NCrl)	abnormal amniotic fluid composition	J:345100
Emc4^{tm1(KOMP)Wtsi}/Emc4⁺ (C57BL/6N-Emc4^{tm1(KOMP)Wtsi}/Nju)	increased fasting circulating glucose level	J:211773
Emc7^tm1Lex/Emc7⁺ (B6;129S5-Emc7^tm1Lex/Mmucd)	increased response to stress-induced hyperthermia	J:171883
Emc10^{Gt(OST181617)Lex}/Emc10^{Gt(OST181617)Lex} (B6;129S5-Emc10^{Gt(OST181617)Lex}/Mmucd)	improved glucose tolerance	J:171883
Emc10^tm1.2Smoc/Emc10^tm1.2Smoc (involves: 129S6/SvEvTac * C57BL/6J * FVB/N * SJL/J)	abnormal bicarbonate homeostasis	J:307574
	abnormal sodium ion homeostasis	J:307574
Emc10^{tm1b(EUCOMM)Wtsi}/Emc10^{tm1b(EUCOMM)Wtsi} (C57BL/6N-Emc10^{tm1b(EUCOMM)Wtsi}/H)	decreased fasting circulating glucose level	J:211773
Emcn^{em1(IMPC)Wtsi}/Emcn^{em1(IMPC)Wtsi} (C57BL/6N-Emcn^{em1(IMPC)Wtsi}/Wtsi)	decreased circulating cholesterol level	J:211773
	decreased circulating HDL cholesterol level	J:211773
	increased circulating amylase level	J:211773
Emd^{em1(IMPC)Kmpc}/Y (C57BL/6NTac-Emd^{em1(IMPC)Kmpc}/Kmpc)	increased circulating phosphate level	J:211773
Emd^{em1(IMPC)Kmpc}/Emd^{em1(IMPC)Kmpc} (C57BL/6NTac-Emd^{em1(IMPC)Kmpc}/Kmpc)	increased circulating phosphate level	J:211773
Emg1^{tm1.1(KOMP)Wtsi}/Emg1⁺ (C57BL/6N-Emg1^{tm1.1(KOMP)Wtsi}/Bay)	decreased circulating aspartate transaminase level	J:211773
Emid1^{tm1a(EUCOMM)Wtsi}/Emid1^{tm1a(EUCOMM)Wtsi} (C57BL/6N-Emid1^{tm1a(EUCOMM)Wtsi}/Cnrm)	decreased circulating free fatty acids level	J:165965
Emilin1^tm1Gmb/Emilin1^tm1Gmb (involves: 129S1/Sv * 129X1/SvJ)	decreased platelet aggregation	J:226863
	increased prothrombin time	J:226863
Emilin1^tm1Gmb/Emilin1^tm1Gmb Emilin2^tm1.2Jhp/Emilin2^tm1.2Jhp (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	abnormal blood coagulation	J:226863
	decreased platelet aggregation	J:226863
Emilin2^tm1.2Jhp/Emilin2^tm1.2Jhp (involves: C57BL/6)	abnormal blood coagulation	J:226863
Emilin2^tm1.2Jhp/Emilin2^tm1.2Jhp (involves: C57BL/6)	decreased platelet aggregation	J:226863
Eml1^{em1(IMPC)Wtsi}/Eml1^{em1(IMPC)Wtsi} (C57BL/6N-Eml1^{em1(IMPC)Wtsi}/Wtsi)	decreased fasting circulating glucose level	J:211773
Emsy^{em1(IMPC)Ccpcz}/Emsy⁺ (C57BL/6NCrl-Emsy^{em1(IMPC)Ccpcz}/Ccpcz)	impaired glucose tolerance	J:211773
En1^{tm1(Otx2)Wrst}/En1⁺ (involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * CD-1)	decreased serotonin level	J:88192
	increased dopamine level	J:88192
En1^tm1Gld/En1⁺ En2^tm1Alj/En2^tm1Alj (involves: 129S/SvEv * 129S2/SvPas * C57BL/6 * Swiss Webster)	decreased dopamine level	J:115270
En1^tm2Alj/En1⁺ Tg(Th-EGFP)6-7Okn/? (involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * DBA/2J * OF1)	decreased dopamine level	J:214073
En2^tm1Alj/En2^tm1Alj (involves: 129S2/SvPas * C57BL/6)	increased serotonin level	J:114464
Enah^tm1Fbg/Enah^tm1Fbg Evl^tm1Fbg/Evl^tm1Fbg Vasp^tm1Ref/Vasp^tm1Ref (involves: 129 * BALB/c * C57BL/6)	hydrops fetalis	J:127447
Enam^Abte2/Enam⁺ (C3HeB/FeJ-Enam^Abte2)	decreased circulating cholesterol level	J:220423
	decreased circulating transferrin level	J:220423
	decreased circulating triglyceride level	J:220423
Enam^abte/Enam⁺ (C3HeB/FeJ-Enam^abte)	decreased circulating cholesterol level	J:220423
Enam^abte/Enam⁺ (C3HeB/FeJ-Enam^abte)	decreased circulating transferrin level	J:220423
Enc1^{tm1a(EUCOMM)Wtsi}/Enc1^{tm1a(EUCOMM)Wtsi} (C57BL/6N-Enc1^{tm1a(EUCOMM)Wtsi}/Wtsi)	decreased blood urea nitrogen level	J:211773
	decreased circulating cholesterol level	J:211773
	decreased circulating glucose level	J:211773
	decreased circulating HDL cholesterol level	J:211773
	increased circulating alkaline phosphatase level	J:211773
	increased circulating bilirubin level	J:211773
Eng^tm1Dyl/Eng^tm1Dyl (involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)	pericardial effusion	J:55403
Eng^tm1Hma/Eng^tm1Hma (involves: 129P2/OlaHsd * C57BL/6J)	pericardial effusion	J:73415
Eng^tm1Mle/Eng^tm1Mle (involves: 129P2/OlaHsd * C57BL/6)	pericardial edema	J:58502
Eng^tm2.1Hma/Eng^tm2.1Hma Gt(ROSA)26Sor^{tm1(cre/ERT)Nat}/Gt(ROSA)26Sor⁺ (involves: 129P2/OlaHsd * 129S1/Sv * 129X1/SvJ)	dehydration	J:227170
Enho^tm1.1Butl/Enho⁺ (B6.Cg-Enho^tm1.1Butl)	impaired glucose tolerance	J:225402
Enho^tm1.1Butl/Enho⁺ (B6.Cg-Enho^tm1.1Butl)	increased liver triglyceride level	J:225402
Enho^tm1.1Butl/Enho^tm1.1Butl (B6.Cg-Enho^tm1.1Butl)	impaired glucose tolerance	J:225402
	increased circulating insulin level	J:225402
	increased circulating triglyceride level	J:225402
	increased fasting circulating glucose level	J:225402
	increased liver triglyceride level	J:225402
	insulin resistance	J:225402
Enkur^em1(IMPC)Mbp/Enkur⁺ (C57BL/6N-Enkur^em1(IMPC)Mbp/Ucd)	increased circulating alkaline phosphatase level	J:211773
Eno3^em1(IMPC)Bay/Eno3⁺ (C57BL/6N-Eno3^em1(IMPC)Bay/BayMmucd)	impaired glucose tolerance	J:211773
Enpp1^asj-2J/Enpp1⁺ (BALB/cJ-Enpp1^asj-2J/GrsrJ)	calcinosis	J:215824
Enpp1^asj-2J/Enpp1^asj-2J (BALB/cJ-Enpp1^asj-2J/GrsrJ)	abnormal calcium ion homeostasis	J:215824
	abnormal circulating calcium level	J:215824
	abnormal circulating mineral level	J:215824
	abnormal circulating phosphate level	J:215824
	calcinosis	J:215824
	decreased circulating phosphate level	J:215824
Enpp1^asj/Enpp1⁺ (C57BL/6J-Enpp1^asj/GrsrJ)	decreased circulating phosphate level	J:201689
Enpp1^asj/Enpp1^asj (C57BL/6J-Enpp1^asj/GrsrJ)	abnormal mineral level	J:201689
	calcinosis	J:252837, J:215824
	decreased circulating phosphate level	J:201689
	middle ear effusion	J:251638
Enpp1^ttw/Enpp1^ttw (involves: ICR)	calcinosis	J:37369
Enpp1^ttw/Enpp1^ttw (involves: ICR)	decreased circulating phosphate level	J:43357
Enpp2^tm1.1Whm/Enpp2^tm1.1Whm (involves: 129P2/OlaHsd * FVB/N)	edema	J:110324
Enpp2^tm1Lex/Enpp2⁺ (involves: 129S/SvEvBrd * C57BL/6J)	abnormal chemokine level	J:103485
	decreased circulating interleukin-6 level	J:103485
	decreased circulating tumor necrosis factor level	J:103485
Enpp4^em1(IMPC)Ics/Enpp4^em1(IMPC)Ics (C57BL/6N-Enpp4^em1(IMPC)Ics/Ics)	increased circulating phosphate level	J:211773
Enpp5^{tm1b(KOMP)Mbp}/Enpp5^{tm1b(KOMP)Mbp} (C57BL/6N-Enpp5^{tm1b(KOMP)Mbp}/J)	decreased circulating glucose level	J:211773
Enpp7^tm1Rudd/Enpp7^tm1Rudd (involves: 129S1/Sv * C57BL/6)	abnormal enzyme/coenzyme level	J:170667
Ensa^em1(IMPC)J/Ensa^em1(IMPC)J (C57BL/6NJ-Ensa^em1(IMPC)J/Mmjax)	abnormal cholesterol homeostasis	J:211773
	decreased circulating calcium level	J:211773
Entpd1^{tm1a(EUCOMM)Wtsi}/Entpd1^{tm1a(EUCOMM)Wtsi} (C57BL/6N-Entpd1^{tm1a(EUCOMM)Wtsi}/Ieg)	abnormal glucose homeostasis	J:165965
	decreased circulating glycerol level	J:165965
Entpd1^{tm1b(EUCOMM)Wtsi}/Entpd1⁺ (C57BL/6N-Entpd1^{tm1b(EUCOMM)Wtsi}/Ieg)	increased circulating chloride level	J:211773
	increased circulating sodium level	J:211773
Entpd1^tm1Djp/Entpd1^tm1Djp (involves: 129 * C57BL/6)	abnormal platelet physiology	J:76092
Entpd1^tm1Djp/Entpd1^tm1Djp (B6.129-Entpd1^tm1Djp)	decreased platelet aggregation	J:143010
Entpd1^tm1Rdr/Entpd1^tm1Rdr (involves: 129S2/SvPas)	decreased platelet aggregation	J:57505
Entpd1^tm1Rdr/Entpd1^tm1Rdr (involves: 129S2/SvPas)	increased bleeding time	J:57505
Entpd5^tm1Rre/Entpd5^tm1Rre (involves: 129S5/SvEvBrd * C57BL/6J)	decreased cholesterol level	J:163795
	decreased circulating serum albumin level	J:163795
	decreased triglyceride level	J:163795
	hypoglycemia	J:163795
	increased circulating alanine transaminase level	J:163795
	increased circulating alkaline phosphatase level	J:163795
	increased circulating bilirubin level	J:163795
Entpd6^{tm1a(KOMP)Wtsi}/Entpd6^{tm1a(KOMP)Wtsi} (C57BL/6N-Entpd6^{tm1a(KOMP)Wtsi}/Wtsi)	increased circulating alanine transaminase level	J:211773
Entr1^em1(IMPC)Mbp/Entr1^em1(IMPC)Mbp (C57BL/6N-Entr1^em1(IMPC)Mbp/MbpMmucd)	increased circulating calcium level	J:211773
	increased circulating cholesterol level	J:211773
	increased circulating HDL cholesterol level	J:211773
	increased circulating total protein level	J:211773
Eomes^{tm1b(EUCOMM)Wtsi}/Eomes⁺ (C57BL/6N-Eomes^{tm1b(EUCOMM)Wtsi}/H)	decreased circulating creatinine level	J:211773
Eomes^tm1Srnr/Eomes^tm1Srnr Tbx21^tm1Srnr/Tbx21^tm1Srnr Tg(Cd4-cre)1Cwi/0 (involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * DBA/2)	abnormal interleukin level	J:137655
Ep300^tm1Dli/Ep300^tm1Dli (either: 129S4/SvJae or (involves: 129S4/SvJae * C57BL/6))	pericardial effusion	J:47301
Ep300^tm1Reck/Ep300⁺ (involves: 129P2/OlaHsd)	cyanosis	J:85949
Ep300^tm1Reck/Ep300⁺ (involves: 129P2/OlaHsd)	edema	J:85950, J:85949
Epas1^tm1.1Fsl/Epas1^tm1.1Fsl (involves: C57BL/6 * C57BL/6NTac)	increased circulating erythropoietin level	J:199595
Epas1^tm1Mcs/Epas1^tm1Mcs Hif1a^tm3Rsjo/Hif1a^tm3Rsjo Vhl^tm1Jae/Vhl^tm1Jae Tg(Sp7-tTA,tetO-EGFP/cre)1Amc/0 (involves: 129S1/Sv * 129S4/SvJae * 129X1/SvJ * CD-1)	decreased circulating erythropoietin level	J:186085
Epas1^tm1Mcs/Epas1^tm1Mcs Vhl^tm1Jae/Vhl^tm1Jae Tg(Sp7-tTA,tetO-EGFP/cre)1Amc/0 (involves: 129S4/SvJae * 129X1/SvJ * CD-1)	decreased circulating erythropoietin level	J:186085
Epas1^tm1Pec/Epas1^tm1Pec (involves: 129/Sv * Swiss)	cyanosis	J:77480
Epas1^tm1Rus/Epas1^tm1Rus (either: (involves: 129S7/SvEvBrd) or (involves: 129S7/SvEvBrd * C57BL/6))	decreased circulating noradrenaline level	J:50964
Epas1^tm1Yms/Epas1^tm1Yms Tg(Vil1-cre)20Syr/0 (B6.Cg-Epas1^tm1Yms Tg(Vil1-cre)20Syr)	decreased circulating iron level	J:189504
Epb41^tm1Cnby/Epb41^tm1Cnby (involves: 129S/SvEv * 129S1/Sv * 129X1/SvJ)	decreased spleen iron level	J:77852
	increased circulating aspartate transaminase level	J:77852
	increased circulating creatine kinase level	J:77852
	increased kidney iron level	J:77852
	increased liver iron level	J:77852
Epb41l4a^{tm1b(KOMP)Mbp}/Epb41l4a^{tm1b(KOMP)Mbp} (C57BL/6N-Epb41l4a^{tm1b(KOMP)Mbp}/J)	decreased circulating glucose level	J:211773
Epb41l5^{tm1a(EUCOMM)Hmgu}/Epb41l5⁺ (C57BL/6N-Epb41l5^{tm1a(EUCOMM)Hmgu}/H)	decreased circulating glycerol level	J:165965
Epb42^tm1Llp/Epb42^tm1Llp (involves: 129P2/OlaHsd * C57BL/6J)	abnormal ion homeostasis	J:67412
	dehydration	J:67412
	increased spleen iron level	J:67412
Epc1^{tm1a(EUCOMM)Wtsi}/Epc1⁺ (Not Specified)	increased circulating creatine kinase level	J:175295
Epc1^{tm1a(EUCOMM)Wtsi}/Epc1⁺ (Not Specified)	increased lactate dehydrogenase level	J:175295
Epc2^{tm1a(EUCOMM)Wtsi}/Epc2^{tm1a(EUCOMM)Wtsi} (C57BL/6N-Epc2^{tm1a(EUCOMM)Wtsi}/Ieg)	decreased lactate dehydrogenase level	J:165965
Epc2^{tm1b(EUCOMM)Wtsi}/Epc2⁺ (C57BL/6N-Epc2^{tm1b(EUCOMM)Wtsi}/Ieg)	increased respiratory quotient	J:211773
Epcam^{Gt(RST556)Byg}/Epcam^{Gt(RST556)Byg} (involves: 129P2/OlaHsd * C57BL/6)	abnormal thrombosis	J:155941
Epcam^tm1.2Msiv/Epcam^tm1.2Msiv (involves: C57BL/6 * FVB/N * SJL)	intestinal edema	J:210901
Epg5^em1(IMPC)H/Epg5^em1(IMPC)H (C57BL/6NTac-Epg5^em1(IMPC)H/H)	decreased circulating glucose level	J:211773
	decreased circulating serum albumin level	J:211773
	increased circulating alanine transaminase level	J:211773
	increased circulating alkaline phosphatase level	J:211773
	increased circulating amylase level	J:211773
	increased circulating aspartate transaminase level	J:211773
	increased circulating iron level	J:211773
Epha3^tm1Abn/Epha3^tm1Abn (involves: 129S1/Sv * 129S1/SvImJ)	cyanosis	J:119874
	pulmonary edema	J:86478
Epha5^{tm1b(NCOM)Mfgc}/Epha5^{tm1b(NCOM)Mfgc} (C57BL/6N-Epha5^{tm1b(NCOM)Mfgc}/Tcp)	increased circulating potassium level	J:211773
Ephx2^tm1Gonz/Ephx2^tm1Gonz (B6.129X1-Ephx2^tm1Gonz)	abnormal lipid level	J:208344
epi/? (involves: CBA/J)	decreased circulating glucose level	J:5421
epi/? (involves: CBA/J)	steatorrhea	J:5421
Epm2a^tm1Kzy/Epm2a^tm1Kzy (involves: 129P2/OlaHsd * C57BL/6J)	abnormal enzyme/coenzyme level	J:173769
	hypoglycemia	J:173769
	improved glucose tolerance	J:173769
	increased cardiac muscle glycogen level	J:173769
	increased circulating cholesterol level	J:173769
	increased circulating free fatty acids level	J:173769
	increased circulating ketone body level	J:173769
	increased circulating triglyceride level	J:173769
	increased energy expenditure	J:173769
	increased insulin sensitivity	J:173769
	increased liver cholesterol level	J:173769
	increased liver triglyceride level	J:173769
	increased oxygen consumption	J:173769
	increased respiratory quotient	J:173769
Epm2aip1^{Gt(BA0314)Wtsi}/Epm2aip1^{Gt(BA0314)Wtsi} (involves: 129P2/OlaHsd * C57BL/6)	abnormal gluconeogenesis	J:204966
	abnormal glucose homeostasis	J:204966
	abnormal glycogen homeostasis	J:204966
	decreased circulating glucose level	J:204966
	decreased liver glycogen level	J:204966
	improved glucose tolerance	J:204966
Epo^{Tg(TAg/Epo)134.3LCPjr}/Epo^{Tg(TAg/Epo)134.3LCPjr} (involves: C57BL/6 * CBA)	decreased oxygen consumption	J:128248
	hemosiderosis	J:79374
	hyperoxia	J:128248
	hypoxia	J:79374
Epo^tm1Jae/Epo^tm1Jae (involves: 129S4/SvJae)	edema	J:53885
Epo^tm1Jae/Epo^tm1Jae (involves: 129S4/SvJae)	pericardial edema	J:53885
Epor^tm1Jae/Epor^tm1Jae (involves: 129S4/SvJae)	edema	J:53885
Epor^tm1Jae/Epor^tm1Jae (involves: 129S4/SvJae)	pericardial edema	J:53885
Eppin^em1(IMPC)Mbp/Eppin^em1(IMPC)Mbp (C57BL/6N-Eppin^em1(IMPC)Mbp/MbpMmucd)	increased circulating creatinine level	J:211773
Eprs1^tm1.1Xen/Eprs1^tm1.1Xen (C57BL/6-Eprs1^tm1.1Xen)	decreased susceptibility to diet-induced obesity	J:244749
	enhanced lipolysis	J:244749
	impaired glucose tolerance	J:244749
	increased carbon dioxide production	J:244749
	increased energy expenditure	J:244749
	increased fatty acid beta-oxidation	J:244749
	increased insulin sensitivity	J:244749
	increased oxygen consumption	J:244749
Eprs1^{tm1b(EUCOMM)Hmgu}/Eprs1⁺ (C57BL/6N-Eprs1^{tm1b(EUCOMM)Hmgu}/Tcp)	decreased circulating creatinine level	J:211773
Eps8l2^{tm1b(EUCOMM)Wtsi}/Eps8l2^{tm1b(EUCOMM)Wtsi} (C57BL/6N-Eps8l2^{tm1b(EUCOMM)Wtsi}/H)	decreased circulating calcium level	J:211773
	decreased circulating cholesterol level	J:211773
	decreased circulating fructosamine level	J:211773
	decreased circulating serum albumin level	J:211773
	increased circulating alkaline phosphatase level	J:211773
	increased circulating aspartate transaminase level	J:211773
Eps15^{tm1a(KOMP)Wtsi}/Eps15^{tm1a(KOMP)Wtsi} (B6JTyr;B6N-Eps15^{tm1a(KOMP)Wtsi}/Wtsi)	increased circulating HDL cholesterol level	J:175295
	increased circulating LDL cholesterol level	J:175295
Eps15^{tm1c(KOMP)Wtsi}/Eps15^{tm1c(KOMP)Wtsi} Eps15l1^tm2.1Noff/Eps15l1^tm2.1Noff Tg(Tek-cre)1Ywa/0 (involves: C57BL/6 * C57BL/6N * SJL)	increased circulating iron level	J:272122
Eps15l1^em1(IMPC)J/Eps15l1^em1(IMPC)J (C57BL/6NJ-Eps15l1^em1(IMPC)J/Mmjax)	increased circulating alkaline phosphatase level	J:211773
Epx^{tm1b(EUCOMM)Wtsi}/Epx^{tm1b(EUCOMM)Wtsi} (C57BL/6N-Epx^{tm1b(EUCOMM)Wtsi}/Orl)	increased circulating triglyceride level	J:211773
Erap1^{tm2b(EUCOMM)Wtsi}/Erap1^{tm2b(EUCOMM)Wtsi} (C57BL/6N-Erap1^{tm2b(EUCOMM)Wtsi}/Kmpc)	decreased circulating serum albumin level	J:211773
	increased circulating calcium level	J:211773
Erbb2^{tm4(Erbb2)Mul}/Erbb2^tm1Haus (involves: 129S1/Sv * 129S4/SvJae * 129X1/SvJ * BALB/c)	cyanosis	J:94397
Erbb3^tm1Cbm/Erbb3^tm1Cbm (either: 129P2/OlaHsd or (involves: 129P2/OlaHsd * C57BL/6))	cyanosis	J:43515
Erbb3^tm2Cbm/Erbb3^tm2Cbm (either: 129P2/OlaHsd or (involves: 129P2/OlaHsd * C57BL/6))	cyanosis	J:43515
Erbb3^tm2Cbm/Erbb3^tm2Cbm (involves: 129P2/OlaHsd)	decreased noradrenaline level	J:48515
Ercc1^tm1Dwm/Ercc1^tm1Dwm Tg(Ttr-Ercc1)17Dwm/0 (involves: 129P2/OlaHsd * BALB/c)	increased circulating lactate level	J:106084
Ercc1^tm1Jhjh/Ercc1^tm1Jhjh (involves: 129P2/OlaHsd * C57BL/6 * FVB)	acidosis	J:117488
	decreased circulating glucose level	J:117488
	decreased circulating insulin level	J:117488
	decreased circulating insulin-like growth factor I level	J:117488
	increased liver triglyceride level	J:117488
	increased urine protein level	J:117488
Ercc2^{tm2(ERCC2)Jhjh}/Ercc2^{tm2(ERCC2)Jhjh} (involves: 129P2/OlaHsd * C57BL/6)	abnormal circulating amino acid level	J:76608
Ercc3^{tm1b(NCOM)Mfgc}/Ercc3⁺ (C57BL/6N-Ercc3^{tm1b(NCOM)Mfgc}/Tcp)	increased circulating potassium level	J:211773
Ercc5^tm1Shm/Ercc5^tm1Shm (Not Specified)	phototoxicity	J:89911
Ercc5^tm1Shm/Ercc5^tm1Shm (involves: 129S2/SvPas * C57BL/6J)	phototoxicity	J:53756
Ercc5^{tm2b(EUCOMM)Hmgu}/Ercc5⁺ (C57BL/6N-Ercc5^{tm2b(EUCOMM)Hmgu}/Bay)	increased fasting circulating glucose level	J:211773
Ercc5^tm2Shm/Ercc5^tm2Shm (involves: 129S2/SvPas * C57BL/6J)	phototoxicity	J:89911
Ercc5^tm3Shm/Ercc5^tm3Shm (involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)	phototoxicity	J:89911
Ercc5^tm4Shm/Ercc5^tm4Shm (involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)	phototoxicity	J:89911
Ercc6^tm1Gvh/Ercc6^tm1Gvh (involves: 129P2/OlaHsd * FVB)	photophobia	J:40211
Ercc6^tm1Gvh/Ercc6^tm1Gvh (involves: 129P2/OlaHsd * FVB)	photosensitivity	J:40211
Ercc6^tm1Gvh/Ercc6^tm1Gvh Xpa^tm1Hvs/Xpa^tm1Hvs (B6.129P2-Xpa^tm1Hvs Ercc6^tm1Gvh)	hypoglycemia	J:122013
	increased liver glycogen level	J:122013
Ercc8^em1(IMPC)H/Ercc8^em1(IMPC)H (C57BL/6N-Ercc8^em1(IMPC)H/H)	increased circulating cholesterol level	J:211773
	increased circulating HDL cholesterol level	J:211773
Ercc8^tm1Jhjh/Ercc8^tm1Jhjh (involves: 129P2/OlaHsd * C57BL/6J)	photophobia	J:74959
Erf^tm1Gmav/Erf^tm1Gmav (involves: 129S4/SvJae * C57BL/6 * CBA)	edema	J:123628
Erfe^tm1Lex/Erfe^tm1Lex (B6;129S5-Erfe^tm1Lex/Mmucd)	decreased circulating iron level	J:211331
Erfe^tm1Lex/Erfe^tm1Lex Hbb-b1^tm1Unc/Hbb-b1⁺ Hbb-b2^tm1Unc/Hbb-b2⁺ (involves: 129P2/OlaHsd * 129S5/SvEvBrd * C57BL/6)	abnormal hormone level	J:211331
	decreased circulating iron level	J:211331
	decreased liver iron level	J:211331
Erg^tm1.1Path/Erg^tm1.1Path (Not Specified)	pulmonary edema	J:227456
Erg^tm2Poet/Erg^tm2Poet (involves: 129S6/SvEvTac * C57BL/6)	pericardial effusion	J:188920
Ergic2^{em1(IMPC)Hmgu}/Ergic2⁺ (C57BL/6N-Ergic2^{em1(IMPC)Hmgu}/Ieg)	increased circulating iron level	J:211773
Erlin1^em1(IMPC)Tcp/Erlin1^em1(IMPC)Tcp (C57BL/6N-Erlin1^em1(IMPC)Tcp/Tcp)	increased circulating alanine transaminase level	J:211773
Erlin2^{tm1a(EUCOMM)Wtsi}/Erlin2^{tm1a(EUCOMM)Wtsi} (C57BL/6N-Erlin2^{tm1a(EUCOMM)Wtsi}/Wtsi)	increased circulating amylase level	J:211773
Ermn^em1(IMPC)H/Ermn^em1(IMPC)H (C57BL/6N-Ermn^em1(IMPC)H/H)	increased blood urea nitrogen level	J:211773
	increased circulating triglyceride level	J:211773
Ermp1^{tm1.1(KOMP)Vlcg}/Ermp1^{tm1.1(KOMP)Vlcg} (C57BL/6N-Ermp1^{tm1.1(KOMP)Vlcg}/J)	decreased circulating calcium level	J:211773
	increased circulating chloride level	J:211773
	increased circulating sodium level	J:211773
Ern1^tm1Dron/Ern1⁺ (129S.129S6-Ern1^tm1Dron)	abnormal glucose homeostasis	J:132805
Ern1^tm1Rjk/Ern1^tm2.1Rjk Speer6-ps1^{Tg(Alb-cre)21Mgn}/Speer6-ps1⁺ (involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * DBA)	abnormal apolipoprotein level	J:171230
	abnormal lipid level	J:171230
	decreased circulating cholesterol level	J:171230
	increased liver triglyceride level	J:171230
Ero1a^{Gt(XST171)Byg}/Ero1a^{Gt(XST171)Byg} Ero1b^{Gt(P077G11)Wrst}/Ero1b^{Gt(P077G11)Wrst} (involves: 129P2/OlaHsd * 129S2/SvPas * C57BL/6)	impaired glucose tolerance	J:158805
Ero1b^{Gt(P077G11)Wrst}/Ero1b⁺ (involves: 129S2/SvPas * C57BL/6)	abnormal glucose homeostasis	J:158805
	decreased insulin secretion	J:158805
	impaired glucose tolerance	J:158805
	increased circulating glucose level	J:158805
Ero1b^{Gt(P077G11)Wrst}/Ero1b⁺ Ins2^Akita/Ins2⁺ (involves: 129S2/SvPas * C57BL/6NSlc)	decreased insulin secretion	J:158805
	impaired glucose tolerance	J:158805
	increased circulating glucose level	J:158805
Ero1b^{Gt(P077G11)Wrst}/Ero1b^{Gt(P077G11)Wrst} (involves: 129S2/SvPas * C57BL/6)	abnormal glucose homeostasis	J:158805
	decreased insulin secretion	J:158805
	impaired glucose tolerance	J:158805
	increased circulating glucose level	J:158805
Errfi1^tm1.1Jwj/Errfi1^tm1.1Jwj (involves: 129 * C57BL/6 * FVB/N * SJL)	cyanosis	J:153715
Errfi1^tm3.1Gvw/Errfi1^tm3.1Gvw Tg(CMV-cre)1Cgn/0 (involves: 129 * 129S4/SvJaeSor * BALB/cJ)	joint swelling	J:206807
Errfi1^tm3.1Gvw/Errfi1^tm3.1Gvw Tg(Col2a1-cre)1Asz/0 (involves: 129S1/Sv * 129S4/SvJaeSor * C57BL/6 * CBA)	joint swelling	J:206807
Esco1^{tm1(KOMP)Wtsi}/Esco1^{tm1(KOMP)Wtsi} (C57BL/6N-Esco1^{tm1(KOMP)Wtsi}/Wtsi)	decreased circulating alanine transaminase level	J:175295
	decreased circulating cholesterol level	J:175295
	decreased circulating LDL cholesterol level	J:175295
	decreased circulating serum albumin level	J:175295
	decreased circulating total protein level	J:175295
Esr1^tm1.1Gust/Esr1^tm1.1Gust (B6.129X1-Esr1^tm1.1Gust)	increased circulating glucose level	J:186230
Esr1^tm1.1Ics/Esr1^tm1.1Ics (involves: C57BL/6NTac)	decreased circulating progesterone level	J:206373
	increased circulating follicle stimulating hormone level	J:206373
	increased circulating luteinizing hormone level	J:206373
Esr1^tm1.1Lja/Esr1⁺ (involves: 129P2/OlaHsd * 129X1/SvJ)	decreased circulating progesterone level	J:79228
Esr1^tm1.1Lja/Esr1^tm1.1Mma (involves: 129P2/OlaHsd * 129S2/SvPas * 129X1/SvJ * C57BL/6)	decreased circulating insulin-like growth factor I level	J:128135
	increased circulating estradiol level	J:128135
Esr1^tm1.1Mma/Esr1^tm1.1Mma (involves: 129S2/SvPas * C57BL/6)	increased circulating estradiol level	J:171276
	increased circulating luteinizing hormone level	J:171276
	increased circulating testosterone level	J:171276
Esr1^tm1.1Ohl/Esr1^tm1.1Ohl (involves: 129S2/SvPas * C57BL/6)	increased circulating estradiol level	J:171276
	increased circulating luteinizing hormone level	J:171276
	increased circulating testosterone level	J:171276
Esr1^tm1.2Awo/Esr1^tm1.2Awo Kiss1^{tm1.1(cre)Uboe}/Kiss1⁺ (involves: 129S6/SvEvTac * C57BL/6 * SJL)	decreased circulating luteinizing hormone level	J:167285
	increased circulating luteinizing hormone level	J:167285
Esr1^tm1.2Awo/Esr1^tm1.2Awo Tg(Cga-cre)1Awo/0 (involves: C57BL/6 * SJL)	abnormal luteinizing hormone level	J:152925
	decreased circulating luteinizing hormone level	J:152925
	increased circulating estradiol level	J:152925
	increased circulating luteinizing hormone level	J:152925
Esr1^tm1.2Mma/Esr1^tm1.2Mma Tg(Cyp17a1-icre)AJako/0 (involves: 129S2/SvPas * C57BL/6 * SJL)	decreased circulating luteinizing hormone level	J:151908
	increased circulating testosterone level	J:151908
Esr1^tm1Arnal/Esr1^tm1Arnal (involves: C57BL/6)	increased circulating estradiol level	J:171276
	increased circulating luteinizing hormone level	J:171276
	increased circulating testosterone level	J:171276
Esr1^tm1Geog/Esr1^tm1Geog (involves: 129X1/SvJ * C57BL/6)	increased circulating estradiol level	J:135981
	increased circulating luteinizing hormone level	J:135981
	increased circulating testosterone level	J:135981
Esr1^tm1Gsc/Esr1^tm1Gsc Tg(Camk2a-cre)2Gsc/0 (involves: 129P2/OlaHsd * C57BL/6 * FVB/N)	abnormal luteinizing hormone level	J:117231
Esr1^tm1Ksk/Esr1^tm1Ksk (involves: 129P2/OlaHsd * C57BL/6J)	decreased circulating insulin-like growth factor I level	J:62222, J:114164
	decreased circulating osteocalcin level	J:62222
	increased circulating cholesterol level	J:66077
	increased circulating estradiol level	J:112080
	increased circulating HDL cholesterol level	J:66077
	increased circulating leptin level	J:66077
	increased circulating testosterone level	J:36658
	increased urine protein level	J:88156
	insulin resistance	J:66077
Esr1^tm1Ksk/Esr1^tm1Ksk (involves: 129P2/OlaHsd)	albuminuria	J:152738
	decreased circulating estradiol level	J:152738
	decreased circulating prolactin level	J:64639
	decreased circulating testosterone level	J:152738
	impaired glucose tolerance	J:151012
	increased circulating estradiol level	J:72221
	increased circulating glucose level	J:151012
	increased circulating testosterone level	J:152738
	insulin resistance	J:151012
Esr1^tm1Ksk/Esr1^tm1Ksk (B6.129P2-Esr1^tm1Ksk)	decreased energy expenditure	J:65806
	impaired glucose tolerance	J:65806
	insulin resistance	J:65806
Esr1^tm1Ksk/Esr1^tm1Ksk (involves: 129P2/OlaHsd * 129S6/SvEvTac)	increased circulating estradiol level	J:84989
Esr1^tm1Ksk/Esr1^tm1Ksk Esr2^tm1Unc/Esr2^tm1Unc (involves: 129P2/OlaHsd)	increased circulating luteinizing hormone level	J:59105
Esr1^tm1Ksk/Esr1^tm1Ksk Esr2^tm1Unc/Esr2^tm1Unc (involves: 129P2/OlaHsd * C57BL/6J)	decreased circulating insulin-like growth factor I level	J:62222
	decreased circulating osteocalcin level	J:62222
	increased circulating cholesterol level	J:66077
	increased circulating HDL cholesterol level	J:66077
	increased circulating leptin level	J:66077
	insulin resistance	J:66077
Esr1^tm1Ksk/Esr1^tm1Ksk Esr2^tm1Unc/Esr2^tm1Unc Inha^tm1Bay/Inha^tm1Bay (involves: 129P2/OlaHsd * 129S6/SvEvTac * 129S7/SvEvBrd)	decreased circulating follicle stimulating hormone level	J:84989
Esr1^tm1Ksk/Esr1^tm1Ksk Inha^tm1Bay/Inha^tm1Bay (involves: 129P2/OlaHsd * 129S6/SvEvTac * 129S7/SvEvBrd)	decreased circulating follicle stimulating hormone level	J:84989
	decreased circulating luteinizing hormone level	J:84989
	increased circulating estradiol level	J:84989
Esr1^tm1Syeh/Esr1^tm1Syeh Tmem163^{Tg(ACTB-cre)2Mrt}/0 (involves: 129X1/SvJ * FVB/N)	increased circulating testosterone level	J:147000
Esr1^tm2Ksk/Esr1^tm2Ksk (involves: C57BL/6)	increased circulating luteinizing hormone level	J:118736
Esr1^tm3.1Ksk/Esr1^tm3.1Ksk (involves: 129S6/SvEvTac * C57BL/6)	increased circulating estradiol level	J:176459
	increased luteinizing hormone level	J:176459
Esr1^tm4.2Ksk/Esr1^tm4.2Ksk (involves: C57BL/6 * C57BL/6NTac * CBA)	increased circulating luteinizing hormone level	J:191182
	increased circulating testosterone level	J:191182
Esr1^tm4.2Ksk/Esr1^tm4.2Ksk Mir22^tm1Boet/Mir22^tm1Boet Tg(Ckmm-cre)5Khn/0 (involves: 129S2/SvPas * C57BL/6 * FVB)	increased fatty acid oxidation	J:266382
Esr2^tm1Unc/Esr2^tm1Unc (involves: 129P2/OlaHsd * C57BL/6J)	increased circulating insulin-like growth factor I level	J:110416
Esr2^tm1Unc/Esr2^tm1Unc (involves: 129P2/OlaHsd * C57BL/6)	increased circulating luteinizing hormone level	J:118736
Esr2^tm1Unc/Esr2^tm1Unc (involves: 129P2/OlaHsd)	ascites	J:108991
	decreased circulating glucose level	J:151012
	decreased insulin secretion	J:151012
	increased circulating glucose level	J:151012
	increased insulin sensitivity	J:151012
	increased urine glycosaminoglycan level	J:122274
Esr2^tm1Unc/Esr2^tm1Unc (B6.129P2-Esr2^tm1Unc)	decreased dopamine level	J:101943
Esr2^tm1Unc/Esr2^tm1Unc (B6.129P2-Esr2^tm1Unc)	decreased serotonin level	J:101943
Esrp1^em1(IMPC)Mbp/Esrp1⁺ (C57BL/6N-Esrp1^em1(IMPC)Mbp/MbpMmucd)	edema	J:211773
Esrp1^em1(IMPC)Mbp/Esrp1^em1(IMPC)Mbp (C57BL/6N-Esrp1^em1(IMPC)Mbp/MbpMmucd)	edema	J:211773
Esrp1^tm1.1Rpc/Esrp1^tm1.1Rpc Esrp2^{tm1(KOMP)Vlcg}/Esrp2^{tm1(KOMP)Vlcg} Tg(KRT14-cre)43Smr/0 (involves: 129S4/SvJae * C57BL/6 * C57BL/6J * C57BL/6NTac * SJL/J)	impaired skin barrier function	J:226997
Esrp2^{tm1(KOMP)Vlcg}/Esrp2^{tm1(KOMP)Vlcg} (involves: C57BL/6J * C57BL/6NTac)	abnormal protein level	J:228040
	decreased circulating serum albumin level	J:228040
Esrra^{tm1.1(KOMP)Vlcg}/Esrra^{tm1.1(KOMP)Vlcg} (C57BL/6N-Esrra^{tm1.1(KOMP)Vlcg}/J)	increased circulating alanine transaminase level	J:211773
Esrra^tm1Vgi/Esrra^tm1Vgi (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	abnormal lipid homeostasis	J:86433
	impaired adaptive thermogenesis	J:119525
	increased triglyceride level	J:119525
Esrra^tm1Vgi/Esrra^tm1Vgi (involves: C57BL/6)	decreased susceptibility to diet-induced obesity	J:86433
Esrrg^tm1Rev/Esrrg^tm1Rev (either: (involves: 129) or (involves: C57BL/6) or (involves: ICR))	increased circulating lactate level	J:129851
Esyt3^{tm1b(EUCOMM)Wtsi}/Esyt3^{tm1b(EUCOMM)Wtsi} (C57BL/6N-Esyt3^{tm1b(EUCOMM)Wtsi}/H)	increased circulating alanine transaminase level	J:211773
Etfbkmt^em1Yshk/Etfbkmt^em1Yshk (C57BL/6J-Etfbkmt^em1Yshk)	decreased susceptibility to induced hypothermia	J:260200
	increased fatty acid beta-oxidation	J:260200
	increased oxygen consumption	J:260200
Ethe1^tm1.1Zev/Ethe1^tm1.1Zev (involves: 129S7/SvEvBrd * C57BL/6)	abnormal blood homeostasis	J:146537
	abnormal mineral level	J:146537
	abnormal urine homeostasis	J:146537
	increased circulating lactate level	J:146537
Ethm1^DBA/2J/? (involves: C57BL/6J * DBA/2J)	abnormal body temperature homeostasis	J:73579
Ethm2^C57BL/6J/? (involves: C57BL/6J * DBA/2J)	abnormal body temperature homeostasis	J:73579
Ethm3^C57BL/6J/? (involves: C57BL/6J * DBA/2J)	abnormal body temperature homeostasis	J:73579
Ethm4^C57BL/6J/? (involves: C57BL/6J * DBA/2J)	abnormal body temperature homeostasis	J:73579
Etnppl^tm1.2Mrl/Etnppl^tm1.2Mrl (C57BL/6-Etnppl^tm1.2Mrl/Tac)	abnormal phospholipid level	J:309545
Ets1^tm1Jml/Ets1^tm1Jml Ets2^tm2Rgo/Ets2^tm2Rgo (involves: 129S/SvEv * C57BL/6 * FVB/N)	edema	J:151187
Ets1^tm1Jml/Ets1^tm1Jml Ets2^tm5.1Rgo/Ets2^tm5.1Rgo Meox2^tm1(cre)Sor/Meox2⁺ (involves: 129S/SvEv * 129S4/SvJaeSor * C57BL/6 * FVB/N)	edema	J:151187
Etv6^{em1(IMPC)Rbrc}/Etv6⁺ (C57BL/6NJcl-Etv6^{em1(IMPC)Rbrc}/Rbrc)	decreased circulating calcium level	J:211773
	decreased circulating cholesterol level	J:211773
	decreased circulating HDL cholesterol level	J:211773
	decreased circulating serum albumin level	J:211773
	decreased circulating total protein level	J:211773
	increased blood uric acid level	J:211773
Etv6^em3Knic/Etv6⁺ (involves: C57BL/6J)	impaired blood coagulation	J:342774
Etv6^{tm1(RUNX1)Haho}/Etv6⁺ Tg(Gata1-cre)1Sho/0 (involves: 129S1/Sv * C57BL/6 * CD-1 * Swiss Webster)	intestinal edema	J:151639
Evc2^em1(IMPC)Mbp/Evc2^em1(IMPC)Mbp (C57BL/6N-Evc2^em1(IMPC)Mbp/MbpMmucd)	decreased blood urea nitrogen level	J:211773
	decreased circulating total protein level	J:211773
Evi5^{tm1a(KOMP)Wtsi}/Evi5^{tm1a(KOMP)Wtsi} (C57BL/6N-Evi5^{tm1a(KOMP)Wtsi}/Wtsi)	decreased fasting circulating glucose level	J:211773
Evl^{tm1b(KOMP)Wtsi}/Evl^{tm1b(KOMP)Wtsi} (C57BL/6N-Evl^{tm1b(KOMP)Wtsi}/H)	increased fasting circulating glucose level	J:211773
Ewsr1^{tm1b(EUCOMM)Wtsi}/Ewsr1⁺ (C57BL/6N-Ewsr1^{tm1b(EUCOMM)Wtsi}/Tcp)	edema	J:211773
	increased circulating alkaline phosphatase level	J:211773
Ewsr1^{tm1b(EUCOMM)Wtsi}/Ewsr1^{tm1b(EUCOMM)Wtsi} (C57BL/6N-Ewsr1^{tm1b(EUCOMM)Wtsi}/Tcp)	edema	J:211773
exf/exf (involves: C3H/HeN(MTV^-))	eyelid edema	J:5649
Exoc3^{tm2b(EUCOMM)Hmgu}/Exoc3⁺ (C57BL/6N-Exoc3^{tm2b(EUCOMM)Hmgu}/Wtsi)	decreased fasting circulating glucose level	J:211773
Exoc3^{tm2c(EUCOMM)Hmgu}/Exoc3^{tm2c(EUCOMM)Hmgu} Tg(Pf4-icre)Q3Rsko/0 (involves: C57BL/6 * C57BL/6N)	abnormal platelet physiology	J:302300
	abnormal thrombosis	J:302300
	decreased bleeding time	J:302300
	decreased platelet aggregation	J:302300
	decreased platelet dense granule secretion	J:302300
	increased platelet dense granule secretion	J:302300
	increased susceptibility to induced thrombosis	J:302300
Exoc3l2^em1(IMPC)J/Exoc3l2⁺ (C57BL/6N-Exoc3l2^em1(IMPC)J/J)	impaired glucose tolerance	J:211773
Exoc3l2^em1(IMPC)J/Exoc3l2⁺ (C57BL/6N-Exoc3l2^em1(IMPC)J/J)	increased circulating serum albumin level	J:211773
Exoc3l2^{tm1b(KOMP)Wtsi}/Exoc3l2⁺ (C57BL/6N-Exoc3l2^{tm1b(KOMP)Wtsi}/Wtsi)	increased circulating iron level	J:211773
Exoc4^em1(IMPC)J/Exoc4⁺ (C57BL/6NJ-Exoc4^em1(IMPC)J/J)	increased circulating sodium level	J:211773
Exoc6^hbd/Exoc6^hbd (AB.Cg-Exoc6^hbd)	decreased spleen iron level	J:8251
	increased circulating iron level	J:8251
	increased erythrocyte protoporphyrin level	J:8251
Exoc6^hbd/Exoc6^hbd (B6.Cg-Exoc6^hbd/J)	abnormal iron homeostasis	J:105712
Exoc6^hbd/Exoc6^hbd (B6.Cg-Exoc6^hbd/J)	increased erythrocyte protoporphyrin level	J:42436
Exoc6b^{em1(IMPC)Hmgu}/Exoc6b⁺ (C57BL/6NCrl-Exoc6b^{em1(IMPC)Hmgu}/Ieg)	decreased circulating glucose level	J:211773
Exosc3^{tm1.1(KOMP)Vlcg}/Exosc3⁺ (C57BL/6N-Exosc3^{tm1.1(KOMP)Vlcg}/Ucd)	increased fasting circulating glucose level	J:211773
Exph5^{tm1b(EUCOMM)Wtsi}/Exph5^{tm1b(EUCOMM)Wtsi} (C57BL/6N-Exph5^{tm1b(EUCOMM)Wtsi}/Ieg)	decreased circulating creatinine level	J:211773
	decreased circulating phosphate level	J:211773
	decreased circulating potassium level	J:211773
Exph5^tm1Tiz/Exph5^tm1Tiz (B6NJcl.Cg-Exph5^tm1Tiz/Tiz)	increased lactate dehydrogenase level	J:313415
Extl3^tm1.1Okam/Extl3^tm1Okam Tg(Ins2-cre)#Okam/0 (involves: 129P2/OlaHsd * ICR)	decreased circulating insulin level	J:148348
	decreased insulin secretion	J:148348
	impaired glucose tolerance	J:148348
Eya1^bor/Eya1^bor (C3HeB/FeJ-Eya1^bor)	increased blood urea nitrogen level	J:54408
Eya4^{tm1b(KOMP)Wtsi}/Eya4⁺ (C57BL/6N-Eya4^{tm1b(KOMP)Wtsi}/Tcp)	edema	J:211773
Eya4^{tm1b(KOMP)Wtsi}/Eya4^{tm1b(KOMP)Wtsi} (C57BL/6N-Eya4^{tm1b(KOMP)Wtsi}/Tcp)	edema	J:211773
Eya4^tm1Jse/Eya4^tm1Jse (involves: 129S6/SvEvTac * CBA/J)	middle ear effusion	J:131873
Ezh1^{tm1b(EUCOMM)Wtsi}/Ezh1^{tm1b(EUCOMM)Wtsi} (C57BL/6N-Ezh1^{tm1b(EUCOMM)Wtsi}/Nju)	increased circulating glucose level	J:211773
Ezh2^{tm1a(EUCOMM)Wtsi}/Ezh2⁺ (C57BL/6N-Ezh2^{tm1a(EUCOMM)Wtsi}/Wtsi)	increased circulating triglyceride level	J:175295
f/f (Not Specified)	abnormal iron homeostasis	J:13598
F2^{tm1b(EUCOMM)Hmgu}/F2⁺ (C57BL/6N-F2^{tm1b(EUCOMM)Hmgu}/H)	increased circulating fructosamine level	J:211773
	increased circulating serum albumin level	J:211773
F2^tm1Jld/F2^tm1Sjd (involves: 129P2/OlaHsd * C57BL/6J)	abnormal blood coagulation	J:144572
F2^tm1Jld/F2^tm1Sjd (involves: 129P2/OlaHsd * C57BL/6J)	increased bleeding time	J:144572
F2^tm1Jld/F2^tm1Sjd Tg(Mx1-cre)1Cgn/0 (involves: 129P2/OlaHsd * C57BL/6 * C57BL/6J * CBA)	abnormal blood coagulation	J:144572
	increased bleeding time	J:144572
F2^tm1Sjd/F2^tm1Sjd (involves: 129P2/OlaHsd * Black Swiss)	hemopericardium	J:48273
F2^tm1Sjd/F2^tm1Sjd (involves: 129P2/OlaHsd * Black Swiss)	impaired blood coagulation	J:48273
F2^tm2Jld/F2⁺ (B6.129P2-F2^tm2Jld)	abnormal circulating protein level	J:174629
	decreased susceptibility to induced thrombosis	J:174629
	increased bleeding time	J:174629
F2r^tm1Ajc/F2r^tm1Ajc (B6.129S4-F2r^tm1Ajc)	abnormal circulating protein level	J:217458
	abnormal urine protein level	J:217458
	decreased tumor necrosis factor (ligand) superfamily member 11 level	J:217458
	hemopericardium	J:71309
	increased tumor necrosis factor receptor superfamily member 11b level	J:217458
	increased urine pH	J:217458
	increased urine sodium level	J:217458
F2r^tm1Ajc/F2r^tm1Ajc F5^tm1Dgi/F5^tm1Dgi (B6.Cg-F5^tm1Dgi F2r^tm1Ajc)	hemopericardium	J:71309
	pericardial effusion	J:71309
F2r^tm1Pago/F2r^tm1Pago (involves: 129P2/OlaHsd)	abnormal cytokine level	J:133917
F2r^tm2Cgh/F2r^tm2Cgh (involves: 129S4/SvJae * C57BL/6)	edema	J:157446
F2rl1^tm1Cgh/F2rl1^tm1Cgh (involves: 129S4/SvJae * C57BL/6)	abnormal glucose homeostasis	J:130781
F2rl1^tm1Cgh/F2rl1^tm1Cgh (involves: 129S4/SvJae * C57BL/6)	improved glucose tolerance	J:130781
F2rl1^tm1Cgh/F2rl1^tm1Cgh Spink5^tm1Hov/Spink5^tm1Hov (involves: 129P2/OlaHsd * 129S4/SvJae)	dehydration	J:180855
F2rl1^tm1Wrf/F2rl1^tm1Wrf (involves: 129P2/OlaHsd)	decreased circulating interleukin-18 level	J:102762
F2rl2^tm1Cgh/F2rl2^tm1Cgh (involves: 129S4/SvJae * C57BL/6)	abnormal platelet physiology	J:49283
	decreased susceptibility to induced thrombosis	J:80154
	increased bleeding time	J:80154
F2rl3^tm1.1Cgh/F2rl3^tm1.1Cgh (involves: 129S4/SvJae * C57BL/6)	decreased susceptibility to induced thrombosis	J:80154
	increased bleeding time	J:80154
F3^tm1.1Dwr/F3^tm1.1Dwr (involves: 129S1/Sv * 129X1/SvJ * MF1 * Swiss)	abnormal blood coagulation	J:91165
	decreased circulating interleukin-1 beta level	J:91165
	decreased circulating interleukin-6 level	J:91165
	decreased circulating tumor necrosis factor level	J:91165
F3^tm1Dco/F3^tm1Dco Tg(F3)1Nmk/0 (B6.Cg-F3^tm1Dco Tg(F3)1Nmk)	abnormal blood coagulation	J:88245
	abnormal interleukin level	J:88245
F3^tm1Dwr/F3⁺ (involves: 129S1/Sv * 129X1/SvJ)	abnormal blood coagulation	J:99260
	abnormal thrombosis	J:99260
	decreased partial thromboplastin time	J:99260
	increased circulating factor IX level	J:99260
	increased circulating factor VIII level	J:99260
	increased circulating factor XI level	J:99260
F3^tm1Dwr/F3^tm1Dwr (involves: 129S1/Sv * 129X1/SvJ)	abnormal atrial thrombosis	J:99260
	abnormal cardiac thrombosis	J:99260
	abnormal thrombosis	J:99260
	abnormal ventricular thrombosis	J:99260
F3^tm1Fct/F3^tm1Fct (involves: 129P2/OlaHsd * C57BL/6J)	abnormal blood coagulation	J:216519
F3^tm1Jld/F3⁺ (involves: 129P2/OlaHsd * NIH Black Swiss)	abnormal blood coagulation	J:33831
F5^tm2Dgi/F5⁺ (B6.129S2-F5^tm2Dgi)	abnormal blood coagulation	J:66260
F5^tm2Dgi/F5⁺ (B6.129S2-F5^tm2Dgi)	abnormal thrombosis	J:66260
F5^tm2Dgi/F5^tm2Dgi (involves: 129S2/SvPas * C57BL/6J)	abnormal blood coagulation	J:66260
F5^tm2Dgi/F5^tm2Dgi (involves: 129S2/SvPas * C57BL/6J)	abnormal thrombosis	J:66260
F5^tm2Dgi/F5^tm2Dgi (B6.129S2-F5^tm2Dgi)	abnormal blood coagulation	J:66260
F5^tm2Dgi/F5^tm2Dgi (involves: 129S2/SvPas * C57BL/6)	abnormal thrombosis	J:62716
F5^tm2Dgi/F5^tm2Dgi Proz^tm1Gjb/Proz⁺ (involves: 129S2/SvPas * 129X1/SvJ * C57BL/6)	abnormal thrombosis	J:62716
F5^tm2Dgi/F5^tm2Dgi Proz^tm1Gjb/Proz^tm1Gjb (involves: 129S2/SvPas * 129X1/SvJ * C57BL/6)	abnormal thrombosis	J:62716
F7^{tm1(tTA,tetO-F7)Edr}/F7^{tm1(tTA,tetO-F7)Edr} (B6.129X1-F7^{tm1(tTA,tetO-F7)Edr})	abnormal blood coagulation	J:144540
	abnormal circulating protein level	J:144540
	increased partial thromboplastin time	J:144540
	increased prothrombin time	J:144540
F7^tm1Pec/F7⁺ Proc^tm1Fjc/Proc^tm1Fjc (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	abnormal blood coagulation	J:61481
F7^tm1Pec/F7⁺ Tfpi^tm1Gjb/Tfpi^tm1Gjb (involves: 129X1/SvJ * C57BL/6)	abnormal blood coagulation	J:89395
F7^tm1Pec/F7^tm1Pec Proc^tm1Fjc/Proc^tm1Fjc (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	abnormal blood coagulation	J:61481
	hydrops fetalis	J:61481
F8^tm1.1Rmnt/F8^tm1.1Rmnt Commd10^{Tg(Vav1-icre)A2Kio}/Commd10⁺ (involves: 129 * C57BL/6 * C57BL/10 * CBA/Ca * SJL)	decreased circulating factor VIII level	J:212401
F8^tm1.1Rmnt/F8^tm1.1Rmnt Tg(Cdh5-cre)7Mlia/0 (involves: 129 * C57BL/6 * FVB/N * SJL)	decreased circulating factor VIII level	J:212401
F8^tm1.1Rmnt/F8^tm1.1Rmnt Tg(Tek-cre)1Ywa/0 (involves: 129 * C57BL/6 * SJL)	decreased circulating factor VIII level	J:212401
F8^tm1Kaz/Y (involves: 129S4/SvJae * C57BL/6)	abnormal blood coagulation	J:24941, J:36698
F8^tm1Kaz/F8^tm1Kaz (involves: 129S4/SvJae * C57BL/6)	abnormal blood coagulation	J:36698
F8^tm2Kaz/Y (involves: 129S4/SvJae * C57BL/6)	abnormal blood coagulation	J:24941, J:36698
F8^tm2Kaz/Y (involves: 129S4/SvJae)	abnormal blood coagulation	J:176909
F8^tm2Kaz/Y Tg(Alb-F8)EBmre/0 (involves: 129S4/SvJae * C57BL/6J)	abnormal blood coagulation	J:176909
F9^em1Dlli/Y (involves: C57BL/6J)	increased partial thromboplastin time	J:262204
F9^em3Dlli/Y (involves: C57BL/6J)	abnormal blood coagulation	J:262204
F9^em3Dlli/Y (involves: C57BL/6J)	increased partial thromboplastin time	J:262204
F9^tm1Dws/Y (involves: 129P2/OlaHsd * C57BL/6)	abnormal blood coagulation	J:44497
F9^tm1Dws/Y (involves: 129P2/OlaHsd)	abnormal blood coagulation	J:166332
F9^tm1Dws/Y (involves: 129P2/OlaHsd)	increased bleeding time	J:166332
F9^tm1Dws/F9^tm1Dws (involves: 129P2/OlaHsd)	abnormal blood coagulation	J:166332
F9^tm1Dws/F9^tm1Dws (involves: 129P2/OlaHsd)	increased bleeding time	J:166332
F9^tm1Emg/Y (involves: 129S/SvEv * C57BL/6J)	abnormal blood coagulation	J:48501
F9^tm1Emg/Y (involves: 129S/SvEv * C57BL/6J)	increased bleeding time	J:48501
F9^tm1Emg/F9⁺ (involves: 129S/SvEv * C57BL/6J)	abnormal blood coagulation	J:48501
F9^tm1Ver/F9^tm1Ver (involves: 129/Sv * C57BL/6)	abnormal blood coagulation	J:43590
F9^tm1Ver/F9^tm1Ver (involves: 129/Sv * C57BL/6)	increased bleeding time	J:43590
F9^tm2(F9)Dws/F9^tm2(F9)Dws (involves: 129S6/SvEvTac * C57BL/6)	increased bleeding time	J:92964
F9^tm3Dws/Y (B6.129P2-F9^tm3Dws)	abnormal blood coagulation	J:166332
F9^tm3Dws/Y (B6.129P2-F9^tm3Dws)	increased bleeding time	J:166332
F9^tm3Dws/F9^tm3Dws (B6.129P2-F9^tm3Dws)	increased bleeding time	J:166332
F10^{tm1b(EUCOMM)Hmgu}/F10⁺ (C57BL/6N-F10^{tm1b(EUCOMM)Hmgu}/H)	decreased circulating creatinine level	J:211773
F10^tm1Ccmt/F10^tm1Ccmt (involves: 129P2/OlaHsd * C57BL/6)	increased bleeding time	J:145092
F10^tm2Ccmt/F10^tm2Ccmt (involves: 129P2/OlaHsd * C57BL/6)	increased heart iron level	J:145092
F11^tm1Gjb/F11^tm1Gjb (involves: 129X1/SvJ * C57BL/6)	decreased platelet aggregation	J:100529
F11^tm1Gjb/F11^tm1Gjb (involves: 129X1/SvJ * C57BL/6)	increased partial thromboplastin time	J:40270
F11^tm1Gjb/F11^tm1Gjb Proc^tm1Fjc/Proc^tm1Fjc (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	abnormal thrombosis	J:67398
F12^tm1Fjc/F12^tm1Fjc (involves: 129X1/SvJ * C57BL/6)	abnormal bradykinin level	J:238837
F12^tm1Fjc/F12^tm1Fjc (involves: 129X1/SvJ * C57BL/6)	increased partial thromboplastin time	J:238837
F13a1^tm1Akic/F13a1^tm1Akic (involves: 129P2/OlaHsd * Black Swiss)	increased bleeding time	J:222849
F13a1^tm1Gdi/F13a1^tm1Gdi (involves: 129P2/OlaHsd * CBA/Ca)	abnormal blood coagulation	J:87293
F13a1^tm1Gdi/F13a1^tm1Gdi (involves: 129P2/OlaHsd * CBA/Ca)	increased bleeding time	J:87293
F13b^tm1Akic/F13b^tm1Akic (involves: 129P2/OlaHsd * C57BL/6J)	increased bleeding time	J:222849
Fa2h^em1(IMPC)Mbp/Fa2h^em1(IMPC)Mbp (C57BL/6NCrl-Fa2h^em1(IMPC)Mbp/MbpMmucd)	decreased circulating cholesterol level	J:211773
	decreased circulating HDL cholesterol level	J:211773
Fa2h^tm1.1Hama/Fa2h^tm1.1Hama (involves: 129 * C57BL/6)	abnormal galactolipid level	J:171655
	abnormal lipid level	J:171655
	decreased cholesterol level	J:171655
Fa2h^tm1Hama/Fa2h^tm1Hama Cnp^tm1(cre)Kan/Cnp⁺ (involves: 129 * C57BL/6)	abnormal galactolipid level	J:171655
	abnormal lipid level	J:171655
Faah^em1(IMPC)H/Faah^em1(IMPC)H (C57BL/6NTac-Faah^em1(IMPC)H/H)	decreased circulating glucose level	J:211773
	increased circulating iron level	J:211773
	increased fasting circulating glucose level	J:211773
Faah^tm1.1Flee/Faah⁺ (B6.Cg-Faah^tm1.1Flee)	increased anandamide level	J:221783
Faah^tm1.1Flee/Faah^tm1.1Flee (B6.Cg-Faah^tm1.1Flee)	increased anandamide level	J:221783
Faah^tm1Crv/Faah^tm1Crv (B6.129X1-Faah^tm1Crv)	decreased body temperature	J:109633
Faah^tm1Crv/Faah^tm1Crv (involves: 129X1/SvJ * C57BL/6)	decreased body temperature	J:70666
Faap100^em1Jzc/Faap100^em1Jzc (involves: C57BL/6J * ICR)	increased circulating follicle stimulating hormone level	J:339060
Fabp1^{tm1b(EUCOMM)Hmgu}/Fabp1^{tm1b(EUCOMM)Hmgu} (C57BL/6N-Fabp1^{tm1b(EUCOMM)Hmgu}/Cnrm)	increased circulating bilirubin level	J:211773
Fabp1^tm1Bin/Fabp1^tm1Bin (involves: 129/Ola * C57BL/6)	abnormal glucose homeostasis	J:83875
Fabp1^tm1Ddsn/Fabp1^tm1Ddsn (involves: 129X1/SvJ * C57BL/6)	abnormal glucose homeostasis	J:87278
	abnormal lipid homeostasis	J:87278
	abnormal lipid level	J:87278
	decreased circulating insulin level	J:87278
	decreased liver triglyceride level	J:87278
Fabp2^{em1(IMPC)Hmgu}/Fabp2^{em1(IMPC)Hmgu} (C57BL/6N-Fabp2^{em1(IMPC)Hmgu}/Ieg)	decreased circulating serum albumin level	J:211773
	decreased circulating total protein level	J:211773
Fabp2^tm1Mto/Fabp2^tm1Mto (B6.129S1-Fabp2^tm1Mto)	abnormal circulating lipid level	J:64975
	decreased circulating cholesterol level	J:64975
	decreased susceptibility to diet-induced obesity	J:64975
	increased circulating glycerol level	J:64975
	increased circulating insulin level	J:64975
	increased circulating leptin level	J:64975
	increased susceptibility to diet-induced obesity	J:64975
Fabp3^Gt(XE705)Byg/Fabp3^Gt(XE705)Byg (involves: 129P2/OlaHsd * C57BL/6J)	abnormal free fatty acids level	J:167535
	abnormal glucose homeostasis	J:167535
	abnormal lipid homeostasis	J:167535
	abnormal triglyceride level	J:167535
	decreased circulating glucose level	J:167535
	decreased fatty acids level	J:167535
	decreased liver glycogen level	J:167535
	decreased triglyceride level	J:167535
	impaired adaptive thermogenesis	J:167535
	increased circulating free fatty acids level	J:167535
	increased circulating triglyceride level	J:167535
	increased fatty acids level	J:167535
	increased oxygen consumption	J:167535
	increased respiratory quotient	J:167535
	increased triglyceride level	J:167535
Fabp3^tm1Bin/Fabp3^tm1Bin (involves: 129P2/OlaHsd * BALB/c)	abnormal lipid homeostasis	J:54614
	hypoglycemia	J:54614
	increased circulating free fatty acids level	J:54614
Fabp3^tm1Jshr/Fabp3⁺ (B6.129-Fabp3^tm1Jshr)	decreased circulating glucose level	J:102858
Fabp3^tm1Jshr/Fabp3⁺ (B6.129-Fabp3^tm1Jshr)	increased insulin sensitivity	J:102858
Fabp4^tm1Brsp/Fabp4^tm1Brsp (involves: 129S5/SvEvBrd * C57BL/6J)	abnormal glucose homeostasis	J:37027
	decreased circulating insulin level	J:57864
	decreased circulating triglyceride level	J:37027
	hypoglycemia	J:37027
	impaired lipolysis	J:57864
	increased fatty acids level	J:37027
	insulin resistance	J:37027
Fabp4^tm1Brsp/Fabp4^tm1Brsp Fabp5^tm1Hota/Fabp5^tm1Hota (B6.Cg-Fabp4^tm1Brsp Fabp5^tm1Hota)	decreased circulating glucose level	J:111878
	increased insulin sensitivity	J:111878
Fabp4^tm1Brsp/Fabp4^tm1Brsp Fabp5^tm1Hota/Fabp5^tm1Hota (involves: 129S7/SvEvBrd * C57BL/6J * SJL)	decreased body surface temperature	J:217245
	decreased circulating glucose level	J:217245
	decreased glycogen level	J:217245
	decreased skeletal muscle glycogen level	J:217245
	decreased triglyceride level	J:217245
	impaired adaptive thermogenesis	J:217245
	increased circulating free fatty acids level	J:217245
Fabp4^tm1Brsp/Fabp4^tm1Brsp Fabp5^tm1Hota/Fabp5^tm1Hota Lep^ob/Lep^ob (B6.Cg-Fabp4^tm1Brsp Fabp5^tm1Hota Lep^ob)	abnormal gluconeogenesis	J:111878
	abnormal glucose homeostasis	J:111878
	abnormal glycogen homeostasis	J:111878
	decreased circulating cholesterol level	J:111878
	decreased circulating glucose level	J:111878
	decreased circulating insulin level	J:111878
	decreased circulating triglyceride level	J:111878
	decreased liver triglyceride level	J:111878
	improved glucose tolerance	J:111878
	increased fatty acids level	J:111878
	increased insulin sensitivity	J:111878
Fabp4^tm1Brsp/Fabp4^tm1Brsp Lep^ob/Lep^ob (B6.Cg-Fabp4^tm1Brsp Lep^ob)	improved glucose tolerance	J:111878
	increased insulin sensitivity	J:111878
Fabp5^tm1Hota/Fabp5^tm1Hota (B6.Cg-Fabp5^tm1Hota)	decreased circulating glucose level	J:81609
	decreased circulating leptin level	J:81609
	decreased susceptibility to diet-induced obesity	J:81609
	improved glucose tolerance	J:81609
	increased insulin sensitivity	J:81609
Fabp5^tm1Hota/Fabp5^tm1Hota Lep^ob/Lep^ob (involves: 129 * C57BL/6J * C57BL/10J * SJL)	decreased circulating glucose level	J:81609
	improved glucose tolerance	J:81609
	increased circulating insulin level	J:81609
	increased insulin sensitivity	J:81609
Fabp5^tm1Hota/Fabp5^tm1Hota Lep^ob/Lep^ob (B6.Cg-Fabp5^tm1Hota Lep^ob)	improved glucose tolerance	J:111878
	increased insulin sensitivity	J:111878
Fabp5^tm1Kdo/Fabp5^tm1Kdo (involves: C57BL/6)	impaired skin barrier function	J:75715
Fabp6^tm1Lbal/Fabp6^tm1Lbal (B6.129-Fabp6^tm1Lbal)	abnormal bile salt homeostasis	J:195544
	decreased circulating cholesterol level	J:195544
	decreased circulating triglyceride level	J:195544
	decreased liver cholesterol level	J:195544
	increased bile salt level	J:195544
Fabp7^tm1Owad/Fabp7^tm1Owad (B6.Cg-Fabp7^tm1Owad)	decreased fatty acids level	J:111540
Fadd^tm1Mpa/Fadd^tm1Mpa Ikbkg^tm1.1Mpa/Ikbkg^tm1.1Mpa Tg(Alb1-cre)7Gsc/0 (involves: C57BL/6 * FVB/N)	decreased circulating alanine transaminase level	J:118336
Fads1^{Gt(IST11525H2)Tigm}/Fads1⁺ (C57BL/6-Fads1^{Gt(IST11525H2)Tigm})	decreased prostaglandin level	J:186265
	increased prostaglandin level	J:186265
Fads1^{Gt(IST11525H2)Tigm}/Fads1^{Gt(IST11525H2)Tigm} (C57BL/6-Fads1^{Gt(IST11525H2)Tigm})	abnormal circulating lipid level	J:186265
	abnormal lipid level	J:186265
	decreased prostaglandin level	J:186265
	increased prostaglandin level	J:186265
Fads1^{tm1.1(KOMP)Vlcg}/Fads1^{tm1.1(KOMP)Vlcg} (C57BL/6N-Fads1^{tm1.1(KOMP)Vlcg}/Ucd)	decreased circulating cholesterol level	J:211773
	decreased circulating triglyceride level	J:211773
	improved glucose tolerance	J:211773
	increased circulating alkaline phosphatase level	J:211773
	increased circulating phosphate level	J:211773
Fads2^tm1Mtna/Fads2^tm1Mtna (involves: 129S6/SvEvTac * C57BL/6J)	increased liver triglyceride level	J:153293
Fads2^tm1Wst/Fads2^tm1Wst (involves: 129P2/OlaHsd)	abnormal platelet physiology	J:140341
	decreased platelet aggregation	J:140341
	decreased prostaglandin level	J:140341
	decreased susceptibility to induced thrombosis	J:140341
	decreased thromboxane level	J:140341
	decreased unsaturated fatty acids level	J:140341
	increased bleeding time	J:140341
Fads3^{tm1a(KOMP)Wtsi}/Fads3^{tm1a(KOMP)Wtsi} (C57BL/6-Fads3^{tm1a(KOMP)Wtsi})	decreased fatty acids level	J:256005
	decreased liver free fatty acids level	J:256005
	increased fatty acids level	J:256005
	increased liver free fatty acids level	J:256005
Fads3^{tm1b(EUCOMM)Hmgu}/Fads3^{tm1b(EUCOMM)Hmgu} (C57BL/6N-Fads3^{tm1b(EUCOMM)Hmgu}/Wtsi)	decreased circulating phosphate level	J:211773
Fads6^{tm1b(EUCOMM)Wtsi}/Fads6^{tm1b(EUCOMM)Wtsi} (C57BL/6N-Fads6^{tm1b(EUCOMM)Wtsi}/Ieg)	increased blood urea nitrogen level	J:211773
	increased circulating calcium level	J:211773
	increased circulating creatinine level	J:211773
	increased circulating potassium level	J:211773
Faf1^em1(IMPC)H/Faf1^em1(IMPC)H (C57BL/6NTac-Faf1^em1(IMPC)H/H)	decreased circulating glucose level	J:211773
	increased circulating alanine transaminase level	J:211773
Faf2^em1(IMPC)Mbp/Faf2⁺ (C57BL/6N-Faf2^em1(IMPC)Mbp/Ucd)	edema	J:211773
Faf2^tm1Tfji/Faf2^tm1Tfji Speer6-ps1^{Tg(Alb-cre)21Mgn}/Speer6-ps1⁺ (involves: C57BL/6 * C57BL/6N * CBA * DBA)	abnormal apolipoprotein level	J:235325
	decreased circulating free fatty acids level	J:235325
	decreased circulating phospholipid level	J:235325
	decreased circulating triglyceride level	J:235325
	decreased circulating VLDL triglyceride level	J:235325
	increased circulating alkaline phosphatase level	J:235325
	increased circulating aspartate transaminase level	J:235325
	increased circulating phospholipid level	J:235325
Fah^1R/Fah^1R (involves: BALB/cRl * C3H/Rl * C57BL/10Rl)	abnormal urine homeostasis	J:54592
Fah^2R/Fah^2R (involves: BALB/cRl)	abnormal urine homeostasis	J:54592
Fah^em1(IMPC)Mbp/Fah^em1(IMPC)Mbp (C57BL/6N-Fah^em1(IMPC)Mbp/MbpMmucd)	edema	J:211773
Fah^tm1Mgo/Fah^tm1Mgo (either: (involves: 129S7/SvEvBrd) or (involves: 129S7/SvEvBrd * C57BL/6J))	abnormal circulating aspartate transaminase level	J:16046
	hypoglycemia	J:16046
	increased circulating creatinine level	J:16046
Fah^tm1Mgo/Fah^tm1Mgo (involves: 129S7/SvEvBrd * PT)	increased circulating tyrosine level	J:77295
Fah^tm1Mgo/Fah^tm1Mgo (involves: 129S7/SvEvBrd * C57BL/6)	aminoaciduria	J:138701
Fah^tm1Mgo/Fah^tm1Mgo (involves: 129S7/SvEvBrd * C57BL)	abnormal amino acid level	J:27735
	abnormal circulating amino acid level	J:27735
	aminoaciduria	J:27735
	increased alpha-fetoprotein level	J:27735
	increased circulating aspartate transaminase level	J:27735
	increased circulating bilirubin level	J:27735
	increased circulating tyrosine level	J:27735
Fah^tm1Mgo/Fah^tm1Mgo Hgd^aku/Hgd⁺ (involves: 129S7/SvEvBrd * NB)	increased circulating tyrosine level	J:77295
Faim^tm1Kplm/Faim^tm1Kplm (involves: 129P2/OlaHsd * C57BL/6)	increased circulating alanine transaminase level	J:164184
Fam3a^em1Cya/Fam3a^em1Cya (involves: C57BL/6)	abnormal nitric oxide homeostasis	J:295206
	decreased superoxide dismutase level	J:295206
	increased circulating alanine transaminase level	J:295206
	increased circulating aspartate transaminase level	J:295206
	increased circulating glutamate dehydrogenase level	J:295206
Fam3b^tm1Bkht/Fam3b^tm1Bkht (involves: 129S6/SvEvTac * C57BL/6)	abnormal glucose homeostasis	J:167823
	abnormal insulin clearance	J:167823
	decreased insulin secretion	J:167823
	impaired glucose tolerance	J:167823
	increased circulating insulin level	J:167823
Fam3d^em1Wko/Fam3d^em1Wko (C57BL/6-Fam3d^em1Wko)	abnormal cytokine level	J:300819
Fam13a^{tm1e(KOMP)Wtsi}/Fam13a^{tm1e(KOMP)Wtsi} (C57BL/6N-Fam13a^{tm1e(KOMP)Wtsi})	enhanced lipolysis	J:258290
	impaired glucose tolerance	J:258290
	increased circulating free fatty acids level	J:258290
	insulin resistance	J:258290
Fam20c^tm1.1Cqi/Fam20c^tm1.1Cqi Edil3^{Tg(Sox2-cre)1Amc}/Edil3⁺ (involves: 129S6/SvEvTac * C57BL/6 * CBA)	abnormal circulating protein level	J:185208
	abnormal vitamin D level	J:185208
	decreased circulating phosphate level	J:185208
	increased circulating parathyroid hormone level	J:185208
Fam20c^tm1.1Cqi/Fam20c^tm1.1Cqi Tg(Col1a1-cre)2Bek/0 (involves: 129S6/SvEvTac * CD-1)	decreased circulating phosphate level	J:225679
	decreased collagen level	J:225679
Fam20c^tm1Lex/Fam20c^tm1Lex (involves: 129S5/SvEvBrd * C57BL/6)	decreased circulating calcium level	J:186384
	decreased circulating phosphate level	J:186384
	increased circulating alkaline phosphatase level	J:186384
Fam43a^em1(IMPC)J/Fam43a^em1(IMPC)J (C57BL/6NJ-Fam43a^em1(IMPC)J/Mmjax)	decreased circulating calcium level	J:211773
Fam53a^{em1(IMPC)Ccpcz}/Fam53a^{em1(IMPC)Ccpcz} (C57BL/6N-Fam53a^{em1(IMPC)Ccpcz}/Ccpcz)	increased circulating total protein level	J:211773
Fam53b^{tm1b(EUCOMM)Hmgu}/Fam53b^{tm1b(EUCOMM)Hmgu} (C57BL/6N-Fam53b^{tm1b(EUCOMM)Hmgu}/Cnrm)	increased circulating fructosamine level	J:211773
	increased circulating sodium level	J:211773
Fam72a^{tm1.1(KOMP)Vlcg}/Fam72a^{tm1.1(KOMP)Vlcg} (C57BL/6N-Fam72a^{tm1.1(KOMP)Vlcg}/Ucd)	increased blood urea nitrogen level	J:211773
Fam83a^em1(IMPC)J/Fam83a^em1(IMPC)J (C57BL/6NJ-Fam83a^em1(IMPC)J/Mmjax)	impaired glucose tolerance	J:211773
Fam83d^{em1(IMPC)Ccpcz}/Fam83d^{em1(IMPC)Ccpcz} (C57BL/6N-Fam83d^{em1(IMPC)Ccpcz}/Ccpcz)	increased circulating aspartate transaminase level	J:211773
	increased fasting circulating glucose level	J:211773
Fam83g^{tm1a(EUCOMM)Wtsi}/Fam83g^{tm1a(EUCOMM)Wtsi} (Not Specified)	decreased circulating triglyceride level	J:165965
Fam83h^{em1(IMPC)Ccpcz}/Fam83h^{em1(IMPC)Ccpcz} (C57BL/6N-Fam83h^{em1(IMPC)Ccpcz}/Ccpcz)	abnormal cholesterol homeostasis	J:211773
	increased circulating potassium level	J:211773
Fam110b^{tm1a(EUCOMM)Wtsi}/Fam110b⁺ (C57BL/6N-Fam110b^{tm1a(EUCOMM)Wtsi}/Cnrm)	decreased blood urea nitrogen level	J:165965
Fam114a1^em1(IMPC)J/Fam114a1^em1(IMPC)J (C57BL/6NJ-Fam114a1^em1(IMPC)J/J)	increased circulating bilirubin level	J:211773
Fam117b^{tm1a(EUCOMM)Wtsi}/Fam117b^{tm1a(EUCOMM)Wtsi} (Not Specified)	decreased blood urea nitrogen level	J:165965
	decreased circulating cholesterol level	J:165965
	decreased circulating HDL cholesterol level	J:165965
	decreased circulating triglyceride level	J:165965
Fam120a^em1(IMPC)J/Fam120a^em1(IMPC)J (C57BL/6NJ-Fam120a^em1(IMPC)J/J)	increased circulating alkaline phosphatase level	J:211773
Fam161a^{tm1b(KOMP)Wtsi}/Fam161a^{tm1b(KOMP)Wtsi} (C57BL/6N-Fam161a^{tm1b(KOMP)Wtsi}/J)	increased circulating sodium level	J:211773
Fam161b^{em1(IMPC)Ccpcz}/Fam161b^{em1(IMPC)Ccpcz} (C57BL/6N-Fam161b^{em1(IMPC)Ccpcz}/Ccpcz)	increased circulating serum albumin level	J:211773
Fam163a^{tm2b(KOMP)Wtsi}/Fam163a^{tm2b(KOMP)Wtsi} (C57BL/6N-Fam163a^{tm2b(KOMP)Wtsi}/Wtsi)	improved glucose tolerance	J:211773
	increased circulating alkaline phosphatase level	J:211773
	increased circulating aspartate transaminase level	J:211773
	increased circulating total protein level	J:211773
Fam168a^em1(IMPC)J/Fam168a^em1(IMPC)J (C57BL/6NJ-Fam168a^em1(IMPC)J/Mmjax)	increased circulating phosphate level	J:211773
Fam171a1^em1(IMPC)J/Fam171a1^em1(IMPC)J (C57BL/6NJ-Fam171a1^em1(IMPC)J/Mmjax)	decreased circulating alanine transaminase level	J:211773
Fam184b^{tm2b(EUCOMM)Wtsi}/Fam184b^{tm2b(EUCOMM)Wtsi} (C57BL/6N-Fam184b^{tm2b(EUCOMM)Wtsi}/Tcp)	increased circulating calcium level	J:211773
	increased circulating glucose level	J:211773
Fam185a^{em1(IMPC)Ccpcz}/Fam185a^{em1(IMPC)Ccpcz} (C57BL/6N-Fam185a^{em1(IMPC)Ccpcz}/Ccpcz)	decreased circulating creatinine level	J:211773
	increased circulating sodium level	J:211773
Fam186b^{tm1b(KOMP)Mbp}/Fam186b^{tm1b(KOMP)Mbp} (C57BL/6N-Fam186b^{tm1b(KOMP)Mbp}/J)	increased fasting circulating glucose level	J:211773
Fam199x^em1(IMPC)Mbp/Fam199x^em1(IMPC)Mbp (C57BL/6N-Fam199x^em1(IMPC)Mbp/MbpMmucd)	increased circulating alanine transaminase level	J:211773
	increased circulating aspartate transaminase level	J:211773
Fam210a^{tm1b(EUCOMM)Wtsi}/Fam210a⁺ (C57BL/6N-Fam210a^{tm1b(EUCOMM)Wtsi}/Tcp)	increased circulating triglyceride level	J:211773
Fam210b^{tm1b(KOMP)Mbp}/Fam210b^{tm1b(KOMP)Mbp} (C57BL/6N-Fam210b^{tm1b(KOMP)Mbp}/Ucd)	decreased circulating alkaline phosphatase level	J:211773
	decreased circulating serum albumin level	J:211773
Fam217b^{tm1.1(KOMP)Vlcg}/Fam217b^{tm1.1(KOMP)Vlcg} (C57BL/6N-Fam217b^{tm1.1(KOMP)Vlcg}/J)	decreased circulating glucose level	J:211773
	decreased circulating iron level	J:211773
	decreased urine magnesium level	J:211773
Fam221a^{em1(IMPC)Ccpcz}/Fam221a^{em1(IMPC)Ccpcz} (C57BL/6N-Fam221a^{em1(IMPC)Ccpcz}/Ccpcz)	increased circulating glucose level	J:211773
	increased circulating total protein level	J:211773
Fam222a^em1(IMPC)J/Fam222a^em1(IMPC)J (C57BL/6NJ-Fam222a^em1(IMPC)J/Mmjax)	decreased circulating calcium level	J:211773
Fam234b^{tm1a(EUCOMM)Wtsi}/Fam234b^{tm1a(EUCOMM)Wtsi} (C57BL/6N-Fam234b^{tm1a(EUCOMM)Wtsi}/Cnrm)	decreased circulating cholesterol level	J:165965
	decreased circulating LDL cholesterol level	J:165965
	decreased circulating triglyceride level	J:165965
	decreased lactate dehydrogenase level	J:165965
	increased circulating calcium level	J:165965
Fan1^{tm1a(KOMP)Wtsi}/Fan1^{tm1a(KOMP)Wtsi} (129S1.B6-Fan1^{tm1a(KOMP)Wtsi})	dehydration	J:242198
	increased blood urea nitrogen level	J:242198
Fancd2^{em1(IMPC)Hmgu}/Fancd2⁺ (C57BL/6NCrl-Fancd2^{em1(IMPC)Hmgu}/Ieg)	increased circulating iron level	J:211773
Fancf^tm1Nki/Fancf^tm1Nki (involves: 129P2/OlaHsd * FVB)	increased circulating follicle stimulating hormone level	J:180025
Fancf^tm1Nki/Fancf^tm1Nki (involves: 129P2/OlaHsd * FVB)	increased circulating luteinizing hormone level	J:180025
Fancl^gcd/Fancl^gcd (involves: C57BL/6J * CBA/J)	increased circulating follicle stimulating hormone level	J:13553
Far1^{em1(IMPC)Wtsi}/Far1^{em1(IMPC)Wtsi} (C57BL/6N-Far1^{em1(IMPC)Wtsi})	abnormal ether lipid level	J:339470
Far2^{tm2b(KOMP)Wtsi}/Far2^{tm2b(KOMP)Wtsi} (C57BL/6N-Far2^{tm2b(KOMP)Wtsi}/J)	decreased circulating cholesterol level	J:211773
	decreased circulating HDL cholesterol level	J:211773
	increased fasting circulating glucose level	J:211773
Far2^{tm2b(KOMP)Wtsi}/Far2^{tm2b(KOMP)Wtsi} (B6N(Cg)-Far2^{tm2b(KOMP)Wtsi}/2J)	abnormal lipid level	J:267002
Farp1^{tm1b(EUCOMM)Hmgu}/Farp1^{tm1b(EUCOMM)Hmgu} (C57BL/6N-Farp1^{tm1b(EUCOMM)Hmgu}/Ccpcz)	increased fasting circulating glucose level	J:211773
Farp2^{tm1a(KOMP)Wtsi}/Farp2^{tm1a(KOMP)Wtsi} (B6JTyr;B6N-Farp2^{tm1a(KOMP)Wtsi}/Wtsi)	decreased circulating triglyceride level	J:175295
Fars2^em1(IMPC)J/Fars2⁺ (C57BL/6NJ-Fars2^em1(IMPC)J/Mmjax)	increased circulating aspartate transaminase level	J:211773
Farsa^{tm2a(EUCOMM)Wtsi}/Farsa⁺ (C57BL/6N-Farsa^{tm2a(EUCOMM)Wtsi}/Wtsi)	decreased circulating chloride level	J:211773
	decreased circulating sodium level	J:211773
	impaired glucose tolerance	J:211773
	increased circulating insulin level	J:211773
Fas^lpr/Fas^lpr (MRL/Mp-Fas^lpr)	abnormal circulating protein level	J:27634
	abnormal interleukin level	J:8267
	increased circulating serum albumin level	J:28885
	increased circulating total protein level	J:28885
	increased urine protein level	J:28885
	joint swelling	J:27634
Fas^lpr/Fas^lpr (MRL/MpJ-Fas^lpr/J)	albuminuria	J:122315
Fas^lpr/Fas^lpr (MRL/MpJ-Fas^lpr/J)	increased urine protein level	J:92084, J:122315
Fas^lpr/Fas^lpr (MRL-Fas^lpr)	increased blood urea nitrogen level	J:126261
Fas^lpr/Fas^lpr (MRL.Cg-Irf1^tm1Mak Fas^lpr)	increased urine protein level	J:114771
Fas^lpr/Fas^lpr (C3.MRL-Fas^lpr)	abnormal interleukin level	J:8267
Fas^lpr/Fas^lpr (involves: 129P2/OlaHsd * MRL)	increased blood urea nitrogen level	J:45448
Fas^lpr/Fas^lpr (involves: 129P2/OlaHsd * MRL)	increased urine protein level	J:45448
Fas^lpr/Fas^lpr Fcer1g^tm1Tks/Fcer1g^tm1Tks (MRL.Cg-Fcer1g^tm1Tks Fas^lpr)	increased urine protein level	J:106188
Fas^lpr/Fas^lpr Hspa13^tm1.1Smoc/Hspa13^tm1.1Smoc Cd19^tm1(cre)Cgn/Cd19⁺ (involves: 129P2/OlaHsd * 129S * C57BL/6 * MRL/Mp)	increased urine protein level	J:303927
Fas^lpr/Fas^lpr Ifnar1^tm1Agt/Ifnar1^tm1Agt (MRL.Cg-Ifnar1^tm1Agt Fas^lpr)	increased urine protein level	J:92084
Fas^lpr/Fas^lpr Ifnar1^tm1Agt/Ifnar1^tm1Agt Ifngr1^tm1Agt/Ifngr1^tm1Agt (MRL.Cg-Ifngr1^tm1Agt Ifnar1^tm1Agt Fas^lpr)	increased urine protein level	J:92084
Fas^lpr/Fas^lpr Ifng^tm1Ts/Ifng⁺ (MRL.Cg-Ifng^tm1Ts Fas^lpr)	increased blood urea nitrogen level	J:123834
Fas^lpr/Fas^lpr Ifng^tm1Ts/Ifng^tm1Ts (involves: 129S7/SvEvBrd * DBA/1 * MRL/Mp)	decreased circulating creatinine level	J:39600
Fas^lpr/Fas^lpr Ifngr1^tm1Agt/Ifngr1^tm1Agt (MRL.Cg-Ifngr1^tm1Agt Fas^lpr)	increased urine protein level	J:92084
Fas^lpr/Fas^lpr Ighm^tm1Cgn/Ighm^tm1Cgn (involves: 129S2/SvPas * C57BL/6 * MRL/Mp)	increased urine protein level	J:119584
Fas^lpr/Fas^lpr Il4^tm1Cgn/Il4^tm1Cgn (involves: 129P2/OlaHsd * C57BL/6J * MRL/Mp)	decreased circulating creatinine level	J:39600
Fas^lpr/Fas^lpr Il27ra^tm1Mak/Il27ra^tm1Mak (MRL.Cg-Il27ra^tm1Mak Fas^lpr)	decreased blood urea nitrogen level	J:122148
	decreased circulating creatinine level	J:122148
	increased circulating interleukin-4 level	J:122148
	increased circulating interleukin-5 level	J:122148
Fas^lpr/Fas^lpr Irf1^tm1Mak/Irf1⁺ (MRL.Cg-Irf1^tm1Mak Fas^lpr)	increased urine protein level	J:114771
Fas^lpr/Fas^lpr Itfg2^{Gt(OST215121)Lex}/Itfg2^{Gt(OST215121)Lex} (involves: 129S5/SvEvBrd * C57BL/6J * MRL/Mp)	increased urine protein level	J:205951
Fas^lpr/Fas^lpr Nos2^tm1Mrl/Nos2^tm1Mrl (involves: 129S7/SvEvBrd * MRL)	abnormal blood homeostasis	J:42666
	abnormal urine homeostasis	J:42666
	decreased urine nitrite level	J:42666
Fas^lpr/Fas^lpr Selplg^tm1Fur/Selplg^tm1Fur (MRL.Cg-Selplg^tm1Fur Fas^lpr)	abnormal chemokine level	J:127199
Fas^lpr/Fas^lpr Tcra^tm1Mjo/Tcra^tm1Mjo (involves: 129P2/OlaHsd * MRL)	increased blood urea nitrogen level	J:45448
	increased urine protein level	J:45448
Fas^lpr/Fas^lpr Tlr9^tm1Aki/Tlr9^tm1Aki (B6.Cg-Tlr9^tm1Aki Fas^lpr)	increased urine protein level	J:135036
Fas^lpr/Fas^lpr Tlr9^tm1Aki/Tlr9^tm1Aki (MRL.Cg-Tlr9^tm1Aki Fas^lpr)	increased circulating interferon-alpha level	J:113557
Fasl^gld/Fasl^gld (C3H/HeJ-Fasl^gld/J)	skin edema	J:7306
Fasl^gld/Fasl^gld (B6Smn.C3-Fasl^gld/J)	decreased circulating alanine transaminase level	J:135830
Fasl^gld/Fasl^gld (C3H/HeJ-Fasl^gld)	abnormal interleukin level	J:8267
Fasl^gld/Fasl^gld (involves: C3H/HeJ * C57BL/6)	increased circulating tumor necrosis factor level	J:153501
Fasl^tm1.1Ast/Fasl^tm1.1Ast (involves: BALB/cJ * C57BL/6)	increased circulating tumor necrosis factor level	J:153501
Fasl^tm1.1Lest/Fasl^tm1.1Lest (involves: 129 * C57BL/6)	increased urine protein level	J:87990
Fasl^tm1.1Lest/Fasl^tm1.1Lest (B6.129-Fasl^tm1.1Lest)	increased urine protein level	J:87990
Fasn^tm1Sem/Fasn^tm1Sem Speer6-ps1^{Tg(Alb-cre)21Mgn}/? (involves: 129X1/SvJ * C57BL/6 * DBA)	abnormal blood homeostasis	J:127793
	decreased circulating cholesterol level	J:127793
	decreased circulating glucose level	J:127793
	decreased circulating insulin level	J:127793
	decreased liver cholesterol level	J:127793
	decreased saturated fatty acids level	J:127793
	increased circulating free fatty acids level	J:127793
	increased circulating glucagon level	J:127793
	increased triglyceride level	J:127793
Fasn^tm1Sem/Fasn^tm1Sem Tg(Ins2-cre)25Mgn/? (involves: 129X1/SvJ * C57BL/6 * DBA)	abnormal fatty acids level	J:127482
	decreased circulating free fatty acids level	J:127482
	increased circulating glucose level	J:127482
	increased circulating insulin level	J:127482
	increased circulating triglyceride level	J:127482
	increased oxygen consumption	J:127482
Fastk^{tm1.1(KOMP)Vlcg}/Fastk^{tm1.1(KOMP)Vlcg} (C57BL/6N-Fastk^{tm1.1(KOMP)Vlcg}/Ucd)	improved glucose tolerance	J:211773
Fastkd5^em1(IMPC)J/Fastkd5^em1(IMPC)J (C57BL/6NJ-Fastkd5^em1(IMPC)J/J)	decreased circulating glucose level	J:211773
Fat1^tm1.1Nsib/Fat1⁺ Tg(NPHS2-cre)295Lbh/0 (involves: 129/Sv * 129S4/SvJaeSor * C57BL/6 * C57BL/6J * SJL)	albuminuria	J:234732
Fat1^tm1.1Nsib/Fat1^tm1.1Nsib Tg(NPHS2-cre)295Lbh/0 (involves: 129/Sv * 129S4/SvJaeSor * C57BL/6 * C57BL/6J * SJL)	albuminuria	J:234732
	increased urine protein level	J:234732
Fbf1^{tm1a(EUCOMM)Wtsi}/Fbf1^{tm1a(EUCOMM)Wtsi} (C57BL/6N-Fbf1^{tm1a(EUCOMM)Wtsi}/Wtsi)	decreased circulating cholesterol level	J:211773
	decreased circulating HDL cholesterol level	J:211773
	decreased circulating LDL cholesterol level	J:211773
	decreased circulating serum albumin level	J:211773
	increased circulating alkaline phosphatase level	J:211773
	increased circulating insulin level	J:211773
	increased fasting circulating glucose level	J:211773
Fbgl1^KK/Ta/Fbgl1^KK/Ta (involves: BALB/c * KK/Ta)	hyperglycemia	J:88209
Fbgl1^KK/Ta/Fbgl1^KK/Ta Fbgl2^KK/Ta/Fbgl2^KK/Ta Ua1^KK/Ta/Ua1^KK/Ta (involves: BALB/c * KK/Ta)	albuminuria	J:97906
Fbgl2^KK/Ta/Fbgl2^KK/Ta (involves: BALB/c * KK/Ta)	hyperglycemia	J:88209
Fbln5^tm1Eno/Fbln5^tm1Eno (involves: 129S6/SvEvTac * C57BL/6)	increased susceptibility to induced thrombosis	J:96831
Fbln7^tm1.1Hiya/Fbln7^tm1.1Hiya (involves: 129S6/SvEvTac * C57BL/6)	decreased circulating creatinine level	J:271278
	increased blood urea nitrogen level	J:271278
Fbn1^em1Chop/Fbn1⁺ (C57BL/6-Fbn1^em1Chop)	decreased circulating leptin level	J:251851
	decreased energy expenditure	J:251851
	decreased susceptibility to diet-induced obesity	J:251851
Fbn1^tm1.1Itl/Fbn1^tm3Rmz Tg(CMV-cre)1Cgn/0 (involves: 129S1/Sv * 129S4/SvJaeSor * 129X1/SvJ * BALB/cJ * C57BL/6J)	hemopericardium	J:187484
Fbn1^tm1Rmz/Fbn1^tm1Rmz (involves: 129S4/SvJae * C57BL/6J)	abnormal arterial thrombosis	J:43199
Fbn1^tm1Rmz/Fbn1^tm1Rmz (involves: 129S4/SvJae * C57BL/6J)	hemopericardium	J:43199
Fbn1^tm2Rmz/Fbn1^tm2Rmz (involves: 129S1/Sv * 129X1/SvJ)	hemopericardium	J:54081
Fbn1^tm3Rmz/Fbn1^tm3Rmz (Not Specified)	hemopericardium	J:110586
Fbn2^{em1(IMPC)Rbrc}/Fbn2^{em1(IMPC)Rbrc} (C57BL/6NJcl-Fbn2^{em1(IMPC)Rbrc}/Rbrc)	decreased circulating amylase level	J:211773
	increased circulating alkaline phosphatase level	J:211773
Fbn2^timon/Fbn2^timon (C57BL/6J-Fbn2^timon)	edema	J:263533
Fbp1^m1Btlr/Fbp1^m1Btlr (C57BL/6J-Fbp1^m1Btlr)	hypoglycemia	J:267693
Fbrs^em1(IMPC)J/Fbrs⁺ (C57BL/6NJ-Fbrs^em1(IMPC)J/Mmjax)	abnormal cholesterol homeostasis	J:211773
	decreased circulating alanine transaminase level	J:211773
	decreased circulating alkaline phosphatase level	J:211773
	decreased circulating aspartate transaminase level	J:211773
	decreased circulating bilirubin level	J:211773
	increased circulating aspartate transaminase level	J:211773
	increased circulating bilirubin level	J:211773
Fbxl3^{em1(IMPC)Ccpcz}/Fbxl3^{em1(IMPC)Ccpcz} (C57BL/6NCrl-Fbxl3^{em1(IMPC)Ccpcz}/Ccpcz)	decreased circulating total protein level	J:211773
	increased circulating alkaline phosphatase level	J:211773
	increased circulating chloride level	J:211773
Fbxl5^{Gt(OST386421)Lex}/Fbxl5⁺ (involves: 129S5/SvEvBrd * C57BL/6)	abnormal iron homeostasis	J:193752
	decreased liver iron level	J:193752
	increased intestinal iron level	J:193752
	increased spleen iron level	J:193752
Fbxl5^L5Jcs32/Fbxl5^L5Jcs32 (involves: C3HeB/FeJ * C57BL/6J)	pericardial edema	J:100332
Fbxl5^tm1Kei/Fbxl5^tm1Kei (B6.129-Fbxl5^tm1Kei)	abnormal iron level	J:176655
Fbxl5^tm1Kei/Fbxl5^tm1Kei Ireb2^tm1Roua/Ireb2^tm1Roua (B6.129-Fbxl5^tm1Kei Ireb2^tm1Roua)	decreased circulating unsaturated transferrin level	J:176655
	decreased liver iron level	J:176655
	increased circulating iron level	J:176655
Fbxl5^tm2.1Kei/Fbxl5^tm2.1Kei (involves: C57BL/6)	abnormal iron level	J:176655
Fbxl5^tm2.1Kei/Fbxl5^tm2.1Kei Speer6-ps1^{Tg(Alb-cre)21Mgn}/Speer6-ps1⁺ (involves: C57BL/6 * DBA)	abnormal blood coagulation	J:176655
	abnormal circulating enzyme level	J:176655
	decreased circulating unsaturated transferrin level	J:176655
	increased circulating alanine transaminase level	J:176655
	increased circulating aspartate transaminase level	J:176655
	increased circulating iron level	J:176655
	increased circulating lactate dehydrogenase level	J:176655
	increased liver iron level	J:176655
	increased partial thromboplastin time	J:176655
	increased prothrombin time	J:176655
Fbxl9^em1(IMPC)Bay/Fbxl9^em1(IMPC)Bay (C57BL/6N-Fbxl9^em1(IMPC)Bay/BayMmucd)	impaired glucose tolerance	J:211773
Fbxl19^{tm1b(EUCOMM)Wtsi}/Fbxl19⁺ (C57BL/6N-Fbxl19^{tm1b(EUCOMM)Wtsi}/Nju)	decreased circulating glucose level	J:211773
	decreased circulating total protein level	J:211773
Fbxo2^{tm1b(EUCOMM)Wtsi}/Fbxo2^{tm1b(EUCOMM)Wtsi} (C57BL/6N-Fbxo2^{tm1b(EUCOMM)Wtsi}/Nju)	decreased fasting circulating glucose level	J:211773
	increased circulating glucose level	J:211773
Fbxo7^{tm1a(EUCOMM)Wtsi}/Fbxo7^{tm1a(EUCOMM)Wtsi} (C57BL/6N-Fbxo7^{tm1a(EUCOMM)Wtsi}/Wtsi)	decreased circulating fructosamine level	J:211773
	decreased circulating iron level	J:211773
	increased circulating bilirubin level	J:211773
	increased circulating sodium level	J:211773
Fbxo7^{tm1a(EUCOMM)Wtsi}/Fbxo7^{tm1a(EUCOMM)Wtsi} (involves: C57BL/6N)	decreased circulating iron level	J:272313
	increased circulating bilirubin level	J:272313
Fbxo9^{tm1b(EUCOMM)Hmgu}/Fbxo9^{tm1b(EUCOMM)Hmgu} (C57BL/6N-Fbxo9^{tm1b(EUCOMM)Hmgu}/Tcp)	increased circulating cholesterol level	J:211773
	increased circulating HDL cholesterol level	J:211773
Fbxo10^{tm1b(KOMP)Wtsi}/Fbxo10^{tm1b(KOMP)Wtsi} (C57BL/6N-Fbxo10^{tm1b(KOMP)Wtsi}/Nju)	decreased blood urea nitrogen level	J:211773
	decreased circulating calcium level	J:211773
	decreased circulating glucose level	J:211773
	decreased circulating phosphate level	J:211773
	decreased circulating triglyceride level	J:211773
Fbxo11^Jf/Fbxo11⁺ (involves: BALB/cAnNCrl * C3H/HeN)	middle ear effusion	J:85263
Fbxo11^Jf/Fbxo11⁺ (involves: BALB/cAnNCrl)	middle ear effusion	J:250208
Fbxo11^{tm2a(EUCOMM)Wtsi}/Fbxo11^{tm2a(EUCOMM)Wtsi} (involves: C57BL/6N)	abnormal protein level	J:220308
Fbxo11^{tm2b(EUCOMM)Wtsi}/Fbxo11⁺ (C57BL/6N-Fbxo11^{tm2b(EUCOMM)Wtsi}/H)	decreased circulating calcium level	J:211773
	decreased circulating iron level	J:211773
	decreased circulating total protein level	J:211773
	increased fasting circulating glucose level	J:211773
Fbxo30^{tm1b(KOMP)Wtsi}/Fbxo30⁺ (C57BL/6N-Fbxo30^{tm1b(KOMP)Wtsi}/J)	decreased circulating glucose level	J:211773
	improved glucose tolerance	J:211773
Fbxo33^{tm1b(EUCOMM)Wtsi}/Fbxo33^{tm1b(EUCOMM)Wtsi} (C57BL/6N-Fbxo33^{tm1b(EUCOMM)Wtsi}/Wtsi)	increased circulating alanine transaminase level	J:211773
Fbxo41^{tm1.1(KOMP)Vlcg}/Fbxo41^{tm1.1(KOMP)Vlcg} (C57BL/6N-Fbxo41^{tm1.1(KOMP)Vlcg}/Ucd)	decreased circulating cholesterol level	J:211773
Fbxo42^em1(IMPC)J/Fbxo42⁺ (C57BL/6NJ-Fbxo42^em1(IMPC)J/Mmjax)	decreased circulating alanine transaminase level	J:211773
	decreased circulating aspartate transaminase level	J:211773
	decreased circulating bilirubin level	J:211773
Fbxw7^tm1Iaai/Fbxw7^tm1Iaai Tg(Amh-cre)8815Reb/0 (involves: 129 * C57BL/6 * C57BL/6J * FVB/N)	decreased circulating testosterone level	J:289161
Fbxw7^tm1Kin/Fbxw7^tm1Kin (involves: C57BL/6)	pericardial edema	J:88517
Fbxw8^{Gt(RRT057)Byg}/Fbxw8^{Gt(RRT057)Byg} (involves: 129P2/OlaHsd * C57BL/6)	cyanosis	J:130238
Fbxw8^{tm1b(EUCOMM)Hmgu}/Fbxw8⁺ (C57BL/6N-Fbxw8^{tm1b(EUCOMM)Hmgu}/Nju)	increased blood urea nitrogen level	J:211773
	increased circulating creatinine level	J:211773
Fbxw15^{em1(IMPC)Ccpcz}/Fbxw15^{em1(IMPC)Ccpcz} (C57BL/6N-Fbxw15^{em1(IMPC)Ccpcz}/Ccpcz)	increased circulating phosphate level	J:211773
Fbxw18^{em1(IMPC)Ccpcz}/Fbxw18⁺ (C57BL/6N-Fbxw18^{em1(IMPC)Ccpcz}/Ccpcz)	increased circulating chloride level	J:211773
	increased circulating sodium level	J:211773
Fcer1a^tm1Ftl/Fcer1a^tm1Ftl (CBy.129S2-Fcer1a^tm1Ftl)	decreased circulating interleukin-4 level	J:120702
Fcer1a^tm1Knt/Fcer1a^tm1Knt (involves: 129 * BALB/c)	reduced thrombolysis	J:47138
Fcer1g^tm1Rav/Fcer1g^tm1Rav (involves: 129P2/OlaHsd * C57BL/6)	abnormal platelet activation	J:118488
	decreased platelet aggregation	J:112819
	decreased platelet calcium level	J:118488
Fcer1g^tm1Rav/Fcer1g^tm1Rav (involves: 129P2/OlaHsd)	decreased platelet aggregation	J:165893
Fcer1g^tm1Rav/Fcer1g^tm1Rav Hexb^tm1Rlp/Hexb^tm1Rlp (involves: 129P2/OlaHsd * 129S4/SvJae * C57BL/6)	abnormal lipid level	J:87617
Fcer1g^tm1Tks/Fcer1g^tm1Tks (involves: C57BL/6)	abnormal cytokine level	J:258645
Fcer2a^tm1Max/Fcer2a^tm1Max (involves: C57BL/6J)	decreased body temperature	J:198154
Fcer2a^tm1Max/Fcer2a^tm1Max Ighg1^tm1.1Pyu/Ighg1⁺ (involves: 129 * BALB/cJ * C57BL/6 * C57BL/6J)	decreased body temperature	J:198154
Fcer2a^tm1Max/Fcer2a^tm1Max Ighg1^tm1.1Pyu/Ighg1^tm1.1Pyu (involves: 129 * BALB/cJ * C57BL/6 * C57BL/6J)	decreased body temperature	J:198154
Fcgbp^{tm1b(EUCOMM)Wtsi}/Fcgbp^{tm1b(EUCOMM)Wtsi} (C57BL/6N-Fcgbp^{tm1b(EUCOMM)Wtsi}/Cnrm)	increased circulating alkaline phosphatase level	J:211773
Fcgr2b^tm1.2Jsv/Fcgr2b^tm1.2Jsv Sle16^C57BL/6/Sle16^C57BL/6 (involves: C57BL/6 * FVB/N)	abnormal glomerular capillary thrombosis	J:179175
	albuminuria	J:179175
Fcgr2b^tm1Ttk/Fcgr2b^tm1.2Jsv Sle21^129P2/Ola/Sle21^C57BL/6 (involves: 129P2/Ola * 129S4/SvJae * C57BL/6 * FVB/N)	albuminuria	J:179175
Fcgr2b^tm1Ttk/Fcgr2b^tm1Ttk (B6.129S4-Fcgr2b^tm1Ttk)	dehydration	J:64152
	edema	J:64152
	increased urine protein level	J:64152
Fcgr2b^tm1Ttk/Fcgr2b^tm1Ttk Pdcd1^tm1Hon/Pdcd1^tm1Hon (involves: 129S2/SvPas * 129S4/SvJae * BALB/c)	abnormal cytokine level	J:207275
	abnormal urine cytokine level	J:207275
Fcgr2b^tm1Ttk/Fcgr2b^tm1Ttk Sle21^129P2/Ola/Sle21^129P2/Ola (B6.129S4-Fcgr2b^tm1Ttk)	abnormal glomerular capillary thrombosis	J:179175
	albuminuria	J:179175
Fcgr3^{tm1b(EUCOMM)Hmgu}/Fcgr3^{tm1b(EUCOMM)Hmgu} (C57BL/6N-Fcgr3^{tm1b(EUCOMM)Hmgu}/H)	decreased circulating calcium level	J:211773
	decreased circulating creatine kinase level	J:211773
	decreased circulating serum albumin level	J:211773
	decreased circulating total protein level	J:211773
Fcgr4^tm1Rav/Fcgr4^tm1Rav Tg(Ctsk-cre)1Rda/0 (involves: C57BL/6)	abnormal circulating protein level	J:197378
Fcgrt^tm1Dcr/Fcgrt^tm1Dcr (B6.129X1-Fcgrt^tm1Dcr/DcrJ)	decreased circulating serum albumin level	J:110885
Fcgrt^tm1Dcr/Fcgrt^tm1Dcr Tg(CAG-FCGRT)276Dcr/0 (involves: 129X1/SvJ * C57BL/6 * C57BL/6J)	increased circulating serum albumin level	J:110885
Fcgrt^tm1Esw/Fcgrt^tm1Esw Tg(Tek-cre)1Ywa/0 (B6.Cg-Tg(Tek-cre)1Ywa Fcgrt^tm1Esw)	decreased circulating serum albumin level	J:146640
Fcho2^{tm1b(EUCOMM)Hmgu}/Fcho2⁺ (C57BL/6N-Fcho2^{tm1b(EUCOMM)Hmgu}/Wtsi)	decreased circulating fructosamine level	J:211773
	decreased circulating serum albumin level	J:211773
Fcmr^tm1.2Khl/Fcmr^tm1.2Khl (involves: C57BL/6)	decreased circulating alanine transaminase level	J:174871
Fcor^tm1Jnak/Fcor^tm1Jnak (involves: C57BL/6NCrlj * CBA/JNCrlj)	decreased respiratory quotient	J:184684
	impaired glucose tolerance	J:184684
	increased oxygen consumption	J:184684
	insulin resistance	J:184684
Fcrl2^em1(IMPC)H/Fcrl2^em1(IMPC)H (C57BL/6NTac-Fcrl2^em1(IMPC)H/H)	increased circulating aspartate transaminase level	J:211773
	increased circulating creatine kinase level	J:211773
	increased circulating phosphate level	J:211773
Fdxacb1^{tm1.1(KOMP)Vlcg}/Fdxacb1^{tm1.1(KOMP)Vlcg} (C57BL/6N-Fdxacb1^{tm1.1(KOMP)Vlcg}/J)	increased circulating sodium level	J:211773
Fdxr^tm1Xch/Fdxr⁺ (B6.Cg-Fdxr^tm1Xch)	abnormal iron homeostasis	J:244082
	abnormal iron level	J:244082
	abnormal protein level	J:244082
	increased alpha-fetoprotein level	J:244082
	increased liver iron level	J:244082
Fdxr^tm1Xch/Fdxr⁺ Trp53^tm1Tyj/Trp53⁺ (involves: 129S2/SvPas * C57BL/6)	abnormal iron level	J:244082
Fdxr^tm1Xch/Fdxr⁺ Trp53^tm1Tyj/Trp53^tm1Tyj (involves: 129S2/SvPas * C57BL/6)	abnormal iron level	J:244082
Fdxr^tm1Xch/Fdxr^tm1Xch (B6.Cg-Fdxr^tm1Xch)	abnormal iron level	J:244082
Fech^m1Pas/Fech^m1Pas (involves: 129/Sv * BALB/c)	abnormal circulating enzyme level	J:2021
	increased circulating alkaline phosphatase level	J:2021
	increased circulating bilirubin level	J:2021
	increased erythrocyte protoporphyrin level	J:2021
	increased porphyrin level	J:2021
Fech^m1Pas/Fech^m1Pas hem6/hem6 (involves: 129 * BALB/c * C57BL/6)	increased erythrocyte protoporphyrin level	J:142791
Fech^m1Pas/Fech^m1Pas hem6/hem6⁺ (involves: 129 * BALB/c * C57BL/6)	increased erythrocyte protoporphyrin level	J:142791
Fech^m1Pas/Fech^{tm1.1(FECH)Emi} (involves: 129 BALB/cJ * C57BL/6J)	increased circulating bilirubin level	J:239515
	increased porphyrin level	J:239515
Fem1b^tm1Jfma/Fem1b^tm1Jfma (involves: 129X1/SvJ * C57BL/6)	decreased insulin secretion	J:100017
Fem1b^tm1Jfma/Fem1b^tm1Jfma (involves: 129X1/SvJ * C57BL/6)	impaired glucose tolerance	J:100017
Fermt1^tm1Ref/Fermt1^tm1Ref (involves: 129S1/Sv * 129X1/SvJ)	dehydration	J:142913
	increased urine osmolality	J:142913
	increased urine protein level	J:142913
Fermt3^tm1.1Efp/Fermt3^tm1.1Efp (involves: C57BL/6)	abnormal platelet activation	J:227094
	abnormal platelet physiology	J:227094
	decreased platelet aggregation	J:227094
	decreased susceptibility to induced thrombosis	J:227094
	increased bleeding time	J:227094
Fermt3^{tm1b(KOMP)Wtsi}/Fermt3^{tm1b(KOMP)Wtsi} (C57BL/6N-Fermt3^{tm1b(KOMP)Wtsi}/J)	edema	J:211773
Fermt3^tm1Ref/Fermt3^tm1Ref (involves: 129S1/Sv * 129X1/SvJ)	abnormal platelet activation	J:133659
	abnormal thrombosis	J:133659
	decreased platelet aggregation	J:133659
	increased bleeding time	J:133659
Fes^tm2Mcs/Fes⁺ (chimera involves: 129X1/SvJ * C57BL/6)	hydrops fetalis	J:76509
Fev^tm1Esd/Fev^tm2Esd Tg(Fev-cre/ERT2)aEsd/0 (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	decreased serotonin level	J:165266
Fez1^tm1Kei/Fez1^tm1Kei (B6.129P2-Fez1^tm1Kei)	increased dopamine level	J:139974
Ffal1^C57BL/6J/? (involves: C57BL/6J * DBA/2J)	increased circulating free fatty acids level	J:84091
Ffaq2^NZW/LacJ/? (involves: NZB/BlNJ * NZW/LacJ)	increased circulating free fatty acids level	J:138463
Ffaq3^NZB/BlNJ/Ffaq3^NZB/BlNJ Ffaq4^NZB/BlNJ/Ffaq4^NZB/BlNJ (involves: NZB/BlNJ * NZW/LacJ)	increased circulating free fatty acids level	J:138463
Ffar1^tm1Dgen/Ffar1^tm1Dgen (involves: 129P2/OlaHsd * C57BL/6)	abnormal circulating hormone level	J:141957
	abnormal circulating insulin level	J:141957
	abnormal triglyceride level	J:141957
	decreased circulating glucagon level	J:141957
	decreased circulating triglyceride level	J:141957
	increased liver triglyceride level	J:141957
Ffar1^tm1Heed/Ffar1^tm1Heed (Not Specified)	abnormal circulating triglyceride level	J:129843
	abnormal gluconeogenesis	J:129843
	decreased circulating insulin level	J:129843
	decreased insulin secretion	J:129843
	improved glucose tolerance	J:129843
	increased insulin sensitivity	J:129843
Ffar1^tm1Lex/Ffar1^tm1Lex (involves: 129 * C57BL/6)	decreased insulin secretion	J:122092
Ffar1^tm1Lex/Ffar1^tm1Lex (involves: C57BL/6 * C57BL/6J)	abnormal glucagon secretion	J:200805
Ffar1^tm1Lex/Ffar1^tm1Lex (involves: C57BL/6 * C57BL/6J)	increased circulating glucose level	J:200805
Ffar2^{tm1b(EUCOMM)Hmgu}/Ffar2^{tm1b(EUCOMM)Hmgu} (C57BL/6N-Ffar2^{tm1b(EUCOMM)Hmgu}/J)	increased circulating alanine transaminase level	J:211773
	increased circulating aspartate transaminase level	J:211773
Ffar2^tm1Fmgb/Ffar2^tm1Fmgb (involves: 129S/SvEv)	decreased circulating insulin level	J:191508
Ffar2^tm1Fmgb/Ffar2^tm1Fmgb (involves: 129S/SvEv)	impaired glucose tolerance	J:191508
Ffar2^tm1Lex/Ffar2^tm1Lex (involves: 129S/SvEvBrd * C57BL/6J)	abnormal circulating free fatty acids level	J:138134
Ffar2^tm1Soff/Ffar2^tm1Soff (B6.129-Ffar2^tm1Soff)	increased circulating insulin level	J:227939
Ffar2^tm2Lex/Ffar2^tm2Lex (involves: 129S7/SvEvBrd * C57BL/6)	abnormal cytokine level	J:157383
	decreased circulating tumor necrosis factor level	J:157383
	increased circulating tumor necrosis factor level	J:157383
Ffar2^tm2Soff/Ffar2^tm2Soff Ffar3^tm2.1Soff/Ffar3^tm2.1Soff Tg(Ins2-cre)25Mgn/0 (involves: 129S4/SvJae * C57BL/6 * DBA)	abnormal insulin secretion	J:227939
	decreased circulating free fatty acids level	J:227939
	improved glucose tolerance	J:227939
	increased circulating insulin level	J:227939
Ffar3^tm1Fmgb/Ffar3^tm1Fmgb (involves: 129S/SvEv)	impaired glucose tolerance	J:191508
Ffar3^tm1Gzt/Ffar3^tm1Gzt (involves: C57BL/6)	abnormal noradrenaline level	J:172798
	abnormal oxygen consumption	J:172798
	decreased body temperature	J:172798
	decreased circulating noradrenaline level	J:172798
	decreased oxygen consumption	J:172798
	increased circulating ketone body level	J:172798
Ffar3^tm1Reh/Ffar3^tm1Reh (involves: 129S6/SvEvTac * C57BL/6J)	abnormal energy homeostasis	J:143567
	decreased circulating leptin level	J:143567
	decreased liver triglyceride level	J:143567
Ffar3^tm1Soff/Ffar3^tm1Soff (B6.129-Ffar3^tm1Soff)	increased circulating insulin level	J:227939
Ffar4^{tm1(KOMP)Vlcg}/Ffar4^{tm1(KOMP)Vlcg} (involves: C57BL/6NTac)	decreased oxygen consumption	J:240649
	impaired adaptive thermogenesis	J:240649
Ffar4^tm1.1Mbj/Ffar4^tm1.1Mbj (involves: C57BL/6)	abnormal insulin secretion	J:211675
Ffar4^tm1Gdds/Ffar4^tm1Gdds (involves: 129 * C57BL/6)	abnormal lipid level	J:182599
	decreased energy expenditure	J:182599
	decreased respiratory quotient	J:182599
	impaired glucose tolerance	J:182599
	increased circulating alanine transaminase level	J:182599
	increased circulating cholesterol level	J:182599
	increased circulating glucose level	J:182599
	increased circulating HDL cholesterol level	J:182599
	increased circulating insulin level	J:182599
	increased circulating LDL cholesterol level	J:182599
	increased circulating leptin level	J:182599
	increased liver triglyceride level	J:182599
	increased susceptibility to diet-induced obesity	J:182599
	insulin resistance	J:182599
Fga^tm1Jld/Fga^tm1Jld (involves: 129P2/OlaHsd * CF-1)	abnormal blood coagulation	J:36591
	decreased circulating fibrinogen level	J:28436
	decreased platelet aggregation	J:28436
	impaired blood coagulation	J:28436
Fga^tm1Jld/Fga^tm1Jld (B6.129P2-Fga^tm1Jld)	decreased circulating fibrinogen level	J:28436
	decreased platelet aggregation	J:28436
	impaired blood coagulation	J:28436
Fga^tm1Jld/Fga^tm1Jld (involves: 129P2/OlaHsd * C57BL/6J)	abnormal blood coagulation	J:63750
Fga^tm1Jld/Fga^tm1Jld Plg^tm1Jld/Plg^tm1Jld (involves: 129P2/OlaHsd * Black Swiss * CF-1)	abnormal blood coagulation	J:36591
Fga^tm1Jld/Fga^tm1Jld Vwf^tm1Wgr/Vwf^tm1Wgr (involves: 129P2/OlaHsd * 129S2/SvPas * C57BL/6J)	abnormal blood coagulation	J:63750
Fgb^{tm1.1(KOMP)Vlcg}/Fgb⁺ (C57BL/6N-Fgb^{tm1.1(KOMP)Vlcg}/Ucd)	decreased circulating phosphate level	J:211773
Fgb^{tm1.1(KOMP)Vlcg}/Fgb⁺ (C57BL/6N-Fgb^{tm1.1(KOMP)Vlcg}/MbpMmucd)	edema	J:211773
Fgb^{tm1.1(KOMP)Vlcg}/Fgb^{tm1.1(KOMP)Vlcg} (C57BL/6N-Fgb^{tm1.1(KOMP)Vlcg}/Ucd)	impaired glucose tolerance	J:211773
Fgb^{tm1.1(KOMP)Vlcg}/Fgb^{tm1.1(KOMP)Vlcg} (C57BL/6N-Fgb^{tm1.1(KOMP)Vlcg}/MbpMmucd)	edema	J:211773
Fgd1^em1(IMPC)Tcp/Y (C57BL/6NCrl-Fgd1^em1(IMPC)Tcp/Tcp)	edema	J:211773
Fgd3^{em1(IMPC)Ccpcz}/Fgd3^{em1(IMPC)Ccpcz} (C57BL/6N-Fgd3^{em1(IMPC)Ccpcz}/Ccpcz)	decreased circulating creatinine level	J:211773
Fgd4^{tm1a(EUCOMM)Wtsi}/Fgd4^{tm1a(EUCOMM)Wtsi} (C57BL/6N-Fgd4^{tm1a(EUCOMM)Wtsi}/Wtsi)	increased circulating LDL cholesterol level	J:211773
Fgd5^em1(IMPC)Mbp/Fgd5⁺ (C57BL/6NCrl-Fgd5^em1(IMPC)Mbp/MbpMmucd)	decreased circulating cholesterol level	J:211773
	decreased circulating glucose level	J:211773
Fgf2^{tm1b(EUCOMM)Wtsi}/Fgf2^{tm1b(EUCOMM)Wtsi} (C57BL/6N-Fgf2^{tm1b(EUCOMM)Wtsi}/H)	increased circulating serum albumin level	J:211773
	increased circulating total protein level	J:211773
Fgf8^tm1Mrc/Fgf8^tm3Mrc (involves: 129 * C57BL/6)	cyanosis	J:87304
Fgf8^tm1Mrc/Fgf8^tm3Mrc (involves: 129 * C57BL/6)	edema	J:87304
Fgf8^tm2Moon/Fgf8^tm1Mrc Mesp1^tm2(cre)Ysa/Mesp1⁺ (involves: C57BL/6 * CBA)	edema	J:109475
	pericardial effusion	J:109475
Fgf9^Eks/Fgf9^Eks (involves: C57BL/6J * DBA/2J)	cyanosis	J:77537
Fgf9^tm1.2Zqch/Fgf9^tm1.2Zqch (involves: 129S6/SvEvTac * C57BL/6J * FVB)	decreased hyaluronic acid level	J:306390
Fgf9^tm1Dor/Fgf9^tm1Dor (involves: 129S6/SvEvTac * C57BL/6)	cyanosis	J:69852
Fgf9^tm1Dor/Fgf9^tm1Dor (involves: 129S6/SvEvTac * C57BL/6)	hypoxia	J:69852
Fgf10^{tm1b(EUCOMM)Wtsi}/Fgf10⁺ (C57BL/6N-Fgf10^{tm1b(EUCOMM)Wtsi}/H)	increased circulating cholesterol level	J:211773
	increased circulating HDL cholesterol level	J:211773
Fgf10^tm1Wss/Fgf10⁺ (involves: 129X1/SvJ)	decreased salivation	J:299375
Fgf10^tm1Wss/Fgf10⁺ (involves: 129X1/SvJ)	xerostomia	J:299375
Fgf14^{em1(IMPC)Ccpcz}/Fgf14^{em1(IMPC)Ccpcz} (C57BL/6N-Fgf14^{em1(IMPC)Ccpcz}/Ccpcz)	increased circulating alkaline phosphatase level	J:211773
Fgf15^{tm1.1(KOMP)Vlcg}/Fgf15^{tm1.1(KOMP)Vlcg} (C57BL/6N-Fgf15^{tm1.1(KOMP)Vlcg}/Ucd)	edema	J:211773
Fgf18^tm1Dor/Fgf18^tm1Dor (involves: 129X1/SvJ * C57BL/6J)	cyanosis	J:75879
Fgf21^tm1.1Djm/Fgf21^tm1.1Djm (involves: 129S6/SvEvTac * C57BL/6)	abnormal gluconeogenesis	J:150831
	decreased circulating glucose level	J:150831
	decreased circulating ketone body level	J:150831
	decreased oxygen consumption	J:150831
	hypoglycemia	J:150831
Fgf21^tm1Emf/Fgf21^tm1Emf (B6.Cg-Fgf21^tm1Emf)	abnormal blood homeostasis	J:157309
	abnormal glucose homeostasis	J:157309
	abnormal lipid homeostasis	J:157309
	abnormal lipid level	J:157309
	decreased body temperature	J:181337
	decreased fatty acids level	J:157309
	decreased oxygen consumption	J:157309
	impaired adaptive thermogenesis	J:181337
	impaired glucose tolerance	J:157309
	impaired lipolysis	J:157309
	increased circulating cholesterol level	J:157309
	increased circulating glucose level	J:157309
	increased circulating insulin level	J:157309
	increased circulating leptin level	J:157309
	increased circulating triglyceride level	J:157309
	increased liver glycogen level	J:157309
	increased liver triglyceride level	J:157309
Fgf21^tm1Fdl/Fgf21^tm1Fdl (B6.Cg-Fgf21^tm1Fdl)	decreased circulating growth hormone level	J:184999
	decreased circulating insulin-like growth factor I level	J:184999
	increased circulating growth hormone level	J:184999
Fgf21^tm1Nit/Fgf21^tm1Nit (C57BL/6-Fgf21^tm1Nit)	abnormal circulating free fatty acids level	J:157334
	decreased circulating free fatty acids level	J:157334
	enhanced lipolysis	J:157334
	impaired lipolysis	J:157334
	increased circulating free fatty acids level	J:157334
	increased circulating ketone body level	J:157334
Fgf22^{tm1b(EUCOMM)Hmgu}/Fgf22^{tm1b(EUCOMM)Hmgu} (C57BL/6N-Fgf22^{tm1b(EUCOMM)Hmgu}/H)	increased circulating amylase level	J:211773
Fgf23^tm1.1Kew/Fgf23⁺ (B6.129-Fgf23^tm1.1Kew)	decreased circulating phosphate level	J:180061
Fgf23^tm1.1Kew/Fgf23⁺ (B6.129-Fgf23^tm1.1Kew)	increased circulating alkaline phosphatase level	J:180061
Fgf23^tm1.1Kew/Fgf23^tm1.1Kew (B6.129-Fgf23^tm1.1Kew)	abnormal vitamin D level	J:180061
	decreased circulating phosphate level	J:180061
	increased circulating alkaline phosphatase level	J:180061
Fgf23^tm1Blan/Fgf23^tm1Blan (Not Specified)	abnormal mineral homeostasis	J:94041
	increased circulating alkaline phosphatase level	J:94041
	increased circulating phosphate level	J:94041
Fgf23^tm1Blan/Fgf23^tm1Blan (involves: 129/Sv * C57BL/6)	decreased circulating insulin level	J:121006
	decreased circulating serum albumin level	J:121006
	hypoglycemia	J:121006
	improved glucose tolerance	J:121006
	increased blood urea nitrogen level	J:121006
	increased circulating alkaline phosphatase level	J:121006
	increased circulating calcium level	J:121006
	increased circulating phosphate level	J:121006
Fgf23^tm1Blan/Fgf23^tm1Blan (involves: 129 * C57BL/6)	increased circulating phosphate level	J:173962
Fgf23^tm1Blan/Fgf23^tm1Blan Phex^Hyp/Y (Not Specified)	increased circulating phosphate level	J:94041
Fgf23^tm1Blan/Fgf23^tm1Blan Sfrp4^tm1.1Blan/Sfrp4^tm1.1Blan (involves: 129 * C57BL/6)	increased circulating phosphate level	J:173962
Fgf23^tm1Blan/Fgf23^tm1Blan Vdr^tm1Rge/Vdr^tm1Rge (involves: 129/Sv * 129S1/Sv * 129X1/SvJ * C57BL/6)	increased circulating alkaline phosphatase level	J:121006
	increased circulating parathyroid hormone level	J:121006
Fgf23^tm1Sliu/Fgf23⁺ Phex^Hyp/Y (involves: 129S/SvEv * C57BL/6)	abnormal vitamin D level	J:110579
	decreased circulating phosphate level	J:110579
Fgf23^tm1Sliu/Fgf23^tm1Sliu (involves: 129S/SvEv * C57BL/6)	abnormal circulating calcium level	J:110579
	abnormal circulating phosphate level	J:110579
	abnormal vitamin D level	J:110579
	decreased circulating parathyroid hormone level	J:110579
Fgf23^tm1Sliu/Fgf23^tm1Sliu Phex^Hyp/Y (involves: 129S/SvEv * C57BL/6)	abnormal circulating calcium level	J:110579
	abnormal circulating phosphate level	J:110579
	abnormal vitamin D level	J:110579
	decreased circulating parathyroid hormone level	J:110579
Fgf23^tm1Tyam/Fgf23^tm1Tyam (involves: C57BL/6 * CBA)	abnormal blood urea nitrogen level	J:88172
	abnormal renal phosphate reabsorption	J:88172
	abnormal vitamin D level	J:88172
	decreased circulating parathyroid hormone level	J:88172
	decreased circulating triglyceride level	J:88172
	hypoglycemia	J:88172
	increased circulating calcium level	J:88172
	increased circulating cholesterol level	J:88172
	increased circulating phosphate level	J:88172
Fgfr1^{tm1.1(KOMP)Vlcg}/Fgfr1⁺ (C57BL/6N-Fgfr1^{tm1.1(KOMP)Vlcg}/Ucd)	increased respiratory quotient	J:211773
Fgfr1^tm1Upir/Fgfr1^tm1Upir Fgfr2^tm1Dor/Fgfr2^tm1Dor Tg(KRT5-cre)5132Jlj/0 (involves: 129X1/SvJ * C57BL/6 * C57BL/6J * DBA/2J)	abnormal chemokine level	J:221184
	impaired skin barrier function	J:158802, J:221184
Fgfr1op2^em1(IMPC)Mbp/Fgfr1op2^em1(IMPC)Mbp (C57BL/6N-Fgfr1op2^em1(IMPC)Mbp/MbpMmucd)	edema	J:211773
Fgfr2^tm1Ewj/Fgfr2⁺ Tg(EIIa-cre)C5379Lmgd/0 (involves: 129S1/Sv * 129X1/SvJ * C57BL/6J * FVB/N)	pulmonary alveolar proteinosis	J:101174
Fgfr2^tm2.3Dsn/Fgfr2⁺ (involves: 129 * C57BL/6 * FVB/N)	hypoglycemia	J:72517
Fgfr3^tm1Led/Fgfr3^tm1Led Fgfr4^tm1Cxd/Fgfr4^tm1Cxd (involves: 129S6/SvEvTac * Black Swiss)	dehydration	J:50677
Fgfrl1^tm1True/Fgfrl1^tm1True (B6.129S6-Fgfrl1^tm1True)	cyanosis	J:130254
Fgg^tm1Fjc/Fgg^tm1Fjc (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	abnormal blood coagulation	J:64396
Fgg^tm1Jld/Fgg^tm1Jld (involves: 129P2/OlaHsd * NIH Black Swiss)	decreased platelet aggregation	J:36873
	increased bleeding time	J:36873
Fgg^tm1Lord/Fgg⁺ (involves: 129P2/OlaHsd * C57BL/6)	abnormal blood coagulation	J:129828
	abnormal thrombolysis	J:129828
	decreased circulating fibrinogen level	J:129828
Fgg^tm1Lord/Fgg^tm1Lord (involves: 129P2/OlaHsd * C57BL/6)	abnormal blood coagulation	J:129828
	abnormal thrombolysis	J:129828
	abnormal thrombosis	J:129828
	decreased circulating fibrinogen level	J:129828
Fgl1^tm1Cuko/Fgl1^tm1Cuko (involves: 129S6/SvEvTac * C57BL/6 * C57BL/6J)	abnormal gluconeogenesis	J:199844
	decreased circulating cholesterol level	J:199844
	decreased circulating free fatty acids level	J:199844
	decreased circulating HDL cholesterol level	J:199844
	decreased respiratory quotient	J:199844
	hyperglycemia	J:199844
	impaired glucose tolerance	J:199844
	increased liver triglyceride level	J:199844
Fgl2^tm1Pam/Fgl2^tm1Pam (involves: 129X1/SvJ * C57BL/6)	abnormal blood coagulation	J:99453
Fgl2^tm1Pam/Fgl2^tm1Pam (B6.129X1-Fgl2^tm1Pam)	abnormal urine albumin level	J:130895
	hematuria	J:130895
	increased circulating creatinine level	J:130895
Fglu2^KK/? (involves: C57BL/6J * KK-A^y)	hyperglycemia	J:81517
Fglu^KK/TaJcl/Fglu^KK/TaJcl (involves: C57BL/6Jcl * KK.B6-A^y/Jcl)	hyperglycemia	J:51880
fh/fh (involves: C57BL/6Sfd * Stanford-J)	edema	J:5810
Fh1^tm1Pjp/Fh1^tm1Pjp Tg(Cdh16-cre)91Igr/0 (involves: 129X1/SvJ * ICR)	abnormal urine homeostasis	J:198486
Fhip1b^em1(IMPC)Tcp/Fhip1b^em1(IMPC)Tcp (C57BL/6NCrl-Fhip1b^em1(IMPC)Tcp/Tcp)	decreased circulating alkaline phosphatase level	J:211773
	decreased fasting circulating glucose level	J:211773
Fhip2a^em1(IMPC)J/Fhip2a^em1(IMPC)J (C57BL/6NJ-Fhip2a^em1(IMPC)J/Mmjax)	impaired glucose tolerance	J:211773
	increased circulating alkaline phosphatase level	J:211773
Fhip2b^em1Wwan/Fhip2b^em1Wwan (involves: C57BL/6)	abnormal cytokine level	J:302658, J:285283
	decreased circulating cholesterol level	J:302658
	decreased circulating LDL cholesterol level	J:302658
	increased circulating alanine transaminase level	J:302658
	increased circulating aspartate transaminase level	J:302658
	increased liver cholesterol level	J:302658
	increased liver triglyceride level	J:302658
	increased susceptibility to diet-induced obesity	J:302658
Fhl1^{tm1a(EUCOMM)Wtsi}/Fhl1^{tm1a(EUCOMM)Wtsi} (C57BL/6N-Fhl1^{tm1a(EUCOMM)Wtsi}/H)	decreased circulating cholesterol level	J:165965
	increased circulating alkaline phosphatase level	J:165965
Fhod3^tm1Hsum/Fhod3^tm1Hsum (involves: C57BL/6 * C57BL/6NCrlj * CBA/JNCrlj)	pericardial effusion	J:187358
Ficd^{tm1b(EUCOMM)Hmgu}/Ficd^{tm1b(EUCOMM)Hmgu} (C57BL/6N-Ficd^{tm1b(EUCOMM)Hmgu}/H)	increased blood urea nitrogen level	J:211773
Firrm^{tm1a(EUCOMM)Hmgu}/Firrm⁺ (C57BL/6N-Firrm^{tm1a(EUCOMM)Hmgu}/H)	increased circulating alkaline phosphatase level	J:165965
	increased circulating cholesterol level	J:165965
	increased circulating HDL cholesterol level	J:165965
Firrm^{tm1b(EUCOMM)Hmgu}/Firrm⁺ (C57BL/6N-Firrm^{tm1b(EUCOMM)Hmgu}/H)	increased circulating amylase level	J:211773
Fis1^tm1.1Itl/Fis1^tm1.1Itl Tg(Ckmm-cre)5Khn/0 (involves: C57BL/6NTac * FVB)	increased body temperature	J:290485
	increased circulating interferon-beta level	J:290485
	increased circulating interleukin-6 level	J:290485
	increased circulating interleukin-12b level	J:290485
	increased circulating interleukin-13 level	J:290485
Fis1^{tm1b(EUCOMM)Hmgu}/Fis1⁺ (C57BL/6N-Fis1^{tm1b(EUCOMM)Hmgu}/Ieg)	increased circulating bilirubin level	J:211773
Fitm2^tm1.1Dls/Fitm2^tm1.1Dls Tg(Fabp4-cre)1Rev/? (involves: 129S6/SvEvTac * C57BL/6J)	abnormal fatty acids level	J:212437
	abnormal glucose homeostasis	J:212437
	increased circulating insulin level	J:212437
	increased circulating tumor necrosis factor level	J:212437
	insulin resistance	J:212437
Fkbp1a^tm1.1Shou/Fkbp1a^tm1Zuk Tg(Tek-cre)1Ywa/0 (involves: 129S7/SvEvBrd * C57BL/6 * SJL)	edema	J:195489
Fkbp1a^tm1Zuk/Fkbp1a^tm1Slh Tg(Ckmm-cre)5Khn/0 (involves: 129S7/SvEvBrd * FVB)	abnormal calcium ion homeostasis	J:94747
Fkbp1a^tm1Zuk/Fkbp1a^tm1Zuk (either: (involves: 129S7/SvEvBrd) or (involves: 129S7/SvEvBrd * C57BL/6J))	edema	J:45536
Fkbp1b^tm1.1Okam/Fkbp1b^tm1.1Okam (ICR.129-Fkbp1b^tm1.1Okam)	decreased insulin secretion	J:136192
	impaired glucose tolerance	J:136192
Fkbp4^em1(IMPC)Mbp/Fkbp4^em1(IMPC)Mbp (C57BL/6N-Fkbp4^em1(IMPC)Mbp/MbpMmucd)	abnormal cholesterol homeostasis	J:211773
Fkbp4^tm1Shou/Fkbp4^tm1Shou (involves: 129S/SvEv)	increased circulating testosterone level	J:120960
Fkbp5^tm1Dvds/Fkbp5^tm1Dvds (involves: 129X1/SvJ * C57BL/6 * Swiss Webster)	decreased circulating corticosterone level	J:177683
Fkbp8^tm1Kei/Fkbp8^tm1Kei (involves: 129P2/OlaHsd * C57BL/6J)	cyanosis	J:132961
	dehydration	J:132961
Fkbp9^{tm1a(EUCOMM)Hmgu}/Fkbp9^{tm1a(EUCOMM)Hmgu} (C57BL/6N-Fkbp9^{tm1a(EUCOMM)Hmgu}/Ics)	decreased circulating alanine transaminase level	J:165965
	decreased circulating aspartate transaminase level	J:165965
	decreased circulating sodium level	J:165965
	decreased circulating total protein level	J:165965
Fkbp10^{tm2a(EUCOMM)Wtsi}/Fkbp10⁺ (C57BL/6N-Fkbp10^{tm2a(EUCOMM)Wtsi}/Ics)	decreased circulating amylase level	J:165965
Fkrp^tm1Itl/Fkrp^tm1Itl (involves: 129S6/SvEvTac * C57BL/6N)	increased circulating alanine transaminase level	J:164448
	increased circulating creatine kinase level	J:164448
Fkrp^tm1Scbr/Fkrp^tm1Scbr (involves: C57BL/6)	edema	J:164634
Fktn^tm1Kcam/Fktn^tm1Kcam Myf5^tm3(cre)Sor/Myf5⁺ (involves: 129S/SvEv * 129S4/SvJaeSor)	increased circulating creatine kinase level	J:187144
Fktn^tm1Kcam/Fktn^tm1Kcam Tg(CAG-cre/Esr1)5Amc/? (involves: 129S/SvEv C57BL/6 * CBA)	increased circulating creatine kinase level	J:187144
Fktn^tm1Kcam/Fktn^tm1Kcam Tg(Ckmm-cre)5Khn/? (involves: 129S/SvEv * FVB)	increased circulating creatine kinase level	J:187144
Fktn^tm3.1Ttd/Fktn^tm3.1Ttd Myf5^tm3(cre)Sor/Myf5⁺ (involves: 129S4/SvJaeSor * C57BL/6)	increased circulating creatine kinase level	J:198535
Fktn^tm3.1Ttd/Fktn^tm3.1Ttd Tg(Ckmm-cre)5Khn/0 (involves: C57BL/6 * FVB)	increased circulating creatine kinase level	J:198535
Fl1sa^A/J/? (involves: A/JSlc * SM/JNshm)	abnormal lipid level	J:124974
Fl1sa^A/J/? (involves: A/JSlc * SM/JNshm)	increased liver triglyceride level	J:124974
Fl1sa^SM/JNshm/Fl1sa^SM/JNshm (A/J-Chr 12^SM/J/Nshm)	decreased liver triglyceride level	J:124974
Fl2sa^A/JNshm/Fl2sa^A/JNshm (involves: A/JSlc * SM/JNshm)	abnormal lipid level	J:124974
Flcn^tm1Baba/Flcn^tm1.1Lss Tg(Cdh16-cre)91Igr/0 (involves: C57BL/6 * FVB/N * ICR * SJL)	increased blood urea nitrogen level	J:130978
Flcn^tm1Btt/Flcn^tm1Btt Tg(Cdh16-cre)91Igr/0 (involves: 129S4/SvJaeSor * C57BL/6 * ICR)	increased blood urea nitrogen level	J:143922
Flg^ft/Flg^ft (B6.Cg-Flg^ft)	impaired skin barrier function	J:151110
Flg^ft/Flg^ft (Not Specified)	impaired skin barrier function	J:192725, J:198332
Flg^ft/Flg^ft (STOCK a/a Tmem79^ma Flg^ft/J)	abnormal cytokine level	J:204304
Flg^ft/Flg^ft (STOCK a/a Tmem79^ma Flg^ft/J)	epidermal spongiosis	J:204304
Flg^ft/Flg^ft Tmem79^ma/Tmem79^ma (involves: CBA/CaGr)	impaired skin barrier function	J:202453
Flg^tm1Amag/Flg^tm1Amag (involves: 129S6/SvEvTac * BALB/c * C57BL/6NTac)	abnormal lipid level	J:198332
	increased cholesterol level	J:198332
Flna^Dilp2/Y (involves: BALB/cAnN * C3H/HeN * C57BL/6)	edema	J:112274
Flna^tm1.1Caw/Y H2az2^{Tg(Wnt1-cre)11Rth}/H2az2⁺ (involves: 129S4/SvJae * C57BL/6 * CBA)	cyanosis	J:118252
Flna^tm1.2Caw/Y (involves: 129S4/SvJae * C57BL/6)	edema	J:118252
Flna^tm1.2Caw/Flna⁺ (involves: 129S4/SvJae * C57BL/6)	abnormal thrombosis	J:118252
Flna^tm1.2Caw/Flna⁺ (involves: 129S4/SvJae * C57BL/6)	edema	J:118252
Flnb^skm2/Flnb^skm2 (involves: 129S1/SvImJ * 129X1/SvJ * DBA/2J)	dehydration	J:218364
Flnb^{tm1b(KOMP)Wtsi}/Flnb⁺ (C57BL/6N-Flnb^{tm1b(KOMP)Wtsi}/H)	increased circulating serum albumin level	J:211773
Flnc^tm1.1Rsdf/Flnc⁺ (involves: C57BL/6)	decreased respiratory quotient	J:226976
Flrt2^tm1Rob/Flrt2^tm1Rob (involves: 129S/SvEv * C57BL/6J)	pericardial edema	J:171515
Flt3^m1Btlr/Flt3^m1Btlr (C57BL/6J-Flt3^m1Btlr)	decreased circulating interferon-alpha level	J:159599
	decreased circulating interferon-gamma level	J:159599
	decreased circulating interleukin-12 level	J:159599
	increased circulating interleukin-6 level	J:159599
	increased circulating tumor necrosis factor level	J:159599
Flt4^Chy/Flt4⁺ (involves: C3H)	chylous ascites	J:13981, J:72387
	edema	J:177405
	extremity edema	J:13981
	lymphedema	J:72387
Flt4^Chy/Flt4^Chy (involves: C3H)	edema	J:177405
Flt4^tm1.1Ichi/Flt4⁺ (B6.Cg-Flt4^tm1.1Ichi)	chylous ascites	J:159024
Flt4^tm1.1Ichi/Flt4⁺ Kras^tm1Mok/Kras⁺ (involves: 129S/SvEv * C57BL/6)	chylous ascites	J:159024
	lymphedema	J:159024
Flt4^tm1.1Ichi/Flt4⁺ Kras^tm1Mok/Kras⁺ Tg(HRAS)2Jic/0 (involves: 129S/SvEv * BALB/c * C57BL/6 * DBA/2)	chylous ascites	J:159024
Flt4^tm1.2Yhe/Flt4^tm1.2Yhe (involves: 129/Sv * C57BL/6J * FVB/N)	edema	J:177405
Flt4^tm1Ali/Flt4⁺ Nrp2^tm1Ddg/Nrp2⁺ (involves: C57BL/6)	skin edema	J:156869
Flt4^tm1Ali/Flt4^tm1Ali (Not Specified)	hemopericardium	J:50761
Flt4^tm1Ali/Flt4^tm1Ali (Not Specified)	pericardial edema	J:50761
Flt4^tm2Ali/Flt4⁺ (involves: 129S1/Sv * 129X1/SvJ * ICR)	chylous ascites	J:137909
Flt4^tm2Ali/Flt4⁺ (involves: 129S1/Sv * 129X1/SvJ * ICR)	hydrops fetalis	J:137909
Flt4^tm2Ali/Flt4^tm2Ali (involves: 129S1/Sv * 129X1/SvJ * ICR)	hydrops fetalis	J:137909
Flvcr1^tm1Etol/Flvcr1^tm1Etol (either: (involves: 129) or (involves: 129 * C57BL/6))	skin edema	J:194202
Flvcr2^tm1.2Tda/Flvcr2^tm1.2Tda (involves: C57BL/6J)	cyanosis	J:287134
Flvcr2^tm1.2Tda/Flvcr2^tm1.2Tda (involves: C57BL/6J)	hypoxia	J:287134
Flvcr2^{tm1a(EUCOMM)Hmgu}/Flvcr2⁺ (C57BL/6N-Flvcr2^{tm1a(EUCOMM)Hmgu}/Wtsi)	increased circulating cholesterol level	J:211773
	increased circulating HDL cholesterol level	J:211773
	increased circulating LDL cholesterol level	J:211773
fm/fm (involves: CBA/H)	abnormal cholesterol level	J:5112
	abnormal sphingomyelin level	J:5112
	sphingomyelinosis	J:5112
Fmnl2^em2(IMPC)Tcp/Fmnl2^em2(IMPC)Tcp (C57BL/6NCrl-Fmnl2^em2(IMPC)Tcp/Tcp)	abnormal cholesterol homeostasis	J:211773
Fmo3^em1Jmbn/Fmo3^em1Jmbn Ldlr^tm1Her/Ldlr^tm1Her (involves: 129S7/SvEvBrd * C57BL/6)	decreased susceptibility to diet-induced obesity	J:254352
Fmo5^tm1Eshe/Fmo5^tm1Eshe (B6.129P2-Fmo5^tm1Eshe)	abnormal glucose homeostasis	J:223365
	decreased circulating cholesterol level	J:223365
	decreased circulating glucose level	J:223365
	decreased circulating HDL cholesterol level	J:223365
	decreased circulating LDL cholesterol level	J:223365
	decreased fasting circulating glucose level	J:223365
	decreased fatty acid oxidation	J:223365
	decreased triglyceride level	J:223365
	increased energy expenditure	J:223365
	increased fatty acid oxidation	J:223365
	increased oxygen consumption	J:223365
	increased respiratory quotient	J:223365
Fn1^tm1Feb/Fn1^tm1Feb (involves: 129X1/SvJ)	abnormal protein level	J:84274
Fn1^tm1Ref/Fn1^tm1Ref Tg(Mx1-cre)1Cgn/0 (involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * CBA)	decreased susceptibility to induced thrombosis	J:82373
Fn3k^tm1Mvdc/Fn3k^tm1Mvdc (involves: 129S1/Sv * 129X1/SvJ)	abnormal urine homeostasis	J:116037
Fnbp1^em1(IMPC)J/Fnbp1^em1(IMPC)J (C57BL/6NJ-Fnbp1^em1(IMPC)J/Mmjax)	increased circulating alkaline phosphatase level	J:211773
Fndc3a^em1(IMPC)Tcp/Fndc3a^em1(IMPC)Tcp (C57BL/6N-Fndc3a^em1(IMPC)Tcp/Tcp)	decreased circulating serum albumin level	J:211773
Fndc4^{tm1.1(KOMP)Vlcg}/Fndc4^{tm1.1(KOMP)Vlcg} (C57BL/6N-Fndc4^{tm1.1(KOMP)Vlcg}/J)	increased fasting circulating glucose level	J:211773
Fndc5^em21Gpt/Fndc5^em21Gpt (C57BL/6JGpt-Fndc5^em21Cd/Gpt)	abnormal circulating enzyme level	J:247171
	abnormal circulating lipid level	J:247171
	abnormal fatty acid oxidation	J:247171
	increased susceptibility to diet-induced obesity	J:291193, J:247171
Fndc7^{tm1.1(KOMP)Vlcg}/Fndc7^{tm1.1(KOMP)Vlcg} (C57BL/6N-Fndc7^{tm1.1(KOMP)Vlcg}/Ucd)	increased circulating cholesterol level	J:211773
	increased circulating HDL cholesterol level	J:211773
	increased circulating total protein level	J:211773
Fndc9^{tm1.1(KOMP)Vlcg}/Fndc9^{tm1.1(KOMP)Vlcg} (C57BL/6N-Fndc9^{tm1.1(KOMP)Vlcg}/Ucd)	increased circulating alkaline phosphatase level	J:211773
	increased circulating bilirubin level	J:211773
Fnip1^LPAB.1/Fnip1^LPAB.1 (C57BL/6J-Fnip1^LPAB.1)	increased liver glycogen level	J:187318
Fnip1^m1Btlr/Fnip1^m1Btlr (C57BL/6J-Fnip1^m1Btlr)	increased cardiac muscle glycogen level	J:234285
Fnip2^{tm1a(KOMP)Wtsi}/Fnip2^{tm1a(KOMP)Wtsi} (C57BL/6N-Fnip2^{tm1a(KOMP)Wtsi}/Wtsi)	increased circulating iron level	J:211773
Focad^em1(IMPC)Bay/Focad⁺ (C57BL/6N-Focad^em1(IMPC)Bay/BayMmucd)	improved glucose tolerance	J:211773
Folr1^{tm1.1(KOMP)Vlcg}/Folr1⁺ (C57BL/6N-Folr1^{tm1.1(KOMP)Vlcg}/Tcp)	abnormal cholesterol homeostasis	J:211773
	increased circulating alanine transaminase level	J:211773
Folr1^tm1Fnn/Folr1⁺ (involves: 129 * C57BL/6J)	abnormal folic acid level	J:96380
Folr1^tm1Fnn/Folr1⁺ (involves: 129P2/OlaHsd * C57BL/6J)	increased circulating homocysteine level	J:57765
Folr1^tm1Fnn/Folr1^tm1Fnn (involves: 129 * C57BL/6J)	abnormal folic acid level	J:96380
Fos^tm5.1Wag/Fos^tm5.1Wag (involves: 129P2/OlaHsd * C57BL/6 * SJL)	increased circulating tumor necrosis factor level	J:175064
Fos^tm6.1Wag/Fos^tm6.1Wag (involves: 129P2/OlaHsd * C57BL/6 * SJL)	increased circulating interleukin-6 level	J:175064
	increased circulating interleukin-10 level	J:175064
	increased circulating tumor necrosis factor level	J:175064
Fos^tm7Wag/Fos^tm7Wag Lyz2^tm1(cre)Ifo/Lyz2⁺ (involves: 129P2/OlaHsd * C57BL/6)	increased circulating interleukin-6 level	J:175064
	increased circulating interleukin-10 level	J:175064
	increased circulating tumor necrosis factor level	J:175064
Fosl2^tm2.1Wag/Fosl2^tm2.1Wag (involves: 129P2/OlaHsd * C57BL/6)	hypoxia	J:137646
Fosl2^tm2Wag/Fosl2^tm2Wag Tg(Sp7-tTA,tetO-EGFP/cre)1Amc/0 (involves: 129P2/OlaHsd * C57BL/6 * CD-1)	decreased circulating glucose level	J:211215
	decreased circulating osteocalcin level	J:211215
	impaired glucose tolerance	J:211215
	insulin resistance	J:211215
Foxa1^tm1Gsc/Foxa1^tm1Gsc (involves: 129P2/OlaHsd * C57BL/6)	abnormal circulating insulin level	J:53312
	decreased circulating glucagon level	J:53312
	hypoglycemia	J:53312
Foxa1^tm1Khk/Foxa1^tm1Khk Foxa2^tm1Khk/Foxa2^tm1Khk Tg(Pdx1-cre)6Cvw/0 (involves: 129 * C57BL/6 * CBA * SJL)	hyperglycemia	J:143476
Foxa1^tm1Stf/Foxa1⁺ (Not Specified)	decreased circulating HDL cholesterol level	J:138581
Foxa1^tm1Stf/Foxa1^tm1Stf (Not Specified)	abnormal glucose homeostasis	J:57493
	decreased circulating glucagon level	J:57493
	decreased circulating insulin level	J:57493
	decreased circulating triglyceride level	J:57493
	decreased insulin secretion	J:57493
	hypoglycemia	J:57493
	impaired glucose tolerance	J:57493
	increased circulating cortisol level	J:57493
	increased circulating growth hormone level	J:57493
Foxa2^tm1.1Stf/Foxa2^tm1.1Stf (B6.129-Foxa2^tm1.1Stf)	increased carbon dioxide production	J:155391
Foxa2^tm1.1Stf/Foxa2^tm1.1Stf (B6.129-Foxa2^tm1.1Stf)	increased oxygen consumption	J:155391
Foxa2^tm1.1Stf/Foxa2^tm1.1Stf Tg(Nes-cre)1Kln/0 (B6.Cg-Foxa2^tm1.1Stf Tg(Nes-cre)1Kln)	decreased circulating free fatty acids level	J:155391
	decreased circulating glucose level	J:155391
	decreased circulating insulin level	J:155391
	improved glucose tolerance	J:155391
	increased carbon dioxide production	J:155391
	increased insulin sensitivity	J:155391
	increased oxygen consumption	J:155391
Foxa2^tm1Dnl/Foxa2⁺ (involves: 129P2/OlaHsd * C57BL/6J)	abnormal glucose homeostasis	J:95662
	increased circulating free fatty acids level	J:95662
	increased circulating triglyceride level	J:95662
	increased liver triglyceride level	J:95662
Foxa2^tm1Khk/Foxa2^tm1Khk (involves: 129P2/OlaHsd * C57BL/6 * CD-1 * DBA)	abnormal insulin secretion	J:70409
	decreased circulating glucagon level	J:70409
	hypoglycemia	J:70409
	increased circulating insulin level	J:70409
	increased glycogen level	J:70409
Foxa2^tm1Khk/Foxa2^tm1Khk Tg(Foxa3-cre)1Khk/0 (involves: 129P2/OlaHsd * C57BL/6 * CD-1 * DBA)	decreased circulating glucagon level	J:96332
	hypoglycemia	J:96332
Foxa2^tm1Khk/Foxa2^tm1Khk Tg(SFTPC-rtTA)5Jaw/0 Tg(tetO-cre)1Jaw/0 (involves: 129 * 129P2/OlaHsd * C57BL/6)	cyanosis	J:93473
Foxa3^tm1Khk/Foxa3^tm1Khk (B6.129P2-Foxa3^tm1Khk)	abnormal lipid homeostasis	J:216477
	decreased circulating cholesterol level	J:216477
	decreased circulating leptin level	J:216477
	decreased fasting circulating glucose level	J:72595
	decreased hepatic glucose production	J:72595
	increased insulin sensitivity	J:216477
	increased oxygen consumption	J:216477
Foxc1^tm1Blh/Foxc1⁺ Foxc2^tm1Blh/Foxc2⁺ (involves: 129S6/SvEvTac * Black Swiss)	hydrops fetalis	J:57677
Foxc1^tm1Blh/Foxc1^tm1Blh (involves: 129S6/SvEvTac * Black Swiss)	hydrops fetalis	J:57677
Foxc2^tm1.1Miu/Foxc2^tm1.1Miu Tg(Tek-cre)1Ywa/0 (involves: C57BL/6 * C57BL/6J * SJL)	lymphedema	J:316530
	pericardial effusion	J:316530
Foxc2^tm1Miu/Foxc2⁺ (involves: 129P2/OlaHsd * C57BL/6 * C57BL/6J)	extremity edema	J:83436
	lymphedema	J:83436
	periorbital edema	J:83436
Foxe1^tm1Rdl/Foxe1^tm1Rdl (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	decreased circulating levels of thyroid hormone	J:48970
	increased circulating thyroid-stimulating hormone level	J:48970
Foxf2^W174R/Foxf2⁺ (involves: BALB/c * C3H/HeH)	optic nerve swelling	J:178103
Foxg1^tm1M/Foxg1^tm1M (involves: 129S1/Sv * C57BL/6J)	cyanosis	J:26720
Foxh1^tm1Jlw/Foxh1^tm1Jlw (involves: 129S1/Sv * 129X1/SvJ * CD-1)	pericardial edema	J:93034
Foxi1^tm1Sven/Foxi1^tm1Sven (involves: CD-1)	increased urine pH	J:90907
Foxi1^tm1Sven/Foxi1^tm1Sven (involves: CD-1)	renal tubular acidosis	J:90907
Foxi2^{tm1.1(KOMP)Vlcg}/Foxi2^{tm1.1(KOMP)Vlcg} (C57BL/6N-Foxi2^{tm1.1(KOMP)Vlcg}/J)	decreased circulating glucose level	J:211773
Foxj3^{tm1a(EUCOMM)Wtsi}/Foxj3^{tm1a(EUCOMM)Wtsi} (C57BL/6N-Foxj3^{tm1a(EUCOMM)Wtsi}/BayMmucd)	increased circulating alkaline phosphatase level	J:211773
	increased circulating calcium level	J:211773
Foxl2^tm1Gpil/Foxl2^tm1Gpil (either: 129S6/SvEvTac or (involves: 129S6/SvEvTac * C57BL/6J) or (involves: 129S6/SvEvTac * NIHS-BC))	decreased circulating insulin-like growth factor I level	J:90371
Foxl2^tm2.1Tre/Foxl2^tm2.1Tre Gnrhr^{tm1.1(cre)Uboe}/Gnrhr⁺ (involves: 129S1/Sv * 129X1/SvJ)	decreased circulating follicle stimulating hormone level	J:204036
	decreased circulating luteinizing hormone level	J:204036
	decreased follicle stimulating hormone level	J:204036
	increased circulating luteinizing hormone level	J:204036
Foxm1^tm1.1Rhc/Foxm1^tm1.1Rhc (involves: 129X1/SvJ)	hydrops fetalis	J:94883
Foxm1^tm1Rhc/Foxm1^tm1Rhc Tg(Pdx1-cre)89.1Dam/0 (involves: 129X1/SvJ * C57BL/6 * CBA)	abnormal glucose homeostasis	J:111026
	abnormal insulin secretion	J:111026
	impaired glucose tolerance	J:111026
Foxn1^nu/Foxn1^nu (involves: BALB/c)	abnormal circulating cytokine level	J:50903
	ascites	J:40405
	decreased circulating alanine transaminase level	J:50903
	decreased circulating interleukin-2 level	J:50903
	decreased circulating interleukin-6 level	J:50903
	decreased circulating tumor necrosis factor level	J:50903
Foxn1^nu/Foxn1^nu (involves: CD-1)	abnormal circulating gonadotropin level	J:106251
	decreased circulating follicle stimulating hormone level	J:106251
	decreased circulating luteinizing hormone level	J:106251
Foxo1^{tm1b(EUCOMM)Wtsi}/Foxo1⁺ (C57BL/6N-Foxo1^{tm1b(EUCOMM)Wtsi}/J)	increased circulating bilirubin level	J:211773
Foxo1^tm1Rdp/Foxo1^tm1.1Rdp Foxo3^tm1Rdp/Foxo3^tm1.1Rdp Amhr2^tm3(cre)Bhr/Amhr2⁺ (involves: 129S6/SvEvTac * 129S7/SvEvBrd)	abnormal circulating hormone level	J:232961
	decreased circulating luteinizing hormone level	J:232961
	increased circulating estradiol level	J:232961
	suppressed circulating follicle stimulating hormone level	J:232961
Foxo1^tm1Rdp/Foxo1^tm1.1Rdp Foxo3^tm1Rdp/Foxo3^tm1.1Rdp Pten^tm1Hwu/Pten^tm1Hwu Tg(CYP19A1-cre)1Jri/0 (involves: 129S4/SvJae * 129S6/SvEvTac)	abnormal circulating hormone level	J:232961
	decreased circulating luteinizing hormone level	J:232961
	suppressed circulating follicle stimulating hormone level	J:232961
Foxo1^tm1Rdp/Foxo1^tm1.1Rdp Foxo3^tm1Rdp/Foxo3^tm1.1Rdp Tg(CYP19A1-cre)1Jri/0 (involves: 129S6/SvEvTac)	abnormal circulating hormone level	J:232961
	decreased circulating luteinizing hormone level	J:232961
	increased circulating estradiol level	J:232961
	suppressed circulating follicle stimulating hormone level	J:232961
Foxo1^tm1Rdp/Foxo1^tm1Rdp Foxo3^tm1Rdp/Foxo3^tm1Rdp Foxo4^tm1Rdp/Foxo4^tm1Rdp Tg(Ins2-cre)23Herr/0 (involves: 129S6/SvEvTac * C57BL/6 * C57BL/6J * CBA/J)	abnormal glucose homeostasis	J:215526
	decreased circulating insulin level	J:215526
	decreased insulin secretion	J:215526
	hyperglycemia	J:215526
	impaired glucose tolerance	J:215526
Foxo1^tm1Rdp/Foxo1^tm1Rdp Irs1^tm1Mfw/Irs1^tm1Mfw Irs2^tm2Mfw/Irs2^tm2Mfw Speer6-ps1^{Tg(Alb-cre)21Mgn}/Speer6-ps1⁺ (involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * DBA * FVB)	abnormal triglyceride level	J:137845
	decreased circulating cholesterol level	J:137845
	decreased circulating free fatty acids level	J:137845
	decreased circulating HDL cholesterol level	J:137845
	decreased circulating triglyceride level	J:137845
Foxo1^tm1Rdp/Foxo1^tm1Rdp Speer6-ps1^{Tg(Alb-cre)21Mgn}/Speer6-ps1⁺ (involves: 129S1/Sv * C57BL/6 * DBA * FVB)	improved glucose tolerance	J:137845
Foxo1^tm1Tf/Foxo1^tm1Tf (involves: C57BL/6J)	pericardial effusion	J:92247
Foxo1^tm1Whb/Foxo1⁺ (Not Specified)	decreased liver glycogen level	J:79560
Foxo1^tm1Whb/Foxo1⁺ Insr^tm1Dac/Insr^tm1Dac (involves: 129S4/SvJae * C57BL/6)	decreased circulating glucose level	J:79560
Foxo1^tm1Whb/Foxo1⁺ Pdpk1^tm1Maka/Pdpk1^tm1Maka Tg(Ins2-cre)23Herr/0 (involves: 129S4/SvJae * C57BL/6J * CBA/J)	decreased circulating glucose level	J:109010
	increased circulating insulin level	J:109010
Foxo1^tm2.1Dac/Foxo1^tm2.1Dac (Not Specified)	abnormal gluconeogenesis	J:179687
	abnormal glucose homeostasis	J:179687
	abnormal lipid homeostasis	J:179687
	decreased carbon dioxide production	J:179687
	decreased circulating cholesterol level	J:179687
	decreased circulating free fatty acids level	J:179687
	decreased circulating triglyceride level	J:179687
	decreased circulating VLDL triglyceride level	J:179687
	decreased energy expenditure	J:179687
	decreased liver triglyceride level	J:179687
	decreased respiratory quotient	J:179687
	increased circulating glucose level	J:179687
	increased circulating insulin level	J:179687
	insulin resistance	J:179687
Foxo1^tm2.1Dac/Foxo1^tm2.1Dac (B6.Cg-Foxo1^tm2.1Dac)	decreased circulating tumor necrosis factor level	J:179687
	decreased liver cholesterol level	J:179687
	increased susceptibility to diet-induced obesity	J:179687
Foxo1^tm2.1Dac/Foxo1^tm2.1Dac Insr^tm1Dac/Insr⁺ (involves: 129S4/SvJae * C57BL/6)	increased circulating insulin level	J:179687
	insulin resistance	J:179687
Foxo1^tm2.1Dac/Foxo1^tm2.1Dac Lepr^db/Lepr^db (B6.Cg-Foxo1^tm2.1Dac Lepr^db)	impaired glucose tolerance	J:179687
	increased circulating insulin level	J:179687
Foxo3^{tm1.1(KOMP)Vlcg}/Foxo3^{tm1.1(KOMP)Vlcg} (C57BL/6N-Foxo3^{tm1.1(KOMP)Vlcg}/J)	decreased circulating chloride level	J:211773
	impaired glucose tolerance	J:211773
Foxo3^tm1.1Rdp/Foxo3^tm1.1Rdp (involves: 129S6/SvEvTac * FVB/N)	impaired glucose tolerance	J:118179, J:84269
	increased circulating follicle stimulating hormone level	J:84269
	increased circulating luteinizing hormone level	J:84269
Foxo6^{tm1(KOMP)Vlcg}/Foxo6^{tm1(KOMP)Vlcg} (B6J.B6NTac-Foxo6^{tm1(KOMP)Vlcg})	abnormal gluconeogenesis	J:236585
	decreased circulating cholesterol level	J:236585
	decreased circulating glucose level	J:236585
	decreased circulating insulin level	J:236585
	decreased fasting circulating glucose level	J:236585
	decreased liver triglyceride level	J:236585
	decreased respiratory quotient	J:236585
	improved glucose tolerance	J:236585
	increased insulin sensitivity	J:236585
	increased oxygen consumption	J:236585
Foxp1^tm1Eem/Foxp1^tm1Eem (involves: 129S6/SvEvTac * C57BL/6)	hydrops fetalis	J:93182
Foxp2^tm2.1Woen/Foxp2^tm2.1Woen (involves: C57BL/6 * C57BL/6J * SJL)	decreased dopamine level	J:150425
Foxp2^tm2.2Woen/Foxp2⁺ (involves: C57BL/6 * C57BL/6J)	abnormal circulating mineral level	J:150425
	abnormal energy homeostasis	J:150425
	increased circulating ferritin level	J:150425
	increased dopamine level	J:150425
	increased serotonin level	J:150425
Foxp3^sf/Y (either: 129Rl.Cg-Foxp3^sf or (involves: 101/Rl * C3Hf/Rl * STOCK MR))	abnormal atrial thrombosis	J:11262
	hemosiderosis	J:11262
	pleural effusion	J:11262
Foxp3^sf/Y (B6.Cg-Foxp3^sf)	abnormal homeostasis	J:167802
Foxp3^tm1Kuch/? Il6^tm1Kopf/Il6^tm1Kopf (involves: 129S2/SvPas * C57BL/6)	decreased circulating interleukin-6 level	J:123352
Foxp3^tm1Tch/Y (C.129X1-Foxp3^tm1Tch)	abnormal chemokine level	J:117165
	increased circulating interferon-gamma level	J:117165
	increased circulating interleukin-4 level	J:117165
	increased circulating interleukin-5 level	J:117165
	increased circulating interleukin-6 level	J:117165
	increased circulating interleukin-10 level	J:117165
	increased circulating tumor necrosis factor level	J:117165
Foxp3^tm1Tch/Y Stat6^tm1Gru/Stat6^tm1Gru (C.129-Stat6^tm1Gru Foxp3^tm1Tch)	increased circulating interferon-gamma level	J:117165
Foxp3^{tm2.1(EGFP/cre)Shori}/Y Pdcd1^tm1Hon/Pdcd1^tm1Hon (involves: 129 * 129S2/SvPas * C57BL/6)	decreased circulating lipase level	J:234397
Foxs1^tm1Sven/Foxs1^tm1Sven (B6.129-Foxs1^tm1Sven)	decreased susceptibility to diet-induced obesity	J:99183
Fpli^C57BL/6J/? (involves: C57BL/6J * KK-A^y)	increased circulating insulin level	J:81517
Fpr3^{tm1b(EUCOMM)Hmgu}/Fpr3^{tm1b(EUCOMM)Hmgu} (C57BL/6N-Fpr3^{tm1b(EUCOMM)Hmgu}/Ics)	increased circulating cholesterol level	J:211773
fpw/fpw (involves: C3H/HeJ * C57BL/6J)	decreased circulating interferon-gamma level	J:151726
	decreased circulating interleukin-1 alpha level	J:151726
	decreased circulating interleukin-6 level	J:151726
	decreased circulating leptin level	J:151726
	increased circulating interleukin-10 level	J:151726
	increased circulating tumor necrosis factor level	J:151726
Frey1^{tm1.1(KOMP)Vlcg}/Frey1^{tm1.1(KOMP)Vlcg} (C57BL/6N-Frey1^{tm1.1(KOMP)Vlcg}/Mmucd)	decreased circulating creatinine level	J:211773
	decreased circulating phosphate level	J:211773
Frk^tm1Liu/Frk^tm1Liu (involves: 129P2/OlaHsd * C57BL/6J)	decreased circulating triiodothyronine level	J:77207
Frmd4a^em1(IMPC)J/Frmd4a⁺ (C57BL/6NJ-Frmd4a^em1(IMPC)J/Mmjax)	decreased circulating calcium level	J:211773
Frrs1^{tm1a(EUCOMM)Wtsi}/Frrs1⁺ (C57BL/6N-Frrs1^{tm1a(EUCOMM)Wtsi}/Wtsi)	increased circulating free fatty acids level	J:211773
Fryl^{tm1b(KOMP)Wtsi}/Fryl⁺ (C57BL/6N-Fryl^{tm1b(KOMP)Wtsi}/Wtsi)	decreased circulating calcium level	J:211773
Fsbp^em1(IMPC)J/Fsbp^em1(IMPC)J (C57BL/6NJ-Fsbp^em1(IMPC)J/Mmjax)	increased circulating creatinine level	J:211773
Fsd2^em1(IMPC)Mbp/Fsd2^em1(IMPC)Mbp (C57BL/6N-Fsd2^em1(IMPC)Mbp/Ucd)	decreased circulating phosphate level	J:211773
Fshb^tm1Zuk/Fshb^tm1Zuk (either: 129S/SvEv or (involves: 129S7/SvEvBrd * C57BL/6))	decreased circulating follicle stimulating hormone level	J:38099
	decreased circulating progesterone level	J:38099
	decreased follicle stimulating hormone level	J:38099
	increased circulating luteinizing hormone level	J:38099
Fshr^{tm1(KOMP)Vlcg}/Fshr^{tm1(KOMP)Vlcg} (C57BL/6N-Fshr^{tm1(KOMP)Vlcg}/Nju)	increased fasting circulating glucose level	J:211773
Fshr^tm1Mha/Fshr^tm1Mha (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	increased circulating follicle stimulating hormone level	J:61909
	increased circulating luteinizing hormone level	J:61909
	increased follicle stimulating hormone level	J:61909
Fshr^tm1Saco/Fshr⁺ (involves: C57BL/6)	decreased circulating testosterone level	J:50933
Fshr^tm1Saco/Fshr⁺ (involves: C57BL/6)	increased circulating follicle stimulating hormone level	J:50933
Fshr^tm1Saco/Fshr⁺ (involves: 129)	decreased circulating progesterone level	J:65577
Fshr^tm1Saco/Fshr⁺ (involves: 129)	increased circulating testosterone level	J:65577
Fshr^tm1Saco/Fshr⁺ (involves: 129T2/SvEmsJ)	abnormal thrombosis	J:81460
	decreased circulating estradiol level	J:81460, J:89713
	decreased circulating progesterone level	J:81460
	increased circulating follicle stimulating hormone level	J:81460
	increased circulating luteinizing hormone level	J:81460
	increased circulating testosterone level	J:81460, J:89713
Fshr^tm1Saco/Fshr^tm1Saco (involves: C57BL/6)	decreased circulating testosterone level	J:61957, J:50933
Fshr^tm1Saco/Fshr^tm1Saco (involves: C57BL/6)	increased circulating follicle stimulating hormone level	J:50933
Fshr^tm1Saco/Fshr^tm1Saco (involves: 129)	calcinosis	J:70933
	decreased circulating estradiol level	J:70933, J:65577
	decreased circulating progesterone level	J:65577
	decreased circulating testosterone level	J:70680
	increased circulating follicle stimulating hormone level	J:70933
	increased circulating luteinizing hormone level	J:70933
	increased circulating testosterone level	J:70933, J:65577
	increased follicle stimulating hormone level	J:70933
	increased luteinizing hormone level	J:70933
Fst^tm1Zuk/Fst^tm1Zuk (involves: 129S7/SvEvBrd)	cyanosis	J:23925
Fst^tm1Zuk/Fst^tm1Zuk (involves: 129S7/SvEvBrd * C57BL/6)	cyanosis	J:23925
Fstl1^tm1.1Ning/Fstl1^tm1.1Ning (involves: 129S4/SvJae * C57BL/6J * FVB/N)	cyanosis	J:171347
	increased glycogen level	J:171347
Fstl1^tm1.2Mvdh/Fstl1^tm1.2Mvdh (involves: 129S4/SvJae * C57BL/6 * FVB)	cyanosis	J:176532
Fstl1^{tm1b(EUCOMM)Hmgu}/Fstl1^{tm1b(EUCOMM)Hmgu} (C57BL/6N-Fstl1^{tm1b(EUCOMM)Hmgu}/H)	decreased fasting circulating glucose level	J:211773
	impaired glucose tolerance	J:211773
	increased circulating cholesterol level	J:211773
	increased circulating HDL cholesterol level	J:211773
Fstl1^{tm2.1(cre/ERT2)Mvdh}/Fstl1^{tm2.1(cre/ERT2)Mvdh} (involves: 129P2/OlaHsd * C57BL/6)	cyanosis	J:176532
Fstl3^tm1Alsc/Fstl3^tm1Alsc (involves: 129S4/SvJae * C57BL/6 * FVB/N)	abnormal enzyme/coenzyme level	J:119526
	decreased liver glycogen level	J:119526
	improved glucose tolerance	J:119526
	increased circulating insulin level	J:119526
	increased insulin sensitivity	J:119526
Fth1^tm1.1Lck/Fth1^tm1.1Lck Tg(Mx1-cre)1Cgn/0 (B6.Cg-Fth1^tm1.1Lck Tg(Mx1-cre)1Cgn)	abnormal iron homeostasis	J:166515
	decreased spleen iron level	J:166515
	increased circulating alanine transaminase level	J:166515
	increased circulating aspartate transaminase level	J:166515
	increased circulating iron level	J:166515
Fth1^tm1Cbea/Fth1⁺ (involves: 129S2/SvPas * C57BL/6)	abnormal iron homeostasis	J:70685
Fth1^tm1Cbea/Fth1⁺ (involves: 129S2/SvPas * C57BL/6)	increased circulating ferritin level	J:70685
Ftl1^{em1(IMPC)Rbrc}/Ftl1^{em1(IMPC)Rbrc} (C57BL/6NJcl-Ftl1^{em1(IMPC)Rbrc}/Rbrc)	abnormal circulating iron level	J:211773
Ftl1^tm1.1Ruvi/Ftl1^tm1.1Ruvi (involves: 129 * C57BL/6)	decreased liver iron level	J:244236
Ftl1^tm1.1Ruvi/Ftl1^tm1.1Ruvi (involves: 129 * C57BL/6)	increased circulating iron level	J:244236
Fto^I367F/Fto⁺ (involves: C3H/HeH * C57BL/6J)	increased carbon dioxide production	J:152163
	increased oxygen consumption	J:152163
	increased respiratory quotient	J:152163
Fto^I367F/Fto^I367F (involves: C3H/HeH * C57BL/6J)	abnormal urine catecholamine level	J:152163
	decreased carbon dioxide production	J:152163
	decreased circulating insulin level	J:152163
	increased carbon dioxide production	J:152163
	increased circulating cholesterol level	J:152163
	increased circulating glucagon level	J:152163
	increased circulating glucose level	J:152163
	increased circulating HDL cholesterol level	J:152163
	increased circulating leptin level	J:152163
	increased circulating triglyceride level	J:152163
	increased oxygen consumption	J:152163
	increased respiratory quotient	J:152163
Fto^tm1.1Pzg/Fto^tm1.1Pzg Tg(Nes-cre)1Kln/0 (involves: 129P2/OlaHsd * 129S4/SvJaeSor * C57BL/6 * SJL)	abnormal carbon dioxide production	J:166984
	abnormal oxygen consumption	J:166984
	decreased circulating insulin-like growth factor I level	J:166984
Fto^tm1.1Rdc/Fto^tm1.1Rdc Ndor1^{Tg(UBC-cre/ERT2)1Ejb}/0 (involves: 129S/SvEv * 129S1/Sv * 129X1/SvJ * C57BL/6 * SJL)	decreased carbon dioxide production	J:194922
	decreased respiratory quotient	J:194922
Fto^tm1.2Pzg/Fto^tm1.2Pzg (involves: 129P2/OlaHsd * 129S4/SvJaeSor * C57BL/6)	abnormal carbon dioxide production	J:166984
	abnormal oxygen consumption	J:166984
	decreased circulating insulin-like growth factor I level	J:166984
	increased susceptibility to diet-induced obesity	J:166984
Fto^tm1.2Rdc/Fto^tm1.2Rdc (involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * C57BL/6J * SJL)	decreased respiratory quotient	J:194922
	improved glucose tolerance	J:194922
	increased oxygen consumption	J:194922
Fto^tm1.3Pzg/Fto^tm1.3Pzg (involves: 129P2/OlaHsd * 129S4/SvJaeSor * C57BL/6)	abnormal carbon dioxide production	J:166984
	abnormal oxygen consumption	J:166984
	decreased circulating insulin-like growth factor I level	J:166984
	increased susceptibility to diet-induced obesity	J:166984
Fto^{tm1a(EUCOMM)Wtsi}/Fto^{tm1a(EUCOMM)Wtsi} (B6JTyr;B6N-Fto^{tm1a(EUCOMM)Wtsi}/Wtsi)	decreased circulating alanine transaminase level	J:175295
	decreased circulating aspartate transaminase level	J:175295
	decreased circulating iron level	J:175295
	decreased circulating LDL cholesterol level	J:175295
	decreased lactate dehydrogenase level	J:175295
Fto^tm1Urt/Fto⁺ (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	decreased susceptibility to diet-induced obesity	J:147471
Fto^tm1Urt/Fto^tm1Urt (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	abnormal circulating hormone level	J:147471
	decreased circulating leptin level	J:147471
	decreased susceptibility to diet-induced obesity	J:147471
	increased carbon dioxide production	J:147471
	increased circulating adrenaline level	J:147471
	increased energy expenditure	J:147471
	increased oxygen consumption	J:147471
Fto^tm1Urt/Fto^tm1Urt Lep^ob/Lep^ob (involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)	insulin resistance	J:219118
Ftsj1^{tm1b(EUCOMM)Wtsi}/Y (C57BL/6N-Ftsj1^{tm1b(EUCOMM)Wtsi}/Bay)	decreased circulating alanine transaminase level	J:211773
	decreased circulating aspartate transaminase level	J:211773
Ftsj1^{tm1b(EUCOMM)Wtsi}/Ftsj1^{tm1b(EUCOMM)Wtsi} (C57BL/6N-Ftsj1^{tm1b(EUCOMM)Wtsi}/Bay)	decreased circulating phosphate level	J:211773
Fuca1^tm1Tlub/Fuca1^tm1Tlub (involves: 129S2/SvPas * C57BL/6)	abnormal urine homeostasis	J:235359
	increased brain cholesterol level	J:235359
Fundc2^tm1Qim/Fundc2^tm1Qim (involves: C57BL/6)	decreased susceptibility to induced thrombosis	J:301680
Fus^{tm1.1(KOMP)Vlcg}/Fus⁺ (C57BL/6N-Fus^{tm1.1(KOMP)Vlcg}/Ucd)	increased respiratory quotient	J:211773
Fut4^em1(IMPC)Ics/Fut4^em1(IMPC)Ics (C57BL/6N-Fut4^em1(IMPC)Ics/Ics)	decreased circulating creatinine level	J:211773
Fuz^em1(IMPC)Mbp/Fuz^em1(IMPC)Mbp (C57BL/6N-Fuz^em1(IMPC)Mbp/MbpMmucd)	edema	J:211773
Fuz^{Gt(AN0439)Wtsi}/Fuz^{Gt(AN0439)Wtsi} (involves: 129P2/OlaHsd * C3H)	edema	J:154370
	pericardial edema	J:154370
Fxn^tm1Mkn/Fxn^tm1Mkn Tg(FXN)YG22Pook/0 (involves: 129/Sv * C57BL/6 * CBA)	abnormal enzyme/coenzyme level	J:114840
	increased heart iron level	J:114840
Fxn^tm1Mkn/Fxn^tm1Pand (involves: 129/Sv * C57BL/6)	increased heart iron level	J:109164
Fxn^tm2Mkn/Fxn^tm2.1Mkn Tg(Ckmm-cre)1Lrsn/0 (involves: 129 * C57BL/6J)	abnormal iron homeostasis	J:75420
	increased heart iron level	J:75420, J:90401
Fxyd4^tm1Grt/Fxyd4^tm1Grt (involves: 129S1/Sv * 129X1/SvJ * MF1)	abnormal ion homeostasis	J:78904
	increased circulating potassium level	J:78904
Fyb1^{tm1b(EUCOMM)Hmgu}/Fyb1^{tm1b(EUCOMM)Hmgu} (C57BL/6N-Fyb1^{tm1b(EUCOMM)Hmgu}/Cnrm)	increased respiratory quotient	J:211773
Fyco1^tm1.1Arte/Fyco1^tm1.1Arte Tg(Prm-cre)58Og/0 (involves: 129S1/SvImJ * 129S4/SvJae * C57BL/6J * C57BL/6NTac)	abnormal phospholipid level	J:336796
Fyco1^tm1.2Arte/Fyco1^tm1.2Arte (involves: C57BL/6J * C57BL/6N * C57BL/6NTac * FVB/N)	abnormal phospholipid level	J:336796
Fyn^tm1Sor/Fyn^tm1Sor (involves: 129S7/SvEvBrd)	abnormal chemokine level	J:80658
Fyn^tm1Sor/Fyn^tm1Sor Yes1^tm1Sor/Yes1^tm1Sor (involves: 129S7/SvEvBrd)	increased urine protein level	J:20346
Fyn^tm1Yik/Fyn^tm1Yik (involves: C57BL/6 * CBA)	increased dopamine level	J:74705
Fyn^tm1Yik/Fyn^tm1Yik (involves: C57BL/6 * CBA)	increased serotonin level	J:74705
Fyttd1^em1(IMPC)J/Fyttd1^em1(IMPC)J (C57BL/6NJ-Fyttd1^em1(IMPC)J/Mmjax)	increased circulating creatinine level	J:211773
Fzd1^tm1.1Nat/Fzd1^tm1.1Nat Fzd2^tm1.1Nat/Fzd2^tm1.1Nat (involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * CBA)	cyanosis	J:165556
Fzd3^{tm1b(EUCOMM)Hmgu}/Fzd3⁺ (C57BL/6N-Fzd3^{tm1b(EUCOMM)Hmgu}/H)	impaired glucose tolerance	J:211773
Fzd3^tm1Nat/Fzd3^tm1Nat (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	cyanosis	J:79213
Fzd4^{tm1.1(KOMP)Vlcg}/Fzd4^{tm1.1(KOMP)Vlcg} (C57BL/6N-Fzd4^{tm1.1(KOMP)Vlcg}/Ucd)	edema	J:211773
Fzd4^tm1Nat/Fzd4^tm1Nat (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	decreased circulating progesterone level	J:115734
G0s2^{tm1(KOMP)Vlcg}/G0s2^{tm1(KOMP)Vlcg} (involves: C57BL/6NTac)	decreased circulating alanine transaminase level	J:209000
	decreased circulating aspartate transaminase level	J:209000
	decreased circulating insulin level	J:209000
	decreased liver triglyceride level	J:209000
	decreased susceptibility to induced hypothermia	J:225236
	enhanced lipolysis	J:209000, J:225236
	improved glucose tolerance	J:209000
	increased circulating free fatty acids level	J:209000
	increased circulating glycerol level	J:225236
	increased insulin sensitivity	J:209000
	increased oxygen consumption	J:225236
G0s2^tm1Jgte/G0s2^tm1Jgte (involves: 129S7/SvEvBrd)	decreased liver triglyceride level	J:219653
	decreased respiratory quotient	J:219653
	decreased susceptibility to diet-induced obesity	J:219653
	decreased susceptibility to induced hypothermia	J:219653
	enhanced lipolysis	J:219653
	improved glucose tolerance	J:219653
	increased insulin sensitivity	J:219653
	increased oxygen consumption	J:219653
G2e3^em1(IMPC)Tcp/G2e3^em1(IMPC)Tcp (C57BL/6NCrl-G2e3^em1(IMPC)Tcp/Tcp)	increased circulating aspartate transaminase level	J:211773
G6pc1^em1Jyc/G6pc1^em1Jyc (involves: 129S4/SvJae * C57BL/6)	abnormal homeostasis	J:320697
	hypoglycemia	J:320697
	increased blood uric acid level	J:320697
	increased circulating cholesterol level	J:320697
	increased circulating triglyceride level	J:320697
	increased liver glycogen level	J:320697
	increased liver triglyceride level	J:320697
G6pc1^tm1.1Ics/G6pc1^tm1.1Ics Alb^{tm1(cre/ERT2)Mtz}/Alb⁺ (involves: 129S2/SvPas * C57BL/6J)	abnormal blood homeostasis	J:195257
	increased blood uric acid level	J:195257
	increased circulating cholesterol level	J:195257
	increased circulating triglyceride level	J:195257
	increased liver glycogen level	J:195257
	increased liver triglyceride level	J:195257
G6pc1^tm1.1Ics/G6pc1^tm1.1Ics Tg(Kap-icre)29066/2Sig/0 (involves: 129S2/SvPas * C57BL/6J * SJL)	abnormal urine homeostasis	J:238264
	decreased urine pH	J:238264
	increased blood uric acid level	J:238264
	increased kidney glycogen level	J:238264
	increased urine magnesium level	J:238264
	increased urine microalbumin level	J:238264
	increased urine phosphate level	J:238264
	increased urine uric acid level	J:238264
G6pc1^tm1Jyc/G6pc1^tm1Jyc (involves: 129S4/SvJae)	abnormal glucose homeostasis	J:33212
	abnormal lipid homeostasis	J:33212
	decreased circulating glucose level	J:33212
	increased blood uric acid level	J:33212
	increased circulating cholesterol level	J:33212
	increased circulating triglyceride level	J:33212
	increased kidney glycogen level	J:33212
	increased liver glycogen level	J:33212
G6pc1^tm2.2Jyc/G6pc1^tm2.2Jyc (involves: 129S4/SvJae * 129S4/SvJaeSor * C57BL/6J * FVB/N)	abnormal blood homeostasis	J:155990
	hypoglycemia	J:155990
	increased blood uric acid level	J:155990
	increased circulating cholesterol level	J:155990
	increased circulating triglyceride level	J:155990
	increased kidney glycogen level	J:155990
	increased liver glycogen level	J:155990
G6pc2^tm1Lex/G6pc2^tm1Lex (involves: 129S5/SvEvBrd * C57BL/6)	decreased circulating glucose level	J:141593
	decreased circulating triglyceride level	J:141593
G6pc3^tm1Rmob/G6pc3^tm1Rmob (involves: 129S5/SvEvBrd * C57BL/6J)	decreased circulating cholesterol level	J:117664
	increased circulating glucagon level	J:117664
G6pdx^a-m1Neu/Y Tg(Myh6-CRYABR120G)7302Ijb/0 (involves: 102/El C3H/El * C57BL/6)	increased glutathione level	J:126781
Gaa^tm1.1Rabn/Gaa^tm1.1Rabn (involves: 129X1/SvJ * C57BL/6 * FVB/N)	increased brain glycogen level	J:76435
	increased cardiac muscle glycogen level	J:76435, J:48839
	increased skeletal muscle glycogen level	J:76435, J:48839
Gaa^tm1Rabn/Gaa^tm1Rabn (involves: 129X1/SvJ * C57BL/6)	increased brain glycogen level	J:76435
	increased cardiac muscle glycogen level	J:235790, J:76435, J:48839
	increased liver glycogen level	J:235790
	increased skeletal muscle glycogen level	J:235790, J:48839, J:73924
Gaa^tm1Rabn/Gaa^tm1Rabn Stbd1^tm1Bsn/Stbd1^tm1Bsn (involves: 129X1/SvJ * C57BL/6)	increased cardiac muscle glycogen level	J:235790
	increased liver glycogen level	J:235790
	increased skeletal muscle glycogen level	J:235790
Gaa^tm1Rabn/Gaa^tm1Rabn Tg(CMV-GAAP545L)#Kjv/0 (involves: 129X1/SvJ C57BL/6)	increased glycogen level	J:219022
	increased skeletal muscle glycogen level	J:219022
Gaa^tm1Vdp/Gaa^tm1Vdp (either: (involves: 129P2/OlaHsd * C57BL/6) or (involves: 129P2/OlaHsd * FVB))	abnormal glycogen homeostasis	J:45386
Gaa^tm2Rabn/Gaa^tm2Rabn (involves: 129X1/SvJ * C57BL/6)	increased brain glycogen level	J:76435
	increased cardiac muscle glycogen level	J:76435
	increased skeletal muscle glycogen level	J:76435
Gab1^tm1Gsf/Gab1^tm1Gsf Speer6-ps1^{Tg(Alb-cre)21Mgn}/Speer6-ps1⁺ (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	abnormal glucose homeostasis	J:98318
	abnormal lipid homeostasis	J:98318
	decreased circulating free fatty acids level	J:98318
	decreased circulating glucose level	J:98318
	decreased circulating insulin level	J:98318
	decreased circulating triglyceride level	J:98318
	decreased glycogen level	J:98318
	improved glucose tolerance	J:98318
	increased insulin sensitivity	J:98318
Gab1^tm1Thir/Gab1^tm1Thir (involves: C57BL/6)	hemopericardium	J:61790
Gabarapl2^{tm1b(EUCOMM)Hmgu}/Gabarapl2⁺ (C57BL/6N-Gabarapl2^{tm1b(EUCOMM)Hmgu}/H)	decreased circulating serum albumin level	J:211773
Gabbr1^tm1Bet/Gabbr1^tm1Bet (BALB/c-Gabbr1^tm1Bet)	increased circulating luteinizing hormone level	J:115850
Gabbr1^tm1Bet/Gabbr1^tm1Bet (BALB/c-Gabbr1^tm1Bet)	increased circulating prolactin level	J:115850
Gabbr1^tm1Dgen/Gabbr1^tm1Dgen (involves: 129P2/OlaHsd * C57BL/6)	dehydration	J:101679
Gabbr1^tm2.1Bet/Gabbr1^tm2.1Bet (BALB/c-Gabbr1^tm2.1Bet)	abnormal body temperature homeostasis	J:94234
Gabpa^em2(IMPC)Mbp/Gabpa⁺ (C57BL/6N-Gabpa^em2(IMPC)Mbp/Ucd)	increased circulating bilirubin level	J:211773
Gabra2^em1(IMPC)H/Gabra2^em1(IMPC)H (C57BL/6N-Gabra2^em1(IMPC)H/H)	decreased fasting circulating glucose level	J:211773
Gabrb1^m1Qnma/Gabrb1⁺ (involves: BALB/cAnN * C3H/HeH)	decreased follicle stimulating hormone level	J:223500
	decreased growth hormone level	J:223500
	decreased luteinizing hormone level	J:223500
	decreased prolactin level	J:223500
	decreased thyroid-stimulating hormone level	J:223500
Gabrb1^m2Qnma/Gabrb1⁺ (involves: BALB/cAnN * C3H/HeH)	decreased growth hormone level	J:223500
Gabrb1^m2Qnma/Gabrb1⁺ (involves: BALB/cAnN * C3H/HeH)	decreased prolactin level	J:223500
Gad1^tm1Mrc/Gad1^tm1Mrc (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	cyanosis	J:43954
	dehydration	J:43954
	hypoxia	J:43954
Gad1^tm1Oba/Gad1⁺ (involves: C57BL/6 * CBA)	decreased gamma-aminobutyric acid level	J:40978
Gad1^tm1Oba/Gad1^tm1Oba (involves: C57BL/6 * CBA)	cyanosis	J:40978
Gad1^tm1Oba/Gad1^tm1Oba (involves: C57BL/6 * CBA)	decreased gamma-aminobutyric acid level	J:40978
Gad1^tm1Oba/Gad1^tm1Oba Gad2^tm1Oba/Gad2^tm1Oba (involves: C57BL/6 * CBA)	decreased gamma-aminobutyric acid level	J:102619
Gad2^{tm1b(EUCOMM)Wtsi}/Gad2^{tm1b(EUCOMM)Wtsi} (C57BL/6N-Gad2^{tm1b(EUCOMM)Wtsi}/Ieg)	decreased respiratory quotient	J:211773
	impaired glucose tolerance	J:211773
	increased circulating alkaline phosphatase level	J:211773
	increased circulating chloride level	J:211773
	increased circulating sodium level	J:211773
	increased fasting circulating glucose level	J:211773
Gad2^tm1Bae/Gad2^tm1Bae (involves: 129X1/SvJ * NOD)	decreased gamma-aminobutyric acid level	J:44638
Gad2^tm1Miya/Gad2^tm1Miya (NOD.129P2-Gad2^tm1Miya)	increased circulating glucose level	J:88785
Gad2^tm1Oba/Gad2⁺ (involves: C57BL/6 * CBA)	decreased gamma-aminobutyric acid level	J:62320
Gad2^tm1Oba/Gad2^tm1Oba (involves: C57BL/6 * CBA)	decreased gamma-aminobutyric acid level	J:62320
Gadd45a^tm1Ajf/Gadd45a^tm1Ajf (either: (involves: 129P2/OlaHsd * C57BL/6) or (involves: 129X1/SvJ * C57BL/6))	increased urine protein level	J:76041
Gadd45g^tm1Flv/Gadd45g^tm1Flv (involves: 129S1/Sv)	decreased core body temperature	J:213702
Gadd45g^tm1Flv/Gadd45g^tm1Flv (involves: 129S1/Sv)	impaired adaptive thermogenesis	J:213702
Gadd45gip1^tm2Kong/Gadd45gip1^tm2Kong Tg(Ins2-cre)25Mgn/0 (involves: 129P2/OlaHsd * C57BL/6 * DBA)	decreased insulin secretion	J:220742
	decreased oxygen consumption	J:220742
	impaired glucose tolerance	J:220742
Gak^tm2Legr/Gak^tm2Legr Speer6-ps1^{Tg(Alb-cre)21Mgn}/Speer6-ps1⁺ (involves: 129S6/SvEvTac * C57BL/6 * DBA)	decreased liver glycogen level	J:180119
Gak^tm2Legr/Gak^tm2Legr Tg(KRT14-cre)1Amc/0 (involves: 129S6/SvEvTac * C57BL/6 * CBA)	dehydration	J:180119
	impaired skin barrier function	J:180119
Gal3st1^{em1(IMPC)Rbrc}/Gal3st1^{em1(IMPC)Rbrc} (C57BL/6NJcl-Gal3st1^{em1(IMPC)Rbrc}/Rbrc)	improved glucose tolerance	J:211773
Gal3st1^tm1.1Hjg/Gal3st1^tm1.1Hjg Pax8^{tm1.1(cre)Mbu}/Pax8⁺ (involves: 129P2/OlaHsd * C57BL/6)	abnormal urine homeostasis	J:197393
	decreased urine ammonia level	J:197393
	decreased urine pH	J:197393
	increased urine potassium level	J:197393
	metabolic acidosis	J:197393
Gal3st1^tm1.1Hjg/Gal3st1^tm1.1Hjg Ugcg^tm1Hjg/Ugcg^tm1Hjg Pax8^{tm1.1(cre)Mbu}/Pax8⁺ (involves: 129P2/OlaHsd * C57BL/6)	abnormal urine homeostasis	J:197393
	decreased urine ammonia level	J:197393
	decreased urine pH	J:197393
	increased urine potassium level	J:197393
Gal^tm1Wyn/Gal^tm1Wyn (129P2-Gal^tm1Wyn)	abnormal circulating insulin level	J:105628
Gal^tm1Wyn/Gal^tm1Wyn (129P2-Gal^tm1Wyn)	decreased insulin secretion	J:105628
Gal^tm1Wyn/Gal^tm1Wyn (involves: 129P2/OlaHsd * C57BL/6)	decreased circulating glucocorticoid level	J:84420
Galc^twi/Galc^twi (B6.CE-Galc^twi/J)	abnormal lipid level	J:165361
	abnormal sphingomyelin level	J:165361
	decreased circulating insulin-like growth factor I level	J:165361
Galc^twi/Galc^twi (involves: CE/J)	abnormal lipid level	J:78223
	abnormal protein level	J:7311
	edema	J:7115
Galc^twi/Galc^twi Glb1^tm1Adz/Glb1⁺ (involves: 129P2/OlaHsd * C57BL/6J * CE/J)	abnormal lipid level	J:63197
Galc^twi/Galc^twi Glb1^tm1Adz/Glb1^tm1Adz (involves: 129P2/OlaHsd * C57BL/6J * CE/J)	abnormal lipid level	J:63197
Galc^twi/Galc^twi Il6⁺/? (involves: 129S2/SvPas * C57BL/6J * CE/J)	abnormal tumor necrosis factor level	J:56656
Galc^twi/Galc^twi Il6^tm1Kopf/Il6^tm1Kopf (involves: 129S2/SvPas * C57BL/6J * CE/J)	abnormal tumor necrosis factor level	J:56656
Galk1^tm1Stb/Galk1^tm1Stb (involves: 129S6/SvEvTac)	abnormal homeostasis	J:63743
Galk1^tm1Stb/Galk1^tm1Stb Tg(Cryaa-AKR1B1)222Smch/0 (involves: 129S6/SvEvTac * C57BL * CBA)	abnormal homeostasis	J:63743
Galk1^tm1Stb/Galk1^tm1Stb Tg(Cryaa-AKR1B1)648Smch/0 (involves: 129S6/SvEvTac * C57BL * CBA)	abnormal homeostasis	J:63743
Galk2^{tm1b(EUCOMM)Hmgu}/Galk2^{tm1b(EUCOMM)Hmgu} (C57BL/6N-Galk2^{tm1b(EUCOMM)Hmgu}/Ieg)	increased circulating alkaline phosphatase level	J:211773
	increased circulating bilirubin level	J:211773
Galns^tm1Toma/Galns^tm1Toma (involves: 129X1/SvJ * C57BL/6)	increased urine glycosaminoglycan level	J:87155
Galnt1^tm1.1Jxm/Galnt1^tm1.1Jxm (B6NHsd.Cg-Galnt1^tm1.1Jxm)	decreased circulating serum albumin level	J:128982
Galnt1^tm1.1Jxm/Galnt1^tm1.1Jxm (B6NHsd.Cg-Galnt1^tm1.1Jxm)	increased bleeding time	J:128982
Galnt2^tm1.2Mrl/Galnt2^tm1.2Mrl (involves: C57BL/6)	decreased circulating HDL cholesterol level	J:251899
Galnt2^tm1.2Mrl/Galnt2^tm1.2Mrl (involves: C57BL/6)	increased triglyceride level	J:251899
Galnt3^tcal/Galnt3^tcal (involves: C3H * C57BL/6J)	abnormal circulating protein level	J:187064
	calcinosis	J:187064
	increased circulating phosphate level	J:187064
	increased vitamin D level	J:187064
Galnt3^tm1.1Cfg/Galnt3^tm1.1Cfg (involves: C57BL/6)	increased circulating bilirubin level	J:217719
Galnt3^tm1Mjec/Galnt3^tm1Mjec (involves: 129S/SvEv * C57BL/6J)	abnormal vitamin D level	J:151805
	decreased circulating alkaline phosphatase level	J:151805
	decreased circulating parathyroid hormone level	J:151805
	increased circulating calcium level	J:151805
	increased circulating phosphate level	J:151805
Galnt11^tm1Kgth/Galnt11^tm1Kgth (B6NHsd.Cg-Galnt11^tm1Kgth)	albuminuria	J:287843
	increased blood urea nitrogen level	J:287843
	increased circulating LDL cholesterol level	J:287843
	increased urine protein level	J:287843
Galnt18^{tm1b(KOMP)Wtsi}/Galnt18^{tm1b(KOMP)Wtsi} (C57BL/6N-Galnt18^{tm1b(KOMP)Wtsi}/Wtsi)	decreased circulating fructosamine level	J:211773
	increased circulating alkaline phosphatase level	J:211773
Galp^tm1Stei/Galp^tm1Stei (involves: 129)	decreased susceptibility to diet-induced obesity	J:141148
Galr1^em1(IMPC)H/Galr1^em1(IMPC)H (C57BL/6N-Galr1^em1(IMPC)H/H)	decreased circulating creatinine level	J:211773
Galr2^em1(IMPC)H/Galr2^em1(IMPC)H (C57BL/6NTac-Galr2^em1(IMPC)H/H)	decreased circulating serum albumin level	J:211773
Galr3^tm1Lex/Galr3^tm1Lex (B6;129S5-Galr3^tm1Lex/Orl)	increased cholesterol level	J:82809
Galr3^tm1Lex/Galr3^tm1Lex (B6;129S5-Galr3^tm1Lex/Orl)	increased triglyceride level	J:82809
Galt^{Gt(E285B04)Wrst}/Galt^{Gt(E285B04)Wrst} (involves: 129P2/OlaHsd * C57BL/6J)	abnormal galactose homeostasis	J:234753
	cerebral edema	J:234753
Galt^tm1Sgl/Galt^tm1Sgl (involves: 129P2/OlaHsd * CF-1)	abnormal galactose homeostasis	J:37472, J:76729
Gamt^tm1Isb/Gamt^tm1Isb (involves: 129S1/Sv * 129X1/SvJ)	abnormal amino acid level	J:90367
	abnormal urine amino acid level	J:90367
	decreased circulating creatine level	J:90367
	decreased circulating creatinine level	J:90367
	decreased creatine level	J:90367
	decreased urine creatine level	J:90367
	decreased urine creatinine level	J:90367
Gar1^{tm1a(EUCOMM)Wtsi}/Gar1⁺ (C57BL/6N-Gar1^{tm1a(EUCOMM)Wtsi}/Ics)	decreased circulating chloride level	J:165965
	decreased circulating sodium level	J:165965
	increased circulating chloride level	J:165965
	increased circulating sodium level	J:165965
Garin1b^{em1(IMPC)Ccpcz}/Garin1b^{em1(IMPC)Ccpcz} (C57BL/6N-Garin1b^{em1(IMPC)Ccpcz}/Ccpcz)	increased circulating potassium level	J:211773
Gars1^em1(IMPC)Tcp/Gars1⁺ (C57BL/6NCrl-Gars1^em1(IMPC)Tcp/Tcp)	increased circulating triglyceride level	J:211773
Gas1^tm2Fan/Gas1^tm2Fan Shh^tm1Chg/Shh^tm1Chg (involves: 129/Sv * 129S1/Sv * 129X1/SvJ * C57BL/6J)	cardiac edema	J:121554
Gas2l3^{tm1d(EUCOMM)Hmgu}/Gas2l3^{tm1d(EUCOMM)Hmgu} (involves: 129S4/SvJaeSor * C57BL/6J * C57BL/6N)	abnormal cardiac thrombosis	J:244087
Gas6^{tm1.1(KOMP)Vlcg}/Gas6^{tm1.1(KOMP)Vlcg} (C57BL/6N-Gas6^{tm1.1(KOMP)Vlcg}/Ucd)	increased circulating alkaline phosphatase level	J:211773
Gas6^tm1Hiar/Gas6^tm1Hiar (B6.129P2-Gas6^tm1Hiar)	abnormal circulating serum albumin level	J:112430
Gas6^tm1Hiar/Gas6^tm1Hiar (B6.129P2-Gas6^tm1Hiar)	albuminuria	J:112430
Gas6^tm1Pec/Gas6^tm1Pec (involves: 129S1/Sv * 129X1/SvJ)	abnormal platelet dense granule physiology	J:77462
	decreased platelet aggregation	J:77462
	decreased susceptibility to induced thrombosis	J:77462
Gast^tm1(INS)Ez/Gast⁺ (involves: 129S4/SvJae * C57BL/6)	abnormal insulin secretion	J:99270
	improved glucose tolerance	J:99270
	increased circulating insulin level	J:99270
Gast^tm1(INS)Ez/Gast⁺ Ins2^Akita/Ins2⁺ (involves: 129S4/SvJae * C57BL/6NSlc)	abnormal circulating glucose level	J:99270
Gast^tm1Lcs/Gast^tm1Lcs (involves: 129S1/Sv * 129X1/SvJ * BALB/c)	abnormal iron homeostasis	J:142455
	decreased circulating iron level	J:142455
	increased circulating unsaturated transferrin level	J:142455
Gata1^tm1Mym/Y (involves: 129P2/OlaHsd)	abnormal iron level	J:58508
Gata1^tm6Sho/Gata1^tm6Sho (involves: 129S1/Sv * BALB/c)	abnormal hemostasis	J:115273
	decreased circulating interleukin-4 level	J:115273
	decreased circulating interleukin-13 level	J:115273
Gata2^tm1Sac/Gata2^tm1Sac Tg(Cga-cre)3Sac/? (involves: 129S1/Sv * 129X1/SvJ * C57BL/6J * SJL)	decreased circulating follicle stimulating hormone level	J:108963
	decreased circulating thyroid-stimulating hormone level	J:108963
Gata3^tm1Jeng/Gata3^tm1Jeng (involves: 129S7/SvEvBrd)	abnormal blood coagulation	J:28393
Gata3^tm1Jfz/Gata3^tm1Jfz Tg(Fev-cre)1Esd/0 (involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * SJL)	decreased serotonin level	J:165266
Gata3^tm3Gsv/Gata3^tm3Gsv Tg(KRT14-cre)8Brn/0 (involves: 129P2/OlaHsd * FVB/N)	impaired skin barrier function	J:117058
Gata4^tm1.1Jmol/Gata4^tm1.1Jmol (involves: 129 * C57BL/6)	decreased circulating testosterone level	J:308912
Gata4^tm1.1Sad/Gata4^tm1.1Sad Amhr2^tm3(cre)Bhr/Amhr2⁺ (involves: 129S1/Sv * 129S7/SvEvBrd * 129X1/SvJ * C57BL/6J)	abnormal circulating hormone level	J:173711
Gata4^tm1.1Sad/Gata4^tm1.1Sad Tg(Myh6-cre)1Jmk/0 (involves: 129S1/Sv * 129X1/SvJ * CD-1)	pulmonary edema	J:121367
Gata4^tm1.1Sad/Gata4^tm1.1Sad Tg(Myh7-cre)1Jmk/0 (involves: 129S1/Sv * 129X1/SvJ * CD-1)	pulmonary edema	J:121367
Gata4^tm1.1Sad/Gata4^tm1.2Sad Tg(Prrx1-cre)1Cjt/0 (involves: 129S1/Sv * 129X1/SvJ * C57BL/6J * SJL/J)	decreased blood oxygen saturation level	J:231793
Gata4^tm1.1Wtp/Gata4^tm1.1Wtp Nkx2-5^tm1(cre)Rjs/Nkx2-5⁺ (involves: 129S7/SvEvBrd)	pericardial effusion	J:99203
Gata4^tm1.2Wtp/Gata4⁺ (B6.Cg-Gata4^tm1.2Wtp)	decreased circulating estradiol level	J:173711
Gata4^tm1Eno/Gata4⁺ Gata6^tm1Eno/Gata6⁺ (involves: 129/Sv * 129S7/SvEvBrd * C57BL/6)	edema	J:111824
Gata4^tm1Jml/Gata4⁺ Gata5^tm1Eem/Gata5^tm1Eem (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	edema	J:155855
Gata4^tm1Sho/Gata4^tm1.1Wtp Nkx2-5^tm1(cre)Rjs/Nkx2-5⁺ (involves: 129S6/SvEvTac * 129S7/SvEvBrd)	skin edema	J:150452
Gata4^tm1Sho/Gata4^tm1Sho (involves: 129S6/SvEvTac)	edema	J:77392
Gata4^tm1Wtp/Gata4^tm1Wtp (involves: 129 * C57BL/6)	hydrops fetalis	J:94637
Gata5^tm1.2Nemr/Gata5^tm1.2Nemr (Not Specified)	increased urine protein level	J:227997
Gata6^tm2Msp/Gata6^tm2Msp Tg(Tagln-cre)1Jjl/0 (involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * FVB/N)	cyanosis	J:107814
Gatad2b^{tm1b(EUCOMM)Hmgu}/Gatad2b⁺ (C57BL/6N-Gatad2b^{tm1b(EUCOMM)Hmgu}/Ics)	increased circulating alkaline phosphatase level	J:211773
Gatm^em1Btlr/Gatm^em1Btlr (C57BL/6J-Gatm^em1Btlr)	decreased creatine level	J:252049
Gatm^m1Btlr/Gatm^m1Btlr (C57BL/6J-Gatm^m1Btlr)	decreased creatine level	J:252049
Gatm^tm1.1Isb/Gatm^tm1.1Isb (B6.129-Gatm^tm1.1Isb)	abnormal gluconeogenesis	J:191142
	abnormal glucose homeostasis	J:191142
	abnormal urine amino acid level	J:191142
	decreased circulating cholesterol level	J:191142
	decreased circulating glucose level	J:191142
	decreased circulating insulin level	J:191142
	decreased circulating leptin level	J:191142
	decreased circulating triglyceride level	J:191142
	decreased liver triglyceride level	J:191142
	decreased susceptibility to diet-induced obesity	J:191142
	decreased urine creatine level	J:191142
	decreased urine creatinine level	J:191142
	improved glucose tolerance	J:191142
Gatm^{tm1b(KOMP)Wtsi}/Gatm^{tm1b(KOMP)Wtsi} (C57BL/6N-Gatm^{tm1b(KOMP)Wtsi}/Ieg)	decreased circulating alkaline phosphatase level	J:211773
	decreased circulating cholesterol level	J:211773
	decreased respiratory quotient	J:211773
	increased circulating amylase level	J:211773
	increased circulating aspartate transaminase level	J:211773
	increased circulating potassium level	J:211773
Gauc^KK/? (involves: C57BL/6J * KK-A^y)	impaired glucose tolerance	J:81517
Gba1^em1(IMPC)H/Gba1⁺ (C57BL/6N-Gba1^em1(IMPC)H/H)	increased circulating amylase level	J:211773
Gba1^tm1.1Pmis/Gba1^tm1.1Pmis Tg(Mx1-cre)1Cgn/0 (involves: C57BL/6 * CBA)	abnormal circulating chemokine level	J:167081
	abnormal circulating cytokine level	J:167081
	decreased circulating HDL cholesterol level	J:167081
	decreased circulating interleukin-1 alpha level	J:167081
	decreased circulating interleukin-1 beta level	J:167081
	decreased circulating interleukin-6 level	J:167081
	decreased circulating tumor necrosis factor level	J:167081
	increased circulating aspartate transaminase level	J:167081
	increased circulating interferon-gamma level	J:167081
	increased circulating interleukin-2 level	J:167081
	increased circulating interleukin-3 level	J:167081
	increased circulating interleukin-9 level	J:167081
	increased circulating interleukin-10 level	J:167081
	increased circulating interleukin-13 level	J:167081
Gba1^tm1.1Pmis/Gba1^tm1.2Pmis Tg(Mx1-cre)1Cgn/0 (involves: C57BL/6 * CBA)	abnormal circulating chemokine level	J:167081
	abnormal circulating cytokine level	J:167081
	decreased circulating HDL cholesterol level	J:167081
	decreased circulating interleukin-1 alpha level	J:167081
	decreased circulating interleukin-1 beta level	J:167081
	decreased circulating interleukin-6 level	J:167081
	decreased circulating tumor necrosis factor level	J:167081
	increased circulating aspartate transaminase level	J:167081
	increased circulating interferon-gamma level	J:167081
	increased circulating interleukin-2 level	J:167081
	increased circulating interleukin-3 level	J:167081
	increased circulating interleukin-9 level	J:167081
	increased circulating interleukin-10 level	J:167081
	increased circulating interleukin-13 level	J:167081
Gba1^tm1Bst/Gba1^tm1Nsb Gba/Mtx1^tm1Bst/Mtx1⁺ (involves: 129S/SvEv * 129S4/SvJae)	abnormal enzyme/coenzyme level	J:25197
Gba1^tm1Karl/Gba1^tm1Karl Tg(Nes-cre)1Kln/? (involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * SJL)	abnormal lipid homeostasis	J:127108
Gba1^tm1Nsb/Gba1^tm1Nsb (involves: 129S/SvEv * C57BL/6)	cyanosis	J:1100
Gba1^tm1Rlp/Gba1^tm1Rlp (involves: 129S4/SvJae * C57BL/6)	decreased circulating cholesterol level	J:76409
	increased circulating alanine transaminase level	J:76409
	increased circulating aspartate transaminase level	J:76409
Gba1^tm2Karl/Gba1^tm2Karl Tg(KRT14-cre)8Brn/? (involves: 129S1/Sv * 129X1/SvJ * FVB/N)	abnormal lipid homeostasis	J:127108
Gba1^tm2Rlp/Gba1^tm2Rlp (involves: 129S4/SvJae)	dehydration	J:46243
Gba2^{tm1a(EUCOMM)Wtsi}/Gba2^{tm1a(EUCOMM)Wtsi} (C57BL/6N-Gba2^{tm1a(EUCOMM)Wtsi}/Wtsi)	decreased circulating creatinine level	J:175295
Gba2^tm1Rus/Gba2^tm1Rus (involves: 129S6/SvEv * C57BL/6J)	abnormal lipid level	J:114991
Gbe1^m1Yty/Gbe1^m1Yty (C3HeB/FeJ-Gbe1^m1Yty)	decreased cardiac muscle glycogen level	J:167233
Gbe1^m1Yty/Gbe1^m1Yty (C3HeB/FeJ-Gbe1^m1Yty)	edema	J:167233
Gbe1^tm1.1Hoa/Gbe1^tm1.1Hoa (involves: 129S7/SvEvBrd)	abnormal glucose homeostasis	J:176889
	decreased liver glycogen level	J:176889
	decreased skeletal muscle glycogen level	J:176889
Gbe1^tm1Hoa/Gbe1^tm1Hoa (involves: 129S7/SvEvBrd)	abnormal glucose tolerance	J:176889
	decreased circulating glucose level	J:176889
	decreased glycogen catabolism rate	J:176889
	increased liver glycogen level	J:176889
	increased skeletal muscle glycogen level	J:176889
Gbe1^tm2.1Hoa/Gbe1^tm2.1Hoa (involves: 129S7/SvEvBrd)	abnormal glucose homeostasis	J:226481
	abnormal muscle glycogen level	J:226481
	decreased fasting circulating glucose level	J:226481
	increased brain glycogen level	J:226481
	increased circulating creatine kinase level	J:226481
	increased glycogen level	J:226481
	increased liver glycogen level	J:226481
Gbe1^tm2Hoa/Gbe1^tm2Hoa (involves: 129S7/SvEvBrd)	abnormal muscle glycogen level	J:226481
	increased brain glycogen level	J:226481
	increased glycogen level	J:226481
	increased liver glycogen level	J:226481
Gbp2^{tm1b(KOMP)Wtsi}/Gbp2^{tm1b(KOMP)Wtsi} (C57BL/6N-Gbp2^{tm1b(KOMP)Wtsi}/Ieg)	increased fasting circulating glucose level	J:211773
Gbp5^{em1(IMPC)Wtsi}/Gbp5^{em1(IMPC)Wtsi} (C57BL/6N-Gbp5^{em1(IMPC)Wtsi}/WtsiIeg)	increased circulating creatinine level	J:211773
Gbp5^tm1Tigm/Gbp5^tm1Tigm (B6.Cg-Gbp5^tm1Tigm)	decreased circulating interleukin-1 beta level	J:183942
Gbp5^tm1Tigm/Gbp5^tm1Tigm (B6.Cg-Gbp5^tm1Tigm)	decreased circulating interleukin-18 level	J:183942
Gbp7^em1(IMPC)J/Gbp7^em1(IMPC)J (C57BL/6NJ-Gbp7^em1(IMPC)J/Mmjax)	increased circulating alkaline phosphatase level	J:211773
Gbx1^{tm1b(KOMP)Wtsi}/Gbx1^{tm1b(KOMP)Wtsi} (C57BL/6N-Gbx1^{tm1b(KOMP)Wtsi}/H)	increased circulating alkaline phosphatase level	J:211773
Gbx2^tm1.1Mrt/Gbx2^tm1.1Mrt (B6.129-Gbx2^tm1.1Mrt)	cyanosis	J:100584
Gc^{tm1.1(KOMP)Vlcg}/Gc^{tm1.1(KOMP)Vlcg} (C57BL/6N-Gc^{tm1.1(KOMP)Vlcg}/Ucd)	decreased circulating cholesterol level	J:211773
	decreased circulating glucose level	J:211773
	decreased circulating HDL cholesterol level	J:211773
	decreased circulating total protein level	J:211773
	decreased circulating triglyceride level	J:211773
	increased circulating alanine transaminase level	J:211773
Gc^tm1Nec/Gc^tm1Nec (involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)	abnormal vitamin D level	J:52225
Gcdh^tm1Dmk/Gcdh^tm1Dmk (involves: 129S4/SvJae * C57BL/6J)	glutaricadicuria	J:77874
Gcg^tm1Yhys/Gcg^tm1Yhys (B6.129S6-Gcg^tm1Yhys)	decreased circulating insulin level	J:154694
	improved glucose tolerance	J:154694
	increased circulating glucose level	J:154694
	increased insulin sensitivity	J:154694
Gcgr^em1Tshu/Gcgr^em1Tshu (involves: C57BL/6J)	decreased fasting circulating glucose level	J:279017
Gcgr^em2Smoc/Gcgr^em2Smoc (C57BL/6J-Gcgr^em2Smoc)	decreased fasting circulating glucose level	J:300368
	improved glucose tolerance	J:300368
	increased circulating glucagon level	J:300368
Gcgr^{tm1.1(KOMP)Vlcg}/Gcgr^{tm1.1(KOMP)Vlcg} (C57BL/6N-Gcgr^{tm1.1(KOMP)Vlcg}/Ucd)	decreased circulating insulin level	J:211773
	decreased fasting circulating glucose level	J:211773
	improved glucose tolerance	J:211773
	increased blood urea nitrogen level	J:211773
	increased circulating calcium level	J:211773
	increased circulating cholesterol level	J:211773
Gcgr^tm1Jcp/Gcgr^tm1Jcp (DBA/1LacJ-Gcgr^tm1Jcp)	decreased circulating glucose level	J:176507
	decreased circulating insulin level	J:176507
	increased circulating glucagon level	J:176507, J:73926
Gcgr^tm1Mjch/Gcgr^tm1Mjch (involves: 129/Sv * C57BL/6J * SJL)	abnormal circulating amino acid level	J:251829
	decreased circulating glucose level	J:81772
	decreased circulating insulin level	J:251829
	decreased circulating leptin level	J:81772
	decreased triglyceride level	J:81772
	hypoglycemia	J:251829, J:81772
	improved glucose tolerance	J:81772
	increased circulating glucagon level	J:251829, J:81772
	increased circulating LDL cholesterol level	J:81772
Gcgr^tm1Mjch/Gcgr^tm1Mjch (involves: 129 * C57BL/6J * SJL)	decreased carbon dioxide production	J:216393
	decreased circulating insulin level	J:208604
	decreased oxygen consumption	J:216393
	decreased susceptibility to diet-induced non-insulin dependent diabetes	J:216393
	decreased susceptibility to diet-induced obesity	J:216393
	improved glucose tolerance	J:208604
	increased bile salt level	J:208604
	increased circulating glucagon level	J:208604
	increased glucagon secretion	J:208604
	increased insulin sensitivity	J:208604
Gcgr^tm1Mjch/Gcgr^tm1Mjch Lepr^tm1Jke/Lepr^tm1Jke (involves: 129 * 129X1/SvJ * C57BL/6J * SJL)	increased liver triglyceride level	J:216393
Gcgr^tm1Mjch/Gcgr^tm1Mjch Slc38a5^{tm1(KOMP)Vlcg}/Slc38a5^{tm1(KOMP)Vlcg} (involves: 129/Sv * C57BL/6 * C57BL/6J * C57BL/6NTac * SJL)	abnormal circulating amino acid level	J:251829
	decreased circulating insulin level	J:251829
	hypoglycemia	J:251829
	increased circulating glucagon level	J:251829
Gcgr^tm2.1Mjch/Gcgr^tm2.1Mjch Speer6-ps1^{Tg(Alb-cre)21Mgn}/Speer6-ps1⁺ (involves: C57BL/6 * DBA * SJL)	abnormal glucose homeostasis	J:208604
	decreased circulating glucose level	J:208604
	decreased circulating insulin level	J:208604
	hypoglycemia	J:208604
	improved glucose tolerance	J:208604
	increased bile salt level	J:208604
	increased circulating glucagon level	J:208604
	increased insulin sensitivity	J:208604
Gch1^em1Ypt/Gch1^em1Ypt (C57BL/6-Gch1^em1Ypt)	decreased nervous system dopamine level	J:295169
	decreased noradrenaline level	J:295169
	decreased serotonin level	J:295169
	increased phenylalanine level	J:295169
Gch1^tm1.2Drg/Gch1^tm1.2Drg (involves: C57BL/6J)	decreased dopamine level	J:219813
Gck^em1(IMPC)H/Gck⁺ (C57BL/6NTac-Gck^em1(IMPC)H/H)	impaired glucose tolerance	J:211773
	increased circulating alkaline phosphatase level	J:211773
	increased circulating fructosamine level	J:211773
	increased circulating glucose level	J:211773
	increased fasting circulating glucose level	J:211773
Gck^Gena348/Gck⁺ (involves: BALB/c * C3H/He)	hyperglycemia	J:82809, J:79719, J:90389
Gck^Gena348/Gck⁺ (involves: BALB/c * C3H/He)	impaired glucose tolerance	J:90389
Gck^Gena348/Gck^Gena348 (involves: BALB/c * C3H/He)	hyperglycemia	J:90389
Gck^Gena348/Gck^Gena348 (involves: BALB/c * C3H/He)	impaired glucose tolerance	J:90389
Gck^Gls006/Gck⁺ (C3HeB/FeJ-Gck^Gls006)	decreased circulating insulin level	J:189544
	decreased insulin secretion	J:189544
	hyperglycemia	J:189544
	impaired glucose tolerance	J:189544
	increased circulating glucose level	J:189544
Gck^Gls006/Gck^Gls006 (C3HeB/FeJ-Gck^Gls006)	hyperglycemia	J:137483, J:189544
Gck^Gls006/Gck^Gls006 (C3HeB/FeJ-Gck^Gls006)	increased circulating glucose level	J:189544
Gck^Hlb62/? (C57BL/6J-Gck^Hlb62/J)	hyperglycemia	J:214141, J:82961
Gck^Hlb62/? (C57BL/6J-Gck^Hlb62/J)	impaired glucose tolerance	J:214141
Gck^M1Btlr/Gck⁺ (C57BL/6J-Gck^M1Btlr)	impaired glucose tolerance	J:221479
Gck^M1Btlr/Gck^M1Btlr (C57BL/6J-Gck^M1Btlr)	impaired glucose tolerance	J:221479
Gck^m1Rge/Gck⁺ (involves: C3HeB/FeJ)	decreased insulin secretion	J:162903
	hyperglycemia	J:162903
	impaired glucose tolerance	J:162903
	increased circulating insulin level	J:162903
	insulin resistance	J:162903
Gck^m1Rge/Gck^m1Rge (involves: C3HeB/FeJ)	hyperglycemia	J:162903
Gck^m1Rge/Gck^m1Rge (involves: C3HeB/FeJ)	increased urine glucose level	J:162903
Gck^m2Btlr/Gck^m2Btlr (C57BL/6J-Gck^m2Btlr)	impaired glucose tolerance	J:264650
Gck^Rgsc149/Gck⁺ (involves: C57BL/6J * DBA/2J)	hyperglycemia	J:88919
Gck^Rgsc149/Gck⁺ (involves: C57BL/6J * DBA/2J)	increased glycosylated hemoglobin level	J:88919
Gck^Rgsc149/Gck⁺ (involves: C57BL/6JJcl * DBA/2JJcl)	hyperglycemia	J:133634
Gck^Rgsc210/Gck⁺ (involves: C57BL/6J * DBA/2J)	hyperglycemia	J:88919
	impaired glucose tolerance	J:88919
	increased glycosylated hemoglobin level	J:88919
Gck^Rgsc210/Gck^Rgsc210 (involves: C57BL/6J * DBA/2J)	decreased liver glycogen level	J:88919
	hyperglycemia	J:88919
	increased urine glucose level	J:88919
Gck^Rgsc236/Gck⁺ (involves: C57BL/6J * DBA/2J)	hyperglycemia	J:88919
Gck^Rgsc236/Gck⁺ (involves: C57BL/6J * DBA/2J)	increased glycosylated hemoglobin level	J:88919
Gck^Rgsc272/Gck⁺ (involves: C57BL/6J * DBA/2J)	decreased circulating insulin level	J:88919
	hyperglycemia	J:88919
	impaired glucose tolerance	J:88919
	increased glycosylated hemoglobin level	J:88919
Gck^Rgsc341/Gck⁺ (involves: C57BL/6J * DBA/2J)	hyperglycemia	J:88919
	impaired glucose tolerance	J:88919
	increased glycosylated hemoglobin level	J:88919
Gck^Rgsc392/Gck⁺ (involves: C57BL/6J * DBA/2J)	decreased circulating insulin level	J:88919
	hyperglycemia	J:88919
	impaired glucose tolerance	J:88919
	increased glycosylated hemoglobin level	J:88919
Gck^Rgsc392/Gck^Rgsc392 (involves: C57BL/6J * DBA/2J)	decreased liver glycogen level	J:88919
Gck^Rgsc392/Gck^Rgsc392 (involves: C57BL/6J * DBA/2J)	hyperglycemia	J:88919
Gck^Rgsc475/Gck⁺ (involves: C57BL/6J * DBA/2J)	decreased circulating insulin level	J:88919
	hyperglycemia	J:88919
	impaired glucose tolerance	J:88919
	increased glycosylated hemoglobin level	J:88919
Gck^Rgsc552/Gck⁺ (involves: C57BL/6J * DBA/2J)	hyperglycemia	J:88919
Gck^Rgsc552/Gck⁺ (involves: C57BL/6J * DBA/2J)	increased glycosylated hemoglobin level	J:88919
Gck^Rgsc553/Gck⁺ (involves: C57BL/6J * DBA/2J)	hyperglycemia	J:88919
Gck^Rgsc553/Gck⁺ (involves: C57BL/6J * DBA/2J)	increased glycosylated hemoglobin level	J:88919
Gck^Rgsc702/Gck⁺ (involves: C57BL/6J * DBA/2J)	decreased circulating insulin level	J:88919
	hyperglycemia	J:88919
	impaired glucose tolerance	J:88919
	increased glycosylated hemoglobin level	J:88919
Gck^Rgsc702/Gck^Rgsc702 (involves: C57BL/6J * DBA/2J)	decreased liver glycogen level	J:88919
	hyperglycemia	J:88919
	increased urine glucose level	J:88919
Gck^Rgsc735/Gck⁺ (involves: C57BL/6J * DBA/2J)	hyperglycemia	J:88919
Gck^Rgsc735/Gck⁺ (involves: C57BL/6J * DBA/2J)	increased glycosylated hemoglobin level	J:88919
Gck^Rgsc960/Gck⁺ (involves: C57BL/6JJcl * DBA/2JJcl)	hyperglycemia	J:133634
Gck^Sgrd-2Nwu/Gck⁺ (C57BL/6J-Gck^Sgrd-2Nwu)	hyperglycemia	J:196563
Gck^Sgrd-2Nwu/Gck^Sgrd-2Nwu (C57BL/6J-Gck^Sgrd-2Nwu)	decreased circulating insulin level	J:196563
Gck^Sgrd-2Nwu/Gck^Sgrd-2Nwu (C57BL/6J-Gck^Sgrd-2Nwu)	hyperglycemia	J:196563
Gck^Sgrd/Gck⁺ (C57BL/6J-Gck^Sgrd)	decreased circulating insulin level	J:196563
Gck^Sgrd/Gck⁺ (C57BL/6J-Gck^Sgrd)	hyperglycemia	J:196563
Gck^Sgrd/Gck^Sgrd-2Nwu (C57BL/6J-Gck^Sgrd/Gck^Sgrd-2Nwu)	decreased circulating insulin level	J:196563
Gck^Sgrd/Gck^Sgrd-2Nwu (C57BL/6J-Gck^Sgrd/Gck^Sgrd-2Nwu)	hyperglycemia	J:196563
Gck^Sgrd/Gck^Sgrd (C57BL/6J-Gck^Sgrd)	decreased circulating insulin level	J:196563
Gck^Sgrd/Gck^Sgrd (C57BL/6J-Gck^Sgrd)	hyperglycemia	J:196563
Gck^tm1.1Mgn/Gck⁺ Tg(Ins2-cre)25Mgn/0 (involves: 129S6/SvEvTac * C57BL/6 * DBA/2)	decreased glycogen level	J:51826
	decreased insulin secretion	J:51826
	hyperglycemia	J:51826
	impaired glucose tolerance	J:51826
Gck^tm1.1Mgn/Gck^tm1.1Mgn (involves: 129S6/SvEvTac * C57BL/6)	increased circulating glucose level	J:51826
Gck^tm1.1Mgn/Gck^tm1.1Mgn (129S6/SvEvTac-Gck^tm1.1Mgn)	increased circulating glucose level	J:51826
Gck^tm1.1Mgn/Gck^tm1.1Mgn Speer6-ps1^{Tg(Alb-cre)21Mgn}/Speer6-ps1⁺ (involves: 129S6/SvEvTac * C57BL/6 * DBA/2)	abnormal glucose homeostasis	J:51826
	decreased glycogen level	J:51826
	decreased insulin secretion	J:51826
	impaired glucose tolerance	J:51826
	increased circulating glucose level	J:51826
	increased circulating insulin level	J:51826
	insulin resistance	J:51826
Gck^tm1.1Mgn/Gck^tm1.1Mgn Tg(Ins2-cre)25Mgn/0 (involves: 129S6/SvEvTac * C57BL/6 * DBA/2)	decreased circulating insulin level	J:51826
	decreased liver glycogen level	J:51826
	hyperglycemia	J:51826
Gck^tm1.2Mgn/Gck⁺ (involves: 129S6/SvEvTac * C57BL/6)	decreased insulin secretion	J:51826
	decreased liver glycogen level	J:51826
	hyperglycemia	J:51826
	impaired glucose tolerance	J:51826
Gck^tm1.2Mgn/Gck^tm1.2Mgn (involves: 129S6/SvEvTac * C57BL/6)	decreased circulating insulin level	J:51826
	decreased liver glycogen level	J:51826
	hyperglycemia	J:51826
	increased circulating free fatty acids level	J:51826
Gck^tm1Efr/Gck⁺ (involves: 129P2/OlaHsd * C57BL/6)	abnormal glucose homeostasis	J:28756
	hyperglycemia	J:28756
	impaired glucose tolerance	J:28756
Gck^tm1Hrt/Gck⁺ Speer6-ps1^{Tg(Alb-cre)21Mgn}/Speer6-ps1⁺ (involves: C57BL/6 * DBA)	impaired glucose tolerance	J:250069, J:105247
	increased circulating glucose level	J:105247
	increased fasting circulating glucose level	J:250069
	insulin resistance	J:250069
Gck^tm1Mgn/Gck^tm1Mgn (involves: 129S6/SvEvTac * C57BL/6)	increased circulating glucose level	J:51826
Gck^tm1Tka/Gck⁺ (involves: 129X1/SvJ * ICR)	decreased insulin secretion	J:30334
	hyperglycemia	J:30334
	impaired glucose tolerance	J:30334
	increased urine glucose level	J:30334
Gck^tm1Tka/Gck⁺ Irs1^tm1Tka/Irs1^tm1Tka (involves: 129X1/SvJ * C57BL/6 * CBA * ICR)	impaired glucose tolerance	J:38899
	increased circulating insulin level	J:38899
	insulin resistance	J:38899
Gck^tm1Tka/Gck^tm1Tka (involves: 129X1/SvJ * ICR)	decreased circulating insulin level	J:30334
	decreased insulin secretion	J:30334
	hyperglycemia	J:30334
	increased urine glucose level	J:30334
	ketosis	J:30334
Gck^tm1Ts/Gck⁺ (either: (involves: 129S7/SvEvBrd * C57BL/6J) or (involves: 129S7/SvEvBrd * DBA/2J))	hyperglycemia	J:29255
	impaired glucose tolerance	J:29255
Gck^tm1Ts/Gck^tm1Ts (either: (involves: 129S7/SvEvBrd * C57BL/6J) or (involves: 129S7/SvEvBrd * DBA/2J))	abnormal circulating cholesterol level	J:29255
	decreased liver glycogen level	J:29255
	increased circulating triglyceride level	J:29255
Gck^tm1Ydor/Gck⁺ Tg(Ins1-cre/ERT)1Lphi/0 (involves: C57BL/6 * C57BL/6J * CD-1)	hypoglycemia	J:302600
	impaired glucose tolerance	J:302600
Gck^tm1Ydor/Gck⁺ Tg(Ins2-cre)25Mgn/0 (involves: C57BL/6 * C57BL/6J * DBA)	decreased fasting circulating glucose level	J:302600
	hypoglycemia	J:302600
	impaired glucose tolerance	J:302600
	increased circulating insulin level	J:302600
	increased insulin secretion	J:302600
Gck^tm2Mgn/Gck⁺ (129S6/SvEvTac-Gck^tm2Mgn)	abnormal glucose homeostasis	J:121910
	abnormal insulin secretion	J:121910
	hyperglycemia	J:121910
	impaired glucose tolerance	J:121910
Gck^tm2Mgn/Gck⁺ (B6.129S6-Gck^tm2Mgn)	hyperglycemia	J:121910
Gck^tm2Mgn/Gck^tm2Mgn (129S6/SvEvTac-Gck^tm2Mgn)	hyperglycemia	J:121910
Gck^tm3Mgn/Gck⁺ (B6.129S6-Gck^tm3Mgn)	hypoglycemia	J:121910
Gck^tm3Mgn/Gck⁺ (129S6/SvEvTac-Gck^tm3Mgn)	abnormal glucose homeostasis	J:121910
	abnormal insulin secretion	J:121910
	hypoglycemia	J:121910
Gck^tm3Mgn/Gck^tm3Mgn (129S6/SvEvTac-Gck^tm3Mgn)	abnormal circulating insulin level	J:121910
	abnormal glucose homeostasis	J:121910
	abnormal insulin secretion	J:121910
	decreased circulating glucose level	J:121910
	hypoglycemia	J:121910
Gckr^em1(IMPC)H/Gckr^em1(IMPC)H (C57BL/6NTac-Gckr^em1(IMPC)H/H)	impaired glucose tolerance	J:211773
	increased blood urea nitrogen level	J:211773
	increased circulating creatinine level	J:211773
Gckr^tm1Bms/Gckr^tm1Bms (involves: 129S1/Sv * ICR)	abnormal enzyme/coenzyme level	J:58949
	abnormal glucose homeostasis	J:58949
	decreased liver glycogen level	J:58949
	impaired glucose tolerance	J:58949
Gckr^tm1Bms/Gckr^tm1Bms (involves: 129S1/Sv * C57BL/6)	abnormal glucose homeostasis	J:58949
	increased circulating glucose level	J:58949
	increased circulating insulin level	J:58949
	insulin resistance	J:58949
Gckr^tm1Jfg/Gckr^tm1Jfg (involves: 129S/SvEv * C57BL/6J)	abnormal enzyme/coenzyme level	J:61183
	decreased circulating insulin level	J:61183
	impaired glucose tolerance	J:61183
Gclc^tm1Tdal/Gclc^tm1Tdal Speer6-ps1^{Tg(Alb-cre)21Mgn}/Speer6-ps1⁺ (involves: 129S6/SvEvTac * C57BL/6 * DBA)	abnormal homeostasis	J:202376
	increased circulating alanine transaminase level	J:202376
	increased circulating aspartate transaminase level	J:202376
Gclm^tm1Tdal/Gclm^tm1Tdal (involves: 129 * C57BL/6J)	decreased circulating cysteine level	J:80927
Gclm^tm1Tdal/Gclm^tm1Tdal (involves: 129 * C57BL/6J)	decreased cysteine level	J:80927
Gclm^tm1Tjka/Gclm^tm1Tjka (B6.129-Gclm^tm1Tjka)	decreased glutathione level	J:226942
Gclm^tm1Tjka/Gclm^tm1Tjka (B6.129-Gclm^tm1Tjka)	increased circulating alanine transaminase level	J:125009
Gcm2^tm1.2Malx/Gcm2^tm1.2Malx (involves: 129S1/SvImJ * 129S4/SvJae * C57BL/6N)	decreased circulating calcium level	J:213334
	decreased circulating parathyroid hormone level	J:213334
	increased circulating phosphate level	J:213334
Gcm2^tm1Kry/Gcm2^tm1Kry (involves: 129S7/SvEvBrd)	decreased circulating calcium level	J:78067, J:63291
	decreased circulating phosphate level	J:63291
	increased urine calcium level	J:63291
Gcn1^em1(IMPC)J/Gcn1⁺ (C57BL/6NJ-Gcn1^em1(IMPC)J/Mmjax)	decreased circulating bilirubin level	J:211773
Gcn1^em1(IMPC)J/Gcn1⁺ (C57BL/6NJ-Gcn1^em1(IMPC)J/Mmjax)	increased circulating glucose level	J:211773
Gcnt2^tm1Tmu/Gcnt2^tm1Tmu (involves: 129S2/SvPas * C57BL/6)	increased blood urea nitrogen level	J:100533
Gcnt2^tm1Tmu/Gcnt2^tm1Tmu (involves: 129S2/SvPas * C57BL/6)	increased circulating creatinine level	J:100533
Gcnt4^tm1.1Jxm/Gcnt4^tm1.1Jxm (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	decreased circulating thyroxine level	J:149909
Gda^{tm1a(KOMP)Wtsi}/Gda^{tm1a(KOMP)Wtsi} (C57BL/6N-Gda^{tm1a(KOMP)Wtsi}/Wtsi)	decreased circulating cholesterol level	J:211773
	decreased circulating fructosamine level	J:211773
	decreased circulating HDL cholesterol level	J:211773
	decreased circulating serum albumin level	J:211773
Gdap1^tm1.2Geno/Gdap1^tm1.2Geno (involves: 129 * C57BL/6)	abnormal calcium ion homeostasis	J:224701
Gdap2^{em1(IMPC)Wtsi}/Gdap2^{em1(IMPC)Wtsi} (C57BL/6N-Gdap2^{em1(IMPC)Wtsi}/WtsiIeg)	decreased circulating amylase level	J:211773
	decreased circulating fructosamine level	J:211773
	decreased circulating serum albumin level	J:211773
	decreased circulating thyroxine level	J:211773
Gdcr1^BALB/cJ/Gdcr1^BALB/cJ (involves: BALB/cJ * C57BL/6J)	abnormal enzyme/coenzyme level	J:7860
Gde1^{tm1b(EUCOMM)Hmgu}/Gde1⁺ (C57BL/6N-Gde1^{tm1b(EUCOMM)Hmgu}/Ieg)	increased circulating alkaline phosphatase level	J:211773
	increased circulating cholesterol level	J:211773
Gdf3^tm1Zuk/Gdf3^tm1Zuk (involves: 129S7/SvEvBrd * C57BL/6J)	decreased susceptibility to diet-induced obesity	J:143083
	improved glucose tolerance	J:143083
Gdf9^tm1Zuk/Gdf9^tm1Zuk (either: (involves: 129S7/SvEvBrd) or (involves: 129S7/SvEvBrd * C57BL/6))	increased circulating follicle stimulating hormone level	J:35782
	increased circulating luteinizing hormone level	J:35782
Gdf10^{tm2b(KOMP)Wtsi}/Gdf10^{tm2b(KOMP)Wtsi} (C57BL/6N-Gdf10^{tm2b(KOMP)Wtsi}/Ucd)	increased circulating bilirubin level	J:211773
Gdf15^tm1Breit/Gdf15^tm1Breit (B6.Cg-Gdf15^tm1Breit)	decreased energy expenditure	J:197174
Gdf15^tm1Sjl/Gdf15^tm1Sjl (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	decreased bleeding time	J:195443
	increased platelet aggregation	J:195443
	increased susceptibility to induced thrombosis	J:195443
	increased urine glucose level	J:202996
Gdf15^tm1Sjl/Gdf15^tm1Sjl Lepr^db/Lepr^db (involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * C57BLKS/J)	albuminuria	J:202996
	hyperglycemia	J:202996
	increased cholesterol level	J:202996
	increased circulating creatinine level	J:202996
	increased circulating HDL cholesterol level	J:202996
	increased urine glucose level	J:202996
Gdi2^{tm1b(EUCOMM)Hmgu}/Gdi2⁺ (C57BL/6N-Gdi2^{tm1b(EUCOMM)Hmgu}/Ieg)	impaired glucose tolerance	J:211773
Gdpd2^{tm1a(KOMP)Wtsi}/Y (C57BL/6N-Gdpd2^{tm1a(KOMP)Wtsi}/Wtsi)	increased fasting circulating glucose level	J:211773
Gem^tm1.1Jgun/Gem^tm1.1Jgun (involves: BALB/c * C57BL/6)	decreased insulin secretion	J:187922
Gem^tm1.1Jgun/Gem^tm1.1Jgun (involves: BALB/c * C57BL/6)	impaired glucose tolerance	J:187922
Gemin4^em1(IMPC)Ics/Gemin4⁺ (C57BL/6N-Gemin4^em1(IMPC)Ics/Ics)	increased circulating alkaline phosphatase level	J:211773
	increased circulating cholesterol level	J:211773
	increased circulating HDL cholesterol level	J:211773
	increased circulating total protein level	J:211773
Gena327/Gena327⁺ (involves: BALB/c * C3H/HeH)	increased circulating triglyceride level	J:82809, J:79719
Gena341/Gena341 (Not Specified)	decreased circulating alkaline phosphatase level	J:163957
Gena341/Gena341 (Not Specified)	decreased circulating phosphate level	J:163957
Gena346/Gena346⁺ (involves: BALB/c * C3H/HeH)	hyperglycemia	J:169366
Gena360/Gena360⁺ (involves: BALB/c * C3H/HeH)	decreased circulating cholesterol level	J:82809, J:79719
Gena360/Gena360⁺ (involves: BALB/c * C3H/HeH)	decreased circulating HDL cholesterol level	J:82809, J:79719
Gena381/Gena381⁺ (involves: BALB/c * C3H/HeH)	decreased cholesterol level	J:169366
Gena381/Gena381⁺ (involves: BALB/c * C3H/HeH)	increased circulating alkaline phosphatase level	J:169366
Gena382/Gena382⁺ (involves: BALB/c * C3H/HeH)	decreased circulating alanine transaminase level	J:169366
Gena382/Gena382⁺ (involves: BALB/c * C3H/HeH)	decreased circulating aspartate transaminase level	J:169366
Gena383/Gena383⁺ (involves: BALB/c * C3H/HeH)	increased circulating chloride level	J:163957, J:79719, J:169366
Gena383/Gena383⁺ (involves: BALB/c * C3H/HeH)	increased circulating sodium level	J:163957, J:79719, J:169366
Gena391/Gena391⁺ (involves: BALB/c * C3H/He)	abnormal circulating glucose level	J:82809
	increased circulating HDL cholesterol level	J:82809
	increased circulating triglyceride level	J:82809
Gena394/Gena394⁺ (involves: BALB/c * C3H/HeH)	impaired glucose tolerance	J:169366
Gena396/Gena396⁺ (involves: BALB/c * C3H/HeH)	hyperglycemia	J:169366
Gena397/Gena397⁺ (involves: BALB/c * C3H/HeH)	hypoglycemia	J:169366
Gfap^tm1Pkny/Gfap^tm1Pkny Ppt1^tm1Hof/Ppt1^tm1Hof Vim^tm1Cba/Vim^tm1Cba (involves: 129P2/OlaHsd * 129S2/SvPas * 129S6/SvEvTac * C57BL/6)	abnormal cytokine level	J:177265
Gfap^tm2Mes/Gfap⁺ (involves: 129S6/SvEvTac * 129S7/SvEvBrd * FVB/N)	abnormal brain iron level	J:114689
Gfer^tm1(KOMP)Mbp/Gfer⁺ (involves: C57BL/6J * C57BL/6N)	abnormal lipid oxidation	J:224792
Gfer^tm1.1Crg/Gfer^tm1.1Crg Speer6-ps1^{Tg(Alb-cre)21Mgn}/Speer6-ps1⁺ (involves: 129 * C57BL/6 * DBA)	decreased liver cholesterol level	J:227242
	increased circulating alanine transaminase level	J:227242
	increased liver cholesterol level	J:227242
	increased liver triglyceride level	J:227242
Gfi1b^{tm1b(EUCOMM)Hmgu}/Gfi1b⁺ (C57BL/6N-Gfi1b^{tm1b(EUCOMM)Hmgu}/H)	increased circulating bilirubin level	J:211773
	increased circulating serum albumin level	J:211773
Gfi1b^tm1Sho/Gfi1b^tm1Sho (involves: 129S1/Sv)	edema	J:74523
Gfm1^{tm1a(EUCOMM)Wtsi}/Gfm1⁺ (C57BL/6N-Gfm1^{tm1a(EUCOMM)Wtsi}/Wtsi)	increased circulating free fatty acids level	J:175295
Gfpt1^{tm1b(EUCOMM)Wtsi}/Gfpt1⁺ (C57BL/6N-Gfpt1^{tm1b(EUCOMM)Wtsi}/H)	increased circulating cholesterol level	J:211773
	increased circulating HDL cholesterol level	J:211773
Gfpt2^{tm1b(EUCOMM)Wtsi}/Gfpt2^{tm1b(EUCOMM)Wtsi} (C57BL/6N-Gfpt2^{tm1b(EUCOMM)Wtsi}/Ieg)	decreased circulating serum albumin level	J:211773
	increased fasting circulating glucose level	J:211773
Gfral^tm1Lex/Gfral^tm1Lex (B6.129S5-Gfral^tm1Lex)	abnormal circulating triglyceride level	J:254140
	abnormal free fatty acids level	J:254140
	impaired glucose tolerance	J:254140
	increased susceptibility to diet-induced obesity	J:254140
Gfus^tm1Jbl/Gfus^tm1Jbl (involves: 129S2/SvPas * C57BL/6J)	dehydration	J:82239
Gfus^tm1Jbl/Gfus^tm1Jbl (involves: 129S2/SvPas * C57BL/6J)	increased circulating creatinine level	J:82239
Gga1^{Gt(AN0619)Wtsi}/Gga1^{Gt(AN0619)Wtsi} (B6J.129P2-Gga1^{Gt(AN0619)Wtsi})	abnormal circulating enzyme level	J:184229
	hypoglycemia	J:184229
Gga1^{Gt(AN0619)Wtsi}/Gga1^{Gt(AN0619)Wtsi} Gga3^{Gt(RRC067)Byg}/Gga3^{Gt(RRC067)Byg} (involves: 129P2/OlaHsd * C57BL/6J)	abnormal circulating enzyme level	J:184229
	hypoglycemia	J:184229
Gga2^{Gt(IST10483E10)Tigm}/Gga2^{Gt(IST10483E10)Tigm} (involves: C57BL/6J * C57BL/6N)	hypoglycemia	J:184229
Gga3^{Gt(RRC067)Byg}/Gga3^{Gt(RRC067)Byg} (involves: 129P2/OlaHsd * C57BL/6J)	abnormal circulating enzyme level	J:184229
	hypoglycemia	J:184229
Ggcx^tm1.1Kry/Ggcx^tm1.1Kry Tg(BGLAP-cre)1Clem/0 (involves: FVB/NJ)	decreased circulating osteocalcin level	J:264734
	improved glucose tolerance	J:264734
Ggcx^tm1.1Kry/Ggcx^tm1.1Kry Tg(Col1a1-cre)1Kry/0 (involves: FVB/N)	abnormal circulating osteocalcin level	J:264734
	decreased susceptibility to diet-induced obesity	J:264734
	hypoglycemia	J:264734
	improved glucose tolerance	J:264734
	increased carbon dioxide production	J:264734
	increased insulin sensitivity	J:264734
	increased oxygen consumption	J:264734
Ggcx^tm1Sinos/Ggcx^tm1Sinos Speer6-ps1^{Tg(Alb-cre)21Mgn}/Speer6-ps1⁺ (B6.Cg-Ggcx^tm1Sinos Speer6-ps1^{Tg(Alb-cre)21Mgn})	impaired blood coagulation	J:212951
	increased bleeding time	J:212951
Ggnbp2^{tm1b(KOMP)Wtsi}/Ggnbp2⁺ (C57BL/6N-Ggnbp2^{tm1b(KOMP)Wtsi}/Tcp)	decreased circulating total protein level	J:211773
	edema	J:211773
	increased circulating alanine transaminase level	J:211773
Ggnbp2^{tm1b(KOMP)Wtsi}/Ggnbp2^{tm1b(KOMP)Wtsi} (C57BL/6N-Ggnbp2^{tm1b(KOMP)Wtsi}/Tcp)	edema	J:211773
Ggps1^{tm1b(EUCOMM)Wtsi}/Ggps1⁺ (C57BL/6N-Ggps1^{tm1b(EUCOMM)Wtsi}/Ieg)	impaired glucose tolerance	J:211773
	increased circulating cholesterol level	J:211773
	increased circulating glucose level	J:211773
	increased circulating HDL cholesterol level	J:211773
Ggt1^dwg/Ggt1^dwg ((STOCK Pou1f1^dw x T(8;16)17H)F1)	decreased thyroxine level	J:14281
Ggt1^enu1/Ggt1^enu1 (C57BL/6J-Ggt1^enu1)	decreased glutathione level	J:55222
	glutathionuria	J:55222
	increased circulating glutathione level	J:55222
Ggt1^tm1Zuk/Ggt1^tm1Zuk (involves: 129S7/SvEvBrd * C57BL/6J)	abnormal glucose homeostasis	J:34309
	decreased circulating cysteine level	J:34309
	decreased circulating estradiol level	J:65574
	decreased circulating follicle stimulating hormone level	J:65574
	decreased circulating insulin-like growth factor I level	J:65574
	decreased circulating testosterone level	J:65574
	decreased cysteine level	J:65574
	increased circulating growth hormone level	J:65574
Gh^Sma1/Gh^Sma1 (C3HeB/FeJ-Gh^Sma1)	increased circulating ghrelin level	J:89518
Gh^{tm1.1(KOMP)Vlcg}/Gh^{tm1.1(KOMP)Vlcg} (C57BL/6N-Gh^{tm1.1(KOMP)Vlcg}/Ucd)	decreased fasting circulating glucose level	J:211773
	impaired glucose tolerance	J:211773
Ghr^tm1.1Dlr/Ghr^tm1.1Dlr Tg(Ins2-cre)23Herr/0 (involves: 129S4/SvJae * C57BL/6J * CBA/J)	decreased serotonin level	J:284574
Ghr^tm1.1Dlr/Ghr^tm1.1Dlr Tg(Ins2-cre)25Mgn/0 (involves: 129S4/SvJae * C3H * C57BL/6 * DBA)	decreased insulin secretion	J:173909
	increased circulating glucose level	J:173909
Ghr^tm1.1Jero/Ghr^tm1.1Jero (B6.129X1-Ghr^tm1.1Jero)	decreased circulating insulin-like growth factor I level	J:155335
Ghr^tm1.1Jero/Ghr^tm1.1Jero (B6.129X1-Ghr^tm1.1Jero)	increased circulating growth hormone level	J:155335
Ghr^tm1.1Masp/Ghr^tm1.1Masp Speer6-ps1^{Tg(Alb-cre)21Mgn}/Speer6-ps1⁺ (involves: 129S4/SvJaeSor * C57BL/6 * DBA)	decreased circulating insulin-like growth factor I level	J:152627
	decreased circulating triglyceride level	J:152627
	decreased liver triglyceride level	J:152627
	impaired glucose tolerance	J:152627
	increased circulating free fatty acids level	J:152627
	increased circulating growth hormone level	J:152627
	increased circulating insulin level	J:152627
Ghr^tm1Arge/Ghr^tm1Arge (involves: 129S/SvEv * C57BL/6J)	decreased circulating insulin-like growth factor I level	J:66913
Ghr^tm1Arge/Ghr^tm1Arge (involves: 129S/SvEv * C57BL/6J)	increased circulating growth hormone level	J:66913
Ghr^{tm1c(KOMP)Wtsi}/Ghr^{tm1c(KOMP)Wtsi} Tg(Fabp4-cre)1Rev/0 (involves: C57BL/6N)	abnormal fluid regulation	J:206358
	decreased circulating adiponectin level	J:206358
	increased circulating insulin-like growth factor I level	J:206358
	increased circulating interleukin-6 level	J:206358
	increased circulating leptin level	J:206358
Ghr^tm1Jjk/Ghr^tm1Jjk (involves: 129P2/OlaHsd)	decreased circulating insulin-like growth factor I level	J:155335
Ghr^tm1Jjk/Ghr^tm1Jjk (involves: 129P2/OlaHsd)	increased circulating growth hormone level	J:155335
Ghr^tm1Jjk/Ghr^tm1Jjk (involves: 129P2/OlaHsd * BALB/c)	abnormal circulating lipid level	J:105686
	decreased circulating cholesterol level	J:105686
	decreased circulating estradiol level	J:79216
	decreased circulating glucose level	J:105686, J:110613
	decreased circulating HDL cholesterol level	J:105686
	decreased circulating insulin level	J:105686, J:110613
	decreased circulating insulin-like growth factor I level	J:53777, J:44604, J:60207, J:63459
	decreased circulating LDL cholesterol level	J:105686
	decreased circulating luteinizing hormone level	J:53777
	decreased circulating testosterone level	J:53777, J:105921
	decreased circulating triglyceride level	J:105686
	decreased circulating VLDL cholesterol level	J:105686
	decreased triiodothyronine level	J:60207
	increased circulating adiponectin level	J:132437
	increased circulating corticosterone level	J:105686
	increased circulating growth hormone level	J:44604
	increased circulating leptin level	J:105686
	increased circulating prolactin level	J:53777
	increased insulin sensitivity	J:110613
Ghr^tm1Jjk/Ghr^tm1Jjk (involves: 129P2/OlaHsd * BALB/c * C3H * C57BL/6)	decreased body temperature	J:103286
	decreased circulating glucose level	J:103286
	decreased circulating insulin level	J:103286
	decreased circulating thyroxine level	J:103286
	decreased circulating triiodothyronine level	J:103286
	increased circulating corticosterone level	J:103286
Ghr^tm1Jjk/Ghr^tm1Jjk (involves: 129P2/OlaHsd * BALB/c * C57BL/6)	abnormal blood homeostasis	J:107763
	decreased circulating glucagon level	J:107763
	decreased circulating glucose level	J:107763
	decreased circulating insulin level	J:107763
	decreased circulating insulin-like growth factor I level	J:107763
	hypoglycemia	J:107763
	increased circulating chloride level	J:107763
	increased circulating creatine kinase level	J:107763
	increased circulating serum albumin level	J:107763
	increased insulin sensitivity	J:107763
Ghr^tm1Mwat/Ghr^tm1Mwat (involves: 129X1/SvJ * C57BL)	decreased circulating insulin-like growth factor I level	J:95149
Ghr^tm1Mwat/Ghr^tm1Mwat (involves: 129X1/SvJ * C57BL)	hyperglycemia	J:95149
Ghr^tm2Mwat/Ghr^tm2Mwat (involves: 129X1/SvJ * C57BL)	decreased circulating insulin-like growth factor I level	J:95149
Ghr^tm2Mwat/Ghr^tm2Mwat (involves: 129X1/SvJ * C57BL)	hyperglycemia	J:95149
Ghrh^{tm1b(EUCOMM)Wtsi}/Ghrh^{tm1b(EUCOMM)Wtsi} (C57BL/6N-Ghrh^{tm1b(EUCOMM)Wtsi}/Tcp)	decreased fasting circulating glucose level	J:211773
	impaired glucose tolerance	J:211773
Ghrh^tm1Salv/Ghrh^tm1Salv (involves: 129 * C57BL/6)	decreased circulating insulin-like growth factor I level	J:91828
Ghrh^tm1Salv/Ghrh^tm1Salv (involves: 129 * C57BL/6)	decreased growth hormone level	J:91828
Ghrhr^lit/Ghrhr^lit (C57BL/6J-Ghrhr^lit)	decreased circulating growth hormone level	J:3735
	decreased growth hormone level	J:5647
	decreased prolactin level	J:5647
Ghrhr^lit/Ghrhr^lit (C57BL/6J-Ghrhr^lit/J)	abnormal glucose homeostasis	J:95779
	abnormal insulin-like growth factor I level	J:209717
	decreased circulating glucose level	J:95779
	decreased circulating insulin-like growth factor I level	J:95779
	increased circulating insulin level	J:95779
Ghrhr^lit/Ghrhr^lit (C3.B6-Ghrhr^lit/J)	abnormal insulin-like growth factor I level	J:209717
Ghrhr^lit/Ghrhr^lit Prlr^tm1Cnp/Prlr^tm1Cnp (involves: 129P2/OlaHsd * C57BL/6J)	decreased circulating glucose level	J:95779
	decreased circulating insulin-like growth factor I level	J:95779
	impaired glucose tolerance	J:95779
	increased circulating glucose level	J:95779
	increased circulating insulin level	J:95779
	increased circulating leptin level	J:95779
	insulin resistance	J:95779
Ghrhr^{tm1.1(KOMP)Vlcg}/Ghrhr⁺ (C57BL/6N-Ghrhr^{tm1.1(KOMP)Vlcg}/J)	increased circulating alanine transaminase level	J:211773
	increased circulating aspartate transaminase level	J:211773
Ghrhr^{tm1.1(KOMP)Vlcg}/Ghrhr^{tm1.1(KOMP)Vlcg} (C57BL/6N-Ghrhr^{tm1.1(KOMP)Vlcg}/J)	decreased circulating glucose level	J:211773
	increased circulating triglyceride level	J:211773
Ghrl^tm1Lex/Ghrl^tm1Lex (involves: 129S5/SvEvBrd * C57BL/6)	decreased respiratory quotient	J:126636
Ghrl^tm1Mko/Ghrl^tm1Mko (B6.Cg-Ghrl^tm1Mko)	abnormal glucose homeostasis	J:121019
	decreased circulating glucose level	J:121019
	improved glucose tolerance	J:121019
	increased circulating insulin level	J:121019
	increased insulin secretion	J:121019
Ghrl^tm1Mws/Ghrl^tm1Mws (involves: C57BL/6)	decreased respiratory quotient	J:90698
Ghrl^tm1Rgs/Ghrl^tm1Rgs (involves: C57BL/6J)	decreased body temperature	J:151960
Ghrl^tm1Rgs/Ghrl^tm1Rgs (involves: C57BL/6J)	impaired adaptive thermogenesis	J:151960
Ghsr^tm1Lowl/Ghsr^tm1Lowl (involves: C57BL/6J)	abnormal energy expenditure	J:104704
	decreased circulating glucose level	J:104704
	decreased respiratory quotient	J:104704
	decreased susceptibility to diet-induced obesity	J:104704
Ghsr^tm1Rgs/Ghsr^tm1Rgs (involves: 129 * C57BL/6J)	abnormal growth hormone level	J:89243
Ghsr^tm1Rgs/Ghsr^tm1Rgs (involves: 129 * C57BL/6J)	decreased circulating insulin-like growth factor I level	J:89243
Gigyf2^{tm1b(EUCOMM)Wtsi}/Gigyf2^{tm1b(EUCOMM)Wtsi} (C57BL/6N-Gigyf2^{tm1b(EUCOMM)Wtsi}/Bay)	increased circulating phosphate level	J:211773
	increased fasting circulating glucose level	J:211773
Gimap5^m1Btlr/Gimap5^m1Btlr (involves: C57BL/6J)	decreased circulating interferon-gamma level	J:160090
Gimap5^m1Btlr/Gimap5^m1Btlr (involves: C57BL/6J)	decreased circulating interleukin-4 level	J:160090
Gimap6^{tm1a(KOMP)Wtsi}/Gimap6^{tm1a(KOMP)Wtsi} (C57BL/6N-Gimap6^{tm1a(KOMP)Wtsi}/Wtsi)	decreased circulating amylase level	J:211773
	impaired glucose tolerance	J:211773
	increased circulating chloride level	J:211773
Gimap6^{tm1b(KOMP)Wtsi}/Gimap6^{tm1b(KOMP)Wtsi} (C57BL/6N-Gimap6^{tm1b(KOMP)Wtsi}/J)	decreased circulating iron level	J:211773
	increased blood urea nitrogen level	J:211773
	increased circulating alkaline phosphatase level	J:211773
	increased circulating calcium level	J:211773
	increased circulating cholesterol level	J:211773
	increased circulating HDL cholesterol level	J:211773
	increased circulating sodium level	J:211773
	increased fasting circulating glucose level	J:211773
Gins2^{tm1b(EUCOMM)Wtsi}/Gins2⁺ (C57BL/6N-Gins2^{tm1b(EUCOMM)Wtsi}/Ieg)	increased circulating lipase level	J:211773
Gipc1^tm1Mvc/Gipc1^tm1Mvc (involves: 129P2/OlaHsd)	increased urine protein level	J:112916, J:111724
Gipc3^{tm1b(KOMP)Wtsi}/Gipc3^{tm1b(KOMP)Wtsi} (C57BL/6N-Gipc3^{tm1b(KOMP)Wtsi}/J)	decreased circulating chloride level	J:211773
Gipr^tm1Thor/Gipr^tm1Thor (involves: 129P2/OlaHsd * C57BL/6)	decreased circulating insulin level	J:88159
	impaired glucose tolerance	J:88159
	increased circulating glucose level	J:88159
Gipr^tm1Thor/Gipr^tm1Thor Glp1r^tm1Ddr/Glp1r^tm1Ddr (involves: 129/Sv * 129P2/OlaHsd * C57BL/6)	decreased circulating insulin level	J:88159
	impaired glucose tolerance	J:88159
	increased circulating glucose level	J:88159
Gipr^tm1Yse/Gipr^tm1Yse (involves: 129P2/Ola * C57BL/6J)	abnormal glucose homeostasis	J:59087
	decreased circulating insulin level	J:59087
	hyperglycemia	J:59087
Giq1^KK/? (involves: C57BL/6J * KK-A^y)	impaired glucose tolerance	J:81517
Git1^tm1Bcb/Git1^tm1Bcb (involves: 129 * C57BL/6)	cyanosis	J:158935
Gja1^tm1Dlg/Gja1^tm1Dlg Tg(Tek-cre)1Ywa/0 (involves: 129S7/SvEvBrd * C57BL/6)	abnormal blood homeostasis	J:71092
	abnormal circulating hormone level	J:71092
Gja1^tm1Kdr/Gja1^tm1Kdr (involves: 129S1/Sv * 129X1/SvJ)	cyanosis	J:24121
Gja1^tm1Kdr/Gja1^tm1Kdr (involves: 129S1/Sv * 129X1/SvJ)	edema	J:24121
Gja1^tm1Kwi/Gja1⁺ Tg(KRT5-cre)5132Jlj/0 (involves: 129P2/OlaHsd * C57BL/6J * DBA/2J)	lymphedema	J:188626
Gja1^tm1Kwi/Gja1^{tm5(cre/ERT)Kwi} (involves: 129P2/OlaHsd * C57BL/6)	impaired skin barrier function	J:85065
Gja1^tm4Kwi/Gja1^tm4Kwi (involves: 129P2/OlaHsd * C57BL/6)	impaired skin barrier function	J:95050
Gja5^tm2.1Kwi/Gja5^tm2.1Kwi (involves: 129P2/OlaHsd * C57BL/6 * SJL)	increased circulating renin level	J:205109
Gja8^Aey69/Gja8^Aey69 H3c14^Aey69/H3c14^Aey69 (C3HeB/FeJ)	hypolipidemia	J:277247
Gja8^Aey69/Gja8^Aey69 H3c14^Aey69/H3c14^Aey69 (C3HeB/FeJ)	increased body temperature	J:277247
Gja8^{tm1b(EUCOMM)Hmgu}/Gja8^{tm1b(EUCOMM)Hmgu} (C57BL/6N-Gja8^{tm1b(EUCOMM)Hmgu}/H)	increased circulating amylase level	J:211773
Gjb1^tm1Kwi/Y (involves: 129S4/SvJae * C57BL/6)	increased liver glycogen level	J:36146
Gjb2^tm2.2Kwi/Gjb2⁺ Tg(Pgk1-cre)1Lni/0 (involves: 129/Sv * 129P2/OlaHsd * BALB/c * C57BL/6)	impaired skin barrier function	J:166732
Gjb2^{tm3.1(Gjb1)Kwi}/Gjb2⁺ Tg(KRT5-cre)5132Jlj/0 (involves: 129P2/OlaHsd * C57BL/6 * DBA/2J * SJL)	lymphedema	J:188626
Gjb2^{tm3.2(Gjb1)Kwi}/Gjb2⁺ (involves: 129P2/OlaHsd * BALB/c * C57BL/6 * SJL)	lymphedema	J:188626
Gjb2^{tm3.3(Gjb1)Kwi}/Gjb2⁺ (involves: 129P2/OlaHsd * BALB/c * C57BL/6)	lymphedema	J:188626
Gjb6^tm1Kwi/Gjb6⁺ (involves: 129P2/OlaHsd * C57BL/6J)	decreased dopamine level	J:89971
Gjb6^tm1Kwi/Gjb6^tm1Kwi (involves: 129P2/OlaHsd * C57BL/6)	abnormal amino acid level	J:120823
Gjc1^{tm1.1(Gjd2)Kwi}/Gjc1^{tm1.1(Gjd2)Kwi} Tg(Myh6-cre)2182Mds/0 (involves: 129P2/OlaHsd * C57BL/6 * FVB/N * SJL)	pericardial effusion	J:182927
Gjc1^{tm1.1(KOMP)Vlcg}/Gjc1^{tm1.1(KOMP)Vlcg} (C57BL/6N-Gjc1^{tm1.1(KOMP)Vlcg}/Ucd)	edema	J:211773
Gjd2^tm1Kwi/Gjd2^tm1Kwi (involves: 129P2/OlaHsd)	decreased insulin secretion	J:117402
Gjd2^tm1Kwi/Gjd2^tm1Kwi (involves: 129P2/OlaHsd * C57BL/6)	abnormal insulin secretion	J:122093
Gjd2^tm4Kwi/Gjd2^tm4Kwi Tg(Ins2-cre)23Herr/? (involves: 129P2/OlaHsd * C57BL/6 * CBA)	abnormal glucose tolerance	J:174834
	increased insulin secretion	J:174834
Gjd4^{tm1.1(KOMP)Vlcg}/Gjd4^{tm1.1(KOMP)Vlcg} (C57BL/6N-Gjd4^{tm1.1(KOMP)Vlcg}/J)	increased circulating sodium level	J:211773
Gk5^m1Btlr/Gk5^m1Btlr (C57BL/6J-Gk5^m1Btlr)	abnormal ceramide level	J:243852
	abnormal lipid level	J:243852
	increased cholesterol level	J:243852
	increased triglyceride level	J:243852
Gk^tm1Wjc/Y (involves: 129S7/SvEvBrd * C57BL/6J)	hypoglycemia	J:43449, J:100255
	increased circulating glycerol level	J:43449
	increased fatty acids level	J:43449
	increased urine glycerol level	J:43449
Gk^tm1Wjc/Gk⁺ (involves: 129S7/SvEvBrd)	decreased circulating glucose level	J:148831
Gk^tm1Wjc/Gk⁺ (involves: 129S7/SvEvBrd)	decreased fatty acids level	J:148831
Gkn2^{tm1.1(KOMP)Vlcg}/Gkn2^{tm1.1(KOMP)Vlcg} (C57BL/6N-Gkn2^{tm1.1(KOMP)Vlcg}/Ucd)	decreased fasting circulating glucose level	J:211773
Gkn2^{tm1.1(KOMP)Vlcg}/Gkn2^{tm1.1(KOMP)Vlcg} (involves: C57BL/6NTac)	abnormal chemokine level	J:234656
	abnormal cytokine level	J:234656
	abnormal interleukin level	J:234656
	abnormal tumor necrosis factor level	J:234656
Gla^tm1Kul/Y Tg(CAG-A4GALT)#Sais/0 (involves: 129S4/SvJae * C57BL/6 * C57BL/6JJms)	albuminuria	J:206001
	decreased urine osmolality	J:206001
	increased blood urea nitrogen level	J:206001
	increased urine beta2-microglobulin level	J:206001
Gla^tm1Kul/Gla^tm1Kul Tg(CAG-A4GALT)#Sais/0 (involves: 129S4/SvJae * C57BL/6 * C57BL/6JJms)	albuminuria	J:206001
	decreased urine osmolality	J:206001
	increased blood urea nitrogen level	J:206001
	increased urine beta2-microglobulin level	J:206001
Glb1l2^tm1Lex/Glb1l2^tm1Lex (B6;129S5-Glb1l2^tm1Lex/Mmucd)	impaired glucose tolerance	J:171883
Gldc^{Gt(EUCG0001d02)Hmgu}/Gldc^{Gt(EUCG0001d02)Hmgu} (B6.129P2-Gldc^{Gt(EUCG0001d02)Hmgu})	abnormal folic acid level	J:221782
	hyperglycinuria	J:221782
	increased circulating glycine level	J:221782
Glg1^{tm1a(KOMP)Wtsi}/Glg1⁺ (C57BL/6N-Glg1^{tm1a(KOMP)Wtsi}/Wtsi)	increased circulating glycerol level	J:211773
	increased circulating triglyceride level	J:211773
Gli2^tm1Alj/Gli2^tm1Alj (either: (involves: 129S1/Sv * 129X1/Sv) or (involves: 129S1/Sv * 129X1/Sv * CD-1))	edema	J:38381
Gli3^Xt-3H/Gli3^Xt-3H (involves: 101/H * C3H/HeH)	edema	J:5123
Gli3^Xt-J/Gli3^Xt-J (involves: C3H * CD-1)	edema	J:4086
Gli3^Xt-J/Gli3^Xt-J (B6.C3-Gli3^Xt-J/J)	edema	J:42454
Gli3^Xt-J/Gli3^Xt-J (involves: C3H/HeJ * CD-1)	edema	J:152259
Gli3^Xt/Gli3^Xt (involves: 101/H * C3H/HeH * CBA/H)	skin edema	J:5049
Glis2^tm1Amj/Glis2^tm1Amj (involves: 129P2/OlaHsd * C57BL/6)	albuminuria	J:134208
	increased blood urea nitrogen level	J:134208
	increased circulating creatinine level	J:134208
	increased urine protein level	J:134208
Glis3^tm1.2Chan/Glis3⁺ (involves: 129S1/Sv * 129S4/SvJae * 129X1/SvJ * C57BL/6J)	decreased circulating insulin level	J:177082
	decreased insulin secretion	J:177082
Glis3^tm1.2Chan/Glis3^tm1.2Chan (involves: 129S1/Sv * 129S4/SvJae * 129X1/SvJ * C57BL/6J)	decreased circulating insulin level	J:177082
	decreased insulin secretion	J:177082
	dehydration	J:177082
	hyperglycemia	J:177082
	increased circulating glucose level	J:177082
	increased circulating ketone body level	J:177082
Glis3^tm1Amj/Glis3^tm1Amj (involves: 129 * C57BL/6)	hyperglycemia	J:148994
Glis3^tm1Amj/Glis3^tm1Amj (involves: 129 * C57BL/6)	increased circulating insulin level	J:148994
Glis3^tm1Hiha/Glis3^tm1Hiha (involves: C57BL/6 * CBA)	impaired glucose tolerance	J:150077
Glis3^tm1Hiha/Glis3^tm1Hiha (involves: C57BL/6 * CBA)	increased circulating glucose level	J:150077
Glmn^{Gt(OST109778)Lex}/Glmn^{Gt(OST109778)Lex} (involves: 129S5/SvEvBrd * C57BL/6)	pericardial effusion	J:184206
Glmp^{Gt(P084H04)Wrst}/Glmp^{Gt(P084H04)Wrst} (involves: 129S2/SvPas * C57BL/6)	increased circulating alanine transaminase level	J:208774
	increased circulating aspartate transaminase level	J:208774
	increased liver iron level	J:208774
Glmp^tm1Lex/Glmp^tm1Lex (B6;129S5-Glmp^tm1Lex/Mmucd)	decreased circulating glucose level	J:171883
Glmp^tm1Lex/Glmp^tm1Lex (B6;129S5-Glmp^tm1Lex/Mmucd)	increased circulating alkaline phosphatase level	J:171883
Glo1^{Gt(VICTR48)1493Lex}/Glo1^{Gt(VICTR48)1493Lex} (involves: 129S5/SvEvBrd * C57BL/6)	decreased circulating insulin level	J:82809
	hyperglycemia	J:82809
Glp1r^tm1.1Stof/Glp1r^tm1.1Stof Tg(CMV-cre)1Cgn/0 (involves: BALB/c * C57BL/6 * SJL)	abnormal glucose homeostasis	J:206563
Glp1r^tm1.2Stof/Glp1r^tm1.2Stof (Not Specified)	abnormal circulating insulin level	J:203834
	abnormal glucose tolerance	J:203834
	impaired glucose tolerance	J:203834
Glp1r^{tm1b(KOMP)Mbp}/Glp1r^{tm1b(KOMP)Mbp} (C57BL/6N-Glp1r^{tm1b(KOMP)Mbp}/H)	impaired glucose tolerance	J:211773
	increased fasting circulating glucose level	J:211773
Glp1r^tm1Ddr/Glp1r^tm1Ddr (involves: 129S1/Sv * 129X1/SvJ)	decreased circulating insulin level	J:36918, J:206563
	impaired glucose tolerance	J:36918
	increased circulating glucose level	J:36918, J:206563
Glp1r^tm1Ddr/Glp1r^tm1Ddr (involves: 129/Sv * C57BL/6)	decreased circulating insulin level	J:88159
	impaired glucose tolerance	J:88159
	increased circulating glucose level	J:88159
Glp1r^tm1Ddr/Glp1r^tm1Ddr (B6.129-Glp1r^tm1Ddr)	increased circulating glucose level	J:200805
Glp2r^tm1.1Xfg/Glp2r^tm1.1Xfg Tg(Pomc1-cre)16Lowl/0 (involves: 129S1/Sv * 129X1/SvJ * C57BL/6J * FVB/N)	increased oxygen consumption	J:189593
Glra2^{tm1b(KOMP)Wtsi}/Y (C57BL/6N-Glra2^{tm1b(KOMP)Wtsi}/H)	increased circulating amylase level	J:211773
	increased circulating fructosamine level	J:211773
Glra4^{tm1b(KOMP)Wtsi}/Y (C57BL/6N-Glra4^{tm1b(KOMP)Wtsi}/Wtsi)	increased circulating LDL cholesterol level	J:211773
Glrb^em1(IMPC)Tcp/Glrb⁺ (C57BL/6NCrl-Glrb^em1(IMPC)Tcp/Tcp)	decreased circulating alkaline phosphatase level	J:211773
	decreased circulating serum albumin level	J:211773
	increased circulating alanine transaminase level	J:211773
	increased circulating aspartate transaminase level	J:211773
Glrb^spa/Glrb^spa (Not Specified)	edema	J:5196
Glrx3^{Gt(RRF094)Byg}/Glrx3^{Gt(RRF094)Byg} (involves: 129P2/OlaHsd * C57BL/6)	pericardial effusion	J:190794
Glrx3^{tm1.1(KOMP)Vlcg}/Glrx3⁺ (C57BL/6N-Glrx3^{tm1.1(KOMP)Vlcg}/J)	increased circulating alkaline phosphatase level	J:211773
Gls001/Gls001⁺ (C3HeB/FeJ-Gls001)	hyperglycemia	J:137483
Gls2^em1Xen/Gls2^em1Xen (involves: C57BL/6NTac)	decreased fasting circulating glucose level	J:271619
	decreased hepatic glucose production	J:271619
	increased circulating glucagon level	J:271619
	increased circulating glutamine level	J:271619
Gls007/Gls007⁺ (C3HeB/FeJ-Gls007)	hyperglycemia	J:137483
Glt8d2^{tm1a(KOMP)Wtsi}/Glt8d2^{tm1a(KOMP)Wtsi} (C57BL/6N-Glt8d2^{tm1a(KOMP)Wtsi}/Wtsi)	increased circulating amylase level	J:211773
	increased circulating insulin level	J:211773
glu5/glu5 (Not Specified)	hyperglycemia	J:85113
glu5/glu5 (Not Specified)	impaired glucose tolerance	J:85113
Gluchos1^C57BL/6J/Gluchos1^C57BL/6J (C57BL/6J)	decreased insulin secretion	J:109356
Gluchos1^C57BL/6J/Gluchos1^C57BL/6J (C57BL/6J)	impaired glucose tolerance	J:109356
Gluchos3^C3H/HeH/Gluchos3^C57BL/6J (involves: C3H/HeH * C57BL/6J)	decreased circulating insulin level	J:106692
Gluchos3^C57BL/6J/Gluchos3^C57BL/6J (involves: C3H/HeH * C57BL/6J)	decreased circulating insulin level	J:106692
Glud1^tm1.1Pma/Glud1^tm1.1Pma (involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * SJL)	decreased insulin secretion	J:145558
Glud1^tm1.1Pma/Glud1^tm1.1Pma Tg(Ins2-cre)23Herr/0 (involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * CBA/J * SJL)	decreased circulating insulin level	J:145558
	decreased insulin secretion	J:145558
Glul^tm1.1Geno/Glul^tm1.1Geno Speer6-ps1^{Tg(Alb-cre)21Mgn}/Speer6-ps1⁺ (involves: C57BL/6 * C57BL/6J * DBA)	increased circulating ammonia level	J:221031
Glul^tm1.1Ncd/Glul^tm1.1Ncd Emx1^tm1(cre)Krj/Emx1⁺ (B6.Cg-Glul^tm1.1Ncd Emx1^tm1(cre)Krj)	decreased aspartic acid level	J:272643
	decreased gamma-aminobutyric acid level	J:272643
	decreased glutamic acid level	J:272643
	decreased glutamine level	J:272643
Glul^tm3Whla/Glul^tm1Whla Tg(Ckmm-cre)5Khn/0 (involves: 129P2/OlaHsd * FVB)	abnormal amino acid level	J:161082
	abnormal ammonia homeostasis	J:161082
	decreased circulating glutamine level	J:161082
	decreased glutamine level	J:161082
Glul^tm3Whla/Glul^tm1Whla Tg(GFAP-cre)25Mes/0 (involves: 129P2/OlaHsd * FVB/N)	abnormal amino acid level	J:162067
	abnormal ammonia homeostasis	J:162067
	decreased circulating glucose level	J:162067
	decreased glutamine level	J:162067
	increased glycine level	J:162067
Glul^tm3Whla/Glul^tm3Whla Tg(Ckmm-cre)5Khn/0 (involves: 129P2/OlaHsd * FVB)	abnormal amino acid level	J:161082
	abnormal ion homeostasis	J:161082
Glul^tm3Whla/Glul^tm3Whla Tg(GFAP-cre)25Mes/0 (involves: 129P2/OlaHsd * FVB/N)	abnormal amino acid level	J:162067
	abnormal ammonia homeostasis	J:162067
	decreased circulating glucose level	J:162067
	decreased glutamine level	J:162067
	increased glycine level	J:162067
Glyctk^em1(IMPC)J/Glyctk^em1(IMPC)J (C57BL/6NJ-Glyctk^em1(IMPC)J/Mmjax)	increased circulating alkaline phosphatase level	J:211773
Gm2a^em1(IMPC)H/Gm2a^em1(IMPC)H (C57BL/6NTac-Gm2a^em1(IMPC)H/H)	increased blood urea nitrogen level	J:211773
	increased circulating calcium level	J:211773
Gm94^{tm1b(KOMP)Wtsi}/Gm94⁺ (C57BL/6N-Gm94^{tm1b(KOMP)Wtsi}/J)	increased circulating cholesterol level	J:211773
Gm572^{tm1b(EUCOMM)Hmgu}/Gm572⁺ (C57BL/6N-Gm572^{tm1b(EUCOMM)Hmgu}/J)	decreased circulating glucose level	J:211773
Gm5127^em1(IMPC)J/Y (C57BL/6NJ-Gm5127^em1(IMPC)J/Mmjax)	increased circulating triglyceride level	J:211773
Gm5127^em1(IMPC)J/Gm5127^em1(IMPC)J (C57BL/6NJ-Gm5127^em1(IMPC)J/Mmjax)	increased circulating aspartate transaminase level	J:211773
	increased circulating creatinine level	J:211773
Gm5134^{tm1a(EUCOMM)Hmgu}/Gm5134^{tm1a(EUCOMM)Hmgu} (C57BL/6N-Gm5134^{tm1a(EUCOMM)Hmgu}/H)	decreased circulating triglyceride level	J:165965
Gm5544^{tm1a(KOMP)Wtsi}/Gm5544^{tm1a(KOMP)Wtsi} (C57BL/6N-Gm5544^{tm1a(KOMP)Wtsi}/Wtsi)	subcutaneous edema	J:239583
Gm15441^em1Gonz/Gm15441^em1Gonz (C57BL/6-Gm15441^em1Gonz)	abnormal homeostasis	J:299830
Gm16364^tm1Zhaoy/Gm16364^tm1Zhaoy (involves: C57BL/6)	decreased susceptibility to diet-induced obesity	J:322340
	improved glucose tolerance	J:322340
	increased energy expenditure	J:322340
	increased insulin sensitivity	J:322340
Gm16364^tm2Zhaoy/Gm16364^tm2Zhaoy (involves: C57BL/6)	decreased susceptibility to diet-induced obesity	J:322340
	improved glucose tolerance	J:322340
	increased insulin sensitivity	J:322340
Gm20646^{em1(IMPC)Wtsi}/Gm20646^{em1(IMPC)Wtsi} (C57BL/6N-Gm20646^{em1(IMPC)Wtsi}/Wtsi)	increased circulating LDL cholesterol level	J:211773
Gm26330^em1Liuq/Gm26330^em1Liuq (C57BL/6-Gm26330^em1Liuq)	decreased body temperature	J:341056
	decreased carbon dioxide production	J:341056
	decreased oxygen consumption	J:341056
	impaired glucose tolerance	J:341056
	increased circulating alanine transaminase level	J:341056
	increased circulating aspartate transaminase level	J:341056
	increased circulating insulin level	J:341056
	increased circulating triglyceride level	J:341056
Gm28729^em1(IMPC)J/Gm28729^em1(IMPC)J (C57BL/6NJ-Gm28729^em1(IMPC)J/Mmjax)	decreased circulating calcium level	J:211773
Gm41610^em1Scrp/Gm41610^em1Scrp (C57BL/6-Gm41610^em1Scrp)	decreased partial thromboplastin time	J:302605
	increased circulating interleukin-5 level	J:302605
	increased circulating interleukin-13 level	J:302605
Gmds^{tm1a(KOMP)Wtsi}/Gmds^{tm1a(KOMP)Wtsi} (C57BL/6N-Gmds^{tm1a(KOMP)Wtsi}/Wtsi)	decreased circulating magnesium level	J:211773
	increased circulating iron level	J:211773
Gmeb2^em1(IMPC)J/Gmeb2⁺ (C57BL/6NJ-Gmeb2^em1(IMPC)J/Mmjax)	decreased circulating alanine transaminase level	J:211773
	decreased circulating aspartate transaminase level	J:211773
	decreased circulating bilirubin level	J:211773
Gmip^{tm1b(KOMP)Wtsi}/Gmip^{tm1b(KOMP)Wtsi} (C57BL/6N-Gmip^{tm1b(KOMP)Wtsi}/BayMmucd)	decreased circulating fructosamine level	J:211773
Gmnc^{tm1b(KOMP)Wtsi}/Gmnc⁺ (C57BL/6N-Gmnc^{tm1b(KOMP)Wtsi}/Wtsi)	increased circulating sodium level	J:211773
Gmnn^tm1Tjm/Gmnn^tm1Tjm Tg(Mx1-cre)1Cgn/0 (involves: 129/Sv * C57BL/6 * C57BL/6J * CBA)	increased circulating erythropoietin level	J:171741
Gmppa^em1(IMPC)Tcp/Gmppa^em1(IMPC)Tcp (C57BL/6N-Gmppa^em1(IMPC)Tcp/Tcp)	increased blood urea nitrogen level	J:211773
Gmppa^{tm1d(EUCOMM)Wtsi}/Gmppa^{tm1d(EUCOMM)Wtsi} (involves: C57BL/6N)	abnormal blood homeostasis	J:305791
Gna11^em1Mman/Gna11⁺ (C57BL/6NCrl-Gna11^em1Mman)	decreased circulating calcium level	J:280180
Gna11^em1Mman/Gna11⁺ (C57BL/6NCrl-Gna11^em1Mman)	decreased circulating parathyroid hormone level	J:280180
Gna11^em1Mman/Gna11^em1Mman (C57BL/6NCrl-Gna11^em1Mman)	decreased circulating calcium level	J:280180
	decreased circulating parathyroid hormone level	J:280180
	increased circulating phosphate level	J:280180
Gna11^{tm1a(EUCOMM)Wtsi}/Gna11^{tm1a(EUCOMM)Wtsi} (C57BL/6N-Gna11^{tm1a(EUCOMM)Wtsi}/Cnrm)	decreased circulating amylase level	J:165965
	decreased circulating phosphate level	J:165965
	decreased circulating total protein level	J:165965
	decreased circulating triglyceride level	J:165965
	increased circulating calcium level	J:165965
Gna11^tm1Soff/Gna11⁺ Gnaq^tm1Soff/Gnaq^tm1Soff (involves: 129S1/Sv * 129S7/SvEvBrd * C57BL/6)	hypoxia	J:49140
Gna11^tm1Soff/Gna11⁺ Gnaq^tm2Soff/Gnaq^tm2Soff Tg(PTH-cre)4167Slib/0 (involves: 129P2/OlaHsd * 129S7/SvEvBrd * C57BL/6)	abnormal circulating calcium level	J:116986
	abnormal urine calcium level	J:116986
	increased circulating parathyroid hormone level	J:116986
Gna11^tm1Soff/Gna11^tm1Soff (involves: 129S7/SvEvBrd)	increased circulating triglyceride level	J:172091
Gna11^tm1Soff/Gna11^tm1Soff (involves: 129S7/SvEvBrd)	increased liver triglyceride level	J:172091
Gna11^tm1Soff/Gna11^tm1Soff Gnaq^tm1Soff/Gnaq⁺ (involves: 129S1/Sv * 129S7/SvEvBrd * C57BL/6)	hypoxia	J:49140
Gna11^tm1Soff/Gna11^tm1Soff Gnaq^tm1Soff/Gnaq^tm1Soff (involves: 129S1/Sv * 129S7/SvEvBrd * C57BL/6)	hemopericardium	J:49140
Gna11^tm1Soff/Gna11^tm1Soff Gnaq^tm2Soff/Gnaq⁺ Tg(PTH-cre)4167Slib/0 (involves: 129P2/OlaHsd * 129S7/SvEvBrd * C57BL/6)	abnormal circulating calcium level	J:116986
	abnormal urine calcium level	J:116986
	increased circulating parathyroid hormone level	J:116986
Gna11^tm1Soff/Gna11^tm1Soff Gnaq^tm2Soff/Gnaq^tm2Soff Tg(PTH-cre)4167Slib/0 (involves: 129P2/OlaHsd * 129S7/SvEvBrd * C57BL/6)	increased circulating parathyroid hormone level	J:116986
	increased urine calcium level	J:116986
Gna11^tm1Soff/Gna11^tm1Soff Gnaq^tm2Soff/Gnaq^tm2Soff Tg(Tek-icre/ERT2)1Soff/0 (B6N.Cg-Gna11^tm1Soff Gnaq^tm2Soff Tg(Tek-icre/ERT2)1Soff)	decreased nitrate level	J:224523
Gna11^tm1Soff/Gna11^tm1Soff Gnaq^tm2Soff/Gnaq^tm2Soff Tg(Tg-cre)1Soff/0 (involves: 129P2/OlaHsd * 129S7/SvEvBrd * C57BL/6)	decreased circulating thyroxine level	J:127484
	increased circulating thyroid-stimulating hormone level	J:127484
Gna12^tm1Citb/Gna12^tm1Citb Gna13^tm2.1Soff/Gna13^tm2.1Soff Tg(Mx1-cre)1Cgn/0 (involves: 129S1/Sv * C57BL/6 * CBA * FVB/N)	abnormal blood coagulation	J:99597
	abnormal platelet physiology	J:99597
	decreased platelet aggregation	J:99597
	increased bleeding time	J:99597
Gna13^tm2.1Soff/Gna13^tm2.1Soff Tg(Mx1-cre)1Cgn/0 (involves: C57BL/6 * CBA * FVB/N)	abnormal blood coagulation	J:99597
	abnormal platelet physiology	J:99597
	increased bleeding time	J:99597
Gna13^tm2.2Soff/Gna13^tm2.2Soff Tg(EIIa-cre)C5379Lmgd/? (involves: FVB)	abnormal blood coagulation	J:99597
	abnormal platelet physiology	J:99597
	increased bleeding time	J:99597
Gna14^{em1(IMPC)Kmpc}/Gna14^{em1(IMPC)Kmpc} (C57BL/6NTac-Gna14^{em1(IMPC)Kmpc}/Kmpc)	abnormal cholesterol homeostasis	J:211773
Gnai1^tm1Drs/Gnai1^tm1Drs Gnai3^tm1Lbi/Gnai3^tm1Lbi (involves: 129S/SvEv)	abnormal thromboxane level	J:104683
Gnai2^tm1Lbi/Gnai2⁺ Tg(WTbeta2)4Wjk/0 (B6.Cg-Gnai2^tm1Lbi Tg(WTbeta2)4Wjk)	ascites	J:125581
	cyanosis	J:125581
	pulmonary edema	J:125581
Gnai2^tm1Lbi/Gnai2^tm1Lbi (involves: 129S7/SvEvBrd)	abnormal cytokine level	J:121471
	increased circulating interferon-gamma level	J:121471
	increased circulating interleukin-4 level	J:121471
	increased circulating interleukin-5 level	J:121471
Gnao1^{tm1b(EUCOMM)Hmgu}/Gnao1⁺ (C57BL/6N-Gnao1^{tm1b(EUCOMM)Hmgu}/H)	decreased circulating iron level	J:211773
	decreased circulating serum albumin level	J:211773
	decreased fasting circulating glucose level	J:211773
	decreased respiratory quotient	J:211773
	increased blood urea nitrogen level	J:211773
	increased circulating amylase level	J:211773
	increased circulating creatinine level	J:211773
	increased circulating triglyceride level	J:211773
Gnao1^tm3Lbi/Gnao1^tm3Lbi (involves: 129S7/SvEvBrd)	abnormal hormone level	J:168245
	decreased circulating glucose level	J:168245
	improved glucose tolerance	J:168245
	increased circulating insulin level	J:168245
	increased insulin secretion	J:168245
Gnao1^tm4Lbi/Gnao1^tm4Lbi Tg(Pdx1-cre)89.1Dam/0 (involves: C57BL/6 * CBA)	abnormal glucose tolerance	J:169627
	increased circulating insulin level	J:169627
	increased insulin secretion	J:169627
Gnaq^tm1Soff/Gnaq^tm1Soff (involves: 129S1/Sv * C57BL/6)	abnormal platelet physiology	J:118488, J:42882
Gnaq^tm1Soff/Gnaq^tm1Soff (involves: 129S1/Sv * C57BL/6)	increased bleeding time	J:42882
Gnaq^tm1Soff/Gnaq^tm1Soff (involves: 129S1/Sv)	decreased platelet aggregation	J:114266
Gnaq^tm2.1Soff/Gnaq^tm2.1Soff (involves: 129P2/OlaHsd * FVB/N)	abnormal blood coagulation	J:77461
Gnas^Oedsml/Gnas⁺ (involves: 101/H * C3H/HeH)	hydrops fetalis	J:65007
Gnas^Oedsml/Gnas⁺ (Not Specified)	decreased circulating calcium level	J:91717
	edema	J:91717
	increased circulating parathyroid hormone level	J:91717
	increased circulating phosphate level	J:91717
Gnas^Oedsml/Gnas⁺ (involves: 101/H * C3H/HeH * M. m. castaneus)	hydrops fetalis	J:65007
Gnas^Oedsml/Gnas⁺ Gnasas1^tm1Jop/Gnasas1⁺ (involves: 101/H * 129S/SvEv * C3H/HeH)	edema	J:106793
Gnas^tm1Kel/Gnas⁺ (involves: 129S2/SvPas * C57BL/6J)	decreased circulating glucagon level	J:91703
	decreased circulating glucose level	J:91703
	decreased circulating insulin level	J:91703
Gnas^tm1Kel/Gnas⁺ (involves: 129S2/SvPas)	increased circulating ghrelin level	J:184320
Gnas^tm1Lsw/Gnas⁺ (involves: 129S4/SvJae * CD-1)	abnormal blood homeostasis	J:106729
	abnormal gas homeostasis	J:60971
	abnormal glucose homeostasis	J:106729
	decreased circulating calcium level	J:49340
	decreased circulating cholesterol level	J:60971
	decreased circulating glucose level	J:106729
	decreased circulating insulin level	J:106729
	decreased circulating triglyceride level	J:60971
	decreased oxygen consumption	J:60971
	decreased urine noradrenaline level	J:60971
	improved glucose tolerance	J:106729
	increased circulating parathyroid hormone level	J:49340
	increased insulin sensitivity	J:106729
	increased oxygen consumption	J:60971
	increased urine dopamine level	J:60971
	increased urine noradrenaline level	J:60971
	skin edema	J:49340
Gnas^tm1Lsw/Gnas⁺ (involves: 129S4/SvJae)	decreased urine osmolality	J:56867
Gnas^tm2.1Lsw/Gnas⁺ (involves: 129S6/SvEvTac * Black Swiss)	decreased circulating parathyroid hormone level	J:97229
Gnas^tm2.1Lsw/Gnas⁺ (involves: 129S6/SvEvTac * Black Swiss)	decreased circulating phosphate level	J:97229
Gnas^tm2Jop/Gnas⁺ (involves: 129S/SvEv)	abnormal gas homeostasis	J:182868
	decreased circulating leptin level	J:182868
	increased carbon dioxide production	J:182868
	increased oxygen consumption	J:182868
Gnas^tm3Lsw/Gnas^tm3Lsw Ren1^tm2(cre)Gom/Ren1⁺ (involves: 129S6/SvEvTac * Black Swiss)	decreased circulating aldosterone level	J:118076
	decreased circulating renin level	J:118076
	decreased urine osmolality	J:118076
	increased urine prostaglandin level	J:118076
Gnas^tm3Lsw/Gnas^tm3Lsw Tg(Col2a1-cre)1Rsjo/0 (involves: 129S6/SvEvTac * FVB/N)	cyanosis	J:97230
Gnas^tm4Lsw/Gnas⁺ (involves: 129S6/SvEvTac * Black Swiss * CD-1)	abnormal glucose homeostasis	J:99237
	decreased oxygen consumption	J:99237
	edema	J:99237
	impaired glucose tolerance	J:99237
	increased circulating glucose level	J:99237
	increased circulating insulin level	J:99237
	increased circulating leptin level	J:99237
	increased circulating triglyceride level	J:99237
	insulin resistance	J:99237
Gnas^tm4Lsw/Gnas⁺ (involves: 129S6/SvEvTac)	abnormal blood homeostasis	J:233851
Gnas^tm5.1Lsw/Gnas^tm5.1Lsw H2az2^{Tg(Wnt1-cre)11Rth}/H2az2⁺ (involves: 129S6/SvEvTac * C57BL/6J * CBA/J)	cyanosis	J:254756
Gnas^tm5.1Lsw/Gnas^tm5.1Lsw Tg(Alb1-cre)1Dlr/? (involves: 129S6/SvEvTac * Black Swiss * FVB/N)	abnormal energy expenditure	J:102504
	decreased circulating insulin level	J:102504
	hypoglycemia	J:102504
	improved glucose tolerance	J:102504
	increased circulating glucagon level	J:102504
	increased circulating triglyceride level	J:102504
	increased liver glycogen level	J:102504
Gnas^tm5.1Lsw/Gnas^tm5.1Lsw Tg(Fabp4-cre)1Abel/0 (involves: FVB)	abnormal urine catecholamine level	J:159612
	decreased circulating free fatty acids level	J:159612
	decreased circulating insulin level	J:159612
	decreased circulating leptin level	J:159612
	decreased circulating triglyceride level	J:159612
	decreased liver triglyceride level	J:159612
	decreased skeletal muscle triglyceride level	J:159612
	decreased susceptibility to diet-induced obesity	J:159612
	hypoglycemia	J:159612
	impaired adaptive thermogenesis	J:159612
	improved glucose tolerance	J:159612
	increased circulating corticosterone level	J:159612
	increased energy expenditure	J:159612
	increased fatty acid oxidation	J:159612
	increased insulin sensitivity	J:159612
Gnas^tm5.1Lsw/Gnas^tm5.1Lsw Tg(Slc5a2-cre)1Tauc/0 (involves: C57BL/6 * DBA/2)	abnormal blood homeostasis	J:233851
	abnormal urine homeostasis	J:233851
	decreased circulating calcium level	J:233851
	decreased vitamin D level	J:233851
	increased circulating parathyroid hormone level	J:233851
Gnasas1^tm1.1Hju/Gnasas1⁺ (either: (involves: 129S4/SvJae) or (involves: 129S4/SvJae * C57BL/6J))	skin edema	J:160293
Gnaz^tm1Lfb/Gnaz^tm1Lfb (involves: 129/Sv * C57BL/6 * C57BL/6J * SJL)	decreased platelet aggregation	J:77282
	decreased susceptibility to induced thrombosis	J:77282
Gnb1l^{Gt(OST35527)Lex}/Gnb1l⁺ (B6;129S5-Gnb1l^{Gt(OST35527)Lex}/Orl)	increased circulating bilirubin level	J:82809
Gnb2^em1(IMPC)J/Gnb2^em1(IMPC)J (C57BL/6NJ-Gnb2^em1(IMPC)J/Mmjax)	abnormal cholesterol homeostasis	J:211773
	decreased blood urea nitrogen level	J:211773
	decreased circulating serum albumin level	J:211773
	decreased circulating total protein level	J:211773
Gnb4^em1(IMPC)H/Gnb4^em1(IMPC)H (C57BL/6NTac-Gnb4^em1(IMPC)H/H)	increased circulating alkaline phosphatase level	J:211773
Gne^em1(IMPC)Mbp/Gne⁺ (C57BL/6N-Gne^em1(IMPC)Mbp/MbpMmucd)	edema	J:211773
Gne^tm1.1Masn/Gne^tm1.1Masn (involves: 129P2/OlaHsd * C57BL/6)	albuminuria	J:184315
Gne^tm1Dar/Gne^tm1Dar (involves: C57BL/6J)	increased blood urea nitrogen level	J:122172
Gne^tm1Dar/Gne^tm1Dar (involves: C57BL/6J)	increased urine protein level	J:122172
Gne^tm1Sngi/Gne^tm1Sngi Tg(ACTB-GNE*D176V)9Sngi/0 (involves: C57BL/6)	increased circulating creatine kinase level	J:117854
Gng3^tm1.1Rbs/Gng3^tm1.1Rbs (involves: FVB/N)	decreased circulating leptin level	J:92791
Gng3^tm1.1Rbs/Gng3^tm1.1Rbs (involves: C57BL/6J * FVB/N)	decreased circulating leptin level	J:92791
Gng7^tm1Lex/Gng7^tm1Lex (involves: 129S5/SvEvBrd * C57BL/6J)	increased circulating insulin level	J:103485
Gng13^{tm1.1(KOMP)Vlcg}/Gng13⁺ (C57BL/6N-Gng13^{tm1.1(KOMP)Vlcg}/Ucd)	increased circulating glucose level	J:211773
Gngt1^tm1Yf/Gngt1^tm1Yf (involves: 129P2/OlaHsd * C57BL/6J)	photosensitivity	J:101020
Gngt2^em1(IMPC)Bay/Gngt2^em1(IMPC)Bay (C57BL/6N-Gngt2^em1(IMPC)Bay/BayMmucd)	increased fasting circulating glucose level	J:211773
Gnl1^em1(IMPC)Tcp/Gnl1^em1(IMPC)Tcp (C57BL/6N-Gnl1^em1(IMPC)Tcp/Tcp)	impaired glucose tolerance	J:211773
Gnmt^tm1Cwa/Gnmt^tm1Cwa (involves: 129 * C57BL/6J)	abnormal amino acid level	J:110257
Gnmt^tm1Ymac/Gnmt^tm1Ymac (involves: 129 * C57BL/6)	decreased circulating glucose level	J:147857
	increased circulating alanine transaminase level	J:147857, J:146081
	increased circulating cholesterol level	J:147857
	increased circulating methionine level	J:147857
	increased liver glycogen level	J:147857
Gnpat^tm1Just/Gnpat^tm1Just (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	abnormal lipid homeostasis	J:84690
Gnptab^{Gt(OST97730)Lex}/Gnptab^{Gt(OST97730)Lex} (involves: 129S5/SvEvBrd * C57BL/6J)	abnormal circulating enzyme level	J:127156
Gnptab^tm1Kkol/Gnptab^tm1Kkol (involves: 129 * C57BL/6)	increased circulating type I collagen C-terminal telopeptide level	J:202751
Gnptg^em1(IMPC)Mbp/Gnptg^em1(IMPC)Mbp (C57BL/6N-Gnptg^em1(IMPC)Mbp/MbpMmucd)	increased circulating alkaline phosphatase level	J:211773
Gnrh1^hpg/Gnrh1^hpg (involves: 101/H * C3H/HeH)	decreased adrenocorticotropin level	J:5877
	decreased circulating follicle stimulating hormone level	J:5877
	decreased follicle stimulating hormone level	J:5877
	decreased luteinizing hormone level	J:5877
	decreased prolactin level	J:5877
Gnrh1^tm1.1Hjn/Gnrh1^tm1.1Hjn (involves: C57BL/6)	abnormal hormone level	J:170674
	increased circulating estradiol level	J:170674
	increased circulating luteinizing hormone level	J:170674
	increased circulating progesterone level	J:170674
Gnrhr^{Gt(181A6)Cmhd}/Gnrhr^{Gt(181A6)Cmhd} (involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)	decreased circulating estradiol level	J:158384
	decreased circulating follicle stimulating hormone level	J:158384
	decreased circulating luteinizing hormone level	J:158384
	decreased circulating progesterone level	J:158384
	decreased circulating testosterone level	J:158384
Gnrhr^hh/Gnrhr^hh (involves: 129S6/SvEvTac * C57BL/6)	abnormal circulating hormone level	J:96941
	decreased circulating dihydrotestosterone level	J:96941
	decreased circulating follicle stimulating hormone level	J:96941
	decreased circulating progesterone level	J:96941
	decreased circulating testosterone level	J:96941
	decreased follicle stimulating hormone level	J:96941
	decreased luteinizing hormone level	J:96941
Gnrhr^hh/Gnrhr^hh (involves: C57BL/6)	decreased circulating follicle stimulating hormone level	J:211771
	decreased circulating gonadotropin level	J:211771
	decreased circulating luteinizing hormone level	J:211771
Gnrhr^{tm1(GNRHR1)Xen}/Gnrhr^{tm1(GNRHR1)Xen} (involves: C57BL/6 * C57BL/6JOlaHsd)	abnormal luteinizing hormone level	J:199193
	decreased circulating luteinizing hormone level	J:199193
	decreased circulating testosterone level	J:199193
	increased circulating estradiol level	J:199193
Gnrhr^{tm1.1(cre)Uboe}/Gnrhr⁺ Tgfbr3^tm1.1Hlin/Tgfbr3^tm1.1Hlin Tgfbr3l^em2Djb/Tgfbr3l^em2Djb (involves: 129S1/Sv * 129S4/SvJae * 129X1/SvJ * C57BL/6N)	increased circulating follicle stimulating hormone level	J:316383
	increased follicle stimulating hormone level	J:316383
Gnrhr^tm1.1Bhr/Gnrhr^tm1.1Bhr (involves: 129S6/SvEvTac * C57BL/6 * C57BL/6J)	decreased circulating follicle stimulating hormone level	J:211771
	decreased circulating gonadotropin level	J:211771
	decreased circulating luteinizing hormone level	J:211771
Gnrhr^{tm2.1(GNRHR)Djb}/Gnrhr^{tm2.1(GNRHR)Djb} (involves: 129 * C57BL/6J * FVB/N)	decreased circulating follicle stimulating hormone level	J:324870
	decreased circulating luteinizing hormone level	J:324870
	decreased follicle stimulating hormone level	J:324870
	decreased luteinizing hormone level	J:324870
	increased luteinizing hormone level	J:324870
Golga3^{tm1b(EUCOMM)Hmgu}/Golga3^{tm1b(EUCOMM)Hmgu} (C57BL/6N-Golga3^{tm1b(EUCOMM)Hmgu}/H)	impaired glucose tolerance	J:211773
	increased circulating alanine transaminase level	J:211773
	increased circulating alkaline phosphatase level	J:211773
	increased circulating aspartate transaminase level	J:211773
Golgb1^em8Lanyu/Golgb1^em8Lanyu (FVB/NJ-Golgb1^em8Lanyu)	decreased hyaluronic acid level	J:235669
Golgb1^em33Lanyu/Golgb1^em33Lanyu (FVB/NJ-Golgb1^em8Lanyu)	decreased hyaluronic acid level	J:235669
Golgb1^m1Lanyu/Golgb1^m1Lanyu (A/J-Golgb1^m1Lanyu)	decreased hyaluronic acid level	J:235669
Golm1^{Gt(KST273)Byg}/Golm1^{Gt(KST273)Byg} (involves: 129P2/OlaHsd * C57BL/6)	abnormal glomerular capillary thrombosis	J:151282
Golph3^em1(IMPC)Tcp/Golph3^em1(IMPC)Tcp (C57BL/6NCrl-Golph3^em1(IMPC)Tcp/Tcp)	increased circulating alkaline phosphatase level	J:211773
	increased circulating triglyceride level	J:211773
Golt1a^{tm1b(KOMP)Wtsi}/Golt1a^{tm1b(KOMP)Wtsi} (C57BL/6N-Golt1a^{tm1b(KOMP)Wtsi}/Wtsi)	decreased circulating glucose level	J:211773
	increased circulating alkaline phosphatase level	J:211773
	increased circulating bilirubin level	J:211773
Gopc^{tm1e.1(EUCOMM)Wtsi}/Gopc⁺ (C57BL/6N-Gopc^{tm1e.1(EUCOMM)Wtsi}/Tcp)	decreased circulating calcium level	J:211773
	increased circulating phosphate level	J:211773
Gorab^Gt(XG183)Byg/Gorab^Gt(XG183)Byg (involves: 129P2/OlaHsd * C57BL/6)	skin edema	J:231070
Gorasp1^{tm1b(KOMP)Wtsi}/Gorasp1⁺ (C57BL/6N-Gorasp1^{tm1b(KOMP)Wtsi}/Orl)	decreased circulating creatinine level	J:211773
Gosr2^{tm1b(EUCOMM)Hmgu}/Gosr2⁺ (C57BL/6N-Gosr2^{tm1b(EUCOMM)Hmgu}/H)	increased circulating amylase level	J:211773
	increased circulating fructosamine level	J:211773
Got1^{tm1b(EUCOMM)Hmgu}/Got1⁺ (C57BL/6N-Got1^{tm1b(EUCOMM)Hmgu}/H)	decreased circulating glucose level	J:211773
Got1l1^tm1.1Himo/Got1l1^tm1.1Himo (involves: C57BL/6N)	decreased glutamic acid level	J:301627
Got1l1^tm1.1Himo/Got1l1^tm1.1Himo (involves: C57BL/6N)	decreased glutamine level	J:301627
Gp1ba^tm1Ware/Gp1ba^tm1Ware (involves: 129S1/Sv * 129X1/SvJ)	increased bleeding time	J:63389
Gp1bb^tm1Frla/Gp1bb^tm1Frla (involves: 129S2/SvPas * C57BL/6)	decreased susceptibility to induced thrombosis	J:135065
	increased bleeding time	J:135065
Gp1bb^tm1Ware/Gp1bb^tm1Ware (Not Specified)	increased bleeding time	J:93756
Gp1bb^tm2Frla/Gp1bb^tm2Frla (involves: 129S2/SvPas * C57BL/6)	decreased susceptibility to induced thrombosis	J:135065
	increased bleeding time	J:135065
Gp5^tm1Drp/Gp5^tm1Drp (involves: 129X1/SvJ * C57BL/6J)	decreased bleeding time	J:58516
Gp6^tm1Beni/Gp6^tm1Beni (involves: 129 * C57BL/6)	abnormal blood coagulation	J:217963
Gp6^tm1Beni/Gp6^tm1Beni (involves: 129 * C57BL/6)	increased bleeding time	J:217963
Gp6^tm1Beni/Gp6^tm1Beni Clec1b^tm1.1Arte/Clec1b^tm1.1Arte Tg(Pf4-icre)Q3Rsko/0 (involves: 129 * C57BL/6)	increased bleeding time	J:217963
Gp6^tm1Ware/Gp6^tm1Ware (involves: Black Swiss)	abnormal blood coagulation	J:85315
	abnormal platelet activation	J:85315
	decreased platelet aggregation	J:85315
Gpam^tm1.1Dali/Gpam^tm1.1Dali (involves: 129S1/Sv * 129X1/SvJ)	decreased circulating cholesterol level	J:134068
	decreased circulating triglyceride level	J:134068
	decreased liver triglyceride level	J:134068
	increased circulating ketone body level	J:134068
	insulin resistance	J:134068
Gpam^tm1Rcol/Gpam^tm1Rcol (involves: 129S6/SvEvTac * C57BL/6J)	abnormal fatty acids level	J:84541
	abnormal lipid homeostasis	J:84541
	decreased circulating cholesterol level	J:84541
	decreased circulating HDL cholesterol level	J:84541
	decreased circulating insulin level	J:84541
	decreased circulating triglyceride level	J:84541
	decreased circulating VLDL triglyceride level	J:84541
	decreased liver triglyceride level	J:84541
Gpat3^tm1Reg/Gpat3^tm1Reg (involves: C57BL/6)	decreased circulating cholesterol level	J:213618
	decreased circulating glucose level	J:213618
	decreased susceptibility to diet-induced obesity	J:213618
	improved glucose tolerance	J:213618
	increased carbon dioxide production	J:213618
	increased circulating alanine transaminase level	J:213618
	increased circulating aspartate transaminase level	J:213618
	increased circulating cholesterol level	J:213618
	increased energy expenditure	J:213618
	increased liver cholesterol level	J:213618
	increased oxygen consumption	J:213618
Gpbar1^{tm1.1(KOMP)Vlcg}/Gpbar1^{tm1.1(KOMP)Vlcg} (C57BL/6N-Gpbar1^{tm1.1(KOMP)Vlcg}/Ucd)	increased circulating alanine transaminase level	J:211773
Gpbar1^tm1.2Auw/Gpbar1^tm1.2Auw (involves: 129 * C57BL/6J)	impaired glucose tolerance	J:152388
Gpbar1^tm1.2Auw/Gpbar1^tm1.2Auw (involves: 129 * C57BL/6J)	increased circulating insulin level	J:152388
Gpbar1^tm1Gvas/Gpbar1^tm1Gvas (involves: 129S1/SvImJ * C57BL/6)	abnormal cholesterol homeostasis	J:115877
Gpbar1^tm1Ktan/Gpbar1^tm1Ktan (involves: 129X1/SvJ * C57BL/6N)	abnormal bile salt homeostasis	J:114971
	increased circulating cholesterol level	J:114971
Gpbp1^{tm1b(EUCOMM)Wtsi}/Gpbp1⁺ (C57BL/6N-Gpbp1^{tm1b(EUCOMM)Wtsi}/Ieg)	improved glucose tolerance	J:211773
	increased circulating bilirubin level	J:211773
Gpc3^tm1Arge/Y (either: (involves: 129S/SvEv * 129S1/Sv) or (involves: 129S1/Sv * C57BL/6J))	hypoglycemia	J:75054
Gpc4^{tm2b(EUCOMM)Wtsi}/Y (C57BL/6N-Gpc4^{tm2b(EUCOMM)Wtsi}/J)	decreased fasting circulating glucose level	J:211773
Gpcpd1^em1(IMPC)Tcp/Gpcpd1⁺ (C57BL/6N-Gpcpd1^em1(IMPC)Tcp/Tcp)	abnormal cholesterol homeostasis	J:211773
	decreased circulating calcium level	J:211773
	decreased circulating creatinine level	J:211773
	decreased circulating serum albumin level	J:211773
Gpcpd1^{tm1c(EUCOMM)Hmgu}/Gpcpd1^{tm1c(EUCOMM)Hmgu} Tg(Ckmm-cre)5Khn/0 (involves: C57BL/6J * C57BL/6N * FVB)	abnormal muscle glycogen level	J:345630
	hyperglycemia	J:345630
	impaired glucose tolerance	J:345630
	increased glycerophosphocholine level	J:345630
	increased insulin secretion	J:345630
Gpd1^{em1(IMPC)Hmgu}/Gpd1^{em1(IMPC)Hmgu} (C57BL/6NCrl-Gpd1^{em1(IMPC)Hmgu}/Ieg)	increased circulating calcium level	J:211773
	increased circulating creatinine level	J:211773
	increased circulating phosphate level	J:211773
	increased circulating potassium level	J:211773
Gpd2^tm1Tka/Gpd2^tm1Tka (involves: C57BL/6 * CBA)	decreased insulin secretion	J:75839
Gpd2^tm1Tka/Gpd2^tm1Tka (B6.Cg-Gpd2^tm1Tka)	abnormal triiodothyronine level	J:87244
	decreased circulating insulin level	J:124766
	decreased oxygen consumption	J:87244
	impaired adaptive thermogenesis	J:87244
	increased body temperature	J:87244
	increased circulating cholesterol level	J:124766
	increased circulating thyroxine level	J:87244
	increased circulating triiodothyronine level	J:87244
Gpd2^tm1Tka/Gpd2^tm1Tka Slc25a13^tm1Lct/Slc25a13^tm1Lct (B6.Cg-Gpd2^tm1Tka Slc25a13^tm1Lct)	abnormal circulating amino acid level	J:124766
	decreased circulating insulin level	J:124766
	hypoglycemia	J:124766
	increased aspartic acid level	J:124766
	increased blood urea nitrogen level	J:124766
	increased circulating alkaline phosphatase level	J:124766
	increased circulating ammonia level	J:124766
	increased circulating free fatty acids level	J:124766
	increased circulating glycerol level	J:124766
	increased liver triglyceride level	J:124766
Gper1^tm1.1Lmlf/Gper1^tm1.1Lmlf (B6.129-Gper1^tm1.1Lmlf)	decreased circulating glucagon level	J:146345
	decreased circulating insulin-like growth factor I level	J:146345
	decreased glucagon secretion	J:146345
	decreased insulin secretion	J:146345
	impaired glucose tolerance	J:146345
	increased circulating glucose level	J:146345
gpg1/gpg1 (involves: BALB/cAnN * C3H/HeH)	edema	J:145068
gpg2/gpg2 (involves: BALB/cAnN * C3H/HeH)	edema	J:145068
gpg3/gpg3 (involves: BALB/cAnN * C3H/HeH)	edema	J:145068
gpg4/gpg4 (involves: BALB/cAnN * C3H/HeH)	edema	J:145068
gpg5/gpg5 (involves: BALB/cAnN * C3H/HeH)	edema	J:145068
Gpi1^b-m1Neu/Gpi1^b-m1Neu (C3.Cg-Gpi1^b-m1Neu)	increased circulating bilirubin level	J:35956
Gpi1^b-m1Neu/Gpi1^b-m1Neu (C3.Cg-Gpi1^b-m1Neu)	increased circulating glucose level	J:35956
Gpi1^b-m2Neu/Gpi1^b-m2Neu (C3.Cg-Gpi1^b-m2Neu)	increased circulating bilirubin level	J:35956
Gpi1^b-m2Neu/Gpi1^b-m2Neu (C3.Cg-Gpi1^b-m2Neu)	increased circulating glucose level	J:35956
Gpihbp1^tm1Sgy/Gpihbp1^tm1Sgy (Not Specified)	decreased circulating HDL cholesterol level	J:129764
	increased circulating cholesterol level	J:129764
	increased circulating triglyceride level	J:129764
	increased circulating VLDL cholesterol level	J:129764
Gpld1^{tm1.1(KOMP)Vlcg}/Gpld1^{tm1.1(KOMP)Vlcg} (C57BL/6N-Gpld1^{tm1.1(KOMP)Vlcg}/Ucd)	decreased circulating cholesterol level	J:211773
	increased circulating alkaline phosphatase level	J:211773
Gpm6b^tm1Kan Plp1^tm1Kan/Y (involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)	decreased cholesterol level	J:193310
Gpnmb^{tm1.1(KOMP)Vlcg}/Gpnmb⁺ (C57BL/6N-Gpnmb^{tm1.1(KOMP)Vlcg}/Ucd)	increased fasting circulating glucose level	J:211773
Gpr3^tm1Cled/Gpr3^tm1Cled (either: B6.129-Gpr3^tm1Cled or (involves: 129S1/Sv * 129X1/SvJ * CD-1))	increased circulating follicle stimulating hormone level	J:105182
Gpr4^tm1Mglg/Gpr4^tm1Mglg (either: (involves: BALB/c) or (involves: BALB/c * C57BL/6J))	acidosis	J:224758
	decreased urine calcium level	J:224758
	hypercapnia	J:224758
	increased urine ammonia level	J:224758
	increased urine creatinine level	J:224758
	increased urine osmolality	J:224758
	increased urine phosphate level	J:224758
	renal tubular acidosis	J:224758
Gpr4^tm1Witt/Gpr4^tm1Witt (either: B6.129X1-Gpr4^tm1Witt or (involves: 129X1/SvJ * C57BL/6))	cyanosis	J:118276
Gpr12^tm1Dgen/Gpr12^tm1Dgen (B6.129P2-Gpr12^tm1Dgen)	abnormal cholesterol homeostasis	J:111942
	abnormal energy expenditure	J:111942
	decreased respiratory quotient	J:111942
	increased circulating cholesterol level	J:111942
	increased circulating glucose level	J:111942
	increased circulating HDL cholesterol level	J:111942
	increased circulating LDL cholesterol level	J:111942
	increased liver triglyceride level	J:111942
Gpr15^em1(IMPC)J/Gpr15^em1(IMPC)J (C57BL/6NJ-Gpr15^em1(IMPC)J/J)	impaired glucose tolerance	J:211773
Gpr21^tm1Dgen/Gpr21^tm1Dgen (B6.129P2-Gpr21^tm1Dgen)	abnormal circulating chemokine level	J:181127
	decreased circulating serum amyloid protein level	J:181127
	decreased susceptibility to diet-induced obesity	J:181127
	improved glucose tolerance	J:181127
	increased insulin sensitivity	J:181127
Gpr22^{tm1b(KOMP)Wtsi}/Gpr22^{tm1b(KOMP)Wtsi} (C57BL/6N-Gpr22^{tm1b(KOMP)Wtsi}/H)	decreased circulating serum albumin level	J:211773
	increased circulating alanine transaminase level	J:211773
	increased circulating aspartate transaminase level	J:211773
	increased circulating creatinine level	J:211773
	increased circulating phosphate level	J:211773
	increased circulating potassium level	J:211773
Gpr26^tm1Yugs/Gpr26^tm1Yugs (involves: C57BL/6)	abnormal circulating hormone level	J:189617
	abnormal glucose homeostasis	J:189617
	decreased circulating ghrelin level	J:189617
	decreased energy expenditure	J:189617
	impaired glucose tolerance	J:189617
	increased circulating cholesterol level	J:189617
	increased circulating glucose level	J:189617
	increased circulating insulin level	J:189617
	increased circulating leptin level	J:189617
	increased circulating triglyceride level	J:189617
	increased susceptibility to diet-induced obesity	J:189617
Gpr27^tm1Tac/Gpr27^tm1Tac (B6.129S-Gpr27^tm1Tac)	decreased circulating insulin level	J:286854
	decreased insulin secretion	J:286854
	impaired glucose tolerance	J:286854
Gpr35^em2Niess/Gpr35^em2Niess Cx3cr1^{tm2.1(cre/ERT2)Litt}/Cx3cr1⁺ (involves: 129P2/OlaHsd * C57BL/6N)	abnormal corticosterone level	J:300275
Gpr35^{tm1(KOMP)Vlcg}/Gpr35^{tm1(KOMP)Vlcg} (C57BL/6N-Gpr35^{tm1(KOMP)Vlcg}/MbpMmucd)	abnormal chemokine level	J:306520
	abnormal interleukin level	J:306520
Gpr37^tm1.1Ryot/Gpr37^tm1.1Ryot (involves: C57BL/6)	decreased dopamine level	J:128745
Gpr37^tm2Gtva/Gpr37^tm2Gtva (involves: 129P2/OlaHsd * C57BL/6J)	decreased dopamine level	J:91390
Gpr39^tm1Dgen/Gpr39^tm1Dgen (B6.129P2-Gpr39^tm1Dgen)	decreased circulating insulin level	J:151806
Gpr39^tm1Dgen/Gpr39^tm1Dgen (B6.129P2-Gpr39^tm1Dgen)	increased circulating glucose level	J:151806
Gpr39^tm1Lex/Gpr39^tm1Lex (involves: 129S5/SvEvBrd * C57BL/6)	increased circulating cholesterol level	J:124913
Gpr50^tm1Dgen/Gpr50^tm1Dgen (involves: C57BL/6)	decreased susceptibility to diet-induced obesity	J:131227
	increased carbon dioxide production	J:131227
	increased oxygen consumption	J:131227
Gpr61^tm1Dgen/Gpr61^tm1Dgen (involves: 129P2/OlaHsd * C57BL/6J)	increased circulating insulin level	J:302257
	increased circulating leptin level	J:302257
	increased circulating triglyceride level	J:302257
	increased liver triglyceride level	J:302257
Gpr63^{tm1.1(KOMP)Vlcg}/Gpr63^{tm1.1(KOMP)Vlcg} (C57BL/6N-Gpr63^{tm1.1(KOMP)Vlcg}/MbpMmucd)	decreased circulating calcium level	J:211773
	increased circulating alanine transaminase level	J:211773
Gpr68^tm1.1Aha/Gpr68^tm1.1Aha (B6.129(C)-Gpr68^tm1.1Aha)	decreased circulating insulin level	J:189192
Gpr68^tm1.1Aha/Gpr68^tm1.1Aha (B6.129(C)-Gpr68^tm1.1Aha)	decreased insulin secretion	J:189192
Gpr68^tm1Aha/Gpr68^tm1Aha (B6.129-Gpr68^tm1Aha)	decreased circulating glucagon level	J:189192
	decreased circulating glucose level	J:189192
	decreased circulating insulin level	J:189192
	decreased insulin secretion	J:189192
	increased insulin sensitivity	J:189192
Gpr82^tm1Shbg/Y (C3Fe.Cg-Gpr82^tm1Shbg)	decreased circulating glucose level	J:301613
	decreased circulating insulin level	J:301613
	decreased circulating VLDL cholesterol level	J:301613
	decreased fasting circulating glucose level	J:301613
	decreased triglyceride level	J:301613
	improved glucose tolerance	J:301613
	increased body temperature	J:301613
Gpr82^tm1Shbg/Gpr82^tm1Shbg (C3Fe.Cg-Gpr82^tm1Shbg)	decreased circulating insulin level	J:301613
	decreased circulating VLDL cholesterol level	J:301613
	decreased triglyceride level	J:301613
	improved glucose tolerance	J:301613
	increased body temperature	J:301613
	increased insulin sensitivity	J:301613
Gpr83^{em1(IMPC)Ccpcz}/Gpr83^{em1(IMPC)Ccpcz} (C57BL/6NCrl-Gpr83^{em1(IMPC)Ccpcz}/Ccpcz)	impaired glucose tolerance	J:211773
Gpr84^{tm1.1(KOMP)Vlcg}/Gpr84^{tm1.1(KOMP)Vlcg} (C57BL/6N-Gpr84^{tm1.1(KOMP)Vlcg}/Ucd)	increased circulating alanine transaminase level	J:211773
Gpr88^tm1.2Ics/Gpr88^tm1.2Ics (involves: 129 * C57BL/6J)	decreased nervous system dopamine level	J:236208
	increased nervous system dopamine level	J:236208
	increased serotonin level	J:236208
Gpr89^tm1.1Ymae/Gpr89^tm1.1Ymae Tg(KRT5-cre)1Tak/0 (involves: C3H * C57BL/6)	impaired skin barrier function	J:189574
Gpr119^tm1Tjkw/Gpr119^tm1Tjkw (C57BL/6J-Gpr119^tm1Tjkw)	decreased circulating insulin level	J:244912
Gpr142^tm1Lex/Gpr142^tm1Lex (B6.129S-Gpr142^tm1Lex)	abnormal circulating glucose level	J:249154
	abnormal circulating hormone level	J:249154
	abnormal circulating insulin level	J:249154
	abnormal circulating non-HDL cholesterol level	J:249154
	decreased circulating insulin level	J:249154
	decreased insulin secretion	J:249154
	increased fasting circulating glucose level	J:249154
Gpr146^em1(IMPC)H/Gpr146^em1(IMPC)H (C57BL/6NTac-Gpr146^em1(IMPC)H/H)	decreased circulating cholesterol level	J:211773
	decreased circulating HDL cholesterol level	J:211773
	decreased circulating iron level	J:211773
	decreased circulating triglyceride level	J:211773
	increased circulating alanine transaminase level	J:211773
Gpr158^{tm1(KOMP)Vlcg}/Gpr158^{tm1(KOMP)Vlcg} (involves: C57BL/6NTac)	decreased response to stress-induced hyperthermia	J:263624
Gpr176^{tm1b(EUCOMM)Hmgu}/Gpr176^{tm1b(EUCOMM)Hmgu} (C57BL/6N-Gpr176^{tm1b(EUCOMM)Hmgu}/H)	decreased circulating total protein level	J:211773
	increased blood urea nitrogen level	J:211773
Gpr182^{tm2c(KOMP)Wtsi}/Gpr182^{tm2c(KOMP)Wtsi} Tg(Cdh5-cre/ERT2)1Rha/0 (B6.Cg-Gpr182^{tm2c(KOMP)Wtsi} Tg(Cdh5-cre/ERT2)1Rha)	abnormal circulating chemokine level	J:305796
	increased circulating CXCL10 level	J:305796
Gpr183^tm1Lex/Gpr183^tm1Lex (involves: 129S5/SvEvBrd * C57BL/6)	abnormal circulating interferon-beta level	J:211122
	increased circulating interferon-alpha level	J:211122
	increased circulating interferon-gamma level	J:211122
Gprasp2^em1(IMPC)J/Gprasp2^em1(IMPC)J (C57BL/6NJ-Gprasp2^em1(IMPC)J/Mmjax)	increased circulating alkaline phosphatase level	J:211773
Gprc5a^em1Jaap/Gprc5a^em1Jaap (FVB-Gprc5a^em1Jaap)	albuminuria	J:293292
Gprc5c^tm1Yhir/Gprc5c^tm1Yhir (B6.Cg-Gprc5c^tm1Yhir)	increased circulating alkaline phosphatase level	J:176063
Gprc5c^tm1Yhir/Gprc5c^tm1Yhir (B6.Cg-Gprc5c^tm1Yhir)	increased circulating lactate dehydrogenase level	J:176063
Gprc6a^tm1Ldq/Gprc6a^tm1Ldq (involves: 129X1/SvJ * C57BL/6)	abnormal circulating hormone level	J:144372
	abnormal circulating phosphate level	J:144372
	abnormal glucose homeostasis	J:144372
	abnormal glucose tolerance	J:144372
	abnormal urine homeostasis	J:144372
	decreased circulating insulin level	J:144372
	decreased circulating testosterone level	J:144372
	increased circulating estradiol level	J:144372
	increased circulating glucose level	J:144372
	increased insulin sensitivity	J:144372
	increased liver triglyceride level	J:144372
	increased urine beta2-microglobulin level	J:144372
	increased urine calcium level	J:144372
	increased urine phosphate level	J:144372
Gpsm1^tm1.1Lajb/Gpsm1⁺ Pkd1^tm1.1Fqi/Pkd1^tm1.1Fqi (involves: 129S6/SvEvTac)	increased blood urea nitrogen level	J:193175
Gpsm1^tm1.1Lajb/Gpsm1^tm1.1Lajb (involves: 129S6/SvEvTac * C57BL/6 * FVB/N * SJL)	increased energy expenditure	J:138126
Gpsm1^tm1.1Lajb/Gpsm1^tm1.1Lajb Pkd1^tm1.1Fqi/Pkd1^tm1.1Fqi (involves: 129S6/SvEvTac)	increased blood urea nitrogen level	J:193175
	increased circulating creatinine level	J:193175
Gpt2^{tm1a(KOMP)Wtsi}/Gpt2^{tm1a(KOMP)Wtsi} (involves: C57BL/6J * C57BL/6N)	abnormal amino acid level	J:238353
Gpx1^tm1Mgr/Gpx1^tm1Mgr (involves: 129 * C57BL/6J)	abnormal lipid level	J:62395
Gpx1^tm1Ysh/Gpx1^tm1Ysh (involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)	abnormal platelet physiology	J:41169
Gpx1^tm1Ysh/Gpx1^tm1Ysh Gpx2^tm2Coh/Gpx2^tm2Coh (involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)	abnormal enzyme/coenzyme level	J:71506
	decreased body temperature	J:71506
	intestinal edema	J:71506
Gpx1^tm1Ysh/Gpx1^tm1Ysh Prkn^tm1Shn/Prkn^tm1Shn Park7^tm1Shn/Park7^tm1Shn (B6.Cg-Park7^tm1Shn Gpx1^tm1Ysh Prkn^tm1Shn)	increased dopamine level	J:202221
	increased serotonin level	J:202221
Gpx3^{tm1b(KOMP)Wtsi}/Gpx3⁺ (C57BL/6N-Gpx3^{tm1b(KOMP)Wtsi}/H)	impaired glucose tolerance	J:211773
Gpx3^tm1Hjco/Gpx3^tm1Hjco (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	abnormal selenium level	J:159745
Gpx3^tm1Hjco/Gpx3^tm1Hjco Selenop^tm1Rfb/Selenop^tm1Rfb (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	abnormal selenium level	J:159745
Gpx3^tm1Jlos/Gpx3⁺ (B6N.Cg-Gpx3^tm1Jlos)	decreased bleeding time	J:183744
Gpx3^tm1Jlos/Gpx3⁺ (B6N.Cg-Gpx3^tm1Jlos)	increased platelet aggregation	J:183744
Gpx3^tm1Jlos/Gpx3^tm1Jlos (B6N.Cg-Gpx3^tm1Jlos)	abnormal blood homeostasis	J:183744
	decreased bleeding time	J:183744
	increased platelet aggregation	J:183744
	increased susceptibility to induced thrombosis	J:183744
Gramd1b^em1Pton/Gramd1b^em1Pton (involves: C57BL/6N)	abnormal cholesterol homeostasis	J:266462
Gramd1b^em1Pton/Gramd1b^em1Pton (involves: C57BL/6N)	decreased circulating corticosterone level	J:266462
Gramd1c^{tm1b(KOMP)Wtsi}/Gramd1c^{tm1b(KOMP)Wtsi} (C57BL/6N-Gramd1c^{tm1b(KOMP)Wtsi}/J)	decreased fasting circulating glucose level	J:211773
	increased circulating aspartate transaminase level	J:211773
	increased urine microalbumin level	J:211773
Gramd2b^em1(IMPC)J/Gramd2b^em1(IMPC)J (C57BL/6NJ-Gramd2b^em1(IMPC)J/Mmjax)	impaired glucose tolerance	J:211773
Grb2^tm2Paw/Grb2^tm2Paw (Not Specified)	edema	J:69138
Grb10^{Gt(Betageo)1Ward}/Grb10⁺ (involves: C57BL/6 * CBA)	increased liver glycogen level	J:84425
Grb10^GT(XC302)Byg/Grb10^GT(XC302)Byg (involves: 129P2/OlaHsd * Black Swiss * C57BL/6)	increased insulin sensitivity	J:125128
Grb10^tm1.1Fliu/Grb10^tm1.1Fliu Tg(Adipoq-cre)#Pesch/0 (involves: 129S/SvEv * FVB)	decreased core body temperature	J:213603
	decreased fatty acid oxidation	J:213603
	decreased oxygen consumption	J:213603
	impaired adaptive thermogenesis	J:213603
	impaired glucose tolerance	J:213603
	increased circulating insulin level	J:213603
	increased susceptibility to diet-induced obesity	J:213603
	insulin resistance	J:213603
Grb10^tm1.1Fliu/Grb10^tm1.1Fliu Tg(Fabp4-cre)1Rev/0 (involves: 129S/SvEv)	impaired glucose tolerance	J:213603
	increased circulating insulin level	J:213603
	increased susceptibility to diet-induced obesity	J:213603
	insulin resistance	J:213603
Grb10^tm1.1Fliu/Grb10^tm1.1Fliu Tg(Pdx1-cre)6Tuv/0 (involves: 129S/SvEv * C57BL/6 * FVB/N)	abnormal glucose homeostasis	J:208498
	decreased circulating glucose level	J:208498
	improved glucose tolerance	J:208498
	increased insulin secretion	J:208498
Grb14^tm1Daly/Grb14^tm1Daly (involves: 129X1/SvJ * C57BL/6)	improved glucose tolerance	J:87892
Grb14^tm1Daly/Grb14^tm1Daly (involves: 129X1/SvJ * C57BL/6)	increased insulin sensitivity	J:87892
Grcc10^{tm1.1(KOMP)Vlcg}/Grcc10^{tm1.1(KOMP)Vlcg} (C57BL/6N-Grcc10^{tm1.1(KOMP)Vlcg}/J)	cyanosis	J:211773
Grem1^tm1Azun/Grem1^tm1Azun (either: (involves: 129S1/Sv * 129X1/SvJ * C57BL/6) or (involves: 129S1/Sv * 129X1/SvJ * CD-1))	cyanosis	J:90991
Grem2^em1Stpg/Grem2^em1Stpg (involves: 129S7/SvEvBrd * C57BL/6 * C57BL/6J)	abnormal circulating hormone level	J:318711
	abnormal hormone level	J:318711
Grem2^tm1Akh/Grem2^tm1Akh (involves: 129/Sv * C57BL/6)	abnormal chemokine level	J:250034
Grem2^tm1Akh/Grem2^tm1Akh (involves: 129/Sv * C57BL/6)	increased transforming growth factor beta level	J:250034
Grhl1^tm1Jane/Grhl1^tm1Jane Grhl3^tm1Jane/Grhl3^tm3.1Jane Tg(KRT14-cre)8Brn/0 (involves: 129S1/Sv * C57BL/6 * FVB/N)	impaired skin barrier function	J:233531
Grhl1^tm1Jane/Grhl1^tm1Jane Grhl3^tm1Jane/Grhl3^tm3.1Jane Tg(KRT14-cre/ERT)20Efu/0 (involves: 129S1/Sv * C57BL/6 * CD-1)	impaired skin barrier function	J:233531
Grhl3^{tm1a(EUCOMM)Wtsi}/Grhl3⁺ (C57BL/6N-Grhl3^{tm1a(EUCOMM)Wtsi}/Ics)	decreased blood urea nitrogen level	J:165965
	decreased circulating alkaline phosphatase level	J:165965
	decreased circulating triglyceride level	J:165965
	increased circulating calcium level	J:165965
	increased circulating glucose level	J:165965
Grhl3^tm1Bogi/Grhl3^tm1Bogi (involves: C57BL/6J)	abnormal lipid level	J:114626
Grhl3^tm1Bogi/Grhl3^tm1Bogi (involves: C57BL/6J)	impaired skin barrier function	J:114626
Grhpr^{Gt(OST383093)Lex}/Grhpr^{Gt(OST383093)Lex} (B6.129S5-Grhpr^{Gt(OST383093)Lex})	hyperoxaluria	J:181969
Grhpr^{Gt(OST383093)Lex}/Grhpr^{Gt(OST383093)Lex} (involves: 129S5/SvEvBrd * C57BL/6)	abnormal blood homeostasis	J:181969
	abnormal urine homeostasis	J:181969
	hyperoxaluria	J:181969
Grhpr^{Gt(OST383093)Lex}/Grhpr^{Gt(OST383093)Lex} (involves: 129S5/SvEvBrd * C57BL/6J)	hyperoxaluria	J:283585
Grhpr^{Gt(OST383093)Lex}/Grhpr^{Gt(OST383093)Lex} Prodh2^em1Jkni/Prodh2^em1Jkni (involves: 129S5/SvEvBrd * C57BL/6J)	hyperoxaluria	J:283585
Gria1^em1(IMPC)H/Gria1^em1(IMPC)H (C57BL/6N-Gria1^em1(IMPC)H/H)	increased blood urea nitrogen level	J:211773
	increased circulating iron level	J:211773
	increased circulating serum albumin level	J:211773
Gria1^{em1(IMPC)Hmgu}/Gria1^{em1(IMPC)Hmgu} (C57BL/6N-Gria1^{em1(IMPC)Hmgu}/Ieg)	increased circulating alkaline phosphatase level	J:211773
	increased circulating amylase level	J:211773
Gria1^tm1Lex/Gria1^tm1Lex (involves: 129S5/SvEvBrd * C57BL/6)	decreased glycosylated hemoglobin level	J:82809
	increased blood urea nitrogen level	J:82809
Gria1^tm1Rsp/Gria1^tm1Rsp (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	abnormal serotonin level	J:101930
Gria2^em1(IMPC)H/Gria2⁺ (C57BL/6NTac-Gria2^em1(IMPC)H/H)	increased circulating alanine transaminase level	J:211773
Grid2^Lc-J/Grid2^Lc-J (BALB/cByJ-Grid2^Lc-J/+)	hypoxia	J:42385
Grid2^Lc/Grid2⁺ (involves: C57BL/6 * CBA)	increased circulating adrenocorticotropin level	J:44206
Grid2^Lc/Grid2⁺ (involves: C57BL/6 * CBA)	increased circulating corticosterone level	J:44206
Grik3^em1(IMPC)Mbp/Grik3^em1(IMPC)Mbp (C57BL/6N-Grik3^em1(IMPC)Mbp/MbpMmucd)	increased fasting circulating glucose level	J:211773
Grik4^em1(IMPC)Mbp/Grik4^em1(IMPC)Mbp (C57BL/6N-Grik4^em1(IMPC)Mbp/MbpMmucd)	impaired glucose tolerance	J:211773
Grin1^tm1.1Phs/Grin1^tm1.1Phs (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	cyanosis	J:75497
Grin1^tm1Cur/Grin1^tm1.1Phs (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	cyanosis	J:75497
Grin1^tm1Cur/Grin1^tm1Cur (involves: 129S1/Sv * C57BL/6)	cyanosis	J:66345
Grin1^tm1Nak/Grin1^tm1Nak (involves: 129S/Sv * C57BL/6 * DBA/2)	cyanosis	J:38582
Grin1^tm1Stl/Grin1^tm1Stl (either: (involves: 129S2/SvPas * 129/Sv) or (involves: 129S2/SvPas * BALB/c) or (involves: 129S2/SvPas * C57BL/6))	cyanosis	J:17384
Grin1^tm2Slab/Grin1^tm1.1Slab (involves: 129P2/OlaHsd * C57BL/6J)	cyanosis	J:82670
Grin2d^{tm1a(EUCOMM)Wtsi}/Grin2d^{tm1a(EUCOMM)Wtsi} (Not Specified)	decreased circulating sodium level	J:165965
	decreased circulating triglyceride level	J:165965
Grin3b^{tm1b(KOMP)Wtsi}/Grin3b^{tm1b(KOMP)Wtsi} (C57BL/6N-Grin3b^{tm1b(KOMP)Wtsi}/H)	decreased circulating triglyceride level	J:211773
	increased circulating bilirubin level	J:211773
	increased circulating potassium level	J:211773
Grip1^eb/Grip1^eb (involves: ATEB/Le * C57BL/6J)	abnormal blood coagulation	J:64538
Grk2^tm1.1Gwd/Grk2^tm1.1Gwd (involves: 129S4/SvJaeSor * FVB/N)	pericardial edema	J:126501
Grk5^tm1Rjl/Grk5^tm1Rjl (involves: 129S4/SvJaeSor * C57BL/6)	decreased body temperature	J:59179
	decreased core body temperature	J:59179
	increased salivation	J:59179
Grk6^tm1.1Mca/Grk6^tm1.1Mca (B6.129S4-Grk6^tm1.1Mca)	increased spleen iron level	J:225063
Grm1^crv4/Grm1⁺ (BALB/cPas-Grm1^crv4)	albuminuria	J:169685
Grm1^crv4/Grm1^crv4 (BALB/cPas-Grm1^crv4)	albuminuria	J:169685
Grm2^tm1Nak/Grm2^tm1Nak (B6.129S-Grm2^tm1Nak)	increased dopamine level	J:97172
Grm3^{tm1b(KOMP)Wtsi}/Grm3^{tm1b(KOMP)Wtsi} (C57BL/6N-Grm3^{tm1b(KOMP)Wtsi}/H)	impaired glucose tolerance	J:211773
	increased circulating cholesterol level	J:211773
	increased circulating HDL cholesterol level	J:211773
	increased circulating triglyceride level	J:211773
Grm8^tm1Duv/Grm8^tm1Duv (B6.129S1-Grm8^tm1Duv)	insulin resistance	J:101087
Grn^tm1.1Aidi/Grn^tm1.1Aidi (involves: C57BL/6J)	abnormal circulating hormone level	J:268827
	abnormal zinc homeostasis	J:268827
	decreased urine creatinine level	J:268827
	decreased urine magnesium level	J:268827
	decreased urine osmolality	J:268827
	decreased urine potassium level	J:268827
	increased circulating antidiuretic hormone level	J:268827
	increased circulating ghrelin level	J:268827
gro22/gro22 (Not Specified)	decreased circulating cholesterol level	J:85113
Grpel1^{tm1c(EUCOMM)Wtsi}/Grpel1^{tm1c(EUCOMM)Wtsi} Tg(ACTA1-cre/ERT2)97.16Mtz/0 (involves: C57BL/6N)	decreased circulating glucose level	J:330869
Grtp1^{tm1b(EUCOMM)Hmgu}/Grtp1^{tm1b(EUCOMM)Hmgu} (C57BL/6N-Grtp1^{tm1b(EUCOMM)Hmgu}/Tcp)	increased circulating alanine transaminase level	J:211773
	increased circulating aspartate transaminase level	J:211773
Grxcr1^em1(IMPC)J/Grxcr1^em1(IMPC)J (C57BL/6NJ-Grxcr1^em1(IMPC)J/Mmjax)	increased circulating cholesterol level	J:211773
Gsdme^{tm1b(KOMP)Wtsi}/Gsdme^{tm1b(KOMP)Wtsi} (C57BL/6N-Gsdme^{tm1b(KOMP)Wtsi}/Wtsi)	increased circulating fructosamine level	J:211773
Gse1^{tm1a(EUCOMM)Wtsi}/Gse1⁺ (C57BL/6N-Gse1^{tm1a(EUCOMM)Wtsi}/H)	decreased circulating serum albumin level	J:165965
	decreased circulating total protein level	J:165965
	increased circulating alkaline phosphatase level	J:165965
	increased circulating total protein level	J:165965
Gsk3a^tm1.1Jrw/Gsk3a^tm1.1Jrw (involves: 129S6/SvEvTac * C57BL/6)	improved glucose tolerance	J:130033
	increased insulin sensitivity	J:130033
	increased liver glycogen level	J:130033
Gsk3a^{tm1a(EUCOMM)Wtsi}/Gsk3a^{tm1a(EUCOMM)Wtsi} (B6JTyr;B6N-Gsk3a^{tm1a(EUCOMM)Wtsi}/Wtsi)	decreased circulating glucose level	J:175295
	decreased circulating glycerol level	J:175295
Gsk3a^{tm1b(EUCOMM)Hmgu}/Gsk3a^{tm1b(EUCOMM)Hmgu} (C57BL/6N-Gsk3a^{tm1b(EUCOMM)Hmgu}/Ieg)	increased circulating alkaline phosphatase level	J:211773
Gsk3a^tm1Dral/Gsk3a^tm1Dral Gsk3b^tm1Dral/Gsk3b^tm1Dral (involves: 129P2/OlaHsd * C57BL/6 * CBA)	increased liver glycogen level	J:98263
Gsk3a^tm1Dral/Gsk3a^tm1Dral Gsk3b^tm1Dral/Gsk3b^tm1Dral (involves: 129P2/OlaHsd)	increased circulating corticosterone level	J:200517
	increased circulating interleukin-6 level	J:200517
Gsk3a^tm1Dral/Gsk3a^tm1Dral Gsk3b^tm1Dral/Gsk3b^tm1Dral Gys1^tm1.1Arte/Gys1^tm1.1Arte (involves: 129P2/OlaHsd * C57BL/6J)	abnormal glycogen homeostasis	J:167911
Gsk3b^tm1Dral/Gsk3b^tm1Dral (involves: 129P2/OlaHsd * C57BL/6 * CBA)	abnormal glycogen homeostasis	J:98263
Gsk3b^tm1Jrw/Gsk3b⁺ (involves: 129 * C57BL/6J)	abnormal glucose homeostasis	J:135659
	decreased circulating glucose level	J:135659
	decreased circulating insulin level	J:135659
Gsk3b^tm1Jrw/Gsk3b⁺ Insr^tm1Dac/Insr⁺ (involves: 129 * C57BL/6J)	abnormal circulating glucose level	J:135659
	abnormal circulating insulin level	J:135659
	improved glucose tolerance	J:135659
	insulin resistance	J:135659
Gsk3b^tm1Jrw/Gsk3b⁺ Irs2^tm1Mfw/Irs2^tm1Mfw (involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)	abnormal circulating glucose level	J:135659
	increased circulating glucose level	J:135659
	increased circulating insulin level	J:135659
	insulin resistance	J:135659
Gsk3b^tm2Jrw/Gsk3b^tm2Jrw Irs2^tm1Mfw/Irs2^tm1Mfw Tg(Ins2-cre)23Herr/? (involves: 129S1/Sv * 129X1/SvJ * C57BL/6J * CBA/J)	abnormal circulating glucose level	J:135659
	increased circulating insulin level	J:135659
Gsk3b^tm2Jrw/Gsk3b^tm2Jrw Tg(Ggt1-cre)M3Egn/0 (involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * C57BL/6J * SJL)	increased glycogen level	J:167190
Gskip^tm1.2Ekn/Gskip^tm1.2Ekn (B6.129P2(Cg)-Gskip^tm1.2Ekn)	cyanosis	J:228948
Gsn^tm1Djk/Gsn^tm1Djk (either: (involves: 129S4/SvJae * BALB/c) or (involves: 129S4/SvJae * C57BL/6))	abnormal platelet activation	J:24346
	increased bleeding time	J:24346
Gsta4^{Gt(OST203280)Lex}/Gsta4^{Gt(OST203280)Lex} (involves: 129S5/SvEvBrd * C57BL/6J)	impaired glucose tolerance	J:103485
Gsta4^tm1Pzim/Gsta4^tm1Pzim (involves: 129S1/Sv * 129S6/SvEvTac)	increased circulating alanine transaminase level	J:87983
	increased circulating aspartate transaminase level	J:87983
Gstcd^{tm1b(EUCOMM)Wtsi}/Gstcd^{tm1b(EUCOMM)Wtsi} (C57BL/6N-Gstcd^{tm1b(EUCOMM)Wtsi}/Bay)	decreased blood urea nitrogen level	J:211773
	decreased circulating potassium level	J:211773
Gstk1^tm1Pgb/Gstk1^tm1Pgb (BALB/c-Gstk1^tm1Pgb)	decreased adiponectin level	J:177201
	decreased circulating triglyceride level	J:177201
	increased urine microalbumin level	J:177201
Gstm1^tm1Gcw/Gstm1^tm1Gcw (involves: 129S/SvEv * C57BL/6)	increased dopamine level	J:159701
Gstm1^tm1Gcw/Gstm1^tm1Gcw (involves: 129S/SvEv * C57BL/6)	increased serotonin level	J:159701
Gstm5^em1(IMPC)Mbp/Gstm5^em1(IMPC)Mbp (C57BL/6N-Gstm5^em1(IMPC)Mbp/MbpMmucd)	increased circulating alkaline phosphatase level	J:211773
	increased circulating serum albumin level	J:211773
Gstm6^{tm1b(EUCOMM)Hmgu}/Gstm6^{tm1b(EUCOMM)Hmgu} (C57BL/6N-Gstm6^{tm1b(EUCOMM)Hmgu}/Ieg)	decreased circulating glucose level	J:211773
	increased circulating phosphate level	J:211773
Gstt1^{tm1a(EUCOMM)Hmgu}/Gstt1^{tm1a(EUCOMM)Hmgu} (Not Specified)	increased circulating glucose level	J:165965
Gstz1^tm1Jmfc/Gstz1^tm1Jmfc (129S4/SvJae-Gstz1^tm1Jmfc)	ketoaciduria	J:86595, J:77040
Gsx2^tm1Ssp/Gsx2^tm1Ssp (involves: 129S2/SvPas)	cyanosis	J:44324
Gsx2^tm1Ssp/Gsx2^tm1Ssp (involves: 129S2/SvPas)	hypoxia	J:44324
Gt(ROSA)26Sor^{em1(CAG-Zfas1)Cya}/Gt(ROSA)26Sor⁺ Tg(Myh6-cre)#Cya/0 (involves: C57BL/6J)	abnormal calcium ion homeostasis	J:294533
Gt(ROSA)26Sor^{tm1(B4galt1)Clib}/Gt(ROSA)26Sor^{tm1(B4galt1)Clib} Tg(Nes-cre)Wme/? (involves: 129S6/SvEvTac * C57BL/6 * CBA)	abnormal homeostasis	J:209737
	decreased circulating interleukin-6 level	J:209737
Gt(ROSA)26Sor^{tm1(CAG-Foxo1)Jcbr}/Gt(ROSA)26Sor⁺ Pdpk1^tm1Jcbr/Pdpk1^tm1Jcbr Tg(Pomc1-cre)16Lowl/0 (involves: C57BL/6 FVB/N)	decreased circulating corticosterone level	J:134336
Gt(ROSA)26Sor^{tm1(CAG-Kcnj11,-GFP)Nich}/? Tg(CAG-Bgeo/GFP)21Lbe/0 Tg(Pmch-cre)1Lowl/0 (involves: 129S1/Sv 129S4/SvJaeSor * 129X1/SvJ * C57BL/6 * FVB/NJ)	impaired glucose tolerance	J:167906
Gt(ROSA)26Sor^{tm1(CAG-Kcnj11,-GFP)Nich}/Gt(ROSA)26Sor⁺ Tg(Ins2-cre)23Herr/0 (involves: C57BL/6 CBA/J)	abnormal circulating glucagon level	J:146650
	abnormal circulating glucose level	J:146650
	decreased circulating glucagon level	J:146650
	decreased circulating insulin level	J:146650
	decreased insulin secretion	J:146650
	hyperglycemia	J:146650
	increased circulating glucagon level	J:146650
Gt(ROSA)26Sor^{tm1(CAG-LMNA)Cyh}/Gt(ROSA)26Sor⁺ Tg(Ckmm-cre)5Khn/0 (involves: C57BL/6JNarl FVB)	decreased body temperature	J:284048
	decreased carbon dioxide production	J:284048
	decreased oxygen consumption	J:284048
	increased circulating creatine kinase level	J:284048
	increased respiratory quotient	J:284048
Gt(ROSA)26Sor^{tm1(CAG-MFN2T105M)Dple}/Gt(ROSA)26Sor⁺ Tg(CAG-cre/Esr1)5Amc/0 (involves: C57BL/6 * CBA)	ascites	J:251584
Gt(ROSA)26Sor^{tm1(CAG-Nr2f2)Tsa}/Gt(ROSA)26Sor⁺ A1cf^{Tg(Myh6-cre/Esr1)1Jmk}/A1cf⁺ (involves: 129S1/Sv 129X1/SvJ * FVB/N)	decreased fatty acid oxidation	J:227012
	decreased oxygen consumption	J:227012
Gt(ROSA)26Sor^{tm1(CARD14)Ribt}/Gt(ROSA)26Sor⁺ Tg(KRT14-cre/ERT)20Efu/0 (involves: 129S6/SvEvTac C57BL/6NCrl * CD-1)	decreased circulating glucose level	J:292094
Gt(ROSA)26Sor^{tm1(cre/ERT2)Tyj}/Gt(ROSA)26Sor⁺ Hprt1^{tm6(CAG-fat-1)Geno}/Hprt1^{tm6(CAG-fat-1)Geno} (involves: 129P2/OlaHsd * 129S4/SvJae * C57BL/6)	abnormal fatty acids level	J:213660
Gt(ROSA)26Sor^{tm1(cre/ERT2)Tyj}/Gt(ROSA)26Sor⁺ Secisbp2^tm1.1Amdu/Secisbp2^tm1.2Amdu (B6(129S4)-Gt(ROSA)26Sor^{tm1(cre/ERT2)Tyj} Secisbp2^tm1.1Amdu Secisbp2^tm1.2Amdu)	abnormal thyroid hormone level	J:251875
	decreased triiodothyronine level	J:251875
	increased circulating thyroid-stimulating hormone level	J:251875
	increased thyroxine level	J:251875
Gt(ROSA)26Sor^{tm1(cre/ERT2)Tyj}/Gt(ROSA)26Sor^{tm1(cre/ERT2)Tyj} Nus1^tm1.1Qrm/Nus1^tm1.1Qrm (involves: 129 * C57BL/6 * SJL)	abnormal lipid homeostasis	J:243753
	increased liver free fatty acids level	J:243753
	increased liver triglyceride level	J:243753
Gt(ROSA)26Sor^{tm1(cre/ERT)Nat}/Gt(ROSA)26Sor⁺ Tardbp^tm1.1Pcw/Tardbp⁺ (involves: 129 * C57BL/6 * SJL)	abnormal respiratory quotient	J:164406
Gt(ROSA)26Sor^{tm1(cre/ERT)Nat}/Gt(ROSA)26Sor⁺ Tardbp^tm1.1Pcw/Tardbp^tm1.1Pcw (involves: 129 * C57BL/6 * SJL)	abnormal lipid oxidation	J:164406
	abnormal respiratory quotient	J:164406
Gt(ROSA)26Sor^tm1(DTA)Jpmb/Gt(ROSA)26Sor⁺ Tg(Trpv1-cre)1Hoon/0 (involves: 129S1/Sv)	abnormal body temperature homeostasis	J:169256
Gt(ROSA)26Sor^tm1(DTA)Riet/Gt(ROSA)26Sor⁺ Tg(Alb1-cre)7Gsc/0 (involves: 129P2/OlaHsd)	increased circulating alanine transaminase level	J:92789
	increased circulating aspartate transaminase level	J:92789
Gt(ROSA)26Sor^tm1(DTA)Vlcg/Gt(ROSA)26Sor^tm1(DTA)Vlcg Tg(BGLAP-cre/ERT2)#Stko/0 (involves: 129S1/Sv * FVB/N)	abnormal glucose homeostasis	J:201507
	abnormal hormone level	J:201507
	abnormal lipid homeostasis	J:201507
	abnormal lipid level	J:201507
	decreased adiponectin level	J:201507
	decreased circulating insulin level	J:201507
	decreased circulating osteocalcin level	J:201507
	decreased circulating testosterone level	J:201507
	decreased insulin secretion	J:201507
	hyperglycemia	J:201507
	impaired glucose tolerance	J:201507
	increased carbon dioxide production	J:201507
	increased circulating glucose level	J:201507
	increased energy expenditure	J:201507
	increased oxygen consumption	J:201507
	insulin resistance	J:201507
Gt(ROSA)26Sor^{tm1(ETV6/SYK)Hjum}/Gt(ROSA)26Sor⁺ Cd79a^{tm3(cre/ERT2)Reth}/Cd79a⁺ (involves: 129S6/SvEvTac * BALB/c)	abnormal circulating chemokine level	J:208904
	abnormal cytokine level	J:208904
	increased circulating interferon-gamma level	J:208904
	increased circulating interleukin-6 level	J:208904
	increased circulating interleukin-10 level	J:208904
	increased circulating tumor necrosis factor level	J:208904
Gt(ROSA)26Sor^tm1(Gck)Ydor/Gt(ROSA)26Sor⁺ Tg(Ins2-cre)25Mgn/0 (involves: C57BL/6 * DBA)	decreased circulating insulin level	J:210493
	hyperglycemia	J:210493
Gt(ROSA)26Sor^tm1(Gck)Ydor/Gt(ROSA)26Sor⁺ Tg(Pdx1-cre/Esr1)#Dam/0 (involves: C57BL/6 CBA)	decreased fasting circulating glucose level	J:210493
	increased circulating insulin level	J:210493
	increased oxygen consumption	J:210493
Gt(ROSA)26Sor^tm1(Gck)Ydor/Gt(ROSA)26Sor⁺ Trp53^tm1Brn/Trp53^tm1Brn Tg(Ins2-cre)25Mgn/0 (involves: 129P2/OlaHsd * C57BL/6 * DBA)	hyperglycemia	J:210493
Gt(ROSA)26Sor^tm1(Gck)Ydor/Gt(ROSA)26Sor^{tm1(Kcnj11V59M)Fmas} Tg(Pdx1-cre/Esr1)#Dam/0 (involves: 129S4/SvJae * C57BL/6 * CBA)	hyperglycemia	J:210493
Gt(ROSA)26Sor^{tm1(Gphb5)Lmac}/Gt(ROSA)26Sor⁺ (Not Specified)	decreased circulating cholesterol level	J:96633
	decreased circulating glucose level	J:96633
	decreased circulating insulin level	J:96633
	decreased susceptibility to diet-induced obesity	J:96633
	decreased triglyceride level	J:96633
	increased circulating thyroxine level	J:96633
	increased circulating triiodothyronine level	J:96633
	increased oxygen consumption	J:96633
Gt(ROSA)26Sor^{tm1(H1/tetO-RNAi:Fxn)Dhg}/Gt(ROSA)26Sor⁺ (B6.129-Gt(ROSA)26Sor^{tm1(H1/tetO-RNAi:Fxn)Dhg})	increased heart iron level	J:254962
Gt(ROSA)26Sor^{tm1(H1/tetO-RNAi:Pdpk1)Mrl}/Gt(ROSA)26Sor⁺ (Not Specified)	abnormal glucose homeostasis	J:170965
	hyperglycemia	J:170965
	increased circulating insulin level	J:170965
Gt(ROSA)26Sor^{tm1(HBEGF)Awai}/Gt(ROSA)26Sor⁺ Tg(Gh1-cre)bKnmn/0 (involves: C57BL/6 * FVB/N)	abnormal circulating hormone level	J:169459
	abnormal energy expenditure	J:169459
	abnormal gas homeostasis	J:169459
	abnormal glucose homeostasis	J:169459
	decreased circulating glucose level	J:169459
	decreased circulating growth hormone level	J:169459
	decreased circulating insulin level	J:169459
	decreased circulating insulin-like growth factor I level	J:169459
	decreased energy expenditure	J:169459
	decreased liver triglyceride level	J:169459
	decreased oxygen consumption	J:169459
	impaired glucose tolerance	J:169459
	increased circulating leptin level	J:169459
	increased insulin sensitivity	J:169459
	increased respiratory quotient	J:169459
Gt(ROSA)26Sor^{tm1(HBEGF)Awai}/Gt(ROSA)26Sor^{tm9(CAG-tdTomato)Hze} Oxt^{tm1.1(cre)Dolsn}/Oxt⁺ (involves: 129S6/SvEvTac * C57BL/6)	decreased oxygen consumption	J:192007
	increased susceptibility to diet-induced obesity	J:192007
Gt(ROSA)26Sor^{tm1(Irx3)Hui}/Gt(ROSA)26Sor⁺ Tg(Ins2-cre)25Mgn/0 (involves: C57BL/6 DBA)	improved glucose tolerance	J:208887
	increased energy expenditure	J:208887
Gt(ROSA)26Sor^{tm1(Kcnj11V59M)Fmas}/Gt(ROSA)26Sor⁺ Tg(Ins2-cre)23Herr/0 (involves: 129S4/SvJae C57BL/6)	decreased circulating insulin level	J:144715
	decreased insulin secretion	J:144715
	increased circulating glucagon level	J:144715
	increased circulating glucose level	J:144715
Gt(ROSA)26Sor^{tm1(Kcnj11V59M)Fmas}/Gt(ROSA)26Sor⁺ Tg(Pdx1-cre/Esr1)#Dam/0 (involves: 129S4/SvJae * C57BL/6 * CBA)	hyperglycemia	J:210493
Gt(ROSA)26Sor^{tm1(Mir7-1,-EGFP)Horn}/Gt(ROSA)26Sor⁺ Tg(Pdx1-cre)89.1Dam/0 (involves: 129S/SvEv * C57BL/6 * C57BL/6J * CBA)	decreased glucagon secretion	J:187631
	decreased insulin secretion	J:187631
Gt(ROSA)26Sor^{tm1(Nfatc2)Rao}/Gt(ROSA)26Sor⁺ Tg(Cd4-cre)1Cwi/0 (involves: C57BL/6 DBA/2)	abnormal interferon level	J:148341
Gt(ROSA)26Sor^{tm1(Notch1)Dam}/Gt(ROSA)26Sor⁺ Lep^ob/Lep^ob Tg(Adipoq-cre)1Evdr/0 (involves: 129S4/SvJaeSor * C57BL/6J * FVB/NJ)	hyperglycemia	J:237232
Gt(ROSA)26Sor^{tm1(Notch1)Dam}/Gt(ROSA)26Sor⁺ Tg(Adipoq-cre)1Evdr/0 (involves: 129S4/SvJaeSor * C57BL/6J * FVB/NJ)	decreased susceptibility to diet-induced obesity	J:237232
	hyperglycemia	J:237232
	increased circulating insulin level	J:237232
	insulin resistance	J:237232
Gt(ROSA)26Sor^{tm1(Notch1)Dam}/Gt(ROSA)26Sor⁺ Tg(Neurog3-cre)C1Able/0 (involves: 129S4/SvJaeSor)	hyperglycemia	J:190530
Gt(ROSA)26Sor^{tm1(Notch1)Dam}/Gt(ROSA)26Sor⁺ Tg(Wt1-cre)#Jbeb/0 (involves: 129S4/SvJaeSor)	hemopericardium	J:178290
Gt(ROSA)26Sor^{tm1(OVAL/fla,GFP)Vnce}/Gt(ROSA)26Sor⁺ Lyz2^tm1(cre)Ifo/Lyz2⁺ (involves: 129P2/OlaHsd * C57BL/6J)	abnormal circulating cytokine level	J:260047
	joint swelling	J:260047
Gt(ROSA)26Sor^{tm1(OVAL/fla,GFP)Vnce}/Gt(ROSA)26Sor⁺ Lyz2^tm1(cre)Ifo/Lyz2⁺ Pycard^tm1Vmd/Pycard^tm1Vmd (involves: 129P2/OlaHsd * 129S1/Sv * 129X1/SvJ * C57BL/6J)	increased circulating interferon-gamma level	J:260047
	increased circulating interleukin-6 level	J:260047
	increased circulating tumor necrosis factor level	J:260047
Gt(ROSA)26Sor^{tm1(OVAL/fla,GFP)Vnce}/Gt(ROSA)26Sor⁺ Tg(S100A8-cre,-EGFP)1Ilw/0 (involves: C3H * C57BL/6 * C57BL/6J)	abnormal circulating cytokine level	J:260047
	increased circulating interleukin-18 level	J:260047
	joint swelling	J:260047
Gt(ROSA)26Sor^tm1(ptxA)Cgh/Gt(ROSA)26Sor⁺ Tg(Ins2-cre)25Mgn/0 (involves: 129P2/OlaHsd * C57BL/6 * DBA/2)	abnormal glucose homeostasis	J:130781
	hypoglycemia	J:130781
	improved glucose tolerance	J:130781
	increased circulating insulin level	J:130781
Gt(ROSA)26Sor^tm1(ptxA)Cgh/Gt(ROSA)26Sor⁺ Tg(Pdx1-cre)6Cvw/0 (involves: 129P2/OlaHsd * C57BL/6 * CBA)	improved glucose tolerance	J:130781
Gt(ROSA)26Sor^{tm1(RNU6-RNAi:Trpv1)Thch}/Gt(ROSA)26Sor⁺ (Not Specified)	abnormal body temperature	J:132700
Gt(ROSA)26Sor^{tm1(rtTA,EGFP)Nagy}/Gt(ROSA)26Sor⁺ Speer6-ps1^{Tg(Alb-cre)21Mgn}/Speer6-ps1⁺ Tg(tetO-Xbp1_is)#Pesch/0 (involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * DBA * FVB)	abnormal glucose homeostasis	J:194290
	decreased circulating insulin level	J:194290
	decreased fasting circulating glucose level	J:194290
	decreased liver glycogen level	J:194290
	enhanced lipolysis	J:194290
	hypoglycemia	J:194290
	increased circulating free fatty acids level	J:194290
	increased insulin sensitivity	J:194290
	increased liver triglyceride level	J:194290
	increased respiratory quotient	J:194290
Gt(ROSA)26Sor^{tm1(rtTA,EGFP)Nagy}/Gt(ROSA)26Sor⁺ Tg(CAG-cre)1Nagy/0 Tg(tetO-Vegfa)90Ala/0 (involves: 129S1/Sv * 129X1/SvJ * FVB/N * ICR)	edema	J:99607
Gt(ROSA)26Sor^{tm1(rtTA,EGFP)Nagy}/Gt(ROSA)26Sor⁺ Tg(Nphs2-cre)1Seq/0 Tg(tetO-Vegfa)90Ala/0 (involves: 129S1/Sv * 129X1/SvJ * FVB/N * ICR)	albuminuria	J:99607
Gt(ROSA)26Sor^{tm1(Sirt1)Ktm}/Gt(ROSA)26Sor⁺ Tg(Agrp-cre)1Gsb/0 (involves: 129 * C57BL/6J * FVB/N)	abnormal homeostasis	J:209418
Gt(ROSA)26Sor^{tm1(Sirt1)Ktm}/Gt(ROSA)26Sor⁺ Tg(Pomc1-cre)16Lowl/0 (involves: 129 * C57BL/6J * FVB/N)	abnormal homeostasis	J:209418
	decreased circulating thyroxine level	J:209418
	decreased susceptibility to induced hypothermia	J:209418
	increased energy expenditure	J:209418
	increased oxygen consumption	J:209418
Gt(ROSA)26Sor^{tm1(Stat3A661CN663C)Sbkv}/Gt(ROSA)26Sor^{tm1(Stat3A661CN663C)Sbkv} Tg(Agrp-cre)1Gsb/? (involves: C57BL/6 * FVB/N)	abnormal glucose homeostasis	J:133218
	decreased circulating adrenaline level	J:133218
	decreased circulating glucose level	J:133218
	decreased circulating insulin level	J:133218
	decreased circulating noradrenaline level	J:133218
	improved glucose tolerance	J:133218
	increased oxygen consumption	J:133218
Gt(ROSA)26Sor^{tm1(Stat3A661CN663C)Sbkv}/Gt(ROSA)26Sor^{tm1(Stat3A661CN663C)Sbkv} Tg(Cd4-cre)1Cwi/0 (involves: C57BL/6 * DBA/2)	increased circulating interleukin-17 level	J:205858
Gt(ROSA)26Sor^{tm1(Tfrc)Nca}/Gt(ROSA)26Sor⁺ Hfe^tm2Nca/Hfe^tm2Nca (involves: 129S4/SvJae 129S6/SvEvTac * FVB/N)	increased circulating iron level	J:133221
	increased liver iron level	J:133221
Gt(ROSA)26Sor^{tm1(Tfrc)Nca}/Gt(ROSA)26Sor^{tm1(Tfrc)Nca} (involves: 129S4/SvJae * FVB/N)	increased circulating iron level	J:133221
	increased heart iron level	J:133221
	increased liver iron level	J:133221
Gt(ROSA)26Sor^{tm1.1(Aco1)Mwh}/Gt(ROSA)26Sor^{tm1.1(Aco1)Mwh} (B6.129P2(129S1)-Gt(ROSA)26Sor^{tm1.1(Aco1*)Mwh})	increased intestinal iron level	J:196374
	increased liver iron level	J:196374
	increased spleen iron level	J:196374
Gt(ROSA)26Sor^{tm1.1(Alb-PCSK9)Mby}/Gt(ROSA)26Sor⁺ (involves: C57BL/6 * C57BL/6N)	increased circulating cholesterol level	J:280156
	increased circulating LDL cholesterol level	J:280156
Gt(ROSA)26Sor^{tm1.1(CAG-Fto)Rdc}/Gt(ROSA)26Sor⁺ (involves: 129S1/Sv * 129X1/SvJ * C57BL/6J * SJL)	abnormal circulating lipid level	J:166829
	abnormal hormone level	J:166829
	decreased adiponectin level	J:166829
	decreased circulating LDL cholesterol level	J:166829
	increased circulating free fatty acids level	J:166829
	increased circulating HDL cholesterol level	J:166829
	increased circulating leptin level	J:166829
	increased circulating triglyceride level	J:166829
	increased susceptibility to diet-induced obesity	J:166829
Gt(ROSA)26Sor^{tm1.1(CAG-Fto)Rdc}/Gt(ROSA)26Sor^{tm1.1(CAG-Fto)Rdc} (involves: 129S1/Sv * 129X1/SvJ * C57BL/6J * SJL)	abnormal circulating lipid level	J:166829
	abnormal hormone level	J:166829
	decreased adiponectin level	J:166829
	decreased circulating LDL cholesterol level	J:166829
	decreased circulating leptin level	J:166829
	impaired glucose tolerance	J:166829
	increased circulating free fatty acids level	J:166829
	increased circulating HDL cholesterol level	J:166829
	increased circulating insulin level	J:166829
	increased circulating triglyceride level	J:166829
	increased energy expenditure	J:166829
	increased susceptibility to diet-induced obesity	J:166829
Gt(ROSA)26Sor^{tm1.1(CAG-Upp1,-GFP)Gp}/Gt(ROSA)26Sor⁺ (involves: C57BL/6 * FVB/N)	decreased fatty acid beta-oxidation	J:195165
Gt(ROSA)26Sor^{tm1.1(CAG-YFP/DROSHAE1147K)Gess}/Gt(ROSA)26Sor^{tm1.1(CAG-YFP/DROSHAE1147K)Gess} Tg(Six2-EGFP/cre)1Amc/0 (involves: 129S6/SvEvTac * C57BL/6 * CD-1)	increased urine protein level	J:321428
Gt(ROSA)26Sor^{tm1.1(Mir26a-1)Coh}/Gt(ROSA)26Sor⁺ Tg(Ins2-cre)25Mgn/0 (involves: C57BL/6 * DBA)	decreased circulating insulin level	J:286108
	decreased fasting circulating glucose level	J:286108
	decreased insulin secretion	J:286108
	decreased susceptibility to diet-induced obesity	J:286108
	improved glucose tolerance	J:286108
	increased insulin sensitivity	J:286108
Gt(ROSA)26Sor^{tm1.1(Ubc-ROCK1*)Dnsh}/Gt(ROSA)26Sor⁺ Tg(NPHS2-icre/ERT2)1Dnsh/0 (involves: C57BL/6)	albuminuria	J:182287
Gt(ROSA)26Sor^tm1Fia/Gt(ROSA)26Sor⁺ Hprt1^{tm1(CMV-cre)Brd}/Hprt1⁺ Nf1^tm1Fcr/Nf1^tm1Fcr (involves: 129S/SvEv * 129S/SvEvBrd)	abnormal enzyme/coenzyme level	J:114455
Gt(ROSA)26Sor^tm1Fia/Gt(ROSA)26Sor⁺ Nf1^tm1Par/Nf1^tm1Par Tg(Fabp7-cre,-lacZ)3Gtm/0 (involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * CBA)	decreased circulating growth hormone level	J:138868
Gt(ROSA)26Sor^tm1Sor/Gt(ROSA)26Sor⁺ Nr2f2^tm2.1Tsa/Nr2f2^tm2.1Tsa Prox1^{tm3(cre/ERT2)Gco}/Prox1⁺ (involves: 129S1/Sv * 129S4/SvJaeSor * 129S7/SvEvBrd * C57BL/6)	edema	J:158959
Gt(ROSA)26Sor^tm1Sor/Gt(ROSA)26Sor^tm1Sor Tg(NPHS2-rtTA2M2)1Jbk/Tg(NPHS2-rtTA2M2)1Jbk Tg(tetO-cre)LC1Bjd/Tg(tetO-cre)LC1Bjd (involves: 129S4/SvJaeSor * BALB/c * C57BL/6 * FVB/N)	increased urine protein level	J:285673
Gt(ROSA)26Sor^{tm2(H1/tetO-RNAi:Kdm1a)Arte}/Gt(ROSA)26Sor⁺ (involves: C57BL/6)	increased circulating erythropoietin level	J:192055
Gt(ROSA)26Sor^{tm2(ITK/Syk)Hjum}/Gt(ROSA)26Sor⁺ Tg(Cd4-cre)1Cwi/0 (involves: 129S6/SvEvTac * C57BL/6 * DBA/2)	abnormal circulating cytokine level	J:207306
	increased circulating interferon-gamma level	J:207306
	increased circulating interleukin-2 level	J:207306
	increased circulating interleukin-4 level	J:207306
	increased circulating interleukin-6 level	J:207306
	increased circulating interleukin-10 level	J:207306
	increased circulating tumor necrosis factor level	J:207306
Gt(ROSA)26Sor^{tm2(ITK/Syk)Hjum}/Gt(ROSA)26Sor⁺ Tg(Lck-cre)I57Jxm/0 (involves: 129S6/SvEvTac * ICR)	abnormal circulating cytokine level	J:207306
	increased circulating interferon-gamma level	J:207306
	increased circulating interleukin-2 level	J:207306
	increased circulating interleukin-4 level	J:207306
	increased circulating interleukin-6 level	J:207306
	increased circulating interleukin-10 level	J:207306
	increased circulating tumor necrosis factor level	J:207306
Gt(ROSA)26Sor^{tm2(Nfatc2)Rao}/Gt(ROSA)26Sor⁺ Tg(Cd4-cre)1Cwi/0 (involves: C57BL/6 DBA/2)	abnormal interferon level	J:148341
Gt(ROSA)26Sor^{tm2(OVA/EGFP)Dwir}/Gt(ROSA)26Sor⁺ Tg(TcraTcrb)1100Mjb/0 Alb^{tm1(cre/ERT2)Mtz}/Alb⁺ (involves: 129P2/OlaHsd * 129S2/SvPas * C57BL/6)	increased circulating alanine transaminase level	J:173806
Gt(ROSA)26Sor^{tm2(SNCA119)Djmo}/Gt(ROSA)26Sor^{tm2(SNCA119)Djmo} 7630403G23Rik^{Tg(Th-cre)1Tmd}/7630403G23Rik⁺ (involves: 129 * C57BL/6)	decreased dopamine level	J:150777
	increased circulating noradrenaline level	J:150777
	increased serotonin level	J:150777
Gt(ROSA)26Sor^{tm2(SNCA119)Djmo}/Gt(ROSA)26Sor^{tm2(SNCA119)Djmo} 7630403G23Rik^{Tg(Th-cre)1Tmd}/7630403G23Rik⁺ (involves: 129 * C57BL/6 * SJL)	decreased dopamine level	J:150777
	increased noradrenaline level	J:150777
	increased serotonin level	J:150777
Gt(ROSA)26Sor^{tm2.1(CAG-PSTPIP1)Dtg}/Gt(ROSA)26Sor⁺ (involves: BALB/cJ C57BL/6)	increased circulating interleukin-1 alpha level	J:196002
	increased circulating interleukin-1 beta level	J:196002
	increased circulating tumor necrosis factor level	J:196002
Gt(ROSA)26Sor^{tm3(CAG-Il17a)Awai}/Gt(ROSA)26Sor⁺ Tg(Cd4-cre)1Cwi/0 (involves: C57BL/6 * DBA/2)	increased circulating interleukin-17 level	J:144710
Gt(ROSA)26Sor^{tm3(CAG-MIR17-92,-EGFP)Rsky}/Gt(ROSA)26Sor^{tm3(CAG-MIR17-92,-EGFP)Rsky} Tg(CD2-icre)4Kio/0 (involves: C57BL/6 * C57BL/10 * CBA/Ca)	increased urine protein level	J:133215
Gt(ROSA)26Sor^{tm3(H1/tetO-RNAi:Mir143)Jcbr}/Gt(ROSA)26Sor⁺ (involves: 129S6/SvEvTac * C57BL/6)	impaired glucose tolerance	J:176266
	increased circulating insulin level	J:176266
	insulin resistance	J:176266
Gt(ROSA)26Sor^{tm3(Irf4)Evdr}/Gt(ROSA)26Sor⁺ Tg(Ucp1-cre)1Evdr/0 (involves: 129 * C57BL/6J * FVB)	improved glucose tolerance	J:214637
	increased carbon dioxide production	J:214637
	increased energy expenditure	J:214637
	increased insulin sensitivity	J:214637
	increased oxygen consumption	J:214637
Gt(ROSA)26Sor^{tm3(tetO-Mir193)Arte}/Gt(ROSA)26Sor⁺ (involves: 129 * BALB/c * C57BL/6)	albuminuria	J:197989
Gt(ROSA)26Sor^{tm3(tetO-Mir193)Arte}/Gt(ROSA)26Sor^{tm3(tetO-Mir193)Arte} (involves: 129 * BALB/c * C57BL/6)	albuminuria	J:197989
Gt(ROSA)26Sor^{tm4(Wnt7b)Flng}/Gt(ROSA)26Sor⁺ Tg(Col1a1-cre)1Ack/0 (involves: FVB/N)	increased circulating osteocalcin level	J:208766
	increased circulating type I collagen C-terminal telopeptide level	J:208766
Gt(ROSA)26Sor^{tm7(CAG-mCherry,-EGFP/tetX)Dym}/Gt(ROSA)26Sor⁺ Tmem163^{Tg(ACTB-cre)2Mrt}/0 Tg(Fev-flpe)1Dym/0 (involves: 129S6/SvEvTac * FVB/N)	abnormal oxygen consumption	J:231745
Gt(ROSA)26Sor^{tm8(RNAi:Crhr1)Rkuhn}/Gt(ROSA)26Sor⁺ (involves: 129S6/SvEvTac * C57BL/6J)	decreased circulating corticosterone level	J:151155
Gt(ROSA)26Sor^{tm9(cre/ESR1)Arte}/? Tnfaip3^tm1Homy/Tnfaip3^tm1Homy (involves: 129S6/SvEvTac * C57BL/6J * C57BL/6NTac)	abnormal circulating cytokine level	J:212681
	abnormal circulating interleukin level	J:212681
	increased circulating interferon-gamma level	J:212681
	increased circulating interleukin-1 beta level	J:212681
	increased circulating interleukin-6 level	J:212681
	increased circulating tumor necrosis factor level	J:212681
Gt(ROSA)26Sor^{tm9(cre/ESR1)Arte}/Gt(ROSA)26Sor⁺ Ripk3^tm1Arte/Ripk3^tm1Arte (involves: C57BL/6NTac)	intestinal edema	J:209137
Gt(ROSA)26Sor^{tm31(H1/tetO-RNAi:Insr)Arte}/Gt(ROSA)26Sor⁺ (involves: C57BL/6)	hyperglycemia	J:151686
	insulin resistance	J:151686
Gtf2e2^{tm1b(EUCOMM)Wtsi}/Gtf2e2⁺ (C57BL/6N-Gtf2e2^{tm1b(EUCOMM)Wtsi}/H)	increased circulating creatinine level	J:211773
Gtf2ird1^{Tg(Alb1-Myc)166.8Sst}/Gtf2ird1^{Tg(Alb1-Myc)166.8Sst} (involves: C57BL/6J * CBA/J)	increased circulating corticosterone level	J:190478
	increased response to stress-induced hyperthermia	J:190478
Gtf2ird1^tm1Hrd/Gtf2ird1^tm1Hrd (involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)	decreased body temperature	J:182346
	increased circulating corticosterone level	J:182346
Gtf2ird1^tm1Lro/Gtf2ird1^tm1Lro (involves: 129S1/Sv * 129X1/SvJ * CD-1)	abnormal serotonin level	J:145599
Gtpbp10^{tm1b(KOMP)Mbp}/Gtpbp10^{tm1b(KOMP)Mbp} (C57BL/6N-Gtpbp10^{tm1b(KOMP)Mbp}/J)	decreased fasting circulating glucose level	J:211773
	increased circulating creatinine level	J:211773
Guca2b^tm1Lorz/Guca2b^tm1Lorz (involves: 129X1/SvJ * Black Swiss)	abnormal urine homeostasis	J:86148
	decreased urine potassium level	J:86148
	decreased urine sodium level	J:86148
	increased circulating sodium level	J:86148
Gucy1a1^tm1.1Dko/Gucy1a1^tm1.1Dko (involves: C57BL/6)	abnormal platelet aggregation	J:110362
Gucy1b1^tm1.1Frb/Gucy1b1^tm1.1Frb (involves: 129 * C57BL/6 * FVB/N)	abnormal platelet activation	J:121321
Gucy1b1^tm1Zhen/Gucy1b1^tm1Zhen Tg(Pf4-icre)Q3Rsko/0 (involves: 129P2/OlaHsd * C57BL/6J)	abnormal platelet physiology	J:177066
	decreased platelet aggregation	J:177066
	decreased susceptibility to induced thrombosis	J:177066
	increased bleeding time	J:177066
Gucy1b2^tm2Mom/Gucy1b2^tm2Mom Trpc2^tm2Mom/Trpc2^tm2Mom (B6;129P2-Trpc2^tm2Mom Gucy1b2^tm2Mom/Mom)	abnormal homeostasis	J:235858
Gucy2c^tm1Gar/Gucy2c^tm1Gar (B6.129S6-Gucy2c^tm1Gar)	impaired glucose tolerance	J:178241
	increased circulating insulin level	J:178241
	increased circulating leptin level	J:178241
	increased liver triglyceride level	J:178241
Guf1^tm1.1Nju/Guf1^tm1.1Nju (involves: 129 * C57BL/6 * FVB/N)	decreased follicle stimulating hormone level	J:333298
	decreased luteinizing hormone level	J:333298
	increased circulating testosterone level	J:333298
Gulo^{em1(IMPC)Ccpcz}/Gulo^{em1(IMPC)Ccpcz} (C57BL/6NCrl-Gulo^{em1(IMPC)Ccpcz}/Ccpcz)	increased circulating cholesterol level	J:211773
	increased circulating HDL cholesterol level	J:211773
Gulo^sfx/Gulo^sfx (BALB/cBy-Gulo^sfx/J)	decreased circulating alkaline phosphatase level	J:66648
	decreased circulating calcium level	J:66648
	decreased circulating insulin-like growth factor I level	J:66648
	decreased circulating phosphate level	J:66648
Gulo^tm1Mae/Gulo^tm1Mae (involves: 129 * C57BL/6)	abnormal vitamin C level	J:59931
	decreased circulating HDL cholesterol level	J:59931
	increased circulating cholesterol level	J:59931
Gulo^tm1Mae/Gulo^tm1Mae (involves: C57BL/6)	abnormal vitamin C level	J:164548
Gusb^mps/Gusb^mps (involves: C57BL/6By)	decreased circulating cholesterol level	J:13923
Gusb^mps/Gusb^mps (involves: C57BL/6By)	increased urine glycosaminoglycan level	J:87155
Gusb^mps/Gusb^mps (B6.Cg-Gusb^mps/BrkJ)	abnormal enzyme/coenzyme level	J:21256
Gusb^tm1Sly/Gusb^tm1Sly (involves: 129X1/SvJ * C57BL/6J)	increased urine glycosaminoglycan level	J:81792
Gusb^tm2Sly/Gusb^tm2Sly (involves: 129X1/SvJ * C57BL/6J)	increased urine glycosaminoglycan level	J:81792
Gusb^tm3Sly/Gusb^tm3Sly (involves: 129X1/SvJ * C57BL/6J)	increased urine glycosaminoglycan level	J:81792
Gxylt1^em1(IMPC)Bay/Gxylt1^em1(IMPC)Bay (C57BL/6N-Gxylt1^em1(IMPC)Bay/Bay)	edema	J:211773
Gy/Y (involves: C3H/Sn * C57BL/6Ei)	decreased circulating calcium level	J:88352
Gy/Y (involves: C3H/Sn * C57BL/6Ei)	decreased circulating potassium level	J:88352
Gy/Y (involves: 101/H * C3H/HeH)	abnormal urine nucleotide level	J:8335
	decreased circulating phosphate level	J:8335
	increased circulating alkaline phosphatase level	J:8335
	increased urine phosphate level	J:8335
Gy/Y (B6.Cg-Gy)	abnormal calcium ion homeostasis	J:17152
Gy/Y (B6.Cg-Gy)	decreased circulating phosphate level	J:17152
Gy/Y (involves: 101/H * C3H/HeH * C3H/HeSnJ * C57BL/6J)	abnormal calcium ion homeostasis	J:17152
Gy/Y (involves: 101/H * C3H/HeH * C3H/HeSnJ * C57BL/6J)	decreased circulating phosphate level	J:17152
Gy/Gy (B6.Cg-Gy)	decreased circulating phosphate level	J:17152
Gy/Gy (involves: 101/H * C3H/HeH * C3H/HeSnJ * C57BL/6J)	decreased circulating phosphate level	J:17152
Gy/Gy⁺ (involves: 101/H * C3H/HeH)	decreased circulating phosphate level	J:8335
Gyg1^{tm1a(KOMP)Wtsi}/Gyg1⁺ (involves: C57BL/6N)	increased cardiac muscle glycogen level	J:244440
Gyg1^{tm1a(KOMP)Wtsi}/Gyg1⁺ (involves: C57BL/6N)	increased skeletal muscle glycogen level	J:244440
Gyg1^{tm1a(KOMP)Wtsi}/Gyg1^{tm1a(KOMP)Wtsi} (involves: C57BL/6N)	abnormal glucose homeostasis	J:244440
	abnormal glycogen homeostasis	J:244440
	abnormal lipid oxidation	J:244440
	decreased carbon dioxide production	J:244440
	decreased energy expenditure	J:244440
	decreased lung glycogen level	J:300001
	decreased oxygen consumption	J:244440
	increased cardiac muscle glycogen level	J:244440
	increased skeletal muscle glycogen level	J:244440
Gypc^{em1(IMPC)Rbrc}/Gypc^{em1(IMPC)Rbrc} (C57BL/6NJcl-Gypc^{em1(IMPC)Rbrc}/Rbrc)	decreased glycosylated hemoglobin level	J:211773
Gys1^em1(IMPC)Bay/Gys1^em1(IMPC)Bay (C57BL/6N-Gys1^em1(IMPC)Bay/BayMmucd)	edema	J:211773
Gys1^{Gt(OST33395)Lex}/Gys1^{Gt(OST33395)Lex} (involves: 129S5/SvEvBrd * 129X1/SvJ * C57BL/6J)	decreased glycogen level	J:92245
Gys1^tm1.1Arte/Gys1⁺ (involves: C57BL/6J)	abnormal glycogen homeostasis	J:167911
Gys1^tm1.1Arte/Gys1⁺ (involves: C57BL/6J)	decreased skeletal muscle glycogen level	J:167911
Gys1^tm1.1Arte/Gys1^tm1.1Arte (involves: C57BL/6J)	abnormal glycogen homeostasis	J:167911
	decreased skeletal muscle glycogen level	J:167911
	increased glycogen catabolism rate	J:167911
Gys1^{tm1a(EUCOMM)Wtsi}/Gys1^{tm1a(EUCOMM)Wtsi} (involves: C57BL/6N)	decreased lung glycogen level	J:300001
Gys1^{tm1c(EUCOMM)Wtsi}/Gys1^{tm1c(EUCOMM)Wtsi} Tg(Nes-cre)1Kln/0 (involves: C57BL/6 * C57BL/6J * C57BL/6N * SJL)	decreased brain glycogen level	J:218886
Gys2^m1Btlr/Gys2^m1Btlr (C57BL/6J-Gys2^m1Btlr)	decreased fasting circulating glucose level	J:265256
Gys2^m2Btlr/Gys2^m2Btlr (C57BL/6J-Gys2^m2Btlr)	decreased fasting circulating glucose level	J:265257
Gys2^m3Btlr/Gys2^m3Btlr (C57BL/6J-Gys2^m3Btlr)	impaired glucose tolerance	J:265258
Gys2^tm1.1Arte/Gys2⁺ (Not Specified)	decreased glycogen catabolism rate	J:208923
	impaired glucose tolerance	J:208923
	increased liver triglyceride level	J:208923
Gys2^tm1.1Arte/Gys2^tm1.1Arte (Not Specified)	abnormal gluconeogenesis	J:208923
	abnormal glucose homeostasis	J:208923
	decreased circulating glucose level	J:208923
	decreased circulating insulin level	J:208923
	decreased glycogen catabolism rate	J:208923
	decreased liver glycogen level	J:208923
	impaired glucose tolerance	J:208923
	increased liver triglyceride level	J:208923
	insulin resistance	J:208923
Gys2^tm1.1Pro/Gys2^tm1.1Pro Speer6-ps1^{Tg(Alb-cre)21Mgn}/Speer6-ps1⁺ (involves: 129S6/SvEvTac * C57BL/6 * C57BL/6J * DBA)	abnormal circulating ketone body level	J:162043
	abnormal gluconeogenesis	J:162043
	abnormal glucose homeostasis	J:162043
	abnormal triglyceride level	J:162043
	decreased circulating glucose level	J:162043
	decreased circulating insulin level	J:162043
	decreased glycogen catabolism rate	J:162043
	decreased glycogen level	J:162043
	impaired glucose tolerance	J:162043
	increased liver triglyceride level	J:162043
Gys2^{tm1a(KOMP)Wtsi}/Gys2^{tm1a(KOMP)Wtsi} (B6J.B6N-Gys2^{tm1a(KOMP)Wtsi})	decreased liver glycogen level	J:208923
Gys2^{tm1a(KOMP)Wtsi}/Gys2^{tm1a(KOMP)Wtsi} (B6JTyr;B6N-Gys2^{tm1a(KOMP)Wtsi}/Wtsi)	decreased circulating glucose level	J:175295, J:165965
	decreased circulating glycerol level	J:175295
	increased circulating calcium level	J:165965
	increased circulating chloride level	J:165965
	increased circulating sodium level	J:165965
	increased circulating total protein level	J:165965
Gzf1^em1(IMPC)Tcp/Gzf1⁺ (C57BL/6NCrl-Gzf1^em1(IMPC)Tcp/Tcp)	decreased circulating alkaline phosphatase level	J:211773
Gzf1^em1(IMPC)Tcp/Gzf1^em1(IMPC)Tcp (C57BL/6NCrl-Gzf1^em1(IMPC)Tcp/Tcp)	decreased circulating alkaline phosphatase level	J:211773
	decreased circulating total protein level	J:211773
H1f8^{tm1b(KOMP)Wtsi}/H1f8^{tm1b(KOMP)Wtsi} (C57BL/6N-H1f8^{tm1b(KOMP)Wtsi}/Tcp)	improved glucose tolerance	J:211773
	increased circulating alanine transaminase level	J:211773
	increased circulating aspartate transaminase level	J:211773
H1f10^{tm1.1(KOMP)Vlcg}/H1f10⁺ (C57BL/6N-H1f10^{tm1.1(KOMP)Vlcg}/J)	increased circulating aspartate transaminase level	J:211773
	increased circulating free fatty acids level	J:211773
	increased circulating sodium level	J:211773
H1f10^{tm1.1(KOMP)Vlcg}/H1f10^{tm1.1(KOMP)Vlcg} (C57BL/6N-H1f10^{tm1.1(KOMP)Vlcg}/J)	increased fasting circulating glucose level	J:211773
H2-Ab1^b-tm1Gru/H2-Ab1^b-tm1Gru Tg(CD4,HLA-DQA1,HLA-DQB1)N8Ell/Tg(CD4,HLA-DQA1,HLA-DQB1)N8Ell (NOD.Cg-H2-Ab1^b-tm1Gru Tg(CD4,HLA-DQA1,HLA-DQB1)N8Ell)	increased circulating thyroid-stimulating hormone level	J:113509
H2-Ab1^b-tm1Gru/H2-Ab1^b-tm1Gru Tg(HLA-DQA1,HLA-DQB1)1Dv/0 Tg(Ins2-CD80)3B7Flv/0 (B6.Cg-H2-Ab1^b-tm1Gru Tg(HLA-DQA1,HLA-DQB1)1Dv Tg(Ins2-CD80)3B7Flv)	increased circulating glucose level	J:59245
	increased urine glucose level	J:59245
H2-Ab1^b-tm1Gru/H2-Ab1^b-tm1Gru Tg(HLA-DQA1,HLA-DQB1)1Dv/0 Tg(Ins2-CD80)3B7Flv/0 (involves: 129S2/SvPas * C57BL/6 * C57BL/10SnJ * CBA)	increased circulating glucose level	J:68641
	increased urine glucose level	J:68641
H2-Ab1^b-tm1Gru/H2-Ab1^b-tm1Gru Tg(HLA-DQA1,HLA-DQB1)73Myl/0 (NOD.Cg-H2-Ab1^b-tm1Gru Tg(HLA-DQA1,HLA-DQB1)73Myl)	abnormal atrial thrombosis	J:88055
	cyanosis	J:88055
	edema	J:88055
	pleural effusion	J:88055
H2-Ab1^bm12/H2-Ab1^bm12 (NZB.B6(C)-H2-Ab1^bm12)	increased urine protein level	J:104189
H2-M3^tm1Crw/H2-M3^tm1Crw (B6.129-H2-M3^tm1Crw)	decreased macrophage nitric oxide production	J:118960
H2-T24^{em1(IMPC)Wtsi}/H2-T24^{em1(IMPC)Wtsi} (C57BL/6N-H2-T24^{em1(IMPC)Wtsi}/Wtsi)	decreased circulating total protein level	J:211773
	increased circulating bilirubin level	J:211773
H2^b/H2^g7 Tg(TcraR28,TcrbR28)KRNDim/0 (involves: C57BL/6 * NOD * SJL)	increased hydroxyproline level	J:275827
H2^g7/H2^g7 Ins2^tm1Jja/Ins2^tm1Jja Rag1^tm1Mom/Rag1^tm1Mom Tg(TcraBDC12-4.1)10Jos/0 Tg(TcrbBDC12-4.1)82Gse/0 (involves: 129S2/SvPas * 129S7/SvEvBrd * C57BL/6 * FVB * NOD)	increased circulating glucose level	J:111874
H2ab3^{em1(IMPC)Wtsi}/H2ab3^{em1(IMPC)Wtsi} (C57BL/6N-H2ab3^{em1(IMPC)Wtsi}/WtsiOulu)	decreased circulating serum albumin level	J:211773
	decreased circulating total protein level	J:211773
H2az1^em1(IMPC)J/H2az1⁺ (C57BL/6NJ-H2az1^em1(IMPC)J/Mmjax)	decreased circulating calcium level	J:211773
	decreased circulating phosphate level	J:211773
	decreased circulating total protein level	J:211773
H3f3b^{tm1.1(KOMP)Mbp}/H3f3b^{tm1.1(KOMP)Mbp} (C57BL/6N-H3f3b^{tm1.1(KOMP)Mbp}/Tcp)	increased circulating cholesterol level	J:211773
H6pd^{tm1c(EUCOMM)Wtsi}/H6pd^{tm1c(EUCOMM)Wtsi} Tg(Adipoq-cre)1Evdr/0 (involves: C57BL/6N * FVB/NJ)	abnormal corticosterone level	J:292236
	decreased circulating free fatty acids level	J:292236
	decreased circulating insulin level	J:292236
	decreased fasting circulating glucose level	J:292236
	impaired lipolysis	J:292236
	improved glucose tolerance	J:292236
	increased insulin sensitivity	J:292236
H6pd^tm1Pmst/H6pd^tm1Pmst (involves: 129P2/OlaHsd * C57BL/6)	decreased circulating corticosterone level	J:189132, J:108281
	decreased circulating glucose level	J:189132
	increased skeletal muscle glycogen level	J:189132
H6pd^tm1Pmst/H6pd^tm1Pmst Hsd11b1^tm1.1Ggla/Hsd11b1^tm1.1Ggla (involves: 129P2/OlaHsd * C57BL/6 * FVB/N)	decreased circulating glucose level	J:189132
	increased skeletal muscle glycogen level	J:189132
H13^{tm1b(KOMP)Wtsi}/H13⁺ (C57BL/6N-H13^{tm1b(KOMP)Wtsi}/Wtsi)	decreased fasting circulating glucose level	J:211773
H13^{tm1b(KOMP)Wtsi}/H13^{tm1b(KOMP)Wtsi} (C57BL/6N-H13^{tm1b(KOMP)Wtsi}/Wtsi)	subcutaneous edema	J:239583
Haao^{tm2b(KOMP)Mbp}/Haao^{tm2b(KOMP)Mbp} (C57BL/6N-Haao^{tm2b(KOMP)Mbp}/Ucd)	increased circulating glucose level	J:211773
Hacd1^em1(IMPC)Mbp/Hacd1⁺ (C57BL/6NCrl-Hacd1^em1(IMPC)Mbp/MbpMmucd)	edema	J:211773
Hacd1^em1(IMPC)Mbp/Hacd1^em1(IMPC)Mbp (C57BL/6NCrl-Hacd1^em1(IMPC)Mbp/MbpMmucd)	edema	J:211773
Hacd2^{tm1a(EUCOMM)Hmgu}/Hacd2^{tm1a(EUCOMM)Hmgu} (involves: C57BL/6N)	hypoglycemia	J:333944
	increased circulating lactate level	J:333944
	lactic acidosis	J:333944
Hacd2^{tm1b(EUCOMM)Hmgu}/Hacd2^{tm1b(EUCOMM)Hmgu} (involves: C57BL/6N)	abnormal lipid oxidation	J:333944
	abnormal phospholipid level	J:333944
	hemopericardium	J:333944
	pericardial edema	J:333944
Hadh^{Gt(RRM279)Byg}/Hadh^{Gt(RRM279)Byg} (B6.129P2-Hadh^{Gt(RRM279)Byg})	abnormal body temperature homeostasis	J:179084
	abnormal fatty acid oxidation	J:179084
	abnormal lipid homeostasis	J:179084
	abnormal urine homeostasis	J:179084
	decreased circulating glucose level	J:179084
	decreased circulating ketone body level	J:179084
	decreased respiratory quotient	J:179084
	decreased susceptibility to diet-induced obesity	J:179084
	increased body temperature	J:179084
	increased circulating free fatty acids level	J:179084
	increased circulating insulin level	J:179084
	increased circulating triglyceride level	J:179084
	increased insulin secretion	J:179084
Hadh^tm1Csta/Hadh^tm1Csta (involves: 129S1/Sv * 129X1/SvJ * NIH Black Swiss)	abnormal fatty acids level	J:166803
	abnormal glucose homeostasis	J:166803
	aciduria	J:166803
	decreased circulating glucose level	J:166803
	increased circulating insulin level	J:166803
	increased fatty acids level	J:166803
Hadha^tm1Jib/Hadha⁺ (involves: 129X1/SvJ * NIH Black Swiss)	increased circulating free fatty acids level	J:101304
	increased circulating insulin level	J:101304
	insulin resistance	J:101304
Hadha^tm1Jib/Hadha^tm1Jib (involves: 129X1/SvJ * NIH Black Swiss)	abnormal blood homeostasis	J:69846
	abnormal urine homeostasis	J:69846
	decreased circulating carnitine level	J:69846
	hypoglycemia	J:69846
	increased blood urea nitrogen level	J:69846
	increased circulating alanine transaminase level	J:69846
	increased circulating bilirubin level	J:69846
	increased circulating carnitine level	J:69846
Hadhb^em1(IMPC)Bay/Hadhb⁺ (C57BL/6N-Hadhb^em1(IMPC)Bay/BayMmucd)	decreased fasting circulating glucose level	J:211773
Hadhb^m1Ytc/Hadhb^m1Ytc (C57BL/6J-Hadhb^m1Yuan)	abnormal lipid homeostasis	J:117738
Hadhb^m1Ytc/Hadhb^m1Ytc (C57BL/6J-Hadhb^m1Yuan)	decreased circulating glucose level	J:117738
Hal^his/Hal^his (involves: C57BL/6)	histidinuria	J:184587
Hamp/Hamp2^{tm1.1(HAMP)Bjs}/Hamp/Hamp2^{tm1.1(HAMP)Bjs} (involves: 129 * NTac:NIHBS)	increased circulating iron level	J:203898
Hamp/Hamp2^{tm1.1(HAMP)Bjs}/Hamp/Hamp2^{tm1.1(HAMP)Bjs} (involves: 129 * NTac:NIHBS)	increased circulating iron level	J:203898
Hamp^{tm1.1(HAMP)Bjs}/Hamp^{tm1.1(HAMP)Bjs} (involves: 129 * NTac:NIHBS)	increased circulating iron level	J:203898
Hamp^tm1Svl/Hamp^tm1Svl (involves: 129S2/SvPas * C57BL/6)	abnormal circulating iron level	J:119004
	decreased spleen iron level	J:119004
	hemosiderosis	J:119004
	increased circulating ferritin level	J:119004
Hamp^tm2.1Svl/Hamp^tm2.1Svl (involves: FVB/N)	abnormal iron level	J:211683
	increased circulating iron level	J:211683
	increased liver iron level	J:211683
Hand1^tm1Eno/Hand1⁺ Hand2os1^em1Eno/Hand2os1⁺ (involves: 129S7/SvEvBrd * C57BL/6)	pericardial effusion	J:241318
Hand1^tm1Eno/Hand1^tm2Eno Tg(Myh6-cre)2182Mds/0 (either: (involves: 129S6/SvEvTac * Black Swiss) or (involves: 129S6/SvEvTac * C57BL/6))	cyanosis	J:94514
Hand1^{tm2.1(Hand1)Abfi}/Hand1^{tm2.1(Hand1)Abfi} (Not Specified)	hemopericardium	J:164028
Hand1^tm5Abfi/Hand1⁺ Nkx2-5^tm1(cre)Rjs/Nkx2-5⁺ (involves: 129S7/SvEvBrd)	cardiac edema	J:311466
Hand2^tm1Cse/Hand2^tm1Dsr H2az2^{Tg(Wnt1-cre)11Rth}/H2az2⁺ (involves: 129S1/Sv * 129S7/SvEvBrd * C57BL/6 * CBA)	abnormal enzyme/coenzyme level	J:122604
Hand2^tm1Dsr/Hand2^tm1Dsr (involves: 129S7/SvEvBrd)	edema	J:62028
Hand2^tm1Dsr/Hand2^tm1Dsr (involves: 129S7/SvEvBrd)	pericardial effusion	J:40768
Hand2^tm1Dsr/Hand2^tm1Dsr Nkx2-5^tm1Wehi/Nkx2-5^tm1Wehi (involves: 129P2/OlaHsd * 129S7/SvEvBrd * C57BL/6)	pericardial effusion	J:72600
Hand2os1^em1Eno/Hand2os1^em1Eno (C57BL/6-Hand2os1^em1Eno)	pericardial effusion	J:241318
Hap1^tm1Hay/Hap1^tm1Hay (involves: 129S1/Sv * 129X1/SvJ * ICR)	decreased circulating leptin level	J:76174
	dehydration	J:76174
Has2^tm1Jam/Has2^tm1Jam (involves: 129P2/OlaHsd * C57BL/6J)	pericardial edema	J:63748
Hba-a1^tm1Shs/Hba-a1⁺ (involves: C57BL/6CrSlc)	hyperoxia	J:81902
	increased carbon dioxide production	J:81902
	increased oxygen consumption	J:81902
Hba^tm1(HBA)Tow/Hba^tm1(HBA)Tow Hbb^{tm2(HBG1,HBB)Tow}/Hbb^{tm2(HBG1,HBB)Tow} (Not Specified)	decreased urine osmolality	J:134980
	increased liver iron level	J:134980
Hba^tm1(HBA)Tow/Hba^tm1(HBA)Tow Hbb^{tm2(HBG1,HBD,HBB)Ryan}/Hbb^{tm2(HBG1,HBD,HBB)Ryan} (Not Specified)	increased circulating bilirubin level	J:148521
Hba^tm1Ney/Hba^tm1Ney (either: (involves: 129P2/OlaHsd) or (involves: 129X1/SvJ))	hydrops fetalis	J:86682
Hba^tm1Paz/Hba^tm1Paz (involves: 129S7/SvEvBrd)	hydrops fetalis	J:28392
Hba^tm1Paz/Hba^tm1Paz Hbb^tm1Tow/Hbb^tm1Tow Tg(HBA-HBBs)41Paz/? (involves: 129S2/SvPas * 129S7/SvEvBrd * Black Swiss * C57BL/6 * DBA/2* FVB/N)	hypoxia	J:44161
	increased kidney iron level	J:44161
	increased liver iron level	J:44161
Hbb-b1^tm1Shs/Hbb-b1⁺ (involves: C57BL/6CrSlc)	acidosis	J:81902
	hyperoxia	J:81902
	increased carbon dioxide production	J:81902
	increased oxygen consumption	J:81902
Hbb-b1^tm1Shs/Hbb-b1^tm1Shs (involves: C57BL/6)	increased spleen iron level	J:78271
Hbb-b1^tm1Unc/Hbb-b1⁺ Hbb-b2^tm1Unc/Hbb-b2⁺ (involves: 129P2/OlaHsd * C57BL/6J)	hemosiderosis	J:88672, J:30155
	increased circulating bilirubin level	J:30155
Hbb-b1^tm1Unc/Hbb-b1⁺ Hbb-b2^tm1Unc/Hbb-b2⁺ (involves: 129P2/OlaHsd * C57BL/6N)	increased circulating erythropoietin level	J:185154
	increased liver iron level	J:185154
	increased spleen iron level	J:185154
Hbb-b1^tm1Unc/Hbb-b1⁺ Hbb-b2^tm1Unc/Hbb-b2⁺ (B6;129-Hbb-b1^tm1Unc Hbb-b2^tm1Unc/J)	increased circulating erythropoietin level	J:211331
Hbb-b1^tm1Unc/Hbb-b1⁺ Hbb-b2^tm1Unc/Hbb-b2⁺ (involves: 129P2/OlaHsd)	increased circulating bilirubin level	J:97548
Hbb-b1^tm1Unc/Hbb-b1⁺ Hbb-b2^tm1Unc/Hbb-b2⁺ Tg(HBB)L2Pai/0 (involves: 129P2/OlaHsd C57BL/6)	increased circulating bilirubin level	J:97548
Hbb-b1^tm1Unc/Hbb-b1⁺ Hbb-b2^tm1Unc/Hbb-b2⁺ Tmprss6^tm1Otin/Tmprss6⁺ (involves: 129P2/OlaHsd * C57BL/6 * C57BL/6N)	abnormal circulating erythropoietin level	J:185154
	abnormal liver iron level	J:185154
	abnormal spleen iron level	J:185154
Hbb-b1^tm1Unc/Hbb-b1⁺ Hbb-b2^tm1Unc/Hbb-b2⁺ Tmprss6^tm1Otin/Tmprss6^tm1Otin (involves: 129P2/OlaHsd * C57BL/6 * C57BL/6N)	increased circulating erythropoietin level	J:185154
Hbb^d3th/Hbb⁺ Tg(HBB-AR-HBA2,-HBB)58Rub/0 Tg(LCR-HBA2,LCR-HBB)11Cos/0 (involves: FVB/N Swiss Webster)	abnormal urine homeostasis	J:94190
	decreased urine osmolality	J:94190
	increased circulating alanine transaminase level	J:94190
	increased circulating aspartate transaminase level	J:94190
Hbb^d3th/Hbb⁺ Tg(LCR-HBA2,LCR-HBB)1Cos/0 (involves: C57BL/6J CBA/J * DBA/2J)	abnormal gas homeostasis	J:94193
Hbb^d3th/Hbb^d3th Tg(HBB-AR-HBA2,-HBB)58Rub/0 Tg(LCR-HBA2,LCR-HBB)11Cos/0 (involves: FVB/N Swiss Webster)	abnormal urine homeostasis	J:94190
	decreased urine osmolality	J:94190
	increased circulating alanine transaminase level	J:94190
	increased circulating aspartate transaminase level	J:94190
Hbb^d4/Hbb⁺ (involves: 101/H)	increased blood oxygen capacity	J:7972
Hbb^d4/Hbb^d4 (involves: 101/H)	increased blood oxygen capacity	J:7972
Hbb^{tm1.1(HBG1,HBB*)Ryan}/Hbb⁺ (involves: C57BL/6J)	abnormal iron level	J:147906
	increased liver iron level	J:147906
	increased spleen iron level	J:147906
Hbb^tm2Unc/Hbb⁺ (involves: 129P2/OlaHsd * C57BL/6J)	increased kidney iron level	J:64295
	increased liver iron level	J:64295
	increased spleen iron level	J:64295
Hbs1l^{tm1a(KOMP)Wtsi}/Hbs1l^{tm1a(KOMP)Wtsi} (C57BL/6N-Hbs1l^{tm1a(KOMP)Wtsi}/Wtsi)	improved glucose tolerance	J:211773
	increased circulating alkaline phosphatase level	J:211773
	increased circulating cholesterol level	J:211773
	increased circulating free fatty acids level	J:211773
	increased circulating HDL cholesterol level	J:211773
	increased circulating iron level	J:211773
	increased circulating total protein level	J:211773
Hc^{tm1b(EUCOMM)Wtsi}/Hc^{tm1b(EUCOMM)Wtsi} (C57BL/6N-Hc^{tm1b(EUCOMM)Wtsi}/J)	decreased fasting circulating glucose level	J:211773
Hcar1^{em1(IMPC)Ccpcz}/Hcar1^{em1(IMPC)Ccpcz} (C57BL/6N-Hcar1^{em1(IMPC)Ccpcz}/Ccpcz)	increased circulating alkaline phosphatase level	J:211773
Hcar1^tm1Dgen/Hcar1^tm1Dgen (B6.Cg-Hcar1^tm1Dgen)	impaired lipolysis	J:144870
Hcar2^tm1Soff/Hcar2^tm1Soff (involves: 129P2/OlaHsd * C57BL/6)	abnormal lipid homeostasis	J:82225
Hccs^tm1Tcc/Y Nkx2-5^tm2(cre)Rph/Nkx2-5⁺ (involves: 129S1/Sv)	decreased cardiac muscle glycogen level	J:143285
Hccs^tm1Tcc/Hccs⁺ Nkx2-5^tm2(cre)Rph/Nkx2-5⁺ (involves: 129S1/Sv)	abnormal atrial thrombosis	J:143285
Hcfc1^em1Poche/Y (C57BL/6J-Hcfc1^em1Poche)	abnormal amino acid level	J:317822
	increased circulating homocysteine level	J:317822
	increased circulating methylmalonic acid level	J:317822
Hcfc2^fkls/Hcfc2^fkls (involves: C57BL/6J)	decreased circulating interferon-alpha level	J:251008
Hcfc2^fkls/Hcfc2^fkls (involves: C57BL/6J)	decreased circulating interferon-beta level	J:251008
Hck^tm1Ern/Hck^tm1Ern (involves: 129S1/Sv * C57BL/6)	increased circulating tumor necrosis factor level	J:111432
Hcrt^tm1Ywa/Hcrt^tm1Ywa (B6.129S6-Hcrt^tm1Ywa)	abnormal circadian temperature homeostasis	J:111673
Hcst^tm1.1Dnax/Hcst^tm1.1Dnax (involves: C57BL/6)	ascites	J:148086
Hdac2^tm1.2Eno/Hdac2^tm1.2Eno (involves: 129S/SvEv * C57BL/6 * CD-1)	cyanosis	J:123173
Hdac3^tm1.1Eno/Hdac3^tm1.1Eno Pgr^tm2(cre)Lyd/Pgr⁺ (involves: 129S/SvEv * 129S1/Sv * 129X1/SvJ * C57BL/6)	increased collagen level	J:269518
Hdac3^tm1.1Eno/Hdac3^tm1.1Eno Tg(Myh6-cre)2182Mds/? (involves: 129S/SvEv * C57BL/6)	abnormal lipid level	J:144604
	increased cardiac muscle triglyceride level	J:144604
Hdac3^tm1Swh/Hdac3^tm1.1Swh Speer6-ps1^{Tg(Alb-cre)21Mgn}/Speer6-ps1⁺ (involves: 129S6/SvEvTac * C57BL/6 * DBA)	abnormal glucose homeostasis	J:134288
	decreased circulating glucagon level	J:134288
	decreased circulating insulin level	J:134288
	decreased liver glycogen level	J:134288
	hypoglycemia	J:134288
	increased cholesterol level	J:134288
	increased circulating alanine transaminase level	J:134288
	increased circulating cholesterol level	J:134288
	increased circulating LDL cholesterol level	J:134288
	increased circulating triglyceride level	J:134288
	increased liver triglyceride level	J:134288
Hdac3^tm1Swh/Hdac3^tm1.1Swh Tg(Mx1-cre)1Cgn/0 (involves: 129S6/SvEvTac * C57BL/6 * CBA)	decreased liver glycogen level	J:134288
Hdac4^{em1(IMPC)Ccpcz}/Hdac4⁺ (C57BL/6N-Hdac4^{em1(IMPC)Ccpcz}/Ccpcz)	increased circulating alkaline phosphatase level	J:211773
Hdac6^tm1.1Pmt/Hdac6^tm1.1Pmt (involves: 129P2/OlaHsd)	decreased circulating interleukin-10 level	J:228570
Hdac7^{tm1b(EUCOMM)Hmgu}/Hdac7⁺ (C57BL/6N-Hdac7^{tm1b(EUCOMM)Hmgu}/Kmpc)	abnormal cholesterol homeostasis	J:211773
	increased circulating alkaline phosphatase level	J:211773
Hdac7^tm1Eno/Hdac7^tm1Eno (either: (involves: 129/Sv) or (involves: 129/Sv * C57BL/6))	pericardial effusion	J:116008
Hdac7^tm1Eno/Hdac7^tm2Eno Tg(Tek-cre)1Ywa/0 (involves: 129S6/SvEvTac * C57BL/6 * SJL)	edema	J:116008
Hdac10^{tm1.1(KOMP)Mbp}/Hdac10^{tm1.1(KOMP)Mbp} (C57BL/6N-Hdac10^{tm1.1(KOMP)Mbp}/J)	increased circulating alkaline phosphatase level	J:211773
Hdac11^{em1(IMPC)Kmpc}/Hdac11^{em1(IMPC)Kmpc} (C57BL/6NTac-Hdac11^{em1(IMPC)Kmpc}/Kmpc)	increased circulating alanine transaminase level	J:211773
Hdc^tm1Nagy/Hdc^tm1Nagy (involves: 129S1/Sv * 129X1/SvJ)	increased dopamine level	J:220412
Hdc^tm1Nagy/Hdc^tm1Nagy (involves: 129S1/Sv * 129X1/SvJ * CD-1)	abnormal energy expenditure	J:85774
	impaired glucose tolerance	J:85774
	increased circulating insulin level	J:85774
	increased circulating leptin level	J:85774
Hddc2^em1(IMPC)H/Hddc2^em1(IMPC)H (C57BL/6NTac-Hddc2^em1(IMPC)H/H)	decreased circulating fructosamine level	J:211773
	decreased circulating serum albumin level	J:211773
	increased blood urea nitrogen level	J:211773
	increased circulating creatinine level	J:211773
	increased circulating phosphate level	J:211773
Hddc3^{tm1.1(KOMP)Vlcg}/Hddc3^{tm1.1(KOMP)Vlcg} (C57BL/6N-Hddc3^{tm1.1(KOMP)Vlcg}/Ucd)	increased circulating alanine transaminase level	J:211773
	increased circulating aspartate transaminase level	J:211773
Hdgfl1^em1(IMPC)Tcp/Hdgfl1⁺ (C57BL/6NCrl-Hdgfl1^em1(IMPC)Tcp/Tcp)	decreased circulating serum albumin level	J:211773
Hdgfl2^tm1Lex/Hdgfl2^tm1Lex (involves: 129S5/SvEvBrd * C57BL/6J)	increased circulating alkaline phosphatase level	J:171883
Hdl1^C57BL/6J/? (involves: C57BL/6J * CAST/Ei)	increased circulating HDL cholesterol level	J:66421
Hdl2^CAST/EiJ/? (involves: C57BL/6J * CAST/Ei)	increased circulating HDL cholesterol level	J:66421
Hdl3^C57BL/6J/? (involves: C57BL/6J * CAST/Ei)	increased circulating HDL cholesterol level	J:66421
Hdl4^CAST/EiJ/? (involves: C57BL/6J * CAST/Ei)	increased circulating HDL cholesterol level	J:66421
Hdl5^C57BL/6J/? (involves: C57BL/6J * DBA/2J)	increased circulating HDL cholesterol level	J:84091
Hdl5^C57BL/6J/? (involves: C57BL/6J * DBA/2J)	increased circulating LDL cholesterol level	J:84091
Hdl6^DBA/2J/? (involves: C57BL/6J * DBA/2J)	increased circulating HDL cholesterol level	J:84091
Hdl7^DBA/2J/Hdl7^DBA/2J (involves: CAST/Ei * DBA/2J)	increased circulating HDL cholesterol level	J:83460
Hdl34^C3H/HeJ/? (involves: C3H/HeJ * C57BL/6J)	increased circulating HDL cholesterol level	J:38473
Hdl35^C57BL/6J/? (involves: C3H/HeJ * C57BL/6J)	decreased circulating HDL cholesterol level	J:38473
Hdl36^C3H/HeJ/? (involves: C3H/HeJ * C57BL/6J)	decreased circulating HDL cholesterol level	J:38473
Hdl40^C57BL/6J/? (involves: C3H/HeJ * C57BL/6J)	decreased circulating HDL cholesterol level	J:38473
Hdlcl1^C57BL/6J/Hdlcl1^C57BL/6J (involves: B6.129S7-Ldlr^tm1Her/J * PERA/EiJ)	increased circulating HDL cholesterol level	J:94548
Hdlcl2^C57BL/6J/Hdlcl2^PERA/EiJ (involves: B6.129S7-Ldlr^tm1Her/J * PERA/EiJ)	increased circulating HDL cholesterol level	J:94548
Hdlq2^NZB/BlNJ/Hdlq2^NZB/BlNJ (involves: NZB/BlNJ * SM/J)	increased circulating HDL cholesterol level	J:76707, J:89309
Hdlq2^NZB/BlNJ/Hdlq2^SM/J (involves: NZB/BlNJ * SM/J)	increased circulating HDL cholesterol level	J:76707, J:89309
Hdlq3^NZB/BlNJ/? (involves: NZB/BlNJ * SM/J)	increased circulating HDL cholesterol level	J:76707
Hdlq4^NZB/BlNJ/Hdlq4^SM/J (involves: NZB/BlNJ * SM/J)	increased circulating HDL cholesterol level	J:76707
Hdlq5^C57BL/6J/Hdlq5^C57BL/6J (involves: C57BL/6J * NZB/BlNJ)	decreased circulating HDL cholesterol level	J:84430
Hdlq5^NZB/BlNJ/Hdlq5^NZB/BlNJ (involves: C57BL/6J * NZB/BlNJ)	increased circulating HDL cholesterol level	J:84430
Hdlq6^C57BL/6J/Hdlq6^C57BL/6J (involves: C57BL/6J * NZB/BlNJ)	decreased circulating HDL cholesterol level	J:84430
Hdlq6^NZB/BlNJ/Hdlq6^NZB/BlNJ (involves: C57BL/6J * NZB/BlNJ)	increased circulating HDL cholesterol level	J:84430
Hdlq7^C57BL/6J/Hdlq7^C57BL/6J (involves: C57BL/6J * NZB/BlNJ)	decreased circulating HDL cholesterol level	J:84430
Hdlq7^C57BL/6J/Hdlq7^C57BL/6J Hdlq9^C57BL/6J/Hdlq9^C57BL/6J (involves: C57BL/6J * NZB/BlNJ)	decreased circulating HDL cholesterol level	J:84430
Hdlq7^NZB/BlNJ/Hdlq7^NZB/BlNJ (involves: C57BL/6J * NZB/BlNJ)	increased circulating HDL cholesterol level	J:84430
Hdlq10^CAST/Ei/Hdlq10^CAST/Ei (involves: CAST/Ei * DBA/2J)	increased circulating HDL cholesterol level	J:83460
Hdlq10^CAST/Ei/Hdlq10^CAST/Ei (involves: 129S1/SvImJ * CAST/Ei)	increased circulating HDL cholesterol level	J:88732
Hdlq10^CAST/Ei/Hdlq10^DBA/2J (involves: CAST/Ei * DBA/2J)	increased circulating HDL cholesterol level	J:83460
Hdlq11^DBA/2J/Hdlq11^CAST/Ei (involves: CAST/Ei * DBA/2J)	increased circulating HDL cholesterol level	J:83460
Hdlq11^DBA/2J/Hdlq11^DBA/2J (involves: CAST/Ei * DBA/2J)	increased circulating HDL cholesterol level	J:83460
Hdlq12^DBA/2J/Hdlq12^CAST/EiJ (involves: CAST/Ei * DBA/2J)	increased circulating HDL cholesterol level	J:83460
Hdlq12^DBA/2J/Hdlq12^DBA/2J (involves: CAST/Ei * DBA/2J)	increased circulating HDL cholesterol level	J:83460
Hdlq13^129S1/SvImJ/Hdlq13^129S1/SvImJ (involves: 129S1/SvImJ * CAST/Ei)	increased circulating HDL cholesterol level	J:88732
Hdlq13^129S1/SvImJ/Hdlq13^CAST/Ei (involves: 129S1/SvImJ * CAST/Ei)	increased circulating HDL cholesterol level	J:88732
Hdlq14^129S1/SvImJ/? (involves: 129S1/SvImJ * C57BL/6J)	increased circulating HDL cholesterol level	J:88486
Hdlq14^C57BL/6J/Hdlq14^C57BL/6J Hdlq15^129S1/SvImJ/Hdlq15^129S1/SvImJ (involves: 129S1/SvImJ * C57BL/6J)	decreased circulating HDL cholesterol level	J:88486
Hdlq15^129S1/SvImJ/? (involves: 129S1/SvImJ * C57BL/6J)	increased circulating HDL cholesterol level	J:144089, J:88486
Hdlq15^129S1/SvImJ/Hdlq15^129S1/SvImJ Hdlq58^C57BL/6J/Hdlq58^C57BL/6J (involves: 129S1/SvImJ * C57BL/6J)	increased circulating HDL cholesterol level	J:144089
Hdlq15^129S1/SvImJ/Hdlq15^129S1/SvImJ Hdlq60^129S1/SvImJ/Hdlq60^C57BL/6J (involves: 129S1/SvImJ * C57BL/6J)	increased circulating HDL cholesterol level	J:144089
Hdlq15^129S1/SvImJ/Hdlq15^129S1/SvImJ Hdlq60^C57BL/6J/Hdlq60^C57BL/6J (involves: 129S1/SvImJ * C57BL/6J)	increased circulating HDL cholesterol level	J:144089
Hdlq15^C57BL/6J/Hdlq15^C57BL/6J Hdlq19^129S1/SvImJ/Hdlq19^129S1/SvImJ (involves: 129S1/SvImJ * C57BL/6J)	decreased circulating HDL cholesterol level	J:88486
Hdlq16^129S1/SvImJ/? (involves: 129S1/SvImJ * C57BL/6J)	increased circulating HDL cholesterol level	J:88486
Hdlq17^129S1/SvImJ/Hdlq17^129S1/SvImJ (involves: 129S1/SvImJ * C57BL/6J)	increased circulating HDL cholesterol level	J:88486
Hdlq17^129S1/SvImJ/Hdlq17^129S1/SvImJ (involves: 129S1/SvImJ * RIIIS/J)	increased circulating HDL cholesterol level	J:89282
Hdlq17^129S1/SvImJ/Hdlq17^C57BL/6J (involves: 129S1/SvImJ * C57BL/6J)	increased circulating HDL cholesterol level	J:88486
Hdlq18^129S1/SvImJ/Hdlq18^129S1/SvImJ (involves: 129S1/SvImJ * C57BL/6J)	increased circulating HDL cholesterol level	J:88486
Hdlq18^129S1/SvImJ/Hdlq18^129S1/SvImJ (involves: 129S1/SvImJ * RIIIS/J)	increased circulating HDL cholesterol level	J:89282
Hdlq18^129S1/SvImJ/Hdlq18^C57BL/6J (involves: 129S1/SvImJ * C57BL/6J)	increased circulating HDL cholesterol level	J:88486
Hdlq18^C57BL/6J/Hdlq18^C57BL/6J Hdlq59^C57BL/6J/Hdlq59^C57BL/6J (involves: 129S1/SvImJ * C57BL/6J)	decreased circulating HDL cholesterol level	J:144089
Hdlq20^NZB/BlNJ/Hdlq20^NZB/BlNJ (involves: NZB/BlNJ * SM/J)	increased circulating HDL cholesterol level	J:89309
Hdlq20^NZB/BlNJ/Hdlq20^SM/J (involves: NZB/BlNJ * SM/J)	increased circulating HDL cholesterol level	J:89309
Hdlq21^NZB/BlNJ/Hdlq21^NZB/BlNJ (involves: NZB/BlNJ * SM/J)	increased circulating HDL cholesterol level	J:89309
Hdlq21^NZB/BlNJ/Hdlq21^SM/J (involves: NZB/BlNJ * SM/J)	increased circulating HDL cholesterol level	J:89309
Hdlq22^NZB/BlNJ/Hdlq22^NZB/BlNJ (involves: NZB/BlNJ * SM/J)	increased circulating HDL cholesterol level	J:89309
Hdlq22^NZB/BlNJ/Hdlq22^SM/J (involves: NZB/BlNJ * SM/J)	increased circulating HDL cholesterol level	J:89309
Hdlq23^NZB/BlNJ/Hdlq23^NZB/BlNJ (involves: NZB/BlNJ * SM/J)	increased circulating HDL cholesterol level	J:89309
Hdlq23^NZB/BlNJ/Hdlq23^SM/J (involves: NZB/BlNJ * SM/J)	increased circulating HDL cholesterol level	J:89309
Hdlq24^NZB/BlNJ/Hdlq24^NZB/BlNJ (involves: NZB/BlNJ * SM/J)	increased circulating HDL cholesterol level	J:89309
Hdlq24^NZB/BlNJ/Hdlq24^SM/J (involves: NZB/BlNJ * SM/J)	increased circulating HDL cholesterol level	J:89309
Hdlq25^NZB/BlNJ/Hdlq25^NZB/BlNJ (involves: NZB/BlNJ * SM/J)	increased circulating HDL cholesterol level	J:89309
Hdlq25^NZB/BlNJ/Hdlq25^SM/J (involves: NZB/BlNJ * SM/J)	increased circulating HDL cholesterol level	J:89309
Hdlq26^NZB/BlNJ/Hdlq26^NZB/BlNJ (involves: NZB/BlNJ * SM/J)	increased circulating HDL cholesterol level	J:89309
Hdlq27^NZB/BlNJ/Hdlq27^NZB/BlNJ (involves: NZB/BlNJ * SM/J)	increased circulating HDL cholesterol level	J:89309
Hdlq28^NZB/BlNJ/Hdlq28^NZB/BlNJ (involves: NZB/BlNJ * SM/J)	increased circulating HDL cholesterol level	J:89309
Hdlq28^NZB/BlNJ/Hdlq28^SM/J (involves: NZB/BlNJ * SM/J)	increased circulating HDL cholesterol level	J:89309
Hdlq29^NZB/BlNJ/Hdlq29^NZB/BlNJ (involves: NZB/BlNJ * SM/J)	increased circulating HDL cholesterol level	J:89309
Hdlq29^NZB/BlNJ/Hdlq29^SM/J (involves: NZB/BlNJ * SM/J)	increased circulating HDL cholesterol level	J:89309
Hdlq30^NZB/BlNJ/Hdlq30^NZB/BlNJ (involves: NZB/BlNJ * SM/J)	increased circulating HDL cholesterol level	J:89309
Hdlq30^NZB/BlNJ/Hdlq30^SM/J (involves: NZB/BlNJ * SM/J)	increased circulating HDL cholesterol level	J:89309
Hdlq31^NZB/BlNJ/Hdlq31^NZB/BlNJ (involves: NZB/BlNJ * SM/J)	increased circulating HDL cholesterol level	J:89309
Hdlq31^NZB/BlNJ/Hdlq31^SM/J (involves: NZB/BlNJ * SM/J)	increased circulating HDL cholesterol level	J:89309
Hdlq32^NZB/BlNJ/Hdlq32^NZB/BlNJ (involves: NZB/BlNJ * SM/J)	increased circulating HDL cholesterol level	J:89309
Hdlq33^PERA/EiJ/? (involves: DBA/2J * PERA/EiJ)	increased circulating HDL cholesterol level	J:112668
Hdlq34^PERA/EiJ/? (involves: I/LnJ * PERA/EiJ)	increased circulating HDL cholesterol level	J:112668
Hdlq35^PERA/EiJ/? (involves: I/LnJ * PERA/EiJ)	increased circulating HDL cholesterol level	J:112668
Hdlq37^PERA/EiJ/? (involves: I/LnJ * PERA/EiJ)	increased circulating HDL cholesterol level	J:112668
Hdlq37^PERA/EiJ/? (involves: DBA/2J * PERA/EiJ)	increased circulating HDL cholesterol level	J:112668
Hdlq40^A/J/Hdlq40^C57BL/6J Hdlq41^A/J/? (involves: A/J * C57BL/6J)	increased circulating HDL cholesterol level	J:114073
Hdlq42^A/J/Hdlq42^A/J (involves: A/J * C57BL/6J)	increased circulating HDL cholesterol level	J:114073
Hdlq42^A/J/Hdlq42^C57BL/6J (involves: A/J * C57BL/6J)	increased circulating HDL cholesterol level	J:114073
Hdlq42^C57BL/6J/Hdlq42^C57BL/6J Hdlq44^A/J/Hdlq44^A/J (involves: A/J * C57BL/6J)	decreased circulating HDL cholesterol level	J:114073
Hdlq43^C57BL/6J/Hdlq43^C57BL/6J (involves: A/J * C57BL/6J)	increased circulating HDL cholesterol level	J:114073
Hdlq44^A/J/Hdlq44^C57BL/6J (involves: A/J * C57BL/6J)	increased circulating HDL cholesterol level	J:114073
Hdlq44^C57BL/6J/? (involves: 129S1/SvImJ * C57BL/6J)	increased circulating HDL cholesterol level	J:144089
Hdlq44^C57BL/6J/Hdlq44^C57BL/6J (involves: A/J * C57BL/6J)	increased circulating HDL cholesterol level	J:114073
Hdlq45^A/J/Hdlq45^C57BL/6J (involves: A/J * C57BL/6J)	increased circulating HDL cholesterol level	J:114073
Hdlq45^C57BL/6J/Hdlq45^C57BL/6J (involves: A/J * C57BL/6J)	increased circulating HDL cholesterol level	J:114073
Hdlq46^C57BL/6J/Hdlq46^C57BL/6J (involves: A/J * C57BL/6J)	increased circulating HDL cholesterol level	J:114073
Hdlq47^C57BL/6J/Hdlq47^C57BL/6J (involves: A/J * C57BL/6J)	increased circulating HDL cholesterol level	J:114073
Hdlq48^C57BL/6J/Hdlq48^C57BL/6J (involves: A/J * C57BL/6J)	increased circulating HDL cholesterol level	J:114073
Hdlq49^A/J/Hdlq49^C57BL/6J (involves: A/J * C57BL/6J)	increased circulating HDL cholesterol level	J:114073
Hdlq49^C57BL/6J/Hdlq49^C57BL/6J (involves: A/J * C57BL/6J)	increased circulating HDL cholesterol level	J:114073
Hdlq50^A/J/Hdlq50^C57BL/6J (involves: A/J * C57BL/6J)	increased circulating HDL cholesterol level	J:114073
Hdlq50^C57BL/6J/Hdlq50^C57BL/6J (involves: A/J * C57BL/6J)	increased circulating HDL cholesterol level	J:114073
Hdlq51^A/J/Hdlq51^C57BL/6J (involves: A/J * C57BL/6J)	increased circulating HDL cholesterol level	J:114073
Hdlq51^C57BL/6J/Hdlq51^C57BL/6J (involves: A/J * C57BL/6J)	increased circulating HDL cholesterol level	J:114073
Hdlq52^129S1/SvImJ/? (involves: 129S1/SvImJ * C57BL/6J)	increased circulating HDL cholesterol level	J:144089
Hdlq53^129S1/SvImJ/? (involves: 129S1/SvImJ * C57BL/6J)	increased circulating HDL cholesterol level	J:144089
Hdlq54^129S1/SvImJ/? (involves: 129S1/SvImJ * C57BL/6J)	increased circulating HDL cholesterol level	J:144089
Hdlq55^129S1/SvImJ/? (involves: 129S1/SvImJ * C57BL/6J)	increased circulating HDL cholesterol level	J:144089
Hdlq56^C57BL/6J/? (involves: 129S1/SvImJ * C57BL/6J)	increased circulating HDL cholesterol level	J:144089
Hdlq57^129S1/SvImJ/? (involves: 129S1/SvImJ * C57BL/6J)	increased circulating HDL cholesterol level	J:144089
Hdlq67^129S1/SvImJ/? (involves: 129S1/SvImJ * CAST/Ei)	increased circulating HDL cholesterol level	J:88732
Hdlq83^PERA/EiJ/? (involves: DBA/2J * PERA/EiJ)	increased circulating HDL cholesterol level	J:112668
Hdlq83^PERA/EiJ/? (involves: I/LnJ * PERA/EiJ)	increased circulating HDL cholesterol level	J:112668
Hdlq89^RIIIS/J/? (involves: 129S1/SvImJ * RIIIS/J)	increased circulating HDL cholesterol level	J:89282
Hdlq90^RIIIS/J/? (involves: 129S1/SvImJ * RIIIS/J)	increased circulating HDL cholesterol level	J:89282
Hdlq92^C57BL/6J/? (involves: 129S1/SvImJ * C57BL/6J)	increased circulating HDL cholesterol level	J:144089
Hdlq99^129S1/SvImJ/Hdlq99^129S1/SvImJ (involves: 129S1/SvImJ * RIIIS/J)	increased circulating HDL cholesterol level	J:89282
Hdlq99^129S1/SvImJ/Hdlq99^RIIIS/J (involves: 129S1/SvImJ * RIIIS/J)	increased circulating HDL cholesterol level	J:89282
Hdlq102^129S1/SvImJ/? (involves: 129S1/SvImJ * C57BL/6J)	increased circulating HDL cholesterol level	J:144089
Heatr3^{tm1a(EUCOMM)Hmgu}/Heatr3⁺ (C57BL/6N-Heatr3^{tm1a(EUCOMM)Hmgu}/Ics)	increased circulating glycerol level	J:165965
Heca^em1(IMPC)J/Heca^em1(IMPC)J (C57BL/6NJ-Heca^em1(IMPC)J/Mmjax)	increased circulating cholesterol level	J:211773
	increased circulating HDL cholesterol level	J:211773
Hectd1^{tm1b(EUCOMM)Hmgu}/Hectd1⁺ (C57BL/6N-Hectd1^{tm1b(EUCOMM)Hmgu}/Nju)	decreased circulating alkaline phosphatase level	J:211773
	increased circulating calcium level	J:211773
Hectd3^tm1Lex/Hectd3^tm1Lex (FVB.129S5(B6)-Hectd3^tm1Lex)	decreased circulating interferon-beta level	J:266602
	decreased circulating interleukin-1 beta level	J:266602
	decreased circulating interleukin-6 level	J:266602
	decreased circulating tumor necrosis factor level	J:266602
Hecw1^{tm2b(EUCOMM)Hmgu}/Hecw1^{tm2b(EUCOMM)Hmgu} (C57BL/6N-Hecw1^{tm2b(EUCOMM)Hmgu}/H)	decreased fasting circulating glucose level	J:211773
	increased circulating phosphate level	J:211773
Heg1^tm1Mlkn/Heg1^tm1Mlkn (either: B6.129-Heg1^tm1Mlkn or (involves: 129 * C57BL/6))	chylous ascites	J:146528
	hemopericardium	J:146528
Hells^{tm1a(EUCOMM)Wtsi}/Hells^{tm1a(EUCOMM)Wtsi} (C57BL/6N-Hells^{tm1a(EUCOMM)Wtsi}/Ieg)	decreased circulating cholesterol level	J:165965
	decreased circulating LDL cholesterol level	J:165965
	decreased circulating triglyceride level	J:165965
Hells^tm1Rarc/Hells^tm1Rarc (involves: 129X1/SvJ * C57BL/6J)	hypoglycemia	J:107145
Helz2^tm1Tesa/Helz2^tm1Tesa (B6.Cg-Helz2^tm1Tesa)	abnormal gas homeostasis	J:218127
	abnormal glucose homeostasis	J:218127
	abnormal lipid level	J:218127
	decreased circulating insulin level	J:218127
	decreased fasting circulating glucose level	J:218127
	decreased liver triglyceride level	J:218127
	decreased respiratory quotient	J:218127
	increased circulating leptin level	J:218127
	increased oxygen consumption	J:218127
hem6/hem6 (involves: 129P2/OlaHsd * 129S6/SvEvTac * C57BL/6)	abnormal homeostasis	J:142791
Hepacam^tm1Vlcg/Hepacam^tm1Vlcg (Not Specified)	cerebral edema	J:244698
Heph^{em1(IMPC)Ccpcz}/Y (C57BL/6NCrl-Heph^{em1(IMPC)Ccpcz}/Ccpcz)	increased circulating creatine kinase level	J:211773
	increased circulating iron level	J:211773
Heph^{em1(IMPC)Ccpcz}/Heph^{em1(IMPC)Ccpcz} (C57BL/6NCrl-Heph^{em1(IMPC)Ccpcz}/Ccpcz)	increased circulating alanine transaminase level	J:211773
	increased circulating aspartate transaminase level	J:211773
	increased circulating iron level	J:211773
	increased circulating phosphate level	J:211773
Heph^sla/Y (involves: C57BL/6J * WB/Re)	increased erythrocyte protoporphyrin level	J:5985
Heph^sla/Y (B6.Cg-Heph^sla)	abnormal iron homeostasis	J:5660
Heph^sla/Y (B6.Cg-Heph^sla)	abnormal iron level	J:6052
Heph^sla/Y Hfe^tm2Nca/Hfe^tm2Nca (involves: 129S6/SvEvTac * C57BL/6J)	increased intestinal iron level	J:62112
	increased liver iron level	J:62112
Heph^sla/Heph^sla (involves: C57BL/6J)	increased intestinal iron level	J:62112
Heph^sla/Heph^sla (B6.Cg-Heph^sla)	abnormal iron level	J:6052
Heph^sla/Heph^sla Hfe^tm2Nca/Hfe^tm2Nca (involves: 129S6/SvEvTac * C57BL/6J)	increased intestinal iron level	J:62112
	increased liver iron level	J:62112
Herc1^{em3(IMPC)Wtsi}/Herc1^{em3(IMPC)Wtsi} (C57BL/6N-Herc1^{em3(IMPC)Wtsi}/Wtsi)	decreased circulating glucose level	J:211773
	impaired glucose tolerance	J:211773
	increased circulating alkaline phosphatase level	J:211773
	increased circulating amylase level	J:211773
	increased circulating chloride level	J:211773
	increased circulating insulin level	J:211773
	increased circulating sodium level	J:211773
	increased fasting circulating glucose level	J:211773
Herpud1^tm1Kame/Herpud1^tm1Kame (B6CrSlc.129-Herpud1^tm1Kame)	impaired glucose tolerance	J:210654
	increased circulating glucose level	J:210654
Hexa^tm1Rlp/Hexa^tm1Rlp Hexb^tm1Rlp/Hexb^tm1Rlp (involves: 129S4/SvJae * C57BL/6)	abnormal urine homeostasis	J:36305
	increased urine glycosaminoglycan level	J:36305
Hexb^lysd/Hexb^lysd (B6.Cg-Hexb^lysd/J)	abnormal lipid homeostasis	J:301674
Hexb^{tm1b(EUCOMM)Hmgu}/Hexb^{tm1b(EUCOMM)Hmgu} (C57BL/6N-Hexb^{tm1b(EUCOMM)Hmgu}/H)	decreased circulating fructosamine level	J:211773
	increased circulating alkaline phosphatase level	J:211773
	increased circulating aspartate transaminase level	J:211773
	increased circulating iron level	J:211773
Hexb^tm1Rlp/Hexb^tm1Rlp (involves: 129P2/OlaHsd * 129S4/SvJae * C57BL/6)	increased circulating interleukin-4 level	J:87617
Hey2^tm1Kkb/Hey2^tm1Kkb (involves: 129S7/SvEvBrd * C57BL/6)	pulmonary edema	J:97120
Hfe^tm1.1Jrco/Hfe^tm1.1Jrco (involves: 129X1/SvJ * C57BL/6J)	abnormal brain iron level	J:201948
	increased liver iron level	J:201948
Hfe^tm1.1Nca/Hfe^tm1.1Nca (Not Specified)	increased liver iron level	J:62112
Hfe^tm1.1Nca/Hfe^tm1.1Nca (involves: 129S6/SvEvTac)	abnormal iron level	J:78536
Hfe^tm1.1Nca/Hfe^tm1.1Nca (involves: 129S6/SvEvTac * C57BL/6J)	abnormal iron level	J:78536
Hfe^tm1.1Nca/Hfe^tm1.1Nca Tfrc^tm1Nca/Tfrc⁺ (Not Specified)	increased liver iron level	J:62112
Hfe^tm1.1Wsr/Hfe^tm1.1Wsr (involves: 129P2/OlaHsd * C57BL/6)	abnormal iron homeostasis	J:141745
	decreased spleen iron level	J:132134
	hemochromatosis	J:132134
	increased circulating iron level	J:132134, J:132141
	increased liver iron level	J:132134, J:132141, J:141745
Hfe^tm1Gfn/? Hfem1^C57BL/6/Hfem1^DBA/2 (involves: 129P2/OlaHsd * C57BL/6 * DBA/2)	hemochromatosis	J:90494
Hfe^tm1Gfn/? Hfem1^DBA/2/Hfem1^DBA/2 (involves: 129P2/OlaHsd * C57BL/6 * DBA/2)	hemochromatosis	J:90494
Hfe^tm1Gfn/? Hfem2^C57BL/6/Hfem2^DBA/2 (involves: 129P2/OlaHsd * C57BL/6 * DBA/2)	hemochromatosis	J:90494
Hfe^tm1Gfn/? Hfem2^DBA/2/Hfem2^DBA/2 (involves: 129P2/OlaHsd * C57BL/6 * DBA/2)	hemochromatosis	J:90494
Hfe^tm1Gfn/? Hfem3^DBA/2/Hfem3^DBA/2 (involves: 129P2/OlaHsd * C57BL/6 * DBA/2)	hemochromatosis	J:90494
Hfe^tm1Gfn/? Hfem4^C57BL/6/Hfem4^DBA/2 (involves: 129P2/OlaHsd * C57BL/6 * DBA/2)	hemochromatosis	J:90494
Hfe^tm1Gfn/? Hfem4^DBA/2/Hfem4^DBA/2 (involves: 129P2/OlaHsd * C57BL/6 * DBA/2)	hemochromatosis	J:90494
Hfe^tm1Gfn/Hfe^tm1Gfn (involves: 129P2/OlaHsd * C57BL/6)	abnormal iron homeostasis	J:68025
	abnormal iron level	J:262906
	increased circulating iron level	J:68025
	increased liver iron level	J:262906, J:68025
	increased spleen iron level	J:68025
Hfe^tm1Sly/Hfe^tm1Sly (Not Specified)	increased liver iron level	J:88143
Hfe^tm1Sly/Hfe^tm2Sly (involves: 129X1/SvJ * C57BL/6J)	increased liver iron level	J:88143
Hfe^tm1Wsr/Hfe^tm1Wsr Tg(Alb1-cre)7Gsc/? (involves: 129P2/OlaHsd * C57BL/6 * FVB/N)	decreased spleen iron level	J:132134
	hemochromatosis	J:132134
	increased circulating iron level	J:132134
	increased liver iron level	J:132134
Hfe^tm2Nca/Hfe⁺ (involves: 129S6/SvEvTac)	increased liver iron level	J:62112
Hfe^tm2Nca/Hfe^tm2Nca (involves: 129S6/SvEvTac)	abnormal iron level	J:78536
	decreased spleen iron level	J:78536
	increased circulating iron level	J:133221
	increased liver iron level	J:62112, J:133221
Hfe^tm2Nca/Hfe^tm2Nca (involves: 129S6/SvEvTac * C57BL/6J)	abnormal iron level	J:78536
Hfe^tm2Nca/Hfe^tm2Nca (involves: 129S6/SvEvTac * C57BL/6J)	decreased spleen iron level	J:78536
Hfe^tm2Nca/Hfe^tm2Nca Slc11a2^mk/Slc11a2^mk (involves: 129S6/SvEvTac * C57BL/6J * MK/ReJ)	decreased liver iron level	J:62112
Hfe^tm2Nca/Hfe^tm2Nca Slc11a2^tm1Nca/Slc11a2^tm1Nca (involves: 129S6/SvEvTac * 129S6.129S4-Slc11a2^tm1Nca)	increased liver iron level	J:98088
Hfe^tm2Nca/Hfe^tm2Nca Tfrc^tm1Nca/Tfrc⁺ (involves: 129S6/SvEvTac)	increased liver iron level	J:62112
Hfe^tm2Nca/Hfe^tm2Nca Tg(Ttr-Hfe)1Nca/0 (involves: 129S6/SvEvTac * C57BL/6)	decreased circulating iron level	J:133221
	decreased liver iron level	J:133221
Hfe^tm2Nca/Hfe^tm2Nca Urod^tm1Kush/Urod⁺ (involves: C57BL/6J)	increased liver iron level	J:66704
	increased porphyrin level	J:66704
Hfe^tm2Sly/Hfe^tm2Sly (involves: 129X1/SvJ * C57BL/6J)	abnormal brain iron level	J:213886
	decreased brain cholesterol level	J:213886
	increased liver iron level	J:88143
Hfe^tm2Sly/Hfe^tm3Sly (involves: 129X1/SvJ * C57BL/6J)	increased liver iron level	J:88143
Hfe^tm3Sly/Hfe^tm3Sly (involves: 129X1/SvJ * C57BL/6J)	increased liver iron level	J:88143
Hgd^aku/Hgd^aku (either: (involves: 129/Sv * BALB/cByJ * NB) or (involves: 129/Sv * C57BL/6J * NB))	abnormal urine color	J:16506
	homogentisic aciduria	J:16506
Hgd^{tm1a(KOMP)Wtsi}/Hgd^{tm1a(KOMP)Wtsi} (involves: C57BL/6N)	abnormal blood homeostasis	J:287389
	homogentisic aciduria	J:287389
Hgd^{tm1c(KOMP)Wtsi}/Hgd^{tm1c(KOMP)Wtsi} Tg(Mx1-cre)1Cgn/0 (involves: C57BL/6J * C57BL/6N * CBA/J)	abnormal blood homeostasis	J:287389
	abnormal urine homeostasis	J:287389
Hgsnat^em4(IMPC)Tcp/Hgsnat^em4(IMPC)Tcp (C57BL/6NCrl-Hgsnat^em4(IMPC)Tcp/Tcp)	abnormal cholesterol homeostasis	J:211773
	increased circulating alkaline phosphatase level	J:211773
	increased circulating phosphate level	J:211773
	increased circulating potassium level	J:211773
Hgsnat^{tm1a(EUCOMM)Wtsi}/Hgsnat^{tm1a(EUCOMM)Wtsi} (involves: C57BL/6N * C57BL/6NTac)	abnormal glycosaminoglycan level	J:235361
	increased blood urea nitrogen level	J:235361
	increased circulating alanine transaminase level	J:235361
Hhat^{Tg(TFAP2A-cre)1Will}/Hhat^{Tg(TFAP2A-cre)1Will} (Not Specified)	edema	J:190013
Hhex^tm1Cwb/Hhex^tm1Cwb (involves: 129X1/SvJ * C57BL/6J)	edema	J:93580
Hhex^tm1Cwb/Hhex^tm1Cwb (involves: 129X1/SvJ * C57BL/6J)	pericardial edema	J:93580
Hibadh^{tm1b(EUCOMM)Wtsi}/Hibadh^{tm1b(EUCOMM)Wtsi} (C57BL/6N-Hibadh^{tm1b(EUCOMM)Wtsi}/Wtsi)	decreased fasting circulating glucose level	J:211773
Hic2^{Gt(E225A08)1.1Wrst}/Hic2^{Gt(E225A08)1.1Wrst} Mesp1^tm2(cre)Ysa/Mesp1⁺ (involves: 129P2/OlaHsd * C57BL/6NCrlj * CBA/JNCrlj)	edema	J:225226
Hif1a^tm1.1Mcs/Hif1a⁺ (involves: 129S6/SvEvTac)	pericardial effusion	J:105812
Hif1a^tm1Jhu/Hif1a^tm1Jhu (involves: 129S4/SvJae * C57BL/6)	pericardial effusion	J:45554
Hif1a^tm1Kats/Hif1a^tm1Kats (involves: 129 * C57BL/6)	abnormal cytokine level	J:117857
Hif1a^tm1Rsjo/Hif1a^tm1Rsjo (involves: 129S1/Sv * 129X1/SvJ)	hypoxia	J:48084
Hif1a^tm1Stom/Hif1a^tm1Stom Tg(Vil1-cre)20Syr/0 (B6.Cg-Hif1a^tm1Stom Tg(Vil1-cre)20Syr)	decreased circulating insulin level	J:325395
	decreased susceptibility to diet-induced obesity	J:325395
	decreased susceptibility to induced hypothermia	J:325395
	improved glucose tolerance	J:325395
	increased bile salt level	J:325395
	increased energy expenditure	J:325395
	increased insulin sensitivity	J:325395
	increased oxygen consumption	J:325395
	increased respiratory quotient	J:325395
Hif1a^tm2Rsjo/Hif1a^tm2Rsjo (involves: 129S1/Sv * 129X1/SvJ)	hypoxia	J:48084
Hif1a^tm3Rsjo/Hif1a^tm3Rsjo (involves: 129S1/Sv * 129X1/SvJ)	abnormal gluconeogenesis	J:152724
	decreased circulating glucose level	J:152724
	decreased liver glycogen level	J:152724
Hif1a^tm3Rsjo/Hif1a^tm3Rsjo Lyz2^tm1(cre)Ifo/Lyz2⁺ (involves: 129P2/OlaHsd * 129S1/Sv * 129X1/SvJ * C57BL/6)	abnormal body temperature	J:148597
Hif1a^tm3Rsjo/Hif1a^tm3Rsjo Tg(Ckmm-cre)5Khn/? (involves: 129S1/Sv * 129X1/SvJ * C57BL/6J * FVB/N)	abnormal glucose homeostasis	J:97761
	increased circulating creatine kinase level	J:97761
Hif1a^tm3Rsjo/Hif1a^tm3Rsjo Tg(MMTV-cre)1Mam/0 (involves: 129S1/Sv * 129X1/SvJ * CD-1 * FVB)	abnormal milk sodium level	J:82618
Hif1a^tm3Rsjo/Hif1a^tm3Rsjo Tg(SFTPC-rtTA)5Jaw/0 Tg(tetO-cre)1Jaw/0 (involves: 129 * 129S1/Sv * 129X1/SvJ * C57BL/6)	cyanosis	J:143384
Hif1a^tm3Rsjo/Hif1a^tm3Rsjo Vhl^tm1Jae/Vhl^tm1Jae Tg(Sp7-tTA,tetO-EGFP/cre)1Amc/0 (involves: 129S1/Sv * 129S4/SvJae * 129X1/SvJ * CD-1)	increased circulating erythropoietin level	J:186085
Hif1an^tm1.1Rsjo/Hif1an^tm1.1Rsjo Tg(Nes-cre)1Wme/0 (involves: 129 * C57BL/6 * CBA)	decreased circulating insulin level	J:160941
	increased insulin sensitivity	J:160941
Hif1an^tm1.2Rsjo/Hif1an^tm1.2Rsjo (B6.129-Hif1an^tm1.2Rsjo)	abnormal circulating hormone level	J:160941
	abnormal oxygen level	J:160941
	alkalosis	J:160941
	decreased circulating cholesterol level	J:160941
	decreased circulating glucose level	J:160941
	decreased circulating HDL cholesterol level	J:160941
	decreased circulating insulin level	J:160941
	decreased circulating LDL cholesterol level	J:160941
	decreased circulating triglyceride level	J:160941
	decreased circulating VLDL triglyceride level	J:160941
	decreased liver triglyceride level	J:160941
	hypocapnia	J:160941
	increased carbon dioxide production	J:160941
	increased circulating cholesterol level	J:160941
	increased insulin sensitivity	J:160941
	increased oxygen consumption	J:160941
Hikeshi^1R/Hikeshi^1R (involves: BALB/cRl * C3H/Rl * C57BL/10Rl)	cyanosis	J:105164
Hilpda^tm1Xen/Hilpda^tm1Xen (C57BL/6-Hilpda^tm1Xen)	decreased body temperature	J:301866
	decreased energy expenditure	J:301866
	decreased oxygen consumption	J:301866
	impaired adaptive thermogenesis	J:301866
	increased circulating HDL cholesterol level	J:301866
Hint2^tm1.1Geno/Hint2^tm1.1Geno (involves: 129S2/SvPas * C57BL/6J)	abnormal body temperature homeostasis	J:237329
	decreased circulating glucagon level	J:237329
	decreased circulating triglyceride level	J:237329
	decreased insulin secretion	J:237329
	decreased noradrenaline level	J:237329
	impaired glucose tolerance	J:237329
	increased adiponectin level	J:237329
	increased circulating alanine transaminase level	J:237329
	increased circulating cholesterol level	J:237329
	increased circulating corticosterone level	J:237329
	increased circulating insulin level	J:237329
	increased circulating leptin level	J:237329
	increased circulating serum albumin level	J:237329
	increased insulin sensitivity	J:237329
	increased liver triglyceride level	J:237329
Hip1^{em1(IMPC)Hmgu}/Hip1^{em1(IMPC)Hmgu} (C57BL/6N-Hip1^{em1(IMPC)Hmgu}/Ieg)	decreased circulating creatinine level	J:211773
Hip1^{tm5.1(HIP1)Tsr}/Hip1^{tm5.1(HIP1)Tsr} (involves: C57BL/6)	abnormal amino acid level	J:267987
	abnormal enzyme/coenzyme level	J:267987
	abnormal vitamin homeostasis	J:267987
	decreased acetylcholine level	J:267987
	decreased cystathionine level	J:267987
	decreased phosphocholine level	J:267987
Hipk2^tm1Ejh/Hipk2^tm1Ejh (involves: 129X1/SvJ * C57BL/6)	decreased dopamine level	J:117465
Hipk3^{Gt(OST51087)Lex}/Hipk3^{Gt(OST51087)Lex} (involves: 129S5/SvEvBrd)	decreased insulin secretion	J:194563
	impaired glucose tolerance	J:194563
Hipk3^{tm1b(EUCOMM)Hmgu}/Hipk3^{tm1b(EUCOMM)Hmgu} (C57BL/6N-Hipk3^{tm1b(EUCOMM)Hmgu}/Ieg)	increased circulating alanine transaminase level	J:211773
	increased fasting circulating glucose level	J:211773
Hipq1^C57BL/6Wehi/Hipq1^C57BL/6Wehi (involves: C57BL/6Wehi * DBA/2Wehi)	decreased insulin secretion	J:129498
	impaired glucose tolerance	J:129498
Hipq1^DBA/2Wehi/Hipq1^DBA/2Wehi (involves: C57BL/6Wehi * DBA/2Wehi)	increased insulin secretion	J:129498
hipr/hipr (involves: C57BL/6J)	increased circulating corticosterone level	J:196485
Hira^tm1Pjs/Hira^tm1Pjs (involves: 129S1/Sv * C57BL/6 * CD-1)	pericardial edema	J:75491
Hivep1^tm1(KOMP)Mbp/Hivep1⁺ (C57BL/6N-Hivep1^tm1(KOMP)Mbp/MbpMmucd)	increased circulating alanine transaminase level	J:211773
	increased circulating aspartate transaminase level	J:211773
Hjv^tm1Arbr/Hjv^tm1Arbr (involves: 129S4/SvJae * 129X1/SvJ)	abnormal iron homeostasis	J:100173
	decreased spleen iron level	J:100173
	hemochromatosis	J:100173
	increased heart iron level	J:100173
	increased liver iron level	J:100173
	increased pancreas iron level	J:100173
Hjv^{tm1b(KOMP)Wtsi}/Hjv^{tm1b(KOMP)Wtsi} (C57BL/6N-Hjv^{tm1b(KOMP)Wtsi}/J)	increased circulating iron level	J:211773
Hjv^tm1Kpan/Hjv^tm1Kpan Speer6-ps1^{Tg(Alb-cre)21Mgn}/Speer6-ps1⁺ (involves: 129S6/SvEvTac * C57BL/6)	abnormal iron homeostasis	J:231428
	decreased circulating unsaturated transferrin level	J:231428
	decreased spleen iron level	J:231428
	hemochromatosis	J:231428
	increased circulating ferritin level	J:231428
	increased circulating iron level	J:231428
	increased liver iron level	J:231428
Hjv^tm1Nca/Hjv⁺ Tmprss6^tm1Dgen/Tmprss6^tm1Dgen (involves: 129P2/OlaHsd * 129S4/SvJae * 129S6/SvEvTac * C57BL/6)	abnormal iron level	J:160248
	decreased heart iron level	J:160248
	decreased liver iron level	J:160248
	decreased pancreas iron level	J:160248
Hjv^tm1Nca/Hjv^tm1Nca (involves: 129S4/SvJae * 129S6/SvEvTac)	abnormal iron homeostasis	J:100178
	abnormal iron level	J:100178
	decreased spleen iron level	J:100178
	hemochromatosis	J:100178
	increased circulating iron level	J:100178
	increased kidney iron level	J:100178
	increased liver iron level	J:100178
Hjv^tm1Nca/Hjv^tm1Nca (involves: 129P2/OlaHsd * 129S4/SvJae * 129S6/SvEvTac * C57BL/6)	abnormal iron level	J:160248
	decreased spleen iron level	J:160248
	increased liver iron level	J:160248
Hjv^tm1Nca/Hjv^tm1Nca (involves: 129S4/SvJae * 129S6/SvEvTac * C57BL/6)	abnormal iron homeostasis	J:231428
	increased liver iron level	J:231428
Hjv^tm1Nca/Hjv^tm1Nca Tmprss6^tm1Dgen/Tmprss6⁺ (involves: 129P2/OlaHsd * 129S4/SvJae * 129S6/SvEvTac * C57BL/6)	abnormal iron level	J:160248
	decreased spleen iron level	J:160248
	increased liver iron level	J:160248
Hjv^tm1Nca/Hjv^tm1Nca Tmprss6^tm1Dgen/Tmprss6^tm1Dgen (involves: 129P2/OlaHsd * 129S4/SvJae * 129S6/SvEvTac * C57BL/6)	abnormal iron level	J:160248
	decreased spleen iron level	J:160248
	increased liver iron level	J:160248
Hk1^dea/Hk1^dea (A/J-Hk1^dea/J)	increased circulating bilirubin level	J:72146
	increased kidney iron level	J:72146
	increased liver iron level	J:72146
Hkdc1^{tm1a(KOMP)Wtsi}/Hkdc1⁺ (involves: C57BL/6N)	decreased liver triglyceride level	J:240354
Hkdc1^{tm1a(KOMP)Wtsi}/Hkdc1⁺ (involves: C57BL/6N)	impaired glucose tolerance	J:240354
hlb52/hlb52 (C57BL/6J-hlb52/J)	increased susceptibility to diet-induced obesity	J:82961
Hlb206/? (C57BL/6J-Hlb206)	decreased circulating HDL cholesterol level	J:82961
Hlb211/? (involves: 129 * C57BL/6)	increased circulating HDL cholesterol level	J:82961
Hlb212/? (involves: 129 * C57BL/6)	increased circulating HDL cholesterol level	J:82961
Hlb216/? (C57BL/6J-Hlb216)	decreased circulating HDL cholesterol level	J:82961
Hlb237/? (C57BL/6J-Hlb237)	decreased circulating cholesterol level	J:82961
Hlb237/? (C57BL/6J-Hlb237)	decreased circulating HDL cholesterol level	J:82961
Hlb239/? (involves: 129 * C57BL/6)	increased circulating cholesterol level	J:82961
Hlb239/? (involves: 129 * C57BL/6)	increased circulating HDL cholesterol level	J:82961
Hlb240/? (involves: 129 * C57BL/6)	increased circulating HDL cholesterol level	J:82961
hlb241/? (C57BL/6J-hlb241/J)	decreased circulating HDL cholesterol level	J:82961
hlb241/? (C57BL/6J-hlb241/J)	increased circulating cholesterol level	J:82961
hlb242/? (C57BL/6J-hlb242/J)	increased circulating cholesterol level	J:82961
hlb243/hlb243 (C57BL/6J-hlb243/J)	increased circulating cholesterol level	J:82961
hlb243/hlb243 (C57BL/6J-hlb243/J)	increased circulating HDL cholesterol level	J:82961
Hlb245/? (C57BL/6J-Hlb245/J)	increased circulating cholesterol level	J:82961
Hlb250/? (involves: 129 * C57BL/6)	increased circulating HDL cholesterol level	J:82961
Hlb252/? (involves: 129 * C57BL/6)	decreased circulating cholesterol level	J:82961
Hlb252/? (involves: 129 * C57BL/6)	decreased circulating HDL cholesterol level	J:82961
hlb258/? (involves: 129S4/SvJae * C57BL/6J)	abnormal blood coagulation	J:82961
hlb258/? (involves: 129S4/SvJae * C57BL/6J)	decreased circulating fibrinogen level	J:82961
Hlb280/? (C57BL/6J-Hlb280/J)	increased circulating HDL cholesterol level	J:82961
Hlb289/? (C57BL/6J-Hlb289/J)	hyperglycemia	J:82961
Hlb290/? (C57BL/6J-Hlb290/J)	hyperglycemia	J:82961
Hlb295/? (C57BL/6J-Hlb295)	decreased circulating HDL cholesterol level	J:82961
Hlb299/? (C57BL/6J-Hlb299/J)	increased circulating cholesterol level	J:82961
Hlb300/? (C57BL/6J-Hlb300)	increased circulating cholesterol level	J:82961
hlb349A/hlb349A (involves: 129S1/SvImJ * C57BL/6J)	increased susceptibility to diet-induced obesity	J:82961
hlb388/hlb388 (C57BL/6J-hlb388/J)	increased circulating HDL cholesterol level	J:77944
Hlb395/? (C57BL/6J-Hlb395)	increased circulating triglyceride level	J:82961
Hlb396/? (C57BL/6J-Hlb396)	increased circulating HDL cholesterol level	J:82961
Hlb397/? (C57BL/6J-Hlb397/J)	increased circulating HDL cholesterol level	J:82961
hlb437/? (C57BL/6J-hlb437/J)	hyperglycemia	J:77944
Hlb446/? (C57BL/6J-Hlb446/J)	increased circulating HDL cholesterol level	J:82961
Hlb476/? (C57BL/6J-Hlb476/J)	increased circulating HDL cholesterol level	J:82961
Hlb477/Hlb477 (C57BL/6J-Hlb477/J)	increased circulating HDL cholesterol level	J:82961
hlb497/hlb497 (C57BL/6J-hlb497/J)	increased circulating triglyceride level	J:82961
hlb505/? (C57BL/6J-hlb505/J)	increased circulating triglyceride level	J:77944
Hlb529/? (C57BL/6J-Hlb529/J)	increased circulating HDL cholesterol level	J:82961
hlb560/? (C57BL/6J-hlb560/J)	increased circulating triglyceride level	J:77944
Hlb561/? (C57BL/6J-Hlb561/J)	increased circulating HDL cholesterol level	J:82961
Hlb586/? (C57BL/6J-Hlb586/J)	increased circulating HDL cholesterol level	J:82961
Hlb589/? (C57BL/6J-Hlb589/J)	increased circulating HDL cholesterol level	J:82961
Hlb592/? (C57BL/6J-Hlb592/J)	increased circulating HDL cholesterol level	J:82961
Hlb594/? (C57BL/6J-Hlb594/J)	increased circulating HDL cholesterol level	J:82961
Hlcs^em1(IMPC)J/Hlcs⁺ (C57BL/6NJ-Hlcs^em1(IMPC)J/Mmjax)	decreased circulating calcium level	J:211773
Hlcs^em1(IMPC)J/Hlcs⁺ (C57BL/6NJ-Hlcs^em1(IMPC)J/Mmjax)	decreased circulating phosphate level	J:211773
Hlpx^C3H/HeJ/? (involves: C3H/HeJ * DBA/2J)	abnormal enzyme/coenzyme level	J:94275
Hlq1^MH/? (involves: C57BL/6J * MH)	abnormal body temperature homeostasis	J:55483
Hlq1^MH/? (involves: MH * ML)	abnormal body temperature homeostasis	J:55483
Hlq2^MH/? (involves: C57BL/6J * MH)	abnormal body temperature homeostasis	J:55483
Hlq3^MH/? (involves: C57BL/6J * MH)	abnormal body temperature homeostasis	J:55483
Hlq4^MH/? (involves: C57BL/6J * MH)	abnormal body temperature homeostasis	J:55483
Hlq5^MH/? (involves: C57BL/6J * MH)	abnormal body temperature homeostasis	J:55483
Hltf^tm1.2Geno/Hltf^tm1.2Geno (B6.129S2-Hltf^tm1.2Geno)	hypoglycemia	J:203735
Hlx^tm1Rph/Hlx^tm1Rph (FVB.129P2-Hlx^tm1Rph)	decreased circulating serum albumin level	J:119681
Hlx^tm1Rph/Hlx^tm1Rph (FVB.129P2-Hlx^tm1Rph)	hydrops fetalis	J:119681
Hmbox1^em1(IMPC)Tcp/Hmbox1^em1(IMPC)Tcp (C57BL/6N-Hmbox1^em1(IMPC)Tcp/Tcp)	decreased circulating chloride level	J:211773
	increased circulating bilirubin level	J:211773
Hmbs^tm1.1Rjde/Hmbs^tm1.1Rjde (involves: 129/Sv * C57BL/6)	abnormal urine homeostasis	J:275245
	decreased hydroxymethylbilane synthase level	J:275245
	increased erythrocyte protoporphyrin level	J:275245
	porphyria	J:275245
Hmbs^tm2Uam/Hmbs^tm3Uam (C57BL/6-Hmbs^tm2Uam/Hmbs^tm3Uam)	abnormal urine homeostasis	J:275245, J:31572
	erythruria	J:31572
	porphyria	J:275245, J:31572
Hmdc^C3H/HeJ/? (involves: C3H/HeJ * DBA/2J)	abnormal enzyme/coenzyme level	J:94275
Hmga1^tm1Brun/Hmga1⁺ (Not Specified)	decreased circulating insulin level	J:99652
	decreased insulin secretion	J:99652
	impaired glucose tolerance	J:99652
	increased insulin sensitivity	J:99652
	insulin resistance	J:99652
Hmga1^tm1Brun/Hmga1^tm1Brun (Not Specified)	decreased circulating insulin level	J:99652
	decreased insulin secretion	J:99652
	impaired glucose tolerance	J:99652
	increased insulin sensitivity	J:99652
	insulin resistance	J:99652
Hmga2^pg/Hmga2^pg (involves: MacArthur's small stock)	abnormal energy homeostasis	J:25351
Hmga2^pg/Hmga2^pg (involves: A/St * C57BL * MacArthur's small stock)	abnormal energy homeostasis	J:13064
Hmga2^tm1Cha/Hmga2⁺ (involves: 129S7/SvEvBrd)	decreased susceptibility to diet-induced obesity	J:61493
Hmga2^tm1Cha/Hmga2^tm1Cha (involves: 129S7/SvEvBrd)	decreased susceptibility to diet-induced obesity	J:61493
Hmgb1^tm1.1Dltg/Hmgb1^tm1.1Dltg Tg(Pdx1-cre)6Tuv/0 (involves: C57BL/6 * FVB/N)	increased circulating amylase level	J:225260
	increased circulating interleukin-6 level	J:225260
	increased circulating lactate dehydrogenase level	J:225260
	increased circulating tumor necrosis factor level	J:225260
Hmgb1^tm1.1Ttg/Hmgb1^tm1.1Ttg Lyz2^tm1(cre)Ifo/Lyz2⁺ (involves: 129P2/OlaHsd)	increased circulating interleukin-1 beta level	J:205499
	increased circulating interleukin-18 level	J:205499
Hmgb1^tm1.1Ttg/Hmgb1^tm1.1Ttg Speer6-ps1^{Tg(Alb-cre)21Mgn}/Speer6-ps1⁺ (involves: 129P2/OlaHsd * C57BL/6 * DBA)	increased circulating interleukin-1 beta level	J:205499
	increased circulating interleukin-18 level	J:205499
Hmgb1^tm1.1Ttg/Hmgb1^tm1.1Ttg Tg(Itgax-cre)1-1Reiz/0 (involves: 129P2/OlaHsd * C57BL/6 * CBA)	increased circulating interleukin-1 beta level	J:205499
	increased circulating interleukin-18 level	J:205499
Hmgb1^tm1Meb/Hmgb1^tm1Meb (involves: 129P2/OlaHsd * BALB/c)	decreased glycogen catabolism rate	J:55880
Hmgb1^tm1Meb/Hmgb1^tm1Meb (involves: 129P2/OlaHsd * BALB/c)	hypoglycemia	J:55880
Hmgcl^tm2Gam/Hmgcl^tm2Gam Speer6-ps1^{Tg(Alb-cre)21Mgn}/Speer6-ps1⁺ (B6.Cg-Hmgcl^tm2Gam Speer6-ps1^{Tg(Alb-cre)21Mgn})	abnormal gluconeogenesis	J:204294
	hypoglycemia	J:204294
	increased circulating ammonia level	J:204294
	increased circulating carnitine level	J:204294
Hmgcr^em1Bcgen/Hmgcr^em1Bcgen (Not Specified)	increased circulating triglyceride level	J:299971
Hmgcr^em1Bcgen/Hmgcr^em1Bcgen Usp20^em1Gpt/Usp20^em1Gpt Speer6-ps1^{Tg(Alb-cre)21Mgn}/Speer6-ps1⁺ (involves: C57BL/6JGpt * DBA)	increased circulating triglyceride level	J:299971
Hmgcr^tm2Ishi/Hmgcr^tm2Ishi Tg(Alb1-cre)1Dlr/0 (involves: 129S7/SvEvBrd * C57BL/6J)	abnormal circulating apolipoprotein level	J:201488
	abnormal circulating lipoprotein level	J:201488
	decreased circulating cholesterol level	J:201488
	decreased circulating LDL cholesterol level	J:201488
	decreased circulating triglyceride level	J:201488
	decreased liver cholesterol level	J:201488
	hypoglycemia	J:201488
	increased circulating alanine transaminase level	J:201488
	increased circulating aspartate transaminase level	J:201488
	increased circulating bilirubin level	J:201488
	increased circulating cholesterol level	J:201488
	increased circulating free fatty acids level	J:201488
	increased circulating LDL cholesterol level	J:201488
	increased circulating phospholipid level	J:201488
	increased collagen level	J:201488
	increased fatty acids level	J:201488
	increased liver triglyceride level	J:201488
	increased unsaturated fatty acids level	J:201488
Hmgcs2^em1(IMPC)Tcp/Hmgcs2⁺ (C57BL/6NCrl-Hmgcs2^em1(IMPC)Tcp)	abnormal circulating ketone body level	J:326918
Hmgcs2^em1(IMPC)Tcp/Hmgcs2^em1(IMPC)Tcp (C57BL/6NCrl-Hmgcs2^em1(IMPC)Tcp)	decreased circulating ketone body level	J:326918
	increased liver triglyceride level	J:326918
Hmgn1^em1(IMPC)Ics/Hmgn1^em1(IMPC)Ics (C57BL/6N-Hmgn1^em1(IMPC)Ics/Ics)	decreased circulating creatinine level	J:211773
Hmgn1^tm1Mbus/Hmgn1^tm1Mbus (involves: 129X1/SvJ)	decreased circulating corticosterone level	J:199604
Hmgn3^tm1.2Mbus/Hmgn3^tm1.2Mbus (B6.Cg-Hmgn3^tm1.2Mbus)	decreased circulating insulin level	J:153774
	impaired glucose tolerance	J:153774
	increased circulating glucose level	J:153774
Hmgn3^tm1.2Mbus/Hmgn3^tm1.2Mbus (involves: 129S4/SvJae * C57BL/6J)	abnormal glucose tolerance	J:199604
	decreased circulating corticosterone level	J:199604
	increased circulating glucose level	J:199604
	increased circulating testosterone level	J:199604
Hmgn5^tm1.2Mbus/Y (involves: 129S4/SvJae * C57BL/6J)	abnormal glucose tolerance	J:199604
Hmgn5^tm1.2Mbus/Hmgn5^tm1.2Mbus (involves: 129S4/SvJae * C57BL/6J)	abnormal glucose tolerance	J:199604
Hmgxb3^{tm1a(EUCOMM)Wtsi}/Hmgxb3^{tm1a(EUCOMM)Wtsi} (C57BL/6N-Hmgxb3^{tm1a(EUCOMM)Wtsi}/Wtsi)	subcutaneous edema	J:239583
Hmox1^em1(IMPC)Mbp/Hmox1⁺ (C57BL/6N-Hmox1^em1(IMPC)Mbp/MbpMmucd)	edema	J:211773
Hmox1^tm1.1Gkl/Hmox1^tm1.1Gkl Lyz2^tm1(cre)Ifo/Lyz2⁺ (involves: 129 * 129P2/OlaHsd * BALB/cJ * C57BL/6)	increased circulating tumor necrosis factor level	J:148498
Hmox1^tm1.1Hes/Hmox1^tm1.1Hes Lyz2^tm1(cre)Ifo/Lyz2⁺ (involves: 129P2/OlaHsd * C57BL/6J * C57BL/6N)	decreased circulating free fatty acids level	J:214639
	improved glucose tolerance	J:214639
	increased energy expenditure	J:214639
	increased insulin sensitivity	J:214639
Hmox1^tm1.1Hes/Hmox1^tm1.1Hes Speer6-ps1^{Tg(Alb-cre)21Mgn}/Speer6-ps1⁺ (involves: C57BL/6 * C57BL/6J * C57BL/6N * DBA)	decreased circulating alanine transaminase level	J:214639
	decreased circulating aspartate transaminase level	J:214639
	increased insulin sensitivity	J:214639
Hmox1^tm1Mlee/Hmox1^tm1Mlee (involves: 129S2/SvPas * BALB/c)	abnormal thrombosis	J:54684
	cerebral edema	J:153083
	increased circulating alanine transaminase level	J:153083
Hmox1^tm1Poss/Hmox1^tm1Poss (involves: 129S2/SvPas * C57BL/6)	abnormal iron homeostasis	J:79254
	decreased circulating iron level	J:79254
	increased blood urea nitrogen level	J:62437
	increased circulating ferritin level	J:79254
Hmox2^tm1Poss/Hmox2^tm1Poss (involves: 129S2/SvPas * C57BL/6)	abnormal iron level	J:46183
Hmox2^tm1Poss/Hmox2^tm1Poss (B6.129S2-Hmox2^tm1Poss)	abnormal circulating protein level	J:91075
Hmox2^tm1Poss/Hmox2^tm1Poss (B6.129S2-Hmox2^tm1Poss)	hypoxia	J:91075
Hmtb1^A/J/Hmtb1^A/J (C57BL/6J-Chr 5^A/J/Na)	abnormal thrombosis	J:114074
Hmtb1^A/J/Hmtb1^A/J (C57BL/6J-Chr 5^A/J/Na)	decreased bleeding time	J:114074
Hmtb1^A/J/Hmtb1^C57BL/6J Hmtb3^A/J/Hmtb3^C57BL/6J (involves: C57BL/6J-Chr 5^A/J * C57BL/6J-Chr 17^A/J)	abnormal blood coagulation	J:114074
	abnormal thrombosis	J:114074
Hmtb2^A/J/Hmtb2^A/J (C57BL/6J-Chr 11^A/J/Na)	abnormal blood coagulation	J:114074
Hmtb3^A/J/Hmtb3^A/J (C57BL/6J-Chr 17^A/J/Na)	abnormal blood coagulation	J:114074
Hmtb3^A/J/Hmtb3^A/J (C57BL/6J-Chr 17^A/J/Na)	decreased bleeding time	J:114074
Hmtb4^C57BL/6J/Hmtb4^C57BL/6J (involves: A/J * C57BL/6J)	abnormal thrombosis	J:139651
Hmtb5^C57BL/6J/Hmtb5^C57BL/6J (involves: A/J * C57BL/6J)	increased bleeding time	J:139651
Hmtb6^A/J/Hmtb6^C57BL/6J (involves: A/J * C57BL/6J)	abnormal thrombosis	J:139651
Hmtb8^C57BL/6J/Hmtb8^C57BL/6J (involves: A/J * C57BL/6J)	abnormal thrombosis	J:139651
Hmtb9^C57BL/6J/Hmtb9^C57BL/6J (involves: A/J * C57BL/6J)	abnormal thrombosis	J:139651
Hmx3/Hmx2^tm3Tlu/Hmx3/Hmx2^tm3Tlu (either: (involves: 129) or (involves: 129 * C57BL/6J))	decreased circulating growth hormone level	J:92940
Hmx3/Hmx2^tm3Tlu/Hmx3/Hmx2^tm3Tlu (either: (involves: 129) or (involves: 129 * C57BL/6J))	decreased circulating growth hormone level	J:92940
Hnf1a^tm1.1Ylee/Hnf1a^tm1.1Ylee (involves: 129X1/SvJ * C57BL/6J)	decreased circulating insulin level	J:47008
	decreased circulating insulin-like growth factor I level	J:47008
	hyperglycemia	J:47008
	increased cholesterol level	J:47008
	increased circulating growth hormone level	J:47008
	increased urine glucose level	J:47008
Hnf1a^tm1.1Ylee/Hnf1a^tm2Ylee (involves: 129X1/SvJ * C57BL/6J)	decreased circulating insulin level	J:81639
	hyperglycemia	J:81639
Hnf1a^tm1.1Ylee/Hnf1a^tm2Ylee Speer6-ps1^{Tg(Alb-cre)21Mgn}/? (involves: 129X1/SvJ * C57BL/6 * DBA)	decreased circulating insulin level	J:81639
	hyperglycemia	J:81639
Hnf1a^tm1Mya/Hnf1a^tm1Mya (involves: 129S2/SvPas)	abnormal circulating amino acid level	J:31627
	abnormal energy homeostasis	J:31627
	abnormal renal glucose reabsorption	J:31627
	abnormal urine calcium level	J:31627
	abnormal urine homeostasis	J:31627
	aminoaciduria	J:31627
	argininuria	J:31627
	decreased insulin secretion	J:48230
	increased circulating alanine transaminase level	J:31627
	increased circulating ammonia level	J:31627
	increased circulating aspartate transaminase level	J:31627
	increased circulating bilirubin level	J:31627
	increased circulating cholesterol level	J:31627
	increased circulating glucose level	J:48230
	increased urine glucose level	J:31627
	increased urine phosphate level	J:31627
	increased urine uric acid level	J:31627
	oroticaciduria	J:31627
Hnf1a^tm2Mya/Hnf1a^tm2Mya (involves: 129S2/SvPas)	abnormal circulating amino acid level	J:31627
	abnormal energy homeostasis	J:31627
	abnormal renal glucose reabsorption	J:31627
	abnormal urine calcium level	J:31627
	abnormal urine homeostasis	J:31627
	aminoaciduria	J:31627
	argininuria	J:31627
	increased circulating alanine transaminase level	J:31627
	increased circulating ammonia level	J:31627
	increased circulating aspartate transaminase level	J:31627
	increased circulating bilirubin level	J:31627
	increased circulating cholesterol level	J:31627
	increased urine glucose level	J:31627
	increased urine phosphate level	J:31627
	increased urine uric acid level	J:31627
	oroticaciduria	J:31627
Hnf1b^tm1Mya/Hnf1b^tm3Mya Tg(Alb1-cre)7Gsc/0 (involves: 129S2/SvPas * C57BL/6 * FVB/N)	abnormal lipid homeostasis	J:75935
	increased circulating bilirubin level	J:75935
	increased circulating cholesterol level	J:75935
	increased circulating triglyceride level	J:75935
Hnf1b^tm2Ics/Hnf1b⁺ (involves: 129 * C57BL/6N)	decreased circulating insulin level	J:306082
	decreased insulin secretion	J:306082
	hyperglycemia	J:306082
	impaired glucose tolerance	J:306082
	increased fasting circulating glucose level	J:306082
Hnf4a^tm1.1Gonz/Hnf4a^tm1.1Gonz Tg(Alb1-cre)1Dlr/0 (involves: 129X1/SvJ * FVB/N)	decreased circulating cholesterol level	J:67396
	decreased circulating HDL cholesterol level	J:67396
	decreased circulating triglyceride level	J:67396
Hnf4a^tm1.1Gonz/Hnf4a^tm1.1Gonz Tg(Ins2-cre)25Mgn/0 (involves: 129X1/SvJ * C57BL/6 * DBA)	decreased circulating insulin level	J:108652
	impaired glucose tolerance	J:108652
Hnf4a^tm1.1Mwei/Hnf4a^tm1.1Mwei (involves: 129S2/SvPas * BALB/c * C57BL/6)	impaired glucose tolerance	J:106993
Hnf4a^{tm1b(EUCOMM)Hmgu}/Hnf4a⁺ (C57BL/6N-Hnf4a^{tm1b(EUCOMM)Hmgu}/Ieg)	improved glucose tolerance	J:211773
	increased circulating bilirubin level	J:211773
	increased circulating cholesterol level	J:211773
	increased circulating HDL cholesterol level	J:211773
Hnf4a^tm1Sad/Hnf4a^tm1Sad Six2^{tm1(tTA,tetO-EGFP/cre)Amc}/Six2⁺ (involves: 129 * 129S1/Sv * 129X1/SvJ * C57BL/6J)	increased urine glucose level	J:266356
	increased urine phosphate level	J:266356
Hnf4a^tm1Sad/Hnf4a^tm1Sad Tg(Alb1-cre)1Khk/0 (involves: C57BL/6 * SJL)	decreased liver glycogen level	J:84076
Hnf4a^tm2.1Mwei/Hnf4a^tm2.1Mwei (involves: 129S2/SvPas * BALB/c * C57BL/6)	abnormal lipid homeostasis	J:106993
	decreased circulating cholesterol level	J:106993
	decreased circulating free fatty acids level	J:106993
	decreased circulating iron level	J:106993
	decreased circulating triglyceride level	J:106993
	hypokalemia	J:106993
	increased circulating bilirubin level	J:106993
	increased circulating ketone body level	J:106993
Hnf4g^tm1Dgen/Hnf4g^tm1Dgen (involves: 129P2/OlaHsd * C57BL/6)	abnormal energy expenditure	J:113034
Hnl^BALB/cBy/Hnl^BALB/cBy (involves: BALB/cBy * C57BL/6By)	increased noradrenaline level	J:5433
Hnmt^{tm1a(KOMP)Wtsi}/Hnmt^{tm1a(KOMP)Wtsi} (involves: C57BL/6J * C57BL/6N)	increased histamine level	J:253575
Hnrnpa2b1^tm1.1Caox/Hnrnpa2b1^tm1.1Caox Lyz2^tm1(cre)Ifo/Lyz2⁺ (involves: 129P2/OlaHsd)	abnormal interferon level	J:283622
	decreased circulating interferon-beta level	J:283622
Hnrnpa3^em1Ionsz/Hnrnpa3^em1Ionsz (C57BL/6J-Hnrnpa3^em1Ionsz)	hypoxia	J:288307
Hnrnpc^{tm1b(EUCOMM)Hmgu}/Hnrnpc⁺ (C57BL/6N-Hnrnpc^{tm1b(EUCOMM)Hmgu}/J)	decreased circulating serum albumin level	J:211773
	improved glucose tolerance	J:211773
Hnrnpd^tm1Rjsc/Hnrnpd^tm1Rjsc (involves: 129S6/SvEvTac * C57BL/6J)	increased blood urea nitrogen level	J:116112
	increased circulating aspartate transaminase level	J:116112
	increased circulating tumor necrosis factor level	J:116112
Hnrnpf^tm1Jsdc/Hnrnpf^tm1Jsdc Pax8^{tm1.1(cre)Mbu}/Pax8⁺ (involves: 129P2/OlaHsd * C57BL/6)	abnormal urine homeostasis	J:284239
	albuminuria	J:284239
	increased angiotensin II level	J:284239
	increased urine glucose level	J:284239
Hoga1^{tm2a(KOMP)Wtsi}/Hoga1^{tm2a(KOMP)Wtsi} (involves: C57BL/6N)	abnormal blood homeostasis	J:231386
	abnormal urine homeostasis	J:231386
Hom1^A/Ph/Hom1^A/Ph (involves: A/Ph * C57BL/10ScSnPh)	increased circulating testosterone level	J:5336, J:5301
Hook3^{tm1b(NCOM)Mfgc}/Hook3^{tm1b(NCOM)Mfgc} (C57BL/6N-Hook3^{tm1b(NCOM)Mfgc}/Tcp)	increased circulating alkaline phosphatase level	J:211773
	increased circulating aspartate transaminase level	J:211773
Hopx^tm1.1Joe/Hopx^tm1.1Joe (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	pericardial effusion	J:79153
Hopx^tm1Eno/Hopx^tm1Eno (involves: 129S6/SvEvTac)	hemopericardium	J:79152
Hoxa1^tm1Ipc/Hoxa1^tm1Ipc (involves: 129S2/SvPas * C57BL/6)	anoxia	J:23837
Hoxa1^tm1Ipc/Hoxa1^tm1Ipc (involves: 129S2/SvPas * C57BL/6)	cyanosis	J:23837
Hoxa2^{tm1b(EUCOMM)Wtsi}/Hoxa2⁺ (C57BL/6N-Hoxa2^{tm1b(EUCOMM)Wtsi}/Ieg)	decreased circulating creatinine level	J:211773
	decreased respiratory quotient	J:211773
	improved glucose tolerance	J:211773
Hoxa5^tm1Rob/Hoxa5^tm1Rob (129S(Cg)-Hoxa5^tm1Rob)	cyanosis	J:45341
	increased circulating estradiol level	J:182519
	increased circulating thyroid-stimulating hormone level	J:84449
Hoxa13^tm1.1Mrc/Hoxa13^tm1.1Mrc (involves: 129S1/Sv * 129X1/SvJ)	edema	J:136953
Hoxb4^tm1Nrm/Hoxb4^tm1Nrm (involves: 129S7/SvEvBrd * C57BL/6)	edema	J:71389
Hoxb^tm1Brd/Hoxb^tm1Brd (involves: 129S7/SvEvBrd * C57BL/6J)	edema	J:62577
Hp^tm1Skl/Hp^tm1Skl (involves: 129P2/OlaHsd * C57BL/6J)	hemoglobinemia	J:49888
Hp^tm1Skl/Hp^tm1Skl (involves: 129P2/OlaHsd * C57BL/6J)	increased kidney iron level	J:97082
Hp^tm1Skl/Hp^tm1Skl Hpx^tm1Altr/Hpx^tm1Altr (involves: 129/Sv * 129P2/OlaHsd * C57BL/6J)	abnormal blood homeostasis	J:80539
	abnormal circulating protein level	J:80539
Hpca^em1(IMPC)H/Hpca^em1(IMPC)H (C57BL/6NTac-Hpca^em1(IMPC)H/H)	impaired glucose tolerance	J:211773
	increased circulating alkaline phosphatase level	J:211773
Hpcal1^em1Ylzg/Hpcal1^em1Ylzg (C57BL/6J-Hpcal1^em1Ylzg)	increased circulating alanine level	J:331711
Hpcal1^em1Ylzg/Hpcal1^em1Ylzg (C57BL/6J-Hpcal1^em1Ylzg)	increased circulating aspartate transaminase level	J:331711
Hpd^hty/Hpd^hty (ICRIII)	abnormal urine homeostasis	J:11113
Hpd^hty/Hpd^hty (ICRIII)	decreased circulating tyrosine level	J:14313, J:11113
Hpgd^tm1Bhk/Hpgd^tm1Bhk (involves: 129P2/OlaHsd)	increased prostaglandin level	J:74466
Hpgd^tm1Bhk/Hpgd^tm1Bhk (involves: 129P2/OlaHsd * C57BL/6)	abnormal prostaglandin level	J:105183
Hpgd^tm1Ljm/Hpgd^tm1Ljm (involves: 129S6/SvEvTac * C57BL/6)	increased circulating progesterone level	J:130001
Hpgd^tm1Ljm/Hpgd^tm1Ljm (involves: 129S6/SvEvTac * C57BL/6)	increased prostaglandin level	J:130001
Hpgds^tm1Urad/Hpgds^tm1Urad (B6.129-Hpgds^tm1Urad)	edema	J:197334
hph1/hph1 (involves: C57BL/6 * CBA/Ca)	abnormal nitric oxide homeostasis	J:109694
hph1/hph1 (involves: C57BL/6 * CBA/Ca)	increased circulating phenylalanine level	J:9146
Hpn^Hlb320/? (C57BL/6J-Hpn^Hlb320/J)	decreased circulating HDL cholesterol level	J:82961
Hpn^Hlb320/? (C57BL/6J-Hpn^Hlb320/J)	increased circulating cholesterol level	J:82961
Hpn^Hlb320/Hpn⁺ (involves: C57BL/6J * C57L/J)	decreased circulating cholesterol level	J:187708
	decreased circulating HDL cholesterol level	J:187708
	decreased circulating triglyceride level	J:187708
Hpn^Hlb320/Hpn^Hlb320 (C57BL/6J-Hpn^Hlb320/J)	decreased circulating cholesterol level	J:187708
	decreased circulating HDL cholesterol level	J:187708
	decreased circulating triglyceride level	J:187708
	increased circulating alkaline phosphatase level	J:187708
Hpn^Hlb320/Hpn^Hlb320 (involves: C57BL/6J * C57L/J)	decreased circulating cholesterol level	J:187708
	decreased circulating HDL cholesterol level	J:187708
	decreased circulating triglyceride level	J:187708
Hpn^tm1Qwu/Hpn^tm1Qwu (involves: 129X1/SvJ * NIH Swiss)	decreased thyroxine level	J:123922
Hpn^tm1Qwu/Hpn^tm1Qwu (involves: 129X1/SvJ * NIH Swiss)	increased circulating alkaline phosphatase level	J:45393
Hprt1^b-m1/Y (involves: 129 * 129S/SvEv)	decreased dopamine level	J:115724
Hprt1^b-m2/Y (involves: 129 * 129S/SvEv)	decreased dopamine level	J:115724
Hprt1^b-m3/Y (B6.129P2-Hprt1^b-m3)	decreased dopamine level	J:17798
Hprt1^b-m3/Hprt1^b-m3 (B6.129P2-Hprt1^b-m3)	decreased dopamine level	J:17798
Hprt1^tm1(AGT)Asku/Y Tg(REN)64071Sig/? (involves: 129P2/OlaHsd * C57BL/6)	abnormal circulating angiotensinogen level	J:143791
	abnormal protein level	J:143791
	increased circulating angiotensin II level	J:143791
Hprt1^{tm1(CAG-Gys1)Jjg}/? Myl1^tm1(cre)Sjb/Myl1⁺ (involves: 129P2/OlaHsd 129S1/Sv * 129X1/SvJ)	increased skeletal muscle glycogen level	J:244440
Hprt1^{tm1(CAG-Gys1*)Jjg}/? Tg(Nes-cre)1Kag/? (involves: 129P2/OlaHsd)	increased brain glycogen level	J:210491
Hprt1^{tm1(Camk2a-APPSweLon,-MAPTP301LR406W)Geno}/Hprt1⁺ Tg(PSEN1)5Dbo/0 (involves: 129P2/OlaHsd)	abnormal glucose homeostasis	J:180977
Hprt1^{tm1(H1-RNAi:Tmsb4x)Prri}/Hprt1⁺ Tg(Tek-cre)1Ywa/0 (involves: C57BL/6 * SJL)	hemopericardium	J:195902
Hprt1^{tm1(Ins2-HBEGF)Herr}/Y (involves: 129 * C57BL/6)	decreased insulin secretion	J:159291
	hyperglycemia	J:159291
	increased insulin secretion	J:159291
	ketoacidosis	J:159291
Hprt1^{tm1(Ins2-HBEGF)Herr}/Hprt1^{tm1(Ins2-HBEGF)Herr} (involves: 129 * C57BL/6)	hyperglycemia	J:159291
Hprt1^{tm1(Nphs1-CMIP)Dsah}/Hprt1⁺ (B6.Cg-Hprt1^{tm1(Nphs1-CMIP)Dsah})	albuminuria	J:185411
	increased urine protein level	J:185411
Hprt1^{tm1(Pck1-cre)Vhh}/Hprt1⁺ Tg(CAG-lacZ,-Miox)#Ysk/0 (involves: 129P2/OlaHsd * C57BL/6J)	increased blood urea nitrogen level	J:266834
	increased circulating creatinine level	J:266834
Hprt1^{tm1(tetO-EGFP/Rac1)Shaw}/Y Tg(Nphs1-rtTA3G)8Jhm/0 (involves: 129S4/SvJae * C57BL/6)	increased urine protein level	J:206088
Hprt1^{tm1(tetO-EGFP/Rac1)Shaw}/Y Tg(NPHS2-rtTA2M2)1Jbk/0 (involves: 129S4/SvJae * C57BL/6 * FVB/N)	increased urine protein level	J:206088
Hprt1^{tm1.1(CAG-Smpd1)Jhkh}/Hprt1⁺ (involves: 129P2/OlaHsd * C57BL/6)	abnormal ceramide level	J:199833
Hprt1^tm2(AGT)Asku/Y Tg(REN)64071Sig/? (involves: 129P2/OlaHsd * C57BL/6)	abnormal circulating angiotensinogen level	J:143791
	abnormal protein level	J:143791
	increased circulating angiotensin II level	J:143791
Hprt1^{tm2(CAG-Ppp1r3c)Jjg}/? (Not Specified)	increased brain glycogen level	J:210491
Hprt1^{tm2(CAG-Ppp1r3c)Jjg}/? Nhlrc1^{tm1(KOMP)Vlcg}/Nhlrc1^{tm1(KOMP)Vlcg} (involves: C57BL/6NTac)	increased brain glycogen level	J:210491
Hprt1^{tm2(Pgk1-Pac/TK)Brd}/Y H2az2^{Tg(Wnt1-cre)11Rth}/H2az2⁺ (involves: 129S7/SvEvBrd * C57BL/6 * CBA)	edema	J:130481
	pericardial effusion	J:130481
Hprt1^{tm2(Pgk1-Pac/TK)Brd}/Hprt1⁺ H2az2^{Tg(Wnt1-cre)11Rth}/H2az2⁺ (involves: 129S7/SvEvBrd * C57BL/6 * CBA)	edema	J:130481
	pericardial effusion	J:130481
Hprt1^{tm4(Tek-IGF1R)Geno}/Y (B6.129P2-Hprt1^{tm4(Tek-IGF1R)Geno})	abnormal nitric oxide homeostasis	J:208523
Hprt1^{tm6(CAG-fat-1)Geno}/Y Gt(ROSA)26Sor^{tm1(cre/ERT2)Tyj}/Gt(ROSA)26Sor⁺ (involves: 129P2/OlaHsd * 129S4/SvJae * C57BL/6)	abnormal fatty acids level	J:213660
Hps1^ep/Hps1^ep (involves: C3HeB/FeJ * C57BL/6J)	abnormal circulating enzyme level	J:6219
	abnormal platelet physiology	J:7327, J:42484
	abnormal urine homeostasis	J:6219
	decreased platelet ATP level	J:7327
	decreased platelet serotonin level	J:7327
	increased bleeding time	J:7327
Hps1^ep/Hps1^ep (B6.C3Fe-Hps1^ep/J)	decreased platelet ATP level	J:7327
	decreased platelet serotonin level	J:7327, J:29748
	increased bleeding time	J:7327
Hps3^coa-6J/Hps3^coa-6J (C3H/HeJ-Hps3^coa-6J/J)	abnormal blood coagulation	J:63693
Hps3^coa-6J/Hps3^coa-6J (C3H/HeJ-Hps3^coa-6J/J)	increased bleeding time	J:63693
Hps3^coa/Hps3^coa (involves: C57BL/10J)	abnormal platelet dense granule physiology	J:9300
	decreased platelet aggregation	J:9300
	decreased platelet ATP level	J:9300
	decreased platelet serotonin level	J:9300
	increased bleeding time	J:9300
Hps4^le/Hps4^le (B6.C3-Pde6b^rd1 Hps4^le)	abnormal platelet physiology	J:11990
	decreased platelet serotonin level	J:7327, J:29748
	decreased urine protein level	J:7416, J:5967
	increased bleeding time	J:7327
Hps4^le/Hps4^le Pde6b^rd1/Pde6b^rd1 (B6.C3-Pde6b^rd1 Hps4^le/J)	abnormal platelet activation	J:221384
	decreased platelet aggregation	J:221384
Hps5^ru2-J/Hps5^ru2-J (C57BL/6J-Hps5^ru2-J/J)	abnormal urine homeostasis	J:6422
Hps5^ru2-mr/Hps5^ru2-mr (B6.Cg-Hps5^ru2-mr/Re)	decreased platelet ATP level	J:7327
	decreased platelet serotonin level	J:7327, J:29748
	increased bleeding time	J:7327
Hpse2^{Gt(OST411605)Lex}/Hpse2^{Gt(OST411605)Lex} (involves: 129S5/SvEvBrd * C57BL/6)	albuminuria	J:219597
	decreased circulating glucose level	J:219597
	decreased circulating serum albumin level	J:219597
	increased circulating alkaline phosphatase level	J:219597
	increased urine protein level	J:219597
Hpse^{tm1b(EUCOMM)Hmgu}/Hpse^{tm1b(EUCOMM)Hmgu} (C57BL/6N-Hpse^{tm1b(EUCOMM)Hmgu}/Tcp)	increased circulating creatinine level	J:211773
Hpx^tm1Altr/Hpx^tm1Altr (either: (involves: 129S1/Sv * 129X1/SvJ) or (involves: 129S1/Sv * 129X1/SvJ * C57BL/6))	hemoglobinuria	J:58821
	increased circulating haptoglobin level	J:58821
	increased kidney iron level	J:58821
Hr^em1(IMPC)H/Hr^em1(IMPC)H (C57BL/6NTac-Hr^em1(IMPC)H/H)	decreased circulating alkaline phosphatase level	J:211773
	decreased circulating amylase level	J:211773
	decreased circulating cholesterol level	J:211773
	decreased circulating HDL cholesterol level	J:211773
Hr^hr/Hr^hr Ptgs1^tm1Unc/Ptgs1⁺ (involves: 129P2/OlaHsd * C57BL/6 * SKH1)	decreased prostaglandin level	J:121635
Hr^hr/Hr^hr Ptgs2^tm1Unc/Ptgs2⁺ (involves: 129P2/OlaHsd * C57BL/6 * SKH1)	decreased prostaglandin level	J:121635
Hr^hr/Hr^hr Tg(CD2-Stat6V625AT626A)78Mhk/0 (involves: C3H * SKH1)	edema	J:230018
Hr^hr/Hr^hr Tg(KRT14-Ptgs2)1Sumf/0 (involves: C57BL/6 * DBA/2 * FVB/N * SKH1)	increased prostaglandin level	J:121635
Hras^tm1Mok/Hras⁺ Nras^tm1Mok/Nras^tm1Mok (involves: 129S/SvEv * C57BL/6 * DBA/2)	chylous ascites	J:159024
Hras^tm1Mok/Hras^tm1Mok (involves: 129S/SvEv * C57BL/6 * DBA/2)	chylous ascites	J:159024
Hras^tm1Mok/Hras^tm1Mok Kras^tm1Mok/Kras⁺ (involves: 129S/SvEv * C57BL/6 * DBA/2)	chylous ascites	J:159024
Hras^tm1Mok/Hras^tm1Mok Kras^tm1Mok/Kras⁺ Nras^tm1Mok/Nras⁺ (involves: 129S/SvEv * C57BL/6 * DBA/2)	chylous ascites	J:159024
Hras^tm1Mok/Hras^tm1Mok Nras^tm1Mok/Nras⁺ (involves: 129S/SvEv * C57BL/6 * DBA/2)	chylous ascites	J:159024
Hras^tm1Mok/Hras^tm1Mok Nras^tm1Mok/Nras^tm1Mok (involves: 129S/SvEv * C57BL/6 * DBA/2)	chylous ascites	J:159024
Hras^tm2Xbr/Hras^tm2Xbr (involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * FVB/N)	decreased urine creatinine level	J:137729
	increased circulating angiotensin II level	J:137729
Hrg^tm1Wja/Hrg^tm1Wja (involves: 129P2/OlaHsd * C57BL/6)	abnormal thrombolysis	J:134621
	decreased bleeding time	J:134621
	decreased prothrombin time	J:134621
	increased circulating fibrinogen level	J:134621
Hrh1^tm1Wtn/Hrh1^tm1Wtn (B6.129P2-Hrh1^tm1Wtn)	decreased circulating insulin level	J:107191
	increased circulating free fatty acids level	J:107191
	increased circulating leptin level	J:107191
	increased liver triglyceride level	J:107191
	increased skeletal muscle triglyceride level	J:107191
Hrh2^tm1Wtn/Hrh2^tm1Wtn (involves: 129P2/OlaHsd * C57BL/6J)	increased circulating gastrin level	J:62871
Hrh2^tm1Yfks/Hrh2^tm1Yfks (involves: 129S6/SvEvTac * C57BL/6)	increased circulating gastrin level	J:102252
Hrh3^tm1.1Jhwa/Hrh3^tm1.1Jhwa (involves: C57BL/6 * C57BL/6NTac)	abnormal glucose homeostasis	J:174155
	increased circulating glucose level	J:174155
Hrh3^tm1Kot/Hrh3^tm1Kot (involves: 129X1/SvJ * C57BL/6N)	abnormal energy expenditure	J:80824
	decreased core body temperature	J:80824
	decreased oxygen consumption	J:80824
	increased circulating insulin level	J:80824
	increased circulating leptin level	J:80824
	insulin resistance	J:80824
Hrh3^tm1Twl/Hrh3^tm1Twl (involves: 129P2/OlaHsd * C57BL/6J)	abnormal circadian temperature homeostasis	J:79168
Hrh3^tm1Twl/Hrh3^tm1Twl (involves: 129P2/OlaHsd * C57BL/6J)	abnormal hormone level	J:89633
Hrh4^tm1Lex/Hrh4^tm1Lex (involves: 129S/SvEv * BALB/c)	abnormal chemokine level	J:131785
Hrh4^tm1Lex/Hrh4^tm1Lex (involves: 129S/SvEv * BALB/c)	abnormal interleukin level	J:131785
Hrnr^{em1(IMPC)Wtsi}/Hrnr^{em1(IMPC)Wtsi} (C57BL/6N-Hrnr^{em1(IMPC)Wtsi}/WtsiIeg)	decreased circulating serum albumin level	J:211773
Hs2st1^tm1.1Je/Hs2st1^tm1.1Je Speer6-ps1^{Tg(Alb-cre)21Mgn}/Speer6-ps1⁺ (B6.Cg-Hs2st1^tm1.1Je Speer6-ps1^{Tg(Alb-cre)21Mgn})	abnormal lipid homeostasis	J:158299
	increased circulating triglyceride level	J:158299
Hs3st3a1^{tm1(KOMP)Vlcg}/Hs3st3a1^{tm1(KOMP)Vlcg} (C57BL/6N-Hs3st3a1^{tm1(KOMP)Vlcg}/MbpMmucd)	increased circulating alanine transaminase level	J:211773
	increased circulating aspartate transaminase level	J:211773
	increased circulating total protein level	J:211773
Hsd3b7^tm1Rus/Hsd3b7^tm1Rus (involves: 129S/SvEv * C57BL/6J)	abnormal bile salt homeostasis	J:122973
	abnormal cholesterol homeostasis	J:122973
	decreased circulating triglyceride level	J:122973
	decreased intestinal cholesterol absorption	J:122973
	increased fatty acids level	J:122973
	increased liver triglyceride level	J:122973
Hsd11b1^tm1.1Ggla/Hsd11b1^tm1.1Ggla (involves: 129P2/OlaHsd)	decreased circulating corticosterone level	J:189059
Hsd11b1^tm1.2Tuck/Hsd11b1^tm1.2Tuck (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	abnormal circulating insulin level	J:203302
Hsd11b1^{tm1a(KOMP)Wtsi}/Hsd11b1⁺ (involves: C57BL/6Jcl * C57BL/6N)	abnormal corticosterone level	J:214146
	decreased collagen level	J:214146
	increased circulating corticosterone level	J:214146
Hsd11b1^{tm1a(KOMP)Wtsi}/Hsd11b1^{tm1a(KOMP)Wtsi} (involves: C57BL/6Jcl * C57BL/6N)	abnormal corticosterone level	J:214146
	decreased collagen level	J:214146
	increased circulating corticosterone level	J:214146
Hsd11b1^tm1Ggla/Hsd11b1^tm1Ggla Speer6-ps1^{Tg(Alb-cre)21Mgn}/Speer6-ps1⁺ (involves: 129P2/OlaHsd * C57BL/6 * DBA)	abnormal glucose tolerance	J:189059
	decreased circulating corticosterone level	J:189059
	decreased circulating insulin level	J:189059
	increased circulating HDL cholesterol level	J:189059
Hsd11b1^tm1Yko/Hsd11b1^tm1Yko (involves: 129P2/OlaHsd * MF1)	abnormal amniotic fluid composition	J:80523
	abnormal circulating cholesterol level	J:72402
	abnormal corticosterone level	J:67184, J:45085
	abnormal glucose homeostasis	J:37960
	abnormal lipid homeostasis	J:72402
	decreased circulating glucose level	J:37960, J:45085
	decreased circulating triglyceride level	J:72402
	improved glucose tolerance	J:72402
	increased circulating cholesterol level	J:72402
	increased circulating HDL cholesterol level	J:72402
	increased liver glycogen level	J:45085
Hsd11b1^tm1Yko/Hsd11b1^tm1Yko (B6.129P2(Cg)-Hsd11b1^tm1Yko)	decreased circulating LDL cholesterol level	J:89080
	improved glucose tolerance	J:89080
	increased circulating HDL cholesterol level	J:89080
Hsd11b2^tm1Yko/Hsd11b2^tm1Yko (involves: 129P2/OlaHsd * MF1)	decreased circulating aldosterone level	J:53391
	decreased circulating chloride level	J:53391
	decreased circulating potassium level	J:53391
	decreased urine creatinine level	J:53391
	decreased urine potassium level	J:53391
	decreased urine sodium level	J:53391
Hsd17b1^{tm1(KOMP)Vlcg}/Hsd17b1^{tm1(KOMP)Vlcg} (involves: C57BL/6NTac)	abnormal progesterone level	J:225533
	increased luteinizing hormone level	J:225533
Hsd17b1^{tm1.1(KOMP)Vlcg}/Hsd17b1^{tm1.1(KOMP)Vlcg} (C57BL/6N-Hsd17b1^{tm1.1(KOMP)Vlcg}/J)	decreased circulating chloride level	J:211773
	decreased circulating glucose level	J:211773
	decreased circulating serum albumin level	J:211773
	increased circulating alkaline phosphatase level	J:211773
	increased circulating potassium level	J:211773
Hsd17b3^tm1.2Mpo/Hsd17b3^tm1.2Mpo (involves: 129S6/SvEvTac * C57BL/6N * C57BL/6NCrl)	abnormal circulating androgen level	J:301756
	abnormal hormone level	J:301756
	abnormal progesterone level	J:301756
	abnormal testosterone level	J:301756
	increased circulating dihydrotestosterone level	J:301756
	increased circulating luteinizing hormone level	J:301756
	increased circulating progesterone level	J:301756
	increased circulating testosterone level	J:301756
Hsd17b4^em1(IMPC)Tcp/Hsd17b4⁺ (C57BL/6NCrl-Hsd17b4^em1(IMPC)Tcp/Tcp)	decreased circulating aspartate transaminase level	J:211773
Hsd17b4^tm1Baes/Hsd17b4^tm1Baes (involves: 129S1/Sv * 129X1/SvJ)	abnormal bile salt level	J:99925
	abnormal lipid homeostasis	J:104835
	abnormal lipid level	J:62314
	increased fatty acids level	J:201698
Hsd17b4^tm2Baes/Hsd17b4^tm2Baes Cnp^tm1(cre)Kan/Cnp⁺ (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	increased fatty acids level	J:201698
Hsd17b4^tm2Baes/Hsd17b4^tm2Baes Tg(Nes-cre)1Kln/0 (involves: 129 * C57BL/6 * SJL)	increased fatty acids level	J:201698
Hsd17b7^tm1Gibo/Hsd17b7^tm1Gibo (involves: 129S1/Sv * C57BL/6)	pericardial effusion	J:140055
Hsd17b7^tm1Mpo/Hsd17b7^tm1Mpo (involves: 129S7/SvEvBrd)	abnormal lipid homeostasis	J:160004
Hsd17b7^tm1Mpo/Hsd17b7^tm1Mpo (involves: 129S7/SvEvBrd)	pericardial effusion	J:160004
Hsd17b11^{tm1.1(KOMP)Vlcg}/Hsd17b11^{tm1.1(KOMP)Vlcg} (C57BL/6N-Hsd17b11^{tm1.1(KOMP)Vlcg}/J)	decreased urine creatinine level	J:211773
	decreased urine microalbumin level	J:211773
Hsd17b13^tm1Lex/Hsd17b13^tm1Lex (involves: 129S5/SvEvBrd * C57BL/6N)	decreased fatty acid beta-oxidation	J:273927
	increased liver triglyceride level	J:273927
Hsd17b14^tm1Lex/Hsd17b14^tm1Lex (B6;129S5-Hsd17b14^tm1Lex/Mmucd)	increased response to stress-induced hyperthermia	J:171883
Hsf1^{tm1.1(KOMP)Vlcg}/Hsf1⁺ (C57BL/6N-Hsf1^{tm1.1(KOMP)Vlcg}/J)	decreased circulating glucose level	J:211773
Hsf2^{tm1b(KOMP)Wtsi}/Hsf2^{tm1b(KOMP)Wtsi} (C57BL/6N-Hsf2^{tm1b(KOMP)Wtsi}/J)	decreased circulating glucose level	J:211773
	increased circulating sodium level	J:211773
Hsf2bp^{tm1a(EUCOMM)Hmgu}/Hsf2bp^{tm1a(EUCOMM)Hmgu} (C57BL/6N-Hsf2bp^{tm1a(EUCOMM)Hmgu}/Cnrm)	decreased circulating glucose level	J:165965
	increased circulating glucose level	J:165965
	increased circulating HDL cholesterol level	J:165965
Hsf4^{tm1b(KOMP)Wtsi}/Hsf4^{tm1b(KOMP)Wtsi} (C57BL/6N-Hsf4^{tm1b(KOMP)Wtsi}/J)	increased circulating alanine transaminase level	J:211773
Hsf5^em1(IMPC)J/Hsf5^em1(IMPC)J (C57BL/6NJ-Hsf5^em1(IMPC)J/Mmjax)	increased fasting circulating glucose level	J:211773
Hsl1^C57BL/6J/? (involves: C3H/HeJ * C57BL/6J)	hyperoxia	J:73581
Hsp90aa1^{tm1(KOMP)Wtsi}/Hsp90aa1^{tm1(KOMP)Wtsi} (C57BL/6N-Hsp90aa1^{tm1(KOMP)Wtsi}/Wtsi)	increased circulating alkaline phosphatase level	J:211773
Hspa1b^tm1Clib/Hspa1b^tm1Clib (involves: 129P2/OlaHsd * C57BL/6J)	abnormal nitric oxide homeostasis	J:76801
	decreased body temperature	J:76801
Hspa1b^tm1Clib/Hspa1b^tm1Clib (involves: 129P2/OlaHsd * C57BL/6)	decreased body temperature	J:123913
Hspa4l^tm1Imad/Hspa4l^tm1Imad (involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)	increased blood urea nitrogen level	J:114659
	increased circulating calcium level	J:114659
	increased circulating sodium level	J:114659
Hspa5^{tm1.1(KOMP)Vlcg}/Hspa5⁺ (C57BL/6N-Hspa5^{tm1.1(KOMP)Vlcg}/J)	decreased circulating chloride level	J:211773
	increased circulating cholesterol level	J:211773
	increased circulating HDL cholesterol level	J:211773
Hspa5^tm1Aoe/Hspa5^tm1Aoe (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	cyanosis	J:131209
Hspa12a^tm1.1Zdi/Hspa12a^tm1.1Zdi (involves: 129 * C57BL/6)	decreased susceptibility to diet-induced obesity	J:287930
Hspa12a^tm1.1Zdi/Hspa12a^tm1.1Zdi (involves: 129 * C57BL/6)	increased insulin sensitivity	J:287930
Hspa13^tm1.1Smoc/Hspa13^tm1.1Smoc Cd19^tm1(cre)Cgn/Cd19⁺ (involves: 129P2/OlaHsd * 129S * C57BL/6)	increased urine protein level	J:303927
Hspb1^{tm1.1(KOMP)Vlcg}/Hspb1^{tm1.1(KOMP)Vlcg} (C57BL/6N-Hspb1^{tm1.1(KOMP)Vlcg}/J)	decreased circulating calcium level	J:211773
Hspb3^{tm1.1(KOMP)Vlcg}/Hspb3^{tm1.1(KOMP)Vlcg} (C57BL/6N-Hspb3^{tm1.1(KOMP)Vlcg}/J)	decreased circulating free fatty acids level	J:211773
	increased fasting circulating glucose level	J:211773
Hspb7^tm1.1Yty/Hspb7^tm1.1Yty Tg(ACTA1-cre)79Jme/0 (involves: 129 * C57BL/6J * SJL)	increased circulating creatine kinase level	J:246267
Hspb8^em1(IMPC)J/Hspb8^em1(IMPC)J (C57BL/6NJ-Hspb8^em1(IMPC)J/Mmjax)	increased circulating phosphate level	J:211773
Hspb8^tm1.1Depr/Hspb8^tm1.1Depr (B.129-Hspb8^tm1.1Depr)	decreased circulating interleukin-6 level	J:186292
Hspg2^tm1Ref/Hspg2^tm1Ref (involves: 129S1/Sv * 129X1/SvJ)	hemopericardium	J:58700
Htas2^C57BL/6J/? (involves: C57BL/6J * DBA/2J)	decreased body temperature	J:18566
Htas3^DBA/2J/? (involves: C57BL/6J * DBA/2J)	decreased body temperature	J:18566
Htas4^C57BL/6J/? (involves: C57BL/6J * DBA/2J)	decreased body temperature	J:18566
htd/htd (C3H/HeJ-htd/J)	decreased circulating thyroxine level	J:68094
	decreased circulating triiodothyronine level	J:68094
	increased circulating corticosterone level	J:68094
Htr1a^tm1Rhn/Htr1a^tm1Rhn (129S6/SvEvTac-Htr1a^tm1Rhn)	abnormal serotonin level	J:70686, J:65662
	increased dopamine level	J:65662
	increased noradrenaline level	J:65662
Htr1a^tm3.1Rhn/Htr1a^tm3.1Rhn Slc6a4^tm1(tTA)Cogr/Slc6a4⁺ (involves: 129S1/Sv * BALB/cJ * C57BL/6 * CBA)	decreased body temperature	J:137439
Htr1f^{tm1.1(KOMP)Vlcg}/Htr1f^{tm1.1(KOMP)Vlcg} (C57BL/6N-Htr1f^{tm1.1(KOMP)Vlcg}/J)	increased circulating sodium level	J:211773
Htr2b^tm1Kry/Htr2b^tm1Kry Tg(Ins2-cre)23Herr/0 (involves: C57BL/6J * CBA/J)	decreased circulating insulin level	J:284574
Htr2c^tm1.1Eme/Y (involves: 129S4/SvJae * 129S6/SvEvTac * C57BL/6)	dehydration	J:163043
	increased energy expenditure	J:163043
Htr2c^tm1Arte/Y (involves: C57BL/6)	increased circulating corticosterone level	J:228775
Htr2c^tm1Jke/Y (B6.129-Htr2c^tm1Jke)	increased circulating leptin level	J:147514
Htr2c^tm1Jke/Y (B6.129-Htr2c^tm1Jke)	increased susceptibility to diet-induced obesity	J:147514
Htr2c^tm1Jul/Y (B6.129S-Htr2c^tm1Jul)	abnormal tumor necrosis factor level	J:50262
	hyperglycemia	J:50262
	impaired glucose tolerance	J:50262
	increased circulating insulin level	J:50262
	increased circulating leptin level	J:50262
	increased susceptibility to diet-induced obesity	J:50262
	insulin resistance	J:50262
Htr2c^tm1Knk/Y (B6.Cg-Htr2c^tm1Knk)	abnormal body temperature	J:142503
	decreased circulating cholesterol level	J:142503
	decreased circulating glucose level	J:142503
	decreased circulating insulin level	J:142503
	decreased circulating insulin-like growth factor I level	J:142503
	decreased circulating leptin level	J:142503
	decreased circulating triglyceride level	J:142503
	increased circulating ghrelin level	J:142503
	increased circulating growth hormone level	J:142503
Htr2c^tm2Jke/Y Tg(Pomc1-cre)16Lowl/0 (involves: 129X1/SvJ * C57BL/6J * FVB/N)	abnormal respiratory quotient	J:207704
	decreased oxygen consumption	J:207704
	hyperglycemia	J:207704
	increased circulating glucagon level	J:207704
	increased circulating glucose level	J:207704
	increased circulating insulin level	J:207704
	increased energy expenditure	J:207704
	increased oxygen consumption	J:207704
	increased susceptibility to diet-induced obesity	J:207704
	insulin resistance	J:207704
Htr2c^tm2Jke/Y Tg(Pomc-cre/ERT2)#Jke/0 (involves: 129X1/SvJ * C57BL/6J)	increased circulating glucagon level	J:207704
	increased circulating glucose level	J:207704
	increased circulating insulin level	J:207704
	increased oxygen consumption	J:207704
Htr2c^tm2Jke/Y Tg(Zp3-cre)93Knw/0 (involves: 129X1/SvJ * C57BL/6J)	hyperglycemia	J:207704
	increased susceptibility to diet-induced obesity	J:207704
Htr2c^tm2Jke/Htr2c^tm2Jke Tg(Pomc1-cre)16Lowl/0 (involves: 129X1/SvJ * C57BL/6J * FVB/N)	abnormal respiratory quotient	J:207704
	decreased oxygen consumption	J:207704
	hyperglycemia	J:207704
	increased circulating glucagon level	J:207704
	increased circulating glucose level	J:207704
	increased circulating insulin level	J:207704
	increased energy expenditure	J:207704
	increased oxygen consumption	J:207704
	increased susceptibility to diet-induced obesity	J:207704
	insulin resistance	J:207704
Htr2c^tm2Jke/Htr2c^tm2Jke Tg(Pomc-cre/ERT2)#Jke/0 (involves: 129X1/SvJ * C57BL/6J)	increased circulating glucagon level	J:207704
	increased circulating glucose level	J:207704
	increased circulating insulin level	J:207704
	increased oxygen consumption	J:207704
Htr3a^tm1Ckn/Htr3a^tm1Ckn (involves: 129S1/Sv * C57BL/6J * DBA/2)	increased blood urea nitrogen level	J:90942
	increased urine protein level	J:90942
Htr4^tm1Dgen/Htr4^tm1Dgen (involves: 129P2/OlaHsd * C57BL/6)	increased blood urea nitrogen level	J:101679
Htr7^{tm1b(KOMP)Wtsi}/Htr7^{tm1b(KOMP)Wtsi} (C57BL/6N-Htr7^{tm1b(KOMP)Wtsi}/J)	decreased fasting circulating glucose level	J:211773
	increased circulating chloride level	J:211773
	increased circulating sodium level	J:211773
Htr7^tm1Mrg/Htr7^tm1Mrg (involves: 129S/SvEv * C57BL/6)	abnormal body temperature homeostasis	J:97159
Htr7^tm1Sut/Htr7^tm1Sut (B6.129X1-Htr7^tm1Sut)	abnormal body temperature homeostasis	J:81842
Htra2^mnd2/Htra2^mnd2 (B6.Cg-Htra2^mnd2)	abnormal interleukin level	J:76481
Htra2^mnd2/Htra2^mnd2 (B6.Cg-Htra2^mnd2)	abnormal tumor necrosis factor level	J:76481
Htt^tm2Detl/Htt⁺ (B6J.129P2-Htt^tm2Detl)	increased taurine level	J:220868
Htt^tm6Mem/Htt^tm8Mem (involves: 129S1/Sv * 129X1/SvJ * Swiss Webster)	increased susceptibility to malignant hyperthermia	J:72915
hubb/hubb (involves: ICR)	abnormal circulating bilirubin level	J:8170
hubb/hubb (involves: ICR)	increased circulating bilirubin level	J:8170
Hunk^{tm1b(EUCOMM)Wtsi}/Hunk^{tm1b(EUCOMM)Wtsi} (C57BL/6N-Hunk^{tm1b(EUCOMM)Wtsi}/Ieg)	increased circulating glucose level	J:211773
Huwe1^tm1Wgu/Y Tg(Ins2-cre)23Herr/0 (involves: C57BL/6J * CBA/J)	decreased circulating insulin level	J:182446
	hyperglycemia	J:182446
	impaired glucose tolerance	J:182446
	increased circulating glucose level	J:182446
Huwe1^tm1Wgu/Y Tg(Ins2-cre)23Herr/0 Trp53^tm1Thl/Trp53^tm1Thl (involves: C57BL/6J * CBA/J)	hyperglycemia	J:182446
Hyal1^tm1Stn/Hyal1^tm1Stn (involves: 129X1/SvJ * C57BL/6J)	increased hyaluronic acid level	J:136860
Hyal2^tm1.1Bfla/Hyal2^tm1.1Bfla (involves: 129P2/OlaHsd * BALB/c * C57BL/6)	increased circulating hyaluronic acid level	J:146040
	increased circulating lactate dehydrogenase level	J:146040
	increased kidney iron level	J:146040
	increased liver iron level	J:146040
	increased spleen iron level	J:146040
Hyal2^tm1.1Bfla/Hyal2^tm1.1Bfla (involves: 129P2/OlaHsd * BALB/c * C57BL/6 * CD-1)	increased hyaluronic acid level	J:238703
Hyal3^{tm1.1(KOMP)Vlcg}/Hyal3^{tm1.1(KOMP)Vlcg} (C57BL/6N-Hyal3^{tm1.1(KOMP)Vlcg}/J)	decreased circulating glucose level	J:211773
Hyal6^em1(IMPC)H/Hyal6^em1(IMPC)H (C57BL/6NTac-Hyal6^em1(IMPC)H/H)	impaired glucose tolerance	J:211773
Hycc1^{em1(IMPC)Ccpcz}/Hycc1^{em1(IMPC)Ccpcz} (C57BL/6N-Hycc1^{em1(IMPC)Ccpcz}/Ccpcz)	decreased circulating sodium level	J:211773
	decreased circulating total protein level	J:211773
	increased circulating bilirubin level	J:211773
	increased circulating potassium level	J:211773
	increased fasting circulating glucose level	J:211773
hydro/? (involves: Mlac:ICR)	decreased circulating calcium level	J:207131
hydro/? (involves: Mlac:ICR)	increased circulating phosphate level	J:207131
Hypch^NZO/HlBom/? (involves: NZO/HlBom * SJL/NBom)	increased circulating cholesterol level	J:83735
Hypism^C57BL/6J/Hypism^PERA/EiJ (involves: B6.129S7-Ldlr^tm1Her/J * PERA/EiJ)	increased circulating insulin level	J:94548
Hyplip2^MRL/MpJ/Hyplip2^MRL/MpJ (involves: BALB/cJ * MRL/MpJ)	decreased circulating HDL cholesterol level	J:92871
	increased circulating cholesterol level	J:92871
	increased triglyceride level	J:92871
Hypn2^C57BL/6/Hypn2^C57BL/6 (involves: 129S6/SvEvTac * C57BL/6)	increased circulating insulin level	J:142949
Hypn3^C57BL/6/Hypn3^C57BL/6 (involves: 129S6/SvEvTac * C57BL/6)	increased circulating insulin level	J:142949
Hypn^C57BL/6/? (involves: 129S6/SvEvTac * C57BL/6-Insr^tm1Dac Irs1^tm1Jos)	increased circulating insulin level	J:83539
Hypn^C57BL/6/Hypn^C57BL/6 (involves: 129S6/SvEvTac * C57BL/6)	increased circulating insulin level	J:142949
Iah1^{tm1b(EUCOMM)Hmgu}/Iah1^{tm1b(EUCOMM)Hmgu} (C57BL/6N-Iah1^{tm1b(EUCOMM)Hmgu}/Ics)	decreased circulating alkaline phosphatase level	J:211773
Iapp^tm1Sgm/Iapp^tm1Sgm (involves: 129P2/OlaHsd * C57BL/6)	improved glucose tolerance	J:50042
Iapp^tm1Sgm/Iapp^tm1Sgm (involves: 129P2/OlaHsd * C57BL/6)	increased circulating insulin level	J:50042
Iars1^em2Nsas/Iars1^em2Nsas (C57BL/6-Iars1^em2Nsas)	increased liver triglyceride level	J:340986
Ibtk^{em1(IMPC)Hmgu}/Ibtk^{em1(IMPC)Hmgu} (C57BL/6N-Ibtk^{em1(IMPC)Hmgu}/Ieg)	increased circulating serum albumin level	J:211773
Ica1^tm1Mdos/Ica1^tm1Mdos (NOD.129-Ica1^tm1Mdos)	abnormal glucose homeostasis	J:83526
Icam1^tm1Bay/Icam1^tm1Bay (B6.129S7-Icam1^tm1Bay)	abnormal nitric oxide homeostasis	J:118196
Icam1^tm1Bay/Icam1^tm1Bay (B6.129S7-Icam1^tm1Bay/J)	increased circulating glucose level	J:118466
Icam1^tm1Bay/Icam1^tm1Bay Sele^tm2Alb/Sele^tm2Alb Selp^tm1Bay/Selp^tm1Bay (involves: 129S7/SvEvBrd * C57BL/6)	skin edema	J:112286
Icam1^tm1Bay/Icam1^tm1Bay Selp^tm1Bay/Selp^tm1Bay (B6.129S7-Icam1^tm1Bay Selp^tm1Bay/J)	edema	J:119906
Icam1^tm1Jcgr/Icam1^tm1Jcgr (involves: 129S4/SvJae * C57BL/6 * DBA/2)	abnormal interleukin level	J:18743
	abnormal tumor necrosis factor level	J:18743
Icam1^tm1Jcgr/Icam1^tm1Jcgr Ldlr^tm1Her/Ldlr^tm1Her Vcam1^tm1Dmil/Vcam1^tm1Dmil (involves: 129S4/SvJae * 129S7/SvEvBrd * C57BL/6)	decreased circulating cholesterol level	J:69597
Icos^tm1Flv/Icos^tm1Flv (involves: 129/Sv * C57BL/6)	abnormal interferon level	J:87123
Icos^tm1Flv/Icos^tm1Flv (involves: 129/Sv * C57BL/6)	abnormal interleukin level	J:87123
Icos^tm1Shr/Icos^tm1Shr (Not Specified)	abnormal interleukin level	J:87124
Icos^tm1Tkan/Icos^tm1Tkan (involves: 129S7/SvEvBrd * C57BL/6)	decreased circulating interferon-gamma level	J:95353
	decreased circulating interleukin-4 level	J:95353
Icosl^tm1Cdon/Icosl^tm1Cdon (involves: 129S6/SvEvTac)	abnormal interferon level	J:86697
Id1^tm1Zhu/Id1⁺ Id3^tm1Zhu/Id3^tm1Zhu (involves: 129S1/Sv * 129S4/SvJaeSor)	middle ear effusion	J:311050
Id1^tm1Zhu/Id1^tm1Zhu Id3^tm1Zhu/Id3⁺ (involves: 129S1/Sv * 129S4/SvJaeSor)	middle ear effusion	J:311050
Id2^{tm2b(EUCOMM)Wtsi}/Id2⁺ (C57BL/6N-Id2^{tm2b(EUCOMM)Wtsi}/Wtsi)	increased blood urea nitrogen level	J:211773
	increased circulating creatinine level	J:211773
Id3^tm1Zhu/Id3^tm1Zhu (involves: 129S4/SvJaeSor)	decreased salivation	J:93916
Id3^tm1Zhu/Id3^tm1Zhu (B6.129S4-Id3^tm1Zhu)	decreased salivation	J:93916
Id3^tm2.1Zhu/Id3^tm2.1Zhu Tg(Lck-cre)#Zhu/0 (involves: 129S6/SvEvTac * C57BL/6 * SJL * SJL/J)	decreased salivation	J:172701
Id4^tm1Vdr/Id4^tm1Vdr Tg(MMTV-cre)1Mam/0 (involves: C57BL/6 * FVB/N)	decreased circulating estradiol level	J:213955
	decreased circulating estrogen level	J:213955
Idd1^NOD/ShiLt/Idd1^NOD/ShiLt (involves: NOD/Lt * NON/Lt)	abnormal glucose homeostasis	J:29464
Idd2^NON/ShiLtJ/Idd2^NON/ShiLtJ (involves: NOD/Lt * NON.NOD-H2^g7/LtJ)	abnormal glucose homeostasis	J:28967
Idd3^{129S6/SvEvTac}/Idd3^{129S6/SvEvTac} (NOD.129-Idd3^{129S6/SvEvTac})	abnormal glucose homeostasis	J:108210
Idd3^C57BL/6/Idd3^C57BL/6 (involves: C57BL/6 * NOD)	abnormal glucose homeostasis	J:52572
Idd3^C57BL/6/Idd3^C57BL/6 (NOD.B6-Idd3^C57BL/6)	abnormal glucose homeostasis	J:108210
Idd3^C57BL/6/Idd3^C57BL/6 Idd5^C57BL/10SnJ/Idd5^C57BL/10SnJ (involves: C57BL/6 * C57BL/10SnJ * NOD)	abnormal glucose homeostasis	J:71276
Idd3^C57BL/10SnJ/Idd3^C57BL/10SnJ Idd5.3^C57BL/10SnJ/Idd5.3^C57BL/10SnJ Idd5.1^C57BL/10SnJ/Idd5.1^C57BL/10SnJ (involves: C57BL/10SnJ * NOD/MrkTac)	abnormal glucose homeostasis	J:143549
Idd3^C57BL/10SnJ/Idd3^C57BL/10SnJ Idd5^C57BL/10SnJ/Idd5^C57BL/10SnJ (involves: C57BL/10 * NOD/MrkTac)	abnormal glucose homeostasis	J:88667
Idd3^NOD/? (involves: C57BL/10 * NOD)	abnormal glucose homeostasis	J:3351, J:17906
Idd4^C57BL/6J/? (involves: C57BL/6J * NOD)	abnormal glucose homeostasis	J:73763
Idd4^MSM/Idd4^MSM (involves: MSM * NOD/Shi)	abnormal glucose homeostasis	J:55926
Idd4^NOD/Jsd/? (involves: NOD/Jsd * NOR/LtJ)	abnormal glucose homeostasis	J:99002
Idd4^NOD/? (involves: C57BL/10 * NOD)	abnormal glucose homeostasis	J:3351
Idd4^NOR/LtJ/? (involves: NOD/Jsd * NOR/LtJ)	abnormal glucose homeostasis	J:99002
Idd5.1^C57BL/6J/Idd5.1^C57BL/6J (involves: C57BL/6J * NOD)	abnormal glucose homeostasis	J:72900
Idd5.1^C57BL/6J/Idd5.1^NOD (involves: C57BL/6J * NOD)	abnormal glucose homeostasis	J:72900
Idd5.1^C57BL/10SnJ/Idd5.1^C57BL/10SnJ (involves: C57BL/10SnJ * NOD/MrkTac)	abnormal glucose homeostasis	J:88667, J:90924, J:143549
Idd5.1^NOD/Idd5.1^NOD (involves: C57BL/6J * NOD)	abnormal glucose homeostasis	J:72900
Idd5.2^C57BL/10SnJ/Idd5.2^C57BL/10SnJ (involves: C57BL/10SnJ * NOD/MrkTac)	abnormal glucose homeostasis	J:88667, J:90924
Idd5.3^C57BL/10SnJ/Idd5.3^C57BL/10SnJ Idd5.4^C57BL/10SnJ/Idd5.4^C57BL/10SnJ Idd5.1^C57BL/10SnJ/Idd5.1^C57BL/10SnJ Idd5.2^C57BL/10SnJ/Idd5.2^C57BL/10SnJ (involves: C57BL/10SnJ * NOD/MrkTac)	abnormal glucose homeostasis	J:143549
Idd5.4^C57BL/10SnJ/Idd5.4^C57BL/10SnJ Idd5.3^C57BL/10SnJ/Idd5.3^C57BL/10SnJ Idd5.2^C57BL/10SnJ/Idd5.2^C57BL/10SnJ (involves: C57BL/10SnJ * NOD/MrkTac)	abnormal glucose homeostasis	J:143549
Idd5^NOD/? (involves: C57BL/10 * NOD)	abnormal glucose homeostasis	J:71276
Idd5^NOD/Idd5^NOD (involves: C57BL/10 * NOD)	abnormal glucose homeostasis	J:33172
Idd5^NOR/LtJ/Idd5^NOR/LtJ (NOD.NOR-Idd5/Jsd)	abnormal glucose homeostasis	J:99002
Idd6^C57BL/6JOrl/Idd6^C57BL/6JOrl (NOD.B6-Klrb1c^a)	abnormal glucose homeostasis	J:68580
Idd6^C57BL/6JOrl/Idd6^NOD/Necker (NOD.B6-Klrb1c^a)	abnormal glucose homeostasis	J:68580
Idd6^NOD/ShiLt/Idd6^NOD/ShiLt (involves: C3H/HeJ * NOD/Lt)	abnormal glucose homeostasis	J:69992
Idd6^NON/ShiLtJ/Idd6^NON/ShiLtJ (involves: NOD/Lt * NON.NOD-H2^g7/LtJ)	abnormal glucose homeostasis	J:28947
Idd7^NOD/ShiLt/Idd7^NOD/ShiLt (involves: NOD/Lt * NON.NOD-H2^g7/LtJ)	abnormal glucose homeostasis	J:28947
Idd7^NOD/ShiLt/Idd7^NOD/ShiLt (involves: B10.NOD-H2^g7 * NOD/Lt)	abnormal glucose homeostasis	J:13557, J:28947
Idd8^NOD/ShiLt/Idd8^NOD/ShiLt (involves: B10.NOD-H2^g7 * NOD/Lt)	abnormal glucose homeostasis	J:13557
Idd9.1^C57BL/10SnJ/Idd9.1^C57BL/10SnJ (NOD.B10-Idd9.1^C57BL/10SnJ)	abnormal glucose homeostasis	J:63670
Idd9.2^C57BL/10SnJ/Idd9.2^C57BL/10SnJ (NOD.B10-Idd9.2^C57BL/10SnJ)	abnormal glucose homeostasis	J:63670
Idd9.3^C57BL/10SnJ/Idd9.3^C57BL/10SnJ (NOD.B10-Idd9.3^C57BL/10SnJ)	abnormal glucose homeostasis	J:63670
Idd9^C57BL/10SnJ/Idd9^C57BL/10SnJ (NOD.B10-Idd9^C57BL/10SnJ)	abnormal glucose homeostasis	J:63670
Idd9^NOD/ShiLt/Idd9^NOD/ShiLt (involves: NOD/Lt * NON.NOD-H2^g7/LtJ)	abnormal glucose homeostasis	J:28947
Idd10^C57BL/6J/Idd10^C57BL/6J (involves: C57BL/6 * NOD)	abnormal glucose homeostasis	J:42103
Idd10^C57BL/6J/Idd10^C57BL/6J Idd3^C57BL/6/Idd3^C57BL/6 (involves: C57BL/6 * NOD)	abnormal glucose homeostasis	J:42103
Idd10^C57BL/6J/Idd10^C57BL/6J Idd17^C57BL/6J/Idd17^C57BL/6J (involves: C57BL/6 * NOD)	abnormal glucose homeostasis	J:42103
Idd10^C57BL/6J/Idd10^C57BL/6J Idd18^C57BL/6/Idd18^C57BL/6 (involves: C57BL/6 * NOD)	abnormal glucose homeostasis	J:46659
Idd10^C57BL/10SnJ/Idd10^C57BL/10SnJ (involves: C57BL/10SnJ * NOD)	abnormal glucose homeostasis	J:42103
Idd10^C57BL/10SnJ/Idd10^C57BL/10SnJ Idd17^C57BL/10SnJ/Idd17^C57BL/10SnJ (involves: C57BL/10SnJ * NOD)	abnormal glucose homeostasis	J:42103
Idd10^IIS/Shi/Idd10^IIS/Shi (NOD.IIS-Idd10)	abnormal glucose homeostasis	J:97940
Idd10^IIS/Shi/Idd10^NOD/Shi (NOD.IIS-Idd10)	abnormal glucose homeostasis	J:97940
Idd11^NOD/ShiLt/Idd11^NOD/ShiLt (involves: C57BL/6 * NOD/Lt)	abnormal glucose homeostasis	J:19245
Idd11^NOD/ShiLt/Idd11^NOD/ShiLt (involves: NOD/Lt * SJL)	abnormal glucose homeostasis	J:19245
Idd12^NOD/ShiLt/Idd12^NOD/ShiLt (involves: C57BL/6 * NOD/Lt)	abnormal glucose homeostasis	J:19245
Idd12^NOD/ShiLt/Idd12^NOD/ShiLt (involves: NOD/Lt * SJL)	abnormal glucose homeostasis	J:19245
Idd13^NOR/Lt/Idd13^NOR/Lt (involves: NOD/Lt * NOR/Lt)	abnormal glucose homeostasis	J:20685
Idd14^NOD/ShiLt/Idd14^NOD/ShiLt (involves: NOD/Lt * NON.NOD-H2^g7/LtJ)	abnormal glucose homeostasis	J:28947
Idd15^NOD/ShiLt/Idd15^NOD/ShiLt (involves: NOD/Lt * NON.NOD-H2^g7/LtJ)	abnormal glucose homeostasis	J:28947
Idd16.1^ALR/LtJ/Idd16.1^ALR/LtJ (involves: ALR/LtJ * NOD/LtJ)	abnormal glucose homeostasis	J:98187
Idd16^ALR/Lt/Idd16^NOD/ShiLt (involves: ALR/Lt * NOD/Lt)	abnormal glucose homeostasis	J:86633
Idd16^C57BL/6J/Idd16^C57BL/6J (involves: C57BL/6J * NOD)	abnormal glucose homeostasis	J:77545, J:94603
Idd16^C57BL/6J/Idd16^NOD (involves: C57BL/6J * NOD)	abnormal glucose homeostasis	J:94603
Idd16^NOD/ShiLt/Idd16^NOD/ShiLt (involves: ALR/Lt * NOD/Lt)	abnormal glucose homeostasis	J:86633
Idd16^NOD/ShiLt/Idd16^NOD/ShiLt Idd22^NOD/ShiLt/Idd22^NOD/ShiLt (involves: ALR/Lt * NOD/Lt)	abnormal glucose homeostasis	J:86633
Idd17^C57BL/6J/Idd17^C57BL/6J (involves: C57BL/6 * NOD)	abnormal glucose homeostasis	J:42103
Idd17^C57BL/10SnJ/Idd17^C57BL/10SnJ (involves: C57BL/10SnJ * NOD)	abnormal glucose homeostasis	J:42103
Idd19^NOD/ShiLt/? (involves: C3H/HeJ * NOD/Lt)	abnormal glucose homeostasis	J:69992
Idd19^PWK/? (involves: NOD * PWK)	abnormal glucose homeostasis	J:48505
Idd21.1^ABH/Idd21.1^ABH (involves: ABH * NOD)	abnormal glucose homeostasis	J:101740
Idd21.2^ABH/Idd21.2^ABH (involves: ABH * NOD)	abnormal glucose homeostasis	J:101740
Idd21.3^ABH/Idd21.3^ABH (involves: ABH * NOD)	abnormal glucose homeostasis	J:101740
Idd21^NOD/Idd21^NOD (involves: ABH * NOD)	abnormal glucose homeostasis	J:83136
Idd23^C57BL/6J/Idd23^C57BL/6J (involves: C57BL/6J * NOD)	abnormal glucose homeostasis	J:94603
Idd25^NOD/ShiLt/Idd25^NOR/Lt (involves: NOD/Lt * NOR/Lt)	abnormal glucose homeostasis	J:100365
Idd25^NOR/Lt/Idd25^NOR/Lt (involves: NOD/Lt * NOR/Lt)	abnormal glucose homeostasis	J:100365
Idd26^NOR/Lt/? (involves: NOD/Lt * NOR/Lt)	abnormal glucose homeostasis	J:100365
Ide^{Gt(OST132429)Lex}/Ide^{Gt(OST132429)Lex} (involves: 129S5/SvEvBrd * C57BL/6-Tyr^c)	hyperglycemia	J:82747
	impaired glucose tolerance	J:82747
	increased circulating insulin level	J:82747
Ide^{tm1a(EUCOMM)Wtsi}/Ide^{tm1a(EUCOMM)Wtsi} (B6JTyr;B6N-Ide^{tm1a(EUCOMM)Wtsi}/Wtsi)	decreased circulating alanine transaminase level	J:175295
	decreased circulating aspartate transaminase level	J:175295
	decreased circulating cholesterol level	J:175295
	increased circulating amylase level	J:175295
Idh1^tm1Mak/Idh1^tm1Mak Lyz2^tm1(cre)Ifo/Lyz2⁺ (involves: 129P2/OlaHsd * C57BL/6)	abnormal blood homeostasis	J:186700
Idh1^tm2Mak/Idh1^tm2Mak Lyz2^tm1(cre)Ifo/Lyz2⁺ (involves: 129P2/OlaHsd * C57BL/6)	abnormal blood homeostasis	J:186700
Ido1^tm1.1Mkks/Ido1^tm1.1Mkks (B6.Cg-Ido1^tm1.1Mkks)	increased urine protein level	J:229059
Ido1^tm1Alm/Ido1^tm1Alm (involves: 129X1/SvJ * BALB/c)	abnormal cytokine level	J:170565
Ido1^tm1Alm/Ido1^tm1Alm (involves: 129X1/SvJ * BALB/c)	abnormal protein level	J:170565
Ido1^tm1Alm/Ido1^tm1Alm (involves: 129X1/SvJ * C57BL/6J)	abnormal blood homeostasis	J:282516
Ids^tm1Dkji/Y (involves: C57BL/6)	abnormal glycosaminoglycan level	J:294717
Ids^tm1Dkji/Y (involves: C57BL/6)	increased urine glycosaminoglycan level	J:294717
Ids^tm1Dkji/Y (involves: 129 * C57BL/6)	abnormal glycosaminoglycan level	J:294523
Ids^tm1Dkji/Y (involves: 129 * C57BL/6)	middle ear effusion	J:294523
Ids^tm1Muen/Y (Not Specified)	joint swelling	J:108761
Ids^tm1Muen/Y (involves: C57BL/6)	abnormal glycosaminoglycan level	J:259752
Ids^tm1Muen/Y (involves: C57BL/6)	increased urine glycosaminoglycan level	J:259752
Idua^tm1.1Kmke/Idua^tm1.1Kmke (B6.129-Idua^tm1.1Kmke)	increased urine glycosaminoglycan level	J:155619
Idua^tm1Clk/Idua^tm1Clk (involves: 129S1/Sv * 129X1/SvJ)	increased urine glycosaminoglycan level	J:39522
Idua^tm1Clk/Idua^tm1Clk (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	abnormal circulating enzyme level	J:138341
Idua^tm1Clk/Idua^tm1Clk (B6.129-Idua^tm1Clk/J)	increased urine glycosaminoglycan level	J:130215
Idua^tm1Efn/Idua^tm1Efn (involves: C57BL/6)	abnormal circadian temperature homeostasis	J:101932
Idua^tm1Efn/Idua^tm1Efn (involves: C57BL/6)	decreased body temperature	J:101932
Ier3^tm1Mxw/Ier3^tm1Mxw (involves: 129 * C57BL/6)	abnormal interleukin level	J:157504
Ier3^tm1Mxw/Ier3^tm1Mxw (involves: 129 * C57BL/6)	abnormal tumor necrosis factor level	J:157504
Ier3ip1^em1(IMPC)J/Ier3ip1⁺ (C57BL/6NJ-Ier3ip1^em1(IMPC)J/Mmjax)	increased circulating alanine transaminase level	J:211773
Ier3ip1^tm1Arvn/Ier3ip1^tm1Arvn Tg(Ins1-cre/ERT)1Lphi/0 (involves: 129S4/SvJaeSor * C57BL/6J * CD-1)	abnormal glucose homeostasis	J:336782
	decreased circulating insulin level	J:336782
	decreased insulin secretion	J:336782
	hyperglycemia	J:336782
	impaired glucose tolerance	J:336782
Ier3ip1^tm1Arvn/Ier3ip1^tm1Arvn Tg(Ins2-cre)25Mgn/0 (involves: C57BL/6 * C57BL/6J * DBA)	abnormal glucose homeostasis	J:336782
	decreased circulating insulin level	J:336782
	decreased insulin secretion	J:336782
	hyperglycemia	J:336782
	impaired glucose tolerance	J:336782
	increased circulating glucose level	J:336782
	increased fasting circulating glucose level	J:336782
Ier5l^em1(IMPC)J/Ier5l^em1(IMPC)J (C57BL/6NJ-Ier5l^em1(IMPC)J/Mmjax)	increased circulating phosphate level	J:211773
If1^l/If1^l (involves: BALB/c)	abnormal circulating interferon level	J:5113
Ifi27l2a^{tm1.1(KOMP)Vlcg}/Ifi27l2a^{tm1.1(KOMP)Vlcg} (C57BL/6N-Ifi27l2a^{tm1.1(KOMP)Vlcg}/Ieg)	increased circulating alkaline phosphatase level	J:211773
	increased circulating bilirubin level	J:211773
Ifi35^em1Hhl/Ifi35^em1Hhl (C57BL/6-Ifi35^em1Hhl)	decreased circulating interleukin-6 level	J:298909
Ifi35^em1Hhl/Ifi35^em1Hhl (C57BL/6-Ifi35^em1Hhl)	decreased circulating tumor necrosis factor level	J:298909
Ifi204^tm1.1Cjul/Ifi204^tm1.1Cjul (B6.129(Cg)-Ifi204^tm1.1Cjul)	decreased circulating interferon-beta level	J:270123
	decreased circulating interleukin-1 beta level	J:270123
	decreased circulating interleukin-6 level	J:270123
	decreased circulating tumor necrosis factor level	J:270123
Ifih1^{em1(IMPC)Wtsi}/Ifih1^{em1(IMPC)Wtsi} (C57BL/6N-Ifih1^{em1(IMPC)Wtsi}/Wtsi)	increased circulating magnesium level	J:211773
Ifih1^Rgsc422/Ifih1⁺ (D2JJcl.B6JJcl-Ifih1^Rgsc422)	abnormal chemokine level	J:209917
Ifih1^Rgsc422/Ifih1⁺ (D2JJcl.B6JJcl-Ifih1^Rgsc422)	abnormal cytokine level	J:209917
Ifih1^tm1Aki/Ifih1^tm1Aki (involves: 129/Sv * C57BL/6)	abnormal interferon level	J:137522
Ifih1^tm1Aki/Ifih1^tm1Aki (involves: 129/Sv * C57BL/6)	abnormal interleukin level	J:137522
Ifih1^tm1Aki/Ifih1^tm1Aki Ticam1^tm1Aki/Ticam1^tm1Aki (involves: 129P2/OlaHsd)	abnormal interferon level	J:137522
	abnormal interleukin level	J:137522
Ifit1^{tm1(KOMP)Vlcg}/Ifit1^{tm1(KOMP)Vlcg} (involves: C57BL/6 * C57BL/6NTac)	abnormal interferon level	J:205203
Ifit2^tm1.1Ebsb/Ifit2^tm1.1Ebsb (B6NCrl.129P2(C)-Ifit2^tm1.1Ebsb)	decreased circulating interleukin-1 beta level	J:199862
	decreased circulating interleukin-6 level	J:199862
	decreased circulating interleukin-12b level	J:199862
	decreased circulating tumor necrosis factor level	J:199862
Ifitm1^tm1.1Ieg/Ifitm1^tm1.1Ieg (B6.129P2-Ifitm1^tm1.1Ieg)	abnormal circulating testosterone level	J:192287
	decreased circulating corticosterone level	J:192287
	increased oxygen consumption	J:192287
Ifnar1^tm1Agt/Ifnar1^tm1Agt (involves: 129S2/SvPas)	increased circulating alanine transaminase level	J:144400
Ifnar1^tm1Agt/Ifnar1^tm1Agt (involves: 129S2/SvPas * 129S6/SvEvTac)	increased circulating interleukin-12 level	J:54482
Ifnar1^tm1Agt/Ifnar1^tm1Agt (involves: 129S2/SvPas * BALB/c)	abnormal cytokine level	J:291874
Ifnar2^tm1Pjh/Ifnar2^tm1Pjh Il6st^tm1Ern/Il6st^tm1Ern (involves: 129S1/Sv)	increased circulating interleukin-6 level	J:168781
Ifnb1^tm1Acgp/Ifnb1^tm1Acgp (involves: 129P2/OlaHsd * C57BL/6)	decreased circulating interferon-beta level	J:61048
Ifnb1^tm1Tl/Ifnb1^tm1Tl (B6.129P2-Ifnb1^tm1Tl)	decreased circulating interferon-alpha level	J:172226
Ifnb1^tm1Tl/Ifnb1^tm1Tl (B6.129P2-Ifnb1^tm1Tl)	decreased circulating interferon-beta level	J:172226
Ifnb1^tm2.1Lien/Ifnb1^tm2.1Lien Tyr^c-2J/Tyr^c-2J Lyz2^tm1(cre)Ifo/Lyz2⁺ (involves: 129P2/OlaHsd * C57BL/6)	decreased circulating interferon-alpha level	J:172226
	decreased circulating interferon-beta level	J:172226
Ifng^tm1.1Hayg/Ifng^tm1.1Hayg (Not Specified)	abnormal circulating cytokine level	J:220784
Ifng^tm1.1Hayg/Ifng^tm1.1Hayg (Not Specified)	abnormal cytokine level	J:220784
Ifng^tm1Ts/Ifng^tm1Ts (involves: 129S7/SvEvBrd)	abnormal cytokine level	J:112600
Ifng^tm1Ts/Ifng^tm1Ts (B6.129S7-Ifng^tm1Ts/J)	abnormal circulating cytokine level	J:47459
	abnormal nitric oxide homeostasis	J:122801
	abnormal urine homeostasis	J:118730
	albuminuria	J:118730
	increased circulating interleukin-6 level	J:47459
Ifng^tm1Ts/Ifng^tm1Ts (C.129S7(B6)-Ifng^tm1Ts/J)	abnormal circulating cytokine level	J:47459
Ifng^tm1Ts/Ifng^tm1Ts (C.129S7(B6)-Ifng^tm1Ts/J)	increased circulating interleukin-6 level	J:47459
Ifng^tm1Ts/Ifng^tm1Ts Tgfb1^tm1Doe/Tgfb1^tm1Doe (C.129-Ifng^tm1Ts Tgfb1^tm1Doe)	increased circulating alanine transaminase level	J:69346
Ifng^tm1Yiw/Ifng^tm1Yiw (B6.129X1-Ifng^tm1Yiw)	abnormal circulating interferon level	J:91691
Ifng^tm1Yiw/Ifng^tm1Yiw (B6.129X1-Ifng^tm1Yiw)	ascites	J:50405
Ifng^tm1Yiw/Ifng^tm1Yiw (C.129X1-Ifng^tm1Yiw)	abnormal circulating interferon level	J:91691
Ifng^tm1Yiw/Ifng^tm1Yiw (C.129X1-Ifng^tm1Yiw)	increased circulating alanine transaminase level	J:91691
Ifngr1^tm1.1Rost/Ifngr1^tm1.1Rost (involves: BALB/cJ * C57BL/6)	abnormal chemokine level	J:152785
	decreased circulating interferon-gamma level	J:152785
	decreased circulating interleukin-12 level	J:152785
Ifngr1^tm1Agt/Ifngr1^tm1Agt (involves: 129S7/SvEvBrd)	decreased circulating tumor necrosis factor level	J:17878
	increased circulating interferon-gamma level	J:314959
	increased circulating interleukin-1 beta level	J:314959
	increased circulating interleukin-6 level	J:174397
Ifngr1^tm1Agt/Ifngr1^tm1Agt (B6.129S7-Ifngr1^tm1Agt/J)	abnormal circulating chemokine level	J:152785
	decreased circulating interleukin-12 level	J:152785
	decreased circulating osteocalcin level	J:233116
Ifngr1^tm1Agt/Ifngr1^tm1Agt Tg(GZMB-Tax)#Lera/0 (involves: 129S7/SvEvBrd * C57BL/6)	increased circulating calcium level	J:147601
Ifnl3^em1Mtba/Ifnl3^em1Mtba (involves: C57BL/6)	abnormal circulating interferon level	J:287260
Ifnl3^{tm1.1(KOMP)Vlcg}/Ifnl3^{tm1.1(KOMP)Vlcg} (C57BL/6N-Ifnl3^{tm1.1(KOMP)Vlcg}/J)	increased circulating sodium level	J:211773
Ift20^tm1.1Gjp/Ift20^tm1.1Gjp Tg(Hoxb7-cre)13Amc/0 (involves: 129S4/SvJaeSor * 129S7/SvEvBrd * C57BL/6)	increased blood urea nitrogen level	J:141071
Ift20^{tm1a(EUCOMM)Wtsi}/Ift20⁺ (C57BL/6N-Ift20^{tm1a(EUCOMM)Wtsi}/Ics)	decreased lactate dehydrogenase level	J:165965
	increased circulating chloride level	J:165965
Ift25^{tm1a(EUCOMM)Wtsi}/Ift25⁺ (B6JTyr;B6N-Ift25^{tm1a(EUCOMM)Wtsi}/Wtsi)	increased circulating free fatty acids level	J:175295
	increased circulating glycerol level	J:175295
Ift25^{tm1a(EUCOMM)Wtsi}/Ift25^{tm1a(EUCOMM)Wtsi} (involves: C57BL/6J * C57BL/6N)	cyanosis	J:184749
Ift25^{tm1b(EUCOMM)Wtsi}/Ift25^{tm1b(EUCOMM)Wtsi} (involves: C57BL/6J * C57BL/6N)	cyanosis	J:184749
Ift27^{tm1b(EUCOMM)Hmgu}/Ift27^{tm1b(EUCOMM)Hmgu} (involves: 129S4/SvJae * C57BL/6J * C57BL/6N)	cyanosis	J:215449
Ift43^{tm1b(EUCOMM)Hmgu}/Ift43⁺ (C57BL/6N-Ift43^{tm1b(EUCOMM)Hmgu}/Bay)	increased circulating bilirubin level	J:211773
	increased circulating cholesterol level	J:211773
	increased circulating creatinine level	J:211773
	increased circulating serum albumin level	J:211773
	increased circulating total protein level	J:211773
Ift46^tm1Cnu/Ift46^tm1Cnu (involves: C57BL/6)	cardiac edema	J:221138
Ift46^tm1Cnu/Ift46^tm1Cnu (involves: C57BL/6)	pericardial edema	J:221138
Ift52^em1(IMPC)Bay/Ift52^em1(IMPC)Bay (C57BL/6N-Ift52^em1(IMPC)Bay/BayMmucd)	edema	J:211773
Ift57^tm1Dwni/Ift57^tm1Dwni (involves: 129S1/SvImJ * C57BL/6J)	pericardial edema	J:119664
Ift57^tm2Dwni/Ift57^tm2Dwni (involves: 129S1/SvImJ * C57BL/6J)	pericardial edema	J:119664
Ift80^{tm1a(KOMP)Wtsi}/Ift80^{tm1a(KOMP)Wtsi} (C57BL/6N-Ift80^{tm1a(KOMP)Wtsi}/Wtsi)	increased blood urea nitrogen level	J:211773
Ift88^Tg737Rpw/Ift88^Tg737Rpw (FVB/N-Ift88^Tg737Rpw)	decreased circulating glucose level	J:95813
	decreased urine osmolality	J:73583
	impaired glucose tolerance	J:95813
	increased bile salt level	J:73583
	increased circulating alkaline phosphatase level	J:73583
Ift88^Tg737Rpw/Ift88^Tg737Rpw (C3.FVB-Ift88^Tg737Rpw)	decreased urine osmolality	J:73583
	increased bile salt level	J:73583
	increased circulating alkaline phosphatase level	J:73583
Ift88^tm1.1Bky/Ift88^tm1.1Bky (involves: 129P2/OlaHsd)	pericardial effusion	J:297055
Ift140^cauli/Ift140^cauli (involves: C3H/HeH * C57BL/6JAnu)	hydrops fetalis	J:220659
Ift172^tm1Lmgd/Ift172^tm1Lmgd (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	edema	J:143572
Ift172^{tm2b(EUCOMM)Hmgu}/Ift172^{tm2b(EUCOMM)Hmgu} (C57BL/6N-Ift172^{tm2b(EUCOMM)Hmgu}/Bay)	edema	J:211773
Igf1^tm1.1Dlr/Igf1^tm1.1Dlr (involves: C57BL/6 * FVB/N)	abnormal glucose homeostasis	J:69518
	decreased circulating glucose level	J:69518
	increased circulating growth hormone level	J:69518
	increased circulating insulin level	J:69518
Igf1^tm1.1Dlr/Igf1^tm1.1Dlr Tg(Ttr-IGF1)1Sykr/0 (FVB.Cg-Igf1^tm1.1Dlr Tg(Ttr-IGF1)1Sykr)	abnormal insulin-like growth factor I level	J:157350
	decreased circulating insulin level	J:157350
	increased circulating insulin-like growth factor I level	J:157350
Igf1^tm1.1Nros/Igf1^tm1.1Nros (involves: BALB/c * C57BL/6)	decreased circulating insulin-like growth factor I level	J:159167
Igf1^tm1Arge/Igf1⁺ Lif^tm1Stw/Lif⁺ (involves: 129S/SvEv * 129S1/Sv * C57BL/6 * MF1)	increased growth hormone level	J:87585
Igf1^tm1Arge/Igf1⁺ Lif^tm1Stw/Lif^tm1Stw (involves: 129S/SvEv * 129S1/Sv * C57BL/6 * MF1)	increased circulating insulin-like growth factor I level	J:87585
	increased circulating leptin level	J:87585
	increased growth hormone level	J:87585
Igf1^tm1Arge/Igf1^tm1Arge (involves: 129S/SvEv * DBA * MF1)	increased circulating growth hormone level	J:66913
Igf1^tm1Dlr/Igf1^tm1Dlr Tg(Alb1-cre)1Dlr/0 (involves: 129/Sv * C57BL/6J * FVB/N)	decreased circulating insulin-like growth factor I level	J:155733
	increased circulating leptin level	J:155733
Igf1^tm1Dlr/Igf1^tm1Dlr Tg(Mx1-cre)1Cgn/0 (involves: 129/Sv * C57BL/6 * CBA)	decreased circulating insulin-like growth factor I level	J:121798, J:55718
	increased circulating growth hormone level	J:121798
	increased urine potassium level	J:121798
	increased urine sodium level	J:121798
Igf1^tm1Dlr/Igf1^tm1Dlr Tg(Serpina1e-cre/ERT)1Sykr/0 (involves: 129/Sv * C57BL/6J * FVB/N)	decreased circulating insulin-like growth factor I level	J:155733
	increased circulating insulin level	J:155733
	increased circulating leptin level	J:155733
Igf1^tm2.1Arge/Igf1^tm2.1Arge (involves: 129S/SvEv * C57BL/6J * CBA)	decreased circulating insulin-like growth factor I level	J:142247
Igf1^tm2Arge/Igf1^tm2.1Arge (involves: 129S/SvEv * C57BL/6J * CBA)	decreased circulating insulin-like growth factor I level	J:142247
Igf1^tm2Arge/Igf1^tm2.1Arge Tg(SERPINA1-cre)1Arge/0 (involves: 129S/SvEv * C57BL/6J * CBA)	decreased circulating insulin-like growth factor I level	J:142247
Igf1^tm2Arge/Igf1^tm2Arge (involves: 129S/SvEv * C57BL/6J)	decreased circulating insulin-like growth factor I level	J:142247
Igf1^tm2Arge/Igf1^tm2Arge Tg(SERPINA1-cre)1Arge/0 (involves: 129S/SvEv * C57BL/6J)	decreased circulating insulin-like growth factor I level	J:142247
Igf1^tm2Ts/Igf1^tm2Ts (involves: 129S7/SvEvBrd * C57BL/6J)	decreased circulating glucose level	J:37969
Igf1^tm2Ts/Igf1^tm2Ts (involves: 129S7/SvEvBrd * C57BL/6J)	decreased circulating growth hormone level	J:37969
Igf1r^hyft/Igf1r^hyft (Not Specified)	hydrops fetalis	J:75360
Igf1r^tm1.1Mhz/Igf1r^tm1.1Mhz Tg(Ins2-cre)25Mgn/0 (involves: 129/Sv * C57BL/6 * DBA/2)	hyperglycemia	J:121640
	impaired glucose tolerance	J:121640
Igf1r^tm1Arge/Igf1r^tm1Arge (involves: 129S/SvEv)	cyanosis	J:15108
Igf1r^tm1Jcbr/Igf1r^tm1Jcbr Ndor1^{Tg(UBC-cre/ERT2)1Ejb}/0 (B6.Cg-Ndor1^{Tg(UBC-cre/ERT2)1Ejb} Igf1r^tm1Jcbr)	decreased collagen level	J:241924
Igf1r^tm1Jcbr/Igf1r^tm1Jcbr Tg(Fabp4-cre)1Abel/? (involves: C57BL/6 * FVB/N)	abnormal glucose homeostasis	J:141321
	decreased adiponectin level	J:141321
	increased circulating glucose level	J:141321
	increased insulin sensitivity	J:141321
Igf1sl1^C3H/HeJ/Igf1sl1^C3H/HeJ (involves: C3H/HeJ * C57BL/6J)	decreased circulating insulin-like growth factor I level	J:66640, J:94512
Igf1sl1^C3H/HeJ/Igf1sl1^C3H/HeJ (B6.C3-(D6Mit93-D6Mit150))	decreased circulating insulin-like growth factor I level	J:112375, J:99471
Igf1sl1^C3H/HeJ/Igf1sl1^C3H/HeJ Igf1sl4^C3H/HeJ/Igf1sl4^C57BL/6J (involves: C3H/HeJ * C57BL/6J)	decreased circulating insulin-like growth factor I level	J:66640
Igf1sl1^C3H/HeJ/Igf1sl1^C3H/HeJ Igf1sl4^C57BL/6J/Igf1sl4^C57BL/6J (involves: C3H/HeJ * C57BL/6J)	decreased circulating insulin-like growth factor I level	J:66640
Igf1sl1^C3H/HeJ/Igf1sl1^C57BL/6J (involves: C3H/HeJ * C57BL/6J)	decreased circulating insulin-like growth factor I level	J:66640
Igf1sl1^C3H/HeJ/Igf1sl1^C57BL/6J Igf1sl4^C3H/HeJ/Igf1sl4^C57BL/6J (involves: C3H/HeJ * C57BL/6J)	decreased circulating insulin-like growth factor I level	J:66640
Igf1sl1^C3H/HeJ/Igf1sl1^C57BL/6J Igf1sl4^C57BL/6J/Igf1sl4^C57BL/6J (involves: C3H/HeJ * C57BL/6J)	decreased circulating insulin-like growth factor I level	J:66640
Igf1sl2^C3H/HeJ/Igf1sl2^C3H/HeJ (involves: C3H/HeJ * C57BL/6J)	increased circulating insulin-like growth factor I level	J:66640
Igf1sl2^C3H/HeJ/Igf1sl2^C3H/HeJ (B6.C3H-Igf1sl2^C3H/HeJ)	increased circulating total protein level	J:111677
Igf1sl2^C3H/HeJ/Igf1sl2^C57BL/6J (involves: C3H/HeJ * C57BL/6J)	increased circulating total protein level	J:66640
Igf1sl3^C3H/HeJ/Igf1sl3^C3H/HeJ (involves: C3H/HeJ * C57BL/6J)	increased circulating insulin-like growth factor I level	J:66640
Igf1sl3^C3H/HeJ/Igf1sl3^C57BL/6J (involves: C3H/HeJ * C57BL/6J)	increased circulating insulin-like growth factor I level	J:66640
Igf2^tm1Rob/Igf2⁺ (involves: 129S/SvEv * C57BL/6J)	abnormal circulating hormone level	J:77413
Igf2bp1^{Gt(OST33739)Lex}/Igf2bp1^{Gt(OST33739)Lex} (involves: 129S5/SvEvBrd * C57BL/6)	dehydration	J:89882
Igf2bp2^tm1Mini/Igf2bp2^tm1Mini (B6.129P2-Igf2bp2^tm1Mini)	abnormal liver triglyceride level	J:271356
	decreased circulating cholesterol level	J:271356
	decreased circulating free fatty acids level	J:271356
	decreased circulating glucose level	J:271356
	decreased circulating insulin level	J:271356
	decreased circulating triglyceride level	J:271356
	decreased fasting circulating glucose level	J:271356
	decreased susceptibility to induced hypothermia	J:271356
	improved glucose tolerance	J:271356
	increased energy expenditure	J:271356
	increased insulin sensitivity	J:271356
	increased susceptibility to diet-induced obesity	J:271356
Igf2r^tm1Arge/Igf2r⁺ (involves: 129)	abnormal circulating hormone level	J:34584
Igf2r^tm1Arge/Igf2r⁺ (involves: 129)	edema	J:34584
Igf2r^tm1Arge/Igf2r^tm1Arge (involves: 129)	abnormal circulating hormone level	J:34584
Igf2r^tm1Arge/Igf2r^tm1Arge (involves: 129)	edema	J:34584
Igf2r^tm1Stw/Igf2r⁺ (involves: 129S1/Sv * C57BL/6)	abnormal circulating hormone level	J:22124
Igf2r^tm1Stw/Igf2r⁺ (involves: 129S1/Sv * C57BL/6)	cyanosis	J:22124
Igf2r^tm2Arge/Igf2r⁺ (involves: 129)	abnormal circulating hormone level	J:34584
Igf2r^tm2Arge/Igf2r⁺ (involves: 129)	edema	J:34584
Igf2r^tm2Arge/Igf2r^tm2Arge (involves: 129)	abnormal circulating hormone level	J:34584
Igf2r^tm2Arge/Igf2r^tm2Arge (involves: 129)	edema	J:34584
Igfals^{tm1b(KOMP)Wtsi}/Igfals^{tm1b(KOMP)Wtsi} (C57BL/6N-Igfals^{tm1b(KOMP)Wtsi}/Tcp)	abnormal cholesterol homeostasis	J:211773
	increased circulating cholesterol level	J:211773
Igfbp3^tm1Jep/Igfbp3^tm1Jep Igfbp4^tm1Jep/Igfbp4^tm1Jep Igfbp5^tm1Jep/Igfbp5^tm1Jep (involves: 129S/SvEv * C57BL/6J)	abnormal glucose homeostasis	J:112029
	decreased circulating glucose level	J:112029
	decreased circulating insulin-like growth factor I level	J:112029
	increased circulating insulin level	J:112029
	increased insulin secretion	J:112029
Igfbp3^tm1Lex/Igfbp3^tm1Lex (involves: 129S5/SvEvBrd * C57BL/6)	abnormal glucose homeostasis	J:168345
	decreased adiponectin level	J:168345
	decreased circulating triglyceride level	J:168345
	increased circulating glucose level	J:168345
	increased circulating insulin level	J:168345
Igfbp3q1^DU6i/Igfbp3q1^DBA/2 (involves: DBA/2J * DU6i)	abnormal circulating protein level	J:68837
Igfbp3q1^DU6i/Igfbp3q1^DU6i (involves: DBA/2J * DU6i)	abnormal circulating protein level	J:68837
Igfbp3q2^DBA/2/Igfbp3q2^DU6i (involves: DBA/2 * DU6i)	abnormal circulating protein level	J:68837
Igfbp3q2^DU6i/Igfbp3q2^DU6i (involves: DBA/2 * DU6i)	abnormal circulating protein level	J:68837
Igfbp4^tm1Jep/Igfbp4^tm1Jep (involves: 129S/SvEv * C57BL/6J)	impaired glucose tolerance	J:112029
Igh-7^tm1Led/Igh-7^tm1Led Lyn^tm1Ard/Lyn^tm1Ard (involves: 129P2/OlaHsd * 129S4/SvJae)	abnormal circulating complement protein level	J:161523
Ighg1^tm1.1Pyu/Ighg1⁺ (B6.C(Cg)-Ighg1^tm1.1Pyu)	decreased body temperature	J:198154
Ighg1^tm1.1Pyu/Ighg1^tm1.1Pyu (B6.C(Cg)-Ighg1^tm1.1Pyu)	decreased body temperature	J:198154
Ighm^tm1Cgn/Ighm⁺ Tg(Igh-6/Igh-V125)2Jwt/0 Tg(Igk-C/Igk-V125)1Jwt/0 (NOD.Cg-Ighm^tm1Cgn Tg(Igh-6/Igh-V125)2Jwt Tg(Igk-C/Igk-V125)1Jwt)	increased circulating glucose level	J:91865
Ighmbp2^nmd-2J/Ighmbp2^nmd-2J (B6.BKS-Ighmbp2^nmd-2J/J)	increased circulating creatine kinase level	J:90418
	pleural effusion	J:90418
	pulmonary edema	J:90418
Ighmbp2^nmd-2J/Ighmbp2^nmd-2J Mnm^C/Mnm^C (involves: C57BL/6J * C57BLKS/J * CAST/Ei * DBA/J)	increased circulating creatine kinase level	J:90418
	pleural effusion	J:90418
	pulmonary edema	J:90418
Ighmbp2^nmd-2J/Ighmbp2^nmd-2J Tg(Eno2-Ighmbp2)17Cx/? (involves: C57BL/6J * C57BLKS/J)	increased circulating creatine kinase level	J:90418
	pleural effusion	J:90418
	pulmonary edema	J:90418
Ighmbp2^nmd-2J/Ighmbp2^nmd-2J Tg(Eno2-Ighmbp2)90Cx/? (involves: C57BL/6J * C57BLKS/J)	pulmonary edema	J:90418
Igk^tm1.1Cog/Igk^tm1.1Cog (involves: 129P2/OlaHsd * C57BL/6 * FVB/N)	decreased blood uric acid level	J:135758
	decreased circulating phosphate level	J:135758
	increased urine phosphate level	J:135758
	increased urine protein level	J:135758
	increased urine uric acid level	J:135758
Igk^tm1.1Cog/Igk^tm1.2Cog (involves: 129P2/OlaHsd * C57BL/6 * FVB/N)	decreased blood uric acid level	J:135758
Igs1^{tm11(CAG-Bgeo,-Edn2)Nat}/Igs1⁺ Tg(Pax6-cre,GFP)2Pgr/0 (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	hypoxia	J:201133
Igs1^{tm11(CAG-Bgeo,-Edn2)Nat}/Igs1⁺ Tg(Six3-cre)69Frty/0 (involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * DBA/2)	hypoxia	J:201133
Igs2^{em5(CAG-Mir802)Gpt}/Igs2^{em5(CAG-Mir802)Gpt} Tg(Ins2-cre)25Mgn/0 (involves: C57BL/6JGpt * DBA)	decreased circulating insulin level	J:287584
	decreased insulin secretion	J:287584
	impaired glucose tolerance	J:287584
Igs2^{tm1(CAG-Ptgs2os)Scrp}/Igs2^{tm1(CAG-Ptgs2os)Scrp} (involves: C57BL/6)	abnormal circulating cytokine level	J:325487
	increased circulating interleukin-10 level	J:325487
Igsf1^tm1Zuk/Y (either: (involves: 129S6/SvEv * 129S7/SvEvBrd) or (involves: 129S7/SvEvBrd * C57BL/6J))	decreased circulating thyroid-stimulating hormone level	J:190867
	decreased circulating triiodothyronine level	J:190867
	decreased thyroid-stimulating hormone level	J:190867
Igsf8^{em1(IMPC)Wtsi}/Igsf8^{em1(IMPC)Wtsi} (C57BL/6N-Igsf8^{em1(IMPC)Wtsi}/WtsiIeg)	impaired glucose tolerance	J:211773
Igsf9^em1(IMPC)J/Igsf9^em1(IMPC)J (C57BL/6NJ-Igsf9^em1(IMPC)J/Mmjax)	increased circulating creatinine level	J:211773
	increased circulating phosphate level	J:211773
Igsf11^{tm1b(KOMP)Wtsi}/Igsf11^{tm1b(KOMP)Wtsi} (C57BL/6N-Igsf11^{tm1b(KOMP)Wtsi}/Ucd)	increased fasting circulating glucose level	J:211773
Igtp^tm1Gvw/Igtp^tm1Gvw (involves: 129S1/Sv * C57BL/6)	increased circulating interferon-gamma level	J:59891
Igtp^tm1Gvw/Igtp^tm1Gvw (involves: 129S1/Sv * C57BL/6)	increased circulating interleukin-12b level	J:59891
Iigp1c^em1Btlr/Iigp1c^em1Btlr (C57BL/6J-Iigp1c^em1Btlr)	abnormal lipid oxidation	J:333470
	decreased liver free fatty acids level	J:333470
	increased circulating alanine transaminase level	J:333470
	increased circulating triglyceride level	J:333470
	increased liver triglyceride level	J:333470
Iigp1c^M1Btlr/Iigp1c⁺ (C57BL/6J-Iigp1c^M1Btlr)	increased liver triglyceride level	J:333470
Iigp1c^M1Btlr/Iigp1c^M1Btlr (C57BL/6J-Iigp1c^M1Btlr)	increased liver triglyceride level	J:333470
Iigp1c^M2Btlr/Iigp1c⁺ (C57BL/6J-Iigp1c^M2Btlr)	increased liver triglyceride level	J:333470
Iigp1c^M2Btlr/Iigp1c^M2Btlr (C57BL/6J-Iigp1c^M2Btlr)	increased liver triglyceride level	J:333470
Ikbip^em1Bcgen/Ikbip^em1Bcgen Lyz2^tm1(cre)Ifo/Lyz2⁺ (involves: 129P2/OlaHsd)	abnormal cytokine level	J:282971
	increased circulating interleukin-6 level	J:282971
	increased circulating tumor necrosis factor level	J:282971
Ikbkb^tm2Mka/Ikbkb^tm2.1Mka Tg(Vil-cre)1Mka/0 (involves: 129/Sv * C57BL/6)	decreased circulating tumor necrosis factor level	J:83313
	intestinal edema	J:83313
Ikbke^tm1Dgen/Ikbke^tm1Dgen (B6.129P2-Ikbke^tm1Dgen)	decreased circulating glucose level	J:171942
	decreased circulating leptin level	J:171942
	increased adiponectin level	J:171942
	increased insulin sensitivity	J:171942
Ikbkg^tm1.1Chtr/Y Tg(Alb1-cre)7Gsc/0 (involves: C57BL/6 * FVB/N * SJL)	increased circulating alanine transaminase level	J:151485
Ikbkg^tm1.1Chtr/Ikbkg^tm1.1Chtr Map3k7^tm1Aki/Map3k7^tm1Aki Tg(Alb1-cre)7Gsc/0 (involves: 129P2/OlaHsd * FVB/N)	increased circulating alanine transaminase level	J:160521
	increased circulating aspartate transaminase level	J:160521
Ikbkg^tm1.1Chtr/Ikbkg^tm1.1Chtr Tg(Alb1-cre)7Gsc/0 (involves: C57BL/6 * FVB/N * SJL)	increased circulating alanine transaminase level	J:151485
	increased circulating tumor necrosis factor level	J:151485
Ikbkg^tm1.1Chtr/Ikbkg^tm1.1Chtr Tg(Alb1-cre)7Gsc/0 (involves: FVB/N)	increased circulating alanine transaminase level	J:160521
	increased circulating aspartate transaminase level	J:160521
	increased circulating glutamate dehydrogenase level	J:160521
Ikbkg^tm1.1Dwat/Y Tnfrsf1a^tm1Imx/Tnfrsf1a^tm1Imx (involves: 129S6/SvEvTac * C57BL/6 * C57BL/6NTac)	increased circulating alanine transaminase level	J:202106
	increased circulating aspartate transaminase level	J:202106
	increased circulating bilirubin level	J:202106
	increased circulating lactate dehydrogenase level	J:202106
Ikbkg^tm1.1Mpa/Ikbkg^tm1.1Mpa Tg(Alb1-cre)7Gsc/0 (involves: C57BL/6 * FVB/N)	decreased circulating glucose level	J:118336
	increased circulating alanine transaminase level	J:118336
Ikzf3^tm1Kge/Ikzf3^tm1Kge (involves: 129S4/SvJae * C57BL/6)	abnormal blood urea nitrogen level	J:81805
	increased circulating creatinine level	J:81805
	increased urine protein level	J:81805
Il1a^{tm1b(EUCOMM)Wtsi}/Il1a^{tm1b(EUCOMM)Wtsi} (C57BL/6N-Il1a^{tm1b(EUCOMM)Wtsi}/J)	decreased circulating serum albumin level	J:211773
Il1a^tm1Yiw/Il1a^tm1Yiw (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	decreased circulating interleukin-1 alpha level	J:47429
Il1a^tm1Yiw/Il1a^tm1Yiw Il1b^tm1Yiw/Il1b^tm1Yiw (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	decreased circulating corticosterone level	J:47429
	decreased circulating interleukin-1 alpha level	J:47429
	decreased circulating interleukin-1 beta level	J:47429
	impaired febrile response	J:47429
Il1b^tm1Dch/Il1b^tm1Dch (involves: 129S2/SvPas * C57BL/6)	abnormal insulin-like growth factor I level	J:71534
Il1b^tm1Lvp/Il1b^tm1Lvp (involves: 129S7/SvEvBrd * C57BL/6)	decreased circulating interleukin-1 beta level	J:27234
Il1b^tm1Lvp/Il1b^tm1Lvp (involves: 129S7/SvEvBrd * C57BL/6)	impaired febrile response	J:27234
Il1b^tm1Yiw/Il1b^tm1Yiw (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	decreased circulating corticosterone level	J:47429
	decreased circulating interleukin-1 beta level	J:47429
	impaired febrile response	J:47429
Il1r1^{em1(IMPC)Ccpcz}/Il1r1^{em1(IMPC)Ccpcz} (C57BL/6NCrl-Il1r1^{em1(IMPC)Ccpcz}/Ccpcz)	decreased circulating chloride level	J:211773
	decreased circulating sodium level	J:211773
Il1r1^em1Qizh/Il1r1^em1Qizh (C57BL/6-Il1r1^em1Qizh)	increased circulating interleukin-6 level	J:338375
Il1r1^em1Qizh/Il1r1^em1Qizh (C57BL/6-Il1r1^em1Qizh)	increased circulating tumor necrosis factor level	J:338375
Il1r1^tm1Imx/Il1r1^tm1Imx (involves: 129 * C57BL/6)	decreased circulating interleukin-6 level	J:43088
Il1r1^tm1Imx/Il1r1^tm1Imx (involves: 129S7/SvEvBrd * C57BL/6)	decreased blood urea nitrogen level	J:112999
	decreased circulating creatinine level	J:112999
Il1r1^tm1Imx/Il1r1^tm1Imx (B6.129S7-Il1r1^tm1Imx/J)	decreased circulating interleukin-6 level	J:125570
	decreased circulating interleukin-18 level	J:125570
	decreased transforming growth factor beta level	J:148779
	impaired glucose tolerance	J:108634
	increased circulating insulin level	J:108634
	increased circulating insulin-like growth factor I level	J:108634
	increased circulating interleukin-1 beta level	J:125570
	increased circulating interleukin-18 level	J:125570
	increased circulating leptin level	J:108634
	increased respiratory quotient	J:108634
	insulin resistance	J:108634
Il1r1^tm1Imx/Il1r1^tm1Imx Tnfrsf1a^tm1Imx/Tnfrsf1a^tm1Imx (involves: 129S7/SvEvBrd * C57BL/6)	abnormal chemokine level	J:126652
Il1r1^tm1Roml/Il1r1^tm1Roml (involves: 129S1/Sv * C57BL/6)	decreased circulating interleukin-6 level	J:42373
	decreased circulating serum amyloid protein level	J:42373
	impaired febrile response	J:42373
Il1rn^tm1Dih/Il1rn^tm1Dih (B6.129S-Il1rn^tm1Dih)	decreased circulating cholesterol level	J:76336
Il1rn^tm1Dih/Il1rn^tm1Dih (involves: 129S/SvEv * C57BL/6J)	decreased circulating cholesterol level	J:76336
	decreased circulating interleukin-1 level	J:36387
	increased circulating interleukin-6 level	J:61600
	increased circulating serum amyloid protein level	J:61600
Il1rn^tm1Yiw/Il1rn^tm1Yiw (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	abnormal body temperature homeostasis	J:47429
Il2^tm1.1Kasm/Il2^tm1.1Kasm Ndor1^{Tg(UBC-cre/ERT2)1Ejb}/? (involves: 129S/SvEv * C57BL/6)	decreased circulating interleukin-17 level	J:190168
Il2^tm1Hor/Il2^tm1Hor (C.129P2-Il2^tm1Hor)	increased circulating bilirubin level	J:29799
Il2^tm1Hor/Il2^tm1Hor (B6.129P2-Il2^tm1Hor/J)	abnormal circulating cytokine level	J:190168
	decreased circulating interferon-gamma level	J:190168
	decreased circulating interleukin-4 level	J:190168
	decreased circulating interleukin-13 level	J:190168
	decreased salivation	J:125129
Il2^tm1Hor/Il2^tm1Hor (involves: 129P2/OlaHsd * C57BL/6J)	increased circulating interleukin-17 level	J:120176
Il2ra^{tm1b(EUCOMM)Wtsi}/Il2ra^{tm1b(EUCOMM)Wtsi} (C57BL/6N-Il2ra^{tm1b(EUCOMM)Wtsi}/Orl)	abnormal cholesterol homeostasis	J:211773
	decreased blood urea nitrogen level	J:211773
	decreased circulating alkaline phosphatase level	J:211773
	decreased circulating calcium level	J:211773
	decreased circulating cholesterol level	J:211773
	decreased circulating glucose level	J:211773
	decreased circulating HDL cholesterol level	J:211773
	decreased circulating serum albumin level	J:211773
	decreased circulating total protein level	J:211773
	improved glucose tolerance	J:211773
	increased circulating aspartate transaminase level	J:211773
	increased circulating phosphate level	J:211773
Il2ra^tm1Dw/Il2ra^tm1Dw (B6.129S4-Il2ra^tm1Dw/J)	decreased salivation	J:125129
Il2rg^tm1Wjl/Il2rg^tm1Wjl Prkdc^scid/Prkdc^scid (NOD.Cg-Prkdc^scid Il2rg^tm1Wjl/Sz)	abnormal glucose homeostasis	J:138005
	hyperglycemia	J:138005
Il4/Il13^tm1.1Lky/Il4/Il13^tm1.1Lky Il4/Il13^tm1.1Lky/Il4/Il13^tm1.1Lky (involves: 129P2/OlaHsd * BALB/c)	decreased core body temperature	J:178294
	decreased fatty acids level	J:178294
	decreased noradrenaline level	J:178294
Il4^tm1Cgn/Il4^tm1Cgn (NOD.129P2-Il4^tm1Cgn)	increased circulating glucose level	J:95105
Il4^tm1Kopf/Il4^tm1Kopf Lyn^tm1Ard/Lyn^tm1Ard (involves: 129P2/OlaHsd * 129S2/SvPas)	abnormal circulating complement protein level	J:161523
Il4^tm2Nnt/Il4^tm2Nnt Tgfb1^tm1Doe/Tgfb1^tm1Doe (C.Cg-Tgfb1^tm1Doe Il4^tm2Nnt)	increased circulating alanine transaminase level	J:69346
Il4i1^{tm1b(EUCOMM)Wtsi}/Il4i1⁺ (C57BL/6N-Il4i1^{tm1b(EUCOMM)Wtsi}/Ieg)	increased circulating lipase level	J:211773
Il4i1^{tm1b(EUCOMM)Wtsi}/Il4i1^{tm1b(EUCOMM)Wtsi} (C57BL/6N-Il4i1^{tm1b(EUCOMM)Wtsi}/Ieg)	decreased circulating potassium level	J:211773
Il4ppq^BXSB/Il4ppq^NZW/Slc (involves: NZB/Slc * NZW/Slc)	increased urine protein level	J:117863
Il4ra^tm1Fbb/Il4ra^tm1Fbb (involves: BALB/cJ)	abnormal circulating cytokine level	J:133518
	abnormal circulating interferon-gamma level	J:133518
	increased circulating interleukin-4 level	J:133518
	increased transforming growth factor beta level	J:133518
Il4ra^tm2Fbb/Il4ra^tm2Fbb Lyz2^tm1(cre)Ifo/? (involves: 129P2/OlaHsd * BALB/c)	decreased core body temperature	J:178294
	decreased fatty acids level	J:178294
Il4ra^tm2Tch/Il4ra^tm2Tch (C.129X1-Il4ra^tm2Tch)	increased circulating interleukin-4 level	J:152376
Il5^{tm1.1(icre)Lky}/Il5⁺ (C57BL/6-Il5^{tm1.1(icre)Lky})	decreased circulating interleukin-5 level	J:206097
Il5^tm1Anjm/Il5^tm1Anjm Il9^tm1Anjm/Il9^tm1Anjm (involves: 129P2/OlaHsd * C57BL/6)	abnormal interleukin level	J:113543
Il5^tm2Anjm/Il5^tm2Anjm Il9^tm1Anjm/Il9^tm1Anjm (involves: 129P2/OlaHsd * C57BL/6)	abnormal interleukin level	J:113543
Il6^tm1Kopf/Il6^tm1Kopf (involves: 129S2/SvPas * C57BL/6)	abnormal acute phase protein level	J:17360
	abnormal homeostasis	J:105633
	abnormal oxygen consumption	J:105633
	increased circulating glucose level	J:105633
Il6^tm1Kopf/Il6^tm1Kopf (B6.129S2-Il6^tm1Kopf/J)	abnormal glucose homeostasis	J:109359
	decreased glucagon secretion	J:139138
	decreased insulin secretion	J:139138
	impaired glucose tolerance	J:139138
	increased body temperature	J:105279, J:136166
Il6^tm1Mur/Il6⁺ (B6.129P2(B6)-Il6^tm1Mur)	abnormal dopamine level	J:86039
Il6^tm1Mur/Il6^tm1Mur (involves: 129/Sv * C57BL/6)	abnormal interferon level	J:40579
Il6^tm1Mur/Il6^tm1Mur (B6.129P2(B6)-Il6^tm1Mur)	abnormal dopamine level	J:86039
Il6^tm1Poli/Il6^tm1Poli (involves: 129S/SvEv * MF1)	decreased circulating interleukin-12 level	J:79314
	decreased dopamine level	J:53180
	impaired febrile response	J:30643
	increased circulating interleukin-10 level	J:79314
Il6^tm1Poli/Il6^tm1Poli (involves: 129S/SvEv * C57BL/6)	impaired febrile response	J:48865
Il6ra^{tm1.1(IL6R)Csk}/Il6ra^{tm1.1(IL6R)Csk} (involves: 129S6/SvEvTac * C57BL/6)	abnormal circulating serum amyloid protein level	J:207264
Il6ra^tm1.1Jcbr/Il6ra^tm1.1Jcbr Lyz2^tm1(cre)Ifo/Lyz2⁺ (involves: 129P2/OlaHsd * C57BL/6)	decreased circulating interleukin-1 beta level	J:188445
	decreased circulating tumor necrosis factor level	J:188445
Il6ra^tm1.1Jcbr/Il6ra^tm1.1Jcbr Tg(Alb1-cre)7Gsc/0 (involves: C57BL/6 * FVB/N)	abnormal glycogen homeostasis	J:166367
	decreased circulating interleukin-1 beta level	J:188445
	decreased circulating tumor necrosis factor level	J:188445
	decreased insulin secretion	J:166367
	decreased liver glycogen level	J:166367
	impaired glucose tolerance	J:166367
	increased circulating interleukin-6 level	J:166367
	increased circulating tumor necrosis factor level	J:166367
	increased glycogen catabolism rate	J:166367
	increased insulin secretion	J:166367
	insulin resistance	J:166367
Il6ra^tm1.2Jcbr/Il6ra^tm1.2Jcbr (involves: C57BL/6)	decreased circulating interleukin-1 beta level	J:188445
	decreased circulating tumor necrosis factor level	J:188445
	increased circulating aspartate transaminase level	J:202764
Il6st^tm1Ard/Il6st^tm1Ard (involves: 129S1/Sv * C57BL/6)	joint swelling	J:79555
Il6st^{tm1b(KOMP)Mbp}/Il6st⁺ (C57BL/6N-Il6st^{tm1b(KOMP)Mbp}/J)	increased circulating bilirubin level	J:211773
Il6st^tm1Ern/Il6st^tm1Ern (involves: 129S1/Sv)	increased circulating interleukin-6 level	J:168781
Il6st^tm1Ern/Il6st^tm1Ern Stat3^tm1Aki/Stat3⁺ (involves: 129P2/OlaHsd * 129S1/Sv)	decreased circulating interleukin-6 level	J:168781
Il6st^tm1Ern/Il6st^tm1Ern Tirap^tm1.1Pjh/Tirap^tm1.1Pjh (involves: 129S1/Sv)	decreased circulating interleukin-6 level	J:168781
Il6st^tm1Kish/Il6st^tm1Kish (involves: 129P2/OlaHsd * ICR)	decreased liver glycogen level	J:54660
Il6st^tm1Kish/Il6st^tm1Kish (involves: 129P2/OlaHsd * CD-1)	decreased circulating calcium level	J:88710
Il6st^tm1Kish/Il6st^tm1Kish (involves: 129P2/OlaHsd * CD-1)	increased circulating parathyroid hormone level	J:88710
Il9^em1(IMPC)Mbp/Il9^em1(IMPC)Mbp (C57BL/6NCrl-Il9^em1(IMPC)Mbp/MbpMmucd)	increased circulating alanine transaminase level	J:211773
Il10^tm1.1Roer/Il10^tm1.1Roer (involves: 129P2/OlaHsd)	decreased circulating interleukin-10 level	J:151551
Il10^tm1Cgn/Il10^tm1Cgn (involves: 129P2/OlaHsd * C57BL/6)	abnormal circulating enzyme level	J:110238
	abnormal circulating protein level	J:110238
	abnormal circulating serum albumin level	J:93577
	abnormal cytokine level	J:35020
	abnormal glucose homeostasis	J:129479
	abnormal homeostasis	J:129479
	abnormal interferon level	J:35020, J:107077, J:125760
	abnormal interleukin level	J:35020, J:107077, J:51636
	abnormal iron level	J:15222
	abnormal lipid level	J:129479
	abnormal nitric oxide homeostasis	J:115459
	abnormal protein level	J:129479
	abnormal tumor necrosis factor level	J:107077, J:51636
	decreased circulating cholesterol level	J:129479
	decreased circulating creatinine level	J:93577
	decreased circulating insulin level	J:129479
	decreased circulating iron level	J:15222
	decreased spleen iron level	J:15222
	increased circulating cholesterol level	J:129479
	increased fatty acids level	J:129479
	increased insulin sensitivity	J:129479
	increased leukotriene level	J:62283
	increased liver triglyceride level	J:129479
Il10^tm1Cgn/Il10^tm1Cgn (involves: 129P2/OlaHsd)	increased circulating interleukin-12 level	J:118833
Il10^tm1Cgn/Il10^tm1Cgn (involves: 129P2/OlaHsd)	increased circulating tumor necrosis factor level	J:118833
Il10^tm1Cgn/Il10^tm1Cgn (B6.129P2-Il10^tm1Cgn/J)	abnormal chemokine level	J:157787
	abnormal cytokine level	J:157787, J:139972
	impaired adaptive thermogenesis	J:114404
	increased circulating interferon-gamma level	J:157787
	increased circulating interleukin-1 alpha level	J:157787
	increased circulating interleukin-1 beta level	J:157787, J:139972
	increased circulating interleukin-2 level	J:157787
	increased circulating interleukin-6 level	J:157787, J:139972
	increased circulating interleukin-12 level	J:157787
	increased circulating interleukin-17 level	J:157787
	increased circulating tumor necrosis factor level	J:157787
Il10^tm1Cgn/Il10^tm1Cgn (B6.129P2-Il10^tm1Cgn)	abnormal circulating interleukin-6 level	J:191723
Il10^tm1Cgn/Il10^tm1Cgn (B6.129P2-Il10^tm1Cgn)	abnormal circulating interleukin-12b level	J:191723
Il10^tm1Cgn/Il10^tm1Cgn Vdr^tm1Mbd/Vdr^tm1Mbd (involves: 129P2/OlaHsd * 129S4/SvJae * C57BL/6)	abnormal cytokine level	J:107077
Il10ra^tm1.1Jack/Il10ra^tm1.1Jack Lyz2^tm1(cre)Ifo/Lyz2⁺ (involves: 129P2/OlaHsd * BALB/c * C57BL/6)	abnormal chemokine level	J:157787
	abnormal cytokine level	J:157787
	increased circulating interferon-gamma level	J:157787
	increased circulating interleukin-1 alpha level	J:157787
	increased circulating interleukin-1 beta level	J:157787
	increased circulating interleukin-2 level	J:157787
	increased circulating interleukin-12 level	J:157787
	increased circulating interleukin-17 level	J:157787
	increased circulating tumor necrosis factor level	J:157787
Il10ra^tm1.2Jack/Il10ra^tm1.2Jack (involves: 129P2/OlaHsd * BALB/c * C57BL/6 * DBA/2)	abnormal chemokine level	J:157787
	abnormal cytokine level	J:157787
	increased circulating interferon-gamma level	J:157787
	increased circulating interleukin-1 alpha level	J:157787
	increased circulating interleukin-1 beta level	J:157787
	increased circulating interleukin-2 level	J:157787
	increased circulating interleukin-6 level	J:157787
	increased circulating interleukin-12 level	J:157787
	increased circulating interleukin-17 level	J:157787
	increased circulating tumor necrosis factor level	J:157787
Il10ra^{tm1b(KOMP)Wtsi}/Il10ra^{tm1b(KOMP)Wtsi} (C57BL/6N-Il10ra^{tm1b(KOMP)Wtsi}/Orl)	decreased blood urea nitrogen level	J:211773
	improved glucose tolerance	J:211773
Il10rb^{tm1a(KOMP)Wtsi}/Il10rb^{tm1a(KOMP)Wtsi} (C57BL/6N-Il10rb^{tm1a(KOMP)Wtsi}/Wtsi)	decreased circulating glucose level	J:211773
Il10rb^tm1Agt/Il10rb^tm1Agt Tg(Cd4-TGFBR2)16Flv/? (involves: 129S2/SvPas * C3H * C57BL/6)	abnormal cytokine level	J:134156
	increased circulating interferon-gamma level	J:134156
	increased circulating interleukin-6 level	J:134156
	increased circulating tumor necrosis factor level	J:134156
Il12a^{tm1b(EUCOMM)Hmgu}/Il12a^{tm1b(EUCOMM)Hmgu} (C57BL/6N-Il12a^{tm1b(EUCOMM)Hmgu}/H)	increased circulating HDL cholesterol level	J:211773
Il12a^tm1Cab/Il12a^tm1Cab (involves: 129S4/SvJae * C57BL/6)	decreased circulating interferon-gamma level	J:54482
Il12a^tm1Cab/Il12a^tm1Cab (involves: 129S4/SvJae * C57BL/6)	decreased circulating interleukin-12 level	J:54482
Il12a^tm1Cab/Il12a^tm1Cab (B6.129S4-Il12a^tm1Cab)	decreased circulating interferon-gamma level	J:79552
Il12b^em1(IMPC)H/Il12b^em1(IMPC)H (C57BL/6NTac-Il12b^em1(IMPC)H/H)	impaired glucose tolerance	J:211773
Il12b^tm1Jm/Il12b^tm1Jm (B6.129S1-Il12b^tm1Jm/J)	decreased circulating interferon-gamma level	J:120806
Il12rb1^tm1Jm/Il12rb1^tm1Jm (involves: 129S1/Sv * C57BL/6J)	decreased circulating interferon-gamma level	J:42105
Il12rb2^tm1Jm/Il12rb2^tm1Jm (B6;129S1-Il12rb2^tm1Jm/J)	increased circulating interleukin-12 level	J:120061
Il13^{tm1.1(KOMP)Vlcg}/Il13^{tm1.1(KOMP)Vlcg} (C57BL/6N-Il13^{tm1.1(KOMP)Vlcg}/Ucd)	increased circulating HDL cholesterol level	J:211773
Il13^tm1.1Anjm/Il13^tm1.1Anjm (involves: 129P2/OlaHsd * C57BL/6)	decreased circulating interleukin-13 level	J:67965
Il13^tm2Anjm/Il13^tm2Anjm (involves: 129)	decreased circulating interleukin-13 level	J:67965
Il13^tm2Anjm/Il13^tm2Anjm (involves: 129P2/OlaHsd * BALB/c * C57BL/6)	abnormal chemokine level	J:131994
Il13ra1^tm1Twy/Y (C.Cg-Il13ra1^tm1Twy)	abnormal nitric oxide homeostasis	J:130488
Il13ra1^tm1Twy/Y (C.Cg-Il13ra1^tm1Twy)	increased circulating interleukin-5 level	J:130488
Il13ra2^{tm1b(EUCOMM)Hmgu}/Il13ra2^{tm1b(EUCOMM)Hmgu} (C57BL/6N-Il13ra2^{tm1b(EUCOMM)Hmgu}/Ieg)	decreased circulating potassium level	J:211773
Il13ra2^tm1Gru/Il13ra2^tm1Gru (C.Cg-Il13ra2^tm1Gru)	decreased circulating interleukin-13 level	J:82376
Il15^{tm1b(EUCOMM)Hmgu}/Il15^{tm1b(EUCOMM)Hmgu} (C57BL/6N-Il15^{tm1b(EUCOMM)Hmgu}/H)	impaired glucose tolerance	J:211773
Il17a^tm1Yiw/Il17a^tm1Yiw (involves: 129P2/OlaHsd * BALB/cA * C57BL/6J)	abnormal interleukin level	J:79127
Il17a^tm1Yiw/Il17a^tm1Yiw Tg(CD2-Rorc)#Staka/0 (involves: 129P2/OlaHsd * C57BL/6)	decreased salivation	J:230700
Il17b^em1Cya/Il17b^em1Cya (C57BL/6-Il17b^em1Cya)	abnormal cytokine level	J:339366
Il17ra^tm1Koll/Il17ra^tm1Koll (involves: 129 * C57BL/6)	pulmonary edema	J:71097
Il17rc^em1(IMPC)Mbp/Il17rc^em1(IMPC)Mbp (C57BL/6NCrl-Il17rc^em1(IMPC)Mbp/MbpMmucd)	decreased circulating triglyceride level	J:211773
Il17rc^tm1Lex/Il17rc^tm1Lex (involves: C57BL/6)	abnormal chemokine level	J:159874
Il18^tm1Aki/Il18^tm1Aki (involves: 129P2/OlaHsd)	decreased circulating interferon-gamma level	J:46514
	decreased circulating interleukin-18 level	J:122588, J:46514
	decreased energy expenditure	J:122588
	decreased oxygen consumption	J:122588
Il18^tm1Khe/Il18^tm1Khe (involves: 129P2/OlaHsd)	decreased circulating interferon-gamma level	J:62263
	decreased circulating interleukin-18 level	J:62263
	increased circulating tumor necrosis factor level	J:62263
Il18^tm1Khe/Il18^tm1Khe (B6.129P2-Il18^tm1Khe)	abnormal cytokine level	J:138759
	abnormal nitric oxide homeostasis	J:138759
	decreased circulating interferon-gamma level	J:138759
	decreased circulating interleukin-6 level	J:138759
	decreased circulating interleukin-18 level	J:138759
Il18^tm1Liew/Il18^tm1Liew (involves: 129P2/OlaHsd * CD-1)	abnormal interferon level	J:86621
	abnormal interleukin level	J:86621
	abnormal tumor necrosis factor level	J:86621
Il18bp^{tm1(KOMP)Vlcg}/Il18bp^{tm1(KOMP)Vlcg} (C57BL/6-Il18bp^{tm1(KOMP)Vlcg})	increased circulating interferon-gamma level	J:255309
Il18bp^{tm1.1(KOMP)Vlcg}/Il18bp^{tm1.1(KOMP)Vlcg} (involves: C57BL/6N)	abnormal circulating chemokine level	J:261967
	increased circulating alanine transaminase level	J:261967
	increased circulating ferritin level	J:261967
	increased circulating interferon-gamma level	J:261967
	increased circulating interleukin-18 level	J:261967
Il20^em1(IMPC)Mbp/Il20^em1(IMPC)Mbp (C57BL/6NCrl-Il20^em1(IMPC)Mbp/MbpMmucd)	increased circulating alanine transaminase level	J:211773
Il20ra^{tm1.1(KOMP)Vlcg}/Il20ra^{tm1.1(KOMP)Vlcg} (C57BL/6N-Il20ra^{tm1.1(KOMP)Vlcg}/Ucd)	increased circulating alanine transaminase level	J:211773
	increased circulating aspartate transaminase level	J:211773
Il20rb^em2(IMPC)Mbp/Il20rb^em2(IMPC)Mbp (C57BL/6N-Il20rb^em2(IMPC)Mbp/Ucd)	increased circulating alanine transaminase level	J:211773
Il20rb^{tm1b(KOMP)Wtsi}/Il20rb^{tm1b(KOMP)Wtsi} (C57BL/6N-Il20rb^{tm1b(KOMP)Wtsi}/Ucd)	increased circulating alanine transaminase level	J:211773
Il21^tm1Lex/Il21^tm1Lex (involves: 129S5/SvEvBrd * C57BL/6J)	abnormal interleukin level	J:123351
Il21r^tm1Lex/Il21r^tm1Lex (involves: 129S5/SvEvBrd * C57BL/6J)	increased circulating triglyceride level	J:103485
Il22^tm1.1Lex/Il22^tm1.1Lex (involves: 129S5/SvEvBrd)	abnormal circulating cytokine level	J:179011
	decreased circulating interleukin-1 alpha level	J:179011
	decreased circulating interleukin-12 level	J:179011
	decreased circulating interleukin-12b level	J:179011
	decreased circulating tumor necrosis factor level	J:179011
	increased circulating interleukin-17 level	J:179011
Il22^tm1Flv/Il22^tm1Flv (B6.Cg-Il22^tm1Flv)	increased circulating alanine transaminase level	J:126103
Il22^tm1Flv/Il22^tm1Flv (B6.Cg-Il22^tm1Flv)	increased circulating aspartate transaminase level	J:126103
Il22ra1^{tm1a(EUCOMM)Wtsi}/Il22ra1^{tm1a(EUCOMM)Wtsi} (C57BL/6N-Il22ra1^{tm1a(EUCOMM)Wtsi}/Wtsi)	decreased circulating serum albumin level	J:175295
Il23a^tm1Dnax/Il23a^tm1Dnax (B6.Cg-Il23a^tm1Dnax)	abnormal interleukin level	J:111568
Il23a^tm1Ngh/Il23a^tm1Ngh (involves: 129 * C57BL/6)	abnormal circulating interleukin level	J:216867
Il23a^tm1Ngh/Il23a^tm1Ngh (involves: 129 * C57BL/6)	increased circulating interleukin-17 level	J:216867
Il23r^tm1.1Ngh/Il23r^tm1.1Ngh (involves: C57BL/6)	abnormal circulating interleukin level	J:216867
Il23r^tm1.1Ngh/Il23r^tm1.1Ngh (involves: C57BL/6)	increased circulating interleukin-17 level	J:216867
Il23r^tm1.1Ngh/Il23r^tm1.1Ngh Rag2^tm1Fwa/Rag2^tm1Fwa (involves: 129S/SvEv * C57BL/6)	abnormal circulating interleukin level	J:216867
Il23r^{tm2a(EUCOMM)Wtsi}/Il23r^{tm2a(EUCOMM)Wtsi} (C57BL/6N-Il23r^{tm2a(EUCOMM)Wtsi}/Wtsi)	increased circulating alanine transaminase level	J:211773
Il24^{tm1.1(KOMP)Vlcg}/Il24^{tm1.1(KOMP)Vlcg} (C57BL/6N-Il24^{tm1.1(KOMP)Vlcg}/J)	increased circulating sodium level	J:211773
Il25^tm1Dart/Il25^tm1Dart (C57BL/6-Il25^tm1Dart)	abnormal interferon level	J:123808
Il25^tm1Dart/Il25^tm1Dart (C57BL/6-Il25^tm1Dart)	abnormal interleukin level	J:123808
Il25^tm1Dart/Il25^tm1Dart (involves: C57BL/6)	abnormal interleukin level	J:125296
Il25^tm1Lex/Il25^tm1Lex (B6;129S5-Il25^tm1Lex/Orl)	increased circulating triglyceride level	J:82809
Il27^tm1Lex/Il27^tm1Lex (involves: 129S/SvEvBrd)	increased circulating interleukin-12b level	J:187660
Il27ra^tm1Mak/Il27ra^tm1Mak (B6.129P2-Il27ra^tm1Mak)	decreased circulating interferon-gamma level	J:116610
	increased circulating alanine transaminase level	J:88618
	increased circulating interferon-gamma level	J:88618
	increased circulating interleukin-1 beta level	J:88618
	increased circulating interleukin-4 level	J:88618
	increased circulating interleukin-6 level	J:88618
	increased circulating interleukin-12 level	J:88618
	increased circulating tumor necrosis factor level	J:88618
Il31ra^tm1Ngh/Il31ra^tm1Ngh (involves: C57BL/6)	abnormal interleukin level	J:123198
Il36a^tm1Yiw/Il36a^tm1Yiw (B6.129P2-Il36a^tm1Yiw)	abnormal cytokine level	J:263315
Il36g^tm1Lex/Il36g^tm1Lex (involves: 129S5/SvEvBrd * C57BL/6J)	abnormal interleukin level	J:264077
	abnormal tumor necrosis factor level	J:264077
Il36g^tm1Lex/Il36g^tm1Lex (involves: 129S5/SvEvBrd * C57BL/6)	abnormal cytokine level	J:296074
Ildr1^{Gt(D178D03)Wrst}/Ildr1^{Gt(D178D03)Wrst} (involves: 129S2/SvPas * C57BL/6J * Swiss Webster)	abnormal circulating hormone level	J:201407
Ildr1^{Gt(D178D03)Wrst}/Ildr1^{Gt(D178D03)Wrst} Tg(Cck-EGFP)BJ203Gsat/0 (involves: 129S2/SvPas * C57BL/6J * FVB/NTac * Swiss Webster)	abnormal circulating hormone level	J:201407
Ildr2^Dbsm1-DBA/2J/Ildr2^Dbsm1-DBA/2J (B6.D2-Ildr2^Dbsm1-DBA/2J)	hyperglycemia	J:138216
Ildr2^Dbsm1-DBA/2J/Ildr2^Dbsm1-DBA/2J Lep^ob/Lep^ob (B6.Cg-Ildr2^Dbsm1-DBA/2J Lep^ob)	decreased circulating insulin level	J:138216
	hyperglycemia	J:138216
	impaired glucose tolerance	J:138216
Ildr2^W87/Ildr2^W87 (involves: C3HeB/FeJ)	decreased circulating insulin level	J:138216
Ildr2^W87/Ildr2^W87 (involves: C3HeB/FeJ)	impaired glucose tolerance	J:138216
Ilf3^tm1Pnk/Ilf3^tm1Pnk (involves: 129S1/Sv * 129X1/SvJ)	cyanosis	J:99935
Ilk^{tm1.1(KOMP)Vlcg}/Ilk⁺ (C57BL/6N-Ilk^{tm1.1(KOMP)Vlcg}/J)	increased circulating phosphate level	J:211773
Ilk^tm1Star/Ilk^tm1Star Tg(KRT14-cre)1Amc/0 (involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * CBA)	skin edema	J:172934
Ilk^tm1Star/Ilk^tm1Star Tg(NPHS2-cre)295Lbh/0 (involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * SJL)	albuminuria	J:129286, J:129244
	increased blood urea nitrogen level	J:129244
	increased circulating cholesterol level	J:129244
	increased circulating creatinine level	J:129286
	increased urine protein level	J:129286, J:129244
Ilkap^{Gt(OST55141)Lex}/Ilkap^{Gt(OST55141)Lex} (B6;129S5-Ilkap^{Gt(OST55141)Lex}/Ieg)	increased cholesterol level	J:82809
Ilrun^em1(IMPC)Tcp/Ilrun^em1(IMPC)Tcp (C57BL/6NCrl-Ilrun^em1(IMPC)Tcp/Tcp)	impaired glucose tolerance	J:211773
Ilrun^{tm1a(KOMP)Wtsi}/Ilrun^{tm1a(KOMP)Wtsi} (involves: C57BL/6N)	abnormal apolipoprotein level	J:302091
	abnormal cholesterol homeostasis	J:302091
	abnormal circulating apolipoprotein level	J:302091
	abnormal circulating non-HDL cholesterol level	J:302091
	decreased circulating cholesterol level	J:302091
	decreased circulating HDL cholesterol level	J:302091
	decreased circulating LDL cholesterol level	J:302091
	decreased circulating phospholipid level	J:302091
	decreased circulating triglyceride level	J:302091
	decreased circulating VLDL triglyceride level	J:302091
	decreased insulin secretion	J:302091
	decreased liver cholesterol level	J:302091
	decreased liver triglyceride level	J:302091
	impaired glucose tolerance	J:302091
Imgt1^KK/Ta/Imgt1^KK/Ta (involves: BALB/c * KK/Ta)	impaired glucose tolerance	J:88209
Immt^{Gt(AW0256)Wtsi}/Immt⁺ (involves: 129P2/OlaHsd)	decreased carbon dioxide production	J:344896
	decreased oxygen consumption	J:344896
	decreased respiratory quotient	J:344896
	increased carbon dioxide production	J:344896
	increased circulating creatine kinase level	J:344896
	increased circulating glucose level	J:344896
	increased circulating lactate dehydrogenase level	J:344896
	increased circulating lactate level	J:344896
	increased oxygen consumption	J:344896
	increased respiratory quotient	J:344896
Impact^tm1.1Casb/Impact^tm1.1Casb (involves: C57BL/6J)	decreased body temperature	J:279071
	decreased fasting circulating glucose level	J:279071
	decreased oxygen consumption	J:279071
	decreased susceptibility to diet-induced obesity	J:279071
	increased insulin sensitivity	J:279071
In(2a;Itch)18H/In(2a;Itch)18H (involves: 101/H * C3H/HeH)	hypoxia	J:24934
In(2a;Itch)18H/In(2a;Itch)18H (involves: 101/H * C3H/HeH)	pulmonary alveolar proteinosis	J:24934
Inava^tm1.1Itl/Inava^tm1.1Itl (involves: 129S6/SvEvTac * C57BL/6NTac)	abnormal protein level	J:257317
Ing2^{tm1.1(KOMP)Vlcg}/Ing2⁺ (C57BL/6N-Ing2^{tm1.1(KOMP)Vlcg}/J)	increased circulating alanine transaminase level	J:211773
	increased circulating bilirubin level	J:211773
Ing4^em1(IMPC)Tcp/Ing4^em1(IMPC)Tcp (C57BL/6NCrl-Ing4^em2(IMPC)Tcp/Tcp)	decreased circulating alkaline phosphatase level	J:211773
	increased circulating chloride level	J:211773
	increased circulating sodium level	J:211773
Ing4^Gt(XG370)Byg/Ing4^Gt(XG370)Byg (involves: 129P2/OlaHsd * C57BL/6)	abnormal chemokine level	J:161381
	increased circulating interleukin-6 level	J:161381
Ing5^em1(IMPC)J/Ing5^em1(IMPC)J (C57BL/6NJ-Ing5^em1(IMPC)J/Mmjax)	impaired glucose tolerance	J:211773
	increased circulating cholesterol level	J:211773
	increased fasting circulating glucose level	J:211773
Inha^tm1Bay/Inha^tm1Bay (involves: 129S7/SvEvBrd * C57BL/6)	increased circulating follicle stimulating hormone level	J:3315
Inha^tm1Bay/Inha^tm1Bay (involves: 129S6/SvEvTac * 129S7/SvEvBrd)	decreased circulating follicle stimulating hormone level	J:84989
	increased circulating estradiol level	J:84989
Inhba^tm1Zuk/Inhba^tm2Zuk (involves: 129S7/SvEvBrd)	decreased circulating estradiol level	J:63882
	decreased circulating progesterone level	J:63882
	hypoglycemia	J:63882
	increased circulating follicle stimulating hormone level	J:63882
Inhba^tm1Zuk/Inhba^tm3Zuk Inhbb^tm1Jae/Inhbb^tm1Jae Amhr2^tm3(cre)Bhr/Amhr2⁺ (involves: 129S4/SvJae * 129S7/SvEvBrd * C57BL/6J)	increased follicle stimulating hormone level	J:125354
Inhba^tm2Zuk/Inhba^tm2Zuk (involves: 129S7/SvEvBrd)	abnormal circulating hormone level	J:63882
Inhbb^tm1Grid/Inhbb^tm1Grid (involves: 129S1/Sv * C57BL/6)	increased circulating aspartate transaminase level	J:19647
Inhbb^tm1Jae/Inhbb^tm1Jae (either: (129S4/SvJae-Inhbb^tm1Jae) or (involves: 129S4/SvJae * BALB/c) or (involves: 129S4/SvJae * C57BL/6))	increased circulating follicle stimulating hormone level	J:16995
Inhbc^tm1Zuk/Inhbc^tm1Zuk (either: (involves: 129S5/SvEvBrd * 129S7/SvEvBrd) or (involves: 129S7/SvEvBrd * C57BL/6))	decreased circulating serum albumin level	J:110815
Inmt^em1(IMPC)Mbp/Inmt^em1(IMPC)Mbp (C57BL/6N-Inmt^em1(IMPC)Mbp/MbpMmucd)	improved glucose tolerance	J:211773
Inpp5a^em1(IMPC)Tcp/Inpp5a⁺ (C57BL/6NCrl-Inpp5a^em1(IMPC)Tcp/Tcp)	edema	J:211773
Inpp5a^em1(IMPC)Tcp/Inpp5a^em1(IMPC)Tcp (C57BL/6NCrl-Inpp5a^em1(IMPC)Tcp/Tcp)	edema	J:211773
Inpp5b^tm1Nbm/Inpp5b^tm1Nbm Ocrl^tm1Nbm/Y Tg(INPP5B)CNbm/0 (involves: 129S/SvEv * 129S6/SvEvTac * FVB/N)	aminoaciduria	J:185879
	increased urine microglobulin level	J:185879
Inpp5b^tm1Nbm/Inpp5b^tm1Nbm Ocrl^tm1Nbm/Ocrl^tm1Nbm Tg(INPP5B)CNbm/0 (involves: 129S/SvEv * 129S6/SvEvTac * FVB/N)	aminoaciduria	J:185879
	increased urine microglobulin level	J:185879
Inpp5d^el20/Inpp5d^el20 (B6.129-Inpp5d^el20)	increased circulating interleukin-6 level	J:173266
Inpp5d^tm1Dmt/Inpp5d^tm1Dmt (involves: 129P2/OlaHsd * C57BL/6)	abnormal blood coagulation	J:121283
	abnormal platelet activation	J:121283
	decreased platelet aggregation	J:121283
	increased bleeding time	J:121283
Inpp5d^tm1Dmt/Inpp5d^tm1Dmt (B6.129P2/OlaHsd-Inpp5d^tm1Dmt)	increased circulating interleukin-6 level	J:173266
Inpp5d^tm1Rav/Inpp5d^tm1Rav Tg(Cd4-cre)1Cwi/? (involves: C57BL/6 * DBA/2)	abnormal interferon level	J:122796
Inpp5d^tm1Rkh/Inpp5d^tm1Rkh (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	abnormal interleukin level	J:173301
	increased circulating interleukin-6 level	J:117320
Inpp5d^tm1Rkh/Inpp5d^tm1Rkh (involves: 129S1/Sv * 129X1/SvJ)	increased circulating interleukin-6 level	J:78771
	pulmonary edema	J:100868
Inpp5e^{tm1.1(KOMP)Vlcg}/Inpp5e^{tm1.1(KOMP)Vlcg} (C57BL/6N-Inpp5e^{tm1.1(KOMP)Vlcg}/MbpMmucd)	edema	J:211773
Inpp5k^tm1Brd/Inpp5k⁺ (B6.Cg-Inpp5k^tm1Brd)	abnormal blood homeostasis	J:139745
	decreased cholesterol level	J:139745
	decreased circulating free fatty acids level	J:139745
	decreased circulating glucose level	J:139745
	decreased circulating insulin level	J:139745
	decreased circulating leptin level	J:139745
	decreased circulating triglyceride level	J:139745
	decreased susceptibility to diet-induced obesity	J:139745
	improved glucose tolerance	J:139745
	increased insulin sensitivity	J:139745
Inppl1^tm1Glas/Inppl1^tm1Glas (involves: C57BL/6J)	abnormal lipid homeostasis	J:96048
	decreased circulating cholesterol level	J:96048
	decreased circulating free fatty acids level	J:96048
	decreased circulating leptin level	J:96048
	decreased circulating triglyceride level	J:96048
	decreased susceptibility to diet-induced obesity	J:96048
Ins1^tm1Jja/Ins1^tm1Jja Ins2^tm1Jja/Ins2^tm1Jja (involves: 129S2/SvPas)	abnormal glucose homeostasis	J:77595, J:40377
	acidosis	J:40377
	increased circulating triglyceride level	J:40377
	increased urine glucose level	J:40377
Ins1^tm1Jja/Ins1^tm1Jja Ins2^tm1Jja/Ins2^tm1Jja Tg(Ins2Y16A)1Ell/0 (NOD.Cg-Ins1^tm1Jja Ins2^tm1Jja Tg(Ins2Y16A)1Ell)	increased circulating glucose level	J:98583
Ins1^tm1Jja/Ins1^tm1Jja Ins2^tm1Mnt/Ins2^tm1Mnt Tg(Aire-cre)1Mnt/0 (involves: 129S2/SvPas * 129S4/SvJaeSor * C57BL/6 * FVB/N)	abnormal circulating insulin level	J:152798
	hyperglycemia	J:152798
	increased circulating glucose level	J:152798
Ins1^tm1Jja/Ins1^tm1Jja Tg(Ins2Y16A)1Ell/0 (NOD.Cg-Ins1^tm1Jja Tg(Ins2Y16A)1Ell)	increased circulating glucose level	J:98583
Ins2^Akita/? (involves: C57BL/6NSlc)	abnormal glucose homeostasis	J:130021
	decreased circulating insulin level	J:130021
	decreased circulating triglyceride level	J:130021
	decreased liver triglyceride level	J:130021
	decreased respiratory quotient	J:130021
	decreased skeletal muscle triglyceride level	J:130021
	hyperglycemia	J:130021
	increased carbon dioxide production	J:130021
	increased energy expenditure	J:130021
	increased oxygen consumption	J:130021
	insulin resistance	J:130021
Ins2^Akita/Ins2⁺ (C57BL/6-Ins2^Akita)	decreased circulating insulin level	J:40063
	decreased insulin secretion	J:40063, J:47883
	hyperglycemia	J:40063, J:125256
	impaired glucose tolerance	J:40063
Ins2^Akita/Ins2⁺ (involves: C3H * C57BL/6NJcl * C57BL/6NSlc)	hyperglycemia	J:40063
	impaired glucose tolerance	J:40063
Ins2^Akita/Ins2⁺ (C57BL/6-Ins2^Akita/J)	hyperglycemia	J:99412, J:76224
Ins2^Akita/Ins2⁺ (C57BL/6-Ins2^Akita/J)	increased insulin sensitivity	J:76224
Ins2^Akita/Ins2⁺ (C.B6N-Ins2^Akita)	albuminuria	J:198186
Ins2^Akita/Ins2⁺ (involves: C57BL/6NSlc)	decreased circulating leptin level	J:200802
	decreased insulin secretion	J:200802
	increased circulating glucose level	J:200802
Ins2^Akita/Ins2⁺ Prf1^tm1Sdz/Prf1^tm1Sdz Rag1^tm1Mom/Rag1^tm1Mom (NOD.Cg-Rag1^tm1Mom Ins2^Akita Prf1^tm1Sdz)	abnormal glucose homeostasis	J:138005
	hyperglycemia	J:138005
Ins2^Akita/Ins2⁺ Rnf213^tm1.1Akoi/Rnf213^tm1.1Akoi (involves: C57BL/6N * C57BL/6NSlc)	decreased circulating leptin level	J:200802
	decreased insulin secretion	J:200802
	impaired glucose tolerance	J:200802
	increased circulating glucose level	J:200802
Ins2^Akita/Ins2^Akita (C57BL/6-Ins2^Akita)	decreased insulin secretion	J:47883
Ins2^Akita/Ins2^Akita (C57BL/6-Ins2^Akita)	hyperglycemia	J:47883
Ins2^Akita/Ins2^Akita (C57BL/6-Ins2^Akita/J)	hyperglycemia	J:76224
Ins2^Akita/Ins2^Akita (involves: C57BL/6NSlc)	decreased circulating insulin level	J:156725
	decreased insulin secretion	J:156725
	hyperglycemia	J:156725
Ins2^Akita/Ins2^Akita (C.B6N-Ins2^Akita)	albuminuria	J:198186
Ins2^Akita/Ins2^Akita (C.B6N-Ins2^Akita)	hyperglycemia	J:198186
Ins2^Akita/Ins2^Akita Itga1^tm1Gdnr/Itga1^tm1Gdnr (C.Cg-Ins2^Akita Itga1^tm1Gdnr)	albuminuria	J:198186
	hyperglycemia	J:198186
Ins2^Akita/Ins2^Akita Jazf1^{tm1c(EUCOMM)Wtsi}/Jazf1^{tm1c(EUCOMM)Wtsi} Tg(Ins2-cre)23Herr/0 (involves: 129S4/SvJaeSor * C57BL/6N * C57BL/6NSlc * CBA/J)	abnormal glucose homeostasis	J:303318
	increased circulating glucose level	J:303318
Ins2^Akita/Ins2^Akita Ldlr^tm1Her/Ldlr^tm1Her (B6.Cg-Ins2^Akita Ldlr^tm1Her)	decreased circulating insulin level	J:174983
	hyperglycemia	J:174983
	impaired glucose tolerance	J:174983
	increased circulating cholesterol level	J:174983
	increased circulating HDL cholesterol level	J:174983
	increased circulating LDL cholesterol level	J:174983
	increased circulating triglyceride level	J:174983
	increased circulating VLDL cholesterol level	J:174983
Ins2^Akita/Ins2^Akita Rpl13a^tm1.1Jesc/Rpl13a^tm1.1Jesc (FVB.Cg-Rpl13a^tm1.1Jesc Ins2^Akita)	abnormal circulating glucose level	J:237822
Ins2^C95S/Ins2⁺ (C3HeB/FeJ-Ins2^C95S)	decreased circulating insulin level	J:122098
	decreased insulin secretion	J:122098
	hyperglycemia	J:122098, J:137483
	increased circulating glucose level	J:122098
	increased urine glucose level	J:122098
	insulin resistance	J:122098
Ins2^C95S/Ins2^C95S (C3HeB/FeJ-Ins2^C95S)	increased circulating glucose level	J:122098
Ins2^C95S/Ins2^C95S (C3HeB/FeJ-Ins2^C95S)	increased urine glucose level	J:122098
Ins2^em#Arak/Ins2⁺ (C.129-Rag2^tm1Fwa Ins2^em#Arak Jak3^tm1Tks/Arak)	abnormal homeostasis	J:294041
	hyperglycemia	J:294041
	impaired glucose tolerance	J:294041
Ins2^tm1Delt/Ins2⁺ (involves: 129S2/SvPas * Black Swiss)	dehydration	J:94589
	increased circulating ketone body level	J:94589
	increased urine glucose level	J:94589
Ins2^tm1Jja/Ins2^tm1Jja (involves: 129S2/SvPas)	increased insulin secretion	J:77595
Ins2^tm1Jja/Ins2^tm1Jja (NOD.129S2-Ins2^tm1Jja)	abnormal glucose homeostasis	J:85309
Insig1^{em1(IMPC)Ccpcz}/Insig1^{em1(IMPC)Ccpcz} (C57BL/6N-Insig1^{em1(IMPC)Ccpcz}/Ccpcz)	abnormal cholesterol homeostasis	J:211773
	decreased circulating chloride level	J:211773
	impaired glucose tolerance	J:211773
	increased fasting circulating glucose level	J:211773
Insig1^tm1.1Aztc/Insig1^tm1.1Aztc (Not Specified)	decreased circulating triglyceride level	J:208931
Insig1^tm1Mbjg/Insig1^tm1Mbjg Insig2^tm1Mbjg/Insig2^tm1Mbjg Tg(Mx1-cre)29-4Her/0 (involves: 129S6/SvEvTac * C57BL/6J * C57BL/6NCrl * SJL)	abnormal cholesterol homeostasis	J:101203
	abnormal lipid homeostasis	J:101203
	decreased circulating triglyceride level	J:101203
	increased circulating cholesterol level	J:101203
	increased fatty acids level	J:101203
	increased liver cholesterol level	J:101203
	increased liver triglyceride level	J:101203
Insl5^tm1Imad/Insl5^tm1Imad (129(B6)-Insl5^tm1Imad)	decreased circulating insulin level	J:189146
	hyperglycemia	J:189146
	impaired glucose tolerance	J:189146
Insm1^tm1Cbm/Insm1^tm1Cbm (involves: 129P2/OlaHsd * C57BL/6 * CD-1)	cyanosis	J:112173
Insm1^tm1Cbm/Insm1^tm1Cbm (involves: 129P2/OlaHsd * C57BL/6)	cyanosis	J:112173
Insm1^tm1Cbm/Insm1^tm1Cbm (involves: 129P2/OlaHsd)	decreased adrenocorticotropin level	J:206319
	decreased follicle stimulating hormone level	J:206319
	decreased growth hormone level	J:206319
	decreased luteinizing hormone level	J:206319
	decreased pituitary hormone level	J:206319
	decreased prolactin level	J:206319
	decreased thyroid-stimulating hormone level	J:206319
Insm1^tm1Cbm/Insm1^tm2.1Cbm (involves: 129P2/OlaHsd * 129S1/Sv * 129X1/SvJ)	decreased adrenocorticotropin level	J:206319
	decreased follicle stimulating hormone level	J:206319
	decreased growth hormone level	J:206319
	decreased luteinizing hormone level	J:206319
	decreased pituitary hormone level	J:206319
	decreased prolactin level	J:206319
	decreased thyroid-stimulating hormone level	J:206319
Insm2^em1Tcai/Insm2^em1Tcai (involves: C57BL/6J)	abnormal blood homeostasis	J:334013
	decreased circulating insulin level	J:334013
	impaired glucose tolerance	J:334013
	increased fasting circulating glucose level	J:334013
Insq2^SM/J/? (involves: A/J * SM/J)	increased circulating insulin level	J:64138
Insq3^SM/J/? (involves: A/J * SM/J)	increased circulating insulin level	J:64138
Insq4^SM/J/? (involves: A/J * SM/J)	increased circulating insulin level	J:64138
Insq5^SM/J/? (involves: A/J * SM/J)	decreased circulating insulin level	J:64138
Insq6^C57BL/6/? (involves: 129S6.129S4(B6)-Insr^tm1Dac * C57BL/6)	increased circulating insulin level	J:61489
Insq7^C57BL/6/? (involves: 129S6.129S4(B6)-Insr^tm1Dac * C57BL/6)	increased circulating insulin level	J:61489
Insq8^C57BL/6/? (involves: 129S6.129S4(B6)-Insr^tm1Dac * C57BL/6)	increased circulating insulin level	J:61489
Insq9^C57BL/6/? (involves: 129S6.129S4(B6)-Insr^tm1Dac * C57BL/6)	increased circulating insulin level	J:61489
Insq10^129/SvIr/? (involves: 129S6.129S4(B6)-Insr^tm1Dac * C57BL/6)	increased circulating insulin level	J:61489
Insr^M2Btlr/Insr^M2Btlr (C57BL/6J-Insr^M2Btlr)	increased insulin secretion	J:267535
Insr^Rgsc294/Insr⁺ (involves: C57BL/6JJcl * DBA/2JJcl)	hyperglycemia	J:133634
	increased circulating insulin level	J:133634
	increased urine glucose level	J:133634
Insr^Rgsc824/Insr⁺ (involves: C57BL/6JJcl * DBA/2JJcl)	hyperglycemia	J:133634
	increased circulating insulin level	J:133634
	increased glycosylated hemoglobin level	J:133634
	increased urine glucose level	J:133634
Insr^Rgsc1777/Insr⁺ (involves: C3H * C57BL/6JJcl)	hyperglycemia	J:133634
Insr^Rgsc1777/Insr⁺ (involves: C3H * C57BL/6JJcl)	increased circulating insulin level	J:133634
Insr^tm1Dac/Insr⁺ (involves: 129 * C57BL/6J)	increased circulating insulin level	J:135659
Insr^tm1Dac/Insr⁺ (involves: 129 * C57BL/6J)	insulin resistance	J:135659
Insr^tm1Dac/Insr⁺ (involves: C3H/HeH * C57BL/6)	increased circulating insulin level	J:141688
Insr^tm1Dac/Insr⁺ (involves: C3H/HeH * C57BL/6)	increased insulin secretion	J:141688
Insr^tm1Dac/Insr⁺ (B6.129S4-Insr^tm1Dac/J)	increased circulating insulin level	J:246319
Insr^tm1Dac/Insr⁺ (B6.129S4-Insr^tm1Dac/J)	insulin resistance	J:246319
Insr^tm1Dac/Insr⁺ Irs2^tm1Mfw/Irs2^tm1Mfw (involves: 129S1/Sv * 129S4/SvJae * 129X1/SvJ * C57BL/6)	abnormal glucose homeostasis	J:80826
Insr^tm1Dac/Insr⁺ Ppp2r2a^igt10/Ppp2r2a⁺ (involves: 129S4/SvJae * C3H/HeH * C57BL/6J)	hyperglycemia	J:246319
	impaired glucose tolerance	J:246319
	increased circulating insulin level	J:246319
	increased urine glucose level	J:246319
	insulin resistance	J:246319
Insr^tm1Dac/Insr⁺ Sox4^Igt4/Sox4⁺ (involves: C3H/HeH * C57BL/6)	impaired glucose tolerance	J:141688
Insr^tm1Dac/Insr^tm1Dac (involves: 129S4/SvJae * C57BL/6)	abnormal glucose homeostasis	J:79560
	hyperglycemia	J:33408
	increased circulating insulin level	J:33408
	ketoaciduria	J:33408
Insr^tm1Dac/Insr^tm1Dac Insrr^tm1Dac/Insrr^tm1Dac (involves: 129S1/Sv * 129S4/SvJae * C57BL/6J)	hyperglycemia	J:70602
	impaired glucose tolerance	J:70602
	increased circulating insulin level	J:70602
	ketoaciduria	J:70602
Insr^tm1Dac/Insr^tm1Dac Tg(TTR-INSR)L1Dac/0 (involves: 129S4/SvJae * C57BL/6 * FVB)	increased circulating glucose level	J:91350
	increased circulating insulin level	J:91350
	increased energy expenditure	J:91350
Insr^tm1Dac/Insr^tm1Dac Tg(TTR-INSR)L2Dac/0 (involves: 129S4/SvJae * C57BL/6 * FVB)	decreased liver glycogen level	J:91350
	increased circulating glucose level	J:91350
	increased circulating insulin level	J:91350
Insr^tm1Dac/Insr^tm1Dac Tg(TTR-INSR)L3Dac/0 (involves: 129S4/SvJae * C57BL/6 * FVB)	decreased liver glycogen level	J:91350
	hyperglycemia	J:91350
	increased circulating glucose level	J:91350
	increased circulating insulin level	J:91350
Insr^tm1Jja/Insr^tm1Jja (involves: 129S2/SvPas * C57BL/6 * DBA/2)	decreased liver glycogen level	J:32538
	hyperglycemia	J:32538
	increased circulating free fatty acids level	J:32538
	increased circulating insulin level	J:32538
	increased circulating triglyceride level	J:32538
	increased urine glucose level	J:32538
	ketoaciduria	J:32538, J:80773
Insr^tm1Jja/Insr^tm1Jja Tg(PAH-INSR)1Rjv/0 (involves: 129S2/SvPas * C57BL/6 * CBA * DBA/2)	decreased liver glycogen level	J:80773
	increased circulating glucose level	J:80773
	increased triglyceride level	J:80773
	increased urine glucose level	J:80773
	ketoaciduria	J:80773
Insr^tm1Khn/Insr^tm1Dac Tg(Ckmm-cre)5Khn/0 (involves: 129S4/SvJae * C57BL/6J * FVB)	hyperglycemia	J:51266
	increased circulating insulin level	J:51266
Insr^tm1Khn/Insr^tm1Khn Lepr^tm1.1Chua/Lepr^tm1.1Chua Tg(Pomc1-cre)16Lowl/0 (involves: 129 * 129S4/SvJae * 129S6/SvEvTac * C57BL/6J * FVB/N)	hyperglycemia	J:192274
	increased circulating leptin level	J:192274
Insr^tm1Khn/Insr^tm1Khn Speer6-ps1^{Tg(Alb-cre)21Mgn}/Speer6-ps1⁺ (involves: 129S4/SvJae * C57BL/6J * DBA/2 * FVB)	abnormal circulating serum albumin level	J:63878
	abnormal glucose homeostasis	J:63878
	abnormal insulin clearance	J:63878
	abnormal lipid homeostasis	J:63878
	decreased circulating free fatty acids level	J:63878
	decreased circulating triglyceride level	J:63878
	hyperglycemia	J:63878
	impaired glucose tolerance	J:63878
	increased bile salt level	J:92861
	increased circulating alkaline phosphatase level	J:63878
	increased circulating aspartate transaminase level	J:63878
	increased circulating insulin level	J:63878
	increased insulin secretion	J:63878
	insulin resistance	J:63878
Insr^tm1Khn/Insr^tm1Khn Speer6-ps1^{Tg(Alb-cre)21Mgn}/Speer6-ps1⁺ (involves: 129S4/SvJae * C57BL/6 * DBA/2)	decreased circulating glucose level	J:121640
	hyperglycemia	J:121640
	impaired glucose tolerance	J:121640
	increased circulating insulin level	J:121640
	insulin resistance	J:121640
Insr^tm1Khn/Insr^tm1Khn Speer6-ps1^{Tg(Alb-cre)21Mgn}/Speer6-ps1⁺ (involves: 129S4/SvJae * C57BL/6 * C57BL/6J)	decreased liver glycogen level	J:234643
	hyperglycemia	J:234643
	impaired glucose tolerance	J:234643
	increased circulating insulin level	J:234643
	insulin resistance	J:234643
Insr^tm1Khn/Insr^tm1Khn Speer6-ps1^{Tg(Alb-cre)21Mgn}/Speer6-ps1⁺ Tg(Ins2-cre)25Mgn/0 (involves: 129S4/SvJae * C57BL/6 * DBA/2)	decreased insulin secretion	J:121640
	hyperglycemia	J:121640
	impaired glucose tolerance	J:121640
	increased circulating insulin level	J:121640
	insulin resistance	J:121640
Insr^tm1Khn/Insr^tm1Khn Tg(Ckmm-cre)5Khn/0 (involves: 129S4/SvJae * C57BL/6J * FVB)	increased fatty acids level	J:51266
	increased triglyceride level	J:51266
Insr^tm1Khn/Insr^tm1Khn Tg(Ins2-cre)25Mgn/0 (involves: 129S4/SvJae * C57BL/6 * DBA/2)	decreased insulin secretion	J:121640
	hyperglycemia	J:121640
	impaired glucose tolerance	J:121640
Insr^tm1Khn/Insr^tm1Khn Tg(Myhca-cre)1Abel/0 (involves: 129S4/SvJae * FVB)	abnormal glucose homeostasis	J:75348
	abnormal lipid homeostasis	J:75348
	increased cardiac muscle glycogen level	J:75348
Insr^tm1Khn/Insr^tm1Khn Tg(Nes-cre)1Kln/0 (involves: 129S4/SvJae * C57BL/6J * SJL)	decreased circulating luteinizing hormone level	J:64790
	increased circulating insulin level	J:64790
	increased circulating leptin level	J:64790
	increased circulating triglyceride level	J:64790
	insulin resistance	J:64790
Insr^tm1Khn/Insr^tm1Khn Tg(Nes-cre)1Kln/0 (involves: 129S4/SvJae * C57BL/6 * SJL)	abnormal glucose homeostasis	J:109359
Insr^tm1Khn/Insr^tm1Khn Tg(Pdgfrb-cre)#Rha/0 (involves: 129S4/SvJae * C57BL/6J)	increased circulating insulin level	J:327000
Insr^tm1Khn/Insr^tm1Khn Tg(Slc2a4-cre)546Dac/0 (involves: 129S4/SvJaeSor * C57BL/6 * FVB)	abnormal glucose homeostasis	J:169404
	decreased liver glycogen level	J:169404
	hyperglycemia	J:169404
	impaired glucose tolerance	J:169404
	increased circulating free fatty acids level	J:169404
	increased circulating glucose level	J:169404
	increased circulating insulin level	J:169404
	increased oxygen consumption	J:169404
	insulin resistance	J:169404
Insr^tm1Shs/Insr⁺ (involves: C57BL/6CrSlc)	hyperglycemia	J:98723
	impaired glucose tolerance	J:98723
	increased circulating insulin level	J:98723
	increased insulin sensitivity	J:98723
	insulin resistance	J:98723
Insr^tm1Shs/Insr^tm1Shs (involves: C57BL/6CrSlc)	ketoacidosis	J:98723
Insyn2b^em1(IMPC)J/Insyn2b^em1(IMPC)J (C57BL/6NJ-Insyn2b^em1(IMPC)J/Mmjax)	decreased circulating phosphate level	J:211773
	increased circulating alanine transaminase level	J:211773
	increased circulating glucose level	J:211773
Ints9^{tm1b(KOMP)Wtsi}/Ints9⁺ (C57BL/6N-Ints9^{tm1b(KOMP)Wtsi}/Wtsi)	increased blood urea nitrogen level	J:211773
	increased circulating amylase level	J:211773
Ints10^{tm1b(KOMP)Wtsi}/Ints10⁺ (C57BL/6N-Ints10^{tm1b(KOMP)Wtsi}/J)	decreased circulating creatinine level	J:211773
Ints12^{tm1a(EUCOMM)Wtsi}/Ints12⁺ (B6JTyr;B6N-Ints12^{tm1a(EUCOMM)Wtsi}/Wtsi)	increased circulating magnesium level	J:175295
Ints12^{tm1b(EUCOMM)Wtsi}/Ints12⁺ (C57BL/6N-Ints12^{tm1b(EUCOMM)Wtsi}/H)	increased circulating triglyceride level	J:211773
Intu^tm1.2Aliu/Intu^tm1.2Aliu (involves: 129P2/OlaHsd * 129S4/SvJae * C3H)	edema	J:159120
	pericardial edema	J:159120
Invs^em1(IMPC)Bay/Invs^em1(IMPC)Bay (C57BL/6N-Invs^em1(IMPC)Bay/BayMmucd)	edema	J:211773
Invs^inv/Invs^inv (involves: FVB/N)	increased blood urea nitrogen level	J:132552
Ip6k1^em1Seyk/Ip6k1^em1Seyk (C57BL/6-Ip6k1^em1Seyk)	abnormal protein level	J:306957
Ip6k1^{Gt(OST137568)Lex}/Ip6k1^{Gt(OST137568)Lex} (involves: 129S5/SvEvBrd * C57BL/6J)	decreased circulating insulin level	J:103485
	impaired glucose tolerance	J:103485
Ip6k1^tm1.1Snyd/Ip6k1^tm1.1Snyd (involves: 129X1/SvJ * BALB/c * C57BL/6)	decreased circulating insulin level	J:132167
	increased insulin sensitivity	J:132167
Ipo7^em1(IMPC)Mbp/Ipo7⁺ (C57BL/6N-Ipo7^em1(IMPC)Mbp/Ucd)	increased circulating insulin level	J:211773
	increased circulating phosphate level	J:211773
	increased circulating triglyceride level	J:211773
Ipo9^em1(IMPC)Bay/Ipo9^em1(IMPC)Bay (C57BL/6N-Ipo9^em1(IMPC)Bay/BayMmucd)	edema	J:211773
Ipo11^{tm1.1(KOMP)Vlcg}/Ipo11⁺ (C57BL/6N-Ipo11^{tm1.1(KOMP)Vlcg}/J)	decreased circulating glucose level	J:211773
	decreased circulating iron level	J:211773
	increased fasting circulating glucose level	J:211773
Ipp^{tm1.1(KOMP)Vlcg}/Ipp^{tm1.1(KOMP)Vlcg} (C57BL/6N-Ipp^{tm1.1(KOMP)Vlcg}/J)	decreased circulating chloride level	J:211773
	decreased circulating glucose level	J:211773
	increased circulating alkaline phosphatase level	J:211773
Iqce^{tm1b(EUCOMM)Hmgu}/Iqce^{tm1b(EUCOMM)Hmgu} (C57BL/6N-Iqce^{tm1b(EUCOMM)Hmgu}/Ics)	decreased circulating glucose level	J:211773
	decreased circulating serum albumin level	J:211773
	increased circulating phosphate level	J:211773
Iqcf1^em1(IMPC)J/Iqcf1^em1(IMPC)J (C57BL/6NJ-Iqcf1^em1(IMPC)J/Mmjax)	impaired glucose tolerance	J:211773
Iqgap2^tm1Vs/Iqgap2^tm1Vs (either: 129S4/SvJae-Iqgap2^tm1Vs or B6.129S4-Iqgap2^tm1Vs)	increased circulating aspartate transaminase level	J:132670
Iqsec3^{tm3b(KOMP)Wtsi}/Iqsec3^{tm3b(KOMP)Wtsi} (C57BL/6N-Iqsec3^{tm3b(KOMP)Wtsi}/Bay)	impaired glucose tolerance	J:211773
	increased fasting circulating glucose level	J:211773
Irag1^{em1(IMPC)Ccpcz}/Irag1^{em1(IMPC)Ccpcz} (C57BL/6NCrl-Irag1^{em1(IMPC)Ccpcz}/Ccpcz)	increased circulating aspartate transaminase level	J:211773
	increased circulating creatinine level	J:211773
	increased circulating glucose level	J:211773
	increased circulating phosphate level	J:211773
	increased circulating triglyceride level	J:211773
	increased fasting circulating glucose level	J:211773
Irak1^{tm1b(EUCOMM)Hmgu}/Y (C57BL/6N-Irak1^{tm1b(EUCOMM)Hmgu}/Wtsi)	increased circulating fructosamine level	J:211773
Irak2^{tm1b(EUCOMM)Wtsi}/Irak2^{tm1b(EUCOMM)Wtsi} (C57BL/6N-Irak2^{tm1b(EUCOMM)Wtsi}/H)	increased circulating alkaline phosphatase level	J:211773
Irak2^tm1Jth/Irak2^tm1Jth (involves: 129 * C57BL/6)	abnormal chemokine level	J:149258
	decreased circulating interleukin-6 level	J:149258
	decreased circulating tumor necrosis factor level	J:149258
Irak3^tm1Flv/Irak3^tm1Flv (NOD.129S1(B6)-Irak3^tm1Flv)	impaired glucose tolerance	J:229884
Irak4^tm1Lix/Irak4^tm1Lix (involves: C57BL/6)	decreased circulating interleukin-6 level	J:125732
Irak4^tm1Lix/Irak4^tm1Lix (involves: C57BL/6)	decreased circulating tumor necrosis factor level	J:125732
Irak4^tm1Yeh/Irak4^tm1Yeh (involves: 129P2/OlaHsd * C57BL/6J)	abnormal cytokine level	J:76098
	decreased circulating interferon-gamma level	J:76098
	decreased circulating interleukin-1 level	J:76098
	decreased circulating interleukin-6 level	J:76098
	decreased circulating tumor necrosis factor level	J:76098
Ireb2^tm1.1Eal/Ireb2^tm1.1Eal (B6J.129-Ireb2^tm1.1Eal)	abnormal iron homeostasis	J:217335
	abnormal iron level	J:217335
	decreased brain iron level	J:217335
	decreased heart iron level	J:217335
	increased brain iron level	J:217335
	increased circulating ferritin level	J:217335
	increased intestinal iron level	J:217335
	increased kidney iron level	J:217335
	increased liver iron level	J:217335
	increased porphyrin level	J:217335
	porphyria	J:217335
Ireb2^tm1.2Mwh/Ireb2^tm1.2Mwh (involves: 129P2/OlaHsd * BALB/c * C57BL/6 * SJL)	abnormal iron homeostasis	J:103414
	decreased spleen iron level	J:103414
	increased intestinal iron level	J:103414
	increased liver iron level	J:103414
Ireb2^tm1Mwh/Ireb2^tm1Mwh (involves: 129P2/OlaHsd * C57BL/6J)	abnormal iron homeostasis	J:105124
	decreased spleen iron level	J:105124
	increased intestinal iron level	J:105124
	increased liver iron level	J:105124
Ireb2^tm1Roua/Ireb2^tm1Roua (involves: C57BL/6)	abnormal iron homeostasis	J:87889
	increased brain iron level	J:67313
	increased circulating ferritin level	J:67313
	increased intestinal iron level	J:67313
	increased liver iron level	J:67313
Ireb2^tm1Roua/Ireb2^tm1Roua (B6.Cg-Ireb2^tm1Roua)	decreased spleen iron level	J:176655
Ireb2^tm1Roua/Ireb2^tm1Roua (B6.Cg-Ireb2^tm1Roua)	increased liver iron level	J:176655
Irf1^tm1Cwe/Irf1^tm1Cwe (involves: 129/Sv * C57BL/6)	abnormal cytokine level	J:110672
	decreased circulating interleukin-2 level	J:110672
	increased circulating interferon-gamma level	J:110672
	increased circulating interleukin-3 level	J:110672
	increased circulating interleukin-4 level	J:110672
	increased circulating interleukin-5 level	J:110672
	increased circulating interleukin-6 level	J:110672
Irf1^tm1Cwe/Irf1^tm1Cwe (involves: 129)	abnormal circulating interleukin-4 level	J:84367
	abnormal circulating interleukin-10 level	J:84367
	abnormal cytokine level	J:84367
	decreased circulating interferon-gamma level	J:84367
	increased circulating interleukin-5 level	J:84367
	increased circulating interleukin-6 level	J:84367
	increased circulating interleukin-13 level	J:84367
Irf1^tm1Mak/Irf1^tm1Mak (B6.129S2-Irf1^tm1Mak/J)	abnormal circulating alanine transaminase level	J:111090
Irf3^em1(IMPC)Mbp/Irf3^em1(IMPC)Mbp (C57BL/6N-Irf3^em1(IMPC)Mbp/MbpMmucd)	increased circulating alkaline phosphatase level	J:211773
	increased circulating phosphate level	J:211773
Irf3^tm1Ttg/Irf3^tm1Ttg (involves: 129S/SvEv * C57BL/6J)	abnormal circulating interferon level	J:98127
Irf4^tm1Rdf/Irf4^tm1Rdf Tg(Ucp1-cre)1Evdr/0 (involves: 129S1/Sv * C57BL/6J * FVB)	decreased carbon dioxide production	J:214637
	decreased core body temperature	J:214637
	decreased fatty acid oxidation	J:214637
	decreased oxygen consumption	J:214637
	impaired adaptive thermogenesis	J:214637
	impaired glucose tolerance	J:214637
	impaired lipolysis	J:214637
	insulin resistance	J:214637
Irf5^tm1Ttg/Irf5^tm1Ttg (involves: 129P2/OlaHsd * C57BL/6)	decreased circulating interleukin-6 level	J:97567
	decreased circulating interleukin-12b level	J:97567
	decreased circulating tumor necrosis factor level	J:97567
Irf6^{em1(IMPC)Wtsi}/Irf6^{em1(IMPC)Wtsi} (C57BL/6N-Irf6^{em1(IMPC)Wtsi}/Wtsi)	increased circulating aspartate transaminase level	J:211773
	increased circulating creatine kinase level	J:211773
	increased circulating creatinine level	J:211773
Irf7^M2Btlr/Irf7⁺ (C57BL/6J-Irf7^M2Btlr)	decreased circulating interferon-beta level	J:217798
Irf7^M2Btlr/Irf7^M2Btlr (C57BL/6J-Irf7^M2Btlr)	decreased circulating interferon-beta level	J:217798
Irf7^tm1Ttg/Irf7^tm1Ttg (involves: 129P2/OlaHsd)	abnormal interferon level	J:97662
Irf8^{tm1b(KOMP)Wtsi}/Irf8^{tm1b(KOMP)Wtsi} (C57BL/6N-Irf8^{tm1b(KOMP)Wtsi}/J)	decreased circulating free fatty acids level	J:211773
	decreased fasting circulating glucose level	J:211773
	increased circulating sodium level	J:211773
	increased circulating total protein level	J:211773
Irf9^M1Btlr/Irf9⁺ (C57BL/6J-Irf9^M1Btlr)	increased circulating interferon-beta level	J:236674
Irf9^M1Btlr/Irf9^M1Btlr (C57BL/6J-Irf9^M1Btlr)	increased circulating interferon-beta level	J:236674
Irgm1^{em1(IMPC)Wtsi}/Irgm1^{em1(IMPC)Wtsi} (C57BL/6N-Irgm1^{em1(IMPC)Wtsi}/Wtsi)	decreased circulating fructosamine level	J:211773
	decreased circulating glucose level	J:211773
	decreased circulating serum albumin level	J:211773
	decreased fasting circulating glucose level	J:211773
	improved glucose tolerance	J:211773
	increased circulating alkaline phosphatase level	J:211773
	increased circulating aspartate transaminase level	J:211773
	increased circulating cholesterol level	J:211773
	increased circulating LDL cholesterol level	J:211773
Irgm1^tm1Gat/Irgm1^tm1Gat (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	increased circulating interferon-gamma level	J:87535
	increased circulating interleukin-12 level	J:87535
Irgm2^em1(IMPC)J/Irgm2^em1(IMPC)J (C57BL/6NJ-Irgm2^em1(IMPC)J/J)	decreased circulating serum albumin level	J:211773
Irs1^m1Btlr/Irs1^m1Btlr (C57BL/6J-Irs1^m1Btlr)	increased circulating insulin level	J:267531
Irs1^Sml/Irs1⁺ (C3.Cg-Irs1^Sml H2^b/GrsrJ)	increased circulating insulin level	J:163661
Irs1^Sml/Irs1^Sml (C3.Cg-Irs1^Sml H2^b/GrsrJ)	decreased circulating glucose level	J:163661
	impaired glucose tolerance	J:163661
	increased circulating insulin level	J:163661
	insulin resistance	J:163661
Irs1^tm1Jos/Irs1⁺ Irs2^tm2Mfw/Irs2^tm2Mfw Tg(Ins2-cre)25Mgn/0 (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	decreased circulating insulin level	J:93415
	hyperglycemia	J:93415
Irs1^tm1Jos/Irs1^tm1Jos (involves: 129S2/SvPas * C57BL/6)	impaired glucose tolerance	J:21374
	increased circulating insulin level	J:21374
	insulin resistance	J:21374
Irs1^tm1Jos/Irs1^tm1Jos Irs3^tm1Lhd/Irs3^tm1Lhd (involves: 129S2/SvPas * 129S4/SvJae * C57BL/6)	decreased circulating free fatty acids level	J:80976
	decreased circulating leptin level	J:80976
	decreased circulating triglyceride level	J:80976
	decreased triglyceride level	J:80976
	hyperglycemia	J:80976
	impaired glucose tolerance	J:80976
	increased circulating insulin level	J:80976
	insulin resistance	J:80976
Irs1^tm1Jos/Irs1^tm1Jos Irs4^tm1Lhd/Y (involves: 129S2/SvPas * 129S4/SvJae * C57BL/6)	impaired glucose tolerance	J:80976
	increased circulating insulin level	J:80976
	insulin resistance	J:80976
Irs1^tm1Jos/Irs1^tm1Jos Irs4^tm1Lhd/Irs4^tm1Lhd (involves: 129S2/SvPas * 129S4/SvJae * C57BL/6)	impaired glucose tolerance	J:80976
	increased circulating insulin level	J:80976
	insulin resistance	J:80976
Irs1^tm1Mfw/Irs1⁺ Irs2^tm2Mfw/Irs2^tm2Mfw Speer6-ps1^{Tg(Alb-cre)21Mgn}/Speer6-ps1⁺ (involves: 129S1/Sv * 129X1/SvJ * C57BL/6J * DBA * FVB/N)	impaired glucose tolerance	J:156999
Irs1^tm1Mfw/Irs1^tm1Mfw Irs2^tm2Mfw/Irs2^tm2Mfw Speer6-ps1^{Tg(Alb-cre)21Mgn}/Speer6-ps1⁺ (involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * DBA)	abnormal triglyceride level	J:137845
	decreased circulating cholesterol level	J:137845
	decreased circulating free fatty acids level	J:137845
	decreased circulating HDL cholesterol level	J:137845
	decreased circulating triglyceride level	J:137845
	decreased liver glycogen level	J:137845
	hyperglycemia	J:137845
	impaired glucose tolerance	J:137845
	increased circulating glucose level	J:137845
	increased circulating insulin level	J:137845
	insulin resistance	J:137845
Irs1^tm1Mfw/Irs1^tm1Mfw Speer6-ps1^{Tg(Alb-cre)21Mgn}/Speer6-ps1⁺ (involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * DBA)	impaired glucose tolerance	J:137845
Irs1^tm1Mfw/Irs1^tm2.1Mfw Irs2^tm2Mfw/Irs2^tm2Mfw Speer6-ps1^{Tg(Alb-cre)21Mgn}/Speer6-ps1⁺ (involves: 129S1/Sv * 129X1/SvJ * C57BL/6J * DBA * FVB/N)	impaired glucose tolerance	J:156999
	increased circulating insulin level	J:156999
	insulin resistance	J:156999
Irs1^tm1Tka/Irs1^tm1Tka (Not Specified)	abnormal glucose homeostasis	J:21373
	increased circulating insulin level	J:21373
	insulin resistance	J:21373
Irs1^tm1Tka/Irs1^tm1Tka (involves: C57BL/6 * CBA)	abnormal lipid level	J:47029
	decreased circulating HDL cholesterol level	J:47029
	decreased insulin secretion	J:65485
	impaired lipolysis	J:47029
	increased circulating free fatty acids level	J:99746
	increased circulating insulin level	J:61479
	increased circulating triglyceride level	J:47029, J:99746
	insulin resistance	J:99746
Irs1^tm2.1Mfw/Irs1⁺ (involves: 129S1/Sv * 129X1/SvJ * C57BL/6J * FVB/N)	increased circulating insulin level	J:156999
Irs1^tm2.1Mfw/Irs1^tm2.1Mfw (involves: 129S1/Sv * 129X1/SvJ * C57BL/6J * FVB/N)	impaired glucose tolerance	J:156999
	increased circulating insulin level	J:156999
	insulin resistance	J:156999
Irs1^tm2.1Mfw/Irs1^tm2.1Mfw Irs2^tm2Mfw/Irs2^tm2Mfw Speer6-ps1^{Tg(Alb-cre)21Mgn}/Speer6-ps1⁺ (involves: 129S1/Sv * 129X1/SvJ * C57BL/6J * DBA * FVB/N)	impaired glucose tolerance	J:156999
	increased circulating insulin level	J:156999
Irs1^tm2Tka/Irs1^tm2Tka Irs2^tm2Tka/Irs2^tm2Tka Speer6-ps1^{Tg(Alb-cre)21Mgn}/Speer6-ps1⁺ (involves: 129P2/OlaHsd * 129S4/SvJae * C57BL/6 * DBA)	insulin resistance	J:137846
Irs1^tm2Tka/Irs1^tm2Tka Speer6-ps1^{Tg(Alb-cre)21Mgn}/Speer6-ps1⁺ (involves: 129P2/OlaHsd * C57BL/6 * DBA)	increased circulating insulin level	J:137846
	insulin resistance	J:137846
Irs2^M1Btlr/Irs2^M1Btlr (C57BL/6J-Irs2^M1Btlr)	hyperglycemia	J:267533
Irs2^M1Btlr/Irs2^M1Btlr (C57BL/6J-Irs2^M1Btlr)	increased insulin secretion	J:267533
Irs2^tm1Mfw/Irs2^tm1Mfw (involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)	abnormal circulating glucose level	J:74303
	abnormal circulating hormone level	J:64791
	abnormal circulating insulin level	J:94000
	abnormal energy homeostasis	J:64791
	abnormal glucose homeostasis	J:64791, J:74303
	abnormal lipid homeostasis	J:96047
	decreased circulating estradiol level	J:64791
	decreased circulating luteinizing hormone level	J:64791
	decreased circulating progesterone level	J:64791
	decreased circulating prolactin level	J:64791
	decreased circulating testosterone level	J:64791
	decreased skeletal muscle glycogen level	J:74303
	hyperglycemia	J:135659, J:94000, J:96047, J:46134
	impaired glucose tolerance	J:64791, J:46134
	increased circulating insulin level	J:135659, J:46134
	increased circulating leptin level	J:64791
	insulin resistance	J:135659, J:46134
Irs2^tm1Mfw/Irs2^tm1Mfw Ptpn1^tm1Bbk/Ptpn1^tm1Bbk (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	hyperglycemia	J:87249
	impaired glucose tolerance	J:87249
	increased insulin sensitivity	J:87249
Irs2^tm1Mfw/Irs2^tm1Mfw Tg(Ins2-Irs2)13Mfw/0 (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	increased circulating insulin level	J:94000
Irs2^tm1Tka/Irs2^tm1Tka (involves: C57BL/6 * CBA)	hyperglycemia	J:99746
	impaired glucose tolerance	J:65485
	increased circulating cholesterol level	J:99746
	increased circulating free fatty acids level	J:99746
	increased circulating HDL cholesterol level	J:99746
	increased circulating insulin level	J:65485
	increased circulating triglyceride level	J:99746
	increased insulin secretion	J:65485
	insulin resistance	J:65485, J:99746
Irs2^tm1With/Irs2^tm1With Tg(Ins2-cre)25Mgn/0 (involves: 129S6/SvEvTac * C57BL/6J)	impaired glucose tolerance	J:97406
	increased circulating glucose level	J:97406
	increased circulating insulin level	J:97406
	increased circulating leptin level	J:97406
Irs2^tm1With/Irs2^tm1With Tg(Nes-cre)1Kln/0 (involves: 129S6/SvEvTac * C57BL/6J)	impaired glucose tolerance	J:97406
	increased circulating glucose level	J:97406
	increased circulating insulin level	J:97406
	increased circulating leptin level	J:97406
Irs2^tm1With/Irs2^tm1With Tg(Nes-cre)1Kln/? (involves: 129S6/SvEvTac * C57BL/6 * SJL)	abnormal prolactin level	J:122064
Irs2^tm2Mfw/Irs2^tm2Mfw Irs4^tm1.1Mfw/Y Tg(Nes-cre)1Kln/? (involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * SJL)	abnormal glucose homeostasis	J:221293
	decreased oxygen consumption	J:221293
	impaired glucose tolerance	J:221293
	increased circulating glucose level	J:221293
	increased circulating insulin level	J:221293
	increased circulating leptin level	J:221293
	increased fasting circulating glucose level	J:221293
	insulin resistance	J:221293
Irs2^tm2Mfw/Irs2^tm2Mfw Tg(Ins2-cre)25Mgn/0 (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	impaired glucose tolerance	J:93415
	increased circulating glucose level	J:93415
	increased circulating insulin level	J:93415
	increased circulating leptin level	J:93415
	insulin resistance	J:93415
Irs2^tm2Mfw/Irs2^tm2Mfw Tg(Nes-cre)1Kln/? (involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * SJL)	abnormal glucose homeostasis	J:221293
	decreased oxygen consumption	J:221293
	impaired glucose tolerance	J:221293
	increased circulating glucose level	J:221293
	increased circulating insulin level	J:221293
	increased circulating leptin level	J:221293
	increased fasting circulating glucose level	J:221293
	insulin resistance	J:221293
Irs2^tm2Tka/Irs2^tm2Tka Speer6-ps1^{Tg(Alb-cre)21Mgn}/Speer6-ps1⁺ (involves: 129S4/SvJae * C57BL/6 * DBA)	increased circulating insulin level	J:137846
	insulin resistance	J:137846
Irs2^tm2Tka/Irs2^tm2Tka Tg(Ins2-cre)25Mgn/0 (involves: 129S4/SvJae * C57BL/6)	impaired glucose tolerance	J:93416
	increased circulating cholesterol level	J:93416
	increased circulating glucose level	J:93416
	increased circulating leptin level	J:93416
	increased circulating triglyceride level	J:93416
	insulin resistance	J:93416
Irs4^tm1.1Mfw/Y (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	increased circulating glucose level	J:221293
Irs4^tm1Lhd/Y (involves: 129S4/SvJae * C57BL/6)	decreased circulating glucose level	J:59964
Irs4^tm1Lhd/Y (involves: 129S4/SvJae * C57BL/6)	impaired glucose tolerance	J:59964
Irs4^tm1Lhd/Y (involves: 129S4/SvJae * BALB/c)	impaired glucose tolerance	J:59964
Irs4^tm1Lhd/Irs4^tm1Lhd (involves: 129S4/SvJae * C57BL/6)	abnormal glucose tolerance	J:59964
Irx1^{tm1(KOMP)Vlcg}/Irx1^{tm1(KOMP)Vlcg} (involves: C57BL/6NTac)	cyanosis	J:248919
Irx3^em2(IMPC)H/Irx3^em2(IMPC)H (C57BL/6N-Irx3^em2(IMPC)H/H)	decreased fasting circulating glucose level	J:211773
Irx3^tm1Hui/Irx3^tm1Hui (involves: 129S1/Sv * 129X1/SvJ)	decreased susceptibility to diet-induced obesity	J:208887
	improved glucose tolerance	J:208887
	increased energy expenditure	J:208887
	increased insulin sensitivity	J:208887
Irx6^{tm1b(KOMP)Mbp}/Irx6^{tm1b(KOMP)Mbp} (C57BL/6N-Irx6^{tm1b(KOMP)Mbp}/Kmpc)	increased circulating phosphate level	J:211773
Isl1^Drsh/Isl1⁺ (C3HeB/FeJ-Isl1^Drsh)	middle ear effusion	J:202214
Ism1^em1.1Kajs/Ism1^em1.1Kajs (involves: C57BL/6J * FVB/N)	impaired glucose tolerance	J:309734
Ism1^em1.1Kajs/Ism1^em1.1Kajs (involves: C57BL/6J * FVB/N)	insulin resistance	J:309734
Itch^{tm1b(EUCOMM)Hmgu}/Itch^{tm1b(EUCOMM)Hmgu} (C57BL/6N-Itch^{tm1b(EUCOMM)Hmgu}/H)	decreased circulating alkaline phosphatase level	J:211773
	decreased circulating fructosamine level	J:211773
	decreased fasting circulating glucose level	J:211773
	increased blood urea nitrogen level	J:211773
	increased circulating amylase level	J:211773
	increased circulating aspartate transaminase level	J:211773
	increased circulating calcium level	J:211773
	increased circulating phosphate level	J:211773
	increased circulating total protein level	J:211773
Itga1^tm1Gdnr/Itga1^tm1Gdnr (involves: 129S4/SvJae * BALB/c)	increased circulating creatinine level	J:91522
	increased circulating serum albumin level	J:91522
Itga2^tm1.1Eck/Itga2⁺ (involves: 129P2/OlaHsd)	abnormal platelet physiology	J:75683
Itga2^tm1.1Eck/Itga2⁺ (involves: 129P2/OlaHsd)	decreased platelet aggregation	J:75683
Itga2^tm1.1Eck/Itga2^tm1.1Eck (involves: 129P2/OlaHsd)	abnormal platelet aggregation	J:75683
	abnormal platelet physiology	J:75683
	decreased platelet aggregation	J:75683
Itga2^tm1.1Tkun/Itga2^tm1.1Tkun Tg(Pf4-icre)Q3Rsko/0 (involves: C57BL/6 * SJL)	abnormal platelet physiology	J:195799
	decreased platelet aggregation	J:195799
Itga2^tm1Ztr/Itga2^tm1Ztr (involves: 129S1/Sv * 129X1/SvJ)	abnormal platelet physiology	J:108331
Itga2b^{tm1(GFP/cre)Emam}/Itga2b^{tm1(GFP/cre)Emam} (involves: 129S6/SvEvTac * C57BL/6)	abnormal platelet physiology	J:84564
Itga2b^tm1Graf/Itga2b⁺ (B6.Cg-Itga2b^tm1Graf)	abnormal platelet activation	J:123159
Itga2b^tm1Tlr/Itga2b⁺ (either: (involves: 129S1/Sv * 129X1/SvJ * BALB/c) or (involves: 129S1/Sv * 129X1/SvJ * C57BL/6))	abnormal platelet activation	J:63961
	abnormal platelet aggregation	J:63961
	abnormal platelet physiology	J:63961
Itga2b^tm1Tlr/Itga2b^tm1Tlr (either: (involves: 129S1/Sv * 129X1/SvJ * BALB/c) or (involves: 129S1/Sv * 129X1/SvJ * C57BL/6))	abnormal blood coagulation	J:63961
	abnormal hemostasis	J:63961
	abnormal platelet activation	J:63961
	abnormal platelet physiology	J:63961
	decreased platelet aggregation	J:63961
	increased bleeding time	J:63961
Itga3^tm1Jak/Itga3^tm1Jak (involves: 129S4/SvJae * C57BL/6J)	dehydration	J:36831
Itga3^tm1Son/Itga3^tm1Son Tg(NPHS2-cre)295Lbh/0 (Not Specified)	albuminuria	J:114988
	edema	J:114988
	increased urine protein level	J:114988
Itga7^tm1Umr/Itga7^tm1Umr (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	increased circulating creatine kinase level	J:43840
Itga8^{tm1b(KOMP)Wtsi}/Itga8⁺ (C57BL/6N-Itga8^{tm1b(KOMP)Wtsi}/J)	decreased circulating glucose level	J:211773
	increased circulating calcium level	J:211773
	increased circulating free fatty acids level	J:211773
	increased circulating sodium level	J:211773
Itga9^tm1Des/Itga9^tm1Des (involves: 129S4/SvJae * C57BL/6)	chylothorax	J:63038
Itga11^em1(IMPC)H/Itga11^em1(IMPC)H (C57BL/6N-Itga11^em1(IMPC)H/H)	decreased fasting circulating glucose level	J:211773
Itgad^tm1.1Zimm/Itgad^tm1.1Zimm (involves: 129S6/SvEvTac * C57BL/6)	increased circulating interleukin-12 level	J:130908
Itgal^em1(IMPC)H/Itgal^em1(IMPC)H (C57BL/6NTac-Itgal^em1(IMPC)H/H)	increased circulating alanine transaminase level	J:211773
	increased circulating aspartate transaminase level	J:211773
Itgal^tm1Mak/Itgal^tm1Mak (B6.129P2-Itgal^tm1Mak)	increased circulating interleukin-2 level	J:123460
	increased circulating interleukin-10 level	J:123460
	increased circulating tumor necrosis factor level	J:123460
Itgam^tm1Myd/Itgam^tm1Myd (B6.129S4-Itgam^tm1Myd)	abnormal blood homeostasis	J:113463
Itgav^tm1Hyn/Itgav^tm1Hyn (either: (involves: 129/Sv * 129S2/SvPas) or (involves: 129S2/SvPas * C57BL/6J))	pericardial edema	J:50951
Itgav^tm2Hyn/Itgav^tm2.1Hyn Tg(Tek-cre)1Ywa/? (involves: 129S2/SvPas * C57BL/6 * FVB * SJL)	abnormal interferon level	J:125508
	abnormal interleukin level	J:125508
	abnormal tumor necrosis factor level	J:125508
Itgb1^tm1Efu/Itgb1^tm1Efu Tg(ATP6V1B1-cre)45Rnel/0 (involves: 129X1/SvJ * C57BL/6)	decreased circulating bicarbonate level	J:167156
	increased urine pH	J:167156
	metabolic acidosis	J:167156
	renal tubular acidosis	J:167156
Itgb1^tm1Efu/Itgb1^tm1Efu Tg(NPHS2-cre)295Lbh/0 (involves: 129X1/SvJ * C57BL/6 * SJL)	albuminuria	J:135414
	edema	J:135414
	increased urine protein level	J:135414
Itgb1^tm1Efu/Itgb1^tm1Efu Tg(Vil1-cre)997Gum/0 (involves: 129X1/SvJ * C57BL/6J * SJL)	abnormal circulating lipid level	J:119155
	steatorrhea	J:119155
Itgb1^tm1Ehi/Itgb1^tm1Ehi (either: (involves: 129S1/Sv * 129X1/SvJ) or (involves: 129S1/Sv * 129X1/SvJ * C57BL/6))	pericardial effusion	J:76216
Itgb1^tm1Ref/Itgb1^tm1Ref Tg(KRT5-cre)5132Jlj/0 (involves: 129S1/Sv * 129X1/SvJ * C57BL/6J * DBA/2J)	impaired skin barrier function	J:65038
Itgb1^tm1Ref/Itgb1^tm1Ref Tg(Mx1-cre)1Cgn/0 (involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * CBA)	abnormal platelet physiology	J:118488
	decreased platelet calcium level	J:118488
Itgb1^tm1Ross/Itgb1^tm1Ross Myl2^tm1(cre)Krc/Myl2⁺ (involves: 129S1/Sv * 129S4/SvJae * 129X1/SvJ * Black Swiss)	abnormal atrial thrombosis	J:82534
	pleural effusion	J:82534
Itgb1^tm1Ross/Itgb1^tm1Ross Tg(Hoxb7-cre)13Amc/0 (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	abnormal urine homeostasis	J:149831
	decreased urine osmolality	J:149831
	increased blood urea nitrogen level	J:149831
Itgb1^tm2Mlkn/Itgb1^tm2Mlkn (involves: 129/Sv * C57BL/6 * SJL)	abnormal platelet physiology	J:108331
Itgb1^tm2Son/Itgb1^tm2Son (FVB.129P2-Itgb1^tm2Son)	cyanosis	J:82463
Itgb1^tm3Mlkn/Itgb1^tm3Mlkn Tg(Mx1-cre)1Cgn/0 (involves: 129/Sv * C57BL/6 * CBA)	decreased circulating noradrenaline level	J:108331
Itgb2^tm1Bay/Itgb2^tm1Bay (involves: 129S7/SvEvBrd * PL/J)	abnormal cytokine level	J:109598
Itgb2^tm1Bay/Itgb2^tm1Bay (B6.129S7-Itgb2^tm1Bay/J)	increased circulating glucose level	J:118466
Itgb2^tm2Bay/Itgb2^tm2Bay (involves: 129S7/SvEvBrd * C57BL/6J)	increased circulating interleukin-3 level	J:48542
	increased circulating interleukin-6 level	J:48542
Itgb3^tm1Aja/Itgb3^tm1Aja (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	abnormal platelet activation	J:148306
	abnormal platelet dense granule physiology	J:148306
	abnormal platelet physiology	J:148306
	decreased susceptibility to induced thrombosis	J:148306
	increased bleeding time	J:148306
Itgb3^tm1Drp/Itgb3^tm1Drp (Not Specified)	abnormal blood coagulation	J:73416
Itgb3^tm1Hyn/Itgb3^tm1.1Wlbcr Lyz2^tm1(cre)Ifo/Lyz2⁺ (involves: 129P2/OlaHsd * 129S2/SvPas * C57BL/6)	decreased collagen level	J:224675
Itgb3^tm1Hyn/Itgb3^tm1.1Wlbcr Tg(Pf4-icre)Q3Rsko/0 (involves: 129S2/SvPas * C57BL/6)	abnormal blood coagulation	J:224675
	abnormal hemostasis	J:224675
	decreased platelet aggregation	J:224675
	increased bleeding time	J:224675
Itgb3^tm1Hyn/Itgb3^tm1Hyn (involves: 129S2/SvPas * C57BL/6)	abnormal platelet activation	J:52262
Itgb3^tm1Hyn/Itgb3^tm1Hyn (involves: 129S2/SvPas * C57BL/6)	increased bleeding time	J:52262
Itgb3^tm1Hyn/Itgb3^tm1Hyn (involves: 129S2/SvPas)	abnormal platelet physiology	J:96049
	decreased circulating calcium level	J:60672
	increased transforming growth factor beta level	J:96049
Itgb3^tm1Hyn/Itgb3^tm1Hyn Ldlr^tm1Her/Ldlr^tm1Her (involves: 129S2/SvPas * 129S7/SvEvBrd * C57BL/6)	decreased circulating cholesterol level	J:83615
	increased circulating glucose level	J:83615
Itgb3^tm1Mgin/Itgb3^tm1Mgin (involves: 129S1/Sv * 129X1/SvJ * C57BL/6J * FVB/N)	abnormal platelet activation	J:123968
	increased bleeding time	J:123968
Itgb3^tm2Mgin/Itgb3^tm2Mgin (involves: 129S1/Sv * 129X1/SvJ * C57BL/6J * FVB/N)	abnormal platelet activation	J:123968
	abnormal thrombosis	J:129707
	increased bleeding time	J:123968
Itgb4^tm1Fgg/Itgb4^tm1Fgg (involves: 129S1/Sv * C57BL/6)	dehydration	J:48924
Itgb4^tm1Son/Itgb4^tm1Son (129P2/OlaHsd-Itgb4^tm1Son)	edema	J:33713
Itgb6^{em1(IMPC)Ccpcz}/Itgb6^{em1(IMPC)Ccpcz} (C57BL/6NCrl-Itgb6^{em1(IMPC)Ccpcz}/Ccpcz)	decreased respiratory quotient	J:211773
Itgb8^tm1Lfr/Itgb8^tm1Lfr (either: (involves: 129/Sv) or (involves: 129/Sv * C57BL/6J))	hemopericardium	J:77682
Itln1^em1Cya/Itln1^em1Cya (involves: C57BL/6)	abnormal cytokine level	J:282124
	decreased circulating osteocalcin level	J:282124
	increased circulating interleukin-1 alpha level	J:282124
	increased circulating interleukin-6 level	J:282124
	increased circulating interleukin-10 level	J:282124
	increased circulating tumor necrosis factor level	J:282124
	increased circulating type I collagen C-terminal telopeptide level	J:282124
Itm2c^em2(IMPC)Tcp/Itm2c^em2(IMPC)Tcp (C57BL/6NCrl-Itm2c^em2(IMPC)Tcp/Tcp)	abnormal cholesterol homeostasis	J:211773
Itpr1^opt/Itpr1⁺ (B6C3Fe-a/a-Itpr1^opt/J)	decreased insulin secretion	J:222913
Itpr1^opt/Itpr1⁺ (B6C3Fe-a/a-Itpr1^opt/J)	impaired glucose tolerance	J:222913
Itpr2^tm1Kmik/Itpr2^tm1Kmik Itpr3^tm1Kmik/Itpr3^tm1Kmik (involves: 129S4/SvJae * C57BL/6J)	decreased circulating glucose level	J:101380
	decreased salivation	J:101380
	steatorrhea	J:101380
Itprid2^tm1Sawa/Itprid2^tm1Sawa (B6.Cg-Itprid2^tm1Sawa)	abnormal circulating hormone level	J:144968
	abnormal glucose homeostasis	J:144968
	decreased circulating glucose level	J:144968
	decreased circulating insulin level	J:144968
	decreased circulating insulin-like growth factor I level	J:144968
	decreased circulating leptin level	J:144968
	decreased circulating thyroxine level	J:144968
	decreased circulating triiodothyronine level	J:144968
	decreased liver triglyceride level	J:144968
	decreased skeletal muscle triglyceride level	J:144968
	decreased susceptibility to diet-induced obesity	J:144968
	improved glucose tolerance	J:144968
	increased adiponectin level	J:144968
	increased insulin sensitivity	J:144968
Itsn1^em1(IMPC)H/Itsn1^em1(IMPC)H (C57BL/6NTac-Itsn1^em1(IMPC)H/H)	increased circulating alkaline phosphatase level	J:211773
	increased circulating amylase level	J:211773
	increased circulating iron level	J:211773
	increased circulating serum albumin level	J:211773
	increased circulating total protein level	J:211773
Itsn2^tm1Kure/Itsn2^tm1Kure (involves: C57BL/6)	albuminuria	J:262845
Ivns1abp^tm1Htno/Ivns1abp^tm1Htno (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	ascites	J:162743
	pleural effusion	J:162743
Izumo1r^{tm2a(KOMP)Wtsi}/Izumo1r^{tm2a(KOMP)Wtsi} (C57BL/6N-Izumo1r^{tm2a(KOMP)Wtsi}/Wtsi)	decreased circulating amylase level	J:211773
	decreased circulating fructosamine level	J:211773
	decreased circulating glucose level	J:211773
	increased circulating chloride level	J:211773
Jade2^em1(IMPC)Tcp/Jade2^em1(IMPC)Tcp (C57BL/6N-Jade2^em1(IMPC)Tcp/Tcp)	decreased fasting circulating glucose level	J:211773
Jag1^Ndr/Jag1^Ndr (involves: C3HeB/FeJ * C57BL/6)	decreased circulating serum albumin level	J:277897
	increased circulating alkaline phosphatase level	J:277897
	increased circulating aspartate transaminase level	J:277897
	increased circulating bilirubin level	J:277897
Jag1^tm1Frad/Jag1^tm1Frad Tg(Tagln-cre)1Her/0 (B6.Cg-Jag1^tm1Frad Tg(Tagln-cre)1Her)	increased circulating alanine transaminase level	J:166890
	increased circulating alkaline phosphatase level	J:166890
	increased circulating aspartate transaminase level	J:166890
	increased circulating bilirubin level	J:166890
	increased circulating cholesterol level	J:166890
	increased circulating gamma-glutamyl transferase level	J:166890
	increased circulating lactate dehydrogenase level	J:166890
Jag1^tm1Grid/Jag1⁺ Notch2^tm1Grid/Notch2⁺ (involves: 129S1/Sv * C57BL/6J)	increased blood urea nitrogen level	J:74574
	increased circulating alanine transaminase level	J:74574
	increased circulating alkaline phosphatase level	J:74574
Jag1^tm1Grid/Jag1^tm2Grid Tg(Tagln-cre)1Her/0 (involves: 129S1/Sv * C57BL/6 * SJL)	cyanosis	J:166769
Jag1^tm2Grid/Jag1^tm2Grid Tg(Tek-cre)12Flv/0 (involves: C3H * C57BL/6)	pericardial edema	J:166769
Jag2^tm1Grid/Jag2^tm1Grid (involves: 129S1/Sv * C57BL/6J)	cyanosis	J:46930
Jak1^M1Mhda/Jak1⁺ (C3HeB/FeJ-Jak1^M1Mhda)	abnormal circulating creatinine level	J:199153
	decreased circulating cholesterol level	J:199153
	decreased circulating parathyroid hormone level	J:199153
	decreased circulating phosphate level	J:199153
	decreased circulating serum albumin level	J:199153
	decreased circulating total protein level	J:199153
	decreased triglyceride level	J:199153
	decreased urine urea nitrogen level	J:199153
	hypoglycemia	J:199153
	increased blood uric acid level	J:199153
	increased circulating calcium level	J:199153
Jak1^M1Mhda/Jak1^M1Mhda (C3HeB/FeJ-Jak1^M1Mhda/Ieg)	decreased circulating phosphate level	J:183993
	increased circulating alkaline phosphatase level	J:183993
	increased circulating calcium level	J:183993
Jak2^{tm1(JAK2)Argr}/Jak2⁺ Dppa3^tm1(cre)Peli/Dppa3⁺ (involves: 129S5/SvEvBrd * 129S7/SvEvBrd * C57BL/6)	abnormal protein level	J:233169
Jak2^tm1.1Ble/Jak2⁺ Commd10^{Tg(Vav1-icre)A2Kio}/Commd10⁺ (involves: 129 * C57BL/6 * C57BL/10 * CBA/Ca)	abnormal blood coagulation	J:257910
	abnormal cytokine level	J:257910
	abnormal thrombosis	J:257910
Jak2^tm1.1Jlvl/Jak2^tm1.1Jlvl (involves: 129S2/SvPas * C57BL/6)	decreased circulating iron level	J:163497
Jak2^tm1.2Ble/Jak2⁺ Picalm^tm1.1Tmae/Picalm^tm1.1Tmae Commd10^{Tg(Vav1-icre)A2Kio}/Commd10⁺ (involves: 129S6/SvEvTac * C57BL/6 * C57BL/10 * CBA * SJL)	abnormal iron homeostasis	J:220728
Jak2^tm1Kuw/Jak2^tm1Kuw Tg(Gnrh1-cre)35Awo/0 (involves: 129X1/SvJ * CD-1)	decreased circulating luteinizing hormone level	J:167849
Jakmip2^em1(IMPC)J/Jakmip2^em1(IMPC)J (C57BL/6NJ-Jakmip2^em1(IMPC)J/Mmjax)	decreased circulating bilirubin level	J:211773
	decreased circulating calcium level	J:211773
	increased circulating glucose level	J:211773
Jam2^{tm1.1(KOMP)Mbp}/Jam2^{tm1.1(KOMP)Mbp} (C57BL/6N-Jam2^{tm1.1(KOMP)Mbp}/J)	increased circulating potassium level	J:211773
	increased circulating sodium level	J:211773
Jam3^{tm1.1(KOMP)Vlcg}/Jam3⁺ (C57BL/6N-Jam3^{tm1.1(KOMP)Vlcg}/J)	decreased fasting circulating glucose level	J:211773
Jam3^tm1Lex/Jam3^tm1Lex (involves: 129S5/SvEvBrd * C57BL/6)	cyanosis	J:145994
Jaml^tm1Fnyi/Jaml⁺ Lepr^db/Lepr^db Tg(NPHS2-cre)295Lbh/0 (B6.Cg-Lepr^db Jaml^tm1Fnyi Tg(NPHS2-cre)295Lbh)	increased urine protein level	J:300243
Jaml^tm1Fnyi/Jaml^tm1Fnyi Lepr^db/Lepr^db Tg(NPHS2-cre)295Lbh/0 (B6.Cg-Lepr^db Jaml^tm1Fnyi Tg(NPHS2-cre)295Lbh)	increased urine protein level	J:300243
Jaml^tm1Fnyi/Jaml^tm1Fnyi Tg(NPHS2-cre)295Lbh/0 (B6.Cg-Jaml^tm1Fnyi Tg(NPHS2-cre)295Lbh)	abnormal urine albumin level	J:300243
	increased urine protein level	J:300243
Jarid2^{Gt(pGT1.8geo)6Pgr}/Jarid2^{Gt(pGT1.8geo)6Pgr} (either: (involves: 129/Sv * 129S2/SvPas) or (involves: 129S1/Sv * 129S2/SvPas * 129X1/SvJ))	edema	J:47982
Jarid2^Gt(ROSA)1Gel/Jarid2^Gt(ROSA)1Gel (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	edema	J:63359
Jarid2^jumonji/Jarid2^jumonji (involves: 129P2/OlaHsd * BALB/cA)	edema	J:25641
Jarid2^jumonji/Jarid2^jumonji (C.129P2-Jarid2^jumonji)	edema	J:42772
Jarid2^jumonji/Jarid2^jumonji (either: B6.129P2-Jarid2^jumonji or D2.129P2-Jarid2^jumonji)	edema	J:42772
Jarid2^{tm1a(KOMP)Wtsi}/Jarid2⁺ (Not Specified)	increased circulating creatinine level	J:175295
Jmjd4^{em1(IMPC)Wtsi}/Jmjd4^{em1(IMPC)Wtsi} (C57BL/6N-Jmjd4^{em1(IMPC)Wtsi}/Wtsi)	decreased circulating fructosamine level	J:211773
	decreased fasting circulating glucose level	J:211773
	increased circulating alkaline phosphatase level	J:211773
Jmjd6^tm1Gbf/Jmjd6^tm1Gbf (C57BL/6-Ptdsr^tm1Gbf)	skin edema	J:102098, J:98905
Jmjd7^{em1(IMPC)Wtsi}/Jmjd7^{em1(IMPC)Wtsi} (C57BL/6N-Jmjd7^{em1(IMPC)Wtsi}/Wtsi)	increased circulating amylase level	J:211773
	increased circulating insulin level	J:211773
Jmjd8^em1Kaso/Jmjd8^em1Kaso (C57BL/6-Jmjd8^em1Kaso)	decreased circulating insulin level	J:319518
	decreased circulating interleukin-1 beta level	J:319518
	improved glucose tolerance	J:319518
	increased insulin sensitivity	J:319518
Jmjd8^{tm1.1(KOMP)Vlcg}/Jmjd8^{tm1.1(KOMP)Vlcg} (C57BL/6N-Jmjd8^{tm1.1(KOMP)Vlcg}/J)	decreased circulating iron level	J:211773
Jph4^tm1Hta/Jph4^tm1Hta (involves: 129S4/SvJae * C57BL/6J)	abnormal calcium ion homeostasis	J:230995
Jph4^tm1Hta/Jph4^tm1Hta (involves: 129S4/SvJae * C57BL/6J)	abnormal interleukin level	J:230995
Jun^em1(IMPC)Mbp/Jun⁺ (C57BL/6N-Jun^em1(IMPC)Mbp/MbpMmucd)	edema	J:211773
Jun^em1(IMPC)Mbp/Jun^em1(IMPC)Mbp (C57BL/6N-Jun^em1(IMPC)Mbp/MbpMmucd)	edema	J:211773
Jun^tm1Wag/Jun^tm1Wag (either: (involves: 129S2/SvPas) or (involves: 129S2/SvPas * C57BL/6))	edema	J:14538
Jun^tm4Wag/Jun^tm4Wag Tg(Sftpc-cre)1Blh/0 (involves: 129P2/OlaHsd * C57BL/6 * DBA/2)	abnormal cytokine level	J:179883
	abnormal tumor necrosis factor level	J:179883
Jun^{tm5.1(Junb)Wag}/Jun^{tm5.1(Junb)Wag} (involves: 129P2/OlaHsd * C57BL/6)	cyanosis	J:75359
Junb^tm3Wag/Junb^tm3Wag Tg(KRT5-cre)1Tak/0 (involves: 129/Sv * 129P2/OlaHsd * C3H * C57BL/6)	albuminuria	J:155575
	increased circulating interleukin-6 level	J:155575
Jund^tm1Mya/Jund^tm1Mya (either: 129S2/SvPas or (involves: 129S2/SvPas * C57BL/6))	decreased circulating follicle stimulating hormone level	J:53906
	decreased circulating growth hormone level	J:53906
	decreased growth hormone level	J:53906
Jund^tm1Mya/Jund^tm1Mya (involves: 129S2/SvPas * C57BL/6J)	decreased circulating glucose level	J:210545
	decreased liver triglyceride level	J:210545
	increased circulating cholesterol level	J:210545
Jund^tm1Mya/Jund^tm1Mya Tg(H2-K-Fosl1)1Wag/0 (involves: 129S2/SvPas * C57BL/6 * CBA)	ascites	J:95691
	edema	J:95691
Jup^{tm1.1(KOMP)Vlcg}/Jup⁺ (C57BL/6N-Jup^{tm1.1(KOMP)Vlcg}/J)	decreased circulating phosphate level	J:211773
	decreased fasting circulating glucose level	J:211773
Jup^{tm1.1(KOMP)Vlcg}/Jup^{tm1.1(KOMP)Vlcg} (C57BL/6N-Jup^{tm1.1(KOMP)Vlcg}/J)	edema	J:211773
Jup^tm1.1Glr/Jup^tm1.1Glr A1cf^{Tg(Myh6-cre/Esr1)1Jmk}/A1cf⁺ (involves: 129S6/SvEvTac C57BL/6 * FVB/N * SJL)	abnormal interleukin level	J:170618
	pulmonary edema	J:170618
Jup^tm1Kem/Jup^tm1Kem (involves: 129S1/Sv * 129X1/SvJ)	hemopericardium	J:38047
Jup^tm1Kem/Jup^tm1Kem (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	abnormal atrial thrombosis	J:38047
	abnormal cardiac thrombosis	J:38047
	abnormal ventricular thrombosis	J:38047
	hemopericardium	J:38047
	impaired skin barrier function	J:38047
Jup^tm1Ruiz/Jup^tm1Ruiz (involves: 129P2/OlaHsd * C57BL/6)	hemopericardium	J:64280
KAL003/KAL003 (C3HeB/FeJ-KAL003)	increased blood urea nitrogen level	J:163957
KAL003/KAL003 (C3HeB/FeJ-KAL003)	increased circulating potassium level	J:163957
KAL004/KAL004 (C3HeB/FeJ-KAL004)	increased blood urea nitrogen level	J:163957
KAL004/KAL004 (C3HeB/FeJ-KAL004)	increased circulating potassium level	J:163957
KAL006/KAL006⁺ (C3HeB/FeJ-KAL006)	increased blood urea nitrogen level	J:163957
KAL006/KAL006⁺ (C3HeB/FeJ-KAL006)	increased circulating potassium level	J:163957
KAL007/KAL007 (C3HeB/FeJ-KAL007)	increased blood urea nitrogen level	J:163957
KAL007/KAL007 (C3HeB/FeJ-KAL007)	increased circulating potassium level	J:163957
Kansl1l^{tm1b(EUCOMM)Wtsi}/Kansl1l^{tm1b(EUCOMM)Wtsi} (C57BL/6N-Kansl1l^{tm1b(EUCOMM)Wtsi}/Ieg)	increased circulating sodium level	J:211773
Kash5^em1(IMPC)J/Kash5^em1(IMPC)J (C57BL/6NJ-Kash5^em1(IMPC)J/Mmjax)	increased circulating HDL cholesterol level	J:211773
Kat2b^{em1(IMPC)Wtsi}/Kat2b^{em1(IMPC)Wtsi} (C57BL/6N-Kat2b^{em1(IMPC)Wtsi}/WtsiIeg)	decreased circulating cholesterol level	J:211773
	decreased circulating HDL cholesterol level	J:211773
	impaired glucose tolerance	J:211773
Kat6a^tm1Avo/Kat6a^tm1Avo (involves: 129/Sv * BALB/c * FVB/N)	cyanosis	J:108453
Kat6a^tm1Iki/Kat6a^tm1Iki (Not Specified)	skin edema	J:108699
Kat8^em1(IMPC)Mbp/Kat8⁺ (C57BL/6N-Kat8^em1(IMPC)Mbp/MbpMmucd)	increased circulating cholesterol level	J:211773
Kat8^tm1.2Avo/Kat8^tm1.2Avo Tg(Nes-cre)1Kln/0 (involves: C57BL/6 * SJL)	increased fatty acids level	J:291094
Katnal2^em1(IMPC)Tcp/Katnal2^em1(IMPC)Tcp (C57BL/6N-Katnal2^em1(IMPC)Tcp/Tcp)	increased circulating alkaline phosphatase level	J:211773
kavh/kavh (mixed)	increased blood urea nitrogen level	J:226961
Kazn^{tm1a(EUCOMM)Wtsi}/Kazn^{tm1a(EUCOMM)Wtsi} (C57BL/6N-Kazn^{tm1a(EUCOMM)Wtsi}/Wtsi)	decreased circulating alanine transaminase level	J:175295
	decreased circulating aspartate transaminase level	J:175295
Kbtbd2^em1Btlr/Kbtbd2^em1Btlr (Not Specified)	increased circulating insulin level	J:236520
	increased fasting circulating glucose level	J:236520
	insulin resistance	J:236520
Kbtbd2^em1Btlr/Kbtbd2^em1Btlr Pik3r1^em1Btlr/Pik3r1^em1Btlr (Not Specified)	decreased circulating glucose level	J:236520
	decreased circulating insulin level	J:236520
	increased insulin sensitivity	J:236520
Kbtbd2^m1Btlr/Kbtbd2^m1Btlr (C57BL/6J-Kbtbd2^m1Btlr)	decreased adiponectin level	J:236520
	decreased circulating leptin level	J:236520
	increased circulating alanine transaminase level	J:236520
	increased circulating aspartate transaminase level	J:236520
	increased circulating insulin level	J:236520
	increased fasting circulating glucose level	J:236520
	increased liver triglyceride level	J:236520
	insulin resistance	J:236520
Kbtbd7^{tm1.1(KOMP)Vlcg}/Kbtbd7^{tm1.1(KOMP)Vlcg} (C57BL/6N-Kbtbd7^{tm1.1(KOMP)Vlcg}/J)	increased circulating bilirubin level	J:211773
Kbtbd8^em1(IMPC)Tcp/Kbtbd8^em1(IMPC)Tcp (C57BL/6N-Kbtbd8^em1(IMPC)Tcp/Tcp)	decreased circulating alkaline phosphatase level	J:211773
	increased circulating alanine transaminase level	J:211773
Kcna1^tm1Tem/Kcna1^tm1Tem (involves: 129S7/SvEvBrd * BALB/cByJ * C3HeB/FeJ)	porphyria	J:119491
Kcna3^tm1Gvd/Kcna3^tm1Gvd (involves: 129S1/Sv * C57BL/6)	abnormal glucose homeostasis	J:88651
	decreased circulating insulin level	J:88651
	decreased susceptibility to diet-induced obesity	J:89447
	increased insulin sensitivity	J:88651
Kcna5^tm1Hket/Kcna5^tm1Hket (involves: 129S6/SvEvTac * 129S7/SvEvBrd)	abnormal nitric oxide homeostasis	J:116545
Kcna6^tm1Lex/Kcna6^tm1Lex (involves: 129S5/SvEvBrd * C57BL/6J)	increased circulating triglyceride level	J:103485
Kcnab2^tm1Kmc/Kcnab2^tm1Kmc (involves: 129S7/SvEvBrd * C57BL/6)	decreased core body temperature	J:106453
Kcnab2^tm1Kmc/Kcnab2^tm1Kmc (B6.129S7-Kcnab2^tm1Kmc)	impaired adaptive thermogenesis	J:106453
Kcnab2^tm1Kmc/Kcnab2^tm1Kmc (involves: 129S6/SvEvTac * 129S7/SvEvBrd)	decreased core body temperature	J:106453
Kcnab3^{tm1.1(KOMP)Vlcg}/Kcnab3^{tm1.1(KOMP)Vlcg} (C57BL/6N-Kcnab3^{tm1.1(KOMP)Vlcg}/Ucd)	abnormal cholesterol homeostasis	J:211773
	increased circulating alanine transaminase level	J:211773
	increased circulating aspartate transaminase level	J:211773
Kcnb1^tm1Dgen/Kcnb1^tm1Dgen (involves: C57BL/6)	hypoglycemia	J:129963
	improved glucose tolerance	J:129963
	increased circulating insulin level	J:129963
	increased insulin secretion	J:129963
Kcnb2^em1(IMPC)J/Kcnb2^em1(IMPC)J (C57BL/6NJ-Kcnb2^em1(IMPC)J/J)	increased circulating alanine transaminase level	J:211773
	increased circulating bilirubin level	J:211773
Kcnc1^tm1Joho/Kcnc1^tm1Joho Kcnc3^tm1Echa/Kcnc3^tm1Echa (involves: 129/Sv * C57BL/6)	decreased body temperature	J:71179
Kcnd3^em1(IMPC)J/Kcnd3^em1(IMPC)J (C57BL/6NJ-Kcnd3^em1(IMPC)J/J)	decreased blood urea nitrogen level	J:211773
Kcne1^{tm1b(EUCOMM)Hmgu}/Kcne1^{tm1b(EUCOMM)Hmgu} (C57BL/6N-Kcne1^{tm1b(EUCOMM)Hmgu}/Ics)	increased blood urea nitrogen level	J:211773
	increased circulating alanine transaminase level	J:211773
	increased circulating alkaline phosphatase level	J:211773
Kcne1^tm1Sfh/Kcne1^tm1Sfh (involves: 129S1/Sv)	abnormal circulating renin level	J:77288
	dehydration	J:77288
	hypokalemia	J:77288
	increased blood osmolality	J:77288
	increased circulating aldosterone level	J:77288
	increased circulating chloride level	J:77288
	increased circulating sodium level	J:77288
Kcne2^{tm1a(EUCOMM)Wtsi}/Kcne2^{tm1a(EUCOMM)Wtsi} (C57BL/6N-Kcne2^{tm1a(EUCOMM)Wtsi}/Wtsi)	decreased circulating iron level	J:175295
	increased circulating magnesium level	J:175295
Kcne2^{tm1a(EUCOMM)Wtsi}/Kcne2^{tm1a(EUCOMM)Wtsi} (C57BL/6N-Kcne2^{tm1a(EUCOMM)Wtsi})	decreased circulating ferritin level	J:230226
	decreased circulating iron level	J:230226
	decreased spleen iron level	J:230226
	increased circulating erythropoietin level	J:230226
	increased circulating magnesium level	J:230226
Kcne2^tm1Gwab/Kcne2^tm1Gwab (involves: 129S4/SvJae * C57BL/6)	increased circulating gastrin level	J:116518
Kcne3^{tm1.1(KOMP)Vlcg}/Kcne3^{tm1.1(KOMP)Vlcg} (C57BL/6NCrl-Kcne3^{tm1.1(KOMP)Vlcg}/MbpMmucd)	decreased circulating total protein level	J:211773
Kcne3^tm1Gwab/Kcne3^tm1Gwab (involves: C57BL/6)	decreased circulating HDL cholesterol level	J:210381
	increased circulating aldosterone level	J:210381
	increased circulating cholesterol level	J:210381
	increased circulating LDL cholesterol level	J:210381
Kcng2^em1(IMPC)Bay/Kcng2^em1(IMPC)Bay (C57BL/6N-Kcng2^em1(IMPC)Bay/Bay)	decreased circulating serum albumin level	J:211773
Kcng4^{tm1.1(KOMP)Vlcg}/Kcng4^{tm1.1(KOMP)Vlcg} (C57BL/6N-Kcng4^{tm1.1(KOMP)Vlcg}/Ucd)	increased circulating aspartate transaminase level	J:211773
Kcnh2^tm1.1Hjd/Kcnh2^tm1.1Hjd (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	pericardial effusion	J:155273
Kcnh3^{tm1.1(KOMP)Vlcg}/Kcnh3⁺ (C57BL/6N-Kcnh3^{tm1.1(KOMP)Vlcg}/J)	increased circulating free fatty acids level	J:211773
Kcnh3^{tm1.1(KOMP)Vlcg}/Kcnh3^{tm1.1(KOMP)Vlcg} (C57BL/6N-Kcnh3^{tm1.1(KOMP)Vlcg}/J)	improved glucose tolerance	J:211773
	increased fasting circulating glucose level	J:211773
Kcnh6^em1Jkya/Kcnh6^em1Jkya (involves: C57BL/6N)	abnormal calcium ion homeostasis	J:271003
	abnormal glucose homeostasis	J:271003
	abnormal insulin secretion	J:271003
	decreased circulating glucose level	J:271003
	decreased circulating insulin level	J:271003
	decreased insulin secretion	J:271003
	impaired glucose tolerance	J:271003
	increased circulating insulin level	J:271003
	increased fasting circulating glucose level	J:271003
	increased insulin secretion	J:271003
Kcnh6^em2Jkya/Kcnh6^em2Jkya (involves: C57BL/6N)	abnormal glucose homeostasis	J:271003
	decreased circulating glucose level	J:271003
	decreased circulating insulin level	J:271003
	decreased insulin secretion	J:271003
	impaired glucose tolerance	J:271003
	increased circulating insulin level	J:271003
	increased fasting circulating glucose level	J:271003
Kcnh6^{tm1.1(KOMP)Vlcg}/Kcnh6^{tm1.1(KOMP)Vlcg} (C57BL/6N-Kcnh6^{tm1.1(KOMP)Vlcg}/Tcp)	increased circulating calcium level	J:211773
	increased circulating serum albumin level	J:211773
	increased circulating total protein level	J:211773
Kcnip3^tm1Bux/Kcnip3^tm1Bux (involves: 129S4/SvJae * C57BL/6)	abnormal protein level	J:85927
Kcnj1^tm1Ges/Kcnj1^tm1Ges (involves: 129X1/SvJ * Black Swiss)	abnormal urine homeostasis	J:79354
	decreased urine osmolality	J:79354
	dehydration	J:79354
	increased circulating sodium level	J:79354
	metabolic acidosis	J:79354
Kcnj2^tm1Swz/Kcnj2^tm1Swz (involves: 129S1/Sv * 129X1/SvJ * FVB)	cyanosis	J:78077
	dehydration	J:78077
Kcnj3^{tm1.1(KOMP)Vlcg}/Kcnj3^{tm1.1(KOMP)Vlcg} (C57BL/6N-Kcnj3^{tm1.1(KOMP)Vlcg}/Ucd)	increased respiratory quotient	J:211773
Kcnj6^em1(IMPC)H/Kcnj6^em1(IMPC)H (C57BL/6N-Kcnj6^em1(IMPC)H/H)	increased circulating amylase level	J:211773
Kcnj6^wv/Kcnj6^wv (B6CBACa A^w-J/A-Kcnj6^wv/J)	decreased dopamine level	J:6717
Kcnj6^wv/Kcnj6^wv (B6CBA A^w-J/A-Kcnj6^wv)	abnormal ion homeostasis	J:106298
Kcnj6^wv/Kcnj6^wv (involves: C57BL/6)	decreased taurine level	J:6875
Kcnj6^wv/Kcnj6^wv (involves: C57BL/6 * CBA/CaGnLe)	increased noradrenaline level	J:164122
Kcnj10^tm1Lst/Kcnj10^tm1Lst (involves: 129S1/Sv * C57BL/6J)	dehydration	J:77663
Kcnj10^tm1Lst/Kcnj10^tm1Lst (involves: 129S1/Sv)	decreased urine calcium level	J:226598
	decreased urine creatinine level	J:226598
	increased urine sodium level	J:226598
Kcnj11^{tm1b(EUCOMM)Wtsi}/Kcnj11^{tm1b(EUCOMM)Wtsi} (C57BL/6N-Kcnj11^{tm1b(EUCOMM)Wtsi}/H)	decreased fasting circulating glucose level	J:211773
	impaired glucose tolerance	J:211773
Kcnj11^tm1Sse/Kcnj11⁺ Tg(Ins1-Kcnj11)#Nich/? (involves: 129P2/OlaHsd C57BL/6 * CBA)	decreased insulin secretion	J:94610
	impaired glucose tolerance	J:94610
	improved glucose tolerance	J:94610
	increased circulating glucose level	J:94610
	increased circulating insulin level	J:94610
	increased insulin secretion	J:94610
Kcnj11^tm1Sse/Kcnj11^tm1Sse (B6.129P2-Kcnj11^tm1Sse)	abnormal glucose homeostasis	J:69163
	decreased glucagon secretion	J:69163
	decreased susceptibility to diet-induced obesity	J:157001
	hypoglycemia	J:69163
	increased circulating atrial natriuretic factor	J:106396
	increased energy expenditure	J:157001
	increased oxygen consumption	J:157001
Kcnj11^tm1Sse/Kcnj11^tm1Sse (involves: 129P2/OlaHsd)	decreased circulating insulin level	J:49755
	impaired glucose tolerance	J:49755
	increased insulin sensitivity	J:49755
Kcnj11^tm1Sse/Kcnj11^tm1Sse Tg(Ins1-Kcnj11)#Nich/? (involves: 129P2/OlaHsd C57BL/6 * CBA)	decreased insulin secretion	J:94610
	impaired glucose tolerance	J:94610
	increased circulating glucose level	J:94610
Kcnj11^Y12stop/Kcnj11^Y12stop (involves: BALB/c * C3H/HeH)	decreased glucagon secretion	J:122088
Kcnj11^Y12stop/Kcnj11^Y12stop (involves: BALB/c * C3H/HeH)	increased insulin secretion	J:122088
Kcnk1^tm1.1Barh/Kcnk1^tm1.1Barh (involves: 129 * C57BL/6 * C57BL/6J * SJL)	abnormal renal phosphate reabsorption	J:183234
	decreased circulating phosphate level	J:183234
	increased urine phosphate level	J:183234
Kcnk2^em1(IMPC)H/Kcnk2^em1(IMPC)H (C57BL/6NTac-Kcnk2^em1(IMPC)H/H)	increased circulating phosphate level	J:211773
Kcnk3^tm1.1Daba/Kcnk3^tm1.1Daba Kcnk9^tm1.1Daba/Kcnk9^tm1.1Daba (involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * CBA)	decreased circulating renin level	J:131927
	hypokalemia	J:131927
	increased circulating aldosterone level	J:131927
Kcnk3^tm1Sgb/Kcnk3^tm1Sgb (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	increased circulating aldosterone level	J:188335
Kcnk5^{Gt(pGT1.8TM)1Gray}/Kcnk5^{Gt(pGT1.8TM)1Gray} (B6.129P2-Kcnk5^{Gt(pGT1.8TM)1Gray})	increased urine chloride ion level	J:90686
	increased urine sodium level	J:90686
Kcnk16^tm1.1Lex/Kcnk16^tm1.1Lex (B6.129S-Kcnk16^tm1.1Lex)	abnormal fasting circulating glucose level	J:259519
Kcnk16^tm1.1Lex/Kcnk16^tm1.1Lex (B6.129S-Kcnk16^tm1.1Lex)	increased insulin secretion	J:259519
Kcnma1^em1(IMPC)H/Kcnma1^em1(IMPC)H (C57BL/6N-Kcnma1^em1(IMPC)H/H)	increased circulating alkaline phosphatase level	J:211773
Kcnn4^{em1(IMPC)Ccpcz}/Kcnn4^{em1(IMPC)Ccpcz} (C57BL/6NCrl-Kcnn4^{em1(IMPC)Ccpcz}/Ccpcz)	increased fasting circulating glucose level	J:211773
Kcnn4^tm1Rklr/Kcnn4^tm1Rklr (involves: 129S/SvEv * C57BL/6)	increased spleen iron level	J:148910
Kcnq1^tm1Apf/Kcnq1^tm1Apf (involves: 129P2/OlaHsd * C57BL/6)	increased circulating gastrin level	J:66428
Kcnq3^em1(IMPC)H/Kcnq3^em1(IMPC)H (C57BL/6N-Kcnq3^em1(IMPC)H/H)	increased blood urea nitrogen level	J:211773
Kcp^tm1Gdr/Kcp^tm1Gdr (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	abnormal response to vitamins	J:97529
Kctd1^em1(IMPC)J/Kctd1^em1(IMPC)J (C57BL/6NJ-Kctd1^em1(IMPC)J/Mmjax)	increased blood urea nitrogen level	J:211773
	increased circulating alkaline phosphatase level	J:211773
	increased circulating bilirubin level	J:211773
	increased circulating calcium level	J:211773
	increased circulating cholesterol level	J:211773
	increased circulating creatinine level	J:211773
	increased circulating HDL cholesterol level	J:211773
	increased circulating total protein level	J:211773
	increased circulating triglyceride level	J:211773
Kctd1^Mhdahst014/Kctd1⁺ (C3HeB/FeJ-Kctd1^Mhdahst014)	decreased circulating chloride level	J:250423
	decreased respiratory quotient	J:250423
	decreased urine albumin level	J:250423
	decreased urine osmolality	J:250423
	decreased urine pH	J:250423
	decreased urine uric acid level	J:250423
	increased blood urea nitrogen level	J:250423
	increased circulating amylase level	J:250423
	increased circulating calcium level	J:250423
	increased circulating creatinine level	J:250423
	increased circulating glucose level	J:250423
	increased circulating potassium level	J:250423
	increased circulating serum albumin level	J:250423
	increased urine calcium level	J:250423
	increased urine magnesium level	J:250423
Kctd3^em1(IMPC)Tcp/Kctd3^em1(IMPC)Tcp (C57BL/6N-Kctd3^em1(IMPC)Tcp/Tcp)	edema	J:211773
Kctd5^em1(IMPC)J/Kctd5⁺ (C57BL/6NJ-Kctd5^em1(IMPC)J/Mmjax)	decreased circulating calcium level	J:211773
Kctd7^em2(IMPC)Bay/Kctd7^em2(IMPC)Bay (C57BL/6N-Kctd7^em2(IMPC)Bay/BayMmucd)	increased fasting circulating glucose level	J:211773
Kctd9^em1(IMPC)J/Kctd9^em1(IMPC)J (C57BL/6NJ-Kctd9^em1(IMPC)J/J)	decreased circulating calcium level	J:211773
Kctd9^em1Beij/Kctd9^em1Beij (BALB/c-Kctd9^em1Beij)	decreased circulating alanine transaminase level	J:281803
Kctd9^em1Beij/Kctd9^em1Beij (BALB/c-Kctd9^em1Beij)	decreased circulating aspartate transaminase level	J:281803
Kctd15^{tm1b(EUCOMM)Wtsi}/Kctd15⁺ (C57BL/6N-Kctd15^{tm1b(EUCOMM)Wtsi}/Ucd)	decreased circulating alkaline phosphatase level	J:211773
Kctd15^{tm1b(EUCOMM)Wtsi}/Kctd15⁺ (C57BL/6N-Kctd15^{tm1b(EUCOMM)Wtsi}/Ics)	increased blood urea nitrogen level	J:211773
	increased circulating creatinine level	J:211773
Kctd19^em1(IMPC)J/Kctd19^em1(IMPC)J (C57BL/6NJ-Kctd19^em1(IMPC)J/Mmjax)	increased circulating cholesterol level	J:211773
Kdf1^shd/Kdf1⁺ Sfn^Er/Sfn⁺ (involves: C3HeB/FeJ * C57BL/6J)	impaired skin barrier function	J:203995
Kdf1^shd/Kdf1^shd (involves: C3HeB/FeJ * C57BL/6J)	impaired skin barrier function	J:203995
Kdf1^shd/Kdf1^{tm1a(EUCOMM)Wtsi} (involves: C3HeB/FeJ * C57BL/6J * C57BL/6N)	impaired skin barrier function	J:203995
Kdf1^{tm1a(EUCOMM)Wtsi}/Kdf1^{tm1a(EUCOMM)Wtsi} (involves: C57BL/6N)	impaired skin barrier function	J:203995
Kdm1a^tm1.1Rsd/Kdm1a^tm1.1Rsd Tg(Pitx1-cre)7Rsd/0 (involves: BALB/c * C57BL/6)	abnormal luteinizing hormone level	J:121427
	abnormal pituitary hormone level	J:121427
	decreased growth hormone level	J:121427
	decreased thyroid-stimulating hormone level	J:121427
Kdm3a^em1(IMPC)Mbp/Kdm3a^em1(IMPC)Mbp (C57BL/6N-Kdm3a^em1(IMPC)Mbp/MbpMmucd)	impaired glucose tolerance	J:211773
Kdm3a^tm1.1Jsak/Kdm3a^tm1.1Jsak (involves: C57BL/6 * CBA)	impaired adaptive thermogenesis	J:158258
	increased circulating cholesterol level	J:158258
	increased circulating glucose level	J:158258
	increased circulating insulin level	J:158258
	increased circulating leptin level	J:158258
	increased circulating triglyceride level	J:158258
	increased respiratory quotient	J:158258
	insulin resistance	J:158258
Kdm3a^tm1.1Yzha/Kdm3a^tm1.1Yzha (B6.129P2-Kdm3a^tm1.1Yzha)	decreased oxygen consumption	J:147295
	hyperlipidemia	J:147295
	impaired adaptive thermogenesis	J:147295
	increased circulating cholesterol level	J:147295
	increased circulating free fatty acids level	J:147295
	increased circulating triglyceride level	J:147295
	increased susceptibility to diet-induced obesity	J:147295
Kdm3b^tm1Jxu/Kdm3b^tm1Jxu (involves: 129S6/SvEvTac * C57BL/6)	decreased circulating estradiol level	J:286338
	decreased circulating insulin-like growth factor I level	J:286338
Kdm4b^{tm1a(EUCOMM)Wtsi}/Kdm4b⁺ (B6Dnk;B6Brd;B6N-Tyr^c-Brd Kdm4b^{tm1a(EUCOMM)Wtsi}/WtsiH)	decreased circulating total protein level	J:175295
	increased circulating creatinine level	J:175295
Kdm4c^{tm1a(KOMP)Wtsi}/Kdm4c⁺ (C57BL/6N-Kdm4c^{tm1a(KOMP)Wtsi}/Wtsi)	increased circulating calcium level	J:165965
	increased circulating serum albumin level	J:165965
Kdm5b^{Gt(RRO123)Byg}/Kdm5b^{Gt(RRO123)Byg} (FVB.129P2-Kdm5b^{Gt(RRO123)Byg})	decreased circulating estradiol level	J:218960
Kdm5c^tm1.2Yshi/Y (involves: 129 * 129S1/SvImJ * C57BL/6J)	increased circulating testosterone level	J:262206
Kdm6a^{Gt(RRA094)Byg}/Y X/Uty^{Gt(XS0378)Wtsi} (either: (involves: 129 * CD-1) or (involves: 129P2/OlaHsd * CD-1) or (involves: 129P2/OlaHsd * C57BL/6 * CD-1))	pericardial edema	J:201868
Kdm6a^{Gt(RRA094)Byg}/Kdm6a^{Gt(RRA094)Byg} (either: (involves: 129 * CD-1) or (involves: 129P2/OlaHsd * CD-1) or (involves: 129P2/OlaHsd * C57BL/6 * CD-1))	pericardial edema	J:201868
Kdm6a^{tm1b(EUCOMM)Wtsi}/Kdm6a^{tm1b(EUCOMM)Wtsi} (either: (involves: C57BL/6 * CD-1) or (involves: 129 * C57BL/6 * CD-1))	pericardial edema	J:201868
Kdm6b^Gt(XB814)Byg/Kdm6b^Gt(XB814)Byg (involves: 129P2/OlaHsd * C57BL/6)	cyanosis	J:196346
Kdm6b^tm1.1Cdcn/Kdm6b^tm1.1Cdcn (involves: C57BL/6)	cyanosis	J:233350
Kdm8^{tm1a(EUCOMM)Wtsi}/Kdm8⁺ (C57BL/6N-Kdm8^{tm1a(EUCOMM)Wtsi}/Ics)	abnormal glucose homeostasis	J:165965
Kel^tm1Slee/Kel^tm1Slee (B6.129X1-Kel^tm1Slee)	decreased erythrocyte magnesium level	J:212528
Kel^tm1Slee/Kel^tm1Slee (B6.129X1-Kel^tm1Slee)	decreased erythrocyte potassium level	J:212528
Kel^tm1Slee/Kel^tm1Slee Xk^tm1Ariv/Y (B6.Cg-Kel^tm1Slee Xk^tm1Ariv)	increased erythrocyte sodium level	J:212528
Khdrbs1^tm1Rchd/Khdrbs1^tm1Rchd (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	decreased circulating leptin level	J:115775
Khdrbs2^{Tg(LRRK2R1441G)135Cjli}/Khdrbs2⁺ (FVB-Khdrbs2^{Tg(LRRK2R1441G)135Cjli})	decreased dopamine level	J:149135
Khdrbs3^{tm1b(EUCOMM)Hmgu}/Khdrbs3^{tm1b(EUCOMM)Hmgu} (C57BL/6N-Khdrbs3^{tm1b(EUCOMM)Hmgu}/Ieg)	increased circulating alkaline phosphatase level	J:211773
Kics2^{tm1b(KOMP)Wtsi}/Kics2^{tm1b(KOMP)Wtsi} (C57BL/6N-Kics2^{tm1b(KOMP)Wtsi}/Nju)	decreased circulating cholesterol level	J:211773
	decreased circulating HDL cholesterol level	J:211773
	decreased circulating phosphate level	J:211773
	increased blood urea nitrogen level	J:211773
Kif1b^{tm1b(KOMP)Wtsi}/Kif1b⁺ (C57BL/6N-Kif1b^{tm1b(KOMP)Wtsi}/J)	decreased blood urea nitrogen level	J:211773
	increased circulating chloride level	J:211773
	increased circulating sodium level	J:211773
Kif2c^{tm1.1(KOMP)Vlcg}/Kif2c⁺ (C57BL/6N-Kif2c^{tm1.1(KOMP)Vlcg}/Rbrc)	increased circulating triglyceride level	J:211773
Kif3a^tm1Gsn/Kif3a⁺ (involves: 129S1/Sv * 129X1/SvJ)	pericardial edema	J:54575
Kif3a^tm1Gsn/Kif3a^tm1Gsn (involves: 129S1/Sv * 129X1/SvJ)	pericardial edema	J:54575
Kif3a^tm1Gsn/Kif3a^tm2Gsn Tg(Cdh16-cre)91Igr/0 (involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * ICR)	increased blood urea nitrogen level	J:83293
Kif3a^tm1Noh/Kif3a^tm1Noh (involves: 129S4/SvJae * C57BL/6J)	pericardial effusion	J:55332
Kif3c^{tm1.1(KOMP)Vlcg}/Kif3c⁺ (C57BL/6N-Kif3c^{tm1.1(KOMP)Vlcg}/J)	increased circulating alkaline phosphatase level	J:211773
Kif5a^{tm1b(EUCOMM)Wtsi}/Kif5a^{tm1b(EUCOMM)Wtsi} (C57BL/6N-Kif5a^{tm1b(EUCOMM)Wtsi}/J)	cyanosis	J:211773
Kif5a^tm1Gsn/Kif5a^tm1Gsn (involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)	cyanosis	J:82911
Kif5a^tm1Gsn/Kif5a^tm2Gsn Tg(Syn1-cre)671Jxm/0 (involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * CBA)	abnormal protein level	J:82911
Kif5b^tm1Njen/Kif5b⁺ Tg(Ins2-cre)25Mgn/0 (involves: 129S1/Sv * C57BL/6 * C57BL/6N * DBA * SJL)	decreased insulin secretion	J:170198
	impaired glucose tolerance	J:170198
Kif5b^tm1Njen/Kif5b^tm1.1Njen Tg(Ins2-cre)25Mgn/0 (involves: 129S1/Sv * C57BL/6 * C57BL/6N * DBA * SJL)	decreased circulating insulin level	J:170198
	decreased insulin secretion	J:170198
	hyperglycemia	J:170198
	impaired glucose tolerance	J:170198
Kif5c^tm1dIcs/Kif5c⁺ (C57BL/6N-Kif5c^tm1dIcs/Ics)	increased circulating total protein level	J:211773
Kif7^tm1.2Hui/Kif7^tm1.2Hui (involves: 129S6/SvEvTac * CD-1)	edema	J:152259
Kif7^tm1Lex/Kif7^tm1Lex (involves: C57BL/6)	edema	J:152551
Kif13b^{Gt(AF0005)Wtsi}/Kif13b^{Gt(AF0005)Wtsi} (involves: 129P2/OlaHsd * C57BL/6J)	increased circulating cholesterol level	J:282570
	increased circulating HDL cholesterol level	J:282570
	increased circulating LDL cholesterol level	J:282570
Kif13b^tm1.1Noh/Kif13b^tm1.1Noh (B6.Cg-Kif13b^tm1.1Noh)	increased circulating cholesterol level	J:208261
	increased circulating factor VIII level	J:208261
	increased circulating HDL cholesterol level	J:208261
	increased circulating LDL cholesterol level	J:208261
Kif13b^{tm1b(EUCOMM)Wtsi}/Kif13b^{tm1b(EUCOMM)Wtsi} (C57BL/6N-Kif13b^{tm1b(EUCOMM)Wtsi}/Wtsi)	increased circulating alkaline phosphatase level	J:211773
	increased circulating LDL cholesterol level	J:211773
Kif18b^{tm1a(EUCOMM)Wtsi}/Kif18b⁺ (C57BL/6N-Kif18b^{tm1a(EUCOMM)Wtsi}/Wtsi)	increased circulating triglyceride level	J:211773
Kif21a^{tm1b(EUCOMM)Hmgu}/Kif21a⁺ (C57BL/6N-Kif21a^{tm1b(EUCOMM)Hmgu}/J)	decreased fasting circulating glucose level	J:211773
Kif21b^{tm1a(KOMP)Wtsi}/Kif21b^{tm1a(KOMP)Wtsi} (C57BL/6N-Kif21b^{tm1a(KOMP)Wtsi}/Wtsi)	decreased circulating alanine transaminase level	J:175295
	decreased circulating aspartate transaminase level	J:175295
	decreased circulating serum albumin level	J:175295
	decreased circulating total protein level	J:175295
Kif26b^{tm2b(KOMP)Wtsi}/Kif26b⁺ (C57BL/6N-Kif26b^{tm2b(KOMP)Wtsi}/J)	decreased circulating free fatty acids level	J:211773
Kifap3^{tm1a(KOMP)Wtsi}/Kifap3⁺ (C57BL/6N-Kifap3^{tm1a(KOMP)Wtsi}/Wtsi)	impaired glucose tolerance	J:211773
Kifbp^em1Hmy/Kifbp^em1Hmy (Not Specified)	cyanosis	J:253679
Kifbp^em2Hmy/Kifbp^em2Hmy (Not Specified)	cyanosis	J:253679
Kifbp^{tm1a(KOMP)Wtsi}/Kifbp⁺ (C57BL/6N-Kifbp^{tm1a(KOMP)Wtsi}/Wtsi)	increased circulating chloride level	J:211773
Kifbp^{tm1a(KOMP)Wtsi}/Kifbp^{tm1a(KOMP)Wtsi} (C57BL/6N-Kifbp^{tm1a(KOMP)Wtsi}/Wtsi)	subcutaneous edema	J:239583
Kin^em1(IMPC)J/Kin⁺ (C57BL/6NJ-Kin^em1(IMPC)J/Mmjax)	decreased circulating calcium level	J:211773
Kirrel1^{Gt(VICTR20)20Lex}/Kirrel1^{Gt(VICTR20)20Lex} (involves: 129S5/SvEvBrd * C57BL/6)	increased urine protein level	J:74230
Kirrel1^tm1.2Geno/Kirrel1^tm1.2Geno (involves: 129S2/SvPas * C57BL/6 * CBA)	increased urine protein level	J:241326
Kiss1^tm1Coll/Kiss1^tm1Coll (involves: 129S/SvEv * 129S6/SvEvTac)	abnormal circulating estradiol level	J:122381
	decreased circulating estradiol level	J:122381
	decreased circulating follicle stimulating hormone level	J:122381
	decreased circulating luteinizing hormone level	J:122381
	decreased circulating testosterone level	J:122381
Kiss1^tm1Rla/Kiss1^tm1Rla (involves: 129S1/SvImJ)	decreased circulating follicle stimulating hormone level	J:126704
Kiss1r^Gt1Stei/Kiss1r^Gt1Stei (involves: 129S1/SvImJ * C57BL/6)	decreased circulating luteinizing hormone level	J:127450, J:124098
Kiss1r^{tm1.1(KOMP)Vlcg}/Kiss1r^{tm1.1(KOMP)Vlcg} (C57BL/6N-Kiss1r^{tm1.1(KOMP)Vlcg}/Ucd)	increased circulating creatinine level	J:211773
Kiss1r^tm1.1Aeh/Kiss1r^tm1.1Aeh Tg(Gnrh1-cre)1Dlc/0 (involves: C57BL/6 * CBA)	decreased circulating follicle stimulating hormone level	J:206044
	decreased luteinizing hormone level	J:206044
Kiss1r^tm1.1Hjn/Kiss1r^tm1.1Hjn Tg(Gnrh1-cre)35Awo/0 (involves: 129 * C57BL/6 * CD-1)	abnormal follicle stimulating hormone level	J:212351
	abnormal luteinizing hormone level	J:212351
	decreased circulating follicle stimulating hormone level	J:212351
	decreased circulating luteinizing hormone level	J:212351
Kiss1r^tm1.1Lex/Kiss1r^tm1.1Lex (involves: 129S4/SvJae)	abnormal blood homeostasis	J:181650
	abnormal follicle stimulating hormone level	J:181650
	decreased circulating cholesterol level	J:181650
	decreased circulating follicle stimulating hormone level	J:181650
	decreased circulating gonadotropin level	J:181650
	decreased circulating luteinizing hormone level	J:181650
	decreased circulating total protein level	J:181650
	decreased circulating triglyceride level	J:181650
	increased blood urea nitrogen level	J:181650
	increased circulating alkaline phosphatase level	J:181650
	increased circulating glucose level	J:181650
	increased circulating serum albumin level	J:181650
Kiss1r^tm1Coll/Kiss1r^tm1Coll (involves: 129S6/SvEvTac)	decreased circulating estradiol level	J:96442
	decreased circulating follicle stimulating hormone level	J:96442, J:96108
	decreased circulating gonadotropin level	J:96442
	decreased circulating luteinizing hormone level	J:96442, J:96108
	decreased circulating testosterone level	J:96442
Kiss1r^tm1Rla/Kiss1r^tm1Rla (involves: 129S1/SvImJ)	decreased circulating follicle stimulating hormone level	J:126704
	decreased circulating testosterone level	J:126704
	decreased luteinizing hormone level	J:126704
Kit^Mhdasco5/Kit^Mhdasco5 (C3HeB/FeJ-Kit^Mhdasco5)	decreased circulating cholesterol level	J:125831
	decreased circulating HDL cholesterol level	J:125831
	decreased circulating LDL cholesterol level	J:125831
Kit^tm1.1Bsm/Kit^tm1.1Bsm (involves: 129S1/Sv * BALB/c * C57BL/6J * FVB/N)	increased circulating luteinizing hormone level	J:61141
Kit^tm1Rosay/Kit⁺ Lep^ob/Lep^ob (involves: 129S7/SvEvBrd * C57BL/6J)	hyperglycemia	J:168676
Kit^W-sh/Kit^W-sh (B6.Cg-Kit^W-sh/HNihrJaeBsmGlliJ)	decreased susceptibility to induced hypothermia	J:275367
Kit^W-sh/Kit^W-sh Lyn^tm1Ard/Lyn^tm1Ard (involves: 101 * 129P2/OlaHsd * C3H/HeH)	abnormal circulating complement protein level	J:161523
	albuminuria	J:161523
Kit^W-v/Kit^W-v (involves: C57BL/6)	increased bleeding time	J:7327
Kit^W/Kit^W-v ((WB/ReJ x C57BL/6J-Kit^W-v/J)F1-Kit^W/Kit^W-v/J)	abnormal interferon level	J:131785
	abnormal interleukin level	J:131785
	increased erythrocyte protoporphyrin level	J:5985
	increased urine protein level	J:113500
Kit^W/Kit^W-v ((WB Kit^W x B6.Cg-Kit^W-v)F1)	abnormal body temperature	J:197334
Kit^W/Kit^W-v ((WB Kit^W x B6.Cg-Kit^W-v)F1)	abnormal circulating histamine level	J:197334
Kitl^Sl/Kitl^Sl-d ((WC/ReJ Kitl^Sl x B6.D2-Kitl^Sl-d/J)F1-Kitl^Sl/Kitl^Sl-d/J)	increased erythrocyte protoporphyrin level	J:5985
Kitl^tm1Pbes/Kitl^tm1Pbes (involves: 129S1/Sv * C57BL/6J)	abnormal blood homeostasis	J:50150
Kl^ecalc1/Kl^ecalc1 (involves: C3H/HeH * C57BL/6J)	abnormal circulating protein level	J:229255
	calcinosis	J:229255
	decreased circulating glucose level	J:229255
	decreased circulating serum albumin level	J:229255
	increased circulating phosphate level	J:229255
	increased vitamin D level	J:229255
Kl^ecalc2/Kl^ecalc2 (involves: C3H/HeH * C57BL/6J)	calcinosis	J:229255
Kl^kl/Kl⁺ (involves: C3H/HeJ * C57BL/6J)	decreased circulating insulin level	J:64878
	decreased insulin secretion	J:64878
	hypoglycemia	J:64878
Kl^kl/Kl^kl (either: C.Cg-Kl^kl or (involves: C3H/HeJ * C57BL/6J))	abnormal circulating mineral level	J:44109
	calcinosis	J:44109
	decreased insulin secretion	J:44109
	hypoglycemia	J:44109
	increased circulating calcium level	J:44109
Kl^kl/Kl^kl (involves: C3H/HeJ * C57BL/6J)	decreased circulating insulin level	J:64878
	decreased insulin secretion	J:64878
	hypoglycemia	J:64878
	increased insulin sensitivity	J:64878
Kl^kl/Kl^kl (involves: C3H/J * C57BL/6J)	abnormal glucose homeostasis	J:66078
	decreased body temperature	J:66078
	decreased circulating insulin level	J:66078
	hypoglycemia	J:66078
	improved glucose tolerance	J:66078
	increased circulating noradrenaline level	J:102218
	increased insulin sensitivity	J:66078
Kl^m1Anu/Kl^m1Anu (C57BL/6NCrlAnu-Kl^m1Anu)	dehydration	J:104190
Kl^m1Anu/Kl^m1Anu (C57BL/6NCrlAnu-Kl^m1Anu)	increased circulating calcium level	J:104190
Kl^tm1.1Tel/Kl^tm1.1Tel Tg(Cdh16-cre)91Igr/0 (involves: C57BL/6 * ICR)	decreased circulating parathyroid hormone level	J:201719
	increased circulating parathyroid hormone level	J:201719
	increased circulating phosphate level	J:201719
	increased urine calcium level	J:201719
Kl^tm1.2Tel/Kl^tm1.2Tel (involves: C57BL/6 * FVB/N)	increased circulating calcium level	J:201719
Kl^tm1.2Tel/Kl^tm1.2Tel (involves: C57BL/6 * FVB/N)	increased circulating phosphate level	J:201719
Kl^tm1Lex/Kl^tm1Lex (B6.129S-Kl^tm1Lex)	increased circulating calcium level	J:173962
Kl^tm1Lex/Kl^tm1Lex (B6.129S-Kl^tm1Lex)	increased circulating phosphate level	J:173962
Kl^tm1Lex/Kl^tm1Lex Sfrp4^tm1.1Blan/Sfrp4^tm1.1Blan (involves: 129S/SvEvBrd * C57BL/6)	increased circulating phosphate level	J:173962
Kl^tm1Yin/Kl^tm1Yin (Not Specified)	abnormal vitamin D level	J:86859
	increased circulating calcium level	J:86859
	increased circulating phosphate level	J:86859
Klb^tm1.1Akha/Klb^tm1.1Akha (C57BL/6-Klb^tm1.1Akha)	abnormal circulating adiponectin level	J:195570
	abnormal circulating cholesterol level	J:195570
	abnormal circulating glucose level	J:195570
	abnormal circulating insulin level	J:195570
	abnormal circulating ketone body level	J:195570
	abnormal circulating leptin level	J:195570
	abnormal energy expenditure	J:195570
	decreased circulating cholesterol level	J:195570
	decreased circulating insulin level	J:195570
Klb^tm1.1Sakl/Klb^tm1.1Sakl Tg(Fabp4-cre)1Rev/0 (involves: 129 * C57BL/6 * SJL)	abnormal glucose homeostasis	J:189018
	increased insulin sensitivity	J:189018
Klb^tm1.2Sakl/Klb⁺ Tg(Apoe-Fgf21)1Sakl/0 (involves: 129 * 129S4/SvJaeSor * C57BL/6)	decreased circulating cholesterol level	J:189018
	decreased circulating free fatty acids level	J:189018
	decreased circulating glucose level	J:189018
	decreased circulating insulin level	J:189018
	decreased circulating leptin level	J:189018
	decreased circulating triglyceride level	J:189018
	decreased liver cholesterol level	J:189018
	decreased liver triglyceride level	J:189018
	improved glucose tolerance	J:189018
	increased circulating adiponectin level	J:189018
	increased insulin sensitivity	J:189018
Klb^tm1.2Sakl/Klb^tm1.2Sakl (involves: 129 * 129S4/SvJaeSor * C57BL/6)	abnormal glucose homeostasis	J:189018
	decreased circulating triglyceride level	J:189018
Klb^tm1.2Sakl/Klb^tm1.2Sakl Tg(Apoe-Fgf21)1Sakl/0 (involves: 129 * 129S4/SvJaeSor * C57BL/6)	abnormal blood homeostasis	J:189018
	abnormal glucose homeostasis	J:189018
	decreased circulating free fatty acids level	J:189018
Klb^tm1Yin/Klb^tm1Yin (involves: C57BL/6 * CBA)	abnormal bile salt homeostasis	J:100209
Klc2^{tm1e(EUCOMM)Wtsi}/Klc2^{tm1e(EUCOMM)Wtsi} (C57BL/6N-Klc2^{tm1e(EUCOMM)Wtsi}/Wtsi)	increased circulating free fatty acids level	J:211773
Klc3^em1(IMPC)J/Klc3^em1(IMPC)J (C57BL/6N-Klc3^em1(IMPC)J/J)	increased circulating alkaline phosphatase level	J:211773
Klf1^Nan/Klf1⁺ (involves: 101/H * C3H/HeH * PT)	increased kidney iron level	J:13933
	increased liver iron level	J:13933
	increased spleen iron level	J:13933
Klf2^tm1Mlkn/Klf2^tm1Mlkn Tg(Tek-cre)12Flv/? (involves: C3H * C57BL/6)	pericardial effusion	J:127228
Klf3^m1Cmhd/Klf3⁺ (involves: C3H/HeJ * C57BL/6J)	increased oxygen consumption	J:206507
Klf4^tm1Efu/Klf4^tm1Efu (Not Specified)	dehydration	J:56495
Klf4^tm1Efu/Klf4^tm1Efu (Not Specified)	impaired skin barrier function	J:56495
Klf4^tm1Khk/Klf4^tm1Khk Plekha5^{Tg(AMH-cre)1Flor}/Plekha5⁺ (involves: C57BL/6 * SJL)	decreased circulating testosterone level	J:132612
Klf5^tm1Jaw/Klf5^tm1Jaw Tg(Pax6-cre,GFP)1Pgr/0 (involves: FVB)	eyelid edema	J:175263
Klf5^tm2.1Rng/Klf5^tm2.1Rng Tg(Postn-cre)1Sjc/0 (involves: C57BL/6)	pulmonary alveolar edema	J:156696
	pulmonary edema	J:156696
Klf7^{tm1b(EUCOMM)Hmgu}/Klf7⁺ (C57BL/6N-Klf7^{tm1b(EUCOMM)Hmgu}/H)	decreased circulating serum albumin level	J:211773
	increased circulating aspartate transaminase level	J:211773
Klf7^tm1Rmz/Klf7^tm1Rmz (involves: 129/Sv * C57BL/6)	cyanosis	J:99181
Klf12^{tm1b(EUCOMM)Wtsi}/Klf12⁺ (C57BL/6N-Klf12^{tm1b(EUCOMM)Wtsi}/Orl)	decreased circulating calcium level	J:211773
	decreased circulating serum albumin level	J:211773
Klf14^{tm1.1(KOMP)Vlcg}/Klf14^{tm1.1(KOMP)Vlcg} (C57BL/6N-Klf14^{tm1.1(KOMP)Vlcg}/Ucd)	increased circulating alanine transaminase level	J:211773
Klf14^tm1.1Yec/Klf14^tm1.1Yec Speer6-ps1^{Tg(Alb-cre)21Mgn}/Speer6-ps1⁺ (involves: C57BL/6 * DBA)	decreased circulating HDL cholesterol level	J:226403
Klf15^hlb444/? (C57BL/6J-Klf15^hlb444/J)	increased circulating triglyceride level	J:77944
Klf15^tm1Jain/Klf15^tm1Jain (B6.129X1-Klf15^tm1Jain)	abnormal circulating amino acid level	J:129763
	abnormal gluconeogenesis	J:129763
	decreased circulating glucose level	J:129763
	decreased circulating lactate level	J:129763
	decreased liver glycogen level	J:129763
	hypoglycemia	J:129763
	improved glucose tolerance	J:129763
	increased circulating glucagon level	J:129763
	increased circulating ketone body level	J:129763
	increased glycerol level	J:129763
	ketoaciduria	J:129763
Klf16^em1(IMPC)J/Klf16⁺ (C57BL/6NJ-Klf16^em1(IMPC)J/Mmjax)	decreased circulating glucose level	J:211773
	decreased circulating total protein level	J:211773
	increased circulating phosphate level	J:211773
Klhdc2^{tm1b(EUCOMM)Hmgu}/Klhdc2⁺ (C57BL/6N-Klhdc2^{tm1b(EUCOMM)Hmgu}/H)	increased circulating creatinine level	J:211773
Klhdc10^em1(IMPC)J/Klhdc10^em1(IMPC)J (C57BL/6NJ-Klhdc10^em1(IMPC)J/Mmjax)	decreased circulating alkaline phosphatase level	J:211773
	increased circulating glucose level	J:211773
Klhdc10^tm1Hijo/Klhdc10^tm1Hijo (B6J.B6N-Klhdc10^tm1Hijo)	decreased circulating interleukin-6 level	J:251158
Klhl3^tm1.1Esoh/Klhl3⁺ (involves: C57BL/6)	hyperkalemia	J:214330
Klhl3^tm1.1Esoh/Klhl3⁺ (involves: C57BL/6)	metabolic acidosis	J:214330
Klhl3^tm1.1Esoh/Klhl3^tm1.1Esoh (involves: C57BL/6)	hyperkalemia	J:214330
Klhl3^tm1.1Esoh/Klhl3^tm1.1Esoh (involves: C57BL/6)	metabolic acidosis	J:214330
Klhl3^tm1.1Slin/Klhl3⁺ (Not Specified)	acidemia	J:284284
	decreased circulating bicarbonate level	J:284284
	decreased urine potassium level	J:284284
	hyperkalemia	J:284284
	increased circulating aldosterone level	J:284284
	increased circulating chloride level	J:284284
	metabolic acidosis	J:284284
Klhl3^tm1.1Slin/Klhl3^tm1.1Slin (Not Specified)	acidemia	J:284284
	decreased circulating bicarbonate level	J:284284
	decreased urine potassium level	J:284284
	hyperkalemia	J:284284
	increased circulating aldosterone level	J:284284
	increased circulating chloride level	J:284284
	metabolic acidosis	J:284284
Klhl3^{tm1b(KOMP)Wtsi}/Klhl3^{tm1b(KOMP)Wtsi} (C57BL/6N-Klhl3^{tm1b(KOMP)Wtsi}/H)	increased circulating alkaline phosphatase level	J:211773
	increased circulating potassium level	J:211773
Klhl3^tm2.1Esoh/Klhl3^tm2.1Esoh (involves: C57BL/6 * C57BL/6J)	acidemia	J:244278
	increased circulating chloride level	J:244278
	increased circulating potassium level	J:244278
Klhl5^{tm1b(EUCOMM)Hmgu}/Klhl5^{tm1b(EUCOMM)Hmgu} (C57BL/6N-Klhl5^{tm1b(EUCOMM)Hmgu}/Ccpcz)	increased circulating triglyceride level	J:211773
Klhl18^{tm1a(KOMP)Wtsi}/Klhl18^{tm1a(KOMP)Wtsi} (C57BL/6N-Klhl18^{tm1a(KOMP)Wtsi}/Wtsi)	increased circulating magnesium level	J:211773
Klhl24^em2Xtan/Klhl24⁺ (C57BL/6-Klhl24^em2Xtan)	abnormal protein level	J:327299
Klhl29^{tm1b(EUCOMM)Hmgu}/Klhl29^{tm1b(EUCOMM)Hmgu} (C57BL/6N-Klhl29^{tm1b(EUCOMM)Hmgu}/Ics)	decreased respiratory quotient	J:211773
Klhl32^em1(IMPC)J/Klhl32^em1(IMPC)J (C57BL/6NJ-Klhl32^em1(IMPC)J/Mmjax)	decreased fasting circulating glucose level	J:211773
	improved glucose tolerance	J:211773
Klk5^{tm2b(KOMP)Wtsi}/Klk5^{tm2b(KOMP)Wtsi} (C57BL/6N-Klk5^{tm2b(KOMP)Wtsi}/Ccpcz)	increased circulating phosphate level	J:211773
Klk6^tm1Gsot/Klk6^tm1Gsot (involves: C57BL/6)	abnormal cytokine level	J:270051
Klk6^tm1Gsot/Klk6^tm1Gsot Spink5^tm1Drh/Spink5^tm1Drh (involves: 129P2/OlaHsd * C57BL/6)	abnormal cytokine level	J:289877
	impaired skin barrier function	J:289877
Klk13^{em1(IMPC)Ccpcz}/Klk13^{em1(IMPC)Ccpcz} (C57BL/6N-Klk13^{em1(IMPC)Ccpcz}/Ccpcz)	increased circulating alanine transaminase level	J:211773
Klk14^{tm1.1(KOMP)Vlcg}/Klk14^{tm1.1(KOMP)Vlcg} (C57BL/6N-Klk14^{tm1.1(KOMP)Vlcg}/J)	increased urine microalbumin level	J:211773
Klkb1^tm1Tigm/Klkb1^tm1Tigm (involves: C57BL/6)	increased partial thromboplastin time	J:168556
Klra8^Cmv1-r/Klra8^Cmv1-r (C.B6-Klra8^Cmv1-r)	decreased transforming growth factor beta level	J:97203
Klra8^Cmv1-r/Klra8^Cmv1-r (C.B6-Klra8^Cmv1-r)	increased circulating interferon-gamma level	J:97203
Klra17^tm1.1Apma/Klra17^tm1.1Apma (involves: 129S1/Sv * 129X1/SvJ)	decreased circulating interferon-alpha level	J:152288
	decreased circulating interleukin-12 level	J:152288
Klrc1^tm1Mmka/Klrc1^tm1Mmka (B6.129-Klrc1^tm1Mmka)	increased circulating alanine transaminase level	J:222503
Klrc3^{em1(IMPC)Wtsi}/Klrc3⁺ (C57BL/6N-Klrc3^{em1(IMPC)Wtsi}/Wtsi)	increased circulating creatinine level	J:211773
Kmo^tm1.2Pjmi/Kmo^tm1.2Pjmi (FVB.B6(Cg)-Kmo^tm1.2Pjmi)	abnormal homeostasis	J:207199
Kmt2a^tm1.1Mlc/Kmt2a^tm1.1Mlc (involves: 129P2/OlaHsd * C57BL/6)	skin edema	J:183048
Kmt2a^tm2.1Mlc/Kmt2a^tm2.1Mlc (involves: 129P2/OlaHsd * C57BL/6)	skin edema	J:207555
Kmt2b^Gena263/Kmt2b⁺ (involves: BALB/c * C3H/HeH)	decreased insulin secretion	J:203736
	impaired glucose tolerance	J:203736
	increased circulating cholesterol level	J:203736
	increased circulating glucose level	J:79719, J:203736
	increased circulating insulin level	J:203736
	increased circulating triglyceride level	J:203736
	increased liver free fatty acids level	J:203736
	increased liver triglyceride level	J:203736
	insulin resistance	J:203736
Kmt2b^Gena263/Kmt2b^Gena263 (involves: BALB/c * C3H/HeH)	pericardial effusion	J:203736
Kmt2b^Gena263/Kmt2b^tm1Afst (involves: 129P2/OlaHsd * BALB/c * C3H/HeH)	edema	J:203736
	pericardial effusion	J:203736
Kmt2b^m1H/Kmt2b⁺ (involves: BALB/c * C3H/HeH)	decreased insulin secretion	J:203736
	impaired glucose tolerance	J:203736
	increased circulating glucose level	J:203736
	increased circulating insulin level	J:203736
	insulin resistance	J:203736
Kmt2b^tm1Afst/Kmt2b⁺ (involves: 129P2/OlaHsd)	decreased insulin secretion	J:203736
	impaired glucose tolerance	J:203736
	increased circulating glucose level	J:203736
	increased circulating insulin level	J:203736
	insulin resistance	J:203736
Kmt2b^tm1Afst/Kmt2b^tm1.1Afst Amhr2^tm3(cre)Bhr/Amhr2⁺ (involves: 129P2/OlaHsd * 129S/SvEv * C57BL/6)	increased circulating follicle stimulating hormone level	J:166778
Kmt2b^tm1Afst/Kmt2b^tm1.1Afst Tg(Gdf9-icre)5092Coo/0 (involves: 129 * 129P2/OlaHsd * C57BL/6)	decreased circulating estradiol level	J:166778
	increased circulating follicle stimulating hormone level	J:166778
	increased circulating luteinizing hormone level	J:166778
Kmt2b^tm1Afst/Kmt2b^tm1.1Afst Tg(Zp3-cre)3Mrt/0 (involves: 129 * 129P2/OlaHsd * C57BL/6 * FVB/N)	increased circulating follicle stimulating hormone level	J:166778
Kmt2c^tm1.1Jwle/Kmt2c⁺ Kmt2d^{Gt(RRT024)Byg}/Kmt2d⁺ (involves: 129P2/OlaHsd * 129X1/SvJ)	improved glucose tolerance	J:301497
	increased bile salt level	J:301497
	increased insulin sensitivity	J:301497
Kmt2d^{Gt(RRT024)Byg}/Kmt2d⁺ (involves: 129P2/OlaHsd)	decreased susceptibility to diet-induced obesity	J:301497
	improved glucose tolerance	J:301497
	increased bile salt level	J:301497
	increased insulin sensitivity	J:301497
Kmt2d^tm1.1Kaig/Kmt2d^tm1.1Kaig Mesp1^tm2(cre)Ysa/Mesp1⁺ (B6.Cg-Mesp1^tm2(cre)Ysa Kmt2d^tm1.1Kaig)	pericardial edema	J:229890
Kmt2d^tm1.1Kaig/Kmt2d^tm1.1Kaig Tg(Nkx2-1-cre)2Sand/0 (involves: C57BL/6)	decreased circulating glucose level	J:301083
Kmt5b^{tm1a(KOMP)Wtsi}/Kmt5b⁺ (B6JTyr;B6N-Kmt5b^{tm1a(KOMP)Wtsi}/Wtsi)	decreased circulating alanine transaminase level	J:175295
Kng1^tm1Krmc/Kng1^tm1Krmc (either: (involves: 129S7/SvEvBrd * C57BL/6J) or (involves: 129S7/SvEvBrd * CD-1))	abnormal blood coagulation	J:130769
	decreased susceptibility to induced thrombosis	J:130769
	increased partial thromboplastin time	J:130769
Kng2^{tm2a(EUCOMM)Wtsi}/Kng2^{tm2a(EUCOMM)Wtsi} (C57BL/6N-Kng2^{tm2a(EUCOMM)Wtsi}/Wtsi)	increased circulating creatinine level	J:211773
Knl1^{tm1b(EUCOMM)Hmgu}/Knl1⁺ (C57BL/6N-Knl1^{tm1b(EUCOMM)Hmgu}/Ieg)	impaired glucose tolerance	J:211773
Knop1^{tm1b(EUCOMM)Wtsi}/Knop1^{tm1b(EUCOMM)Wtsi} (C57BL/6N-Knop1^{tm1b(EUCOMM)Wtsi}/Bay)	increased circulating chloride level	J:211773
Knstrn^{tm1b(KOMP)Wtsi}/Knstrn^{tm1b(KOMP)Wtsi} (C57BL/6N-Knstrn^{tm1b(KOMP)Wtsi}/Ics)	increased fasting circulating glucose level	J:211773
Kntc1^{tm1b(EUCOMM)Hmgu}/Kntc1⁺ (C57BL/6N-Kntc1^{tm1b(EUCOMM)Hmgu}/J)	increased fasting circulating glucose level	J:211773
koro/koro (involves: C57BL/6 * FVB/N)	cardiac edema	J:173681
Kpna1^tm1.2Yyo/Kpna1^tm1.2Yyo (involves: 129S2/SvPas * C57BL/6 * SJL)	decreased circulating cholesterol level	J:188099
	decreased circulating progesterone level	J:188099
	increased circulating alanine transaminase level	J:188099
	increased circulating aspartate transaminase level	J:188099
Kpna2^em1(IMPC)Mbp/Kpna2⁺ (C57BL/6N-Kpna2^em1(IMPC)Mbp/Ucd)	abnormal cholesterol homeostasis	J:211773
Kprp^tm1Msug/Kprp⁺ (involves: C57BL/6)	impaired skin barrier function	J:286659
Kptn^{tm1a(EUCOMM)Wtsi}/Kptn^{tm1a(EUCOMM)Wtsi} (B6JTyr;B6N-Kptn^{tm1a(EUCOMM)Wtsi}/Wtsi)	increased circulating alkaline phosphatase level	J:175295
	increased circulating calcium level	J:175295
	increased circulating serum albumin level	J:175295
	increased circulating total protein level	J:175295
Kras^tm1Mok/Kras⁺ Nras^tm1Mok/Nras⁺ (involves: 129S/SvEv * C57BL/6 * DBA/2)	chylous ascites	J:159024
Kras^tm1Mok/Kras⁺ Nras^tm1Mok/Nras⁺ (B6.129S-Nras^tm1Mok Kras^tm1Mok)	chylous ascites	J:159024
Kras^tm1Mok/Kras⁺ Nras^tm1Mok/Nras^tm1Mok (involves: 129S/SvEv * C57BL/6 * DBA/2)	chylous ascites	J:159024
Kras^tm1Tyj/Kras⁺ Nras^tm1Rak/Nras^tm1Rak (involves: 129/Sv * C57BL/6)	hydrops fetalis	J:43433
Kras^tm1Tyj/Kras^tm1Tyj (involves: 129S2/SvPas)	pericardial edema	J:43433
Kras^tm4Tyj/Kras⁺ Meox2^tm1(cre)Sor/Meox2⁺ (involves: 129S4/SvJae * 129S4/SvJaeSor)	edema	J:119477
Kras^tm4Tyj/Kras⁺ Pten^tm1Hwu/Pten^tm1Hwu Tg(Pdx1-cre)89.1Dam/0 (involves: 129S4/SvJae * BALB/c * C57BL/6 * CBA)	edema	J:164210
Kras^tm4Tyj/Kras⁺ Pten^tm2.1Ppp/Pten^tm2.1Ppp Tg(TPO-cre)1Shk/0 (129.Cg-Kras^tm4Tyj Tg(Tpo-cre)1Shk Pten^tm2.1Ppp)	decreased circulating thyroid-stimulating hormone level	J:147732
	increased thyroxine level	J:147732
Kras^tm4Tyj/Kras⁺ Pten^tm2Mak/Pten^tm2Mak Speer6-ps1^{Tg(Alb-cre)21Mgn}/Speer6-ps1⁺ (involves: 129P2/OlaHsd * 129S4/SvJae * C57BL/6 * DBA)	hemorrhagic ascites	J:254370
Kras^tm4Tyj/Kras⁺ Tg(CAG-Bgeo,-tsA58T)T26Ichi/0 Tg(Pdx1-cre)6Tuv/0 (involves: 129P2/OlaHsd * 129S4/SvJae * C57BL/6 * FVB/N)	hemorrhagic ascites	J:214846
Kras^tm4Tyj/Kras⁺ Tg(Mx1-cre)1Cgn/0 (involves: 129S4/SvJae * C57BL/6 * CBA)	increased circulating erythropoietin level	J:115071
Kras^tm4Tyj/Kras⁺ Tg(Pdx1-cre)89.1Dam/0 (involves: 129S4/SvJae * C57BL/6 * CBA)	ascites	J:164210
Kras^tm4Tyj/Kras⁺ Tgfbr2^tm1.2Hlm/Tgfbr2^tm1.2Hlm Ptf1a^{tm1.1(cre)Cvw}/Ptf1a⁺ (involves: 129S/Sv * 129X1/SvJ * C57BL/6 * DBA/2)	abnormal hepatic portal vein thrombosis	J:116129
	hemorrhagic ascites	J:116129
Kras^tm4Tyj/Kras⁺ Trp53^tm2Tyj/Trp53⁺ Tg(Pdx1-cre)6Tuv/0 (involves: 129S4/SvJae * C57BL/6 * FVB/N)	hemorrhagic ascites	J:98936
Krit1^{tm1.1(KOMP)Vlcg}/Krit1⁺ (C57BL/6N-Krit1^{tm1.1(KOMP)Vlcg}/Ucd)	increased circulating alanine transaminase level	J:211773
Krt1^Mhdadsk12/Krt1^Mhdadsk12 (C3HeB/FeJ-Krt1^Mhdadsk12)	dehydration	J:108758
Krt1^tm1Tmm/Krt1^tm1Tmm (involves: 129 * C57BL/6)	abnormal circulating interleukin level	J:200244
	impaired skin barrier function	J:200244
	increased circulating interleukin-18 level	J:200244
Krt2^{tm1a(KOMP)Wtsi}/Krt2^{tm1a(KOMP)Wtsi} (involves: C57BL/6N)	impaired skin barrier function	J:214772
Krt7^{tm1b(KOMP)Wtsi}/Krt7^{tm1b(KOMP)Wtsi} (C57BL/6N-Krt7^{tm1b(KOMP)Wtsi}/Wtsi)	decreased circulating calcium level	J:211773
	decreased circulating free fatty acids level	J:211773
	decreased circulating HDL cholesterol level	J:211773
Krt8^{tm1b(EUCOMM)Hmgu}/Krt8⁺ (C57BL/6N-Krt8^{tm1b(EUCOMM)Hmgu}/Ics)	improved glucose tolerance	J:211773
Krt9^{tm1.1(KOMP)Vlcg}/Krt9^{tm1.1(KOMP)Vlcg} (C57BL/6N-Krt9^{tm1.1(KOMP)Vlcg}/J)	increased circulating iron level	J:211773
Krt16^{tm1(KOMP)Vlcg}/Krt16^{tm1(KOMP)Vlcg} (C57BL/6-Krt16^{tm1(KOMP)Vlcg})	impaired skin barrier function	J:184621
Krt17^{tm1.1(KOMP)Vlcg}/Krt17⁺ (C57BL/6N-Krt17^{tm1.1(KOMP)Vlcg}/J)	increased circulating alanine transaminase level	J:211773
Krt32^{em1(IMPC)Kmpc}/Krt32^{em1(IMPC)Kmpc} (C57BL/6NTac-Krt32^{em1(IMPC)Kmpc}/Kmpc)	increased blood urea nitrogen level	J:211773
	increased circulating cholesterol level	J:211773
Krt34^{em1(IMPC)Ccpcz}/Krt34^{em1(IMPC)Ccpcz} (C57BL/6NCrl-Krt34^{em1(IMPC)Ccpcz}/Ccpcz)	increased circulating cholesterol level	J:211773
Krt77^em1(IMPC)J/Krt77^em1(IMPC)J (C57BL/6NJ-Krt77^em1(IMPC)J/J)	increased circulating sodium level	J:211773
Krt80^em1(IMPC)J/Krt80^em1(IMPC)J (C57BL/6NJ-Krt80^em1(IMPC)J/J)	decreased circulating glucose level	J:211773
Krt87^{em1(IMPC)Wtsi}/Krt87^{em1(IMPC)Wtsi} (C57BL/6NCrl-Krt87^{em1(IMPC)Wtsi}/Wtsi)	increased circulating alkaline phosphatase level	J:211773
Krtap17-1^{tm1.1(KOMP)Vlcg}/Krtap17-1^{tm1.1(KOMP)Vlcg} (C57BL/6N-Krtap17-1^{tm1.1(KOMP)Vlcg}/Ucd)	decreased circulating cholesterol level	J:211773
	decreased circulating HDL cholesterol level	J:211773
Krtcap2^em1(IMPC)J/Krtcap2^em1(IMPC)J (C57BL/6NJ-Krtcap2^em1(IMPC)J/Mmjax)	decreased circulating bilirubin level	J:211773
	impaired glucose tolerance	J:211773
Ky^em1(IMPC)J/Ky⁺ (C57BL/6NJ-Ky^em1(IMPC)J/Mmjax)	increased circulating glucose level	J:211773
Kynu^em1(IMPC)J/Kynu^em1(IMPC)J (C57BL/6NJ-Kynu^em1(IMPC)J/Mmjax)	increased circulating bilirubin level	J:211773
L2hgdh^{Gt(DC0625)Wtsi}/L2hgdh^{Gt(DC0625)Wtsi} (involves: 129P2/OlaHsd * C57BL/6)	abnormal amino acid level	J:228407
L3mbtl3^em2(IMPC)Tcp/L3mbtl3⁺ (C57BL/6NCrl-L3mbtl3^em2(IMPC)Tcp/Tcp)	edema	J:211773
	increased circulating triglyceride level	J:211773
L3mbtl3^em2(IMPC)Tcp/L3mbtl3^em2(IMPC)Tcp (C57BL/6NCrl-L3mbtl3^em2(IMPC)Tcp/Tcp)	edema	J:211773
l4Jus12/l4Jus12 (Not Specified)	hydrops fetalis	J:109155
l4Jus25/l4Jus25 (involves: 129S7/SvEvBrd * C57BL/6)	pericardial edema	J:148802
l11Jus19/l11Jus19 (Not Specified)	hemopericardium	J:85113
Lacc1^em1Arkr/Lacc1^em1Arkr (C57BL/6NTac-Lacc1^em1Arkr)	decreased circulating interleukin-1 beta level	J:244365
Lacc1^em2Arkr/Lacc1^em2Arkr (C57BL/6NTac-Lacc1^em2Arkr)	decreased circulating interleukin-1 beta level	J:244365
Lacc1^em3Arkr/Lacc1^em3Arkr (C57BL/6NTac-Lacc1^em3Arkr)	increased circulating interleukin-1 beta level	J:244365
Lacc1^em4Arkr/Lacc1^em4Arkr (C57BL/6NTac-Lacc1^em4Arkr)	increased circulating interleukin-1 beta level	J:244365
Lacc1^{tm1a(KOMP)Wtsi}/Lacc1^{tm1a(KOMP)Wtsi} (involves: C57BL/6N * C57BL/6NTac)	decreased circulating tumor necrosis factor level	J:244365
	decreased fatty acids level	J:244365
	increased circulating interleukin-1 beta level	J:244365
Lactb^{tm1.1(KOMP)Mbp}/Lactb^{tm1.1(KOMP)Mbp} (C57BL/6N-Lactb^{tm1.1(KOMP)Mbp}/Ieg)	decreased circulating cholesterol level	J:211773
	decreased circulating HDL cholesterol level	J:211773
	increased circulating bilirubin level	J:211773
Lag3^tm1Daav/Lag3^tm1Daav Tg(Foxp3-EGFP/cre)1cJbs/0 (NOD.Cg-Lag3^tm1Daav Tg(Foxp3-EGFP/cre)1cJbs)	abnormal interleukin level	J:260063
	abnormal tumor necrosis factor level	J:260063
Lag3^tm1Doi/Lag3^tm1Doi (involves: 129S2/SvPas * C57BL/6)	abnormal dopamine level	J:235638
Lama1^{tm2b(EUCOMM)Hmgu}/Lama1⁺ (C57BL/6N-Lama1^{tm2b(EUCOMM)Hmgu}/Ieg)	increased circulating alanine transaminase level	J:211773
Lama2^dy/Lama2^dy (B6.129P1-Lama2^dy/J)	increased circulating prolactin level	J:5000
Lama2^dy/Lama2^dy (129P1/ReJ-Lama2^dy/J)	abnormal galactolipid level	J:7911
	abnormal lipid level	J:7911
	increased cholesterol level	J:7911
Lama3^tm1.1Grsb/Lama3^tm1.1Grsb (involves: C57BL/6)	abnormal chemokine level	J:235712
	abnormal protein level	J:235712
	abnormal tumor necrosis factor level	J:235712
	increased collagen level	J:235712
Lama3^tm1Arte/Lama3^tm1Arte Tg(KRT14-cre/ERT)20Efu/0 (involves: C57BL/6 * CD-1)	increased collagen level	J:240054
Lama4^{tm1.1(KOMP)Vlcg}/Lama4^{tm1.1(KOMP)Vlcg} (C57BL/6N-Lama4^{tm1.1(KOMP)Vlcg}/Ucd)	increased circulating alkaline phosphatase level	J:211773
Lama4^tm1Ktry/Lama4^tm1Ktry (either: B6.129X1-Lama4^tm1Ktry or (involves: 129X1/SvJ * C57BL/6))	abnormal circulating bilirubin level	J:74287
Lama4^tm1Ktry/Lama4^tm1Ktry (B6.129X1-Lama4^tm1Ktry)	hypoxia	J:105789
Lama5^mpc205H/Lama5^mpc205H (involves: BALB/c * C3H/HeH * C57BL/6J)	increased blood urea nitrogen level	J:234901
	increased circulating creatinine level	J:234901
Lama5^tm1Jhm/Lama5^tm2Jhm Tg(SFTPC-rtTA)5Jaw/? Tg(tetO-cre)1Jaw/? (involves: 129S1/Sv * 129X1/SvJ)	cyanosis	J:104565
Lama5^tm2Jhm/Lama5^tm1Jhm Tg(NPHS2-cre)295Lbh/0 (involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * CBA * SJL)	decreased circulating serum albumin level	J:185850
	edema	J:185850
	hematuria	J:185850
	increased circulating cholesterol level	J:185850
	increased urine protein level	J:185850
Lama5^tm3Jhm/Lama5^tm3Jhm (involves: 129S1/Sv * 129X1/SvJ)	increased blood urea nitrogen level	J:128225
Lama5^tm3Jhm/Lama5^tm3Jhm (involves: 129S1/Sv * 129X1/SvJ)	increased urine protein level	J:128225
Lama5^tm3Jhm/Lama5^tm3Jhm (involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * CBA)	hematuria	J:185850
	increased urine protein level	J:185850
Lamb2^npht/Lamb2^npht (involves: C57BL/6)	decreased circulating serum albumin level	J:208069
	decreased circulating total protein level	J:208069
	increased circulating cholesterol level	J:208069
	increased circulating triglyceride level	J:208069
	increased urine protein level	J:208069
Lamb2^tm1Jrs/Lamb2^tm1Jrs (involves: 129S1/Sv * 129X1/SvJ)	albuminuria	J:27732
Lamb2^tm1Jrs/Lamb2^tm1Jrs (involves: 129S1/Sv * 129X1/SvJ)	increased urine protein level	J:27732, J:23783
Lamp1^em1(IMPC)Mbp/Lamp1^em1(IMPC)Mbp (C57BL/6N-Lamp1^em1(IMPC)Mbp/MbpMmucd)	increased circulating phosphate level	J:211773
Lamp2^tm1.2Ces/Y (involves: 129 * 129S4/SvJae * 129S6/SvEvTac * C57BL/6 * SJL)	increased cardiac muscle glycogen level	J:328713
	increased circulating troponin T level	J:328713
Lamp2^tm1Amcu/Y Speer6-ps1^{Tg(Alb-cre)21Mgn}/Speer6-ps1⁺ (involves: 129S6/SvEvTac * C57BL/6 * C57BL/6J)	abnormal glucose homeostasis	J:215605
	abnormal lipid homeostasis	J:215605
	decreased fasting circulating glucose level	J:215605
	decreased hepatic glucose production	J:215605
	decreased liver glycogen level	J:215605
	improved glucose tolerance	J:215605
	increased carbon dioxide production	J:215605
	increased circulating alanine transaminase level	J:215605
	increased energy expenditure	J:215605
	increased liver triglyceride level	J:215605
	increased oxygen consumption	J:215605
	increased respiratory quotient	J:215605
Lamp2^tm1Psa/Lamp2^tm1Psa (either: (involves: 129P2/OlaHsd * 129/Sv * C57BL/6J) or (involves: 129P2/OlaHsd * 129/Sv))	abnormal circulating amino acid level	J:64151
Lamp5^em1(IMPC)J/Lamp5^em1(IMPC)J (C57BL/6NJ-Lamp5^em1(IMPC)J/J)	decreased circulating serum albumin level	J:211773
Lamtor2^tm1.1Lah/Lamtor2^tm1.1Lah Tg(KRT5-cre)1Tak/0 (involves: 129P2/OlaHsd * C3H * C57BL/6 * SJL)	impaired skin barrier function	J:119075
Lamtor5^tm1Lye/Lamtor5^tm1Lye (Not Specified)	decreased insulin secretion	J:258406
Lamtor5^tm1Lye/Lamtor5^tm1Lye Tg(Ins2-cre)25Mgn/0 (involves: C57BL/6 * DBA)	decreased circulating insulin level	J:258406
	decreased insulin secretion	J:258406
	impaired glucose tolerance	J:258406
	increased fasting circulating glucose level	J:258406
Lancl3^em1(IMPC)H/Y (C57BL/6N-Lancl3^em1(IMPC)H/H)	increased circulating serum albumin level	J:211773
Lao1^tm1Oka/Lao1^tm1Oka (involves: 129S2/SvPas * C57BL/6J)	abnormal interleukin level	J:260668
Laptm4a^{tm1b(EUCOMM)Hmgu}/Laptm4a^{tm1b(EUCOMM)Hmgu} (C57BL/6N-Laptm4a^{tm1b(EUCOMM)Hmgu}/Ics)	increased fasting circulating glucose level	J:211773
Laptm4b^{tm1e.1(KOMP)Wtsi}/Laptm4b^{tm1e.1(KOMP)Wtsi} (C57BL/6N-Laptm4b^{tm1e.1(KOMP)Wtsi}/Tcp)	edema	J:211773
Large1^myd/Large1^myd (B6C3Fe a/a-Large1^myd/J)	increased circulating creatine kinase level	J:27793
Large1^vls/Large1^vls (B6.CAST(Cg)-Large1^vls/Pjn)	increased circulating creatinine level	J:100214
Larp1^em1(IMPC)Mbp/Larp1⁺ (C57BL/6N-Larp1^em1(IMPC)Mbp/Ucd)	decreased circulating cholesterol level	J:211773
Larp1^em1(IMPC)Mbp/Larp1⁺ (C57BL/6N-Larp1^em1(IMPC)Mbp/Ucd)	decreased circulating HDL cholesterol level	J:211773
Larp1^{tm1c(EUCOMM)Hmgu}/Larp1^{tm1c(EUCOMM)Hmgu} Tg(Ins2-cre)23Herr/0 (involves: C57BL/6J * C57BL/6N * CBA/J)	impaired glucose tolerance	J:300456
Larp4b^{em1(IMPC)Wtsi}/Larp4b^{em1(IMPC)Wtsi} (C57BL/6N-Larp4b^{em1(IMPC)Wtsi}/Wtsi)	increased circulating insulin level	J:211773
Larp6^em1(IMPC)Tcp/Larp6^em1(IMPC)Tcp (C57BL/6NCrl-Larp6^em1(IMPC)Tcp/Tcp)	increased circulating alkaline phosphatase level	J:211773
	increased circulating triglyceride level	J:211773
Lasp1^{Tg(Col1a1-lacZ)1Ngma}/Lasp1^{Tg(Col1a1-lacZ)1Ngma} (involves: C57BL/6)	abnormal response to vitamins	J:153789
Lat2^tm1Wz/Lat2^tm1Wz (Not Specified)	increased circulating interleukin-6 level	J:181866
Lat2^tm1Wz/Lat2^tm1Wz (Not Specified)	increased circulating tumor necrosis factor level	J:181866
Lat^em1(IMPC)Ics/Lat^em1(IMPC)Ics (C57BL/6N-Lat^em1(IMPC)Ics/Ics)	increased circulating bilirubin level	J:211773
Lat^tm1.1Mal/Lat^tm1.1Mal (involves: 129S2/SvPas)	albuminuria	J:125722
Lat^tm1.1Mal/Lat^tm1.1Mal (involves: 129S2/SvPas)	increased blood urea nitrogen level	J:125722
Lat^tm1.1Mal/Lat^tm1.1Mal Rag1^tm1Bal/Rag1^tm1Bal (involves: 129S2/SvPas * 129S4/SvJae)	abnormal platelet dense granule physiology	J:125744
	decreased platelet aggregation	J:125744
Lat^tm1Bpay/Lat^tm1Bpay (involves: 129S2/SvPas)	abnormal platelet aggregation	J:103904
Lat^tm2.1Mal/Lat^tm2.1Mal Rag1^tm1Bal/Rag1^tm1Bal (involves: 129S2/SvPas * 129S4/SvJae)	abnormal platelet dense granule physiology	J:125744
	abnormal thrombosis	J:125744
	decreased platelet aggregation	J:125744
Lat^tm4.1Mal/Lat^tm4.1Mal (involves: 129P2/OlaHsd)	abnormal thrombosis	J:125744
Lat^tm4.1Mal/Lat^tm4.1Mal (involves: 129P2/OlaHsd)	decreased platelet aggregation	J:125744
Lats1^em1(IMPC)H/Lats1^em1(IMPC)H (C57BL/6NTac-Lats1^em1(IMPC)H/H)	increased circulating alanine transaminase level	J:211773
Lats1^tm1Tx/Lats1^tm1Tx (involves: 129S2/SvPas * C57BL/6J)	decreased circulating growth hormone level	J:52536
	decreased circulating luteinizing hormone level	J:52536
	decreased circulating prolactin level	J:52536
Lats2^tm1Raz/Lats2^tm1Raz (involves: 129P2/OlaHsd * C57BL/6)	hemopericardium	J:93191
Lbp^{tm1b(EUCOMM)Hmgu}/Lbp^{tm1b(EUCOMM)Hmgu} (C57BL/6N-Lbp^{tm1b(EUCOMM)Hmgu}/H)	increased circulating fructosamine level	J:211773
	increased fasting circulating glucose level	J:211773
Lbp^tm1Buru/Lbp^tm1Buru (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	abnormal blood homeostasis	J:44878
Lbp^tm1Buru/Lbp^tm1Buru (involves: 129S1/Sv * 129X1/SvJ * BALB/c)	abnormal nitric oxide homeostasis	J:67090
Lbp^tm1Buru/Lbp^tm1Buru (B6.129-Lbp^tm1Buru)	abnormal chemokine level	J:129411
Lbr^em1(IMPC)Tcp/Lbr^em1(IMPC)Tcp (C57BL/6N-Lbr^em1(IMPC)Tcp/Tcp)	decreased circulating alkaline phosphatase level	J:211773
Lbr^ic-J/Lbr⁺ Tm7sf2^tm1Fdp/Tm7sf2^tm1Fdp (involves: 129S4/SvJae * C57BL/6)	abnormal homeostasis	J:143838
Lbw2^NZW/LacScr/Lbw2^NZW/LacScr (involves: NZB * NZW)	edema	J:98150
Lbw2^NZW/LacScr/Lbw2^NZW/LacScr (involves: NZB * NZW)	increased urine protein level	J:98150
Lbx2^tm1Fchn/Lbx2^tm1Fchn Pax3^Sp/Pax3^Sp (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	edema	J:121890
Lca5l^em1(IMPC)Ics/Lca5l^em1(IMPC)Ics (C57BL/6N-Lca5l^em1(IMPC)Ics/Ics)	increased circulating bilirubin level	J:211773
	increased circulating cholesterol level	J:211773
Lcat^tm1Hgc/Lcat⁺ (involves: C57BL/6 * DBA)	abnormal circulating protein level	J:41208
Lcat^tm1Hgc/Lcat⁺ (involves: C57BL/6 * DBA)	decreased circulating cholesterol level	J:41208
Lcat^tm1Hgc/Lcat^tm1Hgc (involves: C57BL/6 * DBA)	abnormal circulating protein level	J:41208
	abnormal lipid homeostasis	J:41208
	abnormal lipid level	J:41208
	decreased cholesterol level	J:41208
	decreased circulating cholesterol level	J:41208
	decreased circulating HDL cholesterol level	J:41208
	increased cholesterol level	J:41208
Lcat^tm1Hgc/Lcat^tm1Hgc (involves: 129P2/OlaHsd * C57BL/6 * DBA)	abnormal cholesterol homeostasis	J:75567
	abnormal circulating protein level	J:75567
	abnormal lipid homeostasis	J:75567
	decreased circulating HDL cholesterol level	J:75567
Lcat^tm1Hgc/Lcat^tm1Hgc Ldlr^tm1Her/Ldlr^tm1Her (involves: 129P2/OlaHsd * 129S7/SvEvBrd * C57BL/6 * DBA)	abnormal cholesterol homeostasis	J:89015, J:75567
	abnormal circulating protein level	J:75567
	abnormal lipid homeostasis	J:89015, J:75567
	decreased circulating glucose level	J:89015
	decreased circulating HDL cholesterol level	J:89015, J:75567
	decreased circulating insulin level	J:89015
	decreased circulating LDL cholesterol level	J:89015
	increased circulating cholesterol level	J:75567
	increased circulating triglyceride level	J:89015, J:75567
	increased circulating VLDL cholesterol level	J:89015, J:75567
Lcat^tm1Hgc/Lcat^tm1Hgc Tg(SREBP1a)7343Reh/? (involves: 129 * C57BL/6 * C57BL/6J * SJL)	abnormal lipid homeostasis	J:93775
	albuminuria	J:93775
	decreased circulating HDL cholesterol level	J:93775
	decreased circulating LDL cholesterol level	J:93775
	decreased circulating triglyceride level	J:93775
	increased circulating cholesterol level	J:93775
	increased circulating phospholipid level	J:93775
	increased circulating VLDL cholesterol level	J:93775
Lcat^tm1Nsa/Lcat⁺ (involves: 129X1/SvJ * C57BL/6J)	abnormal cholesterol homeostasis	J:39237
	abnormal lipid level	J:39237
	decreased circulating cholesterol level	J:39237
	decreased circulating HDL cholesterol level	J:39237
	increased circulating triglyceride level	J:39237
Lcat^tm1Nsa/Lcat^tm1Nsa (involves: 129X1/SvJ * C57BL/6J)	abnormal cholesterol homeostasis	J:39237
	abnormal lipid level	J:39237
	decreased circulating cholesterol level	J:39237
	decreased circulating HDL cholesterol level	J:39237
	increased circulating triglyceride level	J:39237
Lcat^tm1Nsa/Lcat^tm1Nsa (B6.Cg-Lcat^tm1Nsa)	abnormal circulating phospholipid level	J:69299
	abnormal lipid level	J:69299
	decreased circulating cholesterol level	J:69299
	decreased circulating HDL cholesterol level	J:69299
	decreased circulating VLDL cholesterol level	J:69299
	increased circulating triglyceride level	J:69299
	increased urine protein level	J:69299
Lce1m^{tm1b(EUCOMM)Wtsi}/Lce1m^{tm1b(EUCOMM)Wtsi} (C57BL/6N-Lce1m^{tm1b(EUCOMM)Wtsi}/Wtsi)	increased circulating creatinine level	J:211773
Lch/Lch⁺ (involves: BALB/c * C3H/HeH)	decreased circulating cholesterol level	J:72447, J:79719
Lch/Lch⁺ (involves: BALB/c * C3H/HeH)	decreased circulating HDL cholesterol level	J:72447, J:79719
Lch2/Lch2⁺ (involves: BALB/c * C3H/HeH)	decreased circulating cholesterol level	J:79719, J:79307
Lch2/Lch2⁺ (involves: BALB/c * C3H/HeH)	decreased circulating HDL cholesterol level	J:79719, J:79307
Lclat1^em1(IMPC)Mbp/Lclat1^em1(IMPC)Mbp (C57BL/6N-Lclat1^em1(IMPC)Mbp/MbpMmucd)	increased circulating alanine transaminase level	J:211773
	increased circulating alkaline phosphatase level	J:211773
Lclat1^tm1Arai/Lclat1^tm1Arai (C57BL/6-Lclat1^tm1Arai)	abnormal lipid homeostasis	J:183129
Lclat1^tm1Yugs/Lclat1^tm1Yugs (B6.Cg-Lclat1^tm1Yugs)	abnormal lipid homeostasis	J:163077
	decreased circulating glucose level	J:163077
	decreased circulating insulin level	J:163077
	decreased susceptibility to diet-induced obesity	J:163077
	increased energy expenditure	J:163077
	increased fatty acid oxidation	J:163077
	increased insulin sensitivity	J:163077
	increased oxygen consumption	J:163077
	increased respiratory quotient	J:163077
Lcmt1^{em1(IMPC)Rbrc}/Lcmt1⁺ (C57BL/6NJcl-Lcmt1^{em1(IMPC)Rbrc}/Rbrc)	abnormal circulating phosphate level	J:211773
Lcmt1^{Gt(CSC099)Byg}/Lcmt1^{Gt(CSC099)Byg} (involves: 129P2/OlaHsd * C57BL/6)	impaired glucose tolerance	J:201873
	increased circulating insulin level	J:201873
	insulin resistance	J:201873
Lcn2^tm1Aade/Lcn2^tm1Aade (B6.129P2-Lcn2^tm1Aade)	decreased circulating adiponectin level	J:169355
	impaired adaptive thermogenesis	J:169355
	impaired glucose tolerance	J:169355
	increased circulating cholesterol level	J:169355
	increased circulating insulin level	J:169355
	increased circulating LDL cholesterol level	J:169355
	increased fasting circulating glucose level	J:169355
	increased liver triglyceride level	J:169355
	increased susceptibility to diet-induced obesity	J:169355
	insulin resistance	J:169355
Lcn2^{tm1b(KOMP)Wtsi}/Lcn2^{tm1b(KOMP)Wtsi} (C57BL/6N-Lcn2^{tm1b(KOMP)Wtsi}/J)	decreased circulating glucose level	J:211773
	decreased circulating iron level	J:211773
	decreased circulating serum albumin level	J:211773
	increased urine microalbumin level	J:211773
Lcn6^tm1.1Ylzh/Lcn6^tm1.1Ylzh Ndor1^{Tg(UBC-cre/ERT2)1Ejb}/Ndor1⁺ (involves: 129S/SvEv * C57BL/6)	abnormal calcium ion homeostasis	J:256079
Lcp1^{tm1e.1(KOMP)Wtsi}/Lcp1⁺ (C57BL/6N-Lcp1^{tm1e.1(KOMP)Wtsi}/J)	increased fasting circulating glucose level	J:211773
Lcp2^tm1Gak/Lcp2^tm1Gak (involves: 129S1/Sv * 129X1/SvJ)	abnormal platelet activation	J:162815
Lcp2^tm1Gak/Lcp2^tm1Gak (involves: 129S1/Sv * 129X1/SvJ)	decreased platelet aggregation	J:162815
Lcp2^tm1Gak/Lcp2^tm2Gak Tg(Pf4-icre)Q3Rsko/0 Gt(ROSA)26Sor^tm1(EYFP)Cos/Gt(ROSA)26Sor⁺ (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	abnormal platelet activation	J:162815
Lcp2^tm1Gak/Lcp2^tm2Gak Tg(VAV1-cre)1Graf/0 Gt(ROSA)26Sor^tm1(EYFP)Cos/Gt(ROSA)26Sor⁺ (involves: 129S1/Sv * 129X1/SvJ)	intestinal edema	J:162815
Ldb1^tm1Witz/Ldb1^tm1Witz Tg(NPHS2-cre)295Lbh/0 (involves: C57BL/6 * SJL)	albuminuria	J:122505
Ldb3^tm1Chen/Ldb3^tm1Chen (involves: 129S1/Sv * 129X1/SvJ * Black Swiss)	cyanosis	J:72799
Ldha^a-m1Neu/Ldha^a-m1Neu (C3.Cg-Ldha^a-m1Neu)	increased circulating bilirubin level	J:14326
Ldha^{tm1a(EUCOMM)Wtsi}/Ldha⁺ (B6JTyr;B6N-Ldha^{tm1a(EUCOMM)Wtsi}/Wtsi)	decreased circulating alanine transaminase level	J:175295
	decreased circulating alkaline phosphatase level	J:175295
	decreased circulating HDL cholesterol level	J:175295
	decreased lactate dehydrogenase level	J:175295
Ldlr^Hlb301/Ldlr⁺ (C57BL/6J-Ldlr^Hlb301/J)	increased circulating cholesterol level	J:82961
Ldlr^Hlb301/Ldlr⁺ (C57BL/6J-Ldlr^Hlb301/J)	increased circulating HDL cholesterol level	J:82961
Ldlr^Hlb301/Ldlr^Hlb301 (C57BL/6J-Ldlr^Hlb301/J)	increased circulating cholesterol level	J:82961
Ldlr^Hlb301/Ldlr^Hlb301 (C57BL/6J-Ldlr^Hlb301/J)	increased circulating HDL cholesterol level	J:82961
Ldlr^Rgsc366/Ldlr⁺ (involves: C57BL/6JJcl * DBA/2JJcl)	increased circulating cholesterol level	J:133634
Ldlr^tm1(LDLR)Mae/Ldlr⁺ (involves: 129S6/SvEvTac * C57BL/6)	abnormal circulating lipid level	J:67282
	decreased circulating cholesterol level	J:67282
	decreased circulating HDL cholesterol level	J:67282
Ldlr^{tm1b(EUCOMM)Wtsi}/Ldlr^{tm1b(EUCOMM)Wtsi} (C57BL/6N-Ldlr^{tm1b(EUCOMM)Wtsi}/Ieg)	decreased circulating unsaturated transferrin level	J:211773
	increased circulating cholesterol level	J:211773
	increased circulating HDL cholesterol level	J:211773
	increased circulating iron level	J:211773
Ldlr^tm1Her/Ldlr⁺ (involves: 129S7/SvEvBrd * C57BL/6 * DBA/2)	hyperglycemia	J:100916
Ldlr^tm1Her/Ldlr⁺ (B6.129S7-Ldlr^tm1Her)	increased circulating cholesterol level	J:72027
Ldlr^tm1Her/Ldlr⁺ (B6.129S7-Ldlr^tm1Her)	increased circulating triglyceride level	J:72027
Ldlr^tm1Her/Ldlr⁺ Lep^ob/Lep^ob (B6.Cg-Lep^ob Ldlr^tm1Her)	increased circulating cholesterol level	J:72027
	increased circulating HDL cholesterol level	J:72027
	increased liver cholesterol level	J:72027
	increased liver triglyceride level	J:72027
Ldlr^tm1Her/Ldlr⁺ Tg(H2-K-AKR1B1)1Tj/0 (involves: 129S7/SvEvBrd * C57BL/6 * DBA/2)	hyperglycemia	J:100916
Ldlr^tm1Her/Ldlr^tm1Her (involves: 129S7/SvEvBrd * C57BL/6)	abnormal circulating amino acid level	J:146932
	abnormal glucose homeostasis	J:84844
	decreased circulating corticosterone level	J:108412
	impaired glucose tolerance	J:84844
	increased circulating alanine transaminase level	J:175559
	increased circulating cholesterol level	J:175559
	increased circulating free fatty acids level	J:175559
	increased circulating glucose level	J:84844
	increased circulating insulin level	J:84844
	increased circulating LDL cholesterol level	J:102291
	increased circulating triglyceride level	J:175559
	increased liver cholesterol level	J:175559
	increased liver triglyceride level	J:175559
	insulin resistance	J:84844
Ldlr^tm1Her/Ldlr^tm1Her (involves: 129S7/SvEvBrd)	abnormal circulating cholesterol level	J:48202
	abnormal circulating LDL cholesterol level	J:84694
	increased circulating cholesterol level	J:84694, J:228420, J:48202
	increased circulating LDL cholesterol level	J:114949, J:169834, J:84694
	increased circulating triglyceride level	J:48202
Ldlr^tm1Her/Ldlr^tm1Her (involves: 129S6/SvEvTac * 129S7/SvEvBrd * C57BL/6)	increased circulating cholesterol level	J:96110
Ldlr^tm1Her/Ldlr^tm1Her (B6.129S7-Ldlr^tm1Her)	abnormal circulating cholesterol level	J:100916, J:130278
	abnormal triglyceride level	J:130278
	decreased circulating HDL cholesterol level	J:130794
	decreased circulating interleukin-10 level	J:130794
	hyperglycemia	J:100916, J:130278
	impaired glucose tolerance	J:130278
	increased circulating cholesterol level	J:61287, J:135078, J:137264, J:72027
	increased circulating HDL cholesterol level	J:72027
	increased circulating insulin level	J:130278
	increased circulating interleukin-1 beta level	J:137264
	increased circulating interleukin-6 level	J:137264
	increased circulating LDL cholesterol level	J:130794, J:72027
	increased circulating triglyceride level	J:130278, J:137264, J:72027
	increased circulating tumor necrosis factor level	J:137264
	increased circulating VLDL cholesterol level	J:130278, J:130794
	increased circulating VLDL triglyceride level	J:130278
	increased liver cholesterol level	J:72027
	increased liver triglyceride level	J:130278
Ldlr^tm1Her/Ldlr^tm1Her (B6.129S7-Ldlr^tm1Her/J)	decreased circulating triglyceride level	J:85174
	increased cholesterol level	J:85174
	increased circulating cholesterol level	J:104609, J:85174
	increased circulating HDL cholesterol level	J:85174
	increased circulating LDL cholesterol level	J:85174, J:149005
	increased circulating triglyceride level	J:149005
	increased circulating VLDL cholesterol level	J:85174, J:149005
	increased liver cholesterol level	J:85174
Ldlr^tm1Her/Ldlr^tm1Her (involves: 129P2/OlaHsd * 129S7/SvEvBrd * C57BL/6 * DBA)	abnormal cholesterol homeostasis	J:75567
	abnormal circulating protein level	J:75567
	abnormal lipid homeostasis	J:75567
Ldlr^tm1Her/Ldlr^tm1Her (involves: 129S7/SvEvBrd * C57BL/6 * SJL)	increased circulating cholesterol level	J:114480
	increased circulating LDL cholesterol level	J:114480
Ldlr^tm1Her/Ldlr^tm1Her (involves: 129S7/SvEvBrd * C57BL/6J)	increased circulating cholesterol level	J:29950
Ldlr^tm1Her/Ldlr^tm1Her Lep^ob/Lep^ob (B6.Cg-Lep^ob Ldlr^tm1Her)	abnormal circulating cholesterol level	J:72027
	hyperlipidemia	J:72027
	increased circulating cholesterol level	J:72027
	increased circulating HDL cholesterol level	J:72027
	increased circulating triglyceride level	J:72027
	increased liver cholesterol level	J:72027
	increased liver triglyceride level	J:72027
Ldlr^tm1Her/Ldlr^tm1Her Lipc^tm1Unc/Lipc^tm1Unc (involves: 129P2/OlaHsd * 129S7/SvEvBrd * C57BL/6)	abnormal lipid level	J:108412
	decreased circulating corticosterone level	J:108412
	increased circulating cholesterol level	J:108412
	increased circulating HDL cholesterol level	J:108412
	increased circulating LDL cholesterol level	J:108412
Ldlr^tm1Her/Ldlr^tm1Her Lrp1^tm2Her/Lrp1^tm2Her (involves: 129S7/SvEvBrd)	abnormal cholesterol level	J:67929
	abnormal circulating apolipoprotein E level	J:67929
	abnormal circulating apolipoprotein level	J:67929
	increased circulating cholesterol level	J:67929
	increased circulating LDL cholesterol level	J:67929
	increased circulating triglyceride level	J:67929
	increased circulating VLDL cholesterol level	J:67929
Ldlr^tm1Her/Ldlr^tm1Her Lrp1^tm2Her/Lrp1^tm2Her Tg(Mx1-cre)29-4Her/0 (involves: 129S7/SvEvBrd * C57BL/6 * SJL)	increased circulating cholesterol level	J:117317
	increased circulating factor VIII level	J:117317
	increased circulating triglyceride level	J:117317
	increased circulating von Willebrand factor level	J:117317
Ldlr^tm1Her/Ldlr^tm1Her Lrp1^tm2Her/Lrp1^tm2Her Tg(Mx1-cre)29-4Her/0 (involves: 129S7/SvEvBrd * C57BL/6J * SJL)	abnormal circulating apolipoprotein level	J:67929
	increased circulating cholesterol level	J:67929
	increased circulating LDL cholesterol level	J:67929
	increased circulating triglyceride level	J:67929
	increased circulating VLDL cholesterol level	J:67929
Ldlr^tm1Her/Ldlr^tm1Her Lrp1^tm2Her/Lrp1^tm2Her Vldlr^tm1Her/Vldlr^tm1Her Tg(Mx1-cre)29-4Her/0 (involves: 129S7/SvEvBrd * C57BL/6 * SJL)	increased circulating factor VIII level	J:117317
Ldlr^tm1Her/Ldlr^tm1Her Lrpap1^tm1Her/Lrpap1^tm1Her (involves: 129S7/SvEvBrd * C57BL/6J)	abnormal lipid level	J:43736
	increased circulating cholesterol level	J:43736
	increased circulating triglyceride level	J:43736
Ldlr^tm1Her/Ldlr^tm1Her Mapkapk2^tm1Mgl/Mapkapk2^tm1Mgl (involves: 129P2/OlaHsd * 129S7/SvEvBrd * C57BL/6)	increased circulating cholesterol level	J:142788
Ldlr^tm1Her/Ldlr^tm1Her Mobq5^CAST/EiJ/Mobq5^CAST/EiJ (B6.CAST-Mobq5^CAST/EiJ)	abnormal circulating VLDL cholesterol level	J:116503
	decreased circulating cholesterol level	J:116503
	decreased circulating HDL cholesterol level	J:116503
	decreased circulating LDL cholesterol level	J:116503
Ldlr^tm1Her/Ldlr^tm1Her Mobq6^CAST/EiJ/Mobq6^CAST/EiJ (B6.CAST-Mobq6^CAST/EiJ)	decreased circulating cholesterol level	J:116503
	decreased circulating HDL cholesterol level	J:116503
	decreased circulating LDL cholesterol level	J:116503
	decreased circulating VLDL cholesterol level	J:116503
	decreased susceptibility to diet-induced obesity	J:116503
	improved glucose tolerance	J:116503
Ldlr^tm1Her/Ldlr^tm1Her Npc1^m1N/Npc1^m1N (involves: 129S7/SvEvBrd * BALB/c)	decreased brain cholesterol level	J:130969
	increased cholesterol level	J:130969
	increased circulating LDL cholesterol level	J:104996, J:130969
Ldlr^tm1Her/Ldlr^tm1Her Nr0b2^tm1.1Mjev/Nr0b2^tm1.1Mjev (involves: 129S/SvEvBrd * 129S4/SvJae * 129S7/SvEvBrd * C57BL/6)	decreased circulating LDL cholesterol level	J:149005
	increased circulating HDL cholesterol level	J:149005
Ldlr^tm1Her/Ldlr^tm1Her Nr1h3^tm1.1Djm/Nr1h3^tm1.1Djm Speer6-ps1^{Tg(Alb-cre)21Mgn}/Speer6-ps1⁺ (involves: 129S/SvEv * 129S7/SvEvBrd * C57BL/6 * DBA)	abnormal cholesterol homeostasis	J:184536
	decreased circulating cholesterol level	J:184536
	decreased circulating triglyceride level	J:184536
	increased liver cholesterol level	J:184536
Ldlr^tm1Her/Ldlr^tm1Her Nr5a2^tm1Sjns/Nr5a2^tm1Sjns Speer6-ps1^{Tg(Alb-cre)21Mgn}/Speer6-ps1⁺ (involves: 129/Sv * 129S7/SvEvBrd * C57BL/6 * C57BL/6J * DBA)	abnormal sterol level	J:215556
Ldlr^tm1Her/Ldlr^tm1Her Nr5a2^tm3.1Sjns/Nr5a2^tm3.1Sjns (involves: 129S7/SvEvBrd * C57BL/6J * C57BL/6N)	abnormal cholesterol homeostasis	J:215556
	decreased cholesterol level	J:215556
	decreased circulating LDL cholesterol level	J:215556
	decreased circulating triglyceride level	J:215556
	increased liver cholesterol level	J:215556
Ldlr^tm1Her/Ldlr^tm1Her Olr1^tm1Meht/Olr1^tm1Meht (involves: 129S7/SvEvBrd * 129X1/SvJ * C57BL/6)	decreased circulating HDL cholesterol level	J:130794
	increased circulating interleukin-10 level	J:130794
	increased circulating LDL cholesterol level	J:130794
	increased circulating VLDL cholesterol level	J:130794
Ldlr^tm1Her/Ldlr^tm1Her Pcsk9^tm1.2Prat/Pcsk9^tm1.2Prat (involves: 129S1/Sv * 129S7/SvEvBrd * 129X1/SvJ)	increased circulating LDL cholesterol level	J:169834
Ldlr^tm1Her/Ldlr^tm1Her Scd1^ab-2J/Scd1^ab-2J (B6.Cg-Ldlr^tm1Her Scd1^ab-2J)	abnormal circulating cholesterol level	J:130278
	abnormal lipid level	J:130278
	abnormal triglyceride level	J:130278
	decreased circulating triglyceride level	J:130278
	decreased circulating VLDL cholesterol level	J:130278
	decreased circulating VLDL triglyceride level	J:130278
	decreased liver triglyceride level	J:130278
Ldlr^tm1Her/Ldlr^tm1Her Scd1^ab-J/Scd1^ab-J (B6.Cg-Ldlr^tm1Her Scd1^ab-J)	abnormal lipid level	J:130278
	decreased circulating cholesterol level	J:130278
	decreased circulating triglyceride level	J:130278
	decreased circulating VLDL cholesterol level	J:130278
	decreased circulating VLDL triglyceride level	J:130278
	decreased liver triglyceride level	J:130278
Ldlr^tm1Her/Ldlr^tm1Her Serpine1^tm1Mlg/Serpine1^tm1Mlg (B6.129S-Serpine1^tm1Mlg Ldlr^tm1Her)	increased circulating cholesterol level	J:61287
Ldlr^tm1Her/Ldlr^tm1Her Soat1^tm1Far/Soat1^tm1Far (involves: 129S4/SvJae * 129S7/SvEvBrd * C57BL/6J)	decreased circulating cholesterol level	J:61147
	skin edema	J:61147
	xanthoma	J:61147
Ldlr^tm1Her/Ldlr^tm1Her Tbx21^tm1Glm/Tbx21^tm1Glm (involves: 129S6/SvEvTac * 129S7/SvEvBrd * C57BL/6)	increased circulating cholesterol level	J:96110
Ldlr^tm1Her/Ldlr^tm1Her Tg(APOC1)1Lmh/? (involves: 129S7/SvEvBrd * C57BL/6)	increased circulating cholesterol level	J:65146
	increased circulating triglyceride level	J:65146
	increased circulating VLDL cholesterol level	J:65146
	increased circulating VLDL triglyceride level	J:65146
Ldlr^tm1Her/Ldlr^tm1Her Tg(APOC3)3707Bres/? (involves: 129S7/SvEvBrd * C57BL/6J * CBA/J)	increased circulating LDL cholesterol level	J:37861
	increased circulating VLDL cholesterol level	J:37861
Ldlr^tm1Her/Ldlr^tm1Her Tg(APOC3)3707Bres/? Tg(Mt1-CETP)#Tall/? (involves: 129S7/SvEvBrd * C57BL/6J * CBA/J)	decreased circulating HDL cholesterol level	J:37861
	increased circulating LDL cholesterol level	J:37861
	increased circulating triglyceride level	J:37861
	increased circulating VLDL cholesterol level	J:37861
Ldlr^tm1Her/Ldlr^tm1Her Tg(APOM)NCchr/0 (involves: 129S7/SvEvBrd * C57BL/6 * C57BL/6J * CBA)	abnormal cholesterol homeostasis	J:130647
	decreased circulating triglyceride level	J:130647
Ldlr^tm1Her/Ldlr^tm1Her Tg(APPSWE)2576Kha/0 (involves: 129S7/SvEvBrd * C57BL/6 * SJL)	increased circulating cholesterol level	J:114480
	increased circulating LDL cholesterol level	J:114480
Ldlr^tm1Her/Ldlr^tm1Her Tg(CMV-Serpine1)1Dgi/0 (B6.Cg-Ldlr^tm1Her Tg(CMV-Serpine1)1Dgi)	increased circulating cholesterol level	J:61287
Ldlr^tm1Her/Ldlr^tm1Her Tg(H2-K-AKR1B1)1Tj/0 (involves: 129S7/SvEvBrd * C57BL/6 * DBA/2)	abnormal circulating cholesterol level	J:100916
	hyperglycemia	J:100916
Ldlr^tm1Her/Ldlr^tm1Her Tg(Il1rn)1Dih/Tg(Il1rn)1Dih (involves: 129S7/SvEvBrd * C57BL/6 * CBA)	increased circulating cholesterol level	J:76336
	increased circulating triglyceride level	J:76336
Ldlr^tm1Her/Ldlr^tm1Her Tlr2^tm1Kir/Tlr2^tm1Kir (B6.129-Tlr2^tm1Kir Ldlr^tm1Her)	decreased circulating cholesterol level	J:102502
Ldlrad4^{tm1b(EUCOMM)Wtsi}/Ldlrad4^{tm1b(EUCOMM)Wtsi} (C57BL/6N-Ldlrad4^{tm1b(EUCOMM)Wtsi}/Wtsi)	increased circulating alanine transaminase level	J:211773
Ldlrap1^{Gt(OST149604)Lex}/Ldlrap1^{Gt(OST149604)Lex} (involves: 129S5/SvEvBrd * C57BL/6)	increased circulating cholesterol level	J:102291
	increased circulating LDL cholesterol level	J:102291
Ldlrap1^tm1Her/Ldlrap1^tm1Her (involves: 129S6/SvEvTac)	abnormal circulating LDL cholesterol level	J:84694
	increased circulating cholesterol level	J:84694
	increased circulating LDL cholesterol level	J:84694
	increased circulating triglyceride level	J:84694
Ldoc1^tm1.1Tmki/Y (B6.129S-Ldoc1^tm1.1Tmki)	abnormal progesterone level	J:217586
Ldoc1^tm1.1Tmki/Y (B6.129S-Ldoc1^tm1.1Tmki)	increased circulating progesterone level	J:217586
Leap2^em1Jmz/Leap2^em1Jmz (C57BL/6N-Leap2^em1Jmz)	decreased energy expenditure	J:322589
	decreased oxygen consumption	J:322589
	increased growth hormone level	J:322589
	increased susceptibility to diet-induced obesity	J:322589
lec/lec (Not Specified)	cyanosis	J:6726
Lefty1^{tm1b(KOMP)Wtsi}/Lefty1⁺ (C57BL/6N-Lefty1^{tm1b(KOMP)Wtsi}/Bay)	increased circulating potassium level	J:211773
Lep^m1Yst/Lep^m1Yst (C57BL/6J-Lep^m1Yst)	decreased body temperature	J:167736
	impaired glucose tolerance	J:167736
	increased circulating cholesterol level	J:167736
	increased circulating glucose level	J:167736
	increased circulating insulin level	J:167736
	increased circulating leptin level	J:167736
	increased circulating triglyceride level	J:167736
	insulin resistance	J:167736
Lep^ob/Lep^ob (involves: C57BL/6J)	abnormal corticosterone level	J:13151
	abnormal glucose homeostasis	J:92558
	abnormal hormone level	J:13151
	abnormal insulin secretion	J:14402, J:22634
	hyperglycemia	J:219118, J:92558
	impaired glucose tolerance	J:219118, J:86303
	increased adrenocorticotropin level	J:13151
	increased circulating corticosterone level	J:60001
	increased circulating insulin level	J:92558
	increased fasting circulating glucose level	J:219118
	insulin resistance	J:219118
Lep^ob/Lep^ob (B6.Cg-Lep^ob/J)	abnormal circulating cholesterol level	J:18161
	abnormal circulating glucose level	J:5400
	abnormal oxygen consumption	J:22025, J:22377
	abnormal protein level	J:22025
	abnormal urine catecholamine level	J:4033
	abnormal urine homeostasis	J:4033
	decreased body temperature	J:129662
	decreased circulating glucose level	J:129554, J:145998, J:189019
	decreased insulin secretion	J:145998
	decreased oxygen consumption	J:22377
	hyperglycemia	J:65486, J:122746, J:5400
	hypoglycemia	J:5400
	impaired glucose tolerance	J:107486, J:104171
	increased circulating cholesterol level	J:18161
	increased circulating HDL cholesterol level	J:18161
	increased circulating insulin level	J:104171, J:122746, J:5400
	increased circulating LDL cholesterol level	J:18161
	increased circulating triglyceride level	J:18161, J:104171
	increased circulating VLDL cholesterol level	J:18161
	increased insulin secretion	J:145998
	increased oxygen consumption	J:22377
	insulin resistance	J:104171
Lep^ob/Lep^ob (D2.Cg-Lep^ob/Chua)	hyperglycemia	J:78850
Lep^ob/Lep^ob (D2.Cg-Lep^ob/Chua)	increased circulating insulin level	J:78850
Lep^ob/Lep^ob (FVB.Cg-Lep^ob/Chua)	hyperglycemia	J:78850
Lep^ob/Lep^ob (FVB.Cg-Lep^ob/Chua)	increased circulating insulin level	J:78850
Lep^ob/Lep^ob (involves: 129X1/SvJ * C57BL/6)	abnormal circulating hormone level	J:76479
	abnormal circulating pancreatic peptide level	J:76479
	decreased circulating testosterone level	J:107169, J:76479
	hyperglycemia	J:107169
	increased circulating cholesterol level	J:107169
	increased circulating corticosterone level	J:107169, J:76479
	increased circulating insulin level	J:107169, J:76479
	increased circulating leptin level	J:76479
	increased circulating triglyceride level	J:107169
Lep^ob/Lep^ob (involves: 129 * C57BL/6)	abnormal lipid level	J:121534
	increased circulating insulin level	J:121534
	increased insulin secretion	J:121534
	insulin resistance	J:121534
Lep^ob/Lep^ob (BKS.Cg-Lep^ob/J)	abnormal circulating cholesterol level	J:18161
	abnormal circulating glucose level	J:5400
	hyperglycemia	J:5400
	increased circulating cholesterol level	J:18161
	increased circulating HDL cholesterol level	J:18161
	increased circulating insulin level	J:5400
	increased circulating LDL cholesterol level	J:18161
	increased circulating triglyceride level	J:18161
	increased circulating VLDL cholesterol level	J:18161
	increased urine glucose level	J:5400
Lep^ob/Lep^ob (B6.Cg-Lep^ob/JBomTac)	increased circulating triglyceride level	J:149091
Lep^ob/Lep^ob (involves: STOCK Mlph^ln a Tgfa^wa1 Cdh23^v Ednrb^s)	abnormal glucose homeostasis	J:7702
	abnormal hormone level	J:7702
	decreased body temperature	J:12010
	decreased circulating tumor necrosis factor level	J:115569
	decreased liver triglyceride level	J:199803
	hyperglycemia	J:7702
	impaired adaptive thermogenesis	J:7702, J:12010
	impaired glucose tolerance	J:7702
	increased adrenocorticotropin level	J:7702
	increased circulating insulin level	J:7702
	increased liver triglyceride level	J:199803
Lep^ob/Lep^ob (involves: C57BL/6)	increased circulating cholesterol level	J:72027
	increased circulating HDL cholesterol level	J:72027
	increased circulating triglyceride level	J:72027
	increased liver cholesterol level	J:72027
	increased liver triglyceride level	J:72027
Lep^ob/Lep^ob (BTBR.Cg-Lep^ob)	hyperglycemia	J:65486
Lep^ob/Lep^ob (involves: BTBR * C57BL/6 * V stock)	hyperglycemia	J:65486
Lep^ob/Lep^ob (involves: BTBR * C57BL/6 * V stock)	increased circulating insulin level	J:65486
Lep^ob/Lep^ob (BTBR.Cg-Lep^ob/WiscJ)	albuminuria	J:185261
	hyperglycemia	J:106121, J:185261
	impaired glucose tolerance	J:106121
	increased blood urea nitrogen level	J:185261
	increased cholesterol level	J:185261
	increased circulating insulin level	J:106121
	increased circulating triglyceride level	J:106121, J:185261
	insulin resistance	J:106121
Lep^ob/Lep^ob (B6.Cg-Lep^ob/JRj)	increased cholesterol level	J:277927
	increased circulating free fatty acids level	J:277927
	increased susceptibility to diet-induced obesity	J:277927
Lep^ob/Lep^ob Mapk8^tm1Wag/Mapk8^tm1Wag (B6.Cg-Lep^ob Mapk8^tm1Wag)	decreased circulating glucose level	J:80452
	decreased circulating insulin level	J:80452
Lep^ob/Lep^ob Mir375^tm1Stf/Mir375^tm1Stf (B6.Cg-Mir375^tm1Stf Lep^ob)	abnormal gluconeogenesis	J:147572
	decreased circulating insulin level	J:147572
	increased circulating glucose level	J:147572
Lep^ob/Lep^ob Mogat1^tm1Far/Mogat1^tm1Far (involves: 129S4/SvJae)	increased circulating cholesterol level	J:231617
	increased circulating glucose level	J:231617
	increased circulating insulin level	J:231617
	increased circulating triglyceride level	J:231617
	increased liver triglyceride level	J:231617
	insulin resistance	J:231617
Lep^ob/Lep^ob Nfe2l2^tm1.1Jgpi/Nfe2l2^tm1.1Jgpi Tg(Fabp4-cre)1Rev/0 (involves: C57BL/6)	increased circulating glucose level	J:208590
	increased circulating triglyceride level	J:208590
	insulin resistance	J:208590
Lep^ob/Lep^ob Nfe2l2^tm1Mym/Nfe2l2^tm1Mym (B6.Cg-Nfe2l2^tm1Mym Lep^ob)	abnormal urine color	J:208590
	decreased liver triglyceride level	J:208590
	hyperglycemia	J:208590
	increased circulating triglyceride level	J:208590
	insulin resistance	J:208590
Lep^ob/Lep^ob Npy2r^tm1.1Hhz/Npy2r^tm1.1Hhz (involves: 129X1/SvJ * C57BL/6)	abnormal circulating glucose level	J:107169
	abnormal circulating insulin level	J:107169
	decreased circulating corticosterone level	J:107169
	decreased circulating testosterone level	J:107169
	increased circulating cholesterol level	J:107169
	increased circulating triglyceride level	J:107169
Lep^ob/Lep^ob Npy2r^tm1Pern/Npy2r^tm1Pern (involves: 129 * BALB/c * C57BL/10J)	decreased circulating free fatty acids level	J:102651
	decreased circulating glucose level	J:102651
	decreased circulating LDL cholesterol level	J:102651
	increased circulating cholesterol level	J:102651
	increased circulating HDL cholesterol level	J:102651
	increased triglyceride level	J:102651
Lep^ob/Lep^ob Npy4r^tm1.1Hhz/Npy4r^tm1.1Hhz (involves: 129X1/SvJ * C57BL/6)	abnormal circulating testosterone level	J:76479
	increased circulating corticosterone level	J:76479
Lep^ob/Lep^ob Nr1i3^tm1Dgen/Nr1i3^tm1Dgen (B6.Cg-Nr1i3^tm1Dgen Lep^ob)	decreased circulating triglyceride level	J:149091
Lep^ob/Lep^ob Plin4^tm1Vlcg/Plin4^tm1Vlcg (involves: C57BL/6J)	decreased cardiac muscle triglyceride level	J:195987
Lep^ob/Lep^ob Pmch^{tm1.1(HBEGF)Rpa}/Pmch⁺ (B6.Cg-Lep^ob Pmch^{tm1.1(DTR)Rpa})	improved glucose tolerance	J:181947
Lep^ob/Lep^ob Pmch^tm1Emf/Pmch^tm1Emf (involves: 129S4/SvJae * C57BL/6)	abnormal circulating corticosterone level	J:85176
	abnormal glucose homeostasis	J:85176
	abnormal glucose tolerance	J:85176
	decreased circulating glucose level	J:85176
	impaired adaptive thermogenesis	J:85176
	increased circulating insulin level	J:85176
	increased oxygen consumption	J:85176
Lep^ob/Lep^ob Pparg^tm1Avp/Pparg⁺ (involves: 129S2/SvPas * C57BL/6)	abnormal glucose homeostasis	J:116568
	decreased circulating adiponectin level	J:116568
	increased circulating glucose level	J:116568
	increased circulating insulin level	J:116568
	increased circulating triglyceride level	J:116568
	insulin resistance	J:116568
Lep^ob/Lep^ob Pparg^tm2Avp/Pparg^tm2Avp (involves: 129 * C57BL/6)	abnormal glucose homeostasis	J:121534
	abnormal insulin secretion	J:121534
	abnormal lipid homeostasis	J:121534
	decreased circulating adiponectin level	J:121534
	decreased circulating insulin level	J:121534
	decreased liver triglyceride level	J:121534
	decreased respiratory quotient	J:121534
	decreased triglyceride level	J:121534
	hyperglycemia	J:121534
	increased circulating free fatty acids level	J:121534
	increased circulating glucose level	J:121534
	increased circulating insulin level	J:121534
	increased circulating triglyceride level	J:121534
	increased urine glucose level	J:121534
	insulin resistance	J:121534
Lep^ob/Lep^ob Ptprv^tm1Asmi/Ptprv⁺ (involves: 129P2/OlaHsd * C57BL/10J)	increased circulating insulin level	J:145998
Lep^ob/Lep^ob Ptprv^tm1Asmi/Ptprv^tm1Asmi (involves: 129P2/OlaHsd * C57BL/10J)	decreased circulating glucose level	J:145998
	improved glucose tolerance	J:145998
	increased circulating insulin level	J:145998
Lep^ob/Lep^ob Serpine1^tm1Mlg/Serpine1^tm1Mlg (involves: 129S2/SvPas * C57BL/6)	abnormal tumor necrosis factor level	J:70695
	impaired glucose tolerance	J:70695
	increased circulating insulin level	J:70695
Lep^ob/Lep^ob Sesn2^{Gt(RRJ141)Byg}/Sesn2^{Gt(RRJ141)Byg} (involves: 129P2/OlaHsd * C57BL/6)	decreased fatty acid beta-oxidation	J:189021
	impaired glucose tolerance	J:189021
	increased circulating glucose level	J:189021
	increased liver triglyceride level	J:189021
	increased urine glucose level	J:189021
	insulin resistance	J:189021
Lep^ob/Lep^ob Steap4^tm1Dgen/Steap4^tm1Dgen (involves: 129P2/OlaHsd)	increased circulating glucose level	J:187736
Lep^ob/Lep^ob Stxbp5l^T2dm1/Stxbp5l^T2dm1 (B6.Cg-Lep^ob Chr 16^BTNTTF)	decreased circulating insulin level	J:178002
	increased circulating glucose level	J:178002
Lep^ob/Lep^ob Stxbp5l^T2dm1/Stxbp5l^T2dm1 T2dm2^C57BL/6J/T2dm2^C57BL/6J (involves: BTBR * C57BL/6J)	hyperglycemia	J:65486
Lep^ob/Lep^ob T2dm2^BTBR/T2dm2^BTBR (involves: BTBR * C57BL/6J)	increased circulating insulin level	J:65486
Lep^ob/Lep^ob T2dm2^BTBR/T2dm2^C57BL/6J (involves: BTBR * C57BL/6J)	increased circulating insulin level	J:65486
Lep^ob/Lep^ob Tg(Eno2-Pomc)1Mobb/? (involves: C3H * C57BL/6)	abnormal body temperature	J:86303
	abnormal fatty acids level	J:86303
Lep^ob/Lep^ob Tg(Ins2-Mir184)4Mnpy/0 (involves: C57BL/10J)	decreased circulating insulin level	J:210552
	decreased insulin secretion	J:210552
	hyperglycemia	J:210552
Lep^ob/Lep^ob Tg(Ins2-rtTA)2Efr/0 Tg(tetO-Mir184)#Mnpy/0 (involves: C57BL/6 * CBA)	decreased circulating insulin level	J:210552
	increased circulating glucose level	J:210552
Lep^ob/Lep^ob Tg(Myh6-Med13)1Eno/0 (involves: C57BL/6)	improved glucose tolerance	J:186193
Lep^ob/Lep^ob Tg(Pmch-ATXN3)3Rck/0 (involves: C57BL/6J FVB/NJ)	decreased circulating glucose level	J:104264
Lep^ob/Lep^ob Tg(tetO-Xbp1_is)#Pesch/0 Tg(Adipoq-rtTA)2Zvw/0 (involves: C57BL/6 * C57BL/6N * FVB/N)	decreased susceptibility to diet-induced obesity	J:260830
Lep^ob/Lep^ob Tnfrsf1a^tm1Imx/Tnfrsf1a^tm1Imx Tnfrsf1b^tm1Imx/Tnfrsf1b^tm1Imx (involves: 129S7/SvEvBrd * C57BL/6)	decreased circulating insulin level	J:55722
Lep^ob/Lep^ob Ucp1^tm1Kz/Ucp1^tm1Kz (involves: 129S2/SvPas * C57BL/6)	decreased respiratory quotient	J:129662
	impaired adaptive thermogenesis	J:129662
	increased oxygen consumption	J:129662
Lep^tm1.1Gvcao/Lep^tm1.1Gvcao Tg(Adipoq-cre)1Evdr/0 (involves: 129S4/SvJaeSor * C57BL/6J * FVB/NTac)	decreased circulating follicle stimulating hormone level	J:218720
	decreased circulating growth hormone level	J:218720
	decreased circulating leptin level	J:218720
	decreased circulating luteinizing hormone level	J:218720
	decreased circulating prolactin level	J:218720
	increased pituitary hormone level	J:218720
Lep^tm1.2Gvcao/Lep^tm1.2Gvcao (involves: 129S4/SvJaeSor * FVB/NJ * FVB/NTac)	decreased circulating follicle stimulating hormone level	J:218720
	decreased circulating leptin level	J:218720
	decreased circulating prolactin level	J:218720
	decreased pituitary hormone level	J:218720
Lepr^brta/Lepr^brta (C57BL/6JSfdAnu-Lepr^brta/Anu)	hyperglycemia	J:104190
Lepr^db-2J/Lepr^db-2J (involves: C57BL/6J * STOCK Tyrp1^b Whrn^wi)	abnormal hormone level	J:6157
	decreased follicle stimulating hormone level	J:6157
Lepr^db-3J/Lepr^db-3J (129P3/J-Lepr^db-3J/J)	hyperglycemia	J:6337
	hypoglycemia	J:6337
	increased circulating glucagon level	J:6337
	increased circulating insulin level	J:6337
Lepr^db-3J/Lepr^db-3J (B6.129-Lepr^db-3J)	abnormal circulating glucose level	J:78850
	abnormal circulating insulin level	J:78850
	abnormal glucose homeostasis	J:78850
	increased insulin sensitivity	J:78850
Lepr^db-5J/Lepr^db-5J (NOD/ShiLtJ-Lepr^db-5J/LtJ)	hyperglycemia	J:87061
Lepr^db-5J/Lepr^db-5J (NOD/ShiLtJ-Lepr^db-5J/LtJ)	increased circulating insulin level	J:87061
Lepr^db-5J/Lepr^db-5J (NOD/ShiLt-Lepr^db-5J)	abnormal circulating glucose level	J:118305
	hyperglycemia	J:118305
	increased circulating insulin level	J:118305
	increased circulating leptin level	J:118305
Lepr^db-9J/Lepr^db-9J (involves: C57BL/6 * CBA * SWR)	decreased circulating insulin level	J:129982
	hyperglycemia	J:129982
	increased liver glycogen level	J:129982
Lepr^db-ad/Lepr^db-ad (Not Specified)	increased circulating glucose level	J:31691
Lepr^db-ad/Lepr^db-ad (Not Specified)	increased circulating insulin level	J:31691
Lepr^Db-Btlr/Lepr^Db-Btlr (C57BL/6J-Lepr^Db-Btlr)	hyperglycemia	J:133632
Lepr^db-dmpg/Lepr^db-dmpg (involves: B10.D2-H8^b/Sn * C57BL/6)	hyperglycemia	J:83762
	increased circulating insulin level	J:83762
Lepr^db-lb/Lepr^db-lb (C57BL/6NCrl-Lepr^db-lb/Crl)	abnormal lipid level	J:171755
	increased blood uric acid level	J:171755
	insulin resistance	J:171755
Lepr^db-NCSU/Lepr^db-NCSU (involves: CD-1)	increased circulating glucose level	J:60363
	increased circulating insulin level	J:60363
	increased circulating leptin level	J:60363
	increased urine glucose level	J:60363
	insulin resistance	J:60363
Lepr^db-Nokl/Lepr^db-Nokl (C57BL/6N-Lepr^db-Nokl)	abnormal carbon dioxide production	J:313303
	abnormal oxygen consumption	J:313303
	decreased circulating adiponectin level	J:313303
	decreased core body temperature	J:313303
	impaired glucose tolerance	J:313303
	increased circulating cholesterol level	J:313303
	increased circulating HDL cholesterol level	J:313303
	increased circulating insulin level	J:313303
	increased circulating LDL cholesterol level	J:313303
	increased circulating leptin level	J:313303
	increased circulating triglyceride level	J:313303
	increased fasting circulating glucose level	J:313303
	increased glycosylated hemoglobin level	J:313303
	increased liver triglyceride level	J:313303
	increased susceptibility to diet-induced non-insulin dependent diabetes	J:313303
Lepr^db-Pas/Lepr^db-Pas (involves: DW/Pas)	hyperglycemia	J:174584
	increased circulating cholesterol level	J:174584
	increased circulating insulin level	J:174584
Lepr^db-rlpy/Lepr^db-rlpy (involves: NU/J)	hyperglycemia	J:83762
Lepr^db-rlpy/Lepr^db-rlpy (involves: NU/J)	increased circulating insulin level	J:83762
Lepr^db-rtnd/Lepr^db-rtnd (involves: C57BL/6 * CBA/J)	hyperglycemia	J:83762
Lepr^db-rtnd/Lepr^db-rtnd (involves: C57BL/6 * CBA/J)	increased circulating insulin level	J:83762
Lepr^db/Lepr⁺ (involves: C57BLKS/J)	abnormal circulating insulin level	J:71934
	abnormal glucose homeostasis	J:71934
	abnormal hormone level	J:71934
	decreased circulating insulin level	J:219658
	impaired glucose tolerance	J:219658, J:71934
	increased circulating glucose level	J:71934
	increased circulating leptin level	J:219658
Lepr^db/Lepr⁺ Tg(APPswe,PSEN1dE9)85Dbo/0 (involves: C3H * C57BL/6 * C57BLKS/J)	abnormal circulating cholesterol level	J:186924
	impaired glucose tolerance	J:186924
	increased circulating glucose level	J:186924
	increased circulating insulin level	J:186924
	insulin resistance	J:186924
Lepr^db/Lepr^db-Nokl (B6NTac.Cg-Lepr^db Lepr^db-Nokl)	abnormal carbon dioxide production	J:313303
	abnormal oxygen consumption	J:313303
	decreased circulating adiponectin level	J:313303
	decreased core body temperature	J:313303
	impaired glucose tolerance	J:313303
	increased circulating cholesterol level	J:313303
	increased circulating HDL cholesterol level	J:313303
	increased circulating insulin level	J:313303
	increased circulating LDL cholesterol level	J:313303
	increased circulating leptin level	J:313303
	increased circulating triglyceride level	J:313303
	increased fasting circulating glucose level	J:313303
	increased glycosylated hemoglobin level	J:313303
	increased liver triglyceride level	J:313303
	increased susceptibility to diet-induced non-insulin dependent diabetes	J:313303
Lepr^db/Lepr^db (involves: C57BLKS/J)	abnormal glucose homeostasis	J:107138, J:80996
	decreased body temperature	J:96047
	decreased circulating glucose level	J:117919
	decreased circulating insulin level	J:117919
	hyperglycemia	J:106871, J:117919, J:104790, J:96047, J:232827, J:210493, J:106597
	hyperlipidemia	J:96047
	impaired adaptive thermogenesis	J:89242
	impaired glucose tolerance	J:89242
	increased circulating cholesterol level	J:232827
	increased circulating corticosterone level	J:89242
	increased circulating free fatty acids level	J:106871, J:232827
	increased circulating glucose level	J:89242, J:5010, J:80996
	increased circulating insulin level	J:104790, J:232827, J:106597, J:89242, J:5010, J:80996
	increased circulating leptin level	J:232827, J:89242
	increased circulating triglyceride level	J:232827
	increased glycosylated hemoglobin level	J:104790
	increased urine protein level	J:5257
	insulin resistance	J:117919
Lepr^db/Lepr^db (FVB.BKS-Lepr^db)	abnormal circulating glucose level	J:78850
	hyperglycemia	J:78850
	impaired glucose tolerance	J:78850
	increased circulating insulin level	J:78850
	insulin resistance	J:78850
Lepr^db/Lepr^db (B6.Cg-Dock7^m +/+ Lepr^db/J)	abnormal chemokine level	J:115772
	abnormal circulating cholesterol level	J:18161
	abnormal circulating lipid level	J:18161
	abnormal glucose homeostasis	J:82334
	abnormal hormone level	J:6157
	abnormal interleukin level	J:115772
	decreased circulating adiponectin level	J:115772
	hyperglycemia	J:18161
	increased circulating cholesterol level	J:18161
	increased circulating glucose level	J:82334
	increased circulating HDL cholesterol level	J:18161
	increased circulating insulin level	J:82334
	increased circulating interleukin-6 level	J:115772
	increased circulating LDL cholesterol level	J:18161
	increased circulating leptin level	J:115772, J:82334
	increased circulating triglyceride level	J:18161, J:82334
	increased circulating VLDL cholesterol level	J:18161
Lepr^db/Lepr^db (BKS.Cg-Dock7^m +/+ Lepr^db/J)	abnormal circulating cholesterol level	J:18161
	abnormal circulating glucose level	J:43162
	abnormal circulating lipid level	J:18161
	albuminuria	J:135864
	decreased circulating glucose level	J:91813, J:43162
	decreased circulating insulin level	J:91813, J:43162
	decreased circulating triglyceride level	J:91813
	decreased prostaglandin level	J:185546
	decreased urine albumin level	J:82491
	hyperglycemia	J:185546, J:135864
	improved glucose tolerance	J:43162
	increased circulating cholesterol level	J:18161
	increased circulating glucose level	J:6323
	increased circulating HDL cholesterol level	J:18161
	increased circulating LDL cholesterol level	J:18161
	increased circulating triglyceride level	J:18161
	increased circulating VLDL cholesterol level	J:18161
	increased glucagon secretion	J:6264
Lepr^db/Lepr^db (involves: C57BL/6 * C57BLKS/J)	abnormal oxygen consumption	J:142218
	hyperglycemia	J:142218
	impaired adaptive thermogenesis	J:142218
	impaired glucose tolerance	J:164339, J:142218
	increased circulating glucose level	J:164339
	increased circulating insulin level	J:164339
	increased circulating leptin level	J:142218
	insulin resistance	J:164339, J:142218
Lepr^db/Lepr^db (BKS.Cg-Dock7^m +/+ Lepr^db/Jcl)	hyperglycemia	J:156725
Lepr^db/Lepr^db (BKS.Cg-Dock7^m +/+ Lepr^db/Jcl)	increased circulating insulin level	J:156725
Lepr^db/Lepr^db (B6.BKS(D)-Lepr^db/J)	decreased body temperature	J:166105
	decreased carbon dioxide production	J:166105
	decreased oxygen consumption	J:166105
	impaired glucose tolerance	J:166105
	insulin resistance	J:166105
Lepr^db/Lepr^db (B6.BKS(D)-Lepr^db/JOrlRj)	increased cholesterol level	J:277927
	increased circulating ketone body level	J:277927
	increased susceptibility to diet-induced obesity	J:277927
Lepr^db/Lepr^db (B6NTac.BKS(D)-Lepr^db)	abnormal carbon dioxide production	J:313303
	abnormal oxygen consumption	J:313303
	decreased core body temperature	J:313303
	impaired glucose tolerance	J:313303
	increased circulating cholesterol level	J:313303
	increased circulating HDL cholesterol level	J:313303
	increased circulating insulin level	J:313303
	increased circulating LDL cholesterol level	J:313303
	increased circulating leptin level	J:313303
	increased circulating triglyceride level	J:313303
	increased fasting circulating glucose level	J:313303
	increased glycosylated hemoglobin level	J:313303
	increased liver triglyceride level	J:313303
	increased susceptibility to diet-induced non-insulin dependent diabetes	J:313303
Lepr^db/Lepr^db Nos3^tm1Unc/Nos3^tm1Unc (BKS.Cg-Lepr^db Nos3^tm1Unc)	albuminuria	J:135864
	hyperglycemia	J:135864
	increased circulating creatinine level	J:135864
Lepr^db/Lepr^db Plin1^tm1Chan/Plin1^tm1Chan (involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * C57BLKS/J)	increased oxygen consumption	J:66267
Lepr^db/Lepr^db Pten^tm1Hwu/Pten^tm1Hwu Tg(Ins2-cre)25Mgn/0 (involves: 129S4/SvJae * C57BL/6 * C57BLKS/J * DBA)	increased insulin secretion	J:170206
	insulin resistance	J:170206
Lepr^db/Lepr^db Repin1^tm1.2Arte/Repin1^tm1.2Arte (involves: BALB/c * C57BL/6 * C57BLKS/J)	decreased circulating glucose level	J:238672
	increased insulin sensitivity	J:238672
Lepr^db/Lepr^db Rock1^tm1Leiw/Rock1^tm1Leiw (involves: 129S7/SvEvBrd * C57BLKS/J * FVB/N)	albuminuria	J:182287
	hyperglycemia	J:182287
Lepr^db/Lepr^db Serpine1^tm1Mlg/Serpine1^tm1Mlg (involves: 129S2/SvPas * C57BL/6 * C57BLKS/J)	albuminuria	J:127478
	hyperglycemia	J:127478
	increased blood urea nitrogen level	J:127478
Lepr^db/Lepr^db Tg(Fabp4-Fcor)1Jnak/0 (involves: C57BL/6 * C57BLKS/J * DBA/2)	improved glucose tolerance	J:184684
	increased insulin sensitivity	J:184684
	increased oxygen consumption	J:184684
Lepr^db/Lepr^db Tg(SHBG)4-aGlha/0 (involves: C57BL/6 * C57BLKS/J * CBA)	abnormal blood homeostasis	J:232827
	hyperglycemia	J:232827
	increased circulating cholesterol level	J:232827
	increased circulating free fatty acids level	J:232827
	increased circulating insulin level	J:232827
	increased circulating leptin level	J:232827
	increased circulating testosterone level	J:232827
	increased circulating triglyceride level	J:232827
	increased liver triglyceride level	J:232827
Lepr^KK/Lepr^KK (involves: C57BL/6J * KK/HlLt)	increased circulating glucose level	J:53637
	increased circulating insulin level	J:53637
	increased circulating leptin level	J:53637
Lepr^m5Btlr/Lepr^m5Btlr (C57BL/6-Lepr^m5Btlr)	abnormal circadian temperature homeostasis	J:166105
	decreased carbon dioxide production	J:166105
	decreased oxygen consumption	J:166105
	decreased respiratory quotient	J:166105
	impaired glucose tolerance	J:166105
	increased circulating insulin level	J:166105
	increased circulating leptin level	J:166105
	insulin resistance	J:166105
Lepr^m7Btlr/Lepr^m7Btlr (C57BL/6J-Lepr^m7Btlr)	increased circulating glucose level	J:236685
Lepr^{Tg(Mth11)1Aig}/Lepr^{Tg(Mth11)1Aig} (involves: Him:OF1)	hyperglycemia	J:61119
	increased circulating insulin level	J:61119
	increased urine glucose level	J:61119
Lepr^tm1.1Chua/Lepr^tm1.1Chua (involves: 129 * C57BL/6)	decreased circulating glucose level	J:94019
Lepr^tm1.1Chua/Lepr^tm1.1Chua Nts^tm1(cre)Mgmj/Nts⁺ (involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * FVB)	decreased oxygen consumption	J:176657
	increased circulating leptin level	J:176657
Lepr^tm1.1Chua/Lepr^tm1.1Chua Prlh^tm1(cre)Smln/Prlh⁺ (involves: 129 * C57BL/6J)	abnormal body temperature homeostasis	J:215557
	decreased core body temperature	J:215557
	decreased energy expenditure	J:215557
	decreased oxygen consumption	J:215557
	increased circulating insulin level	J:215557
	increased circulating leptin level	J:215557
Lepr^tm1.1Chua/Lepr^tm1.1Chua Slc32a1^tm2(cre)Lowl/Slc32a1⁺ (involves: 129S6/SvEvTac)	abnormal circulating glucose level	J:174691
	increased circulating insulin level	J:174691
Lepr^tm1.1Chua/Lepr^tm1.1Chua Tg(Agrp-cre)1Gsb/0 (involves: 129 * FVB/N)	decreased liver triglyceride level	J:199803
Lepr^tm1.1Chua/Lepr^tm1.1Chua Tg(Gh1-cre)bKnmn/0 (involves: 129 * C57BL/6 * FVB)	decreased circulating growth hormone level	J:173444
	increased circulating leptin level	J:173444
Lepr^tm1.1Chua/Lepr^tm1.1Chua Tg(Nr5a1-cre)2Lowl/0 (involves: 129 * C57BL/6J * FVB)	abnormal energy expenditure	J:105327
	increased circulating leptin level	J:105327
	increased susceptibility to diet-induced obesity	J:105327
Lepr^tm1.1Chua/Lepr^tm1.1Chua Tg(Nr5a1-cre)2Lowl/0 Tg(Pomc1-cre)16Lowl/0 (involves: 129 * C57BL/6J * FVB)	increased circulating leptin level	J:105327
Lepr^tm1.1Chua/Lepr^tm1.1Chua Tg(Pomc1-cre)16Lowl/0 (involves: 129 * C57BL/6J * FVB)	increased circulating leptin level	J:106354, J:105327
Lepr^tm1.1Chua/Lepr^tm1.1Chua Tg(Syn1-cre)671Jxm/0 (involves: 129 * C57BL/6 * CBA)	decreased circulating adrenaline level	J:145998
	decreased circulating noradrenaline level	J:145998
	increased insulin secretion	J:145998
Lepr^tm1.1Chua/Lepr^tm1.2Chua Nos1^tm1(cre)Mgmj/Nos1⁺ (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	decreased circulating thyroxine level	J:183754
	decreased oxygen consumption	J:183754
	increased circulating corticosterone level	J:183754
	increased circulating glucose level	J:183754
	increased circulating insulin level	J:183754
	increased circulating leptin level	J:183754
Lepr^tm1.2Chua/Lepr^tm1.2Chua (involves: 129 * C57BL/6)	abnormal glucose homeostasis	J:94019
	hyperglycemia	J:94019
	impaired adaptive thermogenesis	J:94019
	increased circulating insulin level	J:94019
Lepr^tm1.2Chua/Lepr^tm1.2Chua Nos1^tm1(cre)Mgmj/Nos1⁺ (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	decreased circulating thyroxine level	J:183754
	decreased oxygen consumption	J:183754
	increased circulating corticosterone level	J:183754
	increased circulating glucose level	J:183754
	increased circulating insulin level	J:183754
	increased circulating leptin level	J:183754
Lepr^{tm1b(EUCOMM)Wtsi}/Lepr^{tm1b(EUCOMM)Wtsi} (C57BL/6N-Lepr^{tm1b(EUCOMM)Wtsi}/H)	decreased circulating chloride level	J:211773
	increased circulating alanine transaminase level	J:211773
	increased circulating alkaline phosphatase level	J:211773
	increased circulating amylase level	J:211773
	increased circulating aspartate transaminase level	J:211773
	increased circulating calcium level	J:211773
	increased circulating cholesterol level	J:211773
	increased circulating fructosamine level	J:211773
	increased circulating glucose level	J:211773
	increased circulating HDL cholesterol level	J:211773
	increased circulating iron level	J:211773
	increased circulating phosphate level	J:211773
	increased circulating potassium level	J:211773
	increased circulating serum albumin level	J:211773
	increased circulating total protein level	J:211773
	increased circulating triglyceride level	J:211773
Lepr^tm1Chua/Lepr^tm1Chua (involves: 129 * C57BL/6)	abnormal glucose homeostasis	J:94019
	impaired adaptive thermogenesis	J:94019
	increased circulating glucose level	J:94019
	increased circulating insulin level	J:94019
	increased circulating leptin level	J:94019
Lepr^tm1Jke/Lepr^tm1Jke (involves: 129X1/SvJ * C57BL/6J)	abnormal gluconeogenesis	J:184572
	abnormal glucose homeostasis	J:184572
	decreased carbon dioxide production	J:184572
	decreased oxygen consumption	J:184572
	decreased respiratory quotient	J:184572
	hyperglycemia	J:184572
	increased circulating cholesterol level	J:184572
	increased circulating glucagon level	J:184572
	increased circulating insulin level	J:184572
	increased circulating leptin level	J:184572
	increased circulating triglyceride level	J:184572
	increased insulin secretion	J:184572
	increased insulin sensitivity	J:184572
	increased liver triglyceride level	J:184572
Lepr^tm1Jke/Lepr^tm1Jke (involves: 129X1/SvJ)	hyperglycemia	J:216393
	increased circulating insulin level	J:216393
	increased liver triglyceride level	J:216393
	increased susceptibility to non-insulin-dependent diabetes	J:216393
Lepr^tm1Jke/Lepr^tm1Jke Tg(Pomc1-cre)16Lowl/0 (involves: 129X1/SvJ * C57BL/6J * FVB/N)	abnormal glucose homeostasis	J:184572
	decreased carbon dioxide production	J:184572
	decreased circulating cholesterol level	J:184572
	decreased circulating glucose level	J:184572
	decreased circulating insulin level	J:184572
	decreased circulating triglyceride level	J:184572
	decreased liver triglyceride level	J:184572
	decreased oxygen consumption	J:184572
	increased carbon dioxide production	J:184572
	increased circulating cholesterol level	J:184572
	increased circulating insulin level	J:184572
	increased circulating leptin level	J:184572
	increased circulating triglyceride level	J:184572
	increased insulin secretion	J:184572
	increased insulin sensitivity	J:184572
	increased liver triglyceride level	J:184572
	increased oxygen consumption	J:184572
	increased respiratory quotient	J:184572
Lepr^tm1Mgmj/Lepr^tm1Mgmj (B6.129-Lepr^tm1Mgmj)	abnormal energy expenditure	J:82334
	abnormal glucose homeostasis	J:82334
	increased circulating glucose level	J:82334
	increased circulating insulin level	J:82334
	increased circulating leptin level	J:82334
	increased circulating triglyceride level	J:82334
Lepr^tm1Rck/Lepr^tm1.1Rck Tg(Syn1-cre)671Jxm/0 (involves: 129P2/OlaHsd * C57BL/6 * CBA)	hyperglycemia	J:72241
	increased circulating insulin level	J:72241
	increased circulating leptin level	J:72241
Lepr^tm1Yli/Lepr^tm1Yli (B6.129-Lepr^tm1Yli)	abnormal body temperature	J:142218
	abnormal circulating glucose level	J:142218
	abnormal oxygen consumption	J:142218
	impaired adaptive thermogenesis	J:142218
	impaired glucose tolerance	J:142218
	increased circulating insulin level	J:142218
	increased circulating leptin level	J:142218
	insulin resistance	J:142218
Lepr^tm2Mgmj/Lepr⁺ (B6.Cg-Lepr^tm2Mgmj)	decreased circulating insulin level	J:122056
Lepr^tm2Mgmj/Lepr^tm2Mgmj (B6.Cg-Lepr^tm2Mgmj)	decreased circulating insulin level	J:122056
Lepr^tm2Mgmj/Lepr^tm2Mgmj (B6.Cg-Lepr^tm2Mgmj)	decreased circulating leptin level	J:122056
Lepr^tm2Mgmj/Lepr^tm2Mgmj (Not Specified)	decreased insulin secretion	J:145998
Lepr^tm2Yli/Lepr^tm2Yli (B6.129-Lepr^tm2Yli)	abnormal body temperature	J:142218
	abnormal circulating glucose level	J:142218
	abnormal oxygen consumption	J:142218
	impaired adaptive thermogenesis	J:142218
	impaired glucose tolerance	J:142218
	increased circulating insulin level	J:142218
	increased circulating leptin level	J:142218
	insulin resistance	J:142218
Lepr^tm3.1Yli/Lepr^tm3.1Yli (B6.129-Lepr^tm3.1Yli)	abnormal oxygen consumption	J:161732
	decreased circulating leptin level	J:161732
	increased circulating glucose level	J:161732
	increased circulating insulin level	J:161732
	increased circulating leptin level	J:161732
	increased susceptibility to diet-induced obesity	J:161732
Lepr^tm4Mgmj/Lepr^tm4Mgmj (B6.Cg-Lepr^tm4Mgmj)	decreased body temperature	J:164339
	impaired glucose tolerance	J:164339
	increased circulating glucose level	J:164339
	increased circulating insulin level	J:164339
	insulin resistance	J:164339
Lepr^tm5Mgmj/Lepr^tm5Mgmj (B6.129-Lepr^tm5Mgmj)	abnormal insulin secretion	J:221245
	increased circulating leptin level	J:179119
	insulin resistance	J:221245
Lepr^tm5Mgmj/Lepr^tm5Mgmj (involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)	increased circulating leptin level	J:221245
	increased oxygen consumption	J:221245
Leprotl1^{tm1b(EUCOMM)Hmgu}/Leprotl1^{tm1b(EUCOMM)Hmgu} (C57BL/6N-Leprotl1^{tm1b(EUCOMM)Hmgu}/H)	increased circulating alanine transaminase level	J:211773
	increased circulating alkaline phosphatase level	J:211773
	increased circulating phosphate level	J:211773
Letm1^{Gt(CC0204)Wtsi}/Letm1⁺ (129S.129P2-Letm1^{Gt(CC0204)Wtsi})	abnormal glucose homeostasis	J:222017
	decreased oxygen consumption	J:222017
Letm1^{Gt(DD0926)Wtsi}/Letm1⁺ (129S.129P2-Letm1^{Gt(DD0926)Wtsi})	abnormal glucose homeostasis	J:222017
	decreased oxygen consumption	J:222017
Letmd1^{em1(IMPC)Kmpc}/Letmd1^{em1(IMPC)Kmpc} (C57BL/6NTac-Letmd1^{em1(IMPC)Kmpc}/Kmpc)	increased fasting circulating glucose level	J:211773
Letmd1^em1Mbp/Letmd1^em1Mbp (C57BL/6J-Letmd1^em1Mbp)	abnormal oxygen consumption	J:321533
	decreased body surface temperature	J:321533
	decreased energy expenditure	J:321533
	decreased susceptibility to xenobiotic induced hyperthermia	J:321533
	impaired adaptive thermogenesis	J:321533
	impaired glucose tolerance	J:321533
	increased susceptibility to diet-induced obesity	J:321533
	insulin resistance	J:321533
Lexis1^tm1.1Pton/Lexis1^tm1.1Pton (B6.Cg-Lexis1^tm1.1Pton)	increased liver cholesterol level	J:233670
Lgals3^tm1Ftl/Lgals3^tm1Ftl (involves: 129S2/SvPas * C57BL/6)	increased circulating testosterone level	J:313172
Lgals3^tm1Ftl/Lgals3^tm1Ftl (involves: 129S2/SvPas * CD-1)	increased circulating alanine transaminase level	J:116073
Lgals3^tm1Ftl/Lgals3^tm1Ftl (involves: 129S2/SvPas * CD-1)	increased liver triglyceride level	J:116073
Lgals3bp^tm1Megt/Lgals3bp^tm1Megt (involves: 129P2/OlaHsd * C57BL/Ka)	increased circulating interferon-gamma level	J:94936
	increased circulating interleukin-12 level	J:94936
Lgals7^{tm1a(EUCOMM)Wtsi}/Lgals7^{tm1a(EUCOMM)Wtsi} (C57BL/6N-Lgals7^{tm1a(EUCOMM)Wtsi}/Wtsi)	increased circulating free fatty acids level	J:211773
	increased circulating glycerol level	J:211773
Lgals12^tm1Ftl/Lgals12^tm1Ftl (B6.129-Lgals12^tm1Ftl)	abnormal free fatty acids level	J:180097
	abnormal hormone level	J:180097
	decreased circulating leptin level	J:180097
	decreased triglyceride level	J:180097
	enhanced lipolysis	J:180097
	improved glucose tolerance	J:180097
	increased circulating insulin level	J:180097
	increased energy expenditure	J:180097
	increased glycerol level	J:180097
	increased insulin sensitivity	J:180097
	increased oxygen consumption	J:180097
Lgdr1^BALB/cJ/? (involves: BALB/cJ * C57BL/6J)	abnormal enzyme/coenzyme level	J:94275
Lgdr2^BALB/cJ/? (involves: BALB/cJ * C57BL/6J)	abnormal enzyme/coenzyme level	J:94275
Lgmn^tm1Cptr/Lgmn^tm1Cptr (B6.129S6-Lgmn^tm1Cptr)	albuminuria	J:172774
	increased circulating creatinine level	J:172774
	increased urine protein level	J:172774
Lgmn^tm1Ihn/Lgmn^tm1Ihn (involves: 129P2/OlaHsd * C57BL/6)	increased body temperature	J:143886
Lgmn^tm1Ihn/Lgmn^tm1Ihn (involves: 129P2/OlaHsd * C57BL/6)	increased circulating tumor necrosis factor level	J:143886
Lgr4^tm1.2Knis/Lgr4^tm1.2Knis (involves: 129P2/OlaHsd * C57BL/6)	increased circulating creatinine level	J:127019
Lgr5^{em1(IMPC)Kmpc}/Lgr5⁺ (C57BL/6NTac-Lgr5^{em1(IMPC)Kmpc}/Kmpc)	increased circulating bilirubin level	J:211773
Lgr5^tm1Ah/Lgr5^tm1Ah (involves: 129S5/SvEvBrd * C57BL/6)	cyanosis	J:94196
Lgr5^tm1Ah/Lgr5^tm1Ah (involves: 129S5/SvEvBrd)	cyanosis	J:127123
Lhb^tm1Kmr/Lhb^tm1Kmr (involves: 129S7/SvEvBrd * C57BL/6J)	decreased circulating estradiol level	J:94719
	decreased circulating progesterone level	J:94719
	decreased circulating testosterone level	J:94719
Lhcgr^tm1.1Pnara/Lhcgr⁺ (involves: 129S1/SvImJ * 129X1/SvJ * C57BL/6J)	abnormal testosterone level	J:203295
	decreased circulating follicle stimulating hormone level	J:203295
	decreased circulating luteinizing hormone level	J:203295
	increased circulating testosterone level	J:203295
	increased urine major urinary protein level	J:203295
Lhcgr^tm1Hht/Lhcgr^tm1Hht (involves: 129S7/SvEvBrd * C57BL/6J)	decreased circulating testosterone level	J:105533, J:66818
	increased circulating follicle stimulating hormone level	J:105533, J:66818
	increased circulating luteinizing hormone level	J:105533, J:66818
Lhcgr^tm1Zmlei/Lhcgr⁺ (either: 129X1/SvJ-Lhcgr^tm1Zmlei or (involves: 129X1/SvJ * C57BL/6))	decreased circulating testosterone level	J:66817
	increased circulating follicle stimulating hormone level	J:66817
Lhcgr^tm1Zmlei/Lhcgr^tm1Zmlei (either: 129X1/SvJ-Lhcgr^tm1Zmlei or (involves: 129X1/SvJ * C57BL/6))	decreased circulating estradiol level	J:66817
	decreased circulating progesterone level	J:66817
	decreased circulating testosterone level	J:66817
	increased circulating estradiol level	J:66817
	increased circulating follicle stimulating hormone level	J:66817
	increased circulating luteinizing hormone level	J:66817
Lhfpl4^em1(IMPC)H/Lhfpl4⁺ (C57BL/6NTac-Lhfpl4^em1(IMPC)H/H)	decreased circulating alanine transaminase level	J:211773
Lhx1^{tm1a(EUCOMM)Wtsi}/Lhx1⁺ (C57BL/6N-Lhx1^{tm1a(EUCOMM)Wtsi}/Ics)	decreased circulating alkaline phosphatase level	J:165965
Lhx2^tm1Dra/Lhx2^tm1Dra (involves: 129S4/SvJae)	hydrops fetalis	J:64676
Lhx3^tm1.1Sjr/Lhx3^tm1.1Sjr (involves: 129S/SvEv * C57BL/6J * FVB/N)	abnormal pituitary hormone level	J:169035
	decreased adrenocorticotropin level	J:169035
	decreased circulating insulin-like growth factor I level	J:169035
	decreased circulating prolactin level	J:169035
	decreased circulating thyroxine level	J:169035
	decreased follicle stimulating hormone level	J:169035
	decreased luteinizing hormone level	J:169035
	decreased prolactin level	J:169035
Lhx3^tm1Lmgd/Lhx3^tm1Lmgd (involves: 129S4/SvJae)	decreased adrenocorticotropin level	J:33050
	decreased growth hormone level	J:33050
	decreased luteinizing hormone level	J:33050
	decreased thyroid-stimulating hormone level	J:33050
Lhx4^tm1Ssp/Lhx4^tm1Ssp (involves: 129S2/SvPas * CF-1)	abnormal blood gas level	J:19373
	decreased growth hormone level	J:79850
	decreased thyroid-stimulating hormone level	J:79850
Lhx4^tm1Ssp/Lhx4^tm1Ssp Prop1^df/Prop1^df (involves: 129S2/SvPas * C57BL/6 * CF-1 * Goodale large mice * pink-eyed stock)	decreased growth hormone level	J:79850
	decreased pituitary hormone level	J:79850
	decreased thyroid-stimulating hormone level	J:79850
Lhx5^tm1Lmgd/Lhx5^tm1Lmgd (involves: 129S1/Sv * 129X1/SvJ * CD-1)	cyanosis	J:55103
Lhx9^tm1Lmgd/Lhx9^tm1Lmgd (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	decreased circulating estradiol level	J:60621
	decreased circulating testosterone level	J:60621
	increased circulating follicle stimulating hormone level	J:60621
Lias^tm1Mae/Lias⁺ (either: 129S6/SvEvTac-Lias^tm1Mae or (involves: 129S6/SvEvTac * C57BL/6J))	decreased glutathione level	J:101368
Liat1^{tm1.1(KOMP)Vlcg}/Liat1^{tm1.1(KOMP)Vlcg} (B6N(Cg)-Liat1^{tm1.1(KOMP)Vlcg}/J)	decreased blood urea nitrogen level	J:211773
	increased circulating alanine transaminase level	J:211773
Lif^tm1Stw/Lif^tm1Stw (involves: 129S1/Sv)	decreased circulating adrenocorticotropin level	J:34269
Lif^tm1Stw/Lif^tm1Stw (involves: 129S1/Sv * C57BL/6)	increased circulating interleukin-1 beta level	J:119777
Lif^tm1Stw/Lif^tm1Stw (involves: 129S1/Sv * C57BL/6 * MF1)	decreased circulating triglyceride level	J:87585
	increased circulating insulin-like growth factor I level	J:87585
	increased circulating leptin level	J:87585
Lif^tm1Stw/Lif^tm1Stw (involves: 129S1/Sv * BALB/c)	increased circulating alanine transaminase level	J:136940
	increased circulating aspartate transaminase level	J:136940
	increased circulating interleukin-6 level	J:136940
	increased circulating serum amyloid protein level	J:136940
	increased circulating tumor necrosis factor level	J:136940
Lif^tm1Stw/Lif^tm1Stw (involves: 129S1/Sv * MF1)	hypoxia	J:137646
Lifr^tm1Imx/Lifr^tm1Imx (involves: 129P3/J * 129S7/SvEvBrd * C57BL/6)	increased liver glycogen level	J:25253
Lilrb4a^tm1Eol/Lilrb4a^tm1Eol (B6.129P2-Lilrb4a^tm1Eol)	abnormal cytokine level	J:129969
	abnormal interferon level	J:129969
	abnormal interleukin level	J:129969
Lima1^tm1.1Blsg/Lima1⁺ (involves: C57BL/6 * FVB/N)	decreased circulating cholesterol level	J:263730
Lima1^tm1.1Blsg/Lima1⁺ (involves: C57BL/6 * FVB/N)	decreased intestinal cholesterol absorption	J:263730
Lima1^tm1.1Blsg/Lima1^tm1.1Blsg (involves: C57BL/6 * FVB/N)	decreased intestinal cholesterol absorption	J:263730
Lima1^tm1Blsg/Lima1⁺ Tg(Vil1-cre/ERT2)23Syr/0 (involves: C57BL/6 * DBA/2)	decreased intestinal cholesterol absorption	J:263730
Lima1^tm1Blsg/Lima1^tm1Blsg Tg(Vil1-cre/ERT2)23Syr/0 (involves: C57BL/6 * DBA/2)	decreased circulating cholesterol level	J:263730
	decreased circulating HDL cholesterol level	J:263730
	decreased circulating LDL cholesterol level	J:263730
	decreased circulating VLDL cholesterol level	J:263730
	decreased intestinal cholesterol absorption	J:263730
	decreased liver cholesterol level	J:263730
Limch1^em1Coop/Limch1^em1Coop (FVB-Limch1^em1Coop)	abnormal calcium ion homeostasis	J:336773
Limd1^em1(IMPC)H/Limd1^em1(IMPC)H (C57BL/6NTac-Limd1^em1(IMPC)H/H)	decreased circulating alkaline phosphatase level	J:211773
Lims1^tm1.1Chen/Lims1^tm1.1Chen Lims2^tm1.1Chen/Lims2^tm1.1Chen Tg(Tnnt2-cre)5Blh/0 (involves: 129/Sv * C57BL/6 * DBA/2)	abnormal atrial thrombosis	J:167114
	ascites	J:167114
	edema	J:167114
	pulmonary edema	J:167114
Lin7c^tm1Dsb/Lin7c^tm1Dsb (involves: 129S1/Sv * 129X1/SvJ)	decreased urine osmolality	J:134806
	increased blood urea nitrogen level	J:134806
	increased urine sodium level	J:134806
Lin28a^tm1.1Gqda/Lin28a^tm1.1Gqda (involves: 129S4/SvJae * C57BL/6)	abnormal glucose homeostasis	J:199720
Lin28a^tm1Egm/Lin28a^tm1Egm (involves: 129S/SvEv * C57BL/6NTac)	decreased circulating follicle stimulating hormone level	J:196313
	decreased circulating testosterone level	J:196313
Lin28a^tm1Gqda/Lin28a^tm1Gqda Myf5^tm3(cre)Sor/Myf5⁺ (involves: 129S4/SvJae * C57BL/6 * CD-1)	impaired glucose tolerance	J:177113
	insulin resistance	J:177113
Lin28b^tm1Gqda/Lin28b^tm1Gqda Myf5^tm1(cre)Mrc/Myf5⁺ (involves: 129S1/Sv * 129S4/SvJae * 129X1/SvJ * C57BL/6)	impaired glucose tolerance	J:199720
	insulin resistance	J:199720
Lin52^em1(IMPC)J/Lin52⁺ (C57BL/6NJ-Lin52^em1(IMPC)J/Mmjax)	decreased circulating calcium level	J:211773
linio/linio (involves: C57BL/6 * FVB/N)	cardiac edema	J:173681
Lipa^{tm1c(EUCOMM)Hmgu}/Lipa^{tm1c(EUCOMM)Hmgu} Speer6-ps1^{Tg(Alb-cre)21Mgn}/Speer6-ps1^{Tg(Alb-cre)21Mgn} (involves: C57BL/6J * C57BL/6N * C57BL/6NTac)	abnormal lipid oxidation	J:270182
	decreased liver triglyceride level	J:270182
	decreased susceptibility to diet-induced obesity	J:270182
	decreased unsaturated fatty acids level	J:270182
	impaired gluconeogenesis	J:270182
	improved glucose tolerance	J:270182
	increased circulating alanine transaminase level	J:270182
	increased circulating aspartate transaminase level	J:270182
	increased circulating cholesterol level	J:270182
	increased circulating ketone body level	J:270182
	increased circulating LDL cholesterol level	J:270182
	increased insulin sensitivity	J:270182
	increased liver cholesterol level	J:270182
	increased respiratory quotient	J:270182
	increased unsaturated fatty acids level	J:270182
Lipa^tm1Ggb/Lipa^tm1Ggb (involves: 129P2/OlaHsd * CF-1)	abnormal lipid level	J:68812
	decreased circulating HDL cholesterol level	J:68812
	increased circulating free fatty acids level	J:68812
	increased circulating insulin level	J:68812
	increased circulating LDL cholesterol level	J:68812
	increased liver cholesterol level	J:49674
	increased liver triglyceride level	J:49674
	insulin resistance	J:68812
Lipc^tm1Unc/Lipc^tm1Unc (involves: 129)	abnormal circulating cholesterol level	J:22938
	abnormal circulating phospholipid level	J:22938
	increased circulating cholesterol level	J:22938
	increased circulating HDL cholesterol level	J:22938
Lipc^tm1Unc/Lipc^tm1Unc (involves: 129P2/OlaHsd * C57BL/6J)	abnormal circulating cholesterol level	J:22938
	abnormal circulating phospholipid level	J:22938
	increased circulating cholesterol level	J:22938
	increased circulating HDL cholesterol level	J:22938
Lipc^tm1Unc/Lipc^tm1Unc (B6.129P2-Lipc^tm1Unc)	decreased circulating corticosterone level	J:108412
	increased circulating cholesterol level	J:120962
	increased circulating triglyceride level	J:120962
Lipe^{tm1b(KOMP)Wtsi}/Lipe^{tm1b(KOMP)Wtsi} (C57BL/6N-Lipe^{tm1b(KOMP)Wtsi}/Ucd)	increased circulating insulin level	J:211773
Lipe^tm1Gam/Lipe^tm1Gam (involves: 129S4/SvJae * BALB/c)	abnormal circulating cholesterol level	J:82299
	abnormal circulating free fatty acids level	J:82299
	decreased circulating leptin level	J:82299
	decreased liver triglyceride level	J:82299
	increased circulating glucose level	J:82299
Lipe^tm1Ishi/Lipe^tm1Ishi (involves: 129S7/SvEvBrd * C57BL/6)	decreased circulating free fatty acids level	J:59889
	decreased circulating glycerol level	J:59889
	increased triglyceride level	J:59889
Lipe^tm1Ishi/Lipe^tm1Ishi (B6.129S7-Lipe^tm1Ishi)	abnormal cholesterol homeostasis	J:152385
	increased circulating cholesterol level	J:152385
	increased circulating free fatty acids level	J:152385
	increased circulating glucose level	J:152385
	increased circulating triglyceride level	J:152385
Lipe^tm1Ishi/Lipe^tm1Ishi Nceh1^tm1Ishi/Nceh1^tm1Ishi (B6.129S7-Nceh1^tm1Ishi Lipe^tm1Ishi)	abnormal cholesterol homeostasis	J:152385
	increased circulating cholesterol level	J:152385
	increased circulating free fatty acids level	J:152385
	increased circulating glucose level	J:152385
	increased circulating triglyceride level	J:152385
Lipe^tm1Land/Lipe^tm1Land (involves: 129 * C57BL/6J)	abnormal lipolysis	J:85540
	decreased circulating adiponectin level	J:133126
	decreased circulating leptin level	J:133126
	decreased susceptibility to diet-induced obesity	J:133126
	hyperglycemia	J:85540
	increased circulating insulin level	J:85540
	increased oxygen consumption	J:133126
	insulin resistance	J:85540
Lipe^tm1Land/Lipe^tm1Land (involves: 129)	abnormal lipid homeostasis	J:106148
Lipe^tm1Land/Lipe^tm1Land (involves: 129)	decreased skeletal muscle glycogen level	J:106148
Lipe^tm1Rze/Lipe^tm1Rze (involves: 129P2/OlaHsd * C57BL/6J)	abnormal fatty acids level	J:74644
	abnormal lipid level	J:74644
	abnormal triglyceride level	J:74644
	decreased cardiac muscle triglyceride level	J:74644
	decreased liver triglyceride level	J:74644
	increased triglyceride level	J:74644
Lipe^tm1Rze/Lipe^tm1Rze (involves: 129P2/OlaHsd)	abnormal hepatic glucose production	J:84822
	decreased circulating adiponectin level	J:84822
	decreased circulating free fatty acids level	J:84822
	decreased circulating insulin level	J:84822
	decreased circulating triglyceride level	J:84822
	decreased liver triglyceride level	J:84822
	increased circulating glucose level	J:84822
Lipe^tm2Rze/Lipe^tm2Rze Tg(Ins2-cre)25Mgn/? (involves: 129 * C57BL/6 * DBA)	abnormal glucose homeostasis	J:144744
	abnormal insulin secretion	J:144744
	impaired glucose tolerance	J:144744
	increased circulating glucose level	J:144744
	increased circulating leptin level	J:144744
Lipg^tm1Chan/Lipg⁺ (involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)	abnormal cholesterol homeostasis	J:82390
	increased circulating cholesterol level	J:82390
	increased circulating HDL cholesterol level	J:82390
Lipg^tm1Chan/Lipg^tm1Chan (involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)	abnormal cholesterol homeostasis	J:82390
	increased circulating cholesterol level	J:82390
	increased circulating HDL cholesterol level	J:82390
	increased circulating phospholipid level	J:82390
Lipg^tm1Tq/Lipg⁺ (B6.129S6-Lipg^tm1Tq)	increased circulating HDL cholesterol level	J:81821
	increased circulating phospholipid level	J:81821
	increased circulating triglyceride level	J:81821
Lipg^tm1Tq/Lipg^tm1Tq (B6.129S6-Lipg^tm1Tq)	increased circulating cholesterol level	J:81821
	increased circulating HDL cholesterol level	J:81821
	increased circulating phospholipid level	J:81821
Lipg^tm1Tq/Lipg^tm1Tq (involves: 129S6/SvEvTac * C57BL/6J)	increased circulating cholesterol level	J:93987
	increased circulating HDL cholesterol level	J:93987
	increased circulating phospholipid level	J:93987
	increased circulating triglyceride level	J:93987
Lipg^tm1Tq/Lipg^tm1Tq (involves: 129S6/SvEvTac)	abnormal circulating HDL cholesterol level	J:129942
Lipi^lpd1/Lipi^lpd1 (involves: CD-1)	increased circulating triglyceride level	J:46789
Lipi^lpd1/Lipi^lpd1 (involves: CD-1)	increased liver triglyceride level	J:46789
Lipn^{tm1.1(KOMP)Vlcg}/Lipn^{tm1.1(KOMP)Vlcg} (C57BL/6N-Lipn^{tm1.1(KOMP)Vlcg}/J)	decreased circulating glucose level	J:211773
Lipq1^BALB/cJ/Lipq1^C57BL/6By (involves: BALB/cJ * B6.C-H25^c/(HW65)ByJ)	increased circulating cholesterol level	J:88731
	increased circulating HDL cholesterol level	J:88731
Lipq1^C57BL/6By/Lipq1^C57BL/6By (involves: BALB/cJ * B6.C-H25^c/(HW65)ByJ)	increased circulating cholesterol level	J:88731
	increased circulating HDL cholesterol level	J:88731
Lipq2^BALB/cJ/Lipq2^BALB/cJ (involves: BALB/cJ * B6.C-H25^c/(HW65)ByJ)	increased circulating cholesterol level	J:88731
	increased circulating HDL cholesterol level	J:88731
Lipq3^BALB/cJ/Lipq3^C57BL/6By (involves: BALB/cJ * B6.C-H25^c/(HW65)ByJ)	increased circulating cholesterol level	J:88731
	increased circulating HDL cholesterol level	J:88731
Lipq3^C57BL/6By/Lipq3^C57BL/6By (involves: BALB/cJ * B6.C-H25^c/(HW65)ByJ)	increased circulating cholesterol level	J:88731
	increased circulating HDL cholesterol level	J:88731
Lith12^CAST/EiJ/Lith12^CAST/EiJ (involves: 129S1/SvImJ * CAST/Ei)	abnormal lipid homeostasis	J:84711
Lith13^129S1/SvImJ/Lith13^129S1/SvImJ (involves: 129S1/SvImJ * CAST/Ei)	abnormal lipid homeostasis	J:84711
Lith14^129S1/SvImJ/Lith14^CAST/EiJ (involves: 129S1/SvImJ * CAST/Ei)	abnormal lipid homeostasis	J:84711
Lith14^CAST/EiJ/Lith14^CAST/EiJ (involves: 129S1/SvImJ * CAST/Ei)	abnormal lipid homeostasis	J:84711
Lith25^129S1/SvImJ/Lith25^CAST/EiJ (involves: 129S1/SvImJ * CAST/Ei)	abnormal lipid homeostasis	J:84711
Lith25^CAST/EiJ/Lith25^CAST/EiJ (involves: 129S1/SvImJ * CAST/Ei)	abnormal lipid homeostasis	J:84711
Llcfc1^{tm1.1(KOMP)Vlcg}/Llcfc1^{tm1.1(KOMP)Vlcg} (C57BL/6N-Llcfc1^{tm1.1(KOMP)Vlcg}/Ucd)	increased circulating bilirubin level	J:211773
Llgl2^{tm1b(KOMP)Wtsi}/Llgl2⁺ (C57BL/6N-Llgl2^{tm1b(KOMP)Wtsi}/J)	decreased circulating HDL cholesterol level	J:211773
Lman1^{Gt(XST010)Byg}/Lman1^{Gt(XST010)Byg} (B6.129-Lman1^{Gt(XST010)Byg})	abnormal circulating protein level	J:262681
	abnormal protein level	J:262681
	decreased circulating aspartate transaminase level	J:262681
	decreased circulating factor VIII level	J:262681
Lman1^{Gt(XST010)Byg}/Lman1^{Gt(XST010)Byg} Mcfd2^tm1Dgi/Mcfd2^tm1Dgi (B6.129-Mcfd2^tm1Dgi Lman1^{Gt(XST010)Byg})	abnormal circulating protein level	J:262681
	abnormal protein level	J:262681
	decreased circulating aspartate transaminase level	J:262681
	decreased circulating factor VIII level	J:262681
Lman1^{tm1c(KOMP)Wtsi}/Lman1^{tm1c(KOMP)Wtsi} Speer6-ps1^{Tg(Alb-cre)21Mgn}/Speer6-ps1⁺ (involves: C57BL/6 * C57BL/6J * C57BL/6N)	abnormal blood homeostasis	J:213133
Lman1^{tm1c(KOMP)Wtsi}/Lman1^{tm1c(KOMP)Wtsi} Tg(Tek-cre)12Flv/0 (involves: C57BL/6 * C57BL/6J * C57BL/6N)	abnormal blood homeostasis	J:213133
Lmf1^cld/Lmf1^cld (STOCK T/t^w73)	cyanosis	J:7083
	hyperchylomicronemia	J:7083
	increased circulating cholesterol level	J:7083
	increased circulating triglyceride level	J:7083
Lmf1^{Gt(OST195742)Lex}/Lmf1^{Gt(OST195742)Lex} (involves: 129S5/SvEvBrd * C57BL/6J)	hyperlipidemia	J:223457
	increased circulating cholesterol level	J:223457
	increased circulating triglyceride level	J:223457
Lmna^Dhe/Lmna⁺ (B6(D2)-Lmna^Dhe/TyGrsrJ)	increased circulating phosphate level	J:188496
Lmna^em1Fenz/Lmna⁺ (C57BL/6-Lmna^em1Fenz)	impaired glucose tolerance	J:338760
	increased circulating alanine transaminase level	J:338760
	increased circulating alkaline phosphatase level	J:338760
	increased circulating aspartate transaminase level	J:338760
	increased circulating cholesterol level	J:338760
	increased circulating LDL cholesterol level	J:338760
	increased liver triglyceride level	J:338760
	insulin resistance	J:338760
Lmna^{Gt(S7-1F1)Sor}/Lmna^{Gt(S7-1F1)Sor} (involves: 129S4/SvJaeSor * C57BL/6)	decreased circulating carnitine level	J:221850
	decreased circulating lactate level	J:221850
	decreased core body temperature	J:221850
	decreased liver glycogen level	J:221850
	hypoglycemia	J:221850
	increased circulating creatine kinase level	J:221850
	increased circulating ketone body level	J:221850
Lmna^tm1.1Otin/Lmna⁺ (involves: 129P2/OlaHsd * C57BL/6)	abnormal blood homeostasis	J:211388
	decreased circulating glucose level	J:177632
	increased circulating alkaline phosphatase level	J:211388
Lmna^tm1.1Otin/Lmna^tm1.1Otin (involves: 129P2/OlaHsd * C57BL/6)	abnormal blood homeostasis	J:177632
	decreased circulating insulin level	J:177632
	decreased circulating leptin level	J:177632
	hypoglycemia	J:177632
	increased circulating adiponectin level	J:177632
	increased circulating growth hormone level	J:177632
Lmna^{tm1b(EUCOMM)Wtsi}/Lmna⁺ (C57BL/6N-Lmna^{tm1b(EUCOMM)Wtsi}/Ics)	improved glucose tolerance	J:211773
Lmna^tm1Gbon/Lmna^tm1Gbon (involves: 129S2/SvPas * C57BL/6)	decreased circulating glucose level	J:95528
Lmna^tm1Gbon/Lmna^tm1Gbon (involves: 129S2/SvPas * C57BL/6)	increased triglyceride level	J:95528
Lmna^tm1Stw/Lmna⁺ (involves: 129S1/Sv * C57BL/6J)	increased circulating insulin level	J:75101
Lmna^tm1Stw/Lmna⁺ (involves: 129S1/Sv * C57BL/6J)	insulin resistance	J:75101
Lmna^tm1Stw/Lmna^tm1Stw (involves: 129S1/Sv * C57BL/6J)	decreased circulating glucose level	J:75101
Lmna^tm1Stw/Lmna^tm1Stw (involves: 129S1/Sv * C57BL/6J)	decreased circulating triglyceride level	J:75101
Lmna^tm2.1Gbon/Lmna⁺ (involves: 129 * C57BL/6)	pulmonary edema	J:198526
Lmna^tm2.1Gbon/Lmna^tm2.1Gbon (involves: 129 * C57BL/6)	abnormal urine homeostasis	J:180603
	decreased circulating insulin level	J:180603
	hypoglycemia	J:180603
Lmnb1^{tm1a(EUCOMM)Wtsi}/Lmnb1⁺ (B6Dnk;B6Brd;B6N-Tyr^c-Brd Lmnb1^{tm1a(EUCOMM)Wtsi}/WtsiH)	decreased circulating alkaline phosphatase level	J:175295
	decreased circulating calcium level	J:175295
Lmnb2^{tm1a(KOMP)Wtsi}/Lmnb2⁺ (B6JTyr;B6N-Lmnb2^{tm1a(KOMP)Wtsi}/Wtsi)	increased circulating creatinine level	J:175295
Lmod3^em1(IMPC)Mbp/Lmod3⁺ (C57BL/6N-Lmod3^em1(IMPC)Mbp/Ucd)	increased blood urea nitrogen level	J:211773
Lmod3^em1(IMPC)Mbp/Lmod3^em1(IMPC)Mbp (C57BL/6N-Lmod3^em1(IMPC)Mbp/Ucd)	abnormal cholesterol homeostasis	J:211773
	decreased circulating HDL cholesterol level	J:211773
	increased circulating insulin level	J:211773
Lmod3^em1Eno/Lmod3^em1Eno (involves: C3H * C57BL/6)	increased skeletal muscle glycogen level	J:222174
Lmr3^BALB/cHeA/? (involves: BALB/cHeA * STS/A)	abnormal tumor necrosis factor level	J:82715
Lmr4^BALB/cHeA/? Lmr5^BALB/cHeA/? (involves: BALB/cHeA * STS/A)	abnormal tumor necrosis factor level	J:82715
Lmr5^BALB/cHeA/? (involves: BALB/cHeA * STS/A)	abnormal interleukin level	J:82715
Lmr5^BALB/cHeA/? (involves: BALB/cHeA * STS/A)	abnormal tumor necrosis factor level	J:82715
Lmr5^CcS5/Dem/Lmr5^CcS5/Dem (involves: BALB/cHeA * STS/A)	increased circulating interleukin-12 level	J:108764
Lmr9^BALB/cHeA/Lmr9^CcS20/Dem (involves: BALB/cHeA * STS/A)	increased circulating interleukin-6 level	J:108764
Lmr9^CcS20/Dem/Lmr9^CcS20/Dem (involves: BALB/cHeA * STS/A)	increased circulating interleukin-6 level	J:108764
Lmr11^BALB/cHeA/Lmr11^CcS20/Dem (involves: BALB/cHeA * STS/A)	increased circulating interleukin-6 level	J:108764
Lmr11^CcS20/Dem/Lmr11^CcS20/Dem (involves: BALB/cHeA * STS/A)	increased circulating interleukin-6 level	J:108764
Lmr12^BALB/cHeA/Lmr12^BALB/cHeA Lmr14^BALB/cHeA/Lmr14^BALB/cHeA (involves: BALB/cHeA * STS/A)	increased circulating tumor necrosis factor level	J:108764
Lmr12^BALB/cHeA/Lmr12^CcS16/Dem (involves: BALB/cHeA * STS/A)	increased circulating interleukin-4 level	J:108764
Lmr12^CcS16/Dem/Lmr12^CcS16/Dem (involves: BALB/cHeA * STS/A)	increased circulating interleukin-4 level	J:108764
Lmr13^CcS16/Dem/Lmr13^CcS16/Dem Lmr14^CcS16/Dem/Lmr14^CcS16/Dem (involves: BALB/cHeA * STS/A)	decreased circulating tumor necrosis factor level	J:108764
Lmr14^BALB/cHeA/Lmr14^CcS16/Dem (involves: BALB/cHeA * STS/A)	increased circulating interferon-gamma level	J:108764
Lmr14^CcS16/Dem/Lmr14^CcS16/Dem (involves: BALB/cHeA * STS/A)	increased circulating interferon-gamma level	J:108764
Lmr14^CcS16/Dem/Lmr14^CcS16/Dem Lmr5^CcS5/Dem/Lmr5^CcS5/Dem (involves: BALB/cHeA * STS/A)	increased circulating interleukin-12 level	J:108764
Lmr15^BALB/cHeA/Lmr15^CcS16/Dem (involves: BALB/cHeA * STS/A)	decreased circulating interferon-gamma level	J:108764
Lmr15^CcS16/Dem/Lmr15^CcS16/Dem (involves: BALB/cHeA * STS/A)	decreased circulating interferon-gamma level	J:108764
Lmr17^BALB/cHeA/Lmr17^CcS20/Dem (involves: BALB/cHeA * STS/A)	increased circulating tumor necrosis factor level	J:108764
Lmr17^CcS20/Dem/Lmr17^CcS20/Dem (involves: BALB/cHeA * STS/A)	increased circulating tumor necrosis factor level	J:108764
Lmr17^CcS20/Dem/Lmr17^CcS20/Dem Lmr3^BALB/cHeA/Lmr3^BALB/cHeA (involves: BALB/cHeA * STS/A)	increased circulating interferon-gamma level	J:108764
Lmtk2^em1(IMPC)Mbp/Lmtk2^em1(IMPC)Mbp (C57BL/6N-Lmtk2^em1(IMPC)Mbp/MbpMmucd)	increased circulating alkaline phosphatase level	J:211773
Lmtk3^tm1Tya/Lmtk3^tm1Tya (B6JJcl.Cg-Lmtk3^tm1Tya)	abnormal homeostasis	J:210612
Lmx1a^tm1Tpe/Lmx1a^tm1Tpe Lmx1b^tm1Zfc/Lmx1b^tm1Zfc Slc6a3^tm1(cre)Lrsn/Slc6a3⁺ (involves: 129S1/Sv * 129S7/SvEvBrd * 129X1/SvJ * C57BL/6)	decreased dopamine level	J:222854
Lmx1a^tm1Tpe/Lmx1a^tm1Tpe Lmx1b^tm1Zfc/Lmx1b^tm1Zfc Tg(Slc6a3-cre/ERT2)1Span/0 (involves: 129S7/SvEvBrd * C57BL/6)	decreased dopamine level	J:222854
Lmx1b^tm1Zfc/Lmx1b^tm1Zfc Tg(Fev-cre/ERT2)#Yqd/0 (Not Specified)	decreased serotonin level	J:168054
Lmx1b^tm4.1Rjo/Lmx1b^tm4.1Rjo Tg(NPHS2-cre)295Lbh/0 (involves: 129S7/SvEvBrd * C57BL/6 * SJL)	albuminuria	J:122505
Lncenc1^em1Smoc/Lncenc1^em1Smoc (C57BL/6J-Lncenc1^em1Smoc)	decreased circulating cholesterol level	J:306153
	decreased circulating HDL cholesterol level	J:306153
	decreased circulating LDL cholesterol level	J:306153
	decreased circulating triglyceride level	J:306153
	decreased liver cholesterol level	J:306153
	decreased liver triglyceride level	J:306153
	decreased respiratory quotient	J:306153
	decreased susceptibility to diet-induced obesity	J:306153
	impaired glucose tolerance	J:306153
	improved glucose tolerance	J:306153
	increased insulin sensitivity	J:306153
	increased oxygen consumption	J:306153
	insulin resistance	J:306153
Lncenc1^em2Smoc/Lncenc1^em2Smoc (C57BL/6J-Lncenc1^em2Smoc)	decreased circulating triglyceride level	J:306153
	decreased susceptibility to diet-induced obesity	J:306153
	impaired glucose tolerance	J:306153
	insulin resistance	J:306153
Lnpep^tm1Ske/Lnpep^tm1Ske (involves: 129S/SvEv * Black Swiss)	abnormal glucose homeostasis	J:76570
	insulin resistance	J:76570
Lnpep^tm1Ske/Lnpep^tm1Ske (B6.129S-Lnpep^tm1Ske)	decreased circulating adiponectin level	J:220356
	decreased circulating cholesterol level	J:220356
	decreased susceptibility to diet-induced obesity	J:220356
	improved glucose tolerance	J:220356
	increased circulating leptin level	J:220356
	increased core body temperature	J:220356
	increased insulin sensitivity	J:220356
	increased oxygen consumption	J:220356
Lnpk^Ul/Lnpk⁺ (B6EiC3-+ a/Lnpk^Ul A/J)	increased bleeding time	J:31800
Lonp1^{tm1b(EUCOMM)Hmgu}/Lonp1⁺ (C57BL/6N-Lonp1^{tm1b(EUCOMM)Hmgu}/Ieg)	decreased circulating iron level	J:211773
	increased circulating HDL cholesterol level	J:211773
Lonrf2^em2(IMPC)H/Lonrf2^em2(IMPC)H (C57BL/6N-Lonrf2^em2(IMPC)H/H)	impaired glucose tolerance	J:211773
	increased blood urea nitrogen level	J:211773
	increased circulating calcium level	J:211773
	increased circulating creatinine level	J:211773
	increased fasting circulating glucose level	J:211773
Lonrf3^{tm1a(KOMP)Wtsi}/Y (C57BL/6N-Lonrf3^{tm1a(KOMP)Wtsi}/Wtsi)	increased circulating free fatty acids level	J:211773
	increased circulating magnesium level	J:211773
Lonrf3^{tm1a(KOMP)Wtsi}/Lonrf3^{tm1a(KOMP)Wtsi} (C57BL/6N-Lonrf3^{tm1a(KOMP)Wtsi}/Wtsi)	increased circulating calcium level	J:211773
Lore1^SS/Lore1^SS (involves: LS * SS)	abnormal blood homeostasis	J:76104
Lore2^SS/Lore2^SS (involves: LS * SS)	abnormal blood homeostasis	J:76104
Loricrin^{tm1.1(KOMP)Vlcg}/Loricrin⁺ (C57BL/6N-Loricrin^{tm1.1(KOMP)Vlcg}/Ucd)	improved glucose tolerance	J:211773
Loricrin^tm1Der/Loricrin^tm1Der (FVB.129S7-Loricrin^tm1Der)	impaired skin barrier function	J:65187
Lox^em1(IMPC)Mbp/Lox^em1(IMPC)Mbp (C57BL/6N-Lox^em1(IMPC)Mbp/MbpMmucd)	edema	J:211773
Lox^tm1Soin/Lox^tm1Soin (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	cyanosis	J:103389
Loxl1^{tm1.1(KOMP)Vlcg}/Loxl1⁺ (B6N(Cg)-Loxl1^{tm1.1(KOMP)Vlcg}/J)	increased fasting circulating glucose level	J:211773
Loxl1^{tm1.1(KOMP)Vlcg}/Loxl1^{tm1.1(KOMP)Vlcg} (B6N(Cg)-Loxl1^{tm1.1(KOMP)Vlcg}/J)	decreased circulating total protein level	J:211773
Loxl2^em1(IMPC)H/Loxl2⁺ (C57BL/6NTac-Loxl2^em1(IMPC)H/H)	increased circulating amylase level	J:211773
Loxl2^tm1.2Acan/Loxl2^tm1.2Acan (Not Specified)	cyanosis	J:220689
Loxl4^{tm1.1(KOMP)Vlcg}/Loxl4^{tm1.1(KOMP)Vlcg} (C57BL/6N-Loxl4^{tm1.1(KOMP)Vlcg}/MbpMmucd)	increased circulating alkaline phosphatase level	J:211773
Lpar1^tm1Mcox/Lpar1^tm1Mcox (B6.129P2-Lpar1^tm1Mcox)	abnormal amino acid level	J:87198
	abnormal serotonin level	J:87198
	increased dopamine level	J:87198
Lpar3^tm1Jch/Lpar3^tm1Jch (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	decreased prostaglandin level	J:98434
Lpar4^{tm1.1(KOMP)Vlcg}/Y (C57BL/6N-Lpar4^{tm1.1(KOMP)Vlcg}/J)	decreased urine magnesium level	J:211773
Lpar4^{tm1.1(KOMP)Vlcg}/Lpar4^{tm1.1(KOMP)Vlcg} (C57BL/6N-Lpar4^{tm1.1(KOMP)Vlcg}/J)	decreased fasting circulating glucose level	J:211773
	decreased urine magnesium level	J:211773
Lpar4^tm1Sati/Y (involves: C57BL/6)	abnormal fluid regulation	J:167262
	hemopericardium	J:167262
	pericardial effusion	J:167262
	skin edema	J:167262
Lpar4^tm1Sati/Lpar4^tm1Sati (involves: C57BL/6)	abnormal fluid regulation	J:167262
	hemopericardium	J:167262
	pericardial effusion	J:167262
	skin edema	J:167262
Lpar6^{tm1.1(KOMP)Vlcg}/Lpar6^{tm1.1(KOMP)Vlcg} (C57BL/6N-Lpar6^{tm1.1(KOMP)Vlcg}/J)	increased circulating alanine transaminase level	J:211773
Lpcat1^{Gt(BC0405)Wtsi}/Lpcat1^{Gt(BC0405)Wtsi} (involves: 129P2/OlaHsd * Black Swiss)	cyanosis	J:161467
Lpcat1^rd11-2J/Lpcat1^rd11-2J (B6.Cg-Lpcat1^rd11-2J/BocJ)	abnormal phospholipid level	J:163743
Lpcat1^rd11/Lpcat1^rd11 (B6.Cg-Lpcat1^rd11/BocJ)	abnormal phospholipid level	J:163743
Lpcat2^em1(IMPC)J/Lpcat2^em1(IMPC)J (C57BL/6NJ-Lpcat2^em1(IMPC)J/Mmjax)	increased circulating cholesterol level	J:211773
	increased circulating HDL cholesterol level	J:211773
Lpcat3^{tm1a(EUCOMM)Wtsi}/Lpcat3^{tm1a(EUCOMM)Wtsi} (involves: C57BL/6N)	decreased circulating glucose level	J:220827
Lpcat3^{tm1c(EUCOMM)Wtsi}/Lpcat3^{tm1c(EUCOMM)Wtsi} (involves: C57BL/6 * C57BL/6N * SJL)	decreased circulating triglyceride level	J:220827
Lpcat3^{tm1c(EUCOMM)Wtsi}/Lpcat3^{tm1c(EUCOMM)Wtsi} Speer6-ps1^{Tg(Alb-cre)21Mgn}/Speer6-ps1⁺ (involves: C57BL/6 * C57BL/6N * SJL)	abnormal circulating apolipoprotein level	J:220827
	abnormal lipid homeostasis	J:220827
	abnormal lipid level	J:220827
	abnormal phospholipid level	J:220827
	decreased circulating triglyceride level	J:220827
	decreased circulating VLDL phospholipid level	J:220827
	decreased circulating VLDL triglyceride level	J:220827
	increased liver cholesterol level	J:220827
	increased liver triglyceride level	J:220827
Lpcat3^{tm1c(EUCOMM)Wtsi}/Lpcat3^{tm1c(EUCOMM)Wtsi} Tg(Vil1-cre)997Gum/0 (involves: C57BL/6 * C57BL/6N * SJL)	abnormal lipid level	J:220827
	decreased circulating glucose level	J:220827
	decreased circulating insulin level	J:220827
	decreased circulating triglyceride level	J:220827
Lpin1^fld-2J/Lpin1^fld-2J (C3H/HeJ-Lpin1^fld-2J/J)	decreased circulating leptin level	J:66739
Lpin1^fld-2J/Lpin1^fld-2J (C3H/HeJ-Lpin1^fld-2J/J)	insulin resistance	J:66739
Lpin1^fld/Lpin1^fld (BALB/cByJ-Lpin1^fld/J)	abnormal enzyme/coenzyme level	J:121022
	abnormal gluconeogenesis	J:121022
	abnormal glucose homeostasis	J:121022
	abnormal respiratory quotient	J:121022
	increased circulating glucose level	J:121022
	increased fatty acids level	J:121022
	increased glycogen level	J:121022
Lpin1^fld/Lpin1^fld (BALB/cByJ-Lpin1^fld)	abnormal cholesterol homeostasis	J:82882
	abnormal lipid homeostasis	J:82882
	abnormal lipid level	J:82882
	abnormal phospholipid level	J:82882
	abnormal triglyceride level	J:82882
	decreased circulating LDL cholesterol level	J:63448
	decreased circulating leptin level	J:66739
	decreased circulating VLDL cholesterol level	J:63448
	decreased fatty acids level	J:63448
	decreased insulin secretion	J:63448
	decreased triglyceride level	J:82882
	impaired glucose tolerance	J:63448
	increased cholesterol level	J:82882
	increased circulating HDL cholesterol level	J:63448
	increased circulating insulin level	J:63448
	increased circulating triglyceride level	J:82882
	increased circulating VLDL triglyceride level	J:147417
	increased fatty acids level	J:82882
	increased liver triglyceride level	J:147417, J:82882
	increased triglyceride level	J:82882
	insulin resistance	J:63448
Lpin1^fld/Lpin1^fld (involves: 129P2/OlaHsd * BALB/cByJ * C57BL/6J)	decreased liver triglyceride level	J:220917
	decreased triglyceride level	J:220917
Lpin1^fld/Lpin1^fld Lpin3^tm1Reue/Lpin3^tm1Reue (involves: 129P2/OlaHsd * BALB/cByJ * C57BL/6J)	decreased liver triglyceride level	J:220917
	decreased triglyceride level	J:220917
Lpin2^tm1Reue/Lpin2^tm1Reue (involves: C57BL/6J)	decreased circulating free fatty acids level	J:189894
	decreased circulating triglyceride level	J:189894
	decreased fasting circulating glucose level	J:189894
	increased liver triglyceride level	J:189894
Lpin3^tm1Reue/Lpin3^tm1Reue (involves: 129P2/OlaHsd * BALB/cByJ * C57BL/6J)	decreased triglyceride level	J:220917
Lpl^tm1Bres/Lpl⁺ (involves: 129S4/SvJae * C57BL/6J)	abnormal lipid homeostasis	J:30062
	increased circulating cholesterol level	J:30062
	increased circulating triglyceride level	J:30062
	increased circulating VLDL cholesterol level	J:30062
	increased circulating VLDL triglyceride level	J:30062
Lpl^tm1Bres/Lpl⁺ (involves: 129S4/SvJae)	increased cholesterol level	J:134171
Lpl^tm1Bres/Lpl⁺ (involves: 129S4/SvJae)	increased triglyceride level	J:134171
Lpl^tm1Bres/Lpl⁺ Tg(Myh6-LPL*)357Ijg/0 (involves: 129S4/SvJae)	abnormal blood homeostasis	J:134550
	abnormal lipid level	J:134550
	increased fatty acids level	J:134550
Lpl^tm1Bres/Lpl^tm1Bres (involves: 129S4/SvJae * C57BL/6J)	abnormal lipid homeostasis	J:30062
	cyanosis	J:30062
	decreased circulating HDL cholesterol level	J:30062
	decreased circulating LDL cholesterol level	J:30062
	increased circulating cholesterol level	J:30062
	increased circulating triglyceride level	J:30062
	increased circulating VLDL cholesterol level	J:30062
Lpl^tm1Ijg/Lpl^tm1Ijg Tg(Myh6-cre)2182Mds/? (involves: C57BL/6)	abnormal glucose homeostasis	J:90737
	abnormal lipid level	J:90737
	decreased cardiac muscle triglyceride level	J:90737
	decreased fatty acids level	J:90737
	increased circulating triglyceride level	J:90737
	increased circulating VLDL triglyceride level	J:90737
Lpl^tm1Ijg/Lpl^tm1Ijg Tg(Myh6-cre)2182Mds/0 (involves: FVB/N)	abnormal glucose homeostasis	J:110484
	increased circulating triglyceride level	J:110484
Lpl^tm1Sem/Lpl⁺ (involves: 129P2/OlaHsd * C57BL/6J)	abnormal lipid homeostasis	J:25652
	increased circulating cholesterol level	J:25652
	increased circulating HDL cholesterol level	J:25652
	increased circulating phospholipid level	J:25652
	increased circulating triglyceride level	J:25652
	increased circulating VLDL triglyceride level	J:25652
Lpl^tm1Sem/Lpl^tm1Sem (involves: 129P2/OlaHsd * C57BL/6J)	decreased circulating HDL cholesterol level	J:25652
	hyperlipidemia	J:25652
	increased circulating cholesterol level	J:25652
	increased circulating phospholipid level	J:25652
	increased circulating triglyceride level	J:25652
Lpn1^NZB/Lpn1^NZB (involves: NZB * NZW)	increased urine protein level	J:6026
Lpn1^NZB/Lpn1^NZW (involves: NZB * NZW)	increased urine protein level	J:6026
Lpn2^NZB/Lpn2^NZW (involves: NZB * NZW)	increased urine protein level	J:6026
Lpn2^NZW/Lpn2^NZW (involves: NZB * NZW)	increased urine protein level	J:6026
Lpp^{tm1b(KOMP)Wtsi}/Lpp⁺ (C57BL/6NCrl-Lpp^{tm1b(KOMP)Wtsi}/Ccpcz)	increased circulating phosphate level	J:211773
Lprq1^MRL/MpJ/Lprq1^MRL/MpJ (involves: BALB/cJ * MRL/MpJ)	decreased circulating cholesterol level	J:53728
Lprq1^MRL/MpJ/Lprq1^MRL/MpJ (involves: BALB/cJ * MRL/MpJ)	decreased circulating VLDL cholesterol level	J:53728
Lprq2^MRL/MpJ/Lprq2^MRL/MpJ (involves: BALB/cJ * MRL/MpJ)	decreased circulating HDL cholesterol level	J:53728
Lprq3^NZB/BlNJ/? (involves: NZB/BlNJ * SM/J)	abnormal circulating protein level	J:29072
Lprq3^NZB/BlNJ/? (involves: NZB/BlNJ * SM/J)	increased circulating HDL cholesterol level	J:29072
Lprq4^NZB/BlNJ/? (involves: NZB/BlNJ * SM/J)	abnormal circulating cholesterol level	J:29072
Lprq4^NZB/BlNJ/? (involves: NZB/BlNJ * SM/J)	increased circulating HDL cholesterol level	J:29072
Lptl1^DBA/2J/? (involves: C57BL/6J * DBA/2J)	abnormal tumor necrosis factor level	J:90647
Lptl1^DBA/2J/Lptl1^DBA/2J Lptl2^DBA/2J/Lptl2^DBA/2J (involves: C57BL/6J * DBA/2J)	abnormal tumor necrosis factor level	J:90647
Lptl2^DBA/2J/? (involves: C57BL/6J * DBA/2J)	abnormal tumor necrosis factor level	J:90647
Lrat^tm1.1Bok/Lrat^tm1.1Bok (involves: 129S2/SvPas)	abnormal vitamin A level	J:132516
Lrat^tm1Bok/Lrat^tm1Bok Tg(Tyrp1-cre)1Ipc/? (involves: 129S2/SvPas)	abnormal vitamin A level	J:132516
Lrat^tm1Log/Lrat^tm1Log (involves: 129S1/Sv * C57BL/6J)	abnormal retinol level	J:104101
Lrat^tm1Log/Lrat^tm1Log (involves: 129S1/Sv * C57BL/6J)	abnormal vitamin A level	J:104101
Lratd2^{em1(IMPC)Ccpcz}/Lratd2^{em1(IMPC)Ccpcz} (C57BL/6N-Lratd2^{em1(IMPC)Ccpcz}/Ccpcz)	decreased respiratory quotient	J:211773
	increased circulating total protein level	J:211773
Lrba^{em1(IMPC)Wtsi}/Lrba^{em1(IMPC)Wtsi} (C57BL/6N-Lrba^{em1(IMPC)Wtsi}/Wtsi)	decreased circulating chloride level	J:211773
	increased blood urea nitrogen level	J:211773
	increased circulating alkaline phosphatase level	J:211773
	increased circulating amylase level	J:211773
	increased circulating calcium level	J:211773
	increased circulating cholesterol level	J:211773
	increased circulating creatinine level	J:211773
	increased circulating HDL cholesterol level	J:211773
	increased circulating total protein level	J:211773
Lrfn2^tm1.1Jaru/Lrfn2^tm1.1Jaru (B6.129P2(Cg)-Lrfn2^tm1.1Jaru)	decreased circulating erythropoietin level	J:301285
Lrig1^{tm1a(EUCOMM)Wtsi}/Lrig1^{tm1a(EUCOMM)Wtsi} (involves: C57BL/6 * C57BL/6N)	decreased circulating alanine transaminase level	J:213427
	decreased circulating alkaline phosphatase level	J:213427
	decreased circulating aspartate transaminase level	J:213427
Lrig3^{em1(IMPC)Ccpcz}/Lrig3^{em1(IMPC)Ccpcz} (C57BL/6NCrl-Lrig3^{em1(IMPC)Ccpcz}/Ccpcz)	decreased circulating alkaline phosphatase level	J:211773
	increased circulating alanine transaminase level	J:211773
	increased circulating aspartate transaminase level	J:211773
	increased circulating creatine kinase level	J:211773
	increased circulating lactate dehydrogenase level	J:211773
Lrig3^tm1.1Hhed/Lrig3^tm1.1Hhed (B6.129(Cg)-Lrig3^tm1.1Hhed)	decreased circulating glycerol level	J:242435
	decreased circulating HDL cholesterol level	J:242435
	decreased circulating insulin level	J:242435
lrm1/lrm1 (involves: BALB/cAnN * C3H/HeH)	edema	J:145068
lrm2/lrm2 (involves: BALB/cAnN * C3H/HeH)	edema	J:145068
Lrmda^{tm1e(EUCOMM)Wtsi}/Lrmda^{tm1e(EUCOMM)Wtsi} (C57BL/6N-1700112E06Rik^{tm1e(EUCOMM)Wtsi}/Wtsi)	increased circulating creatinine level	J:211773
Lrp1^{tm1.1(KOMP)Wtsi}/Lrp1⁺ (C57BL/6N-Lrp1^{tm1.1(KOMP)Wtsi}/J)	increased circulating alkaline phosphatase level	J:211773
Lrp1^tm2Her/Lrp1^tm2Her Tg(Camk2a-cre)T29-1Stl/0 (involves: 129S7/SvEvBrd * BALB/c * C57BL)	abnormal lipid level	J:167724
	decreased brain cholesterol level	J:167724
	decreased triglyceride level	J:167724
Lrp1^tm2Her/Lrp1^tm2Her Tg(Fabp4-cre)1Rev/0 (involves: 129S7/SvEvBrd * C57BL/6)	abnormal body temperature homeostasis	J:127398
	abnormal circulating lipid level	J:127398
	abnormal glucose homeostasis	J:127398
	abnormal lipid homeostasis	J:127398
	decreased body surface temperature	J:127398
	decreased circulating free fatty acids level	J:127398
	decreased circulating glucose level	J:127398
	decreased circulating insulin level	J:127398
	decreased circulating leptin level	J:127398
	decreased liver triglyceride level	J:127398
	decreased susceptibility to diet-induced obesity	J:127398
	impaired adaptive thermogenesis	J:127398
	improved glucose tolerance	J:127398
	increased energy expenditure	J:127398
	increased oxygen consumption	J:127398
Lrp1^tm2Her/Lrp1^tm2Her Tg(Mx1-cre)29-4Her/0 (involves: 129S7/SvEvBrd * C57BL/6J * SJL)	abnormal blood homeostasis	J:83443
	increased circulating factor VIII level	J:83443
	increased circulating von Willebrand factor level	J:83443
Lrp1^tm2Her/Lrp1^tm2Her Tg(Mx1-cre)29-4Her/0 (involves: 129S7/SvEvBrd * C57BL/6 * SJL)	abnormal circulating protein level	J:117317
	increased circulating factor VIII level	J:117317
	increased circulating von Willebrand factor level	J:117317
Lrp1^tm2Her/Lrp1^tm2Her Tg(Syn1-cre)671Jxm/0 (involves: 129S7/SvEvBrd * C57BL/6 * CBA)	decreased circulating insulin level	J:93329
	hypoglycemia	J:93329
Lrp1b^{em1(IMPC)Hmgu}/Lrp1b⁺ (C57BL/6N-Lrp1b^{em1(IMPC)Hmgu}/Ieg)	decreased circulating unsaturated transferrin level	J:211773
	increased circulating iron level	J:211773
Lrp2^m267Asp/Lrp2^m267Asp (involves: C57BL/6J * FVB/N)	abnormal circulating mineral level	J:166387
	abnormal selenium level	J:166387
	increased urine protein level	J:166387
	increased urine selenium level	J:166387
Lrp2^tm1Her/Lrp2^tm1Her (involves: 129S7/SvEvBrd)	abnormal urine homeostasis	J:108230
	cyanosis	J:34835
	increased urine microglobulin level	J:108230
	increased urine protein level	J:184259, J:108230
Lrp2^tm1Her/Lrp2^tm1Her (either: (involves: 129S7/SvEvBrd * CD-1) or (involves: 129/SvEmcTer * 129S7/SvEvBrd * C57BL/6N))	increased circulating dihydrotestosterone level	J:115189
	increased circulating testosterone level	J:115189
Lrp2^tm1Her/Lrp2^tm1Her (involves: 129S7/SvEvBrd * C57BL/6 * FVB/NJ)	abnormal selenium level	J:211934
	increased urine selenium level	J:211934
Lrp2^tm1Tew/Lrp2^tm1Tew Tg(APOE-cre)VITew/0 (Not Specified)	abnormal urine homeostasis	J:81496
	abnormal vitamin D level	J:81496
	decreased circulating calcium level	J:81496
	increased circulating parathyroid hormone level	J:81496
	increased urine protein level	J:81496
Lrp4^mitt/Lrp4^mitt (involves: C57BL/6)	cyanosis	J:119654
Lrp4^mte/Lrp4^mte (involves: C57BL/6)	cyanosis	J:119654
Lrp4^tm1.1Line/Lrp4^tm1.1Line Mnx1^tm4(cre)Tmj/Mnx1⁺ Tg(ACTA1-cre)79Jme/0 (involves: 129S/SvEv * 129S1/Sv * C57BL/6 * C57BL/6J * SJL)	cyanosis	J:188352
Lrp4^tm1.1Pg/Lrp4^tm1.1Pg (involves: C57BL/6N)	abnormal blood homeostasis	J:277372
Lrp5^tm1Jsak/Lrp5⁺ (involves: C57BL/6 * CBA)	decreased circulating insulin level	J:81174
	impaired glucose tolerance	J:81174
	increased cholesterol level	J:81174
Lrp5^tm1Jsak/Lrp5^tm1Jsak (involves: C57BL/6 * CBA)	abnormal calcium ion homeostasis	J:81174
	decreased circulating insulin level	J:81174
	decreased insulin secretion	J:81174
	impaired glucose tolerance	J:81174
	increased cholesterol level	J:81174
	increased circulating VLDL cholesterol level	J:81174
	insulin resistance	J:81174
Lrp5^tm1Kry/Lrp5⁺ (involves: 129S1/Sv * 129X1/SvJ)	increased serotonin level	J:146078
Lrp5^tm1Kry/Lrp5^tm1Kry (involves: 129S1/Sv * 129X1/SvJ)	decreased serotonin level	J:146078
Lrp5^tm1Kry/Lrp5^tm1Kry (involves: 129S1/Sv * 129X1/SvJ)	increased serotonin level	J:146078
Lrp5^tm2Kry/Lrp5^tm2Kry Tg(Vil1-cre)20Syr/0 (involves: C57BL/6 * DBA/2)	abnormal serotonin level	J:146078
Lrp5^{tm3(Lrp5)Kry}/Lrp5^{tm3(Lrp5)Kry} Tg(Vil1-cre)20Syr/0 (involves: C57BL/6 * DBA/2)	decreased serotonin level	J:146078
Lrp6^{Gt(LST067)Byg}/Lrp6⁺ (involves: 129P2/OlaHsd)	abnormal lipid homeostasis	J:155275
Lrp6^{Gt(LST067)Byg}/Lrp6⁺ (B6.Cg-Lrp6^{Gt(LST067)Byg})	decreased circulating glucose level	J:182772
	decreased liver triglyceride level	J:182772
	decreased susceptibility to diet-induced obesity	J:182772
	decreased susceptibility to induced hypothermia	J:182772
	improved glucose tolerance	J:182772
	increased circulating adiponectin level	J:182772
	increased insulin sensitivity	J:182772
Lrp6^tm1Arma/Lrp6⁺ (C57BL/6-Lrp6^tm1Arma)	increased cholesterol level	J:210538
	increased circulating LDL cholesterol level	J:210538
	increased circulating triglyceride level	J:210538
Lrp6^tm1Arma/Lrp6^tm1Arma (C57BL/6-Lrp6^tm1Arma)	abnormal fatty acids level	J:210538
	abnormal lipid homeostasis	J:210538
	hyperlipidemia	J:210538
	increased cholesterol level	J:210538
	increased circulating aspartate transaminase level	J:210538
	increased circulating bilirubin level	J:210538
	increased circulating LDL cholesterol level	J:210538
	increased circulating triglyceride level	J:210538
	increased circulating VLDL triglyceride level	J:210538
	increased liver cholesterol level	J:210538, J:225450
	increased liver triglyceride level	J:210538
	insulin resistance	J:210538
Lrpap1^tm1Her/Lrpap1^tm1Her (involves: 129S7/SvEvBrd * C57BL/6J)	abnormal circulating protein level	J:43736
Lrrc3^{tm1b(EUCOMM)Hmgu}/Lrrc3^{tm1b(EUCOMM)Hmgu} (C57BL/6N-Lrrc3^{tm1b(EUCOMM)Hmgu}/Ics)	increased circulating calcium level	J:211773
	increased circulating phosphate level	J:211773
Lrrc4c^tm1Lex/Lrrc4c^tm1Lex (involves: 129S5/SvEvBrd * C57BL/6J)	increased circulating interleukin-6 level	J:171883
Lrrc7^{Tg(Myl2-TSPYL)1Sich}/Lrrc7^{Tg(Myl2-TSPYL)1Sich} (involves: FVB/N)	dehydration	J:293568
Lrrc8a^em1Uia/Lrrc8a^em1Uia Tg(Adipoq-cre)1Evdr/0 (involves: 129 * C57BL/6 * FVB/NJ)	impaired glucose tolerance	J:246515
	increased energy expenditure	J:246515
	increased susceptibility to diet-induced obesity	J:246515
	insulin resistance	J:246515
Lrrc8a^{tm1.1(KOMP)Vlcg}/Lrrc8a^{tm1.1(KOMP)Vlcg} (C57BL/6N-Lrrc8a^{tm1.1(KOMP)Vlcg}/MbpMmucd)	edema	J:211773
Lrrc8c^em1(IMPC)Mbp/Lrrc8c^em1(IMPC)Mbp (C57BL/6N-Lrrc8c^em1(IMPC)Mbp/MbpMmucd)	decreased circulating calcium level	J:211773
	decreased circulating serum albumin level	J:211773
Lrrc8c^tm1Maim/Lrrc8c^tm1Maim (B6J.129S2-Lrrc8c^tm1Maim)	decreased susceptibility to diet-induced obesity	J:247160
Lrrc8c^tm1Maim/Lrrc8c^tm1Maim (B6J.129S2-Lrrc8c^tm1Maim)	increased insulin sensitivity	J:247160
Lrrc8d^{tm1a(EUCOMM)Wtsi}/Lrrc8d^{tm1a(EUCOMM)Wtsi} (C57BL/6N-Lrrc8d^{tm1a(EUCOMM)Wtsi}/Wtsi)	increased circulating alkaline phosphatase level	J:211773
Lrrc8e^em1Bcgen/Lrrc8e^em1Bcgen (C57BL/6N-Lrrc8e^em1Bcgen)	abnormal circulating cytokine level	J:288504
	decreased circulating interferon-beta level	J:288504
	decreased circulating tumor necrosis factor level	J:288504
Lrrc15^{tm1b(KOMP)Wtsi}/Lrrc15^{tm1b(KOMP)Wtsi} (C57BL/6N-Lrrc15^{tm1b(KOMP)Wtsi}/J)	improved glucose tolerance	J:211773
Lrrc19^tm1Ryag/Lrrc19^tm1Ryag (involves: C57BL/6J * C57BL/6NTac)	decreased circulating interleukin-6 level	J:271376
	decreased circulating tumor necrosis factor level	J:271376
Lrrc23^{tm1a(EUCOMM)Wtsi}/Lrrc23^{tm1a(EUCOMM)Wtsi} (C57BL/6N-Lrrc23^{tm1a(EUCOMM)Wtsi}/Wtsi)	increased circulating creatinine level	J:211773
Lrrc25^em1Cya/Lrrc25^em1Cya (C57BL/6J-Lrrc25^em1Cya/Cya)	abnormal tumor necrosis factor level	J:270157
Lrrc25^em1Cya/Lrrc25^em1Cya (C57BL/6J-Lrrc25^em1Cya/Cya)	increased transforming growth factor beta level	J:270157
Lrrc41^em1(IMPC)J/Lrrc41^em1(IMPC)J (C57BL/6NJ-Lrrc41^em1(IMPC)J/Mmjax)	increased circulating alkaline phosphatase level	J:211773
	increased circulating calcium level	J:211773
	increased circulating glucose level	J:211773
Lrrc55os^em1Caox/Lrrc55os^em1Caox (C57BL/6-Lrrc55os^em1Caox)	decreased circulating interferon-beta level	J:293325
Lrrc56^em1(IMPC)Tcp/Lrrc56^em1(IMPC)Tcp (C57BL/6N-Lrrc56^em1(IMPC)Tcp/Tcp)	increased circulating alanine transaminase level	J:211773
Lrrk1^tm1.1Smo/Lrrk1^tm1.1Smo (involves: 129S/Sv)	decreased circulating alkaline phosphatase level	J:208677
Lrrk1^{tm1b(KOMP)Wtsi}/Lrrk1^{tm1b(KOMP)Wtsi} (C57BL/6N-Lrrk1^{tm1b(KOMP)Wtsi}/H)	decreased circulating alkaline phosphatase level	J:211773
	increased circulating aspartate transaminase level	J:211773
	increased circulating cholesterol level	J:211773
	increased circulating creatine kinase level	J:211773
	increased circulating HDL cholesterol level	J:211773
	increased circulating iron level	J:211773
	increased circulating phosphate level	J:211773
Lrrk2^tm1.1Hlme/Lrrk2⁺ (involves: C57BL/6 * C57BL/6J)	abnormal dopamine level	J:223350
Lrrk2^tm1.1Hlme/Lrrk2^tm1.1Hlme (involves: C57BL/6 * C57BL/6J)	abnormal dopamine level	J:223350
	abnormal lipid level	J:223350
Lrrk2^tm1.2Npa/Lrrk2^tm1.2Npa (involves: BALB/c * C57BL/6J)	increased urine protein level	J:176679
Lrrn3^tm1Lex/Lrrn3^tm1Lex (involves: 129S5/SvEvBrd * C57BL/6J)	improved glucose tolerance	J:171883
Lrtm2^tm1.1Jaru/Lrtm2^tm1.1Jaru (B6.129P2-Lrtm2^tm1.1Jaru)	decreased nervous system dopamine level	J:325069
	decreased serotonin level	J:325069
	increased noradrenaline level	J:325069
Lsm1^{tm1b(EUCOMM)Hmgu}/Lsm1⁺ (C57BL/6N-Lsm1^{tm1b(EUCOMM)Hmgu}/Ieg)	increased circulating sodium level	J:211773
Lsm1^{tm1b(EUCOMM)Hmgu}/Lsm1^{tm1b(EUCOMM)Hmgu} (C57BL/6N-Lsm1^{tm1b(EUCOMM)Hmgu}/Ieg)	increased circulating alkaline phosphatase level	J:211773
Lsm3^em1Caox/Lsm3^em1Caox (involves: C57BL/6J)	increased circulating interferon-alpha level	J:262834
	increased circulating interferon-beta level	J:262834
	increased circulating interleukin-6 level	J:262834
Lsm8^em1(IMPC)Mbp/Lsm8⁺ (C57BL/6N-Lsm8^em1(IMPC)Mbp/MbpMmucd)	increased blood urea nitrogen level	J:211773
	increased circulating alanine transaminase level	J:211773
	increased circulating creatinine level	J:211773
	increased circulating serum albumin level	J:211773
	increased circulating total protein level	J:211773
Lss^{tm1b(KOMP)Wtsi}/Lss⁺ (C57BL/6N-Lss^{tm1b(KOMP)Wtsi}/Ieg)	increased circulating alkaline phosphatase level	J:211773
Lst1^{tm1.1(KOMP)Vlcg}/Lst1^{tm1.1(KOMP)Vlcg} (C57BL/6N-Lst1^{tm1.1(KOMP)Vlcg}/Ucd)	increased circulating triglyceride level	J:211773
Lta/Tnf^tm1Eug/Lta/Tnf^tm1Eug (B6.129-Lta/Tnf^tm1Eug)	decreased circulating interferon-gamma level	J:115034
Lta/Tnf^tm1Eug/Lta/Tnf^tm1Eug (involves: 129 * C57BL/6J)	increased susceptibility to diet-induced obesity	J:112797
Lta/Tnf^tm1Eug/Lta/Tnf^tm1Eug (B6.129-Lta/Tnf^tm1Eug)	decreased circulating interferon-gamma level	J:115034
Lta/Tnf^tm1Eug/Lta/Tnf^tm1Eug (involves: 129 * C57BL/6J)	increased susceptibility to diet-induced obesity	J:112797
Lta^tm1.1Sned/Lta^tm1.1Sned (B6.129-Lta^tm1.1Sned)	abnormal circulating tumor necrosis factor level	J:109621
Ltb4r1^tm1Tksh/Ltb4r1^tm1Tksh (B6.Cg-Ltb4r1^tm1Tksh)	abnormal hormone level	J:118995
Ltb4r1^tm1Tksh/Ltb4r1^tm1Tksh (B6.Cg-Ltb4r1^tm1Tksh)	edema	J:197334
Ltb4r2^tm1Tksh/Ltb4r2^tm1Tksh (B6.Cg-Ltb4r2^tm1Tksh)	edema	J:197334
Ltbp1^{tm1a(EUCOMM)Wtsi}/Ltbp1^{tm1a(EUCOMM)Wtsi} (B6JTyr;B6N-Ltbp1^{tm1a(EUCOMM)Wtsi}/Wtsi)	decreased circulating alanine transaminase level	J:175295
	decreased circulating aspartate transaminase level	J:175295
	decreased circulating cholesterol level	J:175295
	decreased circulating HDL cholesterol level	J:175295
	decreased circulating iron level	J:175295
	decreased circulating LDL cholesterol level	J:175295
	decreased circulating serum albumin level	J:175295
	decreased circulating total protein level	J:175295
	increased blood urea nitrogen level	J:175295
Ltbp1^tm1Veto/Ltbp1^tm1Veto (involves: 129 * C57BL/6)	cyanosis	J:128012
Ltbp1^tm2Veto/Ltbp1^tm2Veto (involves: 129 * C57BL/6)	cyanosis	J:128012
Ltbp2^{tm2b(KOMP)Wtsi}/Ltbp2^{tm2b(KOMP)Wtsi} (C57BL/6N-Ltbp2^{tm2b(KOMP)Wtsi}/J)	increased fasting circulating glucose level	J:211773
Ltbp4^{Gt(E301B04)Wrst}/Ltbp4^{Gt(E301B04)Wrst} (B6N.129P2-Ltbp4^{Gt(E301B04)Wrst})	impaired skin barrier function	J:221200
Ltbr^tm1Avt/Ltbr^tm1Avt Tg(Rorc-cre)1Litt/0 (Not Specified)	abnormal chemokine level	J:158663
Ltf^tm1Omc/Ltf^tm1Omc (either: 129S/SvEv or (involves: 129S/SvEv * C57BL/6))	abnormal iron homeostasis	J:81005
	decreased spleen iron level	J:81005
	increased circulating iron level	J:81005
	increased liver iron level	J:81005
Ltk^em1(IMPC)H/Ltk^em1(IMPC)H (C57BL/6NTac-Ltk^em1(IMPC)H/H)	increased circulating HDL cholesterol level	J:211773
	increased circulating serum albumin level	J:211773
	increased circulating total protein level	J:211773
Ltn1^{tm1b(EUCOMM)Hmgu}/Ltn1^{tm1b(EUCOMM)Hmgu} (C57BL/6N-Ltn1^{tm1b(EUCOMM)Hmgu}/Ccpcz)	decreased circulating alkaline phosphatase level	J:211773
Ltry^NZB/BlNJ/? (NZB/BlNJ)	decreased circulating luteinizing hormone level	J:82664
Luc7l3^em1(IMPC)J/Luc7l3⁺ (C57BL/6NJ-Luc7l3^em1(IMPC)J/Mmjax)	increased circulating alanine transaminase level	J:211773
Lum^{tm1.1(KOMP)Vlcg}/Lum⁺ (C57BL/6N-Lum^{tm1.1(KOMP)Vlcg}/Ucd)	increased circulating alanine transaminase level	J:211773
	increased circulating aspartate transaminase level	J:211773
Lurap1^em1(IMPC)J/Lurap1^em1(IMPC)J (C57BL/6NJ-Lurap1^em1(IMPC)J/Mmjax)	increased circulating phosphate level	J:211773
Luzp1^tm1Acch/Luzp1^tm1Acch (B6.129P2-Luzp1^tm1Acch)	cyanosis	J:141306
Ly6a^tm1Pmf/Ly6a^tm1Pmf (B6.129P2-Ly6a^tm1Pmf)	increased bleeding time	J:81387
Ly6e^{tm1c(EUCOMM)Hmgu}/Ly6e^{tm1c(EUCOMM)Hmgu} Commd10^{Tg(Vav1-icre)A2Kio}/Commd10⁺ (B6.Cg-Ly6e^{tm1c(EUCOMM)Hmgu} Commd10^{Tg(Vav1-icre)A2Kio})	increased circulating alanine transaminase level	J:291868
Ly6e^tm1Zmt/Ly6e^tm1Zmt (involves: 129S1/Sv)	decreased noradrenaline level	J:73972
Ly6g6d^{tm1b(EUCOMM)Hmgu}/Ly6g6d^{tm1b(EUCOMM)Hmgu} (C57BL/6N-Ly6g6d^{tm1b(EUCOMM)Hmgu}/Ieg)	decreased circulating creatinine level	J:211773
	decreased circulating phosphate level	J:211773
	decreased circulating potassium level	J:211773
Ly86^{tm1a(KOMP)Wtsi}/Ly86⁺ (C57BL/6N-Ly86^{tm1a(KOMP)Wtsi}/MbpMmucd)	increased circulating aspartate transaminase level	J:211773
Lyar^em1(IMPC)J/Lyar^em1(IMPC)J (C57BL/6NJ-Lyar^em1(IMPC)J/Mmjax)	impaired glucose tolerance	J:211773
	increased circulating aspartate transaminase level	J:211773
Lyn^tm1.1Calo/Lyn^tm1.1Calo Tg(Itgax-cre)1-1Reiz/0 (involves: 129P2/OlaHsd * C57BL/6 * CBA)	abnormal circulating chemokine level	J:200745
	abnormal circulating cytokine level	J:200745
	increased circulating interferon-gamma level	J:200745
	increased circulating interleukin-1 beta level	J:200745
	increased circulating interleukin-6 level	J:200745
	increased circulating interleukin-12 level	J:200745
	increased circulating interleukin-17 level	J:200745
	increased circulating tumor necrosis factor level	J:200745
Lyn^tm1Ard/Lyn^tm1Ard (involves: 129P2/OlaHsd)	abnormal circulating complement protein level	J:161523
Lyn^tm1Ard/Lyn^tm1Ard (involves: 129P2/OlaHsd)	albuminuria	J:161523
Lyn^{tm1b(EUCOMM)Hmgu}/Lyn^{tm1b(EUCOMM)Hmgu} (C57BL/6N-Lyn^{tm1b(EUCOMM)Hmgu}/H)	increased blood urea nitrogen level	J:211773
Lyn^tm1Sor/Lyn^tm1Sor (involves: 129S4/SvJaeSor)	abnormal chemokine level	J:80658
	abnormal circulating chemokine level	J:200745
	abnormal circulating cytokine level	J:200745
	increased circulating interferon-gamma level	J:200745
	increased circulating interleukin-6 level	J:200745
	increased circulating interleukin-12 level	J:200745
	increased circulating interleukin-17 level	J:200745
Lypd3^{tm1.1(KOMP)Vlcg}/Lypd3⁺ (C57BL/6N-Lypd3^{tm1.1(KOMP)Vlcg}/Ucd)	increased blood urea nitrogen level	J:211773
	increased circulating triglyceride level	J:211773
Lypd6b^{tm1b(KOMP)Wtsi}/Lypd6b^{tm1b(KOMP)Wtsi} (C57BL/6N-Lypd6b^{tm1b(KOMP)Wtsi}/Ucd)	decreased circulating phosphate level	J:211773
	decreased circulating serum albumin level	J:211773
	increased blood urea nitrogen level	J:211773
Lyplal1^em1Espel/Lyplal1^em1Espel (C57BL/6J-Lyplal1^em1Espel)	abnormal glucose homeostasis	J:340413
	decreased circulating alanine transaminase level	J:340413
	decreased circulating aspartate transaminase level	J:340413
	decreased liver triglyceride level	J:340413
	decreased susceptibility to diet-induced obesity	J:340413
	increased circulating triglyceride level	J:340413
Lyplal1^{tm1a(KOMP)Wtsi}/Lyplal1^{tm1a(KOMP)Wtsi} (C57BL/6N-Lyplal1^{tm1a(KOMP)Wtsi}/Wtsi)	increased circulating alkaline phosphatase level	J:211773
Lyset^em1Janc/Lyset^em1Janc (C57BL/6J-Tmem251^em1Janc)	abnormal enzyme/coenzyme level	J:330704
Lyset^em1Janc/Lyset^em1Janc (C57BL/6J-Tmem251^em1Janc)	increased beta-galactosidase level	J:330704
Lyset^em1Janc/Lyset^em2Janc (C57BL/6J-Tmem251^em1Janc Tmem251^em2Janc)	abnormal enzyme/coenzyme level	J:330704
	increased beta-galactosidase level	J:330704
Lyset^em2Janc/Lyset^em2Janc (C57BL/6J-Tmem251^em2Janc)	abnormal enzyme/coenzyme level	J:330704
Lyset^em2Janc/Lyset^em2Janc (C57BL/6J-Tmem251^em2Janc)	increased beta-galactosidase level	J:330704
Lyst^bg-J/Lyst^bg-J (C57BL/6J-Lyst^bg-J/J)	decreased platelet ATP level	J:7327
	decreased platelet serotonin level	J:7327
	increased bleeding time	J:7327
Lyst^bg/Lyst^bg (B6.C3Rl-Lyst^bg)	abnormal urine enzyme level	J:5590
Lyst^{tm1b(EUCOMM)Wtsi}/Lyst^{tm1b(EUCOMM)Wtsi} (C57BL/6N-Lyst^{tm1b(EUCOMM)Wtsi}/Tcp)	increased fasting circulating glucose level	J:211773
Lyz2^tm1(cre)Ifo/Lyz2⁺ Pdcd10^tm1Wami/Pdcd10^tm1Wami (involves: 129 * 129P2/OlaHsd * C57BL/6)	increased circulating creatinine level	J:256076
Lyz2^tm1(cre)Ifo/Lyz2⁺ St18^{tm1c(KOMP)Wtsi}/St18^{tm1c(KOMP)Wtsi} (involves: 129P2/OlaHsd * C57BL/6 * C57BL/6N)	increased circulating interleukin-1 beta level	J:298828
Lyz2^{tm1(HBEGF)Mtka}/Lyz2⁺ (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	increased circulating lactate dehydrogenase level	J:145285
Lyz2^tm1.1Graf/Lyz2^tm1.1Graf (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	abnormal enzyme/coenzyme level	J:82642
Lyz3^{tm1(KOMP)Vlcg}/Lyz3^{tm1(KOMP)Vlcg} (C57BL/6N-Lyz3^{tm1(KOMP)Vlcg}/MbpMmucd)	increased circulating alanine transaminase level	J:211773
	increased circulating aspartate transaminase level	J:211773
Lztfl1^tm1.2Zpl/Lztfl1^tm1.2Zpl Tg(Camk2a-cre)#Stl/0 (involves: 129S4/SvJaeSor * BALB/c * C57BL * C57BL/6 * C57BL/6N)	impaired glucose tolerance	J:287261
	insulin resistance	J:287261
Lztfl1^tm1.3Zpl/Lztfl1^tm1.3Zpl (involves: 129S4/SvJaeSor * C57BL/6 * C57BL/6N)	impaired glucose tolerance	J:287261
	increased circulating glucose level	J:287261
	increased circulating leptin level	J:287261
	insulin resistance	J:287261
m2Jrt/m2Jrt⁺ (involves: C3H/HeJ * C57BL/6J)	decreased circulating calcium level	J:163957
M3.8.6Djba/M3.8.6Djba⁺ (C3H/HeJ-M3.8.6Djba)	decreased circulating type I collagen C-terminal telopeptide level	J:163658
M4.8.4Djba/M4.8.4Djba⁺ (C3H/HeJ-M4.8.4Djba)	increased circulating alkaline phosphatase level	J:163658
m6.11.6Djba/m6.11.6Djba (C3H/HeJ-m6.11.6Djba)	decreased circulating insulin-like growth factor I level	J:163658
M6pr^tm1Hlk/M6pr^tm1Hlk (involves: 129P2/OlaHsd * C57BL/6J)	abnormal urine homeostasis	J:111016
M6pr^tm1Psa/M6pr^tm1Psa (involves: 129P2/OlaHsd * C57BL/6)	abnormal enzyme/coenzyme level	J:106558
m51206CHubr/m51206CHubr (involves: C57BL/6 * FVB/N)	cardiac edema	J:173681
m596223Hubr/m596223Hubr (involves: C57BL/6 * FVB/N)	cardiac edema	J:173681
Mab21l2^em1(IMPC)Mbp/Mab21l2⁺ (C57BL/6N-Mab21l2^em1(IMPC)Mbp/Ucd)	decreased circulating calcium level	J:211773
	decreased circulating creatinine level	J:211773
Macf1^tm2.1Liem/Macf1^tm2.2Liem Tg(Nes-cre)1Kln/0 (involves: 129S6/SvEvTac * C57BL/6 * FVB/N * SJL)	cyanosis	J:164146
Macir^{tm1.1(KOMP)Vlcg}/Macir⁺ (B6N(Cg)-Macir^{tm1.1(KOMP)Vlcg}/J)	decreased fasting circulating glucose level	J:211773
	increased circulating alanine transaminase level	J:211773
	increased circulating chloride level	J:211773
	increased circulating potassium level	J:211773
	increased circulating sodium level	J:211773
Macrod2^{tm1.1(KOMP)Vlcg}/Macrod2⁺ (C57BL/6N-Macrod2^{tm1.1(KOMP)Vlcg}/J)	decreased circulating glucose level	J:211773
	increased fasting circulating glucose level	J:211773
Macrod2^{tm1.1(KOMP)Vlcg}/Macrod2^{tm1.1(KOMP)Vlcg} (C57BL/6N-Macrod2^{tm1.1(KOMP)Vlcg}/J)	increased blood urea nitrogen level	J:211773
	increased fasting circulating glucose level	J:211773
Macroh2a1^tm1.1Oxbo/Macroh2a1^tm1.1Oxbo (B6.Cg-Macroh2a1^tm1.1Oxbo)	decreased circulating alanine transaminase level	J:293382
	decreased circulating aspartate transaminase level	J:293382
Mad2l1bp^tm1.1Itl/Mad2l1bp^tm1.1Itl Speer6-ps1^{Tg(Alb-cre)21Mgn}/Speer6-ps1⁺ (involves: 129S6/SvEvTac * C57BL/6 * C57BL/6J * C57BL/6NTac)	decreased liver glycogen level	J:234643
	decreased liver triglyceride level	J:234643
	hyperglycemia	J:234643
	impaired glucose tolerance	J:234643
	increased circulating insulin level	J:234643
	increased circulating triglyceride level	J:234643
	insulin resistance	J:234643
Mad2l1bp^tm1.2Itl/Mad2l1bp^tm1.2Itl (involves: 129S6/SvEvTac * C57BL/6 * C57BL/6NTac)	decreased liver glycogen level	J:234643
Madd^tm1Bpra/Madd^tm1Bpra Tg(Ins2-cre/ERT)1Dam/0 (involves: 129P2/OlaHsd * C57BL/6 * CBA)	decreased circulating insulin level	J:225256
	decreased insulin secretion	J:225256
	hyperglycemia	J:225256
	impaired glucose tolerance	J:225256
	increased fasting circulating glucose level	J:225256
Maf1^tm1.1Lnh/Maf1^tm1.1Lnh (involves: C57BL/6)	abnormal amino acid level	J:222253
	abnormal homeostasis	J:222253
	abnormal lipid homeostasis	J:222253
	decreased circulating phospholipid level	J:222253
	decreased susceptibility to diet-induced obesity	J:222253
	increased dopamine level	J:222253
	increased energy expenditure	J:222253
	increased insulin sensitivity	J:222253
	increased oxygen consumption	J:222253
	increased proline level	J:222253
Maf^em1(IMPC)Mbp/Maf⁺ (C57BL/6N-Maf^em1(IMPC)Mbp/MbpMmucd)	increased circulating bilirubin level	J:211773
Maf^em1(IMPC)Mbp/Maf^em1(IMPC)Mbp (C57BL/6N-Maf^em1(IMPC)Mbp/MbpMmucd)	edema	J:211773
Maf^Ofl/Maf^Ofl (either: 102/ElH or C3H/HeH)	increased urine glucose level	J:82475
Mafa^tm1Staka/Mafa⁺ (involves: ICR)	decreased circulating insulin level	J:99126
Mafa^tm1Staka/Mafa⁺ (involves: ICR)	impaired glucose tolerance	J:99126
Mafa^tm1Staka/Mafa^tm1Staka (involves: ICR)	decreased circulating insulin level	J:99126
	decreased insulin secretion	J:99126
	impaired glucose tolerance	J:99126
	increased circulating glucose level	J:99126
	increased urine glucose level	J:99126
Mafb^em1Staka/Mafb^em1Staka (involves: C57BL/6J)	increased urine microalbumin level	J:279108
Mafb^tm1.2Good/Mafb^tm1.2Good (involves: 129S4/SvJae * C57BL/6 * SJL)	cyanosis	J:207904
Mafb^tm1Jeng/Mafb^tm1Jeng (involves: 129P2/OlaHsd * C57BL/6J)	increased circulating creatinine level	J:111415
Mafb^tm1Mhs/Mafb^tm1Mhs (involves: 129S1/Sv * 129X1/SvJ)	cyanosis	J:85746
Maged1^tm1.1Urfm/Maged1^tm1.1Urfm (involves: 129P2/OlaHsd)	abnormal tumor necrosis factor level	J:157549
Maged1^tm1Tnab/Y (B6.129P2-Maged1^tm1Tnab)	abnormal serotonin level	J:183858
	decreased serotonin level	J:183858
	increased serotonin level	J:183858
Maged1^tm1Tnab/Maged1^tm1Tnab (B6.129P2-Maged1^tm1Tnab)	abnormal serotonin level	J:183858
	decreased serotonin level	J:183858
	increased serotonin level	J:183858
Magel2^em2(IMPC)H/Magel2^em2(IMPC)H (C57BL/6NTac-Magel2^em2(IMPC)H/H)	decreased circulating serum albumin level	J:211773
	decreased circulating total protein level	J:211773
Magel2^tm1.1Mus/Magel2⁺ (B6.129S2-Magel2^tm1.1Mus)	decreased circulating glucose level	J:166548
Magel2^tm1Stw/Magel2⁺ (C57BL/6-Magel2^tm1Stw)	decreased circulating testosterone level	J:144836
Magi1^tm1Itl/Magi1^tm1Itl Nphs1^tm1Rkl/Nphs1⁺ (involves: 129/Sv * C57BL/6)	increased urine protein level	J:237632
Magi2^tm1.1Knis/Magi2^tm1.1Knis (Not Specified)	increased circulating creatinine level	J:216062
Magi2^tm1Key/Magi2^tm1Key (involves: 129S4/SvJae)	albuminuria	J:213553
	increased blood urea nitrogen level	J:213553
	increased circulating creatinine level	J:213553
	increased urine protein level	J:213553
Magi2^tm1Key/Magi2^tm1Key (involves: 129S4/SvJae * C57BL/6)	increased blood urea nitrogen level	J:213553
	increased circulating creatinine level	J:213553
	increased urine protein level	J:213553
Magix^{em1(IMPC)Hmgu}/Magix^{em1(IMPC)Hmgu} (C57BL/6NCrl-Magix^{em1(IMPC)Hmgu}/Ieg)	increased circulating creatinine level	J:211773
Malrd1^C57BL/6ByJ/Malrd1^C57BL/6ByJ (involves: A/J * C57BL/6J)	decreased circulating LDL cholesterol level	J:61563
	decreased circulating VLDL cholesterol level	J:61563
Mamld1^{tm1.1(NCOM)Mfgc}/Y (C57BL/6N-Mamld1^{tm1.1(NCOM)Mfgc}/Tcp)	abnormal cholesterol homeostasis	J:211773
	decreased respiratory quotient	J:211773
Man1a2^tm1.1Ahe/Man1a2^tm1.1Ahe (involves: 129S4/SvJae * C57BL/6)	cyanosis	J:119977
Man2a1^{em1(IMPC)Hmgu}/Man2a1^{em1(IMPC)Hmgu} (C57BL/6N-Man2a1^{em1(IMPC)Hmgu}/Ieg)	decreased blood urea nitrogen level	J:211773
	decreased circulating alkaline phosphatase level	J:211773
	decreased circulating iron level	J:211773
	increased circulating amylase level	J:211773
	increased circulating aspartate transaminase level	J:211773
	increased circulating bilirubin level	J:211773
Man2a1^tm1Jxm/Man2a1^tm1Jxm (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	hematuria	J:74579
	increased urine protein level	J:74579
Man2a1^tm1Jxm/Man2a1^tm1Jxm Rag1^tm1Mom/Rag1^tm1Mom (B6.129-Rag1^tm1Mom Man2a1^tm1Jxm)	increased urine protein level	J:124348
Man2b1^tm1Psa/Man2b1^tm1Psa (involves: 129 * C57BL/6J)	abnormal homeostasis	J:56659
Man2b1^tm1Psa/Man2b1^tm1Psa (involves: 129 * C57BL/6J)	abnormal urine homeostasis	J:56659
Man2b2^{tm1b(KOMP)Wtsi}/Man2b2^{tm1b(KOMP)Wtsi} (C57BL/6N-Man2b2^{tm1b(KOMP)Wtsi}/Tcp)	increased circulating glucose level	J:211773
Man2b2^{tm1b(KOMP)Wtsi}/Man2b2^{tm1b(KOMP)Wtsi} (C57BL/6N-Man2b2^{tm1b(KOMP)Wtsi}/Wtsi)	decreased circulating fructosamine level	J:211773
	decreased circulating serum albumin level	J:211773
	decreased circulating total protein level	J:211773
Man2c1^tm1.1Tbec/Man2c1^tm1.1Tbec (B6N.129P2-Man2c1^tm1.1Tbec)	edema	J:205550
	increased glycogen level	J:205550
	increased liver glycogen level	J:205550
Manf^{tm1a(KOMP)Wtsi}/Manf^{tm1a(KOMP)Wtsi} (involves: C57BL/6 * C57BL/6N * ICR)	abnormal glucose homeostasis	J:211812
	decreased circulating insulin level	J:211812
	hyperglycemia	J:211812
Manf^{tm1c(KOMP)Wtsi}/Manf^{tm1c(KOMP)Wtsi} (involves: C57BL/6N * FVB/N)	decreased circulating insulin level	J:211812
	hyperglycemia	J:211812
Mansc4^{tm1b(KOMP)Wtsi}/Mansc4^{tm1b(KOMP)Wtsi} (C57BL/6N-Mansc4^{tm1b(KOMP)Wtsi}/Wtsi)	increased circulating bilirubin level	J:211773
Maoa^K284stop Maob^tm1Shih/Y (either: (involves: 129S/SvEv * 129S6/SvEvTac) or (involves: 129S4/SvJae * 129S6/SvEvTac))	increased dopamine level	J:93356
	increased noradrenaline level	J:93356
	increased serotonin level	J:93356
Maoa^{Tg(H2-K1-Ifnb1)8Seif}/Y (involves: C3H/HeJ)	increased dopamine level	J:26232
	increased noradrenaline level	J:26232
	increased serotonin level	J:26232
Maoa^{Tg(H2-K1-Ifnb1)8Seif}/? (involves: C3H/HeJ)	abnormal circulating hormone level	J:106365
	increased dopamine level	J:26232
	increased noradrenaline level	J:26232
	increased serotonin level	J:26232, J:78281
Maob^tm1Shih/Maob^tm1Shih (either: (involves: 129S/SvEv) or (involves: 129S4/SvJae))	abnormal urine homeostasis	J:43648
Map1b^tm1Prop/Map1b^tm1Prop (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	dehydration	J:97423
Map2k1^tm1Chrn/Map2k1^tm1Chrn Map2k2^tm1Chrn/Map2k2^tm1Chrn Tg(Cyp17a1-icre)AJako/0 (involves: 129/Sv * C57BL/6 * C57BL/6J * SJL)	abnormal circulating androgen level	J:278979
	abnormal testosterone level	J:278979
	increased circulating luteinizing hormone level	J:278979
Map2k1^tm1Chrn/Map2k1^tm1Chrn Map2k2^tm1Chrn/Map2k2^tm1Chrn Tg(KRT14-cre)1Efu/? (involves: 129/Sv * C57BL/6J * SJL)	impaired skin barrier function	J:122484
Map3k1^{tm1a(KOMP)Wtsi}/Map3k1⁺ (C57BL/6N-Map3k1^{tm1a(KOMP)Wtsi}/Wtsi)	decreased circulating fructosamine level	J:211773
	decreased fasting circulating glucose level	J:211773
	increased circulating free fatty acids level	J:211773
Map3k4^byg/Map3k4^byg (involves: C3H/HeH * C57BL/6J)	edema	J:153050
Map3k7^Gt(XB444)Byg/Map3k7^Gt(XB444)Byg (involves: 129P2/OlaHsd * C57BL/6J)	edema	J:107401
	pericardial edema	J:107401
Map3k7^tm1.1Gkl/Map3k7^tm1.1Gkl Lyz2^tm1(cre)Ifo/Lyz2⁺ (involves: 129P2/OlaHsd * C57BL/6)	decreased circulating interleukin-10 level	J:211916
	increased circulating interleukin-1 beta level	J:211916
	increased circulating tumor necrosis factor level	J:211916
Map3k7^tm1Aki/Map3k7^tm1Aki Speer6-ps1^{Tg(Alb-cre)21Mgn}/Speer6-ps1⁺ (involves: 129P2/OlaHsd * C57BL/6 * DBA/2)	increased circulating bilirubin level	J:160521
Map3k7^tm1Aki/Map3k7^tm1Aki Tg(Alb1-cre)7Gsc/0 (involves: 129P2/OlaHsd * FVB/N)	increased circulating alanine transaminase level	J:160521
	increased circulating alkaline phosphatase level	J:160521
	increased circulating aspartate transaminase level	J:160521
	increased circulating bilirubin level	J:160521
	increased circulating glutamate dehydrogenase level	J:160521
Map3k7^tm1Aki/Map3k7^tm1Aki Tg(Lck-cre)1Jtak/0 (involves: 129P2/OlaHsd * C57BL/6)	abnormal cytokine level	J:238318
Map3k7^tm1Aki/Map3k7^tm1Aki Tg(Slco1c1-icre/ERT2)1Mrks/0 (involves: 129P2/OlaHsd * C57BL/6 * DBA/2)	impaired febrile response	J:179050
Map3k7^{tm1b(EUCOMM)Wtsi}/Map3k7⁺ (C57BL/6N-Map3k7^{tm1b(EUCOMM)Wtsi}/H)	increased circulating alkaline phosphatase level	J:211773
Map3k8^tm1Pnt/Map3k8^tm1Pnt Nfkb1^tm1Sley/Nfkb1^tm1Sley (involves: 129S1/Sv * 129S4/SvJae)	decreased circulating interleukin-12b level	J:196528
Map3k10^{tm1b(EUCOMM)Hmgu}/Map3k10^{tm1b(EUCOMM)Hmgu} (C57BL/6N-Map3k10^{tm1b(EUCOMM)Hmgu}/Cnrm)	increased circulating cholesterol level	J:211773
	increased circulating HDL cholesterol level	J:211773
Map3k10^tm1Dsd/Map3k10^tm1Dsd Map3k11^tm1Rjd/Map3k11^tm1Rjd (involves: 129 * 129S6/SvEvTac * C57BL/6J)	abnormal circulating chemokine level	J:177426
	abnormal circulating cytokine level	J:177426
Map3k10^tm1Dsd/Map3k10^tm1Dsd Map3k11^tm2.1Rjd/Map3k11^tm2.1Rjd (involves: 129 * C57BL/6J)	abnormal circulating chemokine level	J:177426
	abnormal circulating cytokine level	J:177426
Map3k14^aly/Map3k14⁺ Relb^{Tg(H2-K1/GH1)106Bri}/Relb⁺ (involves: C57BL/6 * C57BL/6J)	decreased circulating interferon-gamma level	J:120659
Map3k14^aly/Map3k14^aly (involves: C57BL/6J)	decreased circulating interferon-gamma level	J:120659
Map3k14^aly/Map3k14^aly (involves: C57BL/6J)	decreased circulating interleukin-4 level	J:120659
Map3k20^em1Smun/Map3k20^em1Smun (involves: 129S6/SvEvTac * C57BL/6NCrl)	cardiac edema	J:231477
Mapk1^tm1.1Hed/Mapk1^tm1.1Hed Tg(Lck-cre)1Cwi/0 (involves: C57BL/6 * DBA/2)	abnormal enzyme/coenzyme level	J:113280
Mapk1^tm1Melo/Mapk1⁺ Tg(CAG-cat,-Ptpn11Q97R)1Rbns/0 Tg(Tek-cre)12Flv/0 (involves: 129S2/SvPas C3H * C57BL/6 * FVB/N)	nuchal edema	J:142212
Mapk3^tm1Gpg/Mapk3⁺ Tg(CAG-cat,-Ptpn11Q97R)1Rbns/0 Tg(Tek-cre)12Flv/0 (involves: 129/Sv C3H * C57BL/6 * FVB/N)	nuchal edema	J:142212
Mapk3^tm1Gpg/Mapk3^tm1Gpg Tg(CAG-cat,-Ptpn11Q97R)1Rbns/0 Tg(Tek-cre)12Flv/0 (involves: 129/Sv C3H * C57BL/6 * FVB/N)	nuchal edema	J:142212
Mapk6^em1(IMPC)Mbp/Mapk6^em1(IMPC)Mbp (C57BL/6N-Mapk6^em1(IMPC)Mbp/MbpMmucd)	edema	J:211773
Mapk6^tm1Melo/Mapk6^tm1Melo (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	cyanosis	J:153218
Mapk7^tm1Kda/Mapk7^tm1Kda (involves: 129S6/SvEvTac)	pericardial edema	J:77725
Mapk8^tm1.1Jcbr/Mapk8^tm1.1Jcbr (involves: 129S4/SvJae * C57BL/6)	decreased circulating leptin level	J:195844
	decreased insulin secretion	J:195844
	decreased susceptibility to diet-induced obesity	J:195844
	improved glucose tolerance	J:195844
	increased insulin sensitivity	J:195844
	increased respiratory quotient	J:195844
Mapk8^tm1Jcbr/Mapk8^tm1Jcbr Tg(Nes-cre)1Kln/0 (involves: 129S4/SvJae * C57BL/6 * SJL)	abnormal glucose homeostasis	J:158650
	decreased circulating glucose level	J:158650
	decreased circulating growth hormone level	J:158650
	decreased circulating insulin level	J:158650
	decreased circulating insulin-like growth factor I level	J:158650
	decreased liver triglyceride level	J:158650
	improved glucose tolerance	J:158650
	increased circulating adiponectin level	J:158650
	increased circulating triiodothyronine level	J:158650
	increased insulin sensitivity	J:158650
	increased oxygen consumption	J:158650
Mapk8^tm1Rjd/Mapk8^tm1Rjd Mapk9^tm2.1Rjd/Mapk9^tm2.1Rjd Lyz2^tm1(cre)Ifo/Lyz2⁺ (B6J.Cg-Lyz2^tm1(cre)Ifo Mapk9^tm2.1Rjd Mapk8^tm1Rjd)	abnormal chemokine level	J:192551
	abnormal circulating chemokine level	J:192551
	abnormal circulating cytokine level	J:192551
	abnormal gluconeogenesis	J:192551
	abnormal glucose homeostasis	J:192551
	abnormal glycogen homeostasis	J:192551
	abnormal lipid homeostasis	J:192551
	decreased circulating glucose level	J:192551
	decreased circulating insulin level	J:192551
	improved glucose tolerance	J:192551
	increased insulin secretion	J:192551
	increased insulin sensitivity	J:192551
Mapk8^tm1Wag/Mapk8^tm1Wag (B6.129P2-Mapk8^tm1Wag)	decreased circulating glucose level	J:80452
	decreased circulating insulin level	J:80452
	decreased susceptibility to diet-induced obesity	J:80452
	improved glucose tolerance	J:80452
	increased insulin sensitivity	J:80452
Mapk8ip1^tm1Rjd/Mapk8ip1^tm1Rjd Mapk8ip2^tm1Rjd/Mapk8ip2^tm1Rjd (involves: 129S6/SvEvTac * 129X1/SvJ)	hypoglycemia	J:152617
Mapk8ip1^tm3.1Rjd/Mapk8ip1^tm3.1Rjd (B6.129S6-Mapk8ip1^tm3.1Rjd)	abnormal gluconeogenesis	J:163808
	decreased circulating leptin level	J:163808
	decreased liver triglyceride level	J:163808
	decreased respiratory quotient	J:163808
	increased insulin sensitivity	J:163808
Mapk8ip3^tm1Plhn/Mapk8ip3^tm1Plhn (involves: 129S4/SvJae * C57BL/6J)	cyanosis	J:95744
Mapk8ip3^tm1Plhn/Mapk8ip3^tm1Plhn (involves: 129S4/SvJae * C57BL/6)	cyanosis	J:136735
Mapk8ip3^tm1Rjd/Mapk8ip3^tm1Rjd (B6.129S6-Mapk8ip3^tm1Rjd)	anoxia	J:85160
Mapk10^tm1Flv/Mapk10^tm1Flv (B6.129S1-Mapk10^tm1Flv)	abnormal dopamine level	J:87428
Mapk10^tm1Flv/Mapk10^tm1Flv Mapk9^tm1Flv/Mapk9^tm1Flv (B6.129S-Mapk9^tm1Flv Mapk10^tm1Flv)	abnormal dopamine level	J:87428
Mapk13^{em1(IMPC)Hmgu}/Mapk13^{em1(IMPC)Hmgu} (C57BL/6N-Mapk13^{em1(IMPC)Hmgu}/Ieg)	increased circulating creatinine level	J:211773
Mapk13^tm2.1Lex/Mapk13^tm2.1Lex (B6.129S5-Mapk13^tm2.1Lex)	decreased circulating glucose level	J:146185
	decreased susceptibility to diet-induced obesity	J:146185
	improved glucose tolerance	J:146185
	increased circulating insulin level	J:146185
	increased insulin secretion	J:146185
	increased insulin sensitivity	J:146185
Mapk14^tm1.1Dvb/Mapk14⁺ (B6(FVB)-Mapk14^tm1.1Dvb)	decreased circulating glucose level	J:151980
Mapk15^{tm1b(EUCOMM)Hmgu}/Mapk15^{tm1b(EUCOMM)Hmgu} (C57BL/6N-Mapk15^{tm1b(EUCOMM)Hmgu}/J)	decreased fasting circulating glucose level	J:211773
Mapkapk2^tm1.2Gkl/Mapkapk2^tm1.2Gkl (involves: BALB/cJ * C57BL/6)	decreased circulating tumor necrosis factor level	J:262876
Mapkapk2^{tm1b(EUCOMM)Hmgu}/Mapkapk2^{tm1b(EUCOMM)Hmgu} (C57BL/6N-Mapkapk2^{tm1b(EUCOMM)Hmgu}/H)	increased circulating glucose level	J:211773
Mapkapk2^tm1Mgl/Mapkapk2^tm1Mgl (involves: 129P2/OlaHsd * C57BL/6J)	abnormal cytokine level	J:59678
	decreased circulating tumor necrosis factor level	J:59678
Mapkbp1^{tm1b(EUCOMM)Hmgu}/Mapkbp1^{tm1b(EUCOMM)Hmgu} (C57BL/6N-Mapkbp1^{tm1b(EUCOMM)Hmgu}/H)	impaired glucose tolerance	J:211773
	increased blood urea nitrogen level	J:211773
	increased circulating phosphate level	J:211773
Marchf2^em1Cnu/Marchf2^em1Cnu (C57BL/6-Marchf2^em1Cnu)	increased circulating interferon-beta level	J:297482
	increased circulating interleukin-6 level	J:297482
	increased circulating interleukin-12 level	J:297482
	increased circulating tumor necrosis factor level	J:297482
Marchf3^em1Hbsh/Marchf3^em1Hbsh (involves: C57BL/6J)	abnormal circulating cytokine level	J:267641
Marchf3^{tm1b(EUCOMM)Hmgu}/Marchf3^{tm1b(EUCOMM)Hmgu} (C57BL/6N-Marchf3^{tm1b(EUCOMM)Hmgu}/Ccpcz)	increased fasting circulating glucose level	J:211773
Marchf5^tm1.1Ygi/Marchf5^tm1.1Ygi Tg(Emx1-cre)#Ito/0 (involves: C57BL/6)	abnormal phospholipid level	J:284572
Marchf5^{tm1a(EUCOMM)Wtsi}/Marchf5⁺ (C57BL/6-Marchf5^{tm1a(EUCOMM)Wtsi})	increased circulating interferon-beta level	J:225000
	increased circulating interleukin-6 level	J:225000
Marchf6^{tm1b(EUCOMM)Hmgu}/Marchf6^{tm1b(EUCOMM)Hmgu} (C57BL/6N-Marchf6^{tm1b(EUCOMM)Hmgu}/Ccpcz)	impaired glucose tolerance	J:211773
	increased fasting circulating glucose level	J:211773
Marchf7^{Gt(ROSABetageo)1Summ}/Marchf7⁺ (involves: BALB/c)	abnormal interleukin level	J:96167
Marchf7^{Gt(ROSABetageo)1Summ}/Marchf7^{Gt(ROSABetageo)1Summ} (involves: BALB/c)	abnormal interleukin level	J:96167
Marchf9^{tm1a(EUCOMM)Wtsi}/Marchf9^{tm1a(EUCOMM)Wtsi} (Not Specified)	decreased circulating HDL cholesterol level	J:165965
Marco^{tm2b(EUCOMM)Hmgu}/Marco^{tm2b(EUCOMM)Hmgu} (C57BL/6N-Marco^{tm2b(EUCOMM)Hmgu}/Ieg)	increased circulating alkaline phosphatase level	J:211773
Mark2^{Gt(pSABetageo)38Bss}/Mark2^{Gt(pSABetageo)38Bss} (involves: 129S2/SvPas * MF1)	decreased circulating progesterone level	J:57958
	decreased circulating prolactin level	J:57958
	increased prolactin level	J:57958
Mark2^tm1Hpw/Mark2⁺ (involves: 129X1/SvJ * C57BL/6)	hemoglobinuria	J:68830
Mark2^tm1Hpw/Mark2⁺ (involves: 129X1/SvJ * C57BL/6)	increased urine protein level	J:68830
Mark2^tm1Hpw/Mark2^tm1Hpw (involves: 129X1/SvJ * C57BL/6)	abnormal glucose homeostasis	J:120128
	decreased circulating adiponectin level	J:163905
	decreased circulating cholesterol level	J:120128
	decreased circulating insulin level	J:120128
	decreased circulating insulin-like growth factor I level	J:120128
	decreased circulating leptin level	J:120128
	decreased circulating triglyceride level	J:120128
	decreased susceptibility to diet-induced obesity	J:120128
	hemoglobinuria	J:68830
	hypoglycemia	J:120128
	improved glucose tolerance	J:120128
	increased energy expenditure	J:120128
	increased insulin sensitivity	J:120128
	increased urine protein level	J:68830
Mark3^tm1Hpw/Mark3^tm1Hpw (involves: 129X1/SvJ * C57BL/6)	decreased circulating insulin level	J:163905
	decreased liver glycogen level	J:163905
	decreased susceptibility to diet-induced obesity	J:163905
	hypoglycemia	J:163905
	improved glucose tolerance	J:163905
	increased circulating adiponectin level	J:163905
	increased energy expenditure	J:163905
Mark4^Gt(XG191)Byg/Mark4^Gt(XG191)Byg (involves: 129P2/OlaHsd * C57BL/6)	abnormal glucose homeostasis	J:192469
	decreased circulating cholesterol level	J:192469
	decreased circulating glucose level	J:192469
	decreased circulating insulin level	J:192469
	decreased circulating triglyceride level	J:192469
	decreased susceptibility to diet-induced obesity	J:192469
	increased carbon dioxide production	J:192469
	increased energy expenditure	J:192469
	increased insulin sensitivity	J:192469
	increased oxygen consumption	J:192469
	increased respiratory quotient	J:192469
Mark4^Gt(XG191)Byg/Mark4^Gt(XG191)Byg (B6.129P2-Mark4^Gt(XG191)Byg)	decreased susceptibility to diet-induced obesity	J:192469
	increased carbon dioxide production	J:192469
	increased oxygen consumption	J:192469
	increased respiratory quotient	J:192469
Mars2^{tm1.1(KOMP)Vlcg}/Mars2⁺ (C57BL/6N-Mars2^{tm1.1(KOMP)Vlcg}/J)	decreased fasting circulating glucose level	J:211773
	decreased urine magnesium level	J:211773
Mas1^tm1Bdr/Mas1^tm1Bdr (involves: 129P2/OlaHsd * C57BL/6)	albuminuria	J:162698
	decreased urine sodium level	J:162698
	increased urine microalbumin level	J:162698
	increased urine osmolality	J:162698
Mast3^{tm1.1(KOMP)Wtsi}/Mast3^{tm1.1(KOMP)Wtsi} (C57BL/6N-Mast3^{tm1.1(KOMP)Wtsi}/J)	increased circulating alkaline phosphatase level	J:211773
Mat1a^tm1Jmm/Mat1a^tm1Jmm (involves: 129/Sv * C57BL/6)	increased circulating methionine level	J:69408
Matr3^em3Tcp/Matr3^em3Tcp (C57BL/6J-Matr3^em3Tcp)	cyanosis	J:298091
Matr3^em4Tcp/Matr3^em4Tcp (C57BL/6J-Matr3^em4Tcp)	cyanosis	J:298091
Matr3^em5Tcp/Matr3^em5Tcp (C57BL/6J-Matr3^em5Tcp)	cyanosis	J:298091
Mavs^tm1Aki/Mavs^tm1Aki (Not Specified)	decreased circulating interleukin-6 level	J:124405
Mavs^tm1Aki/Mavs^tm1Aki (involves: 129P2/OlaHsd * C57BL/6)	decreased circulating interferon-alpha level	J:130954
	decreased circulating interferon-beta level	J:130954
	decreased circulating interferon-gamma level	J:130954
	decreased circulating interleukin-6 level	J:130954
Mavs^tm1Aki/Mavs^tm1Aki (involves: 129S/SvEv * C57BL/6)	abnormal circulating interferon level	J:162888
	increased circulating interferon-gamma level	J:162888
	increased circulating interleukin-6 level	J:162888
	increased circulating tumor necrosis factor level	J:162888
Mavs^tm1Aki/Mavs^tm1Aki Ticam1^tm1Aki/Ticam1^tm1Aki (involves: 129P2/OlaHsd * C57BL/6)	decreased circulating interferon-alpha level	J:130954
	decreased circulating interferon-beta level	J:130954
	decreased circulating interferon-gamma level	J:130954
	decreased circulating interleukin-6 level	J:130954
	decreased circulating interleukin-12b level	J:130954
Mavs^tm1Zjc/Mavs^tm1Zjc (B6.Cg-Mavs^tm1Zjc)	abnormal circulating interferon level	J:243916
Mb^tm1Jsc/Mb^tm1Jsc (involves: 129S1/Sv * 129X1/SvJ * NMRI)	abnormal oxygen level	J:57481
Mb^tm1Wlm/Mb⁺ (either: (involves: 129/Sv) or (involves: C57BL/6))	pericardial effusion	J:74121
Mb^tm1Wlm/Mb^tm1Wlm (Not Specified)	hypoxia	J:72560
Mb^tm1Wlm/Mb^tm1Wlm (either: (involves: 129/Sv) or (involves: C57BL/6))	edema	J:74121
	hypoxia	J:74121
	pericardial effusion	J:74121
Mb^tm1Wlm/Mb^tm1Wlm (B6.Cg-Mb^tm1Wlm)	abnormal nitric oxide homeostasis	J:86546
Mb^tm1Wlm/Mb^tm1Wlm (B6.Cg-Mb^tm1Wlm)	hypoxia	J:86546
Mbd2^tm1Bh/Mbd2^tm1Bh (NOD.129P2(B6)-Mbd2^tm1Bh)	abnormal homeostasis	J:323838
Mbd2^tm1Bh/Mbd2^tm1Bh (NOD.129P2(B6)-Mbd2^tm1Bh)	hyperglycemia	J:323838
Mbd5^tm1.1Gxu/Mbd5^tm1.1Gxu Tg(Nes-cre)1Kln/0 (involves: 129S2/SvPas * C57BL/6 * C57BL/6J * SJL)	decreased circulating growth hormone level	J:192212
	decreased circulating insulin-like growth factor I level	J:192212
Mbd5^tm1.2Gxu/Mbd5^tm1.2Gxu (involves: 129S2/SvPas * C57BL/6J)	abnormal glucose homeostasis	J:192212
	decreased circulating glucose level	J:192212
	decreased circulating insulin level	J:192212
	decreased circulating insulin-like growth factor I level	J:192212
	decreased growth hormone level	J:192212
	hypoglycemia	J:192212
	improved glucose tolerance	J:192212
	increased insulin sensitivity	J:192212
Mbd6^{tm1.1(KOMP)Vlcg}/Mbd6⁺ (C57BL/6N-Mbd6^{tm1.1(KOMP)Vlcg}/Ucd)	increased fasting circulating glucose level	J:211773
Mbip^em1(IMPC)J/Mbip⁺ (C57BL/6NJ-Mbip^em1(IMPC)J/Mmjax)	increased circulating aspartate transaminase level	J:211773
Mbl1^tm1Kata/Mbl1^tm1Kata (involves: 129S4/SvJae * C57BL/6J)	decreased circulating tumor necrosis factor level	J:90437
Mbl1^tm1Kata/Mbl1^tm1Kata Mbl2^tm1Kata/Mbl2^tm1Kata (involves: 129 * C57BL/6)	abnormal circulating interleukin-6 level	J:98124
	abnormal circulating tumor necrosis factor level	J:98124
Mboat4^tm1Jagu/Mboat4^tm1Jagu (involves: C57BL/6)	abnormal circulating ghrelin level	J:151420
	decreased susceptibility to diet-induced obesity	J:151420
	increased energy expenditure	J:151420
Mboat4^tm1Vlcg/Mboat4^tm1Vlcg (involves: 129S6/SvEvTac * C57BL/6J * C57BL/6NTac)	decreased circulating ghrelin level	J:159327
	decreased circulating glucose level	J:159327
	decreased circulating growth hormone level	J:159327
	improved glucose tolerance	J:159327
Mboat4^tm2Vlcg/Mboat4^tm2Vlcg (Not Specified)	abnormal blood homeostasis	J:180107
	abnormal circulating hormone level	J:180107
	increased bile salt level	J:180107
	increased circulating progesterone level	J:180107
Mboat7^{tm1a(KOMP)Wtsi}/Mboat7^{tm1a(KOMP)Wtsi} (involves: C57BL/6 * C57BL/6N)	abnormal lipid homeostasis	J:199847
Mboat7^tm1Arai/Mboat7^tm1Arai (B6.129P2-Mboat7^tm1Arai)	decreased fatty acids level	J:200247
Mboat7^tm1Arai/Mboat7^tm1Arai (B6.129P2-Mboat7^tm1Arai)	increased fatty acids level	J:200247
Mbp^shi/Mbp^shi (SWV-Mbp^shi)	decreased brain cholesterol level	J:9907
Mbp^shi/Mbp^shi (SWV-Mbp^shi)	decreased cholesterol level	J:9907
Mbsyd^C57BL/6J/Mbsyd^PERA/EiJ (involves: B6.129S7-Ldlr^tm1Her/J * PERA/EiJ)	increased circulating triglyceride level	J:94548
Mbtps1^tm1Jdh/Mbtps1^tm1Jdh Tg(Mx1-cre)29-4Her/0 (involves: 129S6/SvEvTac * C57BL/6J * SJL)	abnormal intestinal lipid absorption	J:72930
	abnormal lipid homeostasis	J:72930
	decreased circulating cholesterol level	J:72930
	decreased circulating triglyceride level	J:72930
	decreased liver triglyceride level	J:72930
Mbtps1^wrt/Mbtps1^wrt (C57BL/6J-Mbtps1^wrt)	decreased circulating cholesterol level	J:94077, J:123123
	decreased circulating HDL cholesterol level	J:123123
	increased circulating LDL cholesterol level	J:123123
Mc2r^tm1Dchi/Mc2r^tm1Dchi (B6.129P2-Mc2r^tm1Dchi)	abnormal gluconeogenesis	J:127445
	abnormal glucose homeostasis	J:127445
	decreased circulating adrenaline level	J:127445
	decreased circulating aldosterone level	J:127445
	decreased circulating corticosterone level	J:127445
	hypoglycemia	J:127445
	increased circulating adrenocorticotropin level	J:127445
	increased circulating chloride level	J:127445
	increased circulating potassium level	J:127445
Mc3r^tm1Butl/Mc3r^tm1Butl (B6.Cg-Mc3r^tm1Butl)	abnormal energy homeostasis	J:178147
	decreased circulating triglyceride level	J:178147
	decreased energy expenditure	J:178147
	decreased respiratory quotient	J:178147
	increased circulating insulin level	J:178147
	increased circulating leptin level	J:178147
	increased susceptibility to diet-induced obesity	J:178147
Mc3r^tm1Butl/Mc3r^tm1Butl Tg(Nes-cre)1Kln/0 (B6.Cg-Mc3r^tm1Butl Tg(Nes-Cre)1Kln)	increased susceptibility to diet-induced obesity	J:178147
Mc3r^tm1Butl/Mc3r^tm1Butl Tg(Nr5a1-cre)2Lowl/0 (involves: C57BL/6J * FVB/NJ)	abnormal circulating leptin level	J:178147
	abnormal energy homeostasis	J:178147
	decreased circulating triglyceride level	J:178147
Mc3r^tm1Cone/Mc3r^tm1Cone (involves: 129S4/SvJae * C57BL/6J)	abnormal respiratory quotient	J:78132
Mc3r^tm1Lvp/Mc3r^tm1Lvp (involves: 129S7/SvEvBrd * C57BL/6J)	increased circulating insulin level	J:64365
	increased circulating leptin level	J:64365
	increased susceptibility to diet-induced obesity	J:64365
Mc4r^Glu3/Mc4r⁺ (involves: C57BL/6J)	hyperglycemia	J:85113
Mc4r^Glu3/Mc4r⁺ (involves: 129S6/SvEvTac)	hyperglycemia	J:85113
Mc4r^tm1.1Fbz/Mc4r^tm1.1Fbz (involves: 129S4/SvJae * C57BL/6 * C57BL/6J * C57BL/6NTac)	impaired glucose tolerance	J:225022
	increased energy expenditure	J:225022
Mc4r^tm1Dhu/Mc4r^tm1Dhu (involves: 129S4/SvJae * C57BL/6J)	abnormal glucose homeostasis	J:38224
	hyperglycemia	J:38224
	increased circulating insulin level	J:38224
	increased circulating leptin level	J:38224
	increased susceptibility to diet-induced obesity	J:69814
Mc4r^tm1Lowl/Mc4r^tm1Lowl (involves: 129S4/SvJae * C57BL/6J)	abnormal oxygen consumption	J:115192
	decreased circulating adiponectin level	J:177386
	decreased oxygen consumption	J:115192
	increased circulating alanine transaminase level	J:177386
	increased circulating free fatty acids level	J:177386
	increased circulating insulin level	J:115192
	increased circulating interleukin-6 level	J:177386
	increased circulating leptin level	J:177386
	increased liver triglyceride level	J:177386
	increased susceptibility to diet-induced obesity	J:177386
Mc4r^tm1Lowl/Mc4r^tm1Lowl Chat^tm1(cre)Lowl/Chat⁺ (involves: 129S4/SvJae * 129S6/SvEvTac)	increased circulating insulin level	J:193452
Mc4r^tm1Lowl/Mc4r^tm1Lowl Tg(Sim1-cre)1Lowl/0 (involves: 129S4/SvJae * C57BL/6J * FVB)	abnormal oxygen consumption	J:115192
	decreased oxygen consumption	J:115192
Mc4r^tm1Matsu/Mc4r^tm1Matsu (C57BL/6J-Mc4r^tm1Matsu)	increased circulating alanine transaminase level	J:285412
	increased circulating aspartate transaminase level	J:285412
	increased circulating cholesterol level	J:285412
	increased circulating insulin level	J:285412
	increased hydroxyproline level	J:285412
	increased liver triglyceride level	J:285412
	increased susceptibility to diet-induced obesity	J:285412
Mc5r^tm1Cone/Mc5r^tm1Cone (involves: 129S4/SvJaeSor * 129S6/SvEvTac)	impaired adaptive thermogenesis	J:44727
Mcam^tm1Lex/Mcam^tm1Lex (involves: 129S/SvEvBrd)	abnormal cytokine level	J:193167
Mcat^tm1.1Ssmi/Mcat^tm1.1Ssmi Tg(CAG-cre/Esr1)5Amc/0 (involves: 129P2/OlaHsd C57BL/6 * C57BL/6J * CBA)	abnormal circulating alanine transaminase level	J:192213
	abnormal lipid homeostasis	J:192213
	decreased body temperature	J:192213
	increased circulating chloride level	J:192213
	increased circulating glucose level	J:192213
	increased circulating ketone body level	J:192213
	increased circulating lactate level	J:192213
	increased skeletal muscle glycogen level	J:192213
Mcf2l^{tm1a(EUCOMM)Hmgu}/Mcf2l^{tm1a(EUCOMM)Hmgu} (C57BL/6N-Mcf2l^{tm1a(EUCOMM)Hmgu}/Cnrm)	increased circulating phosphate level	J:165965
	increased circulating serum albumin level	J:211773
Mcfd2^tm1Dgi/Mcfd2^tm1Dgi (129S1/SvImJ-Mcfd2^tm1Dgi)	abnormal circulating protein level	J:262681
	abnormal protein level	J:262681
	decreased circulating aspartate transaminase level	J:262681
	decreased circulating factor VIII level	J:262681
Mchr1^tm1Blak/Mchr1^tm1Blak (involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)	decreased susceptibility to diet-induced obesity	J:101206
Mchr1^tm1Dgam/Mchr1^tm1Dgam (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	abnormal circadian temperature homeostasis	J:95740
	abnormal energy expenditure	J:95740
	decreased susceptibility to diet-induced obesity	J:95740
Mchr1^tm1Lex/Mchr1^tm1Lex (involves: 129S5/SvEvBrd * C57BL/6J)	decreased response to stress-induced hyperthermia	J:136869
	decreased serotonin level	J:136869
	increased body temperature	J:136869
Mchr1^tm1Ohl/Mchr1^tm1Ohl (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	increased circulating type I collagen C-terminal telopeptide level	J:90102
Mchr1^tm1Sqn/Mchr1^tm1Sqn (involves: 129S7/SvEvBrd * C57BL/6)	abnormal hormone level	J:81787
	decreased circulating leptin level	J:81787
	decreased respiratory quotient	J:81787
	decreased susceptibility to diet-induced obesity	J:81787
	decreased thyroxine level	J:81787
	increased circulating corticosterone level	J:81787
Mchr1^tm1Yush/Mchr1^tm1Yush (involves: 129 * C57BL/6)	abnormal energy expenditure	J:106819
	decreased circulating insulin level	J:106819
	decreased circulating leptin level	J:106819
	decreased susceptibility to diet-induced obesity	J:106819
Mcidas^em2(IMPC)Tcp/Mcidas^em2(IMPC)Tcp (C57BL/6NCrl-Mcidas^em2(IMPC)Tcp/Tcp)	increased circulating alanine transaminase level	J:211773
	increased circulating aspartate transaminase level	J:211773
	increased circulating total protein level	J:211773
Mcm10^{tm1(NCOM)Cmhd}/Mcm10⁺ (C57BL/6N-Mcm10^{tm1(NCOM)Cmhd}/Tcp)	decreased circulating alanine transaminase level	J:165965
Mcoln1^tm1Asoy/Mcoln1^tm1Asoy (involves: 129 * C57BL/6)	increased circulating gastrin level	J:173516
Mcoln1^tm1Sasl/Mcoln1^tm1Sasl (involves: 129S6/SvEvTac * C57BL/6)	increased circulating gastrin level	J:135368
Mcoln2^{tm1e.1(KOMP)Wtsi}/Mcoln2^{tm1e.1(KOMP)Wtsi} (involves: C57BL/6J * C57BL/6N)	abnormal chemokine level	J:239875
Mcpt1^tm1Hrpm/Mcpt1^tm1Hrpm (involves: 129P2/OlaHsd * MF1)	decreased circulating tumor necrosis factor level	J:93616
Mcpt4^tm1Mabr/Mcpt4^tm1Mabr (involves: 129X1/SvJ * C57BL/6J)	abnormal blood coagulation	J:84839
Mcrip1^{tm1(KOMP)Vlcg}/Mcrip1^{tm1(KOMP)Vlcg} (C57BL/6-Mcrip1^{tm1(KOMP)Vlcg})	cyanosis	J:278092
Mcrip2^em1Eno/Mcrip2^em1Eno (C57BL/6N-Mcrip2^em1Eno)	impaired adaptive thermogenesis	J:316902
Mcrs1^{tm1.1(KOMP)Vlcg}/Mcrs1⁺ (C57BL/6N-Mcrs1^{tm1.1(KOMP)Vlcg}/J)	increased circulating chloride level	J:211773
Mcts1^em1(IMPC)Mbp/Y (C57BL/6N-Mcts1^em1(IMPC)Mbp/Ucd)	increased circulating alkaline phosphatase level	J:211773
Mcu^{Gt(IST11669F8)Tigm}/Mcu^{Gt(IST11669F8)Tigm} (involves: C57BL/6 * C57BL/6N * CD-1)	increased circulating lactate level	J:208297
Mcu^{tm1b(EUCOMM)Hmgu}/Mcu⁺ (C57BL/6N-Mcu^{tm1b(EUCOMM)Hmgu}/H)	increased circulating cholesterol level	J:211773
	increased circulating HDL cholesterol level	J:211773
	increased fasting circulating glucose level	J:211773
Mdfic^em#Nlh/Mdfic^em#Nlh (C57BL/6J-Mdfic^em#Nlh)	chylothorax	J:326462
Mdk^{tm1.1(KOMP)Mbp}/Mdk⁺ (C57BL/6N-Mdk^{tm1.1(KOMP)Mbp}/J)	increased circulating chloride level	J:211773
Mdk^{tm1.1(KOMP)Mbp}/Mdk⁺ (C57BL/6N-Mdk^{tm1.1(KOMP)Mbp}/J)	increased circulating sodium level	J:211773
Mdk^{tm1.1(KOMP)Mbp}/Mdk^{tm1.1(KOMP)Mbp} (C57BL/6N-Mdk^{tm1.1(KOMP)Mbp}/J)	increased circulating cholesterol level	J:211773
	increased circulating HDL cholesterol level	J:211773
	increased fasting circulating glucose level	J:211773
Mdk^tm1Tmu/Mdk^tm1Tmu (B6.129S2-Mdk^tm1Tmu)	abnormal circulating enzyme level	J:102069
Mdk^tm1Tmu/Mdk^tm1Tmu (B6.129S2-Mdk^tm1Tmu)	decreased dopamine level	J:151029
Mdm1^{em1(IMPC)Kmpc}/Mdm1^{em1(IMPC)Kmpc} (C57BL/6NTac-Mdm1^{em1(IMPC)Kmpc}/Kmpc)	abnormal cholesterol homeostasis	J:211773
Mdm4^tm2Glo/Mdm4^tm2.1Glo Tg(Myh6-cre)2182Mds/0 (involves: 129S4/SvJaeSor * 129S7/SvEvBrd * C57BL/6J * FVB/N)	edema	J:137114
Me1^em1(IMPC)Tcp/Me1^em1(IMPC)Tcp (C57BL/6NCrl-Me1^em1(IMPC)Tcp/Tcp)	improved glucose tolerance	J:211773
	increased circulating alkaline phosphatase level	J:211773
Mecom^Jbo/Mecom⁺ (involves: BALB/c)	middle ear effusion	J:250208
Mecom^tm1.1Miku/Mecom^tm1.1Miku (B6.Cg-Mecom^tm1.1Miku)	skin edema	J:149794
Mecom^tm1Miku/Mecom^tm1Miku Tg(Tek-cre)12Flv/0 (involves: C3H * C57BL/6 * CBA)	skin edema	J:149794
Mecom^tm2.2Aspe/Mecom^tm2.2Aspe (involves: 129 * C57BL/6J * FVB/N)	edema	J:213829
Mecp2^tm1.1Bird/Y (involves: 129P2/OlaHsd * C57BL/6)	decreased noradrenaline level	J:165306
Mecp2^tm1.1Bird/Y (involves: 129P2/OlaHsd * C57BL/6)	decreased serotonin level	J:165306
Mecp2^tm1.1Bird/Y (involves: 129P2/OlaHsd * 129S6/SvEvTac)	increased brain cholesterol level	J:198551
	increased circulating cholesterol level	J:198551
	increased circulating LDL cholesterol level	J:198551
	increased circulating triglyceride level	J:198551
	increased liver triglyceride level	J:198551
Mecp2^tm1.1Bird/Y (B6.129P2(C)-Mecp2^tm1.1Bird/J)	decreased body temperature	J:241788
Mecp2^tm1.1Bird/Mecp2⁺ (B6.129P2(C)-Mecp2^tm1.1Bird/J)	decreased body temperature	J:241788
Mecp2^tm1.1Jae/Y (involves: 129S4/SvJae * BALB/c * C57BL/6)	abnormal body temperature	J:67909
Mecp2^tm1.1Jae/Y (B6.Cg-Mecp2^tm1.1Jae)	increased brain cholesterol level	J:198551
Mecp2^tm1.1Jae/Y (B6.Cg-Mecp2^tm1.1Jae)	increased liver triglyceride level	J:198551
Mecp2^tm1Jae/Y Chat^tm2(cre)Lowl/Chat⁺ (involves: 129S4/SvJae * 129S6/SvEvTac * C57BL/6 * C57BL/6J)	decreased body temperature	J:241788
Mecp2^tm2Bird/Y (B6.129P2-Mecp2^tm2Bird/J)	decreased body temperature	J:241788
Med1^tm1Jkr/Med1^tm1Jkr (involves: 129P2/OlaHsd * C57BL/6)	pericardial effusion	J:74328
Med1^tm1Rgr/Med1⁺ (either: 129X1/SvJ or (involves: 129X1/SvJ * C57BL/6J))	decreased circulating thyroxine level	J:61840
	decreased circulating triiodothyronine level	J:61840
	decreased thyroid-stimulating hormone level	J:61840
Med1^tm2Jkr/Med1^tm2Jkr Tg(Myh6-cre)2182Mds/0 (involves: 129P2/OlaHsd * FVB/N)	cardiac edema	J:243730
	pulmonary edema	J:243730
Med11^{tm1.1(KOMP)Vlcg}/Med11⁺ (C57BL/6N-Med11^{tm1.1(KOMP)Vlcg}/J)	decreased circulating calcium level	J:211773
	decreased circulating glucose level	J:211773
	increased fasting circulating glucose level	J:211773
Med12l^em1(IMPC)J/Med12l^em1(IMPC)J (C57BL/6NJ-Med12l^em1(IMPC)J/Mmjax)	increased circulating alanine transaminase level	J:211773
Med13^tm1Eno/Med13^tm1Eno Tg(Myh6-cre)2182Mds/0 (involves: 129 * C57BL/6 * FVB/N)	impaired glucose tolerance	J:186193
	increased circulating cholesterol level	J:186193
	increased circulating insulin level	J:186193
	increased circulating leptin level	J:186193
	increased circulating triglyceride level	J:186193
	increased liver triglyceride level	J:186193
	increased susceptibility to diet-induced obesity	J:186193
Med13l^em1(IMPC)Mbp/Med13l^em1(IMPC)Mbp (C57BL/6NCrl-Med13l^em1(IMPC)Mbp/MbpMmucd)	edema	J:211773
Med19^{tm1c(EUCOMM)Wtsi}/Med19^{tm1c(EUCOMM)Wtsi} Tg(Adipoq-cre)1Evdr/0 (involves: C57BL/6J * C57BL/6N * FVB/NJ)	hyperglycemia	J:298822
	impaired glucose tolerance	J:298822
	increased circulating insulin level	J:298822
	increased liver triglyceride level	J:298822
	insulin resistance	J:298822
Med19^{tm1c(EUCOMM)Wtsi}/Med19^{tm1c(EUCOMM)Wtsi} Tg(Adipoq-icre/ERT2)1Soff/0 (involves: C57BL/6J * C57BL/6N)	impaired lipolysis	J:298822
Med22^{tm1c(EUCOMM)Hmgu}/Med22^{tm1c(EUCOMM)Hmgu} Tg(Nphs1-cre)#Seq/0 (involves: 129S4/SvJaeSor * C57BL/6J * C57BL/6N)	albuminuria	J:300239
	increased blood urea nitrogen level	J:300239
Med23^{em1(IMPC)Wtsi}/Med23⁺ (C57BL/6N-Med23^{em1(IMPC)Wtsi}/Wtsi)	decreased circulating fructosamine level	J:211773
	increased circulating HDL cholesterol level	J:211773
Med28^{tm1.1(KOMP)Vlcg}/Med28⁺ (C57BL/6N-Med28^{tm1.1(KOMP)Vlcg}/Ucd)	decreased circulating serum albumin level	J:211773
	increased respiratory quotient	J:211773
Med31^l11Jus15/Med31^l11Jus15 (involves: C57BL/6J)	edema	J:85113
Med31^l11Jus15/Med31^l11Jus15 (involves: 129S5/SvEvBrd * C57BL/6J)	edema	J:161417
Mef2c^tm1Eno/Mef2c^tm1Jjs H2az2^{Tg(Wnt1-cre)11Rth}/H2az2⁺ (involves: 129S6/SvEvTac * 129S7/SvEvBrd * C57BL/6J * CBA/J)	cyanosis	J:122483
Mefv^tm1Chae/Mefv^tm1Chae (either: (involves: 129S6/SvEvTac) or (involves: 129S6/SvEvTac * C57BL/6))	abnormal body temperature homeostasis	J:82763
Mefv^{tm5.1(MEFV)Chae}/Mefv^{tm5.1(MEFV)Chae} (B6.129S6-Mefv^{tm5.1(MEFV)Chae})	increased circulating interleukin-1 beta level	J:172117
	increased circulating interleukin-6 level	J:172117
	increased circulating tumor necrosis factor level	J:172117
Mefv^{tm5.1(MEFV)Chae}/Mefv^{tm5.1(MEFV)Chae} Rag1^tm1Mom/Rag1^tm1Mom (involves: 129S6/SvEvTac * 129S7/SvEvBrd * C57BL/6)	increased circulating interleukin-1 beta level	J:172117
	increased circulating interleukin-6 level	J:172117
	increased circulating tumor necrosis factor level	J:172117
Megf8^{Gt(G037A09)Wrst}/Megf8^{Gt(G037A09)Wrst} (involves: 129S6/SvEvTac * C57BL/6J)	edema	J:206541
Megf8^tm1.1Ddg/Megf8^tm1.1Ddg (involves: 129S6/SvEvTac * BALB/cJ)	edema	J:206541
Mei4^em1(IMPC)Mbp/Mei4^em1(IMPC)Mbp (C57BL/6NCrl-Mei4^em1(IMPC)Mbp/MbpMmucd)	increased circulating alanine transaminase level	J:211773
	increased circulating aspartate transaminase level	J:211773
Meis3^{tm1b(EUCOMM)Hmgu}/Meis3^{tm1b(EUCOMM)Hmgu} (C57BL/6N-Meis3^{tm1b(EUCOMM)Hmgu}/Ccpcz)	impaired glucose tolerance	J:211773
Memo1^m1Will/Memo1^m1Will (involves: 129S1/SvImJ * C57BL/6J)	generalized edema	J:233609
Memo1^tm1.1Neh/Memo1^tm1.1Neh Tg(CAG-cre/Esr1)1Lbe/0 (involves: 129P2/OlaHsd 129S1/Sv * 129X1/SvJ)	improved glucose tolerance	J:206626
	increased circulating calcium level	J:206626
	increased circulating parathyroid hormone level	J:206626
	increased insulin sensitivity	J:206626
	increased vitamin D level	J:206626
Memo1^{tm1b(EUCOMM)Wtsi}/Memo1^{tm1b(EUCOMM)Wtsi} (C57BL/6N-Memo1^{tm1b(EUCOMM)Wtsi}/Bay)	edema	J:211773
Men1^tm1.2Ctre/Men1^tm1.2Ctre Pax3^tm1(cre)Joe/Pax3⁺ (involves: 129S6/SvEvTac)	cyanosis	J:127545
Men1^tm1.2Ctre/Men1^tm1.2Ctre Tg(Ins2-cre)1Dh/0 (involves: 129S6/SvEvTac * C57BL/6 * FVB/N)	decreased circulating glucose level	J:85042
	increased circulating insulin level	J:85042
Men1^tm1.2Ctre/Men1^tm1.2Ctre Tg(Ins2-cre)1Heed/0 (involves: 129S6/SvEvTac * C57BL/6 * FVB/N)	decreased circulating glucose level	J:85042
	increased circulating insulin level	J:85042
Men1^tm1.2Ctre/Men1^tm1.2Ctre Tg(Ins2-cre)25Mgn/0 (involves: 129S6/SvEvTac * C57BL/6 * FVB/N)	decreased circulating glucose level	J:85042
	increased circulating insulin level	J:85042
Men1^tm1.2Ctre/Men1^tm1.2Ctre Tg(PTH-cre)4167Slib/0 (Not Specified)	abnormal blood homeostasis	J:86642
	increased circulating calcium level	J:86642
Men1^tm1.2Zqw/Men1^tm1.2Zqw Tg(Ins2-cre)23Herr/0 (involves: 129P2/OlaHsd * C57BL/6J * CBA/J)	hypoglycemia	J:85133
	increased circulating insulin level	J:85133
Men1^tm1Ctre/Men1⁺ (either: (involves: 129S6/SvEvTac * FVB/N) or (involves: 129S6/SvEvTac * Black Swiss * FVB/N))	increased circulating insulin level	J:67128
Men1^tm1Ctre/Men1⁺ Tg(Pdx1-cre)89.1Dam/0 (involves: 129S6/SvEvTac * C57BL/6 * CBA * FVB/N)	increased circulating insulin level	J:146440
Men1^tm1Ctre/Men1^tm1Ctre Tg(Pdx1-cre)89.1Dam/0 (involves: 129S6/SvEvTac * C57BL/6 * CBA * FVB/N)	decreased circulating glucose level	J:146440
	increased circulating insulin level	J:146440
Men1^tm1Mmey/Men1⁺ (involves: 129S6/SvEvTac * FVB/N)	hypoglycemia	J:102494
Men1^tm1Rvt/Men1⁺ (involves: 129 * C57BL/6)	decreased circulating phosphate level	J:191261
	increased circulating calcium level	J:191261
	increased circulating corticosterone level	J:191261
Meox1^tm1Bmk/Meox1^tm1Bmk Meox2^tm1Vpa/Meox2^tm1Vpa (involves: 129P2/OlaHsd * C57BL/6)	cyanosis	J:84754
Meox2^tm1(cre)Sor/Meox2⁺ Procr^tm2Cte/Procr^tm2Cte (involves: 129S4/SvJaeSor * 129S7/SvEvBrd * Black Swiss * C57BL/6)	decreased circulating fibrinogen level	J:119529
	increased circulating C-reactive protein level	J:119529
Meox2^tm1(cre)Sor/Meox2⁺ Slc40a1^tm2Nca/Slc40a1^tm2Nca (involves: 129S4/SvJae * 129S6/SvEvTac)	abnormal liver iron level	J:129846
	increased intestinal iron level	J:129846
	increased spleen iron level	J:129846
Mep1a^{tm1a(KOMP)Wtsi}/Mep1a^{tm1a(KOMP)Wtsi} (C57BL/6N-Mep1a^{tm1a(KOMP)Wtsi}/Wtsi)	decreased fasting circulating glucose level	J:211773
Mep1a^tm1Bond/Mep1a^tm1Bond (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	abnormal blood homeostasis	J:145037
	abnormal blood urea nitrogen level	J:145037
	abnormal body temperature homeostasis	J:145037
	abnormal chemokine level	J:145685
	abnormal circulating creatinine level	J:145037
	abnormal circulating interleukin-1 beta level	J:145037
	abnormal cytokine level	J:145037, J:145685
	abnormal tumor necrosis factor level	J:145037
	increased circulating interleukin-1 beta level	J:145685
	increased circulating interleukin-6 level	J:145685
Mep1b^tm1Bond/Mep1b^tm1Bond (B6.129-Mep1b^tm1Bond)	abnormal blood homeostasis	J:145037
Mep1b^tm1Bond/Mep1b^tm1Bond (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	abnormal urine homeostasis	J:132021
	decreased blood urea nitrogen level	J:132021
	decreased circulating creatinine level	J:132021
Mertk^nmf12/Mertk^nmf12 (involves: C57BL/6J)	abnormal tumor necrosis factor level	J:175587
Mertk^tm1Gkm/Mertk^tm1Gkm (involves: 129P2/OlaHsd * C57BL/6 * DBA/2)	increased circulating tumor necrosis factor level	J:53423
Mertk^tm1Lex/Mertk^tm1Lex (involves: 129S5/SvEvBrd * C57BL/6)	decreased platelet aggregation	J:102333
	decreased susceptibility to induced thrombosis	J:102333
Met^tm1Sst/Met^tm1Sst Tg(Pdx1-cre)89.1Dam/0 (involves: 129P2/OlaHsd * C57BL/6 * CBA)	decreased circulating insulin level	J:196854
	decreased insulin secretion	J:196854
	impaired glucose tolerance	J:196854
	increased circulating glucose level	J:196854
Mettl5^{em1(IMPC)Hmgu}/Mettl5⁺ (C57BL/6N-Mettl5^{em1(IMPC)Hmgu}/Ieg)	decreased blood urea nitrogen level	J:211773
Mettl6^em1(IMPC)J/Mettl6^em1(IMPC)J (C57BL/6NJ-Mettl6^em1(IMPC)J/Mmjax)	increased fasting circulating glucose level	J:211773
Mettl15^em1Pvs/Mettl15^em1Pvs (involves: C57BL/6 * CBA)	hypoglycemia	J:325995
Mettl16^{tm1b(KOMP)Mbp}/Mettl16⁺ (C57BL/6N-Mettl16^{tm1b(KOMP)Mbp}/J)	decreased urine creatinine level	J:211773
	increased circulating cholesterol level	J:211773
	increased circulating HDL cholesterol level	J:211773
Mettl18^em1(IMPC)J/Mettl18^em1(IMPC)J (C57BL/6NJ-Mettl18^em1(IMPC)J/Mmjax)	impaired glucose tolerance	J:211773
	increased fasting circulating glucose level	J:211773
Mettl22^{tm1.1(KOMP)Vlcg}/Mettl22^{tm1.1(KOMP)Vlcg} (C57BL/6N-Mettl22^{tm1.1(KOMP)Vlcg}/J)	increased circulating cholesterol level	J:211773
	increased circulating HDL cholesterol level	J:211773
Mettl23^{em1(IMPC)Hmgu}/Mettl23^{em1(IMPC)Hmgu} (C57BL/6NCrl-Mettl23^{em1(IMPC)Hmgu}/Ieg)	increased circulating unsaturated transferrin level	J:211773
Mettl24^{tm1a(KOMP)Wtsi}/Mettl24^{tm1a(KOMP)Wtsi} (C57BL/6N-Mettl24^{tm1a(KOMP)Wtsi}/Wtsi)	increased circulating alkaline phosphatase level	J:211773
Mex3a^{tm1.1(KOMP)Vlcg}/Mex3a^{tm1.1(KOMP)Vlcg} (involves: 129S4/SvJaeSor * C57BL/6J * C57BL/6NTac)	dehydration	J:287423
Mex3c^{Gt(DD0642)Wtsi}/Mex3c^{Gt(DD0642)Wtsi} (involves: 129P2/OlaHsd * C57BL/6)	increased circulating growth hormone level	J:189503
Mex3c^{Gt(DD0642)Wtsi}/Mex3c^{Gt(DD0642)Wtsi} (B6.129P2-Mex3c^{Gt(DD0642)Wtsi})	cyanosis	J:189503
Mex3c^{Gt(DD0642)Wtsi}/Mex3c^{Gt(DD0642)Wtsi} (FVB.129P2(B6)-Mex3c^{Gt(DD0642)Wtsi})	abnormal insulin-like growth factor I level	J:189503
	decreased circulating insulin-like growth factor I level	J:189503
Mexis^tm1.1Pton/Mexis^tm1.1Pton (involves: C57BL/6)	abnormal lipid homeostasis	J:264834
Mexis^tm1.1Pton/Mexis^tm1.1Pton (involves: C57BL/6)	increased cholesterol level	J:264834
Mfap2^{tm1a(KOMP)Wtsi}/Mfap2^{tm1a(KOMP)Wtsi} (involves: C57BL/6J * C57BL/6N)	hyperglycemia	J:236092
	increased fasting circulating glucose level	J:236092
	insulin resistance	J:236092
Mfap2^tm1Mech/Mfap2⁺ (B6.129X1-Mfap2^tm1Mech)	decreased susceptibility to induced thrombosis	J:134343
Mfap2^tm1Mech/Mfap2^tm1Mech (B6.129X1-Mfap2^tm1Mech)	decreased susceptibility to induced thrombosis	J:134343
Mfap2^tm1Mech/Mfap2^tm1Mech (B6.129X1-Mfap2^tm1Mech)	increased bleeding time	J:134343
Mfn2^tm1.1Arte/Mfn2^tm1.1Arte Slc6a3^tm1(cre)Lrsn/Slc6a3⁺ (involves: 129S1/Sv * 129X1/SvJ)	decreased dopamine level	J:188337
	increased serotonin level	J:188337
Mfng^tm1.1Cfg/Mfng^tm1.1Cfg (involves: C57BL/6)	abnormal circulating enzyme level	J:217719
	decreased partial thromboplastin time	J:217719
	decreased prothrombin time	J:217719
	increased circulating factor IX level	J:217719
	increased circulating factor XI level	J:217719
Mfsd1^em1(IMPC)Tcp/Mfsd1^em1(IMPC)Tcp (C57BL/6N-Mfsd1^em1(IMPC)Tcp/Tcp)	decreased circulating triglyceride level	J:211773
	increased circulating alkaline phosphatase level	J:211773
	increased circulating aspartate transaminase level	J:211773
	increased circulating bilirubin level	J:211773
Mfsd1^{tm1a(KOMP)Wtsi}/Mfsd1^{tm1a(KOMP)Wtsi} (involves: C57BL/6N)	increased circulating alanine transaminase level	J:280713
	increased circulating aspartate transaminase level	J:280713
	increased circulating glutamate dehydrogenase level	J:280713
Mfsd2a^tm1Dls/Mfsd2a^tm1Dls (B6.Cg-Mfsd2a^tm1Dls)	abnormal lipid homeostasis	J:234197
	decreased circulating triglyceride level	J:194781
	decreased susceptibility to diet-induced obesity	J:194781
	decreased triglyceride level	J:194781
	decreased unsaturated fatty acids level	J:234197
	increased energy expenditure	J:194781
	increased fatty acid oxidation	J:194781
	increased respiratory quotient	J:194781
	increased unsaturated fatty acids level	J:234197
Mfsd2b^{tm1a(KOMP)Wtsi}/Mfsd2b^{tm1a(KOMP)Wtsi} (B6JTyr;B6N-Mfsd2b^{tm1a(KOMP)Wtsi}/Wtsi)	decreased circulating iron level	J:175295
Mfsd2b^{tm1a(KOMP)Wtsi}/Mfsd2b^{tm1a(KOMP)Wtsi} (C57BL/6-Mfsd2b^{tm1a(KOMP)Wtsi})	abnormal ceramide level	J:250123
	decreased sphingosine level	J:250123
	increased sphingosine level	J:250123
Mfsd4b4^em1(IMPC)J/Mfsd4b4^em1(IMPC)J (C57BL/6NJ-Mfsd4b4^em1(IMPC)J/Mmjax)	decreased circulating alkaline phosphatase level	J:211773
Mfsd8^{tm1b(EUCOMM)Hmgu}/Mfsd8^{tm1b(EUCOMM)Hmgu} (C57BL/6N-Mfsd8^{tm1b(EUCOMM)Hmgu}/H)	increased circulating aspartate transaminase level	J:211773
Mgam^tm1Lex/Mgam^tm1Lex (129/Sv-Mgam^tm1Lex)	decreased circulating insulin level	J:146501
Mgam^tm1Lex/Mgam^tm1Lex (129/Sv-Mgam^tm1Lex)	decreased glycogen catabolism rate	J:146501
Mgat2^tm1.1Jxm/Mgat2^tm1.1Jxm (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	decreased circulating calcium level	J:80661
	decreased circulating total protein level	J:80661
	hypoglycemia	J:80661
	increased partial thromboplastin time	J:80661
Mgat2^tm1.1Jxm/Mgat2^tm1.1Jxm (involves: 129S1/Sv * 129X1/SvJ * ICR)	hematuria	J:80661
	increased urine protein level	J:80661
Mgat4a^tm1.1Jxm/Mgat4a^tm1.1Jxm (B6.Cg-Mgat4a^tm1.1Jxm)	abnormal blood homeostasis	J:117542
	abnormal circulating insulin level	J:117542
	decreased circulating insulin level	J:117542
	hyperglycemia	J:117542
	impaired glucose tolerance	J:117542
	increased circulating free fatty acids level	J:117542
	increased circulating glucose level	J:117542
	increased circulating triglyceride level	J:117542
	insulin resistance	J:117542
Mgat4a^tm1.1Jxm/Mgat4a^tm1.1Jxm Mgat4b^tm1.1Jxm/Mgat4b^tm1.1Jxm (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	hyperglycemia	J:212313
Mgat4b^tm1.1Jxm/Mgat4b^tm1.1Jxm (B6.129-Mgat4b^tm1.1Jxm)	abnormal circulating protein level	J:212313
	decreased circulating factor IX level	J:212313
	decreased circulating factor VIII level	J:212313
	decreased circulating prothrombin level	J:212313
	decreased circulating VLDL cholesterol level	J:212313
	decreased circulating von Willebrand factor level	J:212313
	increased bleeding time	J:212313
	increased partial thromboplastin time	J:212313
Mgat5^tm1Jwd/Mgat5^tm1Jwd (involves: 129S1/Sv * 129X1/SvJ)	abnormal homeostasis	J:188930
Mgat5^tm1Jwd/Mgat5^tm1Jwd Mgat5b^tm1.1Itl/Mgat5b^tm1.1Itl (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	abnormal homeostasis	J:188930
Mgat5b^tm1.1Cfg/Mgat5b^tm1.1Cfg (involves: 129S6/SvEvTac)	increased circulating glucose level	J:217719
Mgat5b^tm1.1Itl/Mgat5b^tm1.1Itl (involves: C57BL/6)	abnormal homeostasis	J:188930
mgb/0 (involves: C57BL/6 * FVB/N)	increased circulating chloride level	J:130545
mgb/0 (involves: C57BL/6 * FVB/N)	increased circulating potassium level	J:130545
mgb/mgb (involves: C57BL/6 * FVB/N)	abnormal circulating calcium level	J:130545
	increased blood urea nitrogen level	J:130545
	increased circulating creatinine level	J:130545
	increased circulating potassium level	J:130545
Mgdr1^C3H/HeJ/? (involves: C3H/HeJ * DBA/2J)	abnormal enzyme/coenzyme level	J:94275
Mgdr2^C3H/HeJ/? (involves: C3H/HeJ * DBA/2J)	abnormal enzyme/coenzyme level	J:94275
Mglcq1^M16/? (involves: ICR * M16)	increased circulating glucose level	J:101200
Mgll^{Gt(OST113734)Lex}/Mgll^{Gt(OST113734)Lex} (involves: 129S5/SvEvBrd * C57BL/6J)	decreased fatty acids level	J:165274
	increased body temperature	J:165274
Mgll^tm1.1Rzim/Mgll^tm1.1Rzim (involves: 129P2/OlaHsd * C57BL/6)	abnormal glucose homeostasis	J:172679
	abnormal lipid homeostasis	J:172679
	abnormal lipolysis	J:172679
	decreased circulating glycerol level	J:172679
	decreased circulating insulin level	J:172679
	decreased circulating ketone body level	J:172679
	decreased circulating triglyceride level	J:172679
	decreased liver triglyceride level	J:172679
	impaired lipolysis	J:172679
	improved glucose tolerance	J:172679
	increased insulin sensitivity	J:172679
	increased oxygen consumption	J:172679
Mgme1^em1(IMPC)J/Mgme1^em1(IMPC)J (C57BL/6NJ-Mgme1^em1(IMPC)J/Mmjax)	improved glucose tolerance	J:211773
	increased fasting circulating glucose level	J:211773
Mgmt^{tm1b(EUCOMM)Wtsi}/Mgmt^{tm1b(EUCOMM)Wtsi} (C57BL/6N-Mgmt^{tm1b(EUCOMM)Wtsi}/Tcp)	increased blood urea nitrogen level	J:211773
Mgmt^tm1Lds/Mgmt^tm1Lds (involves: 129P2/OlaHsd * C57BL/6)	increased circulating glucose level	J:118148
Mgp^tm1Kry/Mgp^tm1Kry (involves: 129S7/SvEvBrd)	increased circulating osteocalcin level	J:203924
Mgrn1^em1(IMPC)Tcp/Mgrn1^em1(IMPC)Tcp (C57BL/6NCrl-Mgrn1^em1(IMPC)Tcp/Tcp)	increased circulating alkaline phosphatase level	J:211773
	increased circulating bilirubin level	J:211773
Mgrn1^md-2J/Mgrn1^md-2J (involves: 129S1/SvImJ * C3H/HeJ)	pericardial effusion	J:116645
Mgrn1^md-2J/Mgrn1^md-2J (involves: 129S1/SvImJ * C3H/HeJ)	pleural effusion	J:116645
Mgrn1^md-nc/Mgrn1^md-nc (involves: 101/H * C3H/HeH)	pericardial effusion	J:116645
Mgrn1^md-nc/Mgrn1^md-nc (involves: 101/H * C3H/HeH)	pleural effusion	J:116645
Mgst1^em1(IMPC)J/Mgst1^em1(IMPC)J (C57BL/6NJ-Mgst1^em1(IMPC)J/Mmjax)	increased circulating cholesterol level	J:211773
	increased circulating HDL cholesterol level	J:211773
Mhdabap001/Mhdabap001 (C3HeB/FeJ-Mhdabap001)	increased circulating alkaline phosphatase level	J:183993
Mhdabap003/Mhdabap003 (C3HeB/FeJ-Mhdabap003)	increased circulating alkaline phosphatase level	J:183993
Mhdabap003/Mhdabap003 (C3HeB/FeJ-Mhdabap003)	increased circulating calcium level	J:183993
Mhdabap009/Mhdabap009 (C3HeB/FeJ-Mhdabap009)	increased circulating alkaline phosphatase level	J:183993
Mhdabap16/Mhdabap16 (C3HeB/FeJ-Mhdabap16)	increased circulating alkaline phosphatase level	J:183993
Mhdabap17/Mhdabap17 (C3HeB/FeJ-Mhdabap17)	increased circulating alkaline phosphatase level	J:183993
Mhdabap18/Mhdabap18 (C3HeB/FeJ-Mhdabap18)	increased circulating alkaline phosphatase level	J:183993
Mhdabap19/Mhdabap19 (C3HeB/FeJ-Mhdabap19)	increased circulating alkaline phosphatase level	J:183993
Mhdabap21/Mhdabap21 (C3HeB/FeJ-Mhdabap21)	abnormal circulating aspartate transaminase level	J:183993
	decreased circulating alkaline phosphatase level	J:183993
	increased circulating alanine transaminase level	J:183993
Mhdabap22/Mhdabap22 (C3HeB/FeJ-Mhdabap22)	decreased circulating alkaline phosphatase level	J:183993
Mhdabch6/Mhdabch6 (C3HeB/FeJ-Mhdabch6)	increased circulating calcium level	J:183993
Mhdabch8/Mhdabch8 (C3HeB/FeJ-Mhdabch8)	increased circulating calcium level	J:183993
Mhdabch9/Mhdabch9 (C3HeB/FeJ-Mhdabch9)	increased circulating calcium level	J:183993
Mhdabch10/Mhdabch10 (C3HeB/FeJ-Mhdabch10)	increased circulating calcium level	J:183993
Mhdasca1/Mhdasca1 (C3HeB/FeJ-Mhdasca1)	increased circulating calcium level	J:183993
Mia2^cpto/Mia2^cpto (C57BL/6-Mia2^cpto)	decreased circulating cholesterol level	J:176259
	decreased circulating HDL cholesterol level	J:176259
	decreased circulating triglyceride level	J:176259
	decreased circulating VLDL triglyceride level	J:176259
Mia2^tm1Zhxu/Mia2^tm1Zhxu Speer6-ps1^{Tg(Alb-cre)21Mgn}/Speer6-ps1⁺ (involves: 129 * C57BL/6 * DBA)	decreased circulating cholesterol level	J:268333
	decreased circulating triglyceride level	J:268333
	increased liver cholesterol level	J:268333
	increased liver triglyceride level	J:268333
Mia3^tm1Lex/Mia3^tm1Lex (involves: 129S5/SvEvBrd * C57BL/6)	edema	J:172737
Miat^tm1Shna/Miat^tm1Shna (B6.Cg-Miat^tm1Shna)	increased nervous system dopamine level	J:250154
Mib1^tm1Art/Mib1^tm1Art (BTNTTFArt.129S-Mib1^tm1Art)	pericardial edema	J:102528
Mib1^tm2Kong/Mib1^tm2Kong Tg(Tek-cre)12Flv/0 (involves: 129P2/OlaHsd * C3H * C57BL/6)	pericardial effusion	J:130369
Mib2^{tm1a(EUCOMM)Wtsi}/Mib2^{tm1a(EUCOMM)Wtsi} (C57BL/6N-Mib2^{tm1a(EUCOMM)Wtsi}/Ics)	decreased blood urea nitrogen level	J:165965
	decreased circulating amylase level	J:165965
Micos13^{tm1.1(KOMP)Vlcg}/Micos13⁺ (C57BL/6N-Micos13^{tm1.1(KOMP)Vlcg}/Ucd)	decreased blood urea nitrogen level	J:211773
	decreased circulating cholesterol level	J:211773
	decreased circulating creatinine level	J:211773
	decreased circulating HDL cholesterol level	J:211773
	decreased circulating phosphate level	J:211773
Micu1^em#Fink/Micu1^em#Fink (C57BL/6N-Micu1^em#Fink)	increased circulating lactate level	J:238984
Micu2^{tm1a(EUCOMM)Wtsi}/Micu2^{tm1a(EUCOMM)Wtsi} (C57BL/6N-Micu2^{tm1a(EUCOMM)Wtsi}/Wtsi)	decreased circulating fructosamine level	J:211773
	decreased circulating serum albumin level	J:211773
Mier1^{tm1a(EUCOMM)Wtsi}/Mier1^{tm1a(EUCOMM)Wtsi} (B6JTyr;B6N-Mier1^{tm1a(EUCOMM)Wtsi}/Wtsi)	decreased circulating free fatty acids level	J:165965
	decreased circulating glucose level	J:165965
Mif^tm1Dvd/Mif^tm1Dvd (involves: 129S4/SvJae * C57BL/6)	decreased circulating tumor necrosis factor level	J:52300
Miga1^{tm1b(EUCOMM)Wtsi}/Miga1^{tm1b(EUCOMM)Wtsi} (C57BL/6N-Miga1^{tm1b(EUCOMM)Wtsi}/Ieg)	increased circulating alkaline phosphatase level	J:211773
Miga2^{tm1a(KOMP)Wtsi}/Miga2^{tm1a(KOMP)Wtsi} (B6JTyr;B6N-Miga2^{tm1a(KOMP)Wtsi}/Wtsi)	decreased circulating aspartate transaminase level	J:175295
	decreased circulating cholesterol level	J:175295
	decreased circulating HDL cholesterol level	J:175295
	decreased circulating LDL cholesterol level	J:175295
	decreased circulating serum albumin level	J:175295
	decreased circulating total protein level	J:175295
	decreased lactate dehydrogenase level	J:175295
Minar2^{tm1b(KOMP)Wtsi}/Minar2^{tm1b(KOMP)Wtsi} (C57BL/6N-Minar2^{tm1b(KOMP)Wtsi}/Wtsi)	decreased circulating glucose level	J:211773
	decreased circulating phosphate level	J:211773
Mindy1^{tm1a(EUCOMM)Wtsi}/Mindy1^{tm1a(EUCOMM)Wtsi} (Not Specified)	decreased circulating free fatty acids level	J:165965
	decreased circulating glycerol level	J:165965
	increased circulating alkaline phosphatase level	J:165965
Mink1^tm1.2Lgrl/Mink1^tm1.2Lgrl (involves: 129S6/SvEvTac * C57BL/6)	abnormal platelet dense granule physiology	J:231551
	abnormal platelet physiology	J:231551
	decreased platelet aggregation	J:231551
	decreased susceptibility to induced thrombosis	J:231551
	increased bleeding time	J:231551
Mipep^em1(IMPC)Mbp/Mipep⁺ (C57BL/6N-Mipep^em1(IMPC)Mbp/MbpMmucd)	increased circulating serum albumin level	J:211773
Mipol1^{tm1b(EUCOMM)Hmgu}/Mipol1^{tm1b(EUCOMM)Hmgu} (C57BL/6N-Mipol1^{tm1b(EUCOMM)Hmgu}/Ieg)	increased circulating aspartate transaminase level	J:211773
	increased circulating lipase level	J:211773
Mir1a-2^tm1Dsr/Mir1a-2^tm1Dsr (involves: 129/Sv * C57BL/6)	abnormal atrial thrombosis	J:211548
Mir1a-2^tm1Dsr/Mir1a-2^tm1Dsr (involves: 129/Sv * C57BL/6)	pericardial edema	J:211548
Mir10b^em1Rosay/Mir10b^em1Rosay (C57BL/6J-Mir10b^em1Rosay)	hyperglycemia	J:342486
	impaired glucose tolerance	J:342486
	increased susceptibility to diet-induced obesity	J:342486
	insulin resistance	J:342486
Mir21a^tm1.1Mer/Mir21a^tm1.1Mer (involves: 129S1/Sv * C57BL/6 * FVB/N)	abnormal cytokine level	J:179235
	abnormal interferon level	J:179235
	abnormal interleukin level	J:179235
Mir22^tm1Boet/Mir22^tm1Boet (B6.129S2-Mir22^tm1Boet)	decreased circulating free fatty acids level	J:266382
	decreased circulating leptin level	J:266382
	increased fatty acid oxidation	J:266382
Mir26a-1^em1Xfu/Mir26a-1^em1Xfu Mir26a-2^em1Xfu/Mir26a-2^em1Xfu (involves: C57BL/6)	increased circulating glucose level	J:286108
	increased circulating insulin level	J:286108
	increased fasting circulating glucose level	J:286108
	increased susceptibility to diet-induced obesity	J:286108
	insulin resistance	J:286108
Mir32^em1Gpt/Mir32^em1Gpt Alb^em1(icre)Gpt/Alb⁺ (C57BL/6JGpt-Mir32^em1Gpt Alb^em1(icre)Gpt)	decreased circulating alanine transaminase level	J:344660
	decreased circulating aspartate transaminase level	J:344660
	decreased circulating cholesterol level	J:344660
	decreased circulating LDL cholesterol level	J:344660
	decreased liver cholesterol level	J:344660
	decreased liver triglyceride level	J:344660
	improved glucose tolerance	J:344660
	increased insulin sensitivity	J:344660
Mir33^tm1.1Koho/Mir33^tm1.1Koho (involves: C57BL/6)	abnormal cholesterol homeostasis	J:165420
	increased circulating cholesterol level	J:165420
	increased circulating HDL cholesterol level	J:165420
Mir92b^em22Gpt/Mir92b^em22Gpt (involves: C57BL/6JGpt)	improved glucose tolerance	J:346344
	increased insulin sensitivity	J:346344
	increased skeletal muscle glycogen level	J:346344
Mir100^em1Nju/Mir100^em1Nju Speer6-ps1^{Tg(Alb-cre)21Mgn}/Speer6-ps1⁺ (involves: C57BL/6 * DBA)	increased circulating alanine transaminase level	J:281439
	increased circulating aspartate transaminase level	J:281439
Mir122^tm1.1Apts/Mir122^tm1.1Apts (involves: 129 * C57BL/6)	decreased circulating cholesterol level	J:190066
	decreased circulating HDL cholesterol level	J:190066
	decreased circulating triglyceride level	J:190066
	decreased circulating VLDL cholesterol level	J:190066
	decreased liver glycogen level	J:190066
	increased circulating alanine transaminase level	J:190066
	increased circulating alkaline phosphatase level	J:190066
	increased circulating interleukin-6 level	J:190066
	increased liver cholesterol level	J:190066
	increased liver triglyceride level	J:190066
Mir122^tm1.1Kgh/Mir122^tm1.1Kgh (involves: 129S1/Sv * 129X1/SvJ)	abnormal circulating enzyme level	J:190067
	decreased circulating cholesterol level	J:190067
	decreased circulating HDL cholesterol level	J:190067
	increased bile salt level	J:190067
	increased circulating alanine transaminase level	J:190067
	increased circulating alkaline phosphatase level	J:190067
	increased circulating interleukin-6 level	J:190067
	increased liver triglyceride level	J:190067
Mir122^tm1.2Kgh/Mir122^tm1.2Kgh Speer6-ps1^{Tg(Alb-cre)21Mgn}/Speer6-ps1⁺ (involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * DBA)	abnormal circulating enzyme level	J:190067
	abnormal lipid homeostasis	J:190067
	decreased circulating cholesterol level	J:190067
	decreased circulating HDL cholesterol level	J:190067
	decreased circulating LDL cholesterol level	J:190067
	decreased liver glycogen level	J:190067
	increased bile salt level	J:190067
	increased circulating alanine transaminase level	J:190067
	increased circulating alkaline phosphatase level	J:190067
	increased circulating interleukin-6 level	J:190067
	increased liver triglyceride level	J:190067
Mir129-2^{em1(IMPC)Kmpc}/Mir129-2^{em1(IMPC)Kmpc} (C57BL/6NTac-Mir129-2^{em1(IMPC)Kmpc}/Kmpc)	decreased circulating total protein level	J:211773
	impaired glucose tolerance	J:211773
Mir133a-1^tm1Eno/Mir133a-1^tm1Eno Mir133a-2^tm1Eno/Mir133a-2^tm1Eno (involves: 129S/SvEv * C57BL/6)	abnormal atrial thrombosis	J:142220
Mir139^em1Jwli/Mir139^em1Jwli (C57BL/6J-Mir139^em1Jwli)	abnormal cytokine level	J:248779
Mir146^tm1.1Bal/Mir146^tm1.1Bal (involves: C57BL/6 * FVB/N)	increased circulating interleukin-1 beta level	J:173671
	increased circulating interleukin-6 level	J:173671
	increased circulating interleukin-10 level	J:173671
	increased circulating tumor necrosis factor level	J:173671
	increased macrophage nitric oxide production	J:173671
Mir146^tm2.1Bal/Mir146^tm2.1Bal (involves: 129S1/Sv * C57BL/6 * FVB/N)	increased circulating interleukin-1 beta level	J:173671
	increased circulating interleukin-6 level	J:173671
	increased circulating interleukin-10 level	J:173671
	increased circulating tumor necrosis factor level	J:173671
	increased macrophage nitric oxide production	J:173671
Mir149^em1Ydw/Mir149^em1Ydw (C57BL/6J-Mir149^em1Ydw)	increased circulating aspartate transaminase level	J:294318
Mir184^tm1Ics/Mir184^tm1Ics (Not Specified)	decreased fasting circulating glucose level	J:210552
	improved glucose tolerance	J:210552
	increased circulating insulin level	J:210552
	increased insulin secretion	J:210552
Mir192^tm1.1Rnat/Mir192^tm1.1Rnat (involves: 129)	abnormal urine protein level	J:208963
Mir200b^tm1.1Osb/Mir200b^tm1.1Osb Mir429^m1Osb/Mir429^m1Osb (involves: 129S2/SvPas * C57BL/6)	decreased circulating luteinizing hormone level	J:199159
	decreased circulating progesterone level	J:199159
	decreased luteinizing hormone level	J:199159
Mir204^tm1Liam/Mir204⁺ (B6.Cg-Mir204^tm1Liam)	albuminuria	J:326324
Mir204^tm1Liam/Mir204^tm1Liam (B6.Cg-Mir204^tm1Liam)	albuminuria	J:326324
Mir205^tm1.1Mtm/Mir205^tm1.1Mtm (involves: 129P2/OlaHsd * C57BL/6)	decreased circulating prolactin level	J:278363
Mir205hg^tm1.1Oers/Mir205hg^tm1.1Oers (B6(Cg)-Mir205hg^tm1.1Oers)	decreased circulating prolactin level	J:278363
	decreased growth hormone level	J:278363
Mir375^tm1Stf/Mir375^tm1Stf (B6.129-Mir375^tm1Stf)	abnormal gluconeogenesis	J:147572
	abnormal glucose homeostasis	J:147572
	hyperglycemia	J:147572
	increased circulating glucagon level	J:147572
	increased circulating glucose level	J:147572
	increased glucagon secretion	J:147572
	increased insulin secretion	J:147572
Mir378a^tm1.1Eno/Mir378a^tm1.1Eno (involves: 129S/SvEv * C57BL/6)	decreased circulating glucose level	J:190154
	decreased susceptibility to diet-induced obesity	J:190154
	increased circulating triglyceride level	J:190154
	increased energy expenditure	J:190154
	increased oxygen consumption	J:190154
Mir485^em1Ycao/Mir485^em1Ycao (C57BL/6-Mir485^em1Ycao)	decreased oxygen consumption	J:335039
	impaired glucose tolerance	J:335039
	insulin resistance	J:335039
Mir505^em1Xhj/Mir505^em1Xhj (C57BL/6J-Mir505^em1Xhj)	increased circulating follicle stimulating hormone level	J:289998
Mir505^em1Xhj/Mir505^em1Xhj (C57BL/6J-Mir505^em1Xhj)	increased circulating luteinizing hormone level	J:289998
Mir802^em3Gpt/Mir802^em3Gpt Tg(Ins2-cre)25Mgn/0 (involves: C57BL/6JGpt * DBA)	abnormal circulating insulin level	J:287584
	improved glucose tolerance	J:287584
	increased circulating insulin level	J:287584
	increased insulin secretion	J:287584
Mirb^SWR/J/Mirb^SWR/J (involves: C57BL/10J * SWR/J)	hemochromatosis	J:123506
Mirc1^tm1.1Tyj/Mirc1^tm1.1Tyj Pkd1^tm1.1Pcha/Pkd1^tm1.1Pcha Tg(Cdh16-cre)91Igr/0 (involves: 129 * 129S4/SvJae * C57BL/6 * ICR)	decreased blood urea nitrogen level	J:244067
Mirc1^tm1.1Tyj/Mirc1^tm1.1Tyj Pkd1^tm1.1Pcha/Pkd1^tm2Som Tg(Cdh16-cre)91Igr/0 (involves: 129 * 129S4/SvJae * C57BL/6 * ICR)	decreased circulating creatinine level	J:244067
	increased fatty acid oxidation	J:244067
Mirc1^tm1.1Tyj/Mirc1^tm1.1Tyj Pkd1^tm2Som/Pkd1^tm2Som Tg(Cdh16-cre)91Igr/0 (involves: 129S4/SvJae * C57BL/6 * ICR)	decreased circulating creatinine level	J:244067
Mirc1^tm1.1Tyj/Mirc1^tm1.1Tyj Pkd2^tm3Som/Pkd2^tm3Som Tg(Pkhd1-cre)1Igr/0 (involves: 129S4/SvJae * C57BL/6)	decreased circulating creatinine level	J:244067
Mirc3^tm1.1Tyj/Mirc3^tm1.1Tyj Mirc1^tm1.2Tyj/Mirc1^tm1.2Tyj (involves: 129S4/SvJae * C57BL/6 * FVB/N * SJL)	edema	J:134861
Mirc13^tm1.1Mtm/Mirc13^tm1.1Mtm (Not Specified)	abnormal lipid homeostasis	J:256444
	abnormal phospholipid level	J:256444
	abnormal sphingomyelin level	J:256444
	decreased fasting circulating glucose level	J:256444
	decreased liver triglyceride level	J:256444
	decreased saturated fatty acids level	J:256444
	increased bile salt level	J:256444
	increased ceramide level	J:256444
Mirc13^tm1Biat/Mirc13⁺ Mirc4^tm1.1Biat/Mirc4^tm1.1Biat Tg(Ins2-cre)23Herr/0 (involves: C57BL/6J * C57BL/6N * CBA/J)	abnormal circulating glucose level	J:314874
Mirc13^tm1Biat/Mirc13^tm1Biat (involves: C57BL/6J * C57BL/6N)	abnormal circulating glucose level	J:314874
	abnormal glucose homeostasis	J:314874
	decreased susceptibility to diet-induced obesity	J:314874
Mirc13^tm1Biat/Mirc13^tm1Biat Mirc4^tm1.1Biat/Mirc4^tm1.1Biat Tg(Ins2-cre)23Herr/0 (involves: C57BL/6J * C57BL/6N * CBA/J)	abnormal circulating glucose level	J:314874
Mirc29^tm1.1Wtsi/Mirc29^tm1.1Wtsi Mirc33^tm1.1Wtsi/Mirc33^tm1.1Wtsi (C57BL/6N-Mirc29^tm1.1Wtsi Mirc33^tm1.1Wtsi)	decreased circulating glucose level	J:267719
	decreased circulating insulin level	J:267719
	increased fasting circulating glucose level	J:267719
Mirc32^tm1Thbr/Mirc32^tm1Thbr (involves: 129)	improved glucose tolerance	J:176266
Mirc32^tm1Thbr/Mirc32^tm1Thbr (involves: 129)	increased insulin sensitivity	J:176266
Mirc33^em1Smoc/Mirc33^em1Smoc (Not Specified)	abnormal enzyme/coenzyme level	J:324059
	decreased circulating luteinizing hormone level	J:324059
	decreased circulating progesterone level	J:324059
	increased luteinizing hormone level	J:324059
Mirc33^tm1.1Wtsi/Mirc33^tm1.1Wtsi (C57BL/6N-Mirc33^tm1.1Wtsi)	decreased circulating creatinine level	J:267719
Mirc35hg^{Gt(D016D06)Wrst}/Mirc35hg^{Gt(D016D06)Wrst} (involves: 129S2/SvPas * C57BL/6J)	phototoxicity	J:193822
Mirc36^tm1.1Jcav/Mirc36⁺ (B6.129-Mirc36^tm1.1Jcav)	abnormal glucose homeostasis	J:216177
	abnormal insulin secretion	J:216177
	decreased circulating glucose level	J:216177
	decreased circulating ketone body level	J:216177
	hypoglycemia	J:216177
	increased liver glycogen level	J:216177
Mirc54^tm1.1Syu/Mirc54^tm1.1Syu (Not Specified)	decreased circulating cholesterol level	J:310890
	decreased circulating glucose level	J:310890
	decreased circulating triglyceride level	J:310890
	decreased liver triglyceride level	J:310890
	decreased susceptibility to diet-induced obesity	J:310890
	improved glucose tolerance	J:310890
	increased insulin sensitivity	J:310890
Mirc55^tm1.1Cjku/Mirc55^tm1.1Cjku (involves: 129/Sv * 129S1/Sv * C57BL/6)	skin edema	J:143206
Mirc55^tm1.1Eno/Mirc55^tm1.1Eno (Not Specified)	edema	J:139708
Misp^em1Nsas/Misp^em1Nsas (FVB/NJcl-Misp^em1Nsas)	abnormal interleukin level	J:333842
Misp^em1Nsas/Misp^em1Nsas (FVB/NJcl-Misp^em1Nsas)	decreased transforming growth factor beta level	J:333842
Mitf^mi-tg/Mitf^mi-tg (B6.Cg-Mitf^mi-tg)	decreased serotonin level	J:53161
Mitf^Mi-wh/Mitf^Mi-wh (B6.Cg-Mitf^Mi-wh)	decreased bleeding time	J:7327
Mitf^Mi/Mitf^Mi (B6.Cg-Mitf^Mi)	decreased serotonin level	J:53161
Mitf^{Tg(Tff3-Tmem207)2Tamo}/Mitf^{Tg(Tff3-Tmem207)2Tamo} (involves: C57BL/6)	increased circulating creatinine level	J:244533
Mkks^tm1Vcs/Mkks^tm1Vcs (either: (involves: 129S1/Sv * 129X1/SvJ) or (involves: 129S1/Sv * 129X1/SvJ * C57BL/6J))	increased circulating leptin level	J:99276
Mkrn2^{tm1b(KOMP)Wtsi}/Mkrn2^{tm1b(KOMP)Wtsi} (C57BL/6N-Mkrn2^{tm1b(KOMP)Wtsi}/Wtsi)	increased circulating aspartate transaminase level	J:211773
Mkrn3^em1(IMPC)Tcp/Mkrn3^em1(IMPC)Tcp (C57BL/6NCrl-Mkrn3^em1(IMPC)Tcp/Tcp)	decreased fasting circulating glucose level	J:211773
Mkrn3^em1Rhu/Mkrn3⁺ (involves: C57BL/6)	increased circulating follicle stimulating hormone level	J:305000
Mkrn3^em1Rhu/Mkrn3⁺ (involves: C57BL/6)	increased circulating luteinizing hormone level	J:305000
Mks1^hlb614/Mks1^hlb614 (involves: C3H * C57BL/6)	pericardial effusion	J:167534
Mks1^{tm1a(EUCOMM)Wtsi}/Mks1^{tm1a(EUCOMM)Wtsi} (involves: C57BL/6 * C57BL/6N)	cyanosis	J:196290
Mks1^{tm1a(EUCOMM)Wtsi}/Mks1^{tm1a(EUCOMM)Wtsi} (involves: C57BL/6N)	edema	J:200082
Mlc1^tm1.1Vdk/Mlc1^tm1.1Vdk (involves: C57BL/6)	cerebral edema	J:250520
Mlc1^tm1Rhn/Mlc1^tm1Rhn (129S6/SvEvTac-Mlc1^tm1Rhn)	edema	J:237219
Mldhr^em1Zhgn/Mldhr^em1Zhgn (involves: C57BL/6)	abnormal glucose homeostasis	J:303725
	increased cellular ATP level	J:303725
	increased circulating lactate level	J:303725
	increased oxygen consumption	J:303725
Mlec^{tm1a(EUCOMM)Wtsi}/Mlec^{tm1a(EUCOMM)Wtsi} (C57BL/6N-Mlec^{tm1a(EUCOMM)Wtsi}/Wtsi)	increased circulating thyroxine level	J:211773
Mlepq1^M16/? (involves: ICR * M16)	decreased circulating leptin level	J:101200
Mlepq2^M16/? (involves: ICR * M16)	increased circulating leptin level	J:101200
Mlh1^{tm1b(EUCOMM)Hmgu}/Mlh1^{tm1b(EUCOMM)Hmgu} (C57BL/6N-Mlh1^{tm1b(EUCOMM)Hmgu}/H)	increased circulating alanine transaminase level	J:211773
	increased circulating aspartate transaminase level	J:211773
Mllt3^{tm1b(EUCOMM)Hmgu}/Mllt3⁺ (C57BL/6N-Mllt3^{tm1b(EUCOMM)Hmgu}/Cnrm)	increased circulating amylase level	J:211773
Mllt10^em1(IMPC)Mbp/Mllt10^em1(IMPC)Mbp (C57BL/6N-Mllt10^em1(IMPC)Mbp/MbpMmucd)	edema	J:211773
Mlph^ln/Mlph^ln Sgk3^fz/Sgk3^fz (C57BL/6J-Sgk3^fz Mlph^ln)	decreased bleeding time	J:7327
Mlx^{tm1.1(KOMP)Vlcg}/Mlx^{tm1.1(KOMP)Vlcg} (C57BL/6N-Mlx^{tm1.1(KOMP)Vlcg}/J)	decreased circulating glucose level	J:211773
	increased circulating sodium level	J:211773
	increased fasting circulating glucose level	J:211773
Mlxip^tm1.2Lchan/Mlxip^tm1.2Lchan (involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)	decreased respiratory quotient	J:217834
	increased circulating alanine level	J:217834
	increased circulating lactate level	J:217834
	increased fatty acid oxidation	J:217834
Mlxipl^tm1Kuy/Mlxipl^tm1Kuy (involves: 129S6/SvEvTac * C57BL/6J)	abnormal glucose homeostasis	J:89865
	abnormal lipid homeostasis	J:89865
	decreased body temperature	J:89865
	decreased circulating cholesterol level	J:89865
	decreased circulating free fatty acids level	J:89865
	decreased fatty acids level	J:89865
	increased circulating glucose level	J:89865
	increased circulating insulin level	J:89865
	increased liver glycogen level	J:89865
	insulin resistance	J:89865
Mlxipl^tm1Kuy/Mlxipl^tm1Kuy (B6.129S6-Mlxipl^tm1Kuy/J)	decreased body temperature	J:273754
	decreased circulating cholesterol level	J:273754
	decreased circulating glucose level	J:273754
	decreased circulating triglyceride level	J:273754
	decreased liver triglyceride level	J:273754
	increased circulating glucose level	J:273754
Mlycd^tm1Jish/Mlycd^tm1Jish (B6.129S7-Mlycd^tm1Jish)	abnormal glucose homeostasis	J:126455
Mmaa^em1(IMPC)J/Mmaa^em1(IMPC)J (C57BL/6NJ-Mmaa^em1(IMPC)J/Mmjax)	decreased circulating calcium level	J:211773
	decreased circulating total protein level	J:211773
	increased circulating alanine transaminase level	J:211773
	increased circulating alkaline phosphatase level	J:211773
	increased circulating bilirubin level	J:211773
Mmachc^{Gt(AZ0348)Wtsi}/Mmachc⁺ (involves: 129P2/OlaHsd * 129S6/SvEvTac * C57BL/6)	increased circulating homocysteine level	J:212387
Mmachc^{tm1.1(NCOM)Mfgc}/Mmachc^{tm1.1(NCOM)Mfgc} (C57BL/6N-Mmachc^{tm1.1(NCOM)Mfgc}/Tcp)	edema	J:211773
Mmachc^{tm1.1(NCOM)Mfgc}/Mmachc^{tm1.1(NCOM)Mfgc} Tg(CAG-Mmachc,-GFP)1Poche/0 (C57BL/6-Mmachc^{tm1.1(NCOM)Mfgc} Tg(CAG-Mmachc,-GFP)1Poche)	increased circulating homocysteine level	J:297666
	increased circulating methylmalonic acid level	J:297666
Mmd^{em1(IMPC)Hmgu}/Mmd^{em1(IMPC)Hmgu} (C57BL/6N-Mmd^{em1(IMPC)Hmgu}/Ieg)	increased circulating alkaline phosphatase level	J:211773
	increased circulating aspartate transaminase level	J:211773
Mme^em1(IMPC)Mbp/Mme^em1(IMPC)Mbp (C57BL/6N-Mme^em1(IMPC)Mbp/MbpMmucd)	increased circulating phosphate level	J:211773
Mme^tm1Cge/Mme^tm1Cge (involves: 129S4/SvJae * C57BL/6)	abnormal circulating protein level	J:104962
Mme^tm1Cge/Mme^tm1Cge (B6.129S4-Mme^tm1Cge)	skin edema	J:66854
Mmgt2^{tm1b(EUCOMM)Wtsi}/Mmgt2^{tm1b(EUCOMM)Wtsi} (C57BL/6N-Mmgt2^{tm1b(EUCOMM)Wtsi}/Bay)	impaired glucose tolerance	J:211773
Mmp8^{tm1.1(KOMP)Vlcg}/Mmp8^{tm1.1(KOMP)Vlcg} (C57BL/6N-Mmp8^{tm1.1(KOMP)Vlcg}/J)	decreased circulating free fatty acids level	J:211773
Mmp9^tm1Arnd/Mmp9^tm1Arnd (B6.129P2-Mmp9^tm1Arnd)	decreased histamine level	J:110450
Mmp9^tm1Arnd/Mmp9^tm1Arnd (B6.129P2-Mmp9^tm1Arnd)	increased prostaglandin level	J:110450
Mmp9^tm1Tvu/Mmp9^tm1Tvu (involves: 129S6/SvEvTac)	abnormal chemokine level	J:84293
	increased circulating interferon-beta level	J:148442
	increased circulating interferon-gamma level	J:148442
Mmp9^tm1Tvu/Mmp9^tm1Tvu (involves: 129/Sv * 129S6/SvEvTac)	decreased circulating interleukin-10 level	J:55723
Mmp9^tm1Tvu/Mmp9^tm1Tvu (involves: 129S6/SvEvTac * C57BL/6)	abnormal chemokine level	J:88065
Mmp9^tm1Tvu/Mmp9^tm1Tvu (C3N.129S6-Mmp9^tm1Tvu)	joint swelling	J:150311
Mmp11^{tm1b(EUCOMM)Hmgu}/Mmp11^{tm1b(EUCOMM)Hmgu} (C57BL/6N-Mmp11^{tm1b(EUCOMM)Hmgu}/Ics)	decreased circulating serum albumin level	J:211773
Mmp14^tm1Noda/Mmp14^tm1Noda Mmp2^tm1Ito/Mmp2^tm1Ito (Not Specified)	cyanosis	J:91198
Mmp15^{tm1b(KOMP)Wtsi}/Mmp15^{tm1b(KOMP)Wtsi} (C57BL/6N-Mmp15^{tm1b(KOMP)Wtsi}/Bay)	decreased circulating calcium level	J:211773
Mmp17^tm1Ski/Mmp17^tm1Ski (B6.Cg-Mmp17^tm1Ski)	increased urine osmolality	J:171096
Mmp19^tm1Amp/Mmp19^tm1Amp (Not Specified)	increased susceptibility to diet-induced obesity	J:90802
Mmp19^tm1Rase/Mmp19^tm1Rase (B6.129P2-Mmp19^tm1Rase)	abnormal cytokine level	J:137128
Mmut^em1Cpv/Mmut^em1Cpv (involves: 129S/SvEv * C57BL/6 * FVB/N)	increased circulating methylmalonic acid level	J:332892
Mmut^em2Cpv/Mmut^em2Cpv (involves: 129S/SvEv * C57BL/6 * FVB/N)	increased circulating methylmalonic acid level	J:332892
Mmut^tm1.1Mrb/Mmut^tm1.1Mrb (involves: C57BL/6)	abnormal fatty acids level	J:237040
	acidosis	J:237040
	increased circulating ammonia level	J:237040
	increased circulating carnitine level	J:237040
	increased circulating glycine level	J:237040
	methylmalonic aciduria	J:237040
Mmut^tm1Cpv/Mmut^tm1Cpv (Not Specified)	abnormal blood homeostasis	J:147338
	acidemia	J:147338
	aciduria	J:147338
	dehydration	J:147338
Mmut^tm1Cpv/Mmut^tm1Cpv (involves: 129S/SvEv * C57BL/6 * FVB/N)	abnormal blood homeostasis	J:147313
	abnormal circulating amino acid level	J:147313
	organic aciduria	J:147313
Mmut^tm1Cpv/Mmut^tm1Cpv Tg(Alb-Mut)#Cpv/0 (involves: C57BL/6)	decreased circulating bicarbonate level	J:200689
	increased circulating chloride level	J:200689
	increased circulating creatinine level	J:200689
	increased circulating lipocalin 2 level	J:200689
	increased circulating methylmalonic acid level	J:200689
	metabolic acidosis	J:200689
Mmut^tm1Pai/Mmut^tm1.1Mrb (involves: 129S1/Sv * C57BL/6)	abnormal fatty acids level	J:237040
	abnormal sphingolipid level	J:237040
	acidosis	J:237040
	increased blood urea nitrogen level	J:237040
	increased circulating ammonia level	J:237040
	increased circulating carnitine level	J:237040
	increased circulating glycine level	J:237040
	increased lipocalin 2 level	J:237040
	increased urine calcium level	J:237040
	increased urine chloride ion level	J:237040
	increased urine magnesium level	J:237040
	increased urine potassium level	J:237040
	increased urine sodium level	J:237040
	methylmalonic aciduria	J:237040
Mmut^tm1Pai/Mmut^tm1Pai (involves: 129S1/Sv * C57BL/6)	increased circulating carnitine level	J:87081
Mmut^tm1Pai/Mmut^tm1Pai (involves: 129S1/Sv * C57BL/6)	methylmalonic aciduria	J:87081
Mmut^tm1Pai/Mmut^tm1Pai Tg(MUT)AHlps/0 Tg(MUTR403X)#Hlps/0 (involves: 129S1/Sv C57BL/6)	abnormal homeostasis	J:191879
	acidosis	J:191879
	increased circulating carnitine level	J:191879
	methylmalonic aciduria	J:191879
Mmut^tm1Pai/Mmut^tm1Pai Tg(MUTR403X)#Hlps/0 (involves: 129S1/Sv C57BL/6)	abnormal homeostasis	J:191879
	acidosis	J:191879
	increased circulating carnitine level	J:191879
	methylmalonic aciduria	J:191879
Mn1^tm1Ecz/Mn1^tm1Ecz (FVB.129-Mn1^tm1Ecz)	cyanosis	J:98889
Mob1a^tm1.1Asuz/Mob1a^tm1.1Asuz Mob1b^{Gt(CC0690)Wtsi}/Mob1b^{Gt(CC0690)Wtsi} Speer6-ps1^{Tg(Alb-cre)21Mgn}/Speer6-ps1⁺ (B6.Cg-Mob1b^{Gt(CC0690)Wtsi} Mob1a^tm1.1Asuz Speer6-ps1^{Tg(Alb-cre)21Mgn})	increased circulating bilirubin level	J:228499
Mobq1^129P3/J/Mobq1^129P3/J (involves: 129P3/J * C57BL/10SnJ)	decreased circulating cholesterol level	J:24238
Mobq1^BALB/cJ/Mobq1^BALB/cJ (involves: BALB/cJ * C57BL/10SnJ)	decreased circulating cholesterol level	J:24238
Mobq1^C57BL/6J/Mobq1^SPRET/EiJ (involves: C57BL/6J * SPRET/Ei)	decreased body temperature	J:88297
	increased circulating cholesterol level	J:88297
Mobq5^CAST/EiJ/Mobq5^CAST/EiJ (B6.CAST-Mobq5^CAST/EiJ)	abnormal glucose homeostasis	J:116503
	decreased circulating cholesterol level	J:116503
	decreased circulating free fatty acids level	J:116503
	decreased circulating glucose level	J:116503
	decreased circulating triglyceride level	J:116503
Mobq6^CAST/EiJ/Mobq6^CAST/EiJ (B6.CAST-Mobq6^CAST/EiJ)	decreased susceptibility to diet-induced obesity	J:116503
Mocos^em2(IMPC)Ics/Mocos⁺ (C57BL/6N-Mocos^em2(IMPC)Ics/Ics)	increased circulating cholesterol level	J:211773
Mocos^em2(IMPC)Ics/Mocos⁺ (C57BL/6N-Mocos^em2(IMPC)Ics/Ics)	increased circulating HDL cholesterol level	J:211773
Mocos^em2(IMPC)Ics/Mocos^em2(IMPC)Ics (involves: C57BL/6N)	colorless urine	J:336718
	decreased blood uric acid level	J:336718
	decreased circulating alanine transaminase level	J:336718
	decreased urine pH	J:336718
	increased blood urea nitrogen level	J:336718
	increased circulating alkaline phosphatase level	J:336718
	increased circulating creatinine level	J:336718
	increased circulating hypoxanthine level	J:336718
	increased circulating xanthine level	J:336718
	increased urine hypoxanthine level	J:336718
	increased urine xanthine level	J:336718
Mocs1^tm1Jre/Mocs1^tm1Jre (involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)	abnormal urine homeostasis	J:80807
	aminoaciduria	J:80807
	cystinuria	J:80807
	decreased urine uric acid level	J:80807
	increased urine xanthine level	J:80807
	taurinuria	J:80807
Mocs2^{tm1(KOMP)Vlcg}/Mocs2^{tm1(KOMP)Vlcg} (involves: C57BL/6NTac)	abnormal blood homeostasis	J:242197
	cystinuria	J:242197
	decreased blood uric acid level	J:242197
	decreased urine uric acid level	J:242197
	erythrocyturia	J:242197
	hemoglobinuria	J:242197
	increased circulating creatinine level	J:242197
	increased urine hypoxanthine level	J:242197
	increased urine protein level	J:242197
	increased urine xanthine level	J:242197
Mocs2^{tm1b(EUCOMM)Wtsi}/Mocs2⁺ (C57BL/6N-Mocs2^{tm1b(EUCOMM)Wtsi}/Ieg)	decreased circulating sodium level	J:211773
	increased fasting circulating glucose level	J:211773
Mogat2^tm1.1Ryyo/Mogat2^tm1.1Ryyo (B6.Cg-Mogat2^tm1.1Ryyo)	decreased circulating triglyceride level	J:155626
Mogat2^tm1Far/Mogat2⁺ (B6.129S4-Mogat2^tm1Far)	decreased susceptibility to diet-induced obesity	J:149373
Mogat2^tm1Far/Mogat2^tm1Far (B6.129S4-Mogat2^tm1Far)	abnormal intestinal lipid absorption	J:149373
	decreased circulating cholesterol level	J:149373
	decreased circulating insulin level	J:149373
	decreased circulating LDL cholesterol level	J:149373
	decreased circulating triglyceride level	J:149373
	decreased circulating VLDL cholesterol level	J:149373
	decreased susceptibility to diet-induced obesity	J:149373
	decreased susceptibility to hyperlipidemia	J:149373
	improved glucose tolerance	J:149373
	increased body temperature	J:149373
	increased oxygen consumption	J:149373
Mon1a^em1(IMPC)J/Mon1a^em1(IMPC)J (C57BL/6NJ-Mon1a^em1(IMPC)J/J)	decreased fasting circulating glucose level	J:211773
Morc2a^{em1(IMPC)Wtsi}/Morc2a⁺ (C57BL/6N-Morc2a^{em1(IMPC)Wtsi}/WtsiOulu)	decreased circulating HDL cholesterol level	J:211773
Morc2a^{em1(IMPC)Wtsi}/Morc2a^{em1(IMPC)Wtsi} (C57BL/6N-Morc2a^{em1(IMPC)Wtsi}/WtsiOulu)	subcutaneous edema	J:239583
Morc3^{tm1b(EUCOMM)Hmgu}/Morc3⁺ (C57BL/6N-Morc3^{tm1b(EUCOMM)Hmgu}/Ics)	increased circulating alanine transaminase level	J:211773
	increased circulating aspartate transaminase level	J:211773
Morc4^em1(IMPC)Mbp/Morc4^em1(IMPC)Mbp (C57BL/6N-Morc4^em1(IMPC)Mbp/MbpMmucd)	increased circulating creatinine level	J:211773
Morf4l1^tm1Kto/Morf4l1^tm1Kto (involves: 129S7/SvEvBrd)	skin edema	J:97640
Moxd1^{tm2b(KOMP)Wtsi}/Moxd1^{tm2b(KOMP)Wtsi} (C57BL/6N-Moxd1^{tm2b(KOMP)Wtsi}/J)	increased circulating sodium level	J:211773
Mpc1^{tm1c(EUCOMM)Wtsi}/Mpc1^{tm1c(EUCOMM)Wtsi} (involves: C57BL/6J * C57BL/6N)	improved glucose tolerance	J:236662
	increased insulin sensitivity	J:236662
Mpc1^{tm1c(EUCOMM)Wtsi}/Mpc1^{tm1c(EUCOMM)Wtsi} Speer6-ps1^{Tg(Alb-cre)21Mgn}/Speer6-ps1⁺ (involves: C57BL/6 * C57BL/6J * C57BL/6N * DBA)	abnormal gluconeogenesis	J:236662
	decreased circulating cholesterol level	J:236662
	decreased circulating glucose level	J:236662
	decreased circulating triglyceride level	J:236662
	decreased respiratory quotient	J:236662
	improved glucose tolerance	J:236662
	increased circulating ketone body level	J:236662
	increased circulating lactate level	J:236662
	increased fatty acid oxidation	J:236662
	increased triglyceride level	J:236662
Mpc1^{tm1c(EUCOMM)Wtsi}/Mpc1^{tm1c(EUCOMM)Wtsi} Tg(Six3-cre)69Frty/0 (involves: C57BL/6N * DBA/2)	abnormal glucose homeostasis	J:271892
Mpc2^em2Finc/Mpc2^em2Finc (involves: C57BL/6)	decreased circulating insulin level	J:211781
	decreased circulating triglyceride level	J:211781
	decreased insulin secretion	J:211781
	decreased oxygen consumption	J:211781
	impaired glucose tolerance	J:211781
	increased circulating glucose level	J:211781
	increased circulating ketone body level	J:211781
	increased circulating lactate level	J:211781
mpc96H/mpc96H (involves: BALB/c * C3H/HeH * C57BL/6J)	decreased circulating HDL cholesterol level	J:234901
mpc96H/mpc96H (involves: BALB/c * C3H/HeH * C57BL/6J)	decreased circulating LDL cholesterol level	J:234901
mpc107H/mpc107H (involves: BALB/c * C3H/HeH * C57BL/6J)	increased blood urea nitrogen level	J:234901
mpc107H/mpc107H (involves: BALB/c * C3H/HeH * C57BL/6J)	increased circulating creatinine level	J:234901
mpc131H/mpc131H (involves: BALB/c * C3H/HeH * C57BL/6J)	decreased circulating phosphate level	J:234901
	decreased circulating serum albumin level	J:234901
	increased circulating alanine transaminase level	J:234901
	increased circulating alkaline phosphatase level	J:234901
	increased circulating aspartate transaminase level	J:234901
mpc134H/mpc134H (involves: BALB/c * C3H/HeH * C57BL/6J)	increased circulating aspartate transaminase level	J:234901
mpc165H/mpc165H (involves: BALB/c * C3H/HeH * C57BL/6J)	impaired glucose tolerance	J:234901
mpc168H/mpc168H (involves: BALB/c * C3H/HeH * C57BL/6J)	impaired glucose tolerance	J:234901
mpc172H/mpc172H (involves: BALB/c * C3H/HeH * C57BL/6J)	impaired glucose tolerance	J:234901
mpc190H/mpc190H (involves: BALB/c * C3H/HeH * C57BL/6J)	impaired glucose tolerance	J:234901
mpc201H/mpc201H (involves: BALB/c * C3H/HeH * C57BL/6J)	impaired glucose tolerance	J:234901
mpc225H/mpc225H (involves: BALB/c * C3H/HeH * C57BL/6J)	impaired glucose tolerance	J:234901
mpc231H/mpc231H (involves: BALB/c * C3H/HeH * C57BL/6J)	increased fasting circulating glucose level	J:234901
mpc234H/mpc234H (involves: BALB/c * C3H/HeH * C57BL/6J)	increased fasting circulating glucose level	J:234901
mpc256H/mpc256H (involves: BALB/c * C3H/HeH * C57BL/6J)	increased blood urea nitrogen level	J:234901
mpc256H/mpc256H (involves: BALB/c * C3H/HeH * C57BL/6J)	increased circulating creatinine level	J:234901
mpc282H/mpc282H (involves: BALB/c * C3H/HeH * C57BL/6J)	impaired glucose tolerance	J:234901
mpc282H/mpc282H (involves: BALB/c * C3H/HeH * C57BL/6J)	increased urine glucose level	J:234901
mpc285H/mpc285H (involves: BALB/c * C3H/HeH * C57BL/6J)	impaired glucose tolerance	J:234901
mpc286H/mpc286H (involves: BALB/c * C3H/HeH * C57BL/6J)	impaired glucose tolerance	J:234901
mpc291H/mpc291H (involves: BALB/c * C3H/HeH * C57BL/6J)	impaired glucose tolerance	J:234901
mpc312H/mpc312H (involves: BALB/c * C3H/HeH * C57BL/6J)	impaired glucose tolerance	J:234901
Mpdz^em1(IMPC)J/Mpdz^em1(IMPC)J (C57BL/6NJ-Mpdz^em1(IMPC)J/J)	improved glucose tolerance	J:211773
	increased circulating potassium level	J:211773
Mpg^{tm1a(EUCOMM)Wtsi}/Mpg^{tm1a(EUCOMM)Wtsi} (C57BL/6N-Mpg^{tm1a(EUCOMM)Wtsi}/Wtsi)	increased circulating alkaline phosphatase level	J:211773
Mpg^tm1Lds/Mpg^tm1Lds (involves: 129P2/OlaHsd * C57BL/6)	increased circulating glucose level	J:118148
Mpg^tm1Rhe/Mpg^tm1Rhe (involves: 129P2/OlaHsd * C57BL/6J)	enhanced lipolysis	J:70603
Mpg^tm1Rhe/Mpg^tm1Rhe (involves: 129P2/OlaHsd * C57BL/6J)	increased circulating glucose level	J:70603
Mphosph9^{tm1e.1(EUCOMM)Hmgu}/Mphosph9^{tm1e.1(EUCOMM)Hmgu} (C57BL/6N-Mphosph9^{tm1e.1(EUCOMM)Hmgu}/Ieg)	increased circulating amylase level	J:211773
Mpig6b^{tm1.1(KOMP)Vlcg}/Mpig6b^{tm1.1(KOMP)Vlcg} (C57BL/6N-Mpig6b^{tm1.1(KOMP)Vlcg}/Ucd)	decreased circulating phosphate level	J:211773
	increased circulating alkaline phosphatase level	J:211773
Mpig6b^tm1.1Arte/Mpig6b^tm1.1Arte (involves: C57BL/6NTac)	abnormal platelet physiology	J:201266
	decreased platelet aggregation	J:201266
	decreased platelet ATP level	J:201266
	increased bleeding time	J:201266
Mpl^hlb219/Mpl^hlb219 (C57BL/6J-Mpl^hlb219/J)	abnormal circulating cytokine level	J:146577
Mpl^hlb219/Mpl^hlb219 (C57BL/6J-Mpl^hlb219/J)	increased bleeding time	J:146577
Mpl^tm1Wsa/Mpl^tm1Wsa (involves: 129S1/Sv)	abnormal circulating chemokine level	J:162629
Mpp2^{tm1b(KOMP)Wtsi}/Mpp2^{tm1b(KOMP)Wtsi} (C57BL/6N-Mpp2^{tm1b(KOMP)Wtsi}/BayMmucd)	impaired glucose tolerance	J:211773
Mpp3^{tm1b(EUCOMM)Wtsi}/Mpp3^{tm1b(EUCOMM)Wtsi} (C57BL/6N-Mpp3^{tm1b(EUCOMM)Wtsi}/BayMmucd)	decreased circulating glucose level	J:211773
Mprip^em1(IMPC)J/Mprip⁺ (C57BL/6NJ-Mprip^em1(IMPC)J/Mmjax)	increased circulating alkaline phosphatase level	J:211773
Mpst^tm1.1Nori/Mpst^tm1.1Nori (involves: C57BL/6 * C57BL/6JJcl)	increased serotonin level	J:207803
Mpv17/Mpv17 (CFW-Mpv17/J)	abnormal blood homeostasis	J:10661
	albuminuria	J:62419, J:108252
	decreased circulating serum albumin level	J:62419, J:10661
	decreased urine osmolality	J:59102
	increased blood urea nitrogen level	J:10661
	increased circulating alanine transaminase level	J:143355
	increased circulating aspartate transaminase level	J:143355
	increased circulating cholesterol level	J:10661
	increased circulating creatine kinase level	J:143355
	increased circulating creatinine level	J:10661
	increased circulating lactate level	J:143355
	increased urine protein level	J:143355, J:108252, J:10661
	increased urine sodium level	J:59102
Mpv17^em1(IMPC)J/Mpv17^em1(IMPC)J (C57BL/6NJ-Mpv17^em1(IMPC)J/J)	decreased circulating glucose level	J:211773
	increased blood urea nitrogen level	J:211773
Mpv17l^em1Riida/Mpv17l^em1Riida (C57BL/6N-Mpv17l^em1Riida)	improved glucose tolerance	J:319850
Mpz^em1(IMPC)Tcp/Mpz^em1(IMPC)Tcp (C57BL/6NCrl-Mpz^em1(IMPC)Tcp/Tcp)	decreased fasting circulating glucose level	J:211773
Mpzl3^rc/Mpzl3^rc (C57BL/6J-Mpzl3^rc/J)	increased circulating calcium level	J:93038
Mpzl3^tm1Tacz/Mpzl3^tm1Tacz (B6.129P2-Mpzl3^tm1Tacz)	decreased body temperature	J:199257
	decreased circulating cholesterol level	J:199257
	decreased circulating corticosterone level	J:199257
	decreased circulating free fatty acids level	J:199257
	decreased circulating leptin level	J:199257
	decreased circulating phospholipid level	J:199257
	decreased circulating triglyceride level	J:199257
	decreased liver triglyceride level	J:199257
	decreased susceptibility to diet-induced obesity	J:199257
	improved glucose tolerance	J:199257
	increased energy expenditure	J:199257
	increased oxygen consumption	J:199257
	increased respiratory quotient	J:199257
Mr1^em1(IMPC)H/Mr1^em1(IMPC)H (C57BL/6NTac-Mr1^em1(IMPC)H/H)	decreased circulating creatinine level	J:211773
	decreased circulating phosphate level	J:211773
Mrap2^tm1.1Maj/Mrap2^tm1.1Maj (either: B6.129-Mrap2^tm1.1Maj or (involves: 129 * 129S6/SvEvTac))	abnormal adrenaline level	J:199365
	abnormal noradrenaline level	J:199365
	increased circulating leptin level	J:199365
Mrap2^{tm1a(EUCOMM)Wtsi}/Mrap2^{tm1a(EUCOMM)Wtsi} (C57BL/6N-Mrap2^{tm1a(EUCOMM)Wtsi}/Wtsi)	impaired glucose tolerance	J:211773
	increased circulating alkaline phosphatase level	J:211773
	increased circulating calcium level	J:211773
	increased circulating insulin level	J:211773
	increased fasting circulating glucose level	J:211773
Mrap^tm1.2Geno/Mrap^tm1.2Geno (involves: C57BL/6)	decreased circulating corticosterone level	J:278935
	decreased liver glycogen level	J:278935
	increased adrenocorticotropin level	J:278935
Mras^em1(IMPC)H/Mras^em1(IMPC)H (C57BL/6NTac-Mras^em1(IMPC)H/H)	increased circulating creatinine level	J:211773
Mrc1^tm1Jub/Mrc1⁺ (involves: 129X1/SvJ * C57BL/6J)	abnormal circulating estrogen level	J:74332
Mrc1^tm1Jub/Mrc1⁺ (involves: 129X1/SvJ * C57BL/6J)	increased circulating luteinizing hormone level	J:74332
Mrgpre^{tm1.1(KOMP)Vlcg}/Mrgpre^{tm1.1(KOMP)Vlcg} (C57BL/6N-Mrgpre^{tm1.1(KOMP)Vlcg}/J)	decreased urine magnesium level	J:211773
Mrln^em1Eno/Mrln^em1Eno (involves: C3H * C57BL/6)	abnormal calcium ion homeostasis	J:217579
Mrm3^{tm1.1(KOMP)Vlcg}/Mrm3⁺ (C57BL/6N-Mrm3^{tm1.1(KOMP)Vlcg}/J)	decreased circulating glucose level	J:211773
Mrpl22^{tm1b(KOMP)Mbp}/Mrpl22⁺ (C57BL/6N-Mrpl22^{tm1b(KOMP)Mbp}/J)	increased fasting circulating glucose level	J:211773
Mrpl51^{tm1.1(KOMP)Vlcg}/Mrpl51⁺ (B6N(Cg)-Mrpl51^{tm1.1(KOMP)Vlcg}/J)	decreased circulating glucose level	J:211773
	increased urine magnesium level	J:211773
Mrps12^em1.2Afi/Mrps12^em1.2Afi (B6N(Cg)-Mrps12^em1.2Afi)	increased cholesterol level	J:284101
Mrps18c^{tm1.1(KOMP)Vlcg}/Mrps18c⁺ (C57BL/6N-Mrps18c^{tm1.1(KOMP)Vlcg}/J)	decreased circulating creatinine level	J:211773
Mrps22^{tm1.1(KOMP)Vlcg}/Mrps22⁺ (C57BL/6N-Mrps22^{tm1.1(KOMP)Vlcg}/J)	decreased circulating creatinine level	J:211773
Mrps25^{tm1.1(KOMP)Vlcg}/Mrps25⁺ (C57BL/6N-Mrps25^{tm1.1(KOMP)Vlcg}/J)	decreased circulating calcium level	J:211773
	decreased circulating glucose level	J:211773
	increased circulating sodium level	J:211773
Mrps34^m1Anu/Mrps34^m1Anu (C57BL/6J-Mrps34^m1Anu)	decreased oxygen consumption	J:222643
Mrps34^m1Anu/Mrps34^m1Anu (C57BL/6J-Mrps34^m1Anu)	increased circulating alanine transaminase level	J:222643
Mrps35^{tm1a(EUCOMM)Wtsi}/Mrps35⁺ (C57BL/6N-Mrps35^{tm1a(EUCOMM)Wtsi}/Ics)	increased circulating creatinine level	J:165965
Mrs2^em1Muma/Mrs2^em1Muma (B6.Cg-Mrs2^em1Muma)	abnormal blood homeostasis	J:298361
Mrtfa^tm1Swm/Mrtfa^tm1Swm (involves: 129/Sv * C57BL/6)	pericardial edema	J:111560
Mrtfb^{Gt(RRJ478)Byg}/Mrtfb^{Gt(RRJ478)Byg} (involves: 129P2/OlaHsd)	edema	J:160964
Mrtfb^tm1Eno/Mrtfb^tm1Eno (involves: 129S/SvEv * C57BL/6)	pericardial edema	J:102475
Ms4a4d^em1(IMPC)J/Ms4a4d^em1(IMPC)J (C57BL/6NJ-Ms4a4d^em1(IMPC)J/Mmjax)	increased circulating cholesterol level	J:211773
	increased circulating HDL cholesterol level	J:211773
	increased circulating phosphate level	J:211773
Ms4a12^em1(IMPC)Mbp/Ms4a12^em1(IMPC)Mbp (C57BL/6N-Ms4a12^em1(IMPC)Mbp/Ucd)	increased circulating alanine transaminase level	J:211773
Msh5^{tm1b(EUCOMM)Wtsi}/Msh5^{tm1b(EUCOMM)Wtsi} (C57BL/6N-Msh5^{tm1b(EUCOMM)Wtsi}/Ieg)	increased circulating unsaturated transferrin level	J:211773
Msi1^tm1Okn/Msi1^tm1Okn (involves: C57BL/6)	dehydration	J:81794
Msi1^tm1Okn/Msi1^tm1Okn (involves: C57BL/6)	edema	J:81794
Msi2^em1(IMPC)Mbp/Msi2^em1(IMPC)Mbp (C57BL/6N-Msi2^em1(IMPC)Mbp/MbpMmucd)	decreased fasting circulating glucose level	J:211773
	increased circulating alkaline phosphatase level	J:211773
	increased circulating triglyceride level	J:211773
Mskt2^C57BL/6J/? (involves: C57BL/6J * DBA/2J)	increased circulating alkaline phosphatase level	J:111262
mslsHubr/mslsHubr (involves: C57BL/6 * FVB/N)	cardiac edema	J:173681
Msmp^em1Jzx/Msmp^em1Jzx (C57BL/6-Msmp^em1Jzx)	decreased circulating alanine transaminase level	J:311042
	decreased circulating interleukin-6 level	J:311042
	decreased circulating tumor necrosis factor level	J:311042
	decreased transforming growth factor beta level	J:311042
Msra^tm1Jmo/Msra^tm1Jmo (involves: 129X1/SvJ * C57BL/6J)	abnormal enzyme/coenzyme level	J:72532
Mss51^{tm1(KOMP)Vlcg}/Mss51^{tm1(KOMP)Vlcg} (involves: C57BL/6NTac)	impaired glucose tolerance	J:280597
	increased circulating insulin level	J:280597
	increased fasting circulating glucose level	J:280597
	increased skeletal muscle glycogen level	J:280597
	insulin resistance	J:280597
Mst1r^{tm2(Mst1r)Sew}/Mst1r^{tm2(Mst1r)Sew} (FVB.129P2(Cg)-Mst1r^{tm2(Mst1r*)Sew})	increased circulating alanine transaminase level	J:215969
	increased circulating interferon-gamma level	J:215969
Mstn^lean/Mstn^lean (C57BL/6J-Mstn^lean)	abnormal circulating tumor necrosis factor level	J:146513
	abnormal gluconeogenesis	J:146513
	abnormal glucose homeostasis	J:146513
	decreased adiponectin level	J:146513
	decreased circulating cholesterol level	J:146513
	decreased circulating glucose level	J:146513
	decreased circulating insulin level	J:146513
	decreased circulating leptin level	J:146513
	decreased circulating triglyceride level	J:146513
	decreased circulating tumor necrosis factor level	J:146513
	improved glucose tolerance	J:146513
	increased insulin sensitivity	J:146513
	insulin resistance	J:146513
Mstn^tm1.1Mgs/Mstn^tm1.1Mgs (involves: 129S1/Sv * 129X1/SvJ * C57BL * FVB/N)	abnormal enzyme/coenzyme level	J:184622
Mstn^tm1Sjl/Mstn⁺ (B6N.129-Mstn^tm1Sjl)	abnormal hormone level	J:240862
Mstn^tm1Sjl/Mstn^tm1Sjl (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	abnormal lipid level	J:75178
	decreased circulating leptin level	J:75178
Mstn^tm1Sjl/Mstn^tm1Sjl (B6N.129-Mstn^tm1Sjl)	abnormal hormone level	J:240862
Mstn^tm3.1Sjl/Mstn^tm3.1Sjl Tg(CDX2-cre)101Erf/0 (B6.Cg-Mstn^tm3.1Sjl Tg(CDX2-cre)101Erf/Sjl)	abnormal hormone level	J:240862
Msto1^em1(IMPC)Tcp/Msto1⁺ (C57BL/6N-Msto1^em1(IMPC)Tcp/Tcp)	increased circulating triglyceride level	J:211773
Msx1^{tm1b(KOMP)Wtsi}/Msx1⁺ (C57BL/6N-Msx1^{tm1b(KOMP)Wtsi}/J)	increased circulating free fatty acids level	J:211773
Msx1^{tm1b(KOMP)Wtsi}/Msx1^{tm1b(KOMP)Wtsi} (C57BL/6N-Msx1^{tm1b(KOMP)Wtsi}/J)	cyanosis	J:211773
Msx1^tm1Bero/Msx1^tm1Bero (B6.129P2-Msx1^tm1Bero)	cyanosis	J:42035
Msx1^tm1Rilm/Msx1^tm1Rilm (either: (involves: 129S4/SvJae-Msx1^tm1Rilm) or (involves: 129S4/SvJae * BALB/c) or (involves: 129X1/SvJae * C57BL/6J))	cyanosis	J:17489
Mt1^tm1Bri/Mt1^tm1Bri Mt2^tm1Bri/Mt2^tm1Bri (129S7/SvEvBrd-Mt1^tm1Bri Mt2^tm1Bri)	abnormal circulating enzyme level	J:16487
	increased circulating alkaline phosphatase level	J:16487
Mt1^tm1Bri/Mt1^tm1Bri Mt2^tm1Bri/Mt2^tm1Bri (involves: 129S7/SvEvBrd)	abnormal lipid homeostasis	J:120459
	abnormal liver zinc level	J:34407
	abnormal zinc homeostasis	J:34407
	increased circulating alanine transaminase level	J:120459
Mt1^tm1Bri/Mt1^tm1Bri Mt2^tm1Bri/Mt2^tm1Bri (129S7/SvEvBrd-Mt1^tm1Bri Mt2^tm1Bri/J)	abnormal zinc homeostasis	J:89429
	increased blood urea nitrogen level	J:126620
	increased urine glucose level	J:126620
Mt1^tm1Bri/Mt1^tm1Bri Mt2^tm1Bri/Mt2^tm1Bri (involves: 129S7/SvEvBrd * CD-1)	abnormal zinc homeostasis	J:103039
Mt1^tm1Rch/Mt1^tm1Rch Mt2^tm1Rch/Mt2^tm1Rch (involves: 129P2/OlaHsd * C57BL/6J)	abnormal ion homeostasis	J:14416
	abnormal lipid homeostasis	J:120459
	increased circulating alanine transaminase level	J:120459
Mt3^tm1Rpa/Mt3^tm1Rpa (involves: 129S7/SvEvBrd * C57BL/6)	abnormal mineral level	J:38222
mt-Co1^m1Jiha (B6.Cg-mt-Co1^m1Jiha)	increased circulating lactate level	J:132960
mt-Co1^m1Jiha (involves: C57BL/6J * M. m. domesticus)	edema	J:132659
mt-Nd6^m2Jiha (involves: C3H/An * C57BL/6 * C57BL/6J * CBA)	abnormal circulating protein level	J:164405
mt-Nd6^m2Jiha (involves: C3H/An * C57BL/6 * C57BL/6J * CBA)	lactic acidosis	J:164405
mt-Tl1^m1Jiha (involves: C57BL/6NCrlj * CBA/JNCrlj)	abnormal glucose homeostasis	J:344247
	decreased blood urea nitrogen level	J:344247
	impaired glucose tolerance	J:344247
	increased circulating alanine transaminase level	J:344247
	increased circulating glucose level	J:344247
	increased circulating insulin level	J:344247
	increased circulating lactate level	J:344247
	increased circulating triglyceride level	J:344247
	insulin resistance	J:344247
Mta1^{tm1a(EUCOMM)Wtsi}/Mta1⁺ (129S/SvEvBrd-Mta1^{tm1a(EUCOMM)Wtsi}/WtsiH)	increased circulating triglyceride level	J:175295
Mta1^{tm1a(EUCOMM)Wtsi}/Mta1^{tm1a(EUCOMM)Wtsi} (129S/SvEvBrd-Mta1^{tm1a(EUCOMM)Wtsi}/WtsiH)	decreased circulating LDL cholesterol level	J:175295
Mta2^tm1.1Yzha/Mta2^tm1.1Yzha (involves: 129S4/SvJae * C57BL/6 * FVB/N)	increased circulating alanine transaminase level	J:137101
	increased circulating interferon-gamma level	J:137101
	increased circulating interleukin-2 level	J:137101
	increased circulating interleukin-4 level	J:137101
	increased urine protein level	J:137101
Mta3^{tm3a(KOMP)Wtsi}/Mta3^{tm3a(KOMP)Wtsi} (Not Specified)	decreased circulating cholesterol level	J:165965
	decreased circulating LDL cholesterol level	J:165965
	increased circulating alkaline phosphatase level	J:165965
Mtarc1^em1(IMPC)H/Mtarc1^em1(IMPC)H (C57BL/6NTac-Mtarc1^em1(IMPC)H/H)	increased blood urea nitrogen level	J:211773
	increased circulating creatinine level	J:211773
	increased circulating phosphate level	J:211773
Mtf1^{tm1b(KOMP)Wtsi}/Mtf1⁺ (C57BL/6N-Mtf1^{tm1b(KOMP)Wtsi}/J)	decreased circulating glucose level	J:211773
	increased circulating aspartate transaminase level	J:211773
	increased circulating potassium level	J:211773
Mthfd1^Gt(XB175)Byg/Mthfd1⁺ (involves: 129P2/OlaHsd * C57BL/6)	abnormal amino acid level	J:146083
	abnormal enzyme/coenzyme level	J:146083
Mthfd1^tm1.1Rzn/Mthfd1⁺ (involves: 129S1/Sv * 129X1/SvJ * C57BL/6N)	abnormal folic acid level	J:199578
Mthfd1^{tm2b(KOMP)Wtsi}/Mthfd1⁺ (C57BL/6N-Mthfd1^{tm2b(KOMP)Wtsi}/Bay)	decreased circulating serum albumin level	J:211773
Mthfr^tm1Rzn/Mthfr⁺ (involves: 129S1/Sv * 129X1/SvJ * BALB/c)	abnormal lipid homeostasis	J:67779
	increased circulating homocysteine level	J:67779
Mthfr^tm1Rzn/Mthfr⁺ (involves: 129S1/Sv * 129X1/SvJ * BALB/cAnNCrl)	increased circulating homocysteine level	J:150548
Mthfr^tm1Rzn/Mthfr^tm1Rzn (involves: 129S1/Sv * 129X1/SvJ * BALB/c)	abnormal lipid homeostasis	J:67779
	increased circulating homocysteine level	J:67779
Mthfr^tm1Rzn/Mthfr^tm1Rzn (involves: 129S1/Sv * 129X1/SvJ * BALB/cAnNCrl)	increased circulating homocysteine level	J:150548
Mthfr^tm1Rzn/Mthfr^tm1Rzn (involves: 129S1/Sv * 129X1/SvJ)	abnormal blood homeostasis	J:165612
Mthfr^tm1Rzn/Mthfr^tm1Rzn (involves: 129S1/Sv * 129X1/SvJ)	increased circulating homocysteine level	J:165612
Mthfs^{Gt(RRK291)Byg}/Mthfs⁺ (B6.129P2-Mthfs^{Gt(RRK291)Byg})	abnormal folic acid level	J:185874
Mtif3^{tm1b(EUCOMM)Wtsi}/Mtif3⁺ (C57BL/6N-Mtif3^{tm1b(EUCOMM)Wtsi}/Ieg)	decreased circulating phosphate level	J:211773
	increased circulating chloride level	J:211773
Mtln^em1Rlbd/Mtln^em1Rlbd (involves: C57BL/6J * SJL/J)	decreased fatty acid beta-oxidation	J:263464
Mtm1^tm1Itl/Y (B6.Cg-Mtm1^tm1Itl)	decreased susceptibility to diet-induced obesity	J:179741
Mtmr2^{em1(IMPC)Hmgu}/Mtmr2^{em1(IMPC)Hmgu} (C57BL/6NCrl-Mtmr2^{em1(IMPC)Hmgu}/Ieg)	decreased circulating alkaline phosphatase level	J:211773
	increased blood urea nitrogen level	J:211773
Mtmr3^{Gt(OST416539)Lex}/Mtmr3^{Gt(OST416539)Lex} (involves: 129S5/SvEvBrd * C57BL/6J)	impaired glucose tolerance	J:103485
	increased circulating alkaline phosphatase level	J:103485
Mtmr3^{tm1b(EUCOMM)Hmgu}/Mtmr3^{tm1b(EUCOMM)Hmgu} (C57BL/6N-Mtmr3^{tm1b(EUCOMM)Hmgu}/J)	impaired glucose tolerance	J:211773
	increased circulating alkaline phosphatase level	J:211773
	increased circulating potassium level	J:211773
Mtmr14^tm1Ckq/Mtmr14^tm1Ckq (involves: 129S6/SvEvTac * C57BL/6J)	abnormal calcium ion homeostasis	J:267733
Mtnr1b^{tm1.1(KOMP)Vlcg}/Mtnr1b^{tm1.1(KOMP)Vlcg} (C57BL/6N-Mtnr1b^{tm1.1(KOMP)Vlcg}/Ucd)	improved glucose tolerance	J:211773
	increased fasting circulating glucose level	J:211773
Mtor^tm1.1Clyn/Mtor⁺ (involves: BALB/c * C57BL/6J)	decreased circulating insulin-like growth factor I level	J:162945
Mtor^tm1.1Gcon/Mtor^tm1.1Gcon A1cf^{Tg(Myh6-cre/Esr1)1Jmk}/A1cf⁺ (involves: 129S1/Sv 129X1/SvJ * C57BL/6 * FVB/N)	ascites	J:163763
	pleural effusion	J:163763
Mtor^tm1.1Seq/Mtor^tm1.2Seq Tg(Nphs2-cre)1Seq/? (involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * SJL)	abnormal urine homeostasis	J:184667
Mtor^tm1.2Koz/Mtor^tm1.2Koz Tg(ACTA1-cre)79Jme/? (involves: 129S4/SvJae * C57BL/6J * SJL)	abnormal oxygen consumption	J:162918
	decreased circulating glucose level	J:162918
	decreased oxygen consumption	J:162918
	increased skeletal muscle glycogen level	J:162918
Mtor^{tm1a(EUCOMM)Wtsi}/Mtor⁺ (C57BL/6N-Mtor^{tm1a(EUCOMM)Wtsi}/Wtsi)	decreased blood urea nitrogen level	J:175295
	decreased circulating LDL cholesterol level	J:175295
	increased circulating LDL cholesterol level	J:175295
Mtpap^{tm1.1(KOMP)Vlcg}/Mtpap⁺ (C57BL/6N-Mtpap^{tm1.1(KOMP)Vlcg}/Ucd)	decreased circulating creatinine level	J:211773
Mtr^tm1Lcb/Mtr⁺ (129S/SvEv-Mtr^tm1Lcb)	increased circulating homocysteine level	J:67384
Mtr^tm1Lcb/Mtr⁺ (129S/SvEv-Mtr^tm1Lcb)	increased circulating methionine level	J:67384
Mtr^tm1Lcb/Mtr⁺ (involves: 129S/SvEv * Black Swiss)	increased circulating homocysteine level	J:67384
Mtr^tm1Lcb/Mtr⁺ (involves: 129S/SvEv * Black Swiss)	increased circulating methionine level	J:67384
Mtrr^Gt(XG334)Byg/Mtrr^Gt(XG334)Byg (involves: 129P2/OlaHsd * C57BL/6J)	abnormal amino acid level	J:121477
	decreased circulating methionine level	J:121477
	increased circulating homocysteine level	J:121477
Mtrr^Gt(XG334)Byg/Mtrr^Gt(XG334)Byg (B6.129P2-Mtrr^Gt(XG334)Byg)	abnormal amino acid level	J:121477
	abnormal circulating homocysteine level	J:121477
Mtss1^tm1Pla/Mtss1^tm1Pla (Not Specified)	increased circulating alkaline phosphatase level	J:182970
Mtss1^tm1Pla/Mtss1^tm1Pla (Not Specified)	increased urine magnesium level	J:182970
Mtss2^{tm1a(KOMP)Wtsi}/Mtss2^{tm1a(KOMP)Wtsi} (C57BL/6N-tss2^{tm1a(KOMP)Wtsi}/Wtsi)	increased circulating glucose level	J:211773
	increased circulating phosphate level	J:211773
Mttp^tm1Chan/Mttp^tm1Chan (involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)	abnormal circulating cholesterol level	J:53390
	abnormal triglyceride level	J:53390
	decreased circulating HDL cholesterol level	J:53390
	decreased circulating LDL cholesterol level	J:53390
	decreased circulating VLDL cholesterol level	J:53390
	decreased circulating VLDL triglyceride level	J:53390
Mttp^tm1Sgy/Mttp⁺ (involves: 129S4/SvJae)	abnormal circulating cholesterol level	J:48934
	abnormal circulating lipid level	J:48934
	abnormal lipid homeostasis	J:48934
	abnormal lipid level	J:48934
	decreased circulating cholesterol level	J:48934
	decreased circulating LDL cholesterol level	J:48934
	decreased circulating VLDL cholesterol level	J:48934
	increased liver cholesterol level	J:48934
	increased liver triglyceride level	J:48934
Mttp^tm1Sgy/Mttp^tm1Sgy (involves: 129S4/SvJae)	abnormal lipid homeostasis	J:48934
Mttp^tm2Sgy/Mttp^tm2Sgy Tg(Mx1-cre)1Cgn/Tg(Mx1-cre)1Cgn (involves: 129S4/SvJae * C57BL/6 * CBA)	abnormal circulating protein level	J:83459
	decreased circulating cholesterol level	J:83459
	decreased circulating HDL cholesterol level	J:83459
	decreased circulating LDL cholesterol level	J:83459
	decreased circulating triglyceride level	J:83459
	decreased circulating VLDL cholesterol level	J:83459
	increased liver cholesterol level	J:83459
	increased liver triglyceride level	J:83459
Mtx2^em1(IMPC)J/Mtx2⁺ (C57BL/6NJ-Mtx2^em1(IMPC)J/Mmjax)	decreased circulating glucose level	J:211773
Muc1^tm1Gend/Muc1^tm1Gend (involves: FVB)	abnormal intestinal lipid absorption	J:96078
Muc1^tm1Gend/Muc1^tm1Gend (involves: FVB)	decreased intestinal cholesterol absorption	J:96078
Muc2^wnn/Muc2^wnn (C57BL/6-Muc2^wnn)	increased circulating triglyceride level	J:194148
Muc5ac^tm1.1Evns/Muc5ac^tm1.1Evns (B6.129S1-Muc5ac^tm1.1Evns)	increased circulating interferon-gamma level	J:177306
Muc5b^tm1.2Evns/Muc5b^tm1.2Evns (B6.129S1-Muc5b^tm1.2Evns)	hypoxemia	J:207159
Muc5b^tm1.2Evns/Muc5b^tm1.2Evns (B6.129S1-Muc5b^tm1.2Evns)	middle ear effusion	J:207159
Mug1^tm1Vln/Mug1^tm1Vln (B.129P2-Mug1^tm1Vln)	abnormal cytokine level	J:57485
	increased circulating amylase level	J:57485
	increased circulating lipase level	J:57485
Mug1^tm2Vln/Mug1^tm2Vln Pzp^tm1Vln/Pzp^tm1Vln (B.129P2-Pzp^tm1Vln Mug1^tm2Vln)	abnormal cytokine level	J:57485
	increased circulating amylase level	J:57485
	increased circulating lipase level	J:57485
Mupm1^BALB/cJPt/Mupm1^BALB/cJPt (involves: BALB/cJPt * CLA)	abnormal urine enzyme level	J:9292
Mus81^tm1Esse/Mus81^tm1Esse (involves: 129P2/OlaHsd * C57BL/6)	hemopericardium	J:133703
Musk^tm1Gdy/Musk^tm1Gdy (involves: 129P2/OlaHsd * C57BL/6)	cyanosis	J:33132
Mut1293/Mut1293 (involves: 101/H * C3H/HeH)	edema	J:169366
Mvwf2^CASA/RkJ/Mvwf2^CASA/RkJ (involves: A/J * CASA/RkJ)	increased circulating von Willebrand factor level	J:135941
Mvwf2^CASA/RkJ/Mvwf2^CASA/RkJ Mvwf3^CASA/RkJ/Mvwf3^CASA/RkJ (involves: A/J * CASA/RkJ)	increased circulating von Willebrand factor level	J:135941
Mvwf2^CASA/RkJ/Mvwf2^CASA/RkJ Mvwf4^CASA/RkJ/Mvwf4^CASA/RkJ (involves: A/J * CASA/RkJ)	increased circulating von Willebrand factor level	J:135941
Mvwf^CASA/Rk/Mvwf^RIIIS/J (involves: CASA/Rk * RIIIS/J)	decreased circulating von Willebrand factor level	J:37436
Mvwf^RIIIS/J/Mvwf^RIIIS/J (involves: CASA/Rk * RIIIS/J)	decreased circulating von Willebrand factor level	J:37436
Mx2^em1(IMPC)Ics/Mx2^em1(IMPC)Ics (C57BL/6N-Mx2^em1(IMPC)Ics/Ics)	increased circulating bilirubin level	J:211773
Mxd4^em1(IMPC)J/Mxd4^em1(IMPC)J (C57BL/6NJ-Mxd4^em1(IMPC)J/Mmjax)	increased circulating alkaline phosphatase level	J:211773
	increased circulating calcium level	J:211773
Mxra7^{tm1b(EUCOMM)Wtsi}/Mxra7^{tm1b(EUCOMM)Wtsi} (C57BL/6N-Mxra7^{tm1b(EUCOMM)Wtsi}/H)	increased circulating creatine kinase level	J:211773
Mxra8^em1Diam/Mxra8^em1Diam (C57BL/6J-Mxra8^em1Diam)	abnormal cytokine level	J:280585
Mybbp1a^{tm1b(EUCOMM)Hmgu}/Mybbp1a⁺ (C57BL/6N-Mybbp1a^{tm1b(EUCOMM)Hmgu}/Ieg)	increased circulating alkaline phosphatase level	J:211773
	increased circulating sodium level	J:211773
Mybpc3^{tm1a(EUCOMM)Hmgu}/Mybpc3^{tm1a(EUCOMM)Hmgu} (Not Specified)	decreased circulating amylase level	J:165965
	increased circulating chloride level	J:165965
Mybphl^{tm1b(KOMP)Wtsi}/Mybphl^{tm1b(KOMP)Wtsi} (C57BL/6N-Mybphl^{tm1b(KOMP)Wtsi}/Wtsi)	subcutaneous edema	J:239583
Myc^{tm1.1(Nmyc1)Fwa}/Myc^{tm1.1(Nmyc1)Fwa} (involves: 129P2/OlaHsd * C57BL/6)	cyanosis	J:62573
Mycn^tm1Jrt/Mycn^tm1Par (involves: 129S2/SvPas * C57BL/6J)	edema	J:15281
Myd88^tm1Aki/Myd88^tm1Aki (involves: 129P2/OlaHsd)	abnormal cytokine level	J:174941
	abnormal glucose homeostasis	J:124334
	abnormal interferon level	J:137522
	abnormal tumor necrosis factor level	J:103464, J:124334
	decreased circulating tumor necrosis factor level	J:139030
	hyperglycemia	J:148283
Myd88^tm1Aki/Myd88^tm1Aki Ticam1^tm1Aki/Ticam1⁺ (B6.129P2-Myd88^tm1Aki Ticam1^tm1Aki)	decreased macrophage nitric oxide production	J:140485
Myd88^tm1Aki/Myd88^tm1Aki Ticam1^tm1Aki/Ticam1^tm1Aki (B6.129P2-Myd88^tm1Aki Ticam1^tm1Aki)	decreased macrophage nitric oxide production	J:140485
Myd88^tm1Aki/Myd88^tm1Aki Tradd^tm1.1Mpa/Tradd^tm1.1Mpa (involves: 129P2/OlaHsd * BALB/cJ * C57BL/6)	decreased circulating tumor necrosis factor level	J:139030
Myd88^tm1Defr/Myd88^tm1Defr Tg(Itgax-cre)1-1Reiz/0 (B6.Cg-Myd88^tm1Defr Tg(Itgax-cre)1-1Reiz)	decreased circulating interleukin-6 level	J:139001
	decreased circulating interleukin-12b level	J:139001
Myd88^tm1Hlz/Myd88^tm1Hlz (B6.129P2-Myd88^tm1Hlz)	abnormal chemokine level	J:188968
	decreased circulating alanine transaminase level	J:188968
	decreased circulating aspartate transaminase level	J:188968
	decreased circulating interleukin-6 level	J:188968
	decreased circulating interleukin-10 level	J:188968
	decreased circulating interleukin-12b level	J:188968
Myd88^tm1Hlz/Myd88^tm1Hlz Lyz2^tm1(cre)Ifo/Lyz2⁺ (B6.129P2-Myd88^tm1Hlz Lyz2^tm1(cre)Ifo)	abnormal circulating chemokine level	J:188968
	decreased CXCL10 level	J:188968
	increased circulating alanine transaminase level	J:188968
	increased circulating aspartate transaminase level	J:188968
	increased circulating tumor necrosis factor level	J:188968
Myd88^tm1Jcbr/Myd88^tm1Jcbr Tg(Nes-cre)1Kln/0 (B6.Cg-Myd88^tm1Jcbr Tg(Nes-cre)1Kln)	abnormal glucose homeostasis	J:153664
	decreased circulating insulin level	J:153664
	decreased susceptibility to diet-induced obesity	J:153664
	increased energy expenditure	J:153664
	increased insulin sensitivity	J:153664
Myf5^tm3(cre)Sor/Myf5⁺ Sik1^tm1.1Berd/Sik1^tm1.1Berd (involves: 129S4/SvJaeSor * 129S7/SvEvBrd * C57BL/6J * SJL)	abnormal gluconeogenesis	J:236223
	abnormal glucose homeostasis	J:236223
	decreased circulating insulin level	J:236223
	improved glucose tolerance	J:236223
	increased insulin sensitivity	J:236223
Myf5^tm3(cre)Sor/Myf5⁺ Stat5a^tm2Mam/Stat5a^tm2Mam Stat5b^tm1Mam/Stat5b^tm1Mam Tg(Alb1-cre)1Dlr/0 (involves: 129S4/SvJaeSor * 129S6/SvEvTac * FVB/N)	decreased circulating insulin-like growth factor I level	J:119237
Myf5^tm3(cre)Sor/Myf5⁺ Stat5b^tm1Mam/Stat5b^tm1Mam (involves: 129S4/SvJaeSor * 129S6/SvEvTac)	decreased circulating insulin-like growth factor I level	J:119237
	impaired glucose tolerance	J:119237
	increased circulating triglyceride level	J:119237
Myf5^tm3(cre)Sor/Myf5⁺ Stat5b^tm1Mam/Stat5b^tm1Mam Tg(Alb1-cre)1Dlr/0 (involves: 129S4/SvJaeSor * 129S6/SvEvTac * FVB/N)	decreased circulating insulin-like growth factor I level	J:119237
Myg1^tm1Mphi/Myg1^tm1Mphi (involves: 129S6/SvEvTac * C57BL/6)	abnormal corticosterone level	J:154911
Myh1^{tm1b(KOMP)Wtsi}/Myh1^{tm1b(KOMP)Wtsi} (C57BL/6N-Myh1^{tm1b(KOMP)Wtsi}/J)	decreased urine creatinine level	J:211773
	decreased urine glucose level	J:211773
	decreased urine magnesium level	J:211773
Myh6^tm1Jse/Myh6⁺ Tg(Myh6-TNNI3G203S)1Chs/0 (involves: 129X1/SvJ C57BL/6)	abnormal atrial thrombosis	J:153302
Myh6^tm1Jse/Myh6^tm1Jse (involves: 129X1/SvJ * Black Swiss)	abnormal atrial thrombosis	J:51939
Myh7b^{tm1a(KOMP)Wtsi}/Myh7b^{tm1a(KOMP)Wtsi} (C57BL/6N-Myh7b^{tm1a(KOMP)Wtsi}/Wtsi)	decreased circulating cholesterol level	J:211773
Myh8^em1(IMPC)Tcp/Myh8^em1(IMPC)Tcp (C57BL/6N-Myh8^em1(IMPC)Tcp/Tcp)	edema	J:211773
Myh9^{tm1.1(MYH9)Mjk}/Myh9⁺ (B6.Cg-Myh9^{tm1.1(MYH9)Mjk})	albuminuria	J:175367
Myh9^{tm1.1(MYH9)Mjk}/Myh9⁺ (B6.Cg-Myh9^{tm1.1(MYH9)Mjk})	increased bleeding time	J:175367
Myh9^{tm1.1(MYH9)Mjk}/Myh9^{tm1.1(MYH9)Mjk} (B6.129-Myh9^{tm1.1(MYH9*)Mjk})	albuminuria	J:175367
	increased bleeding time	J:175367
Myh9^tm1.1Dash/Myh9⁺ (involves: 129S2/SvPas * C57BL/6 * C57BL/6J * CBA)	albuminuria	J:204923
	hematuria	J:204923
Myh9^tm1.1Gac/Myh9⁺ Tg(Pf4-icre)Q3Rsko/0 (involves: 129 * C57BL/6)	abnormal platelet physiology	J:148233
Myh9^tm1.1Gac/Myh9^tm1.1Gac Tg(NPHS2-cre)295Lbh/0 (involves: 129 * C57BL/6 * SJL)	albuminuria	J:173971
Myh9^tm1.1Gac/Myh9^tm1.1Gac Tg(Pf4-icre)Q3Rsko/0 (involves: 129 * C57BL/6)	abnormal blood coagulation	J:148233
	abnormal platelet physiology	J:148233
	increased bleeding time	J:148233
Myh9^tm5Rsad/Myh9^tm5Rsad Tg(Nphs2-cre)1Seq/0 (involves: 129S1/Sv * 129S6/SvEvTac * 129X1/SvJ)	albuminuria	J:175367
Myh9^{tm6.1(EGFP/MYH9)Rsad}/Myh9⁺ (involves: 129S4/SvJae BALB/cJ * C57BL/6)	abnormal blood coagulation	J:175367
	increased bleeding time	J:175367
Myh9^tm7.1Rsad/Myh9⁺ (involves: BALB/cJ)	albuminuria	J:175367
Myh9^tm7.1Rsad/Myh9⁺ (involves: BALB/cJ)	increased bleeding time	J:175367
Myh9^tm7.1Rsad/Myh9^tm7.1Rsad (involves: BALB/cJ)	albuminuria	J:175367
Myh9^tm7.1Rsad/Myh9^tm7.1Rsad (involves: BALB/cJ)	increased bleeding time	J:175367
Myh10^ehc/Myh10^ehc (involves: 129S5/SvEvBrd * 129S7/SvEvBrd * C57BL/6J)	edema	J:248868
	hemopericardium	J:248868
	pericardial effusion	J:248868
Myh10^em1(IMPC)J/Myh10⁺ (C57BL/6NJ-Myh10^em1(IMPC)J/J)	increased fasting circulating glucose level	J:211773
Myh10^em1(IMPC)J/Myh10^em1(IMPC)J (C57BL/6NJ-Myh10^em1(IMPC)J/J)	edema	J:211773
Myh10^tm3.1Rsad/Myh10^tm3.1Rsad (involves: 129S6/SvEvTac * BALB/c * C57BL/6)	generalized edema	J:245570
Myh10^tm7Rsad/Myh10^tm7Rsad Tg(Myh6-cre)2182Mds/0 (involves: 129S6/SvEvTac * C57BL/6J * FVB/N)	abnormal atrial thrombosis	J:170148
Myh11^tm1Bdr/Myh11^tm1Bdr (Not Specified)	increased circulating renin level	J:82859
Myl1^tm1(cre)Sjb/0 Ndufab1^tm1Xiwa/Ndufab1^tm1Xiwa (involves: 129S1/Sv * 129S4/SvJae * 129X1/SvJ * C57BL/6)	decreased circulating insulin level	J:293657
	decreased liver glycogen level	J:293657
	decreased skeletal muscle glycogen level	J:293657
	hypoglycemia	J:293657
Myl1^tm1(cre)Sjb/Myl1⁺ Smarcd3^tm1Jddl/Smarcd3^tm1Jddl (involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)	impaired glucose tolerance	J:256788
	increased circulating glucose level	J:256788
	insulin resistance	J:256788
Myl2^tm1(cre)Krc/Myl2⁺ Nkx2-5^tm1Krc/Nkx2-5^tm1Krc (either: (involves: 129/Sv * Black Swiss) or (involves: 129/Sv * C57BL/6))	hydrops fetalis	J:89404
Myl2^tm1(cre)Krc/Myl2⁺ Pip5k1c^tm2Csab/Pip5k1c^tm2Csab (Not Specified)	abnormal platelet aggregation	J:196476
	abnormal platelet physiology	J:196476
Myl2^tm1(cre)Krc/Myl2⁺ Tsc1^tm1Djk/Tsc1^tm1Djk (involves: 129S4/SvJae)	abnormal atrial thrombosis	J:96138
Myl2^tm1(cre)Krc/Myl2⁺ Txnrd2^tm1Marc/Txnrd2^tm1.1Marc (involves: 129P2/OlaHsd * C57BL/6)	edema	J:94136
Myl2^{tm1b(EUCOMM)Hmgu}/Myl2⁺ (C57BL/6N-Myl2^{tm1b(EUCOMM)Hmgu}/Ieg)	decreased circulating alkaline phosphatase level	J:211773
Myl4^{tm1a(EUCOMM)Wtsi}/Myl4^{tm1a(EUCOMM)Wtsi} (C57BL/6N-Myl4^{tm1a(EUCOMM)Wtsi}/Ieg)	increased circulating iron level	J:165965
Myl7^tm1(cre)Krc/Myl7^tm1(cre)Krc (involves: 129S1/Sv * 129X1/SvJ * Black Swiss)	pericardial edema	J:87043
Myl12b^{tm1a(EUCOMM)Wtsi}/Myl12b^{tm1a(EUCOMM)Wtsi} (B6JTyr;B6N-Myl12b^{tm1a(EUCOMM)Wtsi}/Wtsi)	decreased circulating potassium level	J:175295
	decreased circulating total protein level	J:175295
	increased blood urea nitrogen level	J:175295
	increased circulating chloride level	J:175295
	increased circulating sodium level	J:175295
Mylip^{tm1.1(KOMP)Vlcg}/Mylip^{tm1.1(KOMP)Vlcg} (C57BL/6N-Mylip^{tm1.1(KOMP)Vlcg}/J)	increased circulating alkaline phosphatase level	J:211773
Mymx^em1Shcs/Mymx^em1Shcs (involves: C57BL/6J)	cyanosis	J:241564
Mymx^em1Shcs/Mymx^em1Shcs (involves: C57BL/6J)	nuchal edema	J:241564
Mynn^em1(IMPC)J/Mynn^em1(IMPC)J (C57BL/6NJ-Mynn^em1(IMPC)J/Mmjax)	decreased circulating calcium level	J:211773
Myo1e^{Gt(ROSA)74Sor}/Myo1e^{Gt(ROSA)74Sor} Pdgfrb^tm1Sor/Pdgfrb⁺ (involves: 129S4/SvJaeSor * 129S7/SvEvBrd)	increased blood urea nitrogen level	J:117491
Myo1e^tm1.1Flv/Myo1e^tm1.1Flv (involves: 129S6/SvEvTac)	abnormal urine homeostasis	J:159163
	albuminuria	J:159163
	hematuria	J:159163
	hemoglobinuria	J:159163
	increased blood urea nitrogen level	J:159163
	increased urine protein level	J:159163
	leukocyturia	J:159163
Myo1e^tm1.1Flv/Myo1e^tm1.1Flv (B6.129S6-Myo1e^tm1.1Flv)	albuminuria	J:188500
Myo1e^tm1Flv/Myo1e^tm1.1Flv Tg(NPHS2-cre)295Lbh/0 (involves: 129S6/SvEvTac * C57BL/6 * SJL)	albuminuria	J:188500
Myo1e^tm1Flv/Myo1e^tm1Flv Tg(NPHS2-cre)295Lbh/0 (involves: 129S6/SvEvTac * C57BL/6 * SJL)	albuminuria	J:188500
Myo1g^{em1(IMPC)Ccpcz}/Myo1g^{em1(IMPC)Ccpcz} (C57BL/6NCrl-Myo1g^{em1(IMPC)Ccpcz}/Ccpcz)	decreased circulating potassium level	J:211773
Myo1h^{tm1b(KOMP)Wtsi}/Myo1h⁺ (C57BL/6N-Myo1h^{tm1b(KOMP)Wtsi}/J)	decreased urine magnesium level	J:211773
Myo3a^{tm1b(KOMP)Wtsi}/Myo3a^{tm1b(KOMP)Wtsi} (C57BL/6N-Myo3a^{tm1b(KOMP)Wtsi}/J)	impaired glucose tolerance	J:211773
Myo5b^tm1.1Cle/Myo5b^tm1.1Cle Tg(Vil1-cre/ERT2)23Syr/0 (involves: 129P2/OlaHsd * 129S4/SvJaeSor * C57BL/6 * DBA/2)	dehydration	J:227079
Myo5b^{tm1a(KOMP)Wtsi}/Myo5b^{tm1a(KOMP)Wtsi} (C57BL/6N-Myo5b^{tm1a(KOMP)Wtsi})	hypoglycemia	J:229427
Myo6^em1(IMPC)Tcp/Myo6^em1(IMPC)Tcp (C57BL/6N-Myo6^em1(IMPC)Tcp/Tcp)	decreased circulating potassium level	J:211773
	increased circulating alkaline phosphatase level	J:211773
	increased circulating phosphate level	J:211773
Myo7a^{tm1a(EUCOMM)Wtsi}/Myo7a^{tm1a(EUCOMM)Wtsi} (C57BL/6N-Myo7a^{tm1a(EUCOMM)Wtsi}/Wtsi)	increased blood urea nitrogen level	J:211773
	increased circulating sodium level	J:211773
Myo7b^{tm1b(EUCOMM)Hmgu}/Myo7b^{tm1b(EUCOMM)Hmgu} (C57BL/6N-Myo7b^{tm1b(EUCOMM)Hmgu}/J)	decreased circulating glucose level	J:211773
	increased circulating chloride level	J:211773
	increased circulating sodium level	J:211773
Myo9a^em1Atuf/Myo9a⁺ (C57BL/6J-Myo9a^em1Atuf)	albuminuria	J:302901
Myo9a^em1Atuf/Myo9a^em1Atuf (C57BL/6J-Myo9a^em1Atuf)	albuminuria	J:302901
Myo9a^em1Atuf/Myo9a^em1Atuf (C57BL/6J-Myo9a^em1Atuf)	increased urine protein level	J:302901
Myo9a^{tm1b(EUCOMM)Wtsi}/Myo9a^{tm1b(EUCOMM)Wtsi} (C57BL/6N-Myo9a^{tm1b(EUCOMM)Wtsi}/Wtsi)	subcutaneous edema	J:239583
Myo10^{tm2(KOMP)Wtsi}/Myo10^{tm2(KOMP)Wtsi} (C57BL/6N-Myo10^{tm2(KOMP)Wtsi}/Wtsi)	decreased circulating creatinine level	J:211773
Myo18b^em2(IMPC)Ics/Myo18b⁺ (C57BL/6N-Myo18b^em2(IMPC)Ics/Ics)	increased circulating triglyceride level	J:211773
Myo18b^tm1Jyo/Myo18b^tm1Jyo (involves: C57BL/6J)	pericardial effusion	J:142442
Myocd^tm1(cre)Dzw/Myocd^tm1(cre)Dzw (involves: 129 * C57BL/6)	cardiac edema	J:217513
Myocd^tm1Eno/Myocd^tm1Eno (involves: 129S/SvEv * C57BL/6)	pericardial effusion	J:84789
Myocd^tm1Msp/Myocd^tm1Msp A1cf^{Tg(Myh6-cre/Esr1)1Jmk}/A1cf⁺ (involves: 129/Sv C57BL/6J * FVB/N)	pericardial effusion	J:154666
Myocd^tm1Msp/Myocd^tm1Msp H2az2^{Tg(Wnt1-cre)11Rth}/H2az2⁺ (involves: 129/Sv * C57BL/6 * CBA)	cyanosis	J:131288
Myocd^tm1Msp/Myocd^tm1Msp Tg(Myh6-cre)2182Mds/0 (involves: 129/Sv * FVB/N)	abnormal atrial thrombosis	J:154666
	abnormal cardiac thrombosis	J:154666
	pericardial effusion	J:154666
Myog^tm1Whk/Myog^tm1Whk (involves: 129S7/SvEvBrd * C57BL/6J)	cyanosis	J:14208
Myog^tm1Whk/Myog^tm1Whk (involves: 129S7/SvEvBrd)	cyanosis	J:110733
Myog^tm1Whk/Myog^tm2Whk (involves: 129S7/SvEvBrd * C57BL/6)	edema	J:54065
Myog^tm2Whk/Myog^tm2Whk (involves: 129S7/SvEvBrd * C57BL/6)	edema	J:54065
Myorg^{tm1b(KOMP)Wtsi}/Myorg^{tm1b(KOMP)Wtsi} (B6N(Cg)-Myorg^{tm1b(KOMP)Wtsi}/2J)	decreased circulating glucose level	J:211773
Myoz1^{tm1b(EUCOMM)Hmgu}/Myoz1^{tm1b(EUCOMM)Hmgu} (C57BL/6N-Myoz1^{tm1b(EUCOMM)Hmgu}/Ieg)	decreased circulating creatinine level	J:211773
Myrip^tm1Tiz/Myrip^tm1Tiz (involves: C57BL/6 * C57BL/6NCrlj * CBA/JNCrlj)	decreased insulin secretion	J:258210
	impaired glucose tolerance	J:258210
Mysm1^{tm1a(KOMP)Wtsi}/Mysm1⁺ (Not Specified)	decreased circulating triglyceride level	J:165965
Mysm1^{tm1a(KOMP)Wtsi}/Mysm1^{tm1a(KOMP)Wtsi} (Not Specified)	decreased circulating cholesterol level	J:165965
	decreased circulating triglyceride level	J:165965
	increased circulating alkaline phosphatase level	J:165965
	increased circulating phosphate level	J:165965
Myt1^tm1Ggu/Myt1^tm1.1Ggu Tg(Pdx1-cre)89.1Dam/? (involves: 129 * C57BL/6 * CBA * CD-1 * SJL)	decreased insulin secretion	J:127471
	impaired glucose tolerance	J:127471
Myt1l^{tm1a(EUCOMM)Wtsi}/Myt1l^{tm1a(EUCOMM)Wtsi} (C57BL/6N-Myt1l^{tm1a(EUCOMM)Wtsi}/Wtsi)	increased circulating fructosamine level	J:211773
Myzap^em1(IMPC)J/Myzap^em1(IMPC)J (C57BL/6NJ-Myzap^em1(IMPC)J/Mmjax)	decreased circulating cholesterol level	J:211773
	decreased circulating HDL cholesterol level	J:211773
	decreased circulating serum albumin level	J:211773
	decreased circulating total protein level	J:211773
Mzb1^{em1(IMPC)Ccpcz}/Mzb1^{em1(IMPC)Ccpcz} (C57BL/6N-Mzb1^{em1(IMPC)Ccpcz}/Ccpcz)	decreased circulating iron level	J:211773
N4bp1^tm1.2Vmd/N4bp1^tm1.2Vmd (involves: C57BL/6)	decreased body temperature	J:297419
	increased circulating interleukin-6 level	J:297419
	increased circulating tumor necrosis factor level	J:297419
Naa10^em1(IMPC)Mbp/Naa10^em1(IMPC)Mbp (C57BL/6NCrl-Naa10^em1(IMPC)Mbp/Mmucd)	decreased circulating bilirubin level	J:211773
	improved glucose tolerance	J:211773
	increased circulating alkaline phosphatase level	J:211773
Naa35^em1(IMPC)J/Naa35⁺ (C57BL/6NJ-Naa35^em1(IMPC)J/Mmjax)	increased circulating phosphate level	J:211773
Naa40^tm1Qwzh/Naa40^tm1Qwzh Speer6-ps1^{Tg(Alb-cre)21Mgn}/Speer6-ps1⁺ (B6.Cg-Speer6-ps1^{Tg(Alb-cre)21Mgn} Naa40^tm1Qwzh)	abnormal lipid homeostasis	J:183119
	decreased circulating LDL cholesterol level	J:183119
	decreased circulating VLDL triglyceride level	J:183119
	decreased liver free fatty acids level	J:183119
	decreased liver triglyceride level	J:183119
	decreased respiratory quotient	J:183119
	improved glucose tolerance	J:183119
	increased circulating glucose level	J:183119
	increased energy expenditure	J:183119
	increased fatty acid oxidation	J:183119
	increased oxygen consumption	J:183119
Naa50^em1(IMPC)Mbp/Naa50⁺ (C57BL/6N-Naa50^em1(IMPC)Mbp/Ucd)	edema	J:211773
Naaa^{tm1a(KOMP)Wtsi}/Naaa^{tm1a(KOMP)Wtsi} (C57BL/6N-Naaa^{tm1a(KOMP)Wtsi}/Wtsi)	increased circulating iron level	J:211773
Nab1^em1(IMPC)H/Nab1^em1(IMPC)H (C57BL/6NTac-Nab1^em1(IMPC)H/H)	increased circulating cholesterol level	J:211773
	increased circulating HDL cholesterol level	J:211773
Nab2^{tm1b(EUCOMM)Hmgu}/Nab2^{tm1b(EUCOMM)Hmgu} (C57BL/6N-Nab2^{tm1b(EUCOMM)Hmgu}/Ics)	decreased circulating cholesterol level	J:211773
	decreased circulating HDL cholesterol level	J:211773
Nabp2^{tm1b(KOMP)Wtsi}/Nabp2^{tm1b(KOMP)Wtsi} (C57BL/6N-Nabp2^{tm1b(KOMP)Wtsi}/Ucd)	edema	J:211773
Naca^tm1Dsr/Naca^tm1Dsr (129S6/SvEvTac-Naca^tm1Dsr)	hemopericardium	J:167169
Naca^tm1Dsr/Naca^tm1Dsr (129S6/SvEvTac-Naca^tm1Dsr)	pericardial edema	J:167169
Nacad^{tm1(KOMP)Wtsi}/Nacad^{tm1(KOMP)Wtsi} (C57BL/6N-Nacad^{tm1(KOMP)Wtsi}/Wtsi)	decreased circulating glucose level	J:211773
	increased circulating insulin level	J:211773
	increased circulating sodium level	J:211773
Nacc1^{em1(IMPC)Hmgu}/Nacc1^{em1(IMPC)Hmgu} (C57BL/6N-Nacc1^{em1(IMPC)Hmgu}/Ieg)	impaired glucose tolerance	J:211773
Nacc2^{tm2b(EUCOMM)Wtsi}/Nacc2^{tm2b(EUCOMM)Wtsi} (C57BL/6N-Nacc2^{tm2b(EUCOMM)Wtsi}/Wtsi)	increased circulating alkaline phosphatase level	J:211773
Nadk2^em1(IMPC)J/Nadk2⁺ (C57BL/6NJ-Nadk2^em1(IMPC)J/J)	decreased fasting circulating glucose level	J:211773
Nadk2^{tm1a(EUCOMM)Wtsi}/Nadk2^{tm1a(EUCOMM)Wtsi} (involves: C57BL/6N * C57BL/6NTac)	decreased energy expenditure	J:255700
	decreased fatty acid oxidation	J:255700
	increased circulating carnitine level	J:255700
	increased circulating free fatty acids level	J:255700
	increased circulating lysine level	J:255700
	increased circulating triglyceride level	J:255700
	increased liver triglyceride level	J:255700
	increased lysine level	J:255700
	increased respiratory quotient	J:255700
Nae1^{tm1b(EUCOMM)Wtsi}/Nae1⁺ (C57BL/6N-Nae1^{tm1b(EUCOMM)Wtsi}/Ics)	increased circulating phosphate level	J:211773
	increased fasting circulating glucose level	J:211773
Nae1^{tm1c(EUCOMM)Wtsi}/Nae1^{tm1c(EUCOMM)Wtsi} Tg(Myh6-cre)2182Mds/0 (involves: C57BL/6J * C57BL/6N * FVB/N * SJL)	cyanosis	J:261328
	extremity edema	J:261328
Naga^{tm1a(EUCOMM)Wtsi}/Naga^{tm1a(EUCOMM)Wtsi} (C57BL/6N-Naga^{tm1a(EUCOMM)Wtsi}/Wtsi)	increased circulating alkaline phosphatase level	J:211773
Nagk^{tm1b(EUCOMM)Hmgu}/Nagk^{tm1b(EUCOMM)Hmgu} (C57BL/6N-Nagk^{tm1b(EUCOMM)Hmgu}/H)	decreased circulating serum albumin level	J:211773
	decreased circulating total protein level	J:211773
	increased fasting circulating glucose level	J:211773
Nags^{tm1(KOMP)Vlcg}/Nags^{tm1(KOMP)Vlcg} (involves: C57BL/6N * Swiss Webster)	abnormal circulating amino acid level	J:184448
	decreased circulating citrulline level	J:184448
	increased circulating ammonia level	J:184448
Nalcn^em1(IMPC)Mbp/Nalcn⁺ (C57BL/6N-Nalcn^em1(IMPC)Mbp/Ucd)	decreased circulating serum albumin level	J:211773
Nampt^{Gt(RRT307)Byg}/Nampt⁺ (B6.129P2-Nampt^{Gt(RRT307)Byg})	decreased circulating glucose level	J:130534
	decreased insulin secretion	J:130534
	impaired glucose tolerance	J:130534
Nanos2^em1(IMPC)Bay/Nanos2^em1(IMPC)Bay (C57BL/6N-Nanos2^em1(IMPC)Bay/BayMmucd)	increased blood urea nitrogen level	J:211773
Napepld^tm1.2Ueda/Napepld^tm1.2Ueda (B6.129S6-Napepld^tm1.2Ueda)	abnormal lipid homeostasis	J:177598
Nat8f2^{tm1.1(KOMP)Vlcg}/Nat8f2^{tm1.1(KOMP)Vlcg} (C57BL/6N-Nat8f2^{tm1.1(KOMP)Vlcg}/J)	increased fasting circulating glucose level	J:211773
Nat8f5^b2b1702.1Clo/Nat8f5^b2b1702.1Clo (C57BL/6J-Nat8f5^b2b1702.1Clo)	hydrops fetalis	J:175213
Nat8l^tm1.2Meck/Nat8l^tm1.2Meck (involves: 129P2/OlaHsd * C57BL/6)	abnormal enzyme/coenzyme level	J:226682
Nav2^em1(IMPC)Tcp/Nav2^em1(IMPC)Tcp (C57BL/6NCrl-Nav2^em1(IMPC)Tcp/Tcp)	increased circulating aspartate transaminase level	J:211773
Naxe^tm1.1Lfan/Naxe^tm1.1Lfan Tg(APOA1)1Rub/0 (involves: C57BL/6 * C57BL/6J)	increased circulating HDL cholesterol level	J:261549
Nbea^{Gt(RRK418)Byg}/Nbea^{Gt(RRK418)Byg} (involves: 129P2/OlaHsd * C57BL/6N)	cyanosis	J:159572
Nbea^{Tg(GH1)240BNec}/Nbea^{Tg(GH1)240BNec} (involves: C57BL/6 * SJL)	cyanosis	J:128767
Nbeal2^tm1Lex/Nbeal2^tm1Lex (involves: 129S5/SvEvBrd * C57BL/6J)	abnormal platelet activation	J:201413
	decreased platelet aggregation	J:201413
	decreased susceptibility to induced thrombosis	J:201413
	increased bleeding time	J:201413
Nbr1^{tm1b(KOMP)Wtsi}/Nbr1^{tm1b(KOMP)Wtsi} (C57BL/6N-Nbr1^{tm1b(KOMP)Wtsi}/H)	impaired glucose tolerance	J:211773
Ncald^{tm1.1(KOMP)Vlcg}/Ncald^{tm1.1(KOMP)Vlcg} (C57BL/6N-Ncald^{tm1.1(KOMP)Vlcg}/J)	increased blood urea nitrogen level	J:211773
	increased circulating alkaline phosphatase level	J:211773
	increased circulating insulin level	J:211773
	increased circulating sodium level	J:211773
Ncam2^{tm1b(EUCOMM)Hmgu}/Ncam2^{tm1b(EUCOMM)Hmgu} (C57BL/6N-Ncam2^{tm1b(EUCOMM)Hmgu}/Orl)	increased circulating alkaline phosphatase level	J:211773
Ncapd3^em1(IMPC)J/Ncapd3⁺ (C57BL/6NJ-Ncapd3^em1(IMPC)J/Mmjax)	increased circulating aspartate transaminase level	J:211773
	increased circulating cholesterol level	J:211773
	increased circulating HDL cholesterol level	J:211773
	increased circulating phosphate level	J:211773
Ncaph2^{tm1a(EUCOMM)Wtsi}/Ncaph2⁺ (B6JTyr;B6N-Ncaph2^{tm1a(EUCOMM)Wtsi}/Wtsi)	increased circulating amylase level	J:175295
Nceh1^tm1Ishi/Nceh1^tm1Ishi (B6.129S7-Nceh1^tm1Ishi)	abnormal cholesterol homeostasis	J:152385
Ncf1^tm1Shl/Ncf1^tm1Shl (B6.129S2-Ncf1^tm1Shl)	increased circulating renin level	J:111142
Ncf2^{tm1a(EUCOMM)Wtsi}/Ncf2^{tm1a(EUCOMM)Wtsi} (C57BL/6N-Ncf2^{tm1a(EUCOMM)Wtsi}/Wtsi)	decreased circulating thyroxine level	J:211773
	increased circulating iron level	J:211773
Ncf2^{tm1b(EUCOMM)Wtsi}/Ncf2⁺ (NZM2328.B6(Cg)-Ncf2^{tm1b(EUCOMM)Wtsi})	increased urine protein level	J:260777
Ncf2^{tm1b(EUCOMM)Wtsi}/Ncf2^{tm1b(EUCOMM)Wtsi} (NZM2328.B6(Cg)-Ncf2^{tm1b(EUCOMM)Wtsi})	increased urine protein level	J:260777
Ncf4^{tm1b(KOMP)Wtsi}/Ncf4^{tm1b(KOMP)Wtsi} (C57BL/6N-Ncf4^{tm1b(KOMP)Wtsi}/H)	increased circulating amylase level	J:211773
Nck1^{tm1b(EUCOMM)Wtsi}/Nck1^{tm1b(EUCOMM)Wtsi} (C57BL/6N-Nck1^{tm1b(EUCOMM)Wtsi}/Ucd)	increased circulating alanine transaminase level	J:211773
	increased circulating alkaline phosphatase level	J:211773
	increased circulating aspartate transaminase level	J:211773
Nck1^tm1Paw/Nck1^tm1Paw Nck2^tm3Paw/Nck2^tm3Paw Tg(Nphs2-cre)1Seq/0 (involves: 129S1/Sv * 129X1/SvJ)	albuminuria	J:107630
Nckap1l^m1Iri/Nckap1l^m1Iri (involves: C57BL/6)	increased circulating interleukin-6 level	J:141377
Nckap1l^m1Iri/Nckap1l^m1Iri (involves: C57BL/6)	increased circulating interleukin-17 level	J:141377
Ncoa1^{tm1.1(KOMP)Vlcg}/Ncoa1^{tm1.1(KOMP)Vlcg} (C57BL/6N-Ncoa1^{tm1.1(KOMP)Vlcg}/Ucd)	decreased fasting circulating glucose level	J:211773
	increased circulating alkaline phosphatase level	J:211773
Ncoa1^tm1.1Hkaw/Ncoa1^tm1.1Hkaw (B6.Cg-Ncoa1^tm1.1Hkaw)	abnormal urine homeostasis	J:111490
	decreased circulating testosterone level	J:111490
	increased circulating alkaline phosphatase level	J:111490
	increased circulating estradiol level	J:111490
	increased circulating leptin level	J:111490
Ncoa1^tm1Bwo/Ncoa1^tm1Bwo (involves: 129/Sv * C57BL/6)	abnormal thyroid hormone level	J:54182
	increased circulating thyroid-stimulating hormone level	J:54182, J:126521
	increased circulating thyroxine level	J:126521
	increased circulating triiodothyronine level	J:126521
	increased thyroxine level	J:54182
	increased triiodothyronine level	J:54182
Ncoa1^tm1Bwo/Ncoa1^tm1Bwo Thra^tm2Jas/Thra^tm2Jas (B6.129-Thra^tm2Jas Ncoa1^tm1Bwo)	decreased circulating thyroid-stimulating hormone level	J:126521
	increased circulating thyroid-stimulating hormone level	J:126521
	increased circulating thyroxine level	J:126521
	increased circulating triiodothyronine level	J:126521
Ncoa1^tm1Bwo/Ncoa1^tm1Bwo Thrb^tm1Olc/Thrb^tm1Olc (B6.129-Ncoa1^tm1Bwo Thrb^tm1Olc)	increased circulating thyroid-stimulating hormone level	J:126521
	increased circulating thyroxine level	J:126521
	increased circulating triiodothyronine level	J:126521
Ncoa2^em1(IMPC)Mbp/Ncoa2⁺ (C57BL/6N-Ncoa2^em1(IMPC)Mbp/MbpMmucd)	increased circulating insulin level	J:211773
Ncoa3^tm1.1Bwo/Ncoa3^tm1.1Bwo (involves: 129S/SvEv * C57BL/6J)	abnormal glucose homeostasis	J:161276
	abnormal hormone level	J:161276
	decreased adiponectin level	J:161276
	decreased body temperature	J:161276
	decreased carbon dioxide production	J:161276
	decreased circulating glucagon level	J:161276
	decreased oxygen consumption	J:161276
	hyperglycemia	J:161276
	impaired adaptive thermogenesis	J:161276
	impaired glucose tolerance	J:161276
	increased circulating insulin-like growth factor I level	J:161276
	increased circulating leptin level	J:161276
	increased liver glycogen level	J:161276
	increased liver triglyceride level	J:161276
	insulin resistance	J:161276
Ncoa3^{tm1b(EUCOMM)Wtsi}/Ncoa3⁺ (C57BL/6N-Ncoa3^{tm1b(EUCOMM)Wtsi}/H)	impaired glucose tolerance	J:211773
	increased circulating bilirubin level	J:211773
Ncoa3^tm1Jxu/Ncoa3^tm1Jxu (involves: 129S6/SvEvTac)	decreased circulating estradiol level	J:62724
Ncoa3^tm1Jxu/Ncoa3^tm1Jxu (involves: 129S6/SvEvTac)	decreased circulating insulin-like growth factor I level	J:62724
Ncoa3^tm1Jxu/Ncoa3^tm1Jxu (involves: 129S6/SvEvTac * C57BL/6J)	decreased circulating cholesterol level	J:144060
	decreased circulating free fatty acids level	J:144060
	decreased circulating glucose level	J:144060
	decreased circulating HDL cholesterol level	J:144060
	decreased circulating insulin level	J:144060
	decreased circulating triglyceride level	J:144060
	decreased susceptibility to diet-induced obesity	J:144060
	improved glucose tolerance	J:144060
	increased carbon dioxide production	J:144060
	increased energy expenditure	J:144060
	increased insulin sensitivity	J:144060
	increased oxygen consumption	J:144060
	increased respiratory quotient	J:144060
Ncoa3^tm1Jxu/Ncoa3^tm1Jxu (involves: 129S6/SvEvTac * C57BL/6)	decreased circulating glucose level	J:120086
	impaired adaptive thermogenesis	J:120086
	increased circulating interleukin-1 beta level	J:120086
	increased circulating interleukin-6 level	J:120086
	increased circulating tumor necrosis factor level	J:120086
Ncoa3^tm1Rsd/Ncoa3^tm1Rsd (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	decreased circulating insulin-like growth factor I level	J:66454
Ncoa3^tm2.2Jxu/Ncoa3^tm2.2Jxu (involves: 129S4/SvJaeSor * 129S6/SvEvTac * C57BL/6 * FVB/N)	decreased circulating insulin-like growth factor I level	J:161101
Ncoa5^tm1Hxia/Ncoa5⁺ (involves: 129 * C57BL/6)	abnormal circulating protein level	J:207622
	impaired glucose tolerance	J:207622
	increased circulating alanine transaminase level	J:207622
	increased fasting circulating glucose level	J:207622
	increased liver triglyceride level	J:207622
	insulin resistance	J:207622
Ncoa5^tm1Hxia/Ncoa5⁺ (C.129(B6)-Ncoa5^tm1Hxia)	impaired glucose tolerance	J:207622
Ncoa5^tm1Hxia/Ncoa5⁺ (C.129(B6)-Ncoa5^tm1Hxia)	increased fasting circulating glucose level	J:207622
Ncoa6^tm1Jkr/Ncoa6^tm1Jkr Tg(Myh6-cre)2182Mds/0 (involves: 129P2/OlaHsd * FVB/N)	abnormal atrial thrombosis	J:269856
	abnormal lipid level	J:269856
Ncoa6^tm1Jxu/Ncoa6^tm1Jxu (involves: 129S6/SvEvTac * C57BL/6)	pericardial effusion	J:80175
Ncoa6^tm2Jxu/Ncoa6^tm2Jxu (involves: 129S6/SvEvTac * C57BL/6 * FVB/N)	abnormal bile salt homeostasis	J:129067
	abnormal circulating triglyceride level	J:129067
	abnormal lipid homeostasis	J:129067
	increased circulating cholesterol level	J:129067
Ncoa7^em1Pelo/Ncoa7^em1Pelo (C57BL/6-Ncoa7^em1Pelo)	increased urine pH	J:305611
Ncor1^tm1.1Anh/Ncor1^tm1.1Anh (involves: 129S4/SvJae * C57BL/6J)	abnormal thyroxine level	J:213990
	decreased circulating thyroxine level	J:213990
	decreased circulating triiodothyronine level	J:213990
	increased energy expenditure	J:213990
	increased oxygen consumption	J:213990
Ncor1^tm1.1Ics/Ncor1^tm1.1Ics (involves: 129 * C57BL/6J)	decreased liver glycogen level	J:206152
Ncor1^tm1.1Ics/Ncor1^tm1.1Ics Tg(ACTA1-cre)79Jme/0 (involves: 129 * C57BL/6 * C57BL/6J * SJL)	abnormal gas homeostasis	J:178827
	decreased circulating cholesterol level	J:178827
	decreased circulating HDL cholesterol level	J:178827
	decreased circulating LDL cholesterol level	J:178827
	decreased respiratory quotient	J:178827
	decreased susceptibility to induced hypothermia	J:178827
	increased oxygen consumption	J:178827
Ncor1^tm1Anh/Ncor1^tm1Anh Speer6-ps1^{Tg(Alb-cre)21Mgn}/Speer6-ps1⁺ (involves: 129S4/SvJae * 129S4/SvJaeSor * C57BL/6 * DBA)	decreased circulating LDL cholesterol level	J:142045
	decreased circulating thyroxine level	J:142045
Ncor1^tm1Laz/Ncor1^tm1Laz (C57BL/6-Ncor1^tm1Laz)	abnormal glucose homeostasis	J:142342
	decreased susceptibility to diet-induced obesity	J:142342
	increased circulating free fatty acids level	J:142342
	increased circulating ketone body level	J:142342
	increased insulin sensitivity	J:142342
	increased oxygen consumption	J:142342
Ncor1^tm1Rsd/Ncor1^tm1Rsd (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	edema	J:65417
Ncor2^em1(IMPC)Mbp/Ncor2^em1(IMPC)Mbp (C57BL/6N-Ncor2^em1(IMPC)Mbp/MbpMmucd)	edema	J:211773
Ncor2^{Gt(RRM275)Byg}/Ncor2⁺ (B6.129P2-Ncor2^{Gt(RRM275)Byg})	abnormal hormone level	J:164558
	decreased carbon dioxide production	J:164558
	decreased circulating insulin level	J:164558
	decreased circulating leptin level	J:164558
	decreased energy expenditure	J:164558
	decreased oxygen consumption	J:164558
	increased insulin sensitivity	J:164558
	increased susceptibility to diet-induced obesity	J:164558
Ncor2^tm1Rev/Ncor2^tm1Rev (involves: 129/Sv * C57BL/6)	abnormal circulating enzyme level	J:202976
	abnormal circulating hormone level	J:202976
	abnormal gas homeostasis	J:142665
	abnormal gluconeogenesis	J:142665
	decreased body temperature	J:142665
	decreased carbon dioxide production	J:142665
	decreased energy expenditure	J:142665
	decreased oxygen consumption	J:142665
	increased adiponectin level	J:142665
	increased circulating glucose level	J:142665
	insulin resistance	J:142665
Ncr1^m1J/Ncr1^m1J Pepc^b/Pepc^b Ptprc^a/Ptprc^a (B6.SJL-Ptprc^a Pepc^b/BoyJ)	abnormal interferon level	J:257226
Ncs1^{tm1b(EUCOMM)Hmgu}/Ncs1^{tm1b(EUCOMM)Hmgu} (C57BL/6N-Ncs1^{tm1b(EUCOMM)Hmgu}/Ics)	increased circulating phosphate level	J:211773
Ndfip1^tm1.1Sest/Ndfip1^tm1.1Sest (involves: C57BL/6)	abnormal iron homeostasis	J:212711
Ndfip2^{tm1a(EUCOMM)Hmgu}/Ndfip2^{tm1a(EUCOMM)Hmgu} (C57BL/6N-Ndfip2^{tm1a(EUCOMM)Hmgu})	abnormal circulating iron level	J:235779
	abnormal circulating unsaturated transferrin level	J:235779
	abnormal iron homeostasis	J:235779
	abnormal liver iron level	J:235779
	decreased liver iron level	J:235779
	increased liver iron level	J:235779
Ndfip2^{tm1b(EUCOMM)Hmgu}/Ndfip2^{tm1b(EUCOMM)Hmgu} (C57BL/6N-Ndfip2^{tm1b(EUCOMM)Hmgu}/Ieg)	increased circulating calcium level	J:211773
	increased circulating serum albumin level	J:211773
	increased circulating sodium level	J:211773
Ndn^tm1.1Mus/Ndn^tm1.1Mus (involves: 129S2/SvPas * C57BL/6J)	cyanosis	J:66557
Ndn^tm1Stw/Ndn⁺ (involves: 129S1/Sv * C57BL/6)	cyanosis	J:57890
Ndn^tm2Stw/Ndn⁺ (involves: 129S1/Sv * C57BL/6J)	cyanosis	J:82266
Ndn^tm2Stw/Ndn⁺ (involves: 129S1/Sv * C57BL/6J)	hypoxia	J:82266
Ndn^tm2Stw/Ndn⁺ (involves: 129S1/Sv * C57BL/6)	cyanosis	J:57890
Ndor1^{Tg(UBC-cre/ERT2)1Ejb}/Ndor1⁺ Rpl11^tm1.1Srn/Rpl11^tm1.1Srn (involves: 129S6/SvEvTac * C57BL/6NCrl * CD-1)	increased liver iron level	J:292575
Ndrg1^{tm2b(KOMP)Wtsi}/Ndrg1^{tm2b(KOMP)Wtsi} (C57BL/6N-Ndrg1^{tm2b(KOMP)Wtsi}/Tcp)	decreased fasting circulating glucose level	J:211773
	increased circulating phosphate level	J:211773
Ndrg3^em1(IMPC)Mbp/Ndrg3⁺ (C57BL/6NCrl-Ndrg3^em1(IMPC)Mbp/Mmucd)	decreased circulating calcium level	J:211773
Ndrg4^{tm1b(KOMP)Wtsi}/Ndrg4^{tm1b(KOMP)Wtsi} (C57BL/6N-Ndrg4^{tm1b(KOMP)Wtsi}/H)	increased blood urea nitrogen level	J:211773
	increased circulating creatinine level	J:211773
Ndst1^tm1Ekf/Ndst1^tm1Ekf (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	cyanosis	J:63996
Ndst1^tm1Hgx/Ndst1^tm1Hgx (involves: 129S4/SvJae * C57BL/6)	cyanosis	J:60280
Ndst1^tm1Je/Ndst1^tm1Je Tg(Tek-cre)1Ywa/0 (involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * SJL)	hypoxia	J:208012
Ndst3^tm1.1Grob/Ndst3^tm1.1Grob (involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * FVB/N)	decreased circulating cholesterol level	J:138557
	decreased circulating HDL cholesterol level	J:138557
Ndufa1^tm1.1Nay/Y (involves: 129S1/SvImJ * 129S4/SvJaeSor * 129S6/SvEvTac)	abnormal cholesterol homeostasis	J:257477
	abnormal circulating amino acid level	J:257477
	abnormal corticosterone level	J:257477
	abnormal glucose homeostasis	J:257477
	abnormal sphingolipid level	J:257477
	decreased circulating bilirubin level	J:257477
	decreased circulating corticosterone level	J:257477
	decreased circulating iron level	J:257477
	decreased energy expenditure	J:257477
	decreased liver cholesterol level	J:257477
	decreased oxygen consumption	J:257477
	decreased respiratory quotient	J:257477
	decreased taurine level	J:257477
	increased fatty acids level	J:257477
Ndufa8^{tm1a(EUCOMM)Hmgu}/Ndufa8⁺ (C57BL/6N-Ndufa8^{tm1a(EUCOMM)Hmgu}/Ieg)	decreased circulating sodium level	J:165965
Ndufa13^em1Nju/Ndufa13⁺ (C57BL/6-Ndufa13^em1Nju)	decreased circulating testosterone level	J:326065
Ndufb9^{tm1b(EUCOMM)Hmgu}/Ndufb9⁺ (C57BL/6N-Ndufb9^{tm1b(EUCOMM)Hmgu}/Ieg)	decreased circulating alkaline phosphatase level	J:211773
	increased circulating insulin level	J:211773
Ndufs1^{tm1b(EUCOMM)Hmgu}/Ndufs1⁺ (C57BL/6N-Ndufs1^{tm1b(EUCOMM)Hmgu}/Ieg)	decreased circulating triglyceride level	J:211773
	increased circulating calcium level	J:211773
	increased circulating creatinine level	J:211773
	increased circulating lipase level	J:211773
	increased circulating phosphate level	J:211773
	increased circulating sodium level	J:211773
Ndufs3^{tm1a(EUCOMM)Wtsi}/Ndufs3⁺ (B6JTyr;B6N-Ndufs3^{tm1a(EUCOMM)Wtsi}/Wtsi)	decreased lactate dehydrogenase level	J:175295
Ndufs4^fky/Ndufs4^fky (C57BL/6-Ndufs4^fky)	abnormal circulating amino acid level	J:186512
	increased circulating carnitine level	J:186512
	increased circulating glycine level	J:186512
	increased circulating phenylalanine level	J:186512
Ndufs4^tm1.1Rpa/Ndufs4^tm1.1Rpa (involves: 129/Sv * 129S4/SvJaeSor * C57BL/6)	decreased body temperature	J:134334
Ndufs4^tm1.1Rpa/Ndufs4^tm1.1Rpa (involves: 129S4/SvJaeSor)	decreased body temperature	J:161393
Ndufs4^tm1.1Rpa/Ndufs4^tm1.1Rpa (B6.129S4-Ndufs4^tm1.1Rpa)	abnormal blood homeostasis	J:190475
Ndufs4^tm1.1Rpa/Ndufs4^tm1.1Rpa (B6.129S4-Ndufs4^tm1.1Rpa)	decreased body temperature	J:190475
Ndufs4^tm1Rpa/Ndufs4^tm1Rpa Tg(Nes-cre)1Kln/0 (involves: 129S4/SvJaeSor * C57BL/6 * SJL)	decreased body temperature	J:161393
Ndufs4^tm1Rpa/Ndufs4^tm1Rpa Tg(Nes-cre)1Kln/0 (B6.Cg-Tg(Nes-cre)1Kln Ndufs4^tm1Rpa)	abnormal blood homeostasis	J:190475
	decreased body temperature	J:190475
Ndufs6^{Gt(AR0138)Wtsi}/Ndufs6^{Gt(AR0138)Wtsi} (involves: 129P2/OlaHsd * C57BL/6)	increased fatty acids level	J:183619
Necap2^em1(IMPC)J/Necap2^em1(IMPC)J (C57BL/6NJ-Necap2^em1(IMPC)J/Mmjax)	decreased circulating calcium level	J:211773
Nectin1^tm1Ytk/Nectin1^tm1Ytk Nectin3^tm1Ytk/Nectin3^tm1Ytk (involves: 129X1/SvJ * C57BL/6)	impaired skin barrier function	J:165548
Nedd1^em1(IMPC)H/Nedd1⁺ (C57BL/6NTac-Nedd1^em1(IMPC)H/H)	decreased circulating calcium level	J:211773
	decreased circulating fructosamine level	J:211773
	increased circulating potassium level	J:211773
Nedd4^{tm2b(EUCOMM)Hmgu}/Nedd4⁺ (C57BL/6N-Nedd4^{tm2b(EUCOMM)Hmgu}/H)	decreased circulating creatinine level	J:211773
	impaired glucose tolerance	J:211773
Nedd4l^andi/Nedd4l^andi (BALB/cByJ-Nedd4l^andi/EiJ)	decreased urine osmolality	J:165173, J:165247
Nedd4l^tm1.2Blyg/Nedd4l^tm1.2Blyg (involves: 129X1/SvJ * C57BL/6J)	increased circulating aldosterone level	J:148641
	increased circulating potassium level	J:148641
	increased circulating sodium level	J:148641
Nedd4l^tm1Shkr/Nedd4l^tm1Shkr (involves: C57BL/6 * C57BL/6J)	cyanosis	J:205657
Nefh^{tm1.1(KOMP)Vlcg}/Nefh^{tm1.1(KOMP)Vlcg} (C57BL/6N-Nefh^{tm1.1(KOMP)Vlcg}/J)	increased circulating alanine transaminase level	J:211773
Negr1^m1H/Negr1^m1H (C3.Cg-Negr1^m1H)	abnormal energy homeostasis	J:189719
Negr1^m1H/Negr1^m1H (C3.Cg-Negr1^m1H)	decreased liver triglyceride level	J:189719
Neil1^tm1Rsld/Neil1^tm1Rsld (involves: 129S1/Sv * C57BL/6)	increased circulating insulin level	J:106077
	increased circulating leptin level	J:106077
	increased circulating triglyceride level	J:106077
Neil2^em1(IMPC)J/Neil2^em1(IMPC)J (C57BL/6NJ-Neil2^em1(IMPC)J/J)	decreased blood urea nitrogen level	J:211773
	decreased circulating calcium level	J:211773
Nek1^kat-2J/Nek1^kat-2J (C57BL/6J-Nek1^kat-2J/J)	increased blood urea nitrogen level	J:59839
Nek2^{tm1b(KOMP)Wtsi}/Nek2^{tm1b(KOMP)Wtsi} (C57BL/6N-Nek2^{tm1b(KOMP)Wtsi}/J)	increased fasting circulating glucose level	J:211773
Nek7^{tm1b(EUCOMM)Hmgu}/Nek7⁺ (C57BL/6N-Nek7^{tm1b(EUCOMM)Hmgu}/J)	increased urine microalbumin level	J:211773
Nek8^jck/Nek8^jck (involves: C57BL/6J)	increased circulating creatinine level	J:11885
Nek8^tm1Bei/Nek8^tm1Bei (involves: 129S6/SvEvTac * C57BL/6NCr)	edema	J:199559
Nek9^{tm1a(EUCOMM)Wtsi}/Nek9⁺ (C57BL/6N-Nek9^{tm1a(EUCOMM)Wtsi}/Wtsi)	increased circulating iron level	J:211773
Nek11^{tm1b(KOMP)Wtsi}/Nek11^{tm1b(KOMP)Wtsi} (C57BL/6N-Nek11^{tm1b(KOMP)Wtsi}/J)	decreased circulating glucose level	J:211773
	decreased circulating iron level	J:211773
Nelfcd^em1(IMPC)J/Nelfcd⁺ (C57BL/6NJ-Nelfcd^em1(IMPC)J/Mmjax)	increased circulating HDL cholesterol level	J:211773
Nemf^{tm1b(EUCOMM)Hmgu}/Nemf⁺ (B6N(Cg)-Nemf^{tm1b(EUCOMM)Hmgu}/J)	decreased circulating glucose level	J:211773
Nenf^tm1Mkga/Nenf^tm1Mkga (involves: 129S6/SvEvTac * C57BL/6NTac)	decreased dopamine level	J:202317
	decreased serotonin level	J:202317
Nepn^{tm1b(KOMP)Wtsi}/Nepn^{tm1b(KOMP)Wtsi} (C57BL/6N-Nepn^{tm1b(KOMP)Wtsi}/Ucd)	decreased circulating triglyceride level	J:211773
Nes^{tm1b(KOMP)Wtsi}/Nes^{tm1b(KOMP)Wtsi} (C57BL/6N-Nes^{tm1b(KOMP)Wtsi}/J)	decreased circulating cholesterol level	J:211773
	increased circulating chloride level	J:211773
Neto2^{em1(IMPC)Hmgu}/Neto2^{em1(IMPC)Hmgu} (C57BL/6N-Neto2^{em1(IMPC)Hmgu}/Ieg)	increased circulating amylase level	J:211773
	increased circulating lipase level	J:211773
Neu1^tm1Adz/Neu1^tm1Adz (either: (involves: 129S1/Sv * C57BL/6) or (involves: 129S1/Sv * NMRI))	abnormal urine homeostasis	J:76937
	decreased circulating total protein level	J:76937
	edema	J:76937
	extremity edema	J:76937
	eyelid edema	J:76937
	skin edema	J:76937
Neu2^em1Kyp/Neu2^em1Kyp (C57BL/6J-Neu2^em1Kyp)	abnormal energy homeostasis	J:321653
	decreased carbon dioxide production	J:321653
	decreased energy expenditure	J:321653
	decreased oxygen consumption	J:321653
	increased blood urea nitrogen level	J:321653
	increased circulating cholesterol level	J:321653
	increased circulating free fatty acids level	J:321653
	increased circulating triglyceride level	J:321653
	increased liver free fatty acids level	J:321653
	increased muscle free fatty acids level	J:321653
Neu4^tm1Avps/Neu4^tm1Avps (involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)	abnormal lipid level	J:135246
	increased cholesterol level	J:135246
	increased unsaturated fatty acids level	J:135246
Neurl2^{tm1.1(KOMP)Vlcg}/Neurl2^{tm1.1(KOMP)Vlcg} (C57BL/6N-Neurl2^{tm1.1(KOMP)Vlcg}/J)	decreased circulating glucose level	J:211773
	decreased circulating iron level	J:211773
Neurod1^tm1Jle/Neurod1^tm1Jle (involves: 129S4/SvJaeSor * C57BL/6)	hyperglycemia	J:74715
Neurod1^tm1Mjts/Neurod1^tm1Mjts (involves: 129S7/SvEvBrd * C57BL/6)	dehydration	J:43010
	hyperglycemia	J:43010
	ketoaciduria	J:43010
Neurod1^tm1Mjts/Neurod1^tm1Mjts (involves: 129S7/SvEvBrd * 129X1/SvJ * C57BL/6J)	hyperglycemia	J:59932
Neurod2^{em1(IMPC)Hmgu}/Neurod2^{em1(IMPC)Hmgu} (C57BL/6N-Neurod2^{em1(IMPC)Hmgu}/Ieg)	decreased circulating calcium level	J:211773
	decreased circulating iron level	J:211773
	decreased respiratory quotient	J:211773
Neurog3^{tm1(Neurog3,cre/ERT)Ggu}/Neurog3^{tm1(Neurog3,cre/ERT)Ggu} Tg(Ins2-cre)25Mgn/0 (involves: 129S6/SvEvTac * C57BL/6 * DBA)	increased circulating glucose level	J:150074
Neurog3^{tm1(Neurog3,cre/ERT)Ggu}/Neurog3^{tm1(Neurog3,cre/ERT)Ggu} Tg(Pdx1-cre/Esr1*)1Mga/0 (involves: 129S6/SvEvTac)	impaired glucose tolerance	J:150074
Neurog3^{tm1(Neurog3,cre/ERT)Ggu}/Neurog3^{tm1.1(cre/ERT)Ggu} (involves: 129S6/SvEvTac)	impaired glucose tolerance	J:150074
Neurog3^{tm1(Neurog3,cre/ERT)Ggu}/Neurog3^{tm1.1(cre/ERT)Ggu} Tg(Ins2-cre)25Mgn/0 (involves: 129S6/SvEvTac * C57BL/6 * DBA)	increased circulating glucose level	J:150074
Neurog3^{tm1(Neurog3,cre/ERT)Ggu}/Neurog3^{tm1.1(cre/ERT)Ggu} Tg(Pdx1-cre/Esr1*)1Mga/0 (involves: 129S6/SvEvTac)	abnormal circulating insulin level	J:150074
	hyperglycemia	J:150074
	impaired glucose tolerance	J:150074
	increased circulating glucose level	J:150074
Neurog3^{tm1.1(cre/ERT)Ggu}/Neurog3⁺ (involves: 129S6/SvEvTac)	impaired glucose tolerance	J:150074
Neurog3^tm1Fgu/Neurog3^tm1Fgu (involves: 129S1/Sv * 129X1/SvJ * CD-1)	dehydration	J:60642
	increased circulating glucose level	J:60642
	increased urine glucose level	J:60642
Neurog3^tm1Fgu/Neurog3^tm3.1Ggr Tg(Vil1-cre)20Syr/0 (involves: 129S2/SvPas * C57BL/6 * CD-1 * DBA/2 * SJL)	abnormal intestinal lipid absorption	J:161480
	decreased circulating cholesterol level	J:161480
	decreased circulating glucose level	J:161480
	decreased circulating HDL cholesterol level	J:161480
	decreased circulating serum albumin level	J:161480
	decreased circulating triglyceride level	J:161480
	improved glucose tolerance	J:161480
	increased blood urea nitrogen level	J:161480
	increased circulating bicarbonate level	J:161480
	increased insulin sensitivity	J:161480
	steatorrhea	J:161480
Neurog3^tm3.1Ggr/Neurog3^tm3.1Ggr Tg(Vil1-cre)20Syr/0 (involves: 129S2/SvPas * C57BL/6 * CD-1 * DBA/2 * SJL)	abnormal intestinal lipid absorption	J:161480
	decreased circulating cholesterol level	J:161480
	decreased circulating glucose level	J:161480
	decreased circulating HDL cholesterol level	J:161480
	decreased circulating serum albumin level	J:161480
	decreased circulating triglyceride level	J:161480
	improved glucose tolerance	J:161480
	increased blood urea nitrogen level	J:161480
	increased circulating bicarbonate level	J:161480
	increased insulin sensitivity	J:161480
	steatorrhea	J:161480
nevo/nevo (involves: C57BL/6 * FVB/N)	cardiac edema	J:173681
nevo/nevo (involves: C57BL/6 * FVB/N)	nuchal edema	J:173681
Nexmif^em1(IMPC)Tcp/Y (C57BL/6N-Nexmif^em1(IMPC)Tcp/Tcp)	increased blood urea nitrogen level	J:211773
Nexmif^em1(IMPC)Tcp/Y (C57BL/6N-Nexmif^em1(IMPC)Tcp/Tcp)	increased circulating triglyceride level	J:211773
Nexn^tm1.1Chen/Nexn^tm1.1Chen (Not Specified)	abnormal ventricular thrombosis	J:290931
Nexn^tm1Chen/Nexn^tm1Chen Tg(myl7.L-cre)1118Tmhn/0 (involves: MF1)	abnormal ventricular thrombosis	J:290931
Nf1^tm1.1Kest/Nf1^tm1.1Kest (involves: 129S4/SvJaeSor * C57BL/6 * C57BL/6NTac)	pericardial effusion	J:234172
Nf1^tm1.1Kest/Nf1^{tm1c(KOMP)Wtsi} Tg(Dhh-cre)1Mejr/0 (involves: 129S4/SvJaeSor * C57BL/6 * C57BL/6N * C57BL/6NTac * FVB/N)	dehydration	J:234172
Nf1^{tm1a(KOMP)Wtsi}/Nf1⁺ (B6JTyr;B6N-Nf1^{tm1a(KOMP)Wtsi}/Wtsi)	decreased circulating alanine transaminase level	J:175295
	decreased circulating aspartate transaminase level	J:175295
	decreased lactate dehydrogenase level	J:175295
Nf1^{tm1c(KOMP)Wtsi}/Nf1^{tm1c(KOMP)Wtsi} Tg(Dhh-cre)1Mejr/0 (involves: 129S4/SvJaeSor * C57BL/6 * C57BL/6N * FVB/N)	dehydration	J:234172
Nf1^tm1Fcr/Nf1^tm1.1Par (involves: 129S/SvEv * 129S1/Sv * 129S2/SvPas * 129X1/SvJ)	edema	J:68558
Nf1^tm1Fcr/Nf1^tm1Fcr (either: (involves: 129S/SvEv) or (involves: 129S/SvEv * C57BL/6J))	edema	J:18048
	pericardial effusion	J:18048
	pleural effusion	J:18048
Nf1^tm1Par/Nf1^tm1Par Tg(Fabp7-cre,-lacZ)3Gtm/0 (involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * CBA)	abnormal hormone level	J:138868
	decreased circulating growth hormone level	J:138868
Nf1^tm1Par/Nf1^tm1Par Tg(Tek-cre)1Ywa/0 (involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * SJL)	pericardial effusion	J:80323
Nf1^tm1Tyj/Nf1^tm1Tyj (involves: 129S2/SvPas * C57BL/6)	hydrops fetalis	J:18542
Nfasc^{tm1a(EUCOMM)Hmgu}/Nfasc⁺ (C57BL/6N-Nfasc^{tm1a(EUCOMM)Hmgu}/Ics)	increased circulating triglyceride level	J:165965
Nfat5^tm1.1Itl/Nfat5^tm1.1Itl Lyz2^tm1(cre)Ifo/Lyz2⁺ (involves: 129P2/OlaHsd * 129S6/SvEvTac * C57BL/6NTac * FVB/N)	abnormal chloride level	J:201429
Nfat5^{tm1b(KOMP)Wtsi}/Nfat5⁺ (C57BL/6N-Nfat5^{tm1b(KOMP)Wtsi}/J)	improved glucose tolerance	J:211773
	increased circulating bilirubin level	J:211773
	increased circulating chloride level	J:211773
	increased circulating sodium level	J:211773
Nfat5^tm1Rao/Nfat5^tm1Rao (B6.129-Nfat5^tm1Rao)	abnormal fluid regulation	J:88636
Nfat5^tm1Skc/Nfat5^tm1Skc (involves: 129S7/SvEvBrd * C57BL/6)	edema	J:175527
Nfatc1^tm1Glm/Nfatc1^tm1Glm (involves: 129S2/SvPas)	edema	J:46398
Nfatc1^tm1Glm/Nfatc1^tm1Glm (involves: 129S2/SvPas)	pericardial effusion	J:46398
Nfatc1^tm1Mak/Nfatc1^tm1Mak (involves: 129P2/OlaHsd * C57BL/6)	edema	J:46399
Nfatc2ip^em1(IMPC)Ics/Nfatc2ip^em1(IMPC)Ics (C57BL/6N-Nfatc2ip^em1(IMPC)Ics/Ics)	increased circulating calcium level	J:211773
Nfatc2ip^tm1.1Glm/Nfatc2ip^tm1.1Glm (either: B6.129-Nfatc2ip^tm1.1Glm or C.129-Nfatc2ip^tm1.1Glm)	decreased circulating interleukin-4 level	J:157559
Nfatc3^tm1Glm/Nfatc3^tm1Glm (involves: 129S2/SvPas)	periorbital edema	J:50124
Nfatc4^{tm1.1(KOMP)Vlcg}/Nfatc4^{tm1.1(KOMP)Vlcg} (C57BL/6N-Nfatc4^{tm1.1(KOMP)Vlcg}/J)	decreased fasting circulating glucose level	J:211773
	increased circulating sodium level	J:211773
Nfe2l1^tm1.1Mym/Nfe2l1⁺ (B6J.Cg-Nfe2l1^tm1.1Mym)	decreased circulating glucose level	J:230118
Nfe2l1^tm1.1Mym/Nfe2l1⁺ (B6J.Cg-Nfe2l1^tm1.1Mym)	decreased circulating insulin level	J:230118
Nfe2l1^tm1Jefc/Nfe2l1^tm1Ywk Speer6-ps1^{Tg(Alb-cre)21Mgn}/Speer6-ps1⁺ (involves: 129X1/SvJ * C57BL/6J)	increased circulating alanine transaminase level	J:97188
Nfe2l1^tm1Mym/Nfe2l1^tm1Mym Speer6-ps1^{Tg(Alb-cre)21Mgn}/Speer6-ps1⁺ (involves: C57BL/6 * DBA)	increased circulating alanine transaminase level	J:143468
	increased circulating aspartate transaminase level	J:143468
Nfe2l2^{em1(IMPC)Ccpcz}/Nfe2l2^{em1(IMPC)Ccpcz} (C57BL/6NCrl-Nfe2l2^{em1(IMPC)Ccpcz}/Ccpcz)	decreased circulating glucose level	J:211773
	increased circulating alkaline phosphatase level	J:211773
	increased circulating aspartate transaminase level	J:211773
	increased circulating creatinine level	J:211773
	increased circulating phosphate level	J:211773
Nfe2l2^tm1Mym/Nfe2l2⁺ (involves: 129P2/OlaHsd)	abnormal iron level	J:95372
Nfe2l2^tm1Mym/Nfe2l2^tm1Mym (involves: 129P2/OlaHsd * ICR)	decreased urine creatinine level	J:104016
Nfe2l2^tm1Mym/Nfe2l2^tm1Mym (involves: 129P2/OlaHsd * ICR)	increased urine protein level	J:104016
Nfe2l2^tm1Mym/Nfe2l2^tm1Mym (involves: 129P2/OlaHsd)	abnormal iron homeostasis	J:95372
	abnormal iron level	J:95372
	increased liver iron level	J:95372
Nfe2l2^tm1Mym/Nfe2l2^tm1Mym (involves: 129P2/OlaHsd * C57BL/6)	hypoglycemia	J:136120
	increased circulating alanine transaminase level	J:136120
	increased circulating interleukin-6 level	J:136120
	increased circulating tumor necrosis factor level	J:136120
Nfe2l2^tm1Mym/Nfe2l2^tm1Mym Tg(Alb1-cre)1Dlr/0 n-TUtca2^tm2Mym/n-TUtca2^tm2.1Mym (involves: 129P2/OlaHsd * C57BL/6 * DBA/2 * FVB/N)	increased circulating alanine transaminase level	J:130723
Nfe2l2^tm1Ywk/Nfe2l2^tm1Ywk (involves: 129X1/SvJ)	decreased circulating interleukin-1 beta level	J:100106
	increased circulating bilirubin level	J:130473
	increased circulating interleukin-1 beta level	J:100106
	increased lactate dehydrogenase level	J:91407
Nfe2l2^tm1Ywk/Nfe2l2^tm1Ywk (B6.129X1-Nfe2l2^tm1Ywk/J)	decreased catalase level	J:233699
Nfe2l2^tm1Ywk/Nfe2l2^tm1Ywk (B6.129X1-Nfe2l2^tm1Ywk)	abnormal enzyme/coenzyme level	J:165602, J:310044
	abnormal lipid homeostasis	J:165602
	decreased glutathione level	J:165602, J:310044
Nfib^tm1Hsch/Nfib^tm1Hsch (involves: 129S1/Sv * C57BL/6)	cyanosis	J:75698
Nfil3^tm1Pbro/Nfil3^tm1Pbro (B6.129S6-Nfil3^tm1Pbro)	abnormal circulating cytokine level	J:209365
	increased circulating interferon-gamma level	J:209365
	increased circulating interleukin-10 level	J:209365
	increased circulating interleukin-12b level	J:209365
	increased circulating interleukin-17 level	J:209365
	increased circulating tumor necrosis factor level	J:209365
Nfkb1^{tm1a(KOMP)Wtsi}/Nfkb1^{tm1a(KOMP)Wtsi} (B6JTyr;B6N-Nfkb1^{tm1a(KOMP)Wtsi}/Wtsi)	decreased circulating amylase level	J:175295
	decreased circulating sodium level	J:165965
	increased circulating alkaline phosphatase level	J:165965
	increased circulating free fatty acids level	J:175295
Nfkb1^{tm1a(KOMP)Wtsi}/Nfkb1^{tm1a(KOMP)Wtsi} (involves: C57BL/6 * C57BL/6N)	decreased respiratory quotient	J:213427
	increased circulating alkaline phosphatase level	J:213427
Nfkb1^tm1Bal/Nfkb1^tm1Bal (B6;129P-Nfkb1^tm1Bal/J)	abnormal calcium ion homeostasis	J:107245
Nfkb1^tm1Sley/Nfkb1^tm1Sley (involves: 129S4/SvJae * 129S8/SvEv)	decreased circulating interleukin-2 level	J:142340
Nfkb2^tm2Brv/Nfkb2^tm2Brv Tg(Tnfsf13b)1Fma/? (B6.Cg-Nfkb2^tm2Brv Tg(Tnfsf13b)1Fma)	increased urine protein level	J:113556
Nfkbia^tm1.1Pjc/Nfkbia^tm1.1Pjc (involves: C57BL/6)	abnormal circulating cytokine level	J:163686
	increased circulating interleukin-1 alpha level	J:163686
	increased circulating interleukin-17 level	J:163686
	increased circulating tumor necrosis factor level	J:163686
Nfkbia^tm1Stw/Nfkbia^tm1Stw (involves: 129S1/Sv)	abnormal tumor necrosis factor level	J:32527
Nfkbib^tm1Bal/Nfkbib^tm1Bal (B6.129S1-Nfkbib^tm1Bal)	decreased circulating interleukin-1 beta level	J:163302
	decreased circulating interleukin-6 level	J:163302
	decreased circulating tumor necrosis factor level	J:163302
Nfkbid^{tm1a(EUCOMM)Wtsi}/Nfkbid⁺ (C57BL/6N-Nfkbid^{tm1a(EUCOMM)Wtsi}/Cnrm)	decreased circulating free fatty acids level	J:165965
	decreased circulating triglyceride level	J:165965
Nfkbil1^{tm1a(KOMP)Wtsi}/Nfkbil1^{tm1a(KOMP)Wtsi} (C57BL/6N-Nfkbil1^{tm1a(KOMP)Wtsi}/Wtsi)	decreased circulating serum albumin level	J:211773
Nfkbiz^tm1.1Muta/Nfkbiz^tm1.1Muta Tg(CAG-cre)13Miya/? (involves: C57BL/6)	eyelid edema	J:194832
Nfkbiz^tm1Aki/Nfkbiz^tm1Aki (involves: 129P2/OlaHsd)	eyelid edema	J:194832
Nfkbiz^tm1Aki/Nfkbiz^tm1Aki (C.129P2-Nfkbiz^tm1Aki)	skin edema	J:141704
Nfkbiz^tm1Aki/Nfkbiz^tm1Aki Stat6^tm1Aki/Stat6^tm1Aki (C.129P2-Stat6^tm1Aki Nfkbiz^tm1Aki)	skin edema	J:141704
Nfkbiz^tm1Aki/Nfkbiz^tm1Aki Tnf^tm1Sek/Tnf^tm1Sek (involves: 129P2/OlaHsd * C57BL/6NCrlj * CBA/JNCrlj)	eyelid edema	J:194832
Nfkbiz^tm1Mamo/Nfkbiz^tm1Mamo (involves: 129S7/SvEvBrd)	eyelid edema	J:95040
Ngdn^{tm1b(EUCOMM)Wtsi}/Ngdn⁺ (C57BL/6N-Ngdn^{tm1b(EUCOMM)Wtsi}/Ieg)	decreased circulating cholesterol level	J:211773
	decreased circulating HDL cholesterol level	J:211773
Ngf^tm1.1Blhe/Ngf⁺ (B6.Cg-Ngf^tm1.1Blhe)	edema	J:190893
Ngfr^{tm1a(EUCOMM)Wtsi}/Ngfr⁺ (C57BL/6N-Ngfr^{tm1a(EUCOMM)Wtsi}/Ics)	decreased circulating alkaline phosphatase level	J:165965
Ngfr^{tm1b(EUCOMM)Wtsi}/Ngfr^{tm1b(EUCOMM)Wtsi} (C57BL/6N-Ngfr^{tm1b(EUCOMM)Wtsi}/H)	increased circulating phosphate level	J:211773
Ngfr^tm1Jae/Ngfr^tm1Jae (involves: 129S4/SvJae * BALB/c)	extremity edema	J:43748
Ngfr^tm1Jae/Ngfr^tm1Jae (involves: 129S4/SvJae)	abnormal tumor necrosis factor level	J:157549
Nhdlq1^129S1/SvImJ/Nhdlq1^CAST/Ei (involves: 129S1/SvImJ * CAST/Ei)	abnormal circulating cholesterol level	J:88732
Nhdlq1^CAST/Ei/Nhdlq1^CAST/Ei (involves: 129S1/SvImJ * CAST/Ei)	abnormal circulating cholesterol level	J:88732
Nhdlq2^129S1/SvImJ/? (involves: 129S1/SvImJ * CAST/Ei)	abnormal circulating cholesterol level	J:88732
Nhdlq3^129S1/SvImJ/Nhdlq3^RIIIS/J (involves: 129S1/SvImJ * RIIIS/J)	abnormal lipid homeostasis	J:89282
Nhdlq3^RIIIS/J/Nhdlq3^RIIIS/J (involves: 129S1/SvImJ * RIIIS/J)	abnormal lipid homeostasis	J:89282
Nhdlq4^129S1/SvImJ/Nhdlq4^129S1/SvImJ (involves: 129S1/SvImJ * C57BL/6J)	abnormal circulating cholesterol level	J:93243
Nhdlq4^129S1/SvImJ/Nhdlq4^129S1/SvImJ Nhdlq5^C57BL/6J/Nhdlq5^C57BL/6J (involves: 129S1/SvImJ * C57BL/6J)	abnormal circulating cholesterol level	J:93243
Nhdlq4^129S1/SvImJ/Nhdlq4^129S1/SvImJ Nhdlq7^C57BL/6J/Nhdlq7^C57BL/6J (involves: 129S1/SvImJ * C57BL/6J)	abnormal circulating cholesterol level	J:93243
Nhdlq9^DBA/2J/? (involves: DBA/2J * PERA/EiJ)	abnormal circulating cholesterol level	J:112668
Nhdlq10^PERA/EiJ/? (involves: I/LnJ * PERA/EiJ)	abnormal circulating cholesterol level	J:112668
Nherf1^em1(IMPC)H/Nherf1^em1(IMPC)H (C57BL/6NTac-Nherf1^em1(IMPC)H/H)	decreased circulating iron level	J:211773
Nherf1^tm1Geo/Nherf1^tm1Geo (involves: C57BL/6J)	decreased circulating phosphate level	J:95282
Nherf1^tm1Ssl/Nherf1^tm1Ssl (involves: 129X1/SvJ * C57BL/6)	increased urine phosphate level	J:78606
Nherf2^{tm2a(EUCOMM)Hmgu}/Nherf2^{tm2a(EUCOMM)Hmgu} (C57BL/6N-Nherf2^{tm2a(EUCOMM)Hmgu}/Wtsi)	increased circulating alkaline phosphatase level	J:211773
Nhil1^C57BL/6JOla/? (involves: C57BL/6JOla * SWR/Ola)	increased liver iron level	J:114755
Nhil2^SWR/Ola/? (involves: C57BL/6JOla * SWR/Ola)	increased liver iron level	J:114755
Nhil3^SWR/Ola/? (involves: C57BL/6JOla * SWR/Ola)	increased liver iron level	J:114755
Nhil4^SWR/Ola/? (involves: C57BL/6JOla * SWR/Ola)	increased liver iron level	J:114755
Nhil5^SWR/Ola/? (involves: C57BL/6JOla * SWR/Ola)	increased liver iron level	J:114755
Nhlh2^em1(IMPC)Mbp/Nhlh2^em1(IMPC)Mbp (C57BL/6N-Nhlh2^em1(IMPC)Mbp/Ucd)	impaired glucose tolerance	J:211773
Nhlh2^{tm1b(KOMP)Mbp}/Nhlh2^{tm1b(KOMP)Mbp} (C57BL/6N-Nhlh2^{tm1b(KOMP)Mbp}/Tcp)	abnormal cholesterol homeostasis	J:211773
	increased circulating alanine transaminase level	J:211773
	increased circulating aspartate transaminase level	J:211773
Nhlh2^tm1Irk/Nhlh2^tm1Irk (involves: 129S4/SvJae * C57BL/6)	decreased circulating follicle stimulating hormone level	J:39356
	decreased circulating testosterone level	J:39356
	decreased core body temperature	J:96351
Nhlh2^tm2Thbr/Nhlh2^tm2Thbr Tg(CMV-cre)1Cgn/0 (involves: 129S7/SvEvBrd * BALB/cJ * C57BL/6)	decreased circulating estradiol level	J:199640
Nhlrc1^{tm1(KOMP)Vlcg}/Nhlrc1^{tm1(KOMP)Vlcg} (involves: C57BL/6J * C57BL/6NTac)	increased brain glycogen level	J:165994
	increased cardiac muscle glycogen level	J:165994
	increased glycogen level	J:165994
	increased skeletal muscle glycogen level	J:165994, J:218959
Nhlrc1^tm1Bmin/Nhlrc1^tm1Bmin (involves: 129S6/SvEvTac * C57BL/6 * C57BL/6NCr)	decreased glycogen catabolism rate	J:181674
	increased liver glycogen level	J:181674
	increased skeletal muscle glycogen level	J:181674
Nhp2^{tm1a(KOMP)Wtsi}/Nhp2⁺ (C57BL/6N-Nhp2^{tm1a(KOMP)Wtsi}/Wtsi)	decreased circulating fructosamine level	J:211773
Nidd1^NON/LtHl/Nidd1^NON/LtHl (involves: NON/LtHl * NZO/Hl)	abnormal glucose homeostasis	J:48957
Nidd1^NON/LtHl/Nidd1^NZO/Hl (involves: NON/LtHl * NZO/Hl)	abnormal glucose homeostasis	J:48957
Nidd1^NZO/Hl/Nidd1^NZO/Hl (involves: NON/LtHl * NZO/Hl)	abnormal glucose homeostasis	J:48957
Nidd1k^KK-A(y)/Jcl/Nidd1k^KK-A(y)/Jcl (involves: KK * PWK)	hyperglycemia	J:76775
Nidd1n^C3H/HeCrj/Nidd1n^NSY (involves: C3H/HeCrj * NSY)	impaired glucose tolerance	J:55284
Nidd1n^NSY/Nidd1n^NSY (involves: C3H/HeCrj * NSY)	impaired glucose tolerance	J:55284
Nidd2^NON/LtHl/Nidd2^NON/LtHl (involves: NON/LtHl * NZO/Hl)	abnormal circulating glucose level	J:48957
Nidd2^NON/LtHl/Nidd2^NON/LtHl (involves: NON/LtHl * NZO/Hl)	abnormal glucose homeostasis	J:48957
Nidd2^NON/LtHl/Nidd2^NZO/Hl (involves: NON/LtHl * NZO/Hl)	abnormal circulating glucose level	J:48957
Nidd2^NON/LtHl/Nidd2^NZO/Hl (involves: NON/LtHl * NZO/Hl)	abnormal glucose homeostasis	J:48957
Nidd2k^KK/TaJcl/Nidd2k^KK/TaJcl (involves: KK * PWK)	hyperglycemia	J:76775
Nidd2n^NSY/Nidd2n^NSY (involves: C3H/HeCrj * NSY)	impaired glucose tolerance	J:55284
Nidd3^NON/LtHl/Nidd3^NZO/Hl (involves: NON/LtHl * NZO/Hl)	abnormal glucose homeostasis	J:48957
Nidd3^NZO/Hl/Nidd3^NZO/Hl (involves: NON/LtHl * NZO/Hl)	abnormal glucose homeostasis	J:48957
Nidd3k^KK/TaJcl/Nidd3k^KK/TaJcl (involves: KK * PWK)	abnormal glucose homeostasis	J:76775
Nidd3k^KK/TaJcl/Nidd3k^KK/TaJcl (involves: KK * PWK)	increased glycosylated hemoglobin level	J:76775
Nidd3n^C3H/HeCrj/Nidd3n^NSY (involves: C3H/HeCrj * NSY)	impaired glucose tolerance	J:55284
Nidd3n^NSY/Nidd3n^NSY (involves: C3H/HeCrj * NSY)	impaired glucose tolerance	J:55284
Nidd4^TSOD/Nidd4^TSOD (involves: BALB/cA * TSOD)	hyperglycemia	J:55285
Nidd4k^KK/TaJcl/Nidd4k^KK/TaJcl (involves: KK * PWK)	hyperglycemia	J:76775
Nidd4n^NSY/Nidd4n^NSY (involves: C3H/HeCrj * NSY)	impaired glucose tolerance	J:55284
Nidd5^BALB/cA/Nidd5^TSOD (involves: BALB/cA * TSOD)	decreased circulating insulin level	J:55285
Nidd5^TSOD/Nidd5^TSOD (involves: BALB/cA * TSOD)	decreased circulating insulin level	J:55285
Nidd5k^KK/TaJcl/Nidd5k^KK/TaJcl (involves: KK * PWK)	hyperglycemia	J:76775
Nidd6k^PWK/Nidd6k^PWK (involves: KK/Jcl-A^y * PWK)	hypoglycemia	J:76775
Nidd7k^KK/TaJcl/Nidd7k^KK/TaJcl (involves: KK * PWK)	hyperglycemia	J:76775
Nidds^NZO/HlBom/Nidds^SJL/NBom (involves: NZO/HlBom * SJL/NBom)	decreased circulating insulin level	J:64158
	hyperglycemia	J:64158
Nidds^SJL/NBom/? (involves: NZO/HlBom * SJL/NBom)	hyperglycemia	J:78920
Nidds^SJL/NBom/? Tbc1d1^{Nobq1-NZO/HlBom}/? (involves: NZO/HlBom * SJL/NBom)	abnormal glucose homeostasis	J:78920
Nil/Nil⁺ (involves: A/Cam)	abnormal intestinal lipid absorption	J:33328
Nin^{tm1c(EUCOMM)Hmgu}/Nin^{tm1c(EUCOMM)Hmgu} Tg(KRT14-cre)1Ipc/0 (involves: C57BL/6 * C57BL/6N * SJL)	impaired skin barrier function	J:277726
Nin^{tm1d(EUCOMM)Hmgu}/Nin^{tm1d(EUCOMM)Hmgu} (involves: BALB/c * C57BL/6 * C57BL/6N)	impaired skin barrier function	J:277726
Ninj2^{tm1a(KOMP)Wtsi}/Ninj2^{tm1a(KOMP)Wtsi} (C57BL/6N-Ninj2^{tm1a(KOMP)Wtsi}/Wtsi)	increased circulating calcium level	J:211773
Nipa1^{tm1a(KOMP)Wtsi}/Nipa1^{tm1a(KOMP)Wtsi} (B6JTyr;B6N-Nipa1^{tm1a(KOMP)Wtsi}/Wtsi)	decreased circulating HDL cholesterol level	J:175295
Nipal4^tm1Akih/Nipal4^tm1Akih (involves: C57BL/6J * C57BL/6NCrlj * CBA/JNCrlj)	abnormal magnesium ion homeostasis	J:261184
	decreased ceramide level	J:261184
	decreased sphingosine level	J:261184
	impaired skin barrier function	J:261184
	increased ceramide level	J:261184
	increased sphingosine level	J:261184
Nipbl^{Gt(RRS564)Byg}/Nipbl⁺ (involves: 129P2/OlaHsd * C57BL/6J * CD-1)	abnormal chemokine level	J:297059
Nisch^{tm1b(EUCOMM)Hmgu}/Nisch⁺ (C57BL/6N-Nisch^{tm1b(EUCOMM)Hmgu}/H)	impaired glucose tolerance	J:211773
Nisch^{tm1b(EUCOMM)Hmgu}/Nisch^{tm1b(EUCOMM)Hmgu} (C57BL/6N-Nisch^{tm1b(EUCOMM)Hmgu}/H)	impaired glucose tolerance	J:211773
	increased circulating cholesterol level	J:211773
	increased circulating HDL cholesterol level	J:211773
	increased circulating phosphate level	J:211773
	increased circulating triglyceride level	J:211773
Nkg7^{tm1.1(KOMP)Vlcg}/Nkg7^{tm1.1(KOMP)Vlcg} (involves: C57BL/6NTac)	decreased circulating interferon-gamma level	J:301637
	decreased circulating tumor necrosis factor level	J:301637
Nkx2-1^tm1Shk/Nkx2-1⁺ (involves: 129S4/SvJae)	increased circulating thyroid-stimulating hormone level	J:74696
Nkx2-1^tm2Shk/Nkx2-1^tm2Shk (involves: 129S4/SvJae * 129X1/SvJ)	increased circulating thyroid-stimulating hormone level	J:111027
Nkx2-1^tm2Shk/Nkx2-1^tm2Shk Tg(TPO-cre)1Shk/0 (involves: 129X1/SvJ * FVB/NCr)	increased circulating thyroid-stimulating hormone level	J:111027
Nkx2-2^tm1Jlr/Nkx2-2^tm1Jlr (involves: 129X1/SvJ)	decreased glucagon secretion	J:48576
	decreased insulin secretion	J:48576
	hyperglycemia	J:48576
Nkx2-2^tm2.1Suss/Nkx2-2^tm2.1Suss (involves: 129S6/SvEvTac * Black Swiss * C57BL/6 * C57BL/6J * SJL)	hyperglycemia	J:177838
Nkx2-2^tm5.1Suss/Nkx2-2^tm5.1Suss Tg(Pdx1-cre)6Tuv/0 (involves: 129S6/SvEvTac * C57BL/6 * FVB/N * NTac:NIHBS * SJL)	hyperglycemia	J:204869
	increased circulating glucose level	J:204869
Nkx2-3^tm1Rph/Nkx2-3^tm1Rph (involves: 129S1/Sv * C57BL/6)	decreased circulating triglyceride level	J:64018
Nkx2-3^tm1Rph/Nkx2-3^tm1Rph (involves: 129S1/Sv * C57BL/6)	steatorrhea	J:64018
Nkx2-5^tm1.1Burg/Nkx2-5^tm1.1Burg (involves: 129S1/Sv * 129S2/SvPasCrl * 129X1/SvJ)	pericardial effusion	J:251389
Nkx2-5^tm1.1Hkas/Nkx2-5⁺ (129S2.Cg-Nkx2-5^tm1.1Hkas)	cyanosis	J:273096
Nkx2-5^tm1Krc/Nkx2-5^tm1Krc Isl1^tm1(cre)Tmj/Isl1⁺ (involves: 129X1/SvJ * C57BL/6)	cyanosis	J:214093
Nkx2-5^tm1Siz/Nkx2-5^tm1Siz (involves: 129S4/SvJaeSor * C57BL/6J)	pericardial effusion	J:52597
Nkx2-5^tm1Siz/Nkx2-5^tm1Siz Nkx2-6^tm1Siz/Nkx2-6^tm1Siz (involves: 129S1/Sv * 129S4/SvJaeSor * 129X1/SvJ * C57BL/6J)	pericardial effusion	J:69976
Nkx2-5^tm1Wehi/Nkx2-5^tm1Wehi (involves: 129P2/OlaHsd * C57BL/6J * C57BL/10)	edema	J:27443
	pericardial edema	J:27443
Nkx2-6^em1(IMPC)H/Nkx2-6^em1(IMPC)H (C57BL/6NTac-Nkx2-6^em1(IMPC)H/H)	increased circulating alanine transaminase level	J:211773
	increased circulating potassium level	J:211773
Nkx3-1^tm1Hha/Nkx3-1^tm1Hha (involves: 129S4/SvJae * C57BL/6)	decreased salivation	J:63764
Nkx6-1^tm1Jlr/Nkx6-1^tm1.1Msan Tg(CAG-Bgeo/GFP)21Lbe/0 Tg(Neurog3-cre)C1Able/0 (involves: 129/Sv * C57BL/6 * SJL)	dehydration	J:195153
	hyperglycemia	J:195153
Nkx6-1^tm1Jlr/Nkx6-1^tm1Jlr (involves: 129 * C57BL/6J)	decreased insulin secretion	J:65594
Nkx6-3^tm1Shiv/Nkx6-3^tm1Shiv (involves: 129S6/SvEvTac * C57BL/6)	decreased circulating gastrin level	J:136085
Nlgn2^tm1.1Gchn/Nlgn2^tm1.1Gchn (involves: 129S/SvEv * C57BL/6J)	increased circulating corticosterone level	J:272181
Nlgn3^{em1(IMPC)Rbrc}/Y (C57BL/6NJcl-Nlgn3^{em1(IMPC)Rbrc}/Rbrc)	abnormal blood uric acid level	J:211773
Nlk^{tm2b(KOMP)Wtsi}/Nlk⁺ (C57BL/6N-Nlk^{tm2b(KOMP)Wtsi}/Orl)	increased circulating alkaline phosphatase level	J:211773
Nln^{Gt(NPX481)Byg}/Nln^{Gt(NPX481)Byg} (B6.129P2-Nln^{Gt(NPX481)Byg})	abnormal gluconeogenesis	J:214116
	improved glucose tolerance	J:214116
	increased insulin sensitivity	J:214116
Nlrc3^tm1Bhk/Nlrc3^tm1Bhk (B6.129S6-Nlrc3^tm1Bhk)	decreased body temperature	J:187586
	increased circulating interleukin-6 level	J:187586
	increased circulating tumor necrosis factor level	J:187586
Nlrc4^em1Vnce/Nlrc4^em1Vnce (C57BL/6-Nlrc4^em1Vnce)	decreased lactate dehydrogenase level	J:294930
Nlrc4^em1Vnce/Nlrc4^em1Vnce Nlrp3^tm1Vmd/Nlrp3^tm1Vmd (involves: C57BL/6J * C57BL/6N)	decreased lactate dehydrogenase level	J:294930
Nlrc4^em2Vnce/Nlrc4^em2Vnce (C57BL/6-Nlrc4^em2Vnce)	decreased lactate dehydrogenase level	J:294930
Nlrc4^em2Vnce/Nlrc4^em2Vnce Nlrp3^tm1Vmd/Nlrp3^tm1Vmd (involves: C57BL/6J * C57BL/6N)	decreased lactate dehydrogenase level	J:294930
Nlrp1a^m2Btlr/Nlrp1a^m2Btlr (C57BL/6J-Nlrp1a^m2Btlr)	hypoglycemia	J:265174
Nlrp1b^tm1Bhk/Nlrp1b^tm1Bhk (129S6/SvEvTac-Nlrp1b^tm1Bhk)	decreased lactate dehydrogenase level	J:189777
Nlrp3^tm1Bhk/Nlrp3^tm1Bhk (involves: 129S6/SvEvTac)	decreased lactate dehydrogenase level	J:189777
Nlrp3^tm1Bhk/Nlrp3^tm1Bhk (B6.129S6-Nlrp3^tm1Bhk/J)	decreased energy expenditure	J:256504
	increased liver triglyceride level	J:256504
	increased susceptibility to diet-induced obesity	J:256504
Nlrp3^tm1Flv/Nlrp3^tm1Flv (involves: 129S5/SvEvBrd * C57BL/6)	decreased circulating interleukin-1 beta level	J:113333
	decreased circulating interleukin-18 level	J:113333
Nlrp3^tm1Hhf/Nlrp3⁺ Lyz2^tm1(cre)Ifo/Lyz2⁺ (involves: 129/Sv * 129P2/OlaHsd * C57BL/6)	abnormal circulating chemokine level	J:150054
	abnormal circulating cytokine level	J:150054
	increased circulating interleukin-1 beta level	J:150054
	increased circulating interleukin-6 level	J:150054
	increased circulating interleukin-18 level	J:150054
	increased circulating tumor necrosis factor level	J:150054
Nlrp3^tm1Vmd/Nlrp3^tm1Vmd (B6.B6N-Nlrp3^tm1Vmd)	decreased circulating interleukin-1 beta level	J:193522
Nlrp3^tm1Vmd/Nlrp3^tm1Vmd (B6.B6N-Nlrp3^tm1Vmd)	decreased circulating interleukin-18 level	J:193522
Nlrp3^tm3.1Hhf/Nlrp3⁺ (involves: 129)	abnormal circulating chemokine level	J:202147
	decreased circulating interleukin-5 level	J:202147
	decreased circulating interleukin-12b level	J:202147
	increased circulating interleukin-1 beta level	J:202147
	increased circulating interleukin-3 level	J:202147
	increased circulating interleukin-4 level	J:202147
	increased circulating interleukin-6 level	J:202147
	increased circulating interleukin-9 level	J:202147
	increased circulating interleukin-13 level	J:202147
	increased circulating interleukin-18 level	J:202147
	increased circulating tumor necrosis factor level	J:202147
Nlrp6^tm1Flv/Nlrp6^tm1Flv (B6.Cg-Nlrp6^tm1Flv)	decreased circulating interleukin-18 level	J:173245
Nlrp6^tm1Macha/Nlrp6^tm1Macha (involves: 129S5/SvEvBrd * C57BL/6J)	intestinal edema	J:173352
Nlrp6^tm1Opaz/Nlrp6^tm1Opaz (B6.Cg-Nlrp6^tm1Opaz)	decreased urine osmolality	J:220441
Nlrp12^tm1Tdk/Nlrp12^tm1Tdk (B6.Cg-Nlrp12^tm1Tdk)	abnormal chemokine level	J:178951
Nlrp12^tm1Tdk/Nlrp12^tm1Tdk (B6.Cg-Nlrp12^tm1Tdk)	abnormal cytokine level	J:178951
Nlrx1^tm1Jpyt/Nlrx1^tm1Jpyt (involves: C57BL/6 * C57BL/6J)	increased circulating interleukin-6 level	J:173995
nm3/nm3 (involves: RIIIS/J)	decreased dopamine level	J:88298
nma/nma (B6C3Fe a/a-nma/J)	decreased circulating glucose level	J:60439
Nmbr^tm1Hoh/Nmbr^tm1Hoh (involves: 129P2/OlaHsd * C57BL/6J)	abnormal body temperature homeostasis	J:52410
Nmi^em1Hhl/Nmi^em1Hhl (C57BL/6-Nmi^em1Hhl)	decreased circulating alanine transaminase level	J:298909
	decreased circulating aspartate transaminase level	J:298909
	decreased circulating interleukin-6 level	J:298909
	decreased circulating tumor necrosis factor level	J:298909
Nmnat2^em1(IMPC)Mbp/Nmnat2^em1(IMPC)Mbp (C57BL/6N-Nmnat2^em1(IMPC)Mbp/Ucd)	edema	J:211773
Nmnat3^Gt(3020)Tgen/Nmnat3^Gt(3020)Tgen (involves: C57BL/6NCrlj * CBA/JNCrlj)	abnormal enzyme/coenzyme level	J:214107
	increased spleen iron level	J:214107
Nmral1^{tm1.1(KOMP)Vlcg}/Nmral1^{tm1.1(KOMP)Vlcg} (C57BL/6N-Nmral1^{tm1.1(KOMP)Vlcg}/Ucd)	increased respiratory quotient	J:211773
Nmrk2^{tm1.1(KOMP)Vlcg}/Nmrk2^{tm1.1(KOMP)Vlcg} (C57BL/6N-Nmrk2^{tm1.1(KOMP)Vlcg}/J)	increased circulating phosphate level	J:211773
	increased circulating sodium level	J:211773
Nmt1^tm1.1Poru/Nmt1^tm1.1Poru Nmt2^tm1.1Poru/Nmt2^tm1.1Poru Tg(Lck-cre)1Cwi/0 (involves: C57BL/6 * DBA/2 * SJL)	decreased circulating interferon-gamma level	J:226234
	decreased circulating interleukin-2 level	J:226234
	decreased circulating tumor necrosis factor level	J:226234
Nmt2^{tm2b(EUCOMM)Hmgu}/Nmt2⁺ (C57BL/6N-Nmt2^{tm2b(EUCOMM)Hmgu}/Ieg)	increased circulating alkaline phosphatase level	J:211773
Nmu^tm1Mko/Nmu^tm1Mko (involves: 129 * C57BL/6)	abnormal glucose homeostasis	J:93213
	abnormal lipid homeostasis	J:93213
	decreased circulating corticosterone level	J:93213
	decreased oxygen consumption	J:93213
	hyperglycemia	J:93213
	impaired adaptive thermogenesis	J:93213
	increased circulating cholesterol level	J:93213
	increased circulating free fatty acids level	J:93213
	increased circulating insulin level	J:93213
	increased circulating leptin level	J:93213
	increased triglyceride level	J:93213
Nmu^tm1Sjab/Nmu^tm1Sjab (involves: 129P2/OlaHsd * C57BL/6)	decreased circulating interleukin-6 level	J:142907
Nmur1^{tm1.1(KOMP)Vlcg}/Nmur1^{tm1.1(KOMP)Vlcg} (C57BL/6N-Nmur1^{tm1.1(KOMP)Vlcg}/Ucd)	decreased blood urea nitrogen level	J:211773
Nmur2^tm1.1Eege/Nmur2^tm1.1Eege (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	increased susceptibility to diet-induced obesity	J:152493
Nmur2^tm1Dgen/Nmur2^tm1Dgen (B6N.Cg-Nmur2^tm1Dgen)	decreased circulating glucose level	J:152371
	decreased circulating leptin level	J:152371
	decreased susceptibility to diet-induced obesity	J:152371
Nnat^tm1.1Geno/Nnat⁺ Ins1^{tm1.1(cre)Thor}/Ins1⁺ (involves: 129S2/SvPas * C57BL/6J)	decreased insulin secretion	J:265677
	impaired glucose tolerance	J:265677
	increased fasting circulating glucose level	J:265677
Nnat^tm1.2Geno/Nnat⁺ (either: 129S2(Cg)-Nnat^tm1.2Geno or B6.129S2(Cg)-Nnat^tm1.2Geno)	decreased insulin secretion	J:265677
	increased circulating insulin level	J:265677
Nnt^C57BL/6J/Nnt^C57BL/6J (C57BL/6J)	decreased circulating corticosterone level	J:185986
	decreased insulin secretion	J:109356
	impaired glucose tolerance	J:109356
Nnt^G745D/Nnt^G745D (involves: BALB/c * C3H/HeH)	decreased insulin secretion	J:108421
Nnt^G745D/Nnt^G745D (involves: BALB/c * C3H/HeH)	impaired glucose tolerance	J:108421
Nnt^N68K/Nnt^N68K (involves: BALB/c * C3H/HeH)	decreased insulin secretion	J:108421
Nnt^N68K/Nnt^N68K (involves: BALB/c * C3H/HeH)	impaired glucose tolerance	J:108421
Nobox^{tm1.1(KOMP)Vlcg}/Nobox⁺ (C57BL/6N-Nobox^{tm1.1(KOMP)Vlcg}/Ucd)	decreased fasting circulating glucose level	J:211773
Nobq2^NZO/HlBom/? (involves: NZO/HlBom * SJL/NBom)	increased circulating insulin level	J:66744
Noc4l^em1(IMPC)J/Noc4l⁺ (C57BL/6NJ-Noc4l^em1(IMPC)J/Mmjax)	increased circulating aspartate transaminase level	J:211773
Noct^tm1Bjc/Noct^tm1Bjc (B6.129S2-Noct^tm1Bjc)	decreased susceptibility to diet-induced obesity	J:122301
	impaired glucose tolerance	J:122301
	increased circulating glucose level	J:122301
	increased insulin sensitivity	J:122301
Nod2^tm1Flv/Nod2^tm1Flv (involves: 129S1/Sv)	increased circulating interferon-gamma level	J:147177
	increased circulating interleukin-2 level	J:147177
	increased circulating tumor necrosis factor level	J:147177
Nod2^tm1Jhgt/Nod2^tm1Jhgt (B6.Cg-Nod2^tm1Jhgt)	abnormal cytokine level	J:124575
	abnormal interferon level	J:124575
	abnormal interleukin level	J:124575
	abnormal tumor necrosis factor level	J:124575
Nod2^tm1Mka/Nod2^tm1Mka (involves: C57BL/6)	abnormal cytokine level	J:96128
Nodal^{TgR(MPSVNeo)413.dRob}/Nodal^tm4Rob (involves: 129S/SvEv * C57BL/6)	pericardial edema	J:84300
Nodal^{tm1b(EUCOMM)Wtsi}/Nodal⁺ (C57BL/6N-Nodal^{tm1b(EUCOMM)Wtsi}/H)	increased circulating cholesterol level	J:211773
	increased circulating HDL cholesterol level	J:211773
	increased circulating triglyceride level	J:211773
Nog^em1(IMPC)Mbp/Nog⁺ (C57BL/6N-Nog^em1(IMPC)Mbp/MbpMmucd)	edema	J:211773
Nog^em1(IMPC)Mbp/Nog⁺ (C57BL/6N-Nog^em1(IMPC)Mbp/MbpMmucd)	increased circulating alkaline phosphatase level	J:211773
Nog^tm1Amc/Nog^tm1Amc (involves: 129S1/Sv * CD-1)	edema	J:108573
Nol4^em1(IMPC)J/Nol4^em1(IMPC)J (C57BL/6NJ-Nol4^em1(IMPC)J/Mmjax)	increased circulating triglyceride level	J:211773
Nol8^{tm1b(EUCOMM)Hmgu}/Nol8⁺ (C57BL/6N-Nol8^{tm1b(EUCOMM)Hmgu}/Ics)	increased fasting circulating glucose level	J:211773
Nol9^em1(IMPC)J/Nol9⁺ (C57BL/6NJ-Nol9^em1(IMPC)J/Mmjax)	decreased blood urea nitrogen level	J:211773
Nol9^em1(IMPC)J/Nol9⁺ (C57BL/6NJ-Nol9^em1(IMPC)J/Mmjax)	increased circulating creatinine level	J:211773
Nop10^{tm1.1(KOMP)Vlcg}/Nop10⁺ (C57BL/6N-Nop10^{tm1.1(KOMP)Vlcg}/J)	increased circulating alkaline phosphatase level	J:211773
Nos1^tm1Plh/Nos1^tm1Plh (involves: 129S4/SvJae * C57BL/6)	abnormal carbon dioxide production	J:106328
	abnormal oxygen consumption	J:106328
	increased oxygen consumption	J:106328
Nos1^tm1Plh/Nos1^tm1Plh (involves: 129S4/SvJae)	insulin resistance	J:62229
Nos1^tm1Plh/Nos1^tm1Plh (B6.129S4-Nos1^tm1Plh)	abnormal serotonin level	J:127032
	decreased adiponectin level	J:155090
	increased circulating triglyceride level	J:155090
Nos1^tm1Plh/Nos1^tm1Plh (involves: 129S4/SvJae * C57BL/6J)	abnormal renal water reabsorption	J:64896
	increased urine bicarbonate level	J:64896
	increased urine pH	J:64896
	metabolic acidosis	J:64896
Nos1^tm1Plh/Nos1^tm1Plh Nos2^tm1Mrl/Nos2^tm1Mrl (involves: 129S4/SvJae * 129S7/SvEvBrd)	decreased urine osmolality	J:100308
	decreased urine sodium level	J:100308
	increased blood osmolality	J:100308
	increased blood urea nitrogen level	J:100308
Nos1^tm1Plh/Nos1^tm1Plh Nos2^tm1Mrl/Nos2^tm1Mrl Nos3^tm1Plh/Nos3^tm1Plh (involves: 129S4/SvJae * 129S7/SvEvBrd)	abnormal glomerular capillary thrombosis	J:100308
	abnormal nitric oxide homeostasis	J:100308
	decreased urine osmolality	J:100308
	decreased urine sodium level	J:100308
	dehydration	J:100308
	increased blood osmolality	J:100308
	increased blood urea nitrogen level	J:100308
	increased circulating alkaline phosphatase level	J:150159
	increased circulating creatinine level	J:100308
	increased prostaglandin level	J:100308
Nos1^tm1Plh/Nos1^tm1Plh Nos2^tm1Mrl/Nos2^tm1Mrl Nos3^tm1Plh/Nos3^tm1Plh (involves: 129S4/SvJae * 129S7/SvEvBrd * C57BL/6)	abnormal circulating glucose level	J:155090
	decreased adiponectin level	J:155090
	increased circulating LDL cholesterol level	J:155090
	increased circulating triglyceride level	J:155090
Nos1^tm1Plh/Nos1^tm1Plh Nos3^tm1Plh/Nos3^tm1Plh (involves: 129S4/SvJae)	decreased urine osmolality	J:100308
	decreased urine sodium level	J:100308
	increased blood osmolality	J:100308
	increased blood urea nitrogen level	J:100308
Nos1^tm2Plh/Nos1^tm2Plh (Not Specified)	decreased circulating follicle stimulating hormone level	J:106816
Nos1^tm2Plh/Nos1^tm2Plh (Not Specified)	increased circulating luteinizing hormone level	J:106816
Nos1ap^{tm1b(KOMP)Wtsi}/Nos1ap^{tm1b(KOMP)Wtsi} (C57BL/6N-Nos1ap^{tm1b(KOMP)Wtsi}/Bay)	decreased circulating alanine transaminase level	J:211773
Nos2^tm1Lau/Nos2^tm1Lau (involves: 129P2/OlaHsd * C57BL/6)	abnormal blood homeostasis	J:120673
	abnormal enzyme/coenzyme level	J:120673
	decreased circulating leptin level	J:94571
	improved glucose tolerance	J:72215
	increased circulating antidiuretic hormone level	J:106197
	increased circulating creatinine level	J:120673
	increased insulin sensitivity	J:72215
Nos2^tm1Lau/Nos2^tm1Lau (B6.129P2-Nos2^tm1Lau)	abnormal blood coagulation	J:117987
	abnormal glucose homeostasis	J:95957
	abnormal platelet physiology	J:117987
Nos2^tm1Lau/Nos2^tm1Lau (involves: 129P2/OlaHsd * C57BL/6J)	increased urine pH	J:64896
Nos2^tm1Lau/Nos2^tm1Lau (B6;129P2-Nos2^tm1Lau/J)	decreased circulating alanine transaminase level	J:148923
Nos2^tm1Lau/Nos2^tm1Lau (B6;129P2-Nos2^tm1Lau/J)	decreased circulating aspartate transaminase level	J:148923
Nos2^tm1Mrl/Nos2^tm1Mrl (involves: 129S7/SvEvBrd)	abnormal homeostasis	J:51635
	abnormal platelet aggregation	J:120499
	decreased urine prostaglandin level	J:120499
Nos2^tm1Mrl/Nos2^tm1Mrl (involves: 129S7/SvEvBrd * C57BL/6)	abnormal adrenocorticotropin level	J:109674
	abnormal blood homeostasis	J:97522
	abnormal circulating estradiol level	J:89542
	abnormal circulating glucose level	J:65562
	abnormal circulating serum albumin level	J:97522
	abnormal glucose homeostasis	J:65562
	abnormal hormone level	J:109674
	decreased adiponectin level	J:155090
	improved glucose tolerance	J:72215
	increased circulating cholesterol level	J:97522
	increased circulating creatinine level	J:97522
	increased circulating triglyceride level	J:155090
	increased insulin sensitivity	J:72215
Nos2^tm1Mrl/Nos2^tm1Mrl (B6.129S7-Nos2^tm1Mrl)	increased circulating prolactin level	J:162957
Nos2^tm1Mrl/Nos2^tm1Mrl Nos3^tm1Plh/Nos3^tm1Plh (involves: 129S4/SvJae * 129S7/SvEvBrd)	decreased urine osmolality	J:100308
	decreased urine sodium level	J:100308
	increased blood osmolality	J:100308
	increased blood urea nitrogen level	J:100308
Nos3^em1(IMPC)Mbp/Nos3^em1(IMPC)Mbp (C57BL/6N-Nos3^em1(IMPC)Mbp/Ucd)	decreased circulating phosphate level	J:211773
	decreased fasting circulating glucose level	J:211773
	increased blood urea nitrogen level	J:211773
Nos3^tm1.2Taka/Nos3^tm1.2Taka (involves: 129S4/SvJae * 129S6/SvEvTac * C57BL/6 * C57BL/6J * CBA)	increased circulating glucose level	J:187860
	increased circulating triglyceride level	J:187860
Nos3^tm1Gdk/Nos3^tm1Gdk (B6.129P2-Nos3^tm1Gdk)	abnormal dopamine level	J:64214
Nos3^tm1Gdk/Nos3^tm1Gdk (B6.129P2-Nos3^tm1Gdk)	abnormal serotonin level	J:64214
Nos3^tm1Plh/Nos3^tm1Plh (involves: 129S4/SvJae)	insulin resistance	J:62229
Nos3^tm1Plh/Nos3^tm1Plh (involves: 129S4/SvJae * C57BL/6J)	increased circulating estradiol level	J:89542
Nos3^tm1Plh/Nos3^tm1Plh (involves: 129S4/SvJae * C57BL/6J)	increased circulating progesterone level	J:89542
Nos3^tm1Plh/Nos3^tm1Plh (B6.129S4-Nos3^tm1Plh)	abnormal circulating glucose level	J:155090
	decreased adiponectin level	J:155090
	increased circulating triglyceride level	J:155090
Nos3^tm1Plh/Nos3^tm1Plh (involves: 129S4/SvJae * C57BL/6)	decreased circulating glucose level	J:133437
	decreased circulating insulin level	J:133437
	decreased prostaglandin level	J:108540
	increased circulating estradiol level	J:89702
Nos3^tm1Plh/Nos3^tm1Plh Ptgs1^tm1Unc/Ptgs1^tm1Unc (involves: 129P2/OlaHsd * 129S4/SvJae * C57BL/6)	decreased prostaglandin level	J:108540
Nos3^tm1Unc/Nos3^tm1Unc (involves: 129P2/OlaHsd * C57BL/6)	decreased body temperature	J:113106
Nos3^tm1Unc/Nos3^tm1Unc (involves: 129P2/OlaHsd * C57BL/6)	increased circulating renin level	J:36559
Nos3^tm1Unc/Nos3^tm1Unc (B6.129P2-Nos3^tm1Unc/J)	abnormal circulating protein level	J:129477
	abnormal glomerular capillary thrombosis	J:148626
	albuminuria	J:148626
	cyanosis	J:98913
	increased blood urea nitrogen level	J:148626
	increased circulating creatine kinase level	J:148626
	increased circulating osteocalcin level	J:129477
	pulmonary alveolar edema	J:103270
Nos3^tm1Unc/Nos3^tm1Unc (involves: 129P2/OlaHsd)	abnormal blood homeostasis	J:103153
	abnormal glucose homeostasis	J:103153
	hyperlipidemia	J:103153
	increased circulating cholesterol level	J:103153
	increased circulating free fatty acids level	J:103153
	increased circulating insulin level	J:103153
	increased circulating triglyceride level	J:103153
	insulin resistance	J:103153
Nos3^tm1Unc/Nos3^tm1Unc (involves: 129P2/OlaHsd * C57BL/6J)	increased circulating renin level	J:36559
Nos3^tm1Unc/Nos3^tm1Unc (BKS.129P2-Nos3^tm1Unc)	albuminuria	J:135864
Nos3^tm2.1Plh/Nos3^tm2.1Plh (involves: 129S4/SvJae * C57BL/6)	decreased adiponectin level	J:198075
	decreased circulating insulin level	J:198075
	increased circulating free fatty acids level	J:198075
	increased circulating LDL cholesterol level	J:198075
	increased circulating leptin level	J:198075
	insulin resistance	J:198075
Nos3^tm3.1Plh/Nos3^tm3.1Plh (involves: 129S4/SvJae * C57BL/6)	improved glucose tolerance	J:198075
	increased circulating glucose level	J:198075
	increased circulating insulin level	J:198075
Nosip^em1(IMPC)Tcp/Nosip^em1(IMPC)Tcp (C57BL/6NCrl-Nosip^em1(IMPC)Tcp/Tcp)	edema	J:211773
Nosip^{Gt(OST138992)Lex}/Nosip^{Gt(OST138992)Lex} (B6.129S5-Nosip^{Gt(OST138992)Lex})	cyanosis	J:245546
Notch1^tm1Agt/Notch1^tm1Agt Tg(Tek-cre)1Ywa/0 (involves: 129 * C57BL/6 * SJL)	hemopericardium	J:100449
	pericardial effusion	J:100449
Notch1^tm1Agt/Notch1^tm1Agt Tg(Tek-cre)12Flv/0 (involves: 129 * C3H * C57BL/6)	hemopericardium	J:100449
	pericardial effusion	J:100449
Notch1^tm1Agt/Notch1^tm1Agt Tg(Wt1-cre)#Jbeb/0 (involves: 129)	hemopericardium	J:178290
Notch1^tm1Grid/Notch1^tm1Grid Notch4^tm1Grid/Notch4^tm1Grid (involves: 129S1/Sv * C57BL/6)	pericardial edema	J:62571
Notch2^tm1.1Hhtg/Notch2⁺ (involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)	abnormal interleukin level	J:311038
	increased circulating interleukin-6 level	J:311038
	increased circulating type I collagen C-terminal telopeptide level	J:311038
Notch2^tm1Grid/Notch2^tm1Grid (involves: 129S1/Sv * C57BL/6J)	pericardial effusion	J:67157
	skin edema	J:67157
Notch2^tm2Grid/Notch2^tm2Grid (involves: 129S1/Sv * C57BL/6J)	pericardial edema	J:105278
Notch2^tm2Grid/Notch2^tm3Grid Speer6-ps1^{Tg(Alb-cre)21Mgn}/Speer6-ps1⁺ (involves: 129S1/Sv * C57BL/6 * DBA)	increased circulating alanine transaminase level	J:133171
	increased circulating alkaline phosphatase level	J:133171
	increased circulating bilirubin level	J:133171
Notch2^tm3.1Grid/Notch2^tm3.1Grid (involves: 129S1/Sv * C57BL/6J)	pericardial edema	J:105278
Notch2^tm3Grid/Notch2^tm3.1Grid Pax3^tm1(cre)Joe/Pax3⁺ (involves: 129 * C57BL/6)	cyanosis	J:132939
Notch2^tm3Grid/Notch2^tm3.1Grid Speer6-ps1^{Tg(Alb-cre)21Mgn}/Speer6-ps1⁺ (involves: 129S1/Sv * C57BL/6 * DBA)	increased circulating alanine transaminase level	J:133171
	increased circulating alkaline phosphatase level	J:133171
	increased circulating bilirubin level	J:133171
Notch2^tm3Grid/Notch2^tm3.1Grid Tg(Tagln-cre)1Her/? (involves: 129 * C57BL/6)	cyanosis	J:132939
Notch3^{tm1.1(KOMP)Vlcg}/Notch3^{tm1.1(KOMP)Vlcg} (C57BL/6N-Notch3^{tm1.1(KOMP)Vlcg}/Ucd)	improved glucose tolerance	J:211773
Notch3^tm1.1Dwr/Notch3⁺ (involves: 129S/SvEv * Swiss)	abnormal brain thrombosis	J:191454
Notch3^tm1.1Dwr/Notch3^tm1.1Dwr (involves: 129S/SvEv * Swiss)	abnormal brain thrombosis	J:191454
Nox1^tm1Kkr/Y (B6.129X1-Nox1^tm1Kkr)	abnormal enzyme/coenzyme level	J:105425
Nox3^het/Nox3^het (B6Ei.GL-Nox3^het/J)	abnormal circadian temperature homeostasis	J:88596
Nox4^em1(IMPC)Mbp/Nox4^em1(IMPC)Mbp (C57BL/6N-Nox4^em1(IMPC)Mbp/MbpMmucd)	increased circulating creatinine level	J:211773
Npas2^tm1Slm/Npas2^tm1Slm (B6.129S6-Npas2^tm1Slm)	decreased circulating adrenaline level	J:125921
Npas2^tm1Slm/Npas2^tm1Slm (B6.129S6-Npas2^tm1Slm)	decreased circulating noradrenaline level	J:125921
Npas2^tm1Slm/Npas2^tm1Slm (involves: 129S6/SvEvTac)	abnormal circulating protein level	J:155089
Npas3^tm1Mesu/Npas3^tm1Mesu (B6.129S6-Npas3^tm1Mesu)	cyanosis	J:150793
Npat^{tm1b(EUCOMM)Wtsi}/Npat^{tm1b(EUCOMM)Wtsi} (C57BL/6N-Npat^{tm1b(EUCOMM)Wtsi}/Wtsi)	subcutaneous edema	J:239583
Npbwr1^tm1Rck/Npbwr1^tm1Rck (involves: 129P/Ola * C57BL/6J)	abnormal lipid homeostasis	J:94820
	decreased oxygen consumption	J:94820
	hyperglycemia	J:94820
	increased circulating insulin level	J:94820
	increased circulating leptin level	J:94820
	increased susceptibility to diet-induced obesity	J:94820
Npc1^m1N/Npc1^m1N (involves: BALB/c)	abnormal lipid level	J:204311
	abnormal phospholipid level	J:204311
	decreased brain cholesterol level	J:104996, J:130969
	decreased circulating prolactin level	J:91430
	decreased prolactin level	J:91430
	increased cholesterol level	J:204311, J:104996, J:130969
	increased circulating cholesterol level	J:18511
	increased circulating follicle stimulating hormone level	J:91430
	increased circulating luteinizing hormone level	J:91430
	lipidosis	J:204311, J:18511
	pulmonary alveolar proteinosis	J:204311
Npc1^m1N/Npc1^m1N (involves: 129S1/Sv * BALB/c * C57BL/6)	abnormal lipid homeostasis	J:89617
Npc1^m1N/Npc1^m1N (involves: 129S1/Sv * BALB/c * C57BL/6)	increased liver cholesterol level	J:89617
Npc1^m1N/Npc1^m1N (BALB/cNctr-Npc1^m1N/J)	abnormal lipid level	J:179744
	decreased liver cholesterol level	J:179744
	increased liver cholesterol level	J:179744
Npc1^m1N/Npc1^m1N (involves: BALB/c * C57BL/6 * CBA)	abnormal phospholipid level	J:144240
Npc1^m1N/Npc1^m1N (B6.C-Npc1^m1N)	abnormal ceramide level	J:221855
	abnormal lipid homeostasis	J:221855
	abnormal lipid level	J:221855
	abnormal sphingomyelin level	J:221855
	increased cholesterol level	J:157113
	increased liver cholesterol level	J:221855
Npc1^m1N/Npc1^m1N (BALB/c-Npc1^m1N)	abnormal ceramide level	J:221855
	abnormal ganglioside level	J:221855
	abnormal lipid homeostasis	J:221855
	abnormal lipid level	J:221855
	abnormal sphingomyelin level	J:221855
	increased brain cholesterol level	J:172769, J:221855
	increased liver cholesterol level	J:221855
Npc1^m1N/Npc1^m1N (involves: BALB/c * C3H/HeJ * C57BL/6J)	abnormal enzyme/coenzyme level	J:188345
Npc1^m1N/Npc1^m1N (involves: BALB/c * C3H/HeJ * C57BL/6J)	increased brain cholesterol level	J:188345
Npc1^m1N/Npc1^m1N Npc2^tm1Plob/Npc2^tm1Plob (involves: 129S1/Sv * BALB/c * C57BL/6)	abnormal lipid homeostasis	J:89617
	increased liver cholesterol level	J:89617
Npc1^m1N/Npc1^m1N Tg(CAG-RAB9A)500Repa/0 (involves: BALB/c * C57BL/6 * CBA)	abnormal phospholipid level	J:144240
Npc1^m1N/Npc1^m1N Tg(PRNP-APPSweInd)8Dwst/0 (involves: BALB/c * C3H/HeJ * C57BL/6J)	abnormal enzyme/coenzyme level	J:188345
	increased brain cholesterol level	J:188345
Npc1^m1N/Npc1^tm1.1Apl Tg(CAG-cre/Esr1)5Amc/0 (B6J.Cg-Npc1^m1N/Npc1^tm1.1Apl Tg(CAG-cre/Esr1)5Amc)	increased brain cholesterol level	J:176888
Npc1^m1N/Npc1^tm1.1Apl Tg(Syn1-cre)671Jxm/0 (B6J.Cg-Npc1^m1N/Npc1^tm1.1Apl Tg(Syn1-cre)671Jxm)	increased brain cholesterol level	J:176888
Npc1^m1N/Npc1^tm1.2Apl (B6.Cg-Npc1^m1N/Npc1^tm1.2Apl)	increased cholesterol level	J:157113
Npc1^nmf164/Npc1^nmf164 (C57BL/6J-Npc1^nmf164/J)	abnormal lipid level	J:179744
	decreased liver cholesterol level	J:179744
	increased brain cholesterol level	J:179744
	increased liver cholesterol level	J:179744
	sphingomyelinosis	J:179744
Npc1^spm/Npc1^spm (C57BLKS/J-Npc1^spm/J)	abnormal cholesterol level	J:7245
	increased liver cholesterol level	J:102782, J:7245
	sphingomyelinosis	J:7245
Npc1^tm1.1Apl/Npc1^tm1.2Apl Tg(Pcp2-cre)2Mpin/0 (B6.Cg-Npc1^tm1.1Apl/Npc1^tm1.2Apl Tg(Pcp2-cre)2Mpin)	increased cholesterol level	J:157113
Npc1^tm1.1Dso/Npc1⁺ (B6.129-Npc1^tm1.1Dso)	increased brain cholesterol level	J:221855
Npc1^tm1.1Dso/Npc1^tm1.1Dso (B6.129-Npc1^tm1.1Dso)	abnormal ceramide level	J:221855
	abnormal cholesterol homeostasis	J:221855
	abnormal ganglioside level	J:221855
	abnormal lipid homeostasis	J:221855
	abnormal lipid level	J:221855
	abnormal sphingolipid level	J:221855
	increased brain cholesterol level	J:221855
	increased liver cholesterol level	J:221855
	sphingomyelinosis	J:221855
Npc1^tm1Mbjg/Npc1^tm1Mbjg (involves: 129S6/SvEvTac * C57BL/6J)	abnormal lipid level	J:176587
	increased cholesterol level	J:176587
	increased liver cholesterol level	J:176587
Npc1^tm1Tacf/Npc1^tm1Tacf (B6(Cg)-Npc1^tm1Tacf)	increased ceramide level	J:266795
Npc1^tm1Tacf/Npc1^tm1Tacf (B6(Cg)-Npc1^tm1Tacf)	increased liver cholesterol level	J:266795
Npc1^tm1Tacf/Npc1^tm2Tacf (B6(Cg)-Npc1^tm1Tacf Npc1^tm2Tacf)	increased ceramide level	J:266795
	increased liver cholesterol level	J:266795
Npc1l1^{tm1a(EUCOMM)Hmgu}/Npc1l1^{tm1a(EUCOMM)Hmgu} (involves: C57BL/6 * C57BL/6N)	abnormal intestinal cholesterol absorption	J:226578
	decreased circulating cholesterol level	J:226578
Npc1l1^{tm1a(EUCOMM)Hmgu}/Npc1l1^{tm1a(EUCOMM)Hmgu} (involves: C57BL/6N)	decreased intestinal cholesterol absorption	J:263730
Npc1l1^tm1Swa/Npc1l1^tm1Swa (involves: 129P2/OlaHsd * C57BL/6)	abnormal cholesterol level	J:89712
	decreased intestinal cholesterol absorption	J:89712
Npc1l1^tm1Yaio/Npc1l1^tm1Yaio (C57BL/6-Npc1l1^tm1Yaio)	abnormal cholesterol homeostasis	J:98568
	abnormal circulating LDL cholesterol level	J:98568
	abnormal intestinal lipid absorption	J:98568
	abnormal lipid homeostasis	J:98568
	abnormal triglyceride level	J:98568
	decreased circulating cholesterol level	J:98568
	decreased circulating glucose level	J:98568
	decreased circulating HDL cholesterol level	J:98568
	decreased intestinal cholesterol absorption	J:98568
	decreased susceptibility to diet-induced obesity	J:98568
	decreased susceptibility to hyperlipidemia	J:98568
Npc2^{tm1e.1(EUCOMM)Wtsi}/Npc2⁺ (C57BL/6N-Npc2^{tm1e.1(EUCOMM)Wtsi}/Tcp)	increased circulating potassium level	J:211773
Npc2^tm1Plob/Npc2^tm1Plob (involves: 129S1/Sv * BALB/c * C57BL/6)	abnormal lipid homeostasis	J:89617
	increased liver cholesterol level	J:89617
Npc2^tm1Plob/Npc2^tm1Plob (involves: 129S1/Sv * BALB/c)	abnormal lipid level	J:204311
	abnormal phospholipid level	J:204311
	increased cholesterol level	J:204311
	lipidosis	J:204311
	pulmonary alveolar proteinosis	J:204311
Npcd^em1(IMPC)J/Npcd^em1(IMPC)J (C57BL/6NJ-Npcd^em1(IMPC)J/Mmjax)	decreased circulating aspartate transaminase level	J:211773
	decreased circulating triglyceride level	J:211773
Npepps^goku/Npepps^goku (involves: 129P2/OlaHsd * BALB/cA)	decreased circulating follicle stimulating hormone level	J:69615
	decreased circulating luteinizing hormone level	J:69615
	decreased circulating prolactin level	J:69615
	decreased circulating testosterone level	J:69615
Npffr1^tm1Lex/Npffr1^tm1Lex (involves: 129 * C57BL/6)	decreased luteinizing hormone level	J:214329
	increased circulating luteinizing hormone level	J:214329
	increased follicle stimulating hormone level	J:214329
	increased luteinizing hormone level	J:214329
Npffr2^tm1.1Hhzg/Npffr2^tm1.1Hhzg (involves: C57BL/6)	abnormal adaptive thermogenesis	J:267918
	decreased energy expenditure	J:267918
	decreased respiratory quotient	J:267918
	increased circulating insulin level	J:267918
	increased circulating leptin level	J:267918
	increased energy expenditure	J:267918
	increased susceptibility to diet-induced obesity	J:267918
Nphp1^em1Lisu/Nphp1^em1Lisu (C57BL/6J-Nphp1^em1Lisu)	increased circulating creatinine level	J:324503
Nphp3^pcy/Nphp3^pcy (KK-Nphp3^pcy)	increased blood urea nitrogen level	J:8302
Nphp3^pcy/Nphp3^pcy (involves: DBA/2Fg * KK)	abnormal cholesterol homeostasis	J:2203
	abnormal circulating phospholipid level	J:2203
	abnormal phospholipid level	J:2203
	increased circulating cholesterol level	J:2203
Nphp3^pcy/Nphp3^pcy (either: D2.KK-Nphp3^pcy or (involves: DBA/2Fg * DBA/2J * KK))	increased blood urea nitrogen level	J:11399
Nphp3^pol/Nphp3^pol (C57BL/6JSfdAnu-Nphp3^pol/Anu)	increased blood urea nitrogen level	J:104190
Nphs1^{Gt(pT1Betageo)1Ruiz}/Nphs1^{Gt(pT1Betageo)1Ruiz} (involves: 129P2/OlaHsd * C57BL/6)	increased urine protein level	J:86048
Nphs1^tm1.1Tbh/Nphs1^tm1.1Tbh (involves: C57BL/6 * CBA)	increased urine protein level	J:241326
Nphs1^tm1Ktry/Nphs1^tm1Ktry (involves: 129X1/SvJ * C57BL/6)	albuminuria	J:66970
	edema	J:66970
	increased urine protein level	J:66970
Nphs1^tm1Rkl/Nphs1^tm1Rkl (involves: 129S2/SvPasCrl)	increased urine protein level	J:78616
Nphs2^tm1Antc/Nphs2^tm1Antc (involves: 129 * C57BL/6J)	albuminuria	J:87577
	increased blood urea nitrogen level	J:87577
	increased circulating creatinine level	J:87577
	increased urine protein level	J:87577
Nphs2^tm1Antc/Nphs2^tm1Antc (129-Nphs2^tm1Antc)	albuminuria	J:87577
	increased blood urea nitrogen level	J:87577
	increased circulating creatinine level	J:87577
	increased urine protein level	J:87577
Nphs2^tm1Antc/Nphs2^tm3.1Antc Tg(CAG-cre/Esr1)86Lbgn/0 (involves: 129 C57BL/6 * DBA)	albuminuria	J:166320
	increased blood urea nitrogen level	J:166320
	increased circulating cholesterol level	J:166320
	increased circulating creatinine level	J:166320
	increased urine protein level	J:166320
Nphs2^tm2.1Antc/Nphs2^tm2.1Antc (involves: 129S2/SvPas * C57BL/6)	albuminuria	J:152878
	increased blood urea nitrogen level	J:152878
	increased circulating creatinine level	J:152878
Nphs2^tm2.1Antc/Nphs2^tm3.1Antc Tg(CAG-cre/Esr1)86Lbgn/0 (involves: 129S2/SvPas C57BL/6 * DBA)	decreased circulating serum albumin level	J:245693
	increased circulating cholesterol level	J:245693
	increased urine creatinine level	J:245693
	increased urine protein level	J:245693
Npl^em1Avps/Npl^em1Avps (C57BL/6-Npl^em1Avps)	abnormal urine homeostasis	J:342764
Npl^em2Avps/Npl^em2Avps (C57BL/6-Npl^em2Avps)	abnormal urine homeostasis	J:342764
Npl^{Gt(OST15553)Lex}/Npl^{Gt(OST15553)Lex} (involves: 129S5/SvEvBrd * C57BL/6J)	increased circulating cholesterol level	J:103485
Npm3^{tm1.1(KOMP)Vlcg}/Npm3^{tm1.1(KOMP)Vlcg} (C57BL/6N-Npm3^{tm1.1(KOMP)Vlcg}/J)	decreased circulating glucose level	J:211773
Nppa^tm1Unc/Nppa^tm1Unc (involves: 129P2/OlaHsd * C57BL/6)	abnormal renal sodium reabsorption	J:95900
Nppa^tm1Unc/Nppa^tm1Unc (involves: 129P2/OlaHsd * C57BL/6)	increased circulating adrenaline level	J:57623
Npr1^tm1(Npr1)Unc/Npr1^tm1(Npr1)Unc (involves: 129P2/OlaHsd * C57BL/6)	increased circulating testosterone level	J:58344
Npr1^tm1.1Rsha/Npr1⁺ (involves: C57BL/6)	increased circulating aldosterone level	J:201932
Npr1^tm1.1Rsha/Npr1^tm1.1Rsha (involves: C57BL/6)	increased circulating aldosterone level	J:201932
Npr1^tm1Gar/Npr1^tm1Gar (involves: 129S7/SvEvBrd * C57BL/6J)	hydrops fetalis	J:30007
	increased circulating atrial natriuretic factor	J:42893
Npr1^tm1Kuhn/Npr1^tm1Kuhn Tg(Myh6-cre)2182Mds/0 (involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * FVB/N)	increased circulating atrial natriuretic factor	J:83298
Npr1^tm1Mae/Npr1^tm1Mae (involves: 129P2/OlaHsd * C57BL/6)	decreased circulating renin level	J:74420
Npr1^tm1Mae/Npr1^tm1Mae (involves: 129P2/OlaHsd * C57BL/6)	decreased circulating testosterone level	J:58344
Npr1^tm1Mae/Npr1^tm1Mae (B6.129P2-Npr1^tm1Mae)	increased circulating atrial natriuretic factor	J:78579
Npr2^cn/Npr2^cn (AKR/J)	cyanosis	J:5109
Npr2^em1(IMPC)H/Npr2^em1(IMPC)H (C57BL/6N-Npr2^em1(IMPC)H/H)	decreased circulating alkaline phosphatase level	J:211773
Npr3^kylb/Npr3^kylb (involves: BALB/c * C57BL/6J)	increased circulating alkaline phosphatase level	J:243806
Npr3^{tm1.1(KOMP)Vlcg}/Npr3⁺ (C57BL/6N-Npr3^{tm1.1(KOMP)Vlcg}/Tcp)	increased circulating phosphate level	J:211773
Npr3^tm1Unc/Npr3⁺ (involves: 129 * C57BL/6)	abnormal urine nucleotide level	J:56058
Npr3^tm1Unc/Npr3⁺ (involves: 129 * C57BL/6)	decreased urine osmolality	J:56058
Npr3^tm1Unc/Npr3^tm1Unc (involves: 129 * C57BL/6)	abnormal blood homeostasis	J:56058
	abnormal urine nucleotide level	J:56058
	decreased urine osmolality	J:56058
	dehydration	J:56058
	increased circulating alkaline phosphatase level	J:56058
Nprl3^tm1.1Drhi/Nprl3^tm1.1Drhi (involves: 129P2/OlaHsd)	edema	J:183988
	nuchal edema	J:183988
	pericardial edema	J:183988
Nptn^{tm1b(EUCOMM)Hmgu}/Nptn^{tm1b(EUCOMM)Hmgu} (C57BL/6N-Nptn^{tm1b(EUCOMM)Hmgu}/H)	increased circulating cholesterol level	J:211773
	increased circulating iron level	J:211773
	increased circulating phosphate level	J:211773
Npy1r^tm1.1Ceva/Npy1r^tm1.1Ceva Tg(Camk2a-tTA)1Mmay/0 Tg(tetO-cre)LC1Bjd/0 (involves: 129S1/Sv * 129X1/SvJ * BALB/c * C57BL/6 * SJL)	decreased circulating leptin level	J:180396
	increased circulating corticosterone level	J:180396
Npy1r^tm1.1Wpg/Npy1r^tm1.1Wpg (involves: 129X1/SvJ * C57BL/6)	decreased circulating interleukin-12 level	J:118850
	decreased circulating tumor necrosis factor level	J:118850
Npy1r^tm1Mnak/Npy1r^tm1Mnak (involves: 129P2/OlaHsd * C57BL/6)	decreased energy expenditure	J:51684
	impaired glucose tolerance	J:51684
	increased circulating insulin level	J:51684
Npy1r^tm1Snby/Npy1r^tm1Snby Npy5r^tm1Snby/Npy5r^tm1Snby (involves: 129 * C57BL/6)	decreased respiratory quotient	J:225097
	impaired glucose tolerance	J:225097
	increased circulating glucose level	J:225097
	increased energy expenditure	J:225097
	increased respiratory quotient	J:225097
Npy1r^tm1Tped/Npy1r^tm1Tped (involves: 129P2/OlaHsd * C57BL/6)	abnormal energy expenditure	J:47972
	decreased oxygen consumption	J:47972
	increased circulating free fatty acids level	J:47972
	increased circulating insulin level	J:47972
	increased circulating leptin level	J:47972
Npy1r^tm1Tped/Npy1r^tm1Tped (B6.129P2-Npy1r^tm1Tped)	abnormal glucose homeostasis	J:102554
	abnormal glycogen level	J:102554
	hyperglycemia	J:102554
	increased circulating corticosterone level	J:87424
	increased circulating insulin level	J:87424, J:102554
	increased circulating leptin level	J:87424
Npy2r^tm1.1Hhz/Npy2r^tm1.1Hhz (involves: 129X1/SvJ * C57BL/6)	abnormal circulating pancreatic peptide level	J:77345
	abnormal testosterone level	J:129609
	decreased circulating corticosterone level	J:107169
	decreased circulating insulin level	J:77345
	increased circulating insulin-like growth factor I level	J:129609
	increased growth hormone level	J:129609
Npy2r^tm1.1Hhz/Npy2r^tm1.1Hhz (involves: 129X1/SvJ * BALB/cJ * C57BL/6)	abnormal circulating pancreatic peptide level	J:84570
Npy2r^tm1.1Hhz/Npy2r^tm1.1Hhz Npy4r^tm1.1Hhz/Npy4r^tm1.1Hhz (involves: 129X1/SvJ * BALB/cJ * C57BL/6)	abnormal circulating pancreatic peptide level	J:84570
	decreased circulating insulin level	J:84570
	decreased circulating leptin level	J:84570
Npy2r^tm1.1Hhz/Npy2r^tm1.1Hhz Npy4r^tm1.1Hhz/Npy4r^tm1.1Hhz (involves: 129X1/SvJ * C57BL/6)	abnormal testosterone level	J:129609
	increased circulating insulin-like growth factor I level	J:129609
	increased growth hormone level	J:129609
Npy2r^tm1Hhz/Npy2r^tm1Hhz (involves: 129X1/SvJ * C57BL/6)	abnormal circulating hormone level	J:77345
	abnormal circulating insulin level	J:77345
	abnormal circulating pancreatic peptide level	J:77345
	increased circulating corticosterone level	J:77345, J:97455
Npy2r^tm1Pern/Npy2r^tm1Pern (involves: 129/Sv * BALB/c)	decreased energy expenditure	J:57961
Npy4r^tm1.1Hhz/Npy4r^tm1.1Hhz (involves: 129X1/SvJ * C57BL/6)	abnormal circulating pancreatic peptide level	J:76479
Npy4r^tm1.1Hhz/Npy4r^tm1.1Hhz (involves: 129X1/SvJ * BALB/cJ * C57BL/6)	abnormal circulating pancreatic peptide level	J:84570
Npy5r^em1(IMPC)H/Npy5r^em1(IMPC)H (C57BL/6NTac-Npy5r^em1(IMPC)H/H)	increased circulating alkaline phosphatase level	J:211773
	increased circulating HDL cholesterol level	J:211773
Npy5r^tm1Aka/Npy5r^tm1Aka (involves: C57BL/6 * CBA)	increased susceptibility to diet-induced obesity	J:109457
Npy5r^tm1Rpa/Npy5r^tm1Rpa (involves: 129S7/SvEvBrd)	increased circulating corticosterone level	J:87424
	increased circulating insulin level	J:87424
	increased circulating leptin level	J:87424
Npy6r^tm1Hhzg/Npy6r^tm1Hhzg (involves: 129S/SvEvBrd * C57BL/6)	abnormal circulating corticosterone level	J:210546
	abnormal circulating insulin-like growth factor I level	J:210546
	abnormal energy expenditure	J:210546
	decreased circulating insulin level	J:210546
	decreased circulating insulin-like growth factor I level	J:210546
	decreased respiratory quotient	J:210546
	impaired glucose tolerance	J:210546
	improved glucose tolerance	J:210546
	increased circulating glucose level	J:210546
	increased circulating insulin level	J:210546
	increased energy expenditure	J:210546
	increased respiratory quotient	J:210546
	increased susceptibility to diet-induced obesity	J:210546
Npy^{tm1(rtTA,tetO-cre/EGFP)Snby}/Npy⁺ Npy2r^tm1Hhz/Npy2r^tm1Hhz (involves: 129X1/SvJ * C57BL/6)	abnormal glucose homeostasis	J:162000
	decreased body temperature	J:162000
	increased liver triglyceride level	J:162000
	increased oxygen consumption	J:162000
Nqo1^tm1Akj/Nqo1^tm1Akj (involves: C57BL/6)	abnormal gluconeogenesis	J:120478
	decreased circulating glucose level	J:120478
	increased circulating glucagon level	J:120478
	increased circulating triglyceride level	J:120478
	increased triglyceride level	J:120478
	insulin resistance	J:120478
Nr0b1^{em2(IMPC)Wtsi}/Y (C57BL/6N-Nr0b1^{em2(IMPC)Wtsi}/Wtsi)	increased circulating alkaline phosphatase level	J:211773
	increased circulating iron level	J:211773
	increased circulating LDL cholesterol level	J:211773
	increased circulating magnesium level	J:211773
	increased circulating serum albumin level	J:211773
Nr0b1^tm1.1Lja/Y (involves: 129S1/Sv * 129X1/SvJ)	abnormal lipid homeostasis	J:71710
Nr0b2^tm1.1Auw/Nr0b2^tm1.1Auw (involves: 129S2/SvPas * C57BL/6J)	increased circulating testosterone level	J:118368
Nr0b2^tm1.1Mjev/Nr0b2^tm1.1Mjev (involves: 129S/SvEvBrd * 129S4/SvJae)	decreased circulating cholesterol level	J:149005
	decreased circulating HDL cholesterol level	J:149005
	decreased circulating LDL cholesterol level	J:149005
	decreased circulating VLDL cholesterol level	J:149005
Nr0b2^tm1Ddm/Nr0b2^tm1Ddm (involves: 129 * C57BL/6)	abnormal bile salt homeostasis	J:77065
	abnormal bile salt level	J:77065
	decreased circulating cholesterol level	J:77065
	increased bile salt level	J:77065
	increased liver triglyceride level	J:77065
Nr0b2^tm1Mjev/Nr0b2^tm1Mjev Speer6-ps1^{Tg(Alb-cre)21Mgn}/Speer6-ps1⁺ (involves: 129S/SvEvBrd * C57BL/6 * DBA)	decreased circulating cholesterol level	J:149005
	decreased circulating LDL cholesterol level	J:149005
Nr0b2^tm1Rus/Nr0b2^tm1Rus (involves: 129P2/OlaHsd * C57BL/6)	abnormal bile salt homeostasis	J:102129
	abnormal bile salt level	J:102129
	abnormal lipid homeostasis	J:102129
	increased circulating alanine transaminase level	J:102129
	increased circulating aspartate transaminase level	J:102129
	increased intestinal cholesterol absorption	J:102129
Nr1d1^tm1.1Rev/Nr1d1^tm1.1Rev Nr1d2^tm1.1Rev/Nr1d2^tm1.1Rev Tg(CAG-cre/Esr1)5Amc/0 (involves: BALB/cJ C57BL/6 * C57BL/6J * CBA)	decreased circulating glucose level	J:183855
	decreased circulating triglyceride level	J:183855
	decreased respiratory quotient	J:183855
	increased circulating free fatty acids level	J:183855
Nr1d1^tm1Schb/Nr1d1^tm1Schb (involves: 129S2/SvPas)	abnormal bile salt homeostasis	J:153064
	decreased liver cholesterol level	J:153064
	decreased liver triglyceride level	J:153064
	increased circulating HDL cholesterol level	J:153064
	increased circulating LDL cholesterol level	J:153064
Nr1d1^tm1Ven/Nr1d1^tm1Ven (B6.Cg-Nr1d1^tm1Ven)	abnormal circadian temperature homeostasis	J:203422
	decreased susceptibility to induced hypothermia	J:203422
	increased body temperature	J:203422
	increased core body temperature	J:203422
	increased oxygen consumption	J:203422
Nr1d2^em1(IMPC)Mbp/Nr1d2^em1(IMPC)Mbp (C57BL/6N-Nr1d2^em1(IMPC)Mbp/Ucd)	increased circulating alanine transaminase level	J:211773
Nr1h2^tm1.1Gstr/Nr1h2^tm1.1Gstr (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	abnormal lipid level	J:234268
Nr1h2^tm1.1Gstr/Nr1h2^tm1.1Gstr Nr1h3^tm1.1Gstr/Nr1h3^tm1.1Gstr (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	abnormal cholesterol homeostasis	J:81790
	abnormal lipid homeostasis	J:81790
	abnormal lipid level	J:234268
Nr1h2^tm1.1Nph/Nr1h2^tm1.1Nph (B6.129-Nr1h2^tm1.1Nph)	abnormal cholesterol homeostasis	J:169945
	abnormal glucose homeostasis	J:169945
	abnormal glycogen homeostasis	J:169945
	abnormal lipid homeostasis	J:169945
Nr1h2^tm1Djm/Nr1h2^tm1Djm Nr1h3^tm1Djm/Nr1h3^tm1Djm (involves: 129S6/SvEvTac)	increased liver cholesterol level	J:64343
Nr1h2^tm1Djm/Nr1h2^tm1Djm Nr1h3^tm1Djm/Nr1h3^tm1Djm (involves: 129S6/SvEvTac * C57BL/6)	decreased circulating luteinizing hormone level	J:120913
	decreased circulating testosterone level	J:120913
Nr1h3^{tm1.1(KOMP)Vlcg}/Nr1h3^{tm1.1(KOMP)Vlcg} (C57BL/6N-Nr1h3^{tm1.1(KOMP)Vlcg}/Ucd)	increased circulating alanine transaminase level	J:211773
Nr1h3^tm1.1Djm/Nr1h3^tm1.1Djm Speer6-ps1^{Tg(Alb-cre)21Mgn}/Speer6-ps1⁺ (involves: 129S/SvEv * C57BL/6 * DBA)	abnormal lipid homeostasis	J:184536
	increased liver cholesterol level	J:184536
Nr1h3^tm1.1Gstr/Nr1h3^tm1.1Gstr (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	increased circulating alanine transaminase level	J:82096
	increased circulating LDL cholesterol level	J:82096
	increased liver cholesterol level	J:82096
Nr1h3^tm1Dgen/Nr1h3^tm1Dgen (Not Specified)	abnormal cholesterol homeostasis	J:112995
Nr1h3^tm1Dgen/Nr1h3^tm1Dgen (Not Specified)	abnormal lipid homeostasis	J:112995
Nr1h3^tm1Djm/Nr1h3^tm1Djm (involves: 129S6/SvEvTac * C57BL/6)	abnormal bile salt homeostasis	J:47971
	decreased circulating luteinizing hormone level	J:120913
	decreased circulating testosterone level	J:120913
	increased circulating alanine transaminase level	J:47971
	increased circulating aspartate transaminase level	J:47971
	increased circulating cholesterol level	J:47971
	increased circulating estradiol level	J:158168
	increased circulating LDL cholesterol level	J:47971
	increased erythrocyte sedimentation rate	J:158168
	increased liver cholesterol level	J:243753, J:47971
Nr1h3^tm1Djm/Nr1h3^tm1Djm Nus1^tm1.1Qrm/Nus1^tm1.1Qrm Speer6-ps1^{Tg(Alb-cre)21Mgn}/Speer6-ps1⁺ (involves: 129 * C57BL/6 * DBA * SJL)	increased liver cholesterol level	J:243753
Nr1h4^tm1.1Gonz/Nr1h4^tm1.1Gonz Tg(Alb1-cre)1Dlr/0 (involves: 129X1/SvJ * C57BL/6)	increased bile salt level	J:129978
	increased circulating cholesterol level	J:129978
	increased circulating triglyceride level	J:129978
Nr1h4^tm1.1Gonz/Nr1h4^tm1.1Gonz Tg(Vil1-cre)997Gum/0 (involves: 129X1/SvJ * C57BL/6 * SJL)	abnormal bile salt homeostasis	J:129978
	increased bile salt level	J:129978
Nr1h4^tm1.1Mbj/Nr1h4^tm1.1Mbj (B6N.B6-Nr1h4^tm1.1Mbj)	decreased circulating free fatty acids level	J:200842
	decreased circulating glucose level	J:200842
	decreased circulating insulin level	J:200842
	impaired glucose tolerance	J:200842
	increased bile salt level	J:200842
	increased circulating alanine transaminase level	J:200842
	increased circulating bilirubin level	J:200842
	increased circulating cholesterol level	J:200842
	increased energy expenditure	J:200842
	increased liver triglyceride level	J:200842
Nr1h4^tm1.2Auw/Nr1h4^tm1.2Auw (involves: 129 * C57BL/6J)	increased bile salt level	J:157882
Nr1h4^tm1Gonz/Nr1h4^tm1Gonz (involves: 129X1/SvJ * C57BL/6N)	abnormal bile salt homeostasis	J:64792
	abnormal bile salt level	J:64792
	decreased body temperature	J:64792
	increased bile salt level	J:121075
	increased circulating cholesterol level	J:64792
	increased circulating phospholipid level	J:64792
	increased circulating triglyceride level	J:64792
	increased liver cholesterol level	J:64792
	increased liver triglyceride level	J:64792
Nr1h4^tm1Gonz/Nr1h4^tm1Gonz (involves: 129X1/SvJ)	increased bile salt level	J:129978
	increased circulating cholesterol level	J:129978
	increased circulating triglyceride level	J:129978
Nr1h4^tm1Gonz/Nr1h4^tm1Gonz (STOCK Nr1h4^tm1Gonz/J)	increased circulating alanine transaminase level	J:149005
	increased circulating aspartate transaminase level	J:149005
	increased circulating cholesterol level	J:149005
	increased circulating triglyceride level	J:149005
Nr1h4^tm1Gonz/Nr1h4^tm1Gonz (involves: 129X1/SvJ * C57BL/6)	increased bile salt level	J:118204
Nr1h4^tm1Gonz/Nr1h4^tm1Gonz (involves: 129X1/SvJ * C57BL/6)	increased circulating aspartate transaminase level	J:118204
Nr1h4^tm1Kok/Nr1h4^tm1Kok (involves: 129P2/OlaHsd * C57BL/6J)	abnormal bile salt homeostasis	J:86154
	abnormal blood homeostasis	J:86154
	increased bile salt level	J:86154
Nr1i2^tm1Sakl/Nr1i2^tm1Sakl (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	abnormal enzyme/coenzyme level	J:103505
Nr1i3^tm1Ddm/Nr1i3^tm1Ddm (C3.129S7-Nr1i3^tm1Ddm)	increased circulating glucose level	J:92777
Nr1i3^tm1Dgen/Nr1i3^tm1Dgen (involves: 129)	abnormal thyroxine level	J:89824
Nr1i3^tm1Dgen/Nr1i3^tm1Dgen (involves: 129)	abnormal triiodothyronine level	J:89824
Nr1i3^tm1Dgen/Nr1i3^tm1Dgen (B6.129-Nr1i3^tm1Dgen)	abnormal lipid oxidation	J:149091
Nr2c2^tm1Amj/Nr2c2^tm1Amj (B6.129-Nr2c2^tm1Amj)	abnormal blood homeostasis	J:169333
	abnormal energy homeostasis	J:169333
	abnormal gas homeostasis	J:169333
	abnormal glucose homeostasis	J:169333
	abnormal lipid homeostasis	J:169333
	decreased circulating alanine transaminase level	J:169333
	decreased circulating aspartate transaminase level	J:169333
	decreased circulating cholesterol level	J:169333
	decreased circulating glucose level	J:169333
	decreased circulating insulin level	J:169333
	decreased circulating LDL cholesterol level	J:169333
	decreased circulating triglyceride level	J:169333
	decreased liver triglyceride level	J:169333
	decreased susceptibility to diet-induced obesity	J:169333
	increased carbon dioxide production	J:169333
	increased energy expenditure	J:169333
	increased oxygen consumption	J:169333
	increased respiratory quotient	J:169333
Nr2c2^{tm1b(EUCOMM)Wtsi}/Nr2c2⁺ (C57BL/6N-Nr2c2^{tm1b(EUCOMM)Wtsi}/Bay)	impaired glucose tolerance	J:211773
Nr2c2^tm1Chc/Nr2c2^tm1Chc (Not Specified)	decreased circulating estradiol level	J:133000
Nr2c2^tm1Chc/Nr2c2^tm1Chc (Not Specified)	decreased circulating progesterone level	J:133000
Nr2f2^tm1Tsa/Nr2f2⁺ (involves: 129S7/SvEvBrd * C57BL/6)	decreased circulating progesterone level	J:100400
Nr2f2^tm1Vco/Nr2f2⁺ Tg(Ins2-cre)25Mgn/0 (involves: 129S2/SvPas * 129X1/SvJ * C57BL/6 * DBA)	abnormal glucose homeostasis	J:98195
	abnormal lipid level	J:98195
	decreased circulating glucose level	J:98195
	decreased fatty acids level	J:98195
	decreased insulin secretion	J:98195
	impaired glucose tolerance	J:98195
	increased circulating insulin level	J:98195
	increased circulating triglyceride level	J:98195
	increased insulin secretion	J:98195
	insulin resistance	J:98195
Nr3c1^{Gt(ESKN92)Hgs}/Nr3c1⁺ (B6.Cg-Nr3c1^{Gt(ESKN92)Hgs})	abnormal circulating corticosterone level	J:141205
	increased circulating aldosterone level	J:141205
	increased circulating angiotensinogen level	J:141205
	increased circulating corticosterone level	J:141205
	increased liver triglyceride level	J:141205
Nr3c1^tm1.1Jaci/Nr3c1^tm1.1Jaci Tg(Myh6-cre)2182Mds/0 (involves: C57BL/6 * FVB/N)	abnormal atrial thrombosis	J:201995
	abnormal calcium ion homeostasis	J:201995
Nr3c1^tm1.1Mvc/Nr3c1⁺ Tg(Sim1-cre)1Lowl/0 (involves: 129 * C57BL/6 * FVB)	increased circulating adrenocorticotropin level	J:179918
	increased circulating corticosterone level	J:179918
Nr3c1^tm1Dage/Nr3c1⁺ (involves: 129P1/ReJ * C57BL/6 * C57BL/6J * SJL)	decreased circulating adrenocorticotropin level	J:147914
	decreased circulating corticosterone level	J:147914
	decreased circulating testosterone level	J:147914
Nr3c1^tm1Dage/Nr3c1^tm1Dage (involves: 129P1/ReJ * C57BL/6 * C57BL/6J * SJL)	decreased circulating adrenocorticotropin level	J:147914
	decreased circulating corticosterone level	J:147914
	decreased circulating testosterone level	J:147914
Nr3c1^tm1Gsc/Nr3c1^tm1Gsc (involves: 129P2/OlaHsd * C57BL/6)	cyanosis	J:27441
	decreased adrenaline level	J:27441
	decreased noradrenaline level	J:27441
	increased circulating adrenocorticotropin level	J:27441
	increased circulating corticosterone level	J:27441
Nr3c1^tm1Gsc/Nr3c1^tm1Gsc (involves: 129P2/OlaHsd)	absent circulating adrenaline	J:54931
Nr3c1^tm1Gsc/Nr3c1^tm1Gsc (involves: 129P2/OlaHsd)	decreased circulating noradrenaline level	J:54931
Nr3c1^tm1Gsc/Nr3c1^tm1Gsc (involves: 129P2/OlaHsd * 129/Sv)	increased circulating corticosterone level	J:98065
Nr3c1^tm2.1Gsc/Nr3c1^tm2.1Gsc (involves: 129P2/OlaHsd)	absent circulating adrenaline	J:54931
Nr3c1^tm2.1Gsc/Nr3c1^tm2.1Gsc (involves: 129P2/OlaHsd)	decreased circulating noradrenaline level	J:54931
Nr3c1^tm2Gsc/Nr3c1^tm2Gsc Tg(Camk2a-cre/ERT2)2Gsc/0 (involves: 129P2/OlaHsd * FVB/N)	increased circulating corticosterone level	J:125230
Nr3c1^tm2Gsc/Nr3c1^tm2Gsc Tg(Nes-cre)1Kln/0 (involves: 129P2/OlaHsd * C57BL/6J * SJL)	decreased circulating adrenocorticotropin level	J:57315
	increased adrenocorticotropin level	J:57315
	increased circulating glucocorticoid level	J:57315
Nr3c1^tm2Ljm/Nr3c1^tm2Ljm Tg(Camk2a-cre)T50Stl/? (involves: 129 * BALB/c * C57BL/6 * CBA)	increased circulating corticosterone level	J:96260
Nr3c1^tm2Ljm/Nr3c1^tm2Ljm Tg(Lck-cre)548Jxm/? (involves: 129S6/SvEvTac * C57BL/6 * CBA)	abnormal interferon level	J:97484
	abnormal interleukin level	J:97484
	abnormal tumor necrosis factor level	J:97484
Nr3c1^tm3Gsc/Nr3c1^tm3Gsc (involves: 129P2/OlaHsd * C57BL/6)	increased circulating corticosterone level	J:67720
Nr3c2^tm1Gsc/Nr3c2⁺ (involves: 129P2/OlaHsd * C57BL/6)	increased circulating aldosterone level	J:77285
	increased circulating angiotensin II level	J:77285
	increased circulating renin level	J:77285
	increased urine sodium level	J:77285
Nr3c2^tm1Gsc/Nr3c2^tm1Gsc (involves: 129P2/OlaHsd * C57BL/6)	abnormal ion homeostasis	J:77285
	abnormal renal sodium reabsorption	J:77285
	decreased circulating sodium level	J:77285
	dehydration	J:77285
	increased circulating aldosterone level	J:77285
	increased circulating angiotensin II level	J:77285
	increased circulating potassium level	J:77285
	increased circulating renin level	J:77285
	increased urine sodium level	J:77285
Nr3c2^tm2Gsc/Nr3c2^tm2Gsc Tg(Aqp2-cre/ERT2)4Gsc/0 (involves: C57BL/6 * FVB/N)	increased circulating aldosterone level	J:169670
	increased urine sodium level	J:169670
Nr4a2^tm1.1Pcn/Nr4a2^tm1.1Pcn (Not Specified)	decreased dopamine level	J:157098
Nr4a2^tm1.1Pcn/Nr4a2^tm1.1Pcn Slc6a3^tm1(cre)Lrsn/Slc6a3^tm1(cre)Lrsn (involves: 129S1/Sv * 129X1/SvJ)	decreased dopamine level	J:157098
	increased serotonin level	J:157098
Nr4a2^tm1Niko/Nr4a2^tm1Niko (involves: 129S4/SvJae)	decreased dopamine level	J:47684
Nr4a2^tm1Niko/Nr4a2^tm1Niko (involves: 129S4/SvJae)	dehydration	J:47684
Nr4a2^tm1Omc/Nr4a2⁺ (involves: 129S7/SvEvBrd * C57BL/6)	decreased dopamine level	J:104902
Nr4a2^tm1Omc/Nr4a2^tm1Omc (involves: 129S7/SvEvBrd * C57BL/6)	decreased dopamine level	J:46856
	decreased noradrenaline level	J:106612
Nr4a2^tm1Tpe/Nr4a2⁺ (involves: 129P2/OlaHsd)	decreased dopamine level	J:39661
Nr4a2^tm1Tpe/Nr4a2⁺ (B6.129P2-Nr4a2^tm1Tpe)	abnormal dopamine level	J:147544
	abnormal noradrenaline level	J:147544
	abnormal serotonin level	J:147544
Nr4a2^tm1Tpe/Nr4a2^tm1Tpe (involves: 129P2/OlaHsd)	decreased dopamine level	J:39661
Nr5a1^tm1.1Hain/Nr5a1^tm1.1Hain (Not Specified)	abnormal aldosterone level	J:175843
	abnormal corticosterone level	J:175843
	abnormal progesterone level	J:175843
	abnormal testosterone level	J:175843
Nr5a1^tm1.1Hain/Nr5a1^tm1.1Hain Shh^tm1Amc/Shh⁺ (involves: 129S1/Sv * 129X1/SvJ)	abnormal aldosterone level	J:175843
Nr5a1^tm2Klp/Nr5a1^tm2.1Klp Tg(Cga-cre)3Sac/0 (involves: 129P2/OlaHsd * C57BL/6J * SJL)	decreased circulating follicle stimulating hormone level	J:66593
	decreased circulating luteinizing hormone level	J:66593
	decreased follicle stimulating hormone level	J:66593
	decreased luteinizing hormone level	J:66593
Nr5a1^tm2Klp/Nr5a1^tm2Klp Tg(Cga-cre)3Sac/0 (involves: 129P2/OlaHsd * C57BL/6J * SJL)	decreased circulating follicle stimulating hormone level	J:70412
	decreased circulating luteinizing hormone level	J:70412
Nr5a2^tm1Auw/Nr5a2⁺ (involves: C57BL/6J)	decreased circulating testosterone level	J:118368
Nr5a2^tm1Auw/Nr5a2⁺ (involves: 129P2/OlaHsd)	edema	J:123697
Nr5a2^tm1Bel/Nr5a2⁺ (involves: 129/Sv * C57BL/6 * SJL)	abnormal bile salt level	J:89523
	decreased circulating cholesterol level	J:91695
	decreased circulating progesterone level	J:124199
Nr5a2^tm1Sakl/Nr5a2^tm1Sakl Speer6-ps1^{Tg(Alb-cre)21Mgn}/Speer6-ps1⁺ (involves: 129S/SvEv * 129S4/SvJaeSor * C57BL/6 * DBA)	decreased circulating aspartate transaminase level	J:135822
	decreased circulating cholesterol level	J:135822
Nr5a2^tm1Sakl/Nr5a2^tm1Sakl Tg(Vil1-cre)997Gum/0 (involves: 129S/SvEv * 129S4/SvJaeSor * C57BL/6J * SJL)	decreased circulating aspartate transaminase level	J:135822
	decreased circulating cholesterol level	J:135822
Nr5a2^tm3.1Sjns/Nr5a2^tm3.1Sjns (B6J.B6N(Cg)-Nr5a2^tm3.1Sjns)	abnormal bile salt homeostasis	J:215556
Nr6a1^tm3Coo/Nr6a1^tm3Coo Tg(Zp3-cre)93Knw/0 (involves: 129S7/SvEvBrd * C57BL/6)	decreased circulating estradiol level	J:85054
	decreased circulating follicle stimulating hormone level	J:85054
	decreased circulating progesterone level	J:85054
	decreased circulating testosterone level	J:85054
Nras^{tm1b(EUCOMM)Hmgu}/Nras⁺ (C57BL/6N-Nras^{tm1b(EUCOMM)Hmgu}/H)	increased circulating glucose level	J:211773
	increased circulating HDL cholesterol level	J:211773
Nras^tm1Mok/Nras^tm1Mok (involves: 129S/SvEv * C57BL/6 * DBA/2)	chylous ascites	J:159024
Nras^tm1Tyj/Nras⁺ Meox2^tm1(cre)Sor/Meox2⁺ (B6.Cg-Nras^tm1Tyj Meox2^tm1(cre)Sor)	hydrops fetalis	J:305401
Nrbp1^tm1.1Dja/Nrbp1^tm1.1Dja Gt(ROSA)26Sor^{tm1(cre/ERT)Brn}/Gt(ROSA)26Sor⁺ (involves: 129P2/OlaHsd * 129S4/SvJaeSor * C57BL/6J)	intestinal edema	J:184685
Nrbp1^tm1.1Dja/Nrbp1^tm1.2Dja Gt(ROSA)26Sor^{tm1(cre/ERT)Brn}/Gt(ROSA)26Sor⁺ (involves: 129P2/OlaHsd * 129S4/SvJaeSor * 129S7/SvEvBrd * C57BL/6J)	intestinal edema	J:184685
Nrcam^{tm2e.1(KOMP)Wtsi}/Nrcam⁺ (C57BL/6N-Nrcam^{tm2e.1(KOMP)Wtsi}/J)	increased fasting circulating glucose level	J:211773
Nrde2^{tm2a(KOMP)Wtsi}/Nrde2⁺ (C57BL/6N-Nrde2^{tm2a(KOMP)Wtsi}/Wtsi)	increased fasting circulating glucose level	J:211773
Nrg1^tm1Lwr/Nrg1^tm1Lwr (129/Sv-Nrg1^tm1Lwr)	cyanosis	J:60159
Nrgn^em1(IMPC)H/Nrgn^em1(IMPC)H (C57BL/6NTac-Nrgn^em1(IMPC)H/H)	decreased circulating amylase level	J:211773
	increased circulating serum albumin level	J:211773
Nrn1l^{tm1.1(KOMP)Vlcg}/Nrn1l^{tm1.1(KOMP)Vlcg} (C57BL/6N-Nrn1l^{tm1.1(KOMP)Vlcg}/J)	decreased circulating glucose level	J:211773
	increased circulating alkaline phosphatase level	J:211773
Nrsn1^{tm1.1(KOMP)Vlcg}/Nrsn1^{tm1.1(KOMP)Vlcg} (C57BL/6N-Nrsn1^{tm1.1(KOMP)Vlcg}/J)	increased fasting circulating glucose level	J:211773
Nrsn2^{em1(IMPC)Kmpc}/Nrsn2^{em1(IMPC)Kmpc} (C57BL/6NTac-Nrsn2^{em1(IMPC)Kmpc}/Kmpc)	increased blood uric acid level	J:211773
	increased circulating calcium level	J:211773
	increased circulating phosphate level	J:211773
Nrxn1^{tm1b(KOMP)Wtsi}/Nrxn1⁺ (C57BL/6N-Nrxn1^{tm1b(KOMP)Wtsi}/H)	increased circulating amylase level	J:211773
Nrxn1^{tm1b(KOMP)Wtsi}/Nrxn1^{tm1b(KOMP)Wtsi} (C57BL/6N-Nrxn1^{tm1b(KOMP)Wtsi}/H)	decreased circulating alkaline phosphatase level	J:211773
	decreased circulating cholesterol level	J:211773
	decreased circulating HDL cholesterol level	J:211773
	decreased circulating serum albumin level	J:211773
	decreased circulating total protein level	J:211773
	decreased fasting circulating glucose level	J:211773
	impaired glucose tolerance	J:211773
	increased circulating aspartate transaminase level	J:211773
Nrxn2^em1(IMPC)H/Nrxn2^em1(IMPC)H (C57BL/6NTac-Nrxn2^em1(IMPC)H/H)	increased blood urea nitrogen level	J:211773
	increased circulating serum albumin level	J:211773
Nsa2^em1(IMPC)Mbp/Nsa2⁺ (C57BL/6N-Nsa2^em1(IMPC)Mbp/Ucd)	edema	J:211773
Nsd3^{tm1b(EUCOMM)Hmgu}/Nsd3^{tm1b(EUCOMM)Hmgu} (C57BL/6N-Nsd3^{tm1b(EUCOMM)Hmgu}/H)	increased circulating alkaline phosphatase level	J:211773
Nsdhl^Bpa-8H/Y (involves: BALB/c * C3H/HeN)	pericardial effusion	J:95508
Nsdhl^Str-1H/Y (involves: 101/H * C3H/HeH)	pericardial effusion	J:95508
Nsf^{tm1b(KOMP)Mbp}/Nsf⁺ (C57BL/6N-Nsf^{tm1b(KOMP)Mbp}/J)	decreased circulating glucose level	J:211773
Nsf^{tm1b(KOMP)Mbp}/Nsf⁺ (C57BL/6N-Nsf^{tm1b(KOMP)Mbp}/J)	decreased circulating HDL cholesterol level	J:211773
Nsg2^{em1(IMPC)Kmpc}/Nsg2^{em1(IMPC)Kmpc} (C57BL/6NTac-Nsg2^{em1(IMPC)Kmpc}/Kmpc)	increased circulating serum albumin level	J:211773
Nsl1^em1(IMPC)J/Nsl1⁺ (C57BL/6NJ-Nsl1^em1(IMPC)J/Mmjax)	decreased circulating calcium level	J:211773
Nsmaf^tm1Mkr/Nsmaf^tm1Mkr (involves: 129P2/OlaHsd)	impaired skin barrier function	J:54972
Nsmce1^{em1(IMPC)Wtsi}/Nsmce1⁺ (C57BL/6N-Nsmce1^{em1(IMPC)Wtsi}/Wtsi)	increased circulating total protein level	J:211773
	increased circulating triglyceride level	J:211773
Nsmf^tm1.2Mrkr/Nsmf^tm1.2Mrkr (involves: C57BL/6 * C57BL/6J)	decreased circulating estradiol level	J:232404
Nsun2^{tm1a(EUCOMM)Wtsi}/Nsun2⁺ (B6JTyr;B6N-Nsun2^{tm1a(EUCOMM)Wtsi}/Wtsi)	decreased circulating amylase level	J:175295
Nsun2^{tm1a(EUCOMM)Wtsi}/Nsun2^{tm1a(EUCOMM)Wtsi} (B6JTyr;B6N-Nsun2^{tm1a(EUCOMM)Wtsi}/Wtsi)	subcutaneous edema	J:239583
Nsun2^{tm1a(EUCOMM)Wtsi}/Nsun2^{tm1a(EUCOMM)Wtsi} (involves: C57BL/6 * C57BL/6N)	decreased circulating amylase level	J:213427
	decreased circulating cholesterol level	J:213427
	decreased circulating free fatty acids level	J:213427
	decreased circulating glucose level	J:213427
	decreased circulating glycerol level	J:213427
	decreased circulating HDL cholesterol level	J:213427
	decreased circulating LDL cholesterol level	J:213427
	decreased energy expenditure	J:213427
	improved glucose tolerance	J:213427
	increased carbon dioxide production	J:213427
	increased energy expenditure	J:213427
	increased oxygen consumption	J:213427
Nsun5^{tm2b(EUCOMM)Wtsi}/Nsun5^{tm2b(EUCOMM)Wtsi} (C57BL/6N-Nsun5^{tm2b(EUCOMM)Wtsi}/J)	increased fasting circulating glucose level	J:211773
Nsun5^{tm2b(EUCOMM)Wtsi}/Nsun5^{tm2b(EUCOMM)Wtsi} (C57BL/6NJ-Nsun5^{tm2b(EUCOMM)Wtsi}/J)	increased circulating alanine transaminase level	J:211773
nt/nt (CD-1)	pericardial effusion	J:45709
Nt5c1b^{tm1b(KOMP)Wtsi}/Nt5c1b^{tm1b(KOMP)Wtsi} (C57BL/6N-Nt5c1b^{tm1b(KOMP)Wtsi}/J)	impaired glucose tolerance	J:211773
Nt5dc1^em1(IMPC)J/Nt5dc1^em1(IMPC)J (C57BL/6NJ-Nt5dc1^em1(IMPC)J/J)	decreased circulating glucose level	J:211773
Nt5dc2^em1(IMPC)J/Nt5dc2^em1(IMPC)J (C57BL/6NJ-Nt5dc2^em1(IMPC)J/Mmjax)	increased blood urea nitrogen level	J:211773
	increased circulating creatinine level	J:211773
Nt5dc3^em1(IMPC)J/Nt5dc3^em1(IMPC)J (C57BL/6NJ-Nt5dc3^em1(IMPC)J/Mmjax)	decreased fasting circulating glucose level	J:211773
Nt5e^tm1Jgsc/Nt5e^tm1Jgsc (involves: 129S/SvEv * C57BL/6J)	increased circulating alkaline phosphatase level	J:92598
Nt5e^tm1Jsc/Nt5e^tm1Jsc (involves: 129S1/Sv * 129X1/SvJ * NMRI)	abnormal platelet physiology	J:102299
	decreased bleeding time	J:102299
	increased susceptibility to induced thrombosis	J:102299
Nt5e^tm1Lft/Nt5e^tm1Lft (involves: 129S1/Sv * C57BL/6)	edema	J:94697
Nt5e^tm1Lft/Nt5e^tm1Lft (B6.129S1-Nt5e^tm1Lft/J)	calcinosis	J:252837
Ntaq1^{tm1.1(KOMP)Vlcg}/Ntaq1^{tm1.1(KOMP)Vlcg} (C57BL/6N-Ntaq1^{tm1.1(KOMP)Vlcg}/J)	increased circulating alanine transaminase level	J:211773
Ntf3^tm1Jae/Ntf3⁺ (involves: 129S4/SvJae * BALB/c)	abnormal noradrenaline level	J:62748
Ntf3^tm1Par/Ntf3^tm1Par (involves: 129S1/Sv)	pulmonary edema	J:35639
Ntf5^{tm1b(EUCOMM)Hmgu}/Ntf5^{tm1b(EUCOMM)Hmgu} (C57BL/6N-Ntf5^{tm1b(EUCOMM)Hmgu}/Ics)	increased circulating cholesterol level	J:211773
	increased circulating HDL cholesterol level	J:211773
	increased circulating total protein level	J:211773
Ntrk2^{tm1b(EUCOMM)Wtsi}/Ntrk2⁺ (C57BL/6N-Ntrk2^{tm1b(EUCOMM)Wtsi}/H)	increased circulating HDL cholesterol level	J:211773
Ntrk2^tm1Mini/Ntrk2⁺ (involves: 129P2/OlaHsd * C57BL/6)	increased circulating adrenocorticotropin level	J:210229
	increased circulating insulin level	J:210229
	increased circulating leptin level	J:210229
Ntrk2^tm1Rohr/Ntrk2⁺ (Not Specified)	abnormal circulating corticosterone level	J:179918
	decreased circulating adrenocorticotropin level	J:179918
	decreased circulating corticosterone level	J:179918
	decreased circulating follicle stimulating hormone level	J:88782
Ntrk2^tm1Rohr/Ntrk2^tm1Rohr (Not Specified)	decreased circulating follicle stimulating hormone level	J:88782
Ntrk2^tm2Kln/Ntrk2^tm2Kln Tg(Cck-cre,-lacZ)1Mini/0 (involves: 129S2/SvPas * C57BL/6 * CBA)	abnormal circulating corticosterone level	J:210229
	abnormal lipid level	J:210229
	impaired glucose tolerance	J:210229
	increased circulating insulin level	J:210229
	increased circulating leptin level	J:210229
Ntsr1^tm1Fer/Ntsr1^tm1Fer (C57BL/6-Ntsr1^tm1Fer)	increased body temperature	J:79712
Ntsr1^tm1Fer/Ntsr1^tm1Fer (Not Specified)	abnormal dopamine level	J:90595
Ntsr1^tm2Dgen/Ntsr1^tm2Dgen (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	decreased body temperature	J:126020
Ntsr1^tm2Pang/Ntsr1^tm2Pang (involves: 129P2/OlaHsd * C57BL/6J)	abnormal body temperature homeostasis	J:155994
Nuak1^tm1Esu/Nuak1^tm1Esu Tg(Ckmm-cre)5Khn/0 (B6.Cg-Nuak1^tm1Esu Tg(Ckmm-cre)5Khn)	decreased circulating glucose level	J:185463
	improved glucose tolerance	J:185463
	increased insulin sensitivity	J:185463
	increased skeletal muscle glycogen level	J:185463
Nuak2^tm1Esu/Nuak2⁺ (B6.129S4-Nuak2^tm1Esu)	decreased circulating free fatty acids level	J:139603
	increased circulating glucose level	J:139603
	increased circulating triglyceride level	J:139603
Nub1^{tm1b(EUCOMM)Hmgu}/Nub1^{tm1b(EUCOMM)Hmgu} (C57BL/6N-Nub1^{tm1b(EUCOMM)Hmgu}/Ccpcz)	decreased circulating iron level	J:211773
	increased circulating potassium level	J:211773
Nubp2^{tm1b(EUCOMM)Hmgu}/Nubp2⁺ (C57BL/6N-Nubp2^{tm1b(EUCOMM)Hmgu}/Ieg)	increased circulating fructosamine level	J:211773
Nucb2^{Gt(OST287865)Lex}/Nucb2^{Gt(OST287865)Lex} (involves: 129S5/SvEvBrd * C57BL/6J)	increased circulating alkaline phosphatase level	J:103485
Nucb2^tm1.1Vdix/Nucb2^tm1.1Vdix Lyz2^tm1(cre)Ifo/Lyz2⁺ (involves: 129P2/OlaHsd * C57BL/6)	impaired glucose tolerance	J:270674
	insulin resistance	J:270674
Nucb2^tm1.1Vdix/Nucb2^tm1.1Vdix Tg(Adipoq-cre/Esr1)1Evdr/0 (involves: 129 C57BL/6)	abnormal glucose homeostasis	J:270674
Nucb2^tm1.2Vdix/Nucb2^tm1.2Vdix (involves: C57BL/6)	abnormal glucose homeostasis	J:270674
	increased circulating free fatty acids level	J:270674
	increased hepatic glucose production	J:270674
Nucks1^tm1.2Vter/Nucks1^tm1.2Vter (involves: 129S2/SvPas * C57BL/6 * C57BL/6NSlc * FVB/N * SJL)	decreased circulating adiponectin level	J:211777
	decreased energy expenditure	J:211777
	impaired glucose tolerance	J:211777
	increased circulating glucose level	J:211777
	increased circulating insulin level	J:211777
	increased circulating leptin level	J:211777
	insulin resistance	J:211777
Nucks1^{tm1b(EUCOMM)Hmgu}/Nucks1^{tm1b(EUCOMM)Hmgu} (C57BL/6N-Nucks1^{tm1b(EUCOMM)Hmgu}/Ieg)	decreased circulating cholesterol level	J:211773
	decreased circulating HDL cholesterol level	J:211773
Nudcd3^{em1(IMPC)Wtsi}/Nudcd3^{em1(IMPC)Wtsi} (C57BL/6N-Nudcd3^{em1(IMPC)Wtsi}/Wtsi)	decreased circulating glucose level	J:211773
	increased blood urea nitrogen level	J:211773
	increased circulating creatinine level	J:211773
	increased circulating insulin level	J:211773
Nudt13^{tm2b(EUCOMM)Hmgu}/Nudt13^{tm2b(EUCOMM)Hmgu} (C57BL/6N-Nudt13^{tm2b(EUCOMM)Hmgu}/BayMmucd)	increased fasting circulating glucose level	J:211773
Nudt21^tm1.1Ejwpj/Nudt21^tm1.1Ejwpj Tg(Col1a1-cre/ERT2)1Crm/0 (involves: C57BL/6J * CBA/J)	increased collagen level	J:283035
Numb^tm1.1Zili/Numb^tm1.1Zili (involves: 129/Sv * FVB/N)	pericardial edema	J:68652
Numb^tm1Zili/Numb^tm1Zili Tg(Vil1-cre/ERT2)23Syr/? (involves: 129/Sv * C57BL/6)	abnormal intestinal cholesterol absorption	J:226578
	decreased circulating cholesterol level	J:226578
Nup133^mermaid/Nup133^mermaid (involves: 129S1/SvImJ * C57BL/6J)	pericardial edema	J:137199
Nup155^em1(IMPC)Mbp/Nup155⁺ (C57BL/6N-Nup155^em1(IMPC)Mbp/MbpMmucd)	increased blood urea nitrogen level	J:211773
Nup205^em1(IMPC)J/Nup205⁺ (C57BL/6NJ-Nup205^em1(IMPC)J/Mmjax)	increased circulating cholesterol level	J:211773
Nupr1^tm1Jlio/Nupr1^tm1Jlio (involves: 129S1/Sv * 129X1/SvJ)	decreased luteinizing hormone level	J:140899
	increased follicle stimulating hormone level	J:140899
	increased luteinizing hormone level	J:140899
Nus1^tm1.1Qrm/Nus1^tm1.1Qrm Speer6-ps1^{Tg(Alb-cre)21Mgn}/Speer6-ps1⁺ (involves: 129 * C57BL/6 * DBA * SJL)	abnormal circulating cholesterol level	J:243753
	abnormal lipid homeostasis	J:243753
	decreased liver cholesterol level	J:243753
	increased circulating free fatty acids level	J:243753
	increased circulating triglyceride level	J:243753
	increased liver free fatty acids level	J:243753
	increased liver triglyceride level	J:243753
Nus1^tm1Wcsa/Nus1^tm1Wcsa Tg(Cdh5-cre/ERT2)1Rha/0 (Not Specified)	subcutaneous edema	J:230506
Nutm1^{tm1b(KOMP)Wtsi}/Nutm1^{tm1b(KOMP)Wtsi} (C57BL/6N-Nutm1^{tm1b(KOMP)Wtsi}/Wtsi)	decreased circulating serum albumin level	J:211773
Nxn^em1(IMPC)J/Nxn⁺ (C57BL/6NJ-Nxn^em1(IMPC)J/J)	increased fasting circulating glucose level	J:211773
Nxn^{tm1b(EUCOMM)Wtsi}/Nxn⁺ (C57BL/6N-Nxn^{tm1b(EUCOMM)Wtsi}/Ics)	increased circulating alkaline phosphatase level	J:211773
Nxn^{tm1b(EUCOMM)Wtsi}/Nxn⁺ (C57BL/6N-Nxn^{tm1b(EUCOMM)Wtsi}/Ccpcz)	increased circulating HDL cholesterol level	J:211773
	increased circulating triglyceride level	J:211773
Nxnl1^tm1.2Tlev/Nxnl1^tm1.2Tlev (involves: BALB/c * BALB/cJ * C57BL/6)	abnormal lipid homeostasis	J:186370
Nxph4^tm1Lex/Nxph4^tm1Lex (involves: 129S5/SvEvBrd * C57BL/6J)	decreased circulating triglyceride level	J:171883
	increased urine nitrite level	J:171883
Oas1g^{tm1b(KOMP)Wtsi}/Oas1g⁺ (C57BL/6N-Oas1g^{tm1b(KOMP)Wtsi}/Ucd)	increased circulating glucose level	J:211773
Oasl1^tm1Yjk/Oasl1^tm1Yjk (B6.129P2-Oasl1^tm1Yjk)	abnormal circulating interferon level	J:194467
Oasl2^{tm1a(EUCOMM)Wtsi}/Oasl2^{tm1a(EUCOMM)Wtsi} (C57BL/6N-Oasl2^{tm1a(EUCOMM)Wtsi}/Wtsi)	decreased circulating glucose level	J:175295
Oat^rhg/Oat^rhg (B6Ei;AKR-Oat^rhg/J)	decreased circulating alkaline phosphatase level	J:147337
	decreased circulating amylase level	J:147337
	decreased circulating serum albumin level	J:147337
	decreased circulating thyroxine level	J:147337
	increased circulating ornithine level	J:213842
Oat^rhg/Oat^tm1Dva (involves: 129S7/SvEvBrd * AKR/J * C57BL/6J * C57BL/6JEi)	increased circulating ornithine level	J:213842
Oat^tm1Dva/Oat^tm1Dva (involves: 129S7/SvEvBrd * C57BL/6J)	abnormal circulating amino acid level	J:29269
	decreased circulating arginine level	J:29269
	decreased circulating citrulline level	J:29269
	decreased circulating ornithine level	J:29269
	decreased circulating phenylalanine level	J:29269
	increased circulating ammonia level	J:29269
	increased circulating ornithine level	J:29269
	oroticaciduria	J:29269
Oat^tm1Dva/Oat^tm1Dva (involves: 129S7/SvEvBrd)	abnormal circulating amino acid level	J:60200
Oaz2^em1(IMPC)J/Oaz2^em1(IMPC)J (C57BL/6NJ-Oaz2^em1(IMPC)J/J)	decreased circulating calcium level	J:211773
	decreased circulating total protein level	J:211773
Obp2a^{tm1b(EUCOMM)Wtsi}/Obp2a^{tm1b(EUCOMM)Wtsi} (C57BL/6N-Obp2a^{tm1b(EUCOMM)Wtsi}/Ics)	increased circulating cholesterol level	J:211773
Obrq13^A/J/Obrq13^A/J (C57BL/6J-Chr 17^A/J/NaJ)	decreased circulating cholesterol level	J:145148
	decreased circulating glucose level	J:145148
	decreased circulating insulin level	J:145148
	decreased circulating triglyceride level	J:145148
	decreased susceptibility to diet-induced obesity	J:145148
	insulin resistance	J:145148
Obrq14^A/J/Obrq14^A/J (C57BL/6J-Chr 17^A/J/NaJ)	increased circulating cholesterol level	J:145148
	increased susceptibility to diet-induced obesity	J:145148
	insulin resistance	J:145148
Obrq15^A/J/Obrq15^A/J (C57BL/6J-Chr 17^A/J/NaJ)	decreased susceptibility to diet-induced obesity	J:145148
Obrq15^A/J/Obrq15^A/J (C57BL/6J-Chr 17^A/J/NaJ)	increased circulating free fatty acids level	J:145148
Obrq16^A/J/Obrq16^A/J (C57BL/6J-Chr 17^A/J/NaJ)	decreased liver triglyceride level	J:145148
Obrq17^A/J/Obrq17^A/J (C57BL/6J-Chr 17^A/J/NaJ)	decreased circulating triglyceride level	J:145148
Obscn^tm1Chen/Obscn^tm1Chen Obsl1^tm1.1Slan/Obsl1^tm1.1Slan Tg(Myog-cre)1Eno/0 (involves: 129 * Black Swiss * C57BL/6 * SJL)	abnormal enzyme/coenzyme level	J:283623
	abnormal glycogen catabolism	J:283623
	increased catalase level	J:283623
Obsty5^SM/J/? (involves: LG/J * SM/J)	increased circulating cholesterol level	J:94605
Obsty5^SM/J/? (involves: LG/J * SM/J)	increased circulating leptin level	J:94605
Oca2^p-30PUb/Oca2^p-x (Not Specified)	abnormal circulating cholesterol level	J:89922
	abnormal circulating HDL cholesterol level	J:89922
	abnormal glucose homeostasis	J:89922
	abnormal lipid homeostasis	J:89922
	hyperglycemia	J:89922
	increased circulating cholesterol level	J:89922
	increased circulating insulin level	J:89922
	increased circulating triglyceride level	J:89922
Ociad1^em1(IMPC)J/Ociad1^em1(IMPC)J (C57BL/6NJ-Ociad1^em1(IMPC)J/Mmjax)	decreased circulating total protein level	J:211773
	increased circulating glucose level	J:211773
	increased circulating phosphate level	J:211773
Ociad2^em1(IMPC)Tcp/Ociad2^em1(IMPC)Tcp (C57BL/6N-Ociad2^em1(IMPC)Tcp/Tcp)	increased circulating alanine transaminase level	J:211773
	increased circulating alkaline phosphatase level	J:211773
	increased circulating aspartate transaminase level	J:211773
Ocstamp^{tm2b(KOMP)Wtsi}/Ocstamp^{tm2b(KOMP)Wtsi} (C57BL/6N-Ocstamp^{tm2b(KOMP)Wtsi}/J)	decreased circulating glucose level	J:211773
	increased circulating alkaline phosphatase level	J:211773
Odad3^{tm1b(EUCOMM)Hmgu}/Odad3⁺ (C57BL/6N-Odad3^{tm1b(EUCOMM)Hmgu}/Ieg)	impaired glucose tolerance	J:211773
Odaph^{em1(IMPC)Ccpcz}/Odaph^{em1(IMPC)Ccpcz} (C57BL/6NCrl-Odaph^{em1(IMPC)Ccpcz}/Ccpcz)	increased circulating alkaline phosphatase level	J:211773
Odf1^{tm1b(EUCOMM)Hmgu}/Odf1^{tm1b(EUCOMM)Hmgu} (C57BL/6N-Odf1^{tm1b(EUCOMM)Hmgu}/BayMmucd)	increased circulating iron level	J:211773
	increased circulating phosphate level	J:211773
oed/oed (STOCK pc-oed)	abnormal cholesterol homeostasis	J:5609
	abnormal circulating cholesterol level	J:5609
	abnormal circulating HDL cholesterol level	J:5609
	abnormal homeostasis	J:5609
	abnormal lipid homeostasis	J:5609
	decreased circulating cholesterol level	J:5609
	decreased circulating LDL cholesterol level	J:5609
	decreased fatty acids level	J:5609
	decreased triglyceride level	J:5609
	edema	J:5609
Ofcc1^em1(IMPC)J/Ofcc1^em1(IMPC)J (C57BL/6NJ-Ofcc1^em1(IMPC)J/J)	increased circulating phosphate level	J:211773
Ofcc1^tm1.2Tohn/Ofcc1^tm1.2Tohn (involves: C57BL/6 * C57BL/6NSlc)	abnormal circulating enzyme level	J:223904
Ogfod1^{tm1a(KOMP)Wtsi}/Ogfod1^{tm1a(KOMP)Wtsi} (B6JTyr;B6N-Ogfod1^{tm1a(KOMP)Wtsi}/Wtsi)	decreased circulating iron level	J:175295
Ogn^{tm1b(KOMP)Wtsi}/Ogn^{tm1b(KOMP)Wtsi} (C57BL/6N-Ogn^{tm1b(KOMP)Wtsi}/J)	increased fasting circulating glucose level	J:211773
Ogn^tm1Hds/Ogn^tm1Hds (B6.129S1-Ogn^tm1Hds)	abnormal adrenocorticotropin level	J:183738
Oit3^tm1Zgh/Oit3^tm1Zgh (involves: 129S6/SvEvTac * C57BL/6J)	decreased blood uric acid level	J:181913
	decreased urine uric acid level	J:181913
Ola1^{Gt(OST312288)Lex}/Ola1^{Gt(OST312288)Lex} (involves: 129S5/SvEvBrd * C57BL/6)	cyanosis	J:236306
Olfm1^tm1.1Lex/Olfm1^tm1.1Lex (involves: 129S/SvEvBrd * 129S4/SvJae)	increased circulating follicle stimulating hormone level	J:226939
Olfm4^em1(IMPC)H/Olfm4^em1(IMPC)H (C57BL/6NTac-Olfm4^em1(IMPC)H/H)	increased blood urea nitrogen level	J:211773
Olfm4^tm1Gpro/Olfm4^tm1Gpro (involves: 129X1/SvJ * Black Swiss)	abnormal cytokine level	J:161279
	increased circulating interleukin-3 level	J:161279
	increased circulating interleukin-12 level	J:161279
Olig1^em2(IMPC)Ics/Olig1^em2(IMPC)Ics (C57BL/6N-Olig1^em2(IMPC)Ics/Ics)	decreased circulating phosphate level	J:211773
Olig3^tm1Qiu/Olig3^tm1Qiu (Not Specified)	cyanosis	J:143462
Olr1^tm1Meht/Olr1^tm1Meht (B6.129X1-Olr1^tm1Meht/Meht)	increased circulating interleukin-10 level	J:130794
Oma1^tm1Otin/Oma1^tm1Otin (involves: 129S6/SvEvTac * C57BL/6 * C57BL/6NCr)	abnormal blood homeostasis	J:184716
	abnormal circadian temperature homeostasis	J:184716
	abnormal gas homeostasis	J:184716
	abnormal glucose homeostasis	J:184716
	decreased body temperature	J:184716
	decreased carbon dioxide production	J:184716
	decreased circulating insulin level	J:184716
	decreased fatty acid beta-oxidation	J:184716
	decreased oxygen consumption	J:184716
	impaired glucose tolerance	J:184716
	increased circulating alanine transaminase level	J:184716
	increased circulating aspartate transaminase level	J:184716
	increased circulating leptin level	J:184716
	increased circulating triglyceride level	J:184716
	increased insulin sensitivity	J:184716
	increased susceptibility to diet-induced obesity	J:184716
Omp^tm4(cre)Mom/Omp⁺ Gucy1b2^tm3Mom Ift88^tm1Bky/Gucy1b2^tm3Mom Ift88^tm1Bky (involves: 129P2/OlaHsd * C57BL/6J)	abnormal homeostasis	J:307157
Onecut1^tm1.1Mga/Onecut1^tm1.1Mga Tg(Pdx1-cre)89.1Dam/0 (involves: 129S6/SvEvTac * C57BL/6 * CBA * SJL)	abnormal glucose homeostasis	J:155058
	increased circulating glucose level	J:155058
Onecut1^tm1Flem/Onecut1^tm1Flem (involves: 129S1/Sv * 129X1/SvJ * Swiss)	decreased circulating glucagon level	J:62595
	decreased circulating glucose level	J:62595
	decreased circulating insulin level	J:62595
	impaired glucose tolerance	J:62595
	increased circulating glucose level	J:62595
Opa1^M1Bewi/Opa1^M1Bewi (involves: C3HeB/FeJ * C57BL/6)	edema	J:154966
Opa1^tm1.1Geno/Opa1⁺ (involves: 129S2/SvPas)	increased creatine level	J:237963
Opa1^tm1.1Hise/Opa1^tm1.2Hise Tg(Ins2-cre)25Mgn/0 (involves: 129S/SvEv * C57BL/6 * DBA * SJL)	decreased circulating insulin level	J:183074
	decreased insulin secretion	J:183074
	decreased oxygen consumption	J:183074
	impaired glucose tolerance	J:183074
	increased circulating glucose level	J:183074
Opa3^m1Votr/Opa3^m1Votr (involves: C3H * C57BL/6JCrl)	abnormal blood homeostasis	J:188346
	abnormal phospholipid level	J:188346
	decreased body surface temperature	J:188346
	decreased circulating insulin-like growth factor I level	J:188346
	decreased liver glycogen level	J:181670
	dehydration	J:181670
	increased liver triglyceride level	J:188346
Oplah^{tm1b(KOMP)Wtsi}/Oplah^{tm1b(KOMP)Wtsi} (C57BL/6N-Oplah^{tm1b(KOMP)Wtsi}/Ieg)	decreased circulating unsaturated transferrin level	J:211773
Opn3^em2Lan/Opn3^em2Lan (Not Specified)	decreased core body temperature	J:287419
Opn3^em2Lan/Opn3^em2Lan (Not Specified)	impaired adaptive thermogenesis	J:287419
Opn3^{tm2b(EUCOMM)Wtsi}/Opn3^{tm2b(EUCOMM)Wtsi} (involves: C57BL/6N * FVB/N)	abnormal homeostasis	J:287419
	decreased core body temperature	J:287419
	decreased energy expenditure	J:287419
	decreased oxygen consumption	J:287419
	impaired adaptive thermogenesis	J:287419
	increased carbon dioxide production	J:287419
Opn3^{tm2c(EUCOMM)Wtsi}/Opn3^{tm2c(EUCOMM)Wtsi} Tg(Adipoq-cre)1Evdr/0 (involves: C57BL/6N * FVB/NJ)	abnormal circulating glycerol level	J:287419
	decreased core body temperature	J:287419
	impaired adaptive thermogenesis	J:287419
Opn4^tm1Skay/Opn4^tm1Skay (involves: 129S1/SvImJ)	photosensitivity	J:107606
Oprk1^tm1Kff/Oprk1^tm1Kff (involves: 129S2/SvPas * C57BL/6)	decreased salivation	J:46089
Oprl1^tm1Hta/Oprl1^tm1Hta (involves: 129S4/SvJae * C57BL/6J)	increased dopamine level	J:90602
Oprm1^tm1Jep/Oprm1^tm1Jep (B6.129S-Oprm1^tm1Jep)	improved glucose tolerance	J:147786
	increased circulating insulin level	J:147786
	increased insulin secretion	J:147786
Oprm1^tm1Loh/Oprm1^tm1Loh (involves: 129P2/OlaHsd * C57BL/6 * DBA/2)	abnormal circulating glucose level	J:106857
Optn^{tm1a(EUCOMM)Wtsi}/Optn⁺ (C57BL/6N-Optn^{tm1a(EUCOMM)Wtsi}/Ieg)	abnormal respiratory quotient	J:165965
Optn^{tm1a(EUCOMM)Wtsi}/Optn^{tm1a(EUCOMM)Wtsi} (C57BL/6N-Optn^{tm1a(EUCOMM)Wtsi}/Wtsi)	decreased circulating cholesterol level	J:175295
	decreased circulating HDL cholesterol level	J:175295
	decreased circulating LDL cholesterol level	J:175295
	decreased circulating potassium level	J:175295
Or1e1c^em1(IMPC)Mbp/Or1e1c^em1(IMPC)Mbp (C57BL/6NCrl-Or1e1c^em1(IMPC)Mbp/Mmucd)	decreased circulating aspartate transaminase level	J:211773
	decreased circulating bilirubin level	J:211773
Or1e32^em1(IMPC)Mbp/Or1e32^em1(IMPC)Mbp (C57BL/6NCrl-Or1e32^em1(IMPC)Mbp/Mmucd)	abnormal cholesterol homeostasis	J:211773
Or2l13b^em1Scjc/Or2l13b^em1Scjc (FVB/NTac-Or2l13b^em1Scjc)	abnormal platelet activation	J:324598
Or2y1g^tm1.1Itl/Or2y1g^tm1.1Itl (involves: 129S6/SvEvTac * C57BL/6NTac)	improved glucose tolerance	J:278264
	increased urine glucose level	J:278264
Or4m1^em1Tshu/Or4m1^em1Tshu (involves: C57BL/6J)	abnormal circulating glucose level	J:314392
	abnormal glucose homeostasis	J:279017
	decreased circulating cholesterol level	J:279017
	decreased circulating free fatty acids level	J:279017
	decreased circulating glucose level	J:279017
	decreased circulating insulin level	J:279017
	decreased circulating leptin level	J:279017
	decreased circulating triglyceride level	J:279017
	decreased fasting circulating glucose level	J:279017
	decreased hepatic glucose production	J:279017
	decreased liver cholesterol level	J:279017
	decreased liver triglyceride level	J:279017
	decreased susceptibility to diet-induced obesity	J:314392
	improved glucose tolerance	J:279017
	increased insulin sensitivity	J:279017
Or5b112^{em1(IMPC)Hmgu}/Or5b112^{em1(IMPC)Hmgu} (C57BL/6NCrl-Or5b112^{em1(IMPC)Hmgu}/Ieg)	increased fasting circulating glucose level	J:211773
Or9g4^em1(IMPC)Mbp/Or9g4^em1(IMPC)Mbp (C57BL/6N-Or9g4^em1(IMPC)Mbp/MbpMmucd)	increased circulating cholesterol level	J:211773
	increased circulating HDL cholesterol level	J:211773
	increased circulating serum albumin level	J:211773
	increased circulating total protein level	J:211773
Orai1^Gt(XL922)Byg/Orai1⁺ (involves: 129P2/OlaHsd * C57BL/6 * DBA/2)	decreased leukotriene level	J:130479
Orai1^Gt(XL922)Byg/Orai1^Gt(XL922)Byg (involves: 129P2/OlaHsd * C57BL/6 * DBA/2)	decreased leukotriene level	J:130479
Orai1^Gt(XL922)Byg/Orai1^Gt(XL922)Byg (involves: 129P2/OlaHsd * ICR)	abnormal calcium ion homeostasis	J:315408
Orai1^tm1Fesk/Orai1^tm1Fesk (C57BL/6-Orai1^tm1Fesk)	abnormal platelet activation	J:144861
Orai1^tm1Fesk/Orai1^tm1Fesk (C57BL/6-Orai1^tm1Fesk)	decreased platelet calcium level	J:144861
Orc6^em1(IMPC)J/Orc6⁺ (C57BL/6NJ-Orc6^em1(IMPC)J/J)	decreased circulating creatinine level	J:211773
Orm2^em1Bcgen/Orm2⁺ (involves: C57BL/6J)	increased circulating alanine transaminase level	J:333118
	increased circulating triglyceride level	J:333118
	increased liver triglyceride level	J:333118
Orm2^em1Bcgen/Orm2^em1Bcgen (involves: C57BL/6J)	increased circulating alanine transaminase level	J:333118
	increased circulating aspartate transaminase level	J:333118
	increased circulating LDL cholesterol level	J:333118
	increased circulating triglyceride level	J:333118
	increased liver triglyceride level	J:333118
Ormdl2^em1Pdra/Ormdl2^em1Pdra Ormdl3^em1Pdra/Ormdl3^em1Pdra (C57BL/6-Ormdl2^em1Pdra Ormdl3^em1Pdra)	increased ceramide level	J:328837
	increased sphingosine level	J:328837
Ormdl3^em1Pdra/Ormdl3^em1Pdra (C57BL/6-Ormdl3^em1Pdra)	increased ceramide level	J:328837
Ormdl3^em1Pdra/Ormdl3^em1Pdra (C57BL/6-Ormdl3^em1Pdra)	increased sphingosine level	J:328837
Os/Os⁺ (ROP/GnLeJ)	increased blood urea nitrogen level	J:3842
Osbpl8^{Gt(DD0748)Wtsi}/Osbpl8^{Gt(DD0748)Wtsi} (B6.129P2-Osbpl8^{Gt(DD0748)Wtsi})	abnormal circulating apolipoprotein E level	J:199891
	abnormal circulating apolipoprotein level	J:199891
	increased circulating cholesterol level	J:199891
	increased circulating phospholipid level	J:199891
	increased circulating triglyceride level	J:199891
Osbpl11^{tm1b(EUCOMM)Hmgu}/Osbpl11⁺ (C57BL/6N-Osbpl11^{tm1b(EUCOMM)Hmgu}/Ieg)	decreased circulating triglyceride level	J:211773
	improved glucose tolerance	J:211773
Osm^{tm1b(KOMP)Wtsi}/Osm^{tm1b(KOMP)Wtsi} (C57BL/6N-Osm^{tm1b(KOMP)Wtsi}/J)	decreased circulating free fatty acids level	J:211773
	decreased circulating glucose level	J:211773
Osmr^tm1Mtan/Osmr^tm1Mtan (B6.129S-Osmr^tm1Mtan)	decreased liver glycogen level	J:214124
	impaired glucose tolerance	J:214124
	increased circulating cholesterol level	J:214124
	increased circulating free fatty acids level	J:214124
	increased circulating glucose level	J:214124
	increased circulating insulin level	J:214124
	increased circulating interleukin-10 level	J:214124
	increased circulating leptin level	J:214124
	increased circulating triglyceride level	J:214124
	increased circulating tumor necrosis factor level	J:214124
	increased liver cholesterol level	J:214124
	increased liver triglyceride level	J:214124
	increased susceptibility to diet-induced obesity	J:214124
	insulin resistance	J:214124
Osr1^tm1Jian/Osr1^tm1Jian (either: (involves: 129S1/Sv * C57BL/6J) or (involves: 129S1/Sv * ICR))	hydrops fetalis	J:104942
Osr1^tm2.1Jian/Osr1^tm2.1Jian (involves: 129S1/Sv * FVB/N)	edema	J:172133
Ostm1^om/Ostm1^om (C3HeB/FeJ-Ostm1^om)	decreased circulating LDL cholesterol level	J:195249
	decreased circulating triglyceride level	J:195249
	increased circulating alkaline phosphatase level	J:195249
Ostn^tm1.1Geno/Ostn^tm1.1Geno (involves: C57BL/6)	decreased oxygen consumption	J:228285
Otc^em1(IMPC)Tcp/Otc⁺ (C57BL/6NCrl-Otc^em1(IMPC)Tcp/Tcp)	increased circulating alanine transaminase level	J:211773
Otc^em1(IMPC)Tcp/Otc⁺ (C57BL/6NCrl-Otc^em1(IMPC)Tcp/Tcp)	increased circulating triglyceride level	J:211773
Otc^spf-ash/Y (Not Specified)	abnormal protein level	J:26976
	increased circulating ammonia level	J:26977
	oroticaciduria	J:26977
Otc^spf-ash/Y (involves: C57BL/6)	abnormal homeostasis	J:23205
Otc^spf-ash/Y (involves: C57BL/6)	oroticaciduria	J:23205
Otc^spf-ash/Y (B6EiC3Sn a/A-Otc^spf-ash/J)	increased circulating ammonia level	J:108979
Otc^spf-ash/Otc⁺ (involves: C57BL/6)	oroticaciduria	J:23205
Otc^spf-J/Y (C57BL/6J-Otc^spf-J/J)	abnormal amino acid level	J:226209
	abnormal blood homeostasis	J:226209
	abnormal circulating amino acid level	J:226209
Otc^spf/Y (Not Specified)	abnormal amino acid level	J:22268
	abnormal circulating amino acid level	J:22268, J:23017
	decreased ornithine level	J:22268
	increased circulating ammonia level	J:23017
	oroticaciduria	J:23017
Otc^spf/Y (involves: C57BL/6)	abnormal body temperature homeostasis	J:1966
Otc^spf/Y (involves: CD-1)	increased circulating ammonia level	J:23195, J:2774, J:784
	increased circulating glutamine level	J:784
	increased glutamine level	J:784
	oroticaciduria	J:16786
Otc^spf/Y (involves: C3H/HeJ * C57BL/6J)	decreased circulating arginine level	J:31237
	decreased circulating citrulline level	J:31237
	decreased circulating ornithine level	J:31237
	increased circulating ammonia level	J:31237
	increased circulating glutamine level	J:31237
	oroticaciduria	J:31237
Otc^spf/Otc⁺ (Not Specified)	abnormal circulating amino acid level	J:23017
Otc^spf/Otc⁺ (Not Specified)	oroticaciduria	J:23017
Otc^spf/Otc^spf (involves: CD-1)	abnormal amino acid level	J:784
Otc^spf/Otc^spf (involves: CD-1)	increased circulating ammonia level	J:784
Otog^em1(IMPC)J/Otog^em1(IMPC)J (C57BL/6NJ-Otog^em1(IMPC)J/Mmjax)	increased circulating aspartate transaminase level	J:211773
Otop1^{em1(IMPC)Ccpcz}/Otop1^{em1(IMPC)Ccpcz} (C57BL/6NCrl-Otop1^{em1(IMPC)Ccpcz}/Ccpcz)	increased circulating alanine transaminase level	J:211773
	increased circulating aspartate transaminase level	J:211773
Otp^M1H/Otp⁺ (C3H.Cg-Otp^M1H)	abnormal energy homeostasis	J:251771
	impaired glucose tolerance	J:251771
	increased circulating insulin level	J:251771
	increased circulating leptin level	J:251771
	increased energy expenditure	J:251771
	insulin resistance	J:251771
Otp^tm1Asim/Otp⁺ (C3H.129P2(B6)-Otp^tm1Asim)	impaired glucose tolerance	J:251771
	increased circulating leptin level	J:251771
	insulin resistance	J:251771
Otp^{tm1b(EUCOMM)Wtsi}/Otp⁺ (C57BL/6N-Otp^{tm1b(EUCOMM)Wtsi}/H)	increased circulating iron level	J:211773
Otub1^{tm1c(EUCOMM)Hmgu}/Otub1^{tm1c(EUCOMM)Hmgu} Cd19^tm1(cre)Cgn/Cd19⁺ (involves: 129P2/OlaHsd * C57BL/6 * C57BL/6N)	increased circulating interleukin-6 level	J:280549
Otud1^em2Gpt/Otud1^em2Gpt (C57BL/6-Otud1^em2Gpt)	increased circulating interferon-beta level	J:287309
Otud5^tm1Vmd/Otud5^tm1Vmd Tg(Cd4-cre)1Cwi/0 (involves: C57BL/6 * DBA/2)	increased circulating interleukin-17 level	J:219495
Otud6a^{tm1(KOMP)Vlcg}/Otud6a^{tm1(KOMP)Vlcg} (C57BL/6N-Otud6a^{tm1(KOMP)Vlcg}/Nju)	increased circulating cholesterol level	J:211773
	increased circulating HDL cholesterol level	J:211773
Otud7b^{tm1(NCOM)Cmhd}/Otud7b^{tm1(NCOM)Cmhd} (C57BL/6N-Otud7b^{tm1(NCOM)Cmhd}/Tcp)	decreased circulating cholesterol level	J:165965
Otulin^{tm1c(EUCOMM)Hmgu}/Otulin^{tm1c(EUCOMM)Hmgu} Tg(KRT14-cre)1Cgn/0 (involves: C57BL/6 * C57BL/6N * DBA/2)	impaired skin barrier function	J:312394
Otx1^tm1Asim/Otx1^tm1Asim (involves: 129P2/OlaHsd * C57BL/6 * DBA/2)	decreased circulating testosterone level	J:47322
Otx2^tm1Pas/Otx2⁺ (involves: C57BL/6 * FVB/N)	decreased circulating luteinizing hormone level	J:210118
Ovol1^tm1Efu/Ovol1^tm1Efu (B6.129-Ovol1^tm1Efu)	impaired skin barrier function	J:118154
Oxct1^{tm1a(KOMP)Wtsi}/Oxct1^{tm1a(KOMP)Wtsi} (C57BL/6-Oxct1^{tm1a(KOMP)Wtsi})	abnormal glucose homeostasis	J:170537
	acidosis	J:170537
	decreased circulating lactate level	J:170537
	hypoglycemia	J:170537
	increased circulating ketone body level	J:170537
Oxgr1^{tm1(KOMP)Vlcg}/Oxgr1^{tm1(KOMP)Vlcg} (involves: C57BL/6J * C57BL/6NTac)	decreased circulating chloride level	J:201611
	decreased urine pH	J:201611
	increased circulating bicarbonate level	J:201611
Oxsr1^tm1.1Ssy/Oxsr1^tm1.1Ssy Tg(Cdh16-cre)91Igr/0 (involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * ICR)	decreased circulating potassium level	J:177443
	decreased urine osmolality	J:177443
	increased urine calcium level	J:177443
	increased urine potassium level	J:177443
	increased urine sodium level	J:177443
Oxtr^{tm1.1(KOMP)Vlcg}/Oxtr^{tm1.1(KOMP)Vlcg} (C57BL/6N-Oxtr^{tm1.1(KOMP)Vlcg}/Rbrc)	increased circulating LDL cholesterol level	J:211773
P2rx2^em1(IMPC)H/P2rx2^em1(IMPC)H (C57BL/6NTac-P2rx2^em1(IMPC)H/H)	decreased circulating glucose level	J:211773
P2rx4^tm1Ando/P2rx4^tm1Ando (Not Specified)	abnormal nitric oxide homeostasis	J:104459
P2rx4^tm1Ando/P2rx4^tm1Ando (Not Specified)	decreased urine nitrite level	J:104459
P2rx7^{tm1a(EUCOMM)Wtsi}/P2rx7^{tm1a(EUCOMM)Wtsi} (C57BL/6N-P2rx7^{tm1a(EUCOMM)Wtsi}/Ieg)	decreased circulating glycerol level	J:165965
P2ry1^tm1Bhk/P2ry1^tm1Bhk (involves: 129P2/OlaHsd * C57BL/6 * DBA/2)	abnormal thrombolysis	J:57960
	decreased platelet aggregation	J:57960
	increased bleeding time	J:57960
P2ry1^tm1Gac/P2ry1⁺ (involves: 129S2/SvPas * C57BL/6)	decreased platelet aggregation	J:59055
P2ry1^tm1Gac/P2ry1^tm1Gac (involves: 129S2/SvPas * C57BL/6)	decreased platelet aggregation	J:59055
	decreased susceptibility to induced thrombosis	J:59055
	increased bleeding time	J:59055
P2ry2^tm1Bhk/P2ry2^tm1Bhk (involves: 129P2/OlaHsd * C57BL/6 * DBA/2)	abnormal ion homeostasis	J:57617, J:57618
P2ry12^tm1Cjf/P2ry12^tm1Cjf (involves: 129)	decreased platelet aggregation	J:70017
P2ry12^tm1Cjf/P2ry12^tm1Cjf (involves: 129)	increased bleeding time	J:70017
P2ry12^tm1Pcon/P2ry12^tm1Pcon (involves: 129P2/OlaHsd * C57BL/6)	abnormal platelet physiology	J:84917
	decreased platelet aggregation	J:84917
	decreased susceptibility to induced thrombosis	J:84917
	increased bleeding time	J:84917
P2ry13^tm1Dgen/P2ry13^tm1Dgen (B6N.Cg-P2ry13^tm1Dgen)	decreased circulating cholesterol level	J:170217
	decreased circulating glycerol level	J:170217
	decreased circulating HDL cholesterol level	J:170217
	decreased circulating LDL cholesterol level	J:170217
	decreased fatty acids level	J:170217
	increased circulating glucose level	J:170217
P2ry13^tm1Loma/P2ry13^tm1Loma (B6.129-P2ry13^tm1Loma)	decreased liver cholesterol level	J:166205
P2ry14^em1(IMPC)H/P2ry14^em1(IMPC)H (C57BL/6NTac-P2ry14^em1(IMPC)H/H)	decreased fasting circulating glucose level	J:211773
	increased circulating alanine transaminase level	J:211773
	increased circulating aspartate transaminase level	J:211773
P2ry14^tm1.1Shbg/P2ry14^tm1.1Shbg (involves: 129S6/SvEvTac * C57BL/6)	decreased circulating insulin level	J:223427
	decreased insulin secretion	J:223427
	impaired glucose tolerance	J:223427
P3h2^em1(IMPC)H/P3h2^em1(IMPC)H (C57BL/6N-P3h2^em1(IMPC)H/H)	decreased circulating fructosamine level	J:211773
	increased circulating potassium level	J:211773
P3h2^tm1Hpb/P3h2^tm1Hpb (involves: 129 * C57BL/6J)	abnormal thrombosis	J:206377
P3h3^{tm1.1(KOMP)Vlcg}/P3h3^{tm1.1(KOMP)Vlcg} (C57BL/6N-P3h3^{tm1.1(KOMP)Vlcg}/Ucd)	decreased circulating phosphate level	J:211773
P4hb^tm1.1Geno/P4hb^tm1.1Geno Tg(Mx1-cre)1Cgn/0 (involves: 129 * C57BL/6 * C57BL/6J * CBA/J)	decreased platelet aggregation	J:229395
	decreased susceptibility to induced thrombosis	J:229395
P4hb^tm1.1Geno/P4hb^tm1.1Geno Tg(Pf4-icre)Q3Rsko/0 (involves: 129 * C57BL/6)	abnormal platelet dense granule physiology	J:229395
	decreased platelet aggregation	J:229395
	decreased susceptibility to induced thrombosis	J:229395
	increased bleeding time	J:229395
P4htm^tm1Jomy/P4htm^tm1Jomy (Not Specified)	increased urine protein level	J:213191
Pabpc4^{tm1a(KOMP)Wtsi}/Pabpc4^{tm1a(KOMP)Wtsi} (C57BL/6N-Pabpc4^{tm1a(KOMP)Wtsi}/Wtsi)	decreased circulating cholesterol level	J:211773
Pabr1^129X1/SvJ/Pabr1^129X1/SvJ (involves: 129X1/SvJ * C57BL/6J)	abnormal circulating protein level	J:69759
Pabr1^C57BL/6J/Pabr1^C57BL/6J (involves: 129X1/SvJ * C57BL/6J)	abnormal circulating protein level	J:69759
Pabr2^129X1/SvJ/Pabr2^129X1/SvJ (involves: 129X1/SvJ * C57BL/6J)	abnormal circulating protein level	J:69759
Pabr2^C57BL/6J/Pabr2^C57BL/6J (involves: 129X1/SvJ * C57BL/6J)	abnormal circulating protein level	J:69759
Pacs1^{em1(IMPC)Hmgu}/Pacs1⁺ (C57BL/6N-Pacs1^{em1(IMPC)Hmgu}/Ieg)	increased circulating lipase level	J:211773
Pacsin1^em1(IMPC)H/Pacsin1^em1(IMPC)H (C57BL/6NTac-Pacsin1^em1(IMPC)H/H)	increased circulating alanine transaminase level	J:211773
Pacsin1^{Gt(OST287788)Lex}/Pacsin1^{Gt(OST287788)Lex} (B6.129S5-Pacsin1^{Gt(OST287788)Lex})	decreased circulating interferon-alpha level	J:187784
Pacsin2^{tm1b(EUCOMM)Hmgu}/Pacsin2^{tm1b(EUCOMM)Hmgu} (C57BL/6N-Pacsin2^{tm1b(EUCOMM)Hmgu}/J)	increased fasting circulating glucose level	J:211773
Padi1^em1(IMPC)J/Padi1^em1(IMPC)J (C57BL/6NJ-Padi1^em1(IMPC)J/Mmjax)	increased circulating phosphate level	J:211773
Padi2^{tm1b(KOMP)Wtsi}/Padi2⁺ (C57BL/6N-Padi2^{tm1b(KOMP)Wtsi}/Ucd)	increased circulating alanine transaminase level	J:211773
Padi3^{tm1b(KOMP)Wtsi}/Padi3^{tm1b(KOMP)Wtsi} (C57BL/6N-Padi3^{tm1b(KOMP)Wtsi}/Orl)	increased circulating HDL cholesterol level	J:211773
Padi4^em1(IMPC)Mbp/Padi4^em1(IMPC)Mbp (C57BL/6N-Padi4^em1(IMPC)Mbp/MbpMmucd)	decreased circulating cholesterol level	J:211773
	increased circulating bilirubin level	J:211773
	increased circulating triglyceride level	J:211773
Pafah2^tm1Arai/Pafah2^tm1Arai (B6.129P2-Pafah2^tm1Arai)	increased circulating alanine transaminase level	J:130728
Pah^em1Skym/Pah^em1Skym (C57BL/6J-Pah^em1Skym)	abnormal amino acid level	J:305392
	decreased circulating cholesterol level	J:305392
	decreased circulating HDL cholesterol level	J:305392
	decreased circulating LDL cholesterol level	J:305392
	decreased circulating tyrosine level	J:305392
	decreased nervous system dopamine level	J:305392
	decreased noradrenaline level	J:305392
	decreased serotonin level	J:305392
	increased circulating phenylalanine level	J:305392
	increased phenylalanine level	J:305392
Pah^enu1/Pah^enu1 (involves: 101 * C3H)	abnormal circulating amino acid level	J:62365, J:10355
Pah^enu1/Pah^enu2 (involves: 101 * C3H * BTBR)	abnormal circulating amino acid level	J:62365
Pah^enu2/Pah^enu2 (involves: BTBR)	abnormal urine homeostasis	J:13320
	decreased serotonin level	J:89662
	increased circulating phenylalanine level	J:13320
Pah^enu2/Pah^enu2 (BTBR-Pah^enu2/J)	abnormal enzyme/coenzyme level	J:178269
Pah^enu2/Pah^enu2 (BTBR-Pah^enu2/J)	increased phenylalanine level	J:178269
Pah^enu3/Pah^enu3 (involves: BTBR)	abnormal urine homeostasis	J:13320
Pah^enu3/Pah^enu3 (involves: BTBR)	increased circulating phenylalanine level	J:13320
Paip1^em1(IMPC)Tcp/Paip1^em1(IMPC)Tcp (C57BL/6NCrl-Paip1^em1(IMPC)Tcp/Tcp)	decreased circulating serum albumin level	J:211773
Pak1^tm1.1Xwg/Pak1^tm1.1Xwg Myl2^tm1(cre)Krc/Myl2⁺ (involves: 129S1/Sv * 129S4/SvJae * 129X1/SvJ * C57BL/6)	pulmonary edema	J:193804
Pak1^{tm1b(EUCOMM)Hmgu}/Pak1^{tm1b(EUCOMM)Hmgu} (C57BL/6N-Pak1^{tm1b(EUCOMM)Hmgu}/H)	increased blood urea nitrogen level	J:211773
	increased circulating triglyceride level	J:211773
Pak1ip1^mray/Pak1ip1^mray (involves: C57BL/6J * FVB/NJ)	skin edema	J:204457
Pak2^em1(IMPC)H/Pak2⁺ (C57BL/6NTac-Pak2^em1(IMPC)H/H)	increased circulating amylase level	J:211773
Palb2^{tm1.1(KOMP)Vlcg}/Palb2⁺ (C57BL/6N-Palb2^{tm1.1(KOMP)Vlcg}/J)	decreased circulating free fatty acids level	J:211773
	increased circulating insulin level	J:211773
Pald1^{em1(IMPC)Kmpc}/Pald1^{em1(IMPC)Kmpc} (C57BL/6NTac-Pald1^{em1(IMPC)Kmpc}/Kmpc)	impaired glucose tolerance	J:211773
Palm^{em1(IMPC)Wtsi}/Palm^{em1(IMPC)Wtsi} (C57BL/6N-Palm^{em1(IMPC)Wtsi}/Wtsi)	decreased circulating HDL cholesterol level	J:211773
	impaired glucose tolerance	J:211773
Pam^{em1(IMPC)Hmgu}/Pam⁺ (C57BL/6N-Pam^{em1(IMPC)Hmgu}/H)	decreased circulating fructosamine level	J:211773
Pam^tm1Jep/Pam⁺ (involves: 129S7/SvEvBrd * C57BL/6J)	impaired glucose tolerance	J:103533
Pam^tm1Jep/Pam⁺ (involves: 129S7/SvEvBrd)	impaired glucose tolerance	J:103533
Pam^tm1Jep/Pam^tm1Jep (involves: 129S7/SvEvBrd * C57BL/6J)	edema	J:103533
Pank1^tm1.1Suja/Pank1^tm1.1Suja (involves: 129S/SvEv * C57BL/6J)	abnormal amino acid level	J:161798
	abnormal blood homeostasis	J:161798
	abnormal gluconeogenesis	J:161798
	abnormal triglyceride level	J:161798
	decreased circulating glucose level	J:161798
	decreased circulating triglyceride level	J:161798
	decreased liver triglyceride level	J:161798
	increased liver triglyceride level	J:161798
Pank1^tm1.1Suja/Pank1^tm1.1Suja (involves: 129S/SvEv)	decreased fatty acid oxidation	J:189609
Pank1^tm1.1Suja/Pank1^tm1.1Suja Pank2^tm1.1Suja/Pank2^tm1.1Suja (involves: 129S/SvEv * C57BL/6J * FVB/N)	abnormal fatty acids level	J:189609
	decreased fatty acid oxidation	J:189609
	hypoglycemia	J:189609
	increased circulating ketone body level	J:189609
	increased liver triglyceride level	J:189609
Pank3^{tm1b(KOMP)Mbp}/Pank3^{tm1b(KOMP)Mbp} (C57BL/6N-Pank3^{tm1b(KOMP)Mbp}/Bay)	decreased circulating fructosamine level	J:211773
Pank4^{em1(IMPC)Kmpc}/Pank4^{em1(IMPC)Kmpc} (C57BL/6NTac-Pank4^{em1(IMPC)Kmpc}/Kmpc)	decreased circulating creatinine level	J:211773
Panx1^{tm1b(KOMP)Wtsi}/Panx1^{tm1b(KOMP)Wtsi} (C57BL/6N-Panx1^{tm1b(KOMP)Wtsi}/Ucd)	decreased circulating serum albumin level	J:211773
Paox^{tm1.1(KOMP)Wtsi}/Paox^{tm1.1(KOMP)Wtsi} (C57BL/6N-Paox^{tm1.1(KOMP)Wtsi}/Ieg)	decreased fasting circulating glucose level	J:211773
	increased circulating aspartate transaminase level	J:211773
Papola^em1(IMPC)J/Papola⁺ (C57BL/6NJ-Papola^em1(IMPC)J/Mmjax)	decreased circulating calcium level	J:211773
	increased circulating aspartate transaminase level	J:211773
Papolg^em1(IMPC)J/Papolg⁺ (C57BL/6NJ-Papolg^em1(IMPC)J/Mmjax)	increased circulating creatinine level	J:211773
Pappa^tm1Cac/Pappa^tm1Cac (involves: 129 * C57BL/6)	abnormal enzyme/coenzyme level	J:161983
	decreased circulating estradiol level	J:161983
	decreased circulating progesterone level	J:161983
	increased circulating estradiol level	J:161983
Papss2^bm/Papss2^bm (B6C3Fe a/a-Papss2^bm/J)	increased bleeding time	J:31800
Paqr6^{tm1b(KOMP)Wtsi}/Paqr6^{tm1b(KOMP)Wtsi} (C57BL/6N-Paqr6^{tm1b(KOMP)Wtsi}/Bay)	increased circulating calcium level	J:211773
Pard3^tm1.1Shoh/Pard3^tm1.1Shoh (involves: 129S4/SvJae * C57BL/6 * C57BL/6J)	edema	J:146415
Pard6a^{tm1.1(KOMP)Vlcg}/Pard6a^{tm1.1(KOMP)Vlcg} (C57BL/6N-Pard6a^{tm1.1(KOMP)Vlcg}/J)	impaired glucose tolerance	J:211773
Parg^tm1Zqw/Parg^tm1Zqw (involves: 129P2/OlaHsd * C57BL/6)	increased circulating glucose level	J:92244
Parg^tm1Zqw/Parg^tm1Zqw (involves: 129P2/OlaHsd * C57BL/6)	increased circulating tumor necrosis factor level	J:92244
Park7^Gt(XE726)Byg/Park7^Gt(XE726)Byg (involves: 129P2/OlaHsd * C57BL/6)	abnormal dopamine level	J:134826
Park7^tm1Xz/Park7^tm1Xz (involves: 129P2/OlaHsd * C57BL/6J)	increased dopamine level	J:99905
Parp1^tm1Zqw/Parp1^tm1Zqw (129S-Parp1^tm1Zqw/J)	decreased circulating creatinine level	J:95418
Parp1^tm2Zqw/Parp1^tm2Zqw (either: (involves: 129P2/OlaHsd * 129/Sv) or (involves: 129P2/OlaHsd * C57BL/6))	decreased circulating interleukin-1 beta level	J:93479
	decreased circulating tumor necrosis factor level	J:93479
Parp4^em1(IMPC)Mbp/Parp4^em1(IMPC)Mbp (C57BL/6N-Parp4^em1(IMPC)Mbp/MbpMmucd)	increased circulating cholesterol level	J:211773
Parp6^em1Msco/Parp6^em1Msco (C57BL/6N-Parp6^em1Msco)	cyanosis	J:319836
Parp9^tm1.2Arte/Parp9^tm1.2Arte (involves: C57BL/6N * FVB/N)	abnormal circulating interferon level	J:306337
Parp11^{tm1.1(KOMP)Vlcg}/Parp11^{tm1.1(KOMP)Vlcg} (C57BL/6N-Parp11^{tm1.1(KOMP)Vlcg}/Ucd)	increased circulating bilirubin level	J:211773
Parva^{em1(IMPC)Ccpcz}/Parva⁺ (C57BL/6NCrl-Parva^{em1(IMPC)Ccpcz}/Ccpcz)	increased circulating aspartate transaminase level	J:211773
	increased circulating phosphate level	J:211773
Parva^tm1Ref/Parva^tm1Ref (Not Specified)	anasarca	J:154437
Parva^tm1Ref/Parva^tm1Ref (Not Specified)	pericardial effusion	J:154437
Parvb^{tm1a(EUCOMM)Wtsi}/Parvb^{tm1a(EUCOMM)Wtsi} (C57BL/6N-Parvb^{tm1a(EUCOMM)Wtsi}/Cnrm)	decreased circulating cholesterol level	J:165965
	decreased circulating glucose level	J:165965
	decreased circulating iron level	J:165965
	decreased circulating total protein level	J:165965
Pask^tm1Weng/Pask^tm1Weng (B6.129S6-Pask^tm1Weng)	abnormal glucose homeostasis	J:125307
	abnormal respiratory quotient	J:125307
	decreased circulating insulin level	J:125307
	decreased insulin secretion	J:125307
	decreased susceptibility to diet-induced obesity	J:125307
	improved glucose tolerance	J:125307
	increased insulin sensitivity	J:125307
	increased oxygen consumption	J:125307
Pate4^{tm1.1(KOMP)Mbp}/Pate4^{tm1.1(KOMP)Mbp} (C57BL/6N-Pate4^{tm1.1(KOMP)Mbp}/J)	increased fasting circulating glucose level	J:211773
Patj^em1(IMPC)J/Patj^em1(IMPC)J (C57BL/6NJ-Patj^em1(IMPC)J/J)	increased circulating aspartate transaminase level	J:211773
Patl1^{tm1b(EUCOMM)Wtsi}/Patl1⁺ (C57BL/6N-Patl1^{tm1b(EUCOMM)Wtsi}/Bay)	decreased fasting circulating glucose level	J:211773
Pawr^{tm1b(EUCOMM)Wtsi}/Pawr⁺ (C57BL/6N-Pawr^{tm1b(EUCOMM)Wtsi}/H)	decreased circulating creatinine level	J:211773
Pax3^{tm1(FOXO1A)Gcg}/Pax3⁺ (either: (involves: 129X1/SvJ * C57BL/6) or (involves: 129X1/SvJ * NMRI))	cyanosis	J:79365
Pax3^tm2Joe/Pax3^tm2Joe H2az2^{Tg(Wnt1-cre)11Rth}/H2az2⁺ (involves: 129S1/Sv * 129X1/SvJ * C57BL/6J * CBA/J)	cyanosis	J:159124
Pax4^{tm1b(EUCOMM)Hmgu}/Pax4⁺ (C57BL/6N-Pax4^{tm1b(EUCOMM)Hmgu}/Ics)	increased circulating alkaline phosphatase level	J:211773
	increased circulating total protein level	J:211773
Pax5^{tm1b(EUCOMM)Wtsi}/Pax5⁺ (C57BL/6N-Pax5^{tm1b(EUCOMM)Wtsi}/Ieg)	impaired glucose tolerance	J:211773
	increased circulating amylase level	J:211773
	increased circulating lipase level	J:211773
	increased circulating triglyceride level	J:211773
Pax6^m1Lsli/Pax6⁺ (involves: C3H/HeJ * C57BL/6J)	abnormal hormone level	J:146325
	decreased adrenocorticotropin level	J:146325
	impaired glucose tolerance	J:146325
Pax6^Sey-Neu/Pax6^Sey-Neu (involves: 102 * C3H)	decreased circulating growth hormone level	J:56185
Pax6^Sey-Neu/Pax6^Sey-Neu (involves: 102 * C3H * CD-1)	abnormal hormone level	J:41624
Pax6^tm1Pgr/Pax6^tm2Pgr Tg(Pax6-cre,GFP)1Pgr/0 (involves: 129S1/Sv * 129X1/SvJ * FVB * NMRI)	decreased circulating insulin level	J:90642
	hyperglycemia	J:90642
	increased circulating ketone body level	J:90642
Pax6^tm2Pgr/Pax6^tm2Pgr Tg(Pax6-cre,GFP)1Pgr/0 (involves: FVB * NMRI)	decreased circulating insulin level	J:90642
	hyperglycemia	J:90642
	increased circulating ketone body level	J:90642
Pax7^{tm1.1(KOMP)Vlcg}/Pax7⁺ (C57BL/6N-Pax7^{tm1.1(KOMP)Vlcg}/J)	decreased circulating triglyceride level	J:211773
Pax8^tm1Pgr/Pax8⁺ (either: (involves: 129S1/Sv * 129X1/SvJ) or (involves: 129S1/Sv * 129X1/SvJ * C57BL/6))	increased circulating thyroid-stimulating hormone level	J:47310
Pax8^tm1Pgr/Pax8^tm1Pgr (either: (involves: 129S1/Sv * 129X1/SvJ) or (involves: 129S1/Sv * 129X1/SvJ * C57BL/6))	decreased circulating thyroxine level	J:47310, J:116236
	decreased circulating triiodothyronine level	J:116236
Pax8^tm1Pgr/Pax8^tm1Pgr (involves: 129S1/Sv * 129X1/SvJ)	increased thyroid-stimulating hormone level	J:130062
Pax8^tm1Rdl/Pax8^{tm1.1(cre)Mbu} (B6.129(Cg)-Pax8^tm1Rdl Pax8^{tm1.1(cre)Mbu})	decreased circulating thyroxine level	J:220108
	increased circulating thyroid-stimulating hormone level	J:220108
Pbrm1^{tm1b(EUCOMM)Wtsi}/Pbrm1⁺ (C57BL/6N-Pbrm1^{tm1b(EUCOMM)Wtsi}/Ieg)	decreased circulating creatinine level	J:211773
Pbx1^em1Dunw/Pbx1^em1Dunw (C57BL/6J-Pbx1^em1Dunw)	subcutaneous edema	J:320934
Pbx1^tm1.1Febe/Pbx1^tm1.1Febe (involves: C57BL/6)	skin edema	J:129552
Pbx1^tm1Mlc/Pbx1⁺ (involves: 129S6/SvEvTac * C57BL/6)	decreased insulin secretion	J:75811
	impaired glucose tolerance	J:75811
	increased insulin sensitivity	J:75811
Pbx1^tm1Mlc/Pbx1^tm1Mlc (involves: 129S6/SvEvTac * C57BL/6)	skin edema	J:70684
Pbx1^tm1Mlc/Pbx1^tm1Mlc (involves: 129S6/SvEvTac)	edema	J:178316
Pbx1^tm1Mlc/Pbx1^tm1Mlc Pbx2^tm1Mlc/Pbx2⁺ (involves: 129S6/SvEvTac)	edema	J:178316
Pbx1^tm1Mlc/Pbx1^tm1Mlc Pbx3^tm1Mlc/Pbx3⁺ (involves: 129S6/SvEvTac)	edema	J:178316
Pbx3^tm1.1Og/Pbx3^tm1.1Og (involves: 129S4/SvJae * C57BL/6)	cyanosis	J:130927
Pbx3^{tm1a(EUCOMM)Wtsi}/Pbx3^{tm1a(EUCOMM)Wtsi} (Not Specified)	decreased circulating cholesterol level	J:165965
	increased circulating cholesterol level	J:165965
Pbx3^{tm1b(EUCOMM)Wtsi}/Pbx3⁺ (C57BL/6N-Pbx3^{tm1b(EUCOMM)Wtsi}/H)	decreased blood urea nitrogen level	J:211773
	increased circulating bilirubin level	J:211773
Pbx3^tm1Mlc/Pbx3^tm1Mlc (involves: C57BL/6)	cyanosis	J:93761
Pcbd1^tm1Grc/Pcbd1^tm1Grc (either: (involves: 129S1/Sv * 129X1/SvJ * C57BL/6J) or (involves: 129S1/Sv * 129X1/SvJ * CD-1))	impaired glucose tolerance	J:78257
	increased circulating insulin level	J:78257
	increased circulating phenylalanine level	J:78257
	ketoaciduria	J:78257
Pcbp2^tm1.2Salr/Pcbp2^tm1.2Salr (involves: 129S4/SvJae * 129S4/SvJaeSor * C57BL/6 * FVB/N)	subcutaneous edema	J:235912
Pcca^tm1Tmiy/Pcca^tm1Tmiy (involves: 129P2/OlaHsd * C57BL/6)	decreased liver glycogen level	J:71660
	dehydration	J:71660
	ketoaciduria	J:71660
Pcca^tm1Tmiy/Pcca^tm1Tmiy Tg(CAG-PCCAA138T,-EGFP)#Maba/0 (involves: 129P2/OlaHsd FVB/N)	abnormal circulating carnitine level	J:286218
	increased circulating alanine level	J:286218
	increased circulating ammonia level	J:286218
	increased circulating glycine level	J:286218
	increased lysine level	J:286218
Pcdh8^em1(IMPC)H/Pcdh8^em1(IMPC)H (C57BL/6N-Pcdh8^em1(IMPC)H/H)	impaired glucose tolerance	J:211773
Pcdh9^{tm1.1(KOMP)Vlcg}/Pcdh9⁺ (C57BL/6N-Pcdh9^{tm1.1(KOMP)Vlcg}/J)	increased circulating aspartate transaminase level	J:211773
	increased circulating bilirubin level	J:211773
	increased circulating phosphate level	J:211773
Pcdh15^av-3J/Pcdh15^av-3J (C57BL/6J-Pcdh15^av-3J/J)	abnormal circulating lipid level	J:320724
	decreased circulating cholesterol level	J:320724
	decreased circulating triglyceride level	J:320724
Pcdh15^em1Zma/Pcdh15^em1Zma (involves: C57BL/6J)	abnormal homeostasis	J:342718
Pcdha^tm3Tyag/Pcdha^tm3Tyag (B6.Cg-Pcdha^tm3Tyag)	increased serotonin level	J:151979
Pcdha^tm4Tyag/Pcdha^tm4Tyag (involves: C57BL/6 * CBA)	abnormal serotonin level	J:143248
Pcdha^tm5.1Tyag/Pcdha^tm5.1Tyag (B6.Cg-Pcdha^tm5.1Tyag)	abnormal serotonin level	J:151979
Pcdha^tm5Tyag/Pcdha^tm5Tyag (involves: C57BL/6 * CBA)	abnormal serotonin level	J:143248
Pcdhb13^em1(IMPC)Tcp/Pcdhb13^em1(IMPC)Tcp (C57BL/6N-Pcdhb13^em1(IMPC)Tcp/Tcp)	decreased circulating cholesterol level	J:211773
	decreased circulating HDL cholesterol level	J:211773
Pcdhgb2^{em1(IMPC)Hmgu}/Pcdhgb2^{em1(IMPC)Hmgu} (C57BL/6N-Pcdhgb2^{em1(IMPC)Hmgu}/Ieg)	increased circulating lipase level	J:211773
Pcgf1^{tm1.1(KOMP)Vlcg}/Pcgf1⁺ (C57BL/6N-Pcgf1^{tm1.1(KOMP)Vlcg}/J)	increased fasting circulating glucose level	J:211773
Pck1^tm1.1Lre/Pck1^tm1.1Lre (involves: 129P2/OlaHsd * BALB/c * C57BL/6)	decreased circulating ketone body level	J:73977
	decreased circulating triglyceride level	J:73977
	decreased liver triglyceride level	J:73977
	hyperglycemia	J:73977
Pck1^tm1.1Mgn/Pck1^tm1.1Mgn Speer6-ps1^{Tg(Alb-cre)21Mgn}/Speer6-ps1⁺ (involves: 129S6/SvEvTac)	decreased liver glycogen level	J:63929
	increased circulating free fatty acids level	J:63929
	increased circulating triglyceride level	J:63929
	increased liver triglyceride level	J:63929
Pck1^tm1.2Mgn/Pck1^tm1.2Mgn (involves: 129S6/SvEvTac)	decreased liver glycogen level	J:63929
Pck1^tm1.2Mgn/Pck1^tm1.2Mgn (involves: 129S6/SvEvTac)	hypoglycemia	J:63929
Pck1^tm1Rwh/Pck1^tm1Rwh (involves: 129P2/OlaHsd * C57BL/6)	abnormal circulating amino acid level	J:145210
	abnormal circulating lipid level	J:145210
	decreased circulating glucose level	J:145210
	decreased liver glycogen level	J:145210
	increased blood urea nitrogen level	J:145210
	increased circulating ammonia level	J:145210
	increased circulating ketone body level	J:145210
	increased circulating lactate level	J:145210
	increased circulating triglyceride level	J:145210
Pck2^em1(IMPC)Tcp/Pck2^em1(IMPC)Tcp (C57BL/6N-Pck2^em1(IMPC)Tcp/Tcp)	decreased circulating triglyceride level	J:211773
	increased circulating aspartate transaminase level	J:211773
Pclaf^{tm1a(EUCOMM)Wtsi}/Pclaf^{tm1a(EUCOMM)Wtsi} (C57BL/6N-Pclaf^{tm1a(EUCOMM)Wtsi}/Wtsi)	impaired glucose tolerance	J:211773
Pcm1^em1(IMPC)Tcp/Pcm1^em1(IMPC)Tcp (C57BL/6NCrl-Pcm1^em1(IMPC)Tcp/Tcp)	impaired glucose tolerance	J:211773
Pcmt1^tm1Scl/Pcmt1^tm1Scl (involves: 129S4/SvJae * C57BL/6)	abnormal homeostasis	J:40967
Pcmt1^tm1Shs/Pcmt1^tm1Shs (involves: 129P2/OlaHsd * C57BL/6)	decreased circulating cholesterol level	J:46228
	decreased circulating creatine kinase level	J:46228
	decreased circulating ferritin level	J:46228
	decreased circulating lactate dehydrogenase level	J:46228
	decreased circulating phosphate level	J:46228
	increased blood urea nitrogen level	J:46228
	increased circulating aldosterone level	J:46228
	increased circulating corticosterone level	J:46228
	increased circulating triglyceride level	J:46228
Pcnt^{Gt(RRU388)Byg}/Pcnt^{Gt(RRU388)Byg} (B6.129P2-Pcnt^{Gt(RRU388)Byg})	hydrops fetalis	J:226309
Pcnx2^em1(IMPC)J/Pcnx2⁺ (C57BL/6NJ-Pcnx2^em1(IMPC)J/J)	increased circulating total protein level	J:211773
Pcsk1^em2Irli/Pcsk1^em2Irli (C57BL/6J-Pcsk1^em2Irli)	decreased adrenocorticotropin level	J:324309
	decreased circulating glucose level	J:324309
	increased circulating insulin level	J:324309
Pcsk1^mpc242H/Pcsk1^mpc242H (involves: BALB/c * C3H/HeH * C57BL/6J)	impaired glucose tolerance	J:234901
	insulin resistance	J:234901
Pcsk1^N222D/Pcsk1^N222D (C57BL/6-Pcsk1^N222D)	increased circulating leptin level	J:109531
Pcsk1^tm1Dfs/Pcsk1⁺ (involves: 129 * C57BL/6J)	abnormal glucose tolerance	J:78369
Pcsk1^tm1Dfs/Pcsk1⁺ (involves: 129 * C57BL/6J)	decreased circulating insulin level	J:78369
Pcsk1^tm1Dfs/Pcsk1^tm1Dfs (involves: 129 * C57BL/6J)	decreased adrenocorticotropin level	J:78369
	decreased circulating glucagon level	J:78369
	decreased circulating growth hormone level	J:78369
	decreased circulating insulin level	J:78369
	hypoglycemia	J:78369
	increased circulating interferon-gamma level	J:184882
	increased circulating interleukin-1 beta level	J:184882
	increased circulating interleukin-6 level	J:184882
	increased circulating interleukin-10 level	J:184882
	increased circulating interleukin-12 level	J:184882
	increased circulating tumor necrosis factor level	J:184882
Pcsk1^tm1Dfs/Pcsk1^tm1Dfs (involves: 129)	abnormal hormone level	J:117652
Pcsk1^tm1Mbi/Pcsk1⁺ (involves: 129S1/Sv * 129X1/SvJ * C57BL/6J * FVB/N)	increased susceptibility to diet-induced obesity	J:122555
Pcsk2^em1(IMPC)H/Pcsk2⁺ (C57BL/6NTac-Pcsk2^em1(IMPC)H/H)	increased circulating alanine transaminase level	J:211773
Pcsk2^em1(IMPC)H/Pcsk2^em1(IMPC)H (C57BL/6NTac-Pcsk2^em1(IMPC)H/H)	decreased circulating glucose level	J:211773
	increased circulating amylase level	J:211773
	increased circulating cholesterol level	J:211773
	increased circulating HDL cholesterol level	J:211773
	increased circulating iron level	J:211773
Pcsk2^tm1Dfs/Pcsk2^tm1Dfs (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	decreased circulating glucose level	J:41505
	decreased circulating insulin level	J:41505
	decreased glucagon secretion	J:41505
	decreased insulin secretion	J:41505
	decreased pituitary hormone level	J:82967
	impaired glucose tolerance	J:41505
Pcsk2^tm1Dfs/Pcsk2^tm1Dfs (B6;129-Pcsk2^tm1Dfs/J)	decreased circulating glucagon level	J:236905
	decreased glucagon secretion	J:236905
	improved glucose tolerance	J:236905
	increased circulating insulin level	J:236905
Pcsk4^{tm1b(KOMP)Wtsi}/Pcsk4^{tm1b(KOMP)Wtsi} (C57BL/6N-Pcsk4^{tm1b(KOMP)Wtsi}/J)	increased circulating sodium level	J:211773
Pcsk5^{tm1b(KOMP)Mbp}/Pcsk5⁺ (C57BL/6N-Pcsk5^{tm1b(KOMP)Mbp}/J)	decreased circulating calcium level	J:211773
	decreased circulating cholesterol level	J:211773
	decreased circulating HDL cholesterol level	J:211773
	increased fasting circulating glucose level	J:211773
Pcsk9^m1Bms/Pcsk9⁺ (B6.Cg-Pcsk9^m1Bms)	decreased circulating LDL cholesterol level	J:200728
Pcsk9^m1Bms/Pcsk9^m1Bms (B6.Cg-Pcsk9^m1Bms)	decreased circulating LDL cholesterol level	J:200728
Pcsk9^m1Bms/Pcsk9^m1Bms (B6.Cg-Pcsk9^m1Bms)	increased bile salt level	J:200728
Pcsk9^tm1.1Prat/Pcsk9^tm1.1Prat Speer6-ps1^{Tg(Alb-cre)21Mgn}/? (involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * DBA)	decreased circulating cholesterol level	J:169834
	decreased circulating HDL cholesterol level	J:169834
	decreased circulating LDL cholesterol level	J:169834
Pcsk9^tm1.2Prat/Pcsk9^tm1.2Prat (involves: 129S1/Sv * 129X1/SvJ)	abnormal cholesterol homeostasis	J:169834
	decreased circulating cholesterol level	J:169834
	decreased circulating HDL cholesterol level	J:169834
	decreased circulating LDL cholesterol level	J:169834
Pcsk9^tm1Jdh/Pcsk9^tm1Jdh (involves: 129S6/SvEvTac)	decreased circulating cholesterol level	J:97836
	decreased circulating HDL cholesterol level	J:97836
	decreased circulating LDL cholesterol level	J:97836
Pcsk9^{tm2b(EUCOMM)Hmgu}/Pcsk9^{tm2b(EUCOMM)Hmgu} (C57BL/6N-Pcsk9^{tm2b(EUCOMM)Hmgu}/Ieg)	decreased circulating cholesterol level	J:211773
	decreased circulating HDL cholesterol level	J:211773
	increased circulating alkaline phosphatase level	J:211773
	increased circulating amylase level	J:211773
	increased circulating lipase level	J:211773
Pctp^R120H/Pctp⁺ (NZO)	abnormal lipid homeostasis	J:114974
Pctp^tm1Bor/Pctp^tm1Bor (involves: 129P2/OlaHsd * C57BL/6J)	abnormal bile salt level	J:115285
Pctp^tm1Bor/Pctp^tm1Bor (involves: 129P2/OlaHsd * C57BL/6J)	abnormal phospholipid level	J:115285
Pctp^tm1Bor/Pctp^tm1Bor (involves: 129P2/OlaHsd * FVB/NJ)	abnormal bile salt level	J:115285
	decreased cholesterol level	J:115285
	increased cholesterol level	J:115285
Pcx^{tm1b(EUCOMM)Wtsi}/Pcx⁺ (C57BL/6N-Pcx^{tm1b(EUCOMM)Wtsi}/H)	decreased respiratory quotient	J:211773
Pcx^{tm1c(EUCOMM)Wtsi}/Pcx^{tm1c(EUCOMM)Wtsi} Speer6-ps1^{Tg(Alb-cre)21Mgn}/Speer6-ps1⁺ (involves: C57BL/6 * C57BL/6N * DBA * SJL)	abnormal fatty acid oxidation	J:332296
	abnormal insulin clearance	J:332296
	abnormal insulin secretion	J:332296
	decreased circulating glucose level	J:332296
	decreased fasting circulating glucose level	J:332296
	hypoglycemia	J:332296
	impaired gluconeogenesis	J:332296
	improved glucose tolerance	J:332296
	increased circulating free fatty acids level	J:332296
	increased circulating ketone body level	J:332296
	increased circulating lactate level	J:332296
	increased circulating triglyceride level	J:332296
	increased liver triglyceride level	J:332296
Pcyt1a^tm1Irt/Pcyt1a^tm1Irt Tg(SFTPC-rtTA)5Jaw/0 Tg(tetO-cre)1Jaw/Tg(tetO-cre)1Jaw (involves: C57BL/6J * FVB/N)	cyanosis	J:118292
	increased triglyceride level	J:118292
Pcyt1b^tm1Mkar/Pcyt1b^tm1Mkar (involves: 129S1/Sv * C57BL/6J)	increased circulating follicle stimulating hormone level	J:90150
	increased circulating luteinizing hormone level	J:90150
Pcyt2^tm1.1Suja/Pcyt2^tm1.1Suja Speer6-ps1^{Tg(Alb-cre)21Mgn}/Speer6-ps1⁺ (involves: C57BL/6 * DBA)	decreased circulating triglyceride level	J:155630
	increased liver cholesterol level	J:155630
	increased liver triglyceride level	J:155630
Pcyt2^tm1Mbak/Pcyt2⁺ (involves: 129S6/SvEvTac * C57BL/6)	abnormal lipid homeostasis	J:121387
Pdc^tm1Luhe/Pdc^tm1Luhe (B6.129P2-Pdc^tm1Luhe)	abnormal urine catecholamine level	J:155373
Pdc^tm1Luhe/Pdc^tm1Luhe (B6.129P2-Pdc^tm1Luhe)	increased circulating noradrenaline level	J:155373
Pdcd1lg2^tm3Shr/Pdcd1lg2^tm3Shr (involves: C57BL/6 * NOD/MrkTac)	hyperglycemia	J:123785
Pdcd6ip^em1(IMPC)Mbp/Pdcd6ip^em1(IMPC)Mbp (C57BL/6NCrl-Pdcd6ip^em1(IMPC)Mbp/Mmucd)	decreased circulating bilirubin level	J:211773
	increased blood urea nitrogen level	J:211773
	increased circulating HDL cholesterol level	J:211773
Pdcd7^em1(IMPC)Mbp/Pdcd7⁺ (C57BL/6N-Pdcd7^em1(IMPC)Mbp/MbpMmucd)	decreased circulating serum albumin level	J:211773
Pdcl^tm1.1Bmw/Pdcl^tm1.1Bmw Tg(Rho-icre)1Ck/0 (involves: 129S4/SvJaeSor * 129S6/SvEvTac * C57BL/6 * SJL)	photosensitivity	J:197148
Pde1a^em1(IMPC)H/Pde1a^em1(IMPC)H (C57BL/6N-Pde1a^em1(IMPC)H/H)	decreased blood urea nitrogen level	J:211773
Pde2a^em1(IMPC)H/Pde2a⁺ (C57BL/6NTac-Pde2a^em1(IMPC)H/H)	decreased circulating triglyceride level	J:211773
Pde2a^em1(IMPC)H/Pde2a⁺ (C57BL/6NTac-Pde2a^em1(IMPC)H/H)	increased circulating bilirubin level	J:211773
Pde3b^tm1Yhc/Pde3b^tm1Yhc (129X1/SvJ-Pde3b^tm1Yhc)	abnormal circulating hormone level	J:117353
	abnormal enzyme/coenzyme level	J:117353
	abnormal glucose homeostasis	J:117353
	enhanced lipolysis	J:117353
	increased circulating adiponectin level	J:117353
	increased circulating free fatty acids level	J:117353
	increased circulating glycerol level	J:117353
	increased circulating insulin level	J:117353
	increased fatty acids level	J:117353
	increased glycerol level	J:117353
	increased insulin secretion	J:117353
	increased triglyceride level	J:117353
	insulin resistance	J:117353
Pde4d^tm1Mct/Pde4d^tm1Mct (involves: 129P2/OlaHsd * C57BL/6)	abnormal tumor necrosis factor level	J:94853
Pde6a^em1(IMPC)Mbp/Pde6a^em1(IMPC)Mbp (C57BL/6NCrl-Pde6a^em1(IMPC)Mbp/Mmucd)	increased circulating phosphate level	J:211773
Pde7b^em1(IMPC)Mbp/Pde7b^em1(IMPC)Mbp (C57BL/6NCrl-Pde7b^em1(IMPC)Mbp/Mmucd)	increased blood urea nitrogen level	J:211773
Pde8a^tm1Dgen/Pde8a^tm1Dgen (B6.129P2-Pde8a^tm1Dgen)	abnormal testosterone level	J:118251
Pde8b^tm1Dgen/Pde8b^tm1Dgen (B6.129P2-Pde8b^tm1Dgen)	decreased circulating adrenocorticotropin level	J:203335
Pde8b^tm1Dgen/Pde8b^tm1Dgen (B6.129P2-Pde8b^tm1Dgen)	increased urine corticosterone level	J:203335
Pde10a^em1(IMPC)H/Pde10a^em1(IMPC)H (C57BL/6NTac-Pde10a^em1(IMPC)H/H)	increased circulating iron level	J:211773
Pde10a^tm1Smsh/Pde10a^tm1Smsh (B6NTac.Cg-Pde10a^tm1Smsh)	abnormal circulating glucose level	J:209032
	abnormal circulating insulin level	J:209032
	decreased circulating alanine transaminase level	J:209032
	decreased circulating cholesterol level	J:209032
	decreased circulating insulin level	J:209032
	decreased circulating leptin level	J:209032
	decreased respiratory quotient	J:209032
	decreased susceptibility to diet-induced obesity	J:209032
	increased insulin sensitivity	J:209032
Pdgfa^tm1Cbet/Pdgfa^tm1Cbet Pdgfc^tm1Nagy/Pdgfc^tm1Nagy (involves: 129S1/Sv * 129X1/SvJ)	hydrops fetalis	J:93954
	pericardial effusion	J:93954
Pdgfb^tm1Cbet/Pdgfb^tm1Cbet (involves: 129P2/OlaHsd * C57BL/6)	skin edema	J:20017
Pdgfb^tm1Cbet/Pdgfb^tm2Cbet Tg(Tie1-cre)9Ref/0 (involves: 129P2/OlaHsd * 129S1/Sv * 129X1/SvJ * C57BL/6 * CBA)	albuminuria	J:89186
Pdgfb^tm3.1Cbet/Pdgfb^tm3.1Cbet (involves: 129S1/Sv * 129X1/SvJ)	albuminuria	J:84701
	increased urine protein level	J:84701
Pdgfc^tm1Nagy/Pdgfc^tm1Nagy (involves: 129S1/Sv * 129X1/SvJ)	edema	J:93954
Pdgfd^{em1(IMPC)Ccpcz}/Pdgfd^{em1(IMPC)Ccpcz} (C57BL/6N-Pdgfd^{em1(IMPC)Ccpcz}/Ccpcz)	decreased circulating potassium level	J:211773
Pdgfd^tm1Ueks/Pdgfd^tm1Ueks (B6.Cg-Pdgfd^tm1Ueks)	decreased circulating chloride level	J:249014
Pdgfd^tm1Ueks/Pdgfd^tm1Ueks (B6.Cg-Pdgfd^tm1Ueks)	increased circulating calcium level	J:249014
Pdgfra^tm1Sor/Pdgfra⁺ Plekha1^{Gt(ROSA)82Sor}/Plekha1^{Gt(ROSA)82Sor} (either: (involves: 129S4/SvJaeSor) or (involves: 129S4/SvJaeSor * C57BL/6))	decreased circulating estradiol level	J:142042
Pdgfra^tm1Sor/Pdgfra⁺ Schip1^{Gt(ROSA)77Sor}/Schip1^{Gt(ROSA)77Sor} (either: (involves: 129S4/SvJaeSor) or (involves: 129S4/SvJaeSor * C57BL/6))	decreased circulating estradiol level	J:142042
Pdgfra^tm1Sor/Pdgfra^tm1Sor (either: 129S4/SvJaeSor-Pdgfra^tm1Sor or (involves: 129S4/SvJaeSor * C57BL/6J))	edema	J:41814
	pericardial edema	J:41814
	skin edema	J:41814
Pdgfra^tm2Sor/Pdgfra^tm2Sor (either: 129S4/SvJaeSor-Pdgfra^tm2Sor or (involves: 129S4/SvJaeSor * C57BL/6J))	edema	J:41814
	pericardial edema	J:41814
	skin edema	J:41814
Pdgfra^tm8Sor/Pdgfra^tm8Sor Pdgfrb^tm1Mdt/Pdgfrb^tm1Mdt H2az2^{Tg(Wnt1-cre)11Rth}/H2az2⁺ (involves: C57BL/6 * CBA)	cyanosis	J:122584
Pdgfra^tm8Sor/Pdgfra^tm8Sor Tg(Nr5a1-cre)2Klp/0 (either: (involves: 129S4/SvJaeSor) or (involves: 129S4/SvJaeSor * C57BL/6))	abnormal testosterone level	J:142042
	decreased circulating estradiol level	J:142042
Pdgfra^{tm10(Pdgfra/tor)Sor}/Pdgfra^{tm10(Pdgfra/tor)Sor} (either: (involves: 129S4/SvJaeSor) or (involves: 129S4/SvJaeSor * C57BL/6))	hydrops fetalis	J:83560
Pdgfra^tm12.1Sor/Pdgfra⁺ (involves: 129 * C57BL/6)	edema	J:146617
Pdgfrb^{tm1b(EUCOMM)Hmgu}/Pdgfrb⁺ (C57BL/6N-Pdgfrb^{tm1b(EUCOMM)Hmgu}/H)	decreased circulating fructosamine level	J:211773
	increased circulating triglyceride level	J:211773
Pdgfrb^tm1Sor/Pdgfrb⁺ Schip1^{Gt(ROSA)77Sor}/Schip1^{Gt(ROSA)77Sor} (involves: 129S4/SvJaeSor * 129S7/SvEvBrd)	increased blood urea nitrogen level	J:117491
Pdgfrb^tm1Sor/Pdgfrb^tm1Sor (either: 129S7/SvEvBrd-Pdgfrb^tm1Sor or (involves: 129S7/SvEvBrd * C57BL/6J))	hydrops fetalis	J:20016
Pdgfrb^tm2Sor/Pdgfrb^tm2Sor (either: 129S7/SvEvBrd-Pdgfrb^tm2Sor or (involves: 129S7/SvEvBrd * C57BL/6J))	hydrops fetalis	J:20016
Pdgfrb^tm5Sor/Pdgfrb^tm5Sor (either: 129S4/SvJaeSor-Pdgfra^tm5Sor or (involves: 129S4/SvJaeSor * C57BL/6))	abnormal glomerular capillary thrombosis	J:67735
Pdgfrb^tm10Sor/Pdgfrb^tm10Sor (involves: 129S4/SvJae * C57BL/6)	hydrops fetalis	J:86542
Pdgfrl^em1(IMPC)J/Pdgfrl^em1(IMPC)J (C57BL/6NJ-Pdgfrl^em1(IMPC)J/J)	decreased circulating calcium level	J:211773
Pdha1^tm1Ptl/Y Tg(Ckmm-cre)5Khn/0 (involves: 129P2/OlaHsd * FVB)	increased circulating insulin level	J:141289
Pdha1^tm1Ptl/Pdha1⁺ Tg(Ckmm-cre)5Khn/0 (involves: 129P2/OlaHsd * FVB)	increased circulating insulin level	J:141289
Pdia4^{tm1b(EUCOMM)Wtsi}/Pdia4^{tm1b(EUCOMM)Wtsi} (C57BL/6N-Pdia4^{tm1b(EUCOMM)Wtsi}/Wtsi)	increased circulating aspartate transaminase level	J:211773
	increased circulating creatine kinase level	J:211773
Pdia4^{tm1b(EUCOMM)Wtsi}/Pdia4^{tm1b(EUCOMM)Wtsi} Tg(Pf4-icre)Q3Rsko/0 (involves: C57BL/6N)	decreased platelet aggregation	J:244748
	decreased platelet ATP level	J:244748
Pdia4^{tm1b(EUCOMM)Wtsi}/Pdia4^{tm1b(EUCOMM)Wtsi} Tg(Tek-cre)12Flv/0 (involves: C3H * C57BL/6N)	decreased platelet aggregation	J:244748
	increased bleeding time	J:244748
Pdia6^em1Btlr/Pdia6^m1Btlr (involves: C57BL/6J)	abnormal circulating cytokine level	J:288824
	decreased circulating insulin level	J:288824
	decreased circulating insulin-like growth factor I level	J:288824
	decreased circulating triglyceride level	J:288824
	increased fasting circulating glucose level	J:288824
	insulin resistance	J:288824
Pdk1^{tm1a(EUCOMM)Hmgu}/Pdk1^{tm1a(EUCOMM)Hmgu} Pdk2^tm1Rhar/Pdk2^tm1Rhar Pdk3^em1Eze/Pdk3^em1Eze Pdk4^tm1Rhar/Pdk4^tm1Rhar (involves: 129 * C57BL/6J * C57BL/6N)	abnormal circulating protein level	J:303714
	decreased circulating glucose level	J:303714
	decreased circulating lactate level	J:303714
	increased circulating ketone body level	J:303714
Pdk4^tm1Rhar/Pdk4^tm1Rhar (B6.129-Pdk4^tm1Rhar)	abnormal blood homeostasis	J:115895
	abnormal circulating amino acid level	J:115895
	abnormal glucose homeostasis	J:115895
	abnormal glycerol level	J:115895
	decreased circulating alanine level	J:115895
	decreased circulating glucose level	J:115895
	decreased circulating lactate level	J:115895
	decreased liver glycogen level	J:115895
	improved glucose tolerance	J:115895
	increased circulating free fatty acids level	J:115895
	increased circulating insulin level	J:115895
	increased circulating ketone body level	J:115895
	ketosis	J:115895
Pdlim1^{Gt(IST12013D3)Tigm}/Pdlim1^{Gt(IST12013D3)Tigm} (involves: C57BL/6N)	abnormal platelet physiology	J:212221
	abnormal thrombosis	J:212221
	increased platelet aggregation	J:212221
Pdlim1^Gt(XC262)Byg/Pdlim1^Gt(XC262)Byg (involves: 129P2/OlaHsd)	abnormal platelet dense granule physiology	J:212221
	abnormal platelet physiology	J:212221
	abnormal thrombosis	J:212221
	increased platelet aggregation	J:212221
Pdlim3^tm1Krc/Pdlim3^tm1Krc (either: (involves: 129S) or (involves: C57BL/6) or (involves: Black Swiss))	edema	J:69097
Pdlim4^em1(IMPC)Ics/Pdlim4^em1(IMPC)Ics (C57BL/6N-Pdlim4^em2(IMPC)Ics/Ics)	decreased circulating glucose level	J:211773
	improved glucose tolerance	J:211773
Pdlim7^{Gt(OST445990)Lex}/Pdlim7⁺ (B6.129S5-Pdlim7^{Gt(OST445990)Lex})	abnormal cardiac thrombosis	J:209780
	decreased bleeding time	J:209780
Pdlim7^{Gt(OST445990)Lex}/Pdlim7^{Gt(OST445990)Lex} (B6.129S5-Pdlim7^{Gt(OST445990)Lex})	abnormal cardiac thrombosis	J:209780
	abnormal thrombosis	J:209780
	decreased bleeding time	J:209780
Pdp1^em1(IMPC)Mbp/Pdp1^em1(IMPC)Mbp (C57BL/6NCrl-Pdp1^em1(IMPC)Mbp/Mmucd)	improved glucose tolerance	J:211773
	increased fasting circulating glucose level	J:211773
Pdpk1^tm1.1Mlw/Pdpk1^tm1.1Mlw Tnfrsf4^tm2(cre)Nik/Tnfrsf4⁺ Gt(ROSA)26Sor^tm1(EYFP)Cos/Gt(ROSA)26Sor⁺ (involves: 129X1/SvJ * C57BL/6)	impaired skin barrier function	J:226194
Pdpk1^tm1Dral/Pdpk1^tm1Dral (B6.129P2-Pdpk1^tm1Dral)	impaired glucose tolerance	J:136089
	increased circulating insulin level	J:136089
	insulin resistance	J:136089
Pdpk1^tm1Jcbr/Pdpk1^tm1Jcbr Tg(Pomc1-cre)16Lowl/0 (involves: C57BL/6 * FVB/N)	abnormal circulating leptin level	J:134336
	abnormal glucose homeostasis	J:134336
	decreased circulating corticosterone level	J:134336
	decreased circulating glucose level	J:134336
	decreased insulin secretion	J:134336
	improved glucose tolerance	J:134336
	increased circulating glucose level	J:134336
	increased insulin sensitivity	J:134336
Pdpk1^tm1Maka/Pdpk1^tm1Maka Stat3^tm2Aki/Stat3^tm2Aki Tg(Alb1-cre)1Dlr/0 (involves: 129S4/SvJae * 129P2/OlaHsd * FVB/N)	abnormal glucose homeostasis	J:109359
	impaired glucose tolerance	J:109359
Pdpk1^tm1Maka/Pdpk1^tm1Maka Tg(Alb1-cre)1Dlr/0 (involves: 129S4/SvJae * FVB/N)	abnormal glucose homeostasis	J:109359
	impaired glucose tolerance	J:109359
	increased circulating glucose level	J:109359
	increased circulating insulin level	J:109359
Pdpk1^tm1Maka/Pdpk1^tm1Maka Tg(CAG-cat,-lacZ)11Miya/0 Tg(Pomc1-cre)16Lowl/0 (involves: 129S4/SvJae * C57BL/6 * DBA/2 * FVB/N)	abnormal homeostasis	J:162892
	decreased circulating corticosterone level	J:162892
	hypoglycemia	J:162892
	increased insulin sensitivity	J:162892
Pdpk1^tm1Maka/Pdpk1^tm1Maka Tg(Ins2-cre)23Herr/0 (involves: 129S4/SvJae * C57BL/6J * CBA/J)	decreased circulating insulin level	J:109010
	hyperglycemia	J:109010
	increased circulating glucose level	J:109010
Pdpn^tm1(cre)Mlkn/Pdpn^tm1(cre)Mlkn (involves: 129S4/SvJae * C57BL/6)	intestinal edema	J:162815
Pdpn^{tm1b(EUCOMM)Wtsi}/Pdpn⁺ (C57BL/6N-Pdpn^{tm1b(EUCOMM)Wtsi}/H)	increased circulating calcium level	J:211773
	increased circulating cholesterol level	J:211773
Pdpn^tm1Mcws/Pdpn^tm1Mcws (involves: 129S6/SvEvTac)	cyanosis	J:82687
Pdpn^tm1Mcws/Pdpn^tm1Mcws (involves: 129S6/SvEvTac)	lymphedema	J:94978
Pdpr^{tm1b(EUCOMM)Wtsi}/Pdpr^{tm1b(EUCOMM)Wtsi} (C57BL/6N-Pdpr^{tm1b(EUCOMM)Wtsi}/Ics)	abnormal cholesterol homeostasis	J:211773
	decreased circulating creatinine level	J:211773
	improved glucose tolerance	J:211773
	increased fasting circulating glucose level	J:211773
Pds5b^tm1Jmi/Pds5b^tm1Jmi (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	cyanosis	J:124279
Pdss2^kd/Pdss2^kd (CBA/H-Pdss2^kd)	abnormal enzyme/coenzyme level	J:197578
	albuminuria	J:5232
	colorless urine	J:5232
Pdss2^{tm1b(EUCOMM)Hmgu}/Pdss2⁺ (C57BL/6N-Pdss2^{tm1b(EUCOMM)Hmgu}/H)	increased circulating bilirubin level	J:211773
Pdss2^tm1Dalg/Pdss2^tm1Dalg Speer6-ps1^{Tg(Alb-cre)21Mgn}/Speer6-ps1⁺ (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	abnormal circulating cholesterol level	J:136670
	abnormal energy homeostasis	J:136670
Pdss2^tm1Dalg/Pdss2^tm1Dalg Tg(NPHS2-cre)295Lbh/? (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	albuminuria	J:136670
	increased circulating cholesterol level	J:136670
Pdx1^tm1.1Stof/Pdx1⁺ (involves: 129/Sv * C57BL/6)	decreased circulating insulin level	J:152582
Pdx1^tm1.1Stof/Pdx1⁺ (involves: 129/Sv * C57BL/6)	impaired glucose tolerance	J:152582
Pdx1^tm1.1Stof/Pdx1^tm1.1Stof (involves: 129/Sv * C57BL/6)	decreased circulating insulin level	J:152582
	hyperglycemia	J:152582
	impaired glucose tolerance	J:152582
Pdx1^{tm1b(EUCOMM)Wtsi}/Pdx1⁺ (C57BL/6N-Pdx1^{tm1b(EUCOMM)Wtsi}/Bay)	impaired glucose tolerance	J:211773
Pdx1^tm1Cvw/Pdx1⁺ (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	decreased insulin secretion	J:165268
	impaired glucose tolerance	J:165268
	increased circulating glucose level	J:165268
Pdx1^tm1Cvw/Pdx1⁺ Pbx1^tm1Mlc/Pbx1⁺ (involves: 129S6/SvEvTac * C57BL/6)	decreased insulin secretion	J:75811
	hyperglycemia	J:75811
	impaired glucose tolerance	J:75811
	increased insulin sensitivity	J:75811
	increased urine glucose level	J:75811
Pdx1^tm1Cvw/Pdx1⁺ Spop^{Gt(BGB118)Byg}/Spop⁺ (involves: 129P2/OlaHsd * 129S1/Sv * 129X1/SvJ * C57BL/6)	decreased insulin secretion	J:165268
	improved glucose tolerance	J:165268
	increased circulating glucose level	J:165268
Pdx1^tm1Cvw/Pdx1^tm1.1Stof (involves: 129/Sv * 129S1/Sv * 129X1/SvJ * C57BL/6)	hyperglycemia	J:152582
Pdx1^tm1Cvw/Pdx1^tm1Cvw (involves: 129S1/Sv * 129X1/SvJ * Black Swiss)	dehydration	J:32017
Pdx1^tm1Cvw/Pdx1^tm4Cvw Tg(Ins2-cre)25Mgn/0 (involves: 129S1/Sv * 129X1/SvJ * Black Swiss * C57BL/6 * DBA)	decreased circulating insulin level	J:130389
	impaired glucose tolerance	J:130389
	increased circulating glucose level	J:130389
Pdx1^tm1Heed/Pdx1^tm1Heed Tg(Ins2-cre)1Heed/0 (involves: 129P2/OlaHsd * C57BL/6 * CBA)	increased circulating glucose level	J:48516
	increased urine glucose level	J:48516
Pdx1^tm1Macd/Pdx1⁺ (involves: 129S1/Sv * 129X1/SvJ)	impaired glucose tolerance	J:79206, J:101742
Pdx1^tm1Macd/Pdx1^tm1Macd Tg(tetO-Ipf1,EGFP)956.6Macd/0 (involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * SJL)	decreased circulating glucose level	J:101742
	decreased insulin secretion	J:101742
	impaired glucose tolerance	J:79206, J:101742
	increased circulating glucose level	J:79206
	increased glucagon secretion	J:101742
Pdx1^tm1Macd/Pdx1^tm1Macd Tg(tetO-Ipf1,lacZ)958.1Macd/0 (involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * SJL)	impaired glucose tolerance	J:103522
Pdx1^tm1Ted/Pdx1⁺ (involves: 129P2/OlaHsd)	decreased insulin secretion	J:82969
	impaired glucose tolerance	J:82969, J:48516
	increased circulating glucose level	J:82969
Pdx1^tm1Ted/Pdx1^tm1Ted (involves: 129P2/OlaHsd)	increased circulating glucose level	J:20779
Pdx1^tm2Cvw/Pdx1⁺ (involves: 129S1/Sv * 129X1/SvJ * Black Swiss)	decreased insulin secretion	J:75664
	impaired glucose tolerance	J:75664
	increased glucagon secretion	J:75664
Pdx1^tm2Cvw/Pdx1⁺ (involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * DBA)	impaired glucose tolerance	J:104617
Pdx1^tm2Cvw/Pdx1⁺ (involves: 129/Sv * Black Swiss)	decreased insulin secretion	J:97234
Pdx1^tm2Cvw/Pdx1⁺ (involves: 129/Sv * Black Swiss)	impaired glucose tolerance	J:97234
Pdx1^tm2Cvw/Pdx1⁺ Slc2a4^tm1Mch/Slc2a4⁺ (involves: 129/Sv * Black Swiss * C57BL/6 * SJL)	decreased circulating insulin level	J:97234
	decreased insulin secretion	J:97234
	impaired glucose tolerance	J:97234
	increased circulating glucose level	J:97234
Pdx1^tm2Cvw/Pdx1^tm2Cvw (involves: 129S1/Sv * 129X1/SvJ * Black Swiss)	dehydration	J:32017
Pdx1^tm2Cvw/Pdx1^tm3Cvw (involves: 129/Sv * C57BL/6 * DBA * FVB/N)	dehydration	J:104617
Pdx1^tm3Cvw/Pdx1⁺ (involves: 129S6/SvEvTac * C57BL/6 * DBA * FVB/N)	decreased circulating insulin level	J:104617
	impaired glucose tolerance	J:104617
	increased circulating glucose level	J:104617
Pdxp^tm1.2Ango/Pdxp^tm1.2Ango (involves: C57BL/6J)	abnormal amino acid level	J:270551
	abnormal vitamin level	J:270551
	decreased glutamine level	J:270551
	decreased glycine level	J:270551
	decreased methionine level	J:270551
	decreased phenylalanine level	J:270551
	increased gamma-aminobutyric acid level	J:270551
	increased serine level	J:270551
	increased threonine level	J:270551
Pdyn^{em1(IMPC)Rbrc}/Pdyn^{em1(IMPC)Rbrc} (C57BL/6NJcl-Pdyn^{em1(IMPC)Rbrc}/Rbrc)	abnormal circulating iron level	J:211773
Pdyn^tm1(cre)Czer/Pdyn^tm1(cre)Czer (involves: 129X1/SvJ * C57BL/6)	abnormal homeostasis	J:122399
	decreased body temperature	J:122399
	decreased circulating glucagon level	J:122399
	decreased circulating glucose level	J:122399
	decreased circulating insulin-like growth factor I level	J:122399
	decreased circulating thyroxine level	J:122399
	decreased respiratory quotient	J:122399
	increased circulating corticosterone level	J:122399
Pdzd2^{Gt(S3-7A1)Sor}/Pdzd2^{Gt(S3-7A1)Sor} (involves: 129S/SvEv * 129S4/SvJaeSor)	decreased circulating glucose level	J:307008
	improved glucose tolerance	J:307008
	increased circulating insulin level	J:307008
	increased insulin secretion	J:307008
Pdzd2^{Gt(S7-9G1)Sor}/Pdzd2^{Gt(S7-9G1)Sor} (involves: 129S/SvEv * 129S4/SvJaeSor)	decreased circulating glucose level	J:307008
	improved glucose tolerance	J:307008
	increased circulating insulin level	J:307008
	increased insulin secretion	J:307008
Pdzd8^{tm1b(EUCOMM)Wtsi}/Pdzd8⁺ (C57BL/6N-Pdzd8^{tm1b(EUCOMM)Wtsi}/Wtsi)	increased blood urea nitrogen level	J:211773
Pdzd8^{tm1b(EUCOMM)Wtsi}/Pdzd8^{tm1b(EUCOMM)Wtsi} (C57BL/6N-Pdzd8^{tm1b(EUCOMM)Wtsi}/Wtsi)	increased circulating amylase level	J:211773
	increased circulating aspartate transaminase level	J:211773
	increased circulating phosphate level	J:211773
	increased circulating triglyceride level	J:211773
Pdzk1^tm1Dls/Pdzk1^tm1Dls (involves: 129S6/SvEvTac * C57BL/6J)	abnormal circulating protein level	J:107125
Pdzk1^tm1Oko/Pdzk1^tm1Oko (either: (involves: 129S7/SvEvBrd) or (involves: 129S7/SvEvBrd * C57BL/6J))	increased circulating cholesterol level	J:81814
Pdzk1^{tm2b(EUCOMM)Wtsi}/Pdzk1⁺ (C57BL/6N-Pdzk1^{tm2b(EUCOMM)Wtsi}/Wtsi)	increased circulating cholesterol level	J:211773
	increased circulating HDL cholesterol level	J:211773
	increased circulating LDL cholesterol level	J:211773
Pdzk1^{tm2b(EUCOMM)Wtsi}/Pdzk1^{tm2b(EUCOMM)Wtsi} (C57BL/6N-Pdzk1^{tm2b(EUCOMM)Wtsi}/Wtsi)	subcutaneous edema	J:239583
Peak1^em1(IMPC)J/Peak1^em1(IMPC)J (C57BL/6NJ-Peak1^em1(IMPC)J/Mmjax)	abnormal cholesterol homeostasis	J:211773
	decreased blood urea nitrogen level	J:211773
	decreased circulating calcium level	J:211773
	decreased circulating cholesterol level	J:211773
	decreased circulating HDL cholesterol level	J:211773
	decreased circulating serum albumin level	J:211773
	decreased circulating total protein level	J:211773
Pear1^{tm1a(KOMP)Wtsi}/Pear1^{tm1a(KOMP)Wtsi} (C57BL/6N-Pear1^{tm1a(KOMP)Wtsi}/Wtsi)	decreased circulating serum albumin level	J:211773
	decreased circulating total protein level	J:211773
Pear1^{tm1a(KOMP)Wtsi}/Pear1^{tm1a(KOMP)Wtsi} (involves: C57BL/6N)	decreased platelet aggregation	J:237835
Pecam1^{Gt(OST16303)Lex}/Pecam1^{Gt(OST16303)Lex} (B6.129S5-Pecam1^{Gt(OST16303)Lex})	abnormal nitric oxide homeostasis	J:104082
Pecam1^tm1Mak/Pecam1^tm1Mak (B6.129P2-Pecam1^tm1Mak)	pulmonary edema	J:95226
Pedm14/Pedm14⁺ (involves: C3H/HeH * C57BL/6J)	hyperglycemia	J:169366
Pedm32/Pedm32⁺ (involves: C3H * C57BL/6J)	albuminuria	J:169366
Pedm35/Pedm35⁺ (involves: C3H/HeH * C57BL/6J)	hyperglycemia	J:169366
Pedm35/Pedm35⁺ (involves: C3H/HeH * C57BL/6J)	increased urine glucose level	J:169366
Pedm105/Pedm105⁺ (Not Specified)	increased circulating phosphate level	J:169366
Peds1^{tm1a(KOMP)Wtsi}/Peds1^{tm1a(KOMP)Wtsi} (B6Brd;B6Dnk;B6N-Peds1^{tm1a(KOMP)Wtsi} Tyr^c-Brd/Wtsi)	decreased circulating calcium level	J:211773
	decreased circulating fructosamine level	J:211773
Peds1^{tm1a(KOMP)Wtsi}/Peds1^{tm1a(KOMP)Wtsi} (involves: C57BL/6N)	decreased brain plasmalogen level	J:287476
	decreased plasmalogen level	J:287476
Peli1^{tm1b(EUCOMM)Wtsi}/Peli1^{tm1b(EUCOMM)Wtsi} (C57BL/6N-Peli1^{tm1b(EUCOMM)Wtsi}/Ucd)	improved glucose tolerance	J:211773
Peli1^tm1Tigm/Peli1^tm1Tigm (involves: 129/Sv * C57BL/6)	decreased circulating interferon-beta level	J:152781
	decreased circulating interleukin-6 level	J:152781
	decreased circulating interleukin-12b level	J:152781
	decreased circulating tumor necrosis factor level	J:152781
Peli2^tm1.1Arte/Peli2^tm1.1Arte (involves: C57BL/6)	abnormal circulating cytokine level	J:265431
Peli2^tm1.1Arte/Peli2^tm1.1Arte (involves: C57BL/6)	decreased circulating interleukin-1 beta level	J:265431
Pemt^tm1J/Pemt^tm1J (involves: 129P2/OlaHsd * C57BL/6)	abnormal circulating cholesterol level	J:83870
	abnormal lipid level	J:83870
	decreased circulating cholesterol level	J:83870
	decreased circulating HDL cholesterol level	J:83870
	decreased circulating homocysteine level	J:81995
Pepd^dal/Pepd^dal (CBA/J-Pepd^dal/GrsrJ)	abnormal urine homeostasis	J:87005
Pepd^dal/Pepd^dal (involves: C3H/HeJ * CBA/J)	decreased circulating testosterone level	J:143333
Pepd^dal/Pepd^dal (involves: C3H/HeJ * CBA/J)	decreased collagen level	J:215150
Pepd^{tm1a(KOMP)Wtsi}/Pepd^{tm1a(KOMP)Wtsi} (C57BL/6N-Pepd^{tm1a(KOMP)Wtsi}/Ucd)	increased circulating insulin level	J:211773
Pepd^{tm1b(KOMP)Wtsi}/Pepd^{tm1b(KOMP)Wtsi} (C57BL/6N-Pepd^{tm1b(KOMP)Wtsi}/Ieg)	decreased circulating HDL cholesterol level	J:211773
	decreased circulating iron level	J:211773
	increased circulating aspartate transaminase level	J:211773
	increased circulating unsaturated transferrin level	J:211773
Per1^tm1Brd/Per1^tm1Brd Per2^tm1Brd/Per2^tm1Brd (involves: 129S7/SvEvBrd)	abnormal urine catecholamine level	J:115188
	increased circulating leptin level	J:115188
Per1^tm1Drw/Per1^tm1Drw (B6.129-Per1^tm1Drw/J)	decreased dopamine level	J:219876
Per1^tm1Drw/Per1^tm1Drw Per2^tm1Drw/Per2^tm1Drw (involves: 129S4/SvJae)	abnormal circadian temperature homeostasis	J:95746
Per2^{tm1a(EUCOMM)Hmgu}/Per2^{tm1a(EUCOMM)Hmgu} (C57BL/6N-Per2^{tm1a(EUCOMM)Hmgu}/H)	increased circulating alkaline phosphatase level	J:165965
Per2^tm1Drw/Per2^tm1Drw (involves: 129)	abnormal circadian temperature homeostasis	J:95746
Per2^tm1Drw/Per2^tm1Drw (B6.129-Per2^tm1Drw/J)	improved glucose tolerance	J:208598
Pes1^{tm1b(EUCOMM)Wtsi}/Pes1⁺ (C57BL/6N-Pes1^{tm1b(EUCOMM)Wtsi}/Bay)	decreased circulating fructosamine level	J:211773
	decreased circulating serum albumin level	J:211773
	decreased circulating total protein level	J:211773
Pex1^tm1.1Hrw/Pex1^tm1.1Hrw (involves: C57BL/6NTac)	abnormal bile salt homeostasis	J:278655
	abnormal fatty acids level	J:278655
	abnormal phospholipid level	J:278655
	abnormal venous thrombosis	J:278655
	decreased liver glycogen level	J:278655
	hyperglycemia	J:278655
	increased liver cholesterol level	J:278655
	increased liver triglyceride level	J:278655
Pex1^tm1.1Sjms/Pex1^tm1.1Sjms (involves: 129 * C57BL/6N)	abnormal bile salt homeostasis	J:210296
	abnormal circulating phospholipid level	J:210296
	abnormal intestinal lipid absorption	J:210296
	decreased fatty acids level	J:210296
	increased fatty acids level	J:210296
	increased saturated fatty acids level	J:210296
Pex2^tm1Plf/Pex2^tm1Plf (involves: 129S1/Sv * 129X1/SvJ * Swiss Webster)	decreased cholesterol level	J:87591
	decreased circulating cholesterol level	J:87591
	decreased circulating HDL cholesterol level	J:87591
	decreased liver cholesterol level	J:87591
Pex2^tm1Plf/Pex2^tm1Plf (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	abnormal circulating free fatty acids level	J:44975
	decreased circulating cholesterol level	J:87591
Pex3^{tm1a(EUCOMM)Wtsi}/Pex3^{tm1a(EUCOMM)Wtsi} (C57BL/6N-Pex3^{tm1a(EUCOMM)Wtsi}/Wtsi)	decreased circulating alanine transaminase level	J:175295
	decreased circulating aspartate transaminase level	J:175295
	decreased circulating cholesterol level	J:175295
	decreased circulating fructosamine level	J:175295
	decreased circulating HDL cholesterol level	J:175295
	decreased circulating LDL cholesterol level	J:175295
	decreased circulating serum albumin level	J:175295
	decreased circulating total protein level	J:175295
	increased circulating fructosamine level	J:175295
Pex5^tm1Pec/Pex5^tm1Pec Speer6-ps1^{Tg(Alb-cre)21Mgn}/Speer6-ps1⁺ (involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * DBA)	abnormal bile salt homeostasis	J:121804
	abnormal blood homeostasis	J:112503
	abnormal fatty acid beta-oxidation	J:121804
	abnormal glucose homeostasis	J:112503
	increased circulating lactate level	J:112503
Pex7^tm1Nbra/Pex7^tm1Nbra (involves: 129S/SvEv * C57BL/6)	decreased fatty acids level	J:158845
	decreased saturated fatty acids level	J:158845
	increased fatty acids level	J:158845
	lipidosis	J:158845
Pex7^tm1Rjaw/Pex7^tm1Rjaw (Swiss)	abnormal lipid level	J:92346
Pex7^tm1Rjaw/Pex7^tm1Rjaw (Swiss)	increased fatty acids level	J:92346
Pex10^m1Nisw/Pex10⁺ (129S1.B6-Pex10^m1Nisw)	abnormal bile salt homeostasis	J:216140
Pex10^m1Nisw/Pex10⁺ (129S1.B6-Pex10^m1Nisw)	decreased plasmalogen level	J:216140
Pex10^m1Nisw/Pex10^m1Nisw (129S1.B6-Pex10^m1Nisw)	abnormal bile salt homeostasis	J:216140
	cyanosis	J:216140
	decreased plasmalogen level	J:216140
	increased fatty acids level	J:216140
Pex11a^tm1Itl/Pex11a^tm1Itl (C57BL/6-Pex11a^tm1Itl)	abnormal circulating triglyceride level	J:195940
	increased circulating free fatty acids level	J:195940
	increased circulating ketone body level	J:195940
	increased liver triglyceride level	J:195940
Pex11b^tm1Sjg/Pex11b^tm1Sjg (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	decreased liver glycogen level	J:76782
Pex13^tm1Crne/Pex13^tm1.1Crne Tg(Nes-cre)1Kln/0 (involves: 129T2/SvEms * C57BL/6 * C57BL/6J * SJL)	abnormal fatty acids level	J:167578
	decreased brain plasmalogen level	J:167578
	increased plasmalogen level	J:167578
Pex16^{tm1c(EUCOMM)Hmgu}/Pex16^{tm1c(EUCOMM)Hmgu} Tg(Adipoq-cre)1Evdr/0 (involves: C57BL/6N * FVB/NJ * SJL)	decreased oxygen consumption	J:270463
	impaired adaptive thermogenesis	J:270463
	impaired glucose tolerance	J:270463
	increased susceptibility to diet-induced obesity	J:270463
Pex16^{tm1c(EUCOMM)Hmgu}/Pex16^{tm1c(EUCOMM)Hmgu} Tg(Ucp1-cre)1Evdr/0 (involves: C57BL/6N * FVB * SJL)	decreased oxygen consumption	J:270463
	impaired adaptive thermogenesis	J:270463
Pf4^tm1Mako/Pf4⁺ (B6.129X1-Pf4^tm1Mako)	decreased susceptibility to induced thrombosis	J:94900
Pf4^tm1Mako/Pf4^tm1Mako (B6.129X1-Pf4^tm1Mako)	decreased susceptibility to induced thrombosis	J:94900
Pfas^em1(IMPC)J/Pfas⁺ (C57BL/6NJ-Pfas^em1(IMPC)J/Mmjax)	decreased circulating aspartate transaminase level	J:211773
Pfdn5^{tm1b(EUCOMM)Wtsi}/Pfdn5^{tm1b(EUCOMM)Wtsi} (C57BL/6N-Pfdn5^{tm1b(EUCOMM)Wtsi}/Bay)	edema	J:211773
Pfdn6^{tm1.1(KOMP)Vlcg}/Pfdn6⁺ (C57BL/6N-Pfdn6^{tm1.1(KOMP)Vlcg}/J)	decreased circulating glucose level	J:211773
Pfkfb2^tm1.2Dap/Pfkfb2^tm1.2Dap (involves: C57BL/6)	decreased blood urea nitrogen level	J:296139
Pfkfb2^tm1.2Dap/Pfkfb2^tm1.2Dap (involves: C57BL/6)	increased kidney glycogen level	J:296139
Pfkfb2^{tm1b(KOMP)Wtsi}/Pfkfb2^{tm1b(KOMP)Wtsi} (C57BL/6N-Pfkfb2^{tm1b(KOMP)Wtsi}/Nju)	increased fasting circulating glucose level	J:211773
Pfkfb3^tm1.1Pec/Pfkfb3^tm1.1Pec Tg(Pdgfb-icre/ERT2,-EGFP)1Frut/0 (involves: 129S6/SvEvTac * C57BL/6 * C57BL/6NCrl * CBA)	abnormal homeostasis	J:296552
	abnormal pH regulation	J:296552
	decreased circulating lactate level	J:296552
	decreased glycogen catabolism rate	J:296552
	hypoxia	J:296552
Pfkm^{GT(OST56064)Lex}/Pfkm^{GT(OST56064)Lex} (involves: 129S5/SvEvBrd * C57BL/6)	abnormal glucose homeostasis	J:125530
	decreased circulating insulin level	J:125530
	decreased insulin secretion	J:125530
	impaired glucose tolerance	J:125530
	increased circulating glucose level	J:125530
Pfkm^tm1Fbos/Pfkm^tm1Fbos (involves: 129S6/SvEvTac * C57BL/6J)	abnormal glucose homeostasis	J:152153
	decreased circulating lactate level	J:152153
	hypoxia	J:152153
	increased cardiac muscle glycogen level	J:152153
	increased circulating bilirubin level	J:152153
	increased lactate dehydrogenase level	J:152153
	increased skeletal muscle glycogen level	J:152153
Pfn1^{tm1a(EUCOMM)Wtsi}/Pfn1⁺ (B6Brd;B6Dnk;B6N-Tyr^c-Brd Pfn1^{tm1a(EUCOMM)Wtsi}/Wtsi)	decreased circulating fructosamine level	J:175295
	improved glucose tolerance	J:211773
	increased circulating amylase level	J:211773
	increased circulating magnesium level	J:211773
Pfn3^em1Hsc/Pfn3^em1Hsc (involves: C57BL/6 * DBA)	abnormal protein level	J:320651
Pfn3^em2Hsc/Pfn3^em2Hsc (involves: C57BL/6 * DBA)	abnormal protein level	J:320651
Pfn3^em3Hsc/Pfn3^em3Hsc (involves: C57BL/6 * DBA)	abnormal protein level	J:320651
Pgam1^tm1.1Hiko/Pgam1^tm1.1Hiko Tg(Cd4-cre)1Cwi/0 (involves: C57BL/6 * DBA/2)	abnormal pH regulation	J:293746
	decreased oxygen consumption	J:293746
Pgam5^{tm1a(EUCOMM)Wtsi}/Pgam5^{tm1a(EUCOMM)Wtsi} (involves: C57BL/6N)	decreased dopamine level	J:225345
Pgam5^{tm1b(EUCOMM)Wtsi}/Pgam5^{tm1b(EUCOMM)Wtsi} (C57BL/6N-Pgam5^{tm1b(EUCOMM)Wtsi}/Ics)	decreased circulating cholesterol level	J:211773
	decreased circulating glucose level	J:211773
	decreased circulating HDL cholesterol level	J:211773
	decreased circulating serum albumin level	J:211773
	decreased circulating total protein level	J:211773
	increased circulating creatinine level	J:211773
Pgap2^clpex/Pgap2^{tm1a(EUCOMM)Wtsi} (involves: A/J * C57BL/6N)	edema	J:277316
	pericardial effusion	J:277316
Pgap4^em1Osbir/Pgap4^em1Osbir (involves: C57BL/6NSlc)	increased circulating alkaline phosphatase level	J:333707
Pgap4^em1Osbir/Pgap4^em1Osbir (involves: C57BL/6NSlc)	increased circulating calcium level	J:333707
Pgbd5^em1(IMPC)Tcp/Pgbd5^em1(IMPC)Tcp (C57BL/6NCrl-Pgbd5^em1(IMPC)Tcp/Tcp)	impaired glucose tolerance	J:211773
	increased circulating alanine transaminase level	J:211773
Pgc^em1Hcz/Pgc^em1Hcz (Not Specified)	decreased circulating alkaline phosphatase level	J:338079
Pgd^tm1.1Pse/Pgd^tm1.1Pse Tg(Cd4-cre)1Cwi/0 (involves: C57BL/6 * DBA/2)	increased glycogen level	J:306553
Pglyrp2^tm1Lky/Pglyrp2^tm1Lky (involves: 129S4/SvJae * C57BL/6)	abnormal tumor necrosis factor level	J:159600
	decreased circulating interleukin-6 level	J:159600
Pglyrp2^tm1Rdz/Pglyrp2^tm1Rdz (C.129S-Pglyrp2^tm1Rdz)	abnormal circulating chemokine level	J:178054
Pgm3^{em1(IMPC)Hmgu}/Pgm3⁺ (C57BL/6NCrl-Pgm3^{em1(IMPC)Hmgu}/Ieg)	impaired glucose tolerance	J:211773
Pgr^tm1Bwo/Pgr^tm1Bwo (involves: 129S7/SvEvBrd)	increased circulating prolactin level	J:85196
Pgr^tm1Bwo/Pgr^tm1Bwo (involves: 129S7/SvEvBrd * C57BL/6)	abnormal follicle stimulating hormone level	J:56917
Pgr^tm1Bwo/Pgr^tm1Bwo (involves: 129S7/SvEvBrd * C57BL/6)	decreased circulating luteinizing hormone level	J:56917
Pgr^tm1Bwo/Pgr^tm1Bwo (involves: 129S7/SvEvBrd * C57BL/6J)	decreased circulating glucose level	J:125584
	improved glucose tolerance	J:125584
	increased circulating insulin level	J:125584
	increased insulin secretion	J:125584
Pgrmc1^em1Ejho/Pgrmc1^em1Ejho (involves: C57BL/6N)	decreased circulating triglyceride level	J:268130
	increased circulating alanine transaminase level	J:268130
	increased circulating free fatty acids level	J:268130
	increased liver triglyceride level	J:268130
Pgrmc2^tm1.1Jjp/Pgrmc2^tm1.1Jjp Pgr^tm2(cre)Lyd/Pgr⁺ (involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)	decreased circulating progesterone level	J:247103
Pgs1^{tm1b(EUCOMM)Hmgu}/Pgs1⁺ (C57BL/6N-Pgs1^{tm1b(EUCOMM)Hmgu}/Ieg)	increased circulating phosphate level	J:211773
Phactr1^em1(IMPC)Mbp/Phactr1^em1(IMPC)Mbp (C57BL/6NCrl-Phactr1^em1(IMPC)Mbp/Mmucd)	decreased circulating alanine transaminase level	J:211773
	decreased circulating aspartate transaminase level	J:211773
	increased circulating alkaline phosphatase level	J:211773
Phb1^em1(IMPC)H/Phb1⁺ (C57BL/6NTac-Phb1^em1(IMPC)H/H)	decreased circulating potassium level	J:211773
Phb1^em1(IMPC)H/Phb1⁺ (C57BL/6NTac-Phb1^em1(IMPC)H/H)	increased blood urea nitrogen level	J:211773
Phc3^{tm2b(KOMP)Wtsi}/Phc3^{tm2b(KOMP)Wtsi} (C57BL/6N-Phc3^{tm2b(KOMP)Wtsi}/Ucd)	increased circulating alkaline phosphatase level	J:211773
Phdlc1^C57BL/6J/Phdlc1^CASA/RkJ (involves: C57BL/6J * CASA/RkJ)	increased circulating HDL cholesterol level	J:94547
Phdlc1^CASA/RkJ/Phdlc1^CASA/RkJ (involves: C57BL/6J * CASA/RkJ)	increased circulating HDL cholesterol level	J:94547
Phdlc2^C57BL/6J/Phdlc2^C57BL/6J (involves: C57BL/6J * CASA/RkJ)	increased circulating HDL cholesterol level	J:94547
Phex^Hpr/Y (involves: C3H/HeH * C57BL/6J)	decreased circulating phosphate level	J:187142
Phex^Hpr/Y (involves: C3H/HeH * C57BL/6J)	increased circulating alkaline phosphatase level	J:187142
Phex^Hpr/Phex⁺ (involves: C3H/HeH * C57BL/6J)	decreased circulating phosphate level	J:187142
Phex^Hpr/Phex⁺ (involves: C3H/HeH * C57BL/6J)	increased circulating alkaline phosphatase level	J:187142
Phex^Hyp-2J/Y (C57BL/6-Phex^Hyp-2J/J)	decreased circulating calcium level	J:88352
Phex^Hyp-2J/Y (C57BL/6-Phex^Hyp-2J/J)	decreased circulating potassium level	J:88352
Phex^Hyp-Duk/Y (involves: BALB/cAnBomUrd)	decreased circulating calcium level	J:88352
Phex^Hyp-Duk/Y (involves: BALB/cAnBomUrd)	decreased circulating potassium level	J:88352
Phex^Hyp/Y (Not Specified)	abnormal renal phosphate reabsorption	J:131043
	abnormal vitamin D level	J:110579
	decreased circulating phosphate level	J:110579, J:131043
Phex^Hyp/Y (B6.Cg-Phex^Hyp/J)	decreased circulating calcium level	J:88352
	decreased circulating phosphate level	J:87808
	decreased circulating potassium level	J:88352
Phex^Hyp/? (involves: C57BL/6J)	decreased circulating phosphate level	J:99866
Phex^Hyp/Y (involves: C57BL/6)	abnormal renal glucose reabsorption	J:8335
	abnormal urine nucleotide level	J:8335
	decreased circulating phosphate level	J:8335
	increased circulating alkaline phosphatase level	J:8335
	increased urine phosphate level	J:8335
Phex^Hyp/Y (involves: C57BL/6J)	decreased circulating phosphate level	J:17152
Phex^Hyp/Y (involves: C3H/HeSnJ * C57BL/6J)	decreased circulating phosphate level	J:17152
Phex^Hyp/Phex⁺ (B6.Cg-Phex^Hyp/J)	decreased circulating phosphate level	J:87808
Phex^Hyp/Phex⁺ (involves: C57BL/6J)	decreased circulating phosphate level	J:17152
Phex^Hyp/Phex⁺ Tg(Bglap2-Phex)1Ldq/? (involves: C57BL/6J)	decreased circulating phosphate level	J:74324
Phex^Hyp/Phex^Hyp (B6.Cg-Phex^Hyp/J)	decreased circulating phosphate level	J:87808
Phex^Hyp/Phex^Hyp (involves: C3H/HeSnJ * C57BL/6J)	decreased circulating phosphate level	J:17152
Phex^m1Jrt/Y (B6.129S1-Phex^M1Jrt)	decreased circulating calcium level	J:196537
	decreased circulating phosphate level	J:196537
	increased circulating alkaline phosphatase level	J:196537
Phex^m1Jrt/Phex⁺ (B6.129S1-Phex^M1Jrt)	decreased circulating calcium level	J:196537
	decreased circulating phosphate level	J:196537
	increased circulating alkaline phosphatase level	J:196537
Phex^Mhdabap012/Phex^Mhdabap012 (C3HeB/FeJ-Phex^Mhdabap012)	decreased circulating phosphate level	J:183993
Phex^Mhdabap012/Phex^Mhdabap012 (C3HeB/FeJ-Phex^Mhdabap012)	increased circulating alkaline phosphatase level	J:183993
Phex^Mhdabap024/Y (C3HeB/FeJ-Phex^Mhdabap024)	abnormal blood homeostasis	J:264682
	decreased circulating C-reactive protein level	J:264682
	decreased circulating phosphate level	J:264682
	decreased urine calcium level	J:264682
	decreased vitamin D level	J:264682
	increased circulating parathyroid hormone level	J:264682
	increased urine creatinine level	J:264682
Phex^Mhdabap024/Phex⁺ (C3HeB/FeJ-Phex^Mhdabap024)	abnormal blood homeostasis	J:264682
	decreased circulating phosphate level	J:264682
	decreased urine calcium level	J:264682
	increased circulating parathyroid hormone level	J:264682
	increased urine phosphate level	J:264682
Phex^Mhdabap024/Phex^Mhdabap024 (C3HeB/FeJ-Phex^Mhdabap024)	decreased circulating alkaline phosphatase level	J:183993
Phex^Mhdabap024/Phex^Mhdabap024 (C3HeB/FeJ-Phex^Mhdabap024)	decreased circulating phosphate level	J:183993
Phex^Pug/Y (involves: C57BL/6J)	decreased circulating calcium level	J:136463
Phex^Pug/Y (involves: C57BL/6J)	decreased circulating phosphate level	J:136463
Phex^Ska1/Y (C57BL/6-Phex^Ska1)	decreased circulating phosphate level	J:79953
Phex^Ska1/Y (C57BL/6-Phex^Ska1)	increased circulating alkaline phosphatase level	J:79953
Phex^Ska1/Phex⁺ (C57BL/6-Phex^Ska1)	decreased circulating phosphate level	J:79953
Phex^Ska1/Phex⁺ (C57BL/6-Phex^Ska1)	increased circulating alkaline phosphatase level	J:79953
Phex^Ska1/Phex^Ska1 (C57BL/6-Phex^Ska1)	decreased circulating calcium level	J:79953
	decreased circulating phosphate level	J:79953
	increased circulating alkaline phosphatase level	J:79953
Phex^tm1.1Mkd/Y Tg(BGLAP-cre)1Clem/0 (B6.Cg-Phex^tm1.1Mkd Tg(BGLAP-cre)1Clem)	abnormal renal phosphate reabsorption	J:131043
	decreased circulating phosphate level	J:131043
Phex^tm1.2Mkd/Y (B6.129-Phex^tm1.2Mkd)	abnormal renal phosphate reabsorption	J:131043
Phex^tm1.2Mkd/Y (B6.129-Phex^tm1.2Mkd)	decreased circulating phosphate level	J:131043
Phf6^tm1.1Avo/Y Tg(Tek-cre)1Ywa/0 (involves: C57BL/6 * SJL)	increased circulating interferon-alpha level	J:276228
Phf6^tm1.2Avo/Y (involves: BALB/c * BALB/cJ * C57BL/6 * FVB/N)	decreased adrenocorticotropin level	J:299742
	decreased circulating growth hormone level	J:299742
	decreased circulating insulin-like growth factor I level	J:299742
	decreased growth hormone level	J:299742
	decreased prolactin level	J:299742
Phf8^{em2(IMPC)Wtsi}/Phf8^{em2(IMPC)Wtsi} (C57BL/6N-Phf8^{em2(IMPC)Wtsi}/Wtsi)	increased circulating cholesterol level	J:211773
	increased circulating HDL cholesterol level	J:211773
	increased circulating LDL cholesterol level	J:211773
Phf8^tm1dIcs/Y (C57BL/6N-Phf8^tm1dIcs/Ics)	improved glucose tolerance	J:211773
Phf8^tm1dIcs/Y (C57BL/6N-Phf8^tm1dIcs/Ics)	increased circulating HDL cholesterol level	J:211773
Phf8^tm1dIcs/Phf8^tm1dIcs (C57BL/6N-Phf8^tm1dIcs/Ics)	increased circulating alanine transaminase level	J:211773
Phf8^tm1dIcs/Phf8^tm1dIcs (C57BL/6N-Phf8^tm1dIcs/Ics)	increased circulating HDL cholesterol level	J:211773
Phf14^{em1(IMPC)Hmgu}/Phf14⁺ (C57BL/6N-Phf14^{em1(IMPC)Hmgu}/Ieg)	decreased circulating alkaline phosphatase level	J:211773
Phf14^tm1Take/Phf14^tm1Take (B6.Cg-Phf14^tm1Take)	cyanosis	J:184822
Phf19^{tm1.1(KOMP)Vlcg}/Phf19^{tm1.1(KOMP)Vlcg} (C57BL/6N-Phf19^{tm1.1(KOMP)Vlcg}/Tcp)	decreased respiratory quotient	J:211773
Phgdh^tm1.2Shfu/Phgdh^tm1.2Shfu Tg(GFAP-cre)25Mes/0 (involves: 129P2/OlaHsd * FVB/N)	decreased arginine level	J:167572
	decreased cystathionine level	J:167572
	decreased glutamic acid level	J:167572
	decreased glycine level	J:167572
	decreased phenylalanine level	J:167572
	decreased serine level	J:167572
	decreased threonine level	J:167572
	increased arginine level	J:167572
	increased circulating glycine level	J:167572
	increased glutamine level	J:167572
	increased phenylalanine level	J:167572
Phgdh^{tm1b(KOMP)Wtsi}/Phgdh⁺ (C57BL/6N-Phgdh^{tm1b(KOMP)Wtsi}/Kmpc)	decreased respiratory quotient	J:211773
Phgdh^{tm1b(KOMP)Wtsi}/Phgdh^{tm1b(KOMP)Wtsi} (C57BL/6N-Phgdh^{tm1b(KOMP)Wtsi}/Kmpc)	edema	J:211773
Phip^em1(IMPC)Tcp/Phip⁺ (C57BL/6NCrl-Phip^em1(IMPC)Tcp/Tcp)	increased circulating aspartate transaminase level	J:211773
Phip^{em1(IMPC)Wtsi}/Phip⁺ (C57BL/6N-Phip^{em1(IMPC)Wtsi}/Wtsi)	decreased circulating chloride level	J:211773
Phip^{Gt(RRJ571)Byg}/Phip^{Gt(RRJ571)Byg} (involves: 129P2/OlaHsd * C57BL/6J)	hypoglycemia	J:164354
	increased insulin sensitivity	J:164354
Phka1^I/FnLn/Y ((I/FnLn x C57BL/FnLn)F1)	increased skeletal muscle glycogen level	J:5156
Phka1^I/FnLn/Y (I/FnLn)	increased skeletal muscle glycogen level	J:5156
Phka1^I/FnLn/Phka1⁺ ((C57BL/FnLn x I/FnLn)F1)	increased skeletal muscle glycogen level	J:5156
Phka1^I/FnLn/Phka1⁺ ((I/FnLn x C57BL/FnLn)F1)	increased skeletal muscle glycogen level	J:5156
Phka1^I/FnLn/Phka1^I/FnLn (I/FnLn)	increased skeletal muscle glycogen level	J:5156
Phkb^em1(IMPC)J/Phkb⁺ (C57BL/6NJ-Phkb^em1(IMPC)J/Mmjax)	decreased circulating glucose level	J:330539
	decreased fasting circulating glucose level	J:330539
	decreased glycogen catabolism rate	J:330539
	decreased liver triglyceride level	J:330539
	enhanced gluconeogenesis	J:330539
	increased blood uric acid level	J:330539
	increased circulating ketone body level	J:330539
	increased circulating triglyceride level	J:330539
	increased liver glycogen level	J:330539
Phospho1^m1Jlm/Phospho1^m1Jlm (involves: C3HeB/FeJ * C57BL/6)	increased circulating phosphate level	J:173678
Phospq1^SM/J/? (involves: A/J * SM/J)	abnormal lipid level	J:64138
Phox2a/Inppl1^tm1Ssch/Phox2a/Inppl1^tm1Ssch (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	abnormal gluconeogenesis	J:96443
	cyanosis	J:96443
	decreased circulating insulin level	J:96443
	hypoglycemia	J:96443
	increased insulin sensitivity	J:96443
Phox2a/Inppl1^tm1Ssch/Phox2a⁺ (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	abnormal glycogen homeostasis	J:96443
	improved glucose tolerance	J:96443
Phox2a/Inppl1^tm1Ssch/Inppl1⁺ (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	abnormal glycogen homeostasis	J:96443
	improved glucose tolerance	J:96443
Phox2a/Inppl1^tm1Ssch/Phox2a/Inppl1^tm1Ssch (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	abnormal gluconeogenesis	J:96443
	cyanosis	J:96443
	decreased circulating insulin level	J:96443
	hypoglycemia	J:96443
	increased insulin sensitivity	J:96443
Phox2b^{tm1(Phox2a)Mist}/Phox2b^{tm1(Phox2a)Mist} (involves: 129S4/SvJae)	abnormal noradrenaline level	J:126634
Phox2b^tm1.1Heno/Phox2b⁺ (either: (involves: 129P2/OlaHsd * C57BL/6) or (involves: 129P2/OlaHsd * C57BL/6 * DBA/2))	cyanosis	J:190742
Phox2b^tm1Jbr/Phox2b^tm1Jbr (Not Specified)	abnormal noradrenaline level	J:55391, J:63723
Phox2b^tm1Rth/Phox2b⁺ Hprt1^{tm1(CAG-cre)Mnn}/? (involves: 129 * 129S1/Sv * C57BL/6)	cyanosis	J:331513
Phox2b^tm2.1Heno/Phox2b⁺ (either: (involves: 129P2/OlaHsd * C57BL/6) or (involves: 129P2/OlaHsd * C57BL/6 * DBA/2))	cyanosis	J:190742
Phox2b^tm2Jbr/Phox2b⁺ (involves: 129S2/SvPas * C57BL/6)	cyanosis	J:131365
Phpt1^tm1.1Eys/Phpt1^tm1.1Eys (involves: C57BL/6J * FVB/N)	decreased circulating glucose level	J:262099
	decreased circulating insulin level	J:262099
	decreased insulin secretion	J:262099
	impaired glucose tolerance	J:262099
	increased circulating insulin level	J:262099
Phrf1^em1(IMPC)Tcp/Phrf1^em1(IMPC)Tcp (C57BL/6N-Phrf1^em1(IMPC)Tcp/Tcp)	increased circulating triglyceride level	J:211773
Phyh^tm1Safe/Phyh^tm1Safe (involves: 129P2/OlaHsd * 129X1/SvJ * Black Swiss * FVB/N)	abnormal blood homeostasis	J:142512
	abnormal circulating lipid level	J:142512
	decreased circulating cholesterol level	J:142512
	decreased circulating free fatty acids level	J:142512
	decreased circulating triglyceride level	J:142512
	increased circulating alanine transaminase level	J:142512
	increased circulating amylase level	J:142512
	lipidosis	J:142512
Phykpl^{tm1a(EUCOMM)Wtsi}/Phykpl^{tm1a(EUCOMM)Wtsi} (C57BL/6N-Phykpl^{tm1a(EUCOMM)Wtsi}/Ics)	decreased circulating alkaline phosphatase level	J:165965
	decreased circulating creatinine level	J:165965
Pi4k2a^{Gt(AK0094)Wtsi}/Pi4k2a^{Gt(AK0094)Wtsi} (involves: 129P2/OlaHsd * BALB/c)	increased circulating aspartate transaminase level	J:150794
Pi16^em1(IMPC)Mbp/Pi16^em1(IMPC)Mbp (C57BL/6NCrl-Pi16^em1(IMPC)Mbp/MbpMmucd)	increased circulating bilirubin level	J:211773
Pi16^tm1.2Engl/Pi16^tm1.2Engl (involves: 129S1/Sv * 129X1/SvJ * C57BL/6N * SJL)	abnormal homeostasis	J:244259
Pianp^em1Bet/Pianp^em1Bet (Not Specified)	abnormal glutamic acid level	J:279537
Pias2^{tm1a(KOMP)Wtsi}/Pias2^{tm1a(KOMP)Wtsi} (C57BL/6N-Pias2^{tm1a(KOMP)Wtsi}/Wtsi)	increased circulating insulin level	J:211773
Pibf1^{tm1.1(KOMP)Vlcg}/Pibf1⁺ (C57BL/6N-Pibf1^{tm1.1(KOMP)Vlcg}/J)	increased circulating bilirubin level	J:211773
Picalm^tm1.1Tmae/Picalm^tm1.1Tmae Commd10^{Tg(Vav1-icre)A2Kio}/Commd10⁺ (involves: 129S6/SvEvTac * C57BL/6 * C57BL/10 * CBA * SJL)	abnormal iron homeostasis	J:220728
	increased circulating erythropoietin level	J:220728
Picalm^tm1.1Tmae/Picalm^tm1.1Tmae Tg(Mx1-cre)1Cgn/0 (involves: C57BL/6 * CBA * SJL)	abnormal iron homeostasis	J:220728
	increased circulating erythropoietin level	J:220728
	increased circulating iron level	J:220728
Picalm^tm1Towa/Picalm^tm1Towa (involves: C57BL/6J * C57BL/6NCrlj * CBA/JNCrlj)	abnormal iron homeostasis	J:185312
	hemosiderosis	J:185312
Pierce1^{tm2b(EUCOMM)Wtsi}/Pierce1^{tm2b(EUCOMM)Wtsi} (C57BL/6N-Pierce1^{tm2b(EUCOMM)Wtsi}/Wtsi)	retropleural edema	J:239583
Piezo1^{Gt(RST343)Byg}/Piezo1^{Gt(RST343)Byg} (involves: 129P2/OlaHsd * C57BL/6J)	pericardial effusion	J:212179
Piezo1^{tm1b(KOMP)Wtsi}/Piezo1⁺ (C57BL/6N-Piezo1^{tm1b(KOMP)Wtsi}/Ucd)	increased circulating alanine transaminase level	J:211773
Piezo1^tm2.1Apat/Piezo1^tm2.1Apat Commd10^{Tg(Vav1-icre)A2Kio}/Commd10⁺ (involves: C57BL/6 * C57BL/10 * CBA)	abnormal calcium ion homeostasis	J:229436
	abnormal erythrocyte ion transport	J:229436
	decreased blood osmolality	J:229436
	decreased circulating haptoglobin level	J:229436
Piezo2^em2(IMPC)J/Piezo2⁺ (C57BL/6NJ-Piezo2^em2(IMPC)J/Mmjax)	increased circulating triglyceride level	J:211773
Piga^tm1Tak/Y Tg(KRT5-cre)1Tak/0 (involves: 129S1/Sv * 129X1/SvJ * C3H * C57BL/6)	abnormal amino acid level	J:91794
	dehydration	J:91794
	impaired skin barrier function	J:91794
Piga^tm1Tak/Piga^tm1Tak Tg(KRT5-cre)1Tak/0 (involves: 129S1/Sv * 129X1/SvJ * C3H * C57BL/6)	abnormal amino acid level	J:91794
	dehydration	J:91794
	impaired skin barrier function	J:91794
Pigc^em1(IMPC)J/Pigc⁺ (C57BL/6NJ-Pigc^em1(IMPC)J/J)	decreased circulating glucose level	J:211773
	decreased fasting circulating glucose level	J:211773
	impaired glucose tolerance	J:211773
Pigh^{tm1.1(KOMP)Vlcg}/Pigh⁺ (C57BL/6N-Pigh^{tm1.1(KOMP)Vlcg}/J)	increased circulating sodium level	J:211773
Pign^em1(IMPC)Mbp/Pign^em1(IMPC)Mbp (C57BL/6N-Pign^em1(IMPC)Mbp/MbpMmucd)	edema	J:211773
Pigq^{tm2b(EUCOMM)Wtsi}/Pigq⁺ (C57BL/6N-Pigq^{tm2b(EUCOMM)Wtsi}/Bay)	impaired glucose tolerance	J:211773
Pigq^{tm2b(EUCOMM)Wtsi}/Pigq^{tm2b(EUCOMM)Wtsi} (C57BL/6N-Pigq^{tm2b(EUCOMM)Wtsi}/Bay)	edema	J:211773
Pigr^tm1Fejo/Pigr^tm1Fejo (involves: 129P2/OlaHsd * C57BL/6)	abnormal homeostasis	J:57987
Pigz^em1(IMPC)J/Pigz^em1(IMPC)J (C57BL/6NJ-Pigz^em1(IMPC)J/Mmjax)	increased circulating glucose level	J:211773
Pik3ap1^{tm1b(KOMP)Wtsi}/Pik3ap1^{tm1b(KOMP)Wtsi} (C57BL/6N-Pik3ap1^{tm1b(KOMP)Wtsi}/Orl)	abnormal cholesterol homeostasis	J:211773
Pik3c2a^{Gt(OST288105)Lex}/Pik3c2a^{Gt(OST288105)Lex} (involves: 129S5/SvEvBrd * C57BL/6J)	abnormal blood homeostasis	J:169710
	decreased circulating bilirubin level	J:169710
	increased blood urea nitrogen level	J:169710
	increased circulating alkaline phosphatase level	J:169710
	increased circulating cholesterol level	J:169710
	increased circulating creatinine level	J:169710
	increased circulating phosphate level	J:169710
	increased circulating potassium level	J:169710
	increased urine protein level	J:169710
Pik3c2a^tm1Bvan/Pik3c2a⁺ (involves: C57BL/6)	abnormal platelet physiology	J:226344
	decreased platelet aggregation	J:226344
	decreased susceptibility to induced thrombosis	J:226344
Pik3c2g^tm1Ehi/Pik3c2g^tm1Ehi (involves: 129 * C57BL/6)	decreased liver glycogen level	J:223018
	impaired glucose tolerance	J:223018
	increased circulating cholesterol level	J:223018
	increased circulating glucose level	J:223018
	increased circulating insulin level	J:223018
	increased circulating triglyceride level	J:223018
	increased susceptibility to diet-induced obesity	J:223018
	insulin resistance	J:223018
Pik3c3^{tm1a(EUCOMM)Wtsi}/Pik3c3⁺ (C57BL/6N-Pik3c3^{tm1a(EUCOMM)Wtsi}/Ics)	decreased circulating aspartate transaminase level	J:165965
Pik3c3^{tm1c(EUCOMM)Wtsi}/Pik3c3^{tm1c(EUCOMM)Wtsi} Speer6-ps1^{Tg(Alb-cre)21Mgn}/Speer6-ps1⁺ (involves: C57BL/6 * C57BL/6N * DBA)	decreased liver glycogen level	J:182628
Pik3ca^tm1.1Rzl/Pik3ca^tm1.1Rzl Tg(Fabp4-cre)1Blw/0 (involves: 129 * C57BL/6 * FVB/N)	abnormal circulating androgen level	J:315599
	abnormal hormone level	J:315599
	decreased circulating luteinizing hormone level	J:315599
	increased circulating leptin level	J:315599
	increased circulating testosterone level	J:315599
Pik3ca^tm1.1Waph/Pik3ca⁺ Pten^tm1Hwu/Pten^tm1Hwu (involves: 129S1/Sv * 129S4/SvJae * BALB/c * C57BL/6)	hemorrhagic ascites	J:184382
Pik3ca^tm1Bvan/Pik3ca⁺ (involves: 129P2/OlaHsd * C57BL/6)	impaired glucose tolerance	J:109024
	increased circulating insulin level	J:109024
	increased circulating leptin level	J:109024
	insulin resistance	J:109024
Pik3ca^tm1Jdo/Pik3ca^tm1Jdo (B6.129S7(Cg)-Pik3ca^tm1Jdo)	chylous ascites	J:122866
Pik3ca^tm1Nbm/Pik3ca⁺ Pik3cb^tm1Nbm/Pik3cb⁺ (involves: 129S6/SvEvTac)	impaired glucose tolerance	J:96761
	increased circulating insulin level	J:96761
Pik3cb^tm1.1Ehi/Pik3cb^tm1.1Ehi (involves: 129/Sv * 129P2/OlaHsd * BALB/c * C57BL/6J)	decreased circulating cholesterol level	J:152332
	decreased circulating triglyceride level	J:152332
Pik3cb^tm1.1Ehi/Pik3cb^tm1.1Ehi (B6.129P2-Pik3cb^tm1.1Ehi)	decreased liver glycogen level	J:152332
	impaired gluconeogenesis	J:152332
	increased circulating glucose level	J:152332
	increased insulin secretion	J:152332
	insulin resistance	J:152332
Pik3cb^tm1.1Ehi/Pik3cb^tm1.1Ehi (involves: 129P2/OlaHsd)	abnormal platelet physiology	J:152267
Pik3cb^tm1.1Ehi/Pik3cb^tm1.1Ehi (involves: 129P2/OlaHsd)	decreased platelet aggregation	J:152267
Pik3cb^tm1.1Ehi/Pik3cb^tm1.1Ehi (involves: 129/Sv * 129P2/OlaHsd * C57BL/6J)	increased circulating follicle stimulating hormone level	J:165087
Pik3cb^{tm1a(EUCOMM)Wtsi}/Pik3cb⁺ (B6JTyr;B6N-Pik3cb^{tm1a(EUCOMM)Wtsi}/Wtsi)	decreased circulating creatinine level	J:175295
Pik3cb^tm1Bvan/Pik3cb^tm1Bvan Tg(Pf4-icre)Q3Rsko/0 (involves: 129P2/OlaHsd)	decreased platelet aggregation	J:158839
Pik3cb^tm1Jjz/Pik3cb^tm1Jjz (involves: 129 * C57BL/6)	impaired glucose tolerance	J:138565
	increased circulating leptin level	J:138565
	insulin resistance	J:138565
Pik3cd^m2Btlr/Pik3cd^m2Btlr (C57BL/6J-Pik3cd^m2Btlr)	increased circulating interferon-alpha level	J:236693
Pik3cd^tm1.1Bvan/Pik3cd^tm1.1Bvan (B6.129P2-Pik3cd^tm1.1Bvan)	abnormal platelet aggregation	J:114310
Pik3cd^tm1Tnr/Pik3cd^tm1Tnr (B6.129S4-Pik3cd^tm1Tnr)	abnormal platelet aggregation	J:114310
Pik3cg^{tm1a(EUCOMM)Wtsi}/Pik3cg^{tm1a(EUCOMM)Wtsi} (B6NTac;B6N-A^tm1Brd Pik3cg^{tm1a(EUCOMM)Wtsi}/WtsiOulu)	decreased circulating alanine transaminase level	J:175295
Pik3cg^tm1Dwu/Pik3cg^tm1Dwu (B6.Cg-Pik3cg^tm1Dwu)	abnormal platelet physiology	J:107460
	decreased platelet aggregation	J:107460
	decreased platelet calcium level	J:107460
	decreased susceptibility to induced thrombosis	J:107460
Pik3cg^tm1Ehi/Pik3cg^tm1Ehi (Not Specified)	decreased platelet aggregation	J:152267
Pik3r1^tm1.1Geno/Pik3r1⁺ (involves: C57BL/6 * C57BL/6J)	decreased insulin secretion	J:234657
	hyperglycemia	J:234657
	impaired glucose tolerance	J:234657
	increased circulating insulin level	J:234657
	increased circulating insulin-like growth factor I level	J:234657
	insulin resistance	J:234657
Pik3r1^tm1Dfr/Pik3r1^tm1Dfr (involves: 129S6/SvEvTac * C57BL/6)	abnormal glucose homeostasis	J:65523
	chylous ascites	J:65523
	decreased circulating insulin level	J:65523
	hypoglycemia	J:65523
	improved glucose tolerance	J:65523
Pik3r1^tm1Khn/Pik3r1^tm1Khn (involves: 129S4/SvJae * C57BL/6J)	abnormal glucose homeostasis	J:87598
	abnormal lipid homeostasis	J:87598
	decreased circulating insulin level	J:87598
	decreased triglyceride level	J:87598
	increased insulin sensitivity	J:87598
Pik3r1^tm1Tka/Pik3r1^tm1Tka (involves: C57BL/6 * CBA)	decreased circulating glucose level	J:52576
	decreased circulating insulin level	J:52576
	hypoglycemia	J:52576
	increased insulin sensitivity	J:52576
Pik3r1^tm2Dfr/Pik3r1⁺ (involves: 129S6/SvEvTac * BALB/c * C57BL/6)	hypoglycemia	J:94077
	improved glucose tolerance	J:94077
	increased insulin sensitivity	J:94077
Pik3r1^tm2Dfr/Pik3r1^tm2Dfr (either: C.129S6-Pik3r1^tm2Dfr or (involves: 129S6/SvEvTac * BALB/c * C57BL/6))	chylous ascites	J:94077
	hypoglycemia	J:94077
Pik3r2^{tm1e(KOMP)Wtsi}/Pik3r2^{tm1e(KOMP)Wtsi} (C57BL/6N-Pik3r2^{tm1e(KOMP)Wtsi}/Wtsi)	decreased circulating creatinine level	J:175295
Pik3r2^tm1Lca/Pik3r2^tm1Lca (involves: 129S6/SvEvTac)	decreased circulating glucose level	J:73703
	decreased circulating insulin level	J:73703
	increased insulin sensitivity	J:73703
Pik3r4^tm1.1Mpnd/Pik3r4^tm1.1Mpnd Tg(ACTA1-cre)79Jme/0 (involves: 129S2/SvPas * C57BL/6J * C57BL/6N * SJL)	increased circulating creatine kinase level	J:198770
	increased skeletal muscle glycogen level	J:198770
Pikfyve^{Gt(AT0926)Wtsi}/Pikfyve^{Gt(AT0926)Wtsi} (involves: 129P2/OlaHsd * C57BL/6)	abnormal lipid level	J:190368
Pikfyve^tm1.1Ashi/Pikfyve^tm1.1Ashi Tg(Ckm-cre)28Arte/0 (involves: C57BL/6)	impaired glucose tolerance	J:199213
	increased circulating insulin level	J:199213
	increased circulating triglyceride level	J:199213
	insulin resistance	J:199213
Pikfyve^tm2.1Tssk/Pikfyve^tm2.1Tssk Tg(Vil1-cre)20Syr/0 (involves: 129P2/OlaHsd * C57BL/6 * DBA/2)	abnormal circulating enzyme level	J:193689
	decreased circulating free fatty acids level	J:193689
	decreased circulating serum albumin level	J:193689
	decreased circulating total protein level	J:193689
Pilra^tm1Osb/Pilra^tm1Osb (B6.129-Pilra^tm1Osb)	increased blood urea nitrogen level	J:191085
	increased circulating alanine transaminase level	J:191085
	increased circulating lactate dehydrogenase level	J:191085
Pilrb1^tm1Pgh/Pilrb1^tm1Pgh (involves: C57BL/6)	abnormal chemokine level	J:157763
	abnormal cytokine level	J:157763
	decreased circulating interleukin-1 beta level	J:157763
	decreased circulating interleukin-6 level	J:157763
	decreased circulating tumor necrosis factor level	J:157763
	increased circulating interferon-gamma level	J:157763
	increased circulating interleukin-12 level	J:157763
Pink1^tm1Aub/Pink1^tm1Aub (involves: 129S/SvEv)	decreased dopamine level	J:150206
Pink1^tm1Hbu/Pink1^tm1Hbu (involves: 129S7/SvEvBrd * C57BL/6)	decreased dopamine level	J:169471
Pink1^tm1Shn/Pink1^tm1Shn (involves: 129S4/SvJae * C57BL/6)	decreased dopamine level	J:122728
Pip4k2b^{Gt(Betageo)1Lca}/Pip4k2b^{Gt(Betageo)1Lca} (involves: 129S/SvEv * C57BL/6)	abnormal circulating insulin level	J:91023
	increased insulin sensitivity	J:91023
Pip4k2c^{tm1b(KOMP)Wtsi}/Pip4k2c^{tm1b(KOMP)Wtsi} (involves: C57BL/6J * C57BL/6N)	abnormal circulating chemokine level	J:234283
	abnormal circulating protein level	J:234283
	decreased blood urea nitrogen level	J:234283
	increased circulating aspartate transaminase level	J:234283
	increased circulating interferon-gamma level	J:234283
	increased circulating interleukin-2 level	J:234283
	increased circulating interleukin-4 level	J:234283
	increased circulating interleukin-10 level	J:234283
	increased circulating interleukin-12 level	J:234283
	increased circulating interleukin-12b level	J:234283
Pip4k2c^{tm1b(KOMP)Wtsi}/Pip4k2c^{tm1b(KOMP)Wtsi} (C57BL/6N-Pip4k2c^{tm1b(KOMP)Wtsi}/J)	increased fasting circulating glucose level	J:211773
Pip5k1c^Gt(XD096)Byg/Pip5k1c^Gt(XD096)Byg (involves: 129P2/OlaHsd)	pericardial effusion	J:131432
Pip5k1c^{tm1b(KOMP)Wtsi}/Pip5k1c⁺ (C57BL/6N-Pip5k1c^{tm1b(KOMP)Wtsi}/J)	increased circulating alkaline phosphatase level	J:211773
Pip5k1c^{tm1b(KOMP)Wtsi}/Pip5k1c^{tm1b(KOMP)Wtsi} (C57BL/6N-Pip5k1c^{tm1b(KOMP)Wtsi}/J)	edema	J:211773
Pip5k1c^tm1Csab/Pip5k1c^tm1Csab Tg(Pf4-icre)Q3Rsko/0 (Not Specified)	abnormal platelet physiology	J:196476
Pip^em1(IMPC)Mbp/Pip^em1(IMPC)Mbp (C57BL/6NCrl-Pip^em1(IMPC)Mbp/MbpMmucd)	increased circulating alanine transaminase level	J:211773
Pitpna^{Gt(OST1152)Lex}/Pitpna^{Gt(OST1152)Lex} (involves: 129S5/SvEvBrd)	abnormal intestinal lipid absorption	J:85204
	abnormal vitamin E level	J:85204
	decreased circulating glucagon level	J:85204
	decreased circulating insulin level	J:85204
	decreased circulating triglyceride level	J:85204
	decreased glycogen catabolism rate	J:85204
	hypoglycemia	J:85204
	increased circulating alkaline phosphatase level	J:85204
	increased circulating aspartate transaminase level	J:85204
	increased circulating bilirubin level	J:85204
	increased circulating corticosterone level	J:85204
Pitpna^tm1Vab/Pitpna^tm1Vab (involves: 129S7/SvEvBrd)	abnormal intestinal lipid absorption	J:85204
	abnormal vitamin absorption	J:85204
	decreased circulating glucagon level	J:85204
	decreased circulating insulin level	J:85204
	decreased circulating triglyceride level	J:85204
	decreased glycogen catabolism rate	J:85204
	hypoglycemia	J:85204
	increased circulating alkaline phosphatase level	J:85204
	increased circulating aspartate transaminase level	J:85204
	increased circulating bilirubin level	J:85204
	increased circulating corticosterone level	J:85204
Pitpnc1^{em1(IMPC)Kmpc}/Pitpnc1^{em1(IMPC)Kmpc} (C57BL/6NTac-Pitpnc1^{em1(IMPC)Kmpc}/Kmpc)	decreased circulating glucose level	J:211773
	improved glucose tolerance	J:211773
	increased circulating alkaline phosphatase level	J:211773
	increased circulating creatine kinase level	J:211773
	increased circulating serum albumin level	J:211773
Pitpnm1^{tm1a(EUCOMM)Wtsi}/Pitpnm1^{tm1a(EUCOMM)Wtsi} (involves: C57BL/6N)	decreased circulating calcium level	J:207051
	decreased circulating cholesterol level	J:207051
Pitpnm1^{tm1a(EUCOMM)Wtsi}/Pitpnm1^{tm1a(EUCOMM)Wtsi} (C57BL/6N-Pitpnm1^{tm1a(EUCOMM)Wtsi}/Wtsi)	decreased circulating calcium level	J:175295
	decreased circulating potassium level	J:175295
Pitrm1^{tm1a(KOMP)Wtsi}/Pitrm1⁺ (C57BL/6N-Pitrm1^{tm1a(KOMP)Wtsi}/Wtsi)	decreased carbon dioxide production	J:236767
	decreased oxygen consumption	J:236767
Pitx2^tm1.1Sac/Pitx2^tm2Sac Tg(Tshb-cre)4Sac/0 (involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * SJL)	increased circulating thyroid-stimulating hormone level	J:197591
Pitx2^tm1Sac/Pitx2^tm1Sac (involves: 129S1/Sv * 129X1/SvJ)	decreased follicle stimulating hormone level	J:73774
Pitx2^tm1Sac/Pitx2^tm1Sac (involves: 129S1/Sv * 129X1/SvJ)	decreased luteinizing hormone level	J:73774
Pitx2^tm2Sac/Pitx2⁺ Tbx1^tm1Bem/Tbx1⁺ (involves: 129S1/Sv * 129X1/SvJ * C57BL/6J * SJL)	cyanosis	J:107397
Pitx2^tm3.1Jfm/Pitx2^tm3.1Jfm (involves: 129S4/SvJaeSor * C57BL/6J)	cyanosis	J:79853
Pitx3^ak/Pitx3^ak (involves: 129S1/Sv * C57BL/6 * C57BLKS/J)	decreased dopamine level	J:109319
Pitx3^eyl/Pitx3^eyl (involves: C3H/He * C57BL/6)	decreased blood uric acid level	J:156878
	decreased circulating amylase level	J:156878
	decreased circulating cholesterol level	J:156878
	decreased circulating iron level	J:156878
	decreased circulating triglyceride level	J:156878
	increased blood uric acid level	J:156878
	increased body temperature	J:156878
	increased circulating alkaline phosphatase level	J:156878
	increased circulating phosphate level	J:156878
	increased energy expenditure	J:156878
Pitx3^{tm1.1(KOMP)Vlcg}/Pitx3^{tm1.1(KOMP)Vlcg} (C57BL/6N-Pitx3^{tm1.1(KOMP)Vlcg}/J)	increased fasting circulating glucose level	J:211773
Pitx3^tm1.1Cai/Pitx3⁺ Tg(tetO-SNCAA53T)E2Cai/0 (involves: 129 C57BL/6J * FVB/N)	decreased dopamine level	J:185958
Pja2^tm1.2Afel/Pja2^tm1.2Afel (involves: 129S6/SvEvTac * C57BL/6J)	edema	J:345592
Pkcal^A/J/? (involves: A/J * C57BL/6J)	abnormal enzyme/coenzyme level	J:63984
Pkd1^m1Bei/Pkd1^m1Bei (involves: A/J * FVB/N)	edema	J:75360
Pkd1^tm1.1Fqi/Pkd1^tm1.1Fqi (B6.129S6-Pkd1^tm1.1Fqi)	increased blood urea nitrogen level	J:127628
Pkd1^tm1.1Fqi/Pkd1^tm1.1Fqi (involves: 129S6/SvEvTac)	increased blood urea nitrogen level	J:193175
Pkd1^tm1.1Fqi/Pkd1^tm1.1Fqi (involves: 129S6/SvEvTac)	increased circulating creatinine level	J:193175
Pkd1^tm1.1Pcha/Pkd1⁺ Pkd2^tm1Som/Pkd2^tm2Som (involves: 129 * C57BL/6J * SJL)	increased blood urea nitrogen level	J:220561
Pkd1^tm1.1Pcha/Pkd1^tm1.1Pcha (involves: 129S1/Sv * C57BL/6)	increased blood urea nitrogen level	J:193544
Pkd1^tm1.1Pcha/Pkd1^tm1.1Pcha Pkd2^tm1Som/Pkd2⁺ (involves: 129 * C57BL/6J * SJL)	increased blood urea nitrogen level	J:220561
Pkd1^tm1.1Pcha/Pkd1^tm1.1Pcha Pkd2^tm1Som/Pkd2^tm2Som (involves: 129 * C57BL/6J * SJL)	increased blood urea nitrogen level	J:220561
Pkd1^tm1.1Pcha/Pkd1^tm1.1Pcha Pkd2^tm2Som/Pkd2⁺ (involves: 129 * C57BL/6J * SJL)	increased blood urea nitrogen level	J:220561
Pkd1^tm1.1Pcha/Pkd1^tm1.1Pcha Tg(Cdh16-cre)91Igr/0 (involves: 129 * 129S4/SvJae * C57BL/6 * ICR)	increased blood urea nitrogen level	J:244067
Pkd1^tm1.1Pcha/Pkd1^tm2Som Tg(Cdh16-cre)91Igr/0 (involves: 129 * 129S4/SvJae * C57BL/6 * ICR)	decreased fatty acid oxidation	J:244067
	increased circulating creatinine level	J:244067
Pkd1^{tm1b(EUCOMM)Hmgu}/Pkd1⁺ (C57BL/6N-Pkd1^{tm1b(EUCOMM)Hmgu}/Bay)	decreased circulating alkaline phosphatase level	J:211773
	decreased circulating total protein level	J:211773
Pkd1^tm1Bdgz/Pkd1^tm1Bdgz (involves: 129S1/Sv * 129X1/SvJ)	skin edema	J:130086
Pkd1^tm1Ggg/Pkd1^tm1Ggg (involves: 129/Sv * Black Swiss)	edema	J:103719
Pkd1^tm1Ggg/Pkd1^tm1Ggg (involves: 129/Sv * Black Swiss)	polyhydramnios	J:103719
Pkd1^tm1Ggg/Pkd1^tm1Ggg (either: (involves: 129/Sv) or (involves: 129/Sv * Black Swiss))	abnormal amniotic fluid composition	J:104483
	polyhydramnios	J:104483
Pkd1^tm1Ggg/Pkd1^tm1Ggg (involves: 129S4/SvJae * C57BL/6)	polyhydramnios	J:165114
Pkd1^tm1Ggg/Pkd1^tm2.1Ggg (involves: 129S4/SvJae * Black Swiss * C57BL/6)	edema	J:103719
	polyhydramnios	J:103719
Pkd1^tm1Ggg/Pkd1^tm2Ggg Meox2^tm1(cre)Sor/Meox2⁺ (involves: 129S4/SvJae * 129S4/SvJaeSor)	edema	J:165114
	polyhydramnios	J:165114
Pkd1^tm1Ggg/Pkd1^tm2Ggg Tg(Tek-cre)1Ywa/0 (involves: 129S4/SvJae * C57BL/6 * SJL)	polyhydramnios	J:165114
Pkd1^tm1Hung/Pkd1^tm1Hung (either: (involves: 129P2/OlaHsd * C57BL/6) or (involves: 129P2/OlaHsd * FVB))	increased blood urea nitrogen level	J:104361
Pkd1^tm1Jzh/Pkd1⁺ (either: (involves: 129S4/SvJae * C57BL/6) or (involves: 129S4/SvJae * BALB/c))	abnormal circulating creatinine level	J:52573
Pkd1^tm1Jzh/Pkd1^tm1Jzh (either: (involves: 129S4/SvJae * C57BL/6) or (involves: 129S4/SvJae * BALB/c))	hydrops fetalis	J:72627
	polyhydramnios	J:72627
	skin edema	J:72627
Pkd1^tm1Maa/Pkd1^tm1Maa (involves: 129S4/SvJae * C57BL/6)	hydrops fetalis	J:68331
Pkd1^tm1Maa/Pkd1^tm1Maa (involves: 129S4/SvJae * C57BL/6)	skin edema	J:68331
Pkd1^tm1Rsa/Pkd1^tm1Rsa (involves: 129S4/SvJaeSor)	edema	J:72238
Pkd1^tm1Rsa/Pkd1^tm1Rsa (involves: 129S4/SvJaeSor)	hemopericardium	J:72238
Pkd1^tm1Shh/Pkd1^tm1.1Pcha (involves: 129P2/OlaHsd * 129S1/Sv * C57BL/6)	increased blood urea nitrogen level	J:193544
	uremia	J:193544
Pkd1^tm1Shh/Pkd1^tm1Shh (involves: 129P2/OlaHsd * C57BL/6J)	skin edema	J:77927
Pkd1^tm1Som/Pkd1⁺ Prkcsh^tm1Som/Prkcsh^tm1Som Tg(Cdh16-cre)91Igr/0 (involves: 129 * C57BL/6 * C57BL/6J * ICR * SJL)	increased blood urea nitrogen level	J:188763
Pkd1^tm1Som/Pkd1⁺ Sec63^tm1Som/Sec63^tm1Som Tg(Cdh16-cre)91Igr/0 (involves: 129 * C57BL/6 * C57BL/6J * ICR * SJL)	increased blood urea nitrogen level	J:188763
Pkd1^tm1Som/Pkd1^tm1Som (involves: 129/Sv * C57BL/6 * SJL)	edema	J:78422
Pkd1^tm2.1Ggg/Pkd1^tm2.1Ggg (involves: 129S4/SvJae * Black Swiss * C57BL/6)	abnormal fluid regulation	J:103719
Pkd1^tm2.2Bol/Pkd1^tm2.2Bol (involves: 129S2/SvPas * C57BL/6 * C57BL/6NTac)	edema	J:153606
Pkd1^tm2Ggg/Pkd1^tm2Ggg Tg(Col1a1-cre)1Bek/0 (involves: 129S4/SvJae * CD-1)	abnormal circulating mineral level	J:191967
	increased blood urea nitrogen level	J:191967
	increased circulating parathyroid hormone level	J:191967
Pkd1^tm2Ggg/Pkd1^tm2Ggg Tg(Hoxb7-cre)13Amc/0 (involves: 129S4/SvJae * C57BL/6)	increased blood urea nitrogen level	J:171619
Pkd1^tm2Ggg/Pkd1^tm2Ggg Tg(Nes-cre)Wme/0 (involves: 129S4/SvJae * C57BL/6 * CBA)	increased blood urea nitrogen level	J:185855
Pkd1^tm2Ggg/Pkd1^tm2Ggg Tg(Pax8-rtTA2SM2)1Koes/0 Tg(tetO-cre)1Jaw/0 (involves: 129S4/SvJae C57BL/6 * C57BL/6N * DBA * SJL)	increased blood urea nitrogen level	J:284006
Pkd1^tm2Jzh/Pkd1^tm2Jzh (either: (involves: 129S4/SvJae * BALB/c) or (involves: 129S4/SvJae * C57BL/6))	hydrops fetalis	J:72627
	polyhydramnios	J:72627
	skin edema	J:72627
Pkd1^tm2Jzh/Pkd1^tm2Jzh (involves: 129S4/SvJae * C57BL/6)	edema	J:140012
Pkd1^tm2Jzh/Pkd1^tm2Jzh (involves: 129S4/SvJae * C57BL/6)	polyhydramnios	J:140012
Pkd1^tm2Som/Pkd1^tm2.1Som Tg(Cdh16-cre)91Igr/0 (involves: C57BL/6 * ICR * SJL)	decreased circulating glucose level	J:135301
	increased blood urea nitrogen level	J:135301
	increased circulating cholesterol level	J:135301
	increased circulating phosphate level	J:135301
Pkd1^tm2Som/Pkd1^tm2Som Tg(Cdh16-cre)91Igr/0 (involves: C57BL/6 * ICR * SJL)	decreased circulating glucose level	J:135301
	increased blood urea nitrogen level	J:135301
	increased circulating cholesterol level	J:135301
	increased circulating phosphate level	J:135301
Pkd1^tm2Som/Pkd1^tm2Som Tg(Cdh16-cre)91Igr/0 (involves: 129S4/SvJae * C57BL/6 * ICR)	increased circulating creatinine level	J:244067
Pkd1^tm3.1Jzh/Pkd1^tm3.1Jzh (involves: 129P2/OlaHsd * C57BL/6)	edema	J:140012
	polyhydramnios	J:140012
Pkd1^tm3.2Bol/Pkd1^tm3.2Bol (involves: 129S2/SvPas * C57BL/6 * C57BL/6NTac)	edema	J:153606
Pkd1l1^rks/Pkd1l1^rks (C3H.B6-Pkd1l1^rks)	edema	J:170490
Pkd2^lrm4/Pkd2^lrm4 (involves: BALB/cAnN * C3H/HeH)	edema	J:145068
Pkd2^lrm4/Pkd2^lrm4 (C3.CAnN-Pkd2^lrm4)	edema	J:170490
Pkd2^tm1.1Gwu/Pkd2^tm1.1Gwu Tg(Vil1-cre)997Gum/0 (involves: C57BL/6 * C57BL/6J * SJL)	increased blood urea nitrogen level	J:265516
	increased circulating creatinine level	J:265516
Pkd2^tm1.1Tjwt/Pkd2^tm1.1Tjwt Tg(Tek-cre)1Ywa/0 (involves: 129S/SvEv * 129X1/SvJ * C57BL/6 * SJL)	polyhydramnios	J:165114
Pkd2^tm1.1Tjwt/Pkd2^tm1.2Tjwt Meox2^tm1(cre)Sor/Meox2⁺ (involves: 129S/Sv * 129X1/SvJ * C57BL/6 * SJL)	edema	J:165114
Pkd2^tm1Dwo/Pkd2^tm1Dwo (either: (involves: 129S1/Sv * 129X1/SvJ) or (involves: 129S1/Sv * 129X1/SvJ * C57BL/6))	hydrops fetalis	J:77401
Pkd2^tm1Som/Pkd2^tm2Som (involves: 129/Sv * C57BL/6J * SJL)	increased blood urea nitrogen level	J:59314, J:220561
Pkd2^tm2Som/Pkd2⁺ Prkcsh^tm1Som/Prkcsh^tm1Som Tg(Cdh16-cre)91Igr/0 (involves: 129 * C57BL/6 * C57BL/6J * ICR * SJL)	increased blood urea nitrogen level	J:188763
Pkd2^tm2Som/Pkd2⁺ Sec63^tm1Som/Sec63^tm1Som Tg(Cdh16-cre)91Igr/0 (involves: 129 * C57BL/6 * C57BL/6J * ICR * SJL)	increased blood urea nitrogen level	J:188763
Pkd2^tm2Som/Pkd2^tm2Som (involves: 129/Sv * C57BL/6J * SJL)	abnormal amniotic fluid composition	J:104483
	hydrops fetalis	J:59314
	pericardial effusion	J:59314
	polyhydramnios	J:104483
Pkd2^tm3Som/Pkd2^tm3Som Tg(Pkhd1-cre)1Igr/0 (involves: 129S4/SvJae * C57BL/6)	increased blood urea nitrogen level	J:244067
	increased circulating creatinine level	J:244067
Pkd2l2^{tm1b(EUCOMM)Wtsi}/Pkd2l2^{tm1b(EUCOMM)Wtsi} (C57BL/6N-Pkd2l2^{tm1b(EUCOMM)Wtsi}/H)	decreased fasting circulating glucose level	J:211773
	increased blood urea nitrogen level	J:211773
	increased circulating creatinine level	J:211773
	increased circulating fructosamine level	J:211773
	increased circulating potassium level	J:211773
Pkdcc^em1(IMPC)Mbp/Pkdcc^em1(IMPC)Mbp (C57BL/6N-Pkdcc^em1(IMPC)Mbp/MbpMmucd)	edema	J:211773
Pkdcc^tm1.1Mask/Pkdcc^tm1.1Mask (involves: C57BL/6 * CBA * FVB/N)	cyanosis	J:158147
Pkdcc^tm1Hssk/Pkdcc^tm1Hssk (involves: C57BL/6 * CBA)	cyanosis	J:140470
Pkig^{tm1b(EUCOMM)Hmgu}/Pkig^{tm1b(EUCOMM)Hmgu} (C57BL/6N-Pkig^{tm1b(EUCOMM)Hmgu}/Ieg)	increased blood urea nitrogen level	J:211773
	increased circulating alkaline phosphatase level	J:211773
	increased circulating aspartate transaminase level	J:211773
Pklr^em1Appsc/Pklr^em1Appsc (involves: C57BL/6J)	abnormal sphingomyelin level	J:342736
	decreased ceramide level	J:342736
	decreased saturated fatty acids level	J:342736
Pklr^slc/Pklr^slc (CBA/NSlc-Pklr^slc)	hemosiderosis	J:30035
Pklr^slc/Pklr^slc (CBA/NSlc-Pklr^slc)	increased circulating bilirubin level	J:30035
Pkn1^tm1Ajmc/Pkn1^tm1Ajmc (B6.129P2-Pkn1^tm1Ajmc)	abnormal calcium ion homeostasis	J:258572
Pkn1^{tm1b(KOMP)Wtsi}/Pkn1^{tm1b(KOMP)Wtsi} (C57BL/6N-Pkn1^{tm1b(KOMP)Wtsi}/H)	decreased fasting circulating glucose level	J:211773
Pkn2^{tm1a(KOMP)Wtsi}/Pkn2^{tm1a(KOMP)Wtsi} (involves: C57BL/6N)	pericardial edema	J:229595
Pkn2^{tm1b(KOMP)Wtsi}/Pkn2⁺ (C57BL/6N-Pkn2^{tm1b(KOMP)Wtsi}/Ieg)	decreased circulating cholesterol level	J:211773
	decreased circulating HDL cholesterol level	J:211773
	decreased circulating total protein level	J:211773
	decreased circulating unsaturated transferrin level	J:211773
	increased circulating bilirubin level	J:211773
Pkn3^{tm1.1(KOMP)Vlcg}/Pkn3^{tm1.1(KOMP)Vlcg} (C57BL/6N-Pkn3^{tm1.1(KOMP)Vlcg}/J)	decreased fasting circulating glucose level	J:211773
Pknox1^{Gt(OST71835)Lex}/Pknox1^{Gt(OST71835)Lex} (B6.129S5-Pknox1^{Gt(OST71835)Lex})	edema	J:111418
Pkp1^{tm2d(KOMP)Wtsi}/Pkp1^{tm2d(KOMP)Wtsi} (involves: C57BL/6J * C57BL/6N * SJL/J)	dehydration	J:233599
	impaired skin barrier function	J:233599
Pkp2^tm1Wbm/Pkp2^tm1Wbm (involves: C57BL/6)	edema	J:93314
	hemopericardium	J:93314
	pericardial edema	J:93314
Pkp4^{tm1b(EUCOMM)Wtsi}/Pkp4^{tm1b(EUCOMM)Wtsi} (C57BL/6N-Pkp4^{tm1b(EUCOMM)Wtsi}/J)	decreased circulating calcium level	J:211773
	decreased circulating iron level	J:211773
	increased circulating alkaline phosphatase level	J:211773
Pla1a^em1Appsc/Pla1a^em1Appsc (C57BL/6J-Pla1a^em1Appsc)	abnormal interleukin level	J:333902
Pla2g1b^tm1Dyh/Pla2g1b^tm1Dyh (involves: 129S1/Sv * 129X1/SvJ * Black Swiss * C57BL/6)	abnormal circulating glucose level	J:80216
	abnormal glucose homeostasis	J:80216
	abnormal intestinal lipid absorption	J:80216
	decreased circulating insulin level	J:80216
	decreased circulating leptin level	J:80216
	improved glucose tolerance	J:80216
	increased insulin sensitivity	J:80216
Pla2g2d^{tm1.1(KOMP)Vlcg}/Pla2g2d^{tm1.1(KOMP)Vlcg} (C57BL/6N-Pla2g2d^{tm1.1(KOMP)Vlcg}/J)	decreased urine magnesium level	J:211773
Pla2g2d^tm1.1Mhg/Pla2g2d^tm1.1Mhg (B6NCrSlc.Cg-Pla2g2d^tm1.1Mhg)	abnormal lipid homeostasis	J:201008
	decreased unsaturated fatty acids level	J:229035
Pla2g2e^{tm1b(EUCOMM)Wtsi}/Pla2g2e^{tm1b(EUCOMM)Wtsi} (C57BL/6N-Pla2g2e^{tm1b(EUCOMM)Wtsi}/Ieg)	increased circulating alkaline phosphatase level	J:211773
Pla2g3^tm1Murm/Pla2g3^tm1Murm (involves: 129S/SvEv * C57BL/6J)	abnormal phospholipid level	J:161462
Pla2g3^tm1Murm/Pla2g3^tm1Murm (involves: 129S/SvEv * C57BL/6)	abnormal body temperature	J:197334
	edema	J:197334
Pla2g4a^tm1Jvb/Pla2g4a^tm1Jvb (involves: 129S4/SvJae)	increased dopamine level	J:120035
Pla2g4a^tm1Jvb/Pla2g4a^tm1Jvb (involves: 129S4/SvJae * C57BL/6)	decreased urine osmolality	J:114240
	increased blood osmolality	J:114240
Pla2g4a^tm1Tksh/Pla2g4a^tm1Tksh (NOD.129P2(B6)-Pla2g4a^tm1Tksh)	impaired glucose tolerance	J:99775
Pla2g4a^tm1Tksh/Pla2g4a^tm1Tksh (B6.129P2-Pla2g4a^tm1Tksh)	abnormal cytokine level	J:107430
Pla2g4e^em1Murm/Pla2g4e^em1Murm (C57BL/6NSlc-Pla2g4e^em1Murm)	abnormal lipid level	J:333700
Pla2g4f^{tm1a(EUCOMM)Hmgu}/Pla2g4f^{tm1a(EUCOMM)Hmgu} (C57BL/6N-Pla2g4f^{tm1a(EUCOMM)Hmgu}/Ics)	increased circulating sodium level	J:165965
Pla2g6^tm1Zyao/Pla2g6^tm1Zyao (involves: 129S6/SvEvTac * C57BL/6)	abnormal apolipoprotein level	J:203038
	increased cholesterol level	J:203038
Pla2g10^Gt712Lex/Pla2g10^Gt712Lex (involves: 129S5/SvEvBrd * C57BL/6J)	abnormal interleukin level	J:125607
	abnormal prostaglandin level	J:125607
Pla2g10^tm1Itl/Pla2g10^tm1Itl (involves: C57BL/6NTac)	increased circulating corticosterone level	J:164545
Pla2g12b^hlb218/Pla2g12b^hlb218 (C57BL/6J-Pla2g12b^hlb218/J)	decreased circulating cholesterol level	J:187708, J:82961
	decreased circulating HDL cholesterol level	J:187708, J:82961
	decreased circulating triglyceride level	J:187708
Pla2g12b^mpc96H/Pla2g12b^mpc96H (involves: BALB/c * C3H/HeH * C57BL/6J)	decreased circulating HDL cholesterol level	J:234901
	decreased circulating LDL cholesterol level	J:234901
Pla2g15^tm1Ytan/Pla2g15^tm1Ytan (involves: 129S/SvEv)	abnormal circulating cholesterol level	J:97471
Plaat3^em1(IMPC)Tcp/Plaat3^em1(IMPC)Tcp (C57BL/6NCrl-Plaat3^em1(IMPC)Tcp/Tcp)	impaired glucose tolerance	J:211773
Plaat3^tm1.1Hsul/Plaat3^tm1.1Hsul (B6.129P2-Pla2g16^tm1.1Hsul)	abnormal glucose homeostasis	J:239202
	abnormal glycogen homeostasis	J:239202
	decreased circulating adiponectin level	J:239202
	decreased circulating free fatty acids level	J:239202
	decreased circulating leptin level	J:239202
	decreased circulating triglyceride level	J:239202
	decreased liver triglyceride level	J:239202
	decreased phospholipase A2 level	J:239202
	decreased susceptibility to diet-induced obesity	J:239202
	decreased triglyceride level	J:239202
	enhanced lipolysis	J:239202
	increased circulating alanine transaminase level	J:239202
	increased circulating glucose level	J:239202
	increased circulating insulin level	J:239202
	increased fasting circulating glucose level	J:239202
	increased fatty acid oxidation	J:239202
	increased oxygen consumption	J:239202
	insulin resistance	J:239202
Plac8^tm1Bhk/Plac8^tm1Bhk (involves: 129S6/SvEvTac * C57BL/6)	decreased body temperature	J:179647
	impaired adaptive thermogenesis	J:179647
Plac9^{tm1b(EUCOMM)Hmgu}/Plac9^{tm1b(EUCOMM)Hmgu} (C57BL/6N-Plac9^{tm1b(EUCOMM)Hmgu}/H)	decreased fasting circulating glucose level	J:211773
	increased circulating fructosamine level	J:211773
Plag1^{em1(IMPC)Hmgu}/Plag1^{em1(IMPC)Hmgu} (C57BL/6N-Plag1^{em1(IMPC)Hmgu}/Ieg)	increased circulating aspartate transaminase level	J:211773
Plagl2^tm1Wjmv/Plagl2^tm1Wjmv (involves: 129S1/Sv * 129X1/SvJ * BALB/c * C57BL/6)	abnormal intestinal lipid absorption	J:130260
	increased circulating cholesterol level	J:130260
	increased circulating triglyceride level	J:130260
Plast1^C57BL/6J/Plast1^C57BL/6J (involves: C57BL/6J * CASA/Rk)	abnormal circulating cholesterol level	J:119976
Plast1^C57BL/6J/Plast1^C57BL/6J Plast2b^CASA/Rk/Plast2b^CASA/Rk (involves: C57BL/6J * CASA/Rk)	abnormal circulating cholesterol level	J:119976
Plast1^C57BL/6J/Plast1^CASA/Rk (involves: C57BL/6J * CASA/Rk)	abnormal circulating cholesterol level	J:119976
Plast1^C57BL/6J/Plast1^CASA/Rk Plast2b^CASA/Rk/Plast2b^CASA/Rk (involves: C57BL/6J * CASA/Rk)	abnormal circulating cholesterol level	J:119976
Plast1a^CASA/Rk/Plast1a^CASA/Rk (involves: C57BL/6J * CASA/Rk)	abnormal circulating cholesterol level	J:116492
	decreased intestinal cholesterol absorption	J:116492
Plast1b^CASA/Rk/Plast1b^CASA/Rk (involves: C57BL/6J * CASA/Rk)	abnormal circulating cholesterol level	J:116492
	decreased intestinal cholesterol absorption	J:116492
Plast2a^C57BL/6J/Plast2a^C57BL/6J (involves: C57BL/6J * CASA/Rk)	abnormal circulating cholesterol level	J:119976
Plast2a^C57BL/6J/Plast2a^CASA/Rk (involves: C57BL/6J * CASA/Rk)	abnormal circulating cholesterol level	J:119976
Plast2b^C57BL/6J/Plast2b^C57BL/6J (involves: C57BL/6J * CASA/Rk)	abnormal circulating cholesterol level	J:119976
Plat^tm1Mlg/Plat^tm1Mlg (involves: 129S2/SvPas * C57BL/6)	abnormal acute phase protein level	J:63134, J:82604
	increased susceptibility to induced thrombosis	J:17427
	reduced thrombolysis	J:17427
Plat^tm1Mlg/Plat^tm1Mlg (B6.Cg-Plat^tm1Mlg)	abnormal acute phase protein level	J:75303
	abnormal cytokine level	J:75303
	decreased dopamine level	J:88913
	increased circulating corticosterone level	J:81694, J:94733
	joint swelling	J:75303
	reduced thrombolysis	J:64220
Plat^tm1Mlg/Plat^tm1Mlg Plau^tm1Mlg/Plau^tm1Mlg (involves: 129S2/SvPas * C57BL/6)	abnormal thrombosis	J:17427
	reduced thrombolysis	J:17427
Plau^tm1Mlg/Plau^tm1Mlg (involves: 129S2/SvPas * C57BL/6)	abnormal acute phase protein level	J:63134, J:82604
	abnormal circulating protein level	J:104962
	abnormal thrombosis	J:17427
	increased susceptibility to induced thrombosis	J:17427
Plau^tm1Mlg/Plau^tm1Mlg (either: B6.Cg-Plau^tm1Mlg or (involves: Black Swiss * C57BL/6))	reduced thrombolysis	J:64220
Plau^tm1Mlg/Plau^tm1Mlg (B6.Cg-Plau^tm1Mlg)	abnormal acute phase protein level	J:68083
Plau^tm1Mlg/Plau^tm1Mlg (B6.Cg-Plau^tm1Mlg)	abnormal cytokine level	J:75303
Plau^tm1Mlg/Plau^tm1Mlg (B6.129S2-Plau^tm1Mlg)	decreased liver glycogen level	J:164542
Plaur^em1(IMPC)H/Plaur^em1(IMPC)H (C57BL/6NTac-Plaur^em1(IMPC)H/H)	increased circulating glucose level	J:211773
Plaur^tm1Mlg/Plaur^tm1Mlg (involves: 129S2/SvPas * C57BL/6)	abnormal cytokine level	J:75573
Plcb2^tm1Dwu/Plcb2^tm1Dwu Plcb3^tm1Dwu/Plcb3^tm1Dwu (involves: 129S1/Sv * CD-1)	abnormal platelet physiology	J:60348
	decreased platelet aggregation	J:60348
	decreased platelet calcium level	J:60348
	decreased susceptibility to induced thrombosis	J:60348
	increased platelet ATP level	J:60348
Plcb3^tm1Dwu/Plcb3^tm1Dwu (involves: CD-1)	abnormal calcium ion homeostasis	J:66819
Plcd1^tm1.1Kfu/Plcd1^tm1.1Kfu Tg(KRT14-cre)1Amc/0 (involves: C57BL/6 * C57BL/6JJcl * CBA)	increased circulating interleukin-17 level	J:205633
Plcd1^tm1Tta/Plcd1^tm1Tta (involves: 129P2/OlaHsd)	increased circulating interleukin-17 level	J:205633
Plce1^tm1Avsm/Plce1^tm1Avsm (B6.129S6-Plce1^tm1Avsm)	abnormal calcium ion homeostasis	J:179540
Plcg2^al/Plcg2^al (involves: 129 * C57BL/6)	chylous ascites	J:143529
Plcg2^em1Msasn/Plcg2^em1Msasn (B6.Cg-Plcg2^em1Msasn/J)	abnormal calcium level	J:308279
Plcg2^tm1Ichi/Plcg2^tm1Ichi (involves: 129 * C57BL/6)	chylous ascites	J:143529
Plcg2^tm1Jni/Plcg2^tm1Jni (involves: 129P2/OlaHsd)	decreased platelet aggregation	J:114266
Plcl2^tm1Tta/Plcl2^tm1Tta (involves: 129P2/OlaHsd)	abnormal calcium ion homeostasis	J:85960
Plcz1^em1(IMPC)H/Plcz1^em1(IMPC)H (C57BL/6N-Plcz1^em1(IMPC)H/H)	decreased circulating iron level	J:211773
	increased fasting circulating glucose level	J:211773
Pld1^tm1.1Mafr/Pld1^tm1.1Mafr (B6.Cg-Pld1^tm1.1Mafr)	abnormal platelet physiology	J:193451
Pld1^tm3Mafr/Pld1^tm3Mafr (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	decreased platelet aggregation	J:211547
Pld1^tm3Mafr/Pld1^tm3Mafr (B6.129-Pld1^tm3Mafr)	abnormal platelet activation	J:216114
Pld1^tm3Mafr/Pld1^tm3Mafr Pld2^{tm1(KOMP)Vlcg}/Pld2^{tm1(KOMP)Vlcg} (involves: C57BL/6 * C57BL/6NTac)	abnormal platelet activation	J:216114
	decreased susceptibility to induced thrombosis	J:216114
Pld2^tm1.1Gdp/Pld2^tm1.1Gdp (involves: 129X1/SvJ * C57BL/6)	abnormal lipid level	J:166741
Pld2^tm1.1Gdp/Pld2^tm1.1Gdp Tg(APPSWE)2576Kha/0 (involves: 129X1/SvJ * C57BL/6 * SJL)	abnormal lipid level	J:166741
Pld3^em1Nemz/Pld3^em1Nemz Pld4^tm1.2Nemz/Pld4^tm1.2Nemz (B6.Cg-Pld3^em1Nemz Pld4^tm1.1Nemz)	abnormal circulating chemokine level	J:281205
	increased circulating CXCL10 level	J:281205
	increased circulating ferritin level	J:281205
	increased circulating interferon-gamma level	J:281205
	increased circulating tumor necrosis factor level	J:281205
Pld4^em1(IMPC)Mbp/Pld4^em1(IMPC)Mbp (C57BL/6N-Pld4^em1(IMPC)Mbp/MbpMmucd)	decreased circulating calcium level	J:211773
Pld4^tm1.2Nemz/Pld4^tm1.2Nemz (B6.129(Cg)-Pld4^tm1.1Nemz)	increased circulating CXCL10 level	J:281205
Pld4^tm1.2Nemz/Pld4^tm1.2Nemz (B6.129(Cg)-Pld4^tm1.1Nemz)	increased circulating interferon-gamma level	J:281205
Pld5^{tm1b(KOMP)Wtsi}/Pld5^{tm1b(KOMP)Wtsi} (B6Brd;B6Dnk;B6N-Pld5^{tm1b(KOMP)Wtsi} Tyr^c-Brd/Wtsi)	increased circulating HDL cholesterol level	J:211773
Plec^em1(IMPC)Bay/Plec^em1(IMPC)Bay (C57BL/6N-Plec^em1(IMPC)Bay/BayMmucd)	edema	J:211773
Plec^tm2Gwi/Plec^tm4Gwi Tg(Krt1-5-cre/ERT)1Ipc/? (involves: 129 * C57BL/6 * SJL)	impaired skin barrier function	J:124213
Plec^tm4Gwi/Plec^tm4Gwi Tg(KRT5-cre)1Tak/? (involves: 129P2/OlaHsd * C3H * C57BL/6)	impaired skin barrier function	J:124213
Plek^tm1Csab/Plek^tm1Csab (involves: 129P2/OlaHsd * C57BL/6J)	abnormal platelet activation	J:148429
	decreased platelet aggregation	J:148429
Plekha1^{Gt(ROSA)82Sor}/Plekha1^{Gt(ROSA)82Sor} (either: (involves: 129S4/SvJaeSor) or (involves: 129S4/SvJaeSor * C57BL/6))	decreased circulating testosterone level	J:142042
Plekha1^tm1.1Arte/Plekha1^tm1.1Arte Plekha2^tm1.1Arte/Plekha2^tm1.1Arte (C57BL/6J-Plekha1^tm1.1Arte Plekha2^tm1.1Arte)	increased insulin sensitivity	J:169475
Plekha1^{tm1b(EUCOMM)Hmgu}/Plekha1^{tm1b(EUCOMM)Hmgu} (C57BL/6N-Plekha1^{tm1b(EUCOMM)Hmgu}/Ieg)	increased circulating calcium level	J:211773
Plekhf1^tm1.1Caox/Plekhf1^tm1.1Caox Lyz2^tm1(cre)Ifo/Lyz2⁺ (B6.Cg-Plekhf1^tm1.1Caox Lyz2^tm1(cre)Ifo)	decreased circulating interferon-beta level	J:277440
	decreased circulating interleukin-6 level	J:277440
	decreased circulating tumor necrosis factor level	J:277440
Plekhf2^{em1(IMPC)Wtsi}/Plekhf2^{em1(IMPC)Wtsi} (C57BL/6NCrl-Plekhf2^{em1(IMPC)Wtsi}/Wtsi)	decreased circulating cholesterol level	J:211773
	decreased circulating HDL cholesterol level	J:211773
	increased circulating alkaline phosphatase level	J:211773
Plekhg1^{tm1a(EUCOMM)Wtsi}/Plekhg1^{tm1a(EUCOMM)Wtsi} (C57BL/6N-Plekhg1^{tm1a(EUCOMM)Wtsi}/Wtsi)	increased circulating fructosamine level	J:175295
Plekhg2^em1(IMPC)J/Plekhg2^em1(IMPC)J (C57BL/6NJ-Plekhg2^em1(IMPC)J/Mmjax)	increased circulating phosphate level	J:211773
Plekhg5^tm1Jbar/Plekhg5^tm1Jbar Tg(Tek-cre)1Ywa/0 (involves: C57BL/6 * SJL)	edema	J:195233
	impaired skin barrier function	J:195233
Plekhh1^{tm1.1(KOMP)Mbp}/Plekhh1^{tm1.1(KOMP)Mbp} (C57BL/6N-Plekhh1^{tm1.1(KOMP)Mbp}/Ieg)	increased circulating lipase level	J:211773
Plekhm1^{tm1b(EUCOMM)Hmgu}/Plekhm1^{tm1b(EUCOMM)Hmgu} (C57BL/6N-Plekhm1^{tm1b(EUCOMM)Hmgu}/Tcp)	increased circulating alanine transaminase level	J:211773
	increased circulating aspartate transaminase level	J:211773
Plekhm2^{tm1a(EUCOMM)Wtsi}/Plekhm2^{tm1a(EUCOMM)Wtsi} (involves: C57BL/6J * C57BL/6N)	increased circulating alkaline phosphatase level	J:233985
Plekhn1^tm1.1Hkon/Plekhn1^tm1.1Hkon (B6.Cg-Plekhn1^tm1.1Hkon)	increased circulating leptin level	J:251603
Plet1^{em1(IMPC)Wtsi}/Plet1^{em1(IMPC)Wtsi} (C57BL/6N-Plet1^{em1(IMPC)Wtsi}/WtsiIeg)	decreased circulating sodium level	J:211773
	increased circulating insulin level	J:211773
Plg^tm1.1Fjc/Plg^tm1.1Fjc (involves: C57BL/6 * C57BL/6JJcl)	increased circulating fibrinogen level	J:210802
Plg^tm1Dco/Plg⁺ (involves: 129S2/SvPas * 129X1/SvJ * C57BL/6)	abnormal blood coagulation	J:80114
Plg^tm1Dco/Plg⁺ (involves: 129S2/SvPas * C57BL/6J)	abnormal blood coagulation	J:30174
Plg^tm1Dco/Plg^tm1Dco (involves: 129S2/SvPas * C57BL/6)	abnormal acute phase protein level	J:82604
Plg^tm1Dco/Plg^tm1Dco (involves: 129S2/SvPas * 129X1/SvJ * C57BL/6)	abnormal blood coagulation	J:80114
Plg^tm1Dco/Plg^tm1Dco (involves: 129S2/SvPas * C57BL/6J)	abnormal blood coagulation	J:30174
Plg^tm1Dco/Plg^tm1Dco (involves: 129S2/SvPas)	increased circulating fibrinogen level	J:210802
Plg^tm1Jld/Plg^tm1Jld (involves: 129P2/OlaHsd * NIH Black Swiss)	abnormal thrombosis	J:39419
Plg^tm1Jld/Plg^tm1Jld (involves: 129P2/OlaHsd * Black Swiss)	abnormal kidney thrombosis	J:36591
	abnormal thrombosis	J:36591
Plin1^tm1Asg/Plin1^tm1Asg (B6.129S6-Plin1^tm1Asg)	abnormal circulating free fatty acids level	J:113735
Plin1^tm1Asg/Plin1^tm1Asg (B6.129S6-Plin1^tm1Asg)	enhanced lipolysis	J:113735
Plin1^tm1Asg/Plin1^tm1Asg Tg(Fabp4-Plin)1Asg/0 (involves: 129S6/SvEvTac C57BL/6)	abnormal body temperature homeostasis	J:121641
	impaired lipolysis	J:113735
Plin1^tm1Cdl/Plin1^tm1Cdl (involves: 129S6/SvEvTac * C57BL/6)	abnormal glucose homeostasis	J:69629
	abnormal lipolysis	J:69629
	enhanced lipolysis	J:69629
	impaired glucose tolerance	J:69629
	impaired lipolysis	J:69629
	increased circulating insulin level	J:69629
	increased circulating leptin level	J:69629
	increased oxygen consumption	J:69629
Plin1^tm1Chan/Plin1^tm1Chan (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	abnormal blood homeostasis	J:66267
	abnormal circulating free fatty acids level	J:66267
	abnormal circulating ketone body level	J:66267
	abnormal glycerol level	J:66267
	decreased circulating leptin level	J:66267
	decreased susceptibility to diet-induced obesity	J:66267
	enhanced lipolysis	J:66267
	impaired adaptive thermogenesis	J:66267
	increased oxygen consumption	J:66267
Plin2^tm1.1Asg/Plin2^tm1.1Asg (B6.129S2(Cg)-Plin2^tm1.1Asg)	decreased circulating free fatty acids level	J:196302
	decreased circulating leptin level	J:196302
	decreased circulating triglyceride level	J:196302
	decreased liver triglyceride level	J:196302
	decreased susceptibility to diet-induced obesity	J:196302
Plin2^tm1Chan/Plin2^tm1Chan (B6.129-Plin2^tm1Chan)	decreased liver triglyceride level	J:105572
Plin3^tm1.1Jbki/Plin3^tm1.1Jbki (B6J.129S(Cg)-Plin3^tm1.1Jbki)	abnormal lipid homeostasis	J:261132
	decreased susceptibility to induced hypothermia	J:261132
	enhanced lipolysis	J:261132
	increased body temperature	J:261132
	increased energy expenditure	J:261132
	increased fatty acid oxidation	J:261132
	increased oxygen consumption	J:261132
Plin4^tm1Vlcg/Plin4^tm1Vlcg (B6.Cg-Plin4^tm1Vlcg)	decreased cardiac muscle triglyceride level	J:195987
Plin5^{tm1e(KOMP)Wtsi}/Plin5^{tm1e(KOMP)Wtsi} (involves: C57BL/6N)	abnormal ceramide level	J:221539
	abnormal sphingomyelin level	J:221539
	decreased cardiac muscle triglyceride level	J:221539
	decreased fatty acid oxidation	J:221539
	decreased skeletal muscle glycogen level	J:221539
	decreased skeletal muscle triglyceride level	J:221539
	enhanced lipolysis	J:221539
	improved glucose tolerance	J:221539
	increased fatty acid oxidation	J:221539
	increased insulin sensitivity	J:221539
	increased respiratory quotient	J:221539
	insulin resistance	J:221539
Plin5^tm1Macl/Plin5^tm1Macl (involves: 129S6/SvEvTac * C57BL/6JBomTac)	decreased cardiac muscle triglyceride level	J:286482
	decreased fatty acid oxidation	J:286482
Plin5^tm1Tosu/Plin5^tm1Tosu (involves: C57BL/6JJcl)	abnormal lipid level	J:188390
	decreased cardiac muscle triglyceride level	J:188390
	decreased fatty acids level	J:188390
	decreased liver free fatty acids level	J:188390
	decreased liver triglyceride level	J:188390
	decreased triglyceride level	J:188390
	increased circulating free fatty acids level	J:188390
	increased fatty acid oxidation	J:188390
	increased liver free fatty acids level	J:188390
	increased liver triglyceride level	J:188390
	increased oxygen consumption	J:188390
Plk4^m1Lja/Plk4⁺ (C57BL/6J-Plk4^m1Lja)	increased circulating follicle stimulating hormone level	J:177071
Pllp^{tm1(KOMP)Vlcg}/Pllp^{tm1(KOMP)Vlcg} (C57BL/6NCrl-Pllp^{tm1(KOMP)Vlcg}/MbpMmucd)	increased circulating cholesterol level	J:211773
	increased circulating serum albumin level	J:211773
Plp1^jp-rsh/Plp1^jp-rsh (C3H * C57BL/6 * STOCK Rb(1.3)1Bnr)	abnormal phospholipid level	J:31089
Plp1^tm1Kan/Y (involves: 129S1/Sv * 129X1/SvJ)	decreased cholesterol level	J:193310
Plpp1^{Gt(RRD231)Byg}/Plpp1^{Gt(RRD231)Byg} (involves: 129P2/OlaHsd * C57BL/6)	abnormal blood homeostasis	J:149782
Plpp3^{tm1b(EUCOMM)Hmgu}/Plpp3⁺ (C57BL/6N-Plpp3^{tm1b(EUCOMM)Hmgu}/Cnrm)	increased circulating creatinine level	J:211773
Plpp3^tm1Stw/Plpp3^tm1Stw (either: (involves: 129S1/Sv * 129X1/SvJ) or (involves: 129S1/Sv * 129X1/SvJ * C57BL/6J))	abnormal phospholipid level	J:84753
Plpp7^em1Eno/Plpp7^em1Eno (involves: C3H * C57BL/6 * C57BL/6N)	hypoglycemia	J:302139
Plppr5^{em1(IMPC)Ccpcz}/Plppr5^{em1(IMPC)Ccpcz} (C57BL/6NCrl-Plppr5^{em1(IMPC)Ccpcz}/Ccpcz)	increased circulating chloride level	J:211773
Pls3^{tm1a(EUCOMM)Wtsi}/Y (C57BL/6N-Pls3^{tm1a(EUCOMM)Wtsi}/Wtsi)	increased circulating phosphate level	J:211773
	increased circulating triglyceride level	J:211773
Pls3^{tm1a(EUCOMM)Wtsi}/Pls3^{tm1a(EUCOMM)Wtsi} (C57BL/6N-Pls3^{tm1a(EUCOMM)Wtsi}/Wtsi)	increased circulating alkaline phosphatase level	J:211773
Plscr1^tm1Lex/Plscr1^tm1Lex Plscr3^tm1Sims/Plscr3^tm1Sims (involves: 129S7/SvEvBrd * C57BL/6J)	abnormal lipid homeostasis	J:92404
	impaired glucose tolerance	J:92404
Plscr3^tm1Sims/Plscr3^tm1Sims (involves: 129S/SvEvBrd * C57BL/6J)	abnormal circulating cholesterol level	J:92404
	abnormal glucose homeostasis	J:92404
	abnormal lipid homeostasis	J:92404
	decreased circulating adiponectin level	J:92404
	hyperglycemia	J:92404
	impaired glucose tolerance	J:92404
	increased circulating free fatty acids level	J:92404
	increased circulating leptin level	J:92404
	increased circulating triglyceride level	J:92404
	insulin resistance	J:92404
Pltp^tm1Jia/Pltp^tm1Jia (involves: C57BL/6)	abnormal circulating cholesterol level	J:53521
	abnormal phospholipid level	J:53521
	abnormal vitamin E level	J:107906
	decreased circulating HDL cholesterol level	J:53521
	increased circulating LDL cholesterol level	J:53521
	increased circulating VLDL cholesterol level	J:53521
Pltp^tm2.1Jia/Pltp^tm2.1Jia (involves: C57BL/6J)	abnormal circulating non-HDL cholesterol level	J:239143
	decreased circulating cholesterol level	J:239143
	decreased circulating HDL cholesterol level	J:239143
	decreased circulating HDL phospholipid level	J:239143
	decreased circulating non-HDL phospholipid level	J:239143
	decreased circulating phospholipid level	J:239143
	decreased circulating triglyceride level	J:239143
Plvap^tm1.1Rvst/Plvap^tm1.1Rvst Tg(Cdh5-cre)1Spe/0 (involves: 129S1/SvImJ * 129S4/SvJae * C57BL/6 * C57BL/6J)	abnormal circulating lipid level	J:191046
	ascites	J:191046
	decreased circulating HDL cholesterol level	J:191046
	decreased circulating total protein level	J:191046
	increased circulating cholesterol level	J:191046
	increased circulating triglyceride level	J:191046
Plvap^tm1.1Rvst/Plvap^tm1.1Rvst Tg(Tek-cre)12Flv/0 (involves: 129S4/SvJae * C3H * C57BL/6)	abnormal circulating lipid level	J:191046
	ascites	J:191046
	decreased circulating HDL cholesterol level	J:191046
	decreased circulating total protein level	J:191046
	increased circulating cholesterol level	J:191046
	increased circulating triglyceride level	J:191046
Plvap^tm1.2Rvst/Plvap^tm1.2Rvst (involves: 129S4/SvJae * BALB/c * C57BL/6 * SJL)	abnormal circulating protein level	J:191046
	abnormal lipid level	J:191046
	ascites	J:191046
	decreased circulating calcium level	J:191046
	decreased circulating HDL cholesterol level	J:191046
	decreased circulating serum albumin level	J:191046
	decreased circulating total protein level	J:191046
	edema	J:191046
	hyperchylomicronemia	J:191046
	increased circulating cholesterol level	J:191046
	increased circulating triglyceride level	J:191046
	intestinal edema	J:191046
	xanthoma	J:191046
Plvap^{tm1e(EUCOMM)Hmgu}/Plvap^{tm1e(EUCOMM)Hmgu} (C57BL/6N-Plvap^{tm1e(EUCOMM)Hmgu})	edema	J:203907
	skin edema	J:203907
Plvap^{tm1e(EUCOMM)Hmgu}/Plvap^{tm1e(EUCOMM)Hmgu} Tg(TIE2GFP)287Sato/0 (involves: C57BL/6N * FVB/N)	edema	J:203907
Plxna4^em1(IMPC)Mbp/Plxna4^em1(IMPC)Mbp (C57BL/6NCrl-Plxna4^em1(IMPC)Mbp/MbpMmucd)	abnormal cholesterol homeostasis	J:211773
Plxnc1^em1(IMPC)Mbp/Plxnc1^em1(IMPC)Mbp (C57BL/6N-Plxnc1^em1(IMPC)Mbp/MbpMmucd)	increased circulating calcium level	J:211773
	increased circulating cholesterol level	J:211773
	increased circulating HDL cholesterol level	J:211773
	increased circulating total protein level	J:211773
Plxnd1^tm1.1Tmj/Plxnd1^tm1.1Tmj Tg(Tek-cre)1Ywa/0 (involves: 129S/SvEv * 129S4/SvJaeSor * C57BL/6 * SJL)	cyanosis	J:143763
Plxnd1^tm1Joe/Plxnd1^tm1Joe (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	cyanosis	J:91658
Pm20d1^em1(IMPC)H/Pm20d1^em1(IMPC)H (C57BL/6NTac-Pm20d1^em1(IMPC)H/H)	increased circulating phosphate level	J:211773
	increased circulating triglyceride level	J:211773
Pm20d1^em1Brsp/Pm20d1^em1Brsp (C57BL/6J-Pm20d1^em1Brsp)	abnormal adaptive thermogenesis	J:264104
	impaired glucose tolerance	J:264104
	insulin resistance	J:264104
Pmch^tm1Emf/Pmch^tm1Emf (involves: 129S4/SvJae * C57BL/6)	decreased circulating leptin level	J:51659
	decreased triglyceride level	J:51659
	increased oxygen consumption	J:51659
Pmel^{tm1b(EUCOMM)Wtsi}/Pmel^{tm1b(EUCOMM)Wtsi} (C57BL/6N-Pmel^{tm1b(EUCOMM)Wtsi}/Ieg)	increased circulating bilirubin level	J:211773
Pmm2^tm1.1Jins/Pmm2^tm2.1Jins (involves: 129S6/SvEvTac * C57BL/6J)	abnormal blood homeostasis	J:236704
	decreased circulating antithrombin level	J:236704
	decreased circulating insulin-like growth factor I level	J:236704
Pmm2^{tm1b(EUCOMM)Hmgu}/Pmm2⁺ (C57BL/6N-Pmm2^{tm1b(EUCOMM)Hmgu}/Tcp)	increased blood urea nitrogen level	J:211773
Pmp2^{tm1.1(KOMP)Vlcg}/Pmp2^{tm1.1(KOMP)Vlcg} (involves: C57BL/6 * C57BL/6NTac)	abnormal lipid homeostasis	J:211344
Pmp22^Mhdatre002/Pmp22^Mhdatre002 (C3HeB/FeJ-Pmp22^Mhdatre002)	increased circulating alkaline phosphatase level	J:183993
Pmpca^em1(IMPC)J/Pmpca⁺ (C57BL/6NJ-Pmpca^em1(IMPC)J/Mmjax)	increased circulating calcium level	J:211773
pnc/pnc (involves: PERU-COPPOCK)	ascites	J:13889
pnc/pnc (involves: PERU-COPPOCK)	increased circulating insulin level	J:13889
Pnhdlc1^C57BL/6J/Pnhdlc1^C57BL/6J (involves: C57BL/6J * CASA/RkJ)	abnormal circulating cholesterol level	J:94547
Pnhdlc2^C57BL/6J/Pnhdlc2^C57BL/6J (involves: C57BL/6J * CASA/RkJ)	abnormal circulating cholesterol level	J:94547
Pnhdlc3^C57BL/6J/Pnhdlc3^CASA/RkJ (involves: C57BL/6J * CASA/RkJ)	abnormal circulating cholesterol level	J:94547
Pnhdlc3^CASA/RkJ/Pnhdlc3^CASA/RkJ (involves: C57BL/6J * CASA/RkJ)	abnormal circulating cholesterol level	J:94547
Pnkd^tm1Ljp/Pnkd^tm1Ljp (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	abnormal dopamine level	J:192798
Pnlip^tm1Dyh/Pnlip^tm1Dyh (B6.129-Pnlip^tm1Dyh)	abnormal bile salt homeostasis	J:86414
	abnormal intestinal lipid absorption	J:86414
	decreased intestinal cholesterol absorption	J:86414
Pnlip^tm1Dyh/Pnlip^tm1Dyh (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	abnormal intestinal lipid absorption	J:124658
	decreased circulating cholesterol level	J:124658
	decreased circulating insulin level	J:124658
	decreased intestinal cholesterol absorption	J:124658
	decreased susceptibility to diet-induced obesity	J:124658
	insulin resistance	J:124658
Pnliprp1^tm1Smoc/Pnliprp1^tm1Smoc (involves: 129S/SvEv * C57BL/6)	impaired glucose tolerance	J:278344
	increased susceptibility to diet-induced obesity	J:278344
	insulin resistance	J:278344
Pnliprp2^tm1Gru/Pnliprp2^tm1Gru (involves: 129S2/SvPas * BALB/c)	abnormal intestinal lipid absorption	J:51627
Pnma3^{em1(IMPC)Rbrc}/Pnma3^{em1(IMPC)Rbrc} (C57BL/6NJcl-Pnma3^{em1(IMPC)Rbrc}/Rbrc)	abnormal blood uric acid level	J:211773
Pnmt^tm1(cre)Sne/Pnmt^tm1(cre)Sne (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	decreased adrenaline level	J:93831
	increased noradrenaline level	J:93831
Pnmt^tm1(cre)Xbao/Pnmt^tm1(cre)Xbao (involves: 129X1/SvJ * C57BL/6)	increased noradrenaline level	J:139932
Pnmt^{tm1.1(KOMP)Vlcg}/Pnmt^{tm1.1(KOMP)Vlcg} (C57BL/6N-Pnmt^{tm1.1(KOMP)Vlcg}/J)	improved glucose tolerance	J:211773
	increased circulating sodium level	J:211773
Pnn^tm1Sps/Pnn^tm1Sps (involves: 129S4/SvJae * C57BL/6)	edema	J:123288
Pnp^e/Pnp^e (involves: C3H/HeHa * C57BL/6J)	abnormal urine nucleotide level	J:23354
Pnp^f/Pnp^f (involves: C3H/HeHa * C57BL/6J)	abnormal urine nucleotide level	J:23354
Pnp^tm1Cmr/Pnp^tm1Cmr (involves: 129)	abnormal urine nucleoside level	J:62870
Pnpla1^tm1.1Fpwr/Pnpla1^tm1.1Fpwr (B6.129P2(Cg)-Pnpla1^tm1.1Fpwr)	abnormal ceramide level	J:240053
	impaired skin barrier function	J:240053
Pnpla1^tm1.1Murm/Pnpla1^tm1.1Murm Tg(KRT14-cre/ERT2)1Ipc/0 (involves: C57BL/6N)	abnormal ceramide level	J:240682
	impaired skin barrier function	J:240682
Pnpla1^{tm1a(KOMP)Wtsi}/Pnpla1^{tm1a(KOMP)Wtsi} (B6NTac;B6N-A^tm1Brd Pnpla1^{tm1a(KOMP)Wtsi}/Ics)	abnormal ceramide level	J:242353
	abnormal free fatty acids level	J:242353
	abnormal sphingomyelin level	J:242353
	decreased fatty acids level	J:242353
	impaired skin barrier function	J:242353
Pnpla1^tm1Murm/Pnpla1^tm1Murm (involves: C57BL/6N)	abnormal ceramide level	J:240682
	abnormal free fatty acids level	J:240682
	impaired skin barrier function	J:240682
	increased cholesterol level	J:240682
	increased triglyceride level	J:240682
Pnpla2^tm1.1Hsul/Pnpla2^tm1.1Hsul Tg(Fabp4-cre)1Rev/0 (involves: 129P2/OlaHsd * C57BL/6 * C57BL/6J * SJL)	abnormal oxygen consumption	J:176083
	decreased circulating glucose level	J:176083
	decreased circulating insulin level	J:176083
	decreased fatty acid oxidation	J:176083
	decreased oxygen consumption	J:176083
	impaired adaptive thermogenesis	J:176083
	impaired lipolysis	J:176083
	increased insulin sensitivity	J:176083
	increased susceptibility to diet-induced obesity	J:176083
Pnpla2^tm1Eek/Pnpla2^tm1Eek Tg(Ckmm-cre)5Khn/0 (involves: 129S * FVB/N)	increased cardiac muscle triglyceride level	J:176252
Pnpla2^tm1Eek/Pnpla2^tm1Eek Tg(Myog-cre)1Eno/0 (involves: 129S * C57BL/6)	abnormal lipid level	J:207007
	increased fatty acids level	J:207007
	increased skeletal muscle triglyceride level	J:207007
Pnpla2^tm1Gam/Pnpla2^tm1Gam Speer6-ps1^{Tg(Alb-cre)21Mgn}/Speer6-ps1⁺ (involves: 129S4/SvJae * C57BL/6 * C57BL/6J * DBA)	decreased fatty acid oxidation	J:185116
	increased circulating alanine transaminase level	J:185116
	increased circulating free fatty acids level	J:185116
	increased liver triglyceride level	J:185116
Pnpla2^tm1Rze/Pnpla2^tm1Rze (involves: 129P2/OlaHsd * C57BL/6)	abnormal circulating glucose level	J:108546
	abnormal circulating hormone level	J:108546
	abnormal circulating insulin level	J:108546
	abnormal gas homeostasis	J:108546
	abnormal glucose tolerance	J:108546
	abnormal homeostasis	J:108546
	abnormal lipid homeostasis	J:108546
	abnormal respiratory quotient	J:108546
	cardiac edema	J:108546
	decreased circulating free fatty acids level	J:108546
	decreased circulating glucose level	J:108546
	decreased circulating HDL cholesterol level	J:108546
	decreased circulating insulin level	J:108546
	decreased circulating triglyceride level	J:108546
	decreased circulating VLDL triglyceride level	J:108546
	decreased oxygen consumption	J:108546
	impaired adaptive thermogenesis	J:108546
	impaired lipolysis	J:108546
	improved glucose tolerance	J:108546
	increased cardiac muscle triglyceride level	J:108546
	increased circulating leptin level	J:108546
	increased insulin sensitivity	J:108546
	increased liver triglyceride level	J:108546
	increased triglyceride level	J:108546
Pnpla2^tm1Rze/Pnpla2^tm1Rze (involves: 129P2/OlaHsd)	abnormal lipid homeostasis	J:160725
	abnormal respiratory quotient	J:176252
	decreased circulating free fatty acids level	J:176252
	decreased circulating triglyceride level	J:176252
	decreased oxygen consumption	J:176252
	impaired lipolysis	J:160725
	increased cardiac muscle glycogen level	J:176252
	increased fatty acids level	J:176252
	increased liver triglyceride level	J:176252, J:160725
	increased respiratory quotient	J:176252
	increased triglyceride level	J:176252, J:160725
Pnpla2^tm1Rze/Pnpla2^tm1Rze Tg(Myh6-Pnpla2)94Biat/0 (involves: 129P2/OlaHsd * C57BL/6 * DBA/2)	decreased circulating free fatty acids level	J:176252
	decreased circulating triglyceride level	J:176252
Pnpla3^tm1.1Hobb/Pnpla3^tm1.1Hobb (involves: 129 * C57BL/6J)	increased fatty acids level	J:264475
	increased liver triglyceride level	J:264475
Pnpla3^tm2.1Hobb/Pnpla3⁺ (involves: 129 * C57BL/6J)	increased liver triglyceride level	J:264475
Pnpla3^tm2.1Hobb/Pnpla3^tm2.1Hobb (involves: 129 * C57BL/6J)	increased liver triglyceride level	J:264475
Pnpla6^tm1Mvc/Pnpla6^tm1Mvc Tg(Nes-cre)1Kln/0 (involves: C57BL/6 * SJL)	abnormal phospholipid level	J:152759
Pnpla7^tm1.1Murm/Pnpla7^tm1.1Murm (B6.Cg-Pnpla7^tm1.1Murm)	decreased choline level	J:333442
Pnpla7^tm1.2Murm/Pnpla7^tm1.2Murm (B6.Cg-Pnpla7^tm1.2Murm)	abnormal circulating triglyceride level	J:333442
	decreased body temperature	J:333442
	decreased choline level	J:333442
	decreased circulating adiponectin level	J:333442
	decreased circulating glucose level	J:333442
	decreased circulating insulin level	J:333442
	decreased circulating insulin-like growth factor I level	J:333442
	decreased circulating leptin level	J:333442
	decreased circulating thyroxine level	J:333442
	decreased liver triglyceride level	J:333442
	decreased respiratory quotient	J:333442
	increased circulating ketone body level	J:333442
	increased liver glycogen level	J:333442
	increased oxygen consumption	J:333442
Pnpla8^tm1Rigr/Pnpla8^tm1Rigr (involves: 129X1/SvJ * C57BL/6J)	decreased body temperature	J:128989
	impaired adaptive thermogenesis	J:128989
Pnpla8^tm1Rigr/Pnpla8^tm1Rigr (involves: 129X1/SvJ)	decreased choline level	J:333442
	decreased circulating glucose level	J:333442
	decreased circulating triglyceride level	J:333442
	decreased liver triglyceride level	J:333442
Pnrc2^tm1Shch/Pnrc2^tm1Shch (involves: 129S1/Sv * C57BL/6)	decreased circulating leptin level	J:130294
	decreased susceptibility to diet-induced obesity	J:130294
	decreased susceptibility to induced hypothermia	J:130294
	increased energy expenditure	J:130294
	increased oxygen consumption	J:130294
Poc1a^{tm1.1(KOMP)Mbp}/Poc1a⁺ (C57BL/6N-Poc1a^{tm1.1(KOMP)Mbp}/J)	decreased fasting circulating glucose level	J:211773
	increased urine microalbumin level	J:211773
Podxl^tm1Kmn/Podxl^tm1Kmn (either: (involves: 129P2/OlaHsd * BALB/c) or (involves: 129P2/OlsHsd * C57BL/6))	hydrops fetalis	J:70294
Pof1b^em1(IMPC)Mbp/Pof1b^em1(IMPC)Mbp (C57BL/6N-Pof1b^em1(IMPC)Mbp/MbpMmucd)	increased circulating calcium level	J:211773
pogo/pogo (KJR/MsKist-pogo)	decreased glutamic acid level	J:108023
Polb^{tm1a(KOMP)Wtsi}/Polb^{tm1a(KOMP)Wtsi} (C57BL/6N-Polb^{tm1a(KOMP)Wtsi}/Wtsi)	subcutaneous edema	J:239583
Polb^tm1Koy/Polb^tm1Koy (involves: 129P2/OlaHsd * C57BL/6)	cyanosis	J:61143
Pold3^{tm1b(EUCOMM)Wtsi}/Pold3⁺ (C57BL/6N-Pold3^{tm1b(EUCOMM)Wtsi}/Wtsi)	increased circulating insulin level	J:211773
Pold4^em1(IMPC)J/Pold4^em1(IMPC)J (C57BL/6NJ-Pold4^em1(IMPC)J/Mmjax)	decreased circulating calcium level	J:211773
	decreased circulating glucose level	J:211773
Pole2^em1(IMPC)Mbp/Pole2⁺ (C57BL/6NCrl-Pole2^em1(IMPC)Mbp/Mmucd)	impaired glucose tolerance	J:211773
Polg^tm1Jiha/Polg^tm1Jiha (involves: C57BL/6JJcl)	decreased circulating glucose level	J:199416
Polg^tm1Jiha/Polg^tm1Jiha (involves: C57BL/6JJcl)	increased circulating lactate level	J:199416
Polr1d^em1(IMPC)J/Polr1d⁺ (C57BL/6NJ-Polr1d^em1(IMPC)J/Mmjax)	increased circulating aspartate transaminase level	J:211773
Polr2h^{tm1.1(KOMP)Wtsi}/Polr2h⁺ (B6N(Cg)-Polr2h^{tm1.1(KOMP)Wtsi}/J)	decreased circulating iron level	J:211773
	decreased circulating sodium level	J:211773
	increased circulating free fatty acids level	J:211773
Polr2m^tm1.1Rgr/Polr2m^tm1.1Rgr Speer6-ps1^{Tg(Alb-cre)21Mgn}/Speer6-ps1⁺ (involves: C57BL/6 * DBA)	decreased circulating triglyceride level	J:291184
	increased circulating alkaline phosphatase level	J:291184
Polr3d^em1(IMPC)Tcp/Polr3d⁺ (C57BL/6N-Polr3d^em1(IMPC)Tcp/Tcp)	abnormal cholesterol homeostasis	J:211773
	decreased circulating alkaline phosphatase level	J:211773
Pomc^{em1(IMPC)Rbrc}/Pomc⁺ (C57BL/6NJcl-Pomc^{em1(IMPC)Rbrc}/Rbrc)	impaired glucose tolerance	J:211773
Pomc^tm1.1Kgm/Pomc^tm1.1Kgm (involves: C57BL/6J)	decreased oxygen consumption	J:263640
Pomc^tm1Low/Pomc^tm1Low (B6.129S2-Pomc^tm1Low)	impaired glucose tolerance	J:115712
	increased circulating insulin level	J:115712
	increased circulating leptin level	J:115712
	increased urine adrenaline level	J:113139
Pomc^tm1Low/Pomc^tm1Low (involves: 129S2/SvPas * C57BL/6)	decreased circulating adrenocorticotropin level	J:102955
	decreased circulating corticosterone level	J:102955
	increased circulating interleukin-6 level	J:102955
Pomc^tm1Low/Pomc^tm1Low (B6.129S2-Pomc^tm1Low/J)	increased circulating corticosterone level	J:84463
Pomc^tm1Low/Pomc^tm1Low (involves: 129S2/SvPas * 129X1/SvJ * C57BL/6 * DBA/2)	decreased adrenocorticotropin level	J:119240
	decreased circulating adrenocorticotropin level	J:119240
	decreased circulating corticosterone level	J:119240
Pomc^tm1Low/Pomc^tm1Low Tg(Pomc)#Low/0 (involves: 129 * C57BL/6 * CBA * DBA/2 * Swiss Webster)	abnormal corticosterone level	J:119240
	decreased adrenocorticotropin level	J:119240
	decreased circulating adrenocorticotropin level	J:119240
	increased circulating adrenocorticotropin level	J:119240
	increased circulating corticosterone level	J:119240
Pomc^tm1Low/Pomc^tm1Low Tg(Pomc)#Low/Tg(Pomc)#Low (involves: 129 * C57BL/6 * CBA * DBA/2 * Swiss Webster)	increased circulating corticosterone level	J:119240
Pomc^tm1Sora/Pomc⁺ (involves: 129S2/SvHsd * 129S6/SvEvTac)	decreased circulating corticosterone level	J:89244
Pomc^tm1Sora/Pomc⁺ (involves: 129S2/SvHsd * 129S6/SvEvTac)	increased susceptibility to diet-induced obesity	J:89244
Pomc^tm1Sora/Pomc^tm1Sora (involves: 129S2/SvHsd * 129S6/SvEvTac)	decreased circulating corticosterone level	J:89244
	decreased circulating thyroxine level	J:89244
	decreased oxygen consumption	J:89244
	increased susceptibility to diet-induced obesity	J:89244
Pomc^tm2Low/Pomc^tm2Low (B6.129S4-Pomc^tm2Low)	decreased oxygen consumption	J:194013
	increased circulating glucose level	J:194013
	increased circulating insulin level	J:194013
	increased circulating leptin level	J:194013
	insulin resistance	J:194013
Pomc^tm2Low/Pomc^tm2Low Tg(CAG-cre/Esr1)5Amc/0 (involves: 129S4/SvJae C57BL/6 * CBA)	decreased oxygen consumption	J:194013
	increased circulating glucose level	J:194013
	increased circulating insulin level	J:194013
	increased circulating leptin level	J:194013
	insulin resistance	J:194013
Pomc^tm2Ute/Pomc⁺ (involves: 129S1/Sv * 129X1/SvJ)	increased circulating leptin level	J:57503
Pomc^tm2Ute/Pomc^tm2Ute (involves: 129S1/Sv * 129X1/SvJ)	decreased circulating adrenaline level	J:57503
	decreased circulating adrenocorticotropin level	J:57503
	decreased circulating aldosterone level	J:57503
	decreased circulating corticosterone level	J:57503
	increased circulating leptin level	J:57503
	increased dopamine level	J:57503
	increased susceptibility to diet-induced obesity	J:57503
Pomgnt1^tm1Lex/Pomgnt1^tm1Lex (B6;129S5-Pomgnt1^tm1Lex/Mmucd)	decreased circulating glucose level	J:171883
Pon1^tm1Lus/Pon1^tm1Lus (involves: 129X1/SvJ * C57BL/6J)	increased circulating LDL cholesterol level	J:63392
Pon1^tm1Lus/Pon1^tm1Lus (involves: 129X1/SvJ * C57BL/6J)	increased circulating VLDL cholesterol level	J:63392
Pon2^Gt(XE661)Byg/Pon2^Gt(XE661)Byg (B6.129P2-Pon2^Gt(XE661)Byg)	abnormal cholesterol homeostasis	J:116935
	abnormal circulating protein level	J:116935
	decreased circulating cholesterol level	J:116935
	decreased circulating LDL cholesterol level	J:116935
	decreased circulating VLDL cholesterol level	J:116935
Pon2^{tm1b(EUCOMM)Hmgu}/Pon2^{tm1b(EUCOMM)Hmgu} (C57BL/6N-Pon2^{tm1b(EUCOMM)Hmgu}/H)	decreased circulating serum albumin level	J:211773
Pon3^{tm1b(KOMP)Wtsi}/Pon3^{tm1b(KOMP)Wtsi} (C57BL/6N-Pon3^{tm1b(KOMP)Wtsi}/Kmpc)	increased circulating triglyceride level	J:211773
Pon3^tm1Dmsh/Pon3^tm1Dmsh (B6J.129X1-Pon3^tm1Dmsh)	abnormal bile salt homeostasis	J:234615
	abnormal lipid level	J:234615
	abnormal protein level	J:234615
	decreased bile salt level	J:234615
	decreased circulating free fatty acids level	J:234615
	decreased circulating HDL cholesterol level	J:234615
	decreased circulating triglyceride level	J:234615
	decreased fatty acid oxidation	J:234615
	decreased liver triglyceride level	J:234615
	decreased oxygen consumption	J:234615
	increased bile salt level	J:234615
	increased circulating alanine transaminase level	J:234615
	increased circulating aspartate transaminase level	J:234615
	increased circulating bilirubin level	J:234615
	increased circulating cholesterol level	J:234615
	increased circulating LDL cholesterol level	J:234615
	increased circulating triglyceride level	J:234615
	increased liver cholesterol level	J:234615
	increased susceptibility to diet-induced obesity	J:234615
Pon3^tm1Lus/Pon3^tm1Lus (involves: 129X1/SvJ)	decreased glutathione level	J:204799
Por^tm1Cbk/Por^tm1Cbk (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	pericardial edema	J:74666
Por^tm1Ding/Por^tm1Ding Speer6-ps1^{Tg(Alb-cre)21Mgn}/Speer6-ps1⁺ (involves: 129S1/Sv * C57BL/6 * DBA)	decreased circulating cholesterol level	J:84422
Por^tm1Wolf/Por^tm1Wolf Speer6-ps1^{Tg(Alb-cre)21Mgn}/Speer6-ps1⁺ (involves: 129P2/OlaHsd * C57BL/6 * DBA/2)	abnormal bile salt level	J:82951
	decreased circulating cholesterol level	J:82951
	decreased circulating triglyceride level	J:82951
	increased circulating alanine transaminase level	J:82951
Por^tm2Ding/Por^tm2Ding (involves: 129S1/Sv * C57BL/6)	abnormal enzyme/coenzyme level	J:119630
	decreased circulating cholesterol level	J:119630
	decreased circulating progesterone level	J:119630
	increased circulating testosterone level	J:119630
Por^tm2Wolf/Por^tm1Wolf Speer6-ps1^{Tg(Alb-cre)21Mgn}/Speer6-ps1⁺ (involves: 129P2/OlaHsd * C57BL/6 * DBA/2)	abnormal bile salt level	J:82951
	decreased circulating cholesterol level	J:82951
	decreased circulating triglyceride level	J:82951
	increased circulating alanine transaminase level	J:82951
Por^tm3Ding/Por^tm3Ding (C57BL/6-Por^tm3Ding)	decreased circulating cholesterol level	J:159168
Por^tm3Ding/Por^tm3Ding Speer6-ps1^{Tg(Alb-cre)21Mgn}/Speer6-ps1⁺ (involves: C57BL/6 * DBA)	increased circulating progesterone level	J:159168
	increased circulating testosterone level	J:159168
Postn^{tm1.1(KOMP)Vlcg}/Postn^{tm1.1(KOMP)Vlcg} (C57BL/6N-Postn^{tm1.1(KOMP)Vlcg}/J)	increased circulating alkaline phosphatase level	J:211773
Pou1f1^dw/Pou1f1^dw (Not Specified)	decreased circulating prolactin level	J:6754
	decreased growth hormone level	J:6589
	decreased prolactin level	J:6589
Pou2af3^{tm1b(NCOM)Mfgc}/Pou2af3^{tm1b(NCOM)Mfgc} (C57BL/6N-Pou2af3^{tm1b(NCOM)Mfgc}/Tcp)	decreased fasting circulating glucose level	J:211773
	increased blood urea nitrogen level	J:211773
	increased circulating phosphate level	J:211773
Pou2f2^tm1Bal/Pou2f2^tm1Bal (involves: 129S2/SvPas)	cyanosis	J:4555
Pou2f2^tm1Bal/Pou2f2^tm1Bal (involves: 129S2/SvPas)	dehydration	J:4555
Pou3f1^tm1Rsd/Pou3f1^tm1Rsd (either: (involves: 129S4/SvJae * 129/Sv * C57BL/6J) or (involves: 129S4/SvJae * C57BL/6 * C57BL/6J))	cyanosis	J:34460
Pou3f3^tm1Tno/Pou3f3^tm1Tno (involves: 129S4/SvJae * C57BL/6J)	increased blood urea nitrogen level	J:84756
	increased circulating potassium level	J:84756
Pou3f3^urehr2/Pou3f3^urehr2 (C3HeB/FeJ-Pou3f3^urehr2)	decreased circulating glucose level	J:121470
	decreased urine sodium level	J:121470
	increased blood urea nitrogen level	J:121470
	increased circulating creatinine level	J:121470
Pou3f4^sdl/Y (C3HeB/FeJ-Pou3f4^sdl)	increased circulating potassium level	J:220419
Pou3f4^sdl/Pou3f4^sdl (C3HeB/FeJ-Pou3f4^sdl)	increased circulating potassium level	J:220419
Pou4f3^tm1Rsd/Pou4f3^tm1Rsd (involves: 129S4/SvJae * C57BL/6)	abnormal body temperature homeostasis	J:81013
	abnormal circadian temperature homeostasis	J:81013
Pou4f3^tm1Xia/Pou4f3^tm1Xia (involves: 129S7/SvEvBrd * C57BL/6J)	abnormal energy expenditure	J:42478
Ppara^tm1Gonz/Ppara^tm1Gonz (involves: 129S4/SvJae * C57BL/6N)	decreased liver glycogen level	J:50024
	hypoglycemia	J:50024
Ppara^tm1Gonz/Ppara^tm1Gonz (129S4/SvJae-Ppara^tm1Gonz)	abnormal circulating glucose level	J:72932
	abnormal circulating HDL cholesterol level	J:72185
	abnormal circulating insulin level	J:72932
	abnormal circulating ketone body level	J:56056
	abnormal glucose homeostasis	J:56056
	increased circulating cholesterol level	J:72185
	increased circulating free fatty acids level	J:56056
	insulin resistance	J:72932
Ppara^tm1Gonz/Ppara^tm1Gonz (B6.129S4-Ppara^tm1Gonz)	abnormal circulating glucose level	J:72932
	abnormal circulating insulin level	J:72932
	increased circulating triglyceride level	J:72185
Ppara^tm1Gonz/Ppara^tm1Gonz (involves: 129S4/SvJae)	decreased circulating glucose level	J:127793
	decreased fatty acid oxidation	J:176083
	impaired adaptive thermogenesis	J:176083
	increased circulating cholesterol level	J:127793
	increased circulating free fatty acids level	J:127793
	increased circulating insulin level	J:127793
Ppara^tm1Gonz/Ppara^tm1Gonz (involves: 129S4/SvJae * C57BL/6J)	abnormal glucose homeostasis	J:129848
	improved glucose tolerance	J:129848
	increased insulin sensitivity	J:129848
	increased skeletal muscle triglyceride level	J:129848
	increased susceptibility to diet-induced obesity	J:129848
Ppara^tm1Gonz/Ppara^tm1Gonz Tg(Ckm-Ppard)LEDpk/0 (involves: 129S4/SvJae * C57BL/6 * C57BL/6J * CBA)	abnormal glucose tolerance	J:129848
Ppard^{tm1(PPARD)Bsls}/Ppard^{tm1(PPARD)Bsls} (B6.Cg-Ppard^{tm1(PPARD)Bsls})	decreased circulating cholesterol level	J:211453
	decreased circulating HDL cholesterol level	J:211453
	hypoglycemia	J:211453
Ppard^tm1Dsvg/Ppard^tm1Dsvg (involves: 129S2/SvPas * C57BL/6)	abnormal circulating protein level	J:219677
	impaired glucose tolerance	J:219677
Ppard^tm1Jps/Ppard^tm1Jps (involves: 129/Sv * C57BL/6N)	abnormal energy expenditure	J:63040
	abnormal lipid level	J:76564
	decreased liver cholesterol level	J:89827
	decreased liver triglyceride level	J:89827
	increased circulating triglyceride level	J:89827
	increased circulating VLDL cholesterol level	J:89827
	increased fatty acids level	J:89827
Ppard^tm1Mtz/Ppard^tm1Mtz Tg(KRT14-cre)1Ipc/0 (involves: C57BL/6 * SJL)	decreased cholesterol level	J:109090
Pparg^tm1.1Auw/Pparg^tm1.1Auw (B6.Cg-Pparg^tm1.1Auw)	abnormal circadian temperature homeostasis	J:144344
	decreased circulating cholesterol level	J:144344
	decreased circulating triglyceride level	J:144344
	improved glucose tolerance	J:144344
	increased insulin sensitivity	J:144344
Pparg^tm1.1Gonz/Pparg^tm1.1Gonz Lyz2^tm1(cre)Ifo/Lyz2⁺ (involves: 129P2/OlaHsd * 129X1/SvJ * C57BL/6)	albuminuria	J:168799
	increased circulating creatine level	J:168799
	increased urine protein level	J:168799
Pparg^tm1.1Gonz/Pparg^tm1.1Gonz Tg(Aqp2-cre)1Dek/0 (involves: 129X1/SvJ * C57BL/6 * SJL)	abnormal circulating aldosterone level	J:99873
	abnormal urine sodium level	J:99873
Pparg^tm1.1Unc/Pparg^tm1.1Unc (involves: 129S6/SvEvTac * C57BL/6J)	impaired glucose tolerance	J:154767
Pparg^tm1Auw/Pparg^tm1Auw (either: 129 or C57BL/6J or (involves: 129 * C57BL/6J))	abnormal circulating alanine transaminase level	J:86705
	abnormal glucose homeostasis	J:86705
	decreased body temperature	J:86705
	hyperlipidemia	J:86705
	impaired glucose tolerance	J:86705
	increased circulating aspartate transaminase level	J:86705
	increased circulating free fatty acids level	J:86705
	increased circulating triglyceride level	J:86705
	increased liver triglyceride level	J:86705
	insulin resistance	J:86705
Pparg^tm1Avp/Pparg⁺ (involves: 129S2/SvPas * C57BL/6)	abnormal lipid homeostasis	J:116568
	abnormal triglyceride level	J:116568
	decreased circulating adiponectin level	J:116568
	increased circulating triglyceride level	J:116568
Pparg^{tm1b(KOMP)Wtsi}/Pparg⁺ (C57BL/6N-Pparg^{tm1b(KOMP)Wtsi}/H)	increased fasting circulating glucose level	J:211773
Pparg^tm1Laz/Pparg^tm1Laz (involves: 129S6/SvEvTac * C57BL/6)	abnormal glucose homeostasis	J:135904
	decreased circulating free fatty acids level	J:135904
	decreased circulating leptin level	J:135904
	decreased circulating triglyceride level	J:135904
	improved glucose tolerance	J:135904
	increased circulating adiponectin level	J:135904
	increased insulin sensitivity	J:135904
Pparg^tm1Lja/Pparg⁺ (involves: 129S1/Sv * 129X1/SvJ)	decreased circulating adiponectin level	J:98786
	increased circulating free fatty acids level	J:98786
	increased circulating insulin level	J:98786
	increased liver triglyceride level	J:98786
	insulin resistance	J:98786
Pparg^tm1Mae/Pparg⁺ (involves: 129S6/SvEvTac * C57BL/6)	improved glucose tolerance	J:91362
Pparg^tm1Rev/Pparg⁺ (involves: 129S4/SvJae * C57BL/6J)	abnormal glucose homeostasis	J:60354
Pparg^tm1Rev/Pparg⁺ (involves: 129S4/SvJae * C57BL/6J)	increased insulin sensitivity	J:60354
Pparg^tm1Tka/Pparg⁺ (involves: C57BL/6 * CBA)	decreased circulating insulin level	J:58222
	decreased susceptibility to diet-induced obesity	J:58222
	increased body temperature	J:58222
	increased circulating leptin level	J:58222
	increased insulin sensitivity	J:58222
Pparg^tm1Yec/Pparg^tm1Yec (involves: 129S4/SvJae * C57BL/6)	decreased circulating adiponectin level	J:91479
	decreased circulating leptin level	J:91479
	insulin resistance	J:91479
Pparg^tm2(tTA)Yba/Pparg⁺ (involves: 129S1/SvImJ * C57BL/6)	hyperglycemia	J:125992
	impaired glucose tolerance	J:125992
	increased circulating cholesterol level	J:125992
	increased circulating free fatty acids level	J:125992
	increased circulating insulin level	J:125992
	increased circulating triglyceride level	J:125992
	insulin resistance	J:125992
Pparg^tm2Avp/Pparg^tm2Avp (Not Specified)	abnormal glucose homeostasis	J:121693
	decreased circulating adiponectin level	J:121693
	impaired glucose tolerance	J:121693
	increased circulating glucose level	J:121693
	increased circulating leptin level	J:121693
Pparg^tm2Avp/Pparg^tm2Avp (involves: 129/Sv * C57BL/6)	decreased circulating adiponectin level	J:121534
Pparg^tm2Rev/Pparg^tm2Rev Tg(Fabp4-cre)1Rev/0 (involves: 129S4/SvJae * C57BL/6)	increased circulating insulin level	J:88210
	insulin resistance	J:88210
Pparg^tm2Rev/Pparg^tm2Rev Tg(Lhb-cre)1Sac/? (involves: 129S4/SvJae * C57BL/6 * SJL)	decreased circulating follicle stimulating hormone level	J:170272
	increased luteinizing hormone level	J:170272
Pparg^tm2Rev/Pparg^tm2Rev Tg(Tek-cre)1Ywa/? (involves: 129S4/SvJae * C57BL/6 * SJL)	increased triglyceride level	J:155909
Pparg^tm3(tTA)Yba/Pparg⁺ (involves: 129S1/SvImJ * C57BL/6)	increased circulating insulin level	J:125992
Pparg^tm3(tTA)Yba/Pparg⁺ (involves: 129S1/SvImJ * C57BL/6)	increased circulating triglyceride level	J:125992
Ppargc1a^tm1Aztc/Ppargc1a⁺ (C57BL/6-Ppargc1a^tm1Aztc)	decreased circulating cholesterol level	J:82809
	decreased respiratory quotient	J:82809
	increased circulating alkaline phosphatase level	J:82809
Ppargc1a^tm1Aztc/Ppargc1a^tm1Aztc (C57BL/6-Ppargc1a^tm1Aztc)	decreased circulating glucose level	J:82809
	decreased circulating insulin level	J:82809
Ppargc1a^tm1Brsp/Ppargc1a^tm1Brsp (involves: 129/Sv * C57BL/6 * FVB/N)	abnormal gluconeogenesis	J:93896
	abnormal glucose homeostasis	J:93896
	abnormal lipid homeostasis	J:93896
	decreased circulating insulin level	J:93896
	decreased liver triglyceride level	J:93896
	decreased susceptibility to diet-induced obesity	J:93896
	hypoglycemia	J:93896
	impaired adaptive thermogenesis	J:93896
	improved glucose tolerance	J:93896
	increased insulin sensitivity	J:93896
	increased oxygen consumption	J:93896
Ppargc1a^tm1Brsp/Ppargc1a^tm2Brsp Tg(Myog-cre)1Eno/0 (involves: 129 * C57BL/6 * FVB/N)	abnormal glucose homeostasis	J:127403
	decreased circulating insulin level	J:127403
	decreased respiratory quotient	J:127403
	decreased susceptibility to diet-induced obesity	J:127403
	hyperglycemia	J:127403
	impaired glucose tolerance	J:127403
	increased circulating glucose level	J:127403
	increased circulating interleukin-6 level	J:127403
	increased oxygen consumption	J:127403
Ppargc1a^tm1Dpk/Ppargc1a^tm1Dpk (involves: 129X1/SvJ * C57BL/6)	decreased oxygen consumption	J:96306
	impaired adaptive thermogenesis	J:96306
	improved glucose tolerance	J:96306
	increased insulin sensitivity	J:96306
Ppargc1a^tm1Dpk/Ppargc1a^tm1Dpk (involves: 129X1/SvJ)	decreased triglyceride level	J:137598
Ppargc1a^tm1Dpk/Ppargc1a^tm1Dpk (B6.129X1-Ppargc1a^tm1Dpk/J)	decreased nervous system dopamine level	J:298664
Ppargc1a^tm1Dpk/Ppargc1a^tm1Dpk Ppargc1b^tm1.1Dpk/Ppargc1b⁺ (involves: 129X1/SvJ * FVB/N)	impaired adaptive thermogenesis	J:137598
Ppargc1a^tm1Dpk/Ppargc1a^tm1Dpk Ppargc1b^tm1.1Dpk/Ppargc1b^tm1.1Dpk (involves: 129X1/SvJ * FVB/N)	decreased circulating glucose level	J:137598
	decreased triglyceride level	J:137598
Ppargc1a^tm2.1Brsp/Ppargc1a^tm2.1Brsp (involves: 129)	decreased dopamine level	J:234906
Ppargc1a^tm2.1Brsp/Ppargc1a^tm2.1Brsp Tg(Myog-cre)1Eno/0 (involves: 129 * BALB/c * C57BL/6J * C57BL/6N)	decreased circulating glucose level	J:208380
	decreased circulating insulin level	J:208380
	decreased respiratory quotient	J:208380
	impaired glucose tolerance	J:208380
	insulin resistance	J:208380
Ppargc1a^tm2Brsp/Ppargc1a⁺ Tg(Myog-cre)1Eno/0 (involves: 129 * C57BL/6)	impaired glucose tolerance	J:127403
	increased circulating glucose level	J:127403
	increased circulating interleukin-6 level	J:127403
Ppargc1a^tm2Brsp/Ppargc1a^tm2Brsp Speer6-ps1^{Tg(Alb-cre)21Mgn}/Speer6-ps1⁺ (involves: 129 * C57BL/6 * DBA)	abnormal blood homeostasis	J:115197
Ppargc1b^tm1.1Avp/Ppargc1b^tm1.1Avp (involves: 129S1/Sv * 129S4/SvJaeSor * 129X1/SvJ * C57BL/6)	decreased circulating cholesterol level	J:116167
	decreased circulating triglyceride level	J:116167
	decreased oxygen consumption	J:116167
Ppargc1b^tm1.1Dpk/Ppargc1b^tm1.1Dpk (involves: 129X1/SvJ * FVB/N)	decreased triglyceride level	J:137598
	impaired adaptive thermogenesis	J:137598
Ppargc1b^tm1.1Rev/Ppargc1b^tm1.1Rev (involves: 129 * C57BL/6J)	decreased circulating free fatty acids level	J:120079
	decreased circulating triglyceride level	J:120079
	impaired adaptive thermogenesis	J:120079
	increased circulating free fatty acids level	J:120079
	increased circulating triglyceride level	J:120079
	increased liver triglyceride level	J:120079
Ppargc1b^tm1Lowl/Ppargc1b^tm1Lowl (involves: C57BL/6)	increased liver triglyceride level	J:129775
Ppargc1b^tm1Lowl/Ppargc1b^tm1Lowl (involves: C57BL/6)	insulin resistance	J:129775
Ppbp^{tm1.1(KOMP)Vlcg}/Ppbp^{tm1.1(KOMP)Vlcg} (C57BL/6N-Ppbp^{tm1.1(KOMP)Vlcg}/Ucd)	increased circulating total protein level	J:211773
Ppdpf^tm1Nju/Ppdpf^tm1Nju Speer6-ps1^{Tg(Alb-cre)21Mgn}/Speer6-ps1⁺ (involves: C57BL/6 * DBA)	impaired glucose tolerance	J:307283
	increased circulating free fatty acids level	J:307283
	increased circulating triglyceride level	J:307283
	increased liver triglyceride level	J:307283
	insulin resistance	J:307283
Ppia^em1(IMPC)Mbp/Ppia^em1(IMPC)Mbp (C57BL/6NCrl-Ppia^em1(IMPC)Mbp/MbpMmucd)	increased blood urea nitrogen level	J:211773
	increased circulating alkaline phosphatase level	J:211773
Ppia^tm1Lubn/Ppia^tm1Lubn (129S6.129P2-Ppia^tm1Lubn)	increased circulating interleukin-4 level	J:93591
Ppib^tm1.1Rjb/Ppib^tm1.1Rjb (Not Specified)	decreased collagen level	J:161748
Ppie^em1(IMPC)Tcp/Ppie⁺ (C57BL/6N-Ppie^em1(IMPC)Tcp/Tcp)	decreased circulating total protein level	J:211773
Ppie^em1(IMPC)Tcp/Ppie⁺ (C57BL/6N-Ppie^em1(IMPC)Tcp/Tcp)	increased circulating chloride level	J:211773
Ppil1^em1(IMPC)Mbp/Ppil1⁺ (C57BL/6N-Ppil1^em1(IMPC)Mbp/MbpMmucd)	increased circulating creatinine level	J:211773
Ppil3^{tm1b(EUCOMM)Wtsi}/Ppil3^{tm1b(EUCOMM)Wtsi} (C57BL/6N-Ppil3^{tm1b(EUCOMM)Wtsi}/Wtsi)	increased circulating cholesterol level	J:211773
	increased circulating free fatty acids level	J:211773
	increased circulating HDL cholesterol level	J:211773
Ppm1a^{tm1b(EUCOMM)Hmgu}/Ppm1a^{tm1b(EUCOMM)Hmgu} (C57BL/6N-Ppm1a^{tm1b(EUCOMM)Hmgu}/H)	decreased fasting circulating glucose level	J:211773
Ppm1d^tm1Lad/Ppm1d^tm1Lad (involves: 129S7/SvEvBrd)	impaired glucose tolerance	J:151980
Ppm1k^tm1Yiwa/Ppm1k^tm1Yiwa (involves: 129/Sv * C57BL/6)	abnormal circulating amino acid level	J:150451
Ppm1l^tm1Dgen/Ppm1l^tm1Dgen (involves: 129P2/OlaHsd * C57BL/6J)	decreased circulating free fatty acids level	J:134171
	improved glucose tolerance	J:134171
	increased circulating glucose level	J:134171
Ppme1^{em1(IMPC)Rbrc}/Ppme1⁺ (C57BL/6NJcl-Ppme1^{em1(IMPC)Rbrc}/Rbrc)	increased circulating triglyceride level	J:211773
Ppox^em1(IMPC)J/Ppox⁺ (C57BL/6NJ-Ppox^em1(IMPC)J/Mmjax)	increased circulating alanine transaminase level	J:211773
Ppox^em1(IMPC)J/Ppox⁺ (C57BL/6NJ-Ppox^em1(IMPC)J/Mmjax)	increased circulating phosphate level	J:211773
Ppox^tm1.1Had/Ppox⁺ (involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)	abnormal urine homeostasis	J:226160
Ppox^tm1Had/Ppox⁺ (involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)	abnormal urine homeostasis	J:226160
Ppp1r3a^tm1Adpr/Ppp1r3a^tm1Adpr (either: (involves: 129/Sv) or (involves: 129/Sv * C57BL/6J))	decreased skeletal muscle glycogen level	J:68370
Ppp1r3a^tm1Ptwc/Ppp1r3a^tm1Ptwc (involves: 129P2/OlaHsd * C57BL/6J)	decreased skeletal muscle glycogen level	J:82422
	impaired glucose tolerance	J:82422
	insulin resistance	J:82422
Ppp1r3a^tm2Adpr/Ppp1r3a⁺ (involves: 129S6/SvEvTac * C57BL/6J)	abnormal glycogen homeostasis	J:134157
	decreased skeletal muscle glycogen level	J:134157
Ppp1r3a^tm2Adpr/Ppp1r3a^tm2Adpr (involves: 129S6/SvEvTac * C57BL/6J)	abnormal glycogen homeostasis	J:134157
	decreased skeletal muscle glycogen level	J:134157
Ppp1r3b^tm1.1Arte/Ppp1r3b⁺ (involves: C57BL/6J * C57BL/6N)	decreased circulating triglyceride level	J:157291
Ppp1r3b^tm1.1Arte/Ppp1r3b⁺ (involves: C57BL/6J * C57BL/6N)	improved glucose tolerance	J:157291
Ppp1r3b^tm1.1Arte/Ppp1r3b^tm1.1Arte (involves: C57BL/6J * C57BL/6N)	decreased circulating glucose level	J:157291
	improved glucose tolerance	J:157291
Ppp1r3c^tm1Adpr/Ppp1r3c^tm1Adpr (involves: C57BL/6J)	abnormal glycogen homeostasis	J:242755
Ppp1r3c^tm1Adpr/Ppp1r3c^tm1Adpr (B6.Cg-Ppp1r3c^tm1Adpr)	abnormal glucose homeostasis	J:242758
	increased energy expenditure	J:242758
	increased insulin sensitivity	J:242758
Ppp1r3c^tm1Ars/Ppp1r3c⁺ (B6.129-Ppp1r3c^tm1Ars)	abnormal glucose homeostasis	J:83297
	abnormal glycogen homeostasis	J:83297
	decreased adipose tissue glycogen level	J:83297
	decreased cardiac muscle glycogen level	J:83297
	decreased glycogen level	J:83297
	decreased liver glycogen level	J:83297
	decreased skeletal muscle glycogen level	J:83297
	impaired glucose tolerance	J:83297
	increased circulating insulin level	J:83297
	increased circulating leptin level	J:83297
	increased circulating triglyceride level	J:83297
	increased skeletal muscle triglyceride level	J:83297
	insulin resistance	J:83297
Ppp1r3g^tm1Nju/Ppp1r3g^tm1Nju (B6.129-Ppp1r3g^tm1Nju)	abnormal glucose homeostasis	J:249135
	decreased adipose tissue glycogen level	J:249135
	decreased liver glycogen level	J:249135
	decreased susceptibility to diet-induced obesity	J:249135
	increased carbon dioxide production	J:249135
	increased insulin sensitivity	J:249135
	increased oxygen consumption	J:249135
Ppp1r9b^{tm1.1(KOMP)Vlcg}/Ppp1r9b^{tm1.1(KOMP)Vlcg} (C57BL/6N-Ppp1r9b^{tm1.1(KOMP)Vlcg}/J)	increased circulating alanine transaminase level	J:211773
	increased circulating aspartate transaminase level	J:211773
Ppp1r13b^tm1Suda/Ppp1r13b^tm1Suda (involves: 129S1/Sv * 129X1/SvJ * ICR)	skin edema	J:135686
Ppp1r13l^tm1.1Xlu/Ppp1r13l^tm1.1Xlu (involves: 129 * C57BL/6J)	abnormal cardiac thrombosis	J:220162
Ppp1r13l^wa3/Ppp1r13l^wa3 (either: C57BL/6-Ppp1r13l^wa3 or (involves: C57BL/6 * DBA/2J))	abnormal arterial thrombosis	J:96392
Ppp1r15a^em2(IMPC)H/Ppp1r15a^em2(IMPC)H (C57BL/6NTac-Ppp1r15a^em2(IMPC)H/H)	increased circulating alanine transaminase level	J:211773
Ppp1r17^em1(IMPC)H/Ppp1r17^em1(IMPC)H (C57BL/6NTac-Ppp1r17^em1(IMPC)H/H)	decreased circulating alkaline phosphatase level	J:211773
	increased circulating potassium level	J:211773
Ppp1r26^{tm1.1(KOMP)Vlcg}/Ppp1r26^{tm1.1(KOMP)Vlcg} (C57BL/6N-Ppp1r26^{tm1.1(KOMP)Vlcg}/J)	increased circulating sodium level	J:211773
Ppp1r35^{tm1.1(KOMP)Vlcg}/Ppp1r35⁺ (C57BL/6N-Ppp1r35^{tm1.1(KOMP)Vlcg}/J)	decreased circulating chloride level	J:211773
	decreased circulating glucose level	J:211773
Ppp2r1b^{tm1b(EUCOMM)Wtsi}/Ppp2r1b^{tm1b(EUCOMM)Wtsi} (C57BL/6N-Ppp2r1b^{tm1b(EUCOMM)Wtsi}/Nju)	increased fasting circulating glucose level	J:211773
Ppp2r2a^igt10/Ppp2r2a⁺ (involves: C3H/HeH * C57BL/6J)	increased circulating insulin level	J:246319
Ppp2r2a^igt10/Ppp2r2a⁺ (involves: C3H/HeH * C57BL/6J)	insulin resistance	J:246319
Ppp2r2b^{tm1a(KOMP)Wtsi}/Ppp2r2b^{tm1a(KOMP)Wtsi} (C57BL/6N-Ppp2r2b^{tm1a(KOMP)Wtsi}/Wtsi)	decreased circulating potassium level	J:175295
Ppp2r2b^{tm1b(KOMP)Wtsi}/Ppp2r2b^{tm1b(KOMP)Wtsi} (C57BL/6N-Ppp2r2b^{tm1b(KOMP)Wtsi}/Tcp)	abnormal cholesterol homeostasis	J:211773
	increased fasting circulating glucose level	J:211773
Ppp2r3a^tm1(KOMP)Mbp/Ppp2r3a^tm1(KOMP)Mbp (C57BL/6N-Ppp2r3a^tm1(KOMP)Mbp/Nju)	increased circulating alkaline phosphatase level	J:211773
Ppp2r5c^em1(IMPC)Mbp/Ppp2r5c^em1(IMPC)Mbp (C57BL/6N-Ppp2r5c^em1(IMPC)Mbp/Ucd)	decreased circulating cholesterol level	J:211773
	increased blood urea nitrogen level	J:211773
	increased circulating alkaline phosphatase level	J:211773
Ppp3ca^tm1Jse/Ppp3ca⁺ (involves: 129S4/SvJae)	abnormal urine osmolality	J:110350
Ppp3ca^tm1Jse/Ppp3ca^tm1Jse (involves: 129S4/SvJae)	decreased circulating calcium level	J:110350
	decreased circulating glucose level	J:110350
	decreased urine creatinine level	J:110350
	decreased urine osmolality	J:110350
	increased blood urea nitrogen level	J:110350
	increased circulating creatinine level	J:110350
Ppp3r1^tm2Grc/Ppp3r1^tm2.1Grc Tg(Pax3-cre)1Joe/0 (involves: 129S6/SvEvTac)	increased blood urea nitrogen level	J:89217
Ppp3r1^tm2Grc/Ppp3r1^tm2Grc Tg(Pax3-cre)1Joe/0 (involves: 129S6/SvEvTac)	increased blood urea nitrogen level	J:89217
Ppp4c^em1(IMPC)Ics/Ppp4c⁺ (C57BL/6N-Ppp4c^em1(IMPC)Ics/Ics)	increased circulating bilirubin level	J:211773
Ppp4r3b^{tm1b(EUCOMM)Hmgu}/Ppp4r3b^{tm1b(EUCOMM)Hmgu} (C57BL/6N-Ppp4r3b^{tm1b(EUCOMM)Hmgu}/Ieg)	impaired glucose tolerance	J:211773
Ppp5c^{tm1a(EUCOMM)Wtsi}/Ppp5c^{tm1a(EUCOMM)Wtsi} (B6Dnk;B6Brd;B6N-Ppp5c^{tm1a(EUCOMM)Wtsi} Tyr^c-Brd/WtsiH)	decreased circulating cholesterol level	J:175295
	decreased circulating glucose level	J:175295
	decreased circulating HDL cholesterol level	J:175295
	decreased circulating triglyceride level	J:175295
Ppp5c^{tm1a(EUCOMM)Wtsi}/Ppp5c^{tm1a(EUCOMM)Wtsi} (involves: C57BL/6 * C57BL/6N)	decreased respiratory quotient	J:213427
Ppp6c^{tm1b(EUCOMM)Hmgu}/Ppp6c⁺ (C57BL/6N-Ppp6c^{tm1b(EUCOMM)Hmgu}/Ics)	decreased blood urea nitrogen level	J:211773
	increased fasting circulating glucose level	J:211773
Ppt1^tm1Hof/Ppt1^tm1Hof (involves: 129P2/OlaHsd * 129S2/SvPas * 129S6/SvEvTac * C57BL/6)	abnormal cytokine level	J:177265
Ppt2^{tm2b(KOMP)Wtsi}/Ppt2^{tm2b(KOMP)Wtsi} (C57BL/6N-Ppt2^{tm2b(KOMP)Wtsi}/H)	increased blood urea nitrogen level	J:211773
Ppy^{tm1b(KOMP)Wtsi}/Ppy^{tm1b(KOMP)Wtsi} (C57BL/6N-Ppy^{tm1b(KOMP)Wtsi}/Ieg)	decreased circulating fructosamine level	J:211773
	increased circulating insulin level	J:211773
Pradc1^{Gt(OST419896)Lex}/Pradc1^{Gt(OST419896)Lex} (involves: 129S5/SvEvBrd * C57BL/6J)	increased circulating glucose level	J:171883
Prag1^em2(IMPC)Tcp/Prag1^em2(IMPC)Tcp (C57BL/6NCrl-Prag1^em2(IMPC)Tcp/Tcp)	decreased fasting circulating glucose level	J:211773
Pramel1^em1(IMPC)Tcp/Pramel1^em1(IMPC)Tcp (C57BL/6NCrl-Pramel1^em1(IMPC)Tcp/Tcp)	increased circulating alanine transaminase level	J:211773
Pramel31^{tm2b(KOMP)Wtsi}/Pramel31^{tm2b(KOMP)Wtsi} (C57BL/6N-Pramel31^{tm2b(KOMP)Wtsi}/Wtsi)	increased circulating amylase level	J:211773
Prap1^tm1Lex/Prap1^tm1Lex (B6.129S5-Prap1^tm1Lex)	increased circulating interleukin-2 level	J:304152
	increased circulating interleukin-4 level	J:304152
	increased circulating interleukin-12 level	J:304152
Prcp^{Gt(KST302)Byg}/Prcp^{Gt(KST302)Byg} (B6.129P2-Prcp^{Gt(KST302)Byg})	decreased susceptibility to diet-induced obesity	J:152535
Prdm1^tm1Clme/Prdm1^tm1Clme Tg(Itgax-cre)1-1Reiz/0 (involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * CBA)	increased urine protein level	J:178876
Prdm4^{tm1b(EUCOMM)Hmgu}/Prdm4^{tm1b(EUCOMM)Hmgu} (C57BL/6N-Prdm4^{tm1b(EUCOMM)Hmgu}/H)	impaired glucose tolerance	J:211773
	increased circulating amylase level	J:211773
Prdm6^tm1.2Jrld/Prdm6^tm1.2Jrld (involves: 129P2/OlaHsd * BALB/c * C57BL/6 * SJL)	edema	J:209773
Prdm8^{em1(IMPC)Wtsi}/Prdm8^{em1(IMPC)Wtsi} (C57BL/6N-Prdm8^{em1(IMPC)Wtsi}/Wtsi)	impaired glucose tolerance	J:211773
	increased circulating sodium level	J:211773
Prdm12^{tm2b(EUCOMM)Hmgu}/Prdm12⁺ (C57BL/6N-Prdm12^{tm2b(EUCOMM)Hmgu}/Tcp)	increased circulating cholesterol level	J:211773
Prdm13^em1(IMPC)Tcp/Prdm13^em1(IMPC)Tcp (C57BL/6NCrl-Prdm13^em1(IMPC)Tcp/Tcp)	increased circulating bilirubin level	J:211773
Prdm14^{tm1a(EUCOMM)Wtsi}/Prdm14^{tm1a(EUCOMM)Wtsi} (C57BL/6N-Prdm14^{tm1a(EUCOMM)Wtsi}/Bay)	decreased respiratory quotient	J:211773
	impaired glucose tolerance	J:211773
Prdm16^tm1.1Brsp/Prdm16^tm1.1Brsp Myf5^tm1(cre)Mrc/Myf5⁺ (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	abnormal oxygen consumption	J:213153
	impaired adaptive thermogenesis	J:213153
	improved glucose tolerance	J:213153
Prdm16^tm1.1Brsp/Prdm16^tm1.1Brsp Tg(Adipoq-cre)1Evdr/0 (involves: 129/Sv * C57BL/6 * FVB/N)	abnormal oxygen consumption	J:208683
	increased circulating insulin level	J:208683
	increased liver triglyceride level	J:208683
	increased respiratory quotient	J:208683
	insulin resistance	J:208683
Prdx1^tm1Rave/Prdx1^tm1Rave (involves: 129S6/SvEvTac * C57BL/6)	decreased circulating haptoglobin level	J:84677
	increased circulating lactate dehydrogenase level	J:84677
Prdx2^tm1Yu/Prdx2^tm1Yu (involves: 129S4/SvJae)	hemosiderosis	J:84271
Prdx3^tm1Hjha/Prdx3^tm1Hjha (involves: 129S4/SvJae * C57BL/6)	abnormal circulating protein level	J:228860
	decreased adiponectin level	J:228860
	decreased circulating adiponectin level	J:228860
	decreased circulating triglyceride level	J:228860
	decreased fatty acid oxidation	J:228860
	impaired glucose tolerance	J:228860
	increased circulating cholesterol level	J:228860
	increased circulating insulin level	J:228860
	increased fasting circulating glucose level	J:228860
	insulin resistance	J:228860
Prdx5^{tm1.1(KOMP)Vlcg}/Prdx5^{tm1.1(KOMP)Vlcg} (involves: C57BL/6J * C57BL/6NTac)	abnormal nitric oxide homeostasis	J:271141
	decreased oxygen consumption	J:271141
	increased circulating interleukin-12b level	J:271141
	increased circulating tumor necrosis factor level	J:271141
Prdx5^tm1Dsle/Prdx5^tm1Dsle (involves: C57BL/6)	impaired glucose tolerance	J:294801
	increased circulating insulin level	J:294801
	increased circulating leptin level	J:294801
	increased liver triglyceride level	J:294801
	increased susceptibility to diet-induced obesity	J:294801
	insulin resistance	J:294801
Prdx6^tm1Pgn/Prdx6^tm1Pgn (either: 129/Sv or (involves: 129/Sv * C57BL/6))	abnormal blood coagulation	J:84376
	abnormal kidney venous thrombosis	J:84376
	abnormal venous thrombosis	J:84376
	pulmonary alveolar edema	J:84376
Prdx6^tm2Abf/Prdx6^tm2Abf (involves: C57BL/6J)	abnormal phospholipid level	J:237406
Prelp^{tm1.1(KOMP)Vlcg}/Prelp^{tm1.1(KOMP)Vlcg} (C57BL/6N-Prelp^{tm1.1(KOMP)Vlcg}/Ucd)	increased circulating bilirubin level	J:211773
	increased circulating calcium level	J:211773
Prep^{Gt(RRM213)Byg}/Prep^{Gt(RRM213)Byg} (involves: 129P2/OlaHsd * C57BL/6)	increased circulating leptin level	J:151643
Prep^{tm1b(KOMP)Wtsi}/Prep⁺ (C57BL/6N-Prep^{tm1b(KOMP)Wtsi}/J)	decreased circulating free fatty acids level	J:211773
	increased circulating potassium level	J:211773
	increased circulating sodium level	J:211773
Prex2^{Gt(AH0440)Wtsi}/Prex2^{Gt(AH0440)Wtsi} (B6.129P2-Prex2^{Gt(AH0440)Wtsi})	impaired glucose tolerance	J:206382
	increased circulating glucose level	J:206382
	insulin resistance	J:206382
Prf1^tm1Sdz/Prf1^tm1Sdz (NOD.B6-Prf1^tm1Sdz)	abnormal circulating glucose level	J:43468
Prf1^tm1Sdz/Prf1^tm1Sdz (C57BL/6-Prf1^tm1Sdz/J)	abnormal body temperature homeostasis	J:92260
	abnormal circulating cytokine level	J:92260
	decreased body temperature	J:193137
	decreased circulating fibrinogen level	J:92260
	increased circulating aspartate transaminase level	J:193137
	increased circulating interferon-alpha level	J:92260
	increased circulating interferon-gamma level	J:92260, J:193137
	increased circulating interleukin-1 beta level	J:193137
	increased circulating interleukin-6 level	J:92260, J:193137
	increased circulating interleukin-10 level	J:92260
	increased circulating interleukin-18 level	J:92260
	increased circulating lactate dehydrogenase level	J:193137
	increased circulating triglyceride level	J:92260
	increased circulating tumor necrosis factor level	J:92260, J:193137
Prf1^tm1Sdz/Prf1^tm1Sdz Rag1^tm1Mom/Rag1^tm1Mom (NOD.Cg-Rag1^tm1Mom Prf1^tm1Sdz/SzJ)	increased circulating glucose level	J:91764
Prf1^tm1Tsc/Prf1^tm1Tsc (involves: 129S2/SvPas)	decreased circulating alanine transaminase level	J:50903
Prg2^{tm1b(EUCOMM)Hmgu}/Prg2^{tm1b(EUCOMM)Hmgu} (C57BL/6N-Prg2^{tm1b(EUCOMM)Hmgu}/Bay)	increased respiratory quotient	J:211773
Prg4^{em1(IMPC)Ccpcz}/Prg4^{em1(IMPC)Ccpcz} (C57BL/6N-Prg4^{em1(IMPC)Ccpcz}/Ccpcz)	improved glucose tolerance	J:211773
	increased circulating potassium level	J:211773
Prg4^tm1Mawa/Prg4^tm1Mawa (involves: 129S1/Sv * 129X1/SvJ)	joint swelling	J:96756
Prkaa1^tm1Sbj/Prkaa1⁺ Prkaa2^tm1Vio/Prkaa2^tm1Vio (involves: 129S2/SvPas * FVB/N)	increased susceptibility to diet-induced obesity	J:123951
Prkaa1^tm1Sbj/Prkaa1^tm1Sbj (involves: 129)	abnormal circulating hormone level	J:147215
Prkaa1^tm1Sbj/Prkaa1^tm1Sbj (involves: 129S2/SvPas)	abnormal circulating hormone level	J:324163
	abnormal enzyme/coenzyme level	J:324163
	abnormal hormone level	J:324163
	abnormal testosterone level	J:324163
Prkaa2^tm1.1Vio/Prkaa2^tm1.1Vio (involves: 129S2/SvPas * C57BL/6)	abnormal glucose homeostasis	J:81120
	abnormal glycogen homeostasis	J:81120
	abnormal urine catecholamine level	J:81120
	decreased circulating insulin level	J:81120
	decreased circulating leptin level	J:81120
	decreased insulin secretion	J:81120
	decreased skeletal muscle glycogen level	J:81120
	hyperglycemia	J:81120
	impaired glucose tolerance	J:81120
	increased circulating free fatty acids level	J:81120
	insulin resistance	J:81120
Prkaa2^tm1.1Vio/Prkaa2^tm1.1Vio (involves: 129S2/SvPas)	decreased circulating insulin level	J:87719
	decreased skeletal muscle glycogen level	J:87719
	impaired glucose tolerance	J:87719
Prkaa2^{tm1b(EUCOMM)Hmgu}/Prkaa2^{tm1b(EUCOMM)Hmgu} (C57BL/6N-Prkaa2^{tm1b(EUCOMM)Hmgu}/H)	decreased circulating alkaline phosphatase level	J:211773
	decreased circulating fructosamine level	J:211773
	decreased circulating serum albumin level	J:211773
	decreased fasting circulating glucose level	J:211773
	increased circulating alanine transaminase level	J:211773
	increased circulating aspartate transaminase level	J:211773
	increased circulating creatine kinase level	J:211773
Prkaa2^tm1Vio/Prkaa2^tm1Vio Tg(Alb1-cre)7Gsc/0 (involves: 129S2/SvPas * FVB/N)	abnormal gluconeogenesis	J:108399
	abnormal glucose homeostasis	J:108399
	impaired glucose tolerance	J:108399
	increased circulating adiponectin level	J:108399
	increased circulating glucose level	J:108399
	increased circulating insulin level	J:108399
	increased circulating leptin level	J:108399
	increased fatty acids level	J:108399
	increased triglyceride level	J:108399
Prkaa2^tm1Vio/Prkaa2^tm1Vio Tg(Pomc1-cre)1Gsb/0 (involves: 129S2/SvPas * FVB/N)	increased susceptibility to diet-induced obesity	J:123951
Prkab1^em1(IMPC)J/Prkab1^em1(IMPC)J (C57BL/6NJ-Prkab1^em1(IMPC)J/J)	decreased fasting circulating glucose level	J:211773
	impaired glucose tolerance	J:211773
Prkab1^{tm1a(KOMP)Wtsi}/Prkab1^{tm1a(KOMP)Wtsi} (C57BL/6N-Prkab1^{tm1a(KOMP)Wtsi}/Wtsi)	decreased circulating magnesium level	J:175295
	increased circulating bilirubin level	J:175295
Prkab1^{tm1b(KOMP)Wtsi}/Prkab1⁺ (C57BL/6N-Prkab1^{tm1b(KOMP)Wtsi}/Ieg)	decreased circulating phosphate level	J:211773
Prkab1^{tm1b(KOMP)Wtsi}/Prkab1^{tm1b(KOMP)Wtsi} (C57BL/6N-Prkab1^{tm1b(KOMP)Wtsi}/Wtsi)	decreased circulating cholesterol level	J:211773
	decreased circulating HDL cholesterol level	J:211773
	decreased circulating LDL cholesterol level	J:211773
	increased circulating bilirubin level	J:211773
Prkab1^{tm1b(KOMP)Wtsi}/Prkab1^{tm1b(KOMP)Wtsi} (C57BL/6N-Prkab1^{tm1b(KOMP)Wtsi}/H)	decreased circulating cholesterol level	J:211773
	decreased circulating HDL cholesterol level	J:211773
	decreased circulating iron level	J:211773
	impaired glucose tolerance	J:211773
	increased fasting circulating glucose level	J:211773
Prkab1^{tm1b(KOMP)Wtsi}/Prkab1^{tm1b(KOMP)Wtsi} (C57BL/6N-Prkab1^{tm1b(KOMP)Wtsi}/Rbrc)	decreased circulating amylase level	J:211773
	increased circulating alkaline phosphatase level	J:211773
	increased circulating bilirubin level	J:211773
	increased glycosylated hemoglobin level	J:211773
Prkab1^{tm1b(KOMP)Wtsi}/Prkab1^{tm1b(KOMP)Wtsi} (B6N(Cg)-Prkab1^{tm1b(KOMP)Wtsi}/J)	decreased circulating cholesterol level	J:211773
	decreased circulating HDL cholesterol level	J:211773
	increased circulating bilirubin level	J:211773
Prkab1^{tm1b(KOMP)Wtsi}/Prkab1^{tm1b(KOMP)Wtsi} (involves: C57BL/6N)	decreased circulating iron level	J:236972
	increased circulating erythropoietin level	J:236972
	increased circulating ferritin level	J:236972
	increased spleen iron level	J:236972
Prkab1^{tm1b(KOMP)Wtsi}/Prkab1^{tm1b(KOMP)Wtsi} (C57BL/6N-Prkab1^{tm1b(KOMP)Wtsi}/MbpMmucd)	decreased circulating cholesterol level	J:211773
	decreased circulating HDL cholesterol level	J:211773
	impaired glucose tolerance	J:211773
Prkab1^{tm1b(KOMP)Wtsi}/Prkab1^{tm1b(KOMP)Wtsi} (C57BL/6N-Prkab1^{tm1b(KOMP)Wtsi}/Ccpcz)	decreased circulating chloride level	J:211773
	increased circulating alanine transaminase level	J:211773
	increased fasting circulating glucose level	J:211773
Prkab1^tm1Eihl/Prkab1^tm1Eihl (involves: C57BL/6)	abnormal lipid level	J:158295
	decreased circulating insulin level	J:158295
	decreased circulating interleukin-6 level	J:158295
	decreased circulating leptin level	J:158295
	decreased liver triglyceride level	J:158295
	decreased susceptibility to diet-induced obesity	J:158295
	increased insulin sensitivity	J:158295
Prkab1^tm1Grst/Prkab1^tm1Grst Prkab2^tm1Grst/Prkab2^tm1Grst Tg(Ckmm-cre)5Khn/0 (involves: C57BL/6 * FVB)	increased circulating glucose level	J:176578
Prkab2^{Gt(AL0483)Wtsi}/Prkab2^{Gt(AL0483)Wtsi} (B6.129P2-Prkab2^{Gt(AL0483)Wtsi})	decreased circulating glucose level	J:186658
	decreased glycogen catabolism rate	J:186658
	decreased skeletal muscle glycogen level	J:186658
	impaired glucose tolerance	J:186658
	increased circulating insulin level	J:186658
	increased circulating triglyceride level	J:186658
	insulin resistance	J:186658
Prkab2^tm1.1Grst/Prkab2^tm1.1Grst (involves: C57BL/6)	abnormal glucose homeostasis	J:167339
	abnormal lipid homeostasis	J:167339
	decreased liver glycogen level	J:167339
	decreased skeletal muscle glycogen level	J:167339
	increased circulating insulin level	J:167339
	increased susceptibility to diet-induced obesity	J:167339
	insulin resistance	J:167339
Prkaca^tm1Gsm/Prkaca^tm1Gsm (involves: 129X1/SvJ * C57BL/6)	decreased urine protein level	J:77110
Prkaca^tm1Gsm/Prkaca^tm1Gsm Prkar1a^tm1Gsm/Prkar1a^tm1Gsm (involves: 129X1/SvJ * C57BL/6)	pericardial edema	J:78010
Prkaca^tm3Gsm/Prkaca^tm3Gsm Speer6-ps1^{Tg(Alb-cre)21Mgn}/Speer6-ps1⁺ (involves: 129X1/SvJ * C57BL/6J)	abnormal glucose homeostasis	J:103418
	abnormal glycogen homeostasis	J:103418
	decreased circulating insulin level	J:103418
	decreased insulin secretion	J:103418
	decreased liver glycogen level	J:103418
	impaired glucose tolerance	J:103418
	increased circulating glucose level	J:103418
	increased circulating triglyceride level	J:103418
Prkacb^em1(IMPC)H/Prkacb⁺ (C57BL/6NTac-Prkacb^em1(IMPC)H/H)	increased circulating alanine transaminase level	J:211773
Prkag1^tm1.2Mfor/Prkag1^tm1.2Mfor (involves: 129S2/SvPas * C57BL/6 * C57BL/6NTac * FVB/N)	abnormal iron level	J:167779
	increased circulating bilirubin level	J:167779
	increased liver iron level	J:167779
	increased spleen iron level	J:167779
Prkag2^tm1.1Geno/Prkag2^tm1.1Geno (B6J.129S(Cg)-Prkag2^tm1.1Geno)	decreased circulating insulin level	J:235379
	impaired glucose tolerance	J:235379
	increased cardiac muscle glycogen level	J:256296
	insulin resistance	J:235379
Prkag3^tm1Sson/Prkag3^tm1Sson (involves: C57BL/6J)	abnormal glucose homeostasis	J:92821
Prkag3^tm1Sson/Prkag3^tm1Sson (involves: C57BL/6J)	decreased skeletal muscle glycogen level	J:92821
Prkar1a^tm1.1Geno/Prkar1a⁺ (involves: C57BL/6J)	abnormal urine homeostasis	J:303060
Prkar1a^tm1.1Geno/Prkar1a⁺ (involves: C57BL/6J)	increased circulating parathyroid hormone level	J:303060
Prkar1a^tm1.2Lsk/Prkar1a^tm1.2Lsk Pten^tm1.1Mwst/Pten^tm1.1Mwst Tg(TPO-cre)1Shk/0 (involves: 129S1/Sv * 129X1/SvJ * FVB/NCr)	increased circulating thyroxine level	J:225245
Prkar1a^tm1.2Lsk/Prkar1a^tm1.2Lsk Tg(Ghrhr-cre)3242Lsk/0 (involves: 129S1/Sv * 129X1/SvJ * FVB/N)	increased circulating growth hormone level	J:130264
Prkar1a^tm1.2Lsk/Prkar1a^tm1.2Lsk Tg(TPO-cre)1Shk/0 (involves: 129S1/Sv * 129X1/SvJ * FVB/NCr)	decreased thyroid-stimulating hormone level	J:241066
	increased thyroxine level	J:241066
Prkar1a^tm1Lsk/Prkar1a^tm1Lsk Tg(Akr1b7-cre)1Anm/0 (involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * DBA/2)	increased circulating corticosterone level	J:161521
Prkar2b^tm1Gsm/Prkar2b^tm1Gsm (Not Specified)	abnormal energy expenditure	J:34751
	decreased circulating leptin level	J:34751
	decreased susceptibility to diet-induced obesity	J:34751
	decreased triglyceride level	J:34751
	increased body temperature	J:34751
Prkar2b^tm1Gsm/Prkar2b^tm1Gsm (B6.129-Prkar2b^tm1Gsm)	decreased circulating cholesterol level	J:72414
	decreased circulating insulin level	J:72414
	decreased circulating LDL cholesterol level	J:72414
	decreased circulating leptin level	J:72414
	decreased circulating VLDL cholesterol level	J:72414
	decreased liver triglyceride level	J:72414
	decreased susceptibility to diet-induced obesity	J:72414
	improved glucose tolerance	J:72414
Prkar2b^tm2Gsm/Prkar2b⁺ (involves: C57BL/6)	decreased circulating leptin level	J:131039
Prkar2b^tm3Gsm/Prkar2b^tm2Gsm Tg(Drd2-cre)ER44Gsat/0 (involves: C57BL/6 * FVB/N)	decreased circulating leptin level	J:196157
Prkar2b^tm3Gsm/Prkar2b^tm2Gsm Tg(Fabp4-cre)1Rev/0 (involves: C57BL/6)	decreased circulating leptin level	J:196157
Prkar2b^tm3Gsm/Prkar2b^tm2Gsm Tg(Ppp1r1b-cre)1Meeh/0 (involves: C57BL/6)	decreased circulating leptin level	J:196157
Prkar2b^tm3Gsm/Prkar2b^tm3Gsm (B6.Cg-Prkar2b^tm3Gsm)	abnormal energy expenditure	J:196157
	decreased circulating cholesterol level	J:196157
	decreased circulating insulin level	J:196157
	decreased circulating LDL cholesterol level	J:196157
	decreased circulating leptin level	J:196157
	decreased circulating VLDL cholesterol level	J:196157
	decreased liver triglyceride level	J:196157
	decreased susceptibility to diet-induced obesity	J:196157
	decreased triglyceride level	J:196157
	improved glucose tolerance	J:196157
	increased energy expenditure	J:196157
	increased respiratory quotient	J:196157
Prkcd^tm1.1Khn/Prkcd^tm1.1Khn (B6.129P2-Prkcd^tm1.1Khn)	improved glucose tolerance	J:173902
Prkcd^tm1.1Khn/Prkcd^tm1.1Khn (B6.129P2-Prkcd^tm1.1Khn)	increased insulin sensitivity	J:173902
Prkcd^tm1Kin/Prkcd^tm1Kin (involves: 129P2/OlaHsd * C57BL/6)	decreased insulin secretion	J:120293
	impaired glucose tolerance	J:120293
Prkcd^tm1Qxu/Prkcd^tm1Qxu (B6.129P2-Prkcd^tm1Qxu)	decreased liver triglyceride level	J:173902
	improved glucose tolerance	J:173902
	increased insulin sensitivity	J:173902
Prkce^tm1Bsca/Prkce^tm1Bsca (involves: 129P2/OlaHsd * C57BL/6)	decreased circulating interleukin-1 beta level	J:103337
	decreased circulating tumor necrosis factor level	J:103337
	decreased macrophage nitric oxide production	J:103337
Prkci^tm1Kido/Prkci^tm1.1Kido Tg(Nphs1-cre)33Mska/0 (involves: C57BL/6 * C57BL/6N * DBA/2)	increased blood urea nitrogen level	J:144995
	increased circulating creatinine level	J:144995
	increased urine protein level	J:144995
Prkci^tm1Kido/Prkci^tm1Kido Tg(Ins2-cre)25Mgn/0 (involves: 129/Sv * C57BL/6 * DBA/2)	decreased circulating glucose level	J:95378
	impaired glucose tolerance	J:95378
Prkci^tm1Rfar/Prkci⁺ Tg(Ckmm-cre)5Khn/? (involves: 129P2/OlaHsd * C57BL/6 * FVB)	abnormal circulating lipid level	J:123964
	abnormal glucose homeostasis	J:123964
	decreased circulating HDL cholesterol level	J:123964
	impaired glucose tolerance	J:123964
	increased circulating cholesterol level	J:123964
	increased circulating free fatty acids level	J:123964
	increased circulating glucose level	J:123964
	increased circulating insulin level	J:123964
	increased circulating LDL cholesterol level	J:123964
	increased circulating leptin level	J:123964
	increased circulating triglyceride level	J:123964
	insulin resistance	J:123964
Prkci^tm1Rfar/Prkci^tm1Rfar Tg(Ckmm-cre)5Khn/0 (involves: 129P2/OlaHsd * C57BL/6 * FVB)	abnormal circulating lipid level	J:123964
	abnormal glucose homeostasis	J:123964
	decreased circulating HDL cholesterol level	J:123964
	impaired glucose tolerance	J:123964
	increased circulating cholesterol level	J:123964
	increased circulating free fatty acids level	J:123964
	increased circulating glucose level	J:123964
	increased circulating insulin level	J:123964
	increased circulating LDL cholesterol level	J:123964
	increased circulating leptin level	J:123964
	increased circulating triglyceride level	J:123964
	insulin resistance	J:123964
Prkci^tm1Rfar/Prkci^tm1Rfar Tg(NPHS2-cre)295Lbh/0 (involves: 129P2/OlaHsd * C57BL/6 * SJL)	increased urine protein level	J:164628
Prkcq^tm1Litt/Prkcq^tm1Litt (involves: 129P2/OlaHsd * C57BL/6)	abnormal glucose homeostasis	J:92834
	increased insulin sensitivity	J:92834
Prkcq^tm1Litt/Prkcq^tm1Litt (involves: 129P2/OlaHsd * C57BL/6J)	abnormal platelet activation	J:144254
	abnormal platelet dense granule physiology	J:144254
	abnormal platelet physiology	J:144254
	increased platelet aggregation	J:144254
Prkcz^{tm1a(EUCOMM)Wtsi}/Prkcz⁺ (B6JTyr;B6N-Prkcz^{tm1a(EUCOMM)Wtsi}/Wtsi)	increased circulating iron level	J:175295
Prkcz^{tm1a(EUCOMM)Wtsi}/Prkcz^{tm1a(EUCOMM)Wtsi} (B6JTyr;B6N-Prkcz^{tm1a(EUCOMM)Wtsi}/Wtsi)	increased circulating alanine transaminase level	J:175295
	increased circulating alkaline phosphatase level	J:175295
	increased circulating aspartate transaminase level	J:175295
Prkcz^{tm1a(EUCOMM)Wtsi}/Prkcz^{tm1a(EUCOMM)Wtsi} (involves: C57BL/6 * C57BL/6N)	increased circulating alkaline phosphatase level	J:213427
Prkd1^{em2(IMPC)Wtsi}/Prkd1⁺ (C57BL/6N-Prkd1^{em2(IMPC)Wtsi}/Wtsi)	increased circulating insulin level	J:211773
Prkd2^{em1(IMPC)Hmgu}/Prkd2^{em1(IMPC)Hmgu} (C57BL/6N-Prkd2^{em1(IMPC)Hmgu}/Ieg)	decreased respiratory quotient	J:211773
	increased circulating alanine transaminase level	J:211773
Prkd3^{tm1b(EUCOMM)Wtsi}/Prkd3⁺ (C57BL/6N-Prkd3^{tm1b(EUCOMM)Wtsi}/Ieg)	decreased circulating cholesterol level	J:211773
	decreased circulating HDL cholesterol level	J:211773
	increased circulating aspartate transaminase level	J:211773
Prkdc^dxnph/Prkdc^dxnph (BALB/cJ)	increased urine protein level	J:96632
Prkdc^dxnph/Prkdc^dxnph (129X1/SvJ)	increased urine protein level	J:96632
Prkdc^dxnph/Prkdc^dxnph (involves: BALB/cJ * 129X1/SvJ)	increased urine protein level	J:96632
Prkdc^em2(IMPC)Ics/Prkdc^em2(IMPC)Ics (C57BL/6N-Prkdc^em2(IMPC)Ics/Ics)	increased circulating phosphate level	J:211773
Prkdc^scid/Prkdc^scid (NOD.Cg-Prkdc^scid/J)	increased circulating glucose level	J:91764
Prkdc^scid/Prkdc^scid Gnrh1^hpg/Gnrh1^hpg (STOCK Prkdc^scid Gnrh1^hpg/Bm)	abnormal circulating protein level	J:138840
	decreased circulating testosterone level	J:138840
Prkdc^scid/Prkdc^scid Idua^tm1Clk/Idua^tm1Clk (NOD.Cg-Prkdc^scid Idua^tm1Clk/J)	abnormal homeostasis	J:139626
	increased urine glycosaminoglycan level	J:139626
Prkdc^scid/Prkdc^scid Tg(B2M)55Hpl/0 Mcph1^{Tg(HLA-A2.1)1Enge}/Mcph1⁺ (NOD.Cg-Mcph1^{Tg(HLA-A2.1)1Enge} Prkdc^scid Tg(B2M)55Hpl/Sz)	increased circulating glucose level	J:91764
Prkdc^scid/Prkdc^scid Tg(INS-HBEGFL148SP149T)70Rin/0 (C.BKa-Prkdc^scid Tg(INS-HBEGFL148SP149T)70Rin)	decreased circulating insulin level	J:204420
	hyperglycemia	J:204420
Prkdc^scid/Prkdc^scid Tgfb1^tm1Doe/Tgfb1^tm1Doe (involves: 129 * C3H * CF-1)	decreased circulating follicle stimulating hormone level	J:129629
	decreased circulating luteinizing hormone level	J:129629
	decreased circulating testosterone level	J:129629
Prkg1^tm1Hfm/Prkg1^tm1Hfm (involves: C57BL/6N)	decreased body surface temperature	J:199222
Prkg1^tm1Hfm/Prkg1^tm1Hfm (involves: C57BL/6N)	decreased triglyceride level	J:199222
Prkg1^tm2.1Naw/Prkg1^tm2.1Naw (involves: 129S1/Sv * 129X1/SvJ)	abnormal circulating hormone level	J:134639
Prkn^tm1Ccs/Prkn^tm1Ccs (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	abnormal dopamine level	J:127250
Prkn^tm1Roo/Prkn^tm1Roo (either: 129S2/SvPas or (involves: 129S2/SvPas * C57BL/6))	decreased core body temperature	J:85561
	increased dopamine level	J:85561
Prkn^tm1Shn/Prkn^tm1Shn (involves: 129S4/SvJae)	increased dopamine level	J:86377
Prkn^tm1Shn/Prkn^tm1Shn Park7^tm1Shn/Park7^tm1Shn (B6.Cg-Park7^tm1Shn Prkn^tm1Shn)	increased serotonin level	J:202221
Prkn^tm1Tmd/Prkn^tm1Tmd (involves: C57BL/6)	decreased noradrenaline level	J:91487
Prkn^tm1Ykt/Prkn^tm1Ykt (involves: 129P2/OlaHsd * C57BL/6)	increased dopamine level	J:117737
Prkn^tm1Ykt/Prkn^tm1Ykt Tg(Prp-GPR37)1Ryot/0 (involves: 129P2/OlaHsd * C3H * C57BL/6)	decreased dopamine level	J:140326
	increased dopamine level	J:140326
Prkn^tm1Ykt/Prkn^tm1Ykt Tg(Prp-GPR37)1Ryot/Tg(Prp-GPR37)1Ryot (involves: 129P2/OlaHsd * C3H * C57BL/6)	decreased dopamine level	J:140326
	increased dopamine level	J:140326
Prkra^em1(IMPC)H/Prkra^em1(IMPC)H (C57BL/6N-Prkra^em1(IMPC)H/H)	decreased circulating alkaline phosphatase level	J:211773
	increased blood urea nitrogen level	J:211773
	increased circulating cholesterol level	J:211773
Prl3c1^{tm1(KOMP)Vlcg}/Prl3c1^{tm1(KOMP)Vlcg} (involves: C57BL/6NTac * CD-1)	increased circulating luteinizing hormone level	J:256588
	increased circulating testosterone level	J:256588
Prl7b1^{tm1.1(KOMP)Vlcg}/Prl7b1^{tm1.1(KOMP)Vlcg} (C57BL/6N-Prl7b1^{tm1.1(KOMP)Vlcg}/Ucd)	increased circulating alanine transaminase level	J:211773
	increased circulating aspartate transaminase level	J:211773
Prl^tm1Hmn/Prl^tm1Hmn (involves: 129S2/SvPas)	decreased circulating estradiol level	J:79661
	decreased circulating estrogen level	J:79661
	decreased circulating luteinizing hormone level	J:83246
	decreased circulating prolactin level	J:45243
	decreased dopamine level	J:83246
	decreased follicle stimulating hormone level	J:83246
	decreased luteinizing hormone level	J:83246
	decreased prolactin level	J:83246, J:45243
Prlh^tm1Taon/Prlh^tm1Taon (B6N.129X1-Prlh^tm1Taon)	impaired glucose tolerance	J:144729
	increased circulating insulin level	J:144729
	increased circulating leptin level	J:144729
	increased circulating triglyceride level	J:144729
	increased liver triglyceride level	J:144729
	increased susceptibility to diet-induced obesity	J:144729
	insulin resistance	J:144729
Prlh^tm2Smln/Prlh^tm2Smln (involves: C57BL/6J)	abnormal body temperature homeostasis	J:215557
	decreased core body temperature	J:215557
	hyperglycemia	J:215557
	increased circulating insulin level	J:215557
	increased circulating leptin level	J:215557
	increased susceptibility to diet-induced obesity	J:215557
Prlh^tm2Smln/Prlh^tm2Smln 7630403G23Rik^{Tg(Th-cre)1Tmd}/7630403G23Rik⁺ (involves: C57BL/6 * C57BL/6J * SJL)	abnormal body temperature homeostasis	J:215557
Prlhr^tm1Askr/Prlhr^tm1Askr (involves: 129S5/SvEvBrd * C57BL/6)	increased circulating insulin level	J:90533
	insulin resistance	J:90533
Prlhr^tm1Dgen/Prlhr^tm1Dgen (involves: 129P2/OlaHsd * C57BL/6)	increased cholesterol level	J:127335
	increased circulating corticosterone level	J:127335
	increased circulating glucose level	J:127335
	increased circulating HDL cholesterol level	J:127335
	increased circulating LDL cholesterol level	J:127335
	increased circulating leptin level	J:127335
Prlhr^tm1Map/Prlhr^tm1Map (involves: 129S6/SvEvTac * CD-1)	decreased circulating corticosterone level	J:103932
Prlr^tm1Cnp/Prlr^tm1Cnp (involves: 129/Sv * 129P2/OlaHsd * C57BL/6)	abnormal circulating calcium level	J:52026
	decreased circulating estradiol level	J:52026
	decreased circulating progesterone level	J:52026
	increased circulating parathyroid hormone level	J:52026
	increased circulating prolactin level	J:52026
Prlr^tm1Cnp/Prlr^tm1Cnp (involves: 129P2/OlaHsd * 129S2/SvPas * C57BL/6)	decreased circulating leptin level	J:67354
	decreased insulin secretion	J:106829
	impaired glucose tolerance	J:106829
Prlr^tm1Cnp/Prlr^tm1Cnp (involves: 129/Sv * 129P2/OlaHsd)	decreased body temperature	J:101609
Prlr^tm1Cnp/Prlr^tm1Cnp (involves: 129/Sv * 129P2/OlaHsd)	decreased thyroxine level	J:101609
Prmt1^{tm1a(EUCOMM)Wtsi}/Prmt1⁺ (B6JTyr;B6N-Prmt1^{tm1a(EUCOMM)Wtsi}/Wtsi)	increased circulating creatinine level	J:175295
Prmt3^{tm1a(EUCOMM)Wtsi}/Prmt3^{tm1a(EUCOMM)Wtsi} (involves: C57BL/6 * C57BL/6N)	decreased respiratory quotient	J:213427
Prmt7^{tm1a(EUCOMM)Wtsi}/Prmt7^{tm1a(EUCOMM)Wtsi} (B6JTyr;B6N-Prmt7^{tm1a(EUCOMM)Wtsi}/Wtsi)	hemopericardium	J:239583
	subcutaneous edema	J:239583
Prmt9^em1(IMPC)J/Prmt9^em1(IMPC)J (C57BL/6NJ-Prmt9^em1(IMPC)J/Mmjax)	improved glucose tolerance	J:211773
Prmt9^em1Cya/Prmt9^em1Cya Lyz2^tm1(cre)Ifo/Lyz2⁺ (involves: 129P2/OlaHsd * C57BL/6N)	increased circulating interferon-beta level	J:328263
Prnp^tm1Cwe/Prnp^tm1Cwe (involves: 129S7/SvEvBrd * C57BL/6)	decreased brain copper level	J:126728
Prnp^tm1Cwe/Prnp^tm1Cwe Tg(Prnp)a20Cwe/0 (involves: 129S7/SvEvBrd * C57BL/6)	abnormal copper level	J:129512
	abnormal magnesium ion homeostasis	J:126728
	increased brain copper level	J:126728
Prnp^tm1Cwe/Prnp^tm1Cwe Tg(Prnp)C4Cwe/0 (involves: 129S7/SvEvBrd * C57BL/6)	decreased brain copper level	J:126728
Prnp^tm2Lnq/Prnp^tm2Lnq (involves: 129P2/OlaHsd * C57BL/6N)	abnormal body temperature homeostasis	J:154937
Proc^tm1Fjc/Proc^tm1Fjc (involves: 129S1/Sv * 129X1/SvJ * Swiss)	abnormal blood coagulation	J:50527
	abnormal brain thrombosis	J:50527
	abnormal cardiac thrombosis	J:50527
	abnormal lung thrombosis	J:50527
Procr^tm1.1Pcl/Procr⁺ (involves: 129S2/SvPas * C57BL/6)	abnormal circulating protein level	J:225914
Procr^tm1.1Pcl/Procr^tm1.1Pcl (involves: 129S2/SvPas * C57BL/6)	abnormal circulating protein level	J:225914
	increased circulating interleukin-6 level	J:225914
	increased susceptibility to induced thrombosis	J:225914
Procr^tm1Cte/Procr⁺ (B6.129S7-Procr^tm1Cte)	abnormal blood coagulation	J:144388
Procr^tm1Cte/Procr^tm1Cte (either: 129S/SvEv-Procr^tm1Cte or (involves: 129S7/SvEvBrd * Black Swiss))	abnormal blood coagulation	J:80043
	abnormal placental thrombosis	J:80043
Prodh2^em1Jkni/Prodh2^em1Jkni (involves: C57BL/6J)	abnormal urine homeostasis	J:283585
	abnormal urine organic anion level	J:283585
	hydroxyprolinuria	J:283585
	increased circulating hydroxyproline level	J:283585
Prodh^m1Kara/Prodh^m1Kara (involves: C57BL/6J * PRO/Re)	decreased aspartic acid level	J:54012
	decreased gamma-aminobutyric acid level	J:54012
	decreased glutamic acid level	J:54012
	increased circulating proline level	J:54012
	increased proline level	J:54012
Prokr1^tm1Lex/Prokr1^tm1Lex (involves: 129S/SvEvBrd * C57BL/6J)	decreased body temperature	J:109984
Prokr2^tm1Api/Prokr2^tm1Api (involves: C57BL/6 * CBA)	decreased circulating testosterone level	J:107587
Prokr2^tm1Api/Prokr2^tm1Api (involves: C57BL/6 * CBA)	decreased follicle stimulating hormone level	J:107587
Prokr2^tm1Brd/Prokr2^tm1Brd (involves: 129S7/SvEvBrd * C57BL/6)	abnormal circadian temperature homeostasis	J:119071
	decreased body temperature	J:119071
Prom2^{tm1.1(KOMP)Vlcg}/Prom2⁺ (C57BL/6N-Prom2^{tm1.1(KOMP)Vlcg}/J)	decreased circulating calcium level	J:211773
	decreased circulating iron level	J:211773
	increased circulating alanine transaminase level	J:211773
	increased circulating aspartate transaminase level	J:211773
	increased circulating potassium level	J:211773
Prop1^df/Prop1^df (STOCK Prop1^df)	decreased circulating follicle stimulating hormone level	J:5900
	decreased circulating growth hormone level	J:6340
	decreased circulating prolactin level	J:5900
	decreased circulating thyroid-stimulating hormone level	J:6340
	decreased follicle stimulating hormone level	J:5900
	decreased luteinizing hormone level	J:5900
Prop1^tm1Sac/Prop1^tm1Sac (involves: 129S1/Sv * 129S1/SvImJ * 129X1/SvJ * C57BL/6J)	cyanosis	J:94409
	increased circulating corticosterone level	J:94409
Pros1^tm1.1Ansc/Pros1⁺ (involves: 129/Sv * C57BL/6J * FVB/N)	increased susceptibility to induced thrombosis	J:152423
Pros1^tm1.1Ansc/Pros1^tm1.1Ansc (involves: 129/Sv * C57BL/6J * FVB/N)	abnormal thrombosis	J:152423
Pros1^tm1.2Grl/Pros1⁺ (involves: 129S1/SvImJ * FVB/N)	decreased bleeding time	J:198769
Pros1^tm1.2Grl/Pros1^tm1.2Grl (involves: 129S1/SvImJ * FVB/N)	abnormal blood coagulation	J:198769
	abnormal thrombosis	J:198769
Pros1^tm1Grl/Pros1^tm1Grl Speer6-ps1^{Tg(Alb-cre)21Mgn}/Speer6-ps1⁺ (involves: 129S1/SvImJ * C57BL/6 * DBA)	abnormal thrombosis	J:198769
Pros1^tm1Grl/Pros1^tm1Grl Tg(Tek-cre)1Ywa/0 (involves: 129S1/SvImJ * C57BL/6 * SJL)	abnormal thrombosis	J:198769
Proser2^{em1(IMPC)Ccpcz}/Proser2^{em1(IMPC)Ccpcz} (C57BL/6NCrl-Proser2^{em1(IMPC)Ccpcz}/Ccpcz)	decreased circulating chloride level	J:211773
Prox1^tm1Gco/Prox1⁺ (involves: 129S1/Sv * 129X1/SvJ * NMRI)	chylothorax	J:102652
	cyanosis	J:102652
	edema	J:102652, J:57646
	increased circulating alanine transaminase level	J:102652
	increased circulating glucagon level	J:102652
	increased circulating insulin level	J:102652
	increased circulating leptin level	J:102652
	increased liver triglyceride level	J:102652
Prox1^tm1Gco/Prox1^tm1Gco (involves: 129S1/Sv * 129X1/SvJ * NMRI)	edema	J:57646
Prox1^tm2Gco/Prox1⁺ Tg(Tek-cre)1Ywa/0 (involves: 129S1/Sv * C57BL/6 * NMRI * SJL)	chylothorax	J:102652
	edema	J:102652
Prox1^tm2Gco/Prox1^tm2Gco Nkx2-5^tm1(cre)Rjs/Nkx2-5⁺ (involves: 129S1/Sv * 129S7/SvEvBrd)	abnormal atrial thrombosis	J:212185
	abnormal cardiac thrombosis	J:212185
	abnormal ventricular thrombosis	J:212185
Prox1^tm4.1Gco/Prox1^tm4.1Gco (involves: 129S1/Sv * C57BL/10 * CBA/Ca)	edema	J:158959
Proz^tm1Gjb/Proz^tm1Gjb (involves: 129X1/SvJ)	increased susceptibility to induced thrombosis	J:136102
Prpf6^{tm1.1(KOMP)Vlcg}/Prpf6⁺ (C57BL/6N-Prpf6^{tm1.1(KOMP)Vlcg}/J)	decreased circulating calcium level	J:211773
	decreased circulating glucose level	J:211773
Prr5^em1(IMPC)J/Prr5^em1(IMPC)J (C57BL/6NJ-Prr5^em1(IMPC)J/Mmjax)	increased circulating cholesterol level	J:211773
	increased circulating HDL cholesterol level	J:211773
Prrc2b^{tm1a(EUCOMM)Wtsi}/Prrc2b^{tm1a(EUCOMM)Wtsi} (C57BL/6N-Prrc2b^{tm1a(EUCOMM)Wtsi}/Wtsi)	retropleural edema	J:239583
Prrg2^{tm1b(EUCOMM)Wtsi}/Prrg2^{tm1b(EUCOMM)Wtsi} (C57BL/6N-Prrg2^{tm1b(EUCOMM)Wtsi}/Wtsi)	increased circulating calcium level	J:211773
	increased circulating iron level	J:211773
Prrg4^em1(IMPC)Mbp/Prrg4^em1(IMPC)Mbp (C57BL/6NCrl-Prrg4^em1(IMPC)Mbp/MbpMmucd)	increased circulating alanine transaminase level	J:211773
Prrt2^{tm1a(KOMP)Wtsi}/Prrt2^{tm1a(KOMP)Wtsi} (C57BL/6N-Prrt2^{tm1a(KOMP)Wtsi}/Wtsi)	increased circulating amylase level	J:211773
Prrt2^{tm1b(KOMP)Wtsi}/Prrt2^{tm1b(KOMP)Wtsi} (C57BL/6N-Prrt2^{tm1b(KOMP)Wtsi}/Ics)	decreased circulating alkaline phosphatase level	J:211773
Prrx1^tm1Jfm/Prrx1^tm1Jfm (involves: 129S4/SvJaeSor)	cyanosis	J:99153
Prrx1^tm1Jfm/Prrx1^tm1Jfm Prrx2^tm1Mjk/Prrx2^tm1Mjk (involves: 129S4/SvJaeSor)	cyanosis	J:51596
Prrx1^tm1Tex/Prrx1^tm1Tex (involves: 129S7/SvEvBrd)	cyanosis	J:25649
Prrx1^tm1Tex/Prrx1^tm1Tex Prrx2^tm1Hubr/Prrx2^tm1Hubr (involves: 129P2/OlaHsd * 129S7/SvEvBrd * FVB)	cyanosis	J:50488
Prrx1^tm1Tex/Prrx1^tm1Tex Prrx2^tm1Mjk/Prrx2^tm1Mjk (involves: 129S7/SvEvBrd * C57BL/6)	cyanosis	J:51596
Prss2^{tm1.1(KOMP)Vlcg}/Prss2^{tm1.1(KOMP)Vlcg} (C57BL/6N-Prss2^{tm1.1(KOMP)Vlcg}/J)	decreased circulating phosphate level	J:211773
Prss3b^tm1.1Satom/Prss3b⁺ (B6(FVB)-Prss3b^tm1.1Satom)	decreased circulating amylase level	J:267764
Prss3b^{tm1b(KOMP)Wtsi}/Prss3b^{tm1b(KOMP)Wtsi} (C57BL/6N-Prss3b^{tm1b(KOMP)Wtsi}/Bay)	decreased circulating alanine transaminase level	J:211773
Prss8^{Gt(IST10122F12)Tigm}/Prss8^{Gt(IST10122F12)Tigm} (involves: 129S6/SvEvTac * Black Swiss * C57BL/6J * C57BL/6N)	dehydration	J:188121
	impaired skin barrier function	J:188121
Prss8^tm1.1Bug/Prss8^{Gt(IST10122F12)Tigm} (involves: 129S6/SvEvTac * Black Swiss * C57BL/6J * C57BL/6N)	impaired skin barrier function	J:214122
Prss8^tm1.1Bug/Prss8^tm1.1Bug (involves: 129S6/SvEvTac * Black Swiss * C57BL/6J * C57BL/6N)	impaired skin barrier function	J:214122
Prss8^tm1.1Hum/Prss8^tm1.2Hum Tg(KRT14-cre)1Ipc/0 (involves: 129/Sv * C57BL/6 * FVB/N * SJL)	abnormal lipid level	J:100139
	dehydration	J:100139
	impaired skin barrier function	J:100139
Prss12^{em1(IMPC)Ccpcz}/Prss12^{em1(IMPC)Ccpcz} (C57BL/6N-Prss12^{em1(IMPC)Ccpcz}/Ccpcz)	increased circulating lactate dehydrogenase level	J:211773
Prss21^{em1(IMPC)Ccpcz}/Prss21⁺ (C57BL/6N-Prss21^{em1(IMPC)Ccpcz}/Ccpcz)	increased circulating total protein level	J:211773
Prss35^{em1(IMPC)Ccpcz}/Prss35^{em1(IMPC)Ccpcz} (C57BL/6N-Prss35^{em1(IMPC)Ccpcz}/Ccpcz)	impaired glucose tolerance	J:211773
Prss47^{em1(IMPC)Ccpcz}/Prss47^{em1(IMPC)Ccpcz} (C57BL/6N-Prss47^{em1(IMPC)Ccpcz}/Ccpcz)	abnormal cholesterol homeostasis	J:211773
	decreased circulating potassium level	J:211773
Prss48^{em1(IMPC)Ccpcz}/Prss48^{em1(IMPC)Ccpcz} (C57BL/6NCrl-Prss48^{em1(IMPC)Ccpcz}/Ccpcz)	decreased respiratory quotient	J:211773
Prss53^{em3(IMPC)Wtsi}/Prss53^{em3(IMPC)Wtsi} (C57BL/6N-Prss53^{em3(IMPC)Wtsi}/Wtsi)	decreased circulating serum albumin level	J:211773
	decreased circulating total protein level	J:211773
	increased circulating creatinine level	J:211773
Prss57^tm1.1Gne/Prss57^tm1.1Gne (C57BL/6N-Prss57^tm1.1Gne)	decreased histamine level	J:301479
Prss57^tm1.1Gne/Prss57^tm1.1Gne (C57BL/6N-Prss57^tm1.1Gne)	decreased serotonin level	J:301479
pru1/pru1 (Not Specified)	albuminuria	J:85113
pru2/pru2 (Not Specified)	albuminuria	J:85113
Prxl2a^{tm1(KOMP)Vlcg}/Prxl2a^{tm1(KOMP)Vlcg} (C57BL/6N-Prxl2a^{tm1(KOMP)Vlcg})	decreased circulating adiponectin level	J:234040
	decreased collagen level	J:234040
	increased adiponectin level	J:234040
	increased circulating insulin level	J:234040
Prxl2b^tm1.2Ksak/Prxl2b^tm1.2Ksak (involves: C57BL/6N * C57BL/6NCrlj * CBA/JNCrlj)	abnormal lipid level	J:307536
Ps/Ps (involves: 101/H * C3H/HeH * C57BL/Gr * CBA/Gr)	edema	J:5125
Ps/Ps (involves: 101/H * C3H/HeH * C57BL/Gr * CBA/Gr)	skin edema	J:5125
Ps/Ps⁺ (involves: 101/H * C3H/HeH * C57BL/Gr * CBA/Gr)	extremity edema	J:5125
Psap^tm1Ggb/Psap^tm1Ggb (involves: 129S/SvEv * C57BL/6J)	abnormal lipid level	J:121761
Psap^tm1Suz/Psap^tm1Suz (involves: 129P2/OlaHsd)	abnormal circulating testosterone level	J:106511
	abnormal enzyme/coenzyme level	J:283977
	abnormal lipid homeostasis	J:33477
	abnormal lipid level	J:78223
	increased beta-galactosidase level	J:283977
Psap^tm1Suz/Psap^tm1Suz (B6.129P2-Psap^tm1Suz)	abnormal lipid level	J:120657
Psap^tm2.1Juma/Psap^tm2.1Juma (involves: 129 * C57BL/6J * FVB/N)	abnormal enzyme/coenzyme level	J:283977
Psap^tm2Ggb/Psap^tm2Ggb (involves: 129S/SvEv * C57BL/6J)	abnormal urine homeostasis	J:137650
Psap^tm2Suz/Psap^tm2Suz (involves: 129S/SvEv * C57BL/6J)	abnormal lipid level	J:73188, J:78223, J:120657
Psap^tm4.1Ggb/Psap^tm4.1Ggb (involves: 129S/SvEv * C57BL/6J)	abnormal lipid homeostasis	J:198242
Psat1^{tm1a(KOMP)Wtsi}/Psat1⁺ (B6JTyr;B6N-Psat1^{tm1a(KOMP)Wtsi}/Wtsi)	decreased blood urea nitrogen level	J:175295
Psen1^{tm1.1(KOMP)Vlcg}/Psen1⁺ (C57BL/6N-Psen1^{tm1.1(KOMP)Vlcg}/Ucd)	edema	J:211773
Psen1^{tm1.1(KOMP)Vlcg}/Psen1^{tm1.1(KOMP)Vlcg} (C57BL/6N-Psen1^{tm1.1(KOMP)Vlcg}/J)	cyanosis	J:211773
	edema	J:211773
Psen1^{tm1.1(KOMP)Vlcg}/Psen1^{tm1.1(KOMP)Vlcg} (C57BL/6N-Psen1^{tm1.1(KOMP)Vlcg}/Ucd)	edema	J:211773
Psen1^tm1.1Ruvi/Psen1^tm1.1Ruvi (C57BL/6J-Psen1^tm1.1Ruvi)	increased circulating follicle stimulating hormone level	J:187475
Psen1^tm1Bdes/Psen1⁺ Psen2^tm1Bdes/Psen2^tm1Bdes (involves: 129P2/OlaHsd)	hematuria	J:91235
	increased urine protein level	J:91235
Psen1^tm1Hko/Psen1^tm1Hko (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	skin edema	J:84418
Psen1^tm1Lpr/Psen1^tm1Lpr (involves: 129 * C57BL/6 * CBA)	increased circulating cholesterol level	J:128243
Psen1^tm1Lpr/Psen1^tm1Lpr Tg(Thy1-APP^SL)28Lpr/0 (involves: 129 * C57BL/6 * CBA)	decreased circulating cholesterol level	J:128243
	increased circulating cholesterol level	J:128243
Psg20^{em1(IMPC)Wtsi}/Psg20^{em1(IMPC)Wtsi} (C57BL/6N-Psg20^{em1(IMPC)Wtsi}/Wtsi)	decreased circulating cholesterol level	J:211773
Psg22^{em1(IMPC)Wtsi}/Psg22^{em1(IMPC)Wtsi} (C57BL/6N-Psg22^{em1(IMPC)Wtsi}/Wtsi)	increased fasting circulating glucose level	J:211773
Psg25^{em1(IMPC)Wtsi}/Psg25^{em1(IMPC)Wtsi} (C57BL/6N-Psg25^{em1(IMPC)Wtsi}/Wtsi)	decreased circulating chloride level	J:211773
	increased blood urea nitrogen level	J:211773
	increased circulating creatinine level	J:211773
Psg27^{em1(IMPC)Wtsi}/Psg27^{em1(IMPC)Wtsi} (C57BL/6N-Psg27^{em1(IMPC)Wtsi}/Wtsi)	increased circulating insulin level	J:211773
Psip1^em1(IMPC)J/Psip1⁺ (C57BL/6NJ-Psip1^em1(IMPC)J/Mmjax)	decreased circulating creatinine level	J:211773
Pskh1^{tm1b(EUCOMM)Wtsi}/Pskh1⁺ (C57BL/6N-Pskh1^{tm1b(EUCOMM)Wtsi}/J)	improved glucose tolerance	J:211773
	increased fasting circulating glucose level	J:211773
Pskh1^{tm1b(EUCOMM)Wtsi}/Pskh1^{tm1b(EUCOMM)Wtsi} (C57BL/6N-Pskh1^{tm1b(EUCOMM)Wtsi}/J)	edema	J:211773
Psmb10^Tub6/Psmb10^Tub6 (C3HeB/FeJ-Psmb10^Tub6)	increased circulating interleukin-1 level	J:261081
	increased circulating interleukin-6 level	J:261081
	increased circulating tumor necrosis factor level	J:261081
Psmc1^tm1Maye/Psmc1^tm1.1Maye Th^tm1(cre)Te/Th⁺ (involves: 129X1/SvJ * CD-1)	abnormal noradrenaline level	J:138991
	decreased dopamine level	J:138991
Psmc1^tm1Maye/Psmc1^tm1Maye Th^tm1(cre)Te/Th⁺ (involves: 129X1/SvJ * CD-1)	abnormal noradrenaline level	J:138991
	decreased dopamine level	J:138991
Psmc2^{tm1b(EUCOMM)Hmgu}/Psmc2⁺ (C57BL/6N-Psmc2^{tm1b(EUCOMM)Hmgu}/Ieg)	decreased circulating alkaline phosphatase level	J:211773
	decreased circulating total protein level	J:211773
	increased circulating bilirubin level	J:211773
Psph^{tm1.1(KOMP)Vlcg}/Psph⁺ (C57BL/6N-Psph^{tm1.1(KOMP)Vlcg}/Ucd)	decreased circulating triglyceride level	J:211773
Psph^{tm1.1(KOMP)Vlcg}/Psph^{tm1.1(KOMP)Vlcg} (C57BL/6N-Psph^{tm1.1(KOMP)Vlcg}/Ucd)	edema	J:211773
Psph^{tm1a(EUCOMM)Hmgu}/Psph^{tm1a(EUCOMM)Hmgu} (C57BL/6N-Psph^{tm1a(EUCOMM)Hmgu}/Wtsi)	subcutaneous edema	J:239583, J:261316
Pstpip1^{em1(IMPC)Ccpcz}/Pstpip1^{em1(IMPC)Ccpcz} (C57BL/6N-Pstpip1^{em1(IMPC)Ccpcz}/Ccpcz)	decreased circulating potassium level	J:211773
	increased circulating total protein level	J:211773
Pstpip2^em1(IMPC)Tcp/Pstpip2^em1(IMPC)Tcp (C57BL/6NCrl-Pstpip2^em1(IMPC)Tcp/Tcp)	improved glucose tolerance	J:211773
	increased circulating alkaline phosphatase level	J:211773
Ptbp2^tm1.1Dblk/Ptbp2^tm1.1Dblk Tg(Nes-cre)1Kln/0 (involves: 129S2/SvPas * C57BL/6 * SJL)	cyanosis	J:207976
Ptcd1^{tm1(KOMP)Vlcg}/Ptcd1⁺ (C57BL/6N-Ptcd1^{tm1(KOMP)Vlcg})	impaired glucose tolerance	J:256004
	increased circulating leptin level	J:256004
	increased circulating triglyceride level	J:256004
	insulin resistance	J:256004
Ptcd3^{tm1.1(KOMP)Vlcg}/Ptcd3⁺ (C57BL/6N-Ptcd3^{tm1.1(KOMP)Vlcg}/J)	decreased circulating HDL cholesterol level	J:211773
Ptch1^tm1Bjw/Ptch1^tm1Bjw Tg(KRT14-cre)8Brn/0 (involves: 129T2/SvEms * FVB/N)	decreased circulating insulin-like growth factor I level	J:231264
Ptch2^{tm3b(EUCOMM)Hmgu}/Ptch2^{tm3b(EUCOMM)Hmgu} (C57BL/6N-Ptch2^{tm3b(EUCOMM)Hmgu}/Bay)	increased fasting circulating glucose level	J:211773
Ptchd1^{tm1b(KOMP)IcsOrl}/Ptchd1^{tm1b(KOMP)IcsOrl} (C57BL/6N-Ptchd1^{tm1b(KOMP)IcsOrl}/Ics)	increased circulating creatinine level	J:211773
Ptdss1^{tm1b(EUCOMM)Hmgu}/Ptdss1^{tm1b(EUCOMM)Hmgu} (C57BL/6N-Ptdss1^{tm1b(EUCOMM)Hmgu}/Ics)	increased circulating calcium level	J:211773
Ptdss1^tm1Jev/Ptdss1⁺ Ptdss2^{Gt(KST314)Byg}/Ptdss2^{Gt(KST314)Byg} (involves: 129P2/OlaHsd * 129S/SvEv * C57BL/6)	abnormal phospholipid level	J:137106
Ptdss1^tm1Jev/Ptdss1^tm1Jev (involves: 129S/SvEv * C57BL/6)	abnormal phospholipid level	J:137106
Ptdss1^tm1Jev/Ptdss1^tm1Jev Ptdss2^{Gt(KST314)Byg}/Ptdss2⁺ (involves: 129P2/OlaHsd * 129S/SvEv * C57BL/6)	abnormal phospholipid level	J:137106
Ptdss2^{Gt(KST314)Byg}/Ptdss2^{Gt(KST314)Byg} (involves: 129P2/OlaHsd * C57BL/6)	increased circulating follicle stimulating hormone level	J:80673
Pten^tm1.1Yxy/Pten^tm1.1Yxy (involves: C57BL/6)	increased glutamic acid level	J:290673
Pten^tm1Hwu/Pten⁺ Tg(Nkx2-1-cre)2Sand/0 (involves: 129S4/SvJae * BALB/c * C57BL/6)	increased thyroxine level	J:197590
Pten^tm1Hwu/Pten⁺ Tg(Nkx2-1-cre)2Sand/0 (B6.Cg-Pten^tm1Hwu Tg(Nkx2-1-cre)2Sand)	decreased thyroxine level	J:197590
Pten^tm1Hwu/Pten^tm1Hwu Lyz2^tm1(cre)Ifo/Lyz2⁺ (involves: 129P2/OlaHsd * 129S4/SvJae)	abnormal cytokine level	J:148947
	pulmonary edema	J:148947
Pten^tm1Hwu/Pten^tm1Hwu Rictor^tm1.1Mgn/Rictor^tm1.1Mgn Tg(Ins2-cre)25Mgn/0 (involves: 129S4/SvJae * 129S6/SvEvTac * BALB/c * C57BL/6 * DBA)	abnormal glucose homeostasis	J:170129
	decreased circulating insulin level	J:170129
	hypoglycemia	J:170129
Pten^tm1Hwu/Pten^tm1Hwu Slc6a3^{tm1.1(cre)Bkmn}/Slc6a3⁺ (involves: 129S4/SvJae * C57BL/6)	increased dopamine level	J:153622
Pten^tm1Hwu/Pten^tm1Hwu Speer6-ps1^{Tg(Alb-cre)21Mgn}/Speer6-ps1⁺ (involves: 129S4/SvJae * C57BL/6 * DBA)	abnormal fatty acids level	J:88441
	decreased circulating free fatty acids level	J:88441
	decreased circulating glucose level	J:88441
	decreased circulating insulin level	J:88441
	decreased circulating leptin level	J:88441
	impaired lipolysis	J:88441
	improved glucose tolerance	J:88441
	increased circulating alanine transaminase level	J:218587
	increased insulin sensitivity	J:88441
	increased liver glycogen level	J:88441
	increased liver triglyceride level	J:88441, J:160759
Pten^tm1Hwu/Pten^tm1Hwu Tg(CAG-EGFP,-PAX8/PPARG)1Rkoe/0 Tg(TPO-cre)1Shk/0 (involves: 129S4/SvJae * FVB/NCr * FVB/NJ)	increased circulating thyroxine level	J:177181
	increased circulating triiodothyronine level	J:177181
Pten^tm1Hwu/Pten^tm1Hwu Tg(CAG-fat-1)1Jxk/0 Tg(Pbsn-cre)4Prb/0 (involves: 129S4/SvJae * BALB/c * C57BL/6 * DBA/2)	abnormal lipid homeostasis	J:124208
Pten^tm1Hwu/Pten^tm1Hwu Tg(Ckmm-cre)5Khn/? (involves: 129S4/SvJae * FVB)	decreased circulating glucose level	J:169364
	decreased circulating insulin level	J:169364
Pten^tm1Hwu/Pten^tm1Hwu Tg(Fabp4-cre)1Abel/0 (involves: 129S4/SvJae)	abnormal cytokine level	J:97588
	decreased circulating insulin level	J:97588
	improved glucose tolerance	J:97588
	increased insulin sensitivity	J:97588
Pten^tm1Hwu/Pten^tm1Hwu Tg(Gdf9-icre)5092Coo/0 (B6.Cg-Pten^tm1Hwu Tg(Gdf9-icre)5092Coo)	increased follicle stimulating hormone level	J:131827
	increased luteinizing hormone level	J:131827
Pten^tm1Hwu/Pten^tm1Hwu Tg(Ins2-cre)25Mgn/0 (involves: 129S4/SvJae * C57BL/6 * DBA)	hypoglycemia	J:106937
	improved glucose tolerance	J:170206
	increased insulin secretion	J:170206
	increased insulin sensitivity	J:170206
Pten^tm1Hwu/Pten^tm1Hwu Tg(Mx1-cre)1Cgn/0 (involves: 129S4/SvJae * C57BL/6 * C57BL/6J * CBA)	abnormal platelet activation	J:165893
	decreased bleeding time	J:165893
	increased platelet aggregation	J:165893
Pten^tm1Hwu/Pten^tm1Hwu Tg(Nkx2-1-cre)2Sand/0 (B6.Cg-Pten^tm1Hwu Tg(Nkx2-1-cre)2Sand)	decreased thyroxine level	J:197590
	increased thyroid-stimulating hormone level	J:197590
Pten^tm1Hwu/Pten^tm1Hwu Trp53^tm2Tyj/Trp53⁺ Amhr2^tm3(cre)Bhr/Amhr2⁺ (involves: 129P2/OlaHsd * 129S4/SvJae * 129S7/SvEvBrd)	ascites	J:222579
Pten^tm1Hwu/Pten^tm1Hwu Twist2^{tm1.1(cre)Dor}/Twist2⁺ (B6.129-Twist2^{tm1.1(cre)Dor} Pten^tm1Hwu)	cyanosis	J:192736
	decreased blood oxygen capacity	J:192736
Pten^tm2.1Ppp/Pten^tm2.1Ppp Tg(TPO-cre)1Shk/0 (129S1.Cg-Pten^tm2.1Ppp Tg(TPO-cre)1Shk)	decreased thyroid-stimulating hormone level	J:165293
	increased thyroxine level	J:165293
Pten^tm2.1Ppp/Pten^tm2.1Ppp Trp53^tm1Brn/Trp53^tm1Brn Tg(TPO-cre)1Shk/0 (129.Cg-Tg(TPO-cre)1Shk Trp53^tm1Brn Pten^tm2.1Ppp)	decreased thyroid-stimulating hormone level	J:211100
Pten^tm2Mak/Pten^tm2Mak Speer6-ps1^{Tg(Alb-cre)21Mgn}/Speer6-ps1⁺ (involves: 129P2/OlaHsd * C57BL/6 * DBA)	increased circulating alanine transaminase level	J:138099
	increased circulating alkaline phosphatase level	J:138099
	increased liver cholesterol level	J:138099
	increased liver triglyceride level	J:138099
Pten^tm2Mak/Pten^tm2Mak Speer6-ps1^{Tg(Alb-cre)21Mgn}/Speer6-ps1⁺ (involves: 129P2/OlaHsd * C57BL/6 * C57BL/6J * DBA)	decreased circulating insulin level	J:90905
	decreased fasting circulating glucose level	J:90905
	increased circulating alanine transaminase level	J:90905
	increased circulating alkaline phosphatase level	J:90905
	increased circulating aspartate transaminase level	J:90905
	increased insulin sensitivity	J:90905
	increased liver triglyceride level	J:90905
	increased saturated fatty acids level	J:90905
Pten^tm2Mak/Pten^tm2Mak Tg(SFTPC-rtTA)5Jaw/0 Tg(tetO-cre)1Jaw/0 (involves: 129 * 129P2/OlaHsd * C57BL/6 * C57BL/6J)	cyanosis	J:127405
	hypoxia	J:127405
	respiratory acidosis	J:127405
Ptf1a^tm1Pkwe/Ptf1a^tm1Pkwe (involves: 129P2/OlaHsd * C57BL/6)	cyanosis	J:51571
	hypoglycemia	J:51571
Ptgdr2^tm1Tasa/Ptgdr2^tm1Tasa (C.129-Ptgdr2^tm1Tasa)	abnormal chemokine level	J:131146
Ptgdr2^tm1Tasa/Ptgdr2^tm1Tasa (C.129-Ptgdr2^tm1Tasa)	decreased prostaglandin level	J:131146
Ptgdr2^tm1Tasa/Ptgdr2^tm1Tasa (B6.129-Ptgdr2^tm1Tasa)	edema	J:197334
Ptgds^tm1Ohy/Ptgds^tm1Ohy (B6.129P2-Ptgds^tm1Ohy)	edema	J:197334
Ptger1^tm1Crjk/Ptger1^tm1Crjk (B6.129S6-Ptger1^tm1Crjk)	abnormal hormone level	J:118519
Ptger1^tm1Crjk/Ptger1^tm1Crjk (B6.129S6-Ptger1^tm1Crjk)	decreased urine osmolality	J:118519
Ptger1^tm1Matb/Ptger1^tm1Matb (129S6/SvEvTac-Ptger1^tm1Matb)	decreased urine sodium level	J:127410
Ptger1^tm1Sna/Ptger1^tm1Sna (B6CrSlc.129P2-Ptger1^tm1Sna/Sna)	decreased circulating adrenocorticotropin level	J:82750
	decreased dopamine level	J:102926
	impaired febrile response	J:105574
	increased dopamine level	J:157627
Ptger2^tm1Brey/Ptger2^tm1Brey (either: (involves: 129S6/SvEvTac) or (involves: 129S6/SvEvTac * C57BL/6))	abnormal circulating calcium level	J:77679
Ptger3^tm1Cof/Ptger3^tm1Cof (either: (involves: 129P2/OlaHsd * C57BL/6 * DBA/2) or (involves: 129P2/OlaHsd * 129S/SvEv))	abnormal urine osmolality	J:52323
Ptger3^tm1Cof/Ptger3^tm1Cof (involves: 129P2/OlaHsd * C57BL/6)	decreased susceptibility to induced thrombosis	J:125376
Ptger3^tm1Csml/Ptger3^tm1Csml (involves: 129S4/SvJae * C57BL/6)	impaired febrile response	J:127396
Ptger3^tm1Csml/Ptger3^tm1Csml Tg(Nes-cre)1Kln/? (involves: 129S4/SvJae * C57BL/6 * SJL)	impaired adaptive thermogenesis	J:127396
	impaired febrile response	J:127396
Ptger3^tm1Sna/Ptger3^tm1Sna (involves: 129P2/OlaHsd * C57BL/6)	impaired febrile response	J:70534
Ptger3^tm1Sna/Ptger3^tm1Sna (B6.129P2-Ptger3^tm1Sna/Sna)	abnormal body temperature homeostasis	J:105574
	decreased circulating adrenocorticotropin level	J:82750
	edema	J:197334
	impaired febrile response	J:105574
Ptger3^tm1Sna/Ptger3^tm1Sna (involves: 129P2/OlaHsd)	impaired febrile response	J:155398
Ptger4^tm1.2Matb/Ptger4⁺ (B6.129S6-Ptger4^tm1.2Matb)	abnormal calcium ion homeostasis	J:112753
Ptger4^tm1.2Matb/Ptger4^tm1.2Matb (B6.129S6-Ptger4^tm1.2Matb)	abnormal calcium ion homeostasis	J:112753
Ptger4^tm1Bhk/Ptger4^tm1Bhk (involves: 129P2/OlaHsd * 129S/SvEv)	pulmonary edema	J:44108
Ptger4^tm1Bhk/Ptger4^tm1Bhk (involves: 129P2/OlaHsd * C57BL/6 * DBA/2)	abnormal circulating interleukin-6 level	J:78964
	abnormal circulating serum amyloid protein level	J:78964
	abnormal cytokine level	J:78964
	abnormal prostaglandin level	J:78964
Ptges2^tm1Kymm/Ptges2^tm1Kymm (B6.Cg-Ptges2^tm1Kymm)	edema	J:197334
Ptges3^{Gt(RST271)Byg}/Ptges3^{Gt(RST271)Byg} (involves: 129P2/OlaHsd * C57BL/6)	impaired skin barrier function	J:117591
Ptges3^{Gt(W069F07)Wrst}/Ptges3^{Gt(W069F07)Wrst} (involves: 129X1/SvJ * C57BL/6)	impaired skin barrier function	J:117591
Ptges3^tm1Nkt/Ptges3^tm1Nkt (involves: 129P2/OlaHsd * C57BL/6)	decreased prostaglandin level	J:125188
Ptges^tm1.1Gaf/Ptges^tm1.1Gaf Lyz2^tm1(cre)Ifo/Lyz2⁺ (involves: 129 * C57BL/6)	decreased prostaglandin level	J:210141
	increased prostaglandin level	J:210141
Ptges^tm1.1Gaf/Ptges^tm1.1Gaf Tg(Tagln-cre)1Her/0 (involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * SJL)	decreased prostaglandin level	J:210141
	increased prostaglandin level	J:210141
Ptges^tm1.1Gaf/Ptges^tm1.1Gaf Tg(Tek-cre)1Ywa/0 (involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * SJL)	decreased prostaglandin level	J:210141
	increased prostaglandin level	J:210141
Ptges^tm1Aki/Ptges^tm1Aki (involves: 129P2/OlaHsd)	decreased leukotriene level	J:92047
Ptges^tm1Aki/Ptges^tm1Aki (involves: 129X1/SvJ * C57BL/6)	abnormal prostaglandin level	J:91821
Ptges^tm1Aki/Ptges^tm1Aki (B6.129P2-Ptges^tm1Aki)	edema	J:197334
Ptges^tm1Lpa/Ptges^tm1Lpa (DBA/1LacJ-Ptges^tm1Lpa)	decreased prostaglandin level	J:106147
Ptgir^tm1Sna/Ptgir^tm1Sna (involves: 129P2/OlaHsd * C57BL/6)	abnormal blood coagulation	J:42275
	abnormal platelet activation	J:79049
	abnormal thromboxane level	J:79049
	decreased prostaglandin level	J:42275
	increased susceptibility to induced thrombosis	J:42275, J:108957
Ptgis^tm1Tada/Ptgis^tm1Tada (B6.129-Ptgis^tm1Tada)	abnormal thromboxane level	J:103380
	decreased prostaglandin level	J:103380
	increased blood urea nitrogen level	J:103380
	increased circulating creatinine level	J:103380
	increased prostaglandin level	J:103380
Ptgs1^tm1Fun/Ptgs1^tm1Fun (involves: 129S6/SvEvTac * C57BL/6)	abnormal thromboxane level	J:108957
	decreased platelet aggregation	J:97351
	decreased susceptibility to induced thrombosis	J:97351
	decreased urine prostaglandin level	J:108957
	increased bleeding time	J:97351
Ptgs1^tm1Unc/Ptgs1⁺ (involves: 129P2/OlaHsd * C57BL/6)	decreased prostaglandin level	J:29511
Ptgs1^tm1Unc/Ptgs1⁺ (involves: 129P2/OlaHsd * C57BL/6 * DBA/2)	decreased prostaglandin level	J:106147
Ptgs1^tm1Unc/Ptgs1⁺ (D1.129P2-Ptgs1^tm1Unc)	increased prostaglandin level	J:102779
Ptgs1^tm1Unc/Ptgs1^tm1Unc (involves: 129P2/OlaHsd * C57BL/6)	abnormal blood coagulation	J:29511
	abnormal urine homeostasis	J:110043
	decreased platelet aggregation	J:29511
	decreased prostaglandin level	J:103388, J:117986, J:60668, J:50148, J:29511
	decreased urine prostaglandin level	J:110043
	increased circulating progesterone level	J:50148
Ptgs1^tm1Unc/Ptgs1^tm1Unc (involves: 129P2/OlaHsd * C57BL/6 * DBA/2)	decreased prostaglandin level	J:106147
Ptgs1^tm1Unc/Ptgs1^tm1Unc (involves: 129P2/OlaHsd)	decreased prostaglandin level	J:108679
Ptgs1^tm1Unc/Ptgs1^tm1Unc Oxt^tm1Ljm/Oxt^tm1Ljm (involves: 129P2/OlaHsd * C57BL/6)	decreased prostaglandin level	J:50148
Ptgs1^tm1Unc/Ptgs1^tm1Unc Ptgs2^tm1Unc/Ptgs2^tm1Unc (involves: 129P2/OlaHsd * C57BL/6J)	cyanosis	J:67208
Ptgs2^tm1.1Fun/Ptgs2^tm1.1Fun (involves: 129S6/SvEvTac * C57BL/6)	decreased prostaglandin level	J:109548
Ptgs2^tm1.1Fun/Ptgs2^tm1.1Fun (involves: 129S6/SvEvTac)	increased blood urea nitrogen level	J:148699
Ptgs2^tm1.1Wls/Ptgs2^tm1.1Wls (B6.129-Ptgs2^tm1.1Wls)	impaired febrile response	J:156331
Ptgs2^tm1.1Wls/Ptgs2^tm1.1Wls (B6.129-Ptgs2^tm1.1Wls)	increased urine prostaglandin level	J:156331
Ptgs2^tm1Fun/Ptgs2^tm1Fun (involves: 129S6/SvEvTac * C57BL/6)	abnormal blood coagulation	J:108957
	abnormal platelet physiology	J:108957
	abnormal thrombolysis	J:108957
	decreased prostaglandin level	J:109548
	decreased susceptibility to induced thrombosis	J:108957
	decreased urine prostaglandin level	J:108957
Ptgs2^tm1Jed/Ptgs2^tm1Jed (involves: 129S7/SvEvBrd)	increased blood urea nitrogen level	J:29974
Ptgs2^tm1Jed/Ptgs2^tm1Jed (involves: 129S7/SvEvBrd)	increased circulating creatinine level	J:29974
Ptgs2^tm1Jed/Ptgs2^tm1Jed (involves: 129S7/SvEvBrd * C57BL/6)	decreased prostaglandin level	J:109548
	increased blood urea nitrogen level	J:104002, J:118171
	increased circulating creatinine level	J:104002
Ptgs2^tm1Unc/Ptgs2⁺ (involves: 129P2/OlaHsd * C57BL/6J)	impaired febrile response	J:54450
Ptgs2^tm1Unc/Ptgs2⁺ (involves: 129/Sv * 129P2/OlaHsd * C57BL/6)	decreased prostaglandin level	J:124756
Ptgs2^tm1Unc/Ptgs2⁺ (D1.129P2-Ptgs2^tm1Unc)	increased circulating insulin level	J:102779
	increased circulating leptin level	J:102779
	increased prostaglandin level	J:102779
	increased susceptibility to diet-induced obesity	J:102779
Ptgs2^tm1Unc/Ptgs2⁺ (B6.129P2-Ptgs2^tm1Unc)	decreased prostaglandin level	J:67211
Ptgs2^tm1Unc/Ptgs2^tm1Unc (involves: 129P2/OlaHsd * C57BL/6J)	abnormal lipid homeostasis	J:121680
	abnormal thrombosis	J:109021
	decreased prostaglandin level	J:109021, J:55145
	impaired febrile response	J:54450
	increased circulating follicle stimulating hormone level	J:55145
	increased circulating luteinizing hormone level	J:55145
	intestinal edema	J:29510
Ptgs2^tm1Unc/Ptgs2^tm1Unc (D1.129P2(B6J)-Ptgs2^tm1Unc)	increased blood urea nitrogen level	J:102777
Ptgs2^tm1Unc/Ptgs2^tm1Unc (D1.129P2(B6J)-Ptgs2^tm1Unc)	increased circulating creatinine level	J:102777
Ptgs2^tm1Unc/Ptgs2^tm1Unc (involves: 129/Sv * 129P2/OlaHsd * C57BL/6)	decreased platelet calcium level	J:124756
	decreased prostaglandin level	J:124756
Ptgs2^tm1Unc/Ptgs2^tm1Unc (involves: 129P2/OlaHsd * C57BL/6)	abnormal enzyme/coenzyme level	J:108054
	decreased lactate dehydrogenase level	J:108054
	decreased prostaglandin level	J:117986, J:60668
	increased blood urea nitrogen level	J:104002
	increased circulating creatinine level	J:104002
Ptgs2^tm1Unc/Ptgs2^tm1Unc (D1.129P2-Ptgs2^tm1Unc)	decreased prostaglandin level	J:102779
Ptgs2^tm1Unc/Ptgs2^tm1Unc (B6.129P2-Ptgs2^tm1Unc)	decreased prostaglandin level	J:67211
Ptgs2^tm1Unc/Ptgs2^tm1Unc (B6;129P2-Ptgs2^tm1Unc/Tac)	decreased prostaglandin level	J:141610
Ptgs2^{tm2.1(Ptgs1)Fun}/Ptgs2^{tm2.1(Ptgs1)Fun} (involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * FVB)	decreased urine prostaglandin level	J:118171
	increased blood urea nitrogen level	J:118171
Ptgs2^tm3Fun/Ptgs2^tm3Fun (involves: 129S6/SvEvTac * C57BL/6J)	abnormal urine homeostasis	J:148699
	increased blood urea nitrogen level	J:148699
	increased platelet aggregation	J:148699
	increased susceptibility to induced thrombosis	J:148699
Ptgs2os^tm1Scrp/Ptgs2os^tm1Scrp (Not Specified)	abnormal chemokine level	J:325487
	decreased CCL3 level	J:325487
	decreased circulating CCL3 level	J:325487
	decreased circulating interleukin-6 level	J:325487
Pth1r^{tm1a(EUCOMM)Hmgu}/Pth1r^{tm1a(EUCOMM)Hmgu} (C57BL/6N-Pth1r^{tm1a(EUCOMM)Hmgu}/Wtsi)	retropharyngeal edema	J:239583
Pth1r^tm1Abas/Pth1r^tm1Abas (B6.Cg-Pth1r^tm1Abas)	abnormal blood homeostasis	J:113660
	abnormal circulating phosphate level	J:113660
	decreased circulating parathyroid hormone level	J:113660
	increased circulating calcium level	J:113660
Pth2r^tm1.1Tbu/Pth2r^tm1.1Tbu (involves: 129 * 129S4/SvJae * C57BL/6)	decreased core body temperature	J:277091
Pth^{tm1a(EUCOMM)Wtsi}/Pth^{tm1a(EUCOMM)Wtsi} (C57BL/6N-Pth^{tm1a(EUCOMM)Wtsi}/Wtsi)	decreased circulating calcium level	J:211773
Pthlh^{tm1a(KOMP)Wtsi}/Pthlh⁺ (C57BL/6N-Pthlh^{tm1a(KOMP)Wtsi}/Wtsi)	increased blood urea nitrogen level	J:211773
Pthlh^tm1Ack/Pthlh^tm1Hmk Tg(LGB-cre)74Acl/0 (involves: 129 * C57BL/6 * CBA)	abnormal circulating hormone level	J:86536
	abnormal urine homeostasis	J:86536
	abnormal vitamin D level	J:86536
Pthlh^tm1Fbe/Pthlh^tm1Fbe (involves: 129S1/Sv * 129X1/SvJ)	abnormal calcium ion homeostasis	J:79622
Pthlh^tm1Fbe/Pthlh^tm1Fbe (involves: 129S1/Sv * 129X1/SvJ)	abnormal circulating calcium level	J:79622
Pthlh^tm1Hmk/Pthlh^tm1Hmk (either: (involves: 129S2/SvPas) or (involves: 129S2/SvPas * C57BL/6))	cyanosis	J:16911
Pthlh^tm2Ack/Pthlh^tm2Ack (involves: 129S2/SvPas * C57BL/6)	decreased circulating glucose level	J:142669
Ptk2^tm1.1Guan/Ptk2^tm1.1Guan Tg(Tek-cre)12Flv/0 (involves: 129P2/OlaHsd * C3H * C57BL/6)	edema	J:162690
Ptk2^tm1.1Guan/Ptk2^tm1.2Guan Tg(Tek-cre)12Flv/0 (involves: 129P2/OlaHsd * C3H * C57BL/6 * C57BL/6J)	edema	J:99637
Ptk2^tm1Heen/Ptk2^tm1Heen (involves: 129/Sv * C57BL/6)	edema	J:157804
Ptk2b^tm1Okig/Ptk2b^tm1Okig (involves: C57BL/6)	abnormal calcium ion homeostasis	J:139849
Ptma^tm1.1Got/Ptma⁺ (involves: C57BL/6J * C57BL/6NTac)	decreased body temperature	J:240549
Ptms^{tm1.1(KOMP)Wtsi}/Ptms⁺ (C57BL/6N-Ptms^{tm1.1(KOMP)Wtsi}/J)	increased circulating phosphate level	J:211773
Ptn^tm1Tmu/Ptn^tm1Tmu (B6.Cg-Ptn^tm1Tmu)	abnormal circulating enzyme level	J:102069
Ptnu1^FGS/Kist/? (involves: C57BL/6J * FGS/Kist)	increased urine protein level	J:99319
Ptnu1^FGS/Kist/Ptnu1^FGS/Kist Ptnu2^FGS/Kist/Ptnu2^FGS/Kist (involves: C57BL/6J * FGS/Kist)	increased urine protein level	J:99319
Ptnu2^FGS/Kist/? (involves: C57BL/6J * FGS/Kist)	increased urine protein level	J:99319
Ptnu3^FGS/Kist/Ptnu3^FGS/Kist Ptnu2^FGS/Kist/Ptnu2^FGS/Kist (involves: C57BL/6J * FGS/Kist)	increased urine protein level	J:99319
Ptnu4^FGS/Kist/Ptnu4^FGS/Kist Ptnu5^C57BL/6J/Ptnu5^FGS/Kist (involves: C57BL/6J * FGS/Kist)	increased urine protein level	J:99319
Ptov1^em1(IMPC)Bay/Ptov1^em1(IMPC)Bay (C57BL/6N-Ptov1^em1(IMPC)Bay/BayMmucd)	edema	J:211773
Ptp4a1^em2(IMPC)Tcp/Ptp4a1^em2(IMPC)Tcp (C57BL/6NCrl-Ptp4a1^em2(IMPC)Tcp/Tcp)	increased circulating alkaline phosphatase level	J:211773
Ptp4a3^tm1.2Xhan/Ptp4a3^tm1.2Xhan (involves: 129S4/SvJaeSor * 129S6/SvEvTac * C57BL/6J * FVB/N)	decreased circulating glucose level	J:197019
Ptpdc1^{tm1.1(KOMP)Vlcg}/Ptpdc1^{tm1.1(KOMP)Vlcg} (C57BL/6N-Ptpdc1^{tm1.1(KOMP)Vlcg}/Ucd)	increased circulating phosphate level	J:211773
Ptpn1^tm1Bbk/Ptpn1⁺ (involves: 129S4/SvJae * C57BL/6J)	decreased circulating insulin level	J:63236
Ptpn1^tm1Bbk/Ptpn1⁺ (involves: 129S4/SvJae * C57BL/6J)	decreased circulating leptin level	J:63236
Ptpn1^tm1Bbk/Ptpn1^tm1Bbk (involves: 129S4/SvJae * C57BL/6J)	abnormal energy expenditure	J:63236
	decreased circulating glucose level	J:63236
	decreased circulating insulin level	J:63236
	decreased circulating leptin level	J:63236
	decreased susceptibility to diet-induced obesity	J:63236
	improved glucose tolerance	J:63236
	increased core body temperature	J:63236
	increased insulin sensitivity	J:63236
Ptpn1^tm1Bpk/Ptpn1⁺ (involves: 129S4/SvJae * BALB/c)	decreased circulating glucose level	J:53437
Ptpn1^tm1Bpk/Ptpn1⁺ (involves: 129S4/SvJae * BALB/c)	decreased susceptibility to diet-induced obesity	J:53437
Ptpn1^tm1Bpk/Ptpn1^tm1Bpk (involves: 129S4/SvJae * BALB/c)	decreased circulating glucose level	J:53437
	decreased circulating insulin level	J:53437
	decreased susceptibility to diet-induced obesity	J:53437
	decreased triglyceride level	J:53437
	improved glucose tolerance	J:53437
	increased insulin sensitivity	J:53437
Ptpn1^tm2Bbk/Ptpn1⁺ Tg(Nes-cre)1Kln/0 (involves: 129S4/SvJae * C57BL/6 * SJL)	decreased circulating glucose level	J:111969
	decreased circulating insulin level	J:111969
Ptpn1^tm2Bbk/Ptpn1^tm2Bbk Ptpn2^tm1.1Ttig/Ptpn2^tm1.1Ttig Tg(Nes-cre)1Kln/0 (involves: 129S4/SvJae * C57BL/6 * C57BL/6J * SJL)	abnormal glucose homeostasis	J:179621
	abnormal homeostasis	J:179621
	abnormal respiratory quotient	J:179621
	decreased circulating glucose level	J:179621
	decreased circulating leptin level	J:179621
	decreased susceptibility to diet-induced obesity	J:179621
	increased energy expenditure	J:179621
	increased insulin sensitivity	J:179621
	increased oxygen consumption	J:179621
Ptpn1^tm2Bbk/Ptpn1^tm2Bbk Tg(Nes-cre)1Kln/0 (involves: 129S4/SvJae * C57BL/6 * SJL)	abnormal homeostasis	J:179621
	abnormal hormone level	J:111969
	decreased circulating glucose level	J:111969
	decreased circulating insulin level	J:111969
	decreased circulating leptin level	J:179621
	decreased respiratory quotient	J:111969
	decreased susceptibility to diet-induced obesity	J:179621
	decreased triglyceride level	J:111969
	improved glucose tolerance	J:111969
	increased circulating adiponectin level	J:111969
	increased circulating leptin level	J:111969
	increased insulin sensitivity	J:111969, J:179621
	increased oxygen consumption	J:111969
Ptpn2^tm1.1Kry/Ptpn2^tm1.1Kry Tg(Col1a1-cre)1Kry/0 (involves: 129 * C57BL/6J * FVB)	increased carbon dioxide production	J:183709
	increased circulating osteocalcin level	J:183709
	increased energy expenditure	J:183709
	increased insulin sensitivity	J:183709
	increased oxygen consumption	J:183709
Ptpn2^tm1.1Ttig/Ptpn2^tm1.1Ttig Tg(Nes-cre)1Kln/0 (involves: C57BL/6 * C57BL/6J * SJL)	abnormal glucose homeostasis	J:179621
	abnormal homeostasis	J:179621
	decreased circulating glucose level	J:179621
	decreased circulating growth hormone level	J:179621
	decreased circulating insulin level	J:179621
	decreased circulating insulin-like growth factor I level	J:179621
	decreased circulating leptin level	J:179621
	decreased susceptibility to diet-induced obesity	J:179621
	increased adiponectin level	J:179621
	increased energy expenditure	J:179621
	increased insulin sensitivity	J:179621
	increased oxygen consumption	J:179621
Ptpn6^m1Amgn/Ptpn6^m1Amgn (involves: C3H/HeSnJ * C57BL/6J * Swiss)	increased circulating interleukin-17 level	J:168664
Ptpn6^me-B2/Ptpn6^me-B2 (involves: BALB/c)	abnormal circulating chemokine level	J:169850
	extremity edema	J:169850
	increased circulating interferon-gamma level	J:169850
	increased circulating interleukin-1 beta level	J:169850
	increased circulating interleukin-6 level	J:169850
	increased circulating interleukin-10 level	J:169850
	increased circulating serum amyloid protein level	J:169850
Ptpn9^tm1Dny/Ptpn9^tm1Dny (B6.129-Ptpn9^tm1Dny)	abnormal platelet physiology	J:118880
Ptpn9^tm1Dny/Ptpn9^tm1Dny (B6.129-Ptpn9^tm1Dny)	decreased platelet aggregation	J:118880
Ptpn11^tm1.1Ics/Ptpn11⁺ (involves: 129S2/SvPas * C57BL/6 * FVB/N)	abnormal lipid level	J:216593
	decreased circulating adiponectin level	J:216593
	decreased circulating alanine transaminase level	J:216593
	decreased circulating glucose level	J:216593
	decreased circulating insulin level	J:216593
	decreased circulating leptin level	J:216593
	decreased liver triglyceride level	J:216593
	decreased skeletal muscle triglyceride level	J:216593
	decreased susceptibility to diet-induced obesity	J:216593
	enhanced lipolysis	J:216593
	improved glucose tolerance	J:216593
	increased energy expenditure	J:216593
	increased glycerol level	J:216593
	increased insulin sensitivity	J:216593
Ptpn11^tm1Bgn/Ptpn11^tm1Bgn (involves: 129S4/SvJae * C57BL/6J)	hydrops fetalis	J:91609
	pericardial effusion	J:91609
Ptpn11^tm1Gsf/Ptpn11^tm1Gsf Speer6-ps1^{Tg(Alb-cre)21Mgn}/Speer6-ps1⁺ (involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * DBA)	increased circulating alanine transaminase level	J:172422
	increased circulating aspartate transaminase level	J:172422
	increased circulating interleukin-6 level	J:172422
Ptpn11^tm1Gsf/Ptpn11^tm1Gsf Stat3^tm1Vpo/Stat3^tm1Vpo Speer6-ps1^{Tg(Alb-cre)21Mgn}/Speer6-ps1⁺ (involves: 129P2/OlaHsd * 129S1/Sv * 129X1/SvJ * C57BL/6 * DBA)	increased circulating alanine transaminase level	J:172422
Ptpn11^tm1Gsf/Ptpn11^tm1Gsf Tg(Camk2a-cre)2Szi/0 (involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * CBA)	abnormal circulating hormone level	J:94738
	abnormal glucose homeostasis	J:94738
	decreased body temperature	J:94738
	decreased circulating thyroxine level	J:94738
	decreased circulating triiodothyronine level	J:94738
	hyperglycemia	J:94738
	hypoglycemia	J:94738
	increased circulating corticosterone level	J:94738
	increased circulating growth hormone level	J:94738
	increased circulating insulin level	J:94738
	increased circulating leptin level	J:94738
	increased circulating thyroid-stimulating hormone level	J:94738
	increased circulating triglyceride level	J:94738
	increased liver glycogen level	J:94738
	increased liver triglyceride level	J:94738
Ptpn11^tm1Gsf/Ptpn11^tm1Gsf Tg(Ckmm-cre)5Khn/0 (involves: 129S1/Sv * 129X1/SvJ * FVB)	impaired glucose tolerance	J:144767
	increased cardiac muscle triglyceride level	J:144767
	increased circulating insulin level	J:144767
	increased circulating triglyceride level	J:144767
	increased skeletal muscle triglyceride level	J:144767
	insulin resistance	J:144767
Ptpn11^tm3Bgn/Ptpn11^tm3Bgn (involves: 129X1/SvJ * C57BL/6J)	improved glucose tolerance	J:167406
Ptpn11^tm3Bgn/Ptpn11^tm3Bgn Speer6-ps1^{Tg(Alb-cre)21Mgn}/Speer6-ps1⁺ (involves: 129X1/SvJ * C57BL/6 * C57BL/6J * DBA)	decreased circulating glucose level	J:167406
	decreased circulating insulin level	J:167406
	decreased circulating triglyceride level	J:167406
	improved glucose tolerance	J:167406
	increased insulin sensitivity	J:167406
Ptpn12^{tm1b(NCOM)Mfgc}/Ptpn12^{tm1b(NCOM)Mfgc} (C57BL/6N-Ptpn12^{tm1b(NCOM)Mfgc}/Tcp)	edema	J:211773
Ptpn14^{Gt(RRR484)Byg}/Ptpn14^{Gt(RRR484)Byg} (involves: 129P2/OlaHsd)	lymphedema	J:169186
	periorbital edema	J:169186
Ptpn18^em1(IMPC)J/Ptpn18⁺ (C57BL/6NJ-Ptpn18^em1(IMPC)J/Mmjax)	decreased circulating bilirubin level	J:211773
Ptpn20^{tm1b(KOMP)Wtsi}/Ptpn20^{tm1b(KOMP)Wtsi} (C57BL/6N-Ptpn20^{tm1b(KOMP)Wtsi}/J)	increased circulating chloride level	J:211773
Ptpn22^tm2Achn/Ptpn22^tm2Achn Ptprc^tm1Weis/Ptprc^tm1Weis (B6.Cg-Ptprc^tm1Weis Ptpn22^tm2Achn)	increased urine protein level	J:147129
Ptpn23^{tm1b(EUCOMM)Hmgu}/Ptpn23⁺ (C57BL/6N-Ptpn23^{tm1b(EUCOMM)Hmgu}/Ieg)	increased circulating alkaline phosphatase level	J:211773
	increased circulating cholesterol level	J:211773
	increased circulating HDL cholesterol level	J:211773
Ptprb^m594684Hubr/Ptprb^m594684Hubr (involves: C57BL/6 * FVB/N)	cardiac edema	J:173681
Ptprc^tm1Weis/Ptprc⁺ (involves: 129X1/SvJ * C57BL/6)	increased urine protein level	J:66501
Ptprc^tm1Weis/Ptprc^tm1Weis (involves: 129X1/SvJ * C57BL/6)	increased urine protein level	J:66501
Ptprd^{tm2a(KOMP)Wtsi}/Ptprd^{tm2a(KOMP)Wtsi} (C57BL/6N-Ptprd^{tm2a(KOMP)Wtsi}/Wtsi)	improved glucose tolerance	J:211773
	increased circulating iron level	J:211773
Ptpre^tm1Ael/Ptpre^tm1Ael (involves: 129S6/SvEvTac * C57BL/6)	decreased circulating type I collagen C-terminal telopeptide level	J:90031
Ptprm^{em1(IMPC)Rbrc}/Ptprm^{em1(IMPC)Rbrc} (C57BL/6NJcl-Ptprm^{em1(IMPC)Rbrc}/Rbrc)	abnormal circulating glucose level	J:211773
	increased circulating creatine kinase level	J:211773
Ptprn2^tm1Aln/Ptprn2^tm1Aln (involves: 129S4/SvJae * C57BL/6N)	impaired glucose tolerance	J:91889
Ptprn^tm1Aln/Ptprn^tm1Aln (involves: 129S4/SvJae * C57BL/6)	impaired glucose tolerance	J:108765
Ptprn^tm1Aln/Ptprn^tm1Aln Ptprn2^tm1Aln/Ptprn2^tm1Aln (involves: 129S4/SvJae * C57BL/6N)	decreased circulating luteinizing hormone level	J:129445
	decreased follicle stimulating hormone level	J:129445
	decreased luteinizing hormone level	J:129445
Ptprs^tm1Mtr/Ptprs^tm1Mtr (involves: 129/Sv * BALB/c)	decreased circulating insulin-like growth factor I level	J:53434
Ptprt^m1Rgsc/Ptprt^m1Rgsc (C57BL/6J-Ptprt^m1Rgsc)	decreased gamma-aminobutyric acid level	J:298303
Ptprt^m1Rgsc/Ptprt^m1Rgsc (C57BL/6J-Ptprt^m1Rgsc)	decreased glutamine level	J:298303
Ptprt^tm1Sata/Ptprt^tm1Sata (involves: 129P2/OlaHsd)	decreased gamma-aminobutyric acid level	J:298303
Ptpru^{tm1.1(KOMP)Vlcg}/Ptpru^{tm1.1(KOMP)Vlcg} (C57BL/6N-Ptpru^{tm1.1(KOMP)Vlcg}/J)	increased fasting circulating glucose level	J:211773
Ptprv^tm1Asmi/Ptprv^tm1Asmi (involves: 129P2/OlaHsd)	decreased circulating glucose level	J:126780
	decreased susceptibility to diet-induced obesity	J:126780
	increased circulating testosterone level	J:170888
Ptprv^tm1Asmi/Ptprv^tm1Asmi (involves: 129P2/OlaHsd * C57BL/6J)	decreased circulating glucose level	J:152695
	increased circulating insulin level	J:152695
Ptprv^{tm1b(NCOM)Mfgc}/Ptprv^{tm1b(NCOM)Mfgc} (C57BL/6N-Ptprv^{tm1b(NCOM)Mfgc}/Tcp)	decreased circulating potassium level	J:211773
Ptprv^tm1Kry/Ptprv^tm1Kry Tg(Col1a1-cre)1Kry/0 (involves: FVB)	abnormal glucose homeostasis	J:126780
	decreased circulating free fatty acids level	J:126780
	decreased circulating glucose level	J:126780
	decreased circulating triglyceride level	J:126780
	hypoglycemia	J:126780
	improved glucose tolerance	J:126780
	increased circulating adiponectin level	J:126780
	increased circulating insulin level	J:126780
	increased circulating testosterone level	J:170888
	increased energy expenditure	J:126780
	increased insulin secretion	J:126780
	increased insulin sensitivity	J:126780
Pts^tm1Ich/Pts^tm1Ich (involves: 129X1/SvJ * C57BL/6J)	abnormal biopterin level	J:84764
	abnormal neopterin level	J:84764
	decreased dopamine level	J:84764
	decreased noradrenaline level	J:84764
	decreased serotonin level	J:84764
	increased phenylalanine level	J:84764
Pts^tm1Ich/Pts^tm1Ich Tg(DBH-PTS)6Csic/0 (B6.Cg-Pts^tm1Ich Tg(DBH-PTS)6Csic)	abnormal biopterin level	J:102278
	abnormal neopterin level	J:102278
	decreased circulating phenylalanine level	J:102278
	decreased serotonin level	J:102278
Pts^tm1Thny/Pts^tm1Thny (involves: 129/Sv * C57BL/6)	abnormal biopterin level	J:84533
	abnormal circulating amino acid level	J:84533
	abnormal dopamine level	J:84533
	abnormal neopterin level	J:84533
	abnormal serotonin level	J:84533
	increased salivation	J:84533
Pttg1^{tm1b(EUCOMM)Wtsi}/Pttg1^{tm1b(EUCOMM)Wtsi} (C57BL/6N-Pttg1^{tm1b(EUCOMM)Wtsi}/Tcp)	increased circulating triglyceride level	J:211773
Pttg1^tm1Sme/Pttg1^tm1Sme (involves: 129S4/SvJae * C57BL/6)	decreased circulating insulin level	J:82724
	hyperglycemia	J:82724
	increased bleeding time	J:72267
Pttg1ip^em1(IMPC)H/Pttg1ip^em1(IMPC)H (C57BL/6NTac-Pttg1ip^em1(IMPC)H/H)	increased blood urea nitrogen level	J:211773
	increased circulating alkaline phosphatase level	J:211773
Pudp^{tm1.1(KOMP)Vlcg}/Pudp^{tm1.1(KOMP)Vlcg} (C57BL/6N-Pudp^{tm1.1(KOMP)Vlcg}/J)	increased fasting circulating glucose level	J:211773
Puf60^em1(IMPC)Bay/Puf60⁺ (C57BL/6N-Puf60^em1(IMPC)Bay/BayMmucd)	impaired glucose tolerance	J:211773
Pus1^em1(IMPC)J/Pus1^em1(IMPC)J (C57BL/6NJ-Pus1^em1(IMPC)J/Mmjax)	increased circulating bilirubin level	J:211773
	increased circulating phosphate level	J:211773
Pus7^em1(IMPC)J/Pus7⁺ (C57BL/6NJ-Pus7^em1(IMPC)J/Mmjax)	decreased circulating glucose level	J:211773
Pus10^{tm1b(EUCOMM)Hmgu}/Pus10^{tm1b(EUCOMM)Hmgu} (C57BL/6N-Pus10^{tm1b(EUCOMM)Hmgu}/Wtsi)	increased circulating alkaline phosphatase level	J:211773
Pvr^{em1(IMPC)Wtsi}/Pvr^{em1(IMPC)Wtsi} (C57BL/6N-Pvr^{em1(IMPC)Wtsi}/Wtsi)	increased circulating insulin level	J:211773
Pwwp2b^em1(IMPC)J/Pwwp2b^em1(IMPC)J (C57BL/6NJ-Pwwp2b^em1(IMPC)J/Mmjax)	impaired glucose tolerance	J:211773
Pwwp2b^tm1.1Bcgen/Pwwp2b^tm1.1Bcgen Tg(Adipoq-cre)1Evdr/0 (involves: C57BL/6 * FVB/NJ)	abnormal adaptive thermogenesis	J:319940
	improved glucose tolerance	J:319940
	increased insulin sensitivity	J:319940
	increased oxygen consumption	J:319940
Pwwp3a^em1(IMPC)Tcp/Pwwp3a^em1(IMPC)Tcp (C57BL/6NCrl-Pwwp3a^em1(IMPC)Tcp/Tcp)	decreased circulating alkaline phosphatase level	J:211773
Pxk^em1(IMPC)Tcp/Pxk^em1(IMPC)Tcp (C57BL/6N-Pxk^em1(IMPC)Tcp/Tcp)	increased circulating alkaline phosphatase level	J:211773
Pxmp2^tm1Jkh/Pxmp2^tm1Jkh (B6.129X1-Pxmp2^tm1Jkh)	abnormal urine homeostasis	J:148171
Pxmp2^tm1Jkh/Pxmp2^tm1Jkh (B6.129X1-Pxmp2^tm1Jkh)	increased blood uric acid level	J:148171
Pxmp4^em1Jwjk/Pxmp4^em1Jwjk (B6.FVB-Pxmp4^em1Jwjk)	abnormal homeostasis	J:322224
Pycard^tm1Flv/Pycard^tm1Flv (involves: 129S5/SvEvBrd * C57BL/6)	decreased circulating interleukin-1 beta level	J:113333
	decreased circulating interleukin-18 level	J:113333, J:158969
Pycard^tm1Vmd/Pycard^tm1Vmd (B6.129-Pycard^tm1Vmd)	decreased circulating interleukin-1 beta level	J:193522
Pycard^tm1Vmd/Pycard^tm1Vmd (B6.129-Pycard^tm1Vmd)	decreased circulating interleukin-18 level	J:193522
Pycr1^{tm1(KOMP)Vlcg}/Pycr1^{tm1(KOMP)Vlcg} (C57BL/6NTac-Pycr1^{tm1(KOMP)Vlcg})	decreased circulating triglyceride level	J:308336
	impaired glucose tolerance	J:308336
Pycr1^{tm1.1(KOMP)Vlcg}/Pycr1^{tm1.1(KOMP)Vlcg} (B6N(Cg)-Pycr1^{tm1.1(KOMP)Vlcg}/J)	decreased circulating free fatty acids level	J:211773
Pycr2^m1J/Pycr2^m1J (involves: C3H/HeJ * C57BL/6J)	decreased circulating cholesterol level	J:308336
	decreased circulating glutamic acid level	J:308336
	decreased circulating HDL cholesterol level	J:308336
	decreased circulating potassium level	J:308336
	decreased circulating triglyceride level	J:308336
	increased blood urea nitrogen level	J:308336
Pycr2^tm1.1Brre/Pycr2^tm1.1Brre (involves: C57BL/6)	abnormal amino acid level	J:296329
Pycr2^{tm1a(EUCOMM)Wtsi}/Pycr2^{tm1a(EUCOMM)Wtsi} (C57BL/6N-Pycr2^{tm1a(EUCOMM)Wtsi}/Wtsi)	increased fasting circulating glucose level	J:211773
Pygl^{tm1a(KOMP)Wtsi}/Pygl^{tm1a(KOMP)Wtsi} (C57BL/6N-Pygl^{tm1a(KOMP)Wtsi})	abnormal homeostasis	J:284765
	decreased circulating cholesterol level	J:284765
	decreased circulating triglyceride level	J:284765
	decreased fasting circulating glucose level	J:284765
	decreased hepatic glucose production	J:284765
	hypoglycemia	J:284765
	increased circulating alanine transaminase level	J:330539, J:284765
	increased circulating aspartate transaminase level	J:330539, J:284765
	increased circulating ketone body level	J:284765
	increased liver glycogen level	J:330539, J:284765
Pygm^tm1.1Adru/Pygm^tm1.1Adru (involves: 129 * C57BL/6J)	increased creatine kinase level	J:226312
	increased skeletal muscle glycogen level	J:226312
	myoglobinuria	J:226312
Pygo2^{tm1b(EUCOMM)Wtsi}/Pygo2^{tm1b(EUCOMM)Wtsi} (C57BL/6N-Pygo2^{tm1b(EUCOMM)Wtsi}/Tcp)	edema	J:211773
Pyy^tm1(cre)Hhzg/Pyy^tm1(cre)Hhzg (involves: 129)	impaired glucose tolerance	J:111480
	increased circulating insulin level	J:111480
	increased circulating insulin-like growth factor I level	J:111480
	increased circulating testosterone level	J:111480
Pyy^tm1.1Batt/Pyy^tm1.1Batt (involves: C57BL/6 * FVB/N * SJL)	increased circulating leptin level	J:129742
Pzp^tm1Vln/Pzp^tm1Vln (B.129P2-Pzp^tm1Vln)	abnormal cytokine level	J:57485
	increased circulating amylase level	J:57485
	increased circulating lipase level	J:57485
Pzp^tm1Vln/Pzp^tm1Vln (B6.129P2-Pzp^tm1Vln)	impaired febrile response	J:113532
Qdpr^tm1Lex/Qdpr^tm1Lex (involves: 129S/SvEvBrd * C57BL/6J)	abnormal homeostasis	J:216352
	abnormal neopterin level	J:216352
	increased circulating homocysteine level	J:216352
Qki^qk-k2/Qki^qk-k2 (involves: C57BL/6 * CBA/Ca)	pericardial effusion	J:106770, J:75828
Qki^qk-l1/Qki^qk-l1 (involves: BTBR)	pericardial effusion	J:106770
Qki^tm1Imeg/Qki^tm1Imeg (involves: 129P2/OlaHsd)	pericardial effusion	J:88215
Qprt^{Gt(OST337946)Lex}/Qprt^{Gt(OST337946)Lex} (involves: 129S5/SvEvBrd * C57BL/6J)	abnormal cytokine level	J:282516
Qrfp^tm1Stak/Qrfp^tm1Stak (B6J.129-Qrfp^tm1Stak)	decreased circulating leptin level	J:250913
Qsox1^{em1(IMPC)Kmpc}/Qsox1^{em1(IMPC)Kmpc} (C57BL/6NTac-Qsox1^{em1(IMPC)Kmpc}/Kmpc)	decreased fasting circulating glucose level	J:211773
	increased circulating lactate dehydrogenase level	J:211773
Qsox2^{em1(IMPC)Kmpc}/Qsox2^{em1(IMPC)Kmpc} (C57BL/6NTac-Qsox2^{em1(IMPC)Kmpc}/Kmpc)	increased fasting circulating glucose level	J:211773
Qtrt1^{Gt(S12-11A1)Sor}/Qtrt1⁺ (involves: 129S4/SvJaeSor)	decreased circulating tyrosine level	J:173496
Qtrt1^{Gt(S12-11A1)Sor}/Qtrt1^{Gt(S12-11A1)Sor} (involves: 129S4/SvJaeSor)	decreased circulating tyrosine level	J:173496
Rab3a^tm1Sud/Rab3a^tm1Sud Rab3b^tm1Sud/Rab3b^tm1Sud Rab3c^tm1Sud/Rab3c^tm1Sud Rab3d^tm1Rja/Rab3d^tm1Rja (involves: 129 * 129P2/OlaHsd)	cyanosis	J:105478
Rab3gap1^em1(IMPC)J/Rab3gap1^em1(IMPC)J (C57BL/6NJ-Rab3gap1^em1(IMPC)J/Mmjax)	increased circulating alkaline phosphatase level	J:211773
Rab3gap2^{tm1b(KOMP)Wtsi}/Rab3gap2^{tm1b(KOMP)Wtsi} (C57BL/6N-Rab3gap2^{tm1b(KOMP)Wtsi}/J)	decreased circulating HDL cholesterol level	J:211773
	increased circulating alkaline phosphatase level	J:211773
	increased circulating bilirubin level	J:211773
Rab3ip^{tm1.1(KOMP)Vlcg}/Rab3ip^{tm1.1(KOMP)Vlcg} (C57BL/6N-Rab3ip^{tm1.1(KOMP)Vlcg}/J)	increased circulating alkaline phosphatase level	J:211773
Rab4a^{tm1b(EUCOMM)Hmgu}/Rab4a^{tm1b(EUCOMM)Hmgu} (C57BL/6N-Rab4a^{tm1b(EUCOMM)Hmgu}/Bay)	decreased circulating creatinine level	J:211773
Rab4b^em1(IMPC)J/Rab4b^em1(IMPC)J (C57BL/6NJ-Rab4b^em1(IMPC)J/J)	increased circulating alkaline phosphatase level	J:211773
	increased circulating creatinine level	J:211773
Rab5a^{tm1b(KOMP)Wtsi}/Rab5a^{tm1b(KOMP)Wtsi} (C57BL/6N-Rab5a^{tm1b(KOMP)Wtsi}/J)	increased circulating potassium level	J:211773
	increased circulating sodium level	J:211773
Rab5c^{tm1a(EUCOMM)Wtsi}/Rab5c⁺ (C57BL/6N-Rab5c^{tm1a(EUCOMM)Wtsi}/Wtsi)	decreased circulating cholesterol level	J:211773
	increased circulating alkaline phosphatase level	J:211773
	increased circulating fructosamine level	J:211773
	increased circulating total protein level	J:211773
Rab10^{tm1c(KOMP)Wtsi}/Rab10^{tm1c(KOMP)Wtsi} Tg(Adipoq-cre)1Evdr/0 (involves: C57BL/6J * C57BL/6N * FVB/NJ)	increased circulating insulin level	J:249843
	increased hepatic glucose production	J:249843
	insulin resistance	J:249843
Rab11a^{tm1b(KOMP)Wtsi}/Rab11a⁺ (C57BL/6N-Rab11a^{tm1b(KOMP)Wtsi}/J)	improved glucose tolerance	J:211773
Rab11fip1^em1(IMPC)Bay/Rab11fip1^em1(IMPC)Bay (C57BL/6N-Rab11fip1^em1(IMPC)Bay/BayMmucd)	increased fasting circulating glucose level	J:211773
Rab11fip5^{tm1.1(KOMP)Vlcg}/Rab11fip5^{tm1.1(KOMP)Vlcg} (C57BL/6N-Rab11fip5^{tm1.1(KOMP)Vlcg}/J)	decreased circulating glucose level	J:211773
Rab15^{tm1a(KOMP)Wtsi}/Rab15^{tm1a(KOMP)Wtsi} (C57BL/6N-Rab15^{tm1a(KOMP)Wtsi}/Wtsi)	decreased circulating insulin level	J:211773
Rab19^{tm1b(EUCOMM)Hmgu}/Rab19^{tm1b(EUCOMM)Hmgu} (C57BL/6N-Rab19^{tm1b(EUCOMM)Hmgu}/Ics)	decreased circulating calcium level	J:211773
Rab20^{tm1b(EUCOMM)Hmgu}/Rab20^{tm1b(EUCOMM)Hmgu} (C57BL/6N-Rab20^{tm1b(EUCOMM)Hmgu}/J)	increased circulating sodium level	J:211773
Rab23^{tm1b(EUCOMM)Wtsi}/Rab23⁺ (C57BL/6N-Rab23^{tm1b(EUCOMM)Wtsi}/H)	increased circulating alanine transaminase level	J:211773
	increased circulating aspartate transaminase level	J:211773
Rab27a^ash/Rab27a^ash (involves: C3H/HeDiSn)	decreased platelet serotonin level	J:63231
Rab27a^ash/Rab27a^ash (involves: C3H/HeDiSn)	increased bleeding time	J:63231
Rab27a^ash/Rab27a^ash (C3H/HeSn-Rab27a^ash/JRos)	decreased platelet serotonin level	J:137593
Rab27a^ash/Rab27a^ash (B6.C3Sn-Rab27a^ash)	decreased body temperature	J:193137
	increased circulating aspartate transaminase level	J:193137
	increased circulating interferon-gamma level	J:193137
	increased circulating interleukin-1 beta level	J:193137
	increased circulating interleukin-6 level	J:193137
	increased circulating lactate dehydrogenase level	J:193137
	increased circulating tumor necrosis factor level	J:193137
Rab27a^ash/Rab27a^ash (C3H/HeSn-Rab27a^ash/J)	abnormal platelet dense granule physiology	J:77395
	decreased platelet aggregation	J:77395
	decreased platelet ATP level	J:77395
	decreased platelet serotonin level	J:77395
	increased bleeding time	J:77395
Rab27a^ash/Rab27a^ash Rab27b^tm1.2Seab/Rab27b^tm1.2Seab (involves: 129X1/SvJ * C3H/HeSn * C57BL/6J)	abnormal blood coagulation	J:120307
	abnormal platelet dense granule physiology	J:120307
	decreased platelet aggregation	J:120307
	decreased platelet serotonin level	J:120307
Rab27b^tm1.2Seab/Rab27b^tm1.2Seab (involves: 129X1/SvJ * C57BL/6J)	abnormal blood coagulation	J:120307
	abnormal platelet dense granule physiology	J:120307
	decreased platelet aggregation	J:120307
	decreased platelet serotonin level	J:120307
Rab28^em1(IMPC)J/Rab28^em1(IMPC)J (C57BL/6NJ-Rab28^em1(IMPC)J/Mmjax)	decreased circulating total protein level	J:211773
	increased circulating triglyceride level	J:211773
Rab32^{tm1b(KOMP)Wtsi}/Rab32⁺ Rab38^tm1.1Ics/Rab38^tm1.1Ics (involves: C57BL/6N * C57BL/6NTac)	decreased platelet ATP level	J:293385
	decreased platelet serotonin level	J:293385
Rab32^{tm1b(KOMP)Wtsi}/Rab32^{tm1b(KOMP)Wtsi} Rab38^tm1.1Ics/Rab38⁺ (involves: C57BL/6N * C57BL/6NTac)	decreased platelet ATP level	J:293385
	decreased platelet serotonin level	J:293385
Rab32^{tm1b(KOMP)Wtsi}/Rab32^{tm1b(KOMP)Wtsi} Rab38^tm1.1Ics/Rab38^tm1.1Ics (involves: C57BL/6N * C57BL/6NTac)	decreased platelet aggregation	J:293385
	decreased platelet ATP level	J:293385
	decreased platelet serotonin level	J:293385
	decreased susceptibility to induced thrombosis	J:293385
	increased bleeding time	J:293385
Rab33a^em1(IMPC)H/Y (C57BL/6N-Rab33a^em1(IMPC)H/H)	increased circulating serum albumin level	J:211773
Rab33b^em1(IMPC)J/Rab33b^em1(IMPC)J (C57BL/6NJ-Rab33b^em1(IMPC)J/Mmjax)	increased circulating aspartate transaminase level	J:211773
Rab34^{tm1b(EUCOMM)Hmgu}/Rab34^{tm1b(EUCOMM)Hmgu} (C57BL/6N-Rab34^{tm1b(EUCOMM)Hmgu}/J)	edema	J:211773
Rab36^{tm1b(KOMP)Wtsi}/Rab36^{tm1b(KOMP)Wtsi} (C57BL/6N-Rab36^{tm1b(KOMP)Wtsi}/J)	abnormal cholesterol homeostasis	J:211773
	decreased blood urea nitrogen level	J:211773
	decreased circulating cholesterol level	J:211773
	decreased circulating HDL cholesterol level	J:211773
	decreased circulating serum albumin level	J:211773
Rab37^tm1Hsliu/Rab37^tm1Hsliu (involves: C57BL/6J * C57BL/6N)	decreased insulin secretion	J:334080
	hyperglycemia	J:334080
Rab39b^em1(IMPC)Tcp/Rab39b^em1(IMPC)Tcp (C57BL/6NCrl-Rab39b^em1(IMPC)Tcp/Tcp)	increased circulating aspartate transaminase level	J:211773
Rab40c^{tm1b(KOMP)Wtsi}/Rab40c⁺ (C57BL/6N-Rab40c^{tm1b(KOMP)Wtsi}/J)	increased circulating sodium level	J:211773
Rab43^{tm1.1(KOMP)Vlcg}/Rab43^{tm1.1(KOMP)Vlcg} (C57BL/6N-Rab43^{tm1.1(KOMP)Vlcg}/J)	decreased fasting circulating glucose level	J:211773
	increased circulating cholesterol level	J:211773
	increased circulating HDL cholesterol level	J:211773
Rab44^em1Rbrc/Rab44^em1Rbrc (Not Specified)	decreased circulating histamine level	J:304506
Rab44^em1Rbrc/Rab44^em1Rbrc (Not Specified)	decreased susceptibility to induced hypothermia	J:304506
Rabgap1^{tm1b(EUCOMM)Hmgu}/Rabgap1^{tm1b(EUCOMM)Hmgu} (C57BL/6N-Rabgap1^{tm1b(EUCOMM)Hmgu}/Ieg)	improved glucose tolerance	J:211773
	increased circulating lipase level	J:211773
Rabgef1^tm1Glli/Rabgef1^tm1Glli (either: (involves: 129P2/OlaHsd * 129S/SvEv) or (involves: 129P2/OlaHsd * C57BL/6))	increased circulating histamine level	J:91790
Rabggta^gm/Rabggta^gm (C57BL/6J-Rabggta^gm)	decreased platelet serotonin level	J:12434
	increased bleeding time	J:12434
	increased circulating von Willebrand factor level	J:12434
Rabl2^{tm1.1(KOMP)Wtsi}/Rabl2^{tm1.1(KOMP)Wtsi} (C57BL/6N-Rabl2^{tm1.1(KOMP)Wtsi}/Ucd)	impaired glucose tolerance	J:211773
	increased circulating insulin level	J:211773
Rac1^em1(IMPC)Mbp/Rac1⁺ (C57BL/6N-Rac1^em1(IMPC)Mbp/MbpMmucd)	increased circulating alkaline phosphatase level	J:211773
Rac1^tm1Djk/Rac1^tm1Djk Tg(Pf4-icre)Q3Rsko/0 (involves: 129S4/SvJae * C57BL/6)	abnormal platelet activation	J:214607
	decreased platelet aggregation	J:214607
Rac2^tm1Mddw/Rac2^tm1Mddw Tg(TcrAND)53Hed/0 (involves: 129S/SvEv * C57BL/6 * SJL)	decreased circulating interleukin-2 level	J:119437
Rad1^{tm1b(KOMP)Wtsi}/Rad1⁺ (C57BL/6N-Rad1^{tm1b(KOMP)Wtsi}/J)	decreased circulating HDL cholesterol level	J:211773
	decreased circulating iron level	J:211773
	increased circulating bilirubin level	J:211773
Rad18^{tm1a(EUCOMM)Wtsi}/Rad18^{tm1a(EUCOMM)Wtsi} (involves: C57BL/6 * C57BL/6N)	increased carbon dioxide production	J:213427
	increased energy expenditure	J:213427
	increased oxygen consumption	J:213427
Rad21l^{tm1b(KOMP)Wtsi}/Rad21l^{tm1b(KOMP)Wtsi} (C57BL/6N-Rad21l^{tm1b(KOMP)Wtsi}/J)	decreased circulating chloride level	J:211773
	decreased circulating glucose level	J:211773
Rad23b^tm1Gvh/Rad23b^tm1Gvh (involves: 129P2/OlaHsd * C57BL/6)	eyelid edema	J:74288
Rad51d^tm1Jcs/Rad51d^tm1Jcs (involves: 129S4/SvJae * C57BL/6J)	pericardial edema	J:61460
Rag1^tm1Mom/Rag1^tm1Mom Sh3bp2^tm1Bjro/Sh3bp2^tm1Bjro (involves: 129S4/SvJae * 129S7/SvEvBrd * BALB/cJ * C57BL/6J)	increased circulating tumor necrosis factor level	J:117880
Rag1^tm1Mom/Rag1^tm1Mom Tg(TcraBDC12-4.1)10Jos/0 Tg(TcrbBDC12-4.1)82Gse/0 (involves: 129S7/SvEvBrd * C57BL/6 * FVB * NOD)	increased circulating glucose level	J:111874
Rag1^tm1Mom/Rag1^tm1Mom Trp53^tm1Brd/Trp53^tm1Brd (involves: 129S7/SvEvBrd * C57BL)	dehydration	J:141515
Rag1^tm1Mom/Rag1^tm1Mom Trp53^tm1Brd/Trp53^tm1Brd Xrcc5^tm1Dbr/Xrcc5^tm1Dbr (involves: 129S7/SvEvBrd * C57BL)	dehydration	J:141515
Rag2^tm1Fwa/Rag2^tm1Fwa Tg(TcraTcrbNY8.3)1Pesa/0 (NOD.Cg-Rag2^tm1Fwa Tg(TcraTcrbNY8.3)1Pesa)	increased circulating glucose level	J:94192
Rai1^tm1Jrl/Rai1⁺ (B6.129S7-Rai1^tm1Jrl/J)	increased circulating corticosterone level	J:164451
Rai1^tm1Jrl/Rai1⁺ (B6.129S7-Rai1^tm1Jrl/J)	increased circulating leptin level	J:164451
Rai1^tm2.1Luo/Rai1^tm2.1Luo Tg(Sim1-cre)1Lowl/? (either: (involves: 129S1/Sv * C57BL/6 * FVB) or (involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * FVB))	increased cholesterol level	J:237687
	increased circulating HDL cholesterol level	J:237687
	increased circulating LDL cholesterol level	J:237687
	increased circulating VLDL cholesterol level	J:237687
	increased triglyceride level	J:237687
Rai14^em1(IMPC)J/Rai14^em1(IMPC)J (C57BL/6NJ-Rai14^em1(IMPC)J/J)	cyanosis	J:211773
	edema	J:211773
Ralgapa1^tm1.1Schen/Ralgapa1^tm1.1Schen (involves: C57BL/6J)	increased circulating cholesterol level	J:287672
	increased circulating free fatty acids level	J:287672
	increased circulating insulin level	J:287672
	increased circulating triglyceride level	J:287672
	increased fasting circulating glucose level	J:287672
	increased liver cholesterol level	J:287672
	increased liver triglyceride level	J:287672
	insulin resistance	J:287672
Ralgapa1^{tm2c(KOMP)Wtsi}/Ralgapa1^{tm2c(KOMP)Wtsi} Myl1^tm1(cre)Sjb/Myl1⁺ (involves: 129S1/Sv * 129X1/SvJ * C57BL/6J * C57BL/6N)	abnormal lipid homeostasis	J:287672
	improved glucose tolerance	J:287672
	increased circulating cholesterol level	J:287672
	increased circulating free fatty acids level	J:287672
	increased circulating insulin level	J:287672
	increased circulating triglyceride level	J:287672
Ralgapb^{tm1a(KOMP)Wtsi}/Ralgapb⁺ (C57BL/6N-Ralgapb^{tm1a(KOMP)Wtsi}/Wtsi)	decreased circulating potassium level	J:211773
Ralgps1^em1(IMPC)J/Ralgps1^em1(IMPC)J (C57BL/6NJ-Ralgps1^em1(IMPC)J/Mmjax)	increased circulating aspartate transaminase level	J:211773
Raly^em2(IMPC)Tcp/Raly^em2(IMPC)Tcp (C57BL/6NCrl-Raly^em2(IMPC)Tcp/Tcp)	increased circulating triglyceride level	J:211773
Ramp1^tm1.1Tsuj/Ramp1^tm1.1Tsuj (C.129S2-Ramp1^tm1.1Tsuj)	increased circulating interferon-gamma level	J:125974
	increased circulating interleukin-6 level	J:125974
	increased circulating tumor necrosis factor level	J:125974
Ramp2^tm1.1Tash/Ramp2^tm1.1Tash (involves: C57BL/6)	edema	J:130931
Ramp2^tm1.1Tash/Ramp2^tm1.1Tash (involves: C57BL/6)	pericardial effusion	J:130931
Ramp2^tm1Kmca/Ramp2^tm1Kmca (involves: 129S6/SvEvTac * C57BL/6)	edema	J:130930
	lymphedema	J:130930
Ranbp1^{tm1b(KOMP)Wtsi}/Ranbp1^{tm1b(KOMP)Wtsi} (C57BL/6N-Ranbp1^{tm1b(KOMP)Wtsi}/Tcp)	edema	J:211773
Ranbp2^{Gt(pGT0pfs)630Wcs}/Ranbp2⁺ (129P2/OlaHsd-Ranbp2^{Gt(pGT0pfs)630Wcs})	decreased susceptibility to diet-induced obesity	J:116134
	impaired glucose tolerance	J:116134
Ranbp10^{Gt(RRZ226)Byg}/Ranbp10^{Gt(RRZ226)Byg} (either: (involves: 129P2/OlaHsd) or (involves: 129P2/OlaHsd * C57BL/6))	abnormal platelet dense granule physiology	J:193236
	decreased platelet aggregation	J:193236
	increased bleeding time	J:193236
Ranbp10^{tm1.1(KOMP)Vlcg}/Ranbp10^{tm1.1(KOMP)Vlcg} (C57BL/6N-Ranbp10^{tm1.1(KOMP)Vlcg}/Ucd)	increased circulating glucose level	J:211773
Rap1b^tm1Gwht/Rap1b^tm1Gwht (involves: 129S/SvEv * C57BL/6)	decreased platelet aggregation	J:96758
	decreased susceptibility to induced thrombosis	J:96758
	increased bleeding time	J:96758
Rap1gap2^{tm1b(EUCOMM)Hmgu}/Rap1gap2^{tm1b(EUCOMM)Hmgu} (C57BL/6N-Rap1gap2^{tm1b(EUCOMM)Hmgu}/Orl)	increased circulating phosphate level	J:211773
Rap1gap^em1(IMPC)H/Rap1gap^em1(IMPC)H (C57BL/6NTac-Rap1gap^em1(IMPC)H/H)	increased circulating amylase level	J:211773
Rap1gds1^tm1Ytk/Rap1gds1^tm1Ytk (involves: 129X1/SvJ * C57BL/6 * DBA)	cyanosis	J:62244
	edema	J:62244
Rap2b^{tm1.1(KOMP)Vlcg}/Rap2b^{tm1.1(KOMP)Vlcg} (C57BL/6N-Rap2b^{tm1.1(KOMP)Vlcg}/J)	decreased circulating glucose level	J:211773
	decreased circulating iron level	J:211773
Rapgef1^{Gt(pGT1.8geo)5Pgr}/Rapgef1^{Gt(pGT1.8geo)5Pgr} (involves: 129/Sv * C57BL/6 * Swiss)	edema	J:80219
Rapgef2^em1(IMPC)H/Rapgef2⁺ (C57BL/6N-Rapgef2^em1(IMPC)H/H)	increased circulating bilirubin level	J:211773
Rapgef3^tm1.1Chen/Rapgef3^tm1.1Chen (B6.129(Cg)-Rapgef3^tm1.1Chen)	abnormal glucose homeostasis	J:207599
	decreased circulating glucose level	J:207599
	decreased circulating insulin level	J:207599
	decreased circulating leptin level	J:207599
	improved glucose tolerance	J:207599
	increased insulin sensitivity	J:207599
Rapgef3^tm1Skc/Rapgef3^tm1Skc (Not Specified)	decreased blood urea nitrogen level	J:201171
	decreased circulating cholesterol level	J:201171
	decreased circulating HDL cholesterol level	J:201171
	decreased circulating insulin level	J:201171
	decreased insulin secretion	J:201171
	hyperglycemia	J:201171
	impaired glucose tolerance	J:201171
	increased circulating triglyceride level	J:201171
	increased respiratory quotient	J:201171
	increased susceptibility to diet-induced obesity	J:201171
	insulin resistance	J:201171
Rapgef4^em1(IMPC)H/Rapgef4^em1(IMPC)H (C57BL/6NTac-Rapgef4^em1(IMPC)H/H)	decreased fasting circulating glucose level	J:211773
Rapgef4^{Gt(OST450264)Lex}/Rapgef4^{Gt(OST450264)Lex} (129S5/SvEvBrd-Rapgef4^{Gt(OST450264)Lex})	abnormal calcium ion homeostasis	J:179540
Rapgef4^tm1.1Sse/Rapgef4^tm1.1Sse (Not Specified)	abnormal insulin secretion	J:128493
Raph1^tm1.2Fbg/Raph1^tm1.2Fbg (involves: 129S4/SvJae * C57BL/6)	abnormal cytokine level	J:238262
	intestinal edema	J:238262
Rapsn^em1Gan/Rapsn^em1Gan (C57BL/6J-Rapsn^em1Gan)	cyanosis	J:282816
Rapsn^{tm1b(EUCOMM)Wtsi}/Rapsn⁺ (C57BL/6N-Rapsn^{tm1b(EUCOMM)Wtsi}/H)	increased circulating HDL cholesterol level	J:211773
Rarg^tm1Ipc/Rarg^tm1Ipc (involves: 129S2/SvPas)	abnormal response to vitamins	J:12691
Rarg^tm1Ipc/Rarg^tm1Ipc (involves: 129S2/SvPas)	impaired skin barrier function	J:109090
Rarg^tm3Ipc/Rarg^tm3Ipc Tg(KRT14-cre)1Ipc/0 (involves: C57BL/6 * SJL)	impaired skin barrier function	J:109090
Rarres2^tm1Yktk/Rarres2^tm1Yktk (B6.Cg-Rarres2^tm1Yktk)	abnormal gluconeogenesis	J:206120
	decreased circulating free fatty acids level	J:206120
	decreased insulin secretion	J:206120
	impaired glucose tolerance	J:206120
	increased circulating glucose level	J:206120
Rars2^{tm1a(EUCOMM)Wtsi}/Rars2⁺ (B6JTyr;B6N-Rars2^{tm1a(EUCOMM)Wtsi}/Wtsi)	increased circulating HDL cholesterol level	J:175295
Rasa1^{tm1b(EUCOMM)Hmgu}/Rasa1⁺ (C57BL/6N-Rasa1^{tm1b(EUCOMM)Hmgu}/J)	decreased circulating glucose level	J:211773
	decreased circulating phosphate level	J:211773
Rasa3^hlb381/Rasa3^hlb381 (C57BL/6J-Rasa3^hlb381/J)	abnormal platelet physiology	J:221899
Rasa3^hlb381/Rasa3^hlb381 Rasgrp2^tm1Amg/Rasgrp2^tm1Amg (involves: C57BL/6J)	abnormal hemostasis	J:221899
Rasa3^scat/Rasa3^scat (involves: BALB/cBy)	hyperlipidemia	J:186485
Rasa3^scat/Rasa3^scat (involves: BALB/cBy)	increased circulating bilirubin level	J:186485
Rasa3^tm1.1Llp/Rasa3^tm1.1Llp Tg(Mx1-cre)1Cgn/? (involves: 129S1/SvImJ * C57BL/6J * CBA/J)	increased circulating bilirubin level	J:301035
	increased circulating lactate dehydrogenase level	J:301035
Rasa3^tm1b(KOMP)J/Rasa3⁺ (C57BL/6N-Rasa3^tm1b(KOMP)J/J)	decreased circulating glucose level	J:211773
Rasa3^tm1Shiw/Rasa3^tm1Shiw (Not Specified)	edema	J:120930
Rasal3^tm1.1Fuj/Rasal3^tm1.1Fuj (involves: C57BL/6N * C57BL/6NCrlj * CBA/JNCrlj)	decreased circulating alanine transaminase level	J:229641
	decreased circulating aspartate transaminase level	J:229641
	decreased circulating interferon-gamma level	J:229641
	decreased circulating interleukin-4 level	J:229641
Rasal3^{tm1b(EUCOMM)Hmgu}/Rasal3^{tm1b(EUCOMM)Hmgu} (C57BL/6N-Rasal3^{tm1b(EUCOMM)Hmgu}/Orl)	decreased circulating creatinine level	J:211773
	increased circulating cholesterol level	J:211773
	increased circulating triglyceride level	J:211773
Rasd1^tm1.1Snyd/Rasd1^tm1.1Snyd (involves: C57BL/6)	abnormal iron homeostasis	J:195135
Rasgrf1^tm1Esn/Rasgrf1^tm1Esn (involves: 129/Sv * C57BL/6N)	decreased circulating insulin level	J:83950
	enhanced lipolysis	J:83950
	impaired glucose tolerance	J:83950
Rasgrf1^tm1Toc/Rasgrf1⁺ (involves: 129)	decreased circulating insulin-like growth factor I level	J:47681
Rasgrf1^tm1Toc/Rasgrf1⁺ (involves: 129)	decreased growth hormone level	J:47681
Rasgrp2^tm1Amg/Rasgrp2^tm1Amg (Not Specified)	abnormal platelet physiology	J:92864
	decreased platelet aggregation	J:122618, J:92864
	increased bleeding time	J:92864
Rasip1^tm1.1Oncl/Rasip1^tm1.1Oncl (involves: C57BL/6 * CBA)	edema	J:174152
Rasip1^tm1.1Wye/Rasip1^tm1.1Wye (C57BL/6-Rasip1^tm1.1Wye)	edema	J:203698
Rasip1^tm1.1Wye/Rasip1^tm1.1Wye (C57BL/6-Rasip1^tm1.1Wye)	pericardial edema	J:203698
Rassf5^tm1Kina/Rassf5^tm1Kina (B6.Cg-Rassf5^tm1Kina)	increased urine protein level	J:168749
Rassf9^{Tg(PDLIM7)2Cml}/Rassf9^{Tg(PDLIM7)2Cml} (involves: ICR)	impaired skin barrier function	J:171677
Raver2^em1(IMPC)J/Raver2^em1(IMPC)J (C57BL/6NJ-Raver2^em1(IMPC)J/Mmjax)	decreased circulating phosphate level	J:211773
Rb1^tm1Brd/Rb1^tm1Brd (involves: 129S7/SvEvBrd * C57BL/6)	edema	J:2516
Rb1^tm1Tyj/Rb1^tm1Tyj (involves: 129S2/SvPas)	hypoxia	J:81643
Rb1^tm1Tyj/Rb1^tm1Tyj (involves: 129S2/SvPas * C57BL/6)	pericardial edema	J:2511
Rb1^tm1Tyj/Rb1^tm1Tyj (involves: 129S2/SvPas * C57BL/6)	skin edema	J:2511
Rb1^tm2Brn/Rb1^tm2Brn Rbl1^tm1Tyj/Rbl1^tm1Tyj Rbl2^tm2Tyj/Rbl2^tm2Tyj (involves: 129 * 129S2/SvPas * 129S4/SvJae)	hematuria	J:217195
Rb1^tm2Brn/Rb1^tm2Brn Rbl2^tm1Tyj/Rbl2^tm1Tyj Tg(Myh6-cre)2182Mds/Tg(Myh6-cre)2182Mds (involves: 129 * 129S2/SvPas * FVB/N)	edema	J:97589
Rb1^tm2Brn/Rb1^tm2Brn Trp53^tm1Brn/Trp53^tm1Brn Tg(Ren-cre)#Kwg/0 (involves: 129 * 129P2/OlaHsd)	increased circulating glucagon level	J:216559
Rb1^tm3Tyj/Rb1^tm3Tyj Tg(Sp7-tTA,tetO-EGFP/cre)1Amc/0 Tg(tetO-RNAi:Trp53)ASlowe/0 (involves: 129S4/SvJae * C57BL/6 * CD-1)	increased circulating alkaline phosphatase level	J:199542
Rb1cc1^tm1.1Guan/Rb1cc1^tm1.1Guan Tg(SFTPC-cre)11Yo/0 (involves: 129P2/OlaHsd * C57BL/6)	cyanosis	J:300057
Rb1cc1^tm1.2Guan/Rb1cc1^tm1.2Guan (involves: 129P2/OlaHsd * C57BL/6)	edema	J:114498
Rbfox2^tm1.1Dblk/Rbfox2^tm1.1Dblk Pax3^tm1(cre)Joe/0 (involves: 129S1/Sv * 129S2/SvPas * 129X1/SvJ * C57BL/6J)	subcutaneous edema	J:279139
Rbfox3^{tm1a(EUCOMM)Hmgu}/Rbfox3^{tm1a(EUCOMM)Hmgu} (Not Specified)	decreased circulating alkaline phosphatase level	J:165965
Rbl1^{tm1b(EUCOMM)Hmgu}/Rbl1⁺ (C57BL/6N-Rbl1^{tm1b(EUCOMM)Hmgu}/Ieg)	improved glucose tolerance	J:211773
Rbl1^tm1Mru/Rbl1^tm1Mru (involves: 129S4/SvJae * BALB/c)	increased oxygen consumption	J:129672
Rbl2^{tm1b(EUCOMM)Hmgu}/Rbl2⁺ (C57BL/6N-Rbl2^{tm1b(EUCOMM)Hmgu}/J)	increased circulating cholesterol level	J:211773
	increased circulating HDL cholesterol level	J:211773
Rbm4^tm1Wtarn/Rbm4^tm1Wtarn (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	abnormal glucose homeostasis	J:192831
	decreased circulating insulin level	J:192831
	hyperglycemia	J:192831
	impaired glucose tolerance	J:192831
Rbm4b^{tm1.1(KOMP)Vlcg}/Rbm4b^{tm1.1(KOMP)Vlcg} (C57BL/6N-Rbm4b^{tm1.1(KOMP)Vlcg}/J)	increased circulating bilirubin level	J:211773
Rbm4b^tm1Wtarn/Rbm4b^tm1Wtarn (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	hyperglycemia	J:192831
	impaired glucose tolerance	J:192831
Rbm6^em1(IMPC)J/Rbm6^em1(IMPC)J (C57BL/6NJ-Rbm6^em1(IMPC)J/Mmjax)	decreased fasting circulating glucose level	J:211773
Rbm14^{tm1a(KOMP)Wtsi}/Rbm14^{tm1a(KOMP)Wtsi} (C57BL/6N-Rbm14^{tm1a(KOMP)Wtsi}/Wtsi)	increased circulating cholesterol level	J:211773
	increased circulating HDL cholesterol level	J:211773
Rbm20^em1(IMPC)Mbp/Rbm20^em1(IMPC)Mbp (C57BL/6N-Rbm20^em1(IMPC)Mbp/MbpMmucd)	increased circulating triglyceride level	J:211773
Rbm45^em1(IMPC)J/Rbm45^em1(IMPC)J (C57BL/6NJ-Rbm45^em1(IMPC)J/Mmjax)	edema	J:211773
Rbms1^{tm1b(EUCOMM)Wtsi}/Rbms1⁺ (C57BL/6N-Rbms1^{tm1b(EUCOMM)Wtsi}/H)	impaired glucose tolerance	J:211773
	increased circulating alkaline phosphatase level	J:211773
Rbms1^tm1Hiro/Rbms1^tm1Hiro (involves: C57BL/6 * CBA)	decreased circulating progesterone level	J:77893
Rbmx^{tm2a(KOMP)Wtsi}/Rbmx^{tm2a(KOMP)Wtsi} (C57BL/6N-Rbmx^{tm2a(KOMP)Wtsi}/Wtsi)	increased circulating insulin level	J:211773
Rbmx^{tm2b(KOMP)Wtsi}/Y (C57BL/6N-Rbmx^{tm2b(KOMP)Wtsi}/Wtsi)	decreased circulating calcium level	J:211773
	increased circulating chloride level	J:211773
Rbmx^{tm2b(KOMP)Wtsi}/Rbmx^{tm2b(KOMP)Wtsi} (C57BL/6N-Rbmx^{tm2b(KOMP)Wtsi}/Wtsi)	increased circulating alkaline phosphatase level	J:211773
Rbp1^tm1Ipc/Rbp1^tm1Ipc (involves: 129S2/SvPas)	abnormal retinol level	J:57825
Rbp1^{tm2b(EUCOMM)Hmgu}/Rbp1^{tm2b(EUCOMM)Hmgu} (C57BL/6N-Rbp1^{tm2b(EUCOMM)Hmgu}/Bay)	decreased fasting circulating glucose level	J:211773
Rbp2^tm1Eli/Rbp2^tm1Eli (B6.129-Rbp2^tm1Eli)	abnormal retinol level	J:79282
Rbp2^tm1Eli/Rbp2^tm1Eli (B6.129-Rbp2^tm1Eli)	abnormal vitamin absorption	J:79282
Rbp4^tm1.1Mma/Rbp4⁺ (involves: 129 * C57BL/6J)	abnormal retinol level	J:108574
Rbp4^tm1.1Mma/Rbp4^tm1.1Mma (involves: 129 * C57BL/6J)	abnormal retinol level	J:108574
Rbp4^tm1.1Mma/Rbp4^tm1.1Mma (involves: 129 * C57BL/6J)	abnormal vitamin level	J:108574
Rbp4^tm1Gott/Rbp4^tm1Gott (involves: 129 * C57BL/6J)	abnormal retinol level	J:57513
Rbp4^tm2Zhel/Rbp4^tm2Zhel (B6J.B6N(CBA)-Rbp4^tm2Zhel)	abnormal retinol level	J:260684
Rbp7^tm1Vgl/Rbp7^tm1Vgl (involves: 129S6/SvEvTac * C57BL/6)	abnormal vitamin A level	J:100844
Rbpj^{tm1b(EUCOMM)Hmgu}/Rbpj⁺ (C57BL/6N-Rbpj^{tm1b(EUCOMM)Hmgu}/J)	decreased circulating HDL cholesterol level	J:211773
	improved glucose tolerance	J:211773
	increased circulating bilirubin level	J:211773
Rbpj^tm1Kyo/Rbpj^tm1Hon Tg(Tek-cre)12Flv/0 (involves: 129P2/OlaHsd * C3H * C57BL/6)	pericardial effusion	J:93125
Rbpjl^{tm1b(KOMP)Wtsi}/Rbpjl^{tm1b(KOMP)Wtsi} (C57BL/6N-Rbpjl^{tm1b(KOMP)Wtsi}/H)	increased circulating amylase level	J:211773
Rbpms^em1(IMPC)H/Rbpms⁺ (C57BL/6NTac-Rbpms^em1(IMPC)H/H)	increased circulating alkaline phosphatase level	J:211773
Rbpms^em1Eno/Rbpms^em1Eno (involves: C3H * C57BL/6)	cyanosis	J:324468
Rc3h1^san/Rc3h1^san (involves: C57BL/6JSfdAnu)	increased circulating tumor necrosis factor level	J:196137
Rc3h1^san/Rc3h1^san Rc3h2^tm1.2Cgv/Rc3h2^tm1.2Cgv (involves: C57BL/6 * C57BL/6JSfdAnu)	increased circulating tumor necrosis factor level	J:196137
Rcan1^tm1Fmc/Rcan1^tm1Fmc (involves: 129S4/SvJae)	abnormal circulating protein level	J:152536
Rcan2^tm1Ypt/Rcan2^tm1Ypt (B6.129-Rcan2^tm1Ypt)	decreased susceptibility to diet-induced obesity	J:169558
	improved glucose tolerance	J:169558
	increased insulin sensitivity	J:169558
Rcc2^{tm1b(EUCOMM)Wtsi}/Rcc2^{tm1b(EUCOMM)Wtsi} (C57BL/6N-Rcc2^{tm1b(EUCOMM)Wtsi}/H)	decreased circulating serum albumin level	J:211773
	decreased circulating total protein level	J:211773
Rce1^tm2Kim/Rce1^tm2.1Kim Tg(Myh6-cre)2182Mds/0 (involves: C57BL/6)	abnormal atrial thrombosis	J:87958
	edema	J:87958
Rcn1^{tm1b(EUCOMM)Hmgu}/Rcn1^{tm1b(EUCOMM)Hmgu} (C57BL/6N-Rcn1^{tm1b(EUCOMM)Hmgu}/Ieg)	decreased blood urea nitrogen level	J:211773
	increased circulating alkaline phosphatase level	J:211773
Rcn3^{tm1b(EUCOMM)Hmgu}/Rcn3^{tm1b(EUCOMM)Hmgu} (C57BL/6N-Rcn3^{tm1b(EUCOMM)Hmgu}/Bay)	edema	J:211773
Rcn3^tm1Rzm/Rcn3^tm1Rzm (involves: 129S6/SvEvTac * C57BL/6J)	abnormal phospholipid level	J:265611
	cyanosis	J:265611
	increased lung glycogen level	J:265611
Rdh1^tm1.1Jln/Rdh1^tm1.1Jln (B6.129P2-Rdh1^tm1.1Jln)	abnormal retinol level	J:134843
Rdh10^trex/Rdh10^trex (involves: 129S1/Sv * C57BL/6)	cardiac edema	J:185330
Rdh16^{tm1a(KOMP)Wtsi}/Rdh16^{tm1a(KOMP)Wtsi} (C57BL/6N-Rdh16^{tm1a(KOMP)Wtsi}/Wtsi)	increased circulating potassium level	J:175295
Rdur^em1Jiche/Rdur^em1Jiche (Not Specified)	increased circulating interleukin-1 level	J:340209
Rdur^em1Jiche/Rdur^em1Jiche (Not Specified)	increased circulating interleukin-6 level	J:340209
Rdx^tm1Sts/Rdx^tm1Sts (involves: 129S4/SvJae * C57BL/6)	abnormal blood homeostasis	J:77485
	increased circulating alkaline phosphatase level	J:77485
	increased circulating aspartate transaminase level	J:77485
	increased circulating bilirubin level	J:77485
Rec8^{tm1b(KOMP)Wtsi}/Rec8^{tm1b(KOMP)Wtsi} (C57BL/6N-Rec8^{tm1b(KOMP)Wtsi}/J)	increased circulating aspartate transaminase level	J:211773
Reep1^{Gt(OST398247)Tigm}/Reep1^{Gt(OST398247)Tigm} (B6J.Cg-Reep1^{Gt(OST398247)Tigm})	decreased circulating cholesterol level	J:239250
	decreased circulating insulin level	J:239250
	decreased circulating triglyceride level	J:239250
	increased glutamic acid level	J:239250
Reg3b^em1(IMPC)Mbp/Reg3b^em1(IMPC)Mbp (C57BL/6NCrl-Reg3b^em1(IMPC)Mbp/MbpMmucd)	increased circulating bilirubin level	J:211773
Reg3b^tm1Lex/Reg3b^tm1Lex (involves: 129S5/SvEvBrd * C57BL/6J)	impaired glucose tolerance	J:171883
Reg3g^{tm1a(KOMP)Wtsi}/Reg3g^{tm1a(KOMP)Wtsi} (C57BL/6N-Reg3g^{tm1a(KOMP)Wtsi}/Wtsi)	increased circulating cholesterol level	J:211773
	increased circulating HDL cholesterol level	J:211773
	increased circulating LDL cholesterol level	J:211773
Rel^{tm1b(EUCOMM)Wtsi}/Rel^{tm1b(EUCOMM)Wtsi} (C57BL/6N-Rel^{tm1b(EUCOMM)Wtsi}/H)	impaired glucose tolerance	J:211773
Rela^tm1Rsch/Rela^tm1Rsch Ptf1a^tm1(cre)Hnak/? (involves: C57BL/6)	abnormal interleukin level	J:122194
	abnormal tumor necrosis factor level	J:122194
Relb^shep/Relb^shep (A;C-Relb^shep/GrsrJ)	abnormal circulating protein level	J:171971
	decreased circulating amylase level	J:171971
	decreased circulating serum albumin level	J:171971
	decreased circulating total protein level	J:171971
Relb^{Tg(H2-K1/GH1)106Bri}/Relb^{Tg(H2-K1/GH1)106Bri} (C57BL/6-Relb^{Tg(H2-K1/GH1)106Bri})	skin edema	J:76450
Relb^{Tg(H2-K1/GH1)106Bri}/Relb^{Tg(H2-K1/GH1)106Bri} (involves: C57BL/6)	decreased circulating interleukin-4 level	J:120659
Relb^tm1Brv/Relb^tm1Brv (involves: 129S2/SvPas * C57BL/6)	abnormal cytokine level	J:40630
	abnormal interferon level	J:40630
	abnormal interleukin level	J:40630
	abnormal tumor necrosis factor level	J:40630
Ren1^tm1.2Sig/Ren1^tm1.2Sig (involves: C57BL/6J)	decreased urine osmolality	J:169129
Ren1^tm1.2Sig/Ren1^tm1.2Sig (involves: C57BL/6J)	increased circulating aldosterone level	J:169129
Ren1^tm1Afu/Ren1^tm1Afu (involves: C57BL/6 * CBA)	abnormal blood homeostasis	J:59299
Ren1^tm1Afu/Ren1^tm1Afu (involves: C57BL/6 * CBA)	decreased circulating renin level	J:59299
Ren1^tm1Bjm/Ren1^tm1Bjm (B6.Cg-Ren1^tm1Bjm)	increased circulating creatinine level	J:117294
Ren1^tm1Gom/Ren1^tm1Gom (involves: 129S6/SvEvTac)	decreased circulating renin level	J:72077
Ren1^tm1Mgfs/Ren1^tm1Mgfs (involves: 129P2/OlaHsd)	abnormal blood homeostasis	J:41714
Ren1^tm1Mgfs/Ren1^tm1Mgfs (involves: 129P2/OlaHsd)	decreased circulating renin level	J:41714
Ren1^tm1Tkh/Ren1^tm1Tkh (C57BL/6-Ren1^tm1Tkh)	abnormal urine homeostasis	J:110082
	decreased circulating angiotensin II level	J:110082
	decreased circulating renin level	J:110082
	decreased urine osmolality	J:110082
	dehydration	J:110082
	increased blood urea nitrogen level	J:110082
	increased circulating creatinine level	J:110082
	metabolic acidosis	J:110082
Ren1^tm3Gom/Ren1⁺ (129S6/SvEvTac-Ren1^tm3Gom)	decreased circulating renin level	J:95786
Ren1^tm3Gom/Ren1^tm3Gom (129S6/SvEvTac-Ren1^tm3Gom)	decreased circulating renin level	J:95786
	increased blood urea nitrogen level	J:95786
	increased circulating potassium level	J:95786
Renbp^tm1Csch/Renbp^tm1Csch (involves: 129 * C57BL/6J)	abnormal urine homeostasis	J:62268
repro19/repro19 (B6;C3Fe-repro19/J)	increased circulating luteinizing hormone level	J:92463
repro19/repro19 (B6;C3Fe-repro19/J)	increased circulating testosterone level	J:92463
Reps2^em1(IMPC)J/Reps2^em1(IMPC)J (C57BL/6NJ-Reps2^em1(IMPC)J/Mmjax)	decreased circulating calcium level	J:211773
Resp18^{tm1.1(KOMP)Vlcg}/Resp18⁺ (C57BL/6N-Resp18^{tm1.1(KOMP)Vlcg}/J)	increased circulating HDL cholesterol level	J:211773
Resp18^{tm1.1(KOMP)Vlcg}/Resp18^{tm1.1(KOMP)Vlcg} (C57BL/6N-Resp18^{tm1.1(KOMP)Vlcg}/J)	decreased circulating free fatty acids level	J:211773
	increased circulating sodium level	J:211773
Ret^tm1Cos/Ret^tm1Cos (involves: 129S/SvEv * MF1)	oligohydramnios	J:30389
Retn^tm1Laz/Retn^tm1Laz (involves: 129S/SvEv * C57BL/6)	decreased circulating glucose level	J:90033
	decreased liver triglyceride level	J:90033
	improved glucose tolerance	J:90033
Retn^tm1Laz/Retn^tm1Laz Tg(CD68-RETN)#Laz/? (involves: 129S6/SvEvTac * C57BL/6)	enhanced lipolysis	J:171262
	impaired glucose tolerance	J:171262
	increased circulating free fatty acids level	J:171262
	increased circulating glycerol level	J:171262
	increased circulating insulin level	J:171262
	increased skeletal muscle triglyceride level	J:171262
	insulin resistance	J:171262
Retnla^tm1Mer/Retnla^tm1Mer (C57BL/6-Retnla^tm1Mer)	decreased circulating leptin level	J:144784
Retnla^tm1Mer/Retnla^tm1Mer (C57BL/6-Retnla^tm1Mer)	improved glucose tolerance	J:144784
Retnla^tm1Mer/Retnla^tm1Mer (C.B6-Retnla^tm1Mer)	improved glucose tolerance	J:144784
Retnlb^tm1Lex/Retnlb^tm1Lex (FVB.129S5-Retnlb^tm1Lex)	decreased circulating interleukin-6 level	J:235058
	impaired glucose tolerance	J:235058
	increased circulating interleukin-13 level	J:235058
Retnlb^tm1Lex/Retnlb^tm1Lex (B6.129S5-Retnlb^tm1Lex)	impaired glucose tolerance	J:235058
Retnlg^em1(IMPC)J/Retnlg^em1(IMPC)J (C57BL/6NJ-Retnlg^em1(IMPC)J/Mmjax)	increased circulating alanine transaminase level	J:211773
Retreg3^{tm2b(EUCOMM)Wtsi}/Retreg3^{tm2b(EUCOMM)Wtsi} (C57BL/6N-Fam134c^{tm2b(EUCOMM)Wtsi}/Wtsi)	increased blood urea nitrogen level	J:211773
	increased circulating alkaline phosphatase level	J:211773
	increased circulating amylase level	J:211773
	increased circulating aspartate transaminase level	J:211773
	increased circulating triglyceride level	J:211773
Rev3l^{tm1b(EUCOMM)Hmgu}/Rev3l⁺ (C57BL/6N-Rev3l^{tm1b(EUCOMM)Hmgu}/J)	decreased blood urea nitrogen level	J:211773
	decreased circulating creatinine level	J:211773
Rev3l^tm1Rwd/Rev3l^tm1Rwd (involves: 129P2/OlaHsd)	pericardial edema	J:65201
Rexo2^{tm1b(EUCOMM)Wtsi}/Rexo2⁺ (C57BL/6N-Rexo2^{tm1b(EUCOMM)Wtsi}/H)	decreased fasting circulating glucose level	J:211773
	increased circulating cholesterol level	J:211773
	increased circulating HDL cholesterol level	J:211773
	increased circulating serum albumin level	J:211773
Rfc1^{tm1b(KOMP)Mbp}/Rfc1⁺ (B6N(Cg)-Rfc1^{tm1b(KOMP)Mbp}/J)	decreased circulating free fatty acids level	J:211773
	increased circulating cholesterol level	J:211773
	increased circulating HDL cholesterol level	J:211773
Rfc5^em1(IMPC)J/Rfc5⁺ (C57BL/6NJ-Rfc5^em1(IMPC)J/Mmjax)	decreased circulating phosphate level	J:211773
Rfk^tm1.1Jcbr/Rfk^tm1.1Jcbr Tg(Mx1-cre)1Cgn/? (involves: C57BL/6 * CBA)	decreased macrophage nitric oxide production	J:151999
Rfx6^{tm1.1(KOMP)Vlcg}/Rfx6⁺ (C57BL/6N-Rfx6^{tm1.1(KOMP)Vlcg}/Ucd)	impaired glucose tolerance	J:211773
Rfx7^{tm2b(EUCOMM)Hmgu}/Rfx7⁺ (C57BL/6N-Rfx7^{tm2b(EUCOMM)Hmgu}/H)	decreased fasting circulating glucose level	J:211773
Rfxank^{tm1b(EUCOMM)Hmgu}/Rfxank^{tm1b(EUCOMM)Hmgu} (C57BL/6N-Rfxank^{tm1b(EUCOMM)Hmgu}/Ieg)	increased circulating alkaline phosphatase level	J:211773
Rgl1^em1(IMPC)Mbp/Rgl1^em1(IMPC)Mbp (C57BL/6N-Rgl1^em1(IMPC)Mbp/MbpMmucd)	edema	J:211773
Rgl3^em1(IMPC)H/Rgl3^em1(IMPC)H (C57BL/6NTac-Rgl3^em1(IMPC)H/H)	decreased circulating alkaline phosphatase level	J:211773
	decreased circulating calcium level	J:211773
	decreased circulating total protein level	J:211773
Rgn^tm1Aish/Y (involves: 129P2/OlaHsd)	abnormal amino acid level	J:108295
	abnormal circulating amino acid level	J:108295
	abnormal phospholipid level	J:88791
	abnormal vitamin C level	J:150664, J:108295
	decreased hydroxyproline level	J:150664
	increased liver cholesterol level	J:88791
	increased liver triglyceride level	J:88791
Rgn^tm1Aish/Y (involves: 129P2/OlaHsd * C57BL/6)	abnormal vitamin C level	J:191530, J:155625
Rgn^tm1Aish/Rgn^tm1Aish (involves: 129P2/OlaHsd * C57BL/6)	abnormal vitamin C level	J:191530
Rgp1^{tm1.1(KOMP)Vlcg}/Rgp1⁺ (C57BL/6N-Rgp1^{tm1.1(KOMP)Vlcg}/J)	decreased circulating calcium level	J:211773
	decreased circulating cholesterol level	J:211773
	decreased circulating glucose level	J:211773
Rgs2^em1(IMPC)H/Rgs2^em1(IMPC)H (C57BL/6NTac-Rgs2^em1(IMPC)H/H)	decreased fasting circulating glucose level	J:211773
Rgs4^em1(IMPC)H/Rgs4^em1(IMPC)H (C57BL/6N-Rgs4^em1(IMPC)H/H)	decreased circulating total protein level	J:211773
Rgs4^tm1Dgen/Rgs4^tm1Dgen (involves: 129P2/OlaHsd * C57BL/6)	increased circulating cholesterol level	J:101679
	increased circulating HDL cholesterol level	J:101679
Rgs4^tm1Sdlk/Rgs4^tm1Sdlk Tg(Myh11-icre/ERT2)1Soff/? (involves: FVB/N)	increased circulating creatinine level	J:215588
Rgs5^tm1.1Rgan/Rgs5^tm1.1Rgan Tg(RIP1-Tag)5Dh/0 (C3.Cg-Rgs5^tm1.1Rgan Tg(RIP1-Tag)5Dh)	edema	J:136259
	hypoglycemia	J:136259
Rgs7^tm1Lex/Rgs7^tm1Lex (involves: 129S5/SvEvBrd * C57BL/6J)	impaired glucose tolerance	J:103485
Rgs10^{Gt(OST24334)Lex}/Rgs10^{Gt(OST24334)Lex} (involves: 129S5/SvEvBrd * C57BL/6J)	impaired glucose tolerance	J:103485
	increased circulating glucose level	J:103485
Rgs16^tm1Tmw/Rgs16^tm1Tmw (involves: 129S4/SvJaeSor * 129X1/SvJ * C57BL/6)	increased circulating ketone body level	J:172091
	increased fatty acid oxidation	J:172091
Rgs18^m1H/Rgs18^m1H (BALB/cAnN-Rgs18^m1H/H)	abnormal hemostasis	J:228457
	decreased bleeding time	J:228457
	increased platelet aggregation	J:228457
	increased susceptibility to induced thrombosis	J:228457
Rgs18^tm1.1Ics/Rgs18^tm1.1Ics (involves: 129S2/SvPas * C57BL/6J)	increased platelet aggregation	J:225296
Rgsc25/Rgsc25⁺ (involves: C57BL/6JJcl * DBA/2JJcl)	hyperglycemia	J:133634
Rgsc25/Rgsc25⁺ (involves: C57BL/6JJcl * DBA/2JJcl)	increased urine glucose level	J:133634
Rgsc160/Rgsc160⁺ (involves: C57BL/6JJcl * DBA/2JJcl)	hyperglycemia	J:133634
Rgsc172/Rgsc172⁺ (involves: C57BL/6JJcl * DBA/2JJcl)	increased blood urea nitrogen level	J:133634
Rgsc172/Rgsc172⁺ (involves: C57BL/6JJcl * DBA/2JJcl)	increased circulating amylase level	J:133634
Rgsc197/Rgsc197⁺ (involves: C57BL/6JJcl * DBA/2JJcl)	decreased circulating cholesterol level	J:133634
Rgsc197/Rgsc197⁺ (involves: C57BL/6JJcl * DBA/2JJcl)	decreased circulating HDL cholesterol level	J:133634
Rgsc263/Rgsc263⁺ (involves: C57BL/6JJcl * DBA/2JJcl)	decreased circulating alkaline phosphatase level	J:133634
Rgsc264/Rgsc264⁺ (involves: C57BL/6JJcl * DBA/2JJcl)	increased circulating alkaline phosphatase level	J:133634
Rgsc273/Rgsc273⁺ (involves: C57BL/6JJcl * DBA/2JJcl)	decreased circulating cholesterol level	J:133634
Rgsc273/Rgsc273⁺ (involves: C57BL/6JJcl * DBA/2JJcl)	decreased circulating HDL cholesterol level	J:133634
Rgsc333/Rgsc333⁺ (involves: C57BL/6JJcl * DBA/2JJcl)	decreased circulating cholesterol level	J:133634
	decreased circulating HDL cholesterol level	J:133634
	decreased circulating total protein level	J:133634
Rgsc370/Rgsc370⁺ (involves: C57BL/6JJcl * DBA/2JJcl)	decreased circulating amylase level	J:133634
Rgsc391/Rgsc391⁺ (involves: C57BL/6JJcl * DBA/2JJcl)	decreased circulating cholesterol level	J:133634
Rgsc391/Rgsc391⁺ (involves: C57BL/6JJcl * DBA/2JJcl)	decreased circulating HDL cholesterol level	J:133634
Rgsc453/Rgsc453⁺ (involves: C57BL/6JJcl * DBA/2JJcl)	decreased circulating cholesterol level	J:133634
Rgsc453/Rgsc453⁺ (involves: C57BL/6JJcl * DBA/2JJcl)	decreased circulating HDL cholesterol level	J:133634
Rgsc466/Rgsc466⁺ (involves: C57BL/6JJcl * DBA/2JJcl)	decreased blood uric acid level	J:133634
Rgsc477/Rgsc477⁺ (involves: C57BL/6JJcl * DBA/2JJcl)	increased circulating copper level	J:133634
Rgsc484/Rgsc484⁺ (involves: C57BL/6JJcl * DBA/2JJcl)	decreased circulating alkaline phosphatase level	J:133634
Rgsc522/Rgsc522⁺ (involves: C57BL/6JJcl * DBA/2JJcl)	decreased circulating amylase level	J:133634
Rgsc528/Rgsc528⁺ (involves: C57BL/6JJcl * DBA/2JJcl)	decreased circulating cholesterol level	J:133634
Rgsc528/Rgsc528⁺ (involves: C57BL/6JJcl * DBA/2JJcl)	decreased circulating HDL cholesterol level	J:133634
Rgsc545/Rgsc545⁺ (involves: C57BL/6JJcl * DBA/2JJcl)	decreased circulating cholesterol level	J:133634
Rgsc545/Rgsc545⁺ (involves: C57BL/6JJcl * DBA/2JJcl)	decreased circulating HDL cholesterol level	J:133634
Rgsc627/Rgsc627⁺ (involves: C57BL/6JJcl * DBA/2JJcl)	increased circulating alkaline phosphatase level	J:133634
	increased circulating bilirubin level	J:133634
	increased circulating copper level	J:133634
Rgsc629/Rgsc629⁺ (involves: C57BL/6JJcl * DBA/2JJcl)	decreased circulating amylase level	J:133634
Rgsc663/Rgsc663⁺ (involves: C57BL/6JJcl * DBA/2JJcl)	decreased circulating cholesterol level	J:133634
Rgsc663/Rgsc663⁺ (involves: C57BL/6JJcl * DBA/2JJcl)	decreased circulating HDL cholesterol level	J:133634
Rgsc668/Rgsc668⁺ (involves: C57BL/6JJcl * DBA/2JJcl)	decreased circulating cholesterol level	J:133634
Rgsc668/Rgsc668⁺ (involves: C57BL/6JJcl * DBA/2JJcl)	decreased circulating HDL cholesterol level	J:133634
Rgsc679/Rgsc679⁺ (involves: C57BL/6JJcl * DBA/2JJcl)	increased circulating cholesterol level	J:133634
Rgsc679/Rgsc679⁺ (involves: C57BL/6JJcl * DBA/2JJcl)	increased circulating HDL cholesterol level	J:133634
Rgsc733/Rgsc733⁺ (involves: C57BL/6JJcl * DBA/2JJcl)	decreased circulating HDL cholesterol level	J:133634
Rgsc832/Rgsc832⁺ (involves: C57BL/6JJcl * DBA/2JJcl)	increased circulating alkaline phosphatase level	J:133634
Rgsc833/Rgsc833⁺ (involves: C57BL/6JJcl * DBA/2JJcl)	decreased circulating alkaline phosphatase level	J:133634
Rgsc846/Rgsc846⁺ (involves: C57BL/6JJcl * DBA/2JJcl)	decreased circulating alkaline phosphatase level	J:133634
Rgsc855/Rgsc855⁺ (involves: C57BL/6JJcl * DBA/2JJcl)	decreased circulating cholesterol level	J:133634
Rgsc855/Rgsc855⁺ (involves: C57BL/6JJcl * DBA/2JJcl)	decreased circulating HDL cholesterol level	J:133634
Rgsc916/Rgsc916⁺ (involves: C57BL/6JJcl * DBA/2JJcl)	decreased blood uric acid level	J:133634
Rgsc1196/Rgsc1196⁺ (involves: C57BL/6JJcl * DBA/2JJcl)	decreased circulating alkaline phosphatase level	J:133634
Rgsc1361/Rgsc1361⁺ (involves: KJR * MSM)	increased circulating glucose level	J:133634
Rgsc1472/Rgsc1472⁺ (involves: C3H * C57BL/6JJcl)	decreased circulating amylase level	J:133634
Rgsc1501/Rgsc1501⁺ (involves: C3H * C57BL/6JJcl)	decreased lactate dehydrogenase level	J:133634
Rgsc1566/Rgsc1566⁺ (involves: C3H * C57BL/6JJcl)	decreased circulating alkaline phosphatase level	J:133634
Rgsc1662/Rgsc1662⁺ (involves: C3H * C57BL/6JJcl)	decreased blood uric acid level	J:133634
Rgsc1663/Rgsc1663⁺ (involves: C3H * C57BL/6JJcl)	increased blood urea nitrogen level	J:133634
Rgsc1666/Rgsc1666⁺ (involves: C3H * C57BL/6JJcl)	decreased blood uric acid level	J:133634
Rgsc1688/Rgsc1688⁺ (involves: C3H * C57BL/6JJcl)	decreased circulating alkaline phosphatase level	J:133634
Rgsc1740/Rgsc1740⁺ (involves: C3H * C57BL/6JJcl)	decreased circulating copper level	J:133634
Rgsc1851/Rgsc1851 (C57BL/6JJcl-Rgsc1851)	increased circulating triglyceride level	J:133634
Rhag^{em1(IMPC)Ccpcz}/Rhag^{em1(IMPC)Ccpcz} (C57BL/6NCrl-Rhag^{em1(IMPC)Ccpcz}/Ccpcz)	increased circulating total protein level	J:211773
Rhag^tm1Goo/Rhag^tm1Goo (involves: 129P2/OlaHsd * C57BL/6)	abnormal blood homeostasis	J:182122
Rhag^tm1Goo/Rhag^tm1Goo (involves: 129P2/OlaHsd * C57BL/6)	increased circulating iron level	J:182122
Rhbdd1^tm1.1Mfm/Rhbdd1^tm1.1Mfm (involves: 129S/SvEv * C57BL/6J)	abnormal protein level	J:346394
Rhbdd3^tm1Caox/Rhbdd3^tm1Caox (B6.129S6-Rhbdd3^tm1Caox)	increased circulating alanine transaminase level	J:197348
	increased circulating aspartate transaminase level	J:197348
	increased circulating interferon-gamma level	J:197348
	increased circulating interleukin-6 level	J:197348
Rhbdf1^tm1.1Mfm/Rhbdf1^tm1.1Mfm (involves: 129S/SvEv * 129S6/SvEvTac * C57BL/6J)	abnormal cardiac thrombosis	J:203951
Rhbdf2^{em1(IMPC)Wtsi}/Rhbdf2^{em1(IMPC)Wtsi} (C57BL/6N-Rhbdf2^{em1(IMPC)Wtsi}/Wtsi)	increased circulating magnesium level	J:211773
Rhbdf2^tm1.1Mfm/Rhbdf2^tm1.1Mfm (B6.129S-Rhbdf2^tm1.1Mfm)	decreased circulating tumor necrosis factor level	J:179654
Rhbdf2^tm1Mak/Rhbdf2^tm1Mak (B6.129P2-Rhbdf2^tm1Mak)	decreased circulating tumor necrosis factor level	J:179653
Rhbdl1^{tm1.1(KOMP)Vlcg}/Rhbdl1⁺ (C57BL/6N-Rhbdl1^{tm1.1(KOMP)Vlcg}/Ucd)	increased circulating alanine transaminase level	J:211773
	increased circulating aspartate transaminase level	J:211773
	increased circulating bilirubin level	J:211773
Rhbg^{em1(IMPC)Hmgu}/Rhbg^{em1(IMPC)Hmgu} (C57BL/6N-Rhbg^{em1(IMPC)Hmgu}/Ieg)	decreased circulating alanine transaminase level	J:211773
	decreased circulating iron level	J:211773
Rhbg^tm1.1Idw/Rhbg^tm1.1Idw Tg(ATP6V1B1-cre)45Rnel/0 (involves: C57BL/6)	decreased urine ammonia level	J:195261
Rhcg^tm1Ibmm/Rhcg^tm1Ibmm (involves: 129P2/OlaHsd * CD-1)	acidosis	J:141372
	decreased circulating potassium level	J:141372
	decreased urine ammonia level	J:141372
	increased urine pH	J:141372
	renal tubular acidosis	J:141372
Rhcg^tm1Ibmm/Rhcg^tm1Ibmm (involves: 129P2/OlaHsd * C57BL/6)	renal tubular acidosis	J:141372
Rhcg^tm1Tigm/Rhcg⁺ (involves: 129S/SvEvBrd * C57BL/6)	acidosis	J:196009
Rhcg^tm1Tigm/Rhcg⁺ (involves: 129S/SvEvBrd * C57BL/6)	increased urine pH	J:196009
Rhcg^tm1Tigm/Rhcg^tm1Tigm (involves: 129S/SvEvBrd * C57BL/6)	acidosis	J:196009
	decreased urine ammonia level	J:196009
Rhd^{tm1a(EUCOMM)Wtsi}/Rhd^{tm1a(EUCOMM)Wtsi} (B6JTyr;B6N-Rhd^{tm1a(EUCOMM)Wtsi}/Wtsi)	decreased circulating alkaline phosphatase level	J:165965
Rhd^tm1Goo/Rhd^tm1Goo (involves: 129P2/OlaHsd * C57BL/6)	increased circulating iron level	J:182122
Rheb^tm1.1Yelg/Rheb^tm1.1Yelg (B6.129P2-Rheb^tm1.1Yelg)	hemopericardium	J:170999
Rho^Noerg1/Rho⁺ (C57BL/6J-Rho^Noerg1/Nwu)	photosensitivity	J:83419
Rho^Noerg1/Rho^Noerg1 (C57BL/6J-Rho^Noerg1/Nwu)	photosensitivity	J:83419
Rho^Tvrm1/Rho⁺ (C57BL/6J-Rho^Tvrm1)	abnormal retinol level	J:159523
Rho^Tvrm1/Rho⁺ (C57BL/6J-Rho^Tvrm1)	photosensitivity	J:159523
Rho^Tvrm4/Rho⁺ (B6.Cg-Rho^Tvrm4/Pjn)	abnormal retinol level	J:159523
Rho^Tvrm4/Rho⁺ (B6.Cg-Rho^Tvrm4/Pjn)	photosensitivity	J:159523
Rhoa^tm1Jrel/Rhoa^tm1Jrel Rhpn1^tm1Ktry/Rhpn1^tm1Ktry Tg(NPHS2-cre)295Lbh/0 (involves: 129X1/SvJ * C57BL/6 * SJL)	increased circulating creatinine level	J:276466
Rhot1^tm1.2Jmsu/Rhot1^tm1.2Jmsu (involves: 129 * 129S1/Sv * C57BL/6 * SJL)	cyanosis	J:216408
Rhot1^{tm1d(EUCOMM)Wtsi}/Rhot1^{tm1d(EUCOMM)Wtsi} (involves: C57BL/6Dnk * C57BL/6N)	cyanosis	J:240500
Rhot2^{tm1(KOMP)Wtsi}/Rhot2^{tm1(KOMP)Wtsi} (C57BL/6N-Rhot2^{tm1(KOMP)Wtsi}/Wtsi)	decreased circulating iron level	J:175295
Rhou^{tm1a(KOMP)Wtsi}/Rhou^{tm1a(KOMP)Wtsi} (C57BL/6N-Rhou^{tm1a(KOMP)Wtsi}/Wtsi)	increased blood urea nitrogen level	J:175295
Rhpn1^{tm1b(KOMP)Wtsi}/Rhpn1^{tm1b(KOMP)Wtsi} (C57BL/6N-Rhpn1^{tm1b(KOMP)Wtsi}/Ucd)	decreased circulating serum albumin level	J:211773
	decreased circulating total protein level	J:211773
	increased circulating HDL cholesterol level	J:211773
Rhpn1^tm1Ktry/Rhpn1^tm1Ktry (involves: 129X1/SvJ * C57BL/6)	albuminuria	J:276466
Rhpn1^tm1Ktry/Rhpn1^tm1Ktry (B6.129X1-Rhpn1^tm1Ktry)	albuminuria	J:276466
Rhpn1^tm1Ktry/Rhpn1^tm1Ktry Rhpn2^tm1Ssch/Rhpn2^tm1Ssch (involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * CD-1)	albuminuria	J:276466
	increased circulating creatinine level	J:276466
Ric1^{tm1a(EUCOMM)Hmgu}/Ric1^{tm1a(EUCOMM)Hmgu} (C57BL/6N-Ric1^{tm1a(EUCOMM)Hmgu}/H)	increased circulating alkaline phosphatase level	J:165965
Rictor^tm1.1Mgn/Rictor^tm1.1Mgn Tg(Ins2-cre)25Mgn/0 (involves: 129S6/SvEvTac * BALB/c * C57BL/6 * DBA)	abnormal glucose homeostasis	J:170129
	decreased insulin secretion	J:170129
	hyperglycemia	J:170129
	impaired glucose tolerance	J:170129
Rictor^tm1.1Mnh/Rictor^tm1.1Mnh Tg(Fabp4-cre)1Rev/0 (B6.Cg-Rictor^tm1.1Mnh Tg(Fabp4-cre)1Rev)	decreased adiponectin level	J:150064
	improved glucose tolerance	J:150064
	increased circulating cholesterol level	J:150064
	increased circulating insulin level	J:150064
	increased circulating insulin-like growth factor I level	J:150064
	insulin resistance	J:150064
Rictor^tm1Mgn/Rictor^tm1Mgn (involves: 129S6/SvEvTac * C57BL/6)	hydrops fetalis	J:119564
Rida^{tm1a(KOMP)Wtsi}/Rida^{tm1a(KOMP)Wtsi} (C57BL/6N-Rida^{tm1a(KOMP)Wtsi}/Wtsi)	decreased circulating iron level	J:211773
Rigi^em1(IMPC)Mbp/Rigi^em1(IMPC)Mbp (C57BL/6N-Rigi^em1(IMPC)Mbp/MbpMmucd)	impaired glucose tolerance	J:211773
Rigi^tm1Aki/Rigi^tm1Aki (involves: 129/Sv * C57BL/6 * ICR)	abnormal interferon level	J:137522
Rilpl1^{tm1b(EUCOMM)Hmgu}/Rilpl1^{tm1b(EUCOMM)Hmgu} (C57BL/6N-Rilpl1^{tm1b(EUCOMM)Hmgu}/Ieg)	increased fasting circulating glucose level	J:211773
Rimoc1^{tm1b(EUCOMM)Wtsi}/Rimoc1^{tm1b(EUCOMM)Wtsi} (C57BL/6N-Rimoc1^{tm1b(EUCOMM)Wtsi}/Bay)	increased body temperature	J:211773
Rims2^tm1Sse/Rims2^tm1Sse (B6.Cg-Rims2^tm1Sse)	decreased circulating adrenaline level	J:163080
	decreased circulating glucose level	J:163080
	decreased circulating growth hormone level	J:163080
	decreased circulating insulin level	J:163080
	decreased circulating insulin-like growth factor I level	J:163080
	decreased insulin secretion	J:163080
	impaired glucose tolerance	J:163080
	increased circulating glucagon level	J:163080
	increased circulating glucose level	J:163080
Rin3^{tm1.1(KOMP)Vlcg}/Rin3^{tm1.1(KOMP)Vlcg} (C57BL/6N-Rin3^{tm1.1(KOMP)Vlcg}/J)	decreased circulating calcium level	J:211773
	decreased circulating chloride level	J:211773
	decreased circulating glucose level	J:211773
	decreased circulating iron level	J:211773
	decreased urine magnesium level	J:211773
	increased fasting circulating glucose level	J:211773
Rint1^{tm1b(KOMP)Wtsi}/Rint1⁺ (C57BL/6N-Rint1^{tm1b(KOMP)Wtsi}/J)	decreased circulating calcium level	J:211773
	decreased circulating free fatty acids level	J:211773
	decreased circulating glucose level	J:211773
	decreased circulating serum albumin level	J:211773
	decreased circulating total protein level	J:211773
	increased circulating bilirubin level	J:211773
Riok2^{tm1b(KOMP)Wtsi}/Riok2⁺ (C57BL/6N-Riok2^{tm1b(KOMP)Wtsi}/Tcp)	increased circulating alanine transaminase level	J:211773
	increased circulating aspartate transaminase level	J:211773
	increased circulating bilirubin level	J:211773
Riok2^{tm1c(KOMP)Wtsi}/Riok2⁺ Commd10^{Tg(Vav1-icre)A2Kio}/Commd10⁺ (involves: C57BL/6N * C57BL/10 * CBA/Ca)	abnormal circulating interleukin level	J:305794
Riox2^tm1Mtsun/Riox2^tm1Mtsun (B6CrSlc.Cg-Riox2^tm1Mtsun)	abnormal circulating interferon-gamma level	J:201871
Riox2^tm1Mtsun/Riox2^tm1Mtsun (B6CrSlc.Cg-Riox2^tm1Mtsun)	abnormal circulating interleukin-4 level	J:201871
Ripk1^tm1.1Vmd/Ripk1⁺ Ripk3^tm2Vmd/Ripk3^tm2Vmd (involves: C57BL/6N)	decreased liver glycogen level	J:209137
Ripk1^tm1Geno/Ripk1^tm1Geno (involves: C57BL/6)	abnormal body temperature	J:209137
Ripk1^tm1Led/Ripk1^tm1Led (involves: 129S6/SvEvTac)	edema	J:46522
Ripk4^tm1Pmh/Ripk4^tm1Pmh (involves: 129 * C57BL/6)	impaired skin barrier function	J:259661
Ripply3^tm1Sjt/Ripply3^tm1Sjt (involves: 129S1/Sv * C57BL/6)	cyanosis	J:167713
Rit1^em1(IMPC)Mbp/Rit1^em1(IMPC)Mbp (C57BL/6N-Rit1^em1(IMPC)Mbp/MbpMmucd)	increased circulating alkaline phosphatase level	J:211773
	increased circulating aspartate transaminase level	J:211773
Rit1^tm1.1Tumg/Rit1⁺ (B6.Cg-Rit1^tm1.1Tumg)	hydrops fetalis	J:277548
Rit1^tm1.1Tumg/Rit1⁺ (B6.Cg-Rit1^tm1.1Tumg)	increased circulating aspartate transaminase level	J:277548
Rln1^tm1Wint/Rln1^tm1Wint (involves: 129S1/Sv * C57BL/6J)	increased blood osmolality	J:52024
Rln3^tm1(KOMP)Mbp/Rln3^tm1(KOMP)Mbp (C57BL/6N-Rln3^tm1(KOMP)Mbp/Ucd)	increased circulating iron level	J:211773
Rln3^tm1Lex/Rln3^tm1Lex (involves: 129S5/SvEvBrd * C57BL/6)	decreased circulating insulin level	J:181242
	decreased circulating leptin level	J:181242
	decreased susceptibility to diet-induced obesity	J:181242
	increased adiponectin level	J:181242
Rmi1^{Gt(pUHachi)0283Imeg}/Rmi1⁺ (involves: C57BL/6)	abnormal glucose tolerance	J:168271
	decreased circulating glucose level	J:168271
	decreased susceptibility to diet-induced obesity	J:168271
Rnase1^tm1.2Rtrs/Rnase1^tm1.2Rtrs (involves: 129S4/SvJaeSor * BALB/cJ * C57BL/6)	abnormal blood coagulation	J:288762
	abnormal blood homeostasis	J:288762
Rnaseh2b^{tm1a(EUCOMM)Wtsi}/Rnaseh2b^{tm1a(EUCOMM)Wtsi} (involves: C57BL/6N)	edema	J:186986
Rnasek^{tm1b(EUCOMM)Wtsi}/Rnasek⁺ (C57BL/6N-Rnasek^{tm1b(EUCOMM)Wtsi}/Wtsi)	increased circulating alanine transaminase level	J:211773
Rnaset2b^{tm1b(EUCOMM)Hmgu}/Rnaset2b^{tm1b(EUCOMM)Hmgu} (C57BL/6N-Rnaset2b^{tm1b(EUCOMM)Hmgu}/H)	impaired glucose tolerance	J:211773
Rnf4^{em1(IMPC)Ccpcz}/Rnf4⁺ (C57BL/6N-Rnf4^{em1(IMPC)Ccpcz}/Ccpcz)	increased circulating total protein level	J:211773
	increased circulating triglyceride level	J:211773
Rnf7^Gt(XE423)Byg/Rnf7^Gt(XE423)Byg (involves: 129P2/OlaHsd * C57BL/6)	pericardial edema	J:178926
Rnf7^{tm1a(EUCOMM)Wtsi}/Rnf7⁺ (Not Specified)	decreased circulating chloride level	J:165965
	decreased circulating triglyceride level	J:165965
	increased circulating chloride level	J:165965
Rnf10^em1(IMPC)Mbp/Rnf10^em1(IMPC)Mbp (C57BL/6N-Rnf10^em1(IMPC)Mbp/Ucd)	increased circulating alanine transaminase level	J:211773
	increased circulating aspartate transaminase level	J:211773
	increased circulating glucose level	J:211773
Rnf10^{tm1a(KOMP)Wtsi}/Rnf10^{tm1a(KOMP)Wtsi} (C57BL/6N-Rnf10^{tm1a(KOMP)Wtsi}/Wtsi)	decreased circulating cholesterol level	J:175295
	decreased circulating HDL cholesterol level	J:175295
	increased circulating cholesterol level	J:175295
	increased circulating HDL cholesterol level	J:175295
	increased circulating triglyceride level	J:175295
Rnf10^{tm1b(KOMP)Wtsi}/Rnf10⁺ (C57BL/6N-Rnf10^{tm1b(KOMP)Wtsi}/Ucd)	decreased circulating serum albumin level	J:211773
	decreased circulating triglyceride level	J:211773
Rnf10^{tm1b(KOMP)Wtsi}/Rnf10⁺ (C57BL/6N-Rnf10^{tm1b(KOMP)Wtsi}/MbpMmucd)	increased circulating HDL cholesterol level	J:211773
Rnf10^{tm1b(KOMP)Wtsi}/Rnf10^{tm1b(KOMP)Wtsi} (C57BL/6N-Rnf10^{tm1b(KOMP)Wtsi}/Ics)	decreased circulating cholesterol level	J:211773
	decreased circulating HDL cholesterol level	J:211773
	decreased circulating serum albumin level	J:211773
	improved glucose tolerance	J:211773
Rnf10^{tm1b(KOMP)Wtsi}/Rnf10^{tm1b(KOMP)Wtsi} (C57BL/6N-Rnf10^{tm1b(KOMP)Wtsi}/H)	decreased circulating alkaline phosphatase level	J:211773
	decreased circulating total protein level	J:211773
Rnf10^{tm1b(KOMP)Wtsi}/Rnf10^{tm1b(KOMP)Wtsi} (C57BL/6N-Rnf10^{tm1b(KOMP)Wtsi}/Wtsi)	increased circulating creatinine level	J:211773
Rnf10^{tm1b(KOMP)Wtsi}/Rnf10^{tm1b(KOMP)Wtsi} (C57BL/6N-Rnf10^{tm1b(KOMP)Wtsi}/J)	decreased circulating glucose level	J:211773
	decreased fasting circulating glucose level	J:211773
	increased circulating sodium level	J:211773
Rnf10^{tm1b(KOMP)Wtsi}/Rnf10^{tm1b(KOMP)Wtsi} (C57BL/6N-Rnf10^{tm1b(KOMP)Wtsi}/Ieg)	decreased circulating serum albumin level	J:211773
	decreased circulating total protein level	J:211773
	increased circulating triglyceride level	J:211773
Rnf14^{em1(IMPC)Ccpcz}/Rnf14^{em1(IMPC)Ccpcz} (C57BL/6N-Rnf14^{em1(IMPC)Ccpcz}/Ccpcz)	increased circulating HDL cholesterol level	J:211773
	increased fasting circulating glucose level	J:211773
Rnf20^{Gt(RRJ249)Byg}/Rnf20⁺ (involves: 129P2/OlaHsd)	abnormal nitric oxide homeostasis	J:268221
Rnf25^{tm1.1(KOMP)Vlcg}/Rnf25^{tm1.1(KOMP)Vlcg} (C57BL/6N-Rnf25^{tm1.1(KOMP)Vlcg}/J)	decreased circulating chloride level	J:211773
	increased circulating cholesterol level	J:211773
	increased circulating HDL cholesterol level	J:211773
	increased circulating sodium level	J:211773
Rnf43^em1(IMPC)Tcp/Rnf43^em1(IMPC)Tcp (C57BL/6NCrl-Rnf43^em1(IMPC)Tcp/Tcp)	increased circulating potassium level	J:211773
Rnf115^em1(IMPC)H/Rnf115^em1(IMPC)H (C57BL/6N-Rnf115^em1(IMPC)H/H)	increased circulating phosphate level	J:211773
Rnf115^em1Gpt/Rnf115^em1Gpt (C57BL/6JGpt-Rnf115^em1Gpt/Gpt)	increased circulating interferon-beta level	J:297834
Rnf125^{tm1a(EUCOMM)Hmgu}/Rnf125^{tm1a(EUCOMM)Hmgu} (C57BL/6N-Rnf125^{tm1a(EUCOMM)Hmgu}/Wtsi)	increased circulating bilirubin level	J:211773
Rnf128^tm1.1Flv/Y (involves: 129S6/SvEvTac * C57BL/6)	increased circulating interleukin-2 level	J:153216
Rnf128^tm1.1Flv/Y Tg(TcraTcrb)425Cbn/0 (involves: 129S6/SvEvTac * BALB/c * C57BL/6)	increased circulating interleukin-2 level	J:153216
Rnf128^tm1.1Flv/Rnf128^tm1.1Flv (involves: 129S6/SvEvTac * C57BL/6)	increased circulating interleukin-2 level	J:153216
Rnf128^tm1.1Flv/Rnf128^tm1.1Flv Tg(TcraTcrb)425Cbn/0 (involves: 129S6/SvEvTac * BALB/c * C57BL/6)	increased circulating interleukin-2 level	J:153216
Rnf130^{tm1a(EUCOMM)Wtsi}/Rnf130^{tm1a(EUCOMM)Wtsi} (involves: C57BL/6N)	abnormal protein level	J:338210
	decreased circulating cholesterol level	J:338210
	decreased circulating LDL cholesterol level	J:338210
Rnf133^{tm1.1(KOMP)Vlcg}/Rnf133^{tm1.1(KOMP)Vlcg} (C57BL/6N-Rnf133^{tm1.1(KOMP)Vlcg}/J)	decreased fasting circulating glucose level	J:211773
Rnf144a^em1(IMPC)Tcp/Rnf144a^em1(IMPC)Tcp (C57BL/6NCrl-Rnf144a^em1(IMPC)Tcp/Tcp)	decreased circulating chloride level	J:211773
Rnf144b^{tm1b(EUCOMM)Hmgu}/Rnf144b^{tm1b(EUCOMM)Hmgu} (C57BL/6N-Rnf144b^{tm1b(EUCOMM)Hmgu}/Ics)	increased circulating calcium level	J:211773
	increased circulating cholesterol level	J:211773
Rnf145^{em1(IMPC)Wtsi}/Rnf145⁺ (C57BL/6N-Rnf145^{em1(IMPC)Wtsi}/Wtsi)	increased circulating amylase level	J:211773
Rnf146^tm1.1Rtpl/Rnf146^tm1.1Rtpl Lyz2^tm1(cre)Ifo/Lyz2⁺ (involves: 129P2/OlaHsd * C57BL/6J)	increased circulating tumor necrosis factor level	J:243612
Rnf146^tm1.1Rtpl/Rnf146^tm1.1Rtpl Tg(Sp7-tTA,tetO-EGFP/cre)1Amc/0 (involves: C57BL/6J * CD-1)	decreased circulating insulin level	J:244583
	decreased circulating osteocalcin level	J:244583
	decreased insulin secretion	J:244583
	impaired glucose tolerance	J:244583
	increased circulating glucose level	J:244583
	increased circulating triglyceride level	J:244583
Rnf148^{em1(IMPC)Ccpcz}/Rnf148^{em1(IMPC)Ccpcz} (C57BL/6N-Rnf148^{em1(IMPC)Ccpcz}/Ccpcz)	decreased circulating serum albumin level	J:211773
	increased circulating alkaline phosphatase level	J:211773
Rnf157^{tm1b(EUCOMM)Wtsi}/Rnf157^{tm1b(EUCOMM)Wtsi} (C57BL/6N-Rnf157^{tm1b(EUCOMM)Wtsi}/Wtsi)	increased circulating amylase level	J:211773
Rnf166^em1(IMPC)J/Rnf166^em1(IMPC)J (C57BL/6NJ-Rnf166^em1(IMPC)J/Mmjax)	decreased circulating phosphate level	J:211773
Rnf168^em1(IMPC)H/Rnf168^em1(IMPC)H (C57BL/6NTac-Rnf168^em1(IMPC)H/H)	increased circulating alanine transaminase level	J:211773
	increased circulating creatine kinase level	J:211773
Rnf168^{tm2b(EUCOMM)Hmgu}/Rnf168^{tm2b(EUCOMM)Hmgu} (C57BL/6N-Rnf168^{tm2b(EUCOMM)Hmgu}/Ccpcz)	increased circulating alanine transaminase level	J:211773
	increased circulating aspartate transaminase level	J:211773
	increased circulating creatine kinase level	J:211773
	increased circulating lactate dehydrogenase level	J:211773
	increased circulating phosphate level	J:211773
Rnf169^{tm1a(EUCOMM)Hmgu}/Rnf169^{tm1a(EUCOMM)Hmgu} (B6NTac;B6N-Rnf169^{tm1a(EUCOMM)Hmgu}/H)	decreased circulating free fatty acids level	J:165965
Rnf180^em1(IMPC)J/Rnf180^em1(IMPC)J (C57BL/6NJ-Rnf180^em1(IMPC)J/Mmjax)	abnormal cholesterol homeostasis	J:211773
	decreased circulating calcium level	J:211773
	decreased circulating serum albumin level	J:211773
	decreased circulating total protein level	J:211773
Rnf180^tm1.1Jaru/Rnf180^tm1.1Jaru (B6J.129P2(Cg)-Rnf180^tm1.1Jaru)	decreased noradrenaline level	J:199865
	decreased serotonin level	J:199865
Rnf208^{em1(IMPC)Ccpcz}/Rnf208^{em1(IMPC)Ccpcz} (C57BL/6N-Rnf208^{em1(IMPC)Ccpcz}/Ccpcz)	increased circulating alanine transaminase level	J:211773
	increased circulating aspartate transaminase level	J:211773
	increased circulating creatine kinase level	J:211773
Rnf213^tm1.1Akoi/Rnf213^tm1.1Akoi (involves: C57BL/6N)	decreased circulating glucose level	J:200802
Rnf213^tm1.1Akoi/Rnf213^tm1.1Akoi (involves: C57BL/6N)	decreased insulin secretion	J:200802
Rnf214^em1(IMPC)J/Rnf214^em1(IMPC)J (C57BL/6NJ-Rnf214^em1(IMPC)J/Mmjax)	increased circulating calcium level	J:211773
	increased circulating phosphate level	J:211773
Rnf216^{tm1b(EUCOMM)Wtsi}/Rnf216^{tm1b(EUCOMM)Wtsi} (C57BL/6N-Rnf216^{tm1b(EUCOMM)Wtsi}/Tcp)	increased fasting circulating glucose level	J:211773
Rnl11/? (C57BL/6J-Rnl11)	albuminuria	J:82961
Rnl20/? (C57BL/6J-Rnl20)	albuminuria	J:82961
Rnl23/? (C57BL/6J-Rnl23)	increased blood urea nitrogen level	J:82961
Rnl25/? (C57BL/6J-Rnl25)	increased blood urea nitrogen level	J:82961
Rnl27/? (C57BL/6J-Rnl27/J)	increased blood urea nitrogen level	J:82961
Rnl29/? (C57BL/6J-Rnl29)	increased blood urea nitrogen level	J:82961
Rnl32/? (C57BL/6J-Rnl32)	increased blood urea nitrogen level	J:82961
Rnl43/? (C57BL/6J-Rnl43)	increased blood urea nitrogen level	J:82961
Rnls^tm1Gvd/Rnls^tm1Gvd (involves: 129S1/Sv * C57BL/6)	increased circulating adrenaline level	J:186878
	increased circulating noradrenaline level	J:186878
	increased dopamine level	J:186878
Robo1^tm1Matl/Robo1^tm1Matl Robo2^tm1Mrt/Robo2^tm1Mrt (involves: 129P2/OlaHsd)	cyanosis	J:193400
Robo2^em1(IMPC)Mbp/Robo2^em1(IMPC)Mbp (C57BL/6N-Robo2^em1(IMPC)Mbp/MbpMmucd)	edema	J:211773
Robo3^em1(IMPC)H/Robo3⁺ (C57BL/6NTac-Robo3^em1(IMPC)H/H)	decreased circulating glucose level	J:211773
Robo3^em1(IMPC)H/Robo3⁺ (C57BL/6NTac-Robo3^em1(IMPC)H/H)	increased circulating bilirubin level	J:211773
Robo3^tm1Matl/Robo3^tm1Matl (involves: C57BL/6)	cyanosis	J:165285
Robo4^tm1Kzh/Robo4^tm1Kzh (involves: C57BL/6)	impaired skin barrier function	J:133680
Robo4^tm1Kzh/Robo4^tm1Kzh (Not Specified)	decreased circulating glucose level	J:294754
	decreased fasting circulating glucose level	J:294754
	decreased susceptibility to diet-induced obesity	J:294754
	improved glucose tolerance	J:294754
Rock1^tm1.1Itl/Rock1^tm1.1Itl Tg(Pomc1-cre)16Lowl/0 (involves: 129S4/SvJaeSor * C57BL/6 * FVB/N)	increased circulating insulin level	J:204885
	increased circulating leptin level	J:204885
	insulin resistance	J:204885
Rock1^{tm1b(NCOM)Mfgc}/Rock1^{tm1b(NCOM)Mfgc} (C57BL/6N-Rock1^{tm1b(NCOM)Mfgc}/Tcp)	edema	J:211773
Rock2^tm1Zpj/Rock2⁺ (involves: 129S1/Sv * 129X1/SvJ * CD-1)	abnormal circulating cholesterol level	J:224630
	decreased circulating free fatty acids level	J:224630
	decreased susceptibility to diet-induced obesity	J:224630
	improved glucose tolerance	J:224630
Rogdi^tm1.2Ics/Rogdi^tm1.2Ics (involves: C57BL/6N)	decreased circulating calcium level	J:344072
Rogdi^tm1.2Ics/Rogdi^tm1.2Ics (involves: C57BL/6N)	increased circulating alkaline phosphatase level	J:344072
Romo1^{em1(IMPC)Kmpc}/Romo1⁺ (C57BL/6NTac-Romo1^{em1(IMPC)Kmpc}/Kmpc)	increased circulating total protein level	J:211773
Ror1^tm1.2Meg/Ror1^tm1.2Meg Ror2^tm1.2Meg/Ror2^tm1.2Meg (involves: 129S4/SvJae * C57BL/6 * FVB/N)	hydrops fetalis	J:182150
Ror1^tm1Ymi/Ror1^tm1Ymi (involves: 129P2/OlaHsd * C57BL/6)	abnormal blood homeostasis	J:72948
Ror1^tm1Ymi/Ror1^tm1Ymi (involves: 129P2/OlaHsd * C57BL/6)	cyanosis	J:72948
Ror2^tm1Ymi/Ror2^tm1Ymi (involves: 129P2/OlaHsd * C57BL/6)	abnormal blood homeostasis	J:60125
Ror2^tm1Ymi/Ror2^tm1Ymi (involves: 129P2/OlaHsd * C57BL/6)	cyanosis	J:60125
Rora^sg/Rora^sg (involves: obese stock)	abnormal hormone level	J:28467
Rora^sg/Rora^sg (involves: C57BL/6)	abnormal lipid homeostasis	J:52105
	decreased circulating cholesterol level	J:52105
	decreased circulating HDL cholesterol level	J:52105
Rora^sg/Rora^sg (involves: C57BL)	decreased aspartic acid level	J:6875
	decreased gamma-aminobutyric acid level	J:6875
	decreased taurine level	J:6875
	increased noradrenaline level	J:164122
Rora^{tm1b(EUCOMM)Wtsi}/Rora⁺ (C57BL/6N-Rora^{tm1b(EUCOMM)Wtsi}/Ieg)	increased circulating alkaline phosphatase level	J:211773
Rorc^tm1Amj/Rorc^tm1Amj (either: (involves: 129/Sv * C57BL/6) or (involves: 129/Sv * C57BL/6 * DBA/2))	abnormal interleukin level	J:123351
Rp9^{tm1b(EUCOMM)Wtsi}/Rp9^{tm1b(EUCOMM)Wtsi} (C57BL/6N-Rp9^{tm1b(EUCOMM)Wtsi}/Ucd)	increased circulating alanine transaminase level	J:211773
Rpa1^{tm1b(KOMP)Wtsi}/Rpa1⁺ (C57BL/6N-Rpa1^{tm1b(KOMP)Wtsi}/J)	decreased circulating free fatty acids level	J:211773
	decreased circulating glucose level	J:211773
Rpap3^em1(IMPC)Mbp/Rpap3⁺ (C57BL/6N-Rpap3^em1(IMPC)Mbp/Ucd)	decreased circulating calcium level	J:211773
	decreased circulating glucose level	J:211773
	decreased circulating phosphate level	J:211773
Rpgrip1l^{tm1a(EUCOMM)Wtsi}/Rpgrip1l^{tm1a(EUCOMM)Wtsi} (C57BL/6N-Rpgrip1l^{tm1a(EUCOMM)Wtsi}/Wtsi)	subcutaneous edema	J:239583
Rph3al^tm1Sse/Rph3al^tm1Sse (B6.129-Rph3al^tm1Sse)	decreased insulin secretion	J:90669
	impaired glucose tolerance	J:90669
	increased circulating glucose level	J:90669
Rpia^{tm1a(KOMP)Wtsi}/Rpia⁺ (C57BL/6N-Rpia^{tm1a(KOMP)Wtsi}/Wtsi)	decreased circulating calcium level	J:211773
	decreased circulating glycerol level	J:211773
	decreased circulating HDL cholesterol level	J:211773
Rpl10a^em2Mbar/Rpl10a^em2Mbar (C57BL/6-Rpl10a^em2Mbar)	edema	J:328993
Rpl13a^tm1.1Jesc/Rpl13a^tm1.1Jesc (FVB.129S5(Cg)-Rpl13a^tm1.1Jesc)	abnormal circulating glucose level	J:237822
	improved glucose tolerance	J:237822
	increased insulin secretion	J:237822
	increased oxygen consumption	J:237822
Rpl13a^tm1.1Mazu/Rpl13a^tm1.1Mazu Lyz2^tm1(cre)Ifo/Lyz2⁺ (involves: C57BL/6)	abnormal cytokine level	J:194920
	increased blood urea nitrogen level	J:194920
	increased circulating aspartate transaminase level	J:194920
	increased circulating tumor necrosis factor level	J:194920
Rpl38^Ts/Rpl38⁺ (TSJ/Le)	increased circulating phosphate level	J:168509
Rplag^FVB/NJ/? (involves: C57BL/6J * FVB/NJ)	abnormal platelet physiology	J:90287
Rpn2^{tm1a(EUCOMM)Wtsi}/Rpn2⁺ (B6JTyr;B6N-Rpn2^{tm1a(EUCOMM)Wtsi}/Wtsi)	decreased circulating glycerol level	J:175295
	increased circulating free fatty acids level	J:175295
	increased circulating glycerol level	J:175295
Rps2^tm1.1Geno/Rps2⁺ (B6.129(Cg)-Rps2^tm1.1Geno)	increased circulating creatine kinase level	J:321029
Rps6^tm1Om/Rps6^tm1Om (involves: 129S1/Sv * 129X1/SvJ * ICR)	decreased circulating insulin level	J:100952
	decreased insulin secretion	J:100952
	impaired glucose tolerance	J:100952
	increased insulin sensitivity	J:100952
Rps6ka3^tm1Ljg/Y (involves: 129 * C57BL/6)	decreased circulating leptin level	J:83536
	decreased skeletal muscle glycogen level	J:67575
	impaired glucose tolerance	J:83536
	increased circulating glucose level	J:83536
	increased circulating insulin level	J:83536
	insulin resistance	J:83536
Rps6ka4^tm1Jsca/Rps6ka4^tm1Jsca Rps6ka5^tm1Jsca/Rps6ka5^tm1Jsca (B6.Cg-Rps6ka5^tm1Jsca Rps6ka4^tm1Jsca)	abnormal cytokine level	J:139576
	decreased circulating interleukin-10 level	J:139576
	increased circulating interleukin-6 level	J:139576
	increased circulating interleukin-12a level	J:139576
	increased circulating interleukin-12b level	J:139576
	increased circulating tumor necrosis factor level	J:139576
Rps6kb1^tm1Gtho/Rps6kb1^tm1Gtho (involves: 129P2/OlaHsd * C57BL/6)	decreased circulating insulin level	J:66406
	decreased insulin secretion	J:66406
	hyperglycemia	J:66406
	impaired glucose tolerance	J:66406
Rps6kb1^tm1Gtho/Rps6kb1^tm1Gtho (B6.129P2-Rps6kb1^tm1Gtho)	decreased circulating insulin level	J:144599
Rps6kb1^tm1Gtho/Rps6kb1^tm1Gtho (B6.129P2-Rps6kb1^tm1Gtho)	increased insulin sensitivity	J:144599
Rps6kb1^tm1Gtho/Rps6kb1^tm1Gtho Rps6kb2^tm1Gtho/Rps6kb2^tm1Gtho (involves: 129P2/OlaHsd * C57BL/6)	cyanosis	J:89696
	hypoxia	J:89696
Rps6kb1^tm1Gtho/Rps6kb1^tm1Gtho Rps6kb2^tm1Gtho/Rps6kb2^tm1Gtho (involves: 129P2/OlaHsd)	abnormal lipid level	J:129852
	increased fatty acid beta-oxidation	J:129852
	increased skeletal muscle glycogen level	J:129852
Rps6kb1^tm1Gtho/Rps6kb1^tm1Gtho Tg(Ins2-Akt1)3Mbb/0 (B6.Cg-Rps6kb1^tm1Gtho Tg(Ins2-Akt1)3Mbb)	decreased circulating glucose level	J:144599
	decreased circulating insulin level	J:144599
	increased insulin sensitivity	J:144599
Rps6kb1^tm1Nte/Rps6kb1^tm1Nte (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	increased carbon dioxide production	J:244749
	increased oxygen consumption	J:244749
Rps6kl1^{tm1.1(KOMP)Vlcg}/Rps6kl1^{tm1.1(KOMP)Vlcg} (C57BL/6N-Rps6kl1^{tm1.1(KOMP)Vlcg}/J)	decreased circulating glucose level	J:211773
	decreased circulating iron level	J:211773
	increased circulating sodium level	J:211773
Rps9^tm1.1Geno/Rps9^tm1.1Geno (involves: C57BL/6)	abnormal lipid oxidation	J:329922
Rps26^{tm2b(EUCOMM)Hmgu}/Rps26^{tm2b(EUCOMM)Hmgu} (C57BL/6N-Rps26^{tm2b(EUCOMM)Hmgu}/Ieg)	increased circulating aspartate transaminase level	J:211773
Rptor^tm1.1Dmsa/Rptor^tm1.1Dmsa Speer6-ps1^{Tg(Alb-cre)21Mgn}/Speer6-ps1⁺ (involves: 129S/SvEv * C57BL/6 * DBA)	increased circulating ketone body level	J:167208
Rptor^tm1Rueg/Rptor^tm1Rueg Tg(ACTA1-cre)1Mll/0 (involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * SJL)	increased skeletal muscle glycogen level	J:143748
Rptor^tm1Rueg/Rptor^tm1Rueg Tg(Fabp4-cre)1Rev/0 (involves: 129S1/SvImJ * C57BL/6J)	decreased adiponectin level	J:143749
	decreased circulating cholesterol level	J:143749
	decreased circulating glucose level	J:143749
	decreased circulating insulin level	J:143749
	decreased circulating leptin level	J:143749
	decreased liver triglyceride level	J:143749
	decreased susceptibility to diet-induced obesity	J:143749
	improved glucose tolerance	J:143749
	increased oxygen consumption	J:143749
Rr2^tm1Hgc/Rr2^tm1Hgc (involves: 129S6/SvEvTac * C57BL/6J)	increased blood urea nitrogen level	J:128347
Rr14^tm1.1Bulg/Rr14^tm1.1Bulg (Not Specified)	abnormal protein level	J:173283
Rr28^tm1Tilg/Rr28⁺ Igf2^tm1Rob/Igf2⁺ (involves: 129S/SvEv * 129S1/Sv * C57BL/6J)	abnormal circulating hormone level	J:77413
	edema	J:77413
	pericardial edema	J:77413
Rr29^Hx/Rr29⁺ (B10.D2/nSn-Rr29^Hx/J)	increased bleeding time	J:31800
Rr143^tm1.1Sson/Rr143⁺ Zbed6^tm1.2Sson/Zbed6^tm1.2Sson (involves: BALB/c * C57BL/6)	increased respiratory quotient	J:265506
Rr249^tm1.1Ebres/Rr249^tm1.1Ebres (involves: 129 * BALB/cJ * C57BL/6)	edema	J:191756
Rr266^em1Hino/Rr266^em1Hino Rr268^em1Hino/Rr268^em1Hino (C57BL/6J-Rr266^em1Hino Rr268^em1Hino)	decreased insulin secretion	J:312429
	hyperglycemia	J:312429
	impaired glucose tolerance	J:312429
Rr327^em1Mgn/Rr327^em1Mgn (C57BL/6J-Rr327^em1Mgn)	increased insulin secretion	J:340414
Rr344^em1Jfer/Rr344^em1Jfer (B6.Cg-Rr344^em1Jfer)	decreased circulating insulin level	J:328047
	decreased glucagon secretion	J:328047
	decreased insulin secretion	J:328047
	hyperglycemia	J:328047
Rr348^tm1.1Drhi/Rr348^tm1.1Drhi Rr349^tm1.1Wgw/Rr349^tm1.1Wgw (involves: 129P2/OlaHsd)	nuchal edema	J:259286
Rr401^em1Yushi/Rr401^em1Yushi (Not Specified)	decreased circulating follicle stimulating hormone level	J:334319
Rr401^em1Yushi/Rr401^em1Yushi (Not Specified)	decreased sterol level	J:334319
Rr124128^tm1.1Jfer/Rr124128^tm1.1Jfer Tg(Pdx1-cre)6Tuv/0 (involves: C57BL/6 * FVB/N)	decreased circulating insulin level	J:332319
	hyperglycemia	J:332319
	impaired glucose tolerance	J:332319
Rr124128^tm1.2Jfer/Rr124128^tm1.2Jfer (involves: C57BL/6 * FVB/N)	decreased circulating insulin level	J:332319
	impaired glucose tolerance	J:332319
Rrad^{tm1.1(KOMP)Vlcg}/Rrad^{tm1.1(KOMP)Vlcg} (C57BL/6N-Rrad^{tm1.1(KOMP)Vlcg}/J)	increased circulating alkaline phosphatase level	J:211773
	increased circulating potassium level	J:211773
Rraga^tm1.1Dmsa/Rraga^tm1.1Dmsa (involves: 129 * C57BL/6 * C57BL/6J)	abnormal circulating amino acid level	J:194401
	abnormal gluconeogenesis	J:194401
	abnormal glycogen homeostasis	J:194401
	hypoglycemia	J:194401
Rraga^tm2Dmsa/Rraga^tm2Dmsa Speer6-ps1^{Tg(Alb-cre)21Mgn}/Speer6-ps1⁺ (involves: 129S4/SvJae * C57BL/6 * DBA)	decreased circulating glucose level	J:213516
	increased insulin sensitivity	J:213516
Rras^em1(IMPC)H/Rras^em1(IMPC)H (C57BL/6N-Rras^em1(IMPC)H/H)	decreased circulating calcium level	J:211773
	decreased fasting circulating glucose level	J:211773
	increased circulating triglyceride level	J:211773
Rrbp1^em1(IMPC)J/Rrbp1^em1(IMPC)J (C57BL/6NJ-Rrbp1^em1(IMPC)J/Mmjax)	decreased circulating cholesterol level	J:211773
	decreased circulating serum albumin level	J:211773
	decreased circulating total protein level	J:211773
Rreb1^{tm1b(EUCOMM)Wtsi}/Rreb1⁺ (C57BL/6N-Rreb1^{tm1b(EUCOMM)Wtsi}/Wtsi)	decreased circulating calcium level	J:211773
	decreased circulating serum albumin level	J:211773
Rrm2^{tm1b(KOMP)Wtsi}/Rrm2⁺ (C57BL/6N-Rrm2^{tm1b(KOMP)Wtsi}/Bay)	increased circulating phosphate level	J:211773
Rrm2b^{Gt(OST85254)Lex}/Rrm2b^{Gt(OST85254)Lex} (involves: 129S5/SvEvBrd * C57BL/6J)	abnormal blood homeostasis	J:186071
	abnormal urine homeostasis	J:186071
	decreased circulating alkaline phosphatase level	J:186071
	decreased circulating glucose level	J:186071
	decreased circulating serum albumin level	J:186071
	hyperlipidemia	J:186071
	increased blood urea nitrogen level	J:186071
	increased circulating cholesterol level	J:186071
	increased circulating creatinine level	J:186071
	increased circulating phosphate level	J:186071
	increased circulating triglyceride level	J:186071
	increased urine protein level	J:186071
Rrm2b^tm1Ynak/Rrm2b^tm1Ynak (involves: 129 * C57BL/6J)	decreased circulating serum albumin level	J:84841
	increased blood urea nitrogen level	J:84841
	increased circulating creatinine level	J:84841
	increased urine protein level	J:84841
Rrn3^tm1.1Igt/Rrn3^tm1.1Igt Tg(Slc6a3-cre/ERT2)1Span/0 (involves: 129/Sv * C57BL/6)	decreased dopamine level	J:168232
Rrn3^tm1.1Igt/Rrn3^tm1.1Igt Tg(Slc6a3-icre)9190Gsc/0 (involves: 129/Sv * C57BL/6 * FVB/N)	decreased dopamine level	J:168232
Rrp1^em1(IMPC)Bay/Rrp1⁺ (C57BL/6N-Rrp1^em1(IMPC)Bay/Bay)	decreased body temperature	J:211773
Rrp8^{tm1.1(KOMP)Vlcg}/Rrp8⁺ (C57BL/6N-Rrp8^{tm1.1(KOMP)Vlcg}/J)	decreased fasting circulating glucose level	J:211773
Rsad1^{tm1.1(KOMP)Vlcg}/Rsad1⁺ (C57BL/6N-Rsad1^{tm1.1(KOMP)Vlcg}/Ucd)	decreased blood urea nitrogen level	J:211773
Rsad2^em1(IMPC)H/Rsad2^em1(IMPC)H (C57BL/6NTac-Rsad2^em1(IMPC)H/H)	increased circulating alkaline phosphatase level	J:211773
	increased circulating creatinine level	J:211773
	increased circulating potassium level	J:211773
	increased circulating serum albumin level	J:211773
Rsad2^tm1Aki/Rsad2^tm1Aki (involves: 129/Sv * C57BL/6)	decreased circulating interferon-alpha level	J:169840
Rsbn1^{tm1b(EUCOMM)Wtsi}/Rsbn1⁺ (C57BL/6N-Rsbn1^{tm1b(EUCOMM)Wtsi}/H)	increased circulating cholesterol level	J:211773
Rsc1a1^tm1Koep/Rsc1a1^tm1Koep (B6.129-Rsc1a1^tm1Koep)	abnormal energy homeostasis	J:95148
	increased circulating cholesterol level	J:95148
	increased circulating leptin level	J:95148
Rspo1^{tm2b(KOMP)Wtsi}/Rspo1^{tm2b(KOMP)Wtsi} (C57BL/6N-Rspo1^{tm2b(KOMP)Wtsi}/Ics)	increased circulating alkaline phosphatase level	J:211773
	increased circulating creatinine level	J:211773
Rspo2^tm1Suda/Rspo2^tm1Suda (B6.Cg-Rspo2^tm1Suda)	cyanosis	J:146829
Rspo3^tm1Arte/Rspo3^tm1Arte Isl1^tm1(cre)Sev/Isl1⁺ (involves: 129 * C57BL/6)	pericardial edema	J:214093
Rspo3^tm1Arte/Rspo3^tm1Arte Isl1^tm1(cre)Tmj/Isl1⁺ (involves: 129X1/SvJ * C57BL/6)	pericardial edema	J:214093
Rspo4^{tm1a(KOMP)Wtsi}/Rspo4^{tm1a(KOMP)Wtsi} (C57BL/6N-Rspo4^{tm1a(KOMP)Wtsi}/Wtsi)	increased fasting circulating glucose level	J:211773
Rtbdn^{tm1a(EUCOMM)Wtsi}/Rtbdn^{tm1a(EUCOMM)Wtsi} (C57BL/6N-Rtbdn^{tm1a(EUCOMM)Wtsi}/Wtsi)	improved glucose tolerance	J:211773
Rtel1^tm1.1Hdin/Rtel1^tm1.1Hdin (involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * FVB/N * SJL)	pericardial effusion	J:130490
Rtel1^tm1Pml/Rtel1^tm1Pml (involves: 129S1/Sv * 129X1/SvJ)	hemopericardium	J:91351
Rtl4^tm1.1Fuis/Rtl4^tm1.1Fuis (B6.Cg-Rtl4^tm1.1Fuis)	decreased noradrenaline level	J:228903
Rtl5^em1(IMPC)Mbp/Rtl5^em1(IMPC)Mbp (C57BL/6NCrl-Rtl5^em1(IMPC)Mbp/Mmucd)	increased circulating total protein level	J:211773
Rtn2^tm1Lex/Rtn2^tm1Lex (involves: 129S/SvEvBrd)	abnormal circulating glucose level	J:158249
Rttn^{Gt(pGT1.8geo)7Pgr}/Rttn^{Gt(pGT1.8geo)7Pgr} (involves: 129S1/Sv * 129X1/SvJ * NMRI)	pericardial effusion	J:76233
Rubcn^em1Dgre/Rubcn^em1Dgre (involves: C57BL/6 * C57BL/6N)	abnormal circulating chemokine level	J:235399
	decreased circulating interleukin-10 level	J:235399
	increased blood urea nitrogen level	J:235399
	increased circulating creatinine level	J:235399
	increased circulating interleukin-1 beta level	J:235399
	increased circulating interleukin-6 level	J:235399
	increased circulating interleukin-12b level	J:235399
	increased urine protein level	J:235399
Rubcn^em1Dgre/Rubcn^em1Dgre Tg(CAG-EGFP/Map1lc3b)53Nmz/0 (involves: C57BL/6 * C57BL/6N * DBA/2)	abnormal circulating chemokine level	J:235399
	decreased circulating interleukin-10 level	J:235399
	increased circulating interleukin-1 beta level	J:235399
	increased circulating interleukin-6 level	J:235399
Rubcnl^em1Qsun/Rubcnl^em1Qsun Speer6-ps1^{Tg(Alb-cre)21Mgn}/Speer6-ps1⁺ (B6.Cg-Speer6-ps1^{Tg(Alb-cre)21Mgn} Rubcnl^em1Qsun)	decreased circulating ketone body level	J:272052
	increased liver glycogen level	J:272052
	increased liver triglyceride level	J:272052
Rufy2^{tm1a(EUCOMM)Wtsi}/Rufy2^{tm1a(EUCOMM)Wtsi} (C57BL/6N-Rufy2^{tm1a(EUCOMM)Wtsi}/Wtsi)	impaired glucose tolerance	J:211773
Rufy3^tm1.1Migar/Rufy3^tm1.1Migar (involves: C57BL/6N * C57BL/6NCrlj * CBA/JNCrlj)	cyanosis	J:253649
Rundc1^{tm1a(EUCOMM)Wtsi}/Rundc1⁺ (C57BL/6N-Rundc1^{tm1a(EUCOMM)Wtsi}/Wtsi)	decreased circulating HDL cholesterol level	J:211773
Runx1^{tm1.1(RUNX1)Homy}/Runx1^{tm1.1(RUNX1)Homy} (B6.129P2-Runx1^{tm1.1(RUNX1*)Homy})	skin edema	J:164806
Runx1^tm1Dow/Runx1^tm1Dow (involves: 129P2/OlaHsd * C57BL/6)	hemopericardium	J:31130
Runx1^tm1Sata/Runx1^tm1Sata (involves: 129S4/SvJae * C57BL/6J)	hemopericardium	J:63424
Runx1^tm1Spe/Runx1^tm1Spe (either: (involves: 129S4/SvJae * BALB/c) or (involves: 129S4/SvJae * C57BL/6))	hemopericardium	J:35115
Runx1^tm2Dow/Runx1⁺ (involves: 129P2/OlaHsd * C57BL/6)	hemopericardium	J:79160
Runx1^tm5Spe/Runx1^tm5Spe (involves: 129/Sv * C57BL/6)	hemopericardium	J:120100
Runx1^tm6Spe/Runx1^tm6Spe (involves: 129/Sv * C57BL/6)	hemopericardium	J:120100
Runx1^tm7Spe/Runx1^tm7Spe (involves: 129/Sv * C57BL/6)	hemopericardium	J:120100
Runx1t1^{tm1b(EUCOMM)Hmgu}/Runx1t1⁺ (C57BL/6N-Runx1t1^{tm1b(EUCOMM)Hmgu}/H)	increased circulating triglyceride level	J:211773
Runx2^tm1Kish/Runx2⁺ (involves: 129P2/OlaHsd * C57BL/6)	decreased circulating thyroxine level	J:162258
	decreased thyroxine level	J:162258
	decreased triiodothyronine level	J:162258
	impaired adaptive thermogenesis	J:162258
	increased thyroid-stimulating hormone level	J:162258
Runx2^tm1Kish/Runx2^tm1Kish (involves: 129P2/OlaHsd * C57BL/6)	cyanosis	J:40783
Runx3^{tm1b(KOMP)Wtsi}/Runx3⁺ (C57BL/6N-Runx3^{tm1b(KOMP)Wtsi}/J)	increased fasting circulating glucose level	J:211773
Runx3^tm1Yg/Runx3^tm1Yg (either: (involves: 129S1/Sv * 129X1/SvJ * ICR) or (involves: 129S1/Sv * 129X1/SvJ * MF1))	abnormal cytokine level	J:93240
	abnormal interferon level	J:93240
	abnormal interleukin level	J:93240
	abnormal tumor necrosis factor level	J:93240
Runx3^tm1Yito/Runx3^tm1Yito (involves: 129P2/OlaHsd * C57BL/6)	decreased circulating glucose level	J:75869
Rwdd1^{tm1b(KOMP)Wtsi}/Rwdd1^{tm1b(KOMP)Wtsi} (C57BL/6N-Rwdd1^{tm1b(KOMP)Wtsi}/Wtsi)	increased circulating alkaline phosphatase level	J:211773
	increased circulating bilirubin level	J:211773
	increased circulating triglyceride level	J:211773
Rwdd2a^em1(IMPC)J/Rwdd2a^em1(IMPC)J (C57BL/6NJ-Rwdd2a^em1(IMPC)J/Mmjax)	decreased circulating calcium level	J:211773
Rxfp2^{tm1b(EUCOMM)Wtsi}/Rxfp2^{tm1b(EUCOMM)Wtsi} (C57BL/6N-Rxfp2^{tm1b(EUCOMM)Wtsi}/Ieg)	increased circulating alkaline phosphatase level	J:211773
	increased circulating aspartate transaminase level	J:211773
	increased circulating calcium level	J:211773
	increased circulating lipase level	J:211773
	increased circulating sodium level	J:211773
Rxfp4^{tm1.1(KOMP)Vlcg}/Rxfp4^{tm1.1(KOMP)Vlcg} (C57BL/6N-Rxfp4^{tm1.1(KOMP)Vlcg}/J)	decreased urine magnesium level	J:211773
	increased fasting circulating glucose level	J:211773
Rxra^tm1Krc/Rxra^tm1Krc Lyz2^tm1(cre)Ifo/Lyz2⁺ (involves: 129P2/OlaHsd * 129S4/SvJae * C57BL/6)	albuminuria	J:168799
	increased circulating creatine level	J:168799
	increased urine protein level	J:168799
Rxra^tm1Rev/Rxra^tm1Rev (involves: 129S4/SvJae * C57BL/6)	skin edema	J:18047
Rxra^tm2Ipc/Rxra^tm4.1Ipc (involves: 129)	edema	J:67149
Rxra^tm4.1Ipc/Rxra^tm4.1Ipc (involves: 129S2/SvPas)	edema	J:67149
Rxra^tm4Ipc/Rxra^tm4Ipc Rxrb^tm1Pcn/Rxrb^tm1Pcn Tg(KRT14-cre)1Ipc/0 (involves: 129S2/SvPas * C57BL/6 * SJL)	decreased cholesterol level	J:109090
Ryk^em1(IMPC)Mbp/Ryk^em1(IMPC)Mbp (C57BL/6NCrl-Ryk^em1(IMPC)Mbp/MbpMmucd)	edema	J:211773
Ryk^tm1Stac/Ryk^tm1Stac (involves: 129S1/Sv * C57BL/6J)	cyanosis	J:84392
Ryr1^em1Tmur/Ryr1⁺ (Not Specified)	abnormal body temperature homeostasis	J:322211
Ryr1^em1Tmur/Ryr1⁺ (Not Specified)	increased susceptibility to malignant hyperthermia	J:322211
Ryr1^m1Nisw/Ryr1⁺ (129S1.B6-Ryr1^m1Nisw)	abnormal potassium ion homeostasis	J:219285
Ryr1^m1Nisw/Ryr1⁺ (129S1.B6-Ryr1^m1Nisw)	increased circulating potassium level	J:219285
Ryr1^tm1.1Dhm/Ryr1⁺ (involves: 129S2/SvPasCrl * 129S6/SvEvTac)	cyanosis	J:155825
Ryr1^tm1.1Dhm/Ryr1^tm1.1Dhm (involves: 129S6/SvEvTac * 129X1/SvJ)	cyanosis	J:127629
	skin edema	J:127629
Ryr1^tm1.1Inp/Ryr1⁺ (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	increased core body temperature	J:181523
	increased susceptibility to malignant hyperthermia	J:181523
Ryr1^tm1.1Inp/Ryr1^tm1.1Inp (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	acidemia	J:181523
	increased core body temperature	J:181523
	increased susceptibility to malignant hyperthermia	J:181523
Ryr1^{tm1b(EUCOMM)Hmgu}/Ryr1⁺ (C57BL/6N-Ryr1^{tm1b(EUCOMM)Hmgu}/H)	increased respiratory quotient	J:211773
Ryr1^tm1Slh/Ryr1⁺ (involves: 129S7/SvEvBrd * C57BL/6)	abnormal body temperature homeostasis	J:105738
Ryr1^tm1Slh/Ryr1⁺ (involves: 129S7/SvEvBrd * C57BL/6)	increased circulating potassium level	J:105738
Ryr1^tm1Slh/Ryr1^tm1Slh (involves: 129S7/SvEvBrd * C57BL/6)	edema	J:105738
Ryr1^tm1Tno/Ryr1^tm1Tno (involves: 129S4/SvJae * C57BL/6J)	cyanosis	J:18895
Ryr1^tm2.1Alle/Ryr1⁺ (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	abnormal calcium ion homeostasis	J:168222
	acidemia	J:168222
	hypercapnia	J:168222
	increased susceptibility to malignant hyperthermia	J:168222
Ryr1^tm2.1Alle/Ryr1^tm2.1Alle (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	abnormal calcium ion homeostasis	J:168222
Ryr1^tm3.1Alle/Ryr1⁺ (involves: 129 * 129S1/Sv * 129X1/SvJ * C57BL/6)	abnormal body temperature homeostasis	J:303297
	increased susceptibility to malignant hyperthermia	J:303297
Ryr1^tm3.1Alle/Ryr1^tm3.1Alle (involves: 129 * 129S1/Sv * 129X1/SvJ * C57BL/6)	abnormal body temperature homeostasis	J:303297
	increased susceptibility to malignant hyperthermia	J:303297
Ryr2^tm1Krbr/Ryr2^tm1Krbr A1cf^{Tg(Myh6-cre/Esr1)1Jmk}/A1cf⁺ (involves: 129S1/Sv 129X1/SvJ * C57BL/6 * FVB/N)	abnormal atrial thrombosis	J:210083
S1pr1^tm1Rlp/S1pr1^tm1Rlp (involves: 129S6/SvEvTac * C57BL/6)	edema	J:71961
	pericardial edema	J:71961
S1pr3^tm1Jch/S1pr3^tm1Jch (involves: 129S1/Sv * 129X1/SvJ)	abnormal cytokine level	J:133917
S1pr3^tm1Rlp/S1pr3^tm1Rlp S1pr2^tm1Rlp/S1pr2^tm1Rlp (involves: 129S6/SvEvTac * C57BL/6)	skin edema	J:106055
S100a1^tm1Jhh/S100a1^tm1Jhh (involves: 129S1/Sv * C57BL/6)	abnormal nitric oxide homeostasis	J:230300
S100a6^{tm1b(KOMP)Wtsi}/S100a6⁺ (C57BL/6N-S100a6^{tm1b(KOMP)Wtsi}/Ucd)	increased respiratory quotient	J:211773
S100a9^tm1Nck/S100a9^tm1Nck (B6.129P2-S100a9^tm1Nck)	decreased circulating tumor necrosis factor level	J:125179
S100a10^tm1Pggd/S100a10^tm1Pggd (involves: 129S/SvEv * C57BL/6)	abnormal serotonin level	J:104116
S100a14^{tm1b(EUCOMM)Hmgu}/S100a14⁺ (C57BL/6N-S100a14^{tm1b(EUCOMM)Hmgu}/Tcp)	increased circulating aspartate transaminase level	J:211773
S100a16^em1(IMPC)J/S100a16⁺ (C57BL/6NJ-S100a16^em1(IMPC)J/Mmjax)	decreased circulating calcium level	J:211773
S100a16^em1.1Gpt/S100a16⁺ (involves: C57BL/6JGpt * FVB/N)	decreased circulating alanine transaminase level	J:330793
S100a16^em1.1Gpt/S100a16⁺ (involves: C57BL/6JGpt * FVB/N)	decreased circulating aspartate transaminase level	J:330793
S100b^{tm1a(EUCOMM)Wtsi}/S100b^{tm1a(EUCOMM)Wtsi} (B6JTyr;B6N-S100b^{tm1a(EUCOMM)Wtsi}/Wtsi)	increased circulating magnesium level	J:175295
S100g^tm1Ebje/S100g^tm1Ebje Del(6Ephb6-Trpv6)1Mhed/Del(6Ephb6-Trpv6)1Mhed (involves: 129P2/OlaHsd * 129S/SvEv)	abnormal calcium ion homeostasis	J:136038
	increased circulating parathyroid hormone level	J:136038
Saa3^{tm1(KOMP)Vlcg}/Saa3⁺ (involves: C57BL/6NTac)	decreased circulating LDL cholesterol level	J:220630
Saa3^{tm1(KOMP)Vlcg}/Saa3^{tm1(KOMP)Vlcg} (involves: C57BL/6NTac)	decreased circulating cholesterol level	J:220630
	decreased circulating LDL cholesterol level	J:220630
	decreased circulating serum amyloid protein level	J:220630
	decreased circulating triglyceride level	J:220630
	decreased susceptibility to diet-induced obesity	J:220630
Saa3^{tm1.1(KOMP)Vlcg}/Saa3^{tm1.1(KOMP)Vlcg} (C57BL/6N-Saa3^{tm1.1(KOMP)Vlcg}/MbpMmucd)	increased circulating alanine transaminase level	J:211773
Sae1^em1(IMPC)J/Sae1⁺ (C57BL/6NJ-Sae1^em1(IMPC)J/J)	increased circulating alanine transaminase level	J:211773
Sae1^em1(IMPC)J/Sae1⁺ (C57BL/6NJ-Sae1^em1(IMPC)J/J)	increased circulating calcium level	J:211773
Safb^tm1So/Safb⁺ (involves: 129 * C57BL/6J)	decreased circulating testosterone level	J:97633
Safb^tm1So/Safb^tm1So (involves: 129 * C57BL/6J)	cyanosis	J:97633
	decreased circulating estradiol level	J:97633
	decreased circulating insulin-like growth factor I level	J:97633
	decreased circulating testosterone level	J:97633
Sag^{tm1a(EUCOMM)Wtsi}/Sag^{tm1a(EUCOMM)Wtsi} (C57BL/6N-Sag^{tm1a(EUCOMM)Wtsi}/Wtsi)	decreased circulating calcium level	J:211773
	decreased circulating fructosamine level	J:211773
	decreased circulating HDL cholesterol level	J:211773
Sall3^tm1Apm/Sall3^tm1Apm (involves: 129X1/SvJ)	dehydration	J:92241
Sall4^tm1Brd/Sall4⁺ (involves: 129S7/SvEvBrd * C57BL/6J)	middle ear effusion	J:117866
Samd1^tm1Pfi/Samd1⁺ (involves: C57BL/6J * C57BL/6N)	abnormal circulating insulin level	J:333561
	abnormal glucose tolerance	J:333561
	decreased circulating HDL cholesterol level	J:333561
	decreased circulating VLDL cholesterol level	J:333561
	increased circulating aldosterone level	J:333561
	increased circulating angiotensin II level	J:333561
	increased circulating corticosterone level	J:333561
Samd1^tm1Pfi/Samd1^tm1Pfi (involves: C57BL/6J * C57BL/6N)	edema	J:333561
Samd3^em1(IMPC)H/Samd3^em1(IMPC)H (C57BL/6N-Samd3^em1(IMPC)H/H)	increased blood urea nitrogen level	J:211773
Samd4^m1Btlr/Samd4^m1Btlr (C57BL/6J-Samd4^m1Btlr)	abnormal glucose homeostasis	J:208616
	decreased circulating cholesterol level	J:208616
	decreased circulating glucose level	J:208616
	decreased circulating HDL cholesterol level	J:208616
	decreased circulating insulin level	J:208616
	decreased insulin secretion	J:208616
	decreased skeletal muscle glycogen level	J:208616
	decreased susceptibility to diet-induced obesity	J:208616
	increased carbon dioxide production	J:208616
	increased circulating LDL cholesterol level	J:208616
	increased insulin sensitivity	J:208616
	increased oxygen consumption	J:208616
Samd8^tm1.1Kwi/Samd8^tm1.1Kwi (involves: 129P2/OlaHsd)	abnormal ceramide level	J:228568
Samd8^tm1.1Kwi/Samd8^tm1.1Kwi Sgms2^tm1Jia/Sgms2^tm1Jia (involves: 129P2/OlaHsd)	abnormal ceramide level	J:228568
	abnormal sphingomyelin level	J:228568
Samd8^tm1Jia/Samd8^tm1Jia (involves: 129S6/SvEvTac * C57BL/6J)	abnormal enzyme/coenzyme level	J:220024
Samd8^tm1Jia/Samd8^tm1Jia Sgms2^tm1Jia/Sgms2^tm1Jia (involves: 129S6/SvEvTac * C57BL/6J)	abnormal ceramide level	J:220024
	abnormal sphingomyelin level	J:220024
Samd8^tm2.2Kwi/Samd8^tm2.2Kwi (involves: 129P2/OlaHsd)	abnormal ceramide level	J:228568
Samd8^tm2.2Kwi/Samd8^tm2.2Kwi Sgms2^tm1Jia/Sgms2^tm1Jia (involves: 129P2/OlaHsd)	abnormal ceramide level	J:228568
Samd9l^{tm1.1(KOMP)Wtsi}/Samd9l^{tm1.1(KOMP)Wtsi} (C57BL/6N-Samd9l^{tm1.1(KOMP)Wtsi}/Ucd)	increased circulating calcium level	J:211773
	increased circulating phosphate level	J:211773
Samsn1^tm1Xyw/Samsn1^tm1Xyw (B6.129P2-Samsn1^tm1Xyw)	increased circulating interferon-gamma level	J:158032
SAP003/SAP003 (C3HeB/FeJ-SAP003)	increased circulating alkaline phosphatase level	J:183993
SAP004/SAP004 (C3HeB/FeJ-SAP004)	decreased circulating calcium level	J:183993
SAP004/SAP004 (C3HeB/FeJ-SAP004)	decreased circulating phosphate level	J:183993
SAP006/SAP006 (C3HeB/FeJ-SAP006)	increased circulating alkaline phosphatase level	J:183993
SAP008/SAP008 (C3HeB/FeJ-SAP008)	increased circulating alkaline phosphatase level	J:183993
Sap30^em1(IMPC)J/Sap30^em1(IMPC)J (C57BL/6NJ-Sap30^em1(IMPC)J/Mmjax)	increased circulating glucose level	J:211773
sar/sar (BTBR-sar)	abnormal blood homeostasis	J:37
	abnormal urine homeostasis	J:37
	aminoaciduria	J:37
	increased circulating glycine level	J:37
	increased circulating methionine level	J:37
Sar1b^em1Emle/Sar1b⁺ (C57BL/6N-Sar1b^em1Emle)	abnormal circulating non-HDL cholesterol level	J:319817
	abnormal intestinal lipid absorption	J:319817
	decreased circulating cholesterol level	J:319817
	decreased circulating HDL cholesterol level	J:319817
	decreased circulating triglyceride level	J:319817
Sar1b^em2Emle/Sar1b⁺ (C57BL/6N-Sar1b^em2Emle)	abnormal circulating non-HDL cholesterol level	J:319817
	abnormal intestinal lipid absorption	J:319817
	decreased circulating cholesterol level	J:319817
	decreased circulating HDL cholesterol level	J:319817
	decreased circulating triglyceride level	J:319817
	increased liver cholesterol level	J:319817
	steatorrhea	J:319817
Sar1b^{tm1a(EUCOMM)Wtsi}/Sar1b⁺ (C57BL/6N-Sar1b^{tm1a(EUCOMM)Wtsi}/Wtsi)	decreased circulating alanine transaminase level	J:175295
	decreased circulating cholesterol level	J:175295
	decreased circulating free fatty acids level	J:175295
	decreased circulating HDL cholesterol level	J:175295
	decreased circulating LDL cholesterol level	J:175295
	increased circulating free fatty acids level	J:175295
Saraf^{tm1c(KOMP)Wtsi}/Saraf^{tm1c(KOMP)Wtsi} Tg(Pgk1-cre)1Lni/0 (involves: 129S4/SvJaeSor * BALB/c * C57BL/6J * C57BL/6N)	abnormal calcium ion homeostasis	J:337869
	increased circulating corticosterone level	J:337869
	increased circulating thyroid-stimulating hormone level	J:337869
Sarm1^tm1.1Diam/Sarm1^tm1.1Diam (involves: 129X1/SvJ * C57BL/6)	abnormal circulating tumor necrosis factor level	J:200140
Sat1^tm1Alh/Sat1^tm1Alh (B6.129X1-Sat1^tm1Alh)	increased circulating leptin level	J:120870
Satb1^{tm1b(EUCOMM)Hmgu}/Satb1⁺ (C57BL/6N-Satb1^{tm1b(EUCOMM)Hmgu}/Ics)	increased circulating aspartate transaminase level	J:211773
Satb1^tm2Kos/Satb1^tm2Kos Commd10^{Tg(Vav1-icre)A2Kio}/Commd10⁺ (involves: C57BL/6 * C57BL/10 * CBA/Ca)	decreased salivation	J:252606
	increased urine protein level	J:252606
Satb2^em3(IMPC)Tcp/Satb2⁺ (C57BL/6NCrl-Satb2^em3(IMPC)Tcp/Tcp)	increased circulating alkaline phosphatase level	J:211773
Satb2^Mhdabap002/Satb2^Mhdabap002 (C3HeB/FeJ-Satb2^Mhdabap002)	increased circulating alkaline phosphatase level	J:183993
	increased circulating calcium level	J:183993
Sav1^tm1Dlim/Sav1^tm1Dlim (involves: 129S1/Sv * 129X1/SvJ)	impaired skin barrier function	J:134270
Sbds^tm1Jrom/Sbds^tm3.1Jrom Ptf1a^tm1(cre)Cvw/Ptf1a⁺ (involves: 129S1/Sv * 129S6/SvEvTac * 129X1/SvJ)	decreased circulating amylase level	J:189357
	impaired glucose tolerance	J:189357
Sbds^tm2.1Jrom/Sbds^tm3.1Jrom Ptf1a^tm1(cre)Cvw/Ptf1a⁺ (involves: 129S1/Sv * 129X1/SvJ)	decreased circulating amylase level	J:189357
Sbf1^em1(IMPC)Mbp/Sbf1^em1(IMPC)Mbp (C57BL/6N-Sbf1^em1(IMPC)Mbp/MbpMmucd)	decreased circulating alkaline phosphatase level	J:211773
	decreased fasting circulating glucose level	J:211773
Sbk2^em1(IMPC)Bay/Sbk2^em1(IMPC)Bay (C57BL/6N-Sbk2^em1(IMPC)Bay/Bay)	decreased circulating serum albumin level	J:211773
Sbno1^{tm1b(EUCOMM)Hmgu}/Sbno1⁺ (C57BL/6N-Sbno1^{tm1b(EUCOMM)Hmgu}/H)	increased circulating fructosamine level	J:211773
Sbsn^{em1(IMPC)Ccpcz}/Sbsn^{em1(IMPC)Ccpcz} (C57BL/6N-Sbsn^{em1(IMPC)Ccpcz}/Ccpcz)	decreased circulating sodium level	J:211773
	increased circulating creatine kinase level	J:211773
	increased circulating potassium level	J:211773
Sbsn^em1Ham/Sbsn^em1Ham (C57BL/6N-Sbsn^em1Ham)	abnormal blood homeostasis	J:296400
Sbsn^em1Ham/Sbsn^em1Ham (C57BL/6N-Sbsn^em1Ham)	impaired skin barrier function	J:296400
Sc5d^tm1Fdp/Sc5d^tm1Fdp (involves: 129S1/Sv * 129X1/SvJ)	abnormal cholesterol homeostasis	J:84450
	decreased brain cholesterol level	J:84450
	decreased cholesterol level	J:84450
	decreased liver glycogen level	J:84450
	skin edema	J:84450
Scamp2^em1(IMPC)J/Scamp2^em1(IMPC)J (C57BL/6NJ-Scamp2^em1(IMPC)J/J)	decreased fasting circulating glucose level	J:211773
	increased circulating total protein level	J:211773
Scamp5^{tm1.1(KOMP)Vlcg}/Scamp5⁺ (C57BL/6N-Scamp5^{tm1.1(KOMP)Vlcg}/J)	increased circulating alanine transaminase level	J:211773
	increased urine microalbumin level	J:211773
Scand1^em1(IMPC)H/Scand1^em1(IMPC)H (C57BL/6NTac-Scand1^em1(IMPC)H/H)	increased circulating creatinine level	J:211773
Scap^tm1Mbjg/Scap^tm1Mbjg Tg(Mx1-cre)29-4Her/0 (involves: 129S6/SvEvTac * C57BL/6J * SJL)	abnormal cholesterol homeostasis	J:69592
	abnormal lipid homeostasis	J:69592
	decreased circulating free fatty acids level	J:69592
	decreased liver cholesterol level	J:69592
	decreased liver triglyceride level	J:69592
Scaper^{tm1b(EUCOMM)Hmgu}/Scaper^{tm1b(EUCOMM)Hmgu} (C57BL/6N-Scaper^{tm1b(EUCOMM)Hmgu}/Ics)	decreased blood urea nitrogen level	J:211773
Scara3^{em1(IMPC)Hmgu}/Scara3^{em1(IMPC)Hmgu} (C57BL/6NCrl-Scara3^{em1(IMPC)Hmgu}/Ieg)	increased circulating unsaturated transferrin level	J:211773
Scarb1^Chohd1/Scarb1⁺ (C3HeB/FeJ-Scarb1^Chohd1/Ieg)	increased circulating cholesterol level	J:94145
	increased circulating HDL cholesterol level	J:94145
	increased circulating LDL cholesterol level	J:94145
Scarb1^{Hdlq1-129S1/SvImJ}/? (involves: 129S1/SvImJ * C57BL/6J)	increased circulating HDL cholesterol level	J:144089
Scarb1^{Hdlq1-129S1/SvImJ}/Scarb1^{Hdlq1-129S1/SvImJ} Hdlq16^129S1/SvImJ/Hdlq16^129S1/SvImJ (involves: 129S1/SvImJ * C57BL/6J)	decreased circulating HDL cholesterol level	J:144089
Scarb1^{Hdlq1-NZB/BlNJ}/Scarb1^{Hdlq1-NZB/BlNJ} (involves: NZB/BlNJ * SM/J)	increased circulating HDL cholesterol level	J:76707, J:89309
Scarb1^{Hdlq1-NZB/BlNJ}/Scarb1^Hdlq1-SM/J (involves: NZB/BlNJ * SM/J)	increased circulating HDL cholesterol level	J:76707, J:89309
Scarb1^Hlb398/? (C57BL/6J-Scarb1^Hlb398)	increased circulating cholesterol level	J:82961
Scarb1^Hlb398/? (C57BL/6J-Scarb1^Hlb398)	increased circulating HDL cholesterol level	J:82961
Scarb1^Hlb398/Scarb1⁺ (C57BL/6J-Scarb1^Hlb398)	increased circulating HDL cholesterol level	J:152482
Scarb1^Hlb398/Scarb1^Hlb398 (C57BL/6J-Scarb1^Hlb398)	abnormal cholesterol homeostasis	J:152482
	abnormal lipid level	J:152482
	increased circulating cholesterol level	J:152482
	increased circulating HDL cholesterol level	J:152482
	increased circulating phospholipid level	J:152482
	increased circulating triglyceride level	J:152482
Scarb1^tm1.1Thh/Scarb1^tm1.1Thh (B6.129X1-Scarb1^tm1.1Thh)	increased circulating cholesterol level	J:114663
	increased circulating HDL cholesterol level	J:114663
	increased circulating interleukin-6 level	J:114663
Scarb1^{tm1b(EUCOMM)Wtsi}/Scarb1^{tm1b(EUCOMM)Wtsi} (C57BL/6N-Scarb1^{tm1b(EUCOMM)Wtsi}/Bay)	increased circulating cholesterol level	J:211773
Scarb1^tm1Dhu/Scarb1^tm1Dhu (involves: 129S4/SvJae * BALB/cByJ)	abnormal cholesterol level	J:47439
	abnormal circulating HDL cholesterol level	J:47439
	abnormal lipid homeostasis	J:47439
	increased circulating HDL cholesterol level	J:47439
Scarb1^tm1Kri/Scarb1⁺ (involves: 129S2/SvPas * C57BL/6)	abnormal cholesterol level	J:44187
	abnormal lipid homeostasis	J:44187
	increased circulating cholesterol level	J:44187
Scarb1^tm1Kri/Scarb1^tm1Kri (involves: 129S2/SvPas * C57BL/6)	abnormal cholesterol level	J:44187
	abnormal circulating cholesterol level	J:73138
	abnormal lipid homeostasis	J:44187
	increased cholesterol level	J:216748
	increased circulating cholesterol level	J:44187
Scarb1^tm1Thh/Scarb1^tm1Thh (B6.129X1-Scarb1^tm1Thh)	increased circulating cholesterol level	J:114663
Scarb1^tm1Thh/Scarb1^tm1Thh (B6.129X1-Scarb1^tm1Thh)	increased circulating HDL cholesterol level	J:114663
Scarb1^tm1Thh/Scarb1^tm1Thh Speer6-ps1^{Tg(Alb-cre)21Mgn}/Speer6-ps1⁺ (B6.Cg-Scarb1^tm1Thh Speer6-ps1^{Tg(Alb-cre)21Mgn})	increased circulating cholesterol level	J:114663
	increased circulating HDL cholesterol level	J:114663
	increased circulating interleukin-6 level	J:114663
Scarb2^em2(IMPC)Tcp/Scarb2^em2(IMPC)Tcp (C57BL/6NCrl-Scarb2^em2(IMPC)Tcp/Tcp)	increased blood urea nitrogen level	J:211773
	increased circulating calcium level	J:211773
Scarb2^tm1Psa/Scarb2^tm1Psa (involves: 129P2/OlaHsd * C57BL/6J)	albuminuria	J:82474
	decreased urine glucose level	J:82474
	decreased urine osmolality	J:82474
	leukocyturia	J:82474
Scarf1^tm1Tkms/Scarf1^tm1Tkms (involves: C57BL/6)	hematuria	J:208237
	increased blood urea nitrogen level	J:208237
	increased urine protein level	J:208237
	pyuria	J:208237
Scd1^ab-2J/Scd1^ab-2J (DBA/1LacJ-Scd1^ab-2J/J)	abnormal lipid level	J:62699
Scd1^ab-2J/Scd1^ab-2J (DBA/1LacJ-Scd1^ab-2J/J)	impaired skin barrier function	J:62699
Scd1^ab/Scd1^ab (involves: BALB/cCrglGa)	photophobia	J:30359
Scd1^tm1Ntam/Scd1^tm1Ntam (involves: 129S6/SvEvTac)	abnormal cholesterol homeostasis	J:71350
	decreased circulating insulin level	J:78607
	decreased unsaturated fatty acids level	J:71350
	improved glucose tolerance	J:78607
	increased circulating ketone body level	J:78607
	increased oxygen consumption	J:78607
	increased saturated fatty acids level	J:71350
Scd1^tm1Ntam/Scd1^tm1Ntam (involves: C57BL/6)	abnormal glucose homeostasis	J:130441
	decreased circulating glucose level	J:130441
	decreased circulating triglyceride level	J:130441
	decreased liver triglyceride level	J:130441
	decreased susceptibility to diet-induced obesity	J:130441
	improved glucose tolerance	J:130441
	increased insulin sensitivity	J:130441
Scd1^tm1Ntam/Scd1^tm1Ntam Sirt3^tm1.1Fwa/Sirt3^tm1.1Fwa (involves: 129S6/SvEvTac * C57BL/6)	decreased liver triglyceride level	J:178653
	increased insulin sensitivity	J:178653
Scd1^tm2Ntam/Scd1^tm2Ntam Speer6-ps1^{Tg(Alb-cre)21Mgn}/Speer6-ps1⁺ (B6.Cg-Speer6-ps1^{Tg(Alb-cre)21Mgn} Scd1^tm2Ntam)	abnormal gluconeogenesis	J:130441
	abnormal lipid homeostasis	J:130441
	decreased circulating glucose level	J:130441
	decreased circulating triglyceride level	J:130441
	decreased circulating VLDL triglyceride level	J:130441
	decreased liver glycogen level	J:130441
	decreased liver triglyceride level	J:130441
	decreased susceptibility to diet-induced obesity	J:130441
	increased circulating cholesterol level	J:130441
Scd2^tm1Myz/Scd2^tm1Myz (129S6.129-Scd2^tm1Myz)	decreased circulating triglyceride level	J:101158
	decreased fatty acids level	J:101158
	decreased liver triglyceride level	J:101158
	dehydration	J:101158
	impaired skin barrier function	J:101158
Scel^{em1(IMPC)Ccpcz}/Scel^{em1(IMPC)Ccpcz} (C57BL/6NCrl-Scel^{em1(IMPC)Ccpcz}/Ccpcz)	increased circulating sodium level	J:211773
Scfd2^em1(IMPC)J/Scfd2^em1(IMPC)J (C57BL/6NJ-Scfd2^em1(IMPC)J/Mmjax)	increased circulating alkaline phosphatase level	J:211773
Scg3^{Gt(VICTR20)13Lex}/Scg3^{Gt(VICTR20)13Lex} (involves: 129S5/SvEvBrd * C57BL/6)	decreased circulating insulin level	J:256077
	impaired glucose tolerance	J:256077
	increased susceptibility to diet-induced obesity	J:256077
Scg5^em1(IMPC)Mbp/Scg5^em1(IMPC)Mbp (C57BL/6NCrl-Scg5^em1(IMPC)Mbp/MbpMmucd)	increased circulating alkaline phosphatase level	J:211773
Scg5^tm1Led/Scg5^tm1Led (either: 129S6/SvEvTac or (involves: 129S6/SvEvTac * FVB) or (involves: 129S6/SvEvTac * C57BL/6))	abnormal circulating insulin level	J:53349
	abnormal glucose homeostasis	J:77510
	abnormal mineral level	J:77510
	decreased body temperature	J:77510
	decreased circulating glucagon level	J:53349
	decreased circulating magnesium level	J:77510
	hypoglycemia	J:53349
	increased adrenocorticotropin level	J:53349
	increased circulating corticosterone level	J:53349
	increased circulating lactate level	J:77510
	increased liver glycogen level	J:77510
Scgb1a1^tm1Abm/Scgb1a1⁺ (involves: 129S1/Sv * 129X1/SvJ)	abnormal complement protein level	J:57504
Scgb1a1^tm1Abm/Scgb1a1^tm1Abm (involves: 129S1/Sv * 129X1/SvJ)	abnormal blood homeostasis	J:57504
	abnormal complement protein level	J:57504
	decreased circulating calcium level	J:40748
	hematuria	J:57504
	increased urine protein level	J:40748
Scimp^tm1Lex/Scimp^tm1Lex (B6;129S5-Scimp^tm1Lex/Mmucd)	increased circulating cholesterol level	J:171883
Scin^em1(IMPC)Mbp/Scin^em1(IMPC)Mbp (C57BL/6NCrl-Scin^em1(IMPC)Mbp/Mmucd)	decreased circulating glucose level	J:211773
Sclt1^em1(IMPC)Tcp/Sclt1⁺ (C57BL/6NCrl-Sclt1^em1(IMPC)Tcp/Tcp)	increased circulating triglyceride level	J:211773
Sclt1^{Tg(CAG-sb10)1Dla}/Sclt1^{Tg(CAG-sb10)1Dla} (FVB/N-Sclt1^{Tg(CAG-sb10)1Dla})	increased blood urea nitrogen level	J:243427
Scml4^em1(IMPC)J/Scml4^em1(IMPC)J (C57BL/6NJ-Scml4^em1(IMPC)J/Mmjax)	increased circulating glucose level	J:211773
Scn2a^tm1Mml/Scn2a^tm1Mml (involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)	cyanosis	J:76457
	hypoxia	J:76457
Scn2b^tm1Lex/Scn2b^tm1Lex (B6;129S5-Scn2b^tm1Lex/Mmucd)	impaired glucose tolerance	J:171883
Scn3a^{Gt(OST52130)Lex}/Scn3a⁺ (involves: 129S5/SvEvBrd * C57BL/6J)	improved glucose tolerance	J:103485
Scn4a^m1Aaa/Scn4a⁺ (involves: BALB/c * C57BL/6J)	decreased circulating leptin level	J:217522
	improved glucose tolerance	J:217522
	increased energy expenditure	J:217522
Scn4a^{tm2b(KOMP)Wtsi}/Scn4a⁺ (C57BL/6N-Scn4a^{tm2b(KOMP)Wtsi}/H)	decreased circulating alkaline phosphatase level	J:211773
	increased circulating amylase level	J:211773
Scnn1a^tm1Rss/Scnn1a^tm1Rss (involves: 129P2/OlaHsd * C57BL/6J)	cyanosis	J:31762
Scnn1a^tm1Rss/Scnn1a^tm1Rss Tg(CMV-Scnn1a)1352Rss/0 (involves: 129P2/OlaHsd * NMRI)	abnormal renal sodium reabsorption	J:43583
	decreased urine bicarbonate level	J:43583
	decreased urine pH	J:43583
	increased circulating aldosterone level	J:43583
	increased urine sodium level	J:43583
	metabolic acidosis	J:43583
Scnn1b^tm1.1Ipt/Scnn1b⁺ (involves: 129P2/OlaHsd * C57BL/6J * FVB/N)	decreased circulating aldosterone level	J:59840
	hypokalemia	J:59840
Scnn1b^tm1.1Ipt/Scnn1b^tm1.1Ipt (involves: 129P2/OlaHsd * C57BL/6J * FVB/N)	alkalosis	J:59840
	decreased circulating aldosterone level	J:59840
	hypokalemia	J:59840
Scnn1b^{tm1b(EUCOMM)Hmgu}/Scnn1b⁺ (C57BL/6N-Scnn1b^{tm1b(EUCOMM)Hmgu}/Cnrm)	increased circulating fructosamine level	J:211773
Scnn1b^tm1Wsh/Scnn1b^tm1Wsh (involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)	abnormal urine homeostasis	J:53058
	decreased circulating sodium level	J:53058
	increased circulating aldosterone level	J:53058
	increased circulating chloride level	J:53058
	increased circulating potassium level	J:53058
Scnn1g^tm1Bhk/Scnn1g^tm1Bhk (involves: 129P2/OlaHsd * C57BL/6 * DBA/2)	decreased circulating sodium level	J:50528
	decreased urine potassium level	J:50528
	increased circulating potassium level	J:50528
	increased urine bicarbonate level	J:50528
	increased urine sodium level	J:50528
Sco1^{tm1c(KOMP)Wtsi}/Sco1^{tm1c(KOMP)Wtsi} Speer6-ps1^{Tg(Alb-cre)21Mgn}/Speer6-ps1⁺ (involves: C57BL/6 * C57BL/6N * DBA)	decreased kidney copper level	J:222036
	decreased liver copper level	J:222036
	increased liver cholesterol level	J:222036
	increased liver iron level	J:222036
	increased liver triglyceride level	J:222036
	increased spleen iron level	J:222036
Sco2^tm1.1Easc/Sco2^tm2.1Easc (129X1/SvJ-Sco2^tm1.1Easc/Sco2^tm2.1Easc)	abnormal copper level	J:155116
	increased liver copper level	J:155116
Sco2^tm2.1Easc/Sco2^tm2.1Easc (129X1/SvJ-Sco2^tm2.1Easc)	abnormal copper level	J:155116
Scoc^em1(IMPC)J/Scoc⁺ (C57BL/6NJ-Scoc^em1(IMPC)J/Mmjax)	decreased circulating calcium level	J:211773
Scp2^tm1Kier/Scp2^tm1Kier (involves: 129P2/OlaHsd * C57BL/6NCr)	abnormal lipid level	J:124895
	decreased circulating triglyceride level	J:124895
	decreased liver triglyceride level	J:124895
	increased circulating cholesterol level	J:124895
	increased fatty acids level	J:124895
Scp2^tm1Usee/Scp2^tm1Usee (involves: 129P2/OlaHsd * C57BL/6)	abnormal bile salt level	J:73460
	abnormal circulating cholesterol level	J:73460
	abnormal lipid level	J:47280
	decreased circulating free fatty acids level	J:47280
	decreased liver cholesterol level	J:73460, J:47280
	decreased liver triglyceride level	J:47280
	increased circulating HDL cholesterol level	J:73460
	increased circulating LDL cholesterol level	J:73460
	increased circulating triglyceride level	J:47280
	increased circulating VLDL cholesterol level	J:73460
	increased fatty acids level	J:47280
scpt/scpt (involves: C57BL/6J)	extremity edema	J:85113
Scrib^{tm1b(NCOM)Mfgc}/Scrib⁺ (C57BL/6N-Scrib^{tm1a(NCOM)Mfgc}/Tcp)	increased circulating triglyceride level	J:211773
Sct^tm1.1Bkcc/Sct^tm1.1Bkcc (B6.Cg-Sct^tm1.1Bkcc)	abnormal circulating antidiuretic hormone level	J:166370
Sctr^tm1Bkcc/Sctr^tm1Bkcc (B6.129S7-Sctr^tm1Bkcc)	abnormal circulating antidiuretic hormone level	J:166370
	decreased urine creatinine level	J:121376
	decreased urine osmolality	J:121376
	decreased urine potassium level	J:121376
	decreased urine sodium level	J:121376
	decreased urine urea nitrogen level	J:121376
	increased circulating glucose level	J:121376
Scube1^tm2.1Rbya/Scube1^tm2.1Rbya (Not Specified)	decreased platelet aggregation	J:223899
	decreased susceptibility to induced thrombosis	J:223899
	increased bleeding time	J:223899
Scube3^m1Mhda/Scube3^m1Mhda (C3HeB/FeJ-Scube3^m1Mhda)	decreased circulating cholesterol level	J:237904
	decreased circulating free fatty acids level	J:237904
	decreased circulating glucose level	J:237904
	decreased circulating glycerol level	J:237904
	decreased circulating phosphate level	J:237904
	decreased circulating serum albumin level	J:237904
	decreased circulating total protein level	J:237904
	decreased circulating triglyceride level	J:237904
	decreased urine albumin level	J:237904
	decreased urine creatinine level	J:237904
	decreased urine glucose level	J:237904
	decreased urine protein level	J:237904
	decreased urine uric acid level	J:237904
	improved glucose tolerance	J:237904
	increased blood urea nitrogen level	J:237904
	increased blood uric acid level	J:237904
	increased circulating calcium level	J:237904
	increased circulating creatinine level	J:237904
	increased circulating potassium level	J:237904
Sdc1^em1(IMPC)H/Sdc1^em1(IMPC)H (C57BL/6NTac-Sdc1^em1(IMPC)H/H)	improved glucose tolerance	J:211773
	increased circulating cholesterol level	J:211773
	increased circulating creatinine level	J:211773
	increased circulating HDL cholesterol level	J:211773
Sdc2^{tm1b(KOMP)Wtsi}/Sdc2^{tm1b(KOMP)Wtsi} (C57BL/6N-Sdc2^{tm1b(KOMP)Wtsi}/Ieg)	increased circulating triglyceride level	J:211773
Sdc3^tm1Rau/Sdc3⁺ (B6.129S-Sdc3^tm1Rau)	decreased susceptibility to diet-induced obesity	J:94417
Sdc3^tm1Rau/Sdc3^tm1Rau (B6.129S-Sdc3^tm1Rau)	abnormal energy expenditure	J:94417
	decreased circulating insulin level	J:94417
	decreased susceptibility to diet-induced obesity	J:94417
	improved glucose tolerance	J:94417
Sdc4^tm1Tmu/Sdc4^tm1Tmu (B6.129S2-Sdc4^tm1Tmu)	increased blood urea nitrogen level	J:68843
Sdc4^{tm2b(KOMP)Wtsi}/Sdc4^{tm2b(KOMP)Wtsi} (C57BL/6N-Sdc4^{tm2b(KOMP)Wtsi}/H)	decreased circulating serum albumin level	J:211773
	decreased circulating total protein level	J:211773
Sdccag8^em1Lji/Sdccag8^em1Lji (involves: C57BL/6)	increased urine protein level	J:328191
Sdccag8^em2Lji/Sdccag8^em2Lji (involves: C57BL/6)	increased urine protein level	J:328191
Sdha^{tm2b(KOMP)Wtsi}/Sdha⁺ (C57BL/6N-Sdha^{tm2b(KOMP)Wtsi}/J)	decreased circulating glucose level	J:211773
	increased circulating free fatty acids level	J:211773
	increased circulating sodium level	J:211773
Sdhb^{Gt(AP0532)Wtsi}/Sdhb⁺ Sdhc^{Gt(BA0521)Wtsi}/Sdhc⁺ (B6;129P2-Sdhc^{Gt(BA0521)Wtsi} Sdhb^{Gt(AP0532)Wtsi})	hypoxia	J:242046
Sdhb^{Gt(AP0532)Wtsi}/Sdhb⁺ Sdhc^{Gt(BA0521)Wtsi}/Sdhc⁺ Sdhd^tm1Jlob/Sdhd⁺ (involves: 129P2/OlaHsd)	hypoxia	J:242046
Sdhb^{tm1b(EUCOMM)Hmgu}/Sdhb⁺ (C57BL/6N-Sdhb^{tm1b(EUCOMM)Hmgu}/Ieg)	increased fasting circulating glucose level	J:211773
Sdhb^{tm1c(EUCOMM)Hmgu}/Sdhb^{tm1c(EUCOMM)Hmgu} Tg(Ins2-cre)23Herr/0 (involves: C57BL/6J * C57BL/6N * CBA/J)	decreased circulating insulin level	J:326592
	decreased insulin secretion	J:326592
	hyperglycemia	J:326592
	impaired glucose tolerance	J:326592
	increased fasting circulating glucose level	J:326592
Sdhc^{tm1c(EUCOMM)Wtsi}/Sdhc^{tm1c(EUCOMM)Wtsi} Gt(ROSA)26Sor^{tm1.1(rtTA,tetO-cre)Bkmn}/Gt(ROSA)26Sor⁺ (involves: 129S1/Sv * 129X1/SvJ * C57BL/6N)	abnormal blood homeostasis	J:284745
	decreased circulating glucose level	J:284745
	decreased circulating insulin level	J:284745
	decreased energy expenditure	J:284745
	increased circulating creatine kinase level	J:284745
	lactic acidosis	J:284745
Sdhd^tm1Jlob/Sdhd^tm2Jlob Th^tm1(cre)Te/Th⁺ (involves: 129S1/Sv * 129X1/SvJ)	decreased dopamine level	J:186713
Sdr9c7^em1Maak/Sdr9c7^em1Maak (involves: C57BL/6J)	impaired skin barrier function	J:295441
Sdr16c5^em1Nyk/Sdr16c5^em1Nyk Sdr16c6^em1Nyk/Sdr16c6^em1Nyk (Not Specified)	eyelid edema	J:283063
Sdsl^{tm1b(EUCOMM)Hmgu}/Sdsl^{tm1b(EUCOMM)Hmgu} (C57BL/6N-Sdsl^{tm1b(EUCOMM)Hmgu}/Ics)	increased circulating alanine transaminase level	J:211773
seb/seb (Him:OF1)	decreased body temperature	J:20987
seb/seb (Him:OF1)	increased energy expenditure	J:20987
Sebox^em1(IMPC)J/Sebox^em1(IMPC)J (C57BL/6NJ-Sebox^em1(IMPC)J/J)	increased fasting circulating glucose level	J:211773
Sec14l1^em1(IMPC)J/Sec14l1^em1(IMPC)J (C57BL/6NJ-Sec14l1^em1(IMPC)J/J)	increased circulating alkaline phosphatase level	J:211773
Sec14l2^tm1Arai/Sec14l2^tm1Arai (involves: 129S7/SvEvBrd)	decreased circulating cholesterol level	J:129749
Sec14l2^tm1Arai/Sec14l2^tm1Arai (involves: 129S7/SvEvBrd)	decreased circulating VLDL cholesterol level	J:129749
Sec16b^{tm1a(KOMP)Wtsi}/Sec16b^{tm1a(KOMP)Wtsi} (C57BL/6N-Sec16b^{tm1a(KOMP)Wtsi}/Wtsi)	decreased circulating cholesterol level	J:175295
	decreased circulating HDL cholesterol level	J:175295
	decreased circulating LDL cholesterol level	J:175295
Sec23a^{Gt(RRE297)Byg}/Sec23a^{Gt(RRE297)Byg} (B6J.129P2-Sec23a^{Gt(RRE297)Byg})	abnormal collagen level	J:237614
Sec23b^{Gt(AD0407)Wtsi}/Sec23b^{Gt(AD0407)Wtsi} (B6J.129P2-Sec23b^{Gt(AD0407)Wtsi})	decreased circulating glucose level	J:186391
Sec24a^{tm1a(KOMP)Wtsi}/Sec24a^{tm1a(KOMP)Wtsi} (B6JTyr;B6N-Sec24a^{tm1a(KOMP)Wtsi}/Wtsi)	decreased circulating alkaline phosphatase level	J:175295
	decreased circulating cholesterol level	J:175295
	decreased circulating free fatty acids level	J:175295
	decreased circulating HDL cholesterol level	J:175295
	decreased circulating LDL cholesterol level	J:175295
	increased blood urea nitrogen level	J:175295
Sec24a^{tm1a(KOMP)Wtsi}/Sec24a^{tm1a(KOMP)Wtsi} (involves: C57BL/6 * C57BL/6N)	decreased circulating cholesterol level	J:213427
	decreased circulating LDL cholesterol level	J:213427
Sec24d^{em1(IMPC)Rbrc}/Sec24d⁺ (C57BL/6NJcl-Sec24d^{em1(IMPC)Rbrc}/Rbrc)	impaired glucose tolerance	J:211773
Sec31a^em3(IMPC)H/Sec31a⁺ (C57BL/6N-Sec31a^em3(IMPC)H/H)	decreased fasting circulating glucose level	J:211773
	increased circulating alanine transaminase level	J:211773
	increased circulating alkaline phosphatase level	J:211773
	increased circulating aspartate transaminase level	J:211773
Sec31b^em1(IMPC)J/Sec31b^em1(IMPC)J (C57BL/6NJ-Sec31b^em1(IMPC)J/Mmjax)	decreased circulating phosphate level	J:211773
Sec61a1^m1Gek/Sec61a1⁺ (C57BL/6J-Sec61a1^m1Gek)	decreased circulating insulin level	J:164159
Sec61a1^m1Gek/Sec61a1⁺ (C57BL/6J-Sec61a1^m1Gek)	hyperglycemia	J:164159
Sec61a1^m1Gek/Sec61a1^m1Gek (C57BL/6J-Sec61a1^m1Gek)	abnormal glucose homeostasis	J:164159
	decreased circulating insulin level	J:164159
	hyperglycemia	J:164159
	impaired glucose tolerance	J:164159
	increased circulating cholesterol level	J:164159
	increased circulating glucagon level	J:164159
	increased circulating triglyceride level	J:164159
Sec61a2^em1(IMPC)J/Sec61a2^em1(IMPC)J (C57BL/6NJ-Sec61a2^em1(IMPC)J/Mmjax)	increased circulating phosphate level	J:211773
Sec61b^em1(IMPC)Mbp/Sec61b^em1(IMPC)Mbp (C57BL/6NCrl-Sec61b^em1(IMPC)Mbp/Mmucd)	increased circulating insulin level	J:211773
Sec63^{tm1b(EUCOMM)Hmgu}/Sec63⁺ (C57BL/6N-Sec63^{tm1b(EUCOMM)Hmgu}/Bay)	increased circulating alanine transaminase level	J:211773
Sec63^tm1Som/Sec63^tm1Som Tg(Cdh16-cre)91Igr/0 (involves: 129 * C57BL/6 * ICR)	increased blood urea nitrogen level	J:188763
Secisbp2^{tm1a(EUCOMM)Wtsi}/Secisbp2⁺ (involves: C57BL/6N)	abnormal selenium level	J:213080
Secisbp2l^em1(IMPC)J/Secisbp2l^em1(IMPC)J (C57BL/6NJ-Secisbp2l^em1(IMPC)J/Mmjax)	decreased circulating alanine transaminase level	J:211773
	decreased circulating aspartate transaminase level	J:211773
Sectm1a^em1Gcfa/Sectm1a^em1Gcfa (C57BL/6-Sectm1a^em1Gcfa)	abnormal interleukin level	J:317204
	abnormal tumor necrosis factor level	J:317204
	increased circulating interleukin-1 beta level	J:317204
	increased circulating interleukin-6 level	J:317204
	increased circulating tumor necrosis factor level	J:317204
Sel1l3^em1(IMPC)J/Sel1l3^em1(IMPC)J (C57BL/6NJ-Sel1l3^em1(IMPC)J/Mmjax)	increased circulating alanine transaminase level	J:211773
Sel1l^{tm1c(KOMP)Wtsi}/Sel1l^{tm1c(KOMP)Wtsi} Tg(CAG-cre/Esr1)5Amc/0 (involves: C57BL/6 C57BL/6N * CBA * SJL)	abnormal intestinal lipid absorption	J:206568
	decreased body temperature	J:206568
	steatorrhea	J:206568
Sele^tm1Hyn/Sele^tm1Hyn Selp^tm1Hyn/Selp^tm1Hyn (involves: 129S2/SvPas)	abnormal cytokine level	J:31626
	increased circulating interleukin-3 level	J:31626
Sele^tm2Alb/Sele^tm2Alb Sell^tm2Alb/Sell^tm2Alb Selp^tm1Bay/Selp^tm1Bay (involves: 129S7/SvEvBrd * C57BL/6)	decreased circulating alanine transaminase level	J:106550
Selenbp1^{tm1b(KOMP)Wtsi}/Selenbp1⁺ (C57BL/6N-Selenbp1^{tm1b(KOMP)Wtsi}/Mbp)	abnormal blood homeostasis	J:255748
Selenbp1^{tm1b(KOMP)Wtsi}/Selenbp1^{tm1b(KOMP)Wtsi} (C57BL/6N-Selenbp1^{tm1b(KOMP)Wtsi}/Mbp)	abnormal blood homeostasis	J:255748
Selenbp1^{tm1b(KOMP)Wtsi}/Selenbp1^{tm1b(KOMP)Wtsi} (C57BL/6N-Selenbp1^{tm1b(KOMP)Wtsi}/Ucd)	decreased circulating alkaline phosphatase level	J:211773
	decreased circulating creatinine level	J:211773
	decreased circulating phosphate level	J:211773
	decreased circulating serum albumin level	J:211773
	increased circulating insulin level	J:211773
Selenbp1^tm1Hyama/Selenbp1^tm1Hyama (C57BL/6-Selenbp1^tm1Hyama)	increased circulating serum albumin level	J:202420
Selenok^tm1.2Itl/Selenok^tm1.2Itl (involves: BALB/cJ * C57BL/6)	abnormal circulating chemokine level	J:169169
Selenok^{tm1a(EUCOMM)Wtsi}/Selenok^{tm1a(EUCOMM)Wtsi} (C57BL/6N-Selenok^{tm1a(EUCOMM)Wtsi}/Wtsi)	decreased circulating magnesium level	J:211773
Selenom^{tm1(KOMP)Vlcg}/Selenom^{tm1(KOMP)Vlcg} (involves: C57BL/6J * C57BL/6NTac)	decreased circulating corticosterone level	J:203545
	increased circulating leptin level	J:203545
Selenop^tm1Rfb/Selenop^tm1Rfb (involves: 129 * C57BL/6J)	abnormal selenium level	J:82921
Selenop^tm1Rfb/Selenop^tm1Rfb (B6.129-Selenop^tm1Rfb)	abnormal selenium level	J:121127
Selenop^tm2Rfb/Selenop^tm2Rfb (B6.Cg-Selenop^tm2Rfb)	abnormal selenium level	J:121127
Selenop^tm3.1Rfb/Selenop^tm3.1Rfb Speer6-ps1^{Tg(Alb-cre)21Mgn}/Speer6-ps1⁺ (involves: C57BL/6 * DBA)	abnormal selenium level	J:192636
	increased urine selenium level	J:192636
Selenot^tm1.1Ics/Selenot^tm1.1Ics Tg(Ins2-cre)25Mgn/0 (involves: 129S2/SvPas * C57BL/6 * C57BL/6J * DBA)	decreased circulating insulin level	J:203279
	decreased insulin secretion	J:203279
	impaired glucose tolerance	J:203279
	increased circulating glucose level	J:203279
Sell^tm1.1Rpmc/Sell^tm1.1Rpmc (involves: 129S1/Sv * C57BL/6J * FVB/N)	increased susceptibility to induced thrombosis	J:249558
Sell^tm2.1Tft/Sell^tm2.1Tft (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	abnormal circulating protein level	J:142184
Sell^tm2Tft/Sell^tm2.1Tft (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	abnormal circulating protein level	J:142184
Sell^tm3Tft/Sell^tm3Tft (involves: 129S1/Sv * 129X1/SvJ)	abnormal circulating protein level	J:142184
Selp^tm1Hyn/Selp^tm1Hyn (involves: 129S2/SvPas * C57BL/6J)	increased bleeding time	J:31431
Selp^tm2Hyn/Selp^tm2Hyn (involves: 129S2/SvPas * C57BL/6J)	abnormal blood coagulation	J:125020
Selp^tm2Hyn/Selp^tm2Hyn (involves: 129S2/SvPas * C57BL/6J)	abnormal blood homeostasis	J:125020, J:51068
Selplg^tm1Rpmc/Selplg^tm1Rpmc (involves: 129S1/Sv * C57BL/6J)	increased bleeding time	J:138731
Selplg^tm2Rpmc/Selplg^tm2Rpmc (B6.Cg-Selplg^tm2Rpmc)	increased bleeding time	J:138731
Sema3a^tm1Mcf/Sema3a^tm1Mcf (involves: 129S4/SvJae)	abnormal atrial thrombosis	J:35824
Sema3e^em1(IMPC)H/Sema3e^em1(IMPC)H (C57BL/6NTac-Sema3e^em1(IMPC)H/H)	decreased circulating phosphate level	J:211773
Sema3f^{tm1b(EUCOMM)Hmgu}/Sema3f^{tm1b(EUCOMM)Hmgu} (C57BL/6N-Sema3f^{tm1b(EUCOMM)Hmgu}/H)	decreased circulating serum albumin level	J:211773
	decreased circulating total protein level	J:211773
	increased circulating iron level	J:211773
Sema4d^{tm1b(EUCOMM)Wtsi}/Sema4d^{tm1b(EUCOMM)Wtsi} (C57BL/6N-Sema4d^{tm1b(EUCOMM)Wtsi}/H)	increased circulating alkaline phosphatase level	J:211773
Senp1^tm1.1Eyeh/Senp1⁺ Tg(Pdx1-cre)6Tuv/0 (involves: C57BL/6)	impaired glucose tolerance	J:226392
Senp1^tm1.1Eyeh/Senp1^tm1.1Eyeh (Not Specified)	decreased insulin secretion	J:226392
Senp1^tm1.1Eyeh/Senp1^tm1.1Eyeh Tg(Pdx1-cre)6Tuv/0 (involves: C57BL/6)	decreased circulating insulin level	J:226392
	decreased insulin secretion	J:226392
	impaired glucose tolerance	J:226392
Senp1^tm1.1Eyeh/Senp1^tm1.1Eyeh Tg(Pdx1-cre/Esr1*)#Dam/0 (involves: C57BL/6)	decreased insulin secretion	J:226392
	impaired glucose tolerance	J:226392
Senp1^tm1Wami/Senp1^tm1Wami Tg(Adipoq-cre)1Evdr/0 (B6.Cg-Senp1^tm1Wami Tg(Adipoq-cre)1Evdr)	decreased insulin secretion	J:228009
	hyperglycemia	J:228009
Senp1^tm1Wami/Senp1^tm1Wami Tg(Fabp4-cre)#Abel/0 (B6.Cg-Senp1^tm1Wami Tg(Fabp4-cre)#Abel)	abnormal chemokine level	J:228009
	abnormal circulating cytokine level	J:228009
	abnormal cytokine level	J:228009
	decreased circulating cholesterol level	J:228009
	decreased circulating insulin level	J:228009
	decreased circulating triglyceride level	J:228009
	decreased insulin secretion	J:228009
	hyperglycemia	J:228009
	impaired glucose tolerance	J:228009
	increased circulating C-reactive protein level	J:228009
	increased circulating interleukin-1 beta level	J:228009
	increased circulating interleukin-6 level	J:228009
	increased circulating ketone body level	J:228009
	increased circulating tumor necrosis factor level	J:228009
	insulin resistance	J:228009
Senp1^tm1Wami/Senp1^tm1Wami Tg(Pdgfra-cre)1Clc/0 (B6.Cg-Senp1^tm1Wami Tg(Pdgfra-cre)1Clc)	hyperglycemia	J:228009
Senp2^{Gt(AN0727)Wtsi}/Senp2^{Gt(AN0727)Wtsi} (involves: 129P2/OlaHsd)	pericardial effusion	J:162938
Senp2^{Gt(OST66117)Lex}/Senp2⁺ (B6;129S5-Senp2^{Gt(OST66117)Lex}/Orl)	decreased circulating glucose level	J:82809
Senp3^{tm1(NCOM)Cmhd}/Senp3⁺ (C57BL/6N-Senp3^{tm1(NCOM)Cmhd}/Tcp)	increased circulating serum albumin level	J:165965
Sephs1^tm1.1Dhat/Sephs1^tm1.1Dhat Speer6-ps1^{Tg(Alb-cre)21Mgn}/Speer6-ps1⁺ (involves: 129S4/SvJae * C57BL/6J)	decreased liver iron level	J:245139
	decreased liver manganese level	J:245139
Sepsecs^em1(IMPC)Tcp/Sepsecs⁺ (C57BL/6N-Sepsecs^em1(IMPC)Tcp/Tcp)	increased circulating calcium level	J:211773
Sepsecs^tm1.1Usch/Sepsecs^tm1.1Usch (B6.Cg-Sepsecs^tm1.1Usch)	cyanosis	J:315052
Septin3^{tm1b(KOMP)Wtsi}/Septin3⁺ (C57BL/6N-Septin3^{tm1b(KOMP)Wtsi}/Orl)	decreased circulating phosphate level	J:211773
Septin5^{tm1b(EUCOMM)Hmgu}/Septin5⁺ (C57BL/6N-Septin5^{tm1b(EUCOMM)Hmgu}/Rbrc)	improved glucose tolerance	J:211773
Septin5^tm1Wtr/Septin5^tm1Wtr (involves: 129S1/Sv * 129X1/SvJ)	abnormal platelet physiology	J:109519
	increased platelet aggregation	J:109519
Septin6^{tm1.1(KOMP)Vlcg}/Y (C57BL/6N-Septin6^{tm1.1(KOMP)Vlcg}/MbpMmucd)	increased circulating alkaline phosphatase level	J:211773
Septin14^em1(IMPC)Tcp/Septin14^em1(IMPC)Tcp (C57BL/6NCrl-Septin14^em1(IMPC)Tcp/Tcp)	increased circulating alanine transaminase level	J:211773
	increased circulating aspartate transaminase level	J:211773
Serac1^em1Bcgen/Serac1^em1Bcgen (C57BL/6N-Serac1^em1Bcgen)	aciduria	J:326672
	decreased circulating cholesterol level	J:326672
	increased liver cholesterol level	J:326672
	increased liver glycogen level	J:326672
	increased liver triglyceride level	J:326672
Serf1^{tm1a(EUCOMM)Hmgu}/Serf1^{tm1a(EUCOMM)Hmgu} (C57BL/6N-Serf1^{tm1a(EUCOMM)Hmgu}/H)	increased circulating cholesterol level	J:165965
	increased circulating HDL cholesterol level	J:165965
Serinc2^em1(IMPC)J/Serinc2^em1(IMPC)J (C57BL/6NJ-Serinc2^em1(IMPC)J/Mmjax)	impaired glucose tolerance	J:211773
Serinc3^{tm1a(KOMP)Wtsi}/Serinc3^{tm1a(KOMP)Wtsi} (C57BL/6N-Serinc3^{tm1a(KOMP)Wtsi}/Wtsi)	decreased circulating magnesium level	J:211773
Serp1^tm1Hori/Serp1^tm1Hori (B6.Cg-Serp1^tm1Hori)	decreased circulating insulin level	J:109619
Serp1^tm1Hori/Serp1^tm1Hori (B6.Cg-Serp1^tm1Hori)	impaired glucose tolerance	J:109619
Serp1^tm1Hori/Serp1^tm1Hori (involves: 129X1/SvJ * C57BL/6)	decreased circulating growth hormone level	J:109619
	decreased circulating insulin level	J:109619
	impaired glucose tolerance	J:109619
Serpina1f^em1(IMPC)J/Serpina1f^em1(IMPC)J (C57BL/6NJ-Serpina1f^em1(IMPC)J/J)	increased circulating total protein level	J:211773
Serpina3c^em1Smoc/Serpina3c^em1Smoc (C57BL/6-Serpina3c^em1Smoc)	abnormal protein level	J:343846
	decreased carbon dioxide production	J:343846
	decreased energy expenditure	J:343846
	decreased oxygen consumption	J:343846
	impaired glucose tolerance	J:343846
	increased circulating triglyceride level	J:343846
	increased susceptibility to diet-induced obesity	J:343846
	insulin resistance	J:343846
Serpina6^tm1.1Mmp/Serpina6⁺ (involves: 129S2/SvPas * C57BL/6 * C57BL/6J * SJL)	abnormal circulating corticosterone level	J:164345
Serpina6^tm1.1Mmp/Serpina6^tm1.1Mmp (involves: 129S2/SvPas * C57BL/6 * C57BL/6J * SJL)	abnormal circulating corticosterone level	J:164345
Serpina6^tm1Tew/Serpina6^tm1Tew (involves: 129/SvEmcTer * C57BL/6N)	abnormal circulating corticosterone level	J:112974
	abnormal circulating cytokine level	J:112974
	abnormal cytokine level	J:112974
	increased adrenocorticotropin level	J:112974
Serpina10^tm1Gjb/Serpina10^tm1Gjb (involves: 129X1/SvJ * C57BL/6)	increased susceptibility to induced thrombosis	J:136102
Serpina12^tm1Jwada/Serpina12⁺ (B6JJcl.129P2-Serpina12^tm1Jwada)	increased circulating leptin level	J:208508
	increased liver triglyceride level	J:208508
Serpina12^tm1Jwada/Serpina12^tm1Jwada (B6JJcl.129P2-Serpina12^tm1Jwada)	increased circulating cholesterol level	J:208508
	increased circulating LDL cholesterol level	J:208508
	increased circulating leptin level	J:208508
	increased liver triglyceride level	J:208508
	insulin resistance	J:208508
Serpinb1a^tm1.1Cben/Serpinb1a^tm1.1Cben (129S6/SvEvTac-Serpinb1a^tm1.1Cben)	abnormal circulating cytokine level	J:125918
Serpinb2^{tm1b(EUCOMM)Wtsi}/Serpinb2^{tm1b(EUCOMM)Wtsi} (C57BL/6N-Serpinb2^{tm1b(EUCOMM)Wtsi}/J)	increased circulating cholesterol level	J:211773
	increased circulating creatinine level	J:211773
	increased circulating HDL cholesterol level	J:211773
Serpinb5^{tm1b(KOMP)Wtsi}/Serpinb5^{tm1b(KOMP)Wtsi} (C57BL/6N-Serpinb5^{tm1b(KOMP)Wtsi}/J)	increased circulating cholesterol level	J:211773
Serpinb9^tm1Arp/Serpinb9^tm1Arp (involves: C57BL/6)	abnormal enzyme/coenzyme level	J:113349
Serpinb10^em1(IMPC)Mbp/Serpinb10^em1(IMPC)Mbp (C57BL/6NCrl-Serpinb10^em1(IMPC)Mbp/Mmucd)	decreased circulating calcium level	J:211773
Serpinc1^tm1Dwr/Serpinc1⁺ (involves: 129S1/Sv * 129X1/SvJ)	abnormal cardiac thrombosis	J:115658
Serpinc1^tm1Dwr/Serpinc1^tm1Dwr (involves: 129S1/Sv * 129X1/SvJ)	abnormal atrial thrombosis	J:115658
	abnormal blood coagulation	J:115658
	abnormal cardiac thrombosis	J:115658
	abnormal placental thrombosis	J:115658
	abnormal thrombosis	J:115658
Serpinc1^tm1Sai/Serpinc1⁺ (involves: 129S2/SvPas * C57BL/6J)	increased susceptibility to induced thrombosis	J:75955
Serpinc1^tm1Sai/Serpinc1^tm1Sai (involves: 129S2/SvPas * C57BL/6J)	abnormal thrombosis	J:65092
Serpind1^tm1Moto/Serpind1⁺ (B6.Cg-Serpind1^tm1Moto)	abnormal platelet aggregation	J:122173
Serpind1^tm1Moto/Serpind1⁺ (B6.Cg-Serpind1^tm1Moto)	increased susceptibility to induced thrombosis	J:122173
Serpind1^tm1Toll/Serpind1^tm1Toll (involves: 129X1/SvJ * C57BL/6)	increased susceptibility to induced thrombosis	J:74337
Serpine1^tm1Mlg/Serpine1^tm1Mlg (involves: 129S2/SvPas * C57BL/6)	abnormal energy expenditure	J:87982
	abnormal interleukin level	J:133227
	decreased circulating interleukin-6 level	J:133227
	decreased liver triglyceride level	J:87982
	decreased skeletal muscle triglyceride level	J:87982
	increased body temperature	J:87982
	increased oxygen consumption	J:87982
	increased urine protein level	J:85989
Serpine1^tm1Mlg/Serpine1^tm1Mlg (involves: 129S2/SvPas * C57BL/6 * C57BLKS/J)	decreased circulating cholesterol level	J:127478
	hyperglycemia	J:127478
	increased blood urea nitrogen level	J:127478
Serpine2^tm1Dmn/Serpine2^tm1Dmn (B6.129P2-Serpine2^tm1Dmn)	abnormal acute phase protein level	J:121263
Serpinf2^tm1Hrl/Serpinf2^tm1Hrl (involves: 129X1/SvJ * C57BL/6J)	abnormal blood coagulation	J:54047
	abnormal thrombolysis	J:54047
Serping1^em1(IMPC)Mbp/Serping1^em1(IMPC)Mbp (C57BL/6N-Serping1^em1(IMPC)Mbp/MbpMmucd)	decreased circulating alkaline phosphatase level	J:211773
Sertad1^tm1Srn/Sertad1^tm1Srn (B6.129-Sertad1^tm1Srn)	decreased insulin secretion	J:157231
Sertad1^tm1Srn/Sertad1^tm1Srn (B6.129-Sertad1^tm1Srn)	impaired glucose tolerance	J:157231
Sertad2^{Gt(OST98734)Lex}/Sertad2⁺ (B6.129S5-Sertad2^{Gt(OST98734)Lex})	decreased circulating cholesterol level	J:194928
	decreased circulating leptin level	J:194928
Sertad2^{Gt(OST98734)Lex}/Sertad2^{Gt(OST98734)Lex} (involves: 129S5/SvEvBrd)	decreased susceptibility to diet-induced obesity	J:194928
Sertad2^{Gt(OST98734)Lex}/Sertad2^{Gt(OST98734)Lex} (B6.129S5-Sertad2^{Gt(OST98734)Lex})	abnormal circulating hormone level	J:194928
	abnormal glucose homeostasis	J:194928
	abnormal hormone level	J:194928
	abnormal lipid homeostasis	J:194928
	decreased circulating cholesterol level	J:194928
	decreased circulating glucose level	J:194928
	decreased circulating insulin level	J:194928
	decreased circulating leptin level	J:194928
	decreased liver triglyceride level	J:194928
	decreased susceptibility to diet-induced obesity	J:194928
	enhanced lipolysis	J:194928
	improved glucose tolerance	J:194928
	increased adiponectin level	J:194928
	increased core body temperature	J:194928
	increased insulin sensitivity	J:194928
	increased oxygen consumption	J:194928
Sesn2^{Gt(RRJ141)Byg}/Sesn2^{Gt(RRJ141)Byg} (involves: 129P2/OlaHsd)	abnormal gluconeogenesis	J:189021
	impaired glucose tolerance	J:189021
	increased liver triglyceride level	J:189021
	insulin resistance	J:189021
Sesn2^{Gt(RRJ141)Byg}/Sesn2^{Gt(RRJ141)Byg} Sesn3^{tm1a(EUCOMM)Wtsi}/Sesn3^{tm1a(EUCOMM)Wtsi} (involves: 129P2/OlaHsd * C57BL/6N)	impaired glucose tolerance	J:189021
	insulin resistance	J:189021
Sesn3^{tm1a(EUCOMM)Wtsi}/Sesn3^{tm1a(EUCOMM)Wtsi} (C57BL/6N-Sesn3^{tm1a(EUCOMM)Wtsi}/Wtsi)	increased circulating chloride level	J:175295
	increased circulating sodium level	J:175295
Set^tm1.1Wgu/Set^tm1.1Wgu (involves: 129S6/SvEvTac)	cardiac edema	J:276962
Setbp1^{tm1b(EUCOMM)Wtsi}/Setbp1⁺ (C57BL/6N-Setbp1^{tm1b(EUCOMM)Wtsi}/Ics)	decreased circulating cholesterol level	J:211773
Setd1a^{tm1a(EUCOMM)Wtsi}/Setd1a⁺ (C57BL/6N-Setd1a^{tm1a(EUCOMM)Wtsi}/Wtsi)	decreased circulating alanine transaminase level	J:175295
	decreased circulating alkaline phosphatase level	J:175295
	decreased circulating cholesterol level	J:175295
	decreased circulating HDL cholesterol level	J:175295
	decreased circulating LDL cholesterol level	J:175295
Setd2^tm1Zhch/Setd2^tm1Zhch (involves: 129S1/Sv * C57BL/6)	edema	J:157570
Setd2^tm1Zhch/Setd2^tm1Zhch (involves: 129S1/Sv * C57BL/6)	pericardial effusion	J:157570
Setd4^{tm1a(KOMP)Wtsi}/Setd4^{tm1a(KOMP)Wtsi} (C57BL/6N-Setd4^{tm1a(KOMP)Wtsi}/Wtsi)	decreased fasting circulating glucose level	J:211773
	increased circulating aspartate transaminase level	J:211773
Setd5^tm1.1Mgn/Setd5^tm1.1Mgn (involves: 129S6/SvEvTac * CD-1)	pericardial effusion	J:237500
Setd5^{tm1a(EUCOMM)Wtsi}/Setd5⁺ (C57BL/6N-Setd5^{tm1a(EUCOMM)Wtsi}/Wtsi)	decreased circulating glucose level	J:211773
	subcutaneous edema	J:239583
Setd5^{tm1c(EUCOMM)Wtsi}/Setd5^{tm1c(EUCOMM)Wtsi} Mesp1^tm2(cre)Ysa/Mesp1⁺ (involves: C57BL/6N * C57BL/6NCrlj * CBA/JNCrlj)	pericardial effusion	J:314464
Setd6^{tm1.1(KOMP)Mbp}/Setd6^{tm1.1(KOMP)Mbp} (C57BL/6N-Setd6^{tm1.1(KOMP)Mbp}/J)	increased circulating alanine transaminase level	J:211773
	increased circulating aspartate transaminase level	J:211773
	increased circulating bilirubin level	J:211773
	increased circulating potassium level	J:211773
Setd7^tm1.1Ital/Setd7^tm1.1Ital (involves: C57BL/6 * CBA)	abnormal protein level	J:238299
Setmar^{tm1a(EUCOMM)Wtsi}/Setmar^{tm1a(EUCOMM)Wtsi} (C57BL/6N-Setmar^{tm1a(EUCOMM)Wtsi}/Wtsi)	decreased circulating glycerol level	J:165965
Setx^{tm1b(EUCOMM)Wtsi}/Setx^{tm1b(EUCOMM)Wtsi} (C57BL/6N-Setx^{tm1b(EUCOMM)Wtsi}/Ics)	improved glucose tolerance	J:211773
Sez6l^{tm1b(EUCOMM)Hmgu}/Sez6l^{tm1b(EUCOMM)Hmgu} (C57BL/6N-Sez6l^{tm1b(EUCOMM)Hmgu}/H)	decreased circulating serum albumin level	J:211773
	decreased respiratory quotient	J:211773
	increased circulating alkaline phosphatase level	J:211773
Sf3b1^tm1.1Mdf/Sf3b1⁺ Tg(Mx1-cre)1Cgn/? (involves: 129S4/SvJae * C57BL/6 * CBA/J)	increased circulating erythropoietin level	J:234976
Sfmbt2^em1(IMPC)Mbp/Sfmbt2⁺ (C57BL/6NCrl-Sfmbt2^em1(IMPC)Mbp/Mmucd)	edema	J:211773
Sfn^Er/Sfn⁺ (Not Specified)	impaired skin barrier function	J:203995
Sfpq^{tm1a(EUCOMM)Wtsi}/Sfpq⁺ (C57BL/6N-Sfpq^{tm1a(EUCOMM)Wtsi}/Wtsi)	decreased circulating amylase level	J:211773
Sfr1^em1(IMPC)Mbp/Sfr1⁺ (C57BL/6NCrl-Sfr1^em1(IMPC)Mbp/Mmucd)	increased circulating aspartate transaminase level	J:211773
Sfrp1^tm1Aksh/Sfrp1^tm1Aksh Sfrp2^tm1Aksh/Sfrp2^tm1Aksh (involves: 129 * C57BL/6)	edema	J:106551
Sfrp1^tm1Bsk/Sfrp1^tm1Bsk (involves: 129S5/SvEvBrd * C57BL/6)	increased circulating phosphate level	J:89547
Sfswap^em1(IMPC)J/Sfswap⁺ (C57BL/6NJ-Sfswap^em1(IMPC)J/Mmjax)	increased circulating alanine transaminase level	J:211773
Sftpa1^tm1Haw/Sftpa1^tm1Haw (involves: 129/Sv * C57BL/6 * CD-1)	abnormal cytokine level	J:86024
	abnormal interferon level	J:86024
	abnormal interleukin level	J:86024
Sftpa1^tm1Kor/Sftpa1^tm1Kor (involves: 129P2/OlaHsd)	abnormal phospholipid level	J:107841
Sftpa1^tm1Kor/Sftpa1^tm1Kor (B6.129P2-Sftpa1^tm1Kor)	abnormal phospholipid level	J:130520
Sftpa1^tm2Haw/Sftpa1^tm2Haw Sftpd^tm2Haw/Sftpd^tm2Haw (involves: C57BL/6J * CD-1)	abnormal phospholipid level	J:86022
Sftpb^tm1Jaw/Sftpb^tm1Jaw (involves: 129S2/SvPas * Black Swiss)	abnormal lipid homeostasis	J:28289
	cyanosis	J:28289
Sftpd^tm1Haw/Sftpd^tm1Haw (involves: C57BL/6J * CD-1)	abnormal cholesterol homeostasis	J:50147
Sftpd^tm1Jhf/Sftpd^tm1Jhf (involves: 129P2/OlaHsd * Black Swiss)	abnormal chemokine level	J:72681
	abnormal cytokine level	J:72681, J:62282
	abnormal lipid homeostasis	J:50436
Sfxn1^{tm1b(EUCOMM)Wtsi}/Sfxn1^{tm1b(EUCOMM)Wtsi} (C57BL/6N-Sfxn1^{tm1b(EUCOMM)Wtsi}/J)	increased fasting circulating glucose level	J:211773
Sfxn3^{tm1b(KOMP)Wtsi}/Sfxn3^{tm1b(KOMP)Wtsi} (C57BL/6N-Sfxn3^{tm1b(KOMP)Wtsi}/Wtsi)	increased circulating insulin level	J:211773
Sfxn5^{tm1b(EUCOMM)Hmgu}/Sfxn5⁺ (C57BL/6N-Sfxn5^{tm1b(EUCOMM)Hmgu}/J)	decreased fasting circulating glucose level	J:211773
Sgca^tm1Kcam/Sgca^tm1Kcam (involves: 129S1/Sv * 129X1/SvJ)	abnormal circulating pyruvate kinase level	J:49992
Sgca^tm1Kcam/Sgca^tm1Kcam (involves: 129S1/Sv * 129X1/SvJ)	increased circulating creatine kinase level	J:49992, J:130252
Sgca^tm2Kcam/Sgca^tm2Kcam (either: (129S6/SvEvTac-Sgca^tm2Kcam) or (involves: 129S6/SvEvTac * C57BL/6J))	increased circulating creatine kinase level	J:130252
Sgca^tm2Kcam/Sgca^tm2Kcam (B6.129S6-Sgca^tm2Kcam/J)	increased circulating creatine kinase level	J:250485
Sgcd^tm1Mcn/Sgcd^tm1Mcn (involves: 129S1/Sv * 129T2/SvEmsJ * 129X1/SvJ)	increased circulating creatine kinase level	J:76730
Sgcd^tm1Mcn/Sgcd^tm1Mcn (B6.129-Sgcd^tm1Mcn/J)	increased circulating creatine kinase level	J:250485
Sgce^{Gt(148G1)Cmhd}/Sgce⁺ (B6.129-Sgce^{Gt(148G1)Cmhd})	increased noradrenaline level	J:251780
Sgcg^tm1Mcn/Sgcg^tm1Mcn (involves: 129X1/SvJ * C57BL/6)	increased circulating creatine kinase level	J:49871, J:57664
Sgcg^tm1Oza/Sgcg^tm1Oza (involves: 129S4/SvJae * C57BL/6)	increased circulating creatine kinase level	J:102780
Sgf29^{tm1a(EUCOMM)Hmgu}/Sgf29⁺ (C57BL/6N-Sgf29^{tm1a(EUCOMM)Hmgu}/Cnrm)	decreased circulating glucose level	J:165965
Sgip1^{tm1b(EUCOMM)Hmgu}/Sgip1⁺ (C57BL/6N-Sgip1^{tm1b(EUCOMM)Hmgu}/Ieg)	increased circulating lipase level	J:211773
Sgk1^tm1.2Palm/Sgk1^tm1.2Palm (129/Sv-Sgk1^tm1.2Palm)	increased circulating aldosterone level	J:148648
	increased urine potassium level	J:148648
	increased urine sodium level	J:148648
Sgk1^tm1Kuhl/Sgk1^tm1Kuhl (either: (involves: 129/Sv * C57BL/6) or (involves: 129/Sv * 129X1/SvJ))	increased circulating aldosterone level	J:80115
Sgk3^tm1Dpea/Sgk3^tm1Dpea (involves: 129X1/SvJ * C57BL/6)	abnormal potassium ion homeostasis	J:279604
Sgk3^tm1Dpea/Sgk3^tm1Dpea (involves: 129X1/SvJ * C57BL/6)	decreased fasting circulating glucose level	J:279604
Sgms1^{Gt(E201D11)Wrst}/Sgms1^{Gt(E201D11)Wrst} (B6.129P2-Sgms1^{Gt(E201D11)Wrst})	abnormal ceramide level	J:249941
	abnormal lipid level	J:249941
	abnormal sphingolipid level	J:249941
	abnormal sphingomyelin level	J:249941
	decreased plasmalogen level	J:249941
	decreased unsaturated fatty acids level	J:249941
Sgms1^{tm1a(EUCOMM)Wtsi}/Sgms1^{tm1a(EUCOMM)Wtsi} (C57BL/6N-Sgms1^{tm1a(EUCOMM)Wtsi}/Wtsi)	increased circulating alkaline phosphatase level	J:211773
	increased circulating creatinine level	J:211773
	increased circulating magnesium level	J:211773
Sgms1^tm1Jia/Sgms1^tm1Jia (involves: C57BL/6)	abnormal ceramide level	J:201497
	abnormal cytokine level	J:201497
	abnormal sphingomyelin level	J:201497
	decreased circulating interleukin-6 level	J:201497
	decreased circulating tumor necrosis factor level	J:201497
Sgms1^tm1Kenw/Sgms1^tm1Kenw (involves: 129S2/SvPas * C57BL/6)	decreased circulating insulin level	J:168726
	decreased insulin secretion	J:168726
	hyperglycemia	J:168726
	impaired glucose tolerance	J:168726
	increased insulin sensitivity	J:168726
Sgms2^tm1Jia/Sgms2^tm1Jia (involves: 129 * C57BL/6)	abnormal circulating protein level	J:162192
	abnormal lipid level	J:162192, J:162226
	abnormal sphingomyelin level	J:162192
Sgms2^tm1Jia/Sgms2^tm1Jia (Not Specified)	abnormal ceramide level	J:228568, J:220024
Sgms2^tm1Jia/Sgms2^tm1Jia (Not Specified)	abnormal sphingomyelin level	J:228568
Sgms2^tm1Kenw/Sgms2^tm1Kenw (B6.129S2-Sgms2^tm1Kenw)	abnormal circulating glucose level	J:175924
	decreased circulating triglyceride level	J:175924
	decreased susceptibility to diet-induced obesity	J:175924
	improved glucose tolerance	J:175924
	increased circulating free fatty acids level	J:175924
	increased insulin sensitivity	J:175924
Sgo1^{tm1a(EUCOMM)Wtsi}/Sgo1⁺ (B6JTyr;B6N-Sgo1^{tm1a(EUCOMM)Wtsi}/Wtsi)	decreased circulating cholesterol level	J:175295
Sgp1^DBA/2/Sgp1^DBA/2 (B10.D2-H2^d)	abnormal circulating protein level	J:7046
Sgp2¹²⁹/Sgp2¹²⁹ (involves: 129 * C57BL/6)	abnormal circulating protein level	J:7218
Sgpl1^{Gt(ROSA)78Sor}/Sgpl1^{Gt(ROSA)78Sor} (involves: 129S4/SvJaeSor)	decreased circulating serum albumin level	J:242932
	increased blood urea nitrogen level	J:117491
Sgpl1^{Gt(ROSA)78Sor}/Sgpl1^{Gt(ROSA)78Sor} (either: (involves: 129S4/SvJaeSor) or (involves: 129S4/SvJaeSor * C57BL/6))	abnormal testosterone level	J:142042
	decreased circulating estradiol level	J:142042
	decreased circulating testosterone level	J:142042
Sgpl1^tm1.2Npa/Sgpl1^tm1.2Npa (involves: BALB/cJ * C57BL/6)	abnormal lipid homeostasis	J:199525
Sgpp1^{tm1(KOMP)Vlcg}/Sgpp1^{tm1(KOMP)Vlcg} (involves: C57BL/6NTac)	abnormal ceramide level	J:199597
	impaired skin barrier function	J:199597
Sgpp2^tm1Rlp/Sgpp2^tm1Rlp (B6.129S6-Sgpp2^tm1Rlp)	abnormal ceramide level	J:235035
	decreased circulating insulin level	J:235035
	decreased insulin secretion	J:235035
Sgsh^em3(IMPC)Tcp/Sgsh^em3(IMPC)Tcp (C57BL/6NCrl-Sgsh^em3(IMPC)Tcp/Tcp)	increased blood urea nitrogen level	J:211773
	increased circulating alkaline phosphatase level	J:211773
Sgsm1^{tm1b(EUCOMM)Wtsi}/Sgsm1^{tm1b(EUCOMM)Wtsi} (C57BL/6N-Sgsm1^{tm1b(EUCOMM)Wtsi}/Wtsi)	increased circulating iron level	J:211773
Sgta^tm1.1Drmcr/Sgta⁺ (involves: C57BL/6)	decreased circulating insulin-like growth factor I level	J:234007
Sgta^tm1.1Drmcr/Sgta^tm1.1Drmcr (involves: C57BL/6)	decreased circulating insulin-like growth factor I level	J:234007
Sgta^{tm1b(KOMP)Mbp}/Sgta^{tm1b(KOMP)Mbp} (C57BL/6N-Sgta^{tm1b(KOMP)Mbp}/J)	increased circulating alkaline phosphatase level	J:211773
	increased circulating aspartate transaminase level	J:211773
Sh2b1^em1(IMPC)Ics/Sh2b1⁺ (C57BL/6N-Sh2b1^em1(IMPC)Ics/Ics)	impaired glucose tolerance	J:211773
Sh2b1^tm1Lr/Sh2b1⁺ (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	hyperglycemia	J:92794
Sh2b1^tm1Lr/Sh2b1^tm1Lr (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	hyperglycemia	J:92794
	impaired glucose tolerance	J:92794
	insulin resistance	J:92794
Sh2b1^tm2.1Lr/Sh2b1^tm2.1Lr Tg(Pdx1-cre)89.1Dam/0 (involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * CBA * SJL)	decreased circulating insulin level	J:209019
	decreased insulin secretion	J:209019
	impaired glucose tolerance	J:209019
	increased circulating glucose level	J:209019
Sh2b2^tm1Yeb/Sh2b2^tm1Yeb (involves: C57BL/6)	decreased circulating insulin level	J:86301
Sh2d1a^tm1.1Knic/Y Gt(ROSA)26Sor^tm1(EYFP)Cos/Gt(ROSA)26Sor⁺ Ndor1^{Tg(UBC-cre/ERT2)1Ejb}/0 (involves: 129S/SvEv * 129X1/SvJ * C57BL/6)	decreased circulating interleukin-4 level	J:196692
Sh2d1a^tm1.1Knic/Sh2d1a^tm1.1Knic Gt(ROSA)26Sor^tm1(EYFP)Cos/Gt(ROSA)26Sor⁺ Ndor1^{Tg(UBC-cre/ERT2)1Ejb}/0 (involves: 129S/SvEv * 129X1/SvJ * C57BL/6)	decreased circulating interleukin-4 level	J:196692
Sh2d5^{tm1a(EUCOMM)Wtsi}/Sh2d5^{tm1a(EUCOMM)Wtsi} (C57BL/6N-Sh2d5^{tm1a(EUCOMM)Wtsi}/Wtsi)	decreased circulating creatinine level	J:211773
Sh3bp2^tm1.1Ics/Sh3bp2⁺ (involves: 129S2/SvPas * C57BL/6)	abnormal circulating cytokine level	J:221901
Sh3bp2^tm1.1Ics/Sh3bp2^tm1.1Ics (involves: 129S2/SvPas * C57BL/6)	abnormal circulating cytokine level	J:221901
	increased circulating interleukin-6 level	J:221901
	increased circulating interleukin-12 level	J:221901
	increased circulating tumor necrosis factor level	J:221901
Sh3bp2^{tm1b(KOMP)Wtsi}/Sh3bp2^{tm1b(KOMP)Wtsi} (C57BL/6N-Sh3bp2^{tm1b(KOMP)Wtsi}/Tcp)	increased circulating aspartate transaminase level	J:211773
Sh3bp2^tm1Bjro/Sh3bp2⁺ (involves: 129S4/SvJae * BALB/cJ * C57BL/6J)	abnormal enzyme/coenzyme level	J:117880
Sh3bp2^tm1Bjro/Sh3bp2^tm1Bjro (involves: 129S4/SvJae * BALB/cJ * C57BL/6J)	abnormal enzyme/coenzyme level	J:117880
	increased circulating tumor necrosis factor level	J:117880
Sh3bp2^tm1Rtpl/Sh3bp2^tm1Rtpl (involves: 129P2/OlaHsd * C57BL/6)	abnormal circulating cytokine level	J:221901
Sh3bp4^{tm1a(EUCOMM)Wtsi}/Sh3bp4^{tm1a(EUCOMM)Wtsi} (C57BL/6N-Sh3bp4^{tm1a(EUCOMM)Wtsi}/Wtsi)	increased circulating bilirubin level	J:211773
Sh3gl2^{tm1b(EUCOMM)Wtsi}/Sh3gl2^{tm1b(EUCOMM)Wtsi} (C57BL/6N-Sh3gl2^{tm1b(EUCOMM)Wtsi}/Tcp)	increased circulating alanine transaminase level	J:211773
	increased circulating aspartate transaminase level	J:211773
Sh3glb2^{Gt(OST224737)Lex}/Sh3glb2^{Gt(OST224737)Lex} (B6.129S5-Sh3glb2^{Gt(OST224737)Lex})	abnormal pH regulation	J:246421
Sh3kbp1^tm1Ivdi/Sh3kbp1^tm1Ivdi (B6.129S-Sh3kbp1^tm1Ivdi)	increased dopamine level	J:162088
Sh3pxd2a^{tm1b(EUCOMM)Wtsi}/Sh3pxd2a⁺ (C57BL/6N-Sh3pxd2a^{tm1b(EUCOMM)Wtsi}/Wtsi)	increased circulating alkaline phosphatase level	J:211773
Sh3pxd2a^{tm1b(EUCOMM)Wtsi}/Sh3pxd2a^{tm1b(EUCOMM)Wtsi} (C57BL/6N-Sh3pxd2a^{tm1b(EUCOMM)Wtsi}/Wtsi)	retropharyngeal edema	J:239583
	retropleural edema	J:239583
	subcutaneous edema	J:239583
Sh3tc1^{tm1b(EUCOMM)Hmgu}/Sh3tc1^{tm1b(EUCOMM)Hmgu} (C57BL/6N-Sh3tc1^{tm1b(EUCOMM)Hmgu}/Orl)	decreased circulating triglyceride level	J:211773
	increased circulating bilirubin level	J:211773
Sh3tc2^{tm1b(KOMP)Wtsi}/Sh3tc2^{tm1b(KOMP)Wtsi} (C57BL/6N-Sh3tc2^{tm1b(KOMP)Wtsi}/J)	decreased circulating glucose level	J:211773
Shank3^em1(IMPC)H/Shank3^em1(IMPC)H (C57BL/6NTac-Shank3^em1(IMPC)H/H)	decreased circulating calcium level	J:211773
Shank3^tm1.1Pfw/Shank3^tm1.1Pfw (B6.129S6-Shank3^tm1.1Pfw)	photophobia	J:204162
Sharpin^cpdm/Sharpin^cpdm (C57BL/KaLawRij-Sharpin^cpdm)	skin edema	J:14539
Shfl^{tm1.1(KOMP)Mbp}/Shfl^{tm1.1(KOMP)Mbp} (C57BL/6N-Shfl^{tm1.1(KOMP)Mbp}/Ucd)	increased circulating bilirubin level	J:211773
Shh^tm1Ahk/Shh^tm1Ahk Slc6a3^tm1(cre)Xz/Slc6a3⁺ (involves: 129S1/Sv * C57BL/6)	decreased dopamine level	J:188348
	increased dopamine level	J:188348
Shh^{tm1b(EUCOMM)Wtsi}/Shh⁺ (C57BL/6N-Shh^{tm1b(EUCOMM)Wtsi}/H)	impaired glucose tolerance	J:211773
	increased circulating HDL cholesterol level	J:211773
Shh^tm1Chg/Shh^tm1Chg Tulp3^hhkr/Tulp3^hhkr (involves: 129S1/Sv * 129X1/SvJ * C3H/HeH * C57BL/6)	edema	J:147584
Shh^tm2Amc/Shh^tm2.1Amc Tg(Nr5a1-cre)2Klp/0 (involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * FVB/N)	decreased circulating corticosterone level	J:168522
	increased circulating adrenocorticotropin level	J:168522
Shisal1^{em1(IMPC)Ccpcz}/Shisal1^{em1(IMPC)Ccpcz} (C57BL/6N-Shisal1^{em1(IMPC)Ccpcz}/Ccpcz)	increased fasting circulating glucose level	J:211773
Shld1^em1(IMPC)Mbp/Shld1^em1(IMPC)Mbp (C57BL/6NCrl-Shld1^em1(IMPC)Mbp/Mmucd)	impaired glucose tolerance	J:211773
Shld1^{em1(IMPC)Wtsi}/Shld1^{em1(IMPC)Wtsi} (C57BL/6N-Shld1^{em1(IMPC)Wtsi}/Wtsi)	increased circulating triglyceride level	J:211773
Shmt1^{tm1b(KOMP)Wtsi}/Shmt1^{tm1b(KOMP)Wtsi} (C57BL/6N-Shmt1^{tm1b(KOMP)Wtsi}/H)	increased circulating amylase level	J:211773
Shmt1^tm1Stov/Shmt1⁺ (involves: 129S7/SvEvBrd * C57BL/6)	decreased circulating cystathionine level	J:141998
Shmt1^tm1Stov/Shmt1^tm1Stov (involves: 129S7/SvEvBrd * C57BL/6)	decreased circulating cystathionine level	J:141998
	increased circulating cysteine level	J:141998
sho/sho (Not Specified)	cyanosis	J:255
Shoc2^tm1.1Mhan/Shoc2^tm1.2Mhan Tg(Tek-cre)#Xya/0 (involves: 129S6/SvEvTac * BALB/c * C57BL/6 * Kunming)	skin edema	J:161211
Shox2^tm1Acgg/Shox2^tm1Acgg (involves: 129 * C57BL/6)	pericardial edema	J:135454
Shroom2^em1(IMPC)Mbp/Y (C57BL/6NCrl-Shroom2^em1(IMPC)Mbp/Mmucd)	increased circulating alkaline phosphatase level	J:211773
Sidt2^{em1(IMPC)Wtsi}/Sidt2^{em1(IMPC)Wtsi} (C57BL/6N-Sidt2^{em1(IMPC)Wtsi}/Wtsi)	decreased circulating calcium level	J:211773
	decreased circulating cholesterol level	J:211773
	decreased circulating glycerol level	J:211773
	decreased circulating HDL cholesterol level	J:211773
	decreased circulating iron level	J:211773
	decreased circulating LDL cholesterol level	J:211773
	decreased circulating total protein level	J:211773
	increased circulating amylase level	J:211773
	increased circulating aspartate transaminase level	J:211773
Sidt2^tm1.1Hzha/Sidt2^tm1.1Hzha (involves: 129S6/SvEvTac * C57BL/6J)	abnormal insulin secretion	J:204228
	decreased circulating insulin level	J:204228
	impaired glucose tolerance	J:204228
	increased circulating alanine transaminase level	J:236042
	increased circulating aspartate transaminase level	J:236042
	increased circulating glucose level	J:204228
	increased circulating triglyceride level	J:236042
	increased liver free fatty acids level	J:236042
	increased liver triglyceride level	J:236042
Siglec1^tm1Croc/Siglec1^tm1Croc (B6.129-Siglec1^tm1Croc)	decreased circulating interleukin-6 level	J:189854
Siglec1^tm1Croc/Siglec1^tm1Croc (B6.129-Siglec1^tm1Croc)	decreased circulating tumor necrosis factor level	J:189854
Siglec1^tm2.1Croc/Siglec1^tm2.1Croc (B6.129P2(C)-Siglec1^tm2.1Croc)	decreased circulating interleukin-6 level	J:189854
	decreased circulating tumor necrosis factor level	J:189854
Siglec15^tm1Yohi/Siglec15^tm1Yohi (B6.129S6-Siglec15^tm1Yohi)	abnormal urine homeostasis	J:193852
	increased circulating osteocalcin level	J:193852
Siglece^{tm1.1(SIGLEC16)Avrk}/Siglece^{tm1.1(SIGLEC16)Avrk} (involves: C57BL/6)	abnormal cytokine level	J:264224
	increased circulating interleukin-6 level	J:264224
	increased circulating interleukin-12 level	J:264224
Siglech^tm1.1Cfg/Siglech^tm1.1Cfg (involves: C57BL/6)	increased blood urea nitrogen level	J:217719
Siglech^tm1.1Ksat/Siglech^tm1.1Ksat (B6.Cg-Siglech^tm1.1Ksat)	abnormal circulating cytokine level	J:179283
	decreased circulating interferon-alpha level	J:179283
	decreased circulating interleukin-12b level	J:179283
	increased circulating interferon-alpha level	J:179283
	increased circulating interleukin-12b level	J:179283
Sik1^{tm1.1(KOMP)Vlcg}/Sik1^{tm1.1(KOMP)Vlcg} (C57BL/6N-Sik1^{tm1.1(KOMP)Vlcg}/Ucd)	decreased circulating cholesterol level	J:211773
	decreased circulating serum albumin level	J:211773
	decreased circulating total protein level	J:211773
	increased circulating alkaline phosphatase level	J:211773
Sik1^tm1.2Berd/Sik1^tm1.2Berd (involves: 129S7/SvEvBrd * C57BL/6 * C57BL/6J * SJL)	abnormal glucose homeostasis	J:236223
	decreased circulating glucose level	J:236223
	increased circulating insulin level	J:236223
	increased insulin sensitivity	J:236223
Sik2^tm1Lex/Sik2^tm1Lex (involves: 129S/SvEvBrd)	decreased circulating adiponectin level	J:229999
	decreased energy expenditure	J:229999
	decreased fatty acid oxidation	J:229999
	decreased respiratory quotient	J:229999
	enhanced lipolysis	J:229999
	impaired glucose tolerance	J:229999
	increased circulating glucose level	J:229999
	increased circulating insulin level	J:229999
	increased circulating triglyceride level	J:229999
	insulin resistance	J:229999
Sik3^{tm1a(EUCOMM)Hmgu}/Sik3^{tm1a(EUCOMM)Hmgu} (C57BL/6N-Sik3^{tm1a(EUCOMM)Hmgu}/Wtsi)	decreased blood urea nitrogen level	J:211773
	decreased circulating calcium level	J:211773
	decreased circulating cholesterol level	J:211773
	decreased circulating fructosamine level	J:211773
	decreased circulating glucose level	J:211773
	decreased circulating HDL cholesterol level	J:211773
	decreased circulating potassium level	J:211773
	improved glucose tolerance	J:211773
	increased circulating alkaline phosphatase level	J:211773
	increased circulating amylase level	J:211773
	increased circulating bilirubin level	J:211773
	increased circulating sodium level	J:211773
Sik3^tm1Htake/Sik3^tm1Htake (involves: C57BL/6JJcl * C57BL/6N)	abnormal cholesterol level	J:183827
	abnormal circulating hormone level	J:183827
	abnormal circulating protein level	J:183827
	abnormal energy homeostasis	J:183827
	abnormal glucose homeostasis	J:183827
	abnormal homeostasis	J:183827
	abnormal lipid homeostasis	J:183827
	abnormal retinol level	J:183827
	decreased circulating alanine transaminase level	J:183827
	decreased circulating cholesterol level	J:183827
	decreased circulating glucose level	J:183827
	decreased circulating HDL cholesterol level	J:183827
	decreased circulating insulin level	J:183827
	decreased circulating leptin level	J:183827
	decreased circulating triglyceride level	J:183827
	decreased circulating VLDL triglyceride level	J:183827
	decreased liver cholesterol level	J:183827
	decreased liver triglyceride level	J:183827
	decreased susceptibility to diet-induced obesity	J:183827
	improved glucose tolerance	J:183827
	increased adiponectin level	J:183827
	increased bile salt level	J:183827
	increased circulating alanine transaminase level	J:183827
	increased circulating alkaline phosphatase level	J:183827
	increased circulating bilirubin level	J:183827
	increased circulating triglyceride level	J:183827
	increased core body temperature	J:183827
	increased liver cholesterol level	J:183827
	increased oxygen consumption	J:183827
	increased respiratory quotient	J:183827
Sim1^Rgsc646/Sim1⁺ (involves: C57BL/6JJcl * DBA/2JJcl)	hyperglycemia	J:133634
	increased circulating insulin level	J:133634
	increased glycosylated hemoglobin level	J:133634
	increased urine glucose level	J:133634
	insulin resistance	J:133634
Sim1^tm1.1Az/Sim1⁺ (involves: 129X1/SvJ * C57BL/6 * FVB)	abnormal energy homeostasis	J:95410
	increased circulating glucose level	J:95410
	increased circulating insulin level	J:95410
	increased circulating leptin level	J:95410
	increased susceptibility to diet-induced obesity	J:95410
Sim1^tm1Fan/Sim1⁺ (involves: 129/Sv * C57BL/6)	abnormal glucose homeostasis	J:70586
Sim1^tm1Fan/Sim1⁺ (involves: 129/Sv * C57BL/6)	increased circulating insulin level	J:70586
Sim2^tm1Shmb/Sim2^tm1Shmb (involves: 129S4/SvJae * C57BL/6J)	increased hyaluronic acid level	J:78252
Sinhcaf^{em1(IMPC)Ccpcz}/Sinhcaf⁺ (C57BL/6N-Sinhcaf^{em1(IMPC)Ccpcz}/Ccpcz)	increased blood urea nitrogen level	J:211773
Sirpa^{tm1b(EUCOMM)Hmgu}/Sirpa^{tm1b(EUCOMM)Hmgu} (C57BL/6N-Sirpa^{tm1b(EUCOMM)Hmgu}/Bay)	decreased blood urea nitrogen level	J:211773
	impaired glucose tolerance	J:211773
Sirpb1a^{em1(IMPC)Wtsi}/Sirpb1a^{em1(IMPC)Wtsi} (C57BL/6N-Sirpb1a^{em1(IMPC)Wtsi}/Wtsi)	increased circulating alanine transaminase level	J:211773
Sirt1^tm1.2Cxd/Sirt1^tm1.2Cxd Tg(Alb1-cre)1Dlr/? (involves: 129S6/SvEvTac * FVB/N)	increased circulating free fatty acids level	J:179193
	increased circulating triglyceride level	J:179193
	increased liver triglyceride level	J:179193
Sirt1^tm1Mcby/Sirt1^tm1Mcby (involves: 129)	pulmonary edema	J:81010
Sirt1^tm1Mcby/Sirt1^tm1Mcby (involves: 129S1/Sv * 129X1/SvJ * CD-1)	abnormal glucose tolerance	J:133127
	decreased circulating thyroxine level	J:133127
	decreased urine osmolality	J:160869
	increased insulin secretion	J:133127
	increased oxygen consumption	J:133127
	increased urine antidiuretic hormone level	J:160869
	pulmonary edema	J:81010
Sirt1^tm1Mcby/Sirt1^tm1Mcby (129/Sv-Sirt1^tm1Mcby)	decreased circulating follicle stimulating hormone level	J:146009
Sirt1^tm1Mcby/Sirt1^tm1Mcby (129/Sv-Sirt1^tm1Mcby)	decreased circulating luteinizing hormone level	J:146009
Sirt1^tm2.1Mcby/Sirt1^tm2.1Mcby (involves: 129S1/Sv * 129X1/SvJ * CD-1)	abnormal energy expenditure	J:180628
	abnormal glucose homeostasis	J:180628
	abnormal glucose tolerance	J:180628
	decreased circulating insulin level	J:180628
	decreased respiratory quotient	J:180628
	increased oxygen consumption	J:180628
Sirt1^tm3Fwa/Sirt1^tm3Fwa Tg(Nes-cre)1Kln/0 (involves: 129S6/SvEvTac * C57BL/6 * SJL)	abnormal circulating hormone level	J:155802
	decreased circulating glucose level	J:155802
	decreased circulating growth hormone level	J:155802
	decreased circulating insulin level	J:155802
	decreased circulating insulin-like growth factor I level	J:155802
	impaired glucose tolerance	J:155802
	increased circulating prolactin level	J:155802
	increased insulin sensitivity	J:155802
Sirt2^{tm1a(EUCOMM)Wtsi}/Sirt2^{tm1a(EUCOMM)Wtsi} (C57BL/6N-Sirt2^{tm1a(EUCOMM)Wtsi}/H)	increased circulating cholesterol level	J:165965
Sirt3^tm1.1Fwa/Sirt3^tm1.1Fwa (involves: 129S6/SvEvTac)	abnormal cytokine level	J:178653
	abnormal enzyme/coenzyme level	J:178653
	abnormal lipid homeostasis	J:178653
	decreased carbon dioxide production	J:178653
	decreased oxygen consumption	J:178653
	hyperglycemia	J:178653
	increased circulating cholesterol level	J:178653
	increased circulating insulin level	J:178653
	increased circulating interferon-gamma level	J:178653
	increased circulating interleukin-6 level	J:178653
	increased circulating interleukin-10 level	J:178653
	increased circulating interleukin-12 level	J:178653
	increased circulating LDL cholesterol level	J:178653
	increased circulating triglyceride level	J:178653
	increased circulating tumor necrosis factor level	J:178653
	increased circulating VLDL cholesterol level	J:178653
	increased liver cholesterol level	J:178653
	increased liver triglyceride level	J:178653
	increased susceptibility to diet-induced obesity	J:178653
	insulin resistance	J:178653
Sirt3^{tm1b(EUCOMM)Wtsi}/Sirt3^{tm1b(EUCOMM)Wtsi} (C57BL/6N-Sirt3^{tm1b(EUCOMM)Wtsi}/H)	increased circulating alanine transaminase level	J:211773
	increased circulating creatine kinase level	J:211773
Sirt4^{tm1b(EUCOMM)Hmgu}/Sirt4^{tm1b(EUCOMM)Hmgu} (C57BL/6N-Sirt4^{tm1b(EUCOMM)Hmgu}/H)	increased circulating fructosamine level	J:211773
	increased circulating serum albumin level	J:211773
	increased circulating total protein level	J:211773
Sirt5^tm1.1Ics/Sirt5^tm1.1Ics (Not Specified)	abnormal homeostasis	J:177830
Sirt6^tm1.1Cxd/Sirt6^tm1.1Cxd Tg(Alb1-cre)1Dlr/0 (involves: 129S6/SvEvTac * FVB/N)	increased circulating glucose level	J:166368
Sirt6^{tm1a(EUCOMM)Wtsi}/Sirt6⁺ (C57BL/6N-Sirt6^{tm1a(EUCOMM)Wtsi}/H)	increased circulating cholesterol level	J:165965
Sirt6^tm1Fwa/Sirt6^tm1Fwa (involves: 129S6/SvEvTac * 129X1/SvJ)	decreased circulating glucose level	J:112817
	decreased circulating insulin-like growth factor I level	J:112817
Sirt6^tm1Fwa/Sirt6^tm1Fwa (involves: 129S6/SvEvTac * BALB/cJ)	decreased circulating insulin level	J:247143
	impaired glucose tolerance	J:247143
Sirt6^tm2.1Cxd/Sirt6^tm2.1Cxd (involves: 129S6/SvEvTac * NIH Black Swiss)	abnormal glucose homeostasis	J:167023
	decreased circulating glucose level	J:167023
	decreased circulating insulin level	J:167023
	hypoglycemia	J:167023
	increased insulin sensitivity	J:167023
Sirt6^tm2.2Cxd/Sirt6^tm2.2Cxd (involves: 129S6/SvEvTac * FVB/N * NIH Black Swiss)	abnormal glucose homeostasis	J:167023
	decreased circulating glucose level	J:167023
	decreased circulating insulin level	J:167023
	hypoglycemia	J:167023
	increased insulin sensitivity	J:167023
Sirt6^tm2.2Cxd/Sirt6^tm2.2Cxd Trp53^tm1Brd/Trp53^tm1Brd (involves: 129S6/SvEvTac * 129S7/SvEvBrd * FVB/N * NIH Black Swiss)	decreased circulating glucose level	J:167023
Sirt7^tm1Evbo/Sirt7^tm1Evbo (involves: 129/Sv * C57BL/6)	abnormal cytokine level	J:147652
Sirt7^tm1Fwa/Sirt7^tm1Fwa (involves: 129S1/Sv)	abnormal lipid homeostasis	J:205529
	decreased circulating triglyceride level	J:205529
	decreased circulating VLDL triglyceride level	J:205529
	increased liver triglyceride level	J:205529
Sis^em1(IMPC)J/Sis^em1(IMPC)J (C57BL/6NJ-Sis^em1(IMPC)J)	decreased circulating glucose level	J:344683
	decreased liver triglyceride level	J:344683
	increased fatty acids level	J:344683
Siva1^{tm1b(EUCOMM)Hmgu}/Siva1^{tm1b(EUCOMM)Hmgu} (C57BL/6N-Siva1^{tm1b(EUCOMM)Hmgu}/Ieg)	increased fasting circulating glucose level	J:211773
Six1^em1(IMPC)Mbp/Six1⁺ (C57BL/6N-Six1^em1(IMPC)Mbp/MbpMmucd)	decreased circulating calcium level	J:211773
	edema	J:211773
Six1^em1(IMPC)Mbp/Six1^em1(IMPC)Mbp (C57BL/6N-Six1^em1(IMPC)Mbp/MbpMmucd)	edema	J:211773
Six5^tm1Rdd/Six5⁺ (129S4/SvJae-Six5^tm1Rdd)	increased circulating follicle stimulating hormone level	J:91207
Six5^tm1Rdd/Six5^tm1Rdd (129S4/SvJae-Six5^tm1Rdd)	increased circulating follicle stimulating hormone level	J:91207
Six6^tm1Rsd/Six6^tm1Rsd (involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)	abnormal protein level	J:168233
	decreased circulating follicle stimulating hormone level	J:168233
Ska2^{tm1b(KOMP)Wtsi}/Ska2⁺ (C57BL/6N-Ska2^{tm1b(KOMP)Wtsi}/J)	decreased circulating free fatty acids level	J:211773
	decreased circulating triglyceride level	J:211773
	increased circulating alanine transaminase level	J:211773
	increased circulating alkaline phosphatase level	J:211773
	increased circulating bilirubin level	J:211773
	increased circulating HDL cholesterol level	J:211773
skc37/skc37 (Not Specified)	abnormal homeostasis	J:89098
skc38/skc38 (Not Specified)	abnormal homeostasis	J:89098
Skic2^{tm2b(EUCOMM)Wtsi}/Skic2⁺ (C57BL/6N-Skic2^{tm2b(EUCOMM)Wtsi}/Bay)	decreased circulating chloride level	J:211773
	increased circulating total protein level	J:211773
Skic3^em1(IMPC)Tcp/Skic3⁺ (C57BL/6NCrl-Skic3^em1(IMPC)Tcp/Tcp)	increased circulating potassium level	J:211773
Skida1^{tm1(KOMP)Wtsi}/Skida1⁺ (C57BL/6N-Skida1^{tm1(KOMP)Wtsi}/Wtsi)	increased circulating thyroxine level	J:211773
skimp/skimp (involves: C3H/HeH)	decreased circulating glucose level	J:77535
	decreased circulating ketone body level	J:77535
	decreased glycogen level	J:77535
Skor1^em1(IMPC)J/Skor1⁺ (C57BL/6NJ-Skor1^em1(IMPC)J/Mmjax)	decreased circulating bilirubin level	J:211773
	decreased circulating phosphate level	J:211773
	increased circulating glucose level	J:211773
Sla2^{em1(IMPC)Ccpcz}/Sla2^{em1(IMPC)Ccpcz} (C57BL/6N-Sla2^{em1(IMPC)Ccpcz}/Ccpcz)	increased circulating cholesterol level	J:211773
	increased circulating HDL cholesterol level	J:211773
	increased circulating total protein level	J:211773
Slain2^em1(IMPC)J/Slain2⁺ (C57BL/6NJ-Slain2^em1(IMPC)J/Mmjax)	decreased circulating bilirubin level	J:211773
	decreased circulating cholesterol level	J:211773
	decreased circulating triglyceride level	J:211773
Slamf6^tm1Dhow/Slamf6^tm1Dhow (involves: 129/Sv * C57BL/6)	increased circulating interleukin-12b level	J:98995
	increased circulating interleukin-16 level	J:98995
	increased circulating tumor necrosis factor level	J:98995
Slbp^{tm1.1(KOMP)Vlcg}/Slbp⁺ (C57BL/6N-Slbp^{tm1.1(KOMP)Vlcg}/J)	increased circulating aspartate transaminase level	J:211773
	increased circulating bilirubin level	J:211773
Slc1a1^{tm1b(KOMP)Wtsi}/Slc1a1^{tm1b(KOMP)Wtsi} (C57BL/6N-Slc1a1^{tm1b(KOMP)Wtsi}/J)	increased circulating iron level	J:211773
	increased circulating sodium level	J:211773
Slc1a1^tm1Wst/Slc1a1^tm1Wst (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	dicarboxylic aciduria	J:41613
Slc1a1^tm1Wst/Slc1a1^tm1Wst (B6.129-Slc1a1^tm1Wst)	increased lactate dehydrogenase level	J:124191
Slc1a2^tm1Kta/Slc1a2^tm1Kta (involves: 129P2/OlaHsd * C57BL/6)	cerebral edema	J:40984
Slc1a3^tm1Kta/Slc1a3^tm1Kta (B6.129P2-Slc1a3^tm1Kta)	increased lactate dehydrogenase level	J:124191
Slc1a4^{tm1e(KOMP)Wtsi}/Slc1a4^{tm1e(KOMP)Wtsi} (C57BL/6N-Slc1a4^{tm1e(KOMP)Wtsi}/Wtsi)	decreased circulating serum albumin level	J:211773
	improved glucose tolerance	J:211773
Slc2a1^tm1Dcdv/Slc2a1⁺ (involves: 129S6/SvEvTac * C57BL/6J)	abnormal glucose homeostasis	J:108250
Slc2a2^{tm1b(KOMP)Wtsi}/Slc2a2⁺ (C57BL/6N-Slc2a2^{tm1b(KOMP)Wtsi}/Rbrc)	increased fasting circulating glucose level	J:211773
	increased glycosylated hemoglobin level	J:211773
Slc2a2^tm1Thor/Slc2a2^tm1Thor (involves: 129P2/OlaHsd * C57BL/6J)	abnormal glucose homeostasis	J:43839
	abnormal glucose tolerance	J:43839
	abnormal lipid homeostasis	J:43839
	decreased circulating insulin level	J:43839
	hyperglycemia	J:43839
	increased blood osmolality	J:43839
	increased circulating glucagon level	J:43839
	increased fatty acids level	J:43839
Slc2a2^tm1Thor/Slc2a2^tm1Thor Tg(Ins1-SLC2A1)1Thor/0 (involves: 129P2/OlaHsd * C57BL/6)	impaired adaptive thermogenesis	J:162050
Slc2a4^tm1Abel/Slc2a4^tm1Abel Tg(Ckmm-cre)5Khn/? (involves: 129/Sv * C57BL/6)	abnormal circulating glucose level	J:75418
	abnormal glucose tolerance	J:75418
	abnormal lipid homeostasis	J:75418
	abnormal lipid level	J:75418
	decreased fatty acids level	J:75418
	decreased triglyceride level	J:75418
	hyperglycemia	J:75418
	increased liver glycogen level	J:75418
	insulin resistance	J:75418
Slc2a4^tm1Abel/Slc2a4^tm1Abel Tg(Ckmm-cre)5Khn/0 (involves: 129S4/SvJae * FVB)	abnormal glucose homeostasis	J:110773
	abnormal lipid homeostasis	J:110773
	increased circulating glucose level	J:110773
	increased circulating insulin level	J:110773
Slc2a4^tm1Abel/Slc2a4^tm1Abel Tg(Fabp4-cre)1Abel/? (involves: 129S4/SvJae * FVB)	abnormal glucose homeostasis	J:67292
	abnormal glucose tolerance	J:67292
	abnormal glycogen homeostasis	J:67292
	insulin resistance	J:67292
Slc2a4^tm1Abel/Slc2a4^tm1Abel Tg(Myhca-cre)1Abel/? (involves: 129S4/SvJae * FVB)	abnormal glucose homeostasis	J:59054
	abnormal glucose tolerance	J:59054
Slc2a4^tm1Abel/Slc2a4^tm1Abel Tg(Myhca-cre)1Abel/? (involves: 129S4/SvJae * C57BL/6 * FVB)	increased cardiac muscle glycogen level	J:108830
Slc2a4^tm1Jdz/Slc2a4^tm1Jdz (involves: 129S1/Sv * C57BL/6)	increased circulating glucose level	J:123335
Slc2a4^tm1Jdz/Slc2a4^tm1Jdz (involves: 129S1/Sv * C57BL/6)	increased circulating insulin level	J:123335
Slc2a4^tm1Jdz/Slc2a4^tm1Jdz Tg(ACTA1-cre)1Jdz/0 (involves: 129S1/Sv * C57BL/6 * CBA)	increased circulating glucose level	J:123335
	increased circulating insulin level	J:123335
Slc2a4^tm1Mch/Slc2a4⁺ (involves: 129/Sv * C57BL/6J * CD-1 * SJL)	abnormal glucose homeostasis	J:43935
	abnormal glycogen homeostasis	J:43935
	hyperglycemia	J:43650
	increased circulating insulin level	J:43935, J:43650
	insulin resistance	J:43935, J:43650
Slc2a4^tm1Mch/Slc2a4⁺ (involves: 129/Sv * C57BL/6 * SJL)	impaired glucose tolerance	J:97234
Slc2a4^tm1Mch/Slc2a4⁺ (involves: 129/Sv * C57BL/6 * SJL)	increased insulin secretion	J:97234
Slc2a4^tm1Mch/Slc2a4^tm1Mch (involves: 129/Sv * C57BL/6 * C57BL/6J * CD-1 * SJL)	abnormal circulating glucose level	J:49328
	decreased circulating free fatty acids level	J:49328
	decreased circulating ketone body level	J:49328
	increased circulating insulin level	J:49328
	insulin resistance	J:49328
Slc2a4^tm1Mch/Slc2a4^tm1Mch (involves: 129/Sv * C57BL/6 * C57BL/6J * SJL)	decreased skeletal muscle glycogen level	J:75600
Slc2a4^tm1Mch/Slc2a4^tm1Mch (involves: C57BL/6 * CBA)	abnormal glucose homeostasis	J:69914
Slc2a6^em1Kusu/Slc2a6^em1Kusu (involves: C57BL/6JCrlj)	increased circulating tumor necrosis factor level	J:270487
Slc2a6^em1Rbr/Slc2a6^em1Rbr (C57BL/6J-Slc2a6^em1Rbr)	decreased respiratory quotient	J:266077
Slc2a8^tm1Khm/Slc2a8^tm1Khm (involves: 129X1/SvJ)	abnormal blood homeostasis	J:189148
	abnormal homeostasis	J:189148
	increased circulating cholesterol level	J:189148
	increased circulating insulin level	J:189148
	increased circulating LDL cholesterol level	J:189148
Slc2a9^tm1.1Thor/Slc2a9⁺ Alb^{tm1(cre/ERT2)Mtz}/Alb⁺ (involves: 129S2/SvPas * C57BL/6 * C57BL/6N)	increased urine magnesium level	J:153089
	increased urine phosphate level	J:153089
Slc2a9^tm1.1Thor/Slc2a9^tm1.1Thor Alb^{tm1(cre/ERT2)Mtz}/Alb⁺ (involves: 129S2/SvPas * C57BL/6 * C57BL/6N)	decreased urine osmolality	J:153089
	decreased urine pH	J:153089
	increased blood uric acid level	J:153089
	increased urine magnesium level	J:153089
	increased urine phosphate level	J:153089
	increased urine potassium level	J:153089
	uraturia	J:153089
Slc2a9^tm1.2Thor/Slc2a9⁺ (involves: C57BL/6 * C57BL/6N)	increased circulating magnesium level	J:153089
Slc2a9^tm1.2Thor/Slc2a9⁺ (involves: C57BL/6 * C57BL/6N)	increased urine sodium level	J:153089
Slc2a9^tm1.2Thor/Slc2a9^tm1.2Thor (involves: C57BL/6 * C57BL/6N)	decreased urine osmolality	J:153089
	decreased urine pH	J:153089
	increased blood uric acid level	J:153089
	increased circulating creatinine level	J:153089
	increased circulating magnesium level	J:153089
	increased urine magnesium level	J:153089
	increased urine potassium level	J:153089
	increased urine sodium level	J:153089
	uraturia	J:153089
Slc2a9^tm1Khm/Slc2a9^tm1Khm Tg(Vil1-cre)997Gum/0 (involves: 129 * C57BL/6 * C57BL/6J)	abnormal circulating lipid level	J:221544
	decreased respiratory quotient	J:221544
	increased blood uric acid level	J:221544
	increased circulating cholesterol level	J:221544
	increased circulating free fatty acids level	J:221544
	increased circulating insulin level	J:221544
	increased circulating triglyceride level	J:221544
	increased energy expenditure	J:221544
	increased liver free fatty acids level	J:221544
	increased liver triglyceride level	J:221544
	increased oxygen consumption	J:221544
	increased urine uric acid level	J:221544
	insulin resistance	J:221544
Slc2a13^em1(IMPC)Mbp/Slc2a13^em1(IMPC)Mbp (C57BL/6NCrl-Slc2a13^em1(IMPC)Mbp/Mmucd)	impaired glucose tolerance	J:211773
Slc3a1^m1Crl/Slc3a1^m1Crl (129S2/SvPasCrl)	aminoaciduria	J:219017
	argininuria	J:219017
	cystinuria	J:219017
	increased circulating creatinine level	J:219017
	lysinuria	J:219017
	ornithinuria	J:219017
Slc3a1^pbl/Slc3a1^pbl (C3HeB/FeJ-Slc3a1^pbl)	aminoaciduria	J:85461
	argininuria	J:85461
	crystalluria	J:85461
	increased circulating cholesterol level	J:85461
	increased circulating creatinine level	J:85461
	increased circulating LDL cholesterol level	J:85461
	lysinuria	J:85461
	ornithinuria	J:85461
	uremia	J:85461
Slc3a1^pbl/Slc3a1^pbl (involves: C3HeB/FeJ * MRL/MpJ)	abnormal urine amino acid level	J:85461
	crystalluria	J:85461
	increased circulating cholesterol level	J:85461
	increased circulating LDL cholesterol level	J:85461
Slc3a1^{tm1.1(KOMP)Vlcg}/Slc3a1^{tm1.1(KOMP)Vlcg} (C57BL/6N-Slc3a1^{tm1.1(KOMP)Vlcg}/Ucd)	increased blood urea nitrogen level	J:211773
	increased circulating alkaline phosphatase level	J:211773
	increased circulating cholesterol level	J:211773
	increased circulating HDL cholesterol level	J:211773
Slc3a1^tm1Jat/Slc3a1^tm1Jat (involves: 129 * C57BL/6)	cystinuria	J:254981, J:254803
Slc4a1^tm1Llp/Slc4a1^tm1Llp (involves: 129S4/SvJae * C57BL/6J)	abnormal blood homeostasis	J:148154
	abnormal urine homeostasis	J:148154
	acidemia	J:148154
	decreased circulating bicarbonate level	J:148154
	decreased urine osmolality	J:148154
	dehydration	J:148154
	increased blood osmolality	J:148154
	increased blood urea nitrogen level	J:148154
	increased circulating chloride level	J:148154
	increased circulating phosphate level	J:148154
	increased urine calcium level	J:148154
	increased urine pH	J:148154
	metabolic acidosis	J:148154
Slc4a3^tm1Cahb/Slc4a3^tm1Cahb (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	abnormal pH regulation	J:104157
Slc4a3^tm1Ges/Slc4a3^tm1Ges Tg(Myh6-Tpm1E180G)57Dfw/0 (involves: 129X1/SvJ FVB/N)	abnormal calcium ion homeostasis	J:171021
	edema	J:171021
Slc4a4^tm1.1Slin/Slc4a4⁺ (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	acidemia	J:186877
	acidosis	J:186877
Slc4a4^tm1.1Slin/Slc4a4^tm1.1Slin (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	abnormal blood homeostasis	J:186877
	abnormal urine homeostasis	J:186877
	acidemia	J:186877
	acidosis	J:186877
	decreased urine osmolality	J:186877
	decreased urine pH	J:186877
	edema	J:186877
	increased circulating aldosterone level	J:186877
	increased circulating calcium level	J:186877
	increased circulating renin level	J:186877
	increased urine calcium level	J:186877
	increased urine sodium level	J:186877
	metabolic acidosis	J:186877
	renal tubular acidosis	J:186877
	uremia	J:186877
Slc4a4^tm1Ges/Slc4a4⁺ (involves: 129S6/SvEvTac * Black Swiss)	abnormal ammonia homeostasis	J:279694
	decreased circulating bicarbonate level	J:279694, J:120867
	decreased urine ammonia level	J:279694
	decreased urine pH	J:279694
	metabolic acidosis	J:279694
Slc4a4^tm1Ges/Slc4a4^tm1Ges (involves: 129S6/SvEvTac * Black Swiss)	abnormal ammonia homeostasis	J:279694
	abnormal ion homeostasis	J:120867
	acidosis	J:120867
	decreased circulating bicarbonate level	J:279694, J:120867
	decreased circulating sodium level	J:120867
	decreased urine ammonia level	J:279694
	decreased urine pH	J:279694
	increased circulating aldosterone level	J:120867
	metabolic acidosis	J:279694
Slc4a5^tm1.1Boet/Slc4a5^tm1.1Boet (involves: 129 * C57BL/6)	abnormal blood homeostasis	J:180608
	abnormal urine homeostasis	J:180608
	decreased circulating aldosterone level	J:180608
	decreased circulating bicarbonate level	J:180608
	decreased circulating creatinine level	J:180608
	decreased circulating renin level	J:180608
	increased circulating atrial natriuretic factor	J:180608
	increased urine bicarbonate level	J:180608
	increased urine protein level	J:180608
	renal tubular acidosis	J:180608
Slc4a7^{Gt(RRL021)Byg}/Slc4a7^{Gt(RRL021)Byg} (involves: 129P2/OlaHsd * C57BL/6)	abnormal pH regulation	J:132199
Slc4a10^tm1.1Cahb/Slc4a10^tm1.1Cahb (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	abnormal pH regulation	J:131058
Slc4a11^tm1.1Jrcy/Slc4a11^tm1.1Jrcy (involves: C57BL/6)	abnormal urine homeostasis	J:214272
	decreased urine calcium level	J:214272
	decreased urine chloride ion level	J:214272
	decreased urine creatine level	J:214272
	decreased urine magnesium level	J:214272
	decreased urine osmolality	J:214272
	decreased urine potassium level	J:214272
	decreased urine sodium level	J:214272
	edema	J:202267, J:214272
Slc4a11^tm1Boet/Slc4a11^tm1Boet (involves: 129 * C57BL/6)	decreased urine osmolality	J:162968
	increased urine chloride ion level	J:162968
	increased urine magnesium level	J:162968
	increased urine potassium level	J:162968
	increased urine sodium level	J:162968
Slc5a1^{Gt(OST315271)Lex}/Slc5a1^{Gt(OST315271)Lex} (involves: 129S5/SvEvBrd * C57BL/6J)	abnormal circulating glucose level	J:195941
	abnormal glucose homeostasis	J:195941
	decreased circulating insulin level	J:195941
	improved glucose tolerance	J:195941
Slc5a1^{Gt(OST315271)Lex}/Slc5a1^{Gt(OST315271)Lex} Slc5a2^tm1Lex/Slc5a2^tm1Lex (involves: 129S5/SvEvBrd * C57BL/6J)	abnormal urine homeostasis	J:195941
	decreased circulating glucose level	J:195941
	decreased circulating insulin level	J:195941
	improved glucose tolerance	J:195941
	increased urine chloride ion level	J:195941
	increased urine glucose level	J:195941
	increased urine magnesium level	J:195941
	increased urine potassium level	J:195941
	increased urine sodium level	J:195941
	increased urine urea nitrogen level	J:195941
Slc5a1^tm1.1Koep/Slc5a1^tm1.1Koep (B6.129P2-Slc5a1^tm1.1Koep)	abnormal circulating hormone level	J:186790
	abnormal renal glucose reabsorption	J:186790
	decreased circulating glucose level	J:186790
	decreased circulating insulin level	J:186790
	increased urine glucose level	J:186790
Slc5a2^tm1Lex/Slc5a2^tm1Lex (B6.129S5-Slc5a2^tm1Lex)	abnormal renal glucose reabsorption	J:169917
	decreased circulating aldosterone level	J:169917
	decreased urine osmolality	J:169917
	increased urine glucose level	J:169917
Slc5a2^tm1Lex/Slc5a2^tm1Lex (involves: 129S5/SvEvBrd * C57BL/6J)	abnormal blood homeostasis	J:195941
	abnormal circulating glucose level	J:195941
	abnormal urine homeostasis	J:195941
	decreased circulating glucose level	J:195941
	decreased circulating insulin level	J:195941
	decreased circulating phosphate level	J:195941
	improved glucose tolerance	J:195941
	increased circulating chloride level	J:195941
	increased circulating sodium level	J:195941
	increased urine chloride ion level	J:195941
	increased urine creatinine level	J:195941
	increased urine glucose level	J:195941
	increased urine magnesium level	J:195941
	increased urine phosphate level	J:195941
	increased urine potassium level	J:195941
	increased urine sodium level	J:195941
	increased urine urea nitrogen level	J:195941
Slc5a3^tm1Gtb/Slc5a3⁺ (involves: 129X1/SvJ)	abnormal amniotic fluid composition	J:83591
Slc5a3^tm1Gtb/Slc5a3⁺ (involves: 129X1/SvJ)	abnormal homeostasis	J:83591
Slc5a3^tm1Gtb/Slc5a3^tm1Gtb (involves: 129X1/SvJ)	abnormal amniotic fluid composition	J:83591
	abnormal homeostasis	J:83591
	cyanosis	J:83591
Slc5a3^tm1Skc/Slc5a3^tm1Skc (involves: 129S7/SvEvBrd)	cyanosis	J:102665
Slc5a5^{tm1b(KOMP)Wtsi}/Slc5a5^{tm1b(KOMP)Wtsi} (C57BL/6N-Slc5a5^{tm1b(KOMP)Wtsi}/J)	decreased urine creatinine level	J:211773
	increased circulating alkaline phosphatase level	J:211773
	increased circulating cholesterol level	J:211773
	increased circulating HDL cholesterol level	J:211773
Slc5a5^{tm1d(KOMP)Wtsi}/Slc5a5^{tm1d(KOMP)Wtsi} (involves: C57BL/6 * FVB/N * SJL)	decreased circulating thyroxine level	J:250121
	decreased circulating triiodothyronine level	J:250121
	increased circulating thyroid-stimulating hormone level	J:250121
Slc5a6^tm1.1Said/Slc5a6^tm1.1Said Tg(Vil1-cre)997Gum/? (involves: C57BL/6)	abnormal vitamin absorption	J:194700
	abnormal vitamin level	J:194700
Slc5a7^{tm1a(KOMP)Wtsi}/Slc5a7⁺ (C57BL/6N-Slc5a7^{tm1a(KOMP)Wtsi}/Wtsi)	decreased circulating fructosamine level	J:211773
Slc5a7^tm1Rbl/Slc5a7^tm1Rbl (involves: 129S6/SvEvTac * C57BL/6)	cyanosis	J:90846
Slc5a8^tm1.1Boet/Slc5a8^tm1.1Boet (involves: C57BL/6)	abnormal urine homeostasis	J:139883
Slc5a10^tm1Csk/Slc5a10^tm1Csk (C57BL/6-Slc5a10^tm1Csk)	abnormal urine homeostasis	J:199406
	decreased circulating triglyceride level	J:199406
	increased circulating alanine transaminase level	J:199406
	increased circulating aspartate transaminase level	J:199406
	increased circulating insulin level	J:199406
	increased circulating lactate dehydrogenase level	J:199406
	increased circulating serum albumin level	J:199406
	increased liver triglyceride level	J:199406
Slc6a2^tm1.1Mkh/Slc6a2⁺ (B6.129S6-Slc6a2^tm1.1Mkh)	abnormal noradrenaline level	J:200046
Slc6a2^tm1.1Mkh/Slc6a2⁺ (B6.129S6-Slc6a2^tm1.1Mkh)	increased circulating noradrenaline level	J:200046
Slc6a2^tm1.1Mkh/Slc6a2^tm1.1Mkh (B6.129S6-Slc6a2^tm1.1Mkh)	abnormal noradrenaline level	J:200046
	increased circulating adrenaline level	J:200046
	increased dopamine level	J:200046
Slc6a2^{tm1b(EUCOMM)Hmgu}/Slc6a2⁺ (C57BL/6N-Slc6a2^{tm1b(EUCOMM)Hmgu}/H)	impaired glucose tolerance	J:211773
Slc6a2^tm1Mca/Slc6a2^tm1Mca (involves: 129S4/SvJaeSor * C57BL/6J)	decreased body temperature	J:61825
Slc6a2^tm1Mca/Slc6a2^tm1Mca (involves: 129S4/SvJaeSor)	abnormal noradrenaline level	J:66729
Slc6a3^tm1(cre)Lrsn/Slc6a3⁺ Tfam^tm1Lrsn/Tfam^tm1Lrsn (involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * SJL)	decreased dopamine level	J:119515
Slc6a3^tm1.1Jaja/Slc6a3^tm1.1Jaja (B6.129-Slc6a3^tm1.1Jaja)	decreased dopamine level	J:180517
Slc6a3^{tm1b(KOMP)Wtsi}/Slc6a3⁺ (C57BL/6N-Slc6a3^{tm1b(KOMP)Wtsi}/J)	increased circulating sodium level	J:211773
Slc6a3^tm1Hhg/Slc6a3^tm1Hhg (involves: 129X1/SvJ * C57BL/6J)	increased dopamine level	J:111041
Slc6a3^tm1Mca/Slc6a3^tm1Mca (involves: 129P2/OlaHsd)	decreased dopamine level	J:31328, J:59670, J:41856, J:79010
Slc6a3^tm1Rbl/Slc6a3^tm1Rbl (involves: 129S6/SvEvTac * C57BL/6J)	increased dopamine level	J:216661
	increased serotonin level	J:216661
Slc6a3^{tm2(HBEGF)Rpa}/Slc6a3⁺ (involves: C57BL/6)	decreased dopamine level	J:215916
Slc6a3^tm2(tTA)Xz/Slc6a3⁺ Tg(tetO-COX8A/PstI)1Ctm/0 (involves: 129X1/SvJ C57BL/6 * C57BL/6J * SJL)	abnormal noradrenaline level	J:178139
	decreased dopamine level	J:178139
	increased serotonin level	J:178139
Slc6a3^tm2(tTA)Xz/Slc6a3^tm3(tetO)Xz (involves: 129X1/SvJ * C57BL/6J)	increased dopamine level	J:144671
Slc6a3^tm2Mca/Slc6a3^tm2Mca (involves: 129S1/Sv * 129X1/SvJ)	increased dopamine level	J:67549
Slc6a3^tm4.1(tTA)Xz/Slc6a3⁺ Tg(tetO-SNCAA53T)E2Cai/0 (involves: 129S4/SvJaeSor 129S6/SvEvTac * C57BL/6)	decreased dopamine level	J:218892
Slc6a4^tm1Kpl/Slc6a4^tm1Kpl (involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)	decreased serotonin level	J:62768
Slc6a4^tm1Kpl/Slc6a4^tm1Kpl (involves: 129S1/Sv * 129X1/SvJ * CD-1)	abnormal body temperature homeostasis	J:59654
	decreased serotonin level	J:76020
Slc6a4^tm1Kpl/Slc6a4^tm1Kpl (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	decreased serotonin level	J:121505
Slc6a4^tm2.1Rbl/Slc6a4^tm2.1Rbl (involves: 129S4/SvJae * 129S6/SvEvTac)	increased serotonin level	J:202876
Slc6a6^em1(IMPC)Mbp/Slc6a6^em1(IMPC)Mbp (C57BL/6N-Slc6a6^em1(IMPC)Mbp/MbpMmucd)	decreased fasting circulating glucose level	J:211773
	increased blood urea nitrogen level	J:211773
	increased circulating phosphate level	J:211773
Slc6a6^tm1Dhau/Slc6a6^tm1Dhau (involves: 129X1/SvJ * C57BL/6J)	decreased circulating taurine level	J:74276
	decreased taurine level	J:74276
Slc6a8^tm1.1Clar/Y Tg(Camk2a-cre)2Gsc/0 (involves: C57BL/6 * C57BL/6J * FVB/N)	decreased creatine level	J:190081
	increased urine creatine level	J:190081
Slc6a8^tm1.1Lbar/Y Tg(Nes-cre)1Kln/0 (involves: 129 * C57BL/6 * C57BL/6J * C57BL/6N * SJL)	decreased creatine level	J:238578
Slc6a8^tm1.2Clar/Y (involves: BALB/cJ * C57BL/6 * C57BL/6J * SJL)	decreased circulating creatine level	J:169472
	decreased creatine level	J:169472
	increased serotonin level	J:169472
Slc6a8^tm1.2Lbar/Y (involves: 129 * 129S1/Sv * C57BL/6N)	decreased circulating creatine level	J:232606
	decreased creatine level	J:232606
	decreased urine creatine level	J:232606
Slc6a8^tm1.2Lbar/Y (involves: 129 * 129S1/Sv * C57BL/6J * C57BL/6N)	decreased creatine level	J:238578
Slc6a8^{tm1e(KOMP)Wtsi}/Y (involves: C57BL/6J * C57BL/6N)	abnormal ion homeostasis	J:264220
	decreased circulating glucose level	J:264220
	decreased creatine level	J:264220
	decreased fasting circulating glucose level	J:264220
	improved glucose tolerance	J:264220
Slc6a9^tm1Betz/Slc6a9^tm1Betz (involves: 129P2/OlaHsd * C57BL/6)	dehydration	J:86624
Slc6a13^tm1.2Ncd/Slc6a13^tm1.2Ncd (involves: 129S1/Sv * 129S4/SvJaeSor * 129S6/SvEvTac * C57BL/6)	decreased taurine level	J:191581
	increased taurine level	J:191581
Slc6a14^tm1Gana/Slc6a14^tm1Gana (Not Specified)	abnormal circulating chemokine level	J:226105
	abnormal circulating cytokine level	J:226105
	decreased circulating interleukin-1 alpha level	J:226105
	decreased circulating interleukin-4 level	J:226105
Slc6a14^tm1Gana/Slc6a14^tm1Gana Tg(MMTV-PyVT)634Mul/0 (Not Specified)	abnormal amino acid level	J:226105
Slc6a15^{em1(IMPC)Hmgu}/Slc6a15^{em1(IMPC)Hmgu} (C57BL/6N-Slc6a15^{em1(IMPC)Hmgu}/Ieg)	increased circulating lipase level	J:211773
Slc6a18^tm1Mca/Slc6a18^tm1Mca (involves: 129X1/SvJ * C57BL/6J)	hyperglycinuria	J:89891
Slc6a19^bucp/Slc6a19^bucp (A/J-Slc6a19^bucp/GrsrJ)	abnormal homeostasis	J:237831
Slc6a19^bucp/Slc6a19^bucp (A/J-Slc6a19^bucp/GrsrJ)	abnormal urine homeostasis	J:237831
Slc6a19^tm1Dgen/Slc6a19^tm1Dgen (involves: 129 * C57BL/6J)	aminoaciduria	J:175382
	decreased circulating insulin level	J:175382
	hyperthreoninuria	J:175382
	insulin resistance	J:175382
Slc7a2^{tm1b(EUCOMM)Hmgu}/Slc7a2^{tm1b(EUCOMM)Hmgu} (C57BL/6N-Slc7a2^{tm1b(EUCOMM)Hmgu}/BayMmucd)	decreased circulating fructosamine level	J:211773
	increased blood urea nitrogen level	J:211773
	increased circulating cholesterol level	J:211773
	increased circulating iron level	J:211773
Slc7a5^em1(IMPC)H/Slc7a5⁺ (C57BL/6NTac-Slc7a5^em1(IMPC)H/H)	increased circulating potassium level	J:211773
Slc7a5^tm1.1Daca/Slc7a5^tm1.1Daca Tg(Ckmm-cre)5Khn/? (involves: 129P2/OlaHsd * C57BL/6 * FVB/N)	abnormal amino acid level	J:213820
	insulin resistance	J:213820
Slc7a5^tm1.1Daca/Slc7a5^tm1.1Daca Tg(Tek-cre)12Flv/0 (B6J.Cg-Slc7a5^tm1.1Daca Tg(Tek-cre)12Flv)	abnormal amino acid level	J:238065
	increased phenylalanine level	J:238065
	increased serine level	J:238065
Slc7a7^em1Lbu/Slc7a7^em1Lbu (involves: 129/SvEv * C57BL/6)	aminoaciduria	J:293773
	argininuria	J:293773
	lysinuria	J:293773
Slc7a7^{Gt(OST41878)Lex}/Slc7a7^{Gt(OST41878)Lex} (B6.129S-Slc7a7^{Gt(OST41878)Lex})	aminoaciduria	J:125847
	increased circulating ammonia level	J:125847
Slc7a8^{tm2b(EUCOMM)Hmgu}/Slc7a8⁺ (C57BL/6N-Slc7a8^{tm2b(EUCOMM)Hmgu}/Bay)	decreased circulating fructosamine level	J:211773
Slc7a9^tm1Nune/Slc7a9⁺ (involves: 129P2/OlaHsd * C57BL/6J)	aminoaciduria	J:85462
	argininuria	J:85462
	cystinuria	J:85462
	lysinuria	J:85462
	ornithinuria	J:85462
Slc7a9^tm1Nune/Slc7a9^tm1Nune (involves: 129P2/OlaHsd * C57BL/6J)	abnormal circulating amino acid level	J:85462
	aminoaciduria	J:85462
	argininuria	J:85462
	crystalluria	J:85462
	cystinuria	J:85462
	hyperglutaminuria	J:85462
	lysinuria	J:85462
	ornithinuria	J:85462
Slc7a10^tm1Dgen/Slc7a10^tm1Dgen (involves: 129P2/OlaHsd * C57BL/6)	abnormal amino acid level	J:122880
Slc7a11^sut/Slc7a11^sut (C3H/HeSnJ-Slc7a11^sut/J)	decreased platelet serotonin level	J:31616
Slc7a11^sut/Slc7a11^sut (C3H/HeSnJ-Slc7a11^sut/J)	increased bleeding time	J:31616
Slc7a11^{tm1b(EUCOMM)Wtsi}/Slc7a11^{tm1b(EUCOMM)Wtsi} (C57BL/6N-Slc7a11^{tm1b(EUCOMM)Wtsi}/Ics)	increased circulating glucose level	J:211773
Slc7a11^tm1Hsat/Slc7a11^tm1Hsat (involves: 129P2/OlaHsd * C57BL/6)	abnormal circulating amino acid level	J:102902
	increased circulating cysteine level	J:102902
Slc8a1^m51207Hubr/Slc8a1^m51207Hubr (involves: C57BL/6 * FVB/N)	edema	J:173681, J:167034
Slc8a1^tm1Herc/Slc8a1⁺ (involves: 129 * CD-1)	abnormal glucose homeostasis	J:186743
Slc8a1^tm1Herc/Slc8a1⁺ (involves: 129 * CD-1)	increased insulin secretion	J:186743
Slc9a1^tm1Smb/Slc9a1^tm1Smb (involves: 129X1/SvJ * Black Swiss)	decreased salivation	J:70551
Slc9a3^tm1Ges/Slc9a3^tm1Ges (Not Specified)	abnormal blood pH regulation	J:70885
	abnormal renal water reabsorption	J:70885
	increased circulating aldosterone level	J:70885
	renal tubular acidosis	J:70885
Slc9a4^{tm1b(EUCOMM)Wtsi}/Slc9a4^{tm1b(EUCOMM)Wtsi} (C57BL/6N-Slc9a4^{tm1b(EUCOMM)Wtsi}/H)	increased circulating cholesterol level	J:211773
Slc9a6^tm1Dgen/Y (B6.129P2-Slc9a6^tm1Dgen/J)	abnormal ganglioside level	J:241124, J:229166
Slc9a6^tm1Dgen/Slc9a6⁺ (B6.129P2-Slc9a6^tm1Dgen/J)	abnormal ganglioside level	J:229166
Slc9a6^tm1Dgen/Slc9a6^tm1Dgen (B6.129P2-Slc9a6^tm1Dgen/J)	abnormal brain cholesterol level	J:241124
Slc9a6^tm1Dgen/Slc9a6^tm1Dgen (B6.129P2-Slc9a6^tm1Dgen/J)	abnormal ganglioside level	J:241124
Slc9a8^{Gt(YHB273)Byg}/Slc9a8^{Gt(YHB273)Byg} (involves: 129P2/OlaHsd * Black Swiss)	abnormal blood coagulation	J:191151
	decreased circulating bicarbonate level	J:191151
Slc9a9^em1(IMPC)J/Slc9a9^em1(IMPC)J (C57BL/6NJ-Slc9a9^em1(IMPC)J/Mmjax)	increased circulating HDL cholesterol level	J:211773
Slc9a9^{tm2d(KOMP)Wtsi}/Slc9a9^{tm2d(KOMP)Wtsi} (involves: C57BL/6 * C57BL/6N * SJL)	abnormal pH regulation	J:258593
Slc9b2^{Gt(D174F03)Wrst}/Slc9b2^{Gt(D174F03)Wrst} (involves: 129S2/SvPas * C57BL/6)	decreased insulin secretion	J:197386
	increased circulating glucose level	J:197386
Slc9b2^{tm1.1(KOMP)Vlcg}/Slc9b2^{tm1.1(KOMP)Vlcg} (C57BL/6N-Slc9b2^{tm1.1(KOMP)Vlcg}/Ucd)	increased circulating phosphate level	J:211773
Slc9b2^tm1.1Dgfu/Slc9b2⁺ (involves: 129 * C57BL/6)	increased circulating glucose level	J:197386
Slc9b2^tm1.1Dgfu/Slc9b2^tm1.1Dgfu (involves: 129 * C57BL/6)	decreased circulating insulin level	J:197386
	decreased insulin secretion	J:197386
	increased circulating glucose level	J:197386
Slc9b2^tm1.1Dgfu/Slc9b2^tm1.1Dgfu (B6.129-Slc9b2^tm1.1Dgfu)	decreased insulin secretion	J:197386
Slc9b2^tm1.1Dgfu/Slc9b2^tm1.1Dgfu (B6.129-Slc9b2^tm1.1Dgfu)	increased circulating glucose level	J:197386
Slc10a1^tm1Tac/Slc10a1^tm1Tac (either: B6.Cg-Slc10a1^tm1Tac or (involves: 129S/SvEv * C57BL/6J))	abnormal bile salt homeostasis	J:274149
	abnormal urine homeostasis	J:274149
	increased bile salt level	J:274149
	increased circulating alkaline phosphatase level	J:274149
	increased circulating bilirubin level	J:274149
Slc10a2^tm1Pda/Slc10a2^tm1Pda (either: (involves: 129P2/OlaHsd * 129S6/SvEv) or (involves: 129P2/OlaHsd * C57BL/6J))	abnormal bile salt homeostasis	J:85312
	abnormal bile salt level	J:85312
	abnormal intestinal lipid absorption	J:85312
	abnormal lipid homeostasis	J:85312
	decreased intestinal cholesterol absorption	J:85312
	increased circulating cholesterol level	J:85312
	steatorrhea	J:85312
Slc10a2^tm1Pda/Slc10a2^tm1Pda (either: B6.129P2-Slc10a2^tm1Pda or (involves: 129P2/OlaHsd * C57BL/6J))	abnormal bile salt homeostasis	J:132778
Slc10a3^em1(IMPC)J/Y (C57BL/6NJ-Slc10a3^em1(IMPC)J/Mmjax)	increased circulating cholesterol level	J:211773
Slc10a3^em1(IMPC)J/Y (C57BL/6NJ-Slc10a3^em1(IMPC)J/Mmjax)	increased circulating HDL cholesterol level	J:211773
Slc10a3^em1(IMPC)J/Slc10a3^em1(IMPC)J (C57BL/6NJ-Slc10a3^em1(IMPC)J/Mmjax)	increased circulating cholesterol level	J:211773
Slc10a6^tm1Jmge/Slc10a6^tm1Jmge (B6N.129S5-Slc10a6^tm1Jmge)	increased circulating cholesterol level	J:301761
Slc11a2^mk/Slc11a2^mk (MK/ReJ)	abnormal iron homeostasis	J:100202
Slc11a2^mk/Slc11a2^mk (129S6.MK-Slc11a2^mk)	increased liver iron level	J:98088
Slc11a2^mk/Slc11a2^mk (involves: C57BL/6J * DBA/2J * WB/Re)	increased erythrocyte protoporphyrin level	J:5985
Slc11a2^tm1Nca/Slc11a2⁺ (involves: 129S6/SvEvTac * 129S6.129S4-Slc11a2^tm1Nca)	decreased liver iron level	J:98088
Slc11a2^tm2Nca/Slc11a2^tm2Nca Tg(Vil1-cre)20Syr/? (involves: 129S6.129S4-Slc11a2^tm2Nca * C57BL/6 * DBA/2)	decreased brain iron level	J:98088
	decreased heart iron level	J:98088
	decreased kidney iron level	J:98088
	decreased liver iron level	J:98088
	decreased spleen iron level	J:98088
Slc12a1^tm1Haca/Slc12a1^tm1Haca (involves: 129S/SvEv * C57BL/6 * FVB/N)	abnormal mineral level	J:135710
	decreased circulating renin level	J:135710
	decreased urine osmolality	J:135710
Slc12a1^tm1Tkh/Slc12a1^tm1Tkh (involves: 129S6/SvEvTac)	abnormal blood homeostasis	J:62224
	abnormal fluid regulation	J:62224
	decreased circulating glucose level	J:62224
	increased circulating chloride level	J:62224
	increased circulating creatinine level	J:62224
	increased circulating sodium level	J:62224
	increased circulating total protein level	J:62224
	increased urine calcium level	J:62224
	metabolic acidosis	J:62224
Slc12a1^tm2Haca/Slc12a1^tm2Haca (involves: 129S/SvEv * FVB/N)	abnormal circulating magnesium level	J:148062
	abnormal renal water reabsorption	J:148062
	decreased urine osmolality	J:148062
	increased circulating renin level	J:148062
Slc12a1^urehr3/Slc12a1^urehr3 (C3HeB/FeJ-Slc12a1^urehr3)	decreased circulating chloride level	J:121470
	decreased circulating glucose level	J:121470
	decreased urine creatinine level	J:121470
	decreased urine sodium level	J:121470
	increased blood urea nitrogen level	J:121470
	increased circulating creatinine level	J:121470
Slc12a1^urehr3/Slc12a1^urehr3 (involves: C3HeB/FeJ)	abnormal blood homeostasis	J:159994
	abnormal urine homeostasis	J:159994
	abnormal urine urea nitrogen level	J:159994
	alkalosis	J:159994
	decreased circulating chloride level	J:159994
	decreased circulating creatinine level	J:159994
	decreased circulating renin level	J:159994
	decreased urine osmolality	J:159994
	decreased urine uric acid level	J:159994
	increased blood urea nitrogen level	J:159994
	increased circulating alkaline phosphatase level	J:159994
	increased circulating atrial natriuretic factor	J:159994
	increased circulating calcium level	J:159994
	increased circulating magnesium level	J:159994
	increased urine calcium level	J:159994
	increased urine creatinine level	J:159994
	increased urine magnesium level	J:159994
	increased urine osmolality	J:159994
	increased urine potassium level	J:159994
	increased urine prostaglandin level	J:159994
	increased urine sodium level	J:159994
Slc12a2^tm1Ges/Slc12a2^tm1Ges (Not Specified)	decreased salivation	J:64324
Slc12a3^em3Gpt/Slc12a3^em3Gpt (involves: C57BL/6)	decreased circulating magnesium level	J:336073
	hypokalemia	J:336073
	increased urine potassium level	J:336073
Slc12a3^em3Gpt/Slc12a3^em4Gpt (involves: C57BL/6)	decreased circulating magnesium level	J:336073
	hypokalemia	J:336073
	increased urine magnesium level	J:336073
	increased urine potassium level	J:336073
Slc12a3^em4Gpt/Slc12a3^em4Gpt (involves: C57BL/6)	decreased circulating magnesium level	J:336073
	hypokalemia	J:336073
	increased urine potassium level	J:336073
Slc12a3^tm1Ges/Slc12a3^tm1Ges (Not Specified)	decreased circulating magnesium level	J:50596
Slc12a3^tm1Ges/Slc12a3^tm1Ges (Not Specified)	decreased urine calcium level	J:50596
Slc12a3^tm1Ges/Slc12a3^tm1Ges (involves: C57BL/6)	decreased urine chloride ion level	J:161474
Slc12a3^tm1Ges/Slc12a3^tm1Ges (involves: C57BL/6)	decreased urine sodium level	J:161474
Slc12a5^em1(IMPC)Mbp/Slc12a5⁺ (C57BL/6N-Slc12a5^em1(IMPC)Mbp/MbpMmucd)	impaired glucose tolerance	J:211773
Slc12a5^em1(IMPC)Mbp/Slc12a5^em1(IMPC)Mbp (C57BL/6N-Slc12a5^em1(IMPC)Mbp/MbpMmucd)	edema	J:211773
Slc12a7^tm1Tjj/Slc12a7^tm1Tjj (involves: 129/Sv * C57BL/6)	increased urine pH	J:76136
Slc12a7^tm1Tjj/Slc12a7^tm1Tjj (involves: 129/Sv * C57BL/6)	renal tubular acidosis	J:76136
Slc13a1^tm1Mark/Slc13a1⁺ (involves: 129T2/SvEms * C57BL/6J)	hyposulfatemia	J:86561
	increased bile salt level	J:86561
	increased urine sulfate level	J:86561
Slc13a1^tm1Mark/Slc13a1^tm1Mark (involves: 129T2/SvEms * C57BL/6J)	decreased circulating insulin-like growth factor I level	J:86561
	hyposulfatemia	J:86561
	increased bile salt level	J:86561
	increased urine sulfate level	J:86561
Slc13a2^tm1Smch/Slc13a2^tm1Smch (B6N.129S7-Slc13a2^tm1Smch)	abnormal urine homeostasis	J:152740
Slc13a2^tm1Smch/Slc13a2^tm1Smch (B6N.129S7-Slc13a2^tm1Smch)	ketoaciduria	J:152740
Slc13a3^{tm1b(KOMP)Wtsi}/Slc13a3^{tm1b(KOMP)Wtsi} (C57BL/6N-Slc13a3^{tm1b(KOMP)Wtsi}/Ucd)	increased circulating creatinine level	J:211773
Slc13a4^{tm1a(EUCOMM)Wtsi}/Slc13a4^{tm1a(EUCOMM)Wtsi} (involves: C57BL/6J * C57BL/6N)	abnormal mineral level	J:239786
	subcutaneous edema	J:239786
Slc13a5^tm1.2Helf/Slc13a5^tm1.2Helf (B6.Cg-Slc13a5^tm1.2Helf)	abnormal glucose homeostasis	J:176732
	abnormal glycerol level	J:176732
	decreased circulating glucose level	J:176732
	decreased circulating insulin level	J:176732
	decreased circulating lactate level	J:176732
	decreased liver triglyceride level	J:176732
	decreased susceptibility to diet-induced obesity	J:176732
	improved glucose tolerance	J:176732
	increased carbon dioxide production	J:176732
	increased energy expenditure	J:176732
	increased insulin sensitivity	J:176732
	increased oxygen consumption	J:176732
Slc14a1^tm1Ask/Slc14a1^tm1Ask (involves: C57BL/6J)	abnormal blood homeostasis	J:75466
	abnormal urine homeostasis	J:75466
	decreased urine creatinine level	J:179936
	decreased urine osmolality	J:75466, J:179936
	decreased urine urea nitrogen level	J:179936
	increased blood urea nitrogen level	J:179936
Slc14a1^tm1Ask/Slc14a1^tm1Ask (involves: C57BL/6J * CD-1)	abnormal blood homeostasis	J:125840
Slc14a1^tm1Ask/Slc14a1^tm1Ask Slc14a2^tm1Bxy/Slc14a2^tm1Bxy (involves: C57BL/6J)	decreased urine creatinine level	J:179936
	decreased urine osmolality	J:179936
	increased blood urea nitrogen level	J:179936
Slc14a2^tm1Raf/Slc14a2^tm1Raf (involves: 129S6/SvEvTac * C57BL/6J)	decreased urine osmolality	J:89834
Slc14a2^tm1Raf/Slc14a2^tm1Raf (B6.129S6-Slc14a2^tm1Raf)	decreased blood urea nitrogen level	J:110070
	decreased urine osmolality	J:110070
	increased urine nitrite level	J:110070
	increased urine urea nitrogen level	J:110070
Slc14a2^tm1Suc/Slc14a2^tm1Suc (involves: 129S2/SvPas * C57BL/6J)	decreased urine osmolality	J:119860
Slc15a2^tm1Dan/Slc15a2^tm1Dan (involves: 129 * C57BL/6)	abnormal renal protein reabsorption	J:83166
Slc15a3^{tm1b(KOMP)Wtsi}/Slc15a3^{tm1b(KOMP)Wtsi} (C57BL/6N-Slc15a3^{tm1b(KOMP)Wtsi}/H)	increased circulating serum albumin level	J:211773
Slc15a4^tm1Tkyo/Slc15a4^tm1Tkyo (involves: C57BL/6)	abnormal circulating cytokine level	J:270965
	decreased circulating interleukin-1 beta level	J:270965
	decreased circulating interleukin-6 level	J:270965
Slc16a1^tm2.1Lupel/Slc16a1⁺ (B6.129P2-Slc16a1^tm2.1Lupel)	abnormal circulating hormone level	J:205481
	decreased circulating alanine transaminase level	J:205481
	decreased circulating insulin level	J:205481
	decreased circulating leptin level	J:205481
	decreased circulating triglyceride level	J:205481
	decreased susceptibility to diet-induced obesity	J:205481
	improved glucose tolerance	J:205481
	increased carbon dioxide production	J:205481
	increased insulin sensitivity	J:205481
	increased oxygen consumption	J:205481
	increased respiratory quotient	J:205481
Slc16a2^tm1.1Sref/Y (involves: 129P2/OlaHsd * C57BL/6J)	abnormal circulating hormone level	J:113732
	abnormal circulating triiodothyronine level	J:113732
	abnormal enzyme/coenzyme level	J:113732
	decreased circulating cholesterol level	J:113732
	decreased circulating thyroxine level	J:113732
	decreased triiodothyronine level	J:113732
	increased circulating alkaline phosphatase level	J:113732
	increased thyroid-stimulating hormone level	J:113732
	increased triiodothyronine level	J:113732
Slc16a2^tm1.1Sref/Y (involves: 129/Sv * 129P2/OlaHsd)	abnormal circulating hormone level	J:113732
	decreased circulating thyroxine level	J:113732
	increased triiodothyronine level	J:113732
Slc16a2^tm1.1Sref/Slc16a2^tm1.1Sref (involves: 129P2/OlaHsd * C57BL/6J)	abnormal circulating hormone level	J:113732
	decreased circulating thyroxine level	J:113732
	increased triiodothyronine level	J:113732
Slc16a2^{tm1a(KOMP)Wtsi}/Y (B6JTyr;B6N-Slc16a2^{tm1a(KOMP)Wtsi}/Wtsi)	decreased circulating cholesterol level	J:175295
	decreased circulating HDL cholesterol level	J:175295
	decreased circulating LDL cholesterol level	J:175295
Slc16a2^{tm1a(KOMP)Wtsi}/Slc16a2^{tm1a(KOMP)Wtsi} (B6JTyr;B6N-Slc16a2^{tm1a(KOMP)Wtsi}/Wtsi)	decreased circulating cholesterol level	J:175295
	decreased circulating creatinine level	J:175295
	decreased circulating fructosamine level	J:175295
	decreased circulating HDL cholesterol level	J:175295
	decreased circulating LDL cholesterol level	J:175295
	increased circulating alkaline phosphatase level	J:175295
	increased circulating amylase level	J:175295
Slc16a2^tm1Dgen/Y (either: (involves: C57BL/6N) or (involves: NMRI))	abnormal thyroxine level	J:120737
	abnormal triiodothyronine level	J:120737
	decreased circulating thyroxine level	J:120737
	increased circulating triiodothyronine level	J:120737
Slc16a2^tm1Dgen/Slc16a2^tm1Dgen (either: (involves: C57BL/6N) or (involves: NMRI))	abnormal thyroxine level	J:120737
	abnormal triiodothyronine level	J:120737
	decreased circulating thyroxine level	J:120737
	increased circulating triiodothyronine level	J:120737
Slc16a4^{tm2e(EUCOMM)Wtsi}/Slc16a4^{tm2e(EUCOMM)Wtsi} (C57BL/6N-Slc16a4^{tm2e(EUCOMM)Wtsi}/Wtsi)	increased blood urea nitrogen level	J:211773
Slc16a10^m1Ingm/Slc16a10^m1Ingm (B6.C3Fe-Slc16a10^m1Ingm)	abnormal amino acid level	J:205101
	abnormal circulating amino acid level	J:205101
	abnormal urine amino acid level	J:205101
	aminoaciduria	J:205101
	increased urine creatinine level	J:205101
	increased urine pH	J:205101
Slc16a10^{Tn(sb-lacZ,GFP)1.4Tcb}/Slc16a10^{Tn(sb-lacZ,GFP)1.4Tcb} (NOD/ShiLt-Slc16a10^{Tn(sb-lacZ,GFP)1.4Tcb})	increased urine glucose level	J:227341
Slc16a13^em1Tac/Slc16a13^em1Tac (C57BL/6N-Slc16a13^em1Tac)	improved glucose tolerance	J:309785
Slc16a13^em1Tac/Slc16a13^em1Tac (C57BL/6N-Slc16a13^em1Tac)	increased insulin sensitivity	J:309785
Slc17a5^tm1Lex/Slc17a5⁺ (involves: 129S5/SvEvBrd * C57BL/6J)	impaired glucose tolerance	J:103485
Slc17a6^tm1.1Kldr/Slc17a6^tm1.1Kldr (involves: 129S1/Sv * 129X1/SvJ * BALB/c * C57BL/6)	cyanosis	J:116180
Slc17a6^tm1.1Thna/Slc17a6^tm1.1Thna Gt(ROSA)26Sor^tm1(EYFP)Cos/Gt(ROSA)26Sor⁺ Slc6a3^tm1(cre)Xz/Slc6a3⁺ (involves: 129/Sv * 129S1/Sv * 129S4/SvJaeSor * 129X1/SvJ * C57BL/6J)	decreased dopamine level	J:167767
Slc17a6^tm1Lowl/Slc17a6^tm1Lowl Tg(CAG-Bgeo/GFP)21Lbe/0 Tg(Nr5a1-cre)2Lowl/0 (involves: 129S1/Sv * 129S6/SvEvTac * 129X1/SvJ * FVB)	abnormal hormone level	J:129860
	decreased circulating adrenaline level	J:129860
	decreased circulating glucagon level	J:129860
	hypoglycemia	J:129860
Slc17a7^em1(IMPC)H/Slc17a7⁺ (C57BL/6N-Slc17a7^em1(IMPC)H/H)	decreased circulating fructosamine level	J:211773
Slc17a9^tm1Nomu/Slc17a9^tm1Nomu (involves: 129 * C57BL/6J)	abnormal catecholamine level	J:256580
	decreased circulating insulin level	J:256580
	hypoglycemia	J:256580
	improved glucose tolerance	J:256580
	increased insulin sensitivity	J:256580
Slc18a2^tm1.1Bgir/Slc18a2^tm1.1Bgir Slc6a4^tm1(cre)Xz/Slc6a4⁺ (involves: 129S1/Sv * C57BL/6J)	abnormal catecholamine level	J:197966
	decreased serotonin level	J:197966
Slc18a2^tm1Edw/Slc18a2⁺ (involves: 129X1/SvJ * C57BL/6)	abnormal noradrenaline level	J:45183
	abnormal serotonin level	J:45183
	decreased dopamine level	J:45183
Slc18a2^tm1Edw/Slc18a2^tm1Edw (involves: 129X1/SvJ)	decreased dopamine level	J:96932
Slc18a2^tm1Edw/Slc18a2^tm1Edw (involves: 129X1/SvJ * C57BL/6)	abnormal noradrenaline level	J:45183
	abnormal serotonin level	J:45183
	decreased dopamine level	J:45183
Slc18a2^tm1Mca/Slc18a2⁺ (involves: 129X1/SvJ)	decreased dopamine level	J:45184
Slc18a2^tm1Mca/Slc18a2⁺ (B6.129X1-Slc18a2^tm1Mca)	abnormal corticosterone level	J:125273
Slc18a2^tm1Mca/Slc18a2^tm1Mca (involves: 129X1/SvJ)	abnormal dopamine level	J:45184
Slc18a2^tm1Mca/Slc18a2^tm1Mca (involves: 129X1/SvJ)	decreased body temperature	J:45184
Slc18a2^tm2Kmo/Slc18a2^tm2Kmo (involves: 129P2/OlaHsd * C57BL/6)	abnormal noradrenaline level	J:70606, J:150414
	decreased dopamine level	J:70606, J:150414, J:123245
	decreased serotonin level	J:70606, J:150414
Slc19a1^tm1Rsc/Slc19a1⁺ (involves: 129P2/OlaHsd * SWV/Fnn)	abnormal homeostasis	J:96380
Slc19a2^tm1Gelb/Slc19a2^tm1Gelb (involves: 129X1/SvJ)	decreased circulating insulin level	J:79974
	impaired glucose tolerance	J:79974
	increased insulin sensitivity	J:79974
Slc19a3^tm1.1Nwak/Slc19a3^tm1.1Nwak (involves: C57BL/6J)	abnormal thiamin level	J:246593
Slc19a3^tm1Said/Slc19a3^tm1Said (involves: C57BL/6)	abnormal thiamin level	J:170952
Slc19a3^tm1Said/Slc19a3^tm1Said (involves: C57BL/6)	abnormal vitamin absorption	J:170952
Slc19a3^tm1Said/Slc19a3^tm1Said (involves: C57BL/6J)	abnormal thiamin level	J:246593
Slc20a1^tm1Lbek/Slc20a1^tm1Lbek (involves: 129S2/SvPas * C57BL/6J)	abnormal fatty acids level	J:157997
Slc20a2^{tm1a(EUCOMM)Wtsi}/Slc20a2^{tm1a(EUCOMM)Wtsi} (C57BL/6N-Slc20a2^{tm1a(EUCOMM)Wtsi}/Wtsi)	increased circulating alkaline phosphatase level	J:211773
	increased circulating magnesium level	J:211773
	subcutaneous edema	J:239583
Slc20a2^{tm1a(EUCOMM)Wtsi}/Slc20a2^{tm1a(EUCOMM)Wtsi} (C57BL/6NTac-Slc20a2^{tm1a(EUCOMM)Wtsi}/Ieg)	abnormal mineral level	J:234034
	decreased circulating phosphate level	J:234034
Slc20a2^{tm1b(EUCOMM)Wtsi}/Slc20a2⁺ (C57BL/6N-Slc20a2^{tm1b(EUCOMM)Wtsi}/Ieg)	impaired glucose tolerance	J:211773
Slc22a1^tm1Ahs/Slc22a1^tm1Ahs (involves: 129P2/OlaHsd * FVB)	abnormal urine organic cation level	J:70604
Slc22a1^tm1Ahs/Slc22a1^tm1Ahs Slc22a2^tm2Ahs/Slc22a2^tm2Ahs (involves: 129P2/OlaHsd * FVB)	abnormal urine organic cation level	J:86270
Slc22a1^tm1Kmgi/Slc22a1^tm1Kmgi (involves: 129P2/OlaHsd * C57BL/6J * FVB/N)	abnormal fasting circulating glucose level	J:122106
	abnormal hepatic glucose production	J:122106
Slc22a3^tm1Dpb/Slc22a3^tm1Dpb (involves: 129P2/OlaHsd)	abnormal dopamine level	J:180517
Slc22a4^tm1Atsu/Slc22a4^tm1Atsu (involves: C57BL/6J)	abnormal amino acid level	J:207006
Slc22a5^jvs/Slc22a5^jvs (C3.OH-H2^o2 Slc22a5^jvs)	abnormal glucose homeostasis	J:31000
	aminoaciduria	J:18523
	decreased circulating carnitine level	J:18523
	hypoglycemia	J:31000
	increased circulating ammonia level	J:31000
Slc22a6^tm1Dgen/Slc22a6^tm1Dgen (involves: 129P2/OlaHsd * C57BL/6J)	abnormal urine organic anion level	J:108655
Slc22a6^tm1Dgen/Slc22a6^tm1Dgen (involves: 129P2/OlaHsd)	decreased urine uric acid level	J:136005
Slc22a8^{tm1b(KOMP)Wtsi}/Slc22a8^{tm1b(KOMP)Wtsi} (C57BL/6N-Slc22a8^{tm1b(KOMP)Wtsi}/H)	increased circulating creatinine level	J:211773
Slc22a8^tm1Ngm/Slc22a8^tm1Ngm (involves: 129/Sv * C57BL/6)	abnormal urine organic anion level	J:78014
Slc22a8^tm1Ngm/Slc22a8^tm1Ngm (involves: 129S1/Sv)	decreased urine uric acid level	J:136005
Slc22a12^tm1Dgen/Slc22a12^tm1Dgen (B6.129P2-Slc22a12^tm1Dgen)	abnormal blood homeostasis	J:136005
	abnormal urine homeostasis	J:136005
	uraturia	J:136005
Slc22a12^tm1Oka/Slc22a12^tm1Oka (involves: 129 * C57BL/6J)	increased urine uric acid level	J:260689
Slc22a14^em1Fjw/Slc22a14^em1Fjw (involves: C57BL/6N)	abnormal ion homeostasis	J:322731
Slc22a14^em1Fjw/Slc22a14^em1Fjw (involves: C57BL/6N)	abnormal pH regulation	J:322731
Slc23a1^tm1Mlev/Slc23a1⁺ (involves: 129S6/SvEvTac * C57BL/6J)	abnormal blood homeostasis	J:159697
	abnormal urine homeostasis	J:159697
	abnormal vitamin absorption	J:159697
	abnormal vitamin homeostasis	J:159697
Slc23a1^tm1Mlev/Slc23a1^tm1Mlev (involves: 129S6/SvEvTac * C57BL/6J)	abnormal urine homeostasis	J:159697
	abnormal vitamin absorption	J:159697
	abnormal vitamin C level	J:159697
	aminoaciduria	J:159697
Slc23a2^tm1Nbm/Slc23a2^tm1Nbm (129S6/SvEvTac-Slc23a2^tm1Nbm)	abnormal adrenaline level	J:85988
	abnormal dopamine level	J:85988
	abnormal vitamin C level	J:76194
	decreased circulating corticosterone level	J:85988
Slc24a2^tm1Jlyt/Slc24a2^tm1Jlyt (either: B6.129-Slc24a2^tm1Jlyt or (involves: 129S1/Sv * 129X1/SvJ * C57BL/6))	abnormal calcium ion homeostasis	J:110313
Slc24a3^{em1(IMPC)Kmpc}/Slc24a3^{em1(IMPC)Kmpc} (C57BL/6NTac-Slc24a3^{em1(IMPC)Kmpc}/Kmpc)	decreased respiratory quotient	J:211773
Slc24a3^em#Ebje/Slc24a3^em#Ebje (C57BL/6J-Slc24a3^em#Ebje)	increased circulating parathyroid hormone level	J:254307
Slc24a4^{tm1b(KOMP)Wtsi}/Slc24a4⁺ (C57BL/6N-Slc24a4^{tm1b(KOMP)Wtsi}/H)	increased circulating cholesterol level	J:211773
	increased circulating fructosamine level	J:211773
	increased circulating HDL cholesterol level	J:211773
Slc24a4^{tm1b(KOMP)Wtsi}/Slc24a4^{tm1b(KOMP)Wtsi} (C57BL/6N-Slc24a4^{tm1b(KOMP)Wtsi}/H)	increased circulating alkaline phosphatase level	J:211773
Slc24a5^{tm1b(KOMP)Mbp}/Slc24a5^{tm1b(KOMP)Mbp} (C57BL/6N-Slc24a5^{tm1b(KOMP)Mbp}/J)	decreased fasting circulating glucose level	J:211773
	increased circulating sodium level	J:211773
Slc25a1^{em1(IMPC)Kmpc}/Slc25a1^{em1(IMPC)Kmpc} (C57BL/6NTac-Slc25a1^{em1(IMPC)Kmpc}/Kmpc)	edema	J:211773
Slc25a3^tm1.1Jmol/Slc25a3^tm1.1Jmol A1cf^{Tg(Myh6-cre/Esr1)1Jmk}/? (involves: 129S6/SvEvTac C57BL/6 * FVB/N)	abnormal calcium ion homeostasis	J:229795
Slc25a4^{tm1a(EUCOMM)Wtsi}/Slc25a4^{tm1a(EUCOMM)Wtsi} (C57BL/6N-A^tm1Brd Slc25a4^{tm1a(EUCOMM)Wtsi}/WtsiH)	decreased circulating chloride level	J:211773
	improved glucose tolerance	J:211773
	increased blood urea nitrogen level	J:211773
	increased circulating alkaline phosphatase level	J:211773
	increased circulating calcium level	J:211773
	increased circulating insulin level	J:211773
Slc25a4^tm2Dwa/Slc25a4^tm2Dwa (involves: 129S4/SvJae * C57BL/6J)	abnormal blood homeostasis	J:41256
	increased circulating alanine level	J:41256
	increased circulating lactate level	J:41256
Slc25a10^{tm1b(EUCOMM)Wtsi}/Slc25a10^{tm1b(EUCOMM)Wtsi} (C57BL/6N-Slc25a10^{tm1b(EUCOMM)Wtsi}/Ieg)	increased circulating amylase level	J:211773
Slc25a12^{Gt(OST123999)Lex}/Slc25a12^{Gt(OST123999)Lex} (involves: 129S5/SvEvBrd * C57BL/6)	abnormal dopamine level	J:193095
	decreased gamma-aminobutyric acid level	J:193095
	decreased serotonin level	J:193095
	increased taurine level	J:243212
Slc25a13^tm1Lct/Slc25a13⁺ (either: 129/Sv-Slc25a13^tm1Lct or (involves: 129S1/Sv * 129X1/SvJ * CD-1))	abnormal amino acid level	J:87578
	abnormal gluconeogenesis	J:87578
Slc25a13^tm1Lct/Slc25a13^tm1Lct (B6.129-Slc25a13^tm1Lct)	decreased circulating insulin level	J:124766
	hypoglycemia	J:124766
	increased liver triglyceride level	J:124766
Slc25a13^tm1Lct/Slc25a13^tm1Lct (either: 129/Sv-Slc25a13^tm1Lct or (involves: 129S1/Sv * 129X1/SvJ * CD-1))	abnormal amino acid level	J:87578
	abnormal gluconeogenesis	J:87578
	abnormal urine homeostasis	J:87578
Slc25a18^{tm1b(KOMP)Wtsi}/Slc25a18^{tm1b(KOMP)Wtsi} (C57BL/6N-Slc25a18^{tm1b(KOMP)Wtsi}/Kmpc)	impaired glucose tolerance	J:211773
	increased circulating alanine transaminase level	J:211773
Slc25a19^tm1Mjl/Slc25a19^tm1Mjl (either: (involves: 129S6/SvEvTac) or (involves: 129S6/SvEvTac * Black Swiss))	abnormal amniotic fluid composition	J:115337
	ketoaciduria	J:115337
Slc25a20^{tm1a(EUCOMM)Wtsi}/Slc25a20^{tm1a(EUCOMM)Wtsi} (C57BL/6N-Slc25a20^{tm1a(EUCOMM)Wtsi}/Wtsi)	edema	J:239583
	retropleural edema	J:239583
Slc25a21^{tm1a(KOMP)Wtsi}/Slc25a21^{tm1a(KOMP)Wtsi} (B6JTyr;B6N-Slc25a21^{tm1a(KOMP)Wtsi}/Wtsi)	decreased circulating alanine transaminase level	J:175295
	decreased circulating aspartate transaminase level	J:175295
	decreased circulating LDL cholesterol level	J:175295
	decreased circulating potassium level	J:175295
Slc25a21^{tm1d(KOMP)Wtsi}/Slc25a21^{tm1d(KOMP)Wtsi} (B6Brd;B6Dnk;B6N-Tyr^c-Brd Slc25a21^{tm1a(KOMP)Wtsi}/Wtsi)	decreased circulating magnesium level	J:211773
Slc25a23^tm1Lex/Slc25a23^tm1Lex (involves: 129 * C57BL/6)	decreased urine urea nitrogen level	J:196890
Slc25a24^tm1Sinos/Slc25a24^tm1Sinos (B6(Cg)-Slc25a24^tm1Sinos)	decreased liver triglyceride level	J:312208
	decreased susceptibility to diet-induced obesity	J:312208
Slc25a25^tm1.1Kz/Slc25a25^tm1.1Kz (involves: C57BL/6J * FVB/N)	abnormal energy homeostasis	J:170924
	decreased susceptibility to diet-induced obesity	J:170924
	increased oxygen consumption	J:170924
Slc25a28^tm1.1Dwrd/Slc25a28^tm1.1Dwrd Slc25a37^tm1.1Kapl/Slc25a37^tm1.1Kapl Speer6-ps1^{Tg(Alb-cre)21Mgn}/0 (involves: 129S6/SvEvTac * C57BL/6 * C57BL/6NCrl * DBA)	decreased liver iron level	J:300667
Slc25a28^tm1.1Dwrd/Slc25a28^tm1.1Dwrd Speer6-ps1^{Tg(Alb-cre)21Mgn}/0 (involves: 129S6/SvEvTac * C57BL/6 * C57BL/6NCrl * DBA)	decreased liver iron level	J:300667
Slc25a28^tm1.2Dwrd/Slc25a28^tm1.2Dwrd (involves: 129S6/SvEvTac * C57BL/6NCrl)	decreased liver iron level	J:300667
Slc25a30^{tm1a(EUCOMM)Wtsi}/Slc25a30^{tm1a(EUCOMM)Wtsi} (C57BL/6N-Slc25a30^{tm1a(EUCOMM)Wtsi}/Wtsi)	decreased circulating serum albumin level	J:211773
Slc25a32^em1Liliu/Slc25a32^em2Liliu (C57BL/6-Slc25a32^em1Liliu/Slc25a32^em2Liliu)	decreased circulating carnitine level	J:338257
	increased circulating carnitine level	J:338257
Slc25a32^em2Liliu/Slc25a32^em2Liliu (C57BL/6-Slc25a32^em2Liliu)	abnormal folic acid level	J:338257
	decreased circulating carnitine level	J:338257
	decreased glycine level	J:338257
	increased circulating carnitine level	J:338257
	increased serine level	J:338257
Slc25a32^em3Liliu/Slc25a32^em3Liliu (C57BL/6-Slc25a32^em3Liliu)	abnormal folic acid level	J:338257
	abnormal homeostasis	J:338257
	decreased circulating carnitine level	J:338257
	increased circulating carnitine level	J:338257
	increased glycine level	J:338257
	increased serine level	J:338257
Slc25a34^em1Duna/Slc25a34^em1Duna (C57BL/6J-Slc25a34^em1Duna)	abnormal glucose tolerance	J:344152
	decreased cholesterol level	J:344152
	decreased circulating glucose level	J:344152
	decreased fasting circulating glucose level	J:344152
	decreased triglyceride level	J:344152
	impaired glucose tolerance	J:344152
	insulin resistance	J:344152
Slc25a37^tm1.1Kapl/Slc25a37^tm1.1Kapl Speer6-ps1^{Tg(Alb-cre)21Mgn}/0 (involves: 129S6/SvEvTac * C57BL/6 * C57BL/6NCrl * DBA)	decreased liver iron level	J:300667
Slc25a37^tm1.1Kapl/Slc25a37^tm1.2Kapl Speer6-ps1^{Tg(Alb-cre)21Mgn}/? (involves: 129S4/SvJaeSor * 129S6/SvEvTac * C57BL/6J * C57BL/6NCr * DBA)	abnormal iron homeostasis	J:173284
Slc25a44^em1Kajim/Slc25a44^em1Kajim Tg(Ucp1-cre)1Evdr/0 (involves: C57BL/6 * FVB)	impaired febrile response	J:345254
Slc25a46^em1(IMPC)J/Slc25a46⁺ (C57BL/6NJ-Slc25a46^em1(IMPC)J/J)	increased circulating glucose level	J:211773
	increased fasting circulating glucose level	J:211773
Slc26a1^tm1Mark/Slc26a1^tm1Mark (involves: 129X1/SvJ * CD-1)	abnormal mineral level	J:158567
	hyposulfatemia	J:158567
	increased circulating alanine transaminase level	J:158567
	increased circulating calcium level	J:158567
	increased urine calcium level	J:158567
	increased urine sulfate level	J:158567
Slc26a2^em1(IMPC)Bay/Slc26a2⁺ (C57BL/6N-Slc26a2^em1(IMPC)Bay/BayMmucd)	impaired glucose tolerance	J:211773
Slc26a3^tm1Sole/Slc26a3^tm1Sole (involves: 129S6/SvEvTac * C57BL/6)	decreased circulating chloride level	J:117587
	decreased circulating potassium level	J:117587
	decreased circulating sodium level	J:117587
	increased blood urea nitrogen level	J:117587
	increased circulating aldosterone level	J:117587
Slc26a4^tm1Egr/Slc26a4^tm1Egr (involves: 129S6/SvEvTac)	abnormal calcium ion homeostasis	J:121442, J:121448
Slc26a4^tm1Sole/Slc26a4^tm1Sole (involves: 129S/SvEv * C57BL/6)	decreased urine pH	J:162257
	increased circulating bicarbonate level	J:162257
	increased urine ammonia level	J:162257
Slc26a6^tm1Psar/Slc26a6^tm1Psar (involves: 129S6/SvEvTac)	abnormal blood homeostasis	J:107558
Slc26a6^tm1Psar/Slc26a6^tm1Psar (involves: 129S6/SvEvTac)	abnormal urine homeostasis	J:107558
Slc26a7^tm1Sole/Slc26a7^tm1Sole (involves: 129)	abnormal thyroid hormone level	J:325346
	acidemia	J:156969
	decreased circulating bicarbonate level	J:156969
	decreased circulating thyroxine level	J:325346
	decreased circulating triiodothyronine level	J:325346
	increased circulating thyroid-stimulating hormone level	J:325346
	increased urine osmolality	J:156969
	increased urine pH	J:156969
	renal tubular acidosis	J:156969
Slc26a11^tm1.1Cidz/Slc26a11^tm1.1Cidz Tg(Pcp2-cre)2Mpin/0 (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	abnormal chloride level	J:240359
Slc27a1^tm1Jkk/Slc27a1^tm1Jkk (involves: 129S/SvEv * C57BL/6J)	abnormal fatty acids level	J:88657
	abnormal glucose homeostasis	J:88657
	abnormal lipid level	J:88657
	abnormal skeletal muscle triglyceride level	J:88657
Slc27a4^tm1.1Wsr/Slc27a4^tm1.1Wsr (involves: 129P2/OlaHsd)	impaired skin barrier function	J:103206
Slc27a4^tm1.1Wsr/Slc27a4^tm1.1Wsr (involves: 129P2/OlaHsd * BALB/cJ)	cyanosis	J:84096
	impaired skin barrier function	J:84096
Slc27a4^tm1Wsr/Slc27a4^tm1Wsr (involves: 129P2/OlaHsd * C57BL/6)	abnormal fluid regulation	J:84096
	impaired skin barrier function	J:84096
Slc27a5^tm1Asta/Slc27a5^tm1Asta (involves: 129/Sv * C57BL/6)	abnormal lipid homeostasis	J:124917
	abnormal lipid level	J:124917
	decreased circulating cholesterol level	J:124917
	decreased circulating free fatty acids level	J:124917
	decreased circulating ketone body level	J:124917
	decreased circulating triglyceride level	J:124917
	decreased fatty acids level	J:124917
	decreased liver cholesterol level	J:124917
	decreased liver triglyceride level	J:124917
	decreased saturated fatty acids level	J:124917
	decreased unsaturated fatty acids level	J:124917
	increased circulating glucose level	J:124917
	increased circulating insulin level	J:124917
Slc27a5^tm1Asta/Slc27a5^tm1Asta (involves: 129)	abnormal lipid level	J:124916
	decreased circulating leptin level	J:124916
	decreased susceptibility to diet-induced obesity	J:124916
	improved glucose tolerance	J:124916
	increased body temperature	J:124916
	increased oxygen consumption	J:124916
Slc28a3^em1(IMPC)H/Slc28a3^em1(IMPC)H (C57BL/6N-Slc28a3^em1(IMPC)H/H)	increased circulating creatine kinase level	J:211773
Slc29a1^{tm2b(NCOM)Mfgc}/Slc29a1^{tm2b(NCOM)Mfgc} (C57BL/6N-Slc29a1^{tm2b(NCOM)Mfgc}/Tcp)	improved glucose tolerance	J:211773
Slc29a3^{em1(IMPC)Wtsi}/Slc29a3^{em1(IMPC)Wtsi} (C57BL/6N-Slc29a3^{em1(IMPC)Wtsi}/Wtsi)	decreased circulating cholesterol level	J:211773
	decreased circulating glucose level	J:211773
	decreased circulating HDL cholesterol level	J:211773
	decreased circulating iron level	J:211773
	decreased circulating LDL cholesterol level	J:211773
	decreased circulating serum albumin level	J:211773
	decreased circulating total protein level	J:211773
	decreased circulating triglyceride level	J:211773
	increased circulating alanine transaminase level	J:211773
	increased circulating amylase level	J:211773
	increased circulating aspartate transaminase level	J:211773
	increased circulating bilirubin level	J:211773
	increased circulating chloride level	J:211773
	increased circulating sodium level	J:211773
Slc30a2^em1(IMPC)Tcp/Slc30a2⁺ (C57BL/6N-Slc30a2^em1(IMPC)Tcp/Tcp)	increased fasting circulating glucose level	J:211773
Slc30a2^tm1Kgna/Slc30a2^tm1Kgna (involves: 129 * C57BL/6)	abnormal zinc homeostasis	J:264481
Slc30a3^tm1Rpa/Slc30a3⁺ (involves: 129S7/SvEvBrd * C57BL/6)	decreased brain zinc level	J:53059
Slc30a3^tm1Rpa/Slc30a3^tm1Rpa (involves: 129S7/SvEvBrd * C57BL/6)	abnormal zinc homeostasis	J:53059
	decreased brain zinc level	J:53059
Slc30a3^tm1Rpa/Slc30a3^tm1Rpa (involves: 129S7/SvEvBrd * C57BL/6 * SJL)	decreased brain zinc level	J:76863
Slc30a3^tm1Rpa/Slc30a3^tm1Rpa Tg(APPSWE)2576Kha/0 (involves: 129S7/SvEvBrd * C57BL/6 * SJL)	decreased brain zinc level	J:76863
Slc30a4^lm/Slc30a4^lm (C57BL/6J-Slc30a4^lm)	abnormal milk zinc level	J:5911, J:7690
Slc30a4^lm/Slc30a4^lm (C57BL/6J-Slc30a4^lm)	abnormal zinc homeostasis	J:5911, J:7690
Slc30a7^Gt(XC827)Byg/Slc30a7^Gt(XC827)Byg (B6.129P2-Slc30a7^Gt(XC827)Byg)	abnormal zinc homeostasis	J:128927
	decreased circulating zinc level	J:128927
Slc30a8^tm1.1Geno/Slc30a8^tm1.1Geno (involves: 129/Sv * C57BL/6JRj)	abnormal zinc homeostasis	J:153253
	decreased insulin secretion	J:153253
	impaired glucose tolerance	J:153253
	increased circulating glucose level	J:153253
	increased susceptibility to diet-induced obesity	J:153253
Slc30a8^tm1.1Htwt/Slc30a8^tm1.1Htwt Tg(Ins2-cre)25Mgn/0 (involves: C57BL/6 * CBA/JNCrlj * DBA)	abnormal insulin clearance	J:204003
	abnormal zinc homeostasis	J:204003
	impaired glucose tolerance	J:204003
	increased insulin secretion	J:204003
Slc30a8^{tm1a(KOMP)Wtsi}/Slc30a8^{tm1a(KOMP)Wtsi} (C57BL/6N-Slc30a8^{tm1a(KOMP)Wtsi}/Wtsi)	increased circulating aspartate transaminase level	J:175295
Slc30a8^tm1Lex/Slc30a8^tm1Lex (involves: 129S6/SvEvTac * C57BL/6)	abnormal zinc homeostasis	J:152629
	decreased circulating insulin level	J:152629
	decreased insulin secretion	J:152629
Slc30a10^tm1.1Sommu/Slc30a10^tm1.1Sommu (involves: 129S4/SvJae * C57BL/6 * C57BL/6J * CBA)	abnormal manganese level	J:243657
	decreased circulating prolactin level	J:243657
	decreased circulating thyroxine level	J:243657
	decreased liver glycogen level	J:243657
	increased brain iron level	J:243657
	increased brain manganese level	J:243657
	increased circulating copper level	J:243657
	increased circulating iron level	J:243657
	increased circulating manganese level	J:243657
	increased circulating thyroid-stimulating hormone level	J:243657
	increased liver manganese level	J:243657
Slc31a1^tm1Djt/Slc31a1⁺ (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	abnormal copper level	J:69897
	decreased liver iron level	J:69897
Slc31a1^tm1Jgt/Slc31a1⁺ (involves: 129X1/SvJ * C57BL/6)	decreased brain copper level	J:69862
Slc31a1^tm2Djt/Slc31a1^tm2Djt Tg(Vil1-cre)997Gum/0 (involves: 129 * C57BL/6 * FVB/N * SJL)	abnormal copper level	J:129741
	abnormal liver copper level	J:129741
	decreased circulating copper level	J:129741
	hemosiderosis	J:129741
Slc33a1^tm1.1Lpu/Slc33a1⁺ (involves: 129S7/SvEvBrd * C57BL/6)	abnormal circulating cytokine level	J:211266
	increased circulating interleukin-17 level	J:211266
	increased circulating interleukin-18 level	J:211266
Slc34a1^tm1Hten/Slc34a1^tm1Hten (involves: 129S2/SvPas * C57BL/6J)	abnormal vitamin D level	J:47637
	decreased circulating parathyroid hormone level	J:47637
	decreased circulating phosphate level	J:47637
	increased circulating alkaline phosphatase level	J:47637
	increased circulating calcium level	J:47637
	increased urine calcium level	J:47637
	increased urine phosphate level	J:47637
Slc34a1^tm1Hten/Slc34a1^tm1Hten (B6.129S2-Slc34a1^tm1Hten/J)	abnormal urine homeostasis	J:152195
	abnormal vitamin D level	J:152195
	decreased circulating phosphate level	J:152195
	increased circulating calcium level	J:152195
	increased urine phosphate level	J:152195
Slc34a1^tm1Hten/Slc34a1^tm1Hten Slc34a3^tm1Kimi/Slc34a3^tm1Kimi (B6.129-Slc34a3^tm1Kimi Slc34a1^tm1Hten)	abnormal circulating protein level	J:152195
	abnormal renal phosphate reabsorption	J:152195
	abnormal urine homeostasis	J:152195
	abnormal vitamin D level	J:152195
	decreased circulating parathyroid hormone level	J:152195
	decreased circulating phosphate level	J:152195
	increased circulating calcium level	J:152195
	increased urine calcium level	J:152195
	increased urine phosphate level	J:152195
Slc34a2^tm1.1Scc/Slc34a2^tm1.1Scc Gt(ROSA)26Sor^{tm9(cre/ESR1)Arte}/Gt(ROSA)26Sor⁺ (involves: 129 * C57BL/6 * C57BL/6NTac)	decreased urine calcium level	J:166317
	decreased urine phosphate level	J:166317
Slc34a2^tm1Sega/Slc34a2⁺ (involves: 129S6/SvEvTac * C57BL/6JJcl)	abnormal vitamin D level	J:179947
	decreased circulating calcium level	J:179947
	decreased circulating creatinine level	J:179947
	decreased circulating phosphate level	J:179947
	decreased urine phosphate level	J:179947
	increased urine calcium level	J:179947
Slc34a3^tm1Kimi/Slc34a3^tm1Kimi (B6.129-Slc34a3^tm1Kimi)	abnormal circulating protein level	J:152521
	abnormal vitamin D level	J:152521
	increased circulating calcium level	J:152521
	increased urine calcium level	J:152521
Slc35a3^em1Tfric/Slc35a3^em1Tfric (C57BL/6J-Slc35a3^em1Tfric)	abnormal glycosaminoglycan level	J:334711
Slc35d1^{tm2b(EUCOMM)Hmgu}/Slc35d1^{tm2b(EUCOMM)Hmgu} (C57BL/6N-Slc35d1^{tm2b(EUCOMM)Hmgu}/Bay)	edema	J:211773
Slc35d3^IAP/Slc35d3^IAP (involves: C3H/HeSn * C3H/HeSnJ * C57BL/6J)	decreased platelet serotonin level	J:137593
Slc35f1^{tm1a(KOMP)Wtsi}/Slc35f1^{tm1a(KOMP)Wtsi} (B6JTyr;B6N-Slc35f1^{tm1a(KOMP)Wtsi}/Wtsi)	decreased lactate dehydrogenase level	J:175295
Slc35f5^{em1(IMPC)Hmgu}/Slc35f5^{em1(IMPC)Hmgu} (C57BL/6NCrl-Slc35f5^{em1(IMPC)Hmgu}/Ieg)	decreased circulating sodium level	J:211773
Slc35f6^{tm1a(EUCOMM)Wtsi}/Slc35f6^{tm1a(EUCOMM)Wtsi} (Not Specified)	decreased circulating triglyceride level	J:165965
Slc37a1^{tm1b(EUCOMM)Hmgu}/Slc37a1^{tm1b(EUCOMM)Hmgu} (C57BL/6N-Slc37a1^{tm1b(EUCOMM)Hmgu}/Orl)	increased circulating bilirubin level	J:211773
Slc37a4^tm1Jyc/Slc37a4^tm1Jyc (involves: 129S4/SvJae * C57BL/6)	abnormal glucose homeostasis	J:86005
	abnormal homeostasis	J:86005
	abnormal lipid homeostasis	J:86005
	hyperlipidemia	J:86005
	hypoglycemia	J:86005
	increased circulating cholesterol level	J:86005
	increased circulating triglyceride level	J:86005
	increased kidney glycogen level	J:86005
	increased liver glycogen level	J:86005
Slc38a2^em1Zhxy/Slc38a2^em1Zhxy (129.B6-Slc38a2^em1Zhxy)	decreased kidney glutathione level	J:345023
	decreased superoxide dismutase level	J:345023
	increased kidney iron level	J:345023
	increased urine osmolality	J:345023
Slc38a2^{tm1a(KOMP)Wtsi}/Slc38a2⁺ (C57BL/6N-Slc38a2^{tm1a(KOMP)Wtsi}/Wtsi)	decreased circulating cholesterol level	J:211773
	decreased circulating glucose level	J:211773
	decreased circulating HDL cholesterol level	J:211773
Slc38a2^{tm1a(KOMP)Wtsi}/Slc38a2⁺ (involves: C57BL/6N)	pulmonary edema	J:304644
Slc38a2^{tm1a(KOMP)Wtsi}/Slc38a2^{tm1a(KOMP)Wtsi} (involves: C57BL/6N)	cyanosis	J:304644
Slc38a3^m1Ingm/Slc38a3^m1Ingm (B6.C3Fe-Slc38a3^m1Ingm)	abnormal amino acid level	J:234835
	abnormal circulating amino acid level	J:234835
	abnormal insulin-like growth factor I level	J:234835
	decreased circulating alanine level	J:234835
	decreased circulating glucose level	J:234835
	decreased circulating insulin level	J:234835
	decreased circulating tyrosine level	J:234835
	decreased gamma-aminobutyric acid level	J:234835
	decreased glutamic acid level	J:234835
	decreased glutamine level	J:234835
	decreased leucine level	J:234835
	decreased phenylalanine level	J:234835
	decreased urine ammonia level	J:234835
	decreased urine urea nitrogen level	J:234835
	increased blood urea nitrogen level	J:234835
	increased circulating cysteine level	J:234835
	increased circulating histidine level	J:234835
	increased circulating homocysteine level	J:234835
	increased circulating leucine level	J:234835
	increased circulating threonine level	J:234835
	increased glutamine level	J:234835
Slc38a4^em#Smtb/Slc38a4⁺ (C57BL/6NSlc-Slc38a4^em#Ogu)	decreased circulating glutamine level	J:280426
	decreased circulating glycine level	J:280426
	decreased circulating histidine level	J:280426
	decreased circulating isoleucine level	J:280426
	decreased circulating serine level	J:280426
	decreased circulating valine level	J:280426
Slc38a4^em#Smtb/Slc38a4^em#Smtb (C57BL/6NSlc-Slc38a4^em#Ogu)	abnormal circulating amino acid level	J:280426
	decreased circulating glutamine level	J:280426
	decreased circulating histidine level	J:280426
	decreased circulating isoleucine level	J:280426
	decreased circulating lysine level	J:280426
Slc38a7^{em1(IMPC)Ccpcz}/Slc38a7^{em1(IMPC)Ccpcz} (C57BL/6NCrl-Slc38a7^{em1(IMPC)Ccpcz}/Ccpcz)	increased circulating creatine kinase level	J:211773
Slc38a8^em1Cya/Slc38a8^em1Cya (C57BL/6J-Slc38a8^em1Cya)	decreased aspartic acid level	J:336781
Slc38a8^em1Cya/Slc38a8^em1Cya (C57BL/6J-Slc38a8^em1Cya)	decreased circulating aspartate transaminase level	J:336781
Slc38a10^{tm1a(EUCOMM)Wtsi}/Slc38a10^{tm1a(EUCOMM)Wtsi} (C57BL/6N-Slc38a10^{tm1a(EUCOMM)Wtsi}/Wtsi)	decreased circulating alkaline phosphatase level	J:211773
	increased circulating iron level	J:211773
Slc38a10^{tm1a(EUCOMM)Wtsi}/Slc38a10^{tm1a(EUCOMM)Wtsi} (B6JTyr;B6N-Slc38a10^{tm1a(EUCOMM)Wtsi}/Wtsi)	decreased circulating alkaline phosphatase level	J:175295
	decreased circulating calcium level	J:175295
	decreased circulating total protein level	J:175295
Slc38a10^{tm1a(EUCOMM)Wtsi}/Slc38a10^{tm1a(EUCOMM)Wtsi} (involves: C57BL/6 * C57BL/6N)	decreased circulating amylase level	J:213427
	decreased circulating serum albumin level	J:213427
	increased circulating creatinine level	J:213427
	increased energy expenditure	J:213427
	increased oxygen consumption	J:213427
Slc38a10^{tm2a(EUCOMM)Wtsi}/Slc38a10^{tm2a(EUCOMM)Wtsi} (C57BL/6N-Slc38a10^{tm2a(EUCOMM)Wtsi}/H)	decreased circulating alkaline phosphatase level	J:165965
	decreased circulating amylase level	J:165965
	decreased circulating calcium level	J:165965
	decreased circulating serum albumin level	J:165965
	decreased circulating sodium level	J:165965
	decreased circulating total protein level	J:165965
	increased circulating potassium level	J:165965
	increased circulating triglyceride level	J:165965
Slc38a11^{tm2b(KOMP)Mbp}/Slc38a11^{tm2b(KOMP)Mbp} (C57BL/6N-Slc38a11^{tm2b(KOMP)Mbp}/Tcp)	increased circulating phosphate level	J:211773
Slc39a2^tm1Gka/Slc39a2^tm1Gka (involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * FVB/N)	abnormal calcium ion homeostasis	J:121899
	abnormal liver iron level	J:121899
Slc39a4^{tm1.1(KOMP)Wtsi}/Slc39a4⁺ (C57BL/6N-Slc39a4^{tm1.1(KOMP)Wtsi}/Ucd)	increased fasting circulating glucose level	J:211773
Slc39a4^tm2Gka/Slc39a4^tm2Gka Tg(Vil1-cre/ERT2)23Syr/0 (involves: 129P2/OlaHsd * C57BL/6 * DBA/2)	abnormal copper level	J:187178
	abnormal mineral homeostasis	J:187178
	abnormal zinc homeostasis	J:187178
	decreased intestinal iron level	J:187178
	decreased intestine copper level	J:187178
	decreased liver copper level	J:187178
	increased liver copper level	J:187178
	increased liver iron level	J:187178
Slc39a5^tm1.1Gka/Slc39a5^tm1.1Gka (involves: 129P2/OlaHsd * C57BL/6 * FVB/N)	abnormal liver zinc level	J:209760
	abnormal zinc homeostasis	J:209760
Slc39a5^{tm1b(KOMP)Wtsi}/Slc39a5^{tm1b(KOMP)Wtsi} (C57BL/6N-Slc39a5^{tm1b(KOMP)Wtsi}/Ucd)	decreased circulating serum albumin level	J:211773
	increased circulating alkaline phosphatase level	J:211773
Slc39a5^tm1Gka/Slc39a5^tm1Gka Tg(Cela1-cre/ERT)1Lgdn/0 (involves: 129P2/OlaHsd * C57BL/6)	abnormal zinc homeostasis	J:209760
	decreased liver iron level	J:209760
Slc39a5^tm1Gka/Slc39a5^tm1Gka Tg(Vil1-cre/ERT2)23Syr/0 (involves: 129P2/OlaHsd * C57BL/6 * DBA/2)	abnormal zinc homeostasis	J:209760
Slc39a8^em1Xijl/Slc39a8^em1Xijl (involves: C57BL/6J)	decreased brain zinc level	J:342738
Slc39a8^em1Xijl/Slc39a8^em1Xijl (involves: C57BL/6J)	increased circulating zinc level	J:342738
Slc39a8^tm1.1Brvo/Slc39a8^tm1.1Brvo (involves: C57BL/6)	abnormal homeostasis	J:341571
	decreased circulating glucose level	J:341571
	increased circulating glucose level	J:341571
	increased circulating insulin level	J:341571
	increased circulating phosphate level	J:341571
	increased insulin secretion	J:341571
	increased urine glucose level	J:341571
	insulin resistance	J:341571
Slc39a8^tm1.2Mrl/Slc39a8^tm1.2Mrl (B6(Cg)-Slc39a8^tm1.2Mrl)	abnormal zinc level	J:258360
Slc39a8^tm1.2Mrl/Slc39a8^tm1.2Mrl (B6(Cg)-Slc39a8^tm1.2Mrl)	edema	J:258360
Slc39a8^{tm1b(EUCOMM)Wtsi}/Slc39a8⁺ (C57BL/6N-Slc39a8^{tm1b(EUCOMM)Wtsi}/Cnrm)	increased circulating triglyceride level	J:211773
Slc39a10^tm1.1Tfk/Slc39a10^tm1.1Tfk Tg(KRT14-cre)1Amc/0 (involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * CBA)	impaired skin barrier function	J:254216
Slc39a14^tm1Lex/Slc39a14^tm1Lex (involves: 129S5/SvEvBrd * C57BL/6J)	abnormal liver zinc level	J:236296
	increased circulating alanine transaminase level	J:236296
Slc39a14^tm1Thir/Slc39a14^tm1Thir (involves: 129 * C57BL/6)	abnormal gluconeogenesis	J:171670
	abnormal growth hormone level	J:171670
	abnormal liver zinc level	J:171670
	decreased circulating insulin-like growth factor I level	J:171670
Slc40a1^ffe/Slc40a1⁺ (either: (involves: 129X1/SvJ * C57BL/6J) or (involves: C3H/HeJ * C57BL/6J))	increased circulating ferritin level	J:118592
	increased circulating unsaturated transferrin level	J:118592
	increased liver iron level	J:118592
Slc40a1^ffe/Slc40a1^ffe (involves: C3H/HeJ * C57BL/6J)	edema	J:118592
Slc40a1^Pcm/Slc40a1⁺ (A.Cg-Slc40a1^Pcm)	decreased liver iron level	J:98335
Slc40a1^Pcm/Slc40a1⁺ (A.Cg-Slc40a1^Pcm)	decreased spleen iron level	J:98335
Slc40a1^Pcm/Slc40a1^Pcm (A.Cg-Slc40a1^Pcm)	decreased circulating iron level	J:89185
	decreased liver iron level	J:98335
	decreased spleen iron level	J:98335
	increased liver iron level	J:89185
Slc40a1^tm1.1Mmfe/Slc40a1⁺ (involves: 129P2/OlaHsd * C57BL/6)	abnormal enzyme/coenzyme level	J:215585
	abnormal iron homeostasis	J:215585
	decreased circulating unsaturated transferrin level	J:215585
	decreased spleen iron level	J:215585
	increased circulating ferritin level	J:215585
	increased circulating iron level	J:215585
	increased circulating lipase level	J:215585
	increased liver iron level	J:215585
	increased pancreas iron level	J:215585
Slc40a1^tm1.1Mmfe/Slc40a1^tm1.1Mmfe (involves: 129P2/OlaHsd * C57BL/6)	abnormal enzyme/coenzyme level	J:215585
	abnormal iron homeostasis	J:215585
	decreased circulating unsaturated transferrin level	J:215585
	decreased intestinal iron level	J:215585
	decreased spleen iron level	J:215585
	hemochromatosis	J:215585
	increased brain iron level	J:215585
	increased circulating ferritin level	J:215585
	increased circulating iron level	J:215585
	increased circulating lipase level	J:215585
	increased heart iron level	J:215585
	increased kidney iron level	J:215585
	increased liver iron level	J:215585
	increased pancreas iron level	J:215585
Slc40a1^{tm1b(EUCOMM)Hmgu}/Slc40a1⁺ (C57BL/6N-Slc40a1^{tm1b(EUCOMM)Hmgu}/H)	increased circulating triglyceride level	J:211773
Slc40a1^tm1Nca/Slc40a1⁺ (involves: 129S4/SvJae * 129S6/SvEvTac)	decreased liver iron level	J:129846
	increased spleen iron level	J:129846
Slc40a1^tm2Nca/Slc40a1^tm2Nca Tg(Vil1-cre/ERT2)23Syr/0 (involves: 129S4/SvJae * 129S6/SvEvTac * C57BL/6 * DBA/2)	decreased liver iron level	J:129846
	decreased spleen iron level	J:129846
	increased intestinal iron level	J:129846
Slc41a1^tm1.1Geno/Slc41a1^tm1.1Geno Slc41a3^{tm1a(KOMP)Wtsi}/Slc41a3^{tm1a(KOMP)Wtsi} (involves: C57BL/6 * C57BL/6N)	decreased circulating magnesium level	J:344881
Slc41a3^{tm1a(KOMP)Wtsi}/Slc41a3^{tm1a(KOMP)Wtsi} (involves: C57BL/6J * C57BL/6N)	abnormal magnesium ion homeostasis	J:236099
	decreased circulating magnesium level	J:236099
Slc41a3^{tm1a(KOMP)Wtsi}/Slc41a3^{tm1a(KOMP)Wtsi} (involves: C57BL/6 * C57BL/6N)	decreased circulating magnesium level	J:344881
Slc43a2^{Gt(258C1)Cmhd}/Slc43a2^{Gt(258C1)Cmhd} (involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * CD-1)	abnormal amino acid level	J:237439
	abnormal amniotic fluid composition	J:237439
	abnormal circulating amino acid level	J:237439
	abnormal circulating glucose level	J:237439
	decreased circulating alanine level	J:237439
	decreased circulating histidine level	J:237439
	decreased circulating proline level	J:237439
	decreased circulating serine level	J:237439
	decreased fasting circulating glucose level	J:237439
	increased circulating carnitine level	J:237439
	increased fatty acids level	J:237439
Slc44a3^{tm1b(EUCOMM)Wtsi}/Slc44a3^{tm1b(EUCOMM)Wtsi} (C57BL/6N-Slc44a3^{tm1b(EUCOMM)Wtsi}/Ieg)	increased circulating alkaline phosphatase level	J:211773
Slc44a4^{tm1b(EUCOMM)Hmgu}/Slc44a4^{tm1b(EUCOMM)Hmgu} (C57BL/6N-Slc44a4^{tm1b(EUCOMM)Hmgu}/Ieg)	increased circulating bilirubin level	J:211773
	increased fasting circulating glucose level	J:211773
Slc46a1^{tm1b(KOMP)Mbp}/Slc46a1⁺ (C57BL/6N-Slc46a1^{tm1b(KOMP)Mbp}/J)	decreased circulating glucose level	J:211773
	decreased circulating iron level	J:211773
	increased circulating aspartate transaminase level	J:211773
	increased circulating bilirubin level	J:211773
	increased circulating potassium level	J:211773
Slc46a1^tm1Hija/Slc46a1^tm1Hija (involves: 129S5/SvEvBrd * C57BL/6J)	abnormal amino acid level	J:150548
	increased circulating homocysteine level	J:150548
Slc46a3^{tm1.1(KOMP)Vlcg}/Slc46a3^{tm1.1(KOMP)Vlcg} (C57BL/6N-Slc46a3^{tm1.1(KOMP)Vlcg}/J)	decreased circulating iron level	J:211773
	increased circulating cholesterol level	J:211773
	increased circulating HDL cholesterol level	J:211773
Slc47a1^{tm1b(EUCOMM)Wtsi}/Slc47a1^{tm1b(EUCOMM)Wtsi} (C57BL/6N-Slc47a1^{tm1b(EUCOMM)Wtsi}/Ieg)	decreased circulating phosphate level	J:211773
	increased circulating total protein level	J:211773
Slc47a1^tm1Kinu/Slc47a1^tm1Kinu (C57BL/6-Slc47a1^tm1Kinu)	increased blood urea nitrogen level	J:163959
Slc47a1^tm1Kinu/Slc47a1^tm1Kinu (C57BL/6-Slc47a1^tm1Kinu)	increased circulating creatinine level	J:163959
Slc47a2^{tm1.1(KOMP)Vlcg}/Slc47a2^{tm1.1(KOMP)Vlcg} (C57BL/6N-Slc47a2^{tm1.1(KOMP)Vlcg}/Ucd)	increased circulating alanine transaminase level	J:211773
Slc48a1^em1Ih/Slc48a1^em1Ih (involves: 129 * C57BL/6J)	abnormal calcium level	J:282829
	abnormal copper level	J:282829
	abnormal iron level	J:282829
	abnormal sulfate level	J:282829
	increased circulating ferritin level	J:282829
	increased liver iron level	J:282829
	increased spleen iron level	J:282829
Slc50a1^{tm1.1(KOMP)Vlcg}/Slc50a1^{tm1.1(KOMP)Vlcg} (C57BL/6N-Slc50a1^{tm1.1(KOMP)Vlcg}/J)	increased circulating alanine transaminase level	J:211773
Slc51a^tm1Pda/Slc51a^tm1Pda (involves: 129S6/SvEvTac * C57BL/6J)	abnormal bile salt homeostasis	J:132778
	abnormal bile salt level	J:132778
	abnormal cholesterol level	J:132778
	decreased circulating cholesterol level	J:132778
	decreased circulating triglyceride level	J:132778
Slc51b^em1(IMPC)Mbp/Slc51b^em1(IMPC)Mbp (C57BL/6NCrl-Slc51b^em1(IMPC)Mbp/Mmucd)	increased circulating alkaline phosphatase level	J:211773
Slc52a3^tm1.1Said/Slc52a3^tm1.1Said Tg(Vil1-cre)997Gum/0 (involves: 129S6/SvEvTac * C57BL/6J * C57BL/6N * SJL)	abnormal vitamin level	J:278571
Slc52a3^{tm2a(KOMP)Wtsi}/Slc52a3^{tm2a(KOMP)Wtsi} (involves: C57BL/6N)	abnormal lipid homeostasis	J:236029
	abnormal vitamin homeostasis	J:236029
	abnormal vitamin level	J:236029
	decreased fatty acid beta-oxidation	J:236029
	glutaricadicuria	J:236029
	hyperlipidemia	J:236029
	hypoglycemia	J:236029
	increased circulating carnitine level	J:236029
Slco1a1^tm1Dgen/Slco1a1^tm1Dgen (B6N.129P2-Slco1a1^tm1Dgen)	abnormal blood homeostasis	J:174999
Slco1a1^tm1Dgen/Slco1a1^tm1Dgen (B6N.129P2-Slco1a1^tm1Dgen)	abnormal urine homeostasis	J:174999
Slco1a4^tm1Dgen/Slco1a4^tm1Dgen (B6N.129P2-Slco1a4^tm1Dgen)	abnormal blood homeostasis	J:174999
Slco1a4^tm1Dgen/Slco1a4^tm1Dgen (B6N.129P2-Slco1a4^tm1Dgen)	abnormal urine homeostasis	J:174999
Slco1b2^em1(IMPC)Mbp/Slco1b2^em1(IMPC)Mbp (C57BL/6NCrl-Slco1b2^em1(IMPC)Mbp/MbpMmucd)	increased circulating bilirubin level	J:211773
Slco1b2^tm1Cdk/Slco1b2^tm1Cdk (B6.129S1-Slco1b2^tm1Cdk)	abnormal circulating mineral level	J:133919
	abnormal circulating protein level	J:133919
	abnormal circulating serum albumin level	J:133919
	decreased circulating amylase level	J:133919
	increased circulating alanine transaminase level	J:133919
	increased circulating bilirubin level	J:133919
	increased circulating chloride level	J:133919
	increased circulating cholesterol level	J:133919
	increased circulating sodium level	J:133919
	increased circulating total protein level	J:133919
Slco1c1^tm1.1Arte/Slco1c1^tm1.1Arte (involves: C57BL/6)	decreased thyroxine level	J:180950
Slco1c1^tm1.1Arte/Slco1c1^tm1.1Arte (involves: C57BL/6)	decreased triiodothyronine level	J:180950
Slco2a1^tm1.2Vsch/Slco2a1^tm1.2Vsch (involves: 129S4/SvJaeSor * 129S6/SvEvTac * C57BL/6 * FVB/N)	abnormal prostaglandin level	J:168442
	abnormal urine homeostasis	J:168442
Slco2b1^{tm1d(KOMP)Wtsi}/Slco2b1^{tm1d(KOMP)Wtsi} (involves: C57BL/6N)	increased blood urea nitrogen level	J:287311
Slco3a1^em1Smoc/Slco3a1^em1Smoc (C57BL/6J-Slco3a1^em1Smoc/Smoc)	abnormal bile salt homeostasis	J:279167
	increased bile salt level	J:279167
	increased circulating alanine transaminase level	J:279167
	increased circulating aspartate transaminase level	J:279167
Slfn2^m1Btlr/Slfn2^m1Btlr (C57BL/6J-Slfn2^m1Btlr)	abnormal nitric oxide homeostasis	J:158985
Slfn4^{tm1c(EUCOMM)Wtsi}/Slfn4^{tm1c(EUCOMM)Wtsi} Gli1^{tm3(cre/ERT2)Alj}/Gli1⁺ (involves: 129S6/SvEvTac * Black Swiss * C57BL/6 * Swiss Webster)	abnormal interleukin level	J:337060
	abnormal tumor necrosis factor level	J:337060
Slfn14^em1Nvm/Slfn14⁺ (C57BL/6J-Slfn14^em1Nvm)	abnormal thrombosis	J:325381
Slitrk1^{tm1.1(KOMP)Vlcg}/Slitrk1^{tm1.1(KOMP)Vlcg} (C57BL/6N-Slitrk1^{tm1.1(KOMP)Vlcg}/Ucd)	improved glucose tolerance	J:211773
	increased circulating alanine transaminase level	J:211773
	increased circulating aspartate transaminase level	J:211773
Slitrk1^tm1Jaru/Slitrk1^tm1Jaru (B6.129P2-Slitrk1^tm1Jaru)	abnormal noradrenaline level	J:145441
Slitrk2^tm1.1Jaru/Slitrk2^tm1.1Jaru (B6.129P2-Slitrk2^tm1.1Jaru)	abnormal dopamine level	J:326787
	abnormal serotonin level	J:326787
Slitrk4^{tm1b(KOMP)Wtsi}/Y (C57BL/6N-Slitrk4^{tm1b(KOMP)Wtsi}/Wtsi)	increased circulating calcium level	J:211773
Sln^tm1Peri/Sln^tm1Peri (involves: C57BL/6J)	decreased body temperature	J:193427
	decreased oxygen consumption	J:193427
	impaired adaptive thermogenesis	J:193427
	impaired glucose tolerance	J:193427
	increased circulating cholesterol level	J:193427
	increased circulating glucose level	J:193427
	increased circulating triglyceride level	J:193427
	increased susceptibility to diet-induced obesity	J:193427
Slpi^tm1Smw/Slpi^tm1Smw (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	increased transforming growth factor beta level	J:65241
Slpi^tm1Smw/Slpi^tm1Smw (involves: 129S1/Sv * 129X1/SvJ)	abnormal platelet physiology	J:95293
Slurp1^tm1Lex/Slurp1^tm1Lex (Not Specified)	decreased circulating cholesterol level	J:210836
	decreased circulating insulin level	J:210836
	decreased circulating leptin level	J:210836
	decreased circulating triglyceride level	J:210836
	decreased susceptibility to diet-induced obesity	J:210836
	impaired skin barrier function	J:210836
	increased carbon dioxide production	J:210836
	increased oxygen consumption	J:210836
	increased respiratory quotient	J:210836
Slurp2^tm1.1Sgy/Slurp2^tm1.1Sgy (involves: 129P2/OlaHsd * C57BL/6)	impaired skin barrier function	J:231067
Slurp2^tm1Lex/Slurp2^tm1Lex (involves: 129P2/OlaHsd * 129S5/SvEvBrd * C57BL/6)	decreased circulating cholesterol level	J:231067
	increased oxygen consumption	J:231067
Slx1b^em1(IMPC)Ics/Slx1b⁺ (C57BL/6N-Slx1b^em1(IMPC)Ics/Ics)	increased circulating alkaline phosphatase level	J:211773
Slx4^{tm1a(EUCOMM)Wtsi}/Slx4^{tm1a(EUCOMM)Wtsi} (C57BL/6N-Slx4^{tm1a(EUCOMM)Wtsi})	impaired glucose tolerance	J:168567
	increased circulating glucose level	J:168567
SMA010/SMA010 (C3HeB/FeJ-SMA010)	increased circulating alkaline phosphatase level	J:183993
SMA010/SMA010 (C3HeB/FeJ-SMA010)	increased circulating calcium level	J:183993
Smad2^tm1Rob/Smad2^tm2Rob Edil3^{Tg(Sox2-cre)1Amc}/Edil3⁺ (involves: 129S/SvEv * C57BL/6 * CBA * CD-1)	pericardial edema	J:84300
Smad3^em1(IMPC)H/Smad3⁺ (C57BL/6NTac-Smad3^em1(IMPC)H/H)	decreased circulating alkaline phosphatase level	J:211773
Smad3^tm1Cxd/Smad3^tm1Cxd (involves: 129S6/SvEvTac * C57BL/6)	increased circulating creatinine level	J:137529
Smad3^tm1Par/Smad3^tm1Par (129-Smad3^tm1Par/J)	abnormal circulating interleukin-6 level	J:175290
	decreased blood urea nitrogen level	J:175290
	decreased circulating creatinine level	J:175290
Smad3^tm1Sche/Smad3^tm1Sche (B6.129P2-Smad3^tm1Sche)	decreased blood urea nitrogen level	J:145114
Smad3^tm1Sche/Smad3^tm1Sche (B6.129P2-Smad3^tm1Sche)	decreased circulating creatinine level	J:145114
Smad5^tm1Zuk/Smad5^tm1Zuk (involves: 129S7/SvEvBrd * C57BL/6)	edema	J:53293
Smad6^tm1Glvn/Smad6^tm1Glvn (involves: 129S6/SvEvTac * BALB/cByJ)	abnormal thrombosis	J:60214
Smad7^tm1.1Ink/Smad7^tm1.1Ink Tg(Cd4-cre)1Cwi/0 (involves: C57BL/6 * DBA/2)	increased transforming growth factor beta level	J:184670
Smad7^tm1.1Shou/Smad7^tm1.1Shou (involves: C57BL/6 * FVB)	skin edema	J:145777
Smad7^tm1Shou/Smad7^tm1Shou Tg(Tek-cre)12Flv/0 (involves: C3H * C57BL/6)	skin edema	J:145777
Smarca2^em1(IMPC)J/Smarca2^em1(IMPC)J (C57BL/6NJ-Smarca2^em1(IMPC)J/Mmjax)	increased circulating aspartate transaminase level	J:211773
	increased circulating bilirubin level	J:211773
	increased circulating phosphate level	J:211773
Smarca2^tm1Mya/Smarca2^tm1Mya Smarca4^tm1.2Pcn/Smarca4^tm1.2Pcn Tg(KRT14-cre/ERT2)1Ipc/? (involves: 129S2/SvPas)	impaired skin barrier function	J:101729
Smarca4^tm1.1Pcn/Smarca4⁺ (involves: 129S2/SvPas * C57BL/6 * DBA/2)	cyanosis	J:172661
Smarca4^tm1.2Pcn/Smarca4^tm1.1Pcn Tg(Myh11-cre,-EGFP)2Mik/0 (involves: 129S2/SvPas * C57BL/6 * DBA/2)	cyanosis	J:172661
	pulmonary alveolar proteinosis	J:172661
Smarca4^tm1.2Pcn/Smarca4^tm1.2Pcn Tg(KRT14-cre)1Ipc/? (involves: 129S2/SvPas * C57BL/6 * SJL)	impaired skin barrier function	J:101729
Smarca4^tm1.2Pcn/Smarca4^tm1.2Pcn Tg(KRT14-cre/ERT2)1Ipc/? (involves: 129S2/SvPas)	impaired skin barrier function	J:101729
Smarcal1^tm1.1Cfbo/Smarcal1^tm1.1Cfbo (either: B6.129-Smarcal1^tm1.1Cfbo or (involves: 129 * C57BL/6))	albuminuria	J:183899
Smarcal1^{tm1a(EUCOMM)Wtsi}/Smarcal1^{tm1a(EUCOMM)Wtsi} (C57BL/6N-Smarcal1^{tm1a(EUCOMM)Wtsi}/Wtsi)	increased circulating alkaline phosphatase level	J:175295
Smarcb1^tm1Mya/Smarcb1^tm2Mya Tg(Alb1-cre)7Gsc/0 (involves: 129S2/SvPas * FVB/N)	decreased glycogen catabolism rate	J:103919
	decreased liver glycogen level	J:103919
	hypoglycemia	J:103919
	impaired gluconeogenesis	J:103919
Smarcd1^tm1.1Jddl/Smarcd1^tm1.1Jddl Speer6-ps1^{Tg(Alb-cre)21Mgn}/Speer6-ps1⁺ (involves: C57BL/6 * DBA)	decreased bile salt level	J:228944
	decreased circulating alanine transaminase level	J:228944
	decreased circulating aspartate transaminase level	J:228944
	decreased circulating cholesterol level	J:228944
	decreased circulating HDL cholesterol level	J:228944
	decreased circulating LDL cholesterol level	J:228944
	decreased circulating VLDL cholesterol level	J:228944
	decreased intestinal cholesterol absorption	J:228944
	increased cholesterol level	J:228944
	increased liver cholesterol level	J:228944
Smarcd2^{tm1.1(KOMP)Vlcg}/Smarcd2⁺ (C57BL/6N-Smarcd2^{tm1.1(KOMP)Vlcg}/Ucd)	edema	J:211773
Smarcd2^{tm1.1(KOMP)Vlcg}/Smarcd2^{tm1.1(KOMP)Vlcg} (C57BL/6N-Smarcd2^{tm1.1(KOMP)Vlcg}/Ucd)	edema	J:211773
Smarce1^em1(IMPC)J/Smarce1⁺ (C57BL/6NJ-Smarce1^em1(IMPC)J/Mmjax)	decreased circulating calcium level	J:211773
Smc5^{tm1b(KOMP)Wtsi}/Smc5⁺ (C57BL/6N-Smc5^{tm1b(KOMP)Wtsi}/Ics)	decreased circulating cholesterol level	J:211773
	decreased circulating glucose level	J:211773
	decreased circulating HDL cholesterol level	J:211773
	increased circulating bilirubin level	J:211773
Smc6^tm1.1Arln/Smc6^tm1.1Arln (involves: 129P2/OlaHsd * C57BL/6 * FVB)	decreased circulating HDL cholesterol level	J:220422
	increased circulating calcium level	J:220422
	increased circulating glucose level	J:220422
Smc6^{tm1b(EUCOMM)Hmgu}/Smc6⁺ (C57BL/6N-Smc6^{tm1b(EUCOMM)Hmgu}/Ieg)	increased circulating serum albumin level	J:211773
Smcr8^em1Btlr/Smcr8^em1Btlr (C57BL/6J-Smcr8^em1Btlr)	increased circulating interleukin-12b level	J:268243
Smcr8^em2Btlr/Smcr8^em2Btlr (C57BL/6J-Smcr8^em2Btlr)	increased circulating interleukin-12b level	J:268243
Smcr8^{tm1(KOMP)Vlcg}/Smcr8^{tm1(KOMP)Vlcg} (involves: 129S1/SvImJ * C57BL/6NTac)	abnormal protein level	J:236977
Smcr8^{tm1.1(KOMP)Vlcg}/Smcr8^{tm1.1(KOMP)Vlcg} (involves: 129S1/SvImJ * C57BL/6J * C57BL/6NTac)	abnormal protein level	J:236977
Smg1^{Gt(AG0297)Wtsi}/Smg1⁺ (involves: 129P2/OlaHsd * C57BL/6)	decreased circulating interleukin-1 beta level	J:193626
	increased circulating interleukin-6 level	J:193626
Smg1^{tm1b(EUCOMM)Hmgu}/Smg1⁺ (C57BL/6N-Smg1^{tm1b(EUCOMM)Hmgu}/Wtsi)	increased circulating bilirubin level	J:211773
Smg9^em1(IMPC)J/Smg9⁺ (C57BL/6NJ-Smg9^em1(IMPC)J/J)	decreased circulating glucose level	J:211773
Smg9^em1(IMPC)J/Smg9^em1(IMPC)J (involves: C57BL/6NJ)	edema	J:231968
Smg9^{tm1b(EUCOMM)Wtsi}/Smg9^{tm1b(EUCOMM)Wtsi} (C57BL/6N-Smg9^{tm1b(EUCOMM)Wtsi}/Wtsi)	subcutaneous edema	J:239583
Smim8^{tm1.1(KOMP)Vlcg}/Smim8^{tm1.1(KOMP)Vlcg} (C57BL/6N-Smim8^{tm1.1(KOMP)Vlcg}/Ucd)	increased circulating alkaline phosphatase level	J:211773
	increased circulating phosphate level	J:211773
Smn1^tm1Hung/Smn1^tm1Hung Tg(SMN2)2Hung/Tg(SMN2)2Hung (involves: 129P2/OlaHsd * FVB/N)	extremity edema	J:59313
Smn1^tm1Jme/Smn1^tm1.1Jme Tg(ACTA1-cre)79Jme/0 (involves: 129 * C57BL/6J * SJL)	increased circulating creatine kinase level	J:67884
Smo^bnb/Smo^bnb (involves: C3H/HeJ * C57BL/6J)	pericardial edema	J:48268
Smo^tm1Amc/Smo^tm1Amc Tulp3^hhkr/Tulp3^hhkr (involves: 129X1/SvJ * C3H/HeH * C57BL/6)	pericardial edema	J:147584
Smoc1^{tm1b(EUCOMM)Wtsi}/Smoc1⁺ (C57BL/6N-Smoc1^{tm1b(EUCOMM)Wtsi}/H)	decreased circulating iron level	J:211773
Smoc2^{tm1.1(KOMP)Vlcg}/Smoc2^{tm1.1(KOMP)Vlcg} (C57BL/6N-Smoc2^{tm1.1(KOMP)Vlcg}/J)	increased circulating phosphate level	J:211773
	increased circulating sodium level	J:211773
Smpd1^tm1Esc/Smpd1^tm1Esc (involves: 129S1/Sv * C57BL/6J)	abnormal lipid homeostasis	J:26732
Smpd1^tm1Esc/Smpd1^tm1Esc (involves: 129S1/Sv * C57BL/6J)	increased circulating HDL cholesterol level	J:26732
Smpd1^tm1Esc/Smpd1^tm1Esc (involves: 129S1/Sv)	abnormal ceramide level	J:199833
Smpd1^tm1Wst/Smpd1^tm1Wst (involves: 129P2/OlaHsd * C57BL/6)	abnormal lipid homeostasis	J:26748
Smpd3^fro/Smpd3^fro (Not Specified)	cyanosis	J:3906
Smpd3^fro/Smpd3^fro (Not Specified)	increased circulating parathyroid hormone level	J:7673, J:100158
Smpd3^fro/Smpd3^fro (involves: C3H/HeN * C57BL/6N)	abnormal lipid level	J:193949
Smpd3^tm1Wst/Smpd3^tm1Wst (involves: 129S1/Sv)	decreased circulating cortisol level	J:97284
	decreased circulating insulin-like growth factor I level	J:97284
	decreased thyroxine level	J:97284
	decreased triiodothyronine level	J:97284
Smpdl3b^{tm1a(EUCOMM)Wtsi}/Smpdl3b^{tm1a(EUCOMM)Wtsi} (C57BL/6-Smpdl3b^{tm1a(EUCOMM)Wtsi})	abnormal circulating chemokine level	J:224870
	increased circulating interleukin-6 level	J:224870
	increased circulating interleukin-12b level	J:224870
	increased circulating tumor necrosis factor level	J:224870
Sms^{tm1a(EUCOMM)Wtsi}/Y (B6JTyr;B6N-Sms^{tm1a(EUCOMM)Wtsi}/Wtsi)	decreased circulating glucose level	J:175295
	decreased circulating potassium level	J:175295
	increased blood urea nitrogen level	J:175295
Smyd2^{tm1a(KOMP)Wtsi}/Smyd2^{tm1a(KOMP)Wtsi} (B6JTyr;B6N-Smyd2^{tm1a(KOMP)Wtsi}/Wtsi)	increased circulating HDL cholesterol level	J:175295
	increased circulating LDL cholesterol level	J:175295
Snap25^Bdr/Snap25⁺ (involves: BALB/cAnNCrl)	decreased glucagon secretion	J:119733
Snap25^Bdr/Snap25⁺ (involves: BALB/cAnNCrl)	decreased insulin secretion	J:119733
Snap25^tm1.1Bark/Snap25^tm1.1Bark (Not Specified)	abnormal insulin secretion	J:226064
	decreased circulating ghrelin level	J:226064
	hyperglycemia	J:226064
	improved glucose tolerance	J:226064
	increased circulating cholesterol level	J:226064
	increased circulating insulin level	J:226064
	increased circulating leptin level	J:226064
	increased circulating triglyceride level	J:226064
	increased susceptibility to diet-induced obesity	J:226064
	insulin resistance	J:226064
Snap25^tm1Mtaka/Snap25^tm1Mtaka (B6N.129P2-Snap25^tm1Mtaka)	abnormal dopamine level	J:177870
Snap25^tm1Mtaka/Snap25^tm1Mtaka (B6N.129P2-Snap25^tm1Mtaka)	abnormal serotonin level	J:177870
Snap29^{tm1c(EUCOMM)Wtsi}/Snap29^{tm1c(EUCOMM)Wtsi} Tg(KRT14-cre)1Cgn/0 (involves: C57BL/6 * C57BL/6N * DBA/2)	impaired skin barrier function	J:236759
Snapc1^{tm1b(KOMP)Mbp}/Snapc1⁺ (C57BL/6N-Snapc1^{tm1b(KOMP)Mbp}/H)	increased circulating potassium level	J:211773
Snapin^{tm1.1(KOMP)Vlcg}/Snapin⁺ (C57BL/6N-Snapin^{tm1.1(KOMP)Vlcg}/J)	increased circulating alanine transaminase level	J:211773
	increased circulating potassium level	J:211773
	increased circulating sodium level	J:211773
Snca^em1(IMPC)H/Snca^em1(IMPC)H (C57BL/6NTac-Snca^em1(IMPC)H/H)	increased circulating alanine transaminase level	J:211773
	increased circulating amylase level	J:211773
	increased circulating creatinine level	J:211773
	increased fasting circulating glucose level	J:211773
Snca^tm1.1Koks/Snca⁺ (either: B6.129P2-Snca^tm1.1Koks or (involves: 129P2/OlaHsd * C57BL/6))	decreased dopamine level	J:201391
Snca^tm1Rosl/Snca^tm1Rosl (involves: 129X1/SvJ * C57BL/6)	decreased dopamine level	J:60151
Snca^tm1Rosl/Snca^tm1Rosl Tg(SNCA)OVX37Rwm/0 (B6.Cg-Tg(SNCA)OVX37Rwm Snca^tm1Rosl)	increased dopamine level	J:201991
Snca^tm1Rosl/Snca^tm1Rosl Tg(SNCAA30P)192Rwm/0 (B6.Cg-Snca^tm1Rosl Tg(SNCAA30P)#Rwm)	decreased dopamine level	J:201961
Snca^tm1Sud/Snca^tm1Sud Sncb^tm1.1Sud/Sncb^tm1.1Sud (involves: 129P2/OlaHsd * 129S1/Sv * 129X1/SvJ)	decreased dopamine level	J:93544
Sncb^{tm1b(EUCOMM)Hmgu}/Sncb^{tm1b(EUCOMM)Hmgu} (C57BL/6N-Sncb^{tm1b(EUCOMM)Hmgu}/H)	impaired glucose tolerance	J:211773
Snd1^em1(IMPC)Tcp/Snd1⁺ (C57BL/6NCrl-Snd1^em1(IMPC)Tcp/Tcp)	increased circulating alanine transaminase level	J:211773
Snf8^{tm1a(EUCOMM)Wtsi}/Snf8⁺ (C57BL/6N-Snf8^{tm1a(EUCOMM)Wtsi}/Wtsi)	decreased circulating free fatty acids level	J:165965
Snip1^{tm1a(EUCOMM)Wtsi}/Snip1⁺ (B6JTyr;B6N-Snip1^{tm1a(EUCOMM)Wtsi}/Wtsi)	decreased circulating total protein level	J:175295
Snorc^tm1Lex/Snorc^tm1Lex (B6;129S5-Snorc^tm1Lex/Mmucd)	decreased circulating triglyceride level	J:171883
Snord116^tm1.1Uta/Snord116⁺ (involves: C57BL/6J)	abnormal homeostasis	J:131662
	decreased circulating glucose level	J:131662
	decreased circulating insulin-like growth factor I level	J:131662
	decreased susceptibility to diet-induced obesity	J:131662
	increased circulating ghrelin level	J:131662
	increased insulin sensitivity	J:131662
	increased oxygen consumption	J:131662
	increased respiratory quotient	J:131662
Snord116^tm1Uta/Snord116⁺ Tg(Zp3-cre)93Knw/0 (involves: C57BL/6J)	abnormal homeostasis	J:131427
	decreased circulating glucose level	J:131427
	decreased circulating insulin-like growth factor I level	J:131427
	decreased susceptibility to diet-induced obesity	J:131427
	increased circulating ghrelin level	J:131427
	increased insulin sensitivity	J:131427
	increased oxygen consumption	J:131427
	increased respiratory quotient	J:131427
Snrk^tm1.1Hxu/Snrk^tm1.1Hxu Tg(Adipoq-cre)1Evdr/0 (B6.Cg-Snrk^tm1.1Hxu Tg(Adipoq-cre)1Evdr)	abnormal circulating chemokine level	J:257980
	decreased core body temperature	J:257980
	decreased energy expenditure	J:257980
	impaired glucose tolerance	J:257980
	increased circulating free fatty acids level	J:257980
	increased circulating interleukin-6 level	J:257980
	increased circulating triglyceride level	J:257980
	increased circulating tumor necrosis factor level	J:257980
	insulin resistance	J:257980
Snrk^tm1Hxu/Snrk⁺ (C57BL/6-Snrk^tm1Hxu)	decreased triglyceride level	J:257980
Snrk^tm1Hxu/Snrk⁺ (C57BL/6-Snrk^tm1Hxu)	increased circulating glucose level	J:257980
Snrk^tm1Hxu/Snrk^tm1Hxu (C57BL/6-Snrk^tm1Hxu)	decreased circulating glucose level	J:257980
Snrk^tm1Rra/Snrk^tm1Rra (involves: C57BL/6J)	abnormal lipid level	J:218247
	decreased circulating free fatty acids level	J:218247
	decreased circulating triglyceride level	J:218247
	increased circulating cholesterol level	J:218247
Snrk^tm2Rra/Snrk^tm2Rra Tg(Myh6-cre)2182Mds/0 (involves: C57BL/6J * FVB/N)	abnormal lipid level	J:218247
Snrnp27^{tm1b(EUCOMM)Wtsi}/Snrnp27⁺ (C57BL/6N-Snrnp27^{tm1b(EUCOMM)Wtsi}/Wtsi)	decreased fasting circulating glucose level	J:211773
Snrnp40^em1Btlr/Snrnp40^swp (C57BL/6J-Snrnp40^em1Btlr/Snrnp40^swp)	increased circulating interferon-beta level	J:282417
	increased circulating interferon-gamma level	J:282417
	increased circulating interleukin-6 level	J:282417
	increased circulating interleukin-12 level	J:282417
	increased circulating interleukin-17 level	J:282417
	increased circulating tumor necrosis factor level	J:282417
Snrpn^tm2Cbr/Snrpn⁺ (involves: 129S1/Sv * C57BL/6)	decreased circulating glucose level	J:47318
Snrpn^tm2Cbr/Snrpn⁺ (involves: 129S1/Sv * C57BL/6)	dehydration	J:47318
Snta1^tm1Scf/Snta1^tm1Scf (involves: 129P2/OlaHsd * C57BL/6)	abnormal fluid regulation	J:81976
	abnormal nitric oxide homeostasis	J:76455
Sntn^em1(IMPC)Mbp/Sntn^em1(IMPC)Mbp (C57BL/6NCrl-Sntn^em1(IMPC)Mbp/Mmucd)	increased circulating alanine transaminase level	J:211773
Snx3^{tm1.1(KOMP)Vlcg}/Snx3⁺ (C57BL/6N-Snx3^{tm1.1(KOMP)Vlcg}/J)	increased blood urea nitrogen level	J:211773
Snx3^{tm1.1(KOMP)Vlcg}/Snx3^{tm1.1(KOMP)Vlcg} (C57BL/6N-Snx3^{tm1.1(KOMP)Vlcg}/J)	edema	J:211773
Snx5^Gt(XA155)Byg/Snx5^Gt(XA155)Byg (B6.129P2-Snx5^Gt(XA155)Byg)	cyanosis	J:199909
Snx5^{tm1a(KOMP)Wtsi}/Snx5^{tm1a(KOMP)Wtsi} (B6JTyr;B6N-Snx5^{tm1a(KOMP)Wtsi}/Wtsi)	decreased circulating alanine transaminase level	J:175295
	decreased circulating cholesterol level	J:175295
	decreased circulating HDL cholesterol level	J:175295
	decreased circulating LDL cholesterol level	J:175295
	decreased circulating potassium level	J:175295
Snx6^em1(IMPC)J/Snx6^em1(IMPC)J (C57BL/6NJ-Snx6^em1(IMPC)J/Mmjax)	increased circulating cholesterol level	J:211773
	increased circulating HDL cholesterol level	J:211773
Snx8^tm1Hbsh/Snx8^tm1Hbsh (Not Specified)	abnormal circulating chemokine level	J:254306
	decreased circulating CXCL10 level	J:254306
	decreased circulating tumor necrosis factor level	J:254306
Snx8^{tm2a(EUCOMM)Hmgu}/Snx8^{tm2a(EUCOMM)Hmgu} (C57BL/6N-Snx8^{tm2a(EUCOMM)Hmgu}/Wtsi)	decreased circulating alkaline phosphatase level	J:211773
	decreased circulating fructosamine level	J:211773
	decreased circulating serum albumin level	J:211773
	decreased circulating total protein level	J:211773
	increased circulating cholesterol level	J:211773
	increased circulating LDL cholesterol level	J:211773
Snx10^em1Ael/Snx10^em1Ael (involves: 129 * C57BL/6J * C57BL/6JOlaHsd)	abnormal blood homeostasis	J:289051
	decreased vitamin D level	J:289051
Snx10^em2Ael/Snx10^em2Ael (involves: 129 * C57BL/6J * C57BL/6JOlaHsd)	abnormal blood homeostasis	J:289051
	decreased vitamin D level	J:289051
Snx10^{tm1a(EUCOMM)Raba}/Snx10^{tm1a(EUCOMM)Raba} (involves: 129S4/SvJae * C57BL/6 * C57BL/6J)	decreased circulating calcium level	J:224711
	decreased vitamin D level	J:224711
	increased circulating parathyroid hormone level	J:224711
Snx12^em1(IMPC)J/Y (C57BL/6NJ-Snx12^em1(IMPC)J/Mmjax)	decreased circulating triglyceride level	J:211773
Snx14^em1(IMPC)H/Snx14⁺ (C57BL/6NTac-Snx14^em1(IMPC)H/H)	increased circulating amylase level	J:211773
Snx15^{tm1.1(KOMP)Vlcg}/Snx15^{tm1.1(KOMP)Vlcg} (C57BL/6N-Snx15^{tm1.1(KOMP)Vlcg}/J)	decreased circulating glucose level	J:211773
	increased circulating alkaline phosphatase level	J:211773
	increased circulating cholesterol level	J:211773
	increased circulating HDL cholesterol level	J:211773
Snx27^{tm1b(KOMP)Wtsi}/Snx27^{tm1b(KOMP)Wtsi} (C57BL/6N-Snx27^{tm1b(KOMP)Wtsi}/MbpMmucd)	edema	J:211773
Soat1^tm1Far/Soat1^tm1Far (involves: 129S4/SvJae * C57BL/6)	abnormal cholesterol homeostasis	J:37049
	abnormal lipid level	J:37049
	increased circulating cholesterol level	J:37049
	increased circulating HDL cholesterol level	J:37049
Soat1^tm1Ishi/Soat1^tm1Ishi (involves: 129S7/SvEvBrd * C57BL/6)	abnormal lipid homeostasis	J:63468
Soat1^tm1Ishi/Soat1^tm1Ishi Apoe^tm1Unc/Apoe^tm1Unc (involves: 129P2/OlaHsd * 129S7/SvEvBrd * C57BL/6)	abnormal lipid homeostasis	J:63468
	increased circulating cholesterol level	J:63468
	xanthoma	J:63468
Soat1^tm1Ishi/Soat1^tm1Ishi Ldlr^tm1Her/Ldlr^tm1Her (involves: 129S7/SvEvBrd * C57BL/6)	abnormal lipid homeostasis	J:63468
	increased circulating cholesterol level	J:63468
	xanthoma	J:63468
Soat2^tm1.1Llr/Soat2^tm1.1Llr Speer6-ps1^{Tg(Alb-cre)21Mgn}/Speer6-ps1⁺ (involves: 129S/SvEv * 129S4/SvJaeSor * C57BL/6 * DBA)	decreased circulating cholesterol level	J:184908
	decreased circulating LDL cholesterol level	J:184908
	decreased circulating VLDL cholesterol level	J:184908
	decreased liver cholesterol level	J:184908
	decreased liver triglyceride level	J:184908
	increased circulating triglyceride level	J:184908
Soat2^tm1.1Llr/Soat2^tm1.1Llr Tg(Vil1-cre)997Gum/0 (involves: 129S/SvEv * 129S4/SvJaeSor * C57BL/6J * SJL)	decreased cholesterol level	J:184908
	decreased circulating cholesterol level	J:184908
	decreased circulating VLDL cholesterol level	J:184908
	decreased intestinal cholesterol absorption	J:184908
	decreased liver cholesterol level	J:184908
	decreased liver triglyceride level	J:184908
	increased cholesterol level	J:184908
	increased circulating triglyceride level	J:184908
Soat2^tm1Far/Soat2^tm1Far (involves: 129S4/SvJae * C57BL/6J)	abnormal cholesterol homeostasis	J:82032
	decreased circulating cholesterol level	J:82032
	decreased circulating LDL cholesterol level	J:82032
	decreased circulating VLDL cholesterol level	J:82032
	decreased intestinal cholesterol absorption	J:82032
	increased circulating HDL cholesterol level	J:82032
	increased circulating triglyceride level	J:82032
Socs1^tm1Jni/Socs1⁺ (Not Specified)	abnormal cytokine level	J:91651
Socs1^tm1Jni/Socs1⁺ (Not Specified)	abnormal interleukin level	J:91651
Socs1^tm3.1Wehi/Socs1^tm3.1Wehi (C57BL/6-Socs1^tm3.1Wehi)	increased circulating interferon-gamma level	J:83009
Socs2^em1(IMPC)H/Socs2^em1(IMPC)H (C57BL/6NTac-Socs2^em1(IMPC)H/H)	increased circulating creatinine level	J:211773
Socs2^hg/Socs2^hg (involves: AKR/J * C3H/HeJ * C57BL/6J * DBA/2J)	abnormal energy expenditure	J:8237
	decreased energy expenditure	J:8237
Socs2^tm1Wehi/Socs2^tm1Wehi (C57BL/6-Socs2^tm1Wehi)	abnormal insulin-like growth factor I level	J:63006
Socs2^tm1Wehi/Socs2^tm1Wehi (C57BL/6-Socs2^tm1Wehi)	abnormal urine homeostasis	J:63006
Socs2^tm1Wehi/Socs2^tm1Wehi (involves: C57BL/6 * C57BL/6J)	abnormal circulating cytokine level	J:186227
	abnormal circulating hormone level	J:186227
	abnormal glucose homeostasis	J:186227
	decreased circulating growth hormone level	J:186227
	decreased circulating insulin-like growth factor I level	J:186227
	decreased liver triglyceride level	J:186227
	impaired glucose tolerance	J:186227
	increased circulating glucose level	J:186227
	increased circulating insulin level	J:186227
	increased circulating interferon-gamma level	J:186227
	increased circulating interleukin-1 beta level	J:186227
	increased skeletal muscle triglyceride level	J:186227
	insulin resistance	J:186227
Socs3^tm1Ayos/Socs3^tm1Ayos Tg(Nes-cre)1Kln/0 (involves: 129 * C57BL/6)	decreased circulating free fatty acids level	J:91796
	decreased circulating triglyceride level	J:91796
	improved glucose tolerance	J:91796
	increased insulin sensitivity	J:91796
Socs3^tm1Ayos/Socs3^tm1Ayos Tg(Syn1-cre)671Jxm/0 (involves: 129 * C57BL/6)	decreased circulating free fatty acids level	J:91796
	decreased circulating triglyceride level	J:91796
	improved glucose tolerance	J:91796
	increased insulin sensitivity	J:91796
Socs3^tm1Jni/Socs3⁺ (involves: 129P2/OlaHsd * C57BL/6)	decreased circulating leptin level	J:91797
Socs3^tm1Jni/Socs3⁺ (involves: 129P2/OlaHsd * C57BL/6)	decreased susceptibility to diet-induced obesity	J:91797
Socs3^tm1Jni/Socs3⁺ (B6.129P2-Socs3^tm1Jni)	decreased susceptibility to diet-induced obesity	J:91797
	improved glucose tolerance	J:91797
	increased insulin sensitivity	J:91797
Socs7^{tm1a(EUCOMM)Wtsi}/Socs7^{tm1a(EUCOMM)Wtsi} (involves: C57BL/6 * C57BL/6N)	decreased response to stress-induced hyperthermia	J:213427
Socs7^tm1Pbro/Socs7^tm1Pbro (B6.129S1-Socs7^tm1Pbro)	hypoglycemia	J:100915
Socs7^tm1Pbro/Socs7^tm1Pbro (involves: 129S1/Sv * C57BL/6)	abnormal glucose homeostasis	J:100915
	improved glucose tolerance	J:100915
	increased insulin sensitivity	J:100915
Sod1^tm1Dkd/Sod1^tm1Dkd (involves: 129S1/Sv * 129X1/SvJ)	abnormal enzyme/coenzyme level	J:60470
Sod1^tm1Leb/Sod1^tm1Leb (involves: 129S7/SvEvBrd * C57BL/6)	decreased circulating luteinizing hormone level	J:64299
	increased circulating interleukin-6 level	J:219024
	increased circulating tumor necrosis factor level	J:219024
	suppressed circulating follicle stimulating hormone level	J:64299
Sod2^tm1Cje/Sod2^tm1Cje (involves: C57BL/6J * CD-1)	calcinosis	J:29899
	decreased body surface temperature	J:29899
	decreased circulating lactate level	J:29899
	increased circulating ketone body level	J:29899
	metabolic acidosis	J:29899
	organic aciduria	J:52592
Sod2^tm1Cje/Sod2^tm1Cje (D2.Cg-Sod2^tm1Cje)	abnormal blood gas level	J:73998
	abnormal blood homeostasis	J:73998
	abnormal enzyme/coenzyme level	J:73998
	abnormal urine homeostasis	J:73998
	decreased circulating glucose level	J:73998
	hyperoxia	J:73998
	hypocapnia	J:73998
	increased blood urea nitrogen level	J:73998
	increased circulating alkaline phosphatase level	J:73998
	increased circulating aspartate transaminase level	J:73998
	increased circulating ketone body level	J:73998
	metabolic acidosis	J:73998
Sod2^tm1Cje/Sod2^tm1Cje (involves: C57BL/6J * DBA/2J)	abnormal blood homeostasis	J:73998
	abnormal blood pH regulation	J:73998
	abnormal enzyme/coenzyme level	J:73998
	abnormal urine homeostasis	J:73998
	acidosis	J:73998
	decreased circulating glucose level	J:73998
	hyperoxia	J:73998
	hypocapnia	J:73998
	increased blood urea nitrogen level	J:73998
	increased circulating ketone body level	J:73998
Sod2^tm1Leb/Sod2^tm1Leb (B6.129S7-Sod2^tm1Leb/J)	abnormal lipid homeostasis	J:36148
Sod2^tm1Shs/Sod2^tm1Shs Tg(Ckmm-cre)5Khn/0 (involves: C57BL/6CrSlc * FVB)	increased cardiac muscle glycogen level	J:117386
Sod2^tm1Shs/Sod2^tm1Shs Tg(TNNI2-icre)1Vrmn/0 (involves: C57BL/6)	abnormal enzyme/coenzyme level	J:155917
Sorbs1^tm1Krc/Sorbs1^tm1Krc (B6.129-Sorbs1^tm1Krc)	abnormal circulating insulin level	J:121762
	abnormal glucose homeostasis	J:121762
	decreased triglyceride level	J:121762
	improved glucose tolerance	J:121762
	increased insulin sensitivity	J:121762
Sorbs2^{tm1.1(KOMP)Mbp}/Sorbs2^{tm1.1(KOMP)Mbp} (C57BL/6N-Sorbs2^{tm1.1(KOMP)Mbp}/J)	decreased circulating glucose level	J:211773
	increased circulating alkaline phosphatase level	J:211773
	increased circulating sodium level	J:211773
Sorcs2^tm1Anyk/Sorcs2^tm1Anyk (B6.129-Sorcs2^tm1Anyk)	decreased dopamine level	J:214739
Sord^C57BL/Lia/Sord⁺ Tg(Cryaa-AKR1B1)222Smch/0 (involves: C57BL * CBA)	abnormal homeostasis	J:106642
Sord^C57BL/Lia/Sord⁺ Tg(Cryaa-AKR1B1)648Smch/0 (involves: C57BL * CBA)	abnormal homeostasis	J:106642
Sord^C57BL/Lia/Sord^C57BL/Lia Tg(Cryaa-AKR1B1)222Smch/Tg(Cryaa-AKR1B1)222Smch (involves: C57BL * CBA)	abnormal homeostasis	J:106642
Sord^C57BL/Lia/Sord^C57BL/Lia Tg(Cryaa-AKR1B1)648Smch/0 (involves: C57BL * CBA)	abnormal homeostasis	J:106642
Sord^C57BL/Lia/Sord^C57BL/Lia Tg(Cryaa-AKR1B1)648Smch/Tg(Cryaa-AKR1B1)648Smch (involves: C57BL * CBA)	abnormal homeostasis	J:106642
Sord^em1Mko/Sord^em1Mko (C57BL/6N-Sord^em1Mko)	impaired glucose tolerance	J:326078
Sord^em1Mko/Sord^em1Mko (C57BL/6N-Sord^em1Mko)	insulin resistance	J:326078
Sort1^tm1Camo/Sort1^tm1Camo (B6.129X1-Sort1^tm1Camo)	abnormal tumor necrosis factor level	J:157549
Sos1^tm1.2Rak/Sos1⁺ (involves: 129S/Sv * C57BL/6 * FVB/N * SJL)	pericardial effusion	J:171873
	skin edema	J:171873
Sos1^tm1.2Rak/Sos1^tm1.2Rak (involves: 129S/Sv * C57BL/6 * FVB/N * SJL)	pericardial effusion	J:171873
	skin edema	J:171873
Sox2^tm1Rlb/Sox2⁺ (involves: 129S/SvEv * MF1)	decreased adrenocorticotropin level	J:114458
	decreased growth hormone level	J:114458
	decreased luteinizing hormone level	J:114458
	decreased prolactin level	J:114458
	decreased thyroid-stimulating hormone level	J:114458
Sox2^tm3(TK)Hoch/Sox2⁺ (involves: 129S4/SvJae * C57BL/6)	edema	J:177655
Sox3^tm1Rlb/Y (involves: 129S7/SvEvBrd * MF1)	decreased follicle stimulating hormone level	J:88507
	decreased growth hormone level	J:88507
	decreased thyroid-stimulating hormone level	J:88507
Sox4^em1(IMPC)Mbp/Sox4⁺ (C57BL/6NCrl-Sox4^em1(IMPC)Mbp/MbpMmucd)	increased circulating alkaline phosphatase level	J:211773
Sox4^Igt4/Sox4⁺ (involves: C3H/HeH * C57BL/6)	decreased circulating insulin level	J:141688
	decreased insulin secretion	J:141688
	impaired glucose tolerance	J:141688
Sox4^Igt4/Del(13)36H (involves: 101/H * C3H/HeH * C57BL/6)	extremity edema	J:141688
Sox4^M91Ark/Sox4⁺ (involves: C3H/HeH)	decreased circulating insulin level	J:141688
	decreased insulin secretion	J:141688
	impaired glucose tolerance	J:141688
Sox4^tm1.1Vlf/Sox4^tm1.1Vlf (involves: 129 * C57BL/6 * SJL)	edema	J:130461
Sox4^tm1Cle/Sox4^tm1Cle (involves: 129P2/OlaHsd * C57BL/6)	hydrops fetalis	J:32741
Sox4^tm1Vlf/Sox4^tm1Vlf Tg(CAG-cre/Esr1)5Amc/0 (involves: 129 C57BL/6 * CBA * SJL)	edema	J:130461
Sox4^tm2Cle/Sox4^tm2Cle (involves: 129P2/OlaHsd * C57BL/6)	hydrops fetalis	J:32741
Sox5^tm1Vlf/Sox5^tm1Vlf Sox6^tm1Vlf/Sox6^tm1Vlf (involves: 129S7/SvEvBrd * C57BL/6)	edema	J:80666
Sox5^{Tn(sb-lacZ,GFP)IF2.OR123Jtak}/Sox5^{Tn(sb-lacZ,GFP)IF2.OR123Jtak} (involves: C3H * C57BL/6 * DBA/2 * ICR)	cyanosis	J:104043
Sox7^tm1.1Dsco/Sox7^tm1.1Dsco (involves: 129S/SvEv * C57BL/6)	pericardial edema	J:187416
Sox9^tm1Gsr/Sox9⁺ Tg(Pdx1-cre)6Cvw/0 (involves: 129P2/OlaHsd * C57BL/6 * C57BL/6J * CBA * FVB/N)	decreased glucagon secretion	J:141017
	decreased insulin secretion	J:141017
Sox9^tm1Gsr/Sox9^tm1Gsr Tg(Tek-cre)1Ywa/0 (involves: 129P2/OlaHsd * C57BL/6 * SJL)	pericardial edema	J:121352
Sox10^tm1Weg/Sox10^tm1Weg (involves: 129S1/Sv * 129X1/SvJ * C3HeB/FeJ * C57BL/6J)	cyanosis	J:67383
Sox11^tm1Weg/Sox11^tm1Weg (involves: 129S1/Sv * 129X1/SvJ)	cyanosis	J:92251
Sox11^tm2.2Weg/Sox11^tm2.2Weg Sox4^tm1.1Vlf/Sox4⁺ (involves: 129 * C57BL/6 * FVB/N)	edema	J:175338
Sox14^{em1(IMPC)Ccpcz}/Sox14^{em1(IMPC)Ccpcz} (C57BL/6N-Sox14^{em1(IMPC)Ccpcz}/Ccpcz)	decreased respiratory quotient	J:211773
Sox17^SHIVA/Sox17⁺ (either: C57BL/6-Sox17^SHIVA or (involves: C57BL/6 * C3H/HeN))	abnormal enzyme/coenzyme level	J:219119
	decreased circulating HDL cholesterol level	J:219119
	decreased circulating ketone body level	J:219119
	decreased fasting circulating glucose level	J:219119
	decreased liver triglyceride level	J:219119
Sox17^tm1Ysk/Sox17⁺ (B6.129S1-Sox17^tm1Ysk)	increased bile salt level	J:194071
	increased circulating alanine transaminase level	J:194071
	increased circulating alkaline phosphatase level	J:194071
Sox18^Ra-Op/Sox18⁺ (involves: C57BL/6J * DBA/2J)	cyanosis	J:260
	edema	J:260, J:279
	skin edema	J:260
Sox18^Ra-Op/Sox18^Ra-Op (B6D2-Sox18^Ra-Op/J)	edema	J:150211
Sox18^Ra-Op/Sox18^Ra-Op (B6D2-Sox18^Ra-Op/J)	skin edema	J:143564, J:150211
Sox18^Ra/Sox18⁺ (Not Specified)	chylous ascites	J:13089
Sox18^Ra/Sox18⁺ (involves: AG/Cam)	chylous ascites	J:6220, J:13089
Sox18^Ra/Sox18^Ra (Not Specified)	edema	J:86
Sox18^Ragl/Sox18⁺ (involves: 129P3/J * C57BL/6J)	chylous ascites	J:83731
Sox18^Ragl/Sox18⁺ (involves: 129P3/J * C57BL/6J)	edema	J:83731
Sox18^Ragl/Sox18^Ragl (involves: 129P3/J * C57BL/6J)	chylous ascites	J:83731
Sox18^Ragl/Sox18^Ragl (involves: 129P3/J * C57BL/6J)	edema	J:83731
Sox18^{tm1.1(KOMP)Vlcg}/Sox18^{tm1.1(KOMP)Vlcg} (C57BL/6N-Sox18^{tm1.1(KOMP)Vlcg}/J)	increased circulating alkaline phosphatase level	J:211773
	increased circulating sodium level	J:211773
Sox18^tm1Koop/Sox18⁺ (B6.129-Sox18^tm1Koop)	skin edema	J:143564
Sox18^tm1Koop/Sox18^tm1Koop (B6.129-Sox18^tm1Koop)	skin edema	J:143564
Sox21^em1(IMPC)Mbp/Sox21^em1(IMPC)Mbp (C57BL/6NCrl-Sox21^em1(IMPC)Mbp/MbpMmucd)	decreased circulating cholesterol level	J:211773
	decreased circulating HDL cholesterol level	J:211773
	decreased circulating serum albumin level	J:211773
Sox30^{tm1b(KOMP)Wtsi}/Sox30^{tm1b(KOMP)Wtsi} (C57BL/6N-Sox30^{tm1b(KOMP)Wtsi}/Bay)	increased fasting circulating glucose level	J:211773
Sp1^tm1Phi/Sp1⁺ Sp3^tm1Sus/Sp3⁺ (involves: 129P2/OlaHsd * C57BL/6)	skin edema	J:123073
Sp5^{tm1b(KOMP)Wtsi}/Sp5^{tm1b(KOMP)Wtsi} (C57BL/6N-Sp5^{tm1b(KOMP)Wtsi}/J)	decreased fasting circulating glucose level	J:211773
Sp7^tm1Crm/Sp7^tm1Crm (involves: 129S7/SvEvBrd * C57BL/6)	cyanosis	J:74344
Spag4^{tm1.1(KOMP)Mbp}/Spag4^{tm1.1(KOMP)Mbp} (C57BL/6N-Spag4^{tm1.1(KOMP)Mbp}/Ucd)	increased fasting circulating glucose level	J:211773
Spag17^{tm1d(KOMP)Wtsi}/Spag17^{tm1d(KOMP)Wtsi} (involves: 129S4/SvJaeSor * C57BL/6J * C57BL/6N)	cyanosis	J:211752
	pulmonary edema	J:211752
Spart^tm1.1Xen/Spart^tm1.1Xen (involves: C57BL/6J)	decreased circulating triglyceride level	J:185987
Spart^tm1.1Xen/Spart^tm1.1Xen (involves: C57BL/6J)	increased blood uric acid level	J:185987
Spart^{tm2b(EUCOMM)Hmgu}/Spart^{tm2b(EUCOMM)Hmgu} (C57BL/6N-Spart^{tm2b(EUCOMM)Hmgu}/Cnrm)	increased fasting circulating glucose level	J:211773
Spata3^em1(IMPC)J/Spata3^em1(IMPC)J (C57BL/6NJ-Spata3^em1(IMPC)J/Mmjax)	increased circulating creatinine level	J:211773
Spata7^{tm1.1(KOMP)Vlcg}/Spata7^{tm1.1(KOMP)Vlcg} (C57BL/6N-Spata7^{tm1.1(KOMP)Vlcg}/J)	decreased fasting circulating glucose level	J:211773
Spatc1l^em1(IMPC)H/Spatc1l^em1(IMPC)H (C57BL/6N-Spatc1l^em1(IMPC)H/H)	decreased circulating creatinine level	J:211773
Specc1l^em1(IMPC)J/Specc1l^em1(IMPC)J (C57BL/6NJ-Specc1l^em1(IMPC)J/Mmjax)	decreased circulating calcium level	J:211773
Speer6-ps1^{Tg(Alb-cre)21Mgn}/Speer6-ps1⁺ Tg(CAG-cat,-Creg1)#Yal/0 (involves: C57BL/6J * DBA)	abnormal circulating enzyme level	J:263073
	abnormal glucose homeostasis	J:263073
	abnormal lipid homeostasis	J:263073
	decreased circulating alanine transaminase level	J:263073
	decreased circulating alkaline phosphatase level	J:263073
	decreased circulating aspartate transaminase level	J:263073
	decreased circulating glucose level	J:263073
	decreased circulating insulin level	J:263073
	decreased liver cholesterol level	J:263073
	decreased liver free fatty acids level	J:263073
	decreased liver triglyceride level	J:263073
	impaired glucose tolerance	J:263073
	increased liver glycogen level	J:263073
	insulin resistance	J:263073
Speer6-ps1^{Tg(Alb-cre)21Mgn}/Speer6-ps1⁺ Tg(CAG-Dusp26)#Jhxia/0 (involves: C57BL/6 * DBA)	decreased liver cholesterol level	J:279111
	decreased liver free fatty acids level	J:279111
	decreased liver triglyceride level	J:279111
	decreased susceptibility to diet-induced obesity	J:279111
	impaired glucose tolerance	J:279111
	increased circulating alanine transaminase level	J:279111
	increased circulating aspartate transaminase level	J:279111
	insulin resistance	J:279111
Speer6-ps1^{Tg(Alb-cre)21Mgn}/Speer6-ps1⁺ Trmu^tm1Tomik/Trmu^tm1Tomik (involves: C57BL/6 * DBA)	abnormal homeostasis	J:235644
	decreased circulating amylase level	J:235644
	decreased circulating calcium level	J:235644
	decreased circulating cholesterol level	J:235644
	decreased circulating creatinine level	J:235644
	decreased circulating HDL cholesterol level	J:235644
	decreased circulating serum albumin level	J:235644
	increased circulating alanine transaminase level	J:235644
	increased circulating aspartate transaminase level	J:235644
	increased circulating lactate dehydrogenase level	J:235644
	increased circulating lactate level	J:235644
Spg11^em1(IMPC)J/Spg11^em1(IMPC)J (C57BL/6NJ-Spg11^em1(IMPC)J/Mmjax)	decreased circulating calcium level	J:211773
	decreased circulating total protein level	J:211773
Sphk1^tm1Rlp/Sphk1^tm1Rlp (involves: 129S6/SvEvTac)	abnormal cytokine level	J:133917
Sphk1^tm1Rlp/Sphk1^tm1Rlp Sphk2^tm1Rlp/Sphk2^tm1Rlp (involves: 129S6/SvEvTac * C57BL/6)	hemopericardium	J:103755
Sphkap^tm1.1Nina/Sphkap^tm1.1Nina (Not Specified)	decreased circulating glucose level	J:272327
	decreased circulating insulin level	J:272327
	decreased insulin secretion	J:272327
	increased circulating insulin level	J:272327
	increased insulin secretion	J:272327
Spic^tm1.1Kmm/Spic^tm1.1Kmm (involves: 129S6/SvEvTac * C57BL/6)	increased spleen iron level	J:143900
Spic^tm1Kmm/Spic^tm1Kmm (involves: 129S6/SvEvTac * C57BL/6)	increased spleen iron level	J:143900
Spice1^{tm1b(EUCOMM)Hmgu}/Spice1^{tm1b(EUCOMM)Hmgu} (C57BL/6N-Spice1^{tm1b(EUCOMM)Hmgu}/H)	improved glucose tolerance	J:211773
	increased circulating alkaline phosphatase level	J:211773
Spin1^{tm1.1(KOMP)Vlcg}/Spin1⁺ (C57BL/6N-Spin1^{tm1.1(KOMP)Vlcg}/J)	increased circulating alkaline phosphatase level	J:211773
Spink1^tm1Kymm/Spink1^tm1Kymm (involves: C57BL/6NCrlj * CBA/JNCrlj)	dehydration	J:104647
Spink5^tm1Drh/Spink5^tm1Drh (involves: 129P2/OlaHsd * C57BL/6)	dehydration	J:95549
	impaired skin barrier function	J:95549
Spink5^tm1Hov/Spink5^tm1Hov (involves: 129P2/OlaHsd * FVB)	impaired skin barrier function	J:96435
Spink5^{Tn(Pgk2-sb10,sb-Tyr)1498Ove}/Spink5^{Tn(Pgk2-sb10,sb-Tyr)1498Ove} (involves: FVB/N)	dehydration	J:93050
	impaired skin barrier function	J:93050
Spink12^em1(IMPC)J/Spink12^em1(IMPC)J (C57BL/6NJ-Spink12^em1(IMPC)J/J)	decreased blood urea nitrogen level	J:211773
	increased circulating alanine transaminase level	J:211773
	increased circulating alkaline phosphatase level	J:211773
	increased circulating bilirubin level	J:211773
Spmap2l^{tm1b(KOMP)Wtsi}/Spmap2l^{tm1b(KOMP)Wtsi} (C57BL/6N-Spmap2l^{tm1b(KOMP)Wtsi}/Bay)	increased circulating chloride level	J:211773
Spmip9^{tm1.1(KOMP)Vlcg}/Spmip9^{tm1.1(KOMP)Vlcg} (C57BL/6N-Spmip9^{tm1.1(KOMP)Vlcg}/Ucd)	increased circulating aspartate transaminase level	J:211773
Spns2^{tm1a(KOMP)Wtsi}/Spns2^{tm1a(KOMP)Wtsi} (involves: C57BL/6 * C57BL/6N)	decreased circulating glucose level	J:213427
	increased circulating bilirubin level	J:213427
Spns2^tm1Tni/Spns2^tm1Tni (B6.Cg-Spns2^tm1Tni)	decreased sphingosine level	J:225108
Spock1^em1(IMPC)H/Spock1^em1(IMPC)H (C57BL/6N-Spock1^em1(IMPC)H/H)	decreased fasting circulating glucose level	J:211773
Spon1^tm1Gdpa/Spon1^tm1Gdpa (Not Specified)	decreased transforming growth factor beta level	J:214251
Spon2^tm1Mjb/Spon2^tm1Mjb (involves: 129S6/SvEvTac * C57BL/6)	abnormal interleukin level	J:87393
	abnormal tumor necrosis factor level	J:87393
Spop^{tm1b(KOMP)Wtsi}/Spop⁺ (C57BL/6N-Spop^{tm1b(KOMP)Wtsi}/Tcp)	decreased respiratory quotient	J:211773
	increased circulating aspartate transaminase level	J:211773
Spp1^tm1Blh/Spp1^tm1Blh (involves: 129S6/SvEvTac * Black Swiss)	abnormal chemokine level	J:127389
	crystalluria	J:103140
	decreased circulating glucose level	J:127389
	decreased circulating insulin level	J:127389
	decreased circulating interleukin-6 level	J:127389
	decreased circulating triglyceride level	J:127389
	improved glucose tolerance	J:127389
	increased insulin sensitivity	J:127389
	increased respiratory quotient	J:127389
Spp1^tm1Blh/Spp1^tm1Blh (129S/SvEv-Spp1^tm1Blh)	crystalluria	J:127526
	decreased urine chloride ion level	J:127526
	decreased urine sodium level	J:127526
Spp1^tm1Blh/Spp1^tm1Blh Umod^tm1Xrw/Umod^tm1Xrw (129S/SvEv-Spp1^tm1Blh Umod^tm1Xrw)	crystalluria	J:127526
	increased urine phosphate level	J:127526
	increased urine uric acid level	J:127526
Spp1^tm1Rit/Spp1^tm1Rit (involves: 129S7/SvEvBrd * C57BL/6)	increased blood urea nitrogen level	J:56204
Spp1^tm1Rit/Spp1^tm1Rit (involves: 129S7/SvEvBrd * C57BL/6)	increased circulating creatinine level	J:56204
Spr^tm1Lex/Spr^tm1Lex (involves: 129S/SvEvBrd * C57BL/6J)	abnormal biopterin level	J:131376
	abnormal neopterin level	J:131376
	decreased dopamine level	J:131376
	decreased noradrenaline level	J:131376
	decreased phenylalanine level	J:131376
	decreased serotonin level	J:131376
Spr^tm1Spo/Spr^tm1Spo (involves: 129 * C57BL/6)	abnormal biopterin level	J:124817
	abnormal enzyme/coenzyme level	J:124817
	abnormal neopterin level	J:124817
	decreased circulating insulin-like growth factor I level	J:124817
	decreased dopamine level	J:124817
	decreased noradrenaline level	J:124817
	decreased serotonin level	J:124817
	increased circulating phenylalanine level	J:124817
Spred1^{em1(IMPC)Ccpcz}/Spred1^{em1(IMPC)Ccpcz} (C57BL/6N-Spred1^{em1(IMPC)Ccpcz}/Ccpcz)	decreased circulating alkaline phosphatase level	J:211773
	increased circulating alanine transaminase level	J:211773
	increased circulating aspartate transaminase level	J:211773
	increased circulating potassium level	J:211773
Spred2^em1(IMPC)Mbp/Spred2^em1(IMPC)Mbp (C57BL/6N-Spred2^em1(IMPC)Mbp/MbpMmucd)	increased circulating bilirubin level	J:211773
Spred3^em1(IMPC)Tcp/Spred3⁺ (C57BL/6NCrl-Spred3^em1(IMPC)Tcp/Tcp)	increased circulating creatinine level	J:211773
Sprr1b^{tm1.1(KOMP)Vlcg}/Sprr1b^{tm1.1(KOMP)Vlcg} (C57BL/6N-Sprr1b^{tm1.1(KOMP)Vlcg}/J)	decreased urine creatinine level	J:211773
Sprr3^{tm1.1(KOMP)Vlcg}/Sprr3^{tm1.1(KOMP)Vlcg} (C57BL/6N-Sprr3^{tm1.1(KOMP)Vlcg}/J)	decreased urine magnesium level	J:211773
Spry4^{tm1b(KOMP)Mbp}/Spry4^{tm1b(KOMP)Mbp} (C57BL/6N-Spry4^{tm1b(KOMP)Mbp}/Kmpc)	decreased fasting circulating glucose level	J:211773
Spryd3^{tm1a(EUCOMM)Hmgu}/Spryd3^{tm1a(EUCOMM)Hmgu} (C57BL/6N-Spryd3^{tm1a(EUCOMM)Hmgu}/Ieg)	increased circulating alkaline phosphatase level	J:165965
Spryd3^{tm1b(EUCOMM)Hmgu}/Spryd3^{tm1b(EUCOMM)Hmgu} (C57BL/6N-Spryd3^{tm1b(EUCOMM)Hmgu}/Ieg)	increased circulating alkaline phosphatase level	J:211773
	increased circulating cholesterol level	J:211773
	increased circulating creatinine level	J:211773
	increased circulating HDL cholesterol level	J:211773
	increased circulating insulin level	J:211773
Spryd4^{em1(IMPC)Ccpcz}/Spryd4^{em1(IMPC)Ccpcz} (C57BL/6N-Spryd4^{em1(IMPC)Ccpcz}/Ccpcz)	increased fasting circulating glucose level	J:211773
Spsb2^tm1Nch/Spsb2⁺ (involves: C57BL/6)	decreased blood urea nitrogen level	J:99226
Spsb2^tm1Nch/Spsb2^tm1Nch (involves: C57BL/6)	decreased blood urea nitrogen level	J:99226
Spta1^ihj/Spta1^ihj (involves: HRS/J * LAH)	increased circulating bilirubin level	J:105409
Spta1^sph-2Bc/Spta1^sph-2Bc (involves: SELH)	increased circulating bilirubin level	J:7048
Spta1^sph-2Bc/Spta1^sph-2Bc ((WB.Cg-Spta1^sph-2Bc/Brk x B6.Cg-Spta1^sph-2Bc/Brk)F1)	abnormal cardiac thrombosis	J:62355
Spta1^sph-3J/Spta1^sph-3J (NOD.Cg-H2^b Spta1^sph-3J)	decreased spleen iron level	J:157766
	increased circulating bilirubin level	J:157766
	increased circulating iron level	J:157766
	increased kidney iron level	J:157766
	increased liver iron level	J:157766
Spta1^sph-4J/Spta1^sph-4J (C57BL/6J-Spta1^sph-4J/Llp)	increased circulating bilirubin level	J:157766
	increased circulating iron level	J:157766
	increased kidney iron level	J:157766
	increased liver iron level	J:157766
Spta1^sph-Dem/Spta1^sph-Dem (CcS3/Dem-Spta1^sph-Dem)	abnormal cardiac thrombosis	J:62355
Spta1^sph-ha/Spta1⁺ (either: (B6.D1-Spta1^sph-ha x WB.D1-Spta1^sph-ha)F1 or (WB.D1-Spta1^sph-ha x B6.D1-Spta1^sph-ha)F1)	increased erythrocyte protoporphyrin level	J:5985
Spta1^sph-ha/Spta1^sph-ha (either: (B6.D1-Spta1^sph-ha x WB.D1-Spta1^sph-ha)F1 or (WB.D1-Spta1^sph-ha x B6.D1-Spta1^sph-ha)F1)	abnormal thrombosis	J:12830
	hemosiderosis	J:12830
	increased circulating bilirubin level	J:12830
	increased erythrocyte protoporphyrin level	J:5985, J:6695
Spta1^sph-ha/Spta1^sph-ha ((WB.D1-Spta1^sph-ha/Brk x B6.D1-Spta1^sph-ha/Brk)F1)	abnormal cardiac thrombosis	J:62355
	increased circulating bilirubin level	J:162532
Spta1^sph/Spta1⁺ (either: (B6.C3-Spta1^sph x WB.C3-Spta1^sph)F1 or (WB.C3-Spta1^sph x B6.C3-Spta1^sph)F1)	increased erythrocyte protoporphyrin level	J:5985
Spta1^sph/Spta1^sph (involves: C3H)	increased circulating bilirubin level	J:12276
Spta1^sph/Spta1^sph (either: (B6.C3-Spta1^sph x WB.C3-Spta1^sph)F1 or (WB.C3-Spta1^sph x B6.C3-Spta1^sph)F1)	increased erythrocyte protoporphyrin level	J:5985, J:111131
Spta1^sph/Spta1^sph ((WB.C3-Spta1^sph x B6.C3-Spta1^sph)F1)	abnormal cardiac thrombosis	J:62355, J:44313
	increased circulating bilirubin level	J:162532
	increased kidney iron level	J:44313
	increased liver iron level	J:44313
Sptan1^em1(IMPC)Mbp/Sptan1^em1(IMPC)Mbp (C57BL/6NCrl-Sptan1^em1(IMPC)Mbp/MbpMmucd)	edema	J:211773
Sptb^ja/Sptb⁺ (129/Sv-Sptb^ja)	increased erythrocyte protoporphyrin level	J:5985
Sptb^ja/Sptb⁺ (involves: 129/Sv * C57BL/6J * WB/Re)	increased erythrocyte protoporphyrin level	J:5985
Sptb^ja/Sptb^ja (involves: 129/Sv * C57BL/6J * WB/Re)	increased erythrocyte protoporphyrin level	J:5985
Sptb^ja/Sptb^ja ((WB.129-Sptb^ja/J x B6.129-Sptb^ja/J)F1)	abnormal cardiac thrombosis	J:62355, J:44313
	decreased circulating glucose level	J:44313
	increased blood urea nitrogen level	J:44313
	increased circulating bilirubin level	J:162532, J:44313
	increased circulating iron level	J:44313
	increased kidney iron level	J:44313
Sptbn1^{tm1a(EUCOMM)Wtsi}/Sptbn1⁺ (B6JTyr;B6N-Sptbn1^{tm1a(EUCOMM)Wtsi}/Wtsi)	decreased circulating alanine transaminase level	J:175295
	decreased circulating cholesterol level	J:175295
	decreased circulating HDL cholesterol level	J:175295
	decreased circulating LDL cholesterol level	J:175295
	decreased circulating serum albumin level	J:175295
	decreased circulating total protein level	J:175295
	decreased lactate dehydrogenase level	J:175295
Sptbn1^{tm1a(EUCOMM)Wtsi}/Sptbn1^{tm1a(EUCOMM)Wtsi} (involves: C57BL/6N)	edema	J:200082
Sptbn2^{tm1b(EUCOMM)Hmgu}/Sptbn2^{tm1b(EUCOMM)Hmgu} (C57BL/6N-Sptbn2^{tm1b(EUCOMM)Hmgu}/H)	increased circulating creatine kinase level	J:211773
	increased circulating phosphate level	J:211773
Sptlc1^tm1Jia/Sptlc1⁺ (B6.Cg-Sptlc1^tm1Jia)	abnormal circulating lipid level	J:140627
Sptlc1^tm1Jia/Sptlc1⁺ (B6.Cg-Sptlc1^tm1Jia)	abnormal lipid level	J:140627
Sptlc2^tm1Jia/Sptlc2⁺ (B6.Cg-Sptlc2^tm1Jia)	abnormal circulating lipid level	J:140627
Sptlc2^tm1Jia/Sptlc2⁺ (B6.Cg-Sptlc2^tm1Jia)	abnormal lipid level	J:140627
Sptlc2^tm1Yhir/Sptlc2^tm1Yhir Gt(ROSA)26Sor^{tm9(cre/ESR1)Arte}/Gt(ROSA)26Sor⁺ (involves: C57BL/6 * C57BL/6NTac)	abnormal circulating protein level	J:202954
	increased blood urea nitrogen level	J:202954
	increased circulating alanine transaminase level	J:202954
	increased circulating serum albumin level	J:202954
Sptlc2^tm1Yhir/Sptlc2^tm1Yhir Tg(KRT5-cre)1Tak/0 (involves: C3H * C57BL/6)	abnormal ceramide level	J:202388
	dehydration	J:202388
	impaired skin barrier function	J:202388
Sptlc2^tm2.1Jia/Sptlc2^tm2.1Jia (involves: 129S4/SvJaeSor * C57BL/6)	abnormal sphingomyelin level	J:155507
	increased circulating cholesterol level	J:155507
	increased circulating HDL cholesterol level	J:155507
	increased circulating phospholipid level	J:155507
Sptlc3^{em1(IMPC)Hmgu}/Sptlc3^{em1(IMPC)Hmgu} (C57BL/6NCrl-Sptlc3^{em1(IMPC)Hmgu}/Ieg)	increased circulating calcium level	J:211773
Sptssa^{tm1b(KOMP)Wtsi}/Sptssa⁺ (C57BL/6N-Sptssa^{tm1b(KOMP)Wtsi}/J)	decreased circulating glucose level	J:211773
	increased circulating sodium level	J:211773
Sptssb^{tm1b(KOMP)Mbp}/Sptssb^{tm1b(KOMP)Mbp} (C57BL/6N-Sptssb^{tm1b(KOMP)Mbp}/J)	decreased circulating glucose level	J:211773
	decreased circulating iron level	J:211773
	decreased fasting circulating glucose level	J:211773
	increased blood urea nitrogen level	J:211773
	increased fasting circulating glucose level	J:211773
Sptssb^Tvrm122/Sptssb^Tvrm122 (involves: A * C57BL/6)	abnormal lipid homeostasis	J:224971
Sqstm1^em1Kmts/Sqstm1⁺ (involves: C57BL/6N)	hypoglycemia	J:342766
	increased blood urea nitrogen level	J:342766
	increased circulating aspartate transaminase level	J:342766
	increased circulating cholesterol level	J:342766
	increased circulating creatinine level	J:342766
Sqstm1^{tm1a(KOMP)Wtsi}/Sqstm1^{tm1a(KOMP)Wtsi} (B6JTyr;B6N-Sqstm1^{tm1a(KOMP)Wtsi}/Wtsi)	decreased circulating glucose level	J:175295
Sqstm1^tm1Hwl/Sqstm1^tm1Hwl (B6.129P2-Sqstm1^tm1Hwl)	decreased oxygen consumption	J:181228
Sqstm1^tm1Keta/Sqstm1^tm1Keta (involves: 129)	hyperglycemia	J:130839
Sqstm1^tm1Keta/Sqstm1^tm1Keta (B6.129-Sqstm1^tm1Keta)	impaired glucose tolerance	J:201732
Sqstm1^tm1Keta/Sqstm1^tm1Keta (B6.129-Sqstm1^tm1Keta)	increased circulating leptin level	J:201732
Sqstm1^tm2.1Jmos/Sqstm1^tm2.1Jmos Tg(Fabp4-cre)1Rev/0 (Not Specified)	decreased core body temperature	J:194291
	decreased energy expenditure	J:194291
	impaired glucose tolerance	J:194291
	insulin resistance	J:194291
Sra1^{tm1a(EUCOMM)Hmgu}/Sra1^{tm1a(EUCOMM)Hmgu} (involves: C57BL/6J * C57BL/6N)	decreased circulating insulin level	J:214131
	decreased circulating tumor necrosis factor level	J:214131
	decreased liver free fatty acids level	J:214131
	decreased liver triglyceride level	J:214131
	decreased susceptibility to diet-induced obesity	J:214131
	improved glucose tolerance	J:214131
	increased insulin sensitivity	J:214131
Srebf1^Gt(XC354)Byg/Srebf1^Gt(XC354)Byg (either: B6.129P2-Srebf1^Gt(XC354)Byg or (involves: 129P2/OlaHsd * C57BL/6))	decreased liver triglyceride level	J:152612
	increased circulating ketone body level	J:152612
Srebf1^tm1Jdh/Srebf1^tm1Jdh (involves: 129S/SvEvBrd * C57BL/6)	increased liver cholesterol level	J:43570
Srebf1^tm1Mbr/Srebf1^tm1Mbr (involves: 129S6/SvEvTac)	decreased circulating cholesterol level	J:75320
	decreased circulating triglyceride level	J:75320
	increased liver cholesterol level	J:75320
Srebf1^tm1Mbr/Srebf1^tm1Mbr (involves: 129S6/SvEvTac * C57BL/6J)	abnormal triglyceride level	J:101307
	decreased circulating cholesterol level	J:101307
	decreased circulating triglyceride level	J:101307
Srebf1^tm2Jdh/Srebf1^tm2Jdh (involves: 129S/SvEvBrd * C57BL/6)	decreased circulating cholesterol level	J:43570
	decreased circulating triglyceride level	J:43570
	increased liver cholesterol level	J:43570
Srebf2^lop13/Srebf2^lop13 (STOCK Srebf2^lop13/J)	decreased brain cholesterol level	J:176249
	decreased cholesterol level	J:176249
	decreased liver cholesterol level	J:176249
Srebf2^tm1Jdh/Srebf2^tm1Jdh Speer6-ps1^{Tg(Alb-cre)21Mgn}/? (involves: 129S6/SvEvTac * C57BL/6 * DBA)	abnormal lipid homeostasis	J:241873
	decreased circulating cholesterol level	J:241873
	decreased circulating triglyceride level	J:241873
	decreased liver cholesterol level	J:241873
	decreased liver triglyceride level	J:241873
Srek1^em1(IMPC)J/Srek1⁺ (C57BL/6NJ-Srek1^em1(IMPC)J/Mmjax)	decreased circulating phosphate level	J:211773
Srf^tm1Rjs/Srf^tm2.1Nor Tg(Myh6-cre)2182Mds/0 (involves: 129P2/OlaHsd * 129S7/SvEvBrd * C57BL/6 * FVB/N)	pericardial effusion	J:101311
Srf^tm2.1Nor/Srf^tm2.1Nor Tg(Myog-cre)1Eno/0 (involves: 129P2/OlaHsd * C57BL/6)	cyanosis	J:96122
Srgap1^{tm1a(KOMP)Wtsi}/Srgap1^{tm1a(KOMP)Wtsi} Six2^{tm1(tTA,tetO-EGFP/cre)Amc}/Six2⁺ (involves: 129 * C57BL/6J * C57BL/6N)	albuminuria	J:333727
Srgap1^{tm1a(KOMP)Wtsi}/Srgap1^{tm1a(KOMP)Wtsi} Tg(NPHS2-cre)295Lbh/0 (involves: C57BL/6 * C57BL/6N * SJL)	albuminuria	J:333727
Srgap3^tm1.1Zi/Srgap3^tm1.1Zi (B6.129(SJL)-Srgap3^tm1.1Zi)	cerebral edema	J:192388
Srgap3^tm1.1Zi/Srgap3^tm1.1Zi (B6.129(SJL)-Srgap3^tm1.1Zi)	decreased circulating testosterone level	J:192388
Sri^tm1.1Hhv/Sri^tm1.1Hhv (involves: 129S1/SvImJ)	decreased circulating insulin level	J:246708
Sri^tm1.1Hhv/Sri^tm1.1Hhv (involves: 129S1/SvImJ)	impaired glucose tolerance	J:246708
Sros1^em1Caox/Sros1^em1Caox (involves: C57BL/6J)	abnormal circulating chemokine level	J:306407
Sros1^em1Caox/Sros1^em1Caox (involves: C57BL/6J)	increased circulating CXCL10 level	J:306407
Srp9^{tm1.1(KOMP)Vlcg}/Srp9⁺ (C57BL/6N-Srp9^{tm1.1(KOMP)Vlcg}/J)	decreased fasting circulating glucose level	J:211773
Srprb^{tm2b(EUCOMM)Hmgu}/Srprb⁺ (C57BL/6N-Srprb^{tm2b(EUCOMM)Hmgu}/Bay)	decreased circulating creatinine level	J:211773
Srpx2^{em1(IMPC)Hmgu}/Srpx2^{em1(IMPC)Hmgu} (C57BL/6NCrl-Srpx2^{em1(IMPC)Hmgu}/Ieg)	decreased circulating phosphate level	J:211773
Srr^rgsc1872/Srr^rgsc1872 (C57BL/6JJcl-Srr^rgsc1872)	decreased serine level	J:151337
Srr^rgsc1872/Srr^rgsc1872 (C57BL/6JJcl-Srr^rgsc1872)	increased serine level	J:151337
Srr^{tm1(cre/PGR)Himo}/Srr^{tm1(cre/PGR)Himo} (C57BL/6N-Srr^{tm1(cre/PGR)Himo})	decreased serine level	J:144030
Srrm4^{tm1b(EUCOMM)Wtsi}/Srrm4^{tm1b(EUCOMM)Wtsi} (involves: C57BL/6J * C57BL/6N)	cyanosis	J:221584
Srsf3^tm1Pjln/Srsf3^tm1Pjln Speer6-ps1^{Tg(Alb-cre)21Mgn}/Speer6-ps1⁺ (involves: BALB/c * C57BL/6 * DBA)	abnormal glucose tolerance	J:205756
	decreased circulating cholesterol level	J:205756
	decreased circulating HDL cholesterol level	J:205756
	decreased circulating insulin-like growth factor I level	J:205756
	decreased circulating serum albumin level	J:205756
	decreased circulating triglyceride level	J:205756
	decreased fatty acid oxidation	J:205756
	decreased liver cholesterol level	J:205756
	decreased liver glycogen level	J:205756
	decreased liver triglyceride level	J:205756
	decreased susceptibility to diet-induced obesity	J:205756
	hypoglycemia	J:205756
	increased circulating alanine transaminase level	J:205756
	increased circulating alkaline phosphatase level	J:205756
	increased circulating aspartate transaminase level	J:205756
	increased circulating bilirubin level	J:205756
	increased circulating growth hormone level	J:205756
	increased insulin sensitivity	J:205756
Srsf4^{tm1a(EUCOMM)Wtsi}/Srsf4⁺ (C57BL/6N-Srsf4^{tm1a(EUCOMM)Wtsi}/Ics)	increased circulating creatinine level	J:165965
Srsf10^tm1Jalm/Srsf10^tm1Jalm (involves: 129P2/OlaHsd * C57BL/6)	edema	J:149480
Srxn1^tm1Mtol/Srxn1^tm1Mtol (either: B6.129S2-Srxn1^tm1Mtol or (involves: 129S2/SvPasCrl * C57BL/6))	increased circulating alanine transaminase level	J:199277
	increased circulating aspartate transaminase level	J:199277
Srxn1^tm1Sgrh/Srxn1^tm1Sgrh Tg(Cyp11a1-cre)16Mchu/? (involves: C57BL/6J)	abnormal circulating corticosterone level	J:222986
	increased circulating adrenocorticotropin level	J:222986
X/Sry^em1Takas (involves: C57BL/6 * DBA/2)	abnormal circulating testosterone level	J:207780
Ss18^em1(IMPC)J/Ss18⁺ (C57BL/6NJ-Ss18^em1(IMPC)J/Mmjax)	increased circulating glucose level	J:211773
Ss18^tm1Adg/Ss18^tm1Adg (involves: C57BL/6)	abnormal oxygen level	J:114839
Ssh2^em1(IMPC)J/Ssh2^em1(IMPC)J (C57BL/6NJ-Ssh2^em1(IMPC)J/Mmjax)	decreased circulating bilirubin level	J:211773
Ssr1^em1(IMPC)Mbp/Ssr1^em1(IMPC)Mbp (C57BL/6N-Ssr1^em1(IMPC)Mbp/MbpMmucd)	edema	J:211773
Ssr1^{Gt(ble-lacZl)16Brr}/Ssr1^{Gt(ble-lacZl)16Brr} (involves: 129S2/SvPas)	edema	J:115006
Ssr2^{tm1b(EUCOMM)Wtsi}/Ssr2^{tm1b(EUCOMM)Wtsi} (C57BL/6N-Ssr2^{tm1b(EUCOMM)Wtsi}/Wtsi)	hemopericardium	J:239583
	subcutaneous edema	J:239583
Ssrq1^A/J/Ssrq1^A/J (involves: A/J * C57BL/6J)	increased response to stress-induced hyperthermia	J:132037
Ssrq2^A/J/Ssrq2^A/J (involves: A/J * C57BL/6J)	increased response to stress-induced hyperthermia	J:132037
Ssrq5^A/J/Ssrq5^A/J (involves: A/J * C57BL/6J)	increased response to stress-induced hyperthermia	J:132037
Ssrq8^A/J/Ssrq8^A/J (involves: A/J * C57BL/6J)	increased response to stress-induced hyperthermia	J:132037
Ssrq10^A/J/Ssrq10^A/J (involves: A/J * C57BL/6J)	increased response to stress-induced hyperthermia	J:132037
Sst^{tm1b(KOMP)Wtsi}/Sst^{tm1b(KOMP)Wtsi} (C57BL/6N-Sst^{tm1b(KOMP)Wtsi}/Rbrc)	decreased circulating alkaline phosphatase level	J:211773
	increased circulating iron level	J:211773
	increased circulating serum albumin level	J:211773
Sst^tm1Low/Sst^tm1Low (B6.129P2-Sst^tm1Low)	abnormal circulating pituitary hormone level	J:70016
	decreased growth hormone level	J:70016
	increased circulating gastrin level	J:126384
Sst^tm1Ute/Sst^tm1Ute (129-Sst^tm1Ute/J)	increased circulating corticosterone level	J:70426
Sst^tm1Ute/Sst^tm1Ute (129-Sst^tm1Ute/J)	increased circulating growth hormone level	J:70426
Sst^tm1Ute/Sst^tm1Ute (involves: 129S4/SvJae * C57BL/6J)	decreased circulating prolactin level	J:179095
	increased circulating ghrelin level	J:179095
	increased circulating insulin level	J:179095
Sstr1^tm1Dgen/Sstr1^tm1Dgen (involves: 129P2/OlaHsd * C57BL/6)	increased circulating cholesterol level	J:101679
	increased circulating HDL cholesterol level	J:101679
Sstr2^tm1Pce/Sstr2^tm1Pce (B6.129P2-Sstr2^tm1Pce)	decreased dopamine level	J:89708
Sstr2^tm1Rgs/Sstr2^tm1Rgs (involves: 129S7/SvEvBrd * C57BL/6)	increased circulating adrenocorticotropin level	J:89420
Sstr4^tm1Szo/Sstr4^tm1Szo (B6.129P2-Sstr4^tm1Szo)	edema	J:152015
Sstr4^tm1Szo/Sstr4^tm1Szo (B6.129P2-Sstr4^tm1Szo)	pulmonary edema	J:152015
Sstr5^tm1Fcb/Sstr5^tm1Fcb (involves: 129)	increased insulin secretion	J:179577
Sstr5^tm1Fcb/Sstr5^tm2Fcb Tg(Ins2-cre)1Heed/0 (involves: 129S7/SvEvBrd * C57BL/6 * CBA)	abnormal insulin clearance	J:99786
	decreased circulating glucose level	J:99786
	decreased insulin secretion	J:99786
	impaired glucose tolerance	J:99786
	increased circulating insulin level	J:99786
	increased insulin secretion	J:99786
Sstr5^tm1Hawi/Sstr5^tm1Hawi (involves: 129S7/SvEvBrd * C57BL/6J)	decreased circulating glucose level	J:101259
	decreased circulating insulin level	J:101259
	improved glucose tolerance	J:101259
	increased circulating glucagon level	J:101259
	increased circulating leptin level	J:101259
	increased insulin secretion	J:101259
	increased insulin sensitivity	J:101259
Ssu72^tm1Cwl/Ssu72^tm1Cwl Speer6-ps1^{Tg(Alb-cre)21Mgn}/Speer6-ps1⁺ (B6.Cg-Ssu72^tm1Cwl Speer6-ps1^{Tg(Alb-cre)21Mgn})	increased circulating alanine transaminase level	J:309624
	increased circulating aspartate transaminase level	J:309624
St3gal2^tm1Jxm/St3gal2^tm1Jxm (Not Specified)	increased bleeding time	J:217719
St3gal4^tm1.1Bsi/St3gal4^tm1.1Bsi (B6J.B6N-St3gal4^tm1.1Bsi)	abnormal insulin-like growth factor I level	J:217104
	decreased growth hormone level	J:217104
St3gal4^tm1.1Jxm/St3gal4^tm1.1Jxm (B6.129-St3gal4^tm1.1Jxm)	abnormal platelet physiology	J:136946
St3gal4^tm1.1Jxm/St3gal4^tm1.1Jxm (B6.129-St3gal4^tm1.1Jxm)	increased bleeding time	J:136946
St3gal5^tm1Rlp/St3gal5^tm1Rlp (involves: 129S/SvEv * C57BL/6)	abnormal glucose homeostasis	J:82723
	abnormal lipid homeostasis	J:82723
	hypoglycemia	J:82723
	improved glucose tolerance	J:82723
	increased insulin sensitivity	J:82723
St3gal5^tm1Skoz/St3gal5^tm1Skoz (Not Specified)	abnormal glycosphingolipid level	J:229230
St6galnac2^tm1.1Cfg/St6galnac2^tm1.1Cfg (involves: 129S1/Sv * 129X1/SvJ)	decreased circulating creatinine level	J:217719
	increased circulating alanine transaminase level	J:217719
St14^{Gt(RST485)Byg}/St14⁺ (involves: 129P2/OlaHsd * Black Swiss)	impaired skin barrier function	J:108567
St14^Gt(XM184)Byg/St14⁺ (involves: 129P2/OlaHsd * Black Swiss)	impaired skin barrier function	J:108567
St14^tm1Bug/St14^tm1Bug (involves: 129P2/OlaHsd * Black Swiss)	dehydration	J:87125
	impaired skin barrier function	J:87125
St14^tm1Bug/St14^tm1Bug (involves: 129P2/OlaHsd)	impaired skin barrier function	J:86715
St14^tm2Bug/St14^tm2Bug (involves: 129P2/OlaHsd)	impaired skin barrier function	J:86715
St14^tm2Bug/St14^tm3Bug Tg(CAG-cre/Esr1)5Amc/0 (involves: 129P2/OlaHsd 129S6/SvEvTac * Black Swiss * C57BL/6 * CBA)	intestinal edema	J:153070
St14^tm2Bug/St14^tm3Bug Tg(MMTV-cre)4Mam/0 (involves: 129P2/OlaHsd * 129S6/SvEvTac * Black Swiss * FVB)	decreased salivation	J:153070
St14^tm2Bug/St14^tm3Bug Tg(MMTV-cre)4Mam/0 (involves: 129P2/OlaHsd * 129S6/SvEvTac * C57BL/6J * FVB/NJ * N:Black Swiss)	decreased salivation	J:213072
St14^tm2Bug/St14^tm3Bug Tg(Vil1-cre)997Gum/0 (involves: 129P2/OlaHsd * 129S6/SvEvTac * Black Swiss * C57BL/6 * SJL)	intestinal edema	J:153070
St14^tm3Bug/St14^tm3Bug (involves: 129S6/SvEvTac)	decreased salivation	J:213072
St18^{tm1a(KOMP)Wtsi}/St18^{tm1a(KOMP)Wtsi} (C57BL/6N-St18^{tm1a(KOMP)Wtsi}/Wtsi)	decreased circulating alanine transaminase level	J:175295
	decreased circulating aspartate transaminase level	J:175295
	decreased circulating LDL cholesterol level	J:175295
	decreased circulating serum albumin level	J:175295
Stab1^tm1.1Cger/Stab1^tm1.1Cger Stab2^tm1.1Cger/Stab2^tm1.1Cger (B6.129S2-Stab2^tm1.1Cger Stab1^tm1.1Cger)	albuminuria	J:171818
	increased circulating glutamate dehydrogenase level	J:171818
Stab1^tm1.1Cger/Stab1^tm1.1Cger Stab2^tm1.1Cger/Stab2^tm1.1Cger (C.129S2-Stab2^tm1.1Cger Stab1^tm1.1Cger)	albuminuria	J:171818
Stab2^tm1Ami/Stab2^tm1Ami (B6.Cg-Stab2^tm1Ami)	increased circulating hyaluronic acid level	J:182239
Stac3^{tm1a(KOMP)Wtsi}/Stac3^{tm1a(KOMP)Wtsi} (involves: C57BL/6N)	abnormal calcium ion homeostasis	J:222015
	hypoxia	J:222015
Stag1^em1(IMPC)Mbp/Stag1⁺ (C57BL/6N-Stag1^em1(IMPC)Mbp/MbpMmucd)	increased circulating triglyceride level	J:211773
Stag1^em1(IMPC)Mbp/Stag1^em1(IMPC)Mbp (C57BL/6N-Stag1^em1(IMPC)Mbp/MbpMmucd)	edema	J:211773
Star^tm1Klp/Star^tm1Klp (involves: 129P2/OlaHsd)	cyanosis	J:43589
	decreased circulating aldosterone level	J:43589
	decreased circulating corticosterone level	J:43589
	increased adrenocorticotropin level	J:43589
	increased circulating corticotropin-releasing hormone level	J:43589
Stard3^tm1Jfs/Stard3^tm1Jfs (involves: 129X1/SvJ * C57BL/6J)	increased liver cholesterol level	J:89362
Stard4^tm1.2Bres/Stard4^tm1.2Bres (involves: BALB/cJ * C57BL/6 * C57BL/6J * SJL)	decreased circulating cholesterol level	J:160807
	decreased circulating LDL cholesterol level	J:160807
Stard7^{tm1b(EUCOMM)Wtsi}/Stard7⁺ (C57BL/6N-Stard7^{tm1b(EUCOMM)Wtsi}/Wtsi)	decreased circulating serum albumin level	J:211773
Stard9^em1(IMPC)J/Stard9^em1(IMPC)J (C57BL/6NJ-Stard9^em1(IMPC)J/Mmjax)	increased circulating creatinine level	J:211773
	increased circulating phosphate level	J:211773
Stard10^tm1Saaa/Stard10^tm1Saaa (B6.Cg-Stard10^tm1Saaa)	abnormal bile salt homeostasis	J:198860
	abnormal phospholipid level	J:198860
	decreased circulating cholesterol level	J:198860
	decreased circulating free fatty acids level	J:198860
	decreased circulating triglyceride level	J:198860
	decreased liver cholesterol level	J:198860
	decreased liver triglyceride level	J:198860
	increased bile salt level	J:198860
Stard13^tm1.1Fms/Stard13^tm1.1Fms Tg(Pdx1-cre)89.1Dam/0 (involves: C57BL/6 * CBA * SJL)	impaired glucose tolerance	J:191071
Stat1^tm1Dlv/Stat1^tm1Dlv (involves: 129S/SvEv)	increased circulating interferon-gamma level	J:130622
Stat1^tm1Dlv/Stat1^tm1Dlv (B6.129S-Stat1^tm1Dlv)	increased circulating interferon-gamma level	J:79552
Stat1^tm1Dlv/Stat1^tm1Dlv (B6.129S-Stat1^tm1Dlv)	increased circulating interleukin-12b level	J:79552
Stat1^tm1Rds/Stat1^tm1Rds (129S6/SvEv-Stat1^tm1Rds/Tac)	abnormal nitric oxide homeostasis	J:122801
	decreased circulating interferon-gamma level	J:122801
	pulmonary edema	J:286237
Stat1^tm1Uvin/Stat1^tm1Uvin (involves: 129 * C57BL/6)	increased macrophage nitric oxide production	J:174863
Stat1^{tm2b(EUCOMM)Wtsi}/Stat1^{tm2b(EUCOMM)Wtsi} (C57BL/6N-Stat1^{tm2b(EUCOMM)Wtsi}/Orl)	decreased circulating alkaline phosphatase level	J:211773
Stat3^tm1Aki/Stat3^tm1Aki Tg(Tek-cre)12Flv/0 (involves: 129P2/OlaHsd * C3H * C57BL/6)	abnormal interleukin level	J:123351
Stat3^tm1Dnl/Stat3^tm1Dlv (involves: C57BL/6)	abnormal circulating insulin-like growth factor I level	J:87599
	decreased growth hormone level	J:87599
	decreased urine protein level	J:87599
Stat3^tm1Flv/Stat3^tm1Flv Tg(Nes-cre)1Kln/0 (involves: C57BL/6 * SJL)	abnormal body temperature homeostasis	J:89242
	abnormal glucose homeostasis	J:89242
	decreased body temperature	J:89242
	decreased energy expenditure	J:89242
	hyperglycemia	J:89242
	impaired adaptive thermogenesis	J:89242
	impaired glucose tolerance	J:89242
	increased circulating corticosterone level	J:89242
	increased circulating insulin level	J:89242
	increased circulating leptin level	J:89242
	increased circulating triglyceride level	J:89242
	insulin resistance	J:89242
Stat3^tm1Flv/Stat3^tm1Flv Tg(Tek-cre)12Flv/0 (involves: 129 * C3H * C57BL/6)	increased circulating interferon-gamma level	J:81973
	increased circulating tumor necrosis factor level	J:81973
Stat3^tm1Jbha/Stat3^tm1Jbha Tg(Fabp4-cre)1Rev/0 (involves: 129S/SvEv * C57BL/6)	decreased circulating adiponectin level	J:136030
Stat3^tm1Vpo/Stat3⁺ Tg(Myh6-cre)2182Mds/0 (involves: 129P2/OlaHsd * FVB/N)	generalized edema	J:141591
Stat3^tm1Vpo/Stat3^tm1Vpo Tg(Myh6-cre)2182Mds/0 (involves: 129P2/OlaHsd * FVB/N)	abnormal atrial thrombosis	J:141591
	generalized edema	J:141591
Stat3^tm1Xyfu/Stat3^tm1.1Xyfu Tg(Myh6-cre)2182Mds/0 (involves: 129S1/Sv * FVB/N)	ascites	J:86400
Stat3^tm2Aki/Stat3^tm2Aki (involves: 129 * 129P2/OlaHsd * C57BL/6 * FVB/N)	increased circulating glucose level	J:131301
	increased circulating insulin level	J:131301
Stat3^tm2Aki/Stat3^tm2Aki Tg(Alb1-cre)1Dlr/0 (involves: 129P2/OlaHsd * FVB/N)	abnormal glucose homeostasis	J:109359
Stat3^tm2Aki/Stat3^tm2Aki Tg(SFTPC-rtTA)5Jaw/0 Tg(tetO-cre)1Jaw/0 (involves: 129 * 129P2/OlaHsd * C57BL/6)	abnormal cytokine level	J:87622
Stat4^ity14/Stat4^ity14 (involves: 129S1/Sv * 129X1/SvJ)	decreased circulating interferon-gamma level	J:207092
Stat4^ity14/Stat4^ity14 (involves: 129S1/Sv * 129X1/SvJ)	increased circulating interleukin-12 level	J:207092
Stat4^tm1Gru/Stat4⁺ (NOD.129S2-Stat4^tm1Gru)	abnormal circulating glucose level	J:90600
Stat4^tm1Gru/Stat4^tm1Gru (involves: 129S2/SvPas * BALB/c)	decreased circulating interferon-gamma level	J:163843
Stat4^tm1Gru/Stat4^tm1Gru (NOD.129S2-Stat4^tm1Gru)	abnormal insulin secretion	J:90600
	decreased circulating interferon-gamma level	J:90600
	decreased circulating interleukin-2 level	J:90600
Stat4^tm1Gru/Stat4^tm1Gru (C.129S2-Stat4^tm1Gru)	decreased circulating interferon-gamma level	J:90600
Stat4^tm1Gru/Stat4^tm1Gru (C.129S2-Stat4^tm1Gru)	decreased circulating interleukin-2 level	J:90600
Stat4^tm1Jni/Stat4^tm1Jni (involves: 129P2/OlaHsd * C57BL/6)	decreased circulating interferon-gamma level	J:79552
Stat5a^tm2Mam/Stat5a^tm2Mam Stat5b^tm1Mam/Stat5b^tm1Mam Myf5^tm3(cre)Sor/Myf5⁺ (involves: 129S4/SvJaeSor * 129S6/SvEvTac)	decreased circulating insulin-like growth factor I level	J:119237
	impaired glucose tolerance	J:119237
	increased circulating triglyceride level	J:119237
Stat5a^tm2Mam/Stat5a^tm2Mam Stat5b^tm1Mam/Stat5b^tm1Mam Tg(Cd4-cre)1Cwi/0 (involves: 129S6/SvEvTac * C57BL/6 * C57BL/6J * DBA/2)	increased circulating interleukin-17 level	J:120176
Stat5a^tm2Mam/Stat5a^tm2Mam Stat5b^tm1Mam/Stat5b^tm1Mam Tg(Ins2-cre)25Mgn/0 (involves: 129S6/SvEvTac * C57BL/6 * DBA)	decreased insulin secretion	J:127051
	impaired glucose tolerance	J:127051
	increased circulating free fatty acids level	J:127051
	increased circulating glucose level	J:127051
	increased circulating leptin level	J:127051
Stat5a^tm2Mam/Stat5a^tm2Mam Stat5b^tm1Mam/Stat5b^tm1Mam Tg(Nes-cre)1Kln/0 (involves: 129 * 129S6/SvEvTac * C57BL/6 * SJL)	decreased oxygen consumption	J:132806
	impaired adaptive thermogenesis	J:132806
	impaired glucose tolerance	J:132806
	increased circulating free fatty acids level	J:132806
	increased circulating insulin level	J:132806
	increased circulating leptin level	J:132806
	increased circulating triglyceride level	J:132806
	insulin resistance	J:132806
Stat5a^tm2Mam/Stat5a^tm2Mam Stat5b^tm1Mam/Stat5b^tm1Mam Tg(Pdx1-cre)89.1Dam/0 (involves: 129S6/SvEvTac * C57BL/6 * CBA)	impaired glucose tolerance	J:127051
Stat5a^tm2Mam/Stat5a^tm2Mam Stat5b^tm1Mam/Stat5b^tm1Mam Tg(Tek-cre)1Ywa/0 (involves: 129S6/SvEvTac * C57BL/6 * SJL)	increased circulating iron level	J:138904
	increased liver iron level	J:138904
Stat5a^tm2Mam/Stat5a^tm2Mam Tg(Ins2-cre)23Herr/0 (involves: 129S6/SvEvTac * C57BL/6J * CBA/J)	decreased serotonin level	J:284574
Stat5b^tm1Hwd/Stat5b^tm1Hwd (involves: 129 * BALB/c)	decreased circulating insulin-like growth factor I level	J:41784
	decreased urine major urinary protein level	J:41784
	increased circulating growth hormone level	J:41784
Stat5b^tm1Mam/Stat5b^tm1Mam Tg(Cd4-cre)1Cwi/0 (involves: 129S6/SvEvTac * C57BL/6 * C57BL/6J * DBA/2)	increased circulating interleukin-17 level	J:120176
Stat5b^tm1Mam/Stat5b^tm1Mam Tg(Ins2-cre)25Mgn/0 (involves: 129S6/SvEvTac * C57BL/6 * DBA)	decreased insulin secretion	J:127051
	impaired glucose tolerance	J:127051
	increased circulating free fatty acids level	J:127051
	increased circulating glucose level	J:127051
	increased circulating leptin level	J:127051
Stat5b^tm1Mam/Stat5b^tm1Mam Tg(Nes-cre)1Kln/0 (involves: 129 * 129S6/SvEvTac * C57BL/6 * SJL)	decreased oxygen consumption	J:132806
	impaired adaptive thermogenesis	J:132806
	impaired glucose tolerance	J:132806
	increased circulating free fatty acids level	J:132806
	increased circulating insulin level	J:132806
	increased circulating leptin level	J:132806
	increased circulating triglyceride level	J:132806
	insulin resistance	J:132806
Stat5b^tm1Mam/Stat5b^tm1Mam Tg(Pdx1-cre)89.1Dam/0 (involves: 129S6/SvEvTac * C57BL/6 * CBA)	impaired glucose tolerance	J:127051
Stat5b^tm1Mam/Stat5b^tm1Mam Tg(Tek-cre)1Ywa/0 (involves: 129S6/SvEvTac * C57BL/6 * SJL)	increased circulating iron level	J:138904
	increased liver iron level	J:138904
Stat6^tm1Aki/Stat6^tm1Aki Tg(KRT14-CASP1)1Miz/0 (involves: 129P2/OlaHsd * C57BL/6)	abnormal circulating histamine level	J:78602
	increased circulating interleukin-18 level	J:78602
Stat6^tm1Gru/Stat6^tm1Gru (involves: 129S2/SvPas * BALB/c)	abnormal circulating alanine transaminase level	J:85386
Stat6^tm1Gru/Stat6^tm1Gru (involves: 129S2/SvPas * BALB/c)	increased circulating tumor necrosis factor level	J:85386
Stat6^tm1Gru/Stat6^tm1Gru (C.129S2-Stat6^tm1Gru)	abnormal circulating interleukin level	J:66222
	abnormal circulating interleukin-4 level	J:66222
	abnormal circulating interleukin-5 level	J:66222
	abnormal noradrenaline level	J:178294
	decreased core body temperature	J:178294
	decreased fatty acids level	J:178294
	increased circulating creatine level	J:84825
Stat6^tm1Gru/Stat6^tm1Gru (involves: 129S2/SvPas * C57BL/6)	decreased core body temperature	J:178294
Stc2^tm1Rred/Stc2^tm1Rred (involves: 129S1/Sv * 129X1/SvJ)	abnormal circulating alkaline phosphatase level	J:136007
Steap3^fred/Steap3^fred (C57BL/6-Steap3^fred)	abnormal iron homeostasis	J:145194
	decreased circulating copper level	J:145194
	increased liver copper level	J:145194
	increased liver iron level	J:145194
Steap3^tm1.1Atel/Steap3^tm1.1Atel (involves: C57BL/6)	abnormal blood osmolality	J:154356
Steap3^tm1.1Atel/Steap3^tm1.1Atel (involves: C57BL/6)	increased circulating glucose level	J:154356
Steap3^tm1.1Mdf/Steap3^tm1.1Mdf (involves: 129S4/SvJae * 129S6/SvEvTac * C57BL/6J * CBA/J)	abnormal iron homeostasis	J:103440
	increased liver iron level	J:103440
Steap3^{tm1b(EUCOMM)Hmgu}/Steap3^{tm1b(EUCOMM)Hmgu} (C57BL/6N-Steap3^{tm1b(EUCOMM)Hmgu}/J)	impaired glucose tolerance	J:211773
Steap4^tm1Dgen/Steap4^tm1Dgen (involves: 129P2/OlaHsd)	abnormal circulating cholesterol level	J:187736
	abnormal gluconeogenesis	J:187736
	decreased circulating insulin level	J:187736
	impaired glucose tolerance	J:187736
	increased circulating glucose level	J:187736
	increased circulating leptin level	J:187736
	increased circulating triglyceride level	J:187736
	increased liver triglyceride level	J:187736
	insulin resistance	J:187736
Stim1^{Gt(RRS558)Byg}/Stim1^{Gt(RRS558)Byg} (involves: 129P2/OlaHsd * C57BL/6)	abnormal calcium ion homeostasis	J:137364
	abnormal platelet activation	J:137364
	abnormal thrombosis	J:137364
	cyanosis	J:137364
	decreased platelet aggregation	J:137364
Stim1^Sax/Stim1⁺ (involves: C3HeB/FeJ * C57BL/6)	abnormal platelet activation	J:127381
	abnormal thrombosis	J:127381
	increased bleeding time	J:127381
Stim1^tm1.1Pg/Stim1⁺ (involves: C57BL/6)	abnormal circulating creatine kinase level	J:285187
Stim1^tm1.1Pg/Stim1⁺ (involves: C57BL/6)	increased bleeding time	J:285187
Stimate^{tm2b(KOMP)Wtsi}/Stimate^{tm2b(KOMP)Wtsi} (C57BL/6N-Stimate^{tm2b(KOMP)Wtsi}/Wtsi)	increased circulating alkaline phosphatase level	J:211773
Sting1^em1Jmin/Sting1⁺ (involves: C57BL/6N)	abnormal cytokine level	J:251372
	abnormal lung thrombosis	J:251372
	increased circulating interleukin-10 level	J:251372
	increased circulating interleukin-13 level	J:251372
	increased circulating tumor necrosis factor level	J:251372
	pleural effusion	J:251372
Sting1^gt/Sting1^gt (C57BL/6-Sting1^gt)	decreased circulating interferon-alpha level	J:201167
Sting1^gt/Sting1^gt (C57BL/6-Sting1^gt)	decreased circulating interferon-beta level	J:201167, J:168746
Sting1^tm1Camb/Sting1^tm1Camb (involves: C57BL/6N)	decreased circulating interferon-beta level	J:179270
Sting1^tm1Camb/Sting1^tm1Camb (involves: C57BL/6N)	decreased circulating interleukin-6 level	J:179270
Stk3^em1(IMPC)H/Stk3^em1(IMPC)H (C57BL/6NTac-Stk3^em1(IMPC)H/H)	increased circulating alanine transaminase level	J:211773
	increased circulating aspartate transaminase level	J:211773
	increased circulating creatinine level	J:211773
Stk3^tm1.1Yy/Stk3⁺ Stk4^tm1.1Yy/Stk4^tm1.1Yy (involves: C57BL/6 * CBA)	decreased circulating alanine transaminase level	J:156541
	decreased circulating aspartate transaminase level	J:156541
Stk3^tm1.1Yy/Stk3^tm1Yy Stk4^tm1.1Yy/Stk4^tm1.1Yy (involves: C57BL/6 * CBA)	decreased circulating alanine transaminase level	J:156541
	decreased circulating aspartate transaminase level	J:156541
Stk3^tm1.1Yy/Stk3^tm1Yy Stk4^tm1.1Yy/Stk4^tm1.1Yy (involves: C57BL/6 * CBA)	increased circulating alanine transaminase level	J:156541
	increased circulating aspartate transaminase level	J:156541
Stk11^tm1.1Arte/Stk11^tm1.1Arte (involves: C57BL/6J)	abnormal lipid homeostasis	J:208379
Stk11^tm1.1Rdp/Stk11^tm1.1Rdp (involves: 129S6/SvEvTac)	abnormal circulating glucose level	J:174020
	abnormal gluconeogenesis	J:174020
	increased circulating glucose level	J:174020
Stk11^tm1.1Rdp/Stk11^tm1.1Rdp Tg(Pdx1-cre)89.1Dam/0 (involves: 129S6/SvEvTac * C57BL/6 * CBA * FVB/N * ICR)	improved glucose tolerance	J:134078
	increased circulating glucose level	J:134078
Stk11^tm1Keis/Stk11^tm1Keis Lyz2^tm1(cre)Ifo/Lyz2⁺ (involves: 129P2/OlaHsd)	increased circulating interleukin-10 level	J:191723
Stk11^tm1Keis/Stk11^tm1Keis Tg(Pomc1-cre)1Gsb/0 (involves: FVB/N)	abnormal gluconeogenesis	J:170130
	abnormal glycogen homeostasis	J:170130
	impaired glucose tolerance	J:170130
	insulin resistance	J:170130
Stk24^{Gt(AM0826)Wtsi}/Stk24^{Gt(AM0826)Wtsi} (B6.129P2-Stk24^{Gt(AM0826)Wtsi})	increased circulating creatinine level	J:256076
Stk26^{tm1b(EUCOMM)Hmgu}/Stk26^{tm1b(EUCOMM)Hmgu} (C57BL/6N-Stk26^{tm1b(EUCOMM)Hmgu}/Ccpcz)	decreased circulating creatinine level	J:211773
Stk33^em1(IMPC)J/Stk33^em1(IMPC)J (C57BL/6NJ-Stk33^em1(IMPC)J/Mmjax)	increased fasting circulating glucose level	J:211773
Stk35^em1(IMPC)J/Stk35^em1(IMPC)J (C57BL/6N-Stk35^em1(IMPC)J/J)	increased circulating alanine transaminase level	J:211773
Stk36^em1(IMPC)J/Stk36⁺ (C57BL/6NJ-Stk36^em1(IMPC)J/J)	increased urine microalbumin level	J:211773
Stk38^{tm1b(KOMP)Wtsi}/Stk38⁺ (C57BL/6N-Stk38^{tm1b(KOMP)Wtsi}/J)	increased fasting circulating glucose level	J:211773
Stk38^tm1Xen/Stk38^tm1Xen (involves: 129S5/SvEvBrd * C57BL/6)	increased circulating interleukin-6 level	J:224932
	increased circulating tumor necrosis factor level	J:224932
Stk39^Rnl5/? (C57BL/6J-Stk39^Rnl5/Pgn)	albuminuria	J:82961
Stk39^tm1.1Arte/Stk39^tm1.1Arte (involves: 129S/SvEvBrd * C57BL/6J)	decreased circulating magnesium level	J:191566
	decreased urine calcium level	J:191566
	hypokalemia	J:191566
	increased urine potassium level	J:191566
	increased urine sodium level	J:191566
Stk39^tm1.2Slin/Stk39^tm1.2Slin (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	abnormal blood homeostasis	J:165706
	decreased circulating magnesium level	J:165706
	decreased circulating potassium level	J:165706
	decreased urine calcium level	J:165706
	decreased urine chloride ion level	J:165706
	decreased urine sodium level	J:165706
	increased circulating aldosterone level	J:165706
	increased urine magnesium level	J:165706
	increased urine potassium level	J:165706
Stk39^tm1Pawe/Stk39^tm1Pawe (involves: 129S6/SvEvTac * C57BL/6J)	alkalosis	J:287773
	hypokalemia	J:287773
	increased blood urea nitrogen level	J:287773
Stk39^tm1Pawe/Stk39^tm1Pawe Pvalb^tm1(cre)Arbr/Pvalb⁺ (B6.129-Stk39^tm1Pawe Pvalb^tm1(cre)Arbr)	decreased blood urea nitrogen level	J:287773
	decreased urine potassium level	J:287773
	hyperkalemia	J:287773
	increased circulating chloride level	J:287773
	metabolic acidosis	J:287773
Stk39^tm2.1Arte/Stk39^tm2.1Arte (involves: C57BL/6J)	decreased circulating magnesium level	J:224087
	decreased circulating potassium level	J:224087
	decreased urine calcium level	J:224087
	increased urine sodium level	J:224087
Stk40^tm1Nju/Stk40^tm1Nju (B6.129-Stk40^tm1Nju)	cyanosis	J:196001
Stk40^tm1Nju/Stk40^tm1Nju (B6.129-Stk40^tm1Nju)	increased lung glycogen level	J:196001
Stmn2^{em1(IMPC)Kmpc}/Stmn2⁺ (C57BL/6NTac-Stmn2^{em1(IMPC)Kmpc}/Kmpc)	increased circulating creatine kinase level	J:211773
Stmn4^{tm1b(KOMP)Wtsi}/Stmn4^{tm1b(KOMP)Wtsi} (C57BL/6N-Stmn4^{tm1b(KOMP)Wtsi}/J)	improved glucose tolerance	J:211773
Stoml2^{tm1(KOMP)Vlcg}/Stoml2^{tm1(KOMP)Vlcg} (C57BL/6N-Stoml2^{tm1(KOMP)Vlcg}/MbpMmucd)	increased circulating alanine transaminase level	J:211773
	increased circulating aspartate transaminase level	J:211773
	increased circulating bilirubin level	J:211773
	increased circulating insulin level	J:211773
Stox2^{tm2b(EUCOMM)Hmgu}/Stox2⁺ (C57BL/6N-Stox2^{tm2b(EUCOMM)Hmgu}/J)	decreased fasting circulating glucose level	J:211773
Stra6^tm1.1Jvli/Stra6^tm1.1Jvli (involves: C57BL/6 * FVB/N)	abnormal vitamin A level	J:214659
Stra6^tm1Nbg/Stra6^tm1Nbg (involves: 129 * C57BL/6J)	abnormal retinol level	J:196841
Stra6^tm1Nbg/Stra6^tm1Nbg (involves: 129S2/SvPas * C57BL/6 * SJL)	abnormal protein level	J:203449
	improved glucose tolerance	J:203449
	increased insulin sensitivity	J:203449
Strbp^{em1(IMPC)Hmgu}/Strbp^{em1(IMPC)Hmgu} (C57BL/6N-Strbp^{em1(IMPC)Hmgu}/Ieg)	decreased circulating amylase level	J:211773
	decreased circulating serum albumin level	J:211773
	decreased respiratory quotient	J:211773
Strn3^{tm1b(KOMP)Wtsi}/Strn3⁺ (C57BL/6N-Strn3^{tm1b(KOMP)Wtsi}/J)	decreased circulating glucose level	J:211773
Strn3^{tm1b(KOMP)Wtsi}/Strn3^{tm1b(KOMP)Wtsi} (C57BL/6N-Strn3^{tm1b(KOMP)Wtsi}/J)	edema	J:211773
Strn^{tm1a(KOMP)Wtsi}/Strn⁺ (C57BL/6N-Strn^{tm1a(KOMP)Wtsi})	increased circulating aldosterone level	J:232621
Stt3b^em1(IMPC)J/Stt3b⁺ (C57BL/6NJ-Stt3b^em1(IMPC)J/Mmjax)	increased circulating alanine transaminase level	J:211773
	increased circulating bilirubin level	J:211773
	increased circulating cholesterol level	J:211773
Stub1^em1Schiz/Stub1^em1Schiz (C57BL/6J-Stub1^em1Schiz)	increased urine chloride ion level	J:260672
	increased urine creatinine level	J:260672
	increased urine osmolality	J:260672
	increased urine potassium level	J:260672
	increased urine sodium level	J:260672
	increased urine urea nitrogen level	J:260672
Stub1^tm1Cpat/Stub1^tm1Cpat (involves: 129S/SvEv * C57BL/6)	increased urine chloride ion level	J:260672
	increased urine creatinine level	J:260672
	increased urine osmolality	J:260672
	increased urine potassium level	J:260672
	increased urine sodium level	J:260672
	increased urine urea nitrogen level	J:260672
Stub1^tm1Cpat/Stub1^tm1Cpat (involves: 129S/SvEv)	decreased follicle stimulating hormone level	J:206229
Stx1a^tm1Tfuj/Stx1a^tm1Tfuj (B6.Cg-Stx1a^tm1Tfuj)	increased serotonin level	J:171786
Stx2^{tm1b(EUCOMM)Wtsi}/Stx2^{tm1b(EUCOMM)Wtsi} (C57BL/6N-Stx2^{tm1b(EUCOMM)Wtsi}/J)	increased circulating cholesterol level	J:211773
	increased circulating HDL cholesterol level	J:211773
Stx4a^tm1Jpes/Stx4a⁺ (involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)	impaired glucose tolerance	J:69598
	increased circulating insulin level	J:69598
	insulin resistance	J:69598
Stx6^em1(IMPC)H/Stx6^em1(IMPC)H (C57BL/6NTac-Stx6^em1(IMPC)H/H)	decreased circulating glucose level	J:211773
	increased blood urea nitrogen level	J:211773
	increased circulating alkaline phosphatase level	J:211773
	increased circulating cholesterol level	J:211773
Stx7^{em1(IMPC)Rbrc}/Stx7^{em1(IMPC)Rbrc} (C57BL/6NJcl-Stx7^{em1(IMPC)Rbrc}/Rbrc)	abnormal circulating phosphate level	J:211773
Stx8^{tm2a(EUCOMM)Wtsi}/Stx8^{tm2a(EUCOMM)Wtsi} (involves: C57BL/6N)	abnormal platelet dense granule physiology	J:218388
	abnormal platelet physiology	J:218388
	abnormal thrombosis	J:218388
	decreased platelet aggregation	J:218388
Stx11^em1(IMPC)Mbp/Stx11^em1(IMPC)Mbp (C57BL/6N-Stx11^em1(IMPC)Mbp/MbpMmucd)	increased blood urea nitrogen level	J:211773
Stx11^tm1.2Ics/Stx11^tm1.2Ics (involves: C57BL/6NTac)	decreased body temperature	J:193137
	increased circulating aspartate transaminase level	J:193137
	increased circulating interferon-gamma level	J:193137
	increased circulating interleukin-1 beta level	J:193137
	increased circulating interleukin-6 level	J:193137
	increased circulating lactate dehydrogenase level	J:193137
	increased circulating tumor necrosis factor level	J:193137
Stx16^{tm1b(KOMP)Wtsi}/Stx16^{tm1b(KOMP)Wtsi} (C57BL/6N-Stx16^{tm1b(KOMP)Wtsi}/J)	decreased circulating serum albumin level	J:211773
	improved glucose tolerance	J:211773
	increased circulating alanine transaminase level	J:211773
	increased circulating alkaline phosphatase level	J:211773
	increased circulating bilirubin level	J:211773
	increased circulating potassium level	J:211773
	increased fasting circulating glucose level	J:211773
Stx18^{tm2b(KOMP)Wtsi}/Stx18⁺ (C57BL/6N-Stx18^{tm2b(KOMP)Wtsi}/J)	decreased circulating glucose level	J:211773
Stx19^{tm1.1(KOMP)Vlcg}/Stx19^{tm1.1(KOMP)Vlcg} (C57BL/6N-Stx19^{tm1.1(KOMP)Vlcg}/J)	decreased circulating chloride level	J:211773
	decreased circulating glucose level	J:211773
	increased fasting circulating glucose level	J:211773
Stxbp1^{tm1b(EUCOMM)Hmgu}/Stxbp1⁺ (C57BL/6N-Stxbp1^{tm1b(EUCOMM)Hmgu}/J)	impaired glucose tolerance	J:211773
Stxbp1^{tm1b(EUCOMM)Hmgu}/Stxbp1^{tm1b(EUCOMM)Hmgu} (C57BL/6N-Stxbp1^{tm1b(EUCOMM)Hmgu}/J)	edema	J:211773
Stxbp3^tm1Jpes/Stxbp3⁺ (B6.129-Stxbp3^tm1Jpes)	decreased insulin secretion	J:96731
	hyperglycemia	J:96731
	impaired glucose tolerance	J:96731
	insulin resistance	J:96731
Stxbp4^{tm1a(EUCOMM)Wtsi}/Stxbp4^{tm1a(EUCOMM)Wtsi} (C57BL/6N-A^tm1Brd Stxbp4^{tm1a(EUCOMM)Wtsi}/WtsiH)	decreased blood urea nitrogen level	J:211773
	decreased circulating calcium level	J:211773
Stxbp5l^{tm1.1(KOMP)Vlcg}/Stxbp5l^{tm1.1(KOMP)Vlcg} (C57BL/6N-Stxbp5l^{tm1.1(KOMP)Vlcg}/Ucd)	increased circulating alkaline phosphatase level	J:211773
Stxbp5l^tm1.1Aljg/Stxbp5l^tm1.1Aljg (involves: C57BL/6J)	increased partial thromboplastin time	J:263474
Stzid2^NOD/Stzid2^NOD (involves: C3H/Or * NOD)	abnormal glucose homeostasis	J:95957
Stzid3^NSY/Stzid3^NSY (C3H/He-Chr 11^NSY)	hyperglycemia	J:95507
Stzid3^NSY/Stzid3^NSY (C3H/He-Chr 11^NSY)	increased urine glucose level	J:95507
Stzid^NOD/Stzid^NOD (involves: C3H/Or * NOD)	abnormal glucose homeostasis	J:95957
Stzid^NOD/Stzid^NOD Stzid2^NOD/Stzid2^NOD (involves: C3H/Or * NOD)	abnormal glucose homeostasis	J:95957
Sucla2^{Gt(IST10208H1)Tigm}/Sucla2⁺ (involves: 129S/SvEv * C57BL/6N)	increased circulating carnitine level	J:241325
Sucla2^{Gt(IST10208H1)Tigm}/Sucla2⁺ Suclg2^{Gt(Ayu21-KBW131)Imeg}/Suclg2⁺ (involves: 129S/SvEv * C57BL/6 * C57BL/6N)	increased circulating carnitine level	J:241325
Sucnr1^tm1Lex/Sucnr1^tm1Lex (involves: 129S/SvEvBrd)	decreased circulating renin level	J:137706
Suco^{Gt(KST050)Byg}/Suco^{Gt(KST050)Byg} (involves: 129P2/OlaHsd * C57BL/6 * CD-1)	decreased circulating insulin-like growth factor I level	J:159823
	decreased circulating osteocalcin level	J:159823
	hypoglycemia	J:159823
	increased circulating alkaline phosphatase level	J:159823
Sufu^rgsc2062/Sufu^rgsc2062 (either: B6JJcl(C3JJcl)-Sufu^rgsc2062 or B6JJcl(D2JJcl)-Sufu^rgsc2062)	edema	J:228335
Sugct^tm1.2Kald/Sugct^tm1.2Kald (B6.Cg-Sugct^tm1.2Kald)	proteinosis	J:293423
Sugp1^em1(IMPC)Mbp/Sugp1⁺ (C57BL/6NCrl-Sugp1^em1(IMPC)Mbp/Mmucd)	edema	J:211773
Sult1a1^tm1Glatt/Sult1a1^tm1Glatt (FVB.Cg-Sult1a1^tm1Glatt)	abnormal blood homeostasis	J:217578
Sult1c1^{tm1b(KOMP)Wtsi}/Sult1c1^{tm1b(KOMP)Wtsi} (C57BL/6N-Sult1c1^{tm1b(KOMP)Wtsi}/Wtsi)	increased blood urea nitrogen level	J:211773
Sult1d1^tm1Glatt/Sult1d1^tm1Glatt (FVB.Cg-Sult1d1^tm1Glatt)	abnormal blood homeostasis	J:217578
Sult1e1^tm1Song/Sult1e1^tm1Song (B6.129S6-Sult1e1^tm1Song)	abnormal amniotic fluid composition	J:96050
	abnormal placental thrombosis	J:96050
	abnormal platelet physiology	J:96050
	increased circulating estradiol level	J:96050
Sult2b1^tm1Rus/Sult2b1^tm1Rus (B6;129-Sult2b1^tm1Rus/J)	abnormal cholesterol level	J:186536
Sun1^{tm1b(EUCOMM)Wtsi}/Sun1^{tm1b(EUCOMM)Wtsi} (C57BL/6N-Sun1^{tm1b(EUCOMM)Wtsi}/Orl)	decreased circulating serum albumin level	J:211773
	decreased circulating total protein level	J:211773
	increased circulating phosphate level	J:211773
Sun1^tm1Mhan/Sun1^tm1Mhan Sun2^tm1Mhan/Sun2^tm1Mhan (involves: 129S6/SvEvTac)	cyanosis	J:150047
Sun5^em1(IMPC)Mbp/Sun5^em1(IMPC)Mbp (C57BL/6N-Sun5^em1(IMPC)Mbp/MbpMmucd)	decreased circulating calcium level	J:211773
Supt7l^{tm1a(EUCOMM)Wtsi}/Supt7l⁺ (C57BL/6N-Supt7l^{tm1a(EUCOMM)Wtsi}/Wtsi)	decreased circulating alkaline phosphatase level	J:175295
Surf4^em1(IMPC)J/Surf4⁺ (C57BL/6NJ-Surf4^em1(IMPC)J/Mmjax)	decreased circulating phosphate level	J:211773
Surf4^em1(IMPC)J/Surf4⁺ (C57BL/6NJ-Surf4^em1(IMPC)J/Mmjax)	impaired glucose tolerance	J:211773
Surf4^em1Bcgen/Surf4⁺ (C57BL/6J-Surf4^em1Bcgen)	decreased circulating cholesterol level	J:302969
Surf4^em1Bcgen/Surf4⁺ (C57BL/6J-Surf4^em1Bcgen)	decreased circulating triglyceride level	J:302969
Surf4^em1Bcgen/Surf4^em1Bcgen (C57BL/6J-Surf4^em1Bcgen)	decreased circulating cholesterol level	J:302969
	decreased circulating triglyceride level	J:302969
	increased liver cholesterol level	J:302969
Susd4^tm1Lex/Susd4^tm1Lex (B6.129S5-Susd4^tm1Lex)	abnormal complement protein level	J:306852
Susd6^{tm1b(KOMP)Wtsi}/Susd6^{tm1b(KOMP)Wtsi} (C57BL/6N-Susd6^{tm1b(KOMP)Wtsi}/Bay)	decreased circulating fructosamine level	J:211773
	decreased circulating HDL cholesterol level	J:211773
	increased circulating alanine transaminase level	J:211773
	increased circulating amylase level	J:211773
	increased circulating aspartate transaminase level	J:211773
	increased circulating bilirubin level	J:211773
	increased circulating iron level	J:211773
	increased circulating potassium level	J:211773
Svep1^{tm1a(EUCOMM)Hmgu}/Svep1^{tm1a(EUCOMM)Hmgu} (involves: C57BL/6N)	lymphedema	J:244466
	nuchal edema	J:244466
Svep1^{tm1b(EUCOMM)Hmgu}/Svep1⁺ (C57BL/6N-Svep1^{tm1b(EUCOMM)Hmgu}/J)	decreased circulating glucose level	J:211773
	decreased circulating phosphate level	J:211773
	decreased circulating sodium level	J:211773
Svep1^{tm1b(EUCOMM)Hmgu}/Svep1^{tm1b(EUCOMM)Hmgu} (C57BL/6N-Svep1^{tm1b(EUCOMM)Hmgu}/J)	edema	J:211773
Svep1^{tm1b(EUCOMM)Hmgu}/Svep1^{tm1b(EUCOMM)Hmgu} (B6N(Cg)-Svep1^{tm1b(EUCOMM)Hmgu}/J)	edema	J:255307
Svil^{Gt(RRF043)Byg}/Svil^{Gt(RRF043)Byg} (B6.129P2-Svil^{Gt(RRF043)Byg})	abnormal platelet physiology	J:198612
	increased platelet aggregation	J:198612
Swt1^em1(IMPC)J/Swt1^em1(IMPC)J (C57BL/6NJ-Swt1^em1(IMPC)J/Mmjax)	impaired glucose tolerance	J:211773
Syce1^{tm1b(KOMP)Wtsi}/Syce1^{tm1b(KOMP)Wtsi} (C57BL/6N-Syce1^{tm1b(KOMP)Wtsi}/J)	improved glucose tolerance	J:211773
	increased fasting circulating glucose level	J:211773
	increased urine microalbumin level	J:211773
Syce1l^{tm1.1(KOMP)Vlcg}/Syce1l^{tm1.1(KOMP)Vlcg} (C57BL/6N-Syce1l^{tm1.1(KOMP)Vlcg}/J)	increased circulating free fatty acids level	J:211773
	increased circulating sodium level	J:211773
Syk^tm1.1Nns/Syk^tm1.1Nns Commd10^{Tg(Vav1-icre)A2Kio}/Commd10⁺ (involves: C57BL/10 * CBA/Ca)	edema	J:181715
Syk^tm1.1Nns/Syk^tm1.1Nns Tg(Pf4-icre)Q3Rsko/0 (involves: C57BL/6)	abnormal platelet physiology	J:181715
	ascites	J:181715
	edema	J:181715
Syk^tm1Paw/Syk^tm1Paw (involves: 129S1/Sv * 129X1/SvJ)	hydrops fetalis	J:29797
Syk^tm1Tyb/Syk^tm1Tyb (involves: 129S2/SvPas * C57BL/6 * DBA/2)	chylous ascites	J:29796
Syk^{tm2.1(ZAP70)Fkfr}/Syk^{tm2.1(ZAP70)Fkfr} (B6.129-Syk^{tm2.1(ZAP70)Fkfr})	decreased blood urea nitrogen level	J:188422
	decreased circulating creatinine level	J:188422
	increased circulating glucose level	J:188422
	increased urine protein level	J:188422
Sympk^{Tg(Tyr)2381AOve}/Sympk^{Tg(Tyr)2381AOve} (FVB/N-Sympk^{Tg(Tyr)2381AOve})	hydrops fetalis	J:175597
Syn3^{tm1.1(KOMP)Vlcg}/Syn3^{tm1.1(KOMP)Vlcg} (C57BL/6N-Syn3^{tm1.1(KOMP)Vlcg}/J)	increased circulating alanine transaminase level	J:211773
	increased circulating sodium level	J:211773
Sync^tm1.1Ked/Sync^tm1.1Ked (involves: 129/Sv * C57BL/6)	increased circulating creatine kinase level	J:138552
Syncrip^{tm1b(EUCOMM)Hmgu}/Syncrip⁺ (C57BL/6N-Syncrip^{tm1b(EUCOMM)Hmgu}/Ieg)	impaired glucose tolerance	J:211773
	increased circulating alkaline phosphatase level	J:211773
Syne1^tm1.1Mcn/Syne1^tm1.1Mcn (involves: 129S4/SvJae * 129S6/SvEvTac * C57BL)	cyanosis	J:144757
Syne3^{tm1b(KOMP)Wtsi}/Syne3^{tm1b(KOMP)Wtsi} (C57BL/6N-Syne3^{tm1b(KOMP)Wtsi}/Ucd)	decreased circulating glucose level	J:211773
	increased circulating triglyceride level	J:211773
Synm^tm1.1Ics/Synm^tm1.1Ics (involves: 129S2/SvPas * C57BL/6 * FVB/N * SJL)	increased oxygen consumption	J:268425
Sypl1^{tm1b(KOMP)Wtsi}/Sypl1^{tm1b(KOMP)Wtsi} (C57BL/6N-Sypl^{tm1b(KOMP)Wtsi})	abnormal protein level	J:339267
Syt4^em2(IMPC)H/Syt4^em2(IMPC)H (C57BL/6N-Syt4^em2(IMPC)H/H)	decreased circulating fructosamine level	J:211773
	decreased circulating serum albumin level	J:211773
	increased blood urea nitrogen level	J:211773
Syt7^em2(IMPC)H/Syt7^em2(IMPC)H (C57BL/6N-Syt7^em2(IMPC)H/H)	decreased circulating phosphate level	J:211773
Syt17^{tm1b(KOMP)Wtsi}/Syt17^{tm1b(KOMP)Wtsi} (C57BL/6N-Syt17^{tm1b(KOMP)Wtsi}/Ucd)	increased blood urea nitrogen level	J:211773
	increased circulating alkaline phosphatase level	J:211773
	increased circulating calcium level	J:211773
	increased circulating serum albumin level	J:211773
	increased circulating total protein level	J:211773
Sytl1^{tm1a(KOMP)Wtsi}/Sytl1^{tm1a(KOMP)Wtsi} (involves: C57BL/6 * C57BL/6N)	decreased circulating amylase level	J:213427
Sytl1^tm1Tiz/Sytl1^tm1Tiz (C3.Cg-Sytl1^tm1Tiz)	decreased insulin secretion	J:200233
Sytl1^tm1Tiz/Sytl1^tm1Tiz Sytl4^tm1Tiz/Sytl4^tm1Tiz (involves: 129P2/OlaHsd * 129S6/SvEvTac * C57BL/6NTac)	decreased insulin secretion	J:200233
Sytl3^{em1(IMPC)Wtsi}/Sytl3^{em1(IMPC)Wtsi} (C57BL/6N-Sytl3^{em1(IMPC)Wtsi}/Wtsi)	decreased circulating total protein level	J:211773
Sytl4^{em1(IMPC)Hmgu}/Y (C57BL/6N-Sytl4^{em1(IMPC)Hmgu}/Ieg)	improved glucose tolerance	J:211773
Sytl4^{em1(IMPC)Hmgu}/Sytl4^{em1(IMPC)Hmgu} (C57BL/6N-Sytl4^{em1(IMPC)Hmgu}/Ieg)	improved glucose tolerance	J:211773
Sytl4^tm1Tiz/Sytl4^tm1Tiz (involves: 129P2/OlaHsd * C3H/He)	decreased circulating glucose level	J:102610
Sytl4^tm1Tiz/Sytl4^tm1Tiz (involves: 129P2/OlaHsd * C3H/He)	increased insulin secretion	J:102610
Szt2^em1(IMPC)Bay/Szt2^em1(IMPC)Bay (C57BL/6N-Szt2^em1(IMPC)Bay/BayMmucd)	edema	J:211773
T/T (Not Specified)	hemopericardium	J:13018
T2dm1sa^SM/JNshm/? (involves: A/J * SM/J)	hyperglycemia	J:80998
T2dm2^C57BL/6J/T2dm2^C57BL/6J (BTBR.B6-T2dm2^C57BL/6J)	decreased circulating insulin level	J:109581
T2dm2sa^A/JNshm/T2dm2sa^A/JNshm (involves: SM/J * SMXA5)	impaired glucose tolerance	J:107889
	increased circulating glucose level	J:107889
	increased circulating insulin level	J:107889
T2dm2sa^A/JNshm/T2dm2sa^A/JNshm (involves: SM.A-(D2Mit295-D2Mit281))	increased circulating glucose level	J:107889
	increased circulating insulin level	J:107889
T^34H/T⁺ (involves: STOCK T^34H * TFH)	edema	J:62655
Taar1^tm1Mmil/Taar1^tm1Mmil (B6.129S2-Taar1^tm1Mmil)	increased core body temperature	J:178061
	increased dopamine level	J:178061
	increased serotonin level	J:178061
Taar1^tm1Tdw/Taar1^tm1Tdw (involves: 129S1/Sv * C57BL/6J)	abnormal noradrenaline level	J:141501
Taar1^tm1Tdw/Taar1^tm1Tdw (involves: 129S1/Sv * C57BL/6J)	increased dopamine level	J:141501
Tab1^tm1.1Mis/Tab1^tm1.1Mis (involves: 129S4/SvJaeSor * 129S7/SvEvBrd * C57BL/6 * CBA)	edema	J:140317
Tab1^tm1Geny/Tab1^tm1Geny (involves: C57BL/6 * CBA)	hydrops fetalis	J:80766
Tab2^tm2.1Aki/Tab2^tm2.1Aki Tab3^tm1Aki/Tab3^tm1Aki Cd19^tm1(cre)Cgn/Cd19⁺ (involves: 129P2/OlaHsd * C57BL/6)	decreased circulating interleukin-6 level	J:195289
Tabw2^TALLYHO/Jng/Tabw2^TALLYHO/Jng (involves: C57BL/6J * TALLYHO/Jng)	increased circulating glucose level	J:100831
Tabw2^TALLYHO/Jng/Tabw2^TALLYHO/Jng (B6.TLHO-Tabw2^TALLYHO/Jng)	increased circulating leptin level	J:100831
	insulin resistance	J:100831
Tabw2^TALLYHO/Jng/Tabw2^TALLYHO/Jng Tanidd1^TALLYHO/Jng/Tanidd1^TALLYHO/Jng (involves: C57BL/6J * TALLYHO/Jng)	increased circulating glucose level	J:100831
Tac2^tm1Tigm/Tac2^tm1Tigm (involves: 129 * C57BL/6)	decreased circulating follicle stimulating hormone level	J:223528
Taco1^em1(IMPC)J/Taco1^em1(IMPC)J (C57BL/6NJ-Taco1^em1(IMPC)J/Mmjax)	decreased circulating alanine transaminase level	J:211773
	decreased circulating creatinine level	J:211773
	decreased circulating triglyceride level	J:211773
Tacr1^tm1Rhn/Tacr1^tm1Rhn (129S/SvEv-Tacr1^tm1Rhn)	abnormal body temperature homeostasis	J:77640
Tacr1^tm1Rhn/Tacr1^tm1Rhn (129S/SvEv-Tacr1^tm1Rhn)	decreased circulating corticosterone level	J:77640
Tacr1^tm1Sph/Tacr1^tm1Sph (involves: 129P2/OlaHsd)	abnormal dopamine level	J:171881
Tacr1^tm1Sph/Tacr1^tm1Sph (involves: 129P2/OlaHsd)	abnormal noradrenaline level	J:171881
Tacr2^{tm1(KOMP)Wtsi}/Tacr2^{tm1(KOMP)Wtsi} (involves: C57BL/6N)	decreased circulating luteinizing hormone level	J:302970
	increased circulating glucose level	J:302970
Tacr3^tm1Jasi/Tacr3^tm1Jasi (involves: 129P2/OlaHsd * C57BL/6)	decreased circulating follicle stimulating hormone level	J:182547
Taf2^{tm1b(EUCOMM)Hmgu}/Taf2⁺ (C57BL/6N-Taf2^{tm1b(EUCOMM)Hmgu}/Ics)	abnormal cholesterol homeostasis	J:211773
	increased circulating cholesterol level	J:211773
	increased circulating HDL cholesterol level	J:211773
Taf4^tm1Idvd/Taf4^tm1Idvd Tg(KRT14-cre)1Ipc/0 (Not Specified)	impaired skin barrier function	J:124111
Taf4^tm1Idvd/Taf4^tm1Idvd Tg(KRT14-cre/ERT2)1Ipc/0 (involves: C57BL/6 * SJL)	impaired skin barrier function	J:124111
Taf4b^tm1Rtj/Taf4b^tm1Rtj (involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)	increased circulating follicle stimulating hormone level	J:156655
Taf4b^tm1Rtj/Taf4b^tm1Rtj (B6.129-Taf4b^tm1Rtj)	increased circulating follicle stimulating hormone level	J:97245
Taf6^{tm1b(EUCOMM)Hmgu}/Taf6⁺ (C57BL/6N-Taf6^{tm1b(EUCOMM)Hmgu}/Bay)	decreased circulating serum albumin level	J:211773
	increased circulating aspartate transaminase level	J:211773
Taf10^tm1Lzt/Taf10^tm1Lzt Tg(KRT14-cre)1Ipc/0 (involves: 129 * C57BL/6 * SJL)	dehydration	J:101668
	impaired skin barrier function	J:101668
Taf15^em1(IMPC)Mbp/Taf15^em1(IMPC)Mbp (C57BL/6NCrl-Taf15^em1(IMPC)Mbp/MbpMmucd)	increased fasting circulating glucose level	J:211773
Tafa1^{tm1(KOMP)Vlcg}/Tafa1^{tm1(KOMP)Vlcg} (C57BL/6N-Tafa1^{tm1(KOMP)Vlcg})	abnormal nervous system dopamine level	J:284736
	increased energy expenditure	J:284736
	increased noradrenaline level	J:284736
Tafa2^em1(IMPC)H/Tafa2^em1(IMPC)H (C57BL/6NTac-Tafa2^em1(IMPC)H/H)	decreased fasting circulating glucose level	J:211773
Tafa4^em1(IMPC)Mbp/Tafa4^em1(IMPC)Mbp (C57BL/6N-Tafa4^em1(IMPC)Mbp/MbpMmucd)	increased circulating alkaline phosphatase level	J:211773
Tafazzin^em1Xfa/Y Tg(myl7.L-cre)1118Tmhn/0 (involves: C57BL/6NCrl * MF1)	abnormal phospholipid level	J:339058
Tagap1^em1(IMPC)Tcp/Tagap1^em1(IMPC)Tcp (C57BL/6N-Tagap1^em1(IMPC)Tcp/Tcp)	decreased circulating cholesterol level	J:211773
	decreased circulating triglyceride level	J:211773
	increased blood urea nitrogen level	J:211773
Tal1^tm1Wehi/Tal1^tm1Wehi (involves: 129S1/Sv * C57BL/6)	skin edema	J:27458
Tal1^tm2Wehi/Tal1^tm2Wehi (involves: 129S1/Sv * C57BL/6)	hypoxia	J:58825
Tal1^tm2Wehi/Tal1^tm2Wehi (involves: 129S1/Sv * C57BL/6)	pericardial edema	J:58825
Tamm41^{tm1(NCOM)Cmhd}/Tamm41^{tm1(NCOM)Cmhd} (C57BL/6N-Tamm41^{tm1(NCOM)Cmhd}/Tcp)	increased circulating iron level	J:165965
Tanc1^em1(IMPC)Tcp/Tanc1^em1(IMPC)Tcp (C57BL/6NCrl-Tanc1^em1(IMPC)Tcp/Tcp)	increased circulating alanine transaminase level	J:211773
	increased circulating aspartate transaminase level	J:211773
Tanc2^{em1(IMPC)Hmgu}/Tanc2^{em1(IMPC)Hmgu} (C57BL/6N-Tanc2^{em1(IMPC)Hmgu}/Ieg)	decreased circulating total protein level	J:211773
	decreased respiratory quotient	J:211773
	impaired glucose tolerance	J:211773
	increased circulating alkaline phosphatase level	J:211773
	increased circulating phosphate level	J:211773
Tanidd1^TALLYHO/Jng/Tanidd1^TALLYHO/Jng (either: (involves: C57BL/6 * TALLYHO/Jng) or (involves: CAST/Ei * TALLYHO/Jng))	hyperglycemia	J:70227
Tanidd2^TALLYHO/Jng/Tanidd2^TALLYHO/Jng (either: (involves: C57BL/6 * TALLYHO/Jng) or (involves: CAST/Ei * TALLYHO/Jng))	hyperglycemia	J:70227
Tanidd3^TALLYHO/Jng/Tanidd3^TALLYHO/Jng (either: (involves: C57BL/6 * TALLYHO/Jng) or (involves: CAST/Ei * TALLYHO/Jng))	hyperglycemia	J:70227
Taok2^tm1.2Dkap/Taok2^tm1.2Dkap (B6(Cg)-Taok2^tm1.2Dkap)	abnormal blood homeostasis	J:206781
Taok2^{tm1b(EUCOMM)Hmgu}/Taok2⁺ (C57BL/6N-Taok2^{tm1b(EUCOMM)Hmgu}/Ics)	increased circulating alkaline phosphatase level	J:211773
Tardbp^tm1.1Pcw/Tardbp^tm1.1Pcw Tg(CAG-cre/Esr1)5Amc/0 (involves: 129 C57BL/6 * CBA * SJL)	abnormal lipid oxidation	J:164406
Tardbp^{tm1b(EUCOMM)Wtsi}/Tardbp⁺ (C57BL/6N-Tardbp^{tm1b(EUCOMM)Wtsi}/H)	decreased blood urea nitrogen level	J:211773
Tardbp^tm3.1Ckjs/Tardbp⁺ Tg(Hlxb9-GFP)1Tmj/0 (involves: C57BL/6 * C57BL/6J * CBA)	abnormal calcium ion homeostasis	J:285792
Tars3^em1(IMPC)J/Tars3^em1(IMPC)J (C57BL/6NJ-Tars3^em1(IMPC)J/Mmjax)	decreased circulating total protein level	J:211773
	increased blood urea nitrogen level	J:211773
Tatdn3^{tm1a(EUCOMM)Wtsi}/Tatdn3^{tm1a(EUCOMM)Wtsi} (C57BL/6N-Tatdn3^{tm1a(EUCOMM)Wtsi}/Wtsi)	decreased blood urea nitrogen level	J:211773
Tax1bp3^{tm1b(EUCOMM)Hmgu}/Tax1bp3⁺ (C57BL/6N-Tax1bp3^{tm1b(EUCOMM)Hmgu}/Ieg)	increased circulating bilirubin level	J:211773
Tbc1d1^{Gt(E140H06)Wrst}/Tbc1d1^{Gt(E140H06)Wrst} (B6.129P2-Tbc1d1^{Gt(E140H06)Wrst})	abnormal homeostasis	J:203285
	abnormal lipid oxidation	J:203285
	decreased respiratory quotient	J:203285
	decreased susceptibility to diet-induced obesity	J:203285
	increased fatty acid oxidation	J:203285
Tbc1d1^{Nobq1-NZO/HlBom}/? (involves: NZO/HlBom * SJL/NBom)	increased circulating insulin level	J:66744
Tbc1d1^{Nobq1-SJL/NBom}/Tbc1d1^{Nobq1-SJL/NBom} (B6.SJL-(D5Mit302-D5Mit307))	decreased circulating glucose level	J:143559
	decreased susceptibility to diet-induced obesity	J:143559
Tbc1d2^{tm1(NCOM)Cmhd}/Tbc1d2^{tm1(NCOM)Cmhd} (C57BL/6N-Tbc1d2^{tm1(NCOM)Cmhd}/Tcp)	increased circulating phosphate level	J:165965
Tbc1d2b^{tm1a(EUCOMM)Hmgu}/Tbc1d2b^{tm1a(EUCOMM)Hmgu} (Not Specified)	decreased circulating serum albumin level	J:165965
	decreased circulating total protein level	J:165965
Tbc1d4^tm1.1Arte/Tbc1d4^tm1.1Arte (involves: C57BL/6)	impaired glucose tolerance	J:169477
Tbc1d4^tm1.1Arte/Tbc1d4^tm1.1Arte (involves: C57BL/6)	insulin resistance	J:169477
Tbc1d4^tm1.2Arte/Tbc1d4^tm1.2Arte (involves: C57BL/6 * CBA)	abnormal gluconeogenesis	J:194026
	abnormal glucose homeostasis	J:194026
	decreased adiponectin level	J:194026
	decreased circulating glucose level	J:194026
	decreased circulating insulin level	J:194026
	decreased energy expenditure	J:194026
	decreased oxygen consumption	J:194026
	impaired glucose tolerance	J:194026
	increased circulating free fatty acids level	J:194026
	insulin resistance	J:194026
Tbc1d4^{tm1b(EUCOMM)Hmgu}/Tbc1d4^{tm1b(EUCOMM)Hmgu} (C57BL/6N-Tbc1d4^{tm1b(EUCOMM)Hmgu}/J)	decreased circulating chloride level	J:211773
	increased circulating sodium level	J:211773
Tbc1d4^tm1Lex/Tbc1d4^tm1Lex (involves: 129S/SvEvBrd * C57BL/6J * C57BL/6N)	abnormal glycogen homeostasis	J:191749
	decreased circulating glucose level	J:191749
	decreased circulating insulin level	J:191749
	impaired glucose tolerance	J:191749
	insulin resistance	J:191749
Tbc1d5^em1(IMPC)J/Tbc1d5^em1(IMPC)J (C57BL/6NJ-Tbc1d5^em1(IMPC)J/J)	increased circulating cholesterol level	J:211773
Tbc1d9b^em1(IMPC)J/Tbc1d9b^em1(IMPC)J (C57BL/6NJ-Tbc1d9b^em1(IMPC)J/Mmjax)	increased circulating cholesterol level	J:211773
	increased circulating HDL cholesterol level	J:211773
Tbc1d10a^{tm2a(EUCOMM)Wtsi}/Tbc1d10a^{tm2a(EUCOMM)Wtsi} (involves: C57BL/6 * C57BL/6N)	decreased circulating alanine transaminase level	J:213427
	decreased circulating alkaline phosphatase level	J:213427
	decreased circulating LDL cholesterol level	J:213427
Tbc1d16^em1(IMPC)J/Tbc1d16^em1(IMPC)J (C57BL/6NJ-Tbc1d16^em1(IMPC)J/Mmjax)	increased circulating alkaline phosphatase level	J:211773
Tbc1d22a^{tm1b(KOMP)Wtsi}/Tbc1d22a^{tm1b(KOMP)Wtsi} (C57BL/6N-Tbc1d22a^{tm1b(KOMP)Wtsi}/Wtsi)	decreased circulating fructosamine level	J:211773
	decreased circulating triglyceride level	J:211773
	increased circulating alanine transaminase level	J:211773
	increased circulating alkaline phosphatase level	J:211773
	increased circulating amylase level	J:211773
	increased circulating aspartate transaminase level	J:211773
	increased circulating creatinine level	J:211773
	increased circulating free fatty acids level	J:211773
Tbc1d23^{Gt(BA0556)Wtsi}/Tbc1d23^{Gt(BA0556)Wtsi} (B6.129P2-Tbc1d23^{Gt(BA0556)Wtsi})	abnormal tumor necrosis factor level	J:181861
	increased circulating interleukin-6 level	J:181861
	increased circulating tumor necrosis factor level	J:181861
Tbc1d30^em1(IMPC)J/Tbc1d30^em1(IMPC)J (C57BL/6NJ-Tbc1d30^em1(IMPC)J/J)	increased circulating calcium level	J:211773
Tbc1d31^em1(IMPC)J/Tbc1d31^em1(IMPC)J (C57BL/6NJ-Tbc1d31^em1(IMPC)J/J)	increased circulating bilirubin level	J:211773
	increased circulating creatinine level	J:211773
Tbc1d32^em1(IMPC)J/Tbc1d32^em1(IMPC)J (C57BL/6NJ-Tbc1d32^em1(IMPC)J/Mmjax)	edema	J:211773
Tbccd1^{tm1b(EUCOMM)Hmgu}/Tbccd1^{tm1b(EUCOMM)Hmgu} (C57BL/6N-Tbccd1^{tm1b(EUCOMM)Hmgu}/Bay)	impaired glucose tolerance	J:211773
Tbdr1^SS/? (involves: LS * SS)	decreased body temperature	J:88523
Tbk1^tm1.1Lex/Tbk1^tm1.1Lex (involves: 129S4/SvJae * 129S5/SvEvBrd)	abnormal cytokine level	J:166476
	increased circulating interleukin-1 beta level	J:166476
	increased circulating interleukin-6 level	J:166476
	increased circulating interleukin-10 level	J:166476
	increased circulating tumor necrosis factor level	J:166476
	skin edema	J:166476
Tbk1^tm1Arte/Tbk1^tm1Arte Cd19^tm1(cre)Cgn/Cd19⁺ (involves: 129/SvEv * 129P2/OlaHsd * C57BL/6)	increased blood urea nitrogen level	J:188560
	increased circulating creatinine level	J:188560
	increased urine protein level	J:188560
Tbl1xr1^tm1.1Arte/Tbl1xr1^tm1.1Arte Tg(Fabp4-cre)1Rev/0 (involves: C57BL/6)	impaired glucose tolerance	J:198124
	impaired lipolysis	J:198124
	increased circulating leptin level	J:198124
	increased liver triglyceride level	J:198124
	increased skeletal muscle triglyceride level	J:198124
	increased susceptibility to diet-induced obesity	J:198124
	insulin resistance	J:198124
Tbl1xr1^{tm1b(EUCOMM)Hmgu}/Tbl1xr1⁺ (C57BL/6N-Tbl1xr1^{tm1b(EUCOMM)Hmgu}/Ieg)	increased blood urea nitrogen level	J:211773
Tbp^tm1.1Ees/Tbp^tm1.1Ees (B6.129X1(Cg)-Tbp^tm1.1Ees)	abnormal blood coagulation	J:77714
Tbr1^{tm1.1(KOMP)Mbp}/Tbr1⁺ (C57BL/6N-Tbr1^{tm1.1(KOMP)Mbp}/Ucd)	decreased blood urea nitrogen level	J:211773
	decreased circulating creatinine level	J:211773
	decreased circulating glucose level	J:211773
Tbx1^em1(IMPC)Mbp/Tbx1^em1(IMPC)Mbp (C57BL/6NCrl-Tbx1^em1(IMPC)Mbp/MbpMmucd)	edema	J:211773
Tbx1^m1H/Tbx1^m1H (involves: C3H/HeH * C57BL/6J)	edema	J:169366
Tbx1^tm1Bld/Tbx1^tm1Bld (involves: 129S7/SvEvBrd)	skin edema	J:159824
Tbx1^tm1Bld/Tbx1^tm3Bld Tg(Tek-cre)1Ywa/0 (involves: 129S7/SvEvBrd * C57BL/6 * SJL)	chylous ascites	J:159824
	dehydration	J:159824
Tbx1^tm1Pa/Tbx1^tm1Pa (either: (involves: 129) or (involves: 129 * C57BL/6) or (involves: 129 * C57BL/6 * Swiss Webster))	hydrops fetalis	J:70730
Tbx1^tm2.1Bem/Tbx1^tm2.2Bem Foxg1^tm1(cre)Skm/Foxg1⁺ (involves: 129 * C57BL/6J * SJL * Swiss Webster)	skin edema	J:105980
Tbx2^tm1Pa/Tbx2^tm1Pa (involves: 129S1/Sv * 129X1/SvJ * C57BL/6NTac * ICR)	hydrops fetalis	J:93610
	pericardial edema	J:93610
Tbx3^em1(IMPC)Mbp/Tbx3⁺ (C57BL/6NCrl-Tbx3^em1(IMPC)Mbp/MbpMmucd)	increased circulating alkaline phosphatase level	J:211773
Tbx3^tm1Jcib/Tbx3^tm1Jcib (involves: 129S4/SvJae * C57BL/6)	pericardial edema	J:129349
Tbx3^tm2.1Moon/Tbx3^tm2.1Moon (involves: 129 * BALB/cJ * C57BL/6 * SJL)	edema	J:179977
Tbx4^tm1.1Pa/Tbx4^tm1.1Pa (involves: 129S1/Sv * 129X1/SvJ)	pericardial edema	J:83256
Tbx4^tm1Pa/Tbx4^tm1Pa (involves: 129S1/Sv * 129X1/SvJ)	pericardial edema	J:83256
Tbx5^tm1.1Jse/Tbx5⁺ (involves: 129/Sv * Black Swiss)	hydrops fetalis	J:71845
Tbx5^tm1.1Jse/Tbx5⁺ (involves: 129/Sv * Black Swiss)	pericardial effusion	J:71845
Tbx19^tm1Jdr/Tbx19^tm1Jdr (either: (involves: 129/Sv) or (involves: BALB/c))	decreased circulating adrenocorticotropin level	J:82562
	decreased circulating corticosterone level	J:82562
	hypoglycemia	J:82562
	increased circulating glucose level	J:82562
Tbx20^tm1Akis/Tbx20^tm1Akis (involves: 129S1/SvImJ * NMRI)	edema	J:98806
Tbx21^tm1Glm/Tbx21⁺ (involves: 129S6/SvEvTac * C57BL/6)	abnormal cytokine level	J:73833
	abnormal interleukin level	J:73832
	abnormal tumor necrosis factor level	J:73832
Tbx21^tm1Glm/Tbx21^tm1Glm (involves: 129S6/SvEvTac * C57BL/6)	abnormal cytokine level	J:73832
	abnormal interleukin level	J:73832
	abnormal tumor necrosis factor level	J:73832
Tbx21^tm1Glm/Tbx21^tm1Glm (involves: 129S6/SvEvTac)	abnormal cytokine level	J:112600
Tbx22^{tm1.1(KOMP)Vlcg}/Y (C57BL/6N-Tbx22^{tm1.1(KOMP)Vlcg}/J)	increased circulating HDL cholesterol level	J:211773
Tbxa2r^tm1Cof/Tbxa2r^tm1Cof (either: (involves: 129P2/OlaHsd * C57BL/6 * DBA/2) or (involves: 129P2/OlaHsd * 129S/SvEv))	abnormal platelet aggregation	J:52125
	increased bleeding time	J:52125
Tbxa2r^tm1Cof/Tbxa2r^tm1Cof (C.129P2(B6)-Tbxa2r^tm1Cof)	abnormal platelet physiology	J:79049
Tbxa2r^tm1Cof/Tbxa2r^tm1Cof (C.129P2(B6)-Tbxa2r^tm1Cof)	abnormal thromboxane level	J:79049
Tbxa2r^tm1Sna/Tbxa2r^tm1Sna (B6.Cg-Tbxa2r^tm1Sna)	edema	J:197334
Tbxas1^tm1Swl/Tbxas1⁺ (involves: 129P2/OlaHsd * BALB/c * C57BL/6J)	decreased platelet aggregation	J:90922
	increased bleeding time	J:90922
Tbxas1^tm1Swl/Tbxas1^tm1Swl (involves: 129P2/OlaHsd * BALB/c * C57BL/6J)	decreased platelet aggregation	J:90922
	increased bleeding time	J:90922
Tcaim^{tm1b(EUCOMM)Wtsi}/Tcaim^{tm1b(EUCOMM)Wtsi} (C57BL/6N-Tcaim^{tm1b(EUCOMM)Wtsi}/H)	increased circulating cholesterol level	J:211773
Tcea1^tm1Skmz/Tcea1^tm1Skmz (involves: 129P2/OlaHsd * C57BL/6JJcl)	pericardial edema	J:107421
Tcea2^em1(IMPC)J/Tcea2^em1(IMPC)J (C57BL/6NJ-Tcea2^em1(IMPC)J/Mmjax)	decreased circulating calcium level	J:211773
Tcerg1l^{tm1a(KOMP)Wtsi}/Tcerg1l^{tm1a(KOMP)Wtsi} (C57BL/6N-Tcerg1l^{tm1a(KOMP)Wtsi}/Wtsi)	decreased fasting circulating glucose level	J:211773
Tcf3^{tm1(TCF3/HLF)Homy}/Tcf3⁺ Tg(Mx1-cre)1Cgn/0 (involves: 129P2/OlaHsd * C57BL/6 * CBA)	abnormal thrombosis	J:160392
Tcf7^{tm1a(EUCOMM)Wtsi}/Tcf7^{tm1a(EUCOMM)Wtsi} (C57BL/6N-Tcf7^{tm1a(EUCOMM)Wtsi}/Ics)	increased circulating alkaline phosphatase level	J:165965
Tcf7l1^tm1.1Bjme/Tcf7l1^tm1.1Bjme (involves: C57BL/6)	hydrops fetalis	J:185554
Tcf7l2^em1Nobr/Tcf7l2⁺ (involves: CD-1)	decreased circulating glucose level	J:175874
	decreased circulating insulin level	J:175874
	hypoglycemia	J:175874
	improved glucose tolerance	J:175874
Tcf7l2^em1Nobr/Tcf7l2^em1Nobr (involves: CD-1)	hypoglycemia	J:175874
Tcf7l2^em2Nobr/Tcf7l2⁺ (involves: CD-1)	decreased circulating glucose level	J:175874
	decreased circulating insulin level	J:175874
	hypoglycemia	J:175874
	improved glucose tolerance	J:175874
Tcf7l2^em2Nobr/Tcf7l2^em2Nobr (involves: CD-1)	hypoglycemia	J:175874
Tcf7l2^em3Nobr/Tcf7l2^em3Nobr (involves: CD-1)	hypoglycemia	J:175874
Tcf7l2^{tm1a(EUCOMM)Wtsi}/Tcf7l2⁺ (C57BL/6-Tcf7l2^{tm1a(EUCOMM)Wtsi})	abnormal glucose homeostasis	J:190447
	impaired glucose tolerance	J:190447
	increased circulating glucose level	J:190447
Tcf7l2^tm1Geno/Tcf7l2^tm1Geno Tg(Pdx1-cre)89.1Dam/0 (involves: C57BL/6 * CBA)	decreased insulin secretion	J:189204
	impaired glucose tolerance	J:189204
	increased circulating insulin level	J:189204
Tcf20^{em1(IMPC)Wtsi}/Tcf20^{em1(IMPC)Wtsi} (C57BL/6N-Tcf20^{em1(IMPC)Wtsi}/Wtsi)	increased circulating alkaline phosphatase level	J:211773
	increased circulating aspartate transaminase level	J:211773
	increased circulating creatine kinase level	J:211773
	increased circulating insulin level	J:211773
Tcf21^em1(IMPC)Mbp/Tcf21⁺ (C57BL/6NCrl-Tcf21^em1(IMPC)Mbp/MbpMmucd)	edema	J:211773
	increased circulating calcium level	J:211773
Tcf21^em1(IMPC)Mbp/Tcf21^em1(IMPC)Mbp (C57BL/6NCrl-Tcf21^em1(IMPC)Mbp/MbpMmucd)	edema	J:211773
Tcf21^tm1Eno/Tcf21^tm1Eno (involves: 129 * Black Swiss)	cyanosis	J:64068
Tcf21^tm1Jrt/Tcf21^tm1Jrt (involves: 129S1/Sv * 129X1/SvJ)	hemopericardium	J:55785
Tcf21^tm2.1Seq/Tcf21^tm1Jrt Tg(Nphs2-cre)1Seq/0 (involves: 129S1/Sv * 129X1/SvJ)	abnormal urine homeostasis	J:217144
	increased urine protein level	J:217144
Tcf21^tm2Eno/Tcf21^tm2Eno (involves: 129 * Black Swiss)	cyanosis	J:64068
Tcf21^tm2Eno/Tcf21^tm2Eno (involves: 129 * C57BL/6)	hemopericardium	J:185552
Tchol1^BALB/c/Tchol1^KK/Ta (involves: BALB/c * KK/Ta)	increased circulating cholesterol level	J:88209
Tchol1^KK/Ta/Tchol1^KK/Ta (involves: BALB/c * KK/Ta)	increased circulating cholesterol level	J:88209
Tchp^{tm1a(EUCOMM)Wtsi}/Tchp^{tm1a(EUCOMM)Wtsi} (C57BL/6N-Tchp^{tm1a(EUCOMM)Wtsi}/Wtsi)	increased circulating cholesterol level	J:211773
	increased circulating HDL cholesterol level	J:211773
	increased circulating LDL cholesterol level	J:211773
Tchp^tm1Inag/Tchp^tm1Inag (B6.129P2-Tchp^tm1Inag)	decreased circulating cholesterol level	J:304307
	decreased circulating triglyceride level	J:304307
	decreased susceptibility to diet-induced obesity	J:304307
	increased body temperature	J:304307
Tcirg1^oc/Tcirg1^oc (B6C3Fe a/a-Tcirg1^oc/J)	decreased circulating insulin level	J:116082
Tcirg1^oc/Tcirg1^oc (B6C3Fe a/a-Tcirg1^oc/J)	decreased insulin secretion	J:116082
Tcirg1^tm1Ypl/Tcirg1^tm1Ypl (involves: 129S4/SvJae * C57BL/6J)	decreased circulating calcium level	J:224711
	decreased vitamin D level	J:224711
Tcnq1^C3H/HeJJcl/Tcnq1^C3H/HeJJcl Tg(Gcg-TGFB1)1Itak/Tg(Gcg-TGFB1)1Itak (involves: C3H/HeJJcl * NOD)	increased circulating insulin level	J:130968
Tcnq1^C3H/HeJJcl/Tcnq1^NOD Tg(Gcg-TGFB1)1Itak/Tg(Gcg-TGFB1)1Itak (involves: C3H/HeJJcl * NOD)	increased circulating insulin level	J:130968
Tcnq2^C3H/HeJJcl/Tcnq2^C3H/HeJJcl Tg(Gcg-TGFB1)1Itak/Tg(Gcg-TGFB1)1Itak (involves: C3H/HeJJcl * NOD)	increased circulating glucose level	J:130968
Tcnq2^C3H/HeJJcl/Tcnq2^NOD Tg(Gcg-TGFB1)1Itak/Tg(Gcg-TGFB1)1Itak (involves: C3H/HeJJcl * NOD)	increased circulating glucose level	J:130968
Tcnq4^NOD/Tcnq4^NOD Tg(Gcg-TGFB1)1Itak/Tg(Gcg-TGFB1)1Itak (involves: C3H/HeJJcl * NOD)	increased circulating glucose level	J:130968
Tcnq5^C3H/HeJJcl/Tcnq5^C3H/HeJJcl Tg(Gcg-TGFB1)1Itak/Tg(Gcg-TGFB1)1Itak (involves: C3H/HeJJcl * NOD)	increased circulating insulin level	J:130968
Tcq1^CAST/EiJ/Tcq1^CAST/EiJ (involves: C57BL/6J * CAST/EiJ)	decreased circulating cholesterol level	J:117545
Tcq2^CAST/EiJ/Tcq2^CAST/EiJ (involves: C57BL/6J * CAST/EiJ)	decreased circulating cholesterol level	J:117545
Tcra-J^tm1Tgi/Tcra-J^tm1Tgi (B6.129-Tcra-J^tm1Tgi)	decreased circulating alanine transaminase level	J:135830
Tcra-J^tm1Tgi/Tcra-J^tm1Tgi (B6.129-Tcra-J^tm1Tgi)	decreased circulating interleukin-5 level	J:121037
Tcra-J^tm1Tgi/Tcra-J^tm1Tgi (involves: 129S1/Sv * 129X1/SvJ)	decreased circulating interferon-gamma level	J:155199
Tcra^tm1Mjo/Tcra^tm1Mjo (involves: 129P2/OlaHsd * MRL)	increased urine protein level	J:45448
Tcrd^tm1Mom/Tcrd^tm1Mom (FVB.129P2-Tcrd^tm1Mom)	impaired skin barrier function	J:106782
Tctn3^em1(IMPC)J/Tctn3⁺ (C57BL/6NJ-Tctn3^em1(IMPC)J/Mmjax)	abnormal cholesterol homeostasis	J:211773
	decreased circulating calcium level	J:211773
	decreased circulating total protein level	J:211773
Tctn3^tm1.2Blnw/Tctn3^tm1.2Blnw (involves: 129S6/SvEvTac * C57BL/6 * FVB/N * SW)	edema	J:249241
Tdg^tm1.1Abc/Tdg^tm1.1Abc (B6.129-Tdg^tm1.1Abc)	hemopericardium	J:174772
Tdg^tm1.1Abc/Tdg^tm1.1Abc (B6.129-Tdg^tm1.1Abc)	pericardial edema	J:174772
Tdg^tm2.1Abc/Tdg^tm2.1Abc (B6.129-Tdg^tm2.1Abc)	pericardial effusion	J:174772
Tdmq1^DBA/2/Tdmq1^DBA/2 (involves: BKS.Cg M +/+ Lepr^db * DBA/2)	increased circulating glucose level	J:97535
Tdo2^{tm1b(KOMP)Mbp}/Tdo2^{tm1b(KOMP)Mbp} (C57BL/6N-Tdo2^{tm1b(KOMP)Mbp}/Tcp)	edema	J:211773
Tdo2^tm1Tnak/Tdo2^tm1Tnak (B6.129-Tdo2^tm1Tnak)	abnormal amino acid level	J:177903
	abnormal circulating amino acid level	J:177903
	increased circulating methionine level	J:177903
	increased circulating threonine level	J:177903
	increased serotonin level	J:177903
Tdp1^Gt(XD105)Byg/Tdp1^Gt(XD105)Byg (involves: 129P2/OlaHsd * C57BL/6)	decreased circulating serum albumin level	J:127605
Tdrkh^{tm1b(KOMP)Wtsi}/Tdrkh^{tm1b(KOMP)Wtsi} (C57BL/6N-Tdrkh^{tm1b(KOMP)Wtsi}/J)	decreased fasting circulating glucose level	J:211773
Tead3^{tm1a(EUCOMM)Wtsi}/Tead3^{tm1a(EUCOMM)Wtsi} (C57BL/6N-Tead3^{tm1a(EUCOMM)Wtsi}/Wtsi)	decreased circulating serum albumin level	J:211773
	increased circulating creatinine level	J:211773
	increased circulating magnesium level	J:211773
Tec^tm1Welm/Tec^tm1Welm (involves: 129P2/OlaHsd * C57BL/6)	decreased platelet aggregation	J:86448
Tecr^{em1(IMPC)Rbrc}/Tecr⁺ (C57BL/6NJcl-Tecr^{em1(IMPC)Rbrc}/Rbrc)	increased circulating LDL cholesterol level	J:211773
Tedc1^em1(IMPC)Tcp/Tedc1⁺ (C57BL/6NCrl-Tedc1^em1(IMPC)Tcp/Tcp)	increased blood urea nitrogen level	J:211773
Teddm1a^em1(IMPC)Tcp/Teddm1a^em1(IMPC)Tcp (C57BL/6N-Teddm1a^em1(IMPC)Tcp/Tcp)	decreased circulating alkaline phosphatase level	J:211773
Tek^tm1Dmt/Tek⁺ Tie1^tm1Jpa/Tie1^tm1Jpa (involves: 129S1/Sv * 129X1/SvJ * CD-1)	edema	J:54983
Tek^tm1Dmt/Tek^tm1Dmt Tie1^tm1Jpa/Tie1^tm1Jpa (involves: 129S1/Sv * 129X1/SvJ * CD-1)	edema	J:54983
Tenm1^em1(IMPC)Tcp/Y (C57BL/6NCrl-Tenm1^em1(IMPC)Tcp/Tcp)	increased circulating alanine transaminase level	J:211773
Tenm4^em1(IMPC)Tcp/Tenm4^em1(IMPC)Tcp (C57BL/6NCrl-Tenm4^em1(IMPC)Tcp/Tcp)	decreased fasting circulating glucose level	J:211773
	increased circulating chloride level	J:211773
	increased circulating sodium level	J:211773
Tent4a^{tm1b(EUCOMM)Hmgu}/Tent4a^{tm1b(EUCOMM)Hmgu} (C57BL/6N-Tent4a^{tm1b(EUCOMM)Hmgu}/Ccpcz)	increased circulating alkaline phosphatase level	J:211773
Tent5a^{em1(IMPC)Ccpcz}/Tent5a^{em1(IMPC)Ccpcz} (C57BL/6N-Tent5a^{em1(IMPC)Ccpcz}/Ccpcz)	decreased circulating glucose level	J:211773
	decreased circulating serum albumin level	J:211773
	decreased respiratory quotient	J:211773
	increased circulating alkaline phosphatase level	J:211773
	increased circulating potassium level	J:211773
Tent5c^{tm1b(KOMP)Wtsi}/Tent5c^{tm1b(KOMP)Wtsi} (C57BL/6N-Tent5c^{tm1b(KOMP)Wtsi}/Wtsi)	subcutaneous edema	J:239583
Terb1^{tm1b(KOMP)Mbp}/Terb1⁺ (C57BL/6N-Terb1^{tm1b(KOMP)Mbp}/Ucd)	increased circulating alanine transaminase level	J:211773
Terc^tm1Rdp/Terc^tm1Rdp Wrn^tm1Lgu/Wrn^tm1Lgu (involves: 129/Sv * BALB/c * C57BL/6 * SLJ)	hyperglycemia	J:91715
	impaired glucose tolerance	J:91715
	increased circulating insulin level	J:91715
Terf1^tm1.1Blas/Terf1^tm1.1Blas Tg(KRT5-cre)1Tak/0 (involves: 129 * C3H * C57BL/6 * SJL)	impaired skin barrier function	J:152077
Terf2ip^em1(IMPC)Mbp/Terf2ip^em1(IMPC)Mbp (C57BL/6N-Terf2ip^em1(IMPC)Mbp/MbpMmucd)	impaired glucose tolerance	J:211773
Terf2ip^tm1.2Tdl/Terf2ip^tm1.2Tdl (involves: C57BL/6J * FVB/N)	impaired glucose tolerance	J:199372
	increased cholesterol level	J:199372
	increased circulating glucose level	J:199372
	increased circulating insulin level	J:199372
	insulin resistance	J:199372
Tesk1^em1(IMPC)J/Tesk1^em1(IMPC)J (C57BL/6NJ-Tesk1^em1(IMPC)J/Mmjax)	increased circulating alanine transaminase level	J:211773
Tex2^em1(IMPC)J/Tex2^em1(IMPC)J (C57BL/6NJ-Tex2^em1(IMPC)J/J)	decreased circulating creatinine level	J:211773
Tex2^{tm1.1(KOMP)Vlcg}/Tex2^{tm1.1(KOMP)Vlcg} (C57BL/6N-Tex2^{tm1.1(KOMP)Vlcg}/J)	increased circulating alanine transaminase level	J:211773
Tex101^{tm1b(KOMP)Wtsi}/Tex101^{tm1b(KOMP)Wtsi} (C57BL/6N-Tex101^{tm1b(KOMP)Wtsi}/J)	decreased circulating glucose level	J:211773
	increased circulating sodium level	J:211773
Tex261^{tm1b(EUCOMM)Wtsi}/Tex261^{tm1b(EUCOMM)Wtsi} (C57BL/6N-Tex261^{tm1b(EUCOMM)Wtsi}/Wtsi)	decreased circulating calcium level	J:211773
	decreased circulating cholesterol level	J:211773
	decreased circulating fructosamine level	J:211773
	decreased circulating HDL cholesterol level	J:211773
	decreased circulating LDL cholesterol level	J:211773
	decreased circulating serum albumin level	J:211773
	decreased circulating total protein level	J:211773
	increased circulating alanine transaminase level	J:211773
	increased circulating alkaline phosphatase level	J:211773
	increased circulating aspartate transaminase level	J:211773
Tfam^tm1Lrsn/Tfam^tm1Lrsn Tg(Ckmm-cre)1Lrsn/0 (involves: 129S1/Sv * 129X1/SvJ)	abnormal enzyme/coenzyme level	J:125471
Tfam^tm1Lrsn/Tfam^tm1Lrsn Tg(Ins2-cre)25Mgn/0 (involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * DBA)	abnormal circulating insulin level	J:65522
	decreased insulin secretion	J:65522
	increased insulin sensitivity	J:65522
Tfap2b^tm1Rbu/Tfap2b^tm1Rbu (129P2.129-Tfap2b^tm1Rbu)	abnormal ion homeostasis	J:83000
	decreased circulating calcium level	J:83000
	decreased urine calcium level	J:83000
	decreased urine osmolality	J:83000
	increased blood urea nitrogen level	J:83000
	increased circulating creatinine level	J:83000
	increased circulating parathyroid hormone level	J:83000
	increased circulating phosphate level	J:83000
Tfap4^{tm1.1(KOMP)Vlcg}/Tfap4^{tm1.1(KOMP)Vlcg} (C57BL/6N-Tfap4^{tm1.1(KOMP)Vlcg}/Ucd)	decreased circulating glucose level	J:211773
Tfb2m^{tm1a(KOMP)Wtsi}/Tfb2m⁺ Tg(Ins2-cre)23Herr/0 (involves: C57BL/6J * C57BL/6N * CBA/J)	decreased circulating insulin level	J:256448
	decreased insulin secretion	J:256448
	impaired glucose tolerance	J:256448
Tfb2m^{tm1a(KOMP)Wtsi}/Tfb2m^{tm1a(KOMP)Wtsi} Tg(Ins2-cre)23Herr/0 (involves: C57BL/6J * C57BL/6N * CBA/J)	decreased circulating insulin level	J:256448
	decreased insulin secretion	J:256448
	hyperglycemia	J:256448
	increased circulating glucose level	J:256448
Tfcp2l1^{Gt(pLSABetageo)1Sjt}/Tfcp2l1^{Gt(pLSABetageo)1Sjt} (B6.129S1-Tfcp2l1^{Gt(pLSABetageo)1Sjt})	increased urine chloride ion level	J:119674
	increased urine potassium level	J:119674
	increased urine sodium level	J:119674
Tfeb^{tm1a(EUCOMM)Wtsi}/Tfeb⁺ (C57BL/6N-Tfeb^{tm1a(EUCOMM)Wtsi}/Bay)	decreased circulating alkaline phosphatase level	J:211773
Tfec^{tm1b(KOMP)Wtsi}/Tfec^{tm1b(KOMP)Wtsi} (C57BL/6N-Tfec^{tm1b(KOMP)Wtsi}/Ucd)	increased circulating cholesterol level	J:211773
Tff1^{tm1a(EUCOMM)Wtsi}/Tff1^{tm1a(EUCOMM)Wtsi} (C57BL/6N-Tff1^{tm1a(EUCOMM)Wtsi}/Wtsi)	decreased circulating fructosamine level	J:211773
	decreased circulating serum albumin level	J:211773
	decreased circulating total protein level	J:211773
Tfpi2^tm1Dgen/Tfpi2^tm1Dgen (involves: 129P2/OlaHsd * C57BL/6J)	increased circulating interleukin-6 level	J:301794
	increased circulating interleukin-10 level	J:301794
Tfpi^tm1.1Rdsi/Tfpi^tm1.1Rdsi Lyz2^tm1(cre)Ifo/Lyz2⁺ (involves: 129P2/OlaHsd * 129S4/SvJaeSor * 129S6/SvEvTac * BALB/cJ * C57BL/6)	abnormal circulating protein level	J:164530
Tfpi^tm1.1Rdsi/Tfpi^tm1.1Rdsi Tg(Tek-cre)12Flv/0 (involves: 129S4/SvJaeSor * 129S6/SvEvTac * BALB/cJ * C3H * C57BL/6)	abnormal circulating protein level	J:164530
	increased susceptibility to induced thrombosis	J:164530
Tfpi^tm1.1Rdsi/Tfpi^tm1.1Rdsi Tg(Tek-cre)12Flv/0 (B6.Cg-Tfpi^tm1.1Rdsi Tg(Tek-cre)12Flv)	abnormal circulating protein level	J:164530
Tfpi^tm1Gjb/Tfpi^tm1Gjb (involves: 129)	abnormal acute phase protein level	J:51137
	abnormal blood coagulation	J:51137
	abnormal thrombosis	J:51137
	pericardial effusion	J:51137
Tfr2^{em1(IMPC)Rbrc}/Tfr2^{em1(IMPC)Rbrc} (C57BL/6N-Tfr2^{em1(IMPC)Rbrc}/Rbrc)	increased circulating iron level	J:211773
Tfr2^m1Btlr/Tfr2^m1Btlr (C57BL/6J-Tfr2^m1Btlr)	abnormal iron homeostasis	J:148982
	increased circulating ferritin level	J:148982
	increased circulating iron level	J:148982
Tfr2^tm1.1Anro/Tfr2^tm1.1Anro (129.Cg-Tfr2^tm1.1Anro)	increased liver iron level	J:160785
Tfr2^tm1.1Anro/Tfr2^tm1.1Anro (129.Cg-Tfr2^tm1.1Anro)	increased spleen iron level	J:160785
Tfr2^tm1.1Nsub/Tfr2^tm1.1Nsub (involves: 129T2/SvEms * C57BL/6)	decreased spleen iron level	J:114330
	hemochromatosis	J:114330
	increased circulating iron level	J:114330
	increased liver iron level	J:114330
Tfr2^tm1.1Nsub/Tfr2^tm1.1Nsub (involves: 129T2/SvEms)	increased circulating iron level	J:160785
	increased liver iron level	J:160785
	increased spleen iron level	J:160785
Tfr2^tm1Slu/Tfr2^tm1Slu (involves: 129X1/SvJ * C57BL/6J)	abnormal iron homeostasis	J:78360
	decreased spleen iron level	J:78360
	increased circulating iron level	J:78360
	increased liver iron level	J:78360
Tfrc^tm1Nca/Tfrc⁺ (either: (involves: 129S4/SvJae * 129S6/SvEvTac) or (involves: 129S4/SvJae * C57BL/6))	abnormal iron homeostasis	J:54107
	abnormal iron level	J:54107
	decreased liver iron level	J:54107
	decreased spleen iron level	J:54107
Tfrc^tm1Nca/Tfrc^tm1Nca (either: (involves: 129S4/SvJae * 129S6/SvEvTac) or (involves: 129S4/SvJae * C57BL/6))	hydrops fetalis	J:54107
	hypoxia	J:54107
	pericardial effusion	J:54107
Tfrc^tm2Nca/Tfrc^tm2Nca (involves: 129S4/SvJae * FVB/N)	decreased circulating iron level	J:133221
Tg(Abcg1)80-90Ssf/? (C57BL/6-Tg(Abcg1)80-90Ssf)	abnormal phospholipid level	J:94077
Tg(Abcg1)80-90Ssf/? (C57BL/6-Tg(Abcg1)80-90Ssf)	increased liver cholesterol level	J:94077
Tg(Abcg1)123Ssf/? (C57BL/6-Tg(Abcg1)123Ssf)	abnormal phospholipid level	J:94077
Tg(Abcg1)123Ssf/? (C57BL/6-Tg(Abcg1)123Ssf)	increased liver cholesterol level	J:94077
Tg(ABCG5/ABCG8)14-2Hobb/0 (involves: C57BL/6J * SJL)	abnormal cholesterol homeostasis	J:78963
	decreased circulating cholesterol level	J:78963
	decreased circulating HDL cholesterol level	J:78963
	decreased circulating phytosterol level	J:78963, J:100491
	decreased intestinal cholesterol absorption	J:78963, J:100491
	increased cholesterol level	J:78963
	steatorrhea	J:78963
Tg(Ace2-ACE2)1Cqin/0 (involves: ICR)	pulmonary edema	J:141460
Tg(ACTA1-Il15)10941Lsq/0 (involves: C3H * C57BL/6)	abnormal interleukin level	J:145611
Tg(ACTA1-Il15)11650Lsq/0 (involves: C3H C57BL/6)	abnormal interleukin level	J:145611
	decreased circulating leptin level	J:145611
	increased circulating interleukin-15 level	J:145611
X/Tg(ACTA1-STIM1)2Jmol (involves: FVB/N)	abnormal calcium ion homeostasis	J:101977
Tg(ACTA1-UCP3)1Clap/0 (involves: C57BL/6 * CBA)	decreased oxygen consumption	J:142293
	decreased susceptibility to diet-induced obesity	J:142293
	improved glucose tolerance	J:142293
	increased insulin sensitivity	J:142293
Tg(ACTB-DDAH1)1Jpck/0 (involves: C57BL/6J)	abnormal enzyme/coenzyme level	J:104238
Tg(ACTB-DDAH1)1Jpck/0 (involves: C57BL/6J)	abnormal nitric oxide homeostasis	J:104238
Tg(ACTB-eGFP,-RAMP1)#Afru/0 Tg(Nes-cre)1Kln/0 (involves: C57BL/6J * SJL/J)	photophobia	J:179493
Tg(Actb-GFP,-Bmp4)1Csk/0 Tg(CAG-cre/Esr1)67Csk/0 (C57BL/6-Tg(Actb-GFP,-Bmp4)1Csk Tg(CAG-cre/Esr1)67Csk)	albuminuria	J:173500
Tg(Actb-Ptma)T12Clwu/Tg(Actb-Ptma)T12Clwu (involves: FVB/N)	increased blood urea nitrogen level	J:128557
Tg(ACTB-SLC2A1)224Cwh/0 (B6.Cg-Tg(ACTB-SLC2A1)224Cwh)	albuminuria	J:160943
Tg(ACTB-SLC2A1)224Cwh/0 (B6.Cg-Tg(ACTB-SLC2A1)224Cwh)	increased circulating creatinine level	J:160943
Tg(ACTB-SOD2)66Ysh/0 (involves: C3H * C57BL/6)	abnormal lactate dehydrogenase level	J:127776
Tg(ACTB-tetR)19Ywz/0 Tg(tetO-Vegfa)1Ywz/0 (involves: 129S1/Sv 129X1/SvJ)	decreased susceptibility to diet-induced obesity	J:189035
Tg(ACTB-THRB*)DSyc/0 (Not Specified)	increased thyroxine level	J:134187
Tg(ACTB-TNFRSF6B)754Jwu/? (B6.Cg-Tg(Actb-TNFRSF6B)754Jwu)	hematuria	J:148162
	increased urine protein level	J:148162
	leukocyturia	J:148162
	skin edema	J:148162
Tg(Adipoq-Apol6)#Hsul/0 (C57BL/6J-Tg(Adipoq-Apol6)#Hsul)	impaired glucose tolerance	J:344362
	impaired lipolysis	J:344362
	insulin resistance	J:344362
Tg(Adipoq-cre)1Evdr/0 (involves: FVB/NJ)	decreased fasting circulating glucose level	J:249843
Tg(Adipoq-cre)1Evdr/0 (involves: FVB/NJ)	improved glucose tolerance	J:249843
Tg(Adipoq-cre)1Evdr/0 Tg(CAG-Jmjd8)#Kaso/0 (involves: C57BL/6 * FVB/NJ)	impaired glucose tolerance	J:319518
	increased circulating insulin level	J:319518
	insulin resistance	J:319518
Tg(Adipoq-LPL)1Fnln/? (B6.Cg-Tg(Adipoq-LPL)1Fnln)	decreased circulating cholesterol level	J:226970
	decreased circulating HDL cholesterol level	J:226970
	decreased circulating LDL cholesterol level	J:226970
	decreased fasting circulating glucose level	J:226970
	decreased liver triglyceride level	J:226970
	decreased susceptibility to diet-induced obesity	J:226970
	improved glucose tolerance	J:226970
	increased circulating adiponectin level	J:226970
	increased energy expenditure	J:226970
	increased insulin sensitivity	J:226970
	increased liver triglyceride level	J:226970
Tg(Adipoq-Zc3h10)#Hsul/0 (Not Specified)	decreased susceptibility to diet-induced obesity	J:287066
	decreased susceptibility to induced hypothermia	J:287066
	improved glucose tolerance	J:287066
	increased insulin sensitivity	J:287066
	increased oxygen consumption	J:287066
Tg(Adipoq-Zc3h10*)#Hsul/0 (Not Specified)	increased oxygen consumption	J:287066
Tg(ADRB1)1Srr/0 (Swiss Webster)	decreased susceptibility to diet-induced obesity	J:37585
Tg(ADRB1)1Srr/0 (Swiss Webster)	enhanced lipolysis	J:37585
Tg(AGT)2-5Afu/0 (involves: C57BL/6)	increased urine protein level	J:130455
Tg(Alb1-cre)7Gsc/0 Tfr2^tm1.1Anro/Tfr2^tm1.1Anro (involves: 129/Sv * C57BL/6 * FVB/N)	increased circulating iron level	J:160785
	increased liver iron level	J:160785
Tg(Alb1-GP33/H2-K^b)1Hpi/0 (B6.Cg-Tg(Alb1-GP33/H2-K^b)1Hpi)	increased circulating alanine transaminase level	J:162605
Tg(Alb1-GP33/H2-K^b)1Hpi/0 Tg(Alb1-HBV)66Bri/0 (involves: C57BL/6 * C57BL/10 * DBA/2)	increased circulating alanine transaminase level	J:162605
Tg(Alb1-Ren)1Unc/0 (involves: 129S6/SvEvTac * C57BL/6)	albuminuria	J:89252
	decreased urine osmolality	J:89252
	increased circulating creatinine level	J:89252
Tg(Alb1-Ren)2Unc/0 (involves: 129S6/SvEvTac * C57BL/6)	albuminuria	J:89252
	decreased urine osmolality	J:89252
	increased circulating creatinine level	J:89252
Tg(ALB-cre,CMV-rtTA)#Wcyy/0 Tg(CMV-EGFP,Rnu6-siAbca1)#Wcyy/0 (involves: ICR)	decreased circulating cholesterol level	J:93624
Tg(Alb-HBx)A112Tfts/0 (involves: C57BL/6)	increased circulating alanine transaminase level	J:104728
Tg(Alb-MYLIP*)1Pton/? (involves: C57BL/6J)	decreased circulating triglyceride level	J:228420
	increased circulating cholesterol level	J:228420
	increased circulating LDL cholesterol level	J:228420
	increased circulating triglyceride level	J:228420
Tg(Alb-Nos2)1Mkan/? (FVB-Tg(Alb-Nos2)1Mkan)	abnormal glucose homeostasis	J:177591
	abnormal glycogen homeostasis	J:177591
	decreased liver glycogen level	J:177591
	hyperglycemia	J:177591
	increased circulating triglyceride level	J:177591
	increased circulating VLDL triglyceride level	J:177591
	increased liver triglyceride level	J:177591
	increased triglyceride level	J:177591
Tg(Alb-PDGFC)#Jcam/0 (involves: C57BL/6)	abnormal circulating enzyme level	J:96979
	abnormal circulating protein level	J:211984
	increased circulating alanine transaminase level	J:211984
	increased circulating alkaline phosphatase level	J:96979, J:211984
	increased circulating aspartate transaminase level	J:211984
	increased circulating interleukin-6 level	J:211984
Tg(Alb-SREBF1_ic)#Jkot/0 (involves: C57BL/6)	abnormal ceramide level	J:249664
	abnormal lipid homeostasis	J:249664
	abnormal lipid oxidation	J:249664
	decreased saturated fatty acids level	J:185313
	decreased unsaturated fatty acids level	J:185313
	increased circulating alanine transaminase level	J:185313
	increased circulating aspartate transaminase level	J:185313
	increased circulating free fatty acids level	J:185313
	increased circulating glucose level	J:185313
	increased circulating insulin level	J:185313
	increased circulating leptin level	J:185313
	increased fatty acids level	J:185313
	increased respiratory quotient	J:249664
	increased triglyceride level	J:185313
	increased unsaturated fatty acids level	J:185313
	insulin resistance	J:249664, J:185313
Tg(AlbLCAT)1Jdm/0 (involves: FVB/N)	decreased circulating triglyceride level	J:121992
	increased circulating cholesterol level	J:121992
	increased circulating HDL cholesterol level	J:121992
Tg(AlbLCAT)1Jdm/0 Tg(APOA1)1Rub/0 (involves: C57BL/6 * FVB/N)	increased circulating cholesterol level	J:121992
	increased circulating HDL cholesterol level	J:121992
	increased circulating LDL cholesterol level	J:121992
	increased circulating VLDL cholesterol level	J:121992
Tg(AlbLCAT)1Jdm/0 Tg(APOA1)1Rub/0 Tg(APOA2)3Rub/0 (involves: C57BL/6 * FVB/N)	increased circulating cholesterol level	J:121992
	increased circulating HDL cholesterol level	J:121992
Tg(AlbLCAT)1Jdm/0 Tg(APOA2)3Rub/0 (involves: C57BL/6 * FVB/N)	decreased circulating cholesterol level	J:121992
	decreased circulating HDL cholesterol level	J:121992
Tg(AMH-Fshr*D580H)14Hht/0 (involves: FVB/N)	decreased circulating follicle stimulating hormone level	J:160015
	decreased circulating luteinizing hormone level	J:160015
	increased circulating estradiol level	J:160015
	increased circulating prolactin level	J:160015
Tg(AMH-Fshr*D580H)#Hht/0 (involves: FVB/N)	decreased luteinizing hormone level	J:160015
Tg(AMH-Fshr*D580H)#Hht/0 (involves: FVB/N)	increased prolactin level	J:160015
Tg(Amh-Smad4)1Tkw/0 (involves: CD-1)	increased circulating testosterone level	J:79698
Tg(Amhr2-SV40TAg)1Dcco/0 ((C57BL/6 x C3H)F1)	hemorrhagic ascites	J:82550
Tg(ANX6)2Agh/0 (FVB/N-Tg(ANX6)2Agh)	abnormal atrial thrombosis	J:92579
Tg(aP2-SREBF1c)9884Reh/0 (involves: C57BL/6J * SJL)	abnormal lipid level	J:249664
	abnormal lipid oxidation	J:249664
	abnormal lipolysis	J:249664
	decreased ceramide level	J:249664
	hyperglycemia	J:50770
	increased ceramide level	J:249664
	increased circulating cholesterol level	J:50770
	increased circulating insulin level	J:50770, J:249664
	increased circulating triglyceride level	J:50770
	increased fasting circulating glucose level	J:249664
	increased hepatic glucose production	J:249664
	increased liver triglyceride level	J:50770
	increased respiratory quotient	J:249664
	increased unsaturated fatty acids level	J:249664
	insulin resistance	J:50770, J:249664
Tg(APCS-Ifng)5Imeg/0 (involves: C57BL/6 * DBA/2)	abnormal circulating enzyme level	J:16979
	abnormal cytokine level	J:135124
	increased circulating alanine transaminase level	J:135124
	increased circulating interleukin-12 level	J:135124
Tg(Apcs-Lep)1Yog/0 (involves: C57BL/6 * DBA/2)	abnormal glucose homeostasis	J:57075
	abnormal lipid level	J:57075
	decreased circulating insulin level	J:57075
	decreased circulating triglyceride level	J:57075
	decreased liver glycogen level	J:57075
	decreased liver triglyceride level	J:57075
	increased insulin sensitivity	J:57075
Tg(Apcs-Lep)1Yog/0 (involves: C57BL/6J * FVB/N)	abnormal glucose homeostasis	J:69591
	abnormal lipid level	J:69591
	decreased circulating free fatty acids level	J:69591
	decreased circulating glucose level	J:69591
	decreased circulating insulin level	J:69591
	decreased circulating triglyceride level	J:69591
	increased insulin sensitivity	J:69591
Tg(APCS-RARRES2)9Yktk/0 (involves: C57BL/6)	improved glucose tolerance	J:206120
Tg(APCS-RARRES2)9Yktk/0 (involves: C57BL/6)	increased insulin secretion	J:206120
Tg(APCS-Tnfsf11)#aKhs/0 (C57BL/6J-Tg(APCS-Tnfsf11)#aKhs)	increased circulating alkaline phosphatase level	J:264357
Tg(APCS-Tnfsf11)#aKhs/0 (C57BL/6J-Tg(APCS-Tnfsf11)#aKhs)	skin edema	J:264357
Tg(APOA1)1Rub/0 (involves: C57BL/6)	decreased circulating triglyceride level	J:121992
Tg(APOA1)1Rub/0 Tg(APOA2)3Rub/0 (involves: C57BL/6)	decreased circulating cholesterol level	J:121992
	decreased circulating HDL cholesterol level	J:121992
	increased circulating cholesterol level	J:129136
	increased circulating HDL cholesterol level	J:129136
	increased circulating triglyceride level	J:129136
Tg(APOA1)1Rub/? Tg(APOA2)3Rub/? (involves: C57BL/6)	abnormal lipid homeostasis	J:92450, J:129704
Tg(APOA1)1Rub/Tg(APOA1)1Rub (C57BL/6-Tg(APOA1)1Rub/J)	abnormal circulating HDL cholesterol level	J:190966
	abnormal circulating interleukin-17 level	J:190966
	abnormal lipid homeostasis	J:92450, J:129704
	abnormal lipid level	J:42425
	increased circulating cholesterol level	J:42425
	increased circulating HDL cholesterol level	J:42425
Tg(APOA1)427Bres/? (involves: C57BL/6J * CBA/J)	abnormal circulating protein level	J:104719
Tg(Apoa2)1Lus/? (involves: C57BL/6J * DBA/2)	abnormal lipid homeostasis	J:92454, J:127063
	increased circulating cholesterol level	J:92454, J:127063
	increased circulating HDL cholesterol level	J:92454, J:127063
	increased circulating LDL cholesterol level	J:92454
	increased circulating triglyceride level	J:92454
	increased circulating VLDL cholesterol level	J:92454
Tg(APOA2)3Rub/? (involves: C57BL/6)	abnormal lipid homeostasis	J:92450
Tg(APOA2)3Rub/0 (involves: C57BL/6)	decreased circulating cholesterol level	J:121992
	decreased circulating HDL cholesterol level	J:121992
	decreased circulating triglyceride level	J:121992
Tg(APOA5)1Hgc/0 (FVB/N-Tg(APOA5)1Hgc)	decreased circulating triglyceride level	J:72092
Tg(APOA5)1Hgc/0 (FVB/N-Tg(APOA5)1Hgc)	decreased circulating VLDL cholesterol level	J:72092
Tg(APOB)11Rub/? (involves: FVB)	increased circulating cholesterol level	J:78212
Tg(APOB)11Rub/? (involves: FVB)	increased circulating LDL cholesterol level	J:78212
Tg(APOB)11Rub/0 Tg(UcpDta)1Kz/0 (involves: C57BL/6J * FVB/N)	abnormal glucose homeostasis	J:73122
	abnormal lipid homeostasis	J:73122
	decreased circulating HDL cholesterol level	J:73122
	increased circulating cholesterol level	J:73122
	increased circulating insulin level	J:73122
	increased circulating LDL cholesterol level	J:73122
	increased circulating triglyceride level	J:73122
	insulin resistance	J:73122
Tg(APOB)1102Sgy/? (B6.Cg-Tg(APOB)1102Sgy)	abnormal cholesterol homeostasis	J:151253
Tg(APOC1)1Bres/Tg(APOC1)1Bres (involves: C57BL/6J * CBA/J)	abnormal lipid homeostasis	J:80950
	hyperlipidemia	J:80950
	impaired lipolysis	J:80950
	increased circulating cholesterol level	J:80950
	increased circulating LDL cholesterol level	J:80950
	increased circulating triglyceride level	J:80950
	increased circulating VLDL cholesterol level	J:80950
	increased circulating VLDL triglyceride level	J:80950
Tg(APOC1)1Lmh/0 (C57BL/6-Tg(APOC1)1Lmh)	increased circulating cholesterol level	J:65036
	increased circulating free fatty acids level	J:65036
	increased circulating triglyceride level	J:65036
	increased circulating VLDL cholesterol level	J:65036
	increased circulating VLDL triglyceride level	J:65036
Tg(APOC1)1Lmh/? (C57BL/6-Tg(APOC1)1Lmh)	increased circulating cholesterol level	J:65146
	increased circulating triglyceride level	J:65146
	increased circulating VLDL cholesterol level	J:65146
	increased circulating VLDL triglyceride level	J:65146
Tg(APOC1)1Lmh/0 Tg(APOC1)3Lmh/0 (C57BL/6-Tg(APOC1)1Lmh Tg(APOC1)3Lmh)	increased circulating cholesterol level	J:65036
	increased circulating free fatty acids level	J:65036
	increased circulating triglyceride level	J:65036
Tg(APOC1)1Lmh/Tg(APOC1)1Lmh (C57BL/6-Tg(APOC1)1Lmh)	increased circulating cholesterol level	J:65036
	increased circulating free fatty acids level	J:65036
	increased circulating triglyceride level	J:65036
	increased circulating VLDL cholesterol level	J:65036
	increased circulating VLDL triglyceride level	J:65036
Tg(APOC1)1Lmh/Tg(APOC1)1Lmh (involves: C57BL/6J)	decreased circulating factor VIII level	J:117317
	increased circulating cholesterol level	J:117317
	increased circulating triglyceride level	J:117317
Tg(APOC1)1Lmh/Tg(APOC1)1Lmh (involves: C57BL/6)	epidermal spongiosis	J:135501
Tg(APOC1)1Lmh/Tg(APOC1)1Lmh (involves: C57BL/6)	impaired skin barrier function	J:135501
Tg(APOC1)3Lmh/Y (C57BL/6-Tg(APOC1)3Lmh)	increased circulating cholesterol level	J:65036
	increased circulating free fatty acids level	J:65036
	increased circulating triglyceride level	J:65036
	increased circulating VLDL cholesterol level	J:65036
	increased circulating VLDL triglyceride level	J:65036
Tg(APOC1)3Lmh/0 (C57BL/6-Tg(APOC1)3Lmh)	increased circulating cholesterol level	J:65036
	increased circulating free fatty acids level	J:65036
	increased circulating triglyceride level	J:65036
Tg(APOC1)3Lmh/? (C57BL/6-Tg(APOC1)3Lmh)	increased circulating cholesterol level	J:65146
Tg(APOC2)2Bres/0 (involves: C57BL/6J * CBA/J)	abnormal lipid homeostasis	J:81186
	increased cholesterol level	J:81186
	increased circulating triglyceride level	J:81186
	increased circulating VLDL triglyceride level	J:81186
Tg(APOC3)2674Bres/0 (involves: C57BL/6J * CBA/J)	abnormal lipid homeostasis	J:81184
	increased circulating triglyceride level	J:81184
	increased circulating VLDL triglyceride level	J:81184
Tg(APOC3)2674Bres/Tg(APOC3)2674Bres (involves: C57BL/6J * CBA/J)	increased circulating triglyceride level	J:81184
Tg(APOC3)2721Bres/0 (involves: C57BL/6J * CBA/J)	decreased circulating HDL cholesterol level	J:81184
	increased circulating triglyceride level	J:81184
	increased circulating VLDL triglyceride level	J:81184
Tg(APOC3)3707Bres/0 (involves: C57BL/6J * CBA/J)	increased circulating cholesterol level	J:119638
Tg(APOC3)3707Bres/0 (involves: C57BL/6J * CBA/J)	increased circulating triglyceride level	J:119638
Tg(APOE-ABCA1)30Ssf/? (C57BL/6N-Tg(APOE-ABCA1)30Ssf)	abnormal apolipoprotein level	J:70494
	abnormal circulating apolipoprotein E level	J:70494
	increased circulating cholesterol level	J:70494
	increased circulating HDL cholesterol level	J:70494
	increased circulating phospholipid level	J:70494
	increased liver cholesterol level	J:70494
	increased triglyceride level	J:70494
Tg(APOE-ABCG1)1Ssf/? (C57BL/6-Tg(APOE-ABCG1)1Ssf)	abnormal phospholipid level	J:94077
	decreased circulating HDL cholesterol level	J:94077
	increased liver cholesterol level	J:94077
Tg(APOE-Adipoq)#Kry/0 (involves: 129 * C57BL/6J)	decreased circulating osteocalcin level	J:199264
Tg(APOE-Adipoq)#Kry/0 (involves: 129 * C57BL/6J)	increased circulating adiponectin level	J:199264
Tg(APOE-ANGPTL4)1Akos/0 (involves: C57BL/6 * SJL)	increased circulating cholesterol level	J:103363
	increased circulating triglyceride level	J:103363
	increased circulating VLDL cholesterol level	J:103363
Tg(APOE-Cyp7a1)1Road/? (B6.Cg-Tg(APOE-Cyp7a1)1Road)	abnormal apolipoprotein level	J:70134
	decreased circulating HDL cholesterol level	J:70134
	decreased circulating LDL cholesterol level	J:70134
	decreased circulating VLDL cholesterol level	J:70134
	increased bile salt level	J:70134
	increased triglyceride level	J:70134
Tg(APOE-DGAT1)1Far/0 (involves: C57BL/6NHsd)	abnormal fatty acids level	J:124005
	abnormal lipid level	J:124005
	increased liver triglyceride level	J:124005
Tg(APOE-DGAT2)1Far/0 (involves: C57BL/6NHsd)	abnormal fatty acids level	J:124005
	abnormal lipid level	J:124005
	decreased circulating free fatty acids level	J:124005
	decreased circulating triglyceride level	J:124005
	increased circulating alanine transaminase level	J:124005
	increased circulating aspartate transaminase level	J:124005
	increased triglyceride level	J:124005
Tg(APOE-DGAT2)24Far/0 (involves: C57BL/6NHsd)	abnormal fatty acids level	J:124005
	abnormal lipid level	J:124005
	decreased circulating free fatty acids level	J:124005
	decreased circulating triglyceride level	J:124005
	increased circulating alanine transaminase level	J:124005
	increased circulating aspartate transaminase level	J:124005
	increased triglyceride level	J:124005
Tg(Apoe-Fgf21)1Sakl/0 (Not Specified)	abnormal gluconeogenesis	J:150831
	increased liver glycogen level	J:150831
	increased oxygen consumption	J:150831
Tg(APOE-FGF23R176Q)#Ack/0 (involves: C57BL/6J CBA)	abnormal renal calcium reabsorption	J:93981
	abnormal renal phosphate reabsorption	J:93981
	abnormal vitamin D level	J:93981
	decreased circulating calcium level	J:93981
	decreased circulating phosphate level	J:93981
	decreased urine calcium level	J:93981
	increased circulating parathyroid hormone level	J:93981
Tg(APOE-GHRL)1Jagu/0 Tg(APOE-MBOAT4)1Jagu/0 (Not Specified)	abnormal circulating hormone level	J:151420
Tg(APOE-GHRL)1Jagu/0 Tg(APOE-MBOAT4)1Jagu/0 (Not Specified)	decreased energy expenditure	J:151420
Tg(APOE-NPC1L1)20Lqyu/0 (involves: C57BL/6 * DBA/2)	increased cholesterol level	J:124193
Tg(APOE-NPC1L1)20Lqyu/0 (involves: C57BL/6 * DBA/2)	increased circulating cholesterol level	J:124193
Tg(APOE-PCSK9)1Jdh/0 (Not Specified)	increased circulating LDL cholesterol level	J:114949
Tg(Apoe-Pcsk9)#Prat/? (involves: C3H * C57BL/6)	increased circulating cholesterol level	J:169834
	increased circulating HDL cholesterol level	J:169834
	increased circulating LDL cholesterol level	J:169834
Tg(APOE-rtTAM2,tetO-Rgs16)#Tmw/0 (involves: C57BL/6 DBA)	decreased circulating cholesterol level	J:172091
	decreased circulating glucose level	J:172091
	decreased circulating ketone body level	J:172091
	decreased fatty acid oxidation	J:172091
	increased circulating triglyceride level	J:172091
	increased liver triglyceride level	J:172091
Tg(APOE-SGMS2)#Jia/0 (involves: C57BL/6 * C57BL/6J * CBA)	abnormal circulating protein level	J:162192
Tg(APOE-SGMS2)#Jia/0 (involves: C57BL/6 * C57BL/6J * CBA)	abnormal sphingomyelin level	J:162192
Tg(APOE_i3,APOC1)2Lmh/? (involves: C57BL/6J CBA)	increased circulating cholesterol level	J:228420
	increased circulating LDL cholesterol level	J:228420
	increased circulating triglyceride level	J:228420
	increased circulating VLDL cholesterol level	J:228420
Tg(APOM)HCchr/0 (B6.Cg-Tg(APOM)HCchr)	increased circulating cholesterol level	J:130647
	increased circulating phospholipid level	J:130647
	increased circulating triglyceride level	J:130647
Tg(APPSWE)2576Kha/0 (involves: 129S7/SvEvBrd * C57BL/6 * SJL)	increased brain zinc level	J:76863
Tg(APPSWE)2576Kha/0 Tg(PSEN1)5Dbo/0 (involves: C57BL/6 * SJL)	abnormal catecholamine level	J:191088
Tg(APPswe,PSEN1dE9)85Dbo/0 (B6;C3-Tg(APPswe,PSEN1dE9)85Dbo/Mmjax)	impaired glucose tolerance	J:129021
	increased circulating cholesterol level	J:129021
	increased circulating insulin level	J:129021
	increased circulating triglyceride level	J:113199
Tg(ATN1)Q129Stsu/0 (involves: 129S/SvEv C57BL/6J)	decreased blood osmolality	J:144379
	decreased circulating antidiuretic hormone level	J:144379
	decreased urine osmolality	J:144379
Tg(AZIP/F)1Vsn/0 (involves: FVB/N)	abnormal glucose homeostasis	J:50807
	abnormal lipid homeostasis	J:50807
	decreased circulating leptin level	J:50807
	hyperglycemia	J:50807
	increased circulating free fatty acids level	J:50807
	increased circulating insulin level	J:50807
	increased circulating triglyceride level	J:50807
	increased liver triglyceride level	J:50807
Tg(AZIP/F)1Vsn/0 (FVB-Tg(AZIP/F)1Vsn/J)	decreased circulating glucose level	J:145998
	increased circulating insulin level	J:145998
	increased insulin secretion	J:145998
Tg(BAC144D14)5A2Masu/0 (B6J.Cg-Tg(BAC144D14)5A2Masu)	hypoglycemia	J:232408
Tg(BAC144D14)5A2Masu/0 (B6J.Cg-Tg(BAC144D14)5A2Masu)	increased body temperature	J:232408
Tg(BAC144D14)5D3Masu/0 (B6J.Cg-Tg(BAC144D14)5D3Masu)	hypoglycemia	J:232408
Tg(BAC144D14)5D3Masu/0 (B6J.Cg-Tg(BAC144D14)5D3Masu)	increased body temperature	J:232408
Tg(BCL2/IGH)#Jcre/0 Tg(H2-K/Igh-Traf2)#Ywc/0 (involves: BALB/c C57BL/6 * CBA/J * FVB/N * SJL/J * SWR/J)	ascites	J:94116
	pleural effusion	J:94116
Tg(CAG-ACE2)AC70Ctkt/0 (either: (involves: BALB/c * C3H/HeJ * C57BL/6J) or (involves: C3H/HeJ * C57BL/6 * C57BL/6J))	abnormal cytokine level	J:117824
Tg(CAG-ANGPT1)5Yo/0 Tg(SFTPC-cre)11Yo/0 (involves: C57BL/6 CBA)	abnormal oxygen consumption	J:147388
	cyanosis	J:147388
Tg(CAG-Angptl6)8.1Yo/0 (involves: C57BL/6 * CBA)	abnormal circulating hormone level	J:97552
	decreased circulating leptin level	J:97552
	decreased susceptibility to diet-induced obesity	J:97552
	increased adiponectin level	J:97552
	increased insulin sensitivity	J:97552
	increased oxygen consumption	J:97552
Tg(CAG-APP)0304Shoj/0 (involves: C3H * C57BL/6N)	abnormal circulating serum amyloid protein level	J:100977
Tg(CAG-Bgeo,-Hras1,-EGFP)#Ichi/0 Tg(Tek-cre)12Flv/0 (involves: 129P2/OlaHsd * C3H * C57BL/6)	edema	J:159024
Tg(CAG-Bgeo/ALPP)1Lbe/0 Tg(Ins2-cre/ERT)1Dam/0 Tg(Ins2-rtTA)2Efr/0 Tg(tetO-DTA)1Gfi/0 (involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * CBA)	hyperglycemia	J:127412
Tg(CAG-Btc)2Ewo/0 (FVB/N-Tg(CAG-Btc)2Ewo)	cyanosis	J:103364
Tg(CAG-Btc)4Ewo/0 (FVB/N-Tg(CAG-Btc)4Ewo)	cyanosis	J:103364
Tg(CAG-C1qtnf6)#Yiw/0 (involves: C57BL/6JJcl)	abnormal complement protein level	J:227217
Tg(CAG-cat,-Ptpn11Q97R)1Rbns/0 Tg(Tek-cre)12Flv/0 (involves: C3H C57BL/6 * FVB/N)	edema	J:142212
	nuchal edema	J:142212
Tg(CAG-COX7A2L)#Sinos/0 (involves: C57BL/6)	increased carbon dioxide production	J:215964
Tg(CAG-COX7A2L)#Sinos/0 (involves: C57BL/6)	increased oxygen consumption	J:215964
Tg(CAG-cre/Esr1)5Amc/0 Tgfbr2^tm1.2Hlm/Tgfbr2^tm1.2Hlm (involves: 129S6/SvEvTac C57BL/6 * CBA)	hypoxia	J:221181
Tg(CAG-CYP27A1)23Etl/0 (involves: C57BL/6JOlaHsd * CBA)	abnormal bile salt level	J:78951
Tg(CAG-CYP27A1)23Etl/0 (involves: C57BL/6JOlaHsd * CBA)	abnormal cholesterol level	J:78951
Tg(CAG-DPP4)4Yuzh/0 (C57BL/6-Tg(CAG-DPP4)4Yuzh)	abnormal circulating cytokine level	J:286175
	increased circulating interferon-gamma level	J:286175
	increased circulating interleukin-17 level	J:286175
Tg(CAG-EPM2AC266S)1Bmin/0 (involves: 129 C57BL/6 * SJL)	increased skeletal muscle glycogen level	J:120356
Tg(CAG-lacZ,-SV40)#Bcv/0 (involves: FVB/N)	ascites	J:158388
Tg(CAG-Lyn)#Paau/0 (B6.Cg-Tg(CAG-Lyn)#Paau)	epidermal spongiosis	J:151886
Tg(CAG-Lyn)#Paau/0 (B6.Cg-Tg(CAG-Lyn)#Paau)	extremity edema	J:151886
Tg(CAG-Map3k7*K63W)1232Mds/0 Tg(Myh6-cre)2182Mds/0 (involves: FVB/N)	abnormal atrial thrombosis	J:117108
	increased cardiac muscle glycogen level	J:117108
	periorbital edema	J:117108
Tg(CAG-Ncoa6)71Hwl/0 (involves: FVB)	abnormal atrial thrombosis	J:80609
Tg(CAG-Ncoa6)87Hwl/0 (involves: FVB)	abnormal atrial thrombosis	J:80609
Tg(CAG-Ncoa6)87Hwl/0 (involves: FVB)	pericardial effusion	J:269856
Tg(CAG-Ncoa6)104Hwl/0 (involves: FVB)	abnormal atrial thrombosis	J:80609
Tg(CAG-Ndufab1)#Xiwa/0 (involves: C57BL/6J)	decreased circulating glucose level	J:293657
	decreased fasting circulating glucose level	J:293657
	decreased susceptibility to diet-induced obesity	J:293657
	improved glucose tolerance	J:293657
	increased carbon dioxide production	J:293657
	increased energy expenditure	J:293657
	increased insulin sensitivity	J:293657
	increased oxygen consumption	J:293657
Tg(CAG-Ngb,-EGFP)1Dgrn/Tg(CAG-Ngb,-EGFP)1Dgrn (involves: C57BL/6 * CD-1 * DBA/2)	abnormal nitric oxide homeostasis	J:117158
Tg(CAG-NRIP1)51Row/0 (involves: FVB/N)	abnormal atrial thrombosis	J:175885
	ascites	J:175885
	pleural effusion	J:175885
Tg(CAG-rtTA)72Wiek/0 Tg(tetO-Rnf5)1Zron/0 (involves: C3H * C57BL/6 * DBA/2)	increased circulating creatine kinase level	J:132185
Tg(CAG-VCPA232E)93Jpat/0 (involves: C57BL/6 SJL)	increased circulating alkaline phosphatase level	J:158713
Tg(CAG-VCPA232E)93Jpat/0 (involves: C57BL/6 SJL)	increased circulating creatine kinase level	J:158713
Tg(CAG-VCPR155H)55Jpat/0 (involves: C57BL/6 SJL)	increased circulating alkaline phosphatase level	J:158713
Tg(CAG-VCPR155H)55Jpat/0 (involves: C57BL/6 SJL)	increased circulating creatine kinase level	J:158713
Tg(CAMalpha1b)7Wjk/? (Not Specified)	abnormal atrial thrombosis	J:134704
Tg(CAMalpha1b)7Wjk/? (Not Specified)	generalized edema	J:134704
Tg(Camk2a-DISC1)10Asaw/0 (C57BL/6-Tg(Camk2a-DISC1)10Asaw)	decreased dopamine level	J:194985
Tg(Camk2a-DISC1)37Asaw/0 (C57BL/6-Tg(Camk2a-DISC1)37Asaw)	decreased dopamine level	J:194985
Tg(Camk2a-DISC1)37Asaw/Tg(Camk2a-DISC1)37Asaw (C57BL/6-Tg(Camk2a-DISC1)37Asaw)	decreased dopamine level	J:194985
Tg(Camk2a-PolgD181A)BTkato/0 (C57BL/6J-Tg(Camk2a-PolgD181A)BTkato)	abnormal dopamine level	J:127895
	decreased noradrenaline level	J:127895
	decreased serotonin level	J:127895
Tg(Camk2a-tTA)1Mmay/? Tg(tetO-DRD2)2-5Kndl/? (involves: 129S6/SvEvTac * C57BL/6 * CBA)	increased dopamine level	J:106982
Tg(Camk2a-tTA)1Mmay/0 Tg(tetO-SNCA)0Olri/0 (involves: C57BL/6)	decreased dopamine level	J:132774
Tg(CD2-CD4,HLA-DQA1,HLA-DQB1)1Ell/Tg(CD2-CD4,HLA-DQA1,HLA-DQB1)1Ell (NOD/MrkTac-Tg(CD2-CD4,HLA-DQA1,HLA-DQB1)1Ell)	hyperglycemia	J:87013, J:86540
Tg(CD2-Rorc)#Staka/0 (involves: C57BL/6)	decreased salivation	J:230700
Tg(Cd2-Smad7)#Chbe/0 (involves: C57BL/6)	decreased transforming growth factor beta level	J:184670
Tg(CD2-Stat6V625AT626A)78Mhk/0 (involves: C3H * C57BL/6)	impaired skin barrier function	J:160119
Tg(CD4-CIITA)357Ccum/? (involves: C57BL/6 * C57BL/6J * SJL)	increased circulating type I collagen C-terminal telopeptide level	J:233241
Tg(CD4-HIV)F21380Pjo/0 (involves: C3H * C57BL/6)	edema	J:78756
Tg(CD4-HIV)F21388Pjo/0 (involves: C3H * C57BL/6)	edema	J:78756
Tg(CD4-HIV)F21407Pjo/0 (involves: C3H * C57BL/6)	edema	J:78756
Tg(CD4-HIV)F26605Pjo/0 (involves: C3H * C57BL/6)	edema	J:78756
Tg(CD4-HIV)F26622Pjo/0 (involves: C3H * C57BL/6)	edema	J:78756
Tg(CD4-HIV)F26990Pjo/0 (involves: C3H * C57BL/6)	edema	J:78756
Tg(CD4-HIV)F27011Pjo/0 (involves: C3H * C57BL/6)	edema	J:78756
Tg(CD4-HIV)F27367Pjo/0 (involves: C3H * C57BL/6)	edema	J:78756
Tg(CD4-HIV)F27372Pjo/0 (involves: C3H * C57BL/6)	edema	J:78756
Tg(CD46)2Gsv/0 (involves: C57BL/6 * FVB/N)	abnormal chemokine level	J:109895
Tg(Cd74-Nlrc4*)1Kyas/0 (involves: C57BL/6N)	increased circulating interleukin-1 beta level	J:219652
	increased circulating interleukin-17 level	J:219652
	joint swelling	J:219652
Tg(Cdh16-Wnk1*)#Cihu/0 (involves: C57BL/6)	decreased circulating potassium level	J:168700
	increased circulating aldosterone level	J:168700
	increased circulating angiotensinogen level	J:168700
	increased urine potassium level	J:168700
	increased urine sodium level	J:168700
Tg(CETP)5203Tall/0 (involves: C57BL/6 * CBA/J)	abnormal lipid level	J:117482
	abnormal phospholipid level	J:117482
	decreased cholesterol level	J:117482
	decreased liver triglyceride level	J:117482
Tg(CETP)5203Tall/0 (involves: C57BL/6J * CBA/J)	decreased circulating HDL cholesterol level	J:48202
Tg(CETP)UCTP20Pnu/0 (C57BL/6-Tg(CETP)UCTP20Pnu)	abnormal circulating cholesterol level	J:118358, J:92448
	abnormal circulating protein level	J:92448
	decreased circulating HDL cholesterol level	J:118358
	increased circulating LDL cholesterol level	J:118358
	increased circulating VLDL cholesterol level	J:118358
Tg(Cga-LHB/CGB)94Jhn/? (involves: C57BL/6 * SJL)	increased circulating luteinizing hormone level	J:55157
Tg(Cga-LHB/CGB)94Jhn/? (involves: C57BL/6 * SJL)	increased circulating progesterone level	J:55157
Tg(Ckm-Cd36)1Naa/0 (involves: FVB)	decreased circulating cholesterol level	J:57650
	decreased circulating free fatty acids level	J:57650
	decreased circulating triglyceride level	J:57650
	decreased circulating VLDL triglyceride level	J:57650
	increased circulating glucose level	J:57650
	increased circulating insulin level	J:57650
Tg(Ckm-DGAT2)10Far/0 (involves: C57BL/6NHsd)	abnormal glucose homeostasis	J:129495
	abnormal lipid level	J:129495
	impaired glucose tolerance	J:129495
	increased skeletal muscle triglyceride level	J:129495
	insulin resistance	J:129495
Tg(Ckm-IGF1RK1003R)1Dlr/0 (FVB/N-Tg(Ckm-IGF1RK1003R)1Dlr)	abnormal glucose homeostasis	J:71205
	abnormal glycogen homeostasis	J:71205
	albuminuria	J:210518
	hyperglycemia	J:210518
	impaired glucose tolerance	J:71205
	increased circulating cholesterol level	J:210518
	increased circulating creatinine level	J:210518
	increased circulating free fatty acids level	J:71205
	increased circulating glucose level	J:71205
	increased circulating insulin level	J:71205
	increased circulating triglyceride level	J:71205
	increased liver triglyceride level	J:71205
	insulin resistance	J:71205
Tg(Ckm-LPL)HRze/0 (involves: C57BL/6J * CBA/J)	decreased circulating triglyceride level	J:101818
	decreased circulating VLDL triglyceride level	J:101818
	increased muscle free fatty acids level	J:101818
	increased skeletal muscle glycogen level	J:101818
Tg(Ckm-LPL)LRze/0 (involves: C57BL/6J * CBA/J)	decreased circulating triglyceride level	J:101818
Tg(Ckm-LPL)LRze/0 (involves: C57BL/6J * CBA/J)	decreased circulating VLDL triglyceride level	J:101818
Tg(Ckm-LPL)MRze/0 (involves: C57BL/6J * CBA/J)	decreased circulating triglyceride level	J:101818
	decreased circulating VLDL triglyceride level	J:101818
	increased muscle free fatty acids level	J:101818
	increased skeletal muscle glycogen level	J:101818
Tg(Ckm-Pnpla2)164Eek/0 (involves: FVB/N)	decreased skeletal muscle triglyceride level	J:207007
Tg(Ckm-Ppara)HEDpk/0 (involves: C57BL/6 * CBA)	abnormal glucose homeostasis	J:129848
	decreased susceptibility to diet-induced obesity	J:129848
	impaired glucose tolerance	J:129848
	increased circulating glucose level	J:129848
	increased circulating insulin level	J:129848
	increased skeletal muscle triglyceride level	J:129848
	insulin resistance	J:129848
Tg(Ckm-Ppard)MEDpk/0 (involves: C57BL/6 * CBA)	impaired glucose tolerance	J:129848
Tg(Ckm-Ppard)MEDpk/0 (involves: C57BL/6 * CBA)	insulin resistance	J:129848
Tg(Ckm-Prkaa2K45R)1Mbb/0 (involves: C57BL/6J SJL/J)	abnormal circulating glucose level	J:110092
Tg(Ckm-PTPN1)45Bbk/0 (involves: FVB)	abnormal glucose homeostasis	J:122895
	abnormal glycogen homeostasis	J:122895
	insulin resistance	J:122895
Tg(Ckm-PTPN1)45Bbk/? Tg(Ckm-PTPRF)13Bbk/? (involves: FVB)	abnormal glucose homeostasis	J:122895
	abnormal glycogen homeostasis	J:122895
	insulin resistance	J:122895
Tg(Ckm-PTPRF)13Bbk/0 (involves: FVB)	abnormal glucose homeostasis	J:122895
	abnormal glycogen homeostasis	J:122895
	insulin resistance	J:122895
Tg(Ckm-Slc2a4)1Klip/Tg(Ckm-Slc2a4)1Klip (Not Specified)	impaired glucose tolerance	J:151818
Tg(Ckmm-Cav3)1Ysu/0 (involves: C57BL/Slc * DBA/Slc)	abnormal nitric oxide homeostasis	J:67174
Tg(CKMM-tTA)A3Rhvh/0 Tg(tetO-H2-K1)#Papl/0 (B6.Cg-Tg(CKMM-tTA)A3Rhvh Tg(tetO-H2-K1)#Papl)	abnormal circulating enzyme level	J:205907
	abnormal cytokine level	J:205907
	increased circulating creatine kinase level	J:205907
Tg(Ckmm-Ucp1)1Boud/0 (involves: C57BL/6J * DBA/2J)	abnormal blood homeostasis	J:80053
	decreased circulating creatinine level	J:80053
	increased energy expenditure	J:80053
Tg(Ckmm-Ucp1)1Boud/Tg(Ckmm-Ucp1)1Boud (involves: C57BL/6J * DBA/2J)	abnormal blood homeostasis	J:80053
	decreased circulating creatinine level	J:80053
	increased energy expenditure	J:80053
Tg(CMV-APPL2)1Smoc/0 (Not Specified)	impaired glucose tolerance	J:230004
Tg(CMV-APPL2)1Smoc/0 (Not Specified)	insulin resistance	J:230004
Tg(CMV-tTA)3Bjd/0 Tg(tetO-Prkar1ax2as)1Stra/0 (involves: C57BL/6 NMRI * SJL)	increased circulating corticosterone level	J:95465
Tg(Cnr1-EGFP/RNAi:Gad1)1Mirn/? (C57BL/6-Tg(Cnr1-EGFP/RNAi:Gad1)1Mirn)	increased serotonin level	J:210380
Tg(Col1a1-Atf4)1Kry/0 (involves: FVB)	abnormal circulating glucose level	J:152695
	decreased circulating insulin level	J:152695
	decreased insulin secretion	J:152695
	impaired glucose tolerance	J:152695
	increased circulating glucose level	J:152695
Tg(Col1a1-FGF2,-Sapphire)203Mmh/Tg(Col1a1-FGF2,-Sapphire)203Mmh (involves: FVB/N)	abnormal circulating protein level	J:159949
	decreased circulating phosphate level	J:159949
	increased circulating parathyroid hormone level	J:159949
	increased circulating type I collagen C-terminal telopeptide level	J:159949
	increased urine phosphate level	J:159949
Tg(Col1a1-Ptprv)1Kry/? (Not Specified)	abnormal glucose homeostasis	J:126780
	decreased adiponectin level	J:126780
	decreased circulating insulin level	J:126780
	decreased insulin secretion	J:126780
	hyperglycemia	J:126780
	impaired glucose tolerance	J:126780
	insulin resistance	J:126780
Tg(Crh)227.1Pbl/0 (involves: C57BL/6 * SJL)	increased circulating adrenocorticotropin level	J:92996
	increased circulating corticosterone level	J:92996
	increased circulating corticotropin-releasing hormone level	J:92996
Tg(Cryaa-AKR1B1)222Smch/0 (involves: C57BL * CBA)	abnormal homeostasis	J:106642
Tg(Cryaa-AKR1B1)648Smch/0 (involves: C57BL * CBA)	abnormal homeostasis	J:106642
Tg(Cryaa-TAg,Ins2-CALM1)26Ove/0 (FVB(Cg)-Tg(Cryaa-Tag,Ins2-CALM1)26Ove/PneJ)	decreased circulating insulin level	J:97926
	decreased insulin secretion	J:97926
	hyperglycemia	J:97926
	increased circulating glucagon level	J:97926
	increased urine glucose level	J:97926
Tg(Cryaa-TAg,Ins2-CALM1)26Ove/0 (FVB-Tg(Cryaa-TAg,Ins2-CALM1)26Ove)	albuminuria	J:94602
	decreased circulating serum albumin level	J:94602
	hyperglycemia	J:106851, J:94602
Tg(Cryaa-TAg,Ins2-CALM1)26Ove/0 Tg(Myh6-SOD2,Tyr)3Pne/0 (FVB-Tg(Cryaa-TAg,Ins2-CALM1)26Ove Tg(Myh6-SOD2,Tyr)3Pne)	hyperglycemia	J:106815
Tg(Csf1r-Tnfsf15,-EGFP)#Targ/0 (involves: C57BL/6)	joint swelling	J:169462
Tg(CSN2-fat-1)1Vane/0 (involves: C57BL/6 * DBA)	decreased unsaturated fatty acids level	J:168456
Tg(CSN2-fat-1)1Vane/0 (involves: C57BL/6 * DBA)	increased unsaturated fatty acids level	J:168456
Tg(Cyp17a1-NGF)2456Oje/Tg(Cyp17a1-NGF)2456Oje (involves: C57BL/6J * DBA/2J)	abnormal hormone level	J:158186
	decreased circulating progesterone level	J:158186
	impaired glucose tolerance	J:218686
	increased circulating estradiol level	J:218686
	increased circulating insulin level	J:218686
	increased circulating testosterone level	J:218686
	insulin resistance	J:218686
Tg(Cyp19)C2-3Rrte/0 (involves: BALB/c * C57BL/6)	increased circulating estradiol level	J:60034
Tg(Cyp21a1-Apoe)614Fet/0 (involves: 129P2/OlaHsd * C57BL/6 * FVB/N)	increased circulating cholesterol level	J:130658
Tg(Cyp21a1-Apoe)619Fet/0 (involves: 129P2/OlaHsd * C57BL/6 * FVB/N)	increased circulating cholesterol level	J:130658
Tg(DBH-SNCA)#Dwei/0 (C57BL/6N-Tg(DBH-SNCA)#Dwei)	abnormal nervous system dopamine level	J:296218
Tg(DMWD,DMPK,SIX5)328Ggo/Tg(DMWD,DMPK,SIX5)328Ggo (involves: C57BL/6 * DBA/2)	decreased blood oxygen saturation level	J:196337
Tg(DPP4)2Nnag/0 (B6.Cg-Tg(DPP4)2Nnag)	abnormal cytokine level	J:286321
Tg(Dyrk1a)189N3Yah/0 (B6.129P2-Tg(Dyrk1a)189N3Yah/Yah)	abnormal circulating androgen level	J:324151
	abnormal enzyme/coenzyme level	J:324151
	abnormal hormone level	J:324151
	decreased circulating follicle stimulating hormone level	J:324151
	decreased circulating gonadotropin level	J:324151
	decreased circulating luteinizing hormone level	J:324151
	decreased circulating testosterone level	J:324151
Tg(ED-L2-IL1RN/IL1B)#Tcw/? (B6.Cg-Tg(ED-L2-IL1RN/IL1B)#Tcw)	abnormal interleukin level	J:180282
Tg(ED-L2-IL1RN/IL1B)#Tcw/? (B6.Cg-Tg(ED-L2-IL1RN/IL1B)#Tcw)	increased circulating interleukin-6 level	J:180282
Tg(Edn1-NOS3)22Yky/0 (involves: C57BL/6 * DBA/2)	abnormal blood homeostasis	J:81132
Tg(EEF1A1-Socs6)1Pwg/? (B6.129P2-Tg(EEF1A1-Socs6)1Pwg)	decreased circulating glucose level	J:181312
	decreased circulating insulin level	J:181312
	improved glucose tolerance	J:181312
	increased insulin sensitivity	J:181312
Tg(EEF1A1-Socs6)2Pwg/? (B6.129P2-Tg(EEF1A1-Socs6)2Pwg)	decreased circulating glucose level	J:181312
	decreased circulating insulin level	J:181312
	improved glucose tolerance	J:181312
	increased insulin sensitivity	J:181312
Tg(Emu-TXLNA)1Amjr/0 (B6.Cg-Tg(Emu-TXLNA)1Amjr)	decreased salivation	J:145185
	increased circulating interferon-alpha level	J:117018
	increased urine protein level	J:117018
Tg(Eno2-TOR1A)13Shas/0 (involves: C3H C57BL/6J)	decreased dopamine level	J:95447
Tg(Eno2-TOR1A)13Shas/0 (involves: C3H C57BL/6J)	increased dopamine level	J:95447
Tg(Fabp1-Nr1h3)#Wexi/? (involves: 129X1/SvJ * C57BL/6)	increased liver triglyceride level	J:135594
Tg(Fabp1-Nr1h3)#Wexi/? Tg(Fabp1-NR1I2)#Wexi/? (involves: 129X1/SvJ * C57BL/6)	increased liver triglyceride level	J:135594
Tg(Fabp1-NR1I2)#Wexi/? (involves: 129X1/SvJ * C57BL/6)	increased liver triglyceride level	J:135594
Tg(Fabp2-Arg1)1Wla/Tg(Fabp2-Arg1)1Wla (involves: FVB)	abnormal amino acid level	J:80556
	decreased arginine level	J:80556
	decreased circulating arginine level	J:80204
	increased circulating glycine level	J:80556
	increased ornithine level	J:80556
Tg(Fabp4-Adissp)#Yxw/0 (involves: C57BL/6J * SJL)	abnormal adaptive thermogenesis	J:332979
	abnormal glucose homeostasis	J:332979
	decreased susceptibility to diet-induced obesity	J:332979
	improved glucose tolerance	J:332979
Tg(Fabp4-Aebp1)1Hsro/? (involves: FVB)	increased circulating insulin level	J:125334
Tg(Fabp4-Aebp1)1Hsro/? (involves: FVB)	increased circulating leptin level	J:125334
Tg(Fabp4-Agt)2Mte/0 (involves: C57BL/6 * CD-1 * DBA/2 * ICR)	abnormal blood homeostasis	J:73163
	decreased circulating renin level	J:73163
Tg(Fabp4-Angptl2)5Yo/0 (involves: C57BL/6)	impaired glucose tolerance	J:152387
Tg(Fabp4-Angptl2)5Yo/0 (involves: C57BL/6)	insulin resistance	J:152387
Tg(Fabp4-Apol6)#Hsul/0 (C57BL/6J-Tg(Fabp4-Apol6)#Hsul)	abnormal circulating glycerol level	J:344362
	decreased circulating free fatty acids level	J:344362
	impaired glucose tolerance	J:344362
	impaired lipolysis	J:344362
	increased circulating cholesterol level	J:344362
	increased circulating HDL cholesterol level	J:344362
	increased circulating LDL cholesterol level	J:344362
	increased circulating triglyceride level	J:344362
	increased liver triglyceride level	J:344362
	insulin resistance	J:344362
Tg(Fabp4-Ccl2)BYt/0 (involves: C57BL/6N)	abnormal gluconeogenesis	J:110277
	abnormal glucose homeostasis	J:110277
	impaired glucose tolerance	J:110277
	increased circulating free fatty acids level	J:110277
	increased circulating glucose level	J:110277
	increased liver triglyceride level	J:110277
	insulin resistance	J:110277
Tg(Fabp4-ENPP1)#Naba/0 (involves: C57BL/6J)	decreased circulating leptin level	J:182179
	decreased susceptibility to diet-induced obesity	J:182179
	impaired glucose tolerance	J:182179
	increased circulating free fatty acids level	J:182179
	increased circulating insulin level	J:182179
	increased circulating triglyceride level	J:182179
	increased liver triglyceride level	J:182179
	insulin resistance	J:182179
Tg(Fabp4-Fabp5)1Hota/0 (involves: C57BL/6)	impaired glucose tolerance	J:81609
Tg(Fabp4-Fabp5)1Hota/0 (involves: C57BL/6)	increased circulating glucose level	J:81609
Tg(Fabp4-Fam13a)1Iked/0 (C57BL/6J-Tg(Fabp4-Fam13a)1Iked)	decreased circulating free fatty acids level	J:258290
	impaired lipolysis	J:258290
	improved glucose tolerance	J:258290
	increased insulin sensitivity	J:258290
Tg(Fabp4-Fcor)1Jnak/0 (involves: C57BL/6 * DBA/2)	decreased respiratory quotient	J:184684
Tg(Fabp4-Fcor)1Jnak/0 (involves: C57BL/6 * DBA/2)	increased insulin sensitivity	J:184684
Tg(Fabp4-Fcor)5Jnak/0 (involves: C57BL/6 * DBA/2)	impaired adaptive thermogenesis	J:184684
Tg(Fabp4-FOXC2)ASven/0 (involves: C57BL/6J * CBA)	decreased circulating free fatty acids level	J:94144
	decreased circulating glucose level	J:94144
	decreased circulating insulin level	J:94144
	decreased circulating triglyceride level	J:94144
	impaired adaptive thermogenesis	J:94144
	increased insulin sensitivity	J:94144
Tg(Fabp4-Hsd11b1)7Jesf/0 (FVB-Tg(Fabp4-Hsd11b1)7Jesf)	abnormal corticosterone level	J:107046
	abnormal glucose homeostasis	J:107046
	abnormal lipid homeostasis	J:107046
	hyperglycemia	J:107046
	impaired glucose tolerance	J:107046
	increased circulating free fatty acids level	J:107046
	increased circulating insulin level	J:107046
	increased circulating leptin level	J:107046
	increased circulating triglyceride level	J:107046
	increased fatty acids level	J:107046
	increased susceptibility to diet-induced obesity	J:107046
	insulin resistance	J:107046
Tg(Fabp4-LEP)F8Ffc/0 (involves: C57BL/6J * DBA/2J)	decreased circulating cholesterol level	J:67311
	decreased circulating glucose level	J:67311
	decreased circulating insulin level	J:67311
	decreased circulating triglyceride level	J:67311
	impaired adaptive thermogenesis	J:67311
	increased circulating leptin level	J:67311
Tg(Fabp4-LEP)F8Ffc/? (B6.Cg-Tg(Fabp4-LEP)F8Ffc)	abnormal glucose homeostasis	J:84349
	decreased circulating glucose level	J:84349
	decreased circulating triglyceride level	J:84349
	increased circulating leptin level	J:84349
	increased insulin secretion	J:84349
Tg(Fabp4-LMNAR482Q)11ACdl/0 (FVB-Tg(Fabp4-LMNAR482Q)11ACdl)	abnormal glucose homeostasis	J:149858
	decreased glycogen catabolism rate	J:149858
	decreased susceptibility to diet-induced obesity	J:149858
	increased circulating glucose level	J:149858
	increased circulating insulin level	J:149858
	insulin resistance	J:149858
Tg(Fabp4-LMNAR482Q)17CCdl/0 (FVB/N-Tg(Fabp4-LMNAR482Q)17CCdl)	abnormal homeostasis	J:149858
Tg(Fabp4-LMNAR482Q)#Hjw/0 (FVB.Cg-Tg(Fabp4-LMNAR482Q)#Hjw)	increased collagen level	J:237920
Tg(Fabp4-Phb)#Smis/0 (involves: CD-1)	decreased circulating cholesterol level	J:230172
	decreased circulating ghrelin level	J:230172
	decreased circulating glycerol level	J:230172
	decreased circulating triglyceride level	J:230172
	impaired glucose tolerance	J:230172
	increased adiponectin level	J:242981, J:230172
	increased circulating estradiol level	J:242981
	increased circulating free fatty acids level	J:230172
	increased circulating insulin level	J:230172
	increased circulating leptin level	J:230172
	insulin resistance	J:230172
Tg(Fabp4-Phb*Y114F)#Smis/0 (Not Specified)	abnormal circulating chemokine level	J:227976
	abnormal circulating cytokine level	J:227976
	abnormal glucose homeostasis	J:227976
	decreased circulating ghrelin level	J:227976
	impaired glucose tolerance	J:227976
	increased adiponectin level	J:227976
	increased circulating ghrelin level	J:227976
	increased circulating insulin level	J:227976
	increased circulating insulin-like growth factor I level	J:227976
	increased circulating leptin level	J:227976
	insulin resistance	J:227976
Tg(Fabp4-Serpina12)1Jwada/0 (involves: C57BL/6JJcl)	decreased circulating insulin level	J:208508
	decreased circulating LDL cholesterol level	J:208508
	decreased circulating leptin level	J:208508
	decreased liver triglyceride level	J:208508
	increased insulin sensitivity	J:208508
Tg(Fabp4-SREBF1)#Dajl/0 (involves: FVB)	decreased triglyceride level	J:189510
	hyperglycemia	J:189510
	impaired glucose tolerance	J:189510
	increased circulating insulin level	J:189510
	insulin resistance	J:189510
Tg(Fabp4-TLE3)#aPton/0 (involves: C57BL/6)	abnormal glucose homeostasis	J:172245
	abnormal hormone level	J:172245
	decreased circulating glucose level	J:172245
	decreased circulating insulin level	J:172245
	decreased energy expenditure	J:198134, J:172245
	impaired adaptive thermogenesis	J:198134
	improved glucose tolerance	J:172245
	increased adiponectin level	J:172245
	increased insulin sensitivity	J:172245
Tg(Fabp4-Wdct1*)1Jmgr/? (involves: ICR)	increased circulating glucose level	J:129966
Tg(Fabp4-Wdtc1)1Jmgr/? (involves: ICR)	decreased circulating glucose level	J:129966
	decreased circulating insulin level	J:129966
	decreased circulating leptin level	J:129966
	increased insulin sensitivity	J:129966
Tg(Fabp4-Zfp516)#Hsul/0 (Not Specified)	abnormal adaptive thermogenesis	J:218161
	decreased susceptibility to diet-induced obesity	J:218161
	improved glucose tolerance	J:218161
	increased core body temperature	J:218161
	increased insulin sensitivity	J:218161
	increased oxygen consumption	J:218161
Tg(FCGR2A)11Mkz/0 Tg(PF4)#Zcy/0 (involves: C57BL/6 * SJL)	decreased body temperature	J:72220
Tg(FCGR2A)11Mkz/0 Tg(PF4)#Zcy/0 (involves: C57BL/6 * SJL)	increased susceptibility to induced thrombosis	J:72220
Tg(Fga,Fgb,Fgg)1Unc/? (C57BL/6-Tg(Fga,Fgb,Fgg)1Unc)	increased circulating fibrinogen level	J:118353
Tg(FGF7)11Efu/0 (Not Specified)	increased salivation	J:65032
Tg(FGF7)29Efu/0 (Not Specified)	increased salivation	J:65032
Tg(FOXJ1-ACE2)1Rba/0 (involves: C3H * C57BL/6)	abnormal lung thrombosis	J:288386
	increased circulating aspartate transaminase level	J:288386
	increased creatine kinase level	J:288386
	pulmonary edema	J:288386
Tg(Foxn1)1Jlb/0 (involves: C57BL/6 * DBA)	impaired skin barrier function	J:56641
Tg(Fst)4Zuk/0 (involves: C3H * C57BL/6 * ICR)	decreased circulating follicle stimulating hormone level	J:45065
Tg(GAS7)63.2Lus/0 (involves: FVB/N)	abnormal cholesterol level	J:148831
	decreased circulating glucose level	J:148831
	decreased triglyceride level	J:148831
	increased cholesterol level	J:148831
Tg(GAS)2Tcw/0 (involves: FVB/N)	abnormal blood homeostasis	J:63579
Tg(Gata1-Zfpm1)1Sho/0 Zfpm1^tm1Sho/Zfpm1^tm1Sho (involves: 129S1/Sv * C57BL/6N * CD-1)	edema	J:99745
Tg(Gfap-TK)7.1Mvs/0 (involves: C57BL/10 * CBA * CFLP)	edema	J:104241
Tg(Gfap-TK)7.1Mvs/0 (involves: C57BL/10 * CBA * CFLP)	increased blood urea nitrogen level	J:104241
Tg(GFAP-tTA)6Hyms/0 Tg(tetO-HMOX1)6Hyms/0 (involves: FVB/N)	increased brain iron level	J:186620, J:190573
	increased dopamine level	J:186620
	increased serotonin level	J:186620
Tg(GFAP-tTA)110Pop/0 Tg(tetO-DISC1)1302BPlet/0 (B6.Cg-Tg(GFAP-tTA)110Pop Tg(tetO-DISC1)1302BPlet)	abnormal serine level	J:244437
	decreased serine level	J:244437
Tg(Ggt1-tTA)#Agoc/0 Tg(tetO/CMV-PTHLH)#Agoc/0 (involves: CD-1)	decreased circulating phosphate level	J:130310
Tg(Gh-Gal)4599Vron/? (involves: C57BL/6 * CD-1 * SJL)	increased circulating growth hormone level	J:86486
Tg(Gh-Gal)4599Vron/? (involves: C57BL/6 * CD-1 * SJL)	increased circulating prolactin level	J:86486
Tg(Gh-Gal)4599Vron/Tg(Gh-Gal)4599Vron (B6.Cg-Tg(Gh-Gal)4599Vron)	decreased oxygen consumption	J:210298
	impaired glucose tolerance	J:210298
	increased cholesterol level	J:210298
	increased circulating insulin level	J:210298
	increased triglyceride level	J:210298
Tg(GHRL-TAg)3-1Hiwa/0 (C57BL/6-Tg(GHRL-TAg)3-1Hiwa)	decreased circulating insulin level	J:152492
	decreased circulating leptin level	J:152492
	impaired glucose tolerance	J:152492
	increased circulating glucose level	J:152492
	increased circulating insulin-like growth factor I level	J:152492
Tg(Gpbar1)1Auw/0 (involves: C57BL/6J)	decreased respiratory quotient	J:152388
	improved glucose tolerance	J:152388
	increased circulating insulin level	J:152388
	increased insulin secretion	J:152388
	increased oxygen consumption	J:152388
Tg(Gt(ROSA)26Sor-BCHEG117H)837Loc/Tg(Gt(ROSA)26Sor-BCHEG117H)837Loc (involves: C57BL/6 * SJL)	abnormal enzyme/coenzyme level	J:89332
Tg(Gt(ROSA)26Sor-BCHEG117H)844Loc/Tg(Gt(ROSA)26Sor-BCHEG117H)844Loc (involves: C57BL/6 * SJL)	abnormal enzyme/coenzyme level	J:89332
	decreased body temperature	J:89332
	increased salivation	J:89332
Tg(H2-Ea-HA)HACIIAjca/0 Tg(Tcra/Tcrb)1Vbo/0 (C.Cg-Tg(H2-Ea-HA)HACIIAjca Tg(Tcra/Tcrb)1Vbo)	abnormal circulating cytokine level	J:209872
	increased circulating interleukin-6 level	J:209872
Tg(H2-Ea-HA)HACIIAjca/0 Tg(TcraS106-1,TcrbS106-1)TS1SWAjca/0 (C.Cg-Tg(H2-Ea-HA)HACIIAjca Tg(TcraS106-1,TcrbS106-1)TS1SWAjca)	abnormal circulating cytokine level	J:209872
	decreased circulating interleukin-6 level	J:209872
	increased circulating interleukin-17 level	J:209872
Tg(H2-K-AKR1B1)1Tj/0 (involves: C57BL/6 * DBA/2)	abnormal glucose homeostasis	J:120049
Tg(H2-K^b-Tcra,-Tcrb)1640Kurs/0 (SJL.FVB-Tg(H2-K^b-Tcra,-Tcrb)1640Kurs)	abnormal cytokine level	J:149511
Tg(H2-L-IL6)1Kish/Tg(H2-L-IL6)1Kish (C57BL/6-Tg(H2-L-IL6)1Kish)	decreased circulating alkaline phosphatase level	J:128016
	decreased circulating glucose level	J:128016
	decreased circulating serum albumin level	J:128016
	decreased circulating triglyceride level	J:128016
	increased circulating total protein level	J:128016
	increased urine protein level	J:128016
Tg(H2-L-IL6)46Kish/Tg(H2-L-IL6)46Kish (involves: BALB/c * C57BL/6)	ascites	J:40405
Tg(HBB-Myc)#Cos/0 (involves: C57BL/6J * CBA/J)	increased blood urea nitrogen level	J:276641
Tg(HBB-Myc)#Cos/0 (involves: C57BL/6J * CBA/J)	increased circulating creatinine level	J:276641
Tg(HBV-HCV)Kko/0 (C57BL/6N-Tg(HBV-HCV)Kko)	decreased glutathione level	J:69727
Tg(HBVX,-Myc)#Skp/Tg(HBVX,-Myc)#Skp (Not Specified)	decreased liver glycogen level	J:81098
Tg(HBVX,-Myc)#Skp/Tg(HBVX,-Myc)#Skp (Not Specified)	increased liver iron level	J:81098
Tg(HBx-HCV)C5Tto/0 (B6.Cg-Tg(HBx-HCV)C5Tto)	increased circulating alanine transaminase level	J:243110
Tg(HCRT-MJD)1Stak/? (involves: C57BL/6 * DBA/1)	decreased energy expenditure	J:69620
Tg(HCRT-MJD)1Stak/? (involves: C57BL/6 * DBA/1)	increased circulating leptin level	J:128233
Tg(HCRT-MJD)1Stak/? (B6.Cg-Tg(HCRT-MJD)1Stak)	abnormal body temperature	J:141058
Tg(HCRT-MJD)1Stak/? (B6.Cg-Tg(HCRT-MJD)1Stak)	decreased energy expenditure	J:141058
Tg(HCRT-tTA)1Ahky/0 Tg(tetO-DTA)1Gfi/0 (B6.Cg-Tg(HCRT-tTA)1Ahky Tg(tetO-DTA)1Gfi)	increased circulating insulin level	J:211045
	increased circulating leptin level	J:211045
Tg(HDexon1)61Gpb/? (involves: C57BL/6 * CBA)	decreased noradrenaline level	J:203027
Tg(HDexon1)61Gpb/? (involves: C57BL/6 * CBA)	increased circulating noradrenaline level	J:203027
Tg(HDexon1)62Gpb/0 (involves: C57BL/6J * CBA/J)	abnormal glucose homeostasis	J:96353
	decreased circulating insulin level	J:96353
	impaired glucose tolerance	J:96353
Tg(HIV)26Aln/0 (involves: FVB/N)	abnormal blood urea nitrogen level	J:90297
	increased circulating creatinine level	J:90297
	increased urine protein level	J:90297
	subcutaneous edema	J:90297
Tg(Hmgcr-PSEN1M146L)#Lpr/0 Tg(Thy1-APP^SL)28Lpr/0 (involves: C57BL/6 CBA)	decreased circulating cholesterol level	J:128243
Tg(IGFBP1)2Miel/0 (involves: C57BL * CBA)	abnormal glucose homeostasis	J:128964
	impaired glucose tolerance	J:128964
	increased circulating glucose level	J:128964
	increased circulating insulin level	J:84652, J:128964
Tg(IGFBP2)1Miel/0 (FVB/N-Tg(IGFBP2)1Miel)	abnormal circulating insulin level	J:121961
	abnormal glucose homeostasis	J:121961
	decreased circulating glucose level	J:121961
	decreased circulating leptin level	J:121961
	decreased circulating triglyceride level	J:121961
	decreased susceptibility to diet-induced obesity	J:121961
	improved glucose tolerance	J:121961
	increased insulin sensitivity	J:121961
Tg(Igh-6/Igh-V125)2Jwt/0 Tg(Igk-C/Igk-V125)1Jwt/0 (NOD.B6-Tg(Igh-6/Igh-V125)2Jwt Tg(Igk-C/Igk-V125)1Jwt)	increased circulating glucose level	J:91865
Tg(Igh-Abl1)40Sco/0 (involves: C57BL/6JWehi * SJL/JWehi)	ascites	J:78204
Tg(Igh-HMGA2)#Cro/0 (FVB/N-Tg(Igh-HMGA2)#Cro)	increased circulating interleukin-6 level	J:233225
Tg(Igh-HMGA2)#Cro/0 (FVB/N-Tg(Igh-HMGA2)#Cro)	increased circulating tumor necrosis factor level	J:233225
Tg(Igh-Lmp2a)13FRdni/0 (involves: C57BL/6 * CD-1 * SJL)	dehydration	J:56614
Tg(Igh-TCL1A)1Ypek/0 (FVB/N-Tg(Igh-TCL1A)1Ypek)	abnormal circulating chemokine level	J:160184
Tg(Igh-TCL1A)1Ypek/0 (FVB/N-Tg(Igh-TCL1A)1Ypek)	increased circulating tumor necrosis factor level	J:160184
Tg(Igh-V-CD40lg)#Tsub/0 (C57BL/6-Tg(Igh-V-CD40lg)#Tsub)	increased urine protein level	J:128824
Tg(Igk-V21-Bax)1967Bvn/0 (involves: FVB/N)	increased urine protein level	J:89049
Tg(Igkv3-5-MYC)24Plbe/0 (C57BL/6J-Tg(Igkv3-5-MYC)DLoxP4Plbe/PlbeMmmh)	ascites	J:131912
Tg(Il1rn)1Dih/0 (involves: C57BL/6 * CBA)	decreased circulating interleukin-6 level	J:88605
Tg(Il1rn)1Dih/0 (involves: C57BL/6 * CBA)	decreased circulating serum amyloid protein level	J:61600
Tg(Il1rn)1Dih/Tg(Il1rn)1Dih (involves: C57BL/6 * CBA)	increased circulating interleukin-1 level	J:36387
Tg(Ins1-Cat,Tyr)25Pne/0 (involves: FVB)	decreased circulating glucose level	J:59275
Tg(Ins1-Cat,Tyr)25Pne/0 (involves: FVB)	increased insulin secretion	J:59275
Tg(Ins1-Cd80)378Psoh/0 Tg(Ins2-GP)#Psoh/0 (involves: C57BL/6 * FVB/N)	hyperglycemia	J:209714
Tg(Ins1-Cd80)378Psoh/0 Tg(Ins2-GP)#Psoh/0 Tg(TcrLCMV)327Sdz/0 (involves: C57BL/6 * DBA/2 * FVB/N)	hyperglycemia	J:209714
	ketosis	J:209714
Tg(Ins1-EGFP/GH1)14Hara/Tg(Ins1-EGFP/GH1)14Hara (NOD/ShiLtJ-Tg(Ins1-EGFP/GH1)14Hara)	decreased circulating insulin level	J:127015
	impaired glucose tolerance	J:127015
Tg(Ins1-GAS)1Sbr/0 (involves: FVB/NTac)	increased circulating gastrin level	J:59575, J:63579
Tg(Ins1-Kcnj11)#Nich/? (B6.Cg-Tg(Ins1-Kcnj11)#Nich)	increased insulin secretion	J:94610
Tg(Ins2-Akt1)3Mbb/0 (involves: C57BL/6 SJL)	abnormal insulin secretion	J:72216
	decreased circulating glucose level	J:72216
	decreased susceptibility to non-insulin-dependent diabetes	J:72216
	improved glucose tolerance	J:72216
	increased circulating insulin level	J:72216
Tg(Ins2-Akt1)3Mbb/0 (B6.Cg-Tg(Ins2-Akt1)3Mbb)	hypoglycemia	J:144599
	improved glucose tolerance	J:144599
	increased circulating insulin level	J:144599
Tg(Ins2-CD80)3B7Flv/? (involves: C57BL/6 * CBA/Ca * NOD/Caj)	increased circulating glucose level	J:26618
	increased urine glucose level	J:26618
Tg(Ins2-CD80)3B7Flv/0 Tg(Ins2-H2-Ea^d,Ins2-H2-Eb1^b)187-7Bri/0 (involves: C57BL/6 * CBA/Ca * SJL)	dehydration	J:93555
Tg(Ins2-CD80)3B7Flv/0 Tg(Ins2-Tnf)17Flv/0 (involves: C57BL/6 * CBA/Ca)	increased circulating glucose level	J:93555
Tg(Ins2-CD86)12B70Flv/0 Tg(Ins2-H2-Ea^d,Ins2-H2-Eb1^b)187-7Bri/0 (involves: C57BL/6 * CBA/Ca * SJL)	dehydration	J:93555
	increased circulating glucose level	J:93555
Tg(Ins2-CD86)12B70Flv/0 Tg(Ins2-Tnf)17Flv/0 (involves: C57BL/6 * CBA/Ca)	increased circulating glucose level	J:93555
Tg(Ins2-CDKN1B)1Maka/0 (involves: C57BL/6J)	decreased circulating insulin level	J:96047
Tg(Ins2-CDKN1B)1Maka/0 (involves: C57BL/6J)	hyperglycemia	J:96047
Tg(Ins2-Cebpb)2Maka/0 (involves: C57BL/6)	decreased circulating insulin level	J:156725
	decreased insulin secretion	J:156725
	increased circulating glucose level	J:156725
Tg(Ins2-Chrm3*)1Jwe/0 (involves: C57BL/6)	abnormal glucose homeostasis	J:129643
	hypoglycemia	J:129643
	improved glucose tolerance	J:129643
	increased circulating insulin level	J:129643
	increased insulin secretion	J:129643
Tg(Ins2-cre)23Herr/0 Tsc2^tm1Kido/Tsc2^tm1Kido (involves: 129S4/SvJae * C57BL/6 * C57BL/6J * CBA/J)	decreased circulating insulin level	J:135811
	hypoglycemia	J:135811
	improved glucose tolerance	J:135811
	increased circulating glucose level	J:135811
	increased circulating insulin level	J:135811
	increased insulin sensitivity	J:135811
Tg(Ins2-cre)25Mgn/0 (involves: C57BL/6 * DBA)	decreased insulin secretion	J:127051
Tg(Ins2-cre)25Mgn/0 (involves: C57BL/6 * DBA)	impaired glucose tolerance	J:127051
Tg(Ins2-cre)25Mgn/0 (either: (B6.Cg-Tg(Ins2-cre)25Mgn/J) or (involves: 129 * C57BL/6 * DBA/2))	abnormal circulating insulin level	J:108244
	abnormal insulin secretion	J:108244
	impaired glucose tolerance	J:108244
Tg(Ins2-GAD2)2Lt/0 (NOD/ShiLt-Tg(Ins2-GAD2)2Lt)	abnormal urine glucose level	J:100251
Tg(Ins2-GLUD1H454Y)1Csta/0 (involves: C57BL/6 SJL)	hypoglycemia	J:113458
Tg(Ins2-GLUD1H454Y)1Csta/0 (involves: C57BL/6 SJL)	increased insulin secretion	J:113458
Tg(Ins2-GLUD1H454Y)2Csta/0 (involves: C57BL/6 SJL)	abnormal insulin secretion	J:113458
Tg(Ins2-GLUD1H454Y)2Csta/0 (involves: C57BL/6 SJL)	hypoglycemia	J:113458
Tg(Ins2-GP)34-20Olds/0 (involves: BALB/c * C57BL/6)	decreased circulating insulin level	J:81287
Tg(Ins2-GP)34-20Olds/0 (involves: BALB/c * C57BL/6)	increased circulating glucose level	J:81287
Tg(Ins2-GP)#Psoh/0 (involves: C57BL/6)	hyperglycemia	J:81285
Tg(Ins2-GP)#Psoh/0 (involves: C57BL/6)	increased urine glucose level	J:81285
Tg(Ins2-GP)#Psoh/0 Tg(TcrLCMV)327Sdz/0 (involves: C57BL/6 * DBA/2)	hyperglycemia	J:81285
	increased urine glucose level	J:81285
Tg(Ins2-H2-Ea^d,Ins2-H2-Eb1^b)187-7Bri/0 (involves: C57BL/6 * SJL)	decreased insulin secretion	J:127706
	hyperglycemia	J:127706
	increased circulating glucose level	J:93555, J:127706
	increased circulating triglyceride level	J:127706
	ketoaciduria	J:127706
Tg(Ins2-HA)165Bri/0 Tg(TcraCl4,TcrbCl4)1Shrm/0 (involves: BALB/c * C57BL/6 * C57BL/10 * DBA/2)	hyperglycemia	J:99756
Tg(Ins2-HA)165Bri/? Tg(TcraCl4,TcrbCl4)1Shrm/? (involves: BALB/c * C57BL/6 * C57BL/10)	hyperglycemia	J:99756
Tg(Ins2-HBEGF)5Rin/? (C57BL/6-Tg(Ins2-HBEGF)5Rin)	decreased circulating insulin level	J:204420
	hyperglycemia	J:204420
	increased urine glucose level	J:204420
	ketoaciduria	J:204420
Tg(Ins2-Hnf1a)#Cbw/0 (involves: C57BL/6 * CBA/J)	decreased circulating insulin level	J:134757
	decreased insulin secretion	J:134757
	impaired glucose tolerance	J:134757
	increased circulating glucose level	J:134757
	increased glucagon secretion	J:134757
Tg(Ins2-IAPP)L13Gjsc/0 (FVB/N-Tg(Ins2-IAPP)L13Gjsc)	abnormal homeostasis	J:142009
	decreased circulating insulin level	J:142009
	decreased insulin secretion	J:142009
	hyperglycemia	J:142009
	impaired glucose tolerance	J:142009
	increased circulating glucagon level	J:142009
Tg(Ins2-IAPP)RHFSoel/Tg(Ins2-IAPP)RHFSoel (involves: FVB/N)	decreased circulating insulin level	J:130022
	decreased insulin secretion	J:130022
	hyperglycemia	J:130022
Tg(Ins2-Irs2)13Mfw/0 (involves: C57BL/6)	improved glucose tolerance	J:94000
	increased circulating insulin level	J:94000
	increased insulin secretion	J:94000
Tg(Ins2-Mir184)4Mnpy/0 (Not Specified)	decreased circulating insulin level	J:210552
	decreased insulin secretion	J:210552
	hyperglycemia	J:210552
Tg(Ins2-Mir184)96Mnpy/0 (Not Specified)	decreased insulin secretion	J:210552
Tg(Ins2-Mir184)96Mnpy/0 (Not Specified)	impaired glucose tolerance	J:210552
Tg(Ins2-Mirc13)E4Biat/0 (C57BL/6N-Tg(Ins2-Mirc13)E4Biat)	decreased circulating insulin level	J:314874
	decreased insulin secretion	J:314874
	hyperglycemia	J:314874
	ketoacidosis	J:314874
Tg(Ins2-Nos2)31Okam/0 (involves: C57BL/6 * CD-1 * DBA/2)	abnormal nitric oxide homeostasis	J:45520
	decreased circulating insulin level	J:45520
	hyperglycemia	J:45520
	increased urine glucose level	J:45520
	ketoaciduria	J:45520
Tg(Ins2-Nos2)40Okam/0 (involves: C57BL/6 * CD-1 * DBA/2)	abnormal nitric oxide homeostasis	J:45520
	decreased circulating insulin level	J:45520
	hyperglycemia	J:45520
	increased circulating ketone body level	J:45520
	increased urine glucose level	J:45520
Tg(Ins2-Nos2)40Okam/0 (involves: 129P2/OlaHsd * C57BL/6 * CD-1 * DBA/2)	albuminuria	J:116040
	hyperglycemia	J:116040
	increased circulating creatinine level	J:116040
Tg(Ins2-Nos2)40Okam/0 Tg(Kdr-AGER)102Hyam/0 (involves: C57BL/6J * CBA/J * CD-1 * DBA/2)	albuminuria	J:70495
	hyperglycemia	J:70495
	increased circulating creatinine level	J:70495
Tg(Ins2-NP)25-3Olds/0 (involves: BALB/c * C57BL/6)	decreased circulating insulin level	J:81287
Tg(Ins2-NP)25-3Olds/0 (involves: BALB/c * C57BL/6)	increased circulating glucose level	J:81284, J:81287
Tg(Ins2-OVA)307Wehi/0 Tg(TcraTcrb)1100Mjb/0 (involves: C57BL/6 * C57BL/6JWehi)	increased urine glucose level	J:99451
Tg(Ins2-rtTA)2Efr/0 Tg(tetO-Ago2)30Mnpy/0 (involves: C57BL/6 * CBA)	decreased insulin secretion	J:210552
	increased circulating glucose level	J:210552
Tg(Ins2-rtTA)2Efr/0 Tg(tetO-DTA)1Gfi/0 (involves: C57BL/6 * CBA)	hyperglycemia	J:127412
	improved glucose tolerance	J:127412
	increased circulating glucose level	J:127412
Tg(Ins2-rtTA)2Efr/0 Tg(tetO-Mir184)#Mnpy/0 (involves: C57BL/6 * CBA)	decreased circulating insulin level	J:210552
	impaired glucose tolerance	J:210552
	increased circulating glucose level	J:210552
Tg(Ins2-rtTA)2Efr/0 Tg(tetO-Sri)1Hhv/0 (involves: C57BL/6 * CBA)	improved glucose tolerance	J:246708
	increased circulating insulin level	J:246708
Tg(Ins2-rtTA)2Efr/0 Tg(tetO-Sri)10Hhv/0 (involves: C57BL/6 * CBA)	decreased fasting circulating glucose level	J:246708
	improved glucose tolerance	J:246708
	increased circulating insulin level	J:246708
Tg(Ins2-rtTA)2Efr/0 Tg(tetO-TAg)1Efr/0 (involves: C3HeB/FeJ * C57BL/6 * CBA)	hypoglycemia	J:130049
Tg(Ins2-TCF1P291)2Kya/0 (involves: C57BL/6 SJL)	decreased insulin secretion	J:73760
Tg(Ins2-TCF1P291)2Kya/0 (involves: C57BL/6 SJL)	hyperglycemia	J:73760
Tg(Ins-Igf2)1Fbos/0 (involves: C57BL/6 * SJL)	hyperglycemia	J:141527
	increased circulating free fatty acids level	J:141527
	increased circulating glucose level	J:141527
	increased circulating insulin level	J:141527
	increased circulating triglyceride level	J:141527
	increased insulin secretion	J:141527
	insulin resistance	J:141527
Tg(Ins-Igf2)1Fbos/0 (involves: C57BL/6 * C57BLKs/J * SJL)	hyperglycemia	J:141527
	increased circulating free fatty acids level	J:141527
	increased circulating insulin level	J:141527
	increased circulating triglyceride level	J:141527
	insulin resistance	J:141527
Tg(INS-Il10)#Sar/0 Tnfrsf1a^tm1Mak/Tnfrsf1a^tm1Mak (involves: 129S2/SvPas * C57BL/6J * NOD)	increased circulating glucose level	J:64051
Tg(INS-Il10)#Sar/0 Tnfrsf1b^tm1Mwm/Tnfrsf1b^tm1Mwm (involves: 129S2/SvPas * C57BL/6J * NOD)	increased circulating glucose level	J:64051
Tg(INS-MT2A,Tyr)1Pne/0 (FVB-Tg(INS-MT2A,Tyr)1Pne)	abnormal enzyme/coenzyme level	J:90564
Tg(INS-MT2A,Tyr)1Pne/0 (FVB-Tg(INS-MT2A,Tyr)1Pne)	hyperglycemia	J:90564
Tg(Itgam-FCAR)83Rcmo/0 (involves: C57BL/6 * NOD)	albuminuria	J:120534
Tg(Itgam-FCAR)83Rcmo/0 (involves: C57BL/6 * NOD)	hematuria	J:120534
Tg(Itgax-TGFBR2)1Flv/0 (C.Cg-Tg(Itgax-TGFBR2)1Flv)	abnormal interferon level	J:98953
Tg(IVL-KLK5)#Hov/0 (involves: C57BL/6 * CBA)	abnormal circulating cytokine level	J:210758
Tg(IVL-KLK5)#Hov/0 (involves: C57BL/6 * CBA)	impaired skin barrier function	J:210758
Tg(JAK2V617F)FF1Rsko/0 Tg(Tek-cre)1Arnd/0 (involves: C57BL/6 CBA * DBA/2)	abnormal blood coagulation	J:206659
	abnormal blood homeostasis	J:206659
	decreased platelet aggregation	J:206659
	decreased susceptibility to induced thrombosis	J:206659
	increased bleeding time	J:206659
Tg(K5-Ptgs2)19Kmd/0 (involves: NMRI)	increased prostaglandin level	J:70039
Tg(K5-Ptgs2)667Kmd/0 (involves: NMRI)	increased prostaglandin level	J:70039
Tg(K5-Ptgs2)675Kmd/0 (involves: NMRI)	increased prostaglandin level	J:70039
Tg(K18-ACE2)2Prlmn/0 (B6.Cg-Tg(K18-ACE2)2Prlmn/J)	abnormal brain thrombosis	J:294084
	abnormal chemokine level	J:302313
	abnormal circulating chemokine level	J:294084
	abnormal circulating cytokine level	J:302313
	abnormal cytokine level	J:294084, J:302313
	abnormal interferon level	J:300960, J:302313
	abnormal interleukin level	J:300960, J:302313
	abnormal tumor necrosis factor level	J:300960, J:302313
	cerebral edema	J:302313
	increased circulating CXCL10 level	J:302313
	increased circulating interferon-gamma level	J:302313
	increased circulating interleukin-6 level	J:294084
	increased circulating interleukin-10 level	J:294084, J:302313
	increased circulating tumor necrosis factor level	J:294084
	increased CXCL10 level	J:300960
	pulmonary edema	J:300960
Tg(KB1430A10)1Ped/0 (involves: BALB/cJ * C57BL/6)	abnormal phospholipid level	J:117028
	decreased cholesterol level	J:117028
	decreased liver triglyceride level	J:117028
	decreased triglyceride level	J:117028
Tg(KRT5-IKBKB)2Armz/0 (involves: C57BL/6 * DBA/2)	abnormal cytokine level	J:160072
	increased circulating interferon-gamma level	J:160072
	increased circulating interleukin-1 alpha level	J:160072
	increased circulating interleukin-2 level	J:160072
	increased circulating interleukin-4 level	J:160072
	increased circulating interleukin-5 level	J:160072
	increased circulating interleukin-6 level	J:160072
	increased circulating interleukin-10 level	J:160072
	increased circulating tumor necrosis factor level	J:160072
Tg(KRT5-rtTA)1Glk/0 Tg(tetO/CMV-Tslp)#Sfz/0 (involves: C3H * C57BL/6 * FVB/N)	abnormal cytokine level	J:100506
	epidermal spongiosis	J:100506
Tg(KRT5-rtTA)1Glk/0 Tg(tetO/CMV-Tslp)#Sfz/0 (C.Cg-Tg(KRT5-rtTA)1Glk Tg(tetO/CMV-Tslp)#Sfz)	increased circulating interleukin-4 level	J:182756
Tg(KRT5-tTA)1216Glk/0 Tg(tetO-Il13)1Tazh/0 (B6.Cg-Tg(KRT5-tTA)1216Glk Tg(tetO-Il13)1Tazh)	epidermal spongiosis	J:150232
Tg(KRT14-CASP1)1Miz/0 (involves: C57BL/6)	increased circulating histamine level	J:78602
	increased circulating interleukin-18 level	J:78602, J:79706
	skin edema	J:78602
Tg(KRT14-FLT4/IGHG1)#Ali/0 (either: (involves: FVB/N) or (involves: BALB/c * DBA))	abnormal chloride level	J:201429
	abnormal sodium ion homeostasis	J:201429
Tg(KRT14-Il1f6)1Hblu/? (involves: C57BL/6 * DBA/2)	abnormal chemokine level	J:126327
Tg(KRT14-Il4)#Lsch/0 (involves: BALB/cBy * C57BL/6)	epidermal spongiosis	J:126285
Tg(KRT14-Il18)#Knak/0 (C57BL/6-Tg(KRT14-Il18)#Knak)	increased circulating histamine level	J:78602
Tg(KRT14-Il18)#Knak/0 (C57BL/6-Tg(KRT14-Il18)#Knak)	increased circulating interleukin-18 level	J:78602
Tg(KRT14-Prss8)1Hum/? (involves: C57BL/6 * DBA/2)	impaired skin barrier function	J:189278
Tg(KRT14-Prss8)2Hum/? (involves: C57BL/6 * DBA/2)	impaired skin barrier function	J:189278
Tg(Krt14-Rac1*G12V)#Mrnk/0 (involves: CBA/CaJ)	abnormal circulating interleukin level	J:237134
Tg(Krt14-Rac1*G12V)#Mrnk/0 (involves: CBA/CaJ)	skin edema	J:237134
Tg(KRT14-Vegfa)3Dtm/0 (FVB/N-Tg(KRT14-Vegfa)3Dtm)	skin edema	J:92643
Tg(KRT14-VP16/NR1I2)13Sdub/? (involves: C57BL/6)	abnormal intercellular signaling peptide or protein level	J:258435
	abnormal pH regulation	J:258435
	impaired skin barrier function	J:258435
Tg(KRT18*R89C)22Rgo/0 (involves: FVB/N)	increased circulating alanine transaminase level	J:241700
Tg(KRT18*R89C)22Rgo/0 (involves: FVB/N)	increased circulating aspartate transaminase level	J:241700
Tg(KRT18*R89C)30Rgo/0 (involves: FVB/N)	increased circulating alanine transaminase level	J:241700
Tg(KRT18*R89C)30Rgo/0 (involves: FVB/N)	increased circulating aspartate transaminase level	J:241700
Tg(KRT18*R89C)50Rgo/0 (involves: FVB/N)	increased circulating alanine transaminase level	J:241700
Tg(KRT18*R89C)50Rgo/0 (involves: FVB/N)	increased circulating aspartate transaminase level	J:241700
Tg(KRT18-DPP4)3Pbmj/0 (involves: C57BL/6J * SJL/J)	pulmonary alveolar edema	J:285467
Tg(KRT19-TAg)7Eps/0 (involves: FVB/N)	increased blood urea nitrogen level	J:64395
Tg(Lcat)1Ssf/Tg(Lcat)1Ssf (C57BL/6-Tg(Lcat)1Ssf)	increased circulating cholesterol level	J:94077
	increased circulating HDL cholesterol level	J:94077
	increased circulating phospholipid level	J:94077
Tg(LCAT)A31Ssf/0 (C57BL/6N-Tg(LCAT)A31Ssf)	increased circulating cholesterol level	J:118356
	increased circulating HDL cholesterol level	J:118356
	increased circulating phospholipid level	J:118356
Tg(LCAT)A31Ssf/Tg(LCAT)A31Ssf (C57BL/6N-Tg(LCAT)A31Ssf)	abnormal circulating apolipoprotein E level	J:118356
	abnormal circulating apolipoprotein level	J:118356
	increased circulating cholesterol level	J:118356
	increased circulating HDL cholesterol level	J:118356
	increased circulating phospholipid level	J:118356
Tg(LCAT)T59Ssf/0 (C57BL/6N-Tg(LCAT)T59Ssf)	increased circulating cholesterol level	J:118356
Tg(LCAT)T59Ssf/0 (C57BL/6N-Tg(LCAT)T59Ssf)	increased circulating HDL cholesterol level	J:118356
Tg(Lck-Tnfsf14)24Yxf/? (C57BL/6-Tg(Lck-Tnfsf14)24Yxf)	abnormal complement protein level	J:128976
	hematuria	J:128976
	increased circulating cholesterol level	J:120962
	increased circulating triglyceride level	J:120962
	increased urine protein level	J:128976
Tg(Lck-Tnfsf14)24Yxf/? Tnfrsf14^tm1Kpf/Tnfrsf14^tm1Kpf (involves: 129P2/OlaHsd * C57BL/6)	increased circulating cholesterol level	J:120962
Tg(Lck-Tnfsf15,-EGFP)#Targ/0 (involves: C57BL/6)	joint swelling	J:169462
Tg(Lck-Tslp)1Chea/0 (B6.Cg-Tg(Lck-Tslp)1Chea)	abnormal glomerular capillary thrombosis	J:72982
	albuminuria	J:72982
	increased blood urea nitrogen level	J:72982
Tg(LckIl4)1315Dbl/0 (involves: C57BL/6J * DBA/2J)	increased circulating phosphate level	J:107359
Tg(LIPC)6784His/0 (C57BL/6-Tg(LIPC)6784His)	decreased circulating HDL cholesterol level	J:48486
	decreased circulating phospholipid level	J:48486
	decreased circulating triglyceride level	J:48486
Tg(LIPG)1Tq/0 (involves: C57BL/6)	abnormal circulating phospholipid level	J:81821
	decreased circulating cholesterol level	J:81821
	decreased circulating HDL cholesterol level	J:81821
	decreased triglyceride level	J:81821
Tg(Lrrk2G2019S)2Yue/0 (involves: C3H C57BL/6 * C57BL/6J)	decreased dopamine level	J:157931
Tg(Mafg-Nfe2l1)1Mym/0 (involves: C57BL/6J * DBA/2)	abnormal blood homeostasis	J:230118
	abnormal glucose homeostasis	J:230118
	decreased circulating ammonia level	J:230118
	hyperglycemia	J:230118
	increased circulating insulin level	J:230118
	increased susceptibility to diet-induced non-insulin dependent diabetes	J:230118
	insulin resistance	J:230118
Tg(Mafg-Nfe2l1)6Mym/0 (involves: C57BL/6J * DBA/2)	hyperglycemia	J:230118
	increased circulating insulin level	J:230118
	increased susceptibility to diet-induced non-insulin dependent diabetes	J:230118
	insulin resistance	J:230118
Tg(Mbp-Pad2)28Fgm/0 (involves: CD-1)	abnormal tumor necrosis factor level	J:142650
Tg(Mc2r-Arntl)1Kyki/0 (C57BL/6J-Tg(Mc2r-Arntl)1Kyki)	abnormal circadian hormone homeostasis	J:146305
	abnormal circulating corticosterone level	J:146305
	abnormal corticosterone level	J:146305
Tg(MECP2)1Hzo/0 (either: (FVB/N x 129S6/SvEvTac)F1 or (FVB/N x C57BL/6J)F1)	abnormal corticosterone level	J:181213
Tg(ML5sHEL)5Ccg/0 (C57BL/6-Tg(ML5sHEL)5Ccg)	abnormal circulating protein level	J:78308
Tg(MMTV-NCOA3)#Mybr/0 (FVB/N-Tg(MMTV-NCOA3)#Mybr)	increased circulating insulin-like growth factor I level	J:93548
Tg(MMTV-PyVT)#Mul/0 (B6.FVB-Tg(MMTV-PyVT)#Mul)	abnormal circulating cytokine level	J:147923
Tg(MMTV-PyVT)#Mul/0 (B6.FVB-Tg(MMTV-PyVT)#Mul)	increased circulating tumor necrosis factor level	J:147923
Tg(Mpz)80.2Wra/0 (involves: FVB/N)	increased collagen level	J:78758
Tg(Mt1)174Bri/0 (involves: C57BL/6 * SJL)	abnormal mineral level	J:29102
Tg(Mt1-GH1)#Jjk/0 (C57BL/6J-Tg(Mt1-GH1)#Jjk)	decreased circulating adiponectin level	J:132437
Tg(Mt1-GH1)#Jjk/0 (C57BL/6J-Tg(Mt1-GH1)#Jjk)	decreased circulating leptin level	J:132437
Tg(Mt1-IL6)28Gci/0 (involves: C57BL/6 * DBA/2)	increased blood urea nitrogen level	J:177825, J:18424
	increased circulating interleukin-6 level	J:177825
	increased circulating serum amyloid protein level	J:177825
	increased urine protein level	J:177825, J:18424
	pulmonary edema	J:18424
Tg(Mt1-LDLR)93-4Reh/0 (involves: C57BL/6 * SJL)	decreased circulating cholesterol level	J:127519
Tg(Mt1-LDLR)93-4Reh/0 (involves: C57BL/6 * SJL)	decreased circulating LDL cholesterol level	J:127519
Tg(Mt1a-GPHB5)1Sok/0 (involves: C57BL/6)	increased circulating thyroxine level	J:105176
Tg(MT2A-TGFBR2)4Rser/0 (involves: C57BL/6 * DBA)	calcinosis	J:44579
Tg(MtTGFA)42Lmb/0 (involves: CD-1)	increased noradrenaline level	J:127695
Tg(MtTGFA)42Lmb/0 (involves: CD-1)	increased serotonin level	J:127695
Tg(Mup3-Plau)350-2Eps/0 (involves: C57BL/6)	increased circulating alanine transaminase level	J:66132
Tg(Mup3-Plau)350-2Eps/0 (involves: C57BL/6 * FVB/N)	subcutaneous edema	J:66132
Tg(Mup3-Plau)350-2Eps/? (C57BL/6-Tg(Mup3-Plau)350-2Eps)	abnormal circulating alanine transaminase level	J:233146
	increased liver cholesterol level	J:233146
	increased liver free fatty acids level	J:233146
	increased liver triglyceride level	J:233146
Tg(Myh6)1Lnwd/0 (involves: C57BL/6 FVB/N)	abnormal cardiac thrombosis	J:55938
Tg(Myh6)1Lnwd/Tg(Myh6)1Lnwd (involves: C57BL/6 * FVB/N)	abnormal cardiac thrombosis	J:55938
Tg(Myh6-1810058I24Rik)#Eno/0 (involves: C57BL/6)	abnormal atrial thrombosis	J:325962
Tg(Myh6-Acsl1)O7Jesc/0 (FVB/N-Tg(Myh6-Acsl1)O7Jesc)	abnormal lipid level	J:68639
	abnormal phospholipid level	J:68639
	cyanosis	J:68639
	increased cardiac muscle triglyceride level	J:68639
Tg(Myh6-ACTC1E99K)#Sbm/0 (involves: C57BL/10 CBA/Ca)	pleural effusion	J:175388
Tg(Myh6-ADRB1)4Mjlo/0 (FVB/N-Tg(Myh6-ADRB1)4Mjlo)	ascites	J:55719
Tg(Myh6-ANKRD1)#Camm/0 (involves: FVB)	abnormal atrial thrombosis	J:302922
Tg(Myh6-Bclaf1)#Cya/0 (Not Specified)	increased circulating lactate dehydrogenase level	J:301260
Tg(Myh6-BRUNOL4*)10Coop/0 (involves: FVB)	abnormal atrial thrombosis	J:99369
Tg(Myh6-CACNA1C)M1Aschw/0 (involves: FVB/N)	abnormal atrial thrombosis	J:134761
	ascites	J:134761
	edema	J:134761
	pulmonary edema	J:134761
Tg(Myh6-Camk2d_ic)LJhb/0 (either: (involves: Black Swiss) or (involves: C57BL/6))	abnormal atrial thrombosis	J:130644
	edema	J:130644
	pleural effusion	J:130644
Tg(Myh6-Camk2d_ic)MJhb/0 (either: (involves: Black Swiss) or (involves: C57BL/6))	abnormal atrial thrombosis	J:130644
	edema	J:130644
	pleural effusion	J:130644
Tg(Myh6-CASQ2)1Mord/0 (Not Specified)	abnormal calcium ion homeostasis	J:46786
Tg(Myh6-CASQ2)1Mord/0 (Not Specified)	abnormal fluid regulation	J:46786
Tg(Myh6-cre)TG9Pjay/0 (involves: FVB/N)	abnormal atrial thrombosis	J:198043
	ascites	J:198043
	edema	J:198043
	pleural effusion	J:198043
Tg(Myh6-CREB1*S133A)1Jml/0 (involves: CD-1)	abnormal atrial thrombosis	J:133881
	abnormal thrombosis	J:133881
	ascites	J:133881
	edema	J:133881
Tg(Myh6-CryabR120G)708Rbns/0 (FVB/N-Tg(Myh6-CryabR120G)708Rbns)	abnormal atrial thrombosis	J:133093
	ascites	J:133093
	pleural effusion	J:133093
	subcutaneous edema	J:133093
Tg(Myh6-CRYAB*R120G)7302Ijb/0 (involves: C57BL/6)	abnormal atrial thrombosis	J:126781
	edema	J:126781
	increased glutathione level	J:126781
Tg(Myh6-EGFR)9-12Iko/0 (involves: C57BL/6 DBA/2)	abnormal blood homeostasis	J:182337
Tg(Myh6-EGFR)9-12Iko/0 (involves: C57BL/6 DBA/2)	decreased growth hormone level	J:182337
Tg(Myh6-GAL4)G#2Vmc/0 (FVB-Tg(Myh6-GAL4)G#2Vmc)	pleural effusion	J:330678
Tg(Myh6-GFP,MAP2K3)58Ywa/? Myl2^tm1(cre)Krc/Myl2⁺ (involves: 129S1/Sv * 129X1/SvJ)	pulmonary edema	J:72242
Tg(Myh6-GFP,MAP2K6)8Ywa/? Myl2^tm1(cre)Krc/Myl2⁺ (involves: 129S1/Sv * 129X1/SvJ)	pulmonary edema	J:72242
Tg(Myh6-Gnaq)25Gwd/0 Tg(Myh6-Gnaq)40Gwd/0 (involves: FVB/N)	pleural effusion	J:41949
Tg(Myh6-GnaqQ209L)44Ejne/Tg(Myh6-GnaqQ209L)44Ejne (involves: FVB)	abnormal atrial thrombosis	J:127756
Tg(Myh6-Gnaq*Q209L)52Ejne/? (involves: FVB)	abnormal atrial thrombosis	J:204274
Tg(Myh6-GnaqQ209L/Esr1)7Rzl/0 (involves: C57BL/6)	edema	J:104100
Tg(Myh6-Grem2)1Akh/0 (involves: C57BL/6)	decreased transforming growth factor beta level	J:250034
Tg(Myh6-HBEGF)#Iko/0 (involves: C57BL/6 * DBA/2)	abnormal atrial thrombosis	J:93335
Tg(Myh6-Med13)1Eno/0 (B6.Cg-Tg(Myh6-Med13)1Eno)	abnormal circulating cholesterol level	J:186193
	abnormal liver triglyceride level	J:186193
	decreased susceptibility to diet-induced obesity	J:186193
	improved glucose tolerance	J:186193
	increased carbon dioxide production	J:186193
	increased oxygen consumption	J:186193
Tg(Myh6-Mef2d)2Eno/0 (Not Specified)	abnormal thrombosis	J:130825
Tg(Myh6-MT2A)15Pne/? (involves: FVB)	increased circulating insulin level	J:126583
Tg(Myh6-Mtpn)4Ssen/0 (involves: FVB)	edema	J:89823
Tg(Myh6-Mtpn)4Ssen/0 (involves: FVB)	pleural effusion	J:89823
Tg(Myh6-Murc)#Tue/0 (Not Specified)	abnormal atrial thrombosis	J:136004
Tg(Myh6-MYL3*E143K)2Dsc/0 (Not Specified)	increased hydroxyproline level	J:258831
Tg(Myh6-Pfkfb3)7Pne/0 (FVB-Tg(Myh6-Pfkfb3)7Pne)	abnormal glucose homeostasis	J:94475
Tg(Myh6-Pfkfb3)7Pne/0 (FVB-Tg(Myh6-Pfkfb3)7Pne)	increased cardiac muscle glycogen level	J:94475
Tg(Myh6-Pln*R9C)#Ces/0 (involves: FVB/N)	cyanosis	J:82353
	pericardial effusion	J:82353
	pleural effusion	J:82353
Tg(Myh6-Ppara)402-2Dpk/0 (involves: C57BL/6 * CBA/J)	abnormal lipid level	J:110580
Tg(Myh6-Ppara)402-2Dpk/0 (involves: C57BL/6 * CBA/J)	increased fatty acids level	J:110580
Tg(Myh6-Ppara)404-3Dpk/0 (involves: C57BL/6 * CBA/J)	abnormal lipid level	J:110580
Tg(Myh6-Ppara)404-3Dpk/0 (involves: C57BL/6 * CBA/J)	increased fatty acids level	J:110580
Tg(Myh6-Ppara)404-4Dpk/0 (involves: C57BL/6 * CBA/J)	abnormal lipid level	J:110580
Tg(Myh6-Ppara)404-4Dpk/0 (involves: C57BL/6 * CBA/J)	increased fatty acids level	J:110580
Tg(Myh6-Ppard)HEDpk/0 (involves: C57BL/6 * CBA)	increased cardiac muscle glycogen level	J:130750
Tg(Myh6-Ppp3ca)37Eno/0 (involves: FVB)	pulmonary edema	J:93176
Tg(Myh6-Prkaa2D157A)1Rti/0 Tg(Myh6-PRKAG2T400N)1Feah/0 (involves: FVB)	increased cardiac muscle glycogen level	J:123005
Tg(Myh6-Prkaca)2Eno/0 (Not Specified)	abnormal atrial thrombosis	J:263774
Tg(Myh6-Prkaca)2Eno/0 (Not Specified)	anasarca	J:263774
Tg(Myh6-Prkaca)33Eno/0 (Not Specified)	abnormal atrial thrombosis	J:263774
Tg(Myh6-Prkaca)33Eno/0 (Not Specified)	edema	J:263774
Tg(Myh6-PRKAG2)2Dca/0 (involves: C57BL/10 * CBA/Ca)	increased cardiac muscle glycogen level	J:108517
Tg(Myh6-PRKAG2*N488I)4623Jse/0 (involves: FVB)	increased cardiac muscle glycogen level	J:128648
Tg(Myh6-PRKAG2*R302Q)#Rro/0 (involves: FVB)	increased cardiac muscle glycogen level	J:108102
Tg(Myh6-PRKAG2R531G)22Dca/0 (involves: C57BL/10 CBA/Ca)	abnormal glycogen homeostasis	J:108517
Tg(Myh6-PRKAG2R531G)22Dca/0 (involves: C57BL/10 CBA/Ca)	increased cardiac muscle glycogen level	J:108517
Tg(Myh6-PRKAG2*T400N)1Feah/0 (involves: FVB/N)	increased cardiac muscle glycogen level	J:123005
Tg(Myh6-rtTA)8585Jam/0 Tg(Myh6/tetO-SCN5AF1759A)#Marx/0 (involves: C57BL/6 * CBA * FVB/NTac)	increased cardiac muscle glycogen level	J:229825
Tg(Myh6-Rxra)41Pcn/0 (Not Specified)	abnormal cardiac thrombosis	J:60351
Tg(Myh6-Rxra)41Pcn/0 (Not Specified)	pleural effusion	J:60351
Tg(Myh6-SLC2A1)54Rti/0 (FVB-Tg(Myh6-SLC2A1)54Rti)	increased cardiac muscle glycogen level	J:106467
Tg(Myh6-Sln)26Peri/0 (involves: C57BL/6)	abnormal calcium ion homeostasis	J:108309
Tg(Myh6-Snai1)B10Jcc/Tg(Myh6-Snai1)B10Jcc (Not Specified)	ascites	J:126850
Tg(Myh6-STK4)28Jusa/0 (involves: C57BL/6)	abnormal atrial thrombosis	J:139414
Tg(Myh6-STK4)28Jusa/0 (involves: C57BL/6)	edema	J:139414
Tg(Myh6-TEAD4)3Afrs/0 (involves: FVB)	abnormal atrial thrombosis	J:112740
Tg(Myh6-Tmod1)65Msus/Tg(Myh6-Tmod1)65Msus (involves: FVB/N)	abnormal atrial thrombosis	J:107823
Tg(Myh6-Tmod1)65Msus/Tg(Myh6-Tmod1)65Msus (FVB/N-Tg(Myh6-Tmod1)65Msus)	anasarca	J:58879
Tg(Myh6-Tnf)1Brgi/? (involves: C57BL/6J * SJL)	abnormal atrial thrombosis	J:100006
Tg(Myh6-Tnf)2Brgi/? (involves: C57BL/6J * SJL)	abnormal atrial thrombosis	J:100006
Tg(Myh6-TNNT2*R141W)#Lian/0 (involves: C57BL/6J)	abnormal thrombosis	J:211769
Tg(Myh6-Tpm1*D175N)#Dfw/0 (Not Specified)	abnormal atrial thrombosis	J:57365
Tg(Myh6-Tpm1*E54K)67Dfw/0 (involves: FVB/N)	edema	J:137813
Tg(Myh6-Tpm1*E180G)57Dfw/0 (involves: FVB/N)	abnormal atrial thrombosis	J:127507
Tg(Myh6-Tpm1*E180G)57Dfw/0 (involves: FVB/N)	abnormal calcium ion homeostasis	J:171021
Tg(Myh6-tTA)6Smbf/0 Tg(tetO-DTA)1Gfi/0 (involves: C57BL/6 * CBA)	abnormal atrial thrombosis	J:128617
Tg(Myh6-tTA)6Smbf/0 Tg(tetO-HDAC5)1Eno/0 (involves: C3H C57BL/6 * CBA)	abnormal lipid level	J:81967
Tg(Myh6-tTA)6Smbf/0 Tg(tetO-NOS2,-lacZ)240iMhus/0 (involves: C57BL/6 * CBA)	edema	J:132082
Tg(Myh6-tTA)6Smbf/0 Tg(tetO-TPR/MET,-EGFP)12Tcre/0 (FVB.Cg-Tg(Myh6-tTA)6Smbf Tg(tetO-TPR/MET,-EGFP)12Tcre)	ascites	J:241276
	cyanosis	J:241276
	pulmonary edema	J:241276
Tg(Myh6-tTA)6Smbf/0 Tg(tetORo1-lacZ)3Conk/0 (FVB.Cg-Tg(Myh6-tTA)6Smbf Tg(tetORo1-lacZ)3Conk)	ascites	J:107363
	dehydration	J:107363
	edema	J:107363
	pleural effusion	J:107363
Tg(Myh6-tTA)55Rbns/0 Tg(Myh6/tetO-PRKAG2*N488I)1Chib/0 (Not Specified)	increased cardiac muscle glycogen level	J:145090
Tg(Myh7-Phc1)#Yota/0 (involves: C57BL/6)	abnormal atrial thrombosis	J:75968
	ascites	J:75968
	edema	J:75968
	pleural effusion	J:75968
Tg(Myh7-Ptpn11Q79R)11Rbns/0 (FVB.Cg-Tg(Myh7-Ptpn11Q79R)11Rbns)	abnormal atrial thrombosis	J:123963
Tg(Myh7-RARA/lacZ)30Mcco/0 (Not Specified)	abnormal atrial thrombosis	J:146424
Tg(Myh7-RARA/lacZ)32Mcco/0 (Not Specified)	abnormal atrial thrombosis	J:146424
Tg(Myl1-Prkag3R225Q)1Sson/0 (involves: C57BL/6J CBA)	abnormal glucose homeostasis	J:92821
	abnormal triglyceride level	J:92821
	increased skeletal muscle glycogen level	J:92821
Tg(Myl2-FGF19)1Dfre/? (involves: FVB)	abnormal energy homeostasis	J:76323
	decreased circulating glucagon level	J:76323
	decreased circulating glucose level	J:76323
	decreased circulating insulin level	J:76323
	decreased circulating insulin-like growth factor I level	J:76323
	decreased circulating leptin level	J:76323
	decreased liver triglyceride level	J:76323
	decreased skeletal muscle triglyceride level	J:76323
	decreased susceptibility to diet-induced obesity	J:76323
	improved glucose tolerance	J:76323
	increased body temperature	J:76323
	increased energy expenditure	J:76323
	increased insulin sensitivity	J:76323
	increased oxygen consumption	J:76323
Tg(Myl2SLC2A1)2Mue/0 (involves: C57BL/6 * SJL)	decreased circulating glucose level	J:93868
Tg(Myog-Ppargc1a_i4)#Brsp/0 (Not Specified)	decreased susceptibility to diet-induced obesity	J:211329
Tg(Neph1-Vegfa)1Seq/0 (Not Specified)	albuminuria	J:82440
Tg(Nes-cre)1Kln/0 (involves: C57BL/6 * SJL)	increased insulin sensitivity	J:207713
Tg(Nes-cre)1Kln/0 Wdr45b^{tm1c(EUCOMM)Hmgu}/Wdr45b^{tm1c(EUCOMM)Hmgu} (involves: C57BL/6 * SJL)	increased brain iron level	J:298097
Tg(Neurog3-cre)C1Able/0 Tg(RNU6-EGFP,-RNAi:Dpp7)#Bhub/0 (involves: 129 * C57BL/6 * CD-1)	hyperglycemia	J:158215
	impaired glucose tolerance	J:158215
	increased circulating glucose level	J:158215
	increased circulating insulin level	J:158215
	insulin resistance	J:158215
Tg(Nphs1-ACE2)#Kdbu/0 (FVB//N-Tg(Nphs1-ACE2)#Kdbu)	abnormal susceptibility to non-insulin-dependent diabetes	J:198181
Tg(Nphs1-ACE2)#Kdbu/0 (FVB//N-Tg(Nphs1-ACE2)#Kdbu)	decreased circulating triglyceride level	J:198181
Tg(Nphs1-IL2RA)18Mska/0 (B6N.Cg-Tg(Nphs1-IL2RA)18Mska)	ascites	J:127013
	decreased circulating total protein level	J:127013
	edema	J:127013
	increased urine protein level	J:127013, J:240316
Tg(Nphs1-Ptgs2)14Rhrs/0 (involves: C57BL/6 * DBA/2)	albuminuria	J:179350, J:148158
Tg(Nphs1-rtTA3G)8Jhm/0 Tg(tetO-GFP,-APOL1)#Susz/0 (involves: C57BL/6J * CBA/J * FVB/N)	albuminuria	J:251848
	increased blood urea nitrogen level	J:251848
	increased circulating creatinine level	J:251848
	uremia	J:251848
Tg(Nphs1-rtTA3G)8Jhm/0 Tg(tetO-GFP,-APOL1S342GI384M)#Susz/0 (involves: C57BL/6J CBA/J * FVB/N)	albuminuria	J:251848
Tg(NPHS2-rtTA2*M2)1Jbk/0 Tg(tetO-RNAi:Vegfa)#Atuf/0 (involves: FVB)	decreased urine creatinine level	J:189626
	increased circulating creatinine level	J:189626
	increased urine protein level	J:189626
Tg(NPHS2-Trpc6)F419Walz/0 (involves: C57BL/6J * CBA/J)	albuminuria	J:165112
Tg(NPHS2-Trpc6E896K)F75aWalz/0 (involves: C57BL/6J CBA/J)	albuminuria	J:165112
Tg(NPHS2-Trpc6P111Q)F615Walz/0 (involves: C57BL/6J CBA/J)	albuminuria	J:165112
Tg(NPPA-Bmp10)1Krc/0 (Not Specified)	edema	J:89404
Tg(PAH-INSR)1Rjv/0 (involves: C57BL/6 * CBA)	hypoglycemia	J:80773
Tg(PAH-INSR)1Rjv/0 (involves: C57BL/6 * CBA)	improved glucose tolerance	J:80773
Tg(PDGF-S100B)36Cqin/0 (C57BL/6-Tg(PDGF-S100B)36Cqin)	increased dopamine level	J:173682
Tg(PDGFB-GPR37)20Ryot/0 (involves: C57BL/6)	increased dopamine level	J:128745
Tg(PDGFB-LRRK2G2019S)340Djmo/0 (involves: C3H/HeJ C57BL/6J)	abnormal homeostasis	J:171645
	increased serotonin level	J:171645
Tg(PDGFB-LRRK2R1441C)574Djmo/0 (involves: C3H/HeJ C57BL/6J)	decreased circulating noradrenaline level	J:171645
	decreased dopamine level	J:171645
Tg(PDGFB-SNCA)4Ema/0 (involves: C57BL/6 * DBA/2)	decreased dopamine level	J:227112
Tg(PDGFB-SNCA*A53T)8Ema/0 (Not Specified)	decreased serotonin level	J:226922
Tg(PDGFB-UCHL1*I93M)HWada/? (involves: C57BL/6J)	decreased nervous system dopamine level	J:128045
Tg(Pdx1-Ffar1)AHeed/0 (Not Specified)	decreased insulin secretion	J:129843
Tg(Pdx1-Ffar1)AHeed/0 (Not Specified)	impaired glucose tolerance	J:129843
Tg(PF4-tTA/VP16)42Kra/0 Tg(tetO-Aurkb,lacZ)41Kra/0 (FVB/NJ-Tg(tetO-Aurkb,lacZ)41Kra Tg(PF4-tTA/VP16)42Kra)	abnormal platelet physiology	J:104239
Tg(PGK1-FTL*)#Sle/0 (involves: FVB/N)	abnormal iron homeostasis	J:227451
Tg(PGK1-FTL*)#Sle/0 (involves: FVB/N)	increased brain iron level	J:227451
Tg(PGK1-FTL)#Sle/0 (B6J.FVB-Tg(PGK1-FTL)#Sle)	decreased circulating ferritin level	J:227451
Tg(PGK1-FTL)#Sle/0 (B6J.FVB-Tg(PGK1-FTL)#Sle)	increased brain iron level	J:227451, J:226967
Tg(Pkd1)6Mtru/0 (involves: C57BL/6J * CBA/J)	decreased urine creatinine level	J:157952
	decreased urine urea nitrogen level	J:157952
	hematuria	J:157952
	increased blood osmolality	J:157952
	increased circulating sodium level	J:157952
	increased urine osmolality	J:157952
	increased urine protein level	J:157952
Tg(Pkd1)18Mtru/0 (involves: C57BL/6J * CBA/J)	increased urine protein level	J:157952
Tg(Pkd1)26Mtru/0 (involves: C57BL/6J * CBA/J)	decreased urine protein level	J:157952
	hematuria	J:157952
	increased blood osmolality	J:157952
	increased circulating phosphate level	J:157952
	increased circulating sodium level	J:157952
	increased urine protein level	J:157952
Tg(Pkd1)39Mtru/0 (involves: C57BL/6J CBA/J)	abnormal ion homeostasis	J:198147
	decreased urine creatinine level	J:198147
	decreased urine osmolality	J:198147
	decreased urine urea nitrogen level	J:198147
	increased blood urea nitrogen level	J:198147
	increased circulating creatinine level	J:198147
	increased urine protein level	J:198147
Tg(Pklr-SV40)1Ak/0 (involves: C57BL/6 * DBA)	abnormal glucose homeostasis	J:185488
Tg(Plp1-LMNB1)1108Qsp/0 (involves: FVB/N)	abnormal lipid level	J:226169
	abnormal phospholipid level	J:226169
	abnormal sphingomyelin level	J:226169
	decreased cholesterol level	J:226169
Tg(PLTP)1Pgn/0 (C57BL/6J-Tg(PLTP)1Pgn/J)	abnormal circulating cholesterol level	J:92804
	decreased circulating cholesterol level	J:92804
	decreased circulating LDL phospholipid level	J:92804
	decreased circulating VLDL phospholipid level	J:92804
	increased circulating HDL phospholipid level	J:92804
Tg(Pmch-ATXN3*)3Rck/0 (involves: FVB/NJ)	decreased circulating glucose level	J:104264
	decreased circulating insulin level	J:104264
	decreased circulating leptin level	J:104264
	increased energy expenditure	J:104264
Tg(PML-RARA)556Kog/? (involves: FVB/N)	abnormal blood coagulation	J:39327
Tg(PML-RARA)556Kog/? (involves: FVB/N)	abnormal lung thrombosis	J:39327
Tg(PnkdA7VA9V,-DsRed)671Ljp/0 (B6.Cg-Tg(PnkdA7VA9V,-DsRed)671Ljp)	abnormal dopamine level	J:192798
	decreased dopamine level	J:192798
Tg(PnkdA7VA9V,-DsRed)704Ljp/0 (B6.Cg-Tg(PnkdA7VA9V,-DsRed)704Ljp)	abnormal dopamine level	J:192798
	decreased dopamine level	J:192798
Tg(Prl-EGFR)#Sme/0 (Not Specified)	increased circulating prolactin level	J:219654
Tg(Prnp-Abca1)EHol/0 (involves: C57BL/6 * CBA)	abnormal protein level	J:131400
Tg(Prnp-APPSweArc)#Rmni/0 (involves: C57BL/6 * DBA/2)	abnormal nitric oxide homeostasis	J:239408
Tg(PRNP-APPSweInd)8Dwst/? (involves: 129S6/SvEvTac)	increased circulating triglyceride level	J:113199
Tg(PRNP-APPSweInd)8Dwst/? (involves: 129S6/SvEvTac)	increased circulating VLDL triglyceride level	J:113199
Tg(PRNP-APPSweInd)8Dwst/0 (involves: C3H/HeJ * C57BL/6J)	increased creatine level	J:166801
Tg(PRNP-APPSweInd)8Dwst/0 (involves: C3H/HeJ * C57BL/6)	abnormal copper level	J:86701
Tg(Prnp-ATXN3)BVcg/0 (involves: C3H/HeJ * C57BL/6)	decreased circulating follicle stimulating hormone level	J:121039
Tg(Prnp-ATXN3)BVcg/Tg(Prnp-ATXN3)BVcg (involves: C3H/HeJ * C57BL/6)	decreased circulating follicle stimulating hormone level	J:121039
	decreased circulating luteinizing hormone level	J:121039
	decreased circulating prolactin level	J:121039
	decreased circulating thyroid-stimulating hormone level	J:121039
Tg(Prnp-ATXN3)CVcg/0 (involves: C3H/HeJ * C57BL/6)	decreased circulating follicle stimulating hormone level	J:121039
Tg(Prnp-ATXN3)CVcg/Tg(Prnp-ATXN3)CVcg (involves: C3H/HeJ * C57BL/6)	decreased circulating follicle stimulating hormone level	J:121039
Tg(Prnp-FTL)4Ruvi/0 (B6.C3Fe-Tg(Prnp-FTL)4Ruvi)	abnormal iron homeostasis	J:131053
Tg(Prnp-FTL)4Ruvi/Tg(Prnp-FTL)4Ruvi (B6.C3Fe-Tg(Prnp-FTL*)4Ruvi)	abnormal iron homeostasis	J:131053
Tg(Prnp-HTT*82Q,KRT14-EGFP)C63Dbo/0 (Not Specified)	dehydration	J:173756
Tg(Prnp-TARDBPA315T)95Balo/0 (B6.Cg-Tg(Prnp-TARDBPA315T)95Balo/J)	dehydration	J:203041
	intestinal edema	J:203041
Tg(Prp-GPR37)1Ryot/0 (involves: C3H * C57BL/6)	increased dopamine level	J:128745
Tg(Psp-Rbbp4)1Yoha/0 (involves: C57BL/6)	decreased salivation	J:141378
Tg(Pten)1Srn/0 (involves: C57BL/6 * CBA)	decreased circulating cholesterol level	J:182671
	decreased circulating insulin level	J:182671
	decreased circulating insulin-like growth factor I level	J:182671
	decreased circulating leptin level	J:182671
	decreased fasting circulating glucose level	J:182671
	increased energy expenditure	J:182671
	increased insulin sensitivity	J:182671
Tg(PTH-CCND1)PC2Anar/0 (FVB/N-Tg(PTH-CCND1)PC2Anar)	abnormal circulating mineral level	J:69423
	increased circulating calcium level	J:69423
	increased circulating parathyroid hormone level	J:69423
Tg(PyLT)1Vb/0 (Not Specified)	increased circulating adrenocorticotropin level	J:55528
Tg(Rgs4-EGFP)#Surm/? (involves: C57BL/6J * DBA)	abnormal blood urea nitrogen level	J:215588
Tg(Rgs4-EGFP)#Surm/? (involves: C57BL/6J * DBA)	abnormal circulating creatinine level	J:215588
Tg(RIP1-Tag)2Dh/0 (involves: C57BL/6J * DBA/2J)	hypoglycemia	J:50695, J:205389
Tg(RIP1-Tag)5Dh/0 (C3.Cg-Rgs5^tm1.1Rgan Tg(RIP1-Tag)5Dh)	hypoglycemia	J:136259
Tg(RIR-Tag)87Dh/0 (involves: C57BL/6J * DBA/2J)	hypoglycemia	J:50695
Tg(RNU6-RNAi:Cldn16)551Dago/0 (involves: C57BL/6 * DBA/2)	decreased circulating magnesium level	J:122766
	hypokalemia	J:122766
	increased circulating aldosterone level	J:122766
	increased urine calcium level	J:122766
	increased urine magnesium level	J:122766
	increased urine potassium level	J:122766
Tg(RP3-340H11)29Kel/0 (involves: C57BL/6J * CBA/Ca)	hyperglycemia	J:91709
	impaired glucose tolerance	J:91709
	increased insulin secretion	J:91709
	increased insulin sensitivity	J:91709
Tg(RP11-466I19/Tcf7l2)1Nobr/0 (involves: CD-1)	impaired glucose tolerance	J:175874
Tg(RP11-578M14)5Mkru/0 (involves: FVB/N)	abnormal blood homeostasis	J:256501
	abnormal circulating hormone level	J:256501
	decreased circulating follicle stimulating hormone level	J:256501
	decreased circulating free fatty acids level	J:256501
	decreased circulating ghrelin level	J:256501
	decreased circulating luteinizing hormone level	J:256501
	decreased circulating thyroid-stimulating hormone level	J:256501
	decreased growth hormone level	J:256501
	decreased prolactin level	J:256501
	impaired adaptive thermogenesis	J:256501
	impaired glucose tolerance	J:256501
	increased cholesterol level	J:256501
	increased circulating insulin level	J:256501
	increased circulating leptin level	J:256501
	increased circulating phospholipid level	J:256501
	increased fasting circulating glucose level	J:256501
	increased triglyceride level	J:256501
Tg(RP23-352G18)1Coppa/0 (C57BL/6-Tg(RP23-352G18)1Coppa)	decreased circulating glucose level	J:229077
	decreased susceptibility to diet-induced non-insulin dependent diabetes	J:229077
	decreased susceptibility to diet-induced obesity	J:229077
	improved glucose tolerance	J:229077
	increased insulin sensitivity	J:229077
Tg(rPEPCKSREBF2)788Reh/0 (Not Specified)	abnormal lipid level	J:86518
	increased circulating cholesterol level	J:86518
	increased fatty acids level	J:86518
	increased liver cholesterol level	J:86518
	increased liver triglyceride level	J:86518
Tg(Scgb1a1-Il17a)3Cdon/0 (C57BL/6-Tg(Scgb1a1-Il17a)3Cdon)	abnormal chemokine level	J:112600
Tg(Scgb1a1-rtTA)1Jaw/0 Tg(tetO-IL1B)KBry/0 (involves: 129 * C57BL/6)	abnormal chemokine level	J:107601, J:130523
Tg(Scgb1a1-rtTA)1Jaw/0 Tg(tetO-TGFA)22.1Kor/0 (involves: 129 * C57BL/6)	increased hydroxyproline level	J:101255
Tg(Scgb1a1-rtTA)1Jaw/0 Tg(tetO-TGFA)22.1Kor/0 (involves: 129 * C57BL/6 * FVB/NJ)	increased hydroxyproline level	J:240947
Tg(SERPINA1E342K)#Slcw/0 (involves: C57BL/6 ICR)	abnormal enzyme/coenzyme level	J:208016
Tg(SERPINA1E342K)#Slcw/Tg(SERPINA1E342K)#Slcw (involves: C57BL/6 * ICR)	abnormal enzyme/coenzyme level	J:208016
Tg(SFTPC-Il18)AThos/0 (B6N.Cg-Tg(SFTPC-Il18)AThos)	impaired glucose tolerance	J:219136
Tg(SFTPC-rtTA)5Jaw/0 Tg(tetO-Fgf9,-EGFP)#Dor/0 (involves: FVB)	ascites	J:204282
Tg(SFTPC-Tnf)2Pva/0 (involves: C57BL/6 * DBA/2)	abnormal blood coagulation	J:28120
	cyanosis	J:28120
	increased collagen level	J:222067
	increased hyaluronic acid level	J:222067
Tg(SHBG)4-aGlha/0 (involves: C57BL/6 * CBA)	increased circulating testosterone level	J:239368
Tg(Sirt1)ASrn/? (involves: C57BL/6 * CBA)	improved glucose tolerance	J:137868
Tg(Sirt1)ASrn/? (involves: C57BL/6 * CBA)	increased energy expenditure	J:137868
Tg(SLC2A4-OGT)15Jaha/0 (involves: C57BL/6)	increased circulating insulin level	J:93113
	increased circulating leptin level	J:93113
	insulin resistance	J:93113
Tg(Slc5a7)1Rbl/? (involves: C57BL/6J)	increased acetylcholine level	J:228637
Tg(Slc6a3-PARK2Q311X)AXwy/0 (FVB/NJ-Tg(Slc6a3-PARK2Q311X)AXwy)	decreased dopamine level	J:146833
Tg(SOD1G37R)29Dpr/0 (involves: C3H/HeJ C57BL/6 * C57BL/6J)	abnormal iron homeostasis	J:144848
	abnormal iron level	J:144848
Tg(Sod1*G86R)M1Jwg/0 (involves: FVB/N)	abnormal circulating hormone level	J:91800
	abnormal energy expenditure	J:91800
	abnormal gas homeostasis	J:91800
	abnormal glucose homeostasis	J:91800
	abnormal glycerol level	J:91800
	abnormal lipid homeostasis	J:91800
	decreased circulating insulin level	J:91800
	decreased circulating leptin level	J:91800
	decreased circulating triiodothyronine level	J:91800
	decreased respiratory quotient	J:91800
	enhanced lipolysis	J:91800
	impaired adaptive thermogenesis	J:91800
	increased circulating corticosterone level	J:91800
	increased circulating glucose level	J:91800
	increased circulating ketone body level	J:91800
	increased oxygen consumption	J:91800
Tg(SOD1G93A)1Gur/0 (involves: C57BL/6 SJL)	abnormal circulating hormone level	J:91800
	abnormal energy expenditure	J:91800
	abnormal nitric oxide homeostasis	J:55026
	decreased circulating insulin level	J:91800
	decreased circulating leptin level	J:91800
	increased circulating corticosterone level	J:91800
	increased oxygen consumption	J:91800
Tg(SOD1G93A)1Gur/0 (B6SJL-Tg(SOD1G93A)1Gur/J)	abnormal calcium ion homeostasis	J:158298
	abnormal glucose homeostasis	J:111280
	edema	J:165019
Tg(SREBP1a)7343Reh/0 (involves: C57BL/6J * SJL/J)	abnormal lipid homeostasis	J:35770
	decreased circulating triglyceride level	J:35770
	increased circulating aspartate transaminase level	J:35770
	increased circulating serum albumin level	J:35770
	increased circulating total protein level	J:35770
	increased liver cholesterol level	J:35770
	increased liver triglyceride level	J:35770
Tg(SREBP1a)7343Reh/0 (B6.Cg-Tg(SREBP1a)7343Reh)	decreased circulating leptin level	J:100328
	improved glucose tolerance	J:100328
	increased circulating glucose level	J:100328
	increased circulating insulin level	J:100328
	insulin resistance	J:100328
Tg(SREBP1a)7343Reh/? (involves: 129 * C57BL/6 * C57BL/6J * SJL)	decreased cholesterol level	J:93775
	decreased circulating cholesterol level	J:93775
	decreased circulating HDL cholesterol level	J:93775
Tg(SULT1A1,SULT1A2)1Glatt/0 (FVB/N-Tg(SULT1A1,SULT1A2)1Glatt)	abnormal blood homeostasis	J:217578
Tg(Tal1-cre/ERT)1Jrg/0 Tsc1^tm1Djk/Tsc1^tm1Djk (involves: 129S4/SvJae * C57BL/6)	edema	J:231316
Tg(TARDBPG348C)#Jpj/0 (involves: C3H C57BL/6)	abnormal cytokine level	J:195184
Tg(Tcra2D2,Tcrb2D2)1Kuch/0 (involves: C57BL/6)	edema	J:83278
Tg(Tcra2D2,Tcrb2D2)1Kuch/0 (involves: C57BL/6)	eyelid edema	J:83278
Tg(TcraTcrb)425Cbn/0 (involves: C57BL/6)	abnormal cytokine level	J:112600
Tg(TcraTcrbNY8.3)1Pesa/? (involves: C57BL/6 * NOD * SJL)	increased circulating glucose level	J:44202
Tg(TcrbAI4)1Dvs/0 (NOD-Tg(TcrbAI4)1Dvs)	abnormal circulating glucose level	J:93553
Tg(Tek-cre)1Ywa/0 Thbd^tm2Rdr/Thbd^tm2Wlr (involves: 129S2/SvPas * C57BL/6 * SJL)	abnormal acute phase protein level	J:71269
	abnormal blood coagulation	J:71269
	abnormal placental thrombosis	J:71269
	abnormal thrombosis	J:71269
	hematuria	J:71269
	increased circulating D-dimer level	J:71269
	increased circulating interleukin-6 level	J:71269
Tg(Tek-Nr2f2)1Tsa/0 (Not Specified)	pericardial effusion	J:98247
Tg(Tek-Procr)1Cte/0 (B6.FVB-Tg(Tek-Procr)1Cte)	abnormal acute phase protein level	J:119637
	abnormal blood coagulation	J:119637
	abnormal enzyme/coenzyme level	J:119637
	abnormal platelet physiology	J:119637
Tg(Tek-tTA)1Rwng/0 Tg(tetO-Notch4*)1Rwng/0 (involves: FVB/N)	abnormal thrombosis	J:139943
Tg(tetO-BRAF*V600E)26Jaf/0 Tg(TG-rtTA)30Jaf/0 (involves: FVB/N)	decreased circulating thyroid-stimulating hormone level	J:184420
	decreased circulating thyroxine level	J:184420
Tg(tetO-Xbp1_is)#Pesch/0 Tg(Adipoq-rtTA)2Zvw/0 (involves: C57BL/6 * C57BL/6N * FVB/N)	decreased body temperature	J:260830
	decreased susceptibility to diet-induced obesity	J:260830
	increased carbon dioxide production	J:260830
	increased fatty acid oxidation	J:260830
	increased oxygen consumption	J:260830
Tg(TG-BRAFV600E)2Jaf/0 (FVB/N-Tg(TG-BRAFV600E)2Jaf)	decreased circulating triiodothyronine level	J:98550
Tg(TG-BRAFV600E)2Jaf/0 (FVB/N-Tg(TG-BRAFV600E)2Jaf)	increased circulating thyroid-stimulating hormone level	J:98550
Tg(TG-BRAFV600E)3Jaf/0 (FVB/N-Tg(TG-BRAFV600E)3Jaf)	increased circulating thyroid-stimulating hormone level	J:98550
Tg(TG-NRAS*Q61K)#Msnt/0 (Not Specified)	increased thyroid-stimulating hormone level	J:210016
Tg(TG-RET/CCDC6)42Cled/0 (involves: FVB/N)	decreased circulating thyroxine level	J:93679
	decreased circulating triiodothyronine level	J:93679
	increased circulating thyroid-stimulating hormone level	J:93679
	increased thyroid-stimulating hormone level	J:55883
Tg(TG-SV40)#Cled/0 (involves: C57BL/6J * DBA/2J)	decreased circulating thyroxine level	J:209788
Tg(Th-SNCA)5Eric/0 (involves: C57BL/6 * C57BL/6J)	decreased dopamine level	J:96494
Tg(Th-SNCA)1702Yosh/0 (involves: C3H C57BL/6J)	decreased dopamine level	J:125149
Tg(Th-SNCAA30PA53T)39Eric/0 (involves: C57BL/6)	decreased dopamine level	J:76482
Tg(Th-SNCAA30PA53T)39Eric/0 (involves: C57BL/6 * C57BL/6J)	decreased dopamine level	J:96494
Tg(THY1-APOD1)1Era/0 (B6.Cg-Tg(THY1-APOD1)1Era)	abnormal lipid homeostasis	J:143809
Tg(Thy1-APPSweInd)fAccu/0 (involves: C3H * C57BL/6)	abnormal enzyme/coenzyme level	J:251735
Tg(Thy1-FUS)19Vlb/0 (B6.Cg-Tg(Thy1-FUS)19Vlb)	dehydration	J:203550
Tg(Thy1-MAPT)22Schd/0 (involves: C57BL/6 * CBA)	decreased serotonin level	J:197067
Tg(Thy1-MAPTK369I)K3Gotz/0 (B6.Cg-Tg(Thy1-MAPTK369I)K3Gotz)	decreased dopamine level	J:143439
Tg(Thy1-SNCA*)#Ztzh/0 (involves: C57BL/6J)	decreased nervous system dopamine level	J:313970
Tg(Thy1/THY1)mhT4Gsv/0 (involves: C57BL/10 * CBA)	increased urine protein level	J:133943
Tg(Thy1/THY1)T6Gsv/0 (involves: C57BL/10 * CBA)	albuminuria	J:294728
Tg(Thy1/THY1)T12Gsv/0 (involves: C57BL/10 * CBA)	increased urine protein level	J:133943
Tg(Tk1-DPP4)27Ysj/0 (involves: C57BL/6 * FVB/N)	abnormal chemokine level	J:290259
	abnormal interleukin level	J:290259
	abnormal tumor necrosis factor level	J:290259
	increased transforming growth factor beta level	J:290259
Tg(Tlr7)1Boll/0 (involves: C57BL/6)	abnormal circulating chemokine level	J:127600
	increased circulating interleukin-6 level	J:127600
	increased circulating tumor necrosis factor level	J:127600
Tg(TNF)197Gkl/0 (involves: C57BL/6 * CBA)	joint swelling	J:97992
Tg(TNFSF11)5519Edou/0 (involves: C57BL/6J * CBA/J)	increased circulating alkaline phosphatase level	J:233240
Tg(Tnfsf13b)1Fma/0 (involves: C57BL/6 * DBA/2J)	increased urine protein level	J:58798
Tg(Tnfsf13b)1Fma/0 (B6.Cg-Tg(Tnfsf13b)1Fma)	decreased salivation	J:73711
Tg(Tnfsf13b)1Fma/0 (B6.Cg-Tg(Tnfsf13b)1Fma)	increased urine protein level	J:114782
Tg(Tnfsf13b)1Fma/? (B6.Cg-Tg(Tnfsf13b)1Fma)	increased urine protein level	J:113556
Tg(Tnfsf13b)1Fma/Tg(Tnfsf13b)1Fma (involves: C57BL/6 * DBA/2)	albuminuria	J:178227
	increased urine protein level	J:178227
Tg(TTR)#Jbux/0 (involves: C57BL/6 * DBA/2)	abnormal protein level	J:68458
Tg(Ttr-Cdkn1a)36Tvd/? (B6.Cg-Tg(Ttr-Cdkn1a)36Tvd)	hyperglycemia	J:94077
Tg(Ttr-Foxo1)305Dac/0 (involves: FVB * C57BL/6)	decreased circulating insulin level	J:79560
	hyperglycemia	J:79560
	impaired glucose tolerance	J:79560
	insulin resistance	J:79560
Tg(Ttr-Foxo1)307Dac/0 (involves: C57BL/6J)	increased circulating cholesterol level	J:94423
	increased circulating HDL cholesterol level	J:94423
	increased circulating triglyceride level	J:94423
Tg(Ttr-Foxo1)307Dac/0 (involves: FVB * C57BL/6)	hyperglycemia	J:79560
	impaired glucose tolerance	J:79560
	increased circulating insulin level	J:79560
	increased insulin sensitivity	J:79560
Tg(Ttr-IGF1)1Sykr/0 (FVB/N-Tg(Ttr-IGF1)1Sykr)	decreased circulating insulin level	J:157350
Tg(Ttr-IGF1)1Sykr/0 (FVB/N-Tg(Ttr-IGF1)1Sykr)	increased circulating insulin-like growth factor I level	J:157350
Tg(Ttr-KLF6)1Fdmn/? (Not Specified)	decreased circulating serum albumin level	J:122903
Tg(TTR-p19Cdkn2a)2Tvd/0 (involves: C57BL/6J * DBA/2J)	increased circulating glucose level	J:94077
Tg(Ttr-Retn)1Laz/? (involves: C57BL/6 * SJL)	hyperglycemia	J:91890
	impaired glucose tolerance	J:91890
	increased circulating glucose level	J:91890
Tg(Tyr,Col2a1-Trpv4*R594H)#Dhco/0 (involves: FVB/N)	abnormal fluid regulation	J:233234
Tg(UAS-Shh)1Rth/0 Tg(Wnt1-GAL4)1Rth/0 (involves: C57BL/6J * CBA/J)	hydromyelia	J:57948
Tg(Ucp1-cre)1Evdr/0 Zc3h10^{tm1c(EUCOMM)Wtsi}/Zc3h10^{tm1c(EUCOMM)Wtsi} (involves: 129S4/SvJaeSor * C57BL/6N * FVB)	decreased oxygen consumption	J:287066
	impaired adaptive thermogenesis	J:287066
	impaired glucose tolerance	J:287066
	insulin resistance	J:287066
Tg(UcpDta)1Kz/? (involves: FVB/N)	abnormal glucose homeostasis	J:78211
	abnormal lipid homeostasis	J:78211
	hyperglycemia	J:78211
	hyperlipidemia	J:78211
	increased circulating cholesterol level	J:78211
	increased circulating insulin level	J:78211
	increased circulating triglyceride level	J:147417, J:78211
	insulin resistance	J:78211
Tg(UcpDta)1Kz/0 (FVB/N-Tg(UcpDta)1Kz/J)	impaired glucose tolerance	J:129848
Tg(Umod*C147W)958Lura/0 (involves: FVB)	decreased urine osmolality	J:161532
	decreased urine pH	J:161532
	increased blood osmolality	J:161532
	increased blood urea nitrogen level	J:161532
	increased circulating antidiuretic hormone level	J:161532
	increased circulating creatinine level	J:161532
	increased urine calcium level	J:161532
Tg(Umod*C217G)1Xrw/0 (involves: FVB/N)	abnormal urine osmolality	J:252420
	decreased urine osmolality	J:252420
	increased urine osmolality	J:252420
	increased urine uric acid level	J:252420
Tg(Upk2-TAg)1Rkl/0 (involves: C57BL/6)	hypoxia	J:173505
Tg(Vav1-JAK2V617F)AZjz/0 (involves: C57BL/6 DBA/2)	abnormal blood homeostasis	J:135993
Tg(Vav1-JAK2V617F)AZjz/0 (involves: C57BL/6 DBA/2)	decreased circulating erythropoietin level	J:135993
Tg(Vav1-Lin28b)C3Apla/0 (involves: C57BL/6)	abnormal cytokine level	J:189197
	ascites	J:189197
	pleural effusion	J:189197
Tg(VDRL233S,luc)T807Pike/0 Vdr^tm1Mbd/Vdr^tm1Mbd (involves: 129S4/SvJae C57BL/6)	decreased circulating calcium level	J:218709
	decreased circulating phosphate level	J:218709
	increased circulating parathyroid hormone level	J:218709
Tg(Vil1-cre)20Syr/0 Vmp1^tm1.1Arte/Vmp1^tm1.1Arte (involves: C57BL/6 * DBA/2)	abnormal lipid level	J:280741
Tg(Vil1-cre)997Gum/? Tlr5^tm1.1Gewr/Tlr5^tm1.1Gewr (involves: C57BL/6J * C57BL/6NTac * SJL/J)	increased circulating cholesterol level	J:229155
	increased circulating triglyceride level	J:229155
	increased fasting circulating glucose level	J:229155
Tg(Vil-SLC3A2)HEMerl/0 (involves: FVB/N)	increased circulating tumor necrosis factor level	J:173946
Tg(Wnk4)#Rpl/Tg(Wnk4)#Rpl (involves: C3H * C57BL/6)	decreased circulating chloride level	J:113094
	decreased circulating magnesium level	J:113094
	decreased circulating potassium level	J:113094
	decreased urine calcium level	J:113094
Tg(Wnk4Q562E)#Rpl/Tg(Wnk4Q562E)#Rpl (involves: C3H * C57BL/6)	decreased circulating bicarbonate level	J:113094
	hyperkalemia	J:113094
	increased circulating chloride level	J:113094
	increased circulating magnesium level	J:113094
	increased urine calcium level	J:113094
Tg(WTbeta2)4Wjk/? (Not Specified)	abnormal atrial thrombosis	J:128583
	increased collagen level	J:128583
	pleural effusion	J:128583
Tg(WTbeta2)4Wjk/0 (B6.Cg-Tg(WTbeta2)4Wjk)	cyanosis	J:125581
Tg(Zp3-cre)93Knw/0 Yy1^tm1Yshi/Yy1^tm2.1Yshi (involves: 129S4/SvJae * C57BL/6J)	abnormal circulating hormone level	J:170240
	increased circulating follicle stimulating hormone level	J:170240
Tg^cog/Tg^cog (AKR/J-Tg^cog)	decreased circulating thyroxine level	J:13923
Tg^cog/Tg^cog (involves: AKR/J * C57BL/6By)	decreased circulating thyroxine level	J:8567
	decreased circulating triiodothyronine level	J:8567
	increased circulating thyroid-stimulating hormone level	J:8567
Tg^em1(IMPC)J/Tg^em1(IMPC)J (C57BL/6NJ-Tg^em1(IMPC)J/Mmjax)	improved glucose tolerance	J:211773
Tg^em1(IMPC)J/Tg^em1(IMPC)J (C57BL/6NJ-Tg^em1(IMPC)J/Mmjax)	increased fasting circulating glucose level	J:211773
Tg^m4Btlr/Tg^m4Btlr (C57BL/6J-Tg^m4Btlr)	increased fasting circulating glucose level	J:272522
Tgds^em1(IMPC)Mbp/Tgds⁺ (C57BL/6N-Tgds^em1(IMPC)Mbp/MbpMmucd)	increased circulating alkaline phosphatase level	J:211773
Tgfb1^{tm1(Tgfb3)Kul}/Tgfb1^{tm1(Tgfb3)Kul} (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	decreased circulating insulin level	J:204892
	decreased circulating leptin level	J:204892
	improved glucose tolerance	J:204892
Tgfb1^tm1.1Mki/Tgfb1^tm1.1Mki (C57BL/6-Tgfb1^tm1.1Mki)	decreased circulating aldosterone level	J:194237
	increased circulating angiotensinogen level	J:194237
	increased circulating renin level	J:194237
Tgfb1^tm1Doe/Tgfb1⁺ (involves: 129S2/SvPas * CF-1)	increased circulating creatinine level	J:137529
Tgfb1^tm1Doe/Tgfb1^tm1Doe (involves: 129S2/SvPas * BALB/c * CF-1)	increased circulating alanine transaminase level	J:69346
Tgfb1^tm1Doe/Tgfb1^tm1Doe (C.129S2-Tgfb1^tm1Doe)	increased circulating alanine transaminase level	J:69346
Tgfb1^tm1Mki/Tgfb1^tm1Mki (C57BL/6-Tgfb1^tm1Mki)	abnormal fluid regulation	J:194237
	abnormal homeostasis	J:194237
	abnormal urine potassium level	J:194237
	decreased circulating angiotensinogen level	J:194237
	decreased circulating potassium level	J:194237
	decreased circulating renin level	J:194237
	decreased urine chloride ion level	J:194237
	decreased urine osmolality	J:194237
	decreased urine sodium level	J:194237
	increased body temperature	J:194237
	increased circulating aldosterone level	J:194237
	increased circulating corticosterone level	J:194237
Tgfb1^tm1N/Tgfb1^tm1N (involves: 129S/SvEv)	abnormal atrial thrombosis	J:50848
Tgfb1^tm1N/Tgfb1^tm1N (involves: 129S/SvEv * C57BL/6J * NIH/Ola)	edema	J:26913
Tgfb1i1^{tm1b(KOMP)Wtsi}/Tgfb1i1^{tm1b(KOMP)Wtsi} (C57BL/6N-Tgfb1i1^{tm1b(KOMP)Wtsi}/Wtsi)	improved glucose tolerance	J:211773
	increased circulating cholesterol level	J:211773
Tgfb2^tm1Doe/Tgfb2⁺ (involves: 129/Sv * 129P2/OlaHsd * Black Swiss * C57BL/6J)	decreased dopamine level	J:108007
Tgfb2^tm1Doe/Tgfb2^tm1Doe (involves: 129P2/OlaHsd * Black Swiss)	cyanosis	J:41682
	increased urine protein level	J:41682
Tgfb3^tm1Doe/Tgfb3^tm1Doe (either: (involves: 129 * 129P2/OlaHsd) or (involves: 129P2/OlaHsd * C57BL/6) or (involves: 129P2/OlaHsd * CF-1))	cyanosis	J:29901
	dehydration	J:29901
Tgfb3^tm1Jhg/Tgfb3^tm1Jhg (either: (involves: 129S1/Sv * 129X1/SvJ * Black Swiss) or (involves: 129S1/Sv * 129X1/SvJ * C57BL/6))	cyanosis	J:29902
Tgfbi^tm1Jwu/Tgfbi^tm1Jwu (B6.129-Tgfbi^tm1Jwu)	decreased insulin secretion	J:213611
Tgfbi^tm1Jwu/Tgfbi^tm1Jwu (B6.129-Tgfbi^tm1Jwu)	increased susceptibility to non-insulin-dependent diabetes	J:213611
Tgfbr1^tm1.1Hcd/Tgfbr1⁺ (129S6(Cg)-Tgfbr1^tm1.1Hcd)	hemopericardium	J:204960
Tgfbr1^tm1.1Karl/Tgfbr1^tm1.1Karl Tg(Tie1-cre)9Ref/? Gt(ROSA)26Sor^tm1Sor/? (involves: 129 * 129S1/Sv * 129X1/SvJ * C57BL/6J)	pericardial effusion	J:128498
Tgfbr1^tm1Karl/Tgfbr1^tm1Karl (Not Specified)	pericardial effusion	J:68770
Tgfbr2^tm1.1Hcd/Tgfbr2⁺ (129S6(Cg)-Tgfbr2^tm1.1Hcd)	hemopericardium	J:204960
Tgfbr2^tm1Dgen/Tgfbr2⁺ (involves: 129P2/OlaHsd)	increased fatty acids level	J:148831
Tgfbr2^tm1Karl/Tgfbr2^tm1Karl Tg(Tie1-cre)9Ref/? Gt(ROSA)26Sor^tm1Sor/? (involves: 129 * 129S1/Sv * 129X1/SvJ * C57BL/6J)	pericardial effusion	J:128498
Tgfbr3^em1(IMPC)Mbp/Tgfbr3^em1(IMPC)Mbp (C57BL/6N-Tgfbr3^em1(IMPC)Mbp/MbpMmucd)	edema	J:211773
Tgfbr3l^em2Djb/Tgfbr3l^em2Djb (C57BL/6N-Tgfbr3l^em2Djb)	increased circulating follicle stimulating hormone level	J:316383
Tgif1^tm1.1Caw/Tgif1^tm1.1Caw (B6.129S-Tgif1^tm1.1Caw)	abnormal cytokine level	J:198238
	abnormal fluid regulation	J:198238
	middle ear effusion	J:198238
Tgif1^tm1Dwot/Tgif1⁺ (involves: 129X1/SvJ * C57BL/6J)	abnormal response to vitamins	J:105576
Tgif1^tm1Dwot/Tgif1^tm1Dwot (involves: 129X1/SvJ * C57BL/6J)	abnormal response to vitamins	J:105576
Tgif2^{tm1b(EUCOMM)Wtsi}/Tgif2⁺ (C57BL/6N-Tgif2^{tm1b(EUCOMM)Wtsi}/Ics)	decreased circulating calcium level	J:211773
Tgl1^KK/Ta/Tgl1^KK/Ta (involves: BALB/c * KK/Ta)	increased triglyceride level	J:88209
Tglq1^MRL/MpJ/Tglq1^MRL/MpJ (involves: MRL/MpJ * SJL/J)	increased circulating triglyceride level	J:106033
Tglq1^MRL/MpJ/Tglq1^SJL/J (involves: MRL/MpJ * SJL/J)	increased circulating triglyceride level	J:106033
Tglq2^MRL/MpJ/Tglq2^SJL/J (involves: MRL/MpJ * SJL/J)	increased circulating triglyceride level	J:106033, J:123776
Tglq2^SJL/J/Tglq2^SJL/J (involves: MRL/MpJ * SJL/J)	increased circulating triglyceride level	J:106033, J:123776
Tglq3^RF/J/Tglq3^RF/J (involves: NZB/BlNJ * RF/J)	decreased circulating triglyceride level	J:123776
Tglq4^NZB/BlNJ/Tglq4^NZB/BlNJ (involves: NZB/BlNJ * RF/J)	increased circulating triglyceride level	J:123776
Tglq4^NZB/BlNJ/Tglq4^RF/J (involves: NZB/BlNJ * RF/J)	increased circulating triglyceride level	J:123776
Tgls1^KK/Ta/Tgls1^KK/Ta (involves: BALB/c * KK/Ta)	decreased circulating triglyceride level	J:88209
Tgm1^tm1Kfyn/Tgm1^tm1Kfyn (involves: 129S1/SvImJ * 129X1/SvJ * C57BL/6)	dehydration	J:45653
	impaired skin barrier function	J:74334, J:45653
Tgm2^tm1Gml/Tgm2^tm1Gml (involves: 129X1/SvJ * C57BL/6)	decreased circulating insulin level	J:78633
	hyperglycemia	J:78633
	impaired glucose tolerance	J:78633
	increased insulin sensitivity	J:78633
Tgm3^tm1Sjo/Tgm3^tm1Sjo (involves: 129P2/OlaHsd * C57BL/6)	impaired skin barrier function	J:203964
Tgm6^{tm1a(KOMP)Wtsi}/Tgm6^{tm1a(KOMP)Wtsi} (C57BL/6N-Tgm6^{tm1a(KOMP)Wtsi}/Wtsi)	decreased circulating serum albumin level	J:211773
	improved glucose tolerance	J:211773
Tgq1^129S1/SvImJ/Tgq1^C57BL/6J (involves: 129S1/SvImJ * C57BL/6J)	increased triglyceride level	J:93243
Tgq2^C57BL/6J/Tgq2^C57BL/6J Tgq3^129S1/SvImJ/Tgq3^129S1/SvImJ (involves: 129S1/SvImJ * C57BL/6J)	increased triglyceride level	J:93243
Tgq4^NZW/LacJ/? (involves: NZB/BlNJ * NZW/LacJ)	increased triglyceride level	J:138463
Tgq5^NZW/LacJ/? (involves: NZB/BlNJ * NZW/LacJ)	increased triglyceride level	J:138463
Tgq6^NZB/BlNJ/? (involves: NZB/BlNJ * NZW/LacJ)	increased triglyceride level	J:138463
Tgq7^NZB/BlNJ/Tgq7^NZB/BlNJ Tgq8^NZW/LacJ/Tgq8^NZW/LacJ (involves: NZB/BlNJ * NZW/LacJ)	increased triglyceride level	J:138463
Tgq9^DBA/2J/? (involves: DBA/1J * DBA/2J)	increased circulating triglyceride level	J:142770
Tgq10^DBA/2J/? (involves: DBA/1J * DBA/2J)	increased circulating triglyceride level	J:142770
Tgq11^DBA/2J/? (involves: DBA/1J * DBA/2J)	increased circulating triglyceride level	J:142770
Tgq13^DBA/2J/? (involves: DBA/1J * DBA/2J)	increased circulating triglyceride level	J:142770
Tgq14^DBA/2J/? (involves: DBA/1J * DBA/2J)	increased circulating triglyceride level	J:142770
Tgq15^DBA/2J/? (involves: DBA/1J * DBA/2J)	increased circulating triglyceride level	J:142770
Tgq17^DBA/2J/? (involves: DBA/1J * DBA/2J)	increased circulating triglyceride level	J:142770
Tgq18^DBA/2J/? (involves: DBA/1J * DBA/2J)	increased circulating triglyceride level	J:142770
Tgq19^DBA/2J/? (involves: DBA/1J * DBA/2J)	increased circulating triglyceride level	J:142770
Tgq20^DBA/2J/? (involves: DBA/1J * DBA/2J)	increased circulating triglyceride level	J:142770
Tgq21^DBA/2J/? (involves: DBA/1J * DBA/2J)	increased circulating triglyceride level	J:142770
Tgq22^DBA/2J/? (involves: DBA/1J * DBA/2J)	increased circulating triglyceride level	J:142770
Tgq23^DBA/2J/? (involves: DBA/1J * DBA/2J)	increased circulating triglyceride level	J:142770
Tgq24^DBA/2J/? (involves: DBA/1J * DBA/2J)	increased circulating triglyceride level	J:142770
Tgq25^DBA/2J/? (involves: DBA/1J * DBA/2J)	increased circulating triglyceride level	J:142770
Tgq26^DBA/2J/? (involves: DBA/1J * DBA/2J)	increased circulating triglyceride level	J:142770
Tgq27^DBA/2J/? (involves: DBA/1J * DBA/2J)	increased circulating triglyceride level	J:142770
Tgq28^DBA/2J/? (involves: DBA/1J * DBA/2J)	increased circulating triglyceride level	J:142770
Tgq29^DBA/2J/? (involves: DBA/1J * DBA/2J)	increased circulating triglyceride level	J:142770
Tgyl1^SM/J/? (involves: LG/J * SM/J)	increased triglyceride level	J:94605
Th^tm1.1Ich/Th^tm1.1Ich (Not Specified)	decreased dopamine level	J:178698
Th^tm1Srt/Th^tm1Srt (involves: 129S2/SvPas * C57BL/6J)	abnormal adrenaline level	J:54692
	abnormal noradrenaline level	J:54692
	decreased dopamine level	J:54692
Th^tm1Srt/Th^tm1Srt Tyr^c/Tyr^c (involves: 129S2/SvPas * C57BL/6J * ICR)	abnormal adrenaline level	J:54692
	abnormal noradrenaline level	J:54692
	decreased dopamine level	J:54692
Th^tm1Tna/Th⁺ (B6.129-Th^tm1Tna)	abnormal noradrenaline level	J:60963
Th^tm1Tna/Th^tm1Tna (either: (involves: 129P2/OlaHsd * C57BL/6) or (involves: 129P2/OlaHsd * ICR))	abnormal adrenaline level	J:30273
	abnormal noradrenaline level	J:30273
	anoxia	J:30273
	decreased dopamine level	J:30273
Th^tm2Te/Th^tm2Te (involves: 129X1/SvJ * C57BL/6)	decreased dopamine level	J:93552
	decreased noradrenaline level	J:93552
	increased serotonin level	J:93552
Th^tm4.1Rpa/Th^tm4.1Rpa Tg(Chx10-EGFP/cre,-ALPP)2Clc/0 (involves: 129S4/SvJaeSor * 129S7/SvEvBrd * C57BL/6 * SJL)	decreased dopamine level	J:185955
Thap11^em1Poche/Thap11^em1Poche (C57BL/6J-Thap11^em1Poche)	abnormal enzyme/coenzyme level	J:317822
Thap11^em1Poche/Thap11^em1Poche (C57BL/6J-Thap11^em1Poche)	cyanosis	J:317822
Thap12^em1(IMPC)J/Thap12⁺ (C57BL/6NJ-Thap12^em1(IMPC)J/Mmjax)	decreased circulating bilirubin level	J:211773
	increased circulating glucose level	J:211773
Thbd^tm1.1Hlwu/Thbd^tm1.1Hlwu Lyz2^tm1(cre)Ifo/Lyz2⁺ (B6.129-Thbd^tm1.1Hlwu Lyz2^tm1(cre)Ifo)	decreased circulating interleukin-6 level	J:188879
	decreased circulating tumor necrosis factor level	J:188879
Thbd^tm1Emc/Thbd^tm1Emc (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	abnormal circulating protein level	J:54997
Thbd^tm1Wlr/Thbd^tm1Wlr (B6.129S2-Thbd^tm1Wlr)	abnormal blood coagulation	J:111502
	decreased circulating tumor necrosis factor level	J:111502
	increased circulating D-dimer level	J:111502
	increased circulating interleukin-1 beta level	J:111502
	increased circulating interleukin-6 level	J:111502
	increased susceptibility to induced thrombosis	J:111502
Thbd^tm1Wlr/Thbd^tm2Rdr (involves: 129S2/SvPas * C57BL/6)	abnormal blood coagulation	J:111502
	abnormal lung thrombosis	J:47676
	increased circulating D-dimer level	J:111502
	increased susceptibility to induced thrombosis	J:111502
Thbd^tm2.1Emc/Thbd^tm2.1Emc (involves: 129/Sv * BALB/c * C57BL/6)	increased circulating interleukin-1 beta level	J:118000
	increased circulating tumor necrosis factor level	J:118000
Thbs1^{tm1.1(KOMP)Vlcg}/Thbs1^{tm1.1(KOMP)Vlcg} (C57BL/6N-Thbs1^{tm1.1(KOMP)Vlcg}/Ucd)	increased circulating alanine transaminase level	J:211773
Thbs1^tm1Hyn/Thbs1^tm1Hyn Thbs2^tm1Bst/Thbs2^tm1Bst (involves: 129T2/SvEms * 129X1/SvJ)	increased bleeding time	J:78876
Thbs2^tm1Bst/Thbs2^tm1Bst (either: (involves: 129S4/SvJae * 129X1/SvJ) or (involves: 129X1/SvJ))	increased bleeding time	J:45509
Them5^tm1Hem/Them5^tm1Hem (involves: 129P2/OlaHsd * C57BL/6)	decreased fatty acids level	J:186657
	increased circulating free fatty acids level	J:186657
Themis2^{tm1a(KOMP)Wtsi}/Themis2^{tm1a(KOMP)Wtsi} (B6JTyr;B6N-Themis2^{tm1a(KOMP)Wtsi}/Wtsi)	decreased circulating potassium level	J:175295
	increased circulating potassium level	J:175295
Thim^{Tg(Myh6-TGFB1)1Ljf}/Thim⁺ (involves: C3HeB/FeJ)	extremity edema	J:59903
Thoc7^em1(IMPC)J/Thoc7⁺ (C57BL/6NJ-Thoc7^em1(IMPC)J/Mmjax)	increased circulating bilirubin level	J:211773
Thop1^{Gt(CSG163)Byg}/Thop1^{Gt(CSG163)Byg} (B6.129P2-Thop1^{Gt(CSG163)Byg})	increased bleeding time	J:290567
Thra^em1Ffla/Thra⁺ (C57BL/6-Thra^em1Ffla)	increased triiodothyronine level	J:268664
Thra^em2Ffla/Thra⁺ (C57BL/6-Thra^em2Ffla)	increased triiodothyronine level	J:268664
Thra^tm1.1Fcas/Thra^tm1.1Fcas (B6.Cg-Thra^tm1.1Fcas)	abnormal glucose homeostasis	J:179839
	abnormal insulin secretion	J:179839
	decreased body temperature	J:179839
	impaired glucose tolerance	J:179839
	increased circulating glucagon level	J:179839
	increased circulating glucose level	J:179839
	increased circulating insulin level	J:179839
	increased circulating thyroxine level	J:179839
	increased circulating triiodothyronine level	J:179839
	increased glucagon secretion	J:179839
	increased insulin secretion	J:179839
	increased insulin sensitivity	J:179839
	insulin resistance	J:179839
Thra^{tm1b(EUCOMM)Wtsi}/Thra⁺ (C57BL/6N-Thra^{tm1b(EUCOMM)Wtsi}/Ics)	improved glucose tolerance	J:211773
	increased blood urea nitrogen level	J:211773
	increased circulating alkaline phosphatase level	J:211773
	increased circulating creatinine level	J:211773
Thra^tm1Brnt/Thra⁺ (involves: 129S4/SvJae * C57BL/6)	decreased core body temperature	J:85803
	impaired adaptive thermogenesis	J:85803
	impaired lipolysis	J:85803
	increased circulating glucose level	J:85803
	increased circulating insulin level	J:85803
	increased circulating leptin level	J:85803
	increased circulating thyroid-stimulating hormone level	J:85803
	increased circulating thyroxine level	J:85803
	increased circulating triiodothyronine level	J:85803
	insulin resistance	J:85803
Thra^tm1Ffla/Thra⁺ Tg(Sycp1-cre)4Min/? (involves: 129/Sv * C57BL/6 * DBA/2)	impaired adaptive thermogenesis	J:125353
Thra^tm1Jas/Thra^tm1Jas (involves: 129S1/Sv * 129X1/SvJ)	decreased circulating thyroxine level	J:68577
Thra^tm1Jas/Thra^tm1Jas Thrb^tm1Olc/Thrb^tm1Olc (involves: 129/Sv * 129S1/Sv * 129X1/SvJ)	increased circulating thyroid-stimulating hormone level	J:52829
	increased circulating thyroxine level	J:52829
	increased triiodothyronine level	J:52829
Thra^tm1Syc/Thra⁺ (involves: 129S6/SvEvTac * NIH Black Swiss)	increased circulating thyroid-stimulating hormone level	J:73446
	increased circulating triiodothyronine level	J:73446
Thra^tm1Syc/Thra⁺ (involves: 129S6/SvEvTac * C57BL/6J * NIH Black Swiss)	abnormal hormone level	J:217018
	increased thyroid-stimulating hormone level	J:217018
	increased triiodothyronine level	J:217018
Thra^tm1Ven/Thra^tm1Ven (involves: 129P2/OlaHsd * BALB/c)	decreased body temperature	J:45675
Thra^tm1Ven/Thra^tm1Ven Thrb^tm1Df/Thrb^tm1Df (B6.129-Thra^tm1Ven Thrb^tm1Df)	abnormal pituitary hormone level	J:117324
	decreased follicle stimulating hormone level	J:117324
	decreased growth hormone level	J:117324
	decreased luteinizing hormone level	J:117324
	decreased prolactin level	J:117324
	increased thyroid-stimulating hormone level	J:117324
Thra^tm1Ven/Thra^tm1Ven Thrb^tm1Df/Thrb^tm1Df (involves: 129P2/OlaHsd * 129S1/Sv * 129X1/SvJ * C57BL/6)	increased circulating thyroid-stimulating hormone level	J:95391
	increased circulating thyroxine level	J:95391
	increased circulating triiodothyronine level	J:95391
Thra^tm2Jas/Thra^tm2Jas (involves: 129)	decreased circulating insulin-like growth factor I level	J:120899
Thra^tm2Jas/Thra^tm2Jas (involves: 129)	decreased circulating thyroxine level	J:68577, J:120899
Thra^tm2Jas/Thra^tm2Jas (involves: 129/Sv * C57BL/6)	decreased circulating thyroxine level	J:126521
Thra^tm2Ven/Thra⁺ (involves: 129P2/OlaHsd * BALB/c)	abnormal thyroid-stimulating hormone level	J:72959
	decreased circulating insulin-like growth factor I level	J:72959
	decreased circulating thyroxine level	J:72959
	decreased circulating triiodothyronine level	J:72959
	increased body temperature	J:72959
Thra^tm2Ven/Thra^tm2Ven (involves: 129P2/OlaHsd * BALB/c)	abnormal thyroid-stimulating hormone level	J:72959
	decreased circulating insulin-like growth factor I level	J:72959
	decreased circulating thyroxine level	J:72959
	decreased circulating triiodothyronine level	J:72959
	increased body temperature	J:72959
Thra^tm2Ven/Thra^tm2Ven Thrb^tm1Df/Thrb^tm1Df (involves: 129P2/OlaHsd * BALB/c * C57BL/6J)	abnormal thyroid hormone level	J:118402
	decreased circulating thyroxine level	J:118402
	decreased circulating triiodothyronine level	J:118402
Thra^tm4.1Ven/Thra⁺ (involves: 129P2/OlaHsd * C57BL/6 * C57BL/6NCrl * FVB/N)	increased circulating triiodothyronine level	J:166513
Thrap3^{tm1c(KOMP)Wtsi}/Thrap3^{tm1c(KOMP)Wtsi} Speer6-ps1^{Tg(Alb-cre)21Mgn}/Speer6-ps1⁺ (involves: C57BL/6 * C57BL/6J * C57BL/6N * DBA)	decreased circulating alanine transaminase level	J:339439
	decreased circulating aspartate transaminase level	J:339439
	decreased circulating cholesterol level	J:339439
	decreased circulating free fatty acids level	J:339439
	decreased circulating glucose level	J:339439
	decreased circulating insulin level	J:339439
	decreased circulating triglyceride level	J:339439
	decreased liver cholesterol level	J:339439
	decreased liver triglyceride level	J:339439
	improved glucose tolerance	J:339439
	increased energy expenditure	J:339439
	increased insulin sensitivity	J:339439
	increased oxygen consumption	J:339439
Thrb^tm1.1Syc/Thrb⁺ (involves: 129S6/SvEvTac * FVB/N * NIH Black Swiss)	increased circulating thyroid-stimulating hormone level	J:65885
	increased circulating thyroxine level	J:65885
	increased circulating triiodothyronine level	J:65885
Thrb^tm1.1Syc/Thrb^tm1.1Syc (involves: 129S6/SvEvTac * FVB/N * NIH Black Swiss)	abnormal circulating hormone level	J:65885
	increased circulating thyroid-stimulating hormone level	J:65885
	increased circulating thyroxine level	J:84310, J:65885
	increased circulating triiodothyronine level	J:65885
Thrb^tm1.1Syc/Thrb^tm1.1Syc (involves: 129S6/SvEvTac * 129X1/SvJ * C57BL/6)	abnormal pituitary hormone level	J:95391
	abnormal thyroid hormone level	J:95391
	increased circulating thyroid-stimulating hormone level	J:95391
	increased circulating thyroxine level	J:95391
	increased circulating triiodothyronine level	J:95391
Thrb^tm1Df/Thrb^tm1Df (involves: 129S1/Sv * C57BL/6J)	decreased circulating thyroxine level	J:34421
	increased circulating thyroxine level	J:34421
	increased circulating triiodothyronine level	J:34421
	increased thyroid-stimulating hormone level	J:34421
Thrb^tm1Df/Thrb^tm1Df (either: B6.129S1-Thrb^tm1Df or (involves: 129S1/Sv * C57BL/6J))	increased circulating thyroxine level	J:103702
	increased circulating triiodothyronine level	J:103702
	increased thyroid-stimulating hormone level	J:103702
Thrb^tm1Few/Thrb^tm1Few (involves: 129S4/SvJae)	increased circulating thyroid-stimulating hormone level	J:56668
	increased thyroxine level	J:56668
	increased triiodothyronine level	J:56668
Thrb^tm1Mkni/Thrb^tm1Mkni Hprt1^{tm1(TG-cre)1Sasr}/Y (involves: 129/Sv * C57BL/6)	abnormal thyroid hormone level	J:208718
	decreased circulating thyroid-stimulating hormone level	J:208718
	increased circulating levels of thyroid hormone	J:208718
	increased circulating thyroxine level	J:208718
	increased thyroxine level	J:208718
Thrb^tm1Olc/Thrb^tm1Olc (involves: 129)	decreased circulating insulin-like growth factor I level	J:120899
	increased circulating thyroid-stimulating hormone level	J:126521, J:52829, J:120899
	increased circulating thyroxine level	J:126521, J:52829, J:68577, J:120899
	increased circulating triiodothyronine level	J:126521, J:52829
Thrb^{tm2a(EUCOMM)Wtsi}/Thrb^{tm2a(EUCOMM)Wtsi} (C57BL/6N-Thrb^{tm2a(EUCOMM)Wtsi}/H)	decreased circulating glycerol level	J:165965
Thrb^tm2Df/Thrb^tm2Df (involves: 129S1/Sv * C57BL/6J)	increased circulating thyroid-stimulating hormone level	J:66737
Thrb^tm2Df/Thrb^tm2Df (involves: 129S1/Sv * C57BL/6J)	increased circulating triiodothyronine level	J:66737
Thrb^tm2Few/Thrb⁺ (involves: 129X1/SvJ * C57BL/6)	increased circulating thyroid-stimulating hormone level	J:77623
	increased thyroxine level	J:77623
	increased triiodothyronine level	J:77623
Thrb^tm2Few/Thrb^tm2Few (involves: 129X1/SvJ * C57BL/6)	increased circulating thyroid-stimulating hormone level	J:77623
	increased thyroxine level	J:77623
	increased triiodothyronine level	J:77623
Thrb^tm3Few/Thrb^tm3Few (involves: 129 * C57BL/6)	increased circulating thyroid-stimulating hormone level	J:85158
	increased circulating thyroxine level	J:85158
	increased circulating triiodothyronine level	J:85158
Thrb^tm4Few/Thrb^tm4Few (involves: 129 * C57BL/6)	increased circulating thyroid-stimulating hormone level	J:85158
Thrb^tm5Few/Thrb⁺ (involves: 129 * C57BL/6)	increased circulating thyroxine level	J:100929
Thrb^tm5Few/Thrb^tm5Few (involves: 129 * C57BL/6)	increased circulating thyroid-stimulating hormone level	J:100929
	increased circulating thyroxine level	J:100929
	increased circulating triiodothyronine level	J:100929
Thrb^tm6.1Few/Thrb⁺ (involves: 129 * C57BL/6)	increased circulating thyroxine level	J:150008
Thrb^tm6.1Few/Thrb⁺ (involves: 129 * C57BL/6)	increased circulating triiodothyronine level	J:150008
Thrb^tm6.1Few/Thrb^tm6.1Few (involves: 129 * C57BL/6)	increased circulating thyroxine level	J:150008
Thrb^tm6.1Few/Thrb^tm6.1Few (involves: 129 * C57BL/6)	increased circulating triiodothyronine level	J:150008
Thrsp^tm1Cnm/Thrsp^tm1Cnm (B6.129-Thrsp^tm1Cnm)	abnormal lipid homeostasis	J:129452
Thrsp^tm1Cnm/Thrsp^tm1Cnm (B6.129-Thrsp^tm1Cnm)	decreased triglyceride level	J:129452
Tial1^{tm1b(EUCOMM)Wtsi}/Tial1⁺ (C57BL/6N-Tial1^{tm1b(EUCOMM)Wtsi}/Wtsi)	decreased circulating calcium level	J:211773
	decreased circulating cholesterol level	J:211773
	decreased circulating HDL cholesterol level	J:211773
	decreased circulating triglyceride level	J:211773
Ticam1^Lps2/Ticam1^Lps2 (involves: C57BL/6)	decreased circulating tumor necrosis factor level	J:86521
Ticam1^Lps2/Ticam1^Lps2 (involves: C57BL/6)	decreased macrophage nitric oxide production	J:84896
Ticam1^Lps2/Ticam1^Lps2 (C57BL/6J-Ticam1^Lps2)	abnormal circulating tumor necrosis factor level	J:138963
Ticam1^Lps2/Ticam1^Lps2 (C57BL/6J-Ticam1^Lps2/J)	abnormal chemokine level	J:288471
Ticam1^tm1Aki/Ticam1^tm1Aki (involves: 129P2/OlaHsd)	abnormal cytokine level	J:174941
	abnormal interleukin level	J:137522
	decreased circulating interleukin-6 level	J:145306
Ticam1^tm1Aki/Ticam1^tm1Aki (involves: 129P2/OlaHsd * C57BL/6)	abnormal cytokine level	J:169158
	decreased circulating interferon-gamma level	J:130954
	decreased circulating interleukin-6 level	J:130954
	decreased circulating interleukin-12b level	J:130954
Ticam1^tm1Aki/Ticam1^tm1Aki (B6.129P2-Ticam1^tm1Aki)	abnormal cytokine level	J:144301
Ticam1^tm1Aki/Ticam1^tm1Aki (B6.129P2-Ticam1^tm1Aki)	decreased circulating tumor necrosis factor level	J:144301
Tie1^tm1.1Scba/Tie1^tm1.1Scba (involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * FVB/N)	edema	J:158668
Tie1^tm1Geno/Tie1^tm1Geno (involves: ICR)	edema	J:159507
Tie1^tm1Jpa/Tie1^tm1Jpa (involves: 129S1/Sv * 129X1/SvJ * CD-1)	edema	J:30121
Tie1^tm1Jpa/Tie1^tm1Jpa (involves: 129S1/Sv * 129X1/SvJ * ICR)	edema	J:159507
Tie1^tm1Sato/Tie1^tm1Sato (either: (involves: 129S1/Sv * 129T2/SvEmsJ) or (involves: 129S1/Sv * C57BL/6J))	intestinal edema	J:26844
	pulmonary edema	J:26844
	skin edema	J:26844
Tie1^tm1Scba/Tie1^tm1Scba (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	edema	J:158668
Tie1^tm2Vlcg/Tie1^tm2Vlcg (Not Specified)	edema	J:200671
Tigd3^em1(IMPC)J/Tigd3^em1(IMPC)J (C57BL/6NJ-Tigd3^em1(IMPC)J/Mmjax)	impaired glucose tolerance	J:211773
	increased circulating alanine transaminase level	J:211773
	increased circulating aspartate transaminase level	J:211773
Tigit^{tm1.1(IMPC)Wtsi}/Tigit^{tm1.1(IMPC)Wtsi} (C57BL/6N-Tigit^{tm1.1(IMPC)Wtsi}/Wtsi)	decreased circulating potassium level	J:211773
	increased circulating free fatty acids level	J:211773
Timd4^tm1Kuch/Timd4^tm1Kuch (involves: C57BL/6)	abnormal circulating chemokine level	J:235399
	decreased circulating interleukin-10 level	J:235399
	increased circulating creatinine level	J:235399
	increased circulating interleukin-1 beta level	J:235399
	increased circulating interleukin-6 level	J:235399
	increased circulating interleukin-12b level	J:235399
Timm8a1^em1(IMPC)Tcp/Y (C57BL/6NCrl-Timm8a1^em1(IMPC)Tcp/Tcp)	decreased circulating total protein level	J:211773
	increased blood urea nitrogen level	J:211773
	increased circulating alkaline phosphatase level	J:211773
Timm8a1^em1(IMPC)Tcp/Timm8a1^em1(IMPC)Tcp (C57BL/6NCrl-Timm8a1^em1(IMPC)Tcp/Tcp)	increased circulating alanine transaminase level	J:211773
	increased circulating alkaline phosphatase level	J:211773
	increased circulating bilirubin level	J:211773
Timm10b^{tm1.1(KOMP)Vlcg}/Timm10b⁺ (C57BL/6N-Timm10b^{tm1.1(KOMP)Vlcg}/J)	increased circulating alkaline phosphatase level	J:211773
Timm22^{tm1b(KOMP)Wtsi}/Timm22⁺ (C57BL/6N-Timm22^{tm1b(KOMP)Wtsi}/J)	increased circulating sodium level	J:211773
Timm50^{tm1b(EUCOMM)Wtsi}/Timm50⁺ (C57BL/6N-Timm50^{tm1b(EUCOMM)Wtsi}/Ics)	increased circulating alanine transaminase level	J:211773
Timmdc1^{tm1b(EUCOMM)Wtsi}/Timmdc1⁺ (C57BL/6N-Timmdc1^{tm1b(EUCOMM)Wtsi}/Wtsi)	increased circulating alanine transaminase level	J:211773
Timo/Timo (either: B6.Cg-Timo or (involves: C57BL/6J * CBA/CaJ))	abnormal glucose homeostasis	J:127183
	impaired glucose tolerance	J:127183
	increased circulating cholesterol level	J:127183
	increased circulating glucose level	J:127183
	increased circulating insulin level	J:127183
	increased circulating LDL cholesterol level	J:127183
	increased circulating leptin level	J:127183
	insulin resistance	J:127183
Timo/Timo⁺ (either: B6.Cg-Timo or (involves: C57BL/6J * CBA/CaJ))	increased circulating LDL cholesterol level	J:127183
Timp1^tm1Pds/Y (involves: 129S4/SvJae)	increased circulating testosterone level	J:49303
Timp1^tm1Pds/Timp1^tm1Pds (involves: 129S4/SvJae)	decreased circulating progesterone level	J:64154
Timp1^tm1Pds/Timp1^tm1Pds (involves: 129S4/SvJae)	increased circulating estradiol level	J:64154
Timp2^tm1Jjc/Timp2^tm1Jjc (involves: 129P2/OlaHsd * C57BL/6)	abnormal enzyme/coenzyme level	J:64002
Timp3^tm1Osya/Timp3^tm1Osya (involves: 129P2/OlaHsd * C57BL/6J)	decreased susceptibility to induced hypothermia	J:215209
	increased body temperature	J:215209
	increased carbon dioxide production	J:215209
	increased oxygen consumption	J:215209
Timp3^tm1Rkho/Timp3^tm1Rkho (involves: 129 * C57BL/6)	pulmonary edema	J:112033
Tiparp^{Gt(ROSA)79Sor}/Tiparp^{Gt(ROSA)79Sor} (involves: 129S4/SvJaeSor)	increased blood urea nitrogen level	J:117491
Tiparp^{Gt(ROSA)79Sor}/Tiparp^{Gt(ROSA)79Sor} (either: (involves: 129S4/SvJaeSor) or (involves: 129S4/SvJaeSor * C57BL/6))	decreased circulating estradiol level	J:142042
Tiparp^{Gt(ROSA)79Sor}/Tiparp^{Gt(ROSA)79Sor} (involves: 129S4/SvJaeSor * C57BL/6 * C57BL/6J)	decreased fasting circulating glucose level	J:250417
	increased circulating alanine transaminase level	J:250417
Tjp1^tm1.1Whun/Tjp1^tm1.1Whun Tg(Nphs1-cre)33Mska/0 (involves: C57BL/6 * C57BL/6N * DBA/2)	albuminuria	J:226210
	increased urine protein level	J:226210
Tjp1^tm1.1Whun/Tjp1^tm1.1Whun Tjp2^tm2Whun/Tjp2^tm2Whun Speer6-ps1^{Tg(Alb-cre)21Mgn}/Speer6-ps1⁺ (involves: 129S6/SvEvTac * C57BL/6 * C57BL/6N * C57BL/6NTac * DBA/2)	increased bile salt level	J:306936
	increased circulating alanine transaminase level	J:306936
	increased circulating alkaline phosphatase level	J:306936
	increased circulating aspartate transaminase level	J:306936
	increased circulating bilirubin level	J:306936
	increased circulating LDL cholesterol level	J:306936
Tjp2^tm2Whun/Tjp2^tm2Whun Speer6-ps1^{Tg(Alb-cre)21Mgn}/Speer6-ps1⁺ (involves: 129S6/SvEvTac * C57BL/6 * C57BL/6NTac * DBA/2)	increased circulating alanine transaminase level	J:306936
	increased circulating aspartate transaminase level	J:306936
	increased circulating LDL cholesterol level	J:306936
Tk1^tm1Vnd/Tk1^tm1Vnd (involves: 129P2/OlaHsd * C57BL/6)	hemosiderosis	J:101669
Tk2^tm1Anka/Tk2^tm1Anka (involves: 129X1/SvJ * C57BL/6)	abnormal adaptive thermogenesis	J:137664
Tk2^tm1Anka/Tk2^tm1Anka (involves: 129X1/SvJ * C57BL/6)	decreased body temperature	J:137664
Tkfc^{em1(IMPC)Ccpcz}/Tkfc^{em1(IMPC)Ccpcz} (C57BL/6NCrl-Tkfc^{em1(IMPC)Ccpcz}/Ccpcz)	increased circulating phosphate level	J:211773
Tldc2^em1(IMPC)J/Tldc2^em1(IMPC)J (C57BL/6NJ-Tldc2^em1(IMPC)J/Mmjax)	decreased circulating calcium level	J:211773
Tle3^tm1.1Pton/Tle3^tm1.1Pton Tg(Adipoq-cre)1Evdr/0 (involves: 129P2/OlaHsd * C57BL/6J * FVB/NJ)	decreased susceptibility to induced hypothermia	J:198134
	increased core body temperature	J:198134
	increased energy expenditure	J:198134
Tle4^em1(IMPC)Mbp/Tle4^em1(IMPC)Mbp (C57BL/6NCrl-Tle4^em1(IMPC)Mbp/Mmucd)	abnormal cholesterol homeostasis	J:211773
	impaired glucose tolerance	J:211773
Tlk1^{tm1b(EUCOMM)Hmgu}/Tlk1^{tm1b(EUCOMM)Hmgu} (C57BL/6N-Tlk1^{tm1b(EUCOMM)Hmgu}/J)	increased circulating alkaline phosphatase level	J:211773
	increased circulating bilirubin level	J:211773
	increased circulating phosphate level	J:211773
Tll1^tm1Dgr/Tll1^tm1Dgr (involves: 129S6/SvEvTac * Black Swiss)	edema	J:54910
Tln1^tm1.1Bpet/Tln1^tm4.1Crit Tg(Pf4-icre)Q3Rsko/0 (involves: 129P2/OlaHsd * C57BL/6)	abnormal platelet physiology	J:177971
	reduced thrombolysis	J:177971
Tln1^tm4.1Crit/Tln1^tm4.1Crit Tg(Mx1-cre)1Cgn/? (involves: 129P2/OlaHsd * C57BL/6 * CBA)	abnormal platelet activation	J:129708
	abnormal thrombosis	J:129708
	increased bleeding time	J:129708
Tln1^tm4.1Crit/Tln1^tm4.1Crit Tg(Pf4-icre)Q3Rsko/? (involves: 129P2/OlaHsd)	abnormal platelet activation	J:129707
	abnormal thrombosis	J:129707
	increased bleeding time	J:129707
Tln1^tm4.1Crit/Tln1^tm4.1Crit Tg(Pf4-icre)Q3Rsko/0 (involves: 129P2/OlaHsd * C57BL/6)	reduced thrombolysis	J:177971
Tlr2^tm1Aki/Tlr2^tm1Aki (involves: 129P2/OlaHsd * C57BL/6)	abnormal chemokine level	J:88174
	abnormal glucose homeostasis	J:124334
	abnormal tumor necrosis factor level	J:124334
Tlr2^tm1Aki/Tlr2^tm1Aki (B6.129P2-Tlr2^tm1Aki)	abnormal circulating cholesterol level	J:158035
	abnormal circulating glucose level	J:158035
	abnormal circulating insulin level	J:158035
	abnormal circulating LDL cholesterol level	J:158035
	abnormal circulating lipid level	J:158035
	abnormal glucose homeostasis	J:158035
	abnormal interleukin level	J:118954
	decreased circulating VLDL cholesterol level	J:158035
	increased circulating free fatty acids level	J:158035
Tlr2^tm1Aki/Tlr2^tm1Aki (involves: 129P2/OlaHsd)	decreased circulating alanine transaminase level	J:135830
	decreased circulating interleukin-1 beta level	J:119941
	decreased circulating tumor necrosis factor level	J:119941
Tlr2^tm1Aki/Tlr2^tm1Aki (NOD.129P2-Tlr2^tm1Aki)	abnormal glucose homeostasis	J:124334
Tlr2^tm1Aki/Tlr2^tm1Aki Tlr4^tm1Aki/Tlr4^tm1Aki (B6.129P2-Tlr2^tm1Aki Tlr4^tm1Aki)	hyperoxia	J:102879
Tlr2^tm1Kir/Tlr2^tm1Kir (either: (involves: 129/Sv * C57BL/6) or (involves: 129/Sv * C57BL/6 * C57BL/6J))	decreased macrophage nitric oxide production	J:85323
Tlr2^tm1Kir/Tlr2^tm1Kir (B6.129-Tlr2^tm1Kir)	abnormal glucose homeostasis	J:162168
	decreased circulating insulin level	J:162168
	decreased circulating leptin level	J:162168
	decreased circulating tumor necrosis factor level	J:162168
	improved glucose tolerance	J:162168
	increased energy expenditure	J:162168
	increased insulin secretion	J:162168
	increased insulin sensitivity	J:162168
Tlr2^tm1Kir/Tlr2^tm1Kir (involves: 129)	abnormal circulating corticosterone level	J:94463
	abnormal circulating pituitary hormone level	J:94463
	decreased circulating corticosterone level	J:94463
	increased circulating adrenocorticotropin level	J:94463
Tlr3^tm1Flv/Tlr3^tm1Flv (involves: 129S1/Sv)	abnormal cytokine level	J:119967
	abnormal interferon level	J:119967
	abnormal interleukin level	J:119967
	abnormal tumor necrosis factor level	J:119967
	hyperglycemia	J:135353
	increased circulating troponin I level	J:119967
Tlr3^tm1Flv/Tlr3^tm1Flv (B6.129S1-Tlr3^tm1Flv/Apb)	abnormal cytokine level	J:129533
Tlr3^tm1Flv/Tlr3^tm1Flv (B6.129S1-Tlr3^tm1Flv/Apb)	abnormal interleukin level	J:126415
Tlr4^Lps-d/Tlr4^Lps-d (involves: C3H/HeJ)	abnormal circulating enzyme level	J:114368
	abnormal tumor necrosis factor level	J:124334, J:114368
	decreased circulating alanine transaminase level	J:114368
Tlr4^Lps-d/Tlr4^Lps-d (C3H/HeJ-Tlr4^Lps-d)	abnormal circulating glucose level	J:126488
	abnormal circulating leptin level	J:126488
	abnormal cytokine level	J:96680
	abnormal fatty acids level	J:126488
	abnormal gas homeostasis	J:126488
	abnormal glucose homeostasis	J:126488
	abnormal interleukin level	J:96680
	abnormal lipid level	J:126488
	abnormal tumor necrosis factor level	J:96680
	decreased body temperature	J:162716
	decreased circulating insulin level	J:126488
	decreased liver triglyceride level	J:126488
	decreased respiratory quotient	J:126488
	improved glucose tolerance	J:126488
	increased adiponectin level	J:126488
	increased circulating interleukin-6 level	J:37271
	increased oxygen consumption	J:126488
	pulmonary edema	J:96680
Tlr4^lps-del/Tlr4^lps-del (involves: C57BL/10ScN)	abnormal circulating enzyme level	J:114368
	abnormal tumor necrosis factor level	J:114368
	decreased circulating alanine transaminase level	J:114368
Tlr4^tm1.1Djh/Tlr4^tm1.1Djh (involves: C57BL/6 * FVB/N * SJL)	abnormal bile salt level	J:193668
Tlr4^tm1Aki/Tlr4^tm1Aki (involves: 129P2/OlaHsd)	decreased circulating interleukin-6 level	J:145306
Tlr4^tm1Djh/Tlr4^tm1Djh Tg(Vil1-cre)997Gum/0 (involves: C57BL/6 * C57BL/6J * FVB/N * SJL)	abnormal bile salt level	J:193668
Tlr5^tm1Flv/Tlr5^tm1Flv (involves: 129S1/Sv * C57BL/6)	abnormal glucose homeostasis	J:158055
	increased circulating cholesterol level	J:158055
	increased circulating insulin level	J:158055
	increased circulating lipocalin 2 level	J:158055
	increased circulating triglyceride level	J:158055
	increased susceptibility to diet-induced obesity	J:158055
	insulin resistance	J:158055
Tlr7^em2Anu/Y (C57BL/6NCrl-Tlr7^em2Anu)	increased circulating interferon-gamma level	J:324448
	increased circulating interleukin-6 level	J:324448
	increased circulating interleukin-10 level	J:324448
	increased circulating tumor necrosis factor level	J:324448
Tlr7^em2Anu/Tlr7⁺ (C57BL/6NCrl-Tlr7^em2Anu)	increased circulating interferon-gamma level	J:324448
	increased circulating interleukin-6 level	J:324448
	increased circulating interleukin-10 level	J:324448
	increased circulating tumor necrosis factor level	J:324448
Tlr7^tm1Flv/Tlr7^tm1Flv (involves: 129S1/Sv)	decreased circulating interferon-alpha level	J:89257
Tlr8^tm1Vlcg/Tlr8^tm1Vlcg (B6.129S1-Tlr8^tm1Vlcg)	increased circulating interleukin-12 level	J:165267
Tlx3^tm1Sjk/Tlx3^tm1Sjk (involves: 129X1/SvJ)	cyanosis	J:60751
tm/tm (Not Specified)	abnormal circulating protein level	J:315
	abnormal mineral level	J:13085
	increased circulating serum albumin level	J:315
Tm2d2^em1(IMPC)Bay/Tm2d2^em1(IMPC)Bay (C57BL/6N-Tm2d2^em1(IMPC)Bay/Bay)	edema	J:211773
Tm2d3^em1(IMPC)J/Tm2d3^em1(IMPC)J (C57BL/6NJ-Tm2d3^em1(IMPC)J/Mmjax)	edema	J:211773
Tm4/Tm4⁺ (involves: C3H/HeH * C57BL/6J)	impaired glucose tolerance	J:169366
Tm6sf2^em1Yech/Tm6sf2^em1Yech (C57BL/6-Tm6sf2^em1Yech)	abnormal cholesterol homeostasis	J:235704
	decreased circulating cholesterol level	J:235704
	decreased circulating HDL cholesterol level	J:235704
	decreased circulating LDL cholesterol level	J:235704
	increased circulating triglyceride level	J:235704
Tm6sf2^{tm1a(KOMP)Wtsi}/Tm6sf2⁺ (C57BL/6N-Tm6sf2^{tm1a(KOMP)Wtsi})	abnormal cholesterol homeostasis	J:234195
	increased liver triglyceride level	J:234195
Tm6sf2^{tm1a(KOMP)Wtsi}/Tm6sf2^{tm1a(KOMP)Wtsi} (C57BL/6N-Tm6sf2^{tm1a(KOMP)Wtsi})	abnormal cholesterol homeostasis	J:234195
	abnormal circulating apolipoprotein level	J:234195
	abnormal intestinal lipid absorption	J:234195
	decreased circulating cholesterol level	J:234195
	decreased circulating HDL cholesterol level	J:234195
	decreased circulating LDL cholesterol level	J:234195
	decreased circulating VLDL triglyceride level	J:234195
	decreased intestinal cholesterol absorption	J:234195
	increased circulating alanine transaminase level	J:234195
	increased circulating triglyceride level	J:234195
	increased liver triglyceride level	J:234195
	increased triglyceride level	J:234195
Tm7sf2^{tm1b(KOMP)Wtsi}/Tm7sf2^{tm1b(KOMP)Wtsi} (C57BL/6N-Tm7sf2^{tm1b(KOMP)Wtsi}/Orl)	decreased circulating serum albumin level	J:211773
Tm7sf2^tm1Fdp/Tm7sf2^tm1Fdp (involves: 129S4/SvJae * C57BL/6)	abnormal homeostasis	J:143838
Tm9sf3^em1(IMPC)Mbp/Tm9sf3⁺ (C57BL/6NCrl-Tm9sf3^em1(IMPC)Mbp/Mmucd)	increased circulating phosphate level	J:211773
	increased circulating triglyceride level	J:211773
Tm9sf3^em1(IMPC)Mbp/Tm9sf3^em1(IMPC)Mbp (C57BL/6NCrl-Tm9sf3^em1(IMPC)Mbp/Mmucd)	edema	J:211773
Tm9sf4^{tm1a(KOMP)Wtsi}/Tm9sf4^{tm1a(KOMP)Wtsi} (C57BL/6N-Tm9sf4^{tm1a(KOMP)Wtsi}/Wtsi)	increased circulating cholesterol level	J:211773
	increased circulating HDL cholesterol level	J:211773
	increased circulating LDL cholesterol level	J:211773
	increased circulating total protein level	J:211773
Tm45/? (involves: C3H/HeH * C57BL/6J)	abnormal glucose tolerance	J:169366
Tm59/? (involves: C3H/HeH * C57BL/6J)	abnormal glucose tolerance	J:169366
Tm59/? (involves: C3H/HeH * C57BL/6J)	increased circulating insulin level	J:169366
Tm60/? (involves: C3H/HeH * C57BL/6J)	abnormal glucose tolerance	J:169366
Tm60/? (involves: C3H/HeH * C57BL/6J)	increased circulating insulin level	J:169366
Tmbim1^tm1Noj/Tmbim1^tm1Noj (B6.129S2-Tmbim1^tm1Noj)	abnormal circulating enzyme level	J:210916
Tmc6^tm1.1Les/Tmc6^tm1.1Les (B6.129S6(Cg)-Tmc6^tm1.1Les)	abnormal protein level	J:300461
Tmc6^{tm1a(EUCOMM)Wtsi}/Tmc6^{tm1a(EUCOMM)Wtsi} (C57BL/6N-Tmc6^{tm1a(EUCOMM)Wtsi}/Wtsi)	decreased circulating aspartate transaminase level	J:175295
Tmc7^em1(IMPC)Mbp/Tmc7^em1(IMPC)Mbp (C57BL/6NCrl-Tmc7^em1(IMPC)Mbp/Mmucd)	increased circulating cholesterol level	J:211773
Tmc8^tm1.1Les/Tmc8^tm1.1Les (B6.129S6(Cg)-Tmc8^tm1.1Les)	abnormal protein level	J:300461
Tmco1^em1Smoc/Tmco1^em1Smoc (C57BL/6J-Tmco1^em1Smoc)	abnormal calcium ion homeostasis	J:233671
Tmco1^tm1Tsta/Tmco1^tm1Tsta (B6.Cg-Tmco1^tm1Tsta)	abnormal calcium ion homeostasis	J:268917
	decreased circulating estradiol level	J:268917
	increased circulating follicle stimulating hormone level	J:268917
	increased circulating luteinizing hormone level	J:268917
Tmco2^{tm1a(KOMP)Wtsi}/Tmco2^{tm1a(KOMP)Wtsi} (C57BL/6N-Tmco2^{tm1a(KOMP)Wtsi}/Wtsi)	decreased circulating fructosamine level	J:211773
Tmed3^{tm2b(EUCOMM)Hmgu}/Tmed3^{tm2b(EUCOMM)Hmgu} (C57BL/6N-Tmed3^{tm2b(EUCOMM)Hmgu}/BayMmucd)	increased circulating iron level	J:211773
Tmem9b^em1(IMPC)J/Tmem9b^em1(IMPC)J (C57BL/6NJ-Tmem9b^em1(IMPC)J/J)	increased circulating cholesterol level	J:211773
	increased circulating HDL cholesterol level	J:211773
Tmem11^em1(IMPC)Tcp/Tmem11^em1(IMPC)Tcp (C57BL/6N-Tmem11^em1(IMPC)Tcp/Tcp)	increased circulating aspartate transaminase level	J:211773
Tmem18^{tm1a(EUCOMM)Wtsi}/Tmem18^{tm1a(EUCOMM)Wtsi} (C57BL/6N-Tmem18^{tm1a(EUCOMM)Wtsi})	increased energy expenditure	J:244315
	increased susceptibility to diet-induced obesity	J:244315
Tmem18^{tm1b(EUCOMM)Wtsi}/Tmem18^{tm1b(EUCOMM)Wtsi} (C57BL/6N-Tmem18^{tm1b(EUCOMM)Wtsi}/Wtsi)	decreased circulating glucose level	J:211773
Tmem30a^tm1.1Xjz/Tmem30a^tm1.1Xjz Speer6-ps1^{Tg(Alb-cre)21Mgn}/Speer6-ps1⁺ (involves: 129S/SvEv * 129S4/SvJaeSor * C57BL/6J * DBA)	increased bile salt level	J:249038
	increased circulating alanine transaminase level	J:249038
	increased circulating aspartate transaminase level	J:249038
	increased circulating bilirubin level	J:249038
Tmem35a^{tm1.1(KOMP)Vlcg}/Y (B6(FVB)-Tmem35a^{tm1.1(KOMP)Vlcg})	increased circulating corticosterone level	J:244268
Tmem37^{tm1a(EUCOMM)Wtsi}/Tmem37^{tm1a(EUCOMM)Wtsi} (C57BL/6N-Tmem37^{tm1a(EUCOMM)Wtsi}/Wtsi)	increased circulating bilirubin level	J:211773
Tmem38b^tm1Hta/Tmem38b^tm1Hta (involves: 129S4/SvJae * C57BL/6J)	abnormal calcium ion homeostasis	J:150355
	acidosis	J:150355
	cyanosis	J:150355
	hypoxia	J:150355
Tmem41b^em1Cya/Tmem41b⁺ (involves: C57BL/6)	decreased circulating cholesterol level	J:316472
	decreased circulating LDL cholesterol level	J:316472
	decreased circulating triglyceride level	J:316472
Tmem42^{tm1b(KOMP)Wtsi}/Tmem42^{tm1b(KOMP)Wtsi} (C57BL/6N-Tmem42^{tm1b(KOMP)Wtsi}/Wtsi)	decreased circulating HDL cholesterol level	J:211773
Tmem51^{tm1b(EUCOMM)Hmgu}/Tmem51^{tm1b(EUCOMM)Hmgu} (C57BL/6N-Tmem51^{tm1b(EUCOMM)Hmgu}/H)	decreased circulating fructosamine level	J:211773
	increased circulating HDL cholesterol level	J:211773
Tmem60^{em1(IMPC)Ccpcz}/Tmem60^{em1(IMPC)Ccpcz} (C57BL/6N-Tmem60^{em1(IMPC)Ccpcz}/Ccpcz)	increased circulating total protein level	J:211773
Tmem63b^{tm1b(EUCOMM)Wtsi}/Tmem63b⁺ (C57BL/6N-Tmem63b^{tm1b(EUCOMM)Wtsi}/Ics)	increased circulating bilirubin level	J:211773
Tmem64^{Gt(SYA242)Byg}/Tmem64^{Gt(SYA242)Byg} (involves: 129P2/OlaHsd * C57BL/6)	increased circulating osteocalcin level	J:198051
Tmem68^{tm1a(EUCOMM)Wtsi}/Tmem68^{tm1a(EUCOMM)Wtsi} (C57BL/6N-Tmem68^{tm1a(EUCOMM)Wtsi}/Ics)	decreased circulating potassium level	J:165965
	increased circulating calcium level	J:165965
Tmem68^{tm1a(EUCOMM)Wtsi}/Tmem68^{tm1a(EUCOMM)Wtsi} (C57BL/6N-Tmem68^{tm1a(EUCOMM)Wtsi})	abnormal lipid oxidation	J:339870
	decreased circulating triglyceride level	J:339870
	decreased liver triglyceride level	J:339870
	decreased triglyceride level	J:339870
	increased respiratory quotient	J:339870
Tmem70^{tm1a(KOMP)Wtsi}/Tmem70^{tm1a(KOMP)Wtsi} (involves: C57BL/6N)	abnormal enzyme/coenzyme level	J:238642
Tmem72^{tm1b(KOMP)Wtsi}/Tmem72^{tm1b(KOMP)Wtsi} (C57BL/6N-Tmem72^{tm1b(KOMP)Wtsi}/Kmpc)	decreased blood urea nitrogen level	J:211773
	increased circulating phosphate level	J:211773
Tmem79^ma/Tmem79^ma (involves: C57BL/6JJcl * CBA/CaGr)	impaired skin barrier function	J:202316
Tmem79^ma/Tmem79^ma (B6.CBACaGr-Tmem79^ma/J)	impaired skin barrier function	J:202453
Tmem79^{tm1.1(KOMP)Wtsi}/Tmem79^{tm1.1(KOMP)Wtsi} (C57BL/6N-Tmem79^{tm1.1(KOMP)Wtsi}/J)	decreased fasting circulating glucose level	J:211773
Tmem86a^{tm1b(KOMP)Mbp}/Tmem86a^{tm1b(KOMP)Mbp} (C57BL/6N-Tmem86a^{tm1b(KOMP)Mbp}/Kmpc)	increased blood urea nitrogen level	J:211773
Tmem87b^em1(IMPC)J/Tmem87b^em1(IMPC)J (C57BL/6NJ-Tmem87b^em1(IMPC)J/J)	increased circulating HDL cholesterol level	J:211773
Tmem100^tm1.1Ysai/Tmem100^tm1.1Ysai (C57BL/6-Tmem100^tm1.1Ysai)	pericardial effusion	J:186473
Tmem100^tm1.1Ysai/Tmem100^tm2.1Ysai Tg(Tek-cre)1Ywa/0 (involves: C57BL/6 * SJL)	pericardial effusion	J:186473
Tmem100^{tm1e.1(KOMP)Wtsi}/Tmem100⁺ (C57BL/6N-Tmem100^{tm1e.1(KOMP)Wtsi}/Tcp)	decreased circulating calcium level	J:211773
Tmem100^{tm1e.1(KOMP)Wtsi}/Tmem100^{tm1e.1(KOMP)Wtsi} (C57BL/6N-Tmem100^{tm1e.1(KOMP)Wtsi}/Tcp)	edema	J:211773
Tmem104^{tm1.1(KOMP)Vlcg}/Tmem104^{tm1.1(KOMP)Vlcg} (C57BL/6N-Tmem104^{tm1.1(KOMP)Vlcg}/J)	increased circulating alanine transaminase level	J:211773
Tmem106b^{tm2b(KOMP)Wtsi}/Tmem106b^{tm2b(KOMP)Wtsi} (C57BL/6N-Tmem106b^{tm2b(KOMP)Wtsi}/Ucd)	increased circulating alkaline phosphatase level	J:211773
Tmem108^{tm1b(EUCOMM)Wtsi}/Tmem108^{tm1b(EUCOMM)Wtsi} (C57BL/6N-Tmem108^{tm1b(EUCOMM)Wtsi}/Ics)	increased circulating aspartate transaminase level	J:211773
Tmem115^{tm1(KOMP)Vlcg}/Tmem115⁺ (C57BL/6N-Tmem115^{tm1(KOMP)Vlcg}/MbpMmucd)	increased circulating bilirubin level	J:211773
Tmem115^{tm1.1(KOMP)Vlcg}/Tmem115^{tm1.1(KOMP)Vlcg} (C57BL/6N-Tmem115^{tm1.1(KOMP)Vlcg}/Ucd)	edema	J:211773
Tmem116^{tm1b(EUCOMM)Hmgu}/Tmem116^{tm1b(EUCOMM)Hmgu} (C57BL/6N-Tmem116^{tm1b(EUCOMM)Hmgu}/Ieg)	decreased circulating alkaline phosphatase level	J:211773
	decreased circulating total protein level	J:211773
	improved glucose tolerance	J:211773
Tmem117^tm1.1Thor/Tmem117^tm1.1Thor (involves: C57BL/6N)	abnormal calcium level	J:339175
	increased circulating antidiuretic hormone level	J:339175
	increased glucagon secretion	J:339175
Tmem121b^em1(IMPC)Tcp/Tmem121b^em1(IMPC)Tcp (C57BL/6NCrl-Tmem121b^em1(IMPC)Tcp/Tcp)	increased circulating alanine transaminase level	J:211773
Tmem126b^em1Cya/Tmem126b^em1Cya (involves: C57BL/6J)	decreased susceptibility to diet-induced obesity	J:291866
Tmem127^{tm1(KOMP)Wtsi}/Tmem127^{tm1(KOMP)Wtsi} (C57BL/6N-Tmem127^{tm1(KOMP)Wtsi}/Wtsi)	increased circulating alkaline phosphatase level	J:211773
	increased circulating amylase level	J:211773
	increased circulating bilirubin level	J:211773
	increased circulating creatinine level	J:211773
Tmem129^{tm1.1(KOMP)Vlcg}/Tmem129^{tm1.1(KOMP)Vlcg} (C57BL/6N-Tmem129^{tm1.1(KOMP)Vlcg}/J)	increased circulating alkaline phosphatase level	J:211773
	increased circulating cholesterol level	J:211773
	increased circulating HDL cholesterol level	J:211773
Tmem131^em1(IMPC)J/Tmem131⁺ (C57BL/6NJ-Tmem131^em1(IMPC)J/Mmjax)	increased circulating alkaline phosphatase level	J:211773
Tmem131^em1(IMPC)J/Tmem131^em1(IMPC)J (C57BL/6NJ-Tmem131^em1(IMPC)J/Mmjax)	edema	J:211773
Tmem132b^{em1(IMPC)Ccpcz}/Tmem132b^{em1(IMPC)Ccpcz} (C57BL/6N-Tmem132b^{em1(IMPC)Ccpcz}/Ccpcz)	abnormal cholesterol homeostasis	J:211773
Tmem145^em1(IMPC)Mbp/Tmem145^em1(IMPC)Mbp (C57BL/6N-Tmem145^em1(IMPC)Mbp/MbpMmucd)	increased circulating alanine transaminase level	J:211773
Tmem151b^{tm1b(KOMP)Wtsi}/Tmem151b^{tm1b(KOMP)Wtsi} (C57BL/6N-Tmem151b^{tm1b(KOMP)Wtsi}/J)	increased circulating sodium level	J:211773
Tmem160^em1.1Bros/Tmem160^em1.1Bros (involves: C57BL/6JRj * FVB/N)	abnormal cytokine level	J:328221
Tmem161b^{tm2b(EUCOMM)Hmgu}/Tmem161b⁺ (C57BL/6N-Tmem161b^{tm2b(EUCOMM)Hmgu}/Bay)	decreased circulating serum albumin level	J:211773
	decreased circulating total protein level	J:211773
Tmem163^em1(IMPC)Mbp/Tmem163^em1(IMPC)Mbp (C57BL/6N-Tmem163^em1(IMPC)Mbp/MbpMmucd)	decreased circulating phosphate level	J:211773
	increased circulating insulin level	J:211773
Tmem163^em1Lwbch/Tmem163^em1Lwbch (C57BL/6J-Tmem163^em1Lwbch)	abnormal platelet physiology	J:323340
	decreased platelet aggregation	J:323340
	increased bleeding time	J:323340
Tmem167^{tm1a(EUCOMM)Hmgu}/Tmem167⁺ (C57BL/6N-Tmem167^{tm1a(EUCOMM)Hmgu}/H)	decreased circulating serum albumin level	J:165965
	decreased circulating total protein level	J:165965
	decreased circulating triglyceride level	J:165965
	increased circulating serum albumin level	J:165965
Tmem174^tm1Myz/Tmem174^tm1Myz (either: B6.Cg-Tmem174^tm1Myz or D2.Cg-Tmem174^tm1Myz)	abnormal circulating hormone level	J:328157
	decreased urine phosphate level	J:328157
	increased circulating parathyroid hormone level	J:328157
	increased circulating phosphate level	J:328157
Tmem175^{tm1b(KOMP)Wtsi}/Tmem175^{tm1b(KOMP)Wtsi} (C57BL/6N-Tmem175^{tm1b(KOMP)Wtsi}/Kmpc)	increased circulating aspartate transaminase level	J:211773
Tmem178b^{tm1a(KOMP)Wtsi}/Tmem178b^{tm1a(KOMP)Wtsi} (C57BL/6N-Tmem178b^{tm1a(KOMP)Wtsi}/Wtsi)	decreased circulating fructosamine level	J:211773
Tmem203^em1(IMPC)H/Tmem203^em1(IMPC)H (C57BL/6N-Tmem203^em1(IMPC)H/H)	decreased circulating cholesterol level	J:211773
	decreased circulating HDL cholesterol level	J:211773
	increased circulating alkaline phosphatase level	J:211773
	increased circulating calcium level	J:211773
Tmem212^em1(IMPC)J/Tmem212^em1(IMPC)J (C57BL/6NJ-Tmem212^em1(IMPC)J/Mmjax)	abnormal cholesterol homeostasis	J:211773
Tmem218^{Gt(OST40451)Lex}/Tmem218^{Gt(OST40451)Lex} (involves: 129S5/SvEvBrd * C57BL/6)	increased blood urea nitrogen level	J:227399
	increased circulating alkaline phosphatase level	J:227399
	increased circulating calcium level	J:227399
	increased circulating chloride level	J:227399
	increased circulating creatinine level	J:227399
Tmem219^{tm1(KOMP)Vlcg}/Tmem219^{tm1(KOMP)Vlcg} (B6J.B6N-Tmem219^{tm1(KOMP)Vlcg})	decreased transforming growth factor beta level	J:236976
Tmem219^{tm1(KOMP)Vlcg}/Tmem219^{tm1(KOMP)Vlcg} Tg(Scgb1a1-rtTA,tetO-Il13)1Eli/0 (involves: C57BL/6 * C57BL/6J * C57BL/6N * CBA)	increased transforming growth factor beta level	J:236976
Tmem237^{tm1b(EUCOMM)Hmgu}/Tmem237⁺ (C57BL/6N-Tmem237^{tm1b(EUCOMM)Hmgu}/Ccpcz)	increased circulating alkaline phosphatase level	J:211773
	increased circulating aspartate transaminase level	J:211773
	increased circulating calcium level	J:211773
	increased circulating chloride level	J:211773
	increased circulating triglyceride level	J:211773
Tmem240^{em1(IMPC)Ccpcz}/Tmem240^{em1(IMPC)Ccpcz} (C57BL/6N-Tmem240^{em1(IMPC)Ccpcz}/Ccpcz)	increased circulating alkaline phosphatase level	J:211773
	increased fasting circulating glucose level	J:211773
Tmem241^{tm1b(EUCOMM)Wtsi}/Tmem241^{tm1b(EUCOMM)Wtsi} (C57BL/6N-Tmem241^{tm1b(EUCOMM)Wtsi}/Wtsi)	decreased circulating alkaline phosphatase level	J:211773
Tmem248^{tm1.1(KOMP)Vlcg}/Tmem248^{tm1.1(KOMP)Vlcg} (C57BL/6N-Tmem248^{tm1.1(KOMP)Vlcg}/Ucd)	decreased circulating cholesterol level	J:211773
	increased circulating alkaline phosphatase level	J:211773
Tmem254^{tm2a(KOMP)Wtsi}/Tmem254^{tm2a(KOMP)Wtsi} (C57BL/6N-Tmem254^{tm1a(KOMP)Wtsi}/Wtsi)	decreased circulating calcium level	J:211773
Tmem260^{tm1a(KOMP)Wtsi}/Tmem260^{tm1a(KOMP)Wtsi} (C57BL/6N-Tmem260^{tm1a(KOMP)Wtsi}/Wtsi)	decreased fasting circulating glucose level	J:211773
Tmem263^em1Gww/Tmem263^em1Gww (C57BL/6J-Tmem263^em1Gww)	abnormal blood homeostasis	J:345905
	decreased circulating calcium level	J:345905
	decreased circulating glucose level	J:345905
	decreased circulating insulin level	J:345905
	decreased circulating insulin-like growth factor I level	J:345905
Tmlhe^em1Plaa/Tmlhe^em1Plaa (C57BL/6N-Tmlhe^em1Plaa)	abnormal fatty acids level	J:341247
	decreased circulating carnitine level	J:341247
	decreased circulating lactate level	J:341247
	decreased fatty acid oxidation	J:341247
	increased fatty acids level	J:341247
	increased unsaturated fatty acids level	J:341247
Tmod1^{tm1a(KOMP)Wtsi}/Tmod1⁺ (C57BL/6N-Tmod1^{tm1a(KOMP)Wtsi}/Wtsi)	increased circulating alkaline phosphatase level	J:175295
Tmod1^tm1Sung/Tmod1^tm1Sung (involves: 129S1/Sv * 129X1/SvJ)	pericardial effusion	J:89956
Tmprss2^{tm2.1(ETV1)Sho}/Tmprss2^{tm2.1(ETV1)Sho} (involves: C57BL/6 * DBA/2)	abnormal testosterone level	J:212219
Tmprss2^{tm2b(EUCOMM)Hmgu}/Tmprss2^{tm2b(EUCOMM)Hmgu} (C57BL/6N-Tmprss2^{tm2b(EUCOMM)Hmgu}/Orl)	improved glucose tolerance	J:211773
	increased circulating total protein level	J:211773
	increased fasting circulating glucose level	J:211773
Tmprss6^hem8/Tmprss6^hem8 (C57BL/6J-Tmprss6^hem8)	abnormal iron homeostasis	J:237155
	decreased circulating iron level	J:237155
	decreased liver iron level	J:237155
	increased circulating unsaturated transferrin level	J:237155
Tmprss6^hem8/Tmprss6^tm1Dgen (involves: C57BL/6 * C57BL/6J)	abnormal iron homeostasis	J:237155
	decreased circulating iron level	J:237155
	decreased liver iron level	J:237155
	increased circulating unsaturated transferrin level	J:237155
Tmprss6^m2Btlr/Tmprss6^m2Btlr (C57BL/6J-Tmprss6^m2Btlr)	decreased circulating iron level	J:140084
Tmprss6^m3Btlr/Tmprss6^m3Btlr (C57BL/6J-Tmprss6^m3Btlr)	decreased circulating iron level	J:143779
Tmprss6^msk/Tmprss6^msk (C57BL/6J-Tmprss6^msk)	abnormal iron homeostasis	J:134446
	decreased circulating iron level	J:134446
	decreased spleen iron level	J:134446
Tmprss6^{tm1b(EUCOMM)Wtsi}/Tmprss6^{tm1b(EUCOMM)Wtsi} (C57BL/6N-Tmprss6^{tm1b(EUCOMM)Wtsi}/Ics)	increased circulating calcium level	J:211773
	increased fasting circulating glucose level	J:211773
Tmprss6^tm1Dgen/Tmprss6⁺ (B6.129P2-Tmprss6^tm1Dgen/Crl)	decreased circulating iron level	J:160248
	decreased liver iron level	J:160248
	decreased spleen iron level	J:160248
Tmprss6^tm1Dgen/Tmprss6^tm1Dgen (B6.129P2-Tmprss6^tm1Dgen/Crl)	abnormal iron homeostasis	J:237155
	decreased circulating iron level	J:237155, J:160248
	decreased liver iron level	J:237155, J:160248
	decreased spleen iron level	J:160248
	increased circulating unsaturated transferrin level	J:237155
Tmprss6^tm1Dgen/Tmprss6^tm1Dgen (involves: 129P2/OlaHsd * 129S4/SvJae * 129S6/SvEvTac * C57BL/6)	abnormal iron level	J:160248
	decreased heart iron level	J:160248
	decreased liver iron level	J:160248
	decreased pancreas iron level	J:160248
Tmprss6^tm1Otin/Tmprss6^tm1Otin (involves: 129P2/OlaHsd * C57BL/6J)	abnormal iron level	J:138734
	decreased circulating iron level	J:138734
Tmprss11a^em3Bug/Tmprss11a^em3Bug Tmprss11b^em2Bug/Tmprss11b^em2Bug Tmprss11c^em3Bug/Tmprss11c^em3Bug Tmprss11d^em3Bug/Tmprss11d^em3Bug Tmprss11e^em2Bug/Tmprss11e^em2Bug Tmprss11f^em3Bug/Tmprss11f^em3Bug Tmprss11g^em2Bug/Tmprss11g^em2Bug (FVB/NJ-Tmprss11c^em3Bug Tmprss11d^em3Bug Tmprss11a^em3Bug Tmprss11g^em2Bug Tmprss11f^em3Bug Tmprss11b^em2Bug Tmprss11e^em2Bug)	impaired skin barrier function	J:279596
Tmprss11f^em1Bug/Tmprss11f^em1Bug (FVB/NJ-Tmprss11f^em1Bug)	impaired skin barrier function	J:279596
Tmprss11f^em1Nju/Tmprss11f^em1Nju (involves: C57BL/6N)	impaired skin barrier function	J:274100
Tmprss13^tm1Dgen/Tmprss13^tm1Dgen (involves: 129P2/OlaHsd * C57BL/6J)	impaired skin barrier function	J:215250
Tmprss15^{tm1a(KOMP)Wtsi}/Tmprss15^{tm1a(KOMP)Wtsi} (C57BL/6N-Tmprss15^{tm1a(KOMP)Wtsi}/Wtsi)	decreased circulating alanine transaminase level	J:175295
	decreased circulating cholesterol level	J:175295
	decreased circulating HDL cholesterol level	J:175295
	increased blood urea nitrogen level	J:175295
	increased circulating amylase level	J:175295
	increased circulating chloride level	J:175295
	increased circulating sodium level	J:175295
Tmrb1^C57BL/6J/? (involves: C57BL/6J * DBA/2J)	abnormal brain iron level	J:135429
Tmrb1^C57BL/6J/? (involves: C57BL/6J * DBA/2J)	abnormal copper homeostasis	J:135429
Tmrb2^C57BL/6J/? (involves: C57BL/6J * DBA/2J)	abnormal copper level	J:135429
Tmrb2^C57BL/6J/? (involves: C57BL/6J * DBA/2J)	abnormal mineral level	J:135429
Tmsb4x^tm1Prri/Tmsb4x^tm1Prri (B6.129-Tmsb4x^tm1Prri)	hemopericardium	J:195902
Tmt1b^{tm1.1(KOMP)Vlcg}/Tmt1b^{tm1.1(KOMP)Vlcg} (C57BL/6N-Timt1b^{tm1.1(KOMP)Vlcg}/J)	decreased circulating chloride level	J:211773
	decreased circulating glucose level	J:211773
Tmtc3^{Gt(JST185)Byg}/Tmtc3^{Gt(JST185)Byg} (involves: 129P2/OlaHsd * C57BL/6)	cyanosis	J:178869
Tmtc3^{Gt(JST185)Byg}/Tmtc3^{Gt(JST185)Byg} (involves: 129P2/OlaHsd * A/J)	cyanosis	J:178869
Tmtc4^{tm1(KOMP)Vlcg}/Tmtc4^{tm1(KOMP)Vlcg} (involves: C57BL/6J * C57BL/6NTac)	abnormal calcium ion homeostasis	J:268046
Tmtc4^{tm1.1(KOMP)Vlcg}/Tmtc4^{tm1.1(KOMP)Vlcg} (C57BL/6N-Tmtc4^{tm1.1(KOMP)Vlcg}/Ucd)	decreased fasting circulating glucose level	J:211773
Tnc^tm1Sia/Tnc^tm1Sia (involves: C57BL/6N * C57BL/6NCrlj * CBA/JNCrlj)	abnormal serotonin level	J:32517
	decreased dopamine level	J:32517
Tnf^Bpsm1/Tnf⁺ (involves: C57BL/6)	increased circulating tumor necrosis factor level	J:226052
Tnf^Bpsm1/Tnf⁺ Tnfrsf1a^tm1Mak/Tnfrsf1a^tm1Mak (involves: 129S2/SvPas * C57BL/6)	increased circulating tumor necrosis factor level	J:226052
Tnf^Bpsm1/Tnf^Bpsm1 (involves: C57BL/6)	increased circulating tumor necrosis factor level	J:226052
Tnf^Bpsm1/Tnf^Bpsm1 Tnfrsf1a^tm1Mak/Tnfrsf1a^tm1Mak (involves: 129S2/SvPas * C57BL/6)	increased circulating tumor necrosis factor level	J:226052
Tnf^tm1.1Sned/Tnf^tm1.1Sned Lyz2^tm1(cre)Ifo/Lyz2⁺ (involves: 129 * 129P2/OlaHsd * C57BL/6)	decreased circulating tumor necrosis factor level	J:95684
Tnf^tm1.1Sned/Tnf^tm1.1Sned Tg(Cd4-cre)1Cwi/0 (involves: 129 * C57BL/6 * DBA/2)	decreased circulating tumor necrosis factor level	J:95684
Tnf^tm1Gkl/Tnf^tm1Gkl (involves: 129S/SvEv * C57BL/6)	abnormal glucose homeostasis	J:42579
	abnormal lipid homeostasis	J:42579
	decreased circulating glucose level	J:42579
	decreased circulating insulin level	J:42579
	decreased circulating leptin level	J:42579
	decreased circulating triglyceride level	J:42579
Tnf^tm1Gkl/Tnf^tm1Gkl (involves: 129S/SvEv)	decreased circulating tumor necrosis factor level	J:95684
Tnf^tm1Gkl/Tnf^tm2Gkl (involves: 129S/SvEv * C57BL/6)	increased circulating tumor necrosis factor level	J:54056
Tnf^tm1Jods/Tnf^tm1Jods (C57BL/6-Tnf^tm1Jods)	abnormal cytokine level	J:118417
Tnf^tm1Ljo/Tnf^tm1Ljo (involves: 129S1/Sv)	decreased circulating tumor necrosis factor level	J:95684
Tnf^tm1Sek/Tnf^tm1Sek (B6.Cg-Tnf^tm1Sek)	decreased circulating interferon-gamma level	J:44841
	decreased circulating interleukin-1 alpha level	J:44841
	decreased circulating interleukin-1 beta level	J:44841
	decreased circulating interleukin-6 level	J:44841
	increased serotonin level	J:102967
Tnf^tm2.1Gkl/Tnf^tm2.1Gkl Tg(Fabp1-cre)1Jig/0 (involves: 129S/SvEv * FVB/N)	increased circulating tumor necrosis factor level	J:204557
Tnf^tm2Gkl/Tnf⁺ (involves: 129S/SvEv * C57BL/6)	abnormal circulating chemokine level	J:204922
	abnormal circulating leptin level	J:204922
	abnormal glucose homeostasis	J:204922
	decreased susceptibility to diet-induced obesity	J:204922
	increased circulating tumor necrosis factor level	J:54056, J:204922
	steatorrhea	J:204922
Tnf^tm2Gkl/Tnf⁺ (involves: 129S/SvEv * C57BL/6J)	increased circulating tumor necrosis factor level	J:264147
Tnf^tm2Gkl/Tnf⁺ Tnfrsf1b^tm1.1Gkl/Tnfrsf1b^tm1.1Gkl Tg(Col6a1-cre)1Gkl/0 (involves: 129S/SvEv * C57BL/6 * C57BL/6J * CBA)	increased circulating tumor necrosis factor level	J:264147
Tnf^tm2Gkl/Tnf⁺ Tnfrsf1b^tm1.2Gkl/Tnfrsf1b^tm1.2Gkl (involves: 129S/SvEv * C57BL/6 * C57BL/6J)	increased circulating tumor necrosis factor level	J:264147
Tnf^tm2Gkl/Tnf^tm2Gkl (involves: 129S/SvEv * C57BL/6)	increased circulating tumor necrosis factor level	J:54056
Tnf^tm2Gkl/Tnf^tm2Gkl Tnfrsf1a^tm1Blt/Tnfrsf1a^tm1Blt (involves: 129P2/OlaHsd * 129S/SvEv * C57BL/6)	increased circulating tumor necrosis factor level	J:54056
Tnf^tm2Jods/Tnf^tm2Jods (involves: C57BL/6 * C57BL/6J)	decreased liver free fatty acids level	J:112797
Tnf^tm3Gkl/Tnf^tm3Gkl (involves: 129S/SvEv * C57BL/6)	decreased circulating tumor necrosis factor level	J:114740
Tnfaip1^{tm1a(EUCOMM)Wtsi}/Tnfaip1^{tm1a(EUCOMM)Wtsi} (C57BL/6N-Tnfaip1^{tm1a(EUCOMM)Wtsi}/H)	increased blood urea nitrogen level	J:165965
	increased circulating alkaline phosphatase level	J:165965
	increased circulating glucose level	J:165965
	increased circulating triglyceride level	J:165965
Tnfaip2^tm1.1Ohno/Tnfaip2^tm1.1Ohno (C.Cg-Tnfaip2^tm1.1Ohno)	albuminuria	J:343202
Tnfaip3^m1Apb/Tnfaip3^m1Apb (C57BL/6-Tnfaip3^m1Apb)	decreased circulating luteinizing hormone level	J:324062
	decreased fasting circulating glucose level	J:324062
	increased circulating insulin level	J:324062
	increased circulating progesterone level	J:324062
	increased tumor necrosis factor (ligand) superfamily member 11 level	J:324062
	increased tumor necrosis factor receptor superfamily member 11b level	J:324062
	insulin resistance	J:324062
Tnfaip3^tm1.1Gvl/Tnfaip3^tm1.1Gvl Tg(Vil1-cre)997Gum/0 (B6.Cg-Tnfaip3^tm1.1Gvl Tg(Vil1-cre)997Gum)	impaired adaptive thermogenesis	J:163410
	increased circulating alanine transaminase level	J:163410
	increased circulating aspartate transaminase level	J:163410
	increased circulating interleukin-6 level	J:163410
Tnfaip3^tm1Homy/Tnfaip3^tm1Homy Tg(Mx1-cre)1Cgn/? (involves: 129S6/SvEvTac * C57BL/6J * CBA/J)	abnormal circulating cytokine level	J:212681
	abnormal circulating interleukin level	J:212681
	increased circulating interferon-gamma level	J:212681
	increased circulating interleukin-1 beta level	J:212681
	increased circulating interleukin-6 level	J:212681
	increased circulating tumor necrosis factor level	J:212681
Tnfaip8^{Gt(IST13629C1)Tigm}/Tnfaip8^{Gt(IST13629C1)Tigm} (involves: C57BL/6N)	increased circulating interleukin-6 level	J:223320
	increased circulating interleukin-17 level	J:223320
Tnfaip8l2^tm1Yhcn/Tnfaip8l2^tm1Yhcn (129S6/SvEvTac-Tnfaip8l2^tm1Yhcn)	increased circulating interleukin-1 beta level	J:139785
	increased circulating interleukin-6 level	J:139785
	increased circulating interleukin-10 level	J:139785
	increased circulating interleukin-12 level	J:139785
	increased circulating tumor necrosis factor level	J:139785
Tnfrsf1a^tm1Blt/Tnfrsf1a⁺ (involves: 129P2/OlaHsd)	decreased circulating interleukin-6 level	J:210950
Tnfrsf1a^tm1Blt/Tnfrsf1a^tm1Blt (involves: 129/Sv * 129P2/OlaHsd * C57BL/6)	decreased circulating alanine transaminase level	J:50903
Tnfrsf1a^tm1Imx/Tnfrsf1a⁺ (involves: C57BL/6)	decreased circulating interleukin-6 level	J:210950
Tnfrsf1a^tm1Imx/Tnfrsf1a^tm1Imx (C57BL/6-Tnfrsf1a^tm1Imx)	increased circulating tumor necrosis factor level	J:45147
Tnfrsf1a^tm1Imx/Tnfrsf1a^tm1Imx (C57BL/6-Tnfrsf1a^tm1Imx/J)	decreased circulating interleukin-6 level	J:160543
Tnfrsf1a^tm1Imx/Tnfrsf1a^tm1Imx (C57BL/6-Tnfrsf1a^tm1Imx/J)	increased circulating tumor necrosis factor level	J:160543
Tnfrsf1a^tm1Imx/Tnfrsf1a^tm1Imx Il1r1^tm1Imx/Il1r1^tm1Imx (B6;129S-Tnfrsf1a^tm1Imx Il1r1^tm1Imx/J)	abnormal circadian temperature homeostasis	J:137505
Tnfrsf1a^tm1Imx/Tnfrsf1a^tm1Imx Tnfrsf1b^tm1Imx/Tnfrsf1b^tm1Imx (involves: 129S7/SvEvBrd * C57BL/6)	abnormal body temperature homeostasis	J:48865
	abnormal thrombosis	J:117987
	increased circulating tumor necrosis factor level	J:45147
Tnfrsf1a^tm1Mak/Tnfrsf1a⁺ (involves: 129S2/SvPas)	decreased circulating interleukin-6 level	J:210950
Tnfrsf1a^tm1Mak/Tnfrsf1a^tm1Mak (involves: 129S2/SvPas)	decreased circulating interleukin-6 level	J:138824
	impaired skin barrier function	J:59056
	increased circulating tumor necrosis factor level	J:139030
Tnfrsf1a^tm1Rsie/Tnfrsf1a⁺ (B6.Cg-Tnfrsf1a^tm1Rsie)	impaired adaptive thermogenesis	J:160543
Tnfrsf1a^tm1Rsie/Tnfrsf1a⁺ (B6.Cg-Tnfrsf1a^tm1Rsie)	increased circulating tumor necrosis factor level	J:160543
Tnfrsf1a^tm1Rsie/Tnfrsf1a^tm1Rsie (B6.Cg-Tnfrsf1a^tm1Rsie)	decreased circulating interleukin-1 beta level	J:160543
	decreased circulating interleukin-6 level	J:160543
	increased circulating tumor necrosis factor level	J:160543
Tnfrsf1a^tm2.1Rsie/Tnfrsf1a⁺ (B6.Cg-Tnfrsf1a^tm2.1Rsie)	decreased circulating interleukin-1 beta level	J:160543
Tnfrsf1a^tm2.1Rsie/Tnfrsf1a⁺ (B6.Cg-Tnfrsf1a^tm2.1Rsie)	decreased circulating interleukin-6 level	J:160543
Tnfrsf1a^tm2.1Rsie/Tnfrsf1a^tm2.1Rsie (B6.Cg-Tnfrsf1a^tm2.1Rsie)	decreased circulating interleukin-6 level	J:160543
	increased circulating tumor necrosis factor level	J:160543
Tnfrsf1a^{tm2b(EUCOMM)Wtsi}/Tnfrsf1a^{tm2b(EUCOMM)Wtsi} (C57BL/6N-Tnfrsf1a^{tm2b(EUCOMM)Wtsi}/H)	decreased circulating calcium level	J:211773
Tnfrsf1b^{tm1a(EUCOMM)Wtsi}/Tnfrsf1b^{tm1a(EUCOMM)Wtsi} (C57BL/6N-Tnfrsf1b^{tm1a(EUCOMM)Wtsi}/Ics)	decreased circulating creatinine level	J:165965
Tnfrsf1b^tm1Imx/Tnfrsf1b^tm1Imx (involves: 129S7/SvEvBrd * C57BL/6)	increased circulating tumor necrosis factor level	J:45147
Tnfrsf1b^tm1Imx/Tnfrsf1b^tm1Imx (B6.129S7-Tnfrsf1b^tm1Imx)	abnormal blood gas level	J:143836
Tnfrsf9^em1Ygch/Tnfrsf9^em1Ygch (NOD/ShiLtDvs-Tnfrsf9^em1Ygch)	abnormal glucose homeostasis	J:208927
Tnfrsf9^em2Ygch/Tnfrsf9^em2Ygch (NOD/ShiLtDvs-Tnfrsf9^em2Ygch)	abnormal glucose homeostasis	J:208927
Tnfrsf10b^tm1Wnt/Tnfrsf10b^tm1Wnt (involves: 129S6/SvEvTac * C57BL/6)	abnormal interferon level	J:94681
	increased circulating interferon-gamma level	J:94681
	increased circulating interleukin-12b level	J:94681
Tnfrsf11a^tm1.1Pngr/Tnfrsf11a^tm1.2Pngr Tg(Gfap-cre)2Brn/0 (involves: 129 * C57BL/6 * C57BL/6NTac * FVB/N)	abnormal body temperature homeostasis	J:155398
	abnormal circadian temperature homeostasis	J:155398
	decreased prostaglandin level	J:155398
	impaired febrile response	J:155398
Tnfrsf11a^tm1.1Pngr/Tnfrsf11a^tm1.2Pngr Tg(Nes-cre)1Kln/0 (involves: 129 * C57BL/6 * C57BL/6NTac * SJL)	abnormal body temperature homeostasis	J:155398
	abnormal circadian temperature homeostasis	J:155398
	decreased prostaglandin level	J:155398
	impaired febrile response	J:155398
Tnfrsf11a^tm1.1Sral/Tnfrsf11a⁺ (B6.129P2(Cg)-Tnfrsf11a^tm1.1Sral)	decreased tumor necrosis factor (ligand) superfamily member 11 level	J:312215
Tnfrsf11b^em1(IMPC)Mbp/Tnfrsf11b^em1(IMPC)Mbp (C57BL/6N-Tnfrsf11b^em1(IMPC)Mbp/MbpMmucd)	increased circulating alkaline phosphatase level	J:211773
	increased circulating phosphate level	J:211773
Tnfrsf13b^tm1Vmd/Tnfrsf13b^tm1Vmd (involves: C57BL/6)	increased urine protein level	J:82331
Tnfsf4^Ath1-A/J/Tnfsf4^Ath1-A/J Ath2^A/J/Ath2^A/J (involves: C3H/HeJ * C57BL/6J)	increased circulating HDL cholesterol level	J:9832
Tnfsf4^Ath1-BALB/cJ/? (involves: BALB/cJ * C57BL/6J)	increased circulating HDL cholesterol level	J:8735
Tnfsf4^Ath1-C3H/HeJ/? (involves: C3H/HeJ * C57BL/6J)	increased circulating HDL cholesterol level	J:9135
Tnfsf4^{Ath1-C57BL/6J}/? (involves: BALB/cJ * C57BL/6J)	abnormal lipid homeostasis	J:8735
Tnfsf4^{Ath1-C57BL/6J}/? (involves: C3H/HeJ * C57BL/6J)	decreased circulating HDL cholesterol level	J:8735, J:9135
Tnfsf4^{Ath1-C57BL/6J}/Tnfsf4^{Ath1-C57BL/6J} Ath2^C57BL/6J/Ath2^C57BL/6J (involves: C3H/HeJ * C57BL/6J)	decreased circulating HDL cholesterol level	J:9832
Tnfsf4^{Ath1-PERA/EiJ}/Tnfsf4^{Ath1-C57BL/6J} (B6.PERA-Tnfsf4^{Ath1-PERA/EiJ}/Pgn)	increased circulating HDL cholesterol level	J:79722
Tnfsf4^{Ath1-PERA/EiJ}/Tnfsf4^{Ath1-PERA/EiJ} (B6.PERA-Tnfsf4^{Ath1-PERA/EiJ}/Pgn)	increased circulating HDL cholesterol level	J:79722
Tnfsf10^{tm1b(KOMP)Wtsi}/Tnfsf10^{tm1b(KOMP)Wtsi} (C57BL/6N-Tnfsf10^{tm1b(KOMP)Wtsi}/Ucd)	increased circulating alanine transaminase level	J:211773
Tnfsf11^tm1Ywc/Tnfsf11^tm1Ywc (involves: 129P2/OlaHsd)	decreased circulating calcium level	J:233265
Tnik^tm1Teya/Tnik^tm1Teya (involves: C57BL/6J)	decreased circulating cholesterol level	J:241611
	decreased circulating glucose level	J:241611
	decreased circulating HDL cholesterol level	J:241611
Tnip1^{Gt(E059E05)Wrst}/Tnip1^{Gt(E059E05)Wrst} (involves: 129P2/OlaHsd * C57BL/6)	increased urine protein level	J:180054
Tnip1^{tm1b(EUCOMM)Hmgu}/Tnip1^{tm1b(EUCOMM)Hmgu} (C57BL/6N-Tnip1^{tm1b(EUCOMM)Hmgu}/H)	decreased circulating cholesterol level	J:211773
	decreased circulating fructosamine level	J:211773
	decreased circulating glucose level	J:211773
	decreased circulating HDL cholesterol level	J:211773
	decreased circulating iron level	J:211773
	decreased circulating serum albumin level	J:211773
	decreased circulating triglyceride level	J:211773
	increased circulating alanine transaminase level	J:211773
	increased circulating alkaline phosphatase level	J:211773
	increased circulating aspartate transaminase level	J:211773
	increased circulating potassium level	J:211773
Tnks1bp1^em1(IMPC)J/Tnks1bp1^em1(IMPC)J (C57BL/6NJ-Tnks1bp1^em1(IMPC)J/J)	decreased circulating serum albumin level	J:211773
Tnks^{em1(IMPC)Hmgu}/Tnks^{em1(IMPC)Hmgu} (C57BL/6N-Tnks^{em1(IMPC)Hmgu}/Ieg)	decreased circulating cholesterol level	J:211773
	decreased circulating glucose level	J:211773
	decreased circulating HDL cholesterol level	J:211773
	decreased circulating triglyceride level	J:211773
	increased circulating alkaline phosphatase level	J:211773
	increased circulating aspartate transaminase level	J:211773
	increased circulating bilirubin level	J:211773
	increased fasting circulating glucose level	J:211773
Tnks^{Gt(RRC239)Byg}/Tnks^{Gt(RRC239)Byg} (involves: 129P2/OlaHsd * C57BL/6)	decreased circulating leptin level	J:154388
	hypoglycemia	J:154388
	increased adiponectin level	J:154388
	increased body temperature	J:154388
	increased circulating insulin level	J:154388
	increased circulating ketone body level	J:154388
	increased oxygen consumption	J:154388
Tnni2^{tm1.1(KOMP)Vlcg}/Tnni2⁺ (C57BL/6N-Tnni2^{tm1.1(KOMP)Vlcg}/Ucd)	decreased circulating glucose level	J:211773
	decreased fasting circulating glucose level	J:211773
Tnni2^tm1Sgao/Tnni2⁺ (involves: 129 * ICR)	decreased collagen level	J:228857
Tnni3k^B/Tnni3k^B (involves: C57BL/6J * DBA/2J)	decreased circulating insulin level	J:339644
	hyperglycemia	J:339644
	insulin resistance	J:339644
Tnnt2^tm1Feah/Tnnt2^tm1Feah (involves: 129S6/SvEvTac * FVB/N)	pericardial effusion	J:137964
Tnr^{em1(IMPC)Rbrc}/Tnr^{em1(IMPC)Rbrc} (C57BL/6NJcl-Tnr^{em1(IMPC)Rbrc}/Rbrc)	abnormal circulating phosphate level	J:211773
Tnrc6c^{Gt(IST11346C2)Tigm}/Tnrc6c^{Gt(IST11346C2)Tigm} (involves: C57BL/6N)	cyanosis	J:248980
Tns2^nph/Tns2^nph (involves: ICR)	albuminuria	J:108691
	decreased circulating total protein level	J:24698
	edema	J:24698
	increased blood urea nitrogen level	J:24698
	increased circulating cholesterol level	J:24698
	increased urine protein level	J:24698
Tns3^em1(IMPC)Bay/Tns3⁺ (C57BL/6N-Tns3^em1(IMPC)Bay/Bay)	increased fasting circulating glucose level	J:211773
Tnxb^{tm1b(EUCOMM)Hmgu}/Tnxb^{tm1b(EUCOMM)Hmgu} (C57BL/6N-Tnxb^{tm1b(EUCOMM)Hmgu}/H)	decreased blood urea nitrogen level	J:211773
	decreased circulating alkaline phosphatase level	J:211773
Toe1^{tm1.1(KOMP)Vlcg}/Toe1⁺ (C57BL/6N-Toe1^{tm1.1(KOMP)Vlcg}/J)	decreased urine magnesium level	J:211773
Tollip^tm1Kbns/Tollip^tm1Kbns (involves: C57BL/6)	decreased circulating interleukin-6 level	J:105514
Top1mt^tm1.1Hlzh/Top1mt^tm1.1Hlzh (Not Specified)	abnormal blood homeostasis	J:189886
Top2a^em2(IMPC)Tcp/Top2a⁺ (C57BL/6NCrl-Top2a^em2(IMPC)Tcp/Tcp)	increased circulating alkaline phosphatase level	J:211773
	increased circulating aspartate transaminase level	J:211773
Top2b^em1(IMPC)Mbp/Top2b^em1(IMPC)Mbp (C57BL/6NCrl-Top2b^em1(IMPC)Mbp/MbpMmucd)	edema	J:211773
Tor1a^tm1Yql/Tor1a⁺ (involves: 129S2/SvPas * C57BL/6)	decreased dopamine level	J:104513
Tox4^{tm1b(KOMP)Mbp}/Tox4⁺ (C57BL/6N-Tox4^{tm1b(KOMP)Mbp}/J)	decreased circulating glucose level	J:211773
	increased circulating creatinine level	J:211773
Tox^{tm1b(KOMP)Wtsi}/Tox^{tm1b(KOMP)Wtsi} (C57BL/6N-Tox^{tm1b(KOMP)Wtsi}/Tcp)	decreased circulating cholesterol level	J:211773
	increased circulating alkaline phosphatase level	J:211773
Tpcn1^{tm1.1(KOMP)Vlcg}/Tpcn1^{tm1.1(KOMP)Vlcg} (C57BL/6N-Tpcn1^{tm1.1(KOMP)Vlcg}/J)	decreased urine magnesium level	J:211773
	increased urine microalbumin level	J:211773
Tpcn2^{tm1b(EUCOMM)Hmgu}/Tpcn2^{tm1b(EUCOMM)Hmgu} (C57BL/6N-Tpcn2^{tm1b(EUCOMM)Hmgu}/H)	increased circulating triglyceride level	J:211773
Tpd52l1^em1(IMPC)J/Tpd52l1^em1(IMPC)J (C57BL/6NJ-Tpd52l1^em1(IMPC)J/J)	increased circulating alkaline phosphatase level	J:211773
Tpgs2^{tm1.1(KOMP)Vlcg}/Tpgs2^{tm1.1(KOMP)Vlcg} (C57BL/6N-Tpgs2^{tm1.1(KOMP)Vlcg}/J)	decreased circulating free fatty acids level	J:211773
Tph1^{tm1c(KOMP)Wtsi}/Tph1^{tm1c(KOMP)Wtsi} Tg(Ins2-cre)23Herr/0 (involves: 129S4/SvJae * C57BL/6J * CBA/J)	impaired glucose tolerance	J:284574
Tph1^tm1Kry/Tph1^tm1Kry Tg(Vil1-cre)20Syr/0 (involves: C57BL/6 * DBA/2)	decreased serotonin level	J:146078
Tph1^tm1Mlt/Tph1^tm1Mlt (either: (involves: 129S1/Sv * 129X1/SvJ) or (involves: 129S1/Sv * 129X1/SvJ * C57BL/6))	decreased serotonin level	J:99733
Tph1^tm2Lex/Tph1^tm2Lex (involves: 129S5/SvEvBrd * C57BL/6J)	abnormal serotonin level	J:144582
Tph1^tm2Lex/Tph1^tm2Lex Tph2^tm1Lex/Tph2^tm1Lex (involves: 129S5/SvEvBrd * C57BL/6J)	decreased serotonin level	J:144582
Tph2^Arg447/Tph2^Arg447 (BALB/cJ)	abnormal serotonin level	J:94745
Tph2^Arg447/Tph2^Arg447 (DBA/2J)	abnormal serotonin level	J:94745
Tph2^Pro447/Tph2^Pro447 (129X1/SvJ)	abnormal serotonin level	J:94745
Tph2^Pro447/Tph2^Pro447 (C57BL/6J)	abnormal serotonin level	J:94745
Tph2^tm1.1Zfc/Tph2^tm1.1Zfc (involves: 129S7/SvEvBrd)	decreased serotonin level	J:170988
Tph2^tm1Bdr/Tph2^tm1Bdr (B6.129P2-Tph2^tm1Bdr)	decreased circulating insulin-like growth factor I level	J:150042
Tph2^tm1Bdr/Tph2^tm1Bdr (FVB.129P2-Tph2^tm1Bdr)	decreased circulating insulin-like growth factor I level	J:150042
Tph2^tm1Bdr/Tph2^tm1Bdr (involves: 129P2/OlaHsd * FVB/N)	decreased circulating insulin-like growth factor I level	J:150042
	decreased serotonin level	J:150042
	impaired adaptive thermogenesis	J:150042
Tph2^tm1Dmkh/Tph2^tm1Dmkh (involves: C57BL/6)	decreased serotonin level	J:196205
Tph2^tm1Dmkh/Tph2^tm1Dmkh (involves: C57BL/6)	increased core body temperature	J:196205
Tph2^tm1Lex/Tph2^tm1Lex (involves: 129S5/SvEvBrd * C57BL/6J)	decreased serotonin level	J:144582
Tph2^tm1Mca/Tph2⁺ (involves: 129S6/SvEvTac * C57BL/6J)	decreased serotonin level	J:131619
Tph2^tm1Mca/Tph2^tm1Mca (involves: 129S6/SvEvTac * C57BL/6J)	decreased serotonin level	J:131619
Tph2^tm2.1Pasq/Tph2^tm2.2Pasq Tg(CMV-cre/ERT)1Ipc/0 (involves: 129P2/OlaHsd * C57BL/6 * SJL)	decreased serotonin level	J:238619
Tph2^tm2.2Pasq/Tph2^tm2.2Pasq (involves: 129P2/OlaHsd * C57BL/6 * SJL)	decreased serotonin level	J:238619
Tpi1^rbc19/Tpi1^rbc19 (SJL-Tpi1^rbc19)	abnormal homeostasis	J:263104
Tpi1^rbc19/Tpi1^rbc19 (SJL-Tpi1^rbc19)	increased circulating bilirubin level	J:263104
Tpm1^em1Clo/Tpm1⁺ (Not Specified)	hydrops fetalis	J:320916
Tpm1^em1Clo/Tpm1⁺ (Not Specified)	pericardial effusion	J:320916
Tpo^em1(IMPC)H/Tpo⁺ (C57BL/6NTac-Tpo^em1(IMPC)H/H)	decreased circulating glucose level	J:211773
Tpo^em1(IMPC)H/Tpo⁺ (C57BL/6NTac-Tpo^em1(IMPC)H/H)	improved glucose tolerance	J:211773
Tpo^em1(IMPC)H/Tpo^em1(IMPC)H (C57BL/6NTac-Tpo^em1(IMPC)H/H)	increased circulating aspartate transaminase level	J:211773
	increased circulating cholesterol level	J:211773
	increased circulating creatinine level	J:211773
	increased circulating iron level	J:211773
Tpo^R479C/Tpo^R479C (involves: ICR)	increased circulating thyroid-stimulating hormone level	J:112930
Tpp1^tm1Dgen/Tpp1^tm1Dgen (involves: 129S1/Sv * C57BL/6)	dehydration	J:101679
Tppp^{tm1.1(KOMP)Vlcg}/Tppp^{tm1.1(KOMP)Vlcg} (C57BL/6N-Tppp^{tm1.1(KOMP)Vlcg}/J)	increased circulating alkaline phosphatase level	J:211773
	increased circulating chloride level	J:211773
	increased circulating iron level	J:211773
Tpst2^grt/Tpst2^grt (involves: DW/JMuaf)	abnormal growth hormone level	J:20343
Tpst2^grt/Tpst2^grt (involves: DW/JMuaf)	decreased circulating thyroxine level	J:20343
Tra2b^{Gt(P142D08)Wrst}/Tra2b⁺ (involves: 129S2/SvPas * C57BL/6J)	increased circulating triglyceride level	J:176730
	increased circulating VLDL triglyceride level	J:176730
Trabd2b^{em2(IMPC)Ccpcz}/Trabd2b^{em2(IMPC)Ccpcz} (C57BL/6N-Trabd2b^{em2(IMPC)Ccpcz}/Ccpcz)	increased blood urea nitrogen level	J:211773
Tradd^tm1.1Mak/Tradd^tm1.1Mak (either: (involves: 129P2/OlaHsd * C57BL/6) or (involves: 129P2/OlaHsd * FVB/N))	decreased circulating interleukin-6 level	J:138824
Tradd^tm1.1Mpa/Tradd^tm1.1Mpa (involves: BALB/cJ * C57BL/6)	abnormal interleukin level	J:139030
Tradd^tm1.1Mpa/Tradd^tm1.1Mpa (involves: BALB/cJ * C57BL/6)	decreased circulating tumor necrosis factor level	J:139030
Traf2^{tm1a(EUCOMM)Wtsi}/Traf2⁺ (C57BL/6N-Traf2^{tm1a(EUCOMM)Wtsi}/Wtsi)	increased circulating chloride level	J:211773
Traf2^tm1Mak/Traf2^tm1Mak (either: (involves: 129P2/OlaHsd * C57BL/6J) or (involves: 129P2/OlaHsd * BALB/c * C57BL/6J))	increased circulating tumor necrosis factor level	J:44360
Traf3^tm1Bal/Traf3^tm1Bal (involves: 129S4/SvJae * C57BL/6J)	hypoglycemia	J:37065
	increased circulating corticosterone level	J:37065
Traf3ip1^em1(IMPC)Bay/Traf3ip1^em1(IMPC)Bay (C57BL/6N-Traf3ip1^em1(IMPC)Bay/BayMmucd)	edema	J:211773
Traf3ip1^{Gt(RRJ005)Byg}/Traf3ip1^{Gt(RRJ005)Byg} (involves: 129P2/OlaHsd * C57BL/6)	cardiac edema	J:178483
Traf3ip2^tm1.1Lix/Traf3ip2^tm1.1Lix (C.129-Traf3ip2^tm1.1Lix)	xerostomia	J:138560
Traf6^tm1.1Mpa/Traf6^tm1.1Mpa Lyz2^tm1(cre)Ifo/Lyz2⁺ (involves: 129P2/OlaHsd * C57BL/6)	decreased circulating interleukin-6 level	J:145306
Traf6^tm1Mak/Traf6^tm1Mak (involves: 129P3/J)	decreased circulating phosphate level	J:54467
Traf6^{tm2a(EUCOMM)Wtsi}/Traf6^{tm2a(EUCOMM)Wtsi} (C57BL/6N-Traf6^{tm2a(EUCOMM)Wtsi}/Wtsi)	subcutaneous edema	J:239583
Trafd1^tm1Ayos/Trafd1^tm1Ayos (involves: 129 * C57BL/6J)	increased circulating alanine transaminase level	J:144594
Trafd1^tm1Ayos/Trafd1^tm1Ayos (involves: 129 * C57BL/6J)	increased circulating interleukin-6 level	J:144594
Traj18^em1Hwata/Traj18^em1Hwata (C57BL/6-Traj18^em1Hwata)	decreased fasting circulating glucose level	J:256533
	decreased susceptibility to diet-induced obesity	J:256533
	improved glucose tolerance	J:256533
	increased insulin sensitivity	J:256533
Traj18^tm1.1Kro/Traj18^tm1.1Kro (involves: C57BL/6NTac)	abnormal circulating interleukin-4 level	J:232957
Tram1^em1(IMPC)J/Tram1^em1(IMPC)J (C57BL/6NJ-Tram1^em1(IMPC)J/Mmjax)	decreased circulating bilirubin level	J:211773
	decreased circulating total protein level	J:211773
	increased blood urea nitrogen level	J:211773
Tram2^{tm1a(KOMP)Wtsi}/Tram2^{tm1a(KOMP)Wtsi} (C57BL/6N-Tram2^{tm1a(KOMP)Wtsi}/Wtsi)	decreased circulating serum albumin level	J:211773
	decreased circulating total protein level	J:211773
	increased circulating alkaline phosphatase level	J:211773
	increased circulating amylase level	J:211773
Trank1^em1(IMPC)J/Trank1^em1(IMPC)J (C57BL/6NJ-Trank1^em1(IMPC)J/Mmjax)	decreased circulating creatinine level	J:211773
Trap1^em1(IMPC)Mbp/Trap1^em1(IMPC)Mbp (C57BL/6N-Trap1^em1(IMPC)Mbp/MbpMmucd)	decreased circulating creatinine level	J:211773
	decreased circulating phosphate level	J:211773
Trap1^{Gt(E150H04)Wrst}/Trap1^{Gt(E150H04)Wrst} (involves: 129P2/OlaHsd * C57BL/6)	decreased circulating creatinine level	J:226880
	decreased circulating glucose level	J:226880
Trappc1^em1(IMPC)Mbp/Trappc1⁺ (C57BL/6NCrl-Trappc1^em1(IMPC)Mbp/Mmucd)	increased circulating alanine transaminase level	J:211773
Trappc9^{tm1a(EUCOMM)Wtsi}/Trappc9^{tm1a(EUCOMM)Wtsi} (C57BL/6N-Trappc9^{tm1a(EUCOMM)Wtsi}/Wtsi)	impaired glucose tolerance	J:211773
	increased circulating insulin level	J:211773
	increased circulating sodium level	J:211773
	increased fasting circulating glucose level	J:211773
Trappc9^{tm1a(EUCOMM)Wtsi}/Trappc9^{tm1a(EUCOMM)Wtsi} (involves: C57BL/6N)	impaired glucose tolerance	J:294716
	increased circulating cholesterol level	J:294716
	increased circulating glycerol level	J:294716
	increased circulating HDL cholesterol level	J:294716
	increased circulating insulin level	J:294716
	increased circulating LDL cholesterol level	J:294716
	increased circulating triglyceride level	J:294716
Trappc10^{tm1b(KOMP)Wtsi}/Trappc10^{tm1b(KOMP)Wtsi} (C57BL/6N-Trappc10^{tm1b(KOMP)Wtsi}/Wtsi)	increased circulating alkaline phosphatase level	J:211773
	increased circulating cholesterol level	J:211773
	increased circulating insulin level	J:211773
Trappc11^em1(IMPC)J/Trappc11⁺ (C57BL/6NJ-Trappc11^em1(IMPC)J/Mmjax)	increased circulating creatinine level	J:211773
Trarg1^{tm1a(KOMP)Wtsi}/Trarg1^{tm1a(KOMP)Wtsi} (C57BL/6N-Trarg1^{tm1a(KOMP)Wtsi})	abnormal circulating insulin level	J:234039
	abnormal fasting circulating glucose level	J:234039
	hyperglycemia	J:234039
	increased circulating insulin level	J:234039
	insulin resistance	J:234039
Trbv19^{em1(IMPC)Wtsi}/Trbv19^{em1(IMPC)Wtsi} (C57BL/6N-Trbv19^{em1(IMPC)Wtsi}/Wtsi)	decreased circulating serum albumin level	J:211773
Treh^tm1Tkam/Treh^tm1Tkam (involves: C57BL/6 * CBA)	abnormal glucose homeostasis	J:99998
Trem2^em2Bwef/Trem2^em2Bwef (involves: C57BL/6J * DBA/2J * FVB/N)	abnormal glucose homeostasis	J:242126
	increased circulating interleukin-6 level	J:242126
	increased circulating tumor necrosis factor level	J:242126
Trem2^tm1Cln/Trem2^tm1Cln (B6.129P2-Trem2^tm1Cln)	abnormal interferon level	J:138057
	abnormal interleukin level	J:138057
	abnormal tumor necrosis factor level	J:138057
Treml1^tm1Mcvic/Treml1^tm1Mcvic (C57BL/6-Treml1^tm1Mcvic)	decreased platelet aggregation	J:150578
	increased bleeding time	J:150578
	increased circulating D-dimer level	J:150578
Trex1^em3Gpt/Trex1^em3Gpt (C57BL/6JGpt-Trex1^em3Gpt)	increased circulating tumor necrosis factor level	J:330879
Trex1^tm1.1Fwpe/Trex1^tm1.1Fwpe (involves: 129S1/SvImJ * 129S4/SvJae * 129S6/SvEvTac)	abnormal atrial thrombosis	J:220965
Trex1^tm1Tld/Trex1^tm1Tld (involves: 129P2/OlaHsd)	abnormal atrial thrombosis	J:92264
Trf^{em1(IMPC)Rbrc}/Trf⁺ (C57BL/6NJcl-Trf^{em1(IMPC)Rbrc}/Rbrc)	abnormal circulating phosphate level	J:211773
	decreased circulating iron level	J:211773
Trf^hpx/Trf⁺ (BALB/cJ-Trf^hpx)	abnormal iron homeostasis	J:64456, J:8936
	hemochromatosis	J:8936
	increased circulating iron level	J:8936
Trf^hpx/Trf^hpx (BALB/cJ-Trf^hpx)	abnormal iron homeostasis	J:64456, J:8936
	hemochromatosis	J:64456, J:8936
	increased circulating iron level	J:8936
Trglyd^RR/? (involves: C57BL/6J * RR)	increased triglyceride level	J:94251
Trh^em1(IMPC)Tcp/Trh^em1(IMPC)Tcp (C57BL/6NCrl-Trh^em1(IMPC)Tcp/Tcp)	increased circulating cholesterol level	J:211773
	increased circulating creatinine level	J:211773
	increased circulating HDL cholesterol level	J:211773
Trh^tm1Mmt/Trh^tm1Mmt (involves: C57BL/6 * CBA)	decreased circulating thyroid-stimulating hormone level	J:59141
Trh^tm1Mmt/Trh^tm1Mmt (involves: C57BL/6 * CBA)	decreased circulating thyroxine level	J:59141
Trh^tm1Mmt/Trh^tm1Mmt (involves: C57BL/6 * CBA * ICR)	decreased circulating insulin level	J:43657
	decreased insulin secretion	J:43657
	hyperglycemia	J:43657
	increased thyroid-stimulating hormone level	J:43657
Trhr^tm1Bau/Trhr^tm1Bau (involves: 129S1/Sv * 129X1/SvJ)	decreased circulating prolactin level	J:90365
	decreased thyroxine level	J:90365
	decreased triiodothyronine level	J:90365
Trhr^tm1Bau/Trhr^tm1Bau (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	abnormal circulating ghrelin level	J:220755
	decreased circulating ghrelin level	J:220755
	decreased circulating levels of thyroid hormone	J:220755
	decreased circulating thyroxine level	J:220755
	decreased circulating triiodothyronine level	J:220755
	increased circulating ghrelin level	J:220755
	increased oxygen consumption	J:220755
Trhr^tm1Hzg/Trhr^tm1Hzg (involves: 129/Sv * 129S1/SvImJ)	decreased circulating thyroxine level	J:125915
Trhr^tm1Hzg/Trhr^tm1Hzg (involves: 129/Sv * 129S1/SvImJ)	increased circulating glucose level	J:125915
Trib1^tm1Aki/Trib1^tm1Aki (involves: 129P2/OlaHsd)	decreased spleen iron level	J:196449
	impaired glucose tolerance	J:196449
	increased liver iron level	J:196449
	insulin resistance	J:196449
Triglq1^SM/J/? (involves: A/J * SM/J)	increased circulating triglyceride level	J:64138
Triglq2^SM/J/? (involves: A/J * SM/J)	increased circulating triglyceride level	J:64138
Trigq2^KK/Trigq2^KK (involves: KK-A^y * RR)	increased triglyceride level	J:87328
Trim8^{em1(IMPC)Wtsi}/Trim8^{em1(IMPC)Wtsi} (C57BL/6N-Trim8^{em1(IMPC)Wtsi}/Wtsi)	decreased circulating cholesterol level	J:211773
	decreased circulating HDL cholesterol level	J:211773
	decreased circulating serum albumin level	J:211773
Trim8^tm1Hbsh/Trim8^tm1Hbsh (involves: 129S6/SvEvTac)	abnormal circulating chemokine level	J:251270
	increased circulating interleukin-6 level	J:251270
	increased circulating tumor necrosis factor level	J:251270
Trim9^{em1(IMPC)Ccpcz}/Trim9^{em1(IMPC)Ccpcz} (C57BL/6N-Trim9^{em1(IMPC)Ccpcz}/Ccpcz)	decreased circulating sodium level	J:211773
Trim13^em1(IMPC)Tcp/Trim13^em1(IMPC)Tcp (C57BL/6N-Trim13^em1(IMPC)Tcp/Tcp)	increased circulating triglyceride level	J:211773
Trim13^tm1.1Jskg/Trim13^tm1.1Jskg (B6.129S7(Cg)-Trim13^tm1.1Jskg)	abnormal circulating interferon level	J:243916
	decreased circulating interferon-beta level	J:243916
Trim16^em1(IMPC)Tcp/Trim16^em1(IMPC)Tcp (C57BL/6NCrl-Trim16^em1(IMPC)Tcp/Tcp)	increased circulating alanine transaminase level	J:211773
Trim21^tm1Mwah/Trim21^tm1Mwah (C57BL/6-Trim21^tm1Mwah)	abnormal interleukin level	J:151775
	abnormal tumor necrosis factor level	J:151775
	increased urine protein level	J:151775
Trim24^mpc232H/Trim24^mpc232H (involves: BALB/c * C3H/HeH * C57BL/6J)	abnormal circulating alanine transaminase level	J:234901
Trim25^{tm2b(EUCOMM)Hmgu}/Trim25^{tm2b(EUCOMM)Hmgu} (C57BL/6N-Trim25^{tm2b(EUCOMM)Hmgu}/Wtsi)	impaired glucose tolerance	J:211773
Trim27^tm1Sis/Trim27^tm1Sis (B6.Cg-Trim27^tm1Sis)	decreased circulating alanine transaminase level	J:206755
Trim27^tm1Sis/Trim27^tm1Sis (B6.Cg-Trim27^tm1Sis)	decreased circulating aspartate transaminase level	J:206755
Trim31^em1Cya/Trim31^em1Cya (involves: C57BL/6)	abnormal circulating cytokine level	J:243237
Trim31^em1Cya/Trim31^em1Cya (involves: C57BL/6)	increased circulating interleukin-1 beta level	J:243237
Trim35^em1Smoc/Trim35^em1Smoc (C57BL/6J-Trim35^em1Smoc)	decreased circulating interferon-beta level	J:303214
Trim37^{Gt(RRO307)Byg}/Trim37^{Gt(RRO307)Byg} (B6J.129P2-Trim37^{Gt(RRO307)Byg})	ascites	J:232482
	decreased circulating insulin level	J:232482
	decreased respiratory quotient	J:232482
	increased circulating follicle stimulating hormone level	J:232482
	increased circulating luteinizing hormone level	J:232482
	increased fasting circulating glucose level	J:232482
	increased liver triglyceride level	J:232482
Trim38^{tm1(KOMP)Vlcg}/Trim38^{tm1(KOMP)Vlcg} (involves: C57BL/6N)	increased circulating interferon-alpha level	J:239773
	increased circulating interferon-beta level	J:239773
	increased circulating interleukin-6 level	J:239773
	increased circulating tumor necrosis factor level	J:239773
Trim39^{tm1b(EUCOMM)Hmgu}/Trim39^{tm1b(EUCOMM)Hmgu} (C57BL/6N-Trim39^{tm1b(EUCOMM)Hmgu}/H)	decreased fasting circulating glucose level	J:211773
	increased fasting circulating glucose level	J:211773
Trim45^{tm1a(KOMP)Wtsi}/Trim45^{tm1a(KOMP)Wtsi} (B6Brd;B6Dnk;B6N-Trim45^{tm1a(KOMP)Wtsi} Tyr^c-Brd/Wtsi)	subcutaneous edema	J:239583
Trim55^tm1Cpat/Trim55^tm1Cpat Trim63^tm1Glas/Trim63^tm1Glas (involves: 129S1/Sv * C57BL/6)	pulmonary edema	J:267246
Trim55^tm1Slbt/Trim55^tm1Slbt Trim63^tm1Slbt/Trim63^tm1Slbt (involves: 129 * C57BL/6)	abnormal cardiac thrombosis	J:130921
	pulmonary edema	J:130921
Trim55^{tm2b(EUCOMM)Hmgu}/Trim55^{tm2b(EUCOMM)Hmgu} (C57BL/6N-Trim55^{tm2b(EUCOMM)Hmgu}/Bay)	decreased fasting circulating glucose level	J:211773
Trim56^{tm1a(EUCOMM)Wtsi}/Trim56^{tm1a(EUCOMM)Wtsi} (C57BL/6N-Trim56^{tm1a(EUCOMM)Wtsi}/Wtsi)	decreased circulating cholesterol level	J:211773
	decreased circulating glucose level	J:211773
	decreased circulating HDL cholesterol level	J:211773
	decreased circulating iron level	J:211773
	increased circulating iron level	J:211773
Trim65^em1Cya/Trim65^em1Cya (involves: C57BL/6)	decreased circulating interferon-alpha level	J:240099
Trim65^em1Cya/Trim65^em1Cya (involves: C57BL/6)	decreased circulating interferon-beta level	J:240099
Trim72^tm1Rpx/Trim72^tm1Rpx (involves: 129/SvJ * C57BL/6)	decreased susceptibility to diet-induced non-insulin dependent diabetes	J:342778
	decreased susceptibility to diet-induced obesity	J:342778
	decreased susceptibility to hyperlipidemia	J:342778
Trio^em1(IMPC)H/Trio⁺ (C57BL/6NTac-Trio^em1(IMPC)H/H)	impaired glucose tolerance	J:211773
Triobp^em1(IMPC)J/Triobp^em1(IMPC)J (C57BL/6NJ-Triobp^em1(IMPC)J/Mmjax)	increased circulating glucose level	J:211773
Trip6^{tm1b(EUCOMM)Hmgu}/Trip6^{tm1b(EUCOMM)Hmgu} (C57BL/6N-Trip6^{tm1b(EUCOMM)Hmgu}/Bay)	increased respiratory quotient	J:211773
Trip10^tm1Sejc/Trip10^tm1Sejc (involves: 129S1/Sv * 129X1/SvJ * ICR)	decreased circulating glucose level	J:159952
Trip11^{Gt(AJ0490)Wtsi}/Trip11^{Gt(AJ0490)Wtsi} (involves: 129P2/OlaHsd * C57BL/6)	cyanosis	J:142875
Trip13^{tm1.1(KOMP)Vlcg}/Trip13⁺ (C57BL/6N-Trip13^{tm1.1(KOMP)Vlcg}/Ucd)	increased circulating alkaline phosphatase level	J:211773
Trip13^{tm1.1(KOMP)Vlcg}/Trip13^{tm1.1(KOMP)Vlcg} (C57BL/6N-Trip13^{tm1.1(KOMP)Vlcg}/Ucd)	increased blood urea nitrogen level	J:211773
	increased circulating cholesterol level	J:211773
	increased circulating HDL cholesterol level	J:211773
	increased circulating serum albumin level	J:211773
	increased fasting circulating glucose level	J:211773
Trmo^{tm1a(EUCOMM)Wtsi}/Trmo^{tm1a(EUCOMM)Wtsi} (B6JTyr;B6N-Trmo^{tm1a(EUCOMM)Wtsi}/Wtsi)	increased circulating aspartate transaminase level	J:175295
Trmt1^{tm1b(EUCOMM)Hmgu}/Trmt1⁺ (C57BL/6N-Trmt1^{tm1b(EUCOMM)Hmgu}/Ics)	decreased circulating cholesterol level	J:211773
Trmt10a^{tm1a(EUCOMM)Wtsi}/Trmt10a^{tm1a(EUCOMM)Wtsi} (involves: C57BL/6N)	increased circulating magnesium level	J:200082
Trmt10a^{tm1a(EUCOMM)Wtsi}/Trmt10a^{tm1a(EUCOMM)Wtsi} (C57BL/6N-Trmt10a^{tm1a(EUCOMM)Wtsi}/Wtsi)	decreased circulating alanine transaminase level	J:175295
	decreased circulating aspartate transaminase level	J:175295
	decreased circulating cholesterol level	J:175295
	decreased circulating HDL cholesterol level	J:175295
	decreased circulating LDL cholesterol level	J:175295
	increased circulating free fatty acids level	J:175295
	increased circulating glycerol level	J:175295
Trmt10b^em1(IMPC)J/Trmt10b^em1(IMPC)J (C57BL/6NJ-Trmt10b^em1(IMPC)J/Mmjax)	increased circulating phosphate level	J:211773
Trnt1^{tm1a(EUCOMM)Hmgu}/Trnt1⁺ (Not Specified)	increased circulating serum albumin level	J:165965
Trp53^tm1.2Awbr/Trp53^tm1.2Awbr (involves: C57BL/6)	increased circulating interferon-gamma level	J:173271
	increased circulating interleukin-3 level	J:173271
	increased circulating interleukin-5 level	J:173271
	increased circulating interleukin-6 level	J:173271
	increased circulating tumor necrosis factor level	J:173271
Trp53^{tm1b(EUCOMM)Hmgu}/Trp53⁺ (C57BL/6N-Trp53^{tm1b(EUCOMM)Hmgu}/H)	decreased circulating creatine kinase level	J:211773
Trp53^tm1Brn/Trp53^tm1Brn Tsc1^tm1Djk/Tsc1^tm1Djk (involves: 129P2/OlaHsd * 129S4/SvJae)	hemorrhagic ascites	J:212578
Trp53^tm1Ldo/Trp53⁺ (B6.129S7-Trp53^tm1Ldo)	decreased circulating insulin-like growth factor I level	J:130123
Trp53^tm1Tyj/Trp53⁺ (involves: 129S2/SvPas * C57BL/6)	abnormal iron level	J:244082
Trp53^tm1Tyj/Trp53^tm1Tyj (involves: 129S2/SvPas * C57BL/6)	abnormal iron homeostasis	J:244082
	abnormal iron level	J:244082
	abnormal protein level	J:244082
Trp53bp2^{tm1b(EUCOMM)Hmgu}/Trp53bp2⁺ (C57BL/6N-Trp53bp2^{tm1b(EUCOMM)Hmgu}/H)	increased circulating aspartate transaminase level	J:211773
Trp53i11^em1(IMPC)J/Trp53i11^em1(IMPC)J (C57BL/6NJ-Trp53i11^em1(IMPC)J/Mmjax)	increased circulating creatinine level	J:211773
Trp53inp1^tm1Acar/Trp53inp1^tm1Acar (involves: 129/Sv * C57BL/6)	hyperglycemia	J:233434
	impaired glucose tolerance	J:233434
	increased circulating insulin level	J:233434
	increased susceptibility to diet-induced non-insulin dependent diabetes	J:233434
	increased susceptibility to diet-induced obesity	J:233434
	insulin resistance	J:233434
Trp63^tm1Brd/Trp63^tm1Brd (involves: 129S7/SvEvBrd * C57BL/6J)	impaired skin barrier function	J:54636
Trp63^tm1Sin/Trp63^tm1Sin (Not Specified)	dehydration	J:181275
Trp63^tm2Brd/Trp63^tm2Brd (involves: 129S7/SvEvBrd * C57BL/6J)	impaired skin barrier function	J:54636
Trp73^em1(IMPC)H/Trp73⁺ (C57BL/6NTac-Trp73^em1(IMPC)H/H)	increased blood urea nitrogen level	J:211773
Trp73^tm1Fmc/Trp73^tm1Fmc (involves: 129S4/SvJae)	periorbital edema	J:60896
Trpc1^em1(IMPC)H/Trpc1^em1(IMPC)H (C57BL/6N-Trpc1^em1(IMPC)H/H)	increased circulating alkaline phosphatase level	J:211773
Trpc1^tm1Lbi/Trpc1^tm1Lbi (involves: 129S/SvEv)	decreased salivation	J:127118
Trpc2^{Gt(OST448844)Lex}/Trpc2^{Gt(OST448844)Lex} (involves: 129S5/SvEvBrd)	increased circulating cholesterol level	J:103485
	increased circulating triglyceride level	J:103485
Trpc4ap^em1Cya/Trpc4ap^em1Cya (C57BL/6J-Trpc4ap^em1Cya/Cya)	decreased susceptibility to diet-induced obesity	J:300649
	increased circulating insulin level	J:300649
	increased fasting circulating glucose level	J:300649
	insulin resistance	J:300649
Trpc5^tm1.1Clph/Trpc5^tm1.1Clph (involves: 129S1/SvImJ)	decreased circulating prolactin level	J:277600
Trpc5^tm1.2Mfre/Trpc5^tm1.2Mfre (B6N.129-Trpc5^tm1.2Mfre)	decreased circulating prolactin level	J:277600
Trpm1^{tm1b(KOMP)Wtsi}/Trpm1^{tm1b(KOMP)Wtsi} (C57BL/6N-Trpm1^{tm1b(KOMP)Wtsi}/H)	impaired glucose tolerance	J:211773
	increased circulating creatine kinase level	J:211773
	increased circulating HDL cholesterol level	J:211773
Trpm2^tm1.1Alp/Trpm2^tm1.1Alp (B6.129P2-Trpm2^tm1.1Alp)	decreased circulating interferon-gamma level	J:174397
	decreased circulating interleukin-12 level	J:174397
	decreased circulating interleukin-12b level	J:174397
Trpm2^tm1Yamo/Trpm2^tm1Yamo (involves: 129S4/SvJae * C57BL/6J)	abnormal interferon level	J:137676
	abnormal interleukin level	J:137676
Trpm4^tm1.1Mfre/Trpm4^tm1.1Mfre (involves: 129S1/Sv * 129X1/SvJ * BALB/cJ)	abnormal calcium ion homeostasis	J:118679
Trpm6^tm1.1Rws/Trpm6⁺ (involves: 129S1/Sv * 129X1/SvJ * C57BL/6J * FVB/N)	decreased circulating magnesium level	J:153718
Trpm6^{tm1b(KOMP)Wtsi}/Trpm6⁺ (C57BL/6N-Trpm6^{tm1b(KOMP)Wtsi}/Orl)	decreased circulating phosphate level	J:211773
Trpm7^tm1Agry/Trpm7⁺ (involves: 129)	abnormal magnesium ion homeostasis	J:205665
	decreased circulating magnesium level	J:205665
	decreased erythrocyte magnesium level	J:205665
	decreased urine magnesium level	J:205665
Trpm7^{tm1b(KOMP)Wtsi}/Trpm7⁺ (C57BL/6N-Trpm7^{tm1b(KOMP)Wtsi}/H)	increased circulating alkaline phosphatase level	J:211773
Trps1^{em1(IMPC)Wtsi}/Trps1⁺ (C57BL/6N-Trps1^{em1(IMPC)Wtsi}/Wtsi)	decreased fasting circulating glucose level	J:211773
Trps1^tm1Ymur/Trps1^tm1Ymur (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	cyanosis	J:130140
Trpv1^tm1Jul/Trpv1^tm1Jul (involves: 129X1/SvJ)	decreased susceptibility to diet-induced obesity	J:137026
Trpv1^tm1Jul/Trpv1^tm1Jul (involves: 129X1/SvJ)	decreased susceptibility to induced hypothermia	J:137026
Trpv1^tm1Jul/Trpv1^tm1Jul (involves: 129X1/SvJ * C57BL/6)	impaired febrile response	J:104828
Trpv1^tm1Jul/Trpv1^tm1Jul (B6.129X1-Trpv1^tm1Jul/J)	increased blood osmolality	J:105254
Trpv1^tm1Jul/Trpv1^tm1Jul (B6.129X1-Trpv1^tm1Jul)	abnormal urine homeostasis	J:154624
Trpv1^tm1Jul/Trpv1^tm1Jul (B6.129X1-Trpv1^tm1Jul)	increased urine protein level	J:154624
Trpv4^tm1Rck/Trpv4^tm1Rck (Not Specified)	abnormal fluid regulation	J:86560
	decreased blood osmolality	J:86560
	decreased circulating antidiuretic hormone level	J:86560
	increased blood osmolality	J:86560
Trpv5^Hcalc1/Trpv5⁺ (involves: C3H/HeH * C57BL/6J)	increased urine calcium level	J:196612
Trpv5^Hcalc1/Trpv5^Hcalc1 (involves: C3H/HeH * C57BL/6J)	abnormal vitamin D level	J:196612
	decreased circulating calcium level	J:196612
	decreased circulating phosphate level	J:196612
	decreased urine pH	J:196612
	increased urine calcium level	J:196612
	increased urine phosphate level	J:196612
Trpv5^tm1Bind/Trpv5^tm1Bind (involves: 129 * C57BL/6)	abnormal calcium ion homeostasis	J:86949
	abnormal renal calcium reabsorption	J:86949
	abnormal vitamin D level	J:86949
	decreased urine pH	J:86949
	increased urine calcium level	J:86949
	increased urine phosphate level	J:86949
Trrap^{tm1a(EUCOMM)Wtsi}/Trrap⁺ (B6JTyr;B6N-Trrap^{tm1a(EUCOMM)Wtsi}/Wtsi)	increased circulating magnesium level	J:175295
Trub1^{tm1b(EUCOMM)Hmgu}/Trub1^{tm1b(EUCOMM)Hmgu} (C57BL/6N-Trub1^{tm1b(EUCOMM)Hmgu}/Bay)	decreased circulating creatinine level	J:211773
	increased circulating aspartate transaminase level	J:211773
	increased circulating creatine kinase level	J:211773
Trub2^{tm2a(EUCOMM)Wtsi}/Trub2⁺ (C57BL/6N-Trub2^{tm2a(EUCOMM)Wtsi}/Wtsi)	increased circulating cholesterol level	J:211773
Try10^em1(IMPC)J/Try10^em1(IMPC)J (C57BL/6NJ-Try10^em1(IMPC)J/Mmjax)	increased circulating creatinine level	J:211773
Tsc1^tm1.1Djk/Tsc1^tm1.1Djk (either: 129S4/SvJae-Tsc1^tm1Djk or (involves: 129S4/SvJae * BALB/cJ) or (involves: 129S4/SvJae * C57BL/6J))	hydrops fetalis	J:75243
	pericardial effusion	J:75243
Tsc1^tm1Djk/Tsc1^tm1Djk (involves: 129S4/SvJae * C57BL/6)	decreased body temperature	J:167208
Tsc1^tm1Djk/Tsc1^tm1Djk (involves: 129S4/SvJae * C57BL/6)	decreased circulating ketone body level	J:167208
Tsc1^tm1Djk/Tsc1^tm1Djk Speer6-ps1^{Tg(Alb-cre)21Mgn}/Speer6-ps1⁺ (involves: 129S4/SvJae * C57BL/6 * DBA)	abnormal homeostasis	J:171445
	decreased circulating triglyceride level	J:171445
	impaired glucose tolerance	J:171445
	insulin resistance	J:171445
Tsc1^tm1Djk/Tsc1^tm1Djk Tg(Gdf9-icre)5092Coo/? (involves: 129S4/SvJae * C57BL/6J)	increased circulating follicle stimulating hormone level	J:155357
	increased circulating luteinizing hormone level	J:155357
Tsc22d3^tm1.2Hum/Y (involves: 129S1/SvImJ)	abnormal circulating hormone level	J:223992
	abnormal circulating sodium level	J:223992
	abnormal glucose homeostasis	J:223992
	abnormal ion homeostasis	J:223992
	decreased circulating corticosterone level	J:223992
	increased circulating follicle stimulating hormone level	J:223992
	increased circulating insulin level	J:223992
	increased circulating potassium level	J:223992
	increased circulating testosterone level	J:223992
Tsga13^em1(IMPC)J/Tsga13^em1(IMPC)J (C57BL/6NJ-Tsga13^em1(IMPC)J/Mmjax)	increased circulating triglyceride level	J:211773
Tshr^hyt-2J/Tshr^hyt-2J (B6;129P3-Tshr^hyt-2J/GrsrJ)	decreased circulating thyroxine level	J:213054
Tshr^hyt/Tshr^hyt (CBy.RF-Tshr^hyt/J)	decreased circulating progesterone level	J:72929
	decreased thyroxine level	J:130062
	impaired adaptive thermogenesis	J:139995
	increased thyroid-stimulating hormone level	J:130062
Tshr^hyt/Tshr^hyt (involves: BALB/cByJ * RF/J)	decreased circulating thyroxine level	J:6479
	increased circulating cholesterol level	J:6479
	increased circulating thyroid-stimulating hormone level	J:6479
Tshr^tm1Rmar/Tshr^tm1Rmar (involves: 129S1/Sv * C57BL/6J)	abnormal thyroid hormone level	J:80513
	decreased circulating levels of thyroid hormone	J:80513
	decreased circulating thyroxine level	J:80513
	decreased circulating triiodothyronine level	J:80513
	increased circulating thyroid-stimulating hormone level	J:80513
Tslp^{tm1(KOMP)Vlcg}/Tslp^{tm1(KOMP)Vlcg} (involves: C57BL/6 * C57BL/6NTac)	decreased circulating interleukin-4 level	J:187770
Tspan7^em1(IMPC)J/Y (C57BL/6NJ-Tspan7^em1(IMPC)J/Mmjax)	decreased circulating calcium level	J:211773
Tspan13^{em1(IMPC)Kmpc}/Tspan13^{em1(IMPC)Kmpc} (C57BL/6NTac-Tspan13^{em1(IMPC)Kmpc}/Kmpc)	decreased fasting circulating glucose level	J:211773
Tspan17^em1(IMPC)H/Tspan17^em1(IMPC)H (C57BL/6N-Tspan17^em1(IMPC)H/H)	increased circulating iron level	J:211773
Tspan18^{tm1.1(KOMP)Vlcg}/Tspan18^{tm1.1(KOMP)Vlcg} (C57BL/6N-Tspan18^{tm1.1(KOMP)Vlcg}/J)	decreased circulating glucose level	J:211773
	decreased circulating serum albumin level	J:211773
	increased circulating alanine transaminase level	J:211773
	increased fasting circulating glucose level	J:211773
Tspan18^tm1Lex/Tspan18^tm1Lex (involves: 129S5/SvEvBrd * C57BL/6J)	abnormal hemostasis	J:295079
	decreased circulating von Willebrand factor level	J:295079
	decreased susceptibility to induced thrombosis	J:295079
Tspo2^em1Muti/Tspo2^em1Muti (C57BL/6-Tspo2^em1Muti)	increased erythrocyte sodium:potassium-exchanging ATPase activity	J:292525
Tspoap1^em1(IMPC)H/Tspoap1^em1(IMPC)H (C57BL/6N-Tspoap1^em1(IMPC)H/H)	increased circulating alkaline phosphatase level	J:211773
Ttbk1^em1(IMPC)J/Ttbk1^em1(IMPC)J (C57BL/6NJ-Ttbk1^em1(IMPC)J/Mmjax)	increased circulating glucose level	J:211773
	increased fasting circulating glucose level	J:211773
Ttc7^fsn/Ttc7^fsn (CByJ.A-Ttc7^fsn)	abnormal circulating iron level	J:92699
	abnormal iron level	J:92699
	abnormal mineral level	J:92699
Ttc7^hea/Ttc7^hea (CFO)	colorless urine	J:7515
Ttc7^hea/Ttc7^hea (WBB6F1)	abnormal mineral level	J:92699
Ttc7^hea/Ttc7^hea (WBB6F1)	increased circulating iron level	J:92699
Ttc17^em1(IMPC)J/Ttc17^em1(IMPC)J (C57BL/6NJ-Ttc17^em1(IMPC)J/J)	increased circulating cholesterol level	J:211773
Ttc21b^{tm2c(KOMP)Wtsi}/Ttc21b^aln Gt(ROSA)26Sor^{tm1(cre/ERT)Nat}/Gt(ROSA)26Sor⁺ (involves: 129S1/Sv * 129X1/SvJ * A/J * C57BL/6N)	increased blood urea nitrogen level	J:213263
Ttc28^{tm1b(EUCOMM)Hmgu}/Ttc28^{tm1b(EUCOMM)Hmgu} (C57BL/6N-Ttc28^{tm1b(EUCOMM)Hmgu}/Tcp)	decreased circulating cholesterol level	J:211773
	decreased circulating HDL cholesterol level	J:211773
	increased circulating alkaline phosphatase level	J:211773
Ttc32^em1(IMPC)J/Ttc32^em1(IMPC)J (C57BL/6NJ-Ttc32^em1(IMPC)J/J)	increased circulating bilirubin level	J:211773
Ttc39a^{tm1b(KOMP)Mbp}/Ttc39a^{tm1b(KOMP)Mbp} (C57BL/6N-Ttc39a^{tm1b(KOMP)Mbp}/Orl)	increased circulating calcium level	J:211773
	increased circulating phosphate level	J:211773
Ttc39b^{tm1e(EUCOMM)Wtsi}/Ttc39b⁺ (Not Specified)	decreased circulating triglyceride level	J:165965
Ttc39b^{tm1e(EUCOMM)Wtsi}/Ttc39b^{tm1e(EUCOMM)Wtsi} (Not Specified)	decreased circulating creatinine level	J:165965
Ttl^{tm1b(EUCOMM)Wtsi}/Ttl^{tm1b(EUCOMM)Wtsi} (C57BL/6N-Ttl^{tm1b(EUCOMM)Wtsi}/Tcp)	edema	J:211773
Ttll3^{tm1a(EUCOMM)Wtsi}/Ttll3^{tm1a(EUCOMM)Wtsi} (B6JTyr;B6N-Ttll3^{tm1a(EUCOMM)Wtsi}/Wtsi)	decreased circulating potassium level	J:165965
Ttll6^{tm1.1(KOMP)Vlcg}/Ttll6^{tm1.1(KOMP)Vlcg} (C57BL/6N-Ttll6^{tm1.1(KOMP)Vlcg}/J)	decreased circulating glucose level	J:211773
	increased circulating potassium level	J:211773
Ttll10^em1(IMPC)J/Ttll10^em1(IMPC)J (C57BL/6NJ-Ttll10^em1(IMPC)J/J)	decreased circulating glucose level	J:211773
Ttll10^{tm1b(EUCOMM)Hmgu}/Ttll10^{tm1b(EUCOMM)Hmgu} (C57BL/6N-Ttll10^{tm1b(EUCOMM)Hmgu}/Wtsi)	impaired glucose tolerance	J:211773
Ttn^shru/Ttn^shru (B6.BTBR-Ttn^shru)	hypoxia	J:92178
Ttn^shru/Ttn^shru (B6.BTBR-Ttn^shru)	pericardial edema	J:92178
Ttn^tm1.1Her/Ttn^tm1.1Her (involves: 129S4/SvJae * 129T2/SvEms)	pericardial effusion	J:111284
Ttn^tm1Brge/Ttn^tm1Brge (B6.Cg-Ttn^tm1Brge)	pericardial edema	J:152736
Ttpa^tm1Far/Ttpa⁺ (involves: 129S4/SvJae * C57BL/6)	abnormal vitamin E level	J:66419
Ttpa^tm1Far/Ttpa^tm1Far (involves: 129S4/SvJae * C57BL/6)	abnormal vitamin E level	J:66419
Ttpa^tm1Hsz/Ttpa⁺ (involves: 129S7/SvEvBrd * C57BL/6J)	abnormal vitamin E level	J:67046
Ttpa^tm1Hsz/Ttpa^tm1Hsz (involves: 129S7/SvEvBrd * C57BL/6J)	abnormal lipid homeostasis	J:90006
	abnormal vitamin E level	J:67046
Ttr^tm1Kymm/Ttr^tm1Kymm (B6.Cg-Ttr^tm1Kymm)	abnormal circulating protein level	J:146510
	abnormal retinol level	J:146510
	decreased circulating thyroxine level	J:146510
	decreased circulating triiodothyronine level	J:146510
Ttr^tm1Wsb/Ttr⁺ (involves: 129S/SvEv * MF1)	decreased circulating thyroxine level	J:4183
Ttr^tm1Wsb/Ttr⁺ (involves: 129S/SvEv * MF1)	decreased circulating triiodothyronine level	J:4183
Ttr^tm1Wsb/Ttr^tm1Wsb (involves: 129S/SvEv)	abnormal blood homeostasis	J:22576
Ttr^tm1Wsb/Ttr^tm1Wsb (involves: 129S/SvEv)	decreased circulating thyroxine level	J:22576
Ttr^tm1Wsb/Ttr^tm1Wsb (involves: 129S/SvEv * MF1)	abnormal circulating protein level	J:4183
	abnormal retinol level	J:4183
	decreased circulating levels of thyroid hormone	J:4183
	decreased circulating thyroxine level	J:4183
	decreased circulating triiodothyronine level	J:4183
Ttr^tm2(TTR)Kymm/Ttr⁺ (B6.Cg-Ttr^tm2(TTR)Kymm)	abnormal circulating protein level	J:146510
	abnormal retinol level	J:146510
	decreased circulating thyroxine level	J:146510
	decreased circulating triiodothyronine level	J:146510
Ttr^tm2(TTR)Kymm/Ttr^tm2(TTR)Kymm (B6.Cg-Ttr^tm2(TTR)Kymm)	abnormal circulating protein level	J:146510
	abnormal retinol level	J:146510
	decreased circulating thyroxine level	J:146510
	decreased circulating triiodothyronine level	J:146510
Ttr^tm2(TTR)Kymm/Ttr^{tm3(TTR)Kymm} (B6.Cg-Ttr^tm2(TTR)Kymm/Ttr^{tm3(TTR)Kymm})	abnormal circulating protein level	J:146510
Ttr^{tm3(TTR)Kymm}/Ttr^{tm3(TTR)Kymm} (B6.Cg-Ttr^{tm3(TTR*)Kymm})	abnormal circulating protein level	J:146510
Tub^tub/Tub^tub (B6(AU)-Tub^tub/J)	increased circulating cholesterol level	J:18161
	increased circulating insulin level	J:32415
	increased circulating triglyceride level	J:18161
Tub^tub/Tub^tub (C57BL/6J-Tub^tub)	increased circulating insulin level	J:13772
Tub^tub/Tub^tub (C57BL/6J-Tub^tub)	increased liver glycogen level	J:13772
Tuba1a^em1(IMPC)Bay/Tuba1a^em1(IMPC)Bay (C57BL/6N-Tuba1a^em1(IMPC)Bay/BayMmucd)	edema	J:211773
Tuba1a^em1Rstot/Tuba1a^em1Rstot (involves: C57BL/6J * C57BL/6N)	edema	J:278765
Tuba1a^em2Rstot/Tuba1a^em2Rstot (involves: C57BL/6J * C57BL/6N)	edema	J:278765
Tuba1c^em1(IMPC)J/Tuba1c^em1(IMPC)J (C57BL/6NJ-Tuba1c^em1(IMPC)J/Mmjax)	increased circulating alkaline phosphatase level	J:211773
Tubal3^em1(IMPC)J/Tubal3^em1(IMPC)J (C57BL/6NJ-Tubal3^em1(IMPC)J/Mmjax)	decreased circulating calcium level	J:211773
Tubb1^tm1Shiv/Tubb1^tm1Shiv (involves: 129/Sv * BALB/c)	increased bleeding time	J:94498
Tubb1^tm1Shiv/Tubb1^tm1Shiv (Not Specified)	abnormal platelet physiology	J:95293
Tubb4a^{tm1.1(KOMP)Wtsi}/Tubb4a^{tm1.1(KOMP)Wtsi} (C57BL/6N-Tubb4a^{tm1.1(KOMP)Wtsi}/J)	decreased fasting circulating glucose level	J:211773
Tuft1^{tm1a(KOMP)Wtsi}/Tuft1^{tm1a(KOMP)Wtsi} (C57BL/6N-Tuft1^{tm1a(KOMP)Wtsi}/Wtsi)	decreased circulating alkaline phosphatase level	J:211773
	decreased circulating HDL cholesterol level	J:211773
	improved glucose tolerance	J:211773
Tulp3^hhkr/Tulp3^hhkr (involves: C3H/HeH * C57BL/6)	edema	J:147584
Tulp3^hhkr/Tulp3^tm1Jng (involves: 129S1/Sv * 129X1/SvJ * C3H/HeH * C57BL/6)	edema	J:147584
Tulp3^m1Kflj/Tulp3^m1Kflj (involves: C57BL/6J * FVB/NJ)	increased blood urea nitrogen level	J:284006
Tulp3^m1Kflj/Tulp3^m1Kflj (involves: C57BL/6J * FVB/NJ)	increased circulating creatinine level	J:284006
Tulp3^{tm1b(EUCOMM)Hmgu}/Tulp3⁺ (C57BL/6N-Tulp3^{tm1b(EUCOMM)Hmgu}/H)	decreased fasting circulating glucose level	J:211773
	impaired glucose tolerance	J:211773
	increased circulating alanine transaminase level	J:211773
	increased circulating aspartate transaminase level	J:211773
	increased circulating bilirubin level	J:211773
Tulp3^{tm1b(EUCOMM)Hmgu}/Tulp3^{tm1b(EUCOMM)Hmgu} (involves: C57BL/6 * C57BL/6N * FVB/NJ)	edema	J:284006
Tulp3^{tm1c(EUCOMM)Hmgu}/Tulp3⁺ Pkd1^tm2Ggg/Pkd1^tm2Ggg Tg(Pax8-rtTA2SM2)1Koes/0 Tg(tetO-cre)1Jaw/0 (involves: 129S4/SvJae C57BL/6 * C57BL/6N * DBA * SJL)	increased blood urea nitrogen level	J:284006
Tulp3^{tm1c(EUCOMM)Hmgu}/Tulp3^{tm1c(EUCOMM)Hmgu} Pkd1^tm2Ggg/Pkd1⁺ Tg(Pax8-rtTA2SM2)1Koes/0 Tg(tetO-cre)1Jaw/0 (involves: 129S4/SvJae C57BL/6 * C57BL/6N * DBA * SJL)	increased blood urea nitrogen level	J:284006
Tulp3^{tm1c(EUCOMM)Hmgu}/Tulp3^{tm1c(EUCOMM)Hmgu} Pkd1^tm2Ggg/Pkd1^tm2Ggg Tg(Pax8-rtTA2SM2)1Koes/0 Tg(tetO-cre)1Jaw/0 (involves: 129S4/SvJae C57BL/6 * C57BL/6N * DBA * SJL)	increased blood urea nitrogen level	J:284006
Tulp4^{tm1a(KOMP)Wtsi}/Tulp4⁺ (involves: C57BL/6N * C57BL/6NRj)	subcutaneous edema	J:344151
Tusc2^tm1Avi/Tusc2⁺ (involves: 129S1/Sv * C57BL/6J)	abnormal glomerular capillary thrombosis	J:119985
Tusc2^tm1Avi/Tusc2^tm1Avi (involves: 129S1/Sv * C57BL/6J)	abnormal glomerular capillary thrombosis	J:119985
Tusc2^tm1Avi/Tusc2^tm1Avi (involves: 129S1/Sv)	abnormal calcium ion homeostasis	J:309768
Tusc2^tm1Avi/Tusc2^tm1Avi (involves: 129S1/Sv)	abnormal glomerular capillary thrombosis	J:309768
Tut4^{Gt(RRR277)Byg}/Tut4^{Gt(RRR277)Byg} (B6.129P2-Tut4^{Gt(RRR277)Byg})	decreased circulating insulin-like growth factor I level	J:194669
Twf1^{tm1a(EUCOMM)Wtsi}/Twf1^{tm1a(EUCOMM)Wtsi} (C57BL/6N-Twf1^{tm1a(EUCOMM)Wtsi}/Wtsi)	decreased circulating alkaline phosphatase level	J:165965
Twist2^tm1(cre)Dor/Twist2^tm1(cre)Dor (involves: 129/Sv * 129X1/SvJ)	abnormal interleukin level	J:81485
	abnormal tumor necrosis factor level	J:81485
	decreased liver glycogen level	J:81485
	decreased skeletal muscle glycogen level	J:81485
	hypoglycemia	J:81485
Twsg1^tm1Ecan/Twsg1^tm1Ecan (involves: 129 * C57BL/6)	decreased circulating osteocalcin level	J:137597
Txlna^{tm1b(EUCOMM)Hmgu}/Txlna^{tm1b(EUCOMM)Hmgu} (C57BL/6N-Txlna^{tm1b(EUCOMM)Hmgu}/H)	increased circulating potassium level	J:211773
Txndc2^tm1Lex/Txndc2^tm1Lex (involves: 129S5/SvEvBrd * C57BL/6J)	abnormal circulating phosphate level	J:103485
	decreased circulating interleukin-6 level	J:103485
Txndc5^{tm1.1(KOMP)Vlcg}/Txndc5⁺ (C57BL/6N-Txndc5^{tm1.1(KOMP)Vlcg}/Ucd)	decreased circulating cholesterol level	J:211773
	decreased circulating serum albumin level	J:211773
	decreased circulating triglyceride level	J:211773
	increased circulating insulin level	J:211773
Txndc5^{tm1.1(KOMP)Vlcg}/Txndc5^{tm1.1(KOMP)Vlcg} (C57BL/6N-Txndc5^{tm1.1(KOMP)Vlcg}/Ucd)	increased circulating insulin level	J:211773
Txndc11^em1(IMPC)J/Txndc11^em1(IMPC)J (C57BL/6NJ-Txndc11^em1(IMPC)J/Mmjax)	increased circulating cholesterol level	J:211773
Txnip^Hyplip1/Txnip^Hyplip1 (HcB19/Dem-Txnip^Hyplip1)	increased circulating cholesterol level	J:47109
	increased circulating triglyceride level	J:47109
	increased circulating VLDL cholesterol level	J:47109
Txnip^Hyplip1/Txnip^Hyplip1 (B6.HcB19-Txnip^Hyplip1)	abnormal lipid homeostasis	J:102224
Txnip^Hyplip1/Txnip^Hyplip1 (B6.HcB19-Txnip^Hyplip1)	increased fatty acids level	J:102224
Txnip^tm1.1Rlee/Txnip^tm1.1Rlee (involves: 129S4/SvJae)	decreased circulating glucose level	J:141487
Txnip^tm1.1Road/Txnip^tm1.1Road (B6.Cg-Txnip^tm1.1Road)	abnormal gluconeogenesis	J:132756
	abnormal glucose homeostasis	J:132756
	hypoglycemia	J:132756
	improved glucose tolerance	J:132756
	increased circulating ketone body level	J:132756
	increased circulating lactate level	J:132756
	increased circulating triglyceride level	J:132756
	increased insulin sensitivity	J:132756
Txnip^{tm1b(EUCOMM)Hmgu}/Txnip^{tm1b(EUCOMM)Hmgu} (C57BL/6N-Txnip^{tm1b(EUCOMM)Hmgu}/H)	decreased circulating alkaline phosphatase level	J:211773
	increased circulating calcium level	J:211773
	increased circulating phosphate level	J:211773
	increased circulating triglyceride level	J:211773
Txnip^tm1Jjy/Txnip^tm1Jjy (involves: C57BL/6 * CBA)	abnormal blood homeostasis	J:104563
	abnormal circulating insulin level	J:104563
	abnormal circulating phospholipid level	J:104563
	abnormal glucose homeostasis	J:104563
	abnormal lipid homeostasis	J:104563
	decreased circulating antithrombin level	J:104563
	decreased circulating glucose level	J:104563
	decreased circulating sodium level	J:104563
	hematuria	J:104563
	increased bleeding time	J:104563
	increased blood urea nitrogen level	J:104563
	increased circulating cholesterol level	J:104563
	increased circulating free fatty acids level	J:104563
	increased circulating ketone body level	J:104563
	increased circulating potassium level	J:104563
	increased circulating triglyceride level	J:104563
	increased partial thromboplastin time	J:104563
	increased prothrombin time	J:104563
Txnip^tm1Road/Txnip^tm1Road Tg(Ckmm-cre)5Khn/0 (involves: C57BL/6 * FVB)	hypoglycemia	J:132756
	improved glucose tolerance	J:132756
	increased circulating ketone body level	J:132756
	increased circulating triglyceride level	J:132756
Tyk2^E775K/Tyk2^E775K (B10.D1-H2^q/SgJ)	increased circulating interleukin-12 level	J:120304
Tyk2^tm1Biat/Tyk2^tm1Biat (involves: 129P2/OlaHsd * C57BL/6)	abnormal nitric oxide homeostasis	J:116703
	decreased macrophage nitric oxide production	J:65408
Tyk2^tm1Shmd/Tyk2^tm1Shmd (either: (involves: 129 * 129P2/OlaHsd) or (involves: 129P2/OlaHsd * C57BL/6))	abnormal body temperature homeostasis	J:195099
	decreased energy expenditure	J:195099
	impaired adaptive thermogenesis	J:195099
	impaired glucose tolerance	J:195099
	increased cholesterol level	J:195099
	increased circulating free fatty acids level	J:195099
	increased circulating insulin level	J:195099
Tymp^tm1Akiy/Tymp^tm1Akiy (involves: 129X1/SvJ)	abnormal enzyme/coenzyme level	J:78036
Tymp^tm1Akiy/Tymp^tm1Akiy Upp1^tm1Akiy/Upp1^tm1Akiy (involves: 129X1/SvJ)	abnormal enzyme/coenzyme level	J:78036
Tyro3^{em1(IMPC)Ccpcz}/Tyro3^{em1(IMPC)Ccpcz} (C57BL/6NCrl-Tyro3^{em1(IMPC)Ccpcz}/Ccpcz)	increased circulating chloride level	J:211773
	increased circulating creatine kinase level	J:211773
Tyrp1^b-J/Tyrp1^b-J (C57BL/6J-Tyrp1^b-J/J)	decreased bleeding time	J:7327
Tyrp1^B-lt/Tyrp1^B-lt (involves: C57BL/6J)	increased bleeding time	J:7327
Tysnd1^tm1.1Arte/Tysnd1^tm1.1Arte (involves: C57BL/6J * C57BL/6N)	decreased plasmalogen level	J:223054
	increased circulating alanine transaminase level	J:223054
	increased circulating aspartate transaminase level	J:223054
	increased circulating lactate dehydrogenase level	J:223054
Tyw1^{tm1b(KOMP)Wtsi}/Tyw1^{tm1b(KOMP)Wtsi} (C57BL/6N-Tyw1^{tm1b(KOMP)Wtsi}/J)	decreased circulating alkaline phosphatase level	J:211773
	decreased circulating serum albumin level	J:211773
U2af2^em1(IMPC)J/U2af2⁺ (C57BL/6NJ-U2af2^em1(IMPC)J/Mmjax)	abnormal cholesterol homeostasis	J:211773
U2af2^em1(IMPC)J/U2af2⁺ (C57BL/6NJ-U2af2^em1(IMPC)J/Mmjax)	decreased circulating calcium level	J:211773
U2surp^em1(IMPC)J/U2surp⁺ (C57BL/6NJ-U2surp^em1(IMPC)J/Mmjax)	decreased circulating glucose level	J:211773
U90926^em1Dnkv/U90926^em1Dnkv (C57BL6/J-U90926^em1Dnkv)	increased circulating interleukin-6 level	J:340649
Ua1^BALB/c/Ua1^KK/Ta (involves: BALB/c * KK/Ta)	albuminuria	J:97906
Ua1^KK/Ta/Ua1^KK/Ta (involves: BALB/c * KK/Ta)	albuminuria	J:97906
Uaca^tm1Kiy/Uaca^tm1Kiy (B6.129P2-Uaca^tm1Kiy)	increased circulating alanine transaminase level	J:157049
	increased circulating alkaline phosphatase level	J:157049
	increased circulating aspartate transaminase level	J:157049
	increased circulating cholesterol level	J:157049
	increased circulating lactate dehydrogenase level	J:157049
Uba6^tm1Whpr/Uba6^tm1Whpr Tg(Nes-cre)1Kln/0 (B6.Cg-Uba6^tm1Whpr Tg(Nes-cre)1Kln)	increased carbon dioxide production	J:198126
	increased energy expenditure	J:198126
	increased oxygen consumption	J:198126
Ubac1^em1(IMPC)J/Ubac1^em1(IMPC)J (C57BL/6NJ-Ubac1^em1(IMPC)J/Mmjax)	increased circulating serum albumin level	J:211773
Ubap2^em1(IMPC)J/Ubap2^em1(IMPC)J (C57BL/6NJ-Ubap2^em1(IMPC)J/Mmjax)	decreased blood urea nitrogen level	J:211773
	increased circulating glucose level	J:211773
Ubash3a^{tm1b(KOMP)Wtsi}/Ubash3a^{tm1b(KOMP)Wtsi} (C57BL/6N-Ubash3a^{tm1b(KOMP)Wtsi}/Ieg)	decreased circulating triglyceride level	J:211773
Ubb^tm1Rrk/Ubb^tm1Rrk (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	abnormal energy homeostasis	J:132767
	increased circulating leptin level	J:132767
Ube2b^{tm1a(EUCOMM)Wtsi}/Ube2b⁺ (C57BL/6N-Ube2b^{tm1a(EUCOMM)Wtsi}/Ics)	decreased circulating triglyceride level	J:165965
	increased circulating triglyceride level	J:165965
Ube2d1^{tm3e(EUCOMM)Wtsi}/Ube2d1^{tm3e(EUCOMM)Wtsi} (C57BL/6N-Ube2d1^{tm3e(EUCOMM)Wtsi}/Wtsi)	decreased circulating cholesterol level	J:211773
	increased circulating bilirubin level	J:211773
Ube2i^em1(IMPC)J/Ube2i⁺ (C57BL/6NJ-Ube2i^em1(IMPC)J/Mmjax)	increased circulating calcium level	J:211773
Ube2i^em1(IMPC)J/Ube2i⁺ (C57BL/6NJ-Ube2i^em1(IMPC)J/Mmjax)	increased circulating phosphate level	J:211773
Ube2j1^{tm1.1(NCOM)Mfgc}/Ube2j1^{tm1.1(NCOM)Mfgc} (C57BL/6N-Ube2j1^{tm1.1(NCOM)Mfgc}/Rbrc)	increased circulating amylase level	J:211773
	increased circulating cholesterol level	J:211773
Ube2j2^{em1(IMPC)Rbrc}/Ube2j2^{em1(IMPC)Rbrc} (C57BL/6NJcl-Ube2j2^{em1(IMPC)Rbrc}/Rbrc)	abnormal blood urea nitrogen level	J:211773
Ube2m^{tm1.1(KOMP)Wtsi}/Ube2m⁺ (C57BL/6N-Ube2m^{tm1.1(KOMP)Wtsi}/J)	increased circulating sodium level	J:211773
Ube2o^{tm1.1(KOMP)Mbp}/Ube2o⁺ (B6N(Cg)-Ube2o^{tm1.1(KOMP)Mbp}/J)	increased circulating alanine transaminase level	J:211773
	increased circulating cholesterol level	J:211773
Ube2q1^tm1Grz/Ube2q1^tm1Grz (involves: 129S1/Sv * 129X1/SvJ)	decreased circulating prolactin level	J:195898
Ube2w^{tm1b(EUCOMM)Wtsi}/Ube2w^{tm1b(EUCOMM)Wtsi} (C57BL/6N-Ube2w^{tm1b(EUCOMM)Wtsi}/Nju)	increased fasting circulating glucose level	J:211773
Ube3a^{em1(IMPC)Hmgu}/Ube3a⁺ (C57BL/6N-Ube3a^{em1(IMPC)Hmgu}/Ieg)	decreased respiratory quotient	J:211773
Ube3a^{em1(IMPC)Hmgu}/Ube3a^{em1(IMPC)Hmgu} (C57BL/6N-Ube3a^{em1(IMPC)Hmgu}/Ieg)	decreased respiratory quotient	J:211773
Ube3a^tm1Alb/Ube3a⁺ (involves: 129S7/SvEvBrd * C57BL/6J)	abnormal adrenaline level	J:190050
	increased dopamine level	J:190050
	increased serotonin level	J:190050
Ube3b^{Gt(RRJ142)Byg}/Ube3b^{Gt(RRJ142)Byg} (involves: 129P2/OlaHsd * CBA/Ca)	decreased circulating cholesterol level	J:203652
	decreased circulating LDL cholesterol level	J:203652
Ube3c^{tm1b(EUCOMM)Hmgu}/Ube3c^{tm1b(EUCOMM)Hmgu} (C57BL/6N-Ube3c^{tm1b(EUCOMM)Hmgu}/Rbrc)	decreased circulating serum albumin level	J:211773
	decreased respiratory quotient	J:211773
	increased circulating alkaline phosphatase level	J:211773
	increased circulating lactate dehydrogenase level	J:211773
Ube3c^{tm1b(EUCOMM)Hmgu}/Ube3c^{tm1b(EUCOMM)Hmgu} (C57BL/6NCrl-Ube3c^{tm1b(EUCOMM)Hmgu}/Rbrc)	decreased circulating iron level	J:211773
	increased circulating alkaline phosphatase level	J:211773
	increased circulating cholesterol level	J:211773
Ube4a^em1(IMPC)Tcp/Ube4a^em1(IMPC)Tcp (C57BL/6N-Ube4a^em1(IMPC)Tcp/Tcp)	impaired glucose tolerance	J:211773
Ube4b^tm1Kei/Ube4b^tm1Kei (involves: C57BL/6)	pericardial edema	J:103761
Ube4b^tm1Kei/Ube4b^tm1Kei (involves: C57BL/6)	pericardial effusion	J:103761
Ubiad1^em1Wwk/Ubiad1^em1Wwk (C57BL/6N-Ubiad1^em1Wwk)	abnormal phospholipid level	J:268574
Ubiad1^tm1.1Thka/Ubiad1⁺ (C57BL/6-Ubiad1^tm1.1Thka)	abnormal vitamin homeostasis	J:221005
	increased circulating cholesterol level	J:221005
	increased circulating HDL cholesterol level	J:221005
Ubiad1^tm1.1Thka/Ubiad1^tm1.1Thka (C57BL/6-Ubiad1^tm1.1Thka)	abnormal vitamin homeostasis	J:221005
Ubl4a^tm1.2Arte/Y (involves: C57BL/6)	abnormal glycogen homeostasis	J:226059
Ubl4a^tm1.2Arte/Y (involves: C57BL/6)	cyanosis	J:226059
Ubl4a^tm1.2Arte/Ubl4a^tm1.2Arte (involves: C57BL/6)	abnormal glycogen homeostasis	J:226059
Ubl4a^tm1.2Arte/Ubl4a^tm1.2Arte (involves: C57BL/6)	cyanosis	J:226059
Ubl4b^{em1(IMPC)Ccpcz}/Ubl4b^{em1(IMPC)Ccpcz} (C57BL/6N-Ubl4b^{em1(IMPC)Ccpcz}/Ccpcz)	increased circulating serum albumin level	J:211773
Ubl7^em1(IMPC)Tcp/Ubl7^em1(IMPC)Tcp (C57BL/6N-Ubl7^em1(IMPC)Tcp/Tcp)	increased blood urea nitrogen level	J:211773
Ubn1^em1(IMPC)J/Ubn1^em1(IMPC)J (C57BL/6NJ-Ubn1^em1(IMPC)J/J)	increased circulating alanine transaminase level	J:211773
Ubp1^{tm1b(KOMP)Mbp}/Ubp1⁺ (C57BL/6N-Ubp1^{tm1b(KOMP)Mbp}/Bay)	decreased circulating alkaline phosphatase level	J:211773
	decreased circulating calcium level	J:211773
	decreased circulating serum albumin level	J:211773
	increased circulating creatinine level	J:211773
Ubqln4^em1(IMPC)Mbp/Ubqln4^em1(IMPC)Mbp (C57BL/6NCrl-Ubqln4^em1(IMPC)Mbp/MbpMmucd)	increased circulating alkaline phosphatase level	J:211773
	increased circulating aspartate transaminase level	J:211773
Ubr1^tm1Avar/Ubr1^tm1Avar (either: (involves: 129S/SvEv * 129S1/Sv) or (involves: 129S1/Sv * C57BL/6J))	decreased blood urea nitrogen level	J:72859
	decreased circulating serum albumin level	J:72859
	decreased circulating total protein level	J:72859
	decreased circulating triglyceride level	J:72859
	hypoglycemia	J:72859
Ubr1^tm1Avar/Ubr1^tm1Avar Ubr2^tm1Ytkw/Ubr2^tm1Ytkw (involves: 129S1/Sv * C57BL/6)	pericardial effusion	J:109036
Ubr3^tm1Ytkw/Ubr3^tm1Ytkw (B6.129S1-Ubr3^tm1Ytkw)	abnormal noradrenaline level	J:123383
Ubr5^tm1Ckww/Ubr5^tm1Ckww (involves: 129X1/SvJ * C57BL/6)	pericardial effusion	J:92269
Ubr7^em1(IMPC)Tcp/Ubr7^em1(IMPC)Tcp (C57BL/6NCrl-Ubr7^em1(IMPC)Tcp/Tcp)	decreased circulating serum albumin level	J:211773
	improved glucose tolerance	J:211773
Ubtf^em1(IMPC)Mbp/Ubtf⁺ (C57BL/6NCrl-Ubtf^em1(IMPC)Mbp/Mmucd)	decreased circulating serum albumin level	J:211773
Ubxn1^em1(IMPC)J/Ubxn1^em1(IMPC)J (C57BL/6N-Ubxn1^em1(IMPC)J/J)	decreased circulating total protein level	J:211773
Ubxn2a^{tm1b(EUCOMM)Hmgu}/Ubxn2a^{tm1b(EUCOMM)Hmgu} (C57BL/6N-Ubxn2a^{tm1b(EUCOMM)Hmgu}/MbpMmucd)	edema	J:211773
Ubxn10^{tm1b(EUCOMM)Wtsi}/Ubxn10^{tm1b(EUCOMM)Wtsi} (C57BL/6N-Ubxn10^{tm1b(EUCOMM)Wtsi}/Wtsi)	increased circulating alanine transaminase level	J:211773
	increased circulating creatine kinase level	J:211773
Uchl1^{tm1b(EUCOMM)Hmgu}/Uchl1⁺ (C57BL/6N-Uchl1^{tm1b(EUCOMM)Hmgu}/H)	increased circulating alkaline phosphatase level	J:211773
Uchl4^{em1(IMPC)Ccpcz}/Uchl4^{em1(IMPC)Ccpcz} (C57BL/6N-Uchl4^{em1(IMPC)Ccpcz}/Ccpcz)	increased fasting circulating glucose level	J:211773
Uckl1^em1(IMPC)J/Uckl1^em1(IMPC)J (C57BL/6NJ-Uckl1^em1(IMPC)J/Mmjax)	increased circulating alkaline phosphatase level	J:211773
Ucn2^tm1Pbl/Ucn2^tm1Pbl (involves: 129 * C57BL/6)	increased circulating adrenocorticotropin level	J:108744
Ucn2^tm1Pbl/Ucn2^tm1Pbl (involves: 129 * C57BL/6)	increased circulating corticosterone level	J:108744
Ucn3^{tm1.1(KOMP)Vlcg}/Ucn3^{tm1.1(KOMP)Vlcg} (C57BL/6N-Ucn3^{tm1.1(KOMP)Vlcg}/Ucd)	increased circulating creatinine level	J:211773
Ucn3^tm1Pbl/Ucn3^tm1Pbl (Not Specified)	decreased circulating insulin level	J:119417
	decreased insulin secretion	J:119417
	improved glucose tolerance	J:119417
Ucn^tm1Abas/Ucn^tm1Abas (B6.129S4-Ucn^tm1Abas)	abnormal circulating corticosterone level	J:122730
Ucn^tm1Abas/Ucn^tm1Abas (B6.129S4-Ucn^tm1Abas)	increased circulating corticosterone level	J:122730
Ucp1^m1H/Ucp1^m1H (C57BL/6J-Ucp1^m1H/H)	abnormal body temperature homeostasis	J:148827
Ucp1^{tm1b(EUCOMM)Hmgu}/Ucp1^{tm1b(EUCOMM)Hmgu} (C57BL/6N-Ucp1^{tm1b(EUCOMM)Hmgu}/Ieg)	decreased circulating triglyceride level	J:211773
Ucp1^tm1Kz/Ucp1^tm1Kz (involves: 129S2/SvPas)	abnormal oxygen consumption	J:40053
	decreased oxygen consumption	J:62312
	decreased susceptibility to diet-induced obesity	J:40053
	impaired adaptive thermogenesis	J:40053
Ucp1^tm1Kz/Ucp1^tm1Kz (129S1.Cg-Ucp^tm1Kz)	impaired adaptive thermogenesis	J:69573
Ucp1^tm1Kz/Ucp1^tm1Kz (B6.Cg-Ucp^tm1Kz)	abnormal lipid homeostasis	J:81820
	decreased circulating free fatty acids level	J:81820
	decreased circulating thyroxine level	J:81820
	decreased circulating triglyceride level	J:81820
	decreased respiratory quotient	J:81820
	decreased susceptibility to diet-induced obesity	J:81820
	impaired adaptive thermogenesis	J:69573
	increased body temperature	J:81820
	increased circulating triiodothyronine level	J:81820
Ucp1^tm1Kz/Ucp1^tm1Kz (involves: 129S2/SvPas * C57BL/6)	impaired febrile response	J:345254
Ucp1^tm1Kz/Ucp1^tm1Kz Ucp3^tm1Rei/Ucp3^tm1Rei (involves: 129S2/SvPas * 129S6/SvEvTac * Black Swiss)	decreased oxygen consumption	J:62312
Ucp2^tm1Lowl/Ucp2^tm1Lowl (involves: 129S4/SvJae * C57BL/6)	decreased dopamine level	J:96713
Ucp2^tm1Rcq/Ucp2^tm1Rcq (involves: 129X1/SvJ * C57BL/6)	decreased adiponectin level	J:122094
	decreased circulating glucose level	J:122094
	decreased circulating lactate level	J:122094
Ucp2^tm2.1Lowl/Ucp2^tm2.1Lowl Gt(ROSA)26Sor^{tm1(CAG-Kcnj11,-GFP)Nich}/? Tg(Pmch-cre)1Lowl/0 (involves: 129S4/SvJaeSor 129S6/SvEvTac * C57BL/6 * FVB/NJ)	impaired glucose tolerance	J:167906
Ucp2^tm2.1Lowl/Ucp2^tm2.1Lowl Tg(CAG-Bgeo/GFP)21Lbe/0 Tg(Pmch-cre)1Lowl/0 (involves: 129S1/Sv * 129S6/SvEvTac * 129X1/SvJ * C57BL/6 * FVB/NJ)	decreased circulating glucose level	J:167906
	decreased circulating insulin level	J:167906
	improved glucose tolerance	J:167906
Ucp3^tm1Brnd/Ucp3^tm1Brnd (Not Specified)	decreased skeletal muscle triglyceride level	J:106901
Ucp3^tm1Lowl/Ucp3^tm1Lowl (involves: 129S4/SvJae * C57BL/6)	increased fatty acids level	J:62313
Ucp3^tm1Rei/Ucp3^tm1Rei (involves: 129S6/SvEvTac * Black Swiss)	decreased circulating free fatty acids level	J:62312
	decreased circulating glucose level	J:62312
Ucp3^tm1Rei/Ucp3^tm1Rei (involves: 129S6/SvEvTac)	improved glucose tolerance	J:142293
Ucp3^tm1Rei/Ucp3^tm1Rei (involves: 129S6/SvEvTac)	increased insulin sensitivity	J:142293
Ufl1^{tm1a(EUCOMM)Wtsi}/Ufl1⁺ (C57BL/6N-Ufl1^{tm1a(EUCOMM)Wtsi}/Wtsi)	decreased circulating alanine transaminase level	J:175295
	decreased circulating aspartate transaminase level	J:175295
Ugcg^em1(IMPC)H/Ugcg⁺ (C57BL/6NTac-Ugcg^em1(IMPC)H/H)	increased circulating alanine transaminase level	J:211773
Ugcg^tm1Hjg/Ugcg^tm1.1Hjg Tg(Nes-cre)1Kln/0 (involves: 129P2/OlaHsd * C57BL/6 * SJL)	abnormal lipid homeostasis	J:101155
Ugcg^tm1Hjg/Ugcg^tm1Hjg Pax8^{tm1.1(cre)Mbu}/Pax8⁺ (involves: 129P2/OlaHsd * C57BL/6)	decreased urine pH	J:197393
Uggt1^em1(IMPC)Mbp/Uggt1⁺ (C57BL/6N-Uggt1^em1(IMPC)Mbp/MbpMmucd)	edema	J:211773
Uggt1^em1(IMPC)Mbp/Uggt1^em1(IMPC)Mbp (C57BL/6N-Uggt1^em1(IMPC)Mbp/MbpMmucd)	edema	J:211773
Ugt1^tm1.1Afmu/Ugt1^tm1.1Afmu (involves: 129 * C57BL/6 * SJL)	increased circulating bilirubin level	J:182805
Ugt1^tm1.1Afmu/Ugt1^tm1.1Afmu (B6.Cg-Ugt1^tm1.1Afmu)	increased circulating bilirubin level	J:216224
Ugt1^tm1.1Afmu/Ugt1^tm1.1Afmu (FVB.Cg-Ugt1^tm1.1Afmu)	increased circulating bilirubin level	J:216224
Ugt1^tm1Rhtu/Ugt1^tm1Rhtu (involves: 129 * C57BL/6)	increased circulating bilirubin level	J:133790
Ugt8a^tm1Pop/Ugt8a⁺ (involves: 129P2/OlaHsd * C57BL/6)	abnormal lipid level	J:77226
Ugt8a^tm1Pop/Ugt8a^tm1Pop (involves: 129P2/OlaHsd * C57BL/6)	abnormal lipid level	J:77226
Ugt8a^tm1Wst/Ugt8a^tm1Wst (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	abnormal lipid level	J:36558
Uhmk1^tm1Enbl/Uhmk1^tm1Enbl (involves: 129/Sv * C57BL/6)	increased circulating cholesterol level	J:144737
Uhrf2^{tm1b(EUCOMM)Wtsi}/Uhrf2^{tm1b(EUCOMM)Wtsi} (C57BL/6N-Uhrf2^{tm1b(EUCOMM)Wtsi}/Tcp)	increased circulating alkaline phosphatase level	J:211773
Ulk2^tm1Lex/Ulk2^tm1Lex (involves: 129S5/SvEvBrd * C57BL/6J)	increased response to stress-induced hyperthermia	J:103485
Ulk3^em2(IMPC)Tcp/Ulk3^em2(IMPC)Tcp (C57BL/6NCrl-Ulk3^em2(IMPC)Tcp/Tcp)	decreased circulating serum albumin level	J:211773
	increased circulating cholesterol level	J:211773
	increased circulating creatinine level	J:211773
	increased circulating sodium level	J:211773
Umod^em1Duf/Umod⁺ (C57BL/6J-Umod^em1Duf)	increased blood urea nitrogen level	J:252597
Umod^em1Duf/Umod⁺ (C57BL/6J-Umod^em1Duf)	increased circulating creatinine level	J:252597
Umod^tm1.1Rvt/Umod⁺ (either: B6J.129-Umod^tm1.1Rvt or (involves: 129S1/Sv * 129X1/SvJ))	decreased urine osmolality	J:242593
	decreased urine pH	J:242593
	decreased urine protein level	J:242593
	decreased urine uric acid level	J:242593
	increased blood osmolality	J:242593
	increased blood urea nitrogen level	J:242593
	increased circulating creatinine level	J:242593
	increased urine calcium level	J:242593
Umod^tm1.1Rvt/Umod^tm1.1Rvt (either: B6J.129-Umod^tm1.1Rvt or (involves: 129S1/Sv * 129X1/SvJ))	decreased urine osmolality	J:242593
	decreased urine pH	J:242593
	decreased urine protein level	J:242593
	decreased urine uric acid level	J:242593
	increased blood osmolality	J:242593
	increased blood urea nitrogen level	J:242593
	increased circulating calcium level	J:242593
	increased circulating creatinine level	J:242593
	increased urine calcium level	J:242593
Umod^tm1Kuma/Umod^tm1Kuma (involves: 129)	abnormal urine homeostasis	J:245853
	abnormal urine osmolality	J:96653
	increased urine chloride ion level	J:245853
	increased urine potassium level	J:245853
	increased urine sodium level	J:245853
Umod^tm1Xrw/Umod^tm1Xrw (129S/SvEv-Umod^tm1Xrw)	abnormal urine homeostasis	J:163552, J:127526
	abnormal urine organic anion level	J:163552
	crystalluria	J:127526
	decreased urine citrate level	J:163552
	decreased urine pH	J:163552
	increased urine ammonia level	J:163552
	increased urine calcium level	J:163552
	increased urine chloride ion level	J:163552, J:127526
	increased urine creatinine level	J:163552
	increased urine magnesium level	J:163552
	increased urine phosphate level	J:163552, J:127526
	increased urine potassium level	J:163552
	increased urine sodium level	J:127526
	increased urine uric acid level	J:163552
Umod^Urehd1/Umod⁺ (C3HeB/FeJ-Umod^Urehd1)	decreased circulating glucose level	J:121470
	decreased urine creatinine level	J:121470
	decreased urine sodium level	J:121470
	increased blood urea nitrogen level	J:121470
	increased circulating creatinine level	J:121470
	increased urine potassium level	J:121470
Umod^Urehd1/Umod⁺ (involves: C3HeB/FeJ)	abnormal urine urea nitrogen level	J:201084
	decreased circulating cholesterol level	J:201084
	decreased circulating ferritin level	J:201084
	decreased circulating iron level	J:201084
	decreased circulating phosphate level	J:201084
	decreased circulating transferrin level	J:201084
	decreased circulating triglyceride level	J:201084
	decreased urine osmolality	J:201084
	decreased urine uric acid level	J:201084
	increased blood urea nitrogen level	J:201084
	increased circulating alkaline phosphatase level	J:201084
	increased circulating calcium level	J:201084
	increased circulating creatinine level	J:201084
	increased circulating potassium level	J:201084
	increased urine calcium level	J:201084
	increased urine chloride ion level	J:201084
	increased urine magnesium level	J:201084
	increased urine potassium level	J:201084
	increased urine sodium level	J:201084
Umod^Urehd1/Umod^Urehd1 (involves: C3HeB/FeJ)	increased blood urea nitrogen level	J:201084
Umod^urehr4/Umod⁺ (C3HeB/FeJ-Umod^urehr4)	abnormal blood homeostasis	J:153895
	abnormal circulating lipid level	J:153895
	decreased body temperature	J:153895
	decreased circulating cholesterol level	J:153895
	decreased circulating triglyceride level	J:153895
	increased blood urea nitrogen level	J:201084
	increased circulating creatinine level	J:153895
Umod^urehr4/Umod^urehr4 (C3HeB/FeJ-Umod^urehr4)	abnormal blood homeostasis	J:153895
	abnormal circulating lipid level	J:153895
	abnormal urine homeostasis	J:153895
	decreased body temperature	J:153895
	decreased circulating cholesterol level	J:153895
	decreased circulating triglyceride level	J:153895
	decreased urine osmolality	J:153895
	decreased urine sodium level	J:121470
	increased blood urea nitrogen level	J:121470
	increased blood uric acid level	J:153895
	increased circulating calcium level	J:153895
	increased circulating creatinine level	J:153895, J:121470
	increased urine potassium level	J:153895
	increased urine sodium level	J:153895
	uremia	J:153895
Unc5cl^em1(IMPC)Mbp/Unc5cl^em1(IMPC)Mbp (C57BL/6NCrl-Unc5cl^em1(IMPC)Mbp/Mmucd)	increased circulating cholesterol level	J:211773
Unc13a^tm1Bros/Unc13a⁺ (involves: 129)	decreased insulin secretion	J:215257, J:108689
Unc13a^tm1Bros/Unc13a⁺ (involves: 129)	impaired glucose tolerance	J:108689
Unc13c^em1(IMPC)H/Unc13c^em1(IMPC)H (C57BL/6N-Unc13c^em1(IMPC)H/H)	increased circulating creatinine level	J:211773
	increased circulating phosphate level	J:211773
Unc13d^{tm1(KOMP)Vlcg}/Unc13d^{tm1(KOMP)Vlcg} (involves: C57BL/6NTac)	abnormal platelet dense granule physiology	J:231217
	decreased platelet aggregation	J:231217
	impaired blood coagulation	J:231217
	increased bleeding time	J:231217
Unc80^em1(IMPC)Tcp/Unc80⁺ (C57BL/6N-Unc80^em1(IMPC)Tcp/Tcp)	decreased circulating chloride level	J:211773
Unc80^em1(IMPC)Tcp/Unc80⁺ (C57BL/6N-Unc80^em1(IMPC)Tcp/Tcp)	decreased circulating sodium level	J:211773
Unc93b1^3d/Unc93b1^3d (C57BL/6J-Unc93b1^3d)	abnormal circulating interferon level	J:105484
Unc93b1^3d/Unc93b1^3d (C57BL/6J-Unc93b1^3d)	increased circulating tumor necrosis factor level	J:105484
Unc93b1^{tm1(KOMP)Vlcg}/Unc93b1^{tm1(KOMP)Vlcg} (involves: C57BL/6NTac)	abnormal tumor necrosis factor level	J:211069
	decreased circulating interleukin-6 level	J:211069
	decreased circulating interleukin-12b level	J:211069
Unc93b1^tm1.1Kmiy/Unc93b1^tm1.1Kmiy (involves: 129P2/OlaHsd * C57BL/6)	increased circulating alanine transaminase level	J:174308
	increased circulating aspartate transaminase level	J:174308
	increased circulating bilirubin level	J:174308
	increased circulating creatinine level	J:174308
	increased circulating lactate dehydrogenase level	J:174308
Unc119b^{tm1.1(KOMP)Vlcg}/Unc119b^{tm1.1(KOMP)Vlcg} (C57BL/6N-Unc119b^{tm1.1(KOMP)Vlcg}/Ucd)	abnormal cholesterol homeostasis	J:211773
Unk^{tm1a(KOMP)Wtsi}/Unk^{tm1a(KOMP)Wtsi} (C57BL/6N-Unk^{tm1a(KOMP)Wtsi}/Wtsi)	subcutaneous edema	J:239583
Uox^em1Cli/Uox^em1Cli (C57BL/6J-Uox^em1Cli)	abnormal cytokine level	J:271949
	decreased circulating triglyceride level	J:271949
	decreased insulin secretion	J:271949
	impaired glucose tolerance	J:271949
	increased blood urea nitrogen level	J:271949
	increased blood uric acid level	J:271949
	increased circulating cholesterol level	J:271949
	increased circulating creatinine level	J:271949
	increased circulating LDL cholesterol level	J:271949
	increased circulating triglyceride level	J:271949
	increased susceptibility to non-insulin-dependent diabetes	J:271949
Uoxⁱⁿ/Uoxⁱⁿ (involves: C57BL/6J * DBA/2J)	abnormal urine homeostasis	J:70677
	increased blood urea nitrogen level	J:70677
	increased circulating creatinine level	J:70677
Uox^tm1Bay/Uox^tm1Bay (involves: 129S7/SvEvBrd * C57BL/6J)	abnormal urine color	J:103187
	crystalluria	J:103187
	decreased urine osmolality	J:103187
	increased blood urea nitrogen level	J:103187
	increased blood uric acid level	J:16490
	increased urine uric acid level	J:16490, J:103187
	uremia	J:103187
Upf3b^em1(IMPC)Tcp/Y (C57BL/6NCrl-Upf3b^em1(IMPC)Tcp/Tcp)	increased fasting circulating glucose level	J:211773
Upf3b^em1(IMPC)Tcp/Upf3b^em1(IMPC)Tcp (C57BL/6NCrl-Upf3b^em1(IMPC)Tcp/Tcp)	increased fasting circulating glucose level	J:211773
Upk2^tm1Tsun/Upk2^tm1Tsun (involves: 129S/SvEv * Black Swiss)	abnormal urine homeostasis	J:95622
	decreased urine chloride ion level	J:95622
	decreased urine creatinine level	J:95622
	decreased urine potassium level	J:95622
	decreased urine sodium level	J:95622
	decreased urine uric acid level	J:95622
	increased blood urea nitrogen level	J:95622
Upk3a^tm1Tsun/Upk3a^tm1Tsun (either: (involves: 129S/SvEv) or (involves: 129S/SvEv * Swiss Webster))	increased blood urea nitrogen level	J:77653
	increased circulating creatinine level	J:77653
	increased urine pH	J:77653
Upp1^tm1Akiy/Upp1^tm1Akiy (Not Specified)	abnormal enzyme/coenzyme level	J:78036
Upp1^tm1Gp/Upp1^tm1Gp (involves: 129)	abnormal blood homeostasis	J:99912
	abnormal enzyme/coenzyme level	J:99912
	abnormal urine nucleoside level	J:99912
Uqcc6^em1Lenh/Uqcc6^em1Lenh (C57BL/6J-Uqcc6^em1Lenh)	increased circulating lactate level	J:330815
Urah^plt2/Urah^plt2 (C57BL/6-Urah^plt2)	increased blood uric acid level	J:267227
urehr1/urehr1 (C3HeB/FeJ-urehr1)	abnormal glomerular capillary thrombosis	J:121470
	albuminuria	J:121470
	decreased circulating glucose level	J:121470
	decreased urine creatinine level	J:121470
	decreased urine sodium level	J:121470
	increased blood urea nitrogen level	J:121470
	increased circulating cholesterol level	J:121470
	increased circulating creatinine level	J:121470
Uri1^tm1.1Ndj/Uri1⁺ Alb^{tm1(cre/ERT2)Mtz}/Alb⁺ (B6.Cg-Alb^{tm1(cre/ERT2)Mtz} Uri1^tm1.1Ndj)	abnormal enzyme/coenzyme level	J:217463
Uri1^tm1.1Ndj/Uri1^tm1.1Ndj Alb^{tm1(cre/ERT2)Mtz}/Alb⁺ (B6.Cg-Alb^{tm1(cre/ERT2)Mtz} Uri1^tm1.1Ndj)	increased circulating alanine transaminase level	J:217463
Uri1^{tm1a(EUCOMM)Wtsi}/Uri1^{tm1a(EUCOMM)Wtsi} (C57BL/6N-Uri1^{tm1a(EUCOMM)Wtsi}/Wtsi)	increased fasting circulating glucose level	J:211773
Urm1^em1(IMPC)J/Urm1⁺ (C57BL/6NJ-Urm1^em1(IMPC)J/Mmjax)	increased circulating aspartate transaminase level	J:211773
Urm1^em1(IMPC)J/Urm1⁺ (C57BL/6NJ-Urm1^em1(IMPC)J/Mmjax)	increased circulating cholesterol level	J:211773
Uros^tm1Cged/Uros^tm1Cged (involves: 129S2/SvPas)	erythruria	J:105776
Uros^tm1Cged/Uros^tm1Cged (involves: 129S2/SvPas)	porphyria	J:105776
Uros^tm1Rjde/Uros^tm3Rjde (involves: 129S6/SvEvTac * C57BL/6)	increased porphyrin level	J:132542
Uros^tm2Rjde/Uros^tm3Rjde (involves: 129S6/SvEvTac * C57BL/6)	decreased circulating haptoglobin level	J:132542
	increased porphyrin level	J:132542
	increased spleen iron level	J:132542
Uros^tm2Rjde/Uros^tm3Rjde (involves: 129S6/SvEvTac * C57BL/6 * SKH1)	increased porphyrin level	J:132542
Uros^tm3Rjde/Uros^tm3Rjde (involves: 129S6/SvEvTac * C57BL/6)	increased porphyrin level	J:132542
Uros^tm3Rjde/Uros^tm3Rjde (involves: 129S6/SvEvTac * C57BL/6 * SKH1)	increased porphyrin level	J:132542
Uros^tm3Rjde/Uros^tm4Rjde (involves: 129S6/SvEvTac * C57BL/6)	increased porphyrin level	J:132542
Usb1^em1(IMPC)Bay/Usb1^em1(IMPC)Bay (C57BL/6N-Usb1^em1(IMPC)Bay/BayMmucd)	edema	J:211773
Ush1c^{tm1a(KOMP)Wtsi}/Ush1c^{tm1a(KOMP)Wtsi} (C57BL/6N-Ush1c^{tm1a(KOMP)Wtsi}/Wtsi)	decreased circulating amylase level	J:211773
	decreased circulating glucose level	J:211773
	improved glucose tolerance	J:211773
	increased circulating chloride level	J:211773
	increased circulating sodium level	J:211773
Usp1^tm1.1Ada/Usp1^tm1.1Ada (C57BL/6-Usp1^tm1.1Ada)	cyanosis	J:146616
Usp1^tm1.1Ada/Usp1^tm1.1Ada (C57BL/6-Usp1^tm1.1Ada)	edema	J:146616
Usp1^{tm1b(KOMP)Wtsi}/Usp1^{tm1b(KOMP)Wtsi} (C57BL/6N-Usp1^{tm1b(KOMP)Wtsi}/Wtsi)	increased blood urea nitrogen level	J:211773
	increased circulating creatinine level	J:211773
	increased circulating insulin level	J:211773
	increased circulating potassium level	J:211773
Usp1^{tm1d(KOMP)Wtsi}/Usp1^{tm1d(KOMP)Wtsi} (involves: C57BL/6N)	decreased circulating alkaline phosphatase level	J:207363
Usp8^tm1.1Kpk/Usp8^tm1.1Kpk Tg(Mx1-cre)1Cgn/0 (involves: 129P2/OlaHsd * C57BL/6 * CBA * FVB/N)	increased circulating bilirubin level	J:122732
Usp11^{tm1(KOMP)Wtsi}/Y (C57BL/6N-Usp11^{tm1(KOMP)Wtsi}/Wtsi)	increased circulating HDL cholesterol level	J:211773
	increased circulating LDL cholesterol level	J:211773
Usp12^{tm1a(EUCOMM)Hmgu}/Usp12^{tm1a(EUCOMM)Hmgu} (Not Specified)	decreased circulating alanine transaminase level	J:165965
Usp12^{tm1b(EUCOMM)Hmgu}/Usp12^{tm1b(EUCOMM)Hmgu} (C57BL/6N-Usp12^{tm1b(EUCOMM)Hmgu}/Ieg)	impaired glucose tolerance	J:211773
	increased circulating alkaline phosphatase level	J:211773
	increased circulating cholesterol level	J:211773
Usp15^{tm1b(EUCOMM)Wtsi}/Usp15^{tm1b(EUCOMM)Wtsi} (C57BL/6N-Usp15^{tm1b(EUCOMM)Wtsi}/Wtsi)	decreased circulating fructosamine level	J:211773
	decreased circulating glucose level	J:211773
	decreased fasting circulating glucose level	J:211773
	increased circulating sodium level	J:211773
Usp18^ity9/Usp18^ity9 (involves: 129S1/SvImJ * C57BL/6)	decreased circulating interferon-gamma level	J:163843
Usp18^ity9/Usp18^ity9 (involves: 129S1/SvImJ * C57BL/6)	increased circulating interleukin-6 level	J:163843
Usp18^tm1Dez/Usp18^tm1Dez (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	abnormal circulating enzyme level	J:214425
	abnormal cytokine level	J:214425
	decreased circulating interferon-alpha level	J:214425
	decreased circulating interferon-beta level	J:214425
	decreased circulating interferon-gamma level	J:214425
Usp19^Gt(XG128)Byg/Usp19^Gt(XG128)Byg (involves: 129P2/OlaHsd * C57BL/6)	abnormal protein level	J:225526
Usp20^em1Cya/Usp20^em1Cya (Not Specified)	decreased circulating cholesterol level	J:299971
	decreased circulating triglyceride level	J:299971
	improved glucose tolerance	J:299971
	increased insulin sensitivity	J:299971
Usp20^em1Dalin/Usp20^em1Dalin (involves: C57BL/6)	abnormal circulating chemokine level	J:274572
	decreased circulating interferon-beta level	J:274572
	decreased circulating interleukin-6 level	J:274572
Usp20^em1Gpt/Usp20^em1Gpt Speer6-ps1^{Tg(Alb-cre)21Mgn}/Speer6-ps1⁺ (involves: C57BL/6JGpt * DBA)	abnormal circulating enzyme level	J:299971
	abnormal enzyme/coenzyme level	J:299971
	decreased circulating cholesterol level	J:299971
	decreased circulating free fatty acids level	J:299971
	decreased circulating glucose level	J:299971
	decreased circulating HDL cholesterol level	J:299971
	decreased circulating insulin level	J:299971
	decreased circulating LDL cholesterol level	J:299971
	decreased circulating triglyceride level	J:299971
	decreased circulating VLDL triglyceride level	J:299971
	decreased fasting circulating glucose level	J:299971
	decreased liver cholesterol level	J:299971
	decreased liver triglyceride level	J:299971
	improved glucose tolerance	J:299971
	increased body surface temperature	J:299971
	increased energy expenditure	J:299971
	increased insulin sensitivity	J:299971
	increased oxygen consumption	J:299971
Usp20^{tm1a(EUCOMM)Hmgu}/Usp20^{tm1a(EUCOMM)Hmgu} (C57BL/6N-Usp20^{tm1a(EUCOMM)Hmgu}/Wtsi)	increased circulating alkaline phosphatase level	J:211773
	increased circulating chloride level	J:211773
Usp21^tm1.1Jhy/Usp21^tm1.1Jhy (B6.129S7(Cg)-Usp21^tm1.1Jhy)	abnormal interferon level	J:208320
	increased circulating interferon-alpha level	J:208320
	increased circulating interferon-beta level	J:208320
Usp21^{tm1a(EUCOMM)Wtsi}/Usp21^{tm1a(EUCOMM)Wtsi} (C57BL/6N-Usp21^{tm1a(EUCOMM)Wtsi}/Wtsi)	decreased blood urea nitrogen level	J:211773
	decreased circulating fructosamine level	J:211773
Usp22^{Gt(RRS377)Byg}/Usp22^{Gt(RRS377)Byg} (involves: 129P2/OlaHsd * C57BL/6)	hypoxia	J:272613
Usp24^{tm1a(KOMP)Wtsi}/Usp24^{tm1a(KOMP)Wtsi} (C57BL/6N-Usp24^{tm1a(KOMP)Wtsi}/Wtsi)	increased circulating triglyceride level	J:211773
Usp26^tm1Smoc/Y (B6.129S6-Usp26^tm1Smoc)	decreased circulating follicle stimulating hormone level	J:277424
	decreased circulating testosterone level	J:277424
	increased circulating luteinizing hormone level	J:277424
Usp30^{tm2b(EUCOMM)Hmgu}/Usp30^{tm2b(EUCOMM)Hmgu} (C57BL/6N-Usp30^{tm2b(EUCOMM)Hmgu}/Wtsi)	impaired glucose tolerance	J:211773
	increased circulating alkaline phosphatase level	J:211773
Usp31^em1(IMPC)H/Usp31^em1(IMPC)H (C57BL/6NTac-Usp31^em1(IMPC)H/H)	increased circulating potassium level	J:211773
Usp32^{em1(IMPC)Mhzh}/Usp32⁺ (C57BL/6N-Usp32^{em1(IMPC)Mhzh}/Mhzh)	decreased circulating glucose level	J:211773
	decreased circulating serum albumin level	J:211773
Usp33^{tm1a(EUCOMM)Wtsi}/Usp33^{tm1a(EUCOMM)Wtsi} (C57BL/6N-Usp33^{tm1a(EUCOMM)Wtsi}/Wtsi)	increased circulating bilirubin level	J:175295
Usp36^{tm1b(EUCOMM)Hmgu}/Usp36⁺ (C57BL/6N-Usp36^{tm1b(EUCOMM)Hmgu}/Nju)	increased circulating glucose level	J:211773
Usp38^{tm1b(EUCOMM)Hmgu}/Usp38^{tm1b(EUCOMM)Hmgu} (C57BL/6N-Usp38^{tm1b(EUCOMM)Hmgu}/H)	decreased circulating creatinine level	J:211773
Usp47^{tm1b(EUCOMM)Wtsi}/Usp47^{tm1b(EUCOMM)Wtsi} (C57BL/6N-Usp47^{tm1b(EUCOMM)Wtsi}/Nju)	increased circulating alkaline phosphatase level	J:211773
	increased circulating cholesterol level	J:211773
	increased circulating glucose level	J:211773
	increased circulating HDL cholesterol level	J:211773
Usp49^em1Gpt/Usp49^em1Gpt (involves: C57BL/6NGpt)	increased circulating interferon-beta level	J:285681
Usp49^em1Gpt/Usp49^em1Gpt (involves: C57BL/6NGpt)	increased circulating interleukin-6 level	J:285681
Usp53^em1(IMPC)Tcp/Usp53^em1(IMPC)Tcp (C57BL/6N-Usp53^em1(IMPC)Tcp/Tcp)	increased circulating alkaline phosphatase level	J:211773
	increased circulating bilirubin level	J:211773
	increased circulating cholesterol level	J:211773
	increased circulating total protein level	J:211773
Usp54^{tm1b(KOMP)Wtsi}/Usp54^{tm1b(KOMP)Wtsi} (C57BL/6N-Usp54^{tm1b(KOMP)Wtsi}/H)	decreased circulating amylase level	J:211773
	decreased circulating fructosamine level	J:211773
	decreased circulating serum albumin level	J:211773
	decreased circulating total protein level	J:211773
	increased circulating alanine transaminase level	J:211773
	increased circulating aspartate transaminase level	J:211773
Utp4^em1(IMPC)J/Utp4⁺ (C57BL/6NJ-Utp4^em1(IMPC)J/Mmjax)	increased circulating alkaline phosphatase level	J:211773
Utp14b^jsd/Utp14b^jsd (involves: C57BL/6J)	increased circulating follicle stimulating hormone level	J:9278
Uts2^tm1Ags/Uts2^tm1Ags (B6.129P2-Uts2^tm1Ags)	abnormal apolipoprotein level	J:214289
	abnormal cholesterol homeostasis	J:214289
	decreased circulating LDL cholesterol level	J:214289
	increased circulating HDL cholesterol level	J:214289
Uvrag^{Tn(pb-Act-RFP)1.100107015-HRAZhu}/Uvrag^{Tn(pb-Act-RFP)1.100107015-HRAZhu} (involves: FVB/NJ)	abnormal interleukin level	J:219546
	abnormal tumor necrosis factor level	J:219546
Vamp3^tm1Jpes/Vamp3^tm1Jpes (involves: 129P2/OlaHsd * C57BL/6J)	abnormal platelet physiology	J:121010
Vamp7^tm1.1Ics/Y (involves: 129S2/SvPas * C57BL/6)	decreased body temperature	J:181320
Vamp7^tm1.1Ics/Y (involves: 129S2/SvPas * C57BL/6)	increased circulating glycerol level	J:181320
Vamp8^tm1.1Hong/Vamp8^tm1.1Hong (involves: 129P2/OlaHsd * BALB/cJ * C57BL/6)	colorless urine	J:156248
	decreased urine osmolality	J:156248
Vamp8^tm1.1Hong/Vamp8^tm1.1Hong (129-Vamp8^tm1.1Hong)	increased blood osmolality	J:156248
Vamp8^tm1.1Hong/Vamp8^tm1.1Hong (129-Vamp8^tm1.1Hong)	increased circulating renin level	J:156248
Vamp8^tm1Hong/Vamp8^tm1Hong (involves: 129P2/OlaHsd * C57BL/6)	abnormal circulating amylase level	J:137704
	abnormal circulating lipase level	J:137704
Vamp8^tm1Hong/Vamp8^tm1Hong (involves: 129P2/OlaHsd * C57BL/6J)	abnormal platelet activation	J:121010
	abnormal platelet physiology	J:121010
Vangl2^em1(IMPC)Mbp/Vangl2⁺ (C57BL/6N-Vangl2^em1(IMPC)Mbp/MbpMmucd)	decreased circulating phosphate level	J:211773
Vapb^em1(IMPC)H/Vapb^em1(IMPC)H (C57BL/6NTac-Vapb^em1(IMPC)H/H)	improved glucose tolerance	J:211773
Vasp^tm1Mzim/Vasp^tm1Mzim (involves: 129P2/OlaHsd * C57BL/6)	abnormal platelet activation	J:56356
Vasp^tm1Ref/Vasp^tm1Ref (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	abnormal platelet physiology	J:51905
	increased platelet aggregation	J:51905
Vav1^tm4Tyb/Vav1^tm4Tyb (either: 129S8.129S4-Vav1^tm4Tyb or (involves: 129S4/SvJae * 129S8/SvEv * C57BL/10 * C57BR/cd))	increased circulating interferon-gamma level	J:190087
Vav2^tm1Tnr/Vav2^tm1Tnr (involves: 129P2/OlaHsd)	abnormal bradykinin level	J:124056
	decreased urine sodium level	J:124056
	increased circulating adrenaline level	J:124056
	increased circulating aldosterone level	J:124056
	increased circulating antidiuretic hormone level	J:124056
	increased circulating noradrenaline level	J:124056
	increased circulating renin level	J:124056
Vav2^tm1Tnr/Vav2^tm1Tnr Vav3^tm1Xrb/Vav3^tm1Xrb (involves: 129P2/OlaHsd)	increased circulating adrenaline level	J:124056
	increased circulating noradrenaline level	J:124056
	increased dopamine level	J:124056
Vav3^tm1Xrb/Vav3^tm1Xrb (Not Specified)	abnormal blood homeostasis	J:111973
	abnormal bradykinin level	J:111973
	abnormal urine homeostasis	J:111973
	decreased urine potassium level	J:111973
	decreased urine sodium level	J:111973
	increased circulating adrenaline level	J:111973, J:124056
	increased circulating aldosterone level	J:111973
	increased circulating angiotensin II level	J:111973
	increased circulating antidiuretic hormone level	J:111973
	increased circulating noradrenaline level	J:111973, J:124056
	increased circulating renin level	J:111973
	increased dopamine level	J:111973, J:124056
Vax1^{tm1b(KOMP)Mbp}/Vax1⁺ (C57BL/6N-Vax1^{tm1b(KOMP)Mbp}/J)	decreased circulating glucose level	J:211773
	increased circulating alkaline phosphatase level	J:211773
Vcam1^tm1Roml/Vcam1^tm1Roml (involves: 129S1/Sv * C57BL/6J)	hydropic allantois	J:28110
Vcam1^tm1Roml/Vcam1^tm1Roml (involves: 129S1/Sv * C57BL/6J)	pericardial effusion	J:23137, J:28110
Vcan^tm2Hwat/Vcan^tm2Hwat (involves: 129 * BALB/c * C57BL/6)	cyanosis	J:225115
Vcf1^{tm2a(EUCOMM)Wtsi}/Vcf1^{tm2a(EUCOMM)Wtsi} (B6JTyr;B6N-Vcf1^{tm2a(EUCOMM)Wtsi}/Wtsi)	increased circulating aspartate transaminase level	J:175295
Vcp^em1Kene/Vcp⁺ (C57BL/6J-Vcp^em1Kene)	decreased susceptibility to diet-induced obesity	J:325062
	increased circulating triglyceride level	J:325062
	increased insulin sensitivity	J:325062
	increased susceptibility to diet-induced obesity	J:325062
Vcpkmt^{tm1.1(KOMP)Vlcg}/Vcpkmt^{tm1.1(KOMP)Vlcg} (C57BL/6N-Vcpkmt^{tm1.1(KOMP)Vlcg}/J)	abnormal cholesterol homeostasis	J:211773
	decreased circulating glucose level	J:211773
	increased circulating bilirubin level	J:211773
Vdac1^{tm1b(EUCOMM)Wtsi}/Vdac1⁺ (C57BL/6N-Vdac1^{tm1b(EUCOMM)Wtsi}/Ieg)	impaired glucose tolerance	J:211773
Vdr^tm1.1Gcm/Vdr^tm1.1Gcm (involves: 129S1/Sv * 129X1/SvJ)	abnormal urine homeostasis	J:111515
	abnormal vitamin D level	J:111515
	decreased circulating calcium level	J:111515
Vdr^tm1.1Gcm/Vdr^tm1.1Gcm (involves: 129 * BALB/c * C57BL/6 * Swiss)	abnormal vitamin D level	J:72578
	decreased circulating calcium level	J:72578
	increased circulating parathyroid hormone level	J:72578
Vdr^tm1.1Sgcg/Vdr^tm1.2Sgcg Myl2^tm1(cre)Krc/Myl2⁺ (involves: 129 * C57BL/6 * CBA * SJL)	increased circulating atrial natriuretic factor	J:189471
Vdr^tm1.2Sgcg/Vdr^tm1.2Sgcg (involves: 129 * C57BL/6 * CBA * SJL)	decreased circulating calcium level	J:189471
	increased circulating atrial natriuretic factor	J:189471
Vdr^tm1Gcm/Vdr^tm1Gcm Tg(Col2a1-cre)1Bhr/? (involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * SJL)	abnormal mineral homeostasis	J:117377
	abnormal vitamin D level	J:117377
	increased circulating phosphate level	J:117377
Vdr^tm1Mbd/Vdr^tm1Mbd (involves: 129S4/SvJae)	decreased circulating calcium level	J:42815, J:78067
	increased circulating angiotensin II level	J:78067
	increased circulating angiotensinogen level	J:78067
	increased circulating parathyroid hormone level	J:42815, J:78067, J:63291
	increased circulating renin level	J:78067
	increased urine potassium level	J:78067
	increased urine sodium level	J:78067
Vdr^tm1Mbd/Vdr^tm1Mbd (involves: 129S4/SvJae * C57BL/6J)	abnormal mineral homeostasis	J:99866
Vdr^tm1Mbd/Vdr^tm1Mbd (involves: 129S4/SvJae * C57BL/6J)	decreased circulating phosphate level	J:99866
Vdr^tm1Mbd/Vdr^tm1Mbd (involves: 129S4/SvJae * C57BL/6)	abnormal interleukin level	J:107077
Vdr^tm1Mbd/Vdr^tm1Mbd (involves: 129S4/SvJae * C57BL/6)	abnormal tumor necrosis factor level	J:107077
Vdr^tm1Rge/Vdr^tm1Rge (involves: 129S1/Sv * 129X1/SvJ)	abnormal response to vitamins	J:77748
	abnormal vitamin D level	J:77748
	decreased circulating calcium level	J:77748
	increased circulating parathyroid hormone level	J:77748
	increased urine calcium level	J:77748
Vdr^tm1Rge/Vdr^tm1Rge (B6.129-Vdr^tm1Rge)	decreased circulating phosphate level	J:121006
	increased circulating alkaline phosphatase level	J:121006
	increased circulating parathyroid hormone level	J:121006
Vdr^tm1Rge/Vdr^tm1Rge (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	abnormal nitric oxide homeostasis	J:134827
Vdr^tm1Ska/Vdr^tm1Ska (involves: C57BL/6NCrlj * CBA/JNCrlj)	abnormal blood homeostasis	J:112519
	abnormal fat-soluble vitamin level	J:71459, J:112519
	abnormal vitamin D level	J:42054
	decreased circulating calcium level	J:83237, J:71459, J:42054, J:69822, J:112519, J:72578
	decreased circulating phosphate level	J:42054
	increased circulating alkaline phosphatase level	J:42054
	increased circulating follicle stimulating hormone level	J:83237
	increased circulating luteinizing hormone level	J:83237
Vdr^tm1Ska/Vdr^tm1Ska (NOD.Cg-Vdr^tm1Ska/CmatJ)	abnormal glucose tolerance	J:127787
Vdr^tm1Ska/Vdr^tm1Ska (NOD.Cg-Vdr^tm1Ska/CmatJ)	decreased circulating calcium level	J:127787
Vdr^tm1Tyam/Vdr^tm1Tyam (involves: C57BL/6 * CBA)	abnormal vitamin D level	J:101456
	decreased circulating calcium level	J:101456
	decreased circulating phosphate level	J:101456
	increased circulating parathyroid hormone level	J:101456
Vdr^tm2.1Ska/Vdr^tm2.1Ska (involves: C57BL/6 * CBA/JNCrlj * SJL)	abnormal vitamin D level	J:196471
	decreased circulating calcium level	J:196471
	decreased circulating phosphate level	J:196471
Vegfa^tm1.1Nagy/Vegfa^tm1.1Nagy (involves: 129S1/Sv * 129X1/SvJ)	edema	J:64090
Vegfa^tm1Pec/Vegfa^tm1Pec (involves: 129S1/Sv * 129X1/SvJ)	cyanosis	J:81698
	increased blood urea nitrogen level	J:111504
	increased circulating creatinine level	J:111504
Vegfa^tm2Gne/Vegfa⁺ Tg(Nphs1-cre)1Seq/0 (involves: 129)	albuminuria	J:82440
	increased blood urea nitrogen level	J:82440
	increased circulating creatinine level	J:82440
	increased urine protein level	J:82440
Vegfa^tm2Gne/Vegfa^tm2.1Nagy Tg(Nes-cre)1Kln/0 (involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * CD-1 * SJL)	dehydration	J:86207
	hypoxia	J:86207
Vegfa^tm2Gne/Vegfa^tm2Gne Tg(Nphs1-cre)1Seq/0 (involves: 129)	edema	J:82440
Vegfa^tm2Gne/Vegfa^tm2Gne Tg(SFTPC-cre)#Mliu/0 (involves: 129/Sv * ICR)	pulmonary edema	J:158566
Vegfb^{tm1b(EUCOMM)Hmgu}/Vegfb^{tm1b(EUCOMM)Hmgu} (C57BL/6N-Vegfb^{tm1b(EUCOMM)Hmgu}/J)	decreased circulating phosphate level	J:211773
	decreased fasting circulating glucose level	J:211773
Vegfc^tm1Ali/Vegfc⁺ (involves: 129S1/Sv * 129X1/SvJ * ICR)	chylous ascites	J:87394
Vegfc^tm1Ali/Vegfc⁺ (involves: 129S1/Sv * 129X1/SvJ * ICR)	lymphedema	J:87394
Vegfc^tm1Ali/Vegfc^tm1Ali (involves: 129S1/Sv * 129X1/SvJ * ICR)	hydrops fetalis	J:87394
Vezt^{tm1b(EUCOMM)Hmgu}/Vezt⁺ (C57BL/6N-Vezt^{tm1b(EUCOMM)Hmgu}/J)	decreased circulating glucose level	J:211773
	increased urine microalbumin level	J:211773
Vgf^em1(IMPC)H/Vgf^em1(IMPC)H (C57BL/6NTac-Vgf^em1(IMPC)H/H)	decreased circulating fructosamine level	J:211773
	decreased circulating glucose level	J:211773
	increased circulating alanine transaminase level	J:211773
	increased circulating aspartate transaminase level	J:211773
	increased circulating total protein level	J:211773
Vgf^tm1Srjs/Vgf^tm1Srjs (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	decreased circulating glucose level	J:56499
	decreased circulating insulin level	J:56499
	decreased circulating thyroid-stimulating hormone level	J:56499
	decreased circulating thyroxine level	J:56499
	increased circulating corticosterone level	J:56499
	increased oxygen consumption	J:56499
Vgf^tm1Vlcg/Vgf^tm1Vlcg (involves: 129S6/SvEvTac * C57BL/6J * C57BL/6NTac)	abnormal adrenaline level	J:212045
	increased circulating adrenaline level	J:212045
	increased noradrenaline level	J:212045
Vgll4^{tm1b(EUCOMM)Hmgu}/Vgll4⁺ (C57BL/6N-Vgll4^{tm1b(EUCOMM)Hmgu}/Ieg)	increased circulating lipase level	J:211773
Vhl^tm1Jae/Vhl^tm1Jae Tg(NPHS2-cre)295Lbh/? (involves: 129S4/SvJae * C57BL/6 * SJL)	albuminuria	J:162099
	edema	J:162099
	increased blood urea nitrogen level	J:162099
Vhl^tm1Jae/Vhl^tm1Jae Tg(Sp7-tTA,tetO-EGFP/cre)1Amc/0 (involves: 129S4/SvJae * CD-1)	increased circulating erythropoietin level	J:186085
Vhl^tm1Lss/Vhl^tm1.1Lss Tg(CAG-cre/Esr1)1Lbe/0 (involves: 129S1/Sv 129X1/SvJ)	decreased blood urea nitrogen level	J:155367
	decreased circulating creatinine level	J:155367
Vil1^{em1(IMPC)Wtsi}/Vil1^{em1(IMPC)Wtsi} (C57BL/6N-Vil1^{em1(IMPC)Wtsi}/Wtsi)	decreased circulating cholesterol level	J:211773
	decreased circulating fructosamine level	J:211773
	decreased circulating HDL cholesterol level	J:211773
Vim^tm1Cba/Vim^tm1Cba (involves: 129S2/SvPas)	increased circulating creatinine level	J:43049
Vip^tm1Clw/Vip^tm1Clw (B6.129S-Vip^tm1Clw)	decreased circulating follicle stimulating hormone level	J:122403
Vip^tm1Clw/Vip^tm1Clw (B6.129S-Vip^tm1Clw)	decreased circulating testosterone level	J:122403
Vipr1^tm1Msod/Vipr1^tm1Msod (B6.129-Vipr1^tm1Msod)	abnormal glucose homeostasis	J:177616
	hypoglycemia	J:177616
	impaired glucose tolerance	J:177616
	increased insulin sensitivity	J:177616
Vipr2^tm1Hmh/Vipr2^tm1Hmh (involves: 129P2/OlaHsd * C57BL/6)	increased circulating triiodothyronine level	J:106803
	increased insulin sensitivity	J:106803
Vkorc1^L128S/Vkorc1^L128S (involves: wild)	abnormal blood coagulation	J:101681
Vkorc1^tm1.1Jobg/Vkorc1^tm1.1Jobg (involves: 129S4/SvJae * BALB/cJ * C57BL/6)	abnormal blood coagulation	J:207884
Vkorc1^tm1.1Kry/Vkorc1^tm1.1Kry Tg(BGLAP-cre)1Clem/0 (involves: FVB/NJ)	abnormal circulating osteocalcin level	J:264734
Vkorc1^tm1.1Kry/Vkorc1^tm1.1Kry Vkorc1l1^tm1.1Kry/Vkorc1l1^tm1.1Kry Tg(BGLAP-cre)1Clem/0 (involves: FVB/NJ)	abnormal circulating osteocalcin level	J:264734
Vkorc1^Y139C/Vkorc1^Y139C (involves: Swiss outbred * wild)	abnormal blood coagulation	J:101681
Vkorc1l1^em1(IMPC)J/Vkorc1l1^em1(IMPC)J (C57BL/6NJ-Vkorc1l1^em1(IMPC)J/Mmjax)	abnormal cholesterol homeostasis	J:211773
	decreased circulating calcium level	J:211773
	decreased circulating cholesterol level	J:211773
	decreased circulating serum albumin level	J:211773
	decreased circulating total protein level	J:211773
	increased fasting circulating glucose level	J:211773
Vldlr^tm1Her/Vldlr^tm1Her (involves: 129S7/SvEvBrd * C57BL/6)	increased circulating cholesterol level	J:117317
	increased circulating triglyceride level	J:117317
Vmbic3^C57BL/6J/? (involves: C57BL/6J * DBA/2J)	increased brain iron level	J:87918
Vmbic8^C57BL/6J/? (involves: C57BL/6J * DBA/2J)	increased liver iron level	J:87918
Vmbic9^DBA/2J/? (involves: C57BL/6J * DBA/2J)	abnormal copper level	J:114154
	abnormal iron homeostasis	J:114154
	abnormal mineral level	J:114154
Vmp1^{tm1a(KOMP)Wtsi}/Vmp1^{tm1a(KOMP)Wtsi} (C57BL/6-Vmp1^{tm1a(KOMP)Wtsi})	abnormal lipid level	J:280741
Vnn1^tm1Pna/Vnn1^tm1Pna (involves: 129P2/OlaHsd)	abnormal enzyme/coenzyme level	J:65449
Vpreb3^{em1(IMPC)Wtsi}/Vpreb3^{em1(IMPC)Wtsi} (C57BL/6N-Vpreb3^{em1(IMPC)Wtsi}/Wtsi)	decreased circulating total protein level	J:211773
Vps13b^em1(IMPC)Tcp/Vps13b^em1(IMPC)Tcp (C57BL/6N-Vps13b^em1(IMPC)Tcp/Tcp)	decreased circulating alkaline phosphatase level	J:211773
	impaired glucose tolerance	J:211773
Vps13c^tm1.1Geno/Vps13c^tm1.1Geno (involves: C57BL/6)	decreased circulating insulin level	J:241413
	decreased circulating insulin level	J:241413
	impaired glucose tolerance	J:241413
Vps13c^{tm1b(EUCOMM)Hmgu}/Vps13c^{tm1b(EUCOMM)Hmgu} (C57BL/6N-Vps13c^{tm1b(EUCOMM)Hmgu}/Ieg)	increased circulating alkaline phosphatase level	J:211773
	increased circulating amylase level	J:211773
	increased circulating lipase level	J:211773
Vps13c^{tm1b(EUCOMM)Hmgu}/Vps13c^{tm1b(EUCOMM)Hmgu} (C57BL/6NTac-Vps13c^{tm1b(EUCOMM)Hmgu}/Ieg)	decreased circulating fructosamine level	J:211773
	increased circulating alanine transaminase level	J:211773
	increased circulating amylase level	J:211773
	increased circulating aspartate transaminase level	J:211773
Vps33a^bf/Vps33a^bf (C57BL/6J-Vps33a^bf)	abnormal blood coagulation	J:88018
	abnormal platelet physiology	J:88018
	decreased platelet aggregation	J:88018
	increased bleeding time	J:7327
Vps33b^tm1.1Arte/Vps33b^tm1.1Arte Gt(ROSA)26Sor^{tm1(cre/ERT2)Tyj}/Gt(ROSA)26Sor⁺ (involves: C57BL/6 * C57BL/6J)	decreased platelet aggregation	J:222766
	increased bleeding time	J:222766
Vps33b^{tm1a(EUCOMM)Wtsi}/Vps33b⁺ (C57BL/6N-Vps33b^{tm1a(EUCOMM)Wtsi}/Wtsi)	increased circulating HDL cholesterol level	J:211773
Vps35^{Gt(RRK261)Byg}/Vps35⁺ (B6.129P2-Vps35^{Gt(RRK261)Byg})	decreased dopamine level	J:225806
Vps35^tm1.1Mjff/Vps35⁺ (B6.Cg-Vps35^tm1.1Mjff)	abnormal nervous system dopamine level	J:274797
Vps35^tm1.1Mjff/Vps35^tm1.1Mjff (B6.Cg-Vps35^tm1.1Mjff)	abnormal nervous system dopamine level	J:274797
Vps36^em1(IMPC)J/Vps36^em1(IMPC)J (C57BL/6NJ-Vps36^em1(IMPC)J/Mmjax)	edema	J:211773
Vps37b^em1(IMPC)H/Vps37b^em1(IMPC)H (C57BL/6NTac-Vps37b^em1(IMPC)H/H)	increased circulating serum albumin level	J:211773
	increased circulating total protein level	J:211773
Vps51^{tm1a(KOMP)Wtsi}/Vps51⁺ (C57BL/6N-Vps51^{tm1a(KOMP)Wtsi}/Wtsi)	increased circulating bilirubin level	J:211773
Vps54^wr/Vps54^wr (multiple strains)	decreased circulating estrogen level	J:6029
Vrk1^em1(IMPC)Mbp/Vrk1⁺ (C57BL/6N-Vrk1^em1(IMPC)Mbp/Ucd)	increased circulating alanine transaminase level	J:211773
Vrk1^em1(IMPC)Mbp/Vrk1⁺ (C57BL/6N-Vrk1^em1(IMPC)Mbp/Ucd)	increased circulating aspartate transaminase level	J:211773
Vsig4^{tm1b(EUCOMM)Hmgu}/Y (C57BL/6N-Vsig4^{tm1b(EUCOMM)Hmgu}/J)	abnormal cholesterol homeostasis	J:211773
	decreased circulating glucose level	J:211773
	increased circulating alanine transaminase level	J:211773
	increased circulating alkaline phosphatase level	J:211773
	increased circulating aspartate transaminase level	J:211773
	increased circulating potassium level	J:211773
	increased urine microalbumin level	J:211773
Vsig4^{tm1b(EUCOMM)Hmgu}/Vsig4^{tm1b(EUCOMM)Hmgu} (C57BL/6N-Vsig4^{tm1b(EUCOMM)Hmgu}/J)	decreased circulating glucose level	J:211773
	increased blood urea nitrogen level	J:211773
	increased circulating sodium level	J:211773
	increased urine microalbumin level	J:211773
Vsig4^tm1Gne/Vsig4^tm1Gne (C57BL/6-Vsig4^tm1Gne)	increased circulating interleukin-1 beta level	J:281762
Vsig8^{tm1.1(KOMP)Mbp}/Vsig8^{tm1.1(KOMP)Mbp} (C57BL/6N-Vsig8^{tm1.1(KOMP)Mbp}/J)	decreased blood urea nitrogen level	J:211773
	decreased circulating glucose level	J:211773
	increased circulating potassium level	J:211773
Vtcn1^tm1Xxz/Vtcn1^tm1Xxz (involves: 129S4/SvJae * BALB/c * C57BL/6)	increased circulating glucose level	J:177612
Vti1a^{tm1.1(KOMP)Vlcg}/Vti1a^{tm1.1(KOMP)Vlcg} (C57BL/6N-Vti1a^{tm1.1(KOMP)Vlcg}/Ucd)	decreased fasting circulating glucose level	J:211773
	increased circulating alkaline phosphatase level	J:211773
Vtn^tm1Dgi/Vtn^tm1Dgi (B6.129S2-Vtn^tm1Dgi)	abnormal blood coagulation	J:134443
Vtn^tm1Dgi/Vtn^tm1Dgi (B6.129S2-Vtn^tm1Dgi)	abnormal platelet aggregation	J:134443
Vwa8^{tm1b(EUCOMM)Wtsi}/Vwa8^{tm1b(EUCOMM)Wtsi} (C57BL/6N-Vwa8^{tm1b(EUCOMM)Wtsi}/Ieg)	increased circulating potassium level	J:211773
	increased fasting circulating glucose level	J:211773
Vwf^tm1.1Diac/Vwf^tm1.1Diac (Not Specified)	abnormal platelet activation	J:181672
	impaired blood coagulation	J:220792
	increased bleeding time	J:220792, J:181672
Vwf^tm1.1Geno/Vwf⁺ (involves: C57BL/6)	abnormal platelet aggregation	J:250145
	abnormal platelet physiology	J:250145
	decreased platelet aggregation	J:250145
	increased bleeding time	J:250145
Vwf^tm1.1Geno/Vwf^tm1.1Geno (involves: C57BL/6)	abnormal platelet aggregation	J:250145
	abnormal platelet physiology	J:250145
	decreased platelet aggregation	J:250145
	decreased susceptibility to induced thrombosis	J:250145
	increased bleeding time	J:250145
Vwf^tm1.1Vhf/Vwf⁺ (involves: C57BL/6J * C57BL/6N)	abnormal blood coagulation	J:295694
	abnormal platelet physiology	J:295694
	decreased susceptibility to induced thrombosis	J:295694
	increased bleeding time	J:295694
Vwf^tm1.1Vhf/Vwf^tm1.1Vhf (involves: C57BL/6J * C57BL/6N)	abnormal blood coagulation	J:295694
	abnormal platelet physiology	J:295694
	decreased susceptibility to induced thrombosis	J:295694
	increased bleeding time	J:295694
Vwf^tm1Wgr/Vwf⁺ (involves: 129S2/SvPas * C57BL/6J)	abnormal blood coagulation	J:49083
Vwf^tm1Wgr/Vwf^tm1Wgr (involves: 129S2/SvPas * C57BL/6J)	abnormal blood coagulation	J:49083
	abnormal platelet physiology	J:49083
	decreased susceptibility to induced thrombosis	J:63750
	increased bleeding time	J:49083
	increased partial thromboplastin time	J:49083
Vwf^tm1Wgr/Vwf^tm1Wgr (B6.129S2-Vwf^tm1Wgr)	decreased susceptibility to induced thrombosis	J:133469
Vwf^tm2.1Diac/Vwf^tm2.1Diac (Not Specified)	impaired blood coagulation	J:220792
Vwf^tm2.1Diac/Vwf^tm2.1Diac (Not Specified)	increased bleeding time	J:220792
Vwf^{tm3.1(VWF)Diac}/Vwf^{tm3.1(VWF)Diac} (Not Specified)	impaired blood coagulation	J:220792
Vwf^{tm3.1(VWF)Diac}/Vwf^{tm3.1(VWF)Diac} (Not Specified)	increased bleeding time	J:220792
Wac^{tm2b(EUCOMM)Wtsi}/Wac⁺ (C57BL/6N-Wac^{tm2b(EUCOMM)Wtsi}/Wtsi)	decreased circulating amylase level	J:211773
	decreased circulating triglyceride level	J:211773
	increased circulating alkaline phosphatase level	J:211773
Wars1^{tm1b(EUCOMM)Hmgu}/Wars1⁺ (C57BL/6N-Wars^{tm1b(EUCOMM)Hmgu}/Ieg)	decreased circulating unsaturated transferrin level	J:211773
	increased circulating alanine transaminase level	J:211773
	increased circulating alkaline phosphatase level	J:211773
Was^tm1Sbs/Was^tm1Sbs (129S6/SvEvTac-Was^tm1Sbs/J)	increased urine protein level	J:180407
Wasf2^tm1Tta/Wasf2^tm1Tta (involves: 129P2/OlaHsd * C57BL/6J)	edema	J:84651
	hemopericardium	J:84651
Washc4^em1(IMPC)J/Washc4⁺ (C57BL/6NJ-Washc4^em1(IMPC)J/Mmjax)	increased fasting circulating glucose level	J:211773
Washc4^em1Ssod/Washc4^em1Ssod (involves: C57BL/6J * SJL/J)	abnormal protein level	J:303795
Wasl^tm1.1Ttha/Wasl^tm1.1Ttha Tg(KRT14-cre)1Amc/0 (involves: C57BL/6 * C57BL/6N * CBA)	abnormal circulating chemokine level	J:271857
	impaired skin barrier function	J:271857
	increased circulating interleukin-1 alpha level	J:271857
	increased circulating interleukin-6 level	J:271857
	increased circulating interleukin-17 level	J:271857
	increased circulating tumor necrosis factor level	J:271857
Wbp1l^{tm2b(EUCOMM)Hmgu}/Wbp1l^{tm2b(EUCOMM)Hmgu} (C57BL/6N-Wbp1l^{tm2b(EUCOMM)Hmgu}/Bay)	decreased circulating alkaline phosphatase level	J:211773
	decreased circulating calcium level	J:211773
	decreased circulating serum albumin level	J:211773
	decreased circulating total protein level	J:211773
Wbp2^{tm2a(EUCOMM)Wtsi}/Wbp2^{tm2a(EUCOMM)Wtsi} (C57BL/6N-Wbp2^{tm2a(EUCOMM)Wtsi}/Wtsi)	decreased circulating fructosamine level	J:175295
	decreased circulating serum albumin level	J:175295
Wbp2^{tm2a(EUCOMM)Wtsi}/Wbp2^{tm2a(EUCOMM)Wtsi} (involves: C57BL/6N * C57BL/6NTac)	decreased circulating amylase level	J:229594
Wbp11^em1Gcha/Wbp11⁺ (involves: C57BL/6J * FVB/N)	cerebral edema	J:300837
Wdfy2^tm1.1Wgz/Wdfy2^tm1.1Wgz (involves: C57BL/6J)	decreased liver glycogen level	J:296933
	impaired glucose tolerance	J:296933
	increased circulating cholesterol level	J:296933
	increased circulating insulin level	J:296933
	increased circulating triglyceride level	J:296933
	increased hepatic glucose production	J:296933
	increased liver cholesterol level	J:296933
	increased liver triglyceride level	J:296933
	insulin resistance	J:296933
Wdfy3^em1(IMPC)Mbp/Wdfy3^em1(IMPC)Mbp (C57BL/6N-Wdfy3^em1(IMPC)Mbp/MbpMmucd)	edema	J:211773
Wdfy3^{Tn(pb-Act-RFP)1.1Zhu}/Wdfy3^{Tn(pb-Act-RFP)1.1Zhu} (involves: C57BL/6 * FVB/NJ)	cyanosis	J:285853
	edema	J:285853
Wdhd1^{em1(IMPC)Rbrc}/Wdhd1⁺ (C57BL/6NJcl-Wdhd1^{em1(IMPC)Rbrc}/Rbrc)	increased circulating aspartate transaminase level	J:211773
	increased circulating bilirubin level	J:211773
Wdr1^rede/Wdr1^rede (C57BL/6-Wdr1^rede)	increased bleeding time	J:134092
Wdr6^em1(IMPC)J/Wdr6^em1(IMPC)J (C57BL/6NJ-Wdr6^em1(IMPC)J/Mmjax)	improved glucose tolerance	J:211773
	increased fasting circulating glucose level	J:211773
Wdr11^em1(IMPC)Mbp/Wdr11⁺ (C57BL/6NCrl-Wdr11^em1(IMPC)Mbp/Mmucd)	improved glucose tolerance	J:211773
Wdr13^tm1Kuma/Y (involves: 129S1/Sv * 129X1/SvJ * CD-1)	decreased circulating glucose level	J:225111
	improved glucose tolerance	J:225111
	increased circulating insulin level	J:225111
	increased susceptibility to diet-induced obesity	J:225111
Wdr35^yeti/Wdr35^yeti (Not Specified)	edema	J:171617
Wdr36^{tm1.1(KOMP)Vlcg}/Wdr36⁺ (C57BL/6N-Wdr36^{tm1.1(KOMP)Vlcg}/J)	decreased circulating glucose level	J:211773
	decreased circulating iron level	J:211773
Wdr37^{tm1a(KOMP)Wtsi}/Wdr37^{tm1a(KOMP)Wtsi} (C57BL/6N-Wdr37^{tm1a(KOMP)Wtsi}/Wtsi)	increased circulating alkaline phosphatase level	J:211773
	increased circulating calcium level	J:211773
	increased circulating insulin level	J:211773
Wdr41^em1(IMPC)J/Wdr41^em1(IMPC)J (C57BL/6NJ-Wdr41^em1(IMPC)J/Mmjax)	increased circulating HDL cholesterol level	J:211773
Wdr41^m1Btlr/Wdr41^m1Btlr (C57BL/6J-Wdr41^m1Btlr)	increased circulating interleukin-12b level	J:268243
Wdr45^em1(IMPC)J/Y (C57BL/6NJ-Wdr45^em1(IMPC)J/J)	increased circulating HDL cholesterol level	J:211773
Wdr45^em1(IMPC)J/Wdr45^em1(IMPC)J (C57BL/6NJ-Wdr45^em1(IMPC)J/J)	increased circulating alkaline phosphatase level	J:211773
Wdr45^em1Wrst/Y (involves: C57BL/6N * FVB)	decreased circulating amylase level	J:307284
	decreased circulating lactate level	J:307284
	decreased circulating serum albumin level	J:307284
	decreased circulating total protein level	J:307284
	decreased circulating triglyceride level	J:307284
	decreased circulating unsaturated transferrin level	J:307284
	increased circulating aspartate transaminase level	J:307284
	increased circulating glucose level	J:307284
	increased circulating iron level	J:307284
	increased circulating lactate dehydrogenase level	J:307284
Wdr45^em1Wrst/Wdr45^em1Wrst (involves: C57BL/6N * FVB)	decreased circulating lactate level	J:307284
	impaired glucose tolerance	J:307284
	increased circulating aspartate transaminase level	J:307284
	increased circulating glucose level	J:307284
	increased circulating iron level	J:307284
	increased circulating lactate dehydrogenase level	J:307284
Wdr47^{tm1a(EUCOMM)Wtsi}/Wdr47^{tm1a(EUCOMM)Wtsi} (B6JTyr;B6N-Wdr47^{tm1a(EUCOMM)Wtsi}/Wtsi)	decreased circulating LDL cholesterol level	J:175295
	increased circulating alkaline phosphatase level	J:175295
Wdr53^em1(IMPC)J/Wdr53^em1(IMPC)J (C57BL/6NJ-Wdr53^em1(IMPC)J/Mmjax)	decreased circulating glucose level	J:211773
	increased circulating bilirubin level	J:211773
	increased circulating cholesterol level	J:211773
	increased circulating HDL cholesterol level	J:211773
	increased circulating total protein level	J:211773
Wdr62^em1(IMPC)Tcp/Wdr62^em1(IMPC)Tcp (C57BL/6NCrl-Wdr62^em1(IMPC)Tcp/Tcp)	increased circulating sodium level	J:211773
Wdr73^em1(IMPC)J/Wdr73⁺ (C57BL/6NJ-Wdr73^em1(IMPC)J/Mmjax)	decreased circulating calcium level	J:211773
Wdr81^em1(IMPC)J/Wdr81⁺ (C57BL/6NJ-Wdr81^em1(IMPC)J/J)	increased blood urea nitrogen level	J:211773
Wdr83^tm1Guwo/Wdr83⁺ (involves: C57BL/6)	decreased blood urea nitrogen level	J:153983
Wdr83^tm1Guwo/Wdr83⁺ (involves: C57BL/6)	decreased circulating creatinine level	J:153983
Wdr89^{tm1a(KOMP)Wtsi}/Wdr89^{tm1a(KOMP)Wtsi} (C57BL/6N-Wdr89^{tm1a(KOMP)Wtsi}/Wtsi)	increased circulating creatinine level	J:211773
Wdsub1^{tm1b(EUCOMM)Wtsi}/Wdsub1⁺ (C57BL/6N-Wdsub1^{tm1b(EUCOMM)Wtsi}/Ccpcz)	decreased circulating serum albumin level	J:211773
	increased circulating creatinine level	J:211773
Wdtc1^{Gt(RRF015)Byg}/Wdtc1⁺ (involves: 129P2/OlaHsd * ICR)	increased circulating glucose level	J:129966
	increased circulating insulin level	J:129966
	increased circulating leptin level	J:129966
	insulin resistance	J:129966
Wdtc1^{tm1a(KOMP)Wtsi}/Wdtc1^{tm1a(KOMP)Wtsi} (C57BL/6N-Wdtc1^{tm1a(KOMP)Wtsi}/Wtsi)	decreased circulating HDL cholesterol level	J:211773
	decreased circulating LDL cholesterol level	J:211773
	decreased fasting circulating glucose level	J:211773
Wee1^{tm1b(EUCOMM)Wtsi}/Wee1⁺ (C57BL/6N-Wee1^{tm1b(EUCOMM)Wtsi}/Tcp)	increased circulating alanine transaminase level	J:211773
Wee2^em1(IMPC)J/Wee2^em1(IMPC)J (C57BL/6NJ-Wee2^em1(IMPC)J/J)	decreased circulating iron level	J:211773
Wfdc2^em1(IMPC)H/Wfdc2⁺ (C57BL/6NTac-Wfdc2^em1(IMPC)H/H)	increased circulating amylase level	J:211773
Wfdc2^em1Fcw/Wfdc2^em1Fcw (involves: C57)	cyanosis	J:293623
Wfdc2^em1Fcw/Wfdc2^em1Fcw (involves: C57)	decreased blood oxygen saturation level	J:293623
Wfdc2^tm1.1Ohbo/Wfdc2^tm1.1Ohbo (involves: C57BL/6NCrlj * CBA/JNCrlj)	abnormal cytokine level	J:282576
	abnormal phospholipid level	J:282576
	cyanosis	J:282576
Wfdc18^{tm1a(KOMP)Wtsi}/Wfdc18^{tm1a(KOMP)Wtsi} (C57BL/6N-Wfdc18^{tm1a(KOMP)Wtsi}/Wtsi)	decreased circulating chloride level	J:211773
Wfs1^tm1Koks/Wfs1⁺ (involves: 129S6/SvEvTac * C57BL/6)	impaired glucose tolerance	J:145548
Wfs1^tm1Koks/Wfs1^tm1Koks (involves: 129S6/SvEvTac * C57BL/6)	impaired glucose tolerance	J:145548, J:157967
	increased circulating corticosterone level	J:145548
Wfs1^tm1Koks/Wfs1^tm1Koks (129S6/SvEvTac-Wfs1^tm1Koks)	abnormal blood homeostasis	J:221943
	decreased circulating glucose level	J:221943
	decreased circulating insulin level	J:221943
	decreased circulating leptin level	J:221941
	hyperglycemia	J:221943
	impaired glucose tolerance	J:157967, J:221943
	increased circulating insulin-like growth factor I level	J:157967
	increased oxygen consumption	J:221941
Wfs1^tm1Perm/Wfs1^tm1Perm Tg(Ins2-cre)23Herr/0 (involves: 129X1/SvJ * C57BL/6J * CBA/J)	abnormal glucose homeostasis	J:104712
	decreased circulating insulin level	J:104712
	decreased insulin secretion	J:104712
	hyperglycemia	J:104712
	impaired glucose tolerance	J:104712
Wfs1^tm1Yoka/Wfs1^tm1Yoka (involves: 129/Sv * C57BL/6)	increased circulating glucose level	J:90420
Wfs1^tm1Yoka/Wfs1^tm1Yoka (involves: 129/Sv * C57BL/6)	increased glucagon secretion	J:90420
Wfs1^tm1Yoka/Wfs1^tm1Yoka (B6.Cg-Wfs1^tm1Yoka)	decreased circulating insulin level	J:90420
	impaired glucose tolerance	J:90420
	increased glucagon secretion	J:90420
Whrn^wi/Whrn^wi (involves: C57BL/6J * STOCK a Tyrp1^b Myo5a^d Oca2^p Ednrb^s)	decreased circulating glucose level	J:5538
	decreased liver glycogen level	J:5538
	increased circulating corticosterone level	J:5538
	increased oxygen consumption	J:5538, J:5037
Wiz^{em1(IMPC)Ccpcz}/Wiz⁺ (C57BL/6N-Wiz^{em1(IMPC)Ccpcz}/Ccpcz)	increased blood urea nitrogen level	J:211773
Wls^tm1.1Arte/Wls^tm1.1Arte Krt14^tm1(cre)Wbm/Krt14⁺ (involves: 129P2/OlaHsd * C57BL/6)	decreased body surface temperature	J:202499
	epidermal spongiosis	J:202499
	impaired skin barrier function	J:202499
Wnk1^{Gt(OST38262)Lex}/Wnk1^{Gt(OST38262)Lex} (involves: 129S5/SvEvBrd)	pericardial edema	J:152906
Wnk1^tm1.1Juha/Wnk1^tm1.1Juha (involves: 129S2/SvPas * C57BL/6 * C57BL/6N * SJL)	abnormal urine homeostasis	J:165537
Wnk1^tm1Clhu/Wnk1^tm1Clhu Tg(Tek-cre)12Flv/0 (involves: C3H * C57BL/6)	pericardial edema	J:152906
Wnk1^tm2.1Juha/Wnk1⁺ Tg(Pgk1-cre)1Lni/0 (involves: 129S2/SvPas * BALB/c * C57BL/6 * SJL)	hyperkalemia	J:200742
	increased circulating chloride level	J:200742
	increased urine aldosterone level	J:200742
	increased urine calcium level	J:200742
	metabolic acidosis	J:200742
Wnk1^tm2Cihu/Wnk1^tm2Cihu (129-Wnk1^tm2Cihu)	decreased urine sodium level	J:168700
Wnk1^tm2Cihu/Wnk1^tm2Cihu (129-Wnk1^tm2Cihu)	increased circulating sodium level	J:168700
Wnk4^em1Cjc/Wnk4^em1Cjc (Not Specified)	abnormal carbon dioxide level	J:274218
	abnormal urine sodium level	J:274218
	decreased circulating bicarbonate level	J:274218
	decreased urine potassium level	J:274218
	hyperkalemia	J:274218
	increased circulating chloride level	J:274218
	increased circulating potassium level	J:274218
	increased urine potassium level	J:274218
	increased urine sodium level	J:274218
	metabolic acidosis	J:274218
Wnk4^tm1Pfi/Wnk4^tm1Pfi (involves: 129S6/SvEvTac * C57BL/6J)	abnormal blood homeostasis	J:184790
	abnormal urine homeostasis	J:184790
	alkalosis	J:184790
	decreased circulating aldosterone level	J:184790
	decreased circulating chloride level	J:184790
	decreased circulating magnesium level	J:184790
	hypokalemia	J:184790
	increased circulating renin level	J:184790
	increased urine chloride ion level	J:184790
	increased urine potassium level	J:184790
	increased urine sodium level	J:184790
Wnk4^tm1Suc/Wnk4⁺ (involves: 129S4/SvJae * C57BL/6)	acidosis	J:129716
	decreased circulating bicarbonate level	J:129716
	decreased urine potassium level	J:129716
	increased circulating potassium level	J:129716
Wnk4^tm2.1Suc/Wnk4^tm2.1Suc (involves: 129S4/SvJae * C57BL/6)	increased urine potassium level	J:152915
	increased urine sodium level	J:152915
Wnk4^tm3.1Suc/Wnk4^tm3.1Suc (involves: 129S4/SvJae * C57BL/6J)	alkalemia	J:241978
	decreased circulating chloride level	J:241978
	decreased circulating sodium level	J:241978
Wnt1^{tm1b(EUCOMM)Wtsi}/Wnt1⁺ (C57BL/6N-Wnt1^{tm1b(EUCOMM)Wtsi}/Tcp)	increased circulating cholesterol level	J:211773
	increased circulating creatinine level	J:211773
Wnt2^{tm1.1(rtTA)Eem}/Wnt2^{tm1.1(rtTA)Eem} (involves: 129X1/SvJ * C57BL/6)	cyanosis	J:153098
Wnt7b^tm2Amc/Wnt7b^tm2.1Amc Edil3^{Tg(Sox2-cre)1Amc}/Edil3⁺ (involves: 129X1/SvJ * C57BL/6 * CBA)	cyanosis	J:134483
Wnt7b^tm2Amc/Wnt7b^tm2.1Amc Tg(Hoxb7-cre)13Amc/0 (involves: 129X1/SvJ * C57BL/6)	decreased urine osmolality	J:142685
Wnt11^{tm1.1(KOMP)Vlcg}/Wnt11^{tm1.1(KOMP)Vlcg} (C57BL/6N-Wnt11^{tm1.1(KOMP)Vlcg}/Ucd)	increased blood urea nitrogen level	J:211773
Wrap53^{tm1b(EUCOMM)Wtsi}/Wrap53⁺ (C57BL/6N-Wrap53^{tm1b(EUCOMM)Wtsi}/Wtsi)	decreased circulating cholesterol level	J:211773
	decreased circulating fructosamine level	J:211773
	decreased circulating HDL cholesterol level	J:211773
	decreased circulating LDL cholesterol level	J:211773
Wrn^tm1Led/Wrn^tm1Led (B6.129S6(BKSW)-Wrn^tm1Led)	hyperglycemia	J:106446
	hyperlipidemia	J:106446
	increased circulating cholesterol level	J:106446
	increased circulating hyaluronic acid level	J:106446
	increased circulating insulin level	J:106446
	increased circulating triglyceride level	J:106446
	insulin resistance	J:106446
Wrn^tm1Led/Wrn^tm1Led (involves: 129S6/SvEvTac * Black Swiss)	abnormal thrombosis	J:106446
Wrnip1^{tm1a(EUCOMM)Wtsi}/Wrnip1^{tm1a(EUCOMM)Wtsi} (C57BL/6N-Wrnip1^{tm1a(EUCOMM)Wtsi}/Cnrm)	decreased circulating triglyceride level	J:165965
Wsb2^{tm1b(EUCOMM)Hmgu}/Wsb2^{tm1b(EUCOMM)Hmgu} (C57BL/6N-Wsb2^{tm1b(EUCOMM)Hmgu}/Cnrm)	decreased respiratory quotient	J:211773
	increased circulating alkaline phosphatase level	J:211773
Wscd2^em1(IMPC)J/Wscd2^em1(IMPC)J (C57BL/6NJ-Wscd2^em1(IMPC)J/J)	decreased circulating creatinine level	J:211773
Wt1^tm1.1Ceng/Wt1^tm1.1Ceng Tg(tetO-cre)LC1Bjd/0 Tg(NPHS2-rtTA2M2)1Jbk/0 (involves: BALB/c C57BL/6 * FVB/N)	albuminuria	J:197989
Wt1^tm1.1Lahe/Wt1⁺ (involves: 129S2/SvPas * C57BL/6 * FVB/NCrl * SJL)	increased urine protein level	J:154995
Wt1^tm1.1Ndha/Wt1^tm1Nhsn Tg(GATA5-cre)1Krc/0 (involves: 129P2/OlaHsd * 129S2/SvPas)	edema	J:166573
	hemopericardium	J:166573
Wt1^tm1Jae/Wt1^tm1Jae (involves: 129S4/SvJae * C57BL/6)	edema	J:14317
Wt1^tm1Jae/Wt1^tm1Jae (involves: 129S4/SvJae * C57BL/6)	hemopericardium	J:14317
Wt1^tm1Mlh/Wt1⁺ (involves: 129P2/OlaHsd * C57BL/6)	increased urine protein level	J:135449
Wt1^tm1Mlh/Wt1⁺ (129P2/OlaHsd-Wt1^tm1Mlh)	increased urine protein level	J:135449
Wt1^tm1Mlh/Wt1⁺ (involves: 129P2/OlaHsd * C57BL/6 * MF1)	increased urine protein level	J:135449
Wt1^tm1Mlh/Wt1^tm1Mlh (involves: 129P2/OlaHsd * C57BL/6)	hemopericardium	J:135449
Wt1^tm1Vih/Wt1⁺ (involves: 129S7/SvEvBrd * C57BL/6 * MF1)	increased urine protein level	J:94225
Wtip^Gt(XH617)Byg/Wtip⁺ (B6.129P2-Wtip^Gt(XH617)Byg)	increased urine protein level	J:327589
Wtip^Gt(XH617)Byg/Wtip⁺ (FVB.129P2(B6)-Wtip^Gt(XH617)Byg)	increased urine protein level	J:327589
ww1/ww1 (Not Specified)	decreased circulating testosterone level	J:85113
Wwox^tm1.1Mald/Wwox^tm1.1Mald (involves: C57BL/6 * FVB/N)	decreased circulating bicarbonate level	J:155406
	decreased circulating calcium level	J:155406
	decreased circulating glucose level	J:155406
	increased blood urea nitrogen level	J:155406
	increased circulating chloride level	J:155406
Wwox^tm1Ria/Wwox^tm1Ria (involves: 129X1/SvJ * C57BL/6J)	abnormal circulating enzyme level	J:138140
	abnormal homeostasis	J:146986
	decreased circulating alkaline phosphatase level	J:138140
	decreased circulating aspartate transaminase level	J:138140
	decreased circulating calcium level	J:138140
	decreased circulating chloride level	J:138140
	decreased circulating cholesterol level	J:138140
	decreased circulating serum albumin level	J:138140
	decreased circulating sodium level	J:138140
	decreased circulating testosterone level	J:146986
	decreased circulating total protein level	J:138140
	decreased circulating triglyceride level	J:138140
	hypoglycemia	J:138140
	increased blood uric acid level	J:138140
	increased circulating bilirubin level	J:138140
	increased circulating phosphate level	J:138140
	increased circulating potassium level	J:138140
Wwox^tm2.1Ria/Wwox^tm2.1Ria (involves: 129S1/Sv * 129X1/SvJ * C57BL/6J * FVB/N)	hypoglycemia	J:198845
Wwp1^em1(IMPC)H/Wwp1^em1(IMPC)H (C57BL/6N-Wwp1^em1(IMPC)H/H)	decreased fasting circulating glucose level	J:211773
	increased circulating phosphate level	J:211773
Wwp2^tm1.1Yyiw/Wwp2^tm1.1Yyiw (involves: 129S/SvEv * C57BL/6 * FVB/N)	increased circulating interferon-beta level	J:228707
	increased circulating interleukin-6 level	J:228707
	increased circulating tumor necrosis factor level	J:228707
Wwtr1^tm1.1Eno/Wwtr1^tm1.1Eno Yap1^tm1.1Eno/Yap1⁺ Tg(Myh6-cre)2182Mds/0 (involves: 129S/SvEv * FVB/N)	abnormal atrial thrombosis	J:200670
Wwtr1^tm1Hku/Wwtr1^tm1Hku (involves: 129 * C57BL/6 * ICR)	decreased urine osmolality	J:132020
Wwtr1^tm1Whun/Wwtr1^tm1Whun (either: (involves: 129S6/SvEvTac) or (involves: 129S6/SvEvTac * C57BL/6))	increased blood urea nitrogen level	J:119488
Xbp1^{tm1a(EUCOMM)Wtsi}/Xbp1⁺ (C57BL/6N-Xbp1^{tm1a(EUCOMM)Wtsi}/Ics)	decreased circulating cholesterol level	J:165965
	decreased circulating triglyceride level	J:165965
Xbp1^tm1Nogu/Xbp1^tm1Nogu (involves: 129S/SvEv * A/J)	anoxia	J:56678
Xbp1^tm2Glm/Xbp1^tm2Glm Tg(Mx1-cre)1Cgn/0 (involves: 129S6/SvEvTac * C57BL/6 * CBA)	abnormal lipid homeostasis	J:137188
	decreased cholesterol level	J:137188
	decreased circulating triglyceride level	J:137188
	decreased fatty acids level	J:137188
Xdh^renf/Xdh^renf (involves: C3H * C57BL/6J)	decreased blood uric acid level	J:187066
	increased blood urea nitrogen level	J:187066
	increased circulating alkaline phosphatase level	J:187066
	increased circulating calcium level	J:187066
	increased circulating creatinine level	J:187066
Xdh^tm1Fink/Xdh^tm1Fink (involves: 129X1/SvJ * C57BL/6J)	abnormal lipid homeostasis	J:166326
	crystalluria	J:166326
	decreased blood uric acid level	J:103558
	hypoxia	J:166326
	increased blood urea nitrogen level	J:103558
	increased circulating amylase level	J:103558
	increased circulating hypoxanthine level	J:166326
	increased circulating xanthine level	J:166326
	increased triglyceride level	J:166326
	increased urine hypoxanthine level	J:166326
	increased urine xanthine level	J:166326
Xiap^tm1Vdr/Xiap^tm1Vdr (involves: 129S1/Sv)	hemopericardium	J:182515
Xk^tm1Ariv/Y (B6.Cg-Xk^tm1Ariv)	increased erythrocyte magnesium level	J:212528
Xk^{tm1b(KOMP)Mbp}/Xk^{tm1b(KOMP)Mbp} (C57BL/6N-Xk^{tm1b(KOMP)Mbp}/Ucd)	increased circulating alanine transaminase level	J:211773
	increased circulating aspartate transaminase level	J:211773
Xkr5^{tm1b(KOMP)Mbp}/Xkr5^{tm1b(KOMP)Mbp} (C57BL/6N-Xkr5^{tm1b(KOMP)Mbp}/Ieg)	increased fasting circulating glucose level	J:211773
Xpa^tm1Hvs/Xpa^tm1Hvs (involves: 129P2/OlaHsd)	skin edema	J:145759
Xpa^tm1Tnka/Xpa^tm1Tnka (involves: C57BL/6 * CBA)	increased circulating follicle stimulating hormone level	J:141237
Xpa^tm1Tnka/Xpa^tm1Tnka (involves: C57BL/6 * CBA)	increased prostaglandin level	J:60201
Xpc^tm1Brd/Xpc^tm1Brd (involves: 129S7/SvEvBrd * C57BL)	photosensitivity	J:28708
Xpnpep1^{Gt(S22-1B1)Sor}/Xpnpep1^{Gt(S22-1B1)Sor} (involves: 129S4/SvJae * C57BL/6J)	abnormal urine color	J:193753
	increased urine protein level	J:193753
Xpnpep1^{tm1a(KOMP)Wtsi}/Xpnpep1^{tm1a(KOMP)Wtsi} (C57BL/6N-Xpnpep1^{tm1a(KOMP)Wtsi}/Wtsi)	subcutaneous edema	J:239583
Xpo4^em1(IMPC)Tcp/Xpo4^em1(IMPC)Tcp (C57BL/6NCrl-Xpo4^em1(IMPC)Tcp/Tcp)	edema	J:211773
Xrcc2^tm1Jtk/Xrcc2^tm1Jtk (involves: 129S/SvEv * C57BL/6)	cyanosis	J:66529
Xylb^{tm1a(EUCOMM)Hmgu}/Xylb^{tm1a(EUCOMM)Hmgu} (Not Specified)	decreased circulating alkaline phosphatase level	J:165965
Xylt2^tm1Meh/Xylt2^tm1Meh (involves: 129P2/OlaHsd)	increased blood urea nitrogen level	J:122291
X/Yaa ((NZB x BXSB)F1)	porphyria	J:6235
X/Yaa (BXSB/MpJ)	increased circulating interleukin-21 level	J:93740
X/Yaa (BXSB/MpJ)	increased urine protein level	J:7308
Yae1d1^{tm1b(EUCOMM)Hmgu}/Yae1d1⁺ (C57BL/6N-Yae1d1^{tm1b(EUCOMM)Hmgu}/Ieg)	increased circulating alkaline phosphatase level	J:211773
	increased circulating cholesterol level	J:211773
	increased circulating HDL cholesterol level	J:211773
	increased circulating lipase level	J:211773
Yap1^tm1.1Dupa/Yap1^tm1.1Dupa Speer6-ps1^{Tg(Alb-cre)21Mgn}/Speer6-ps1⁺ (involves: 129P2/OlaHsd * C57BL/6 * DBA)	increased circulating alanine transaminase level	J:162628
	increased circulating bilirubin level	J:162628
Yap1^tm1.1Eno/Yap1^tm1.1Eno Tg(Myh6-cre)2182Mds/0 (involves: 129S/SvEv * FVB/N)	abnormal atrial thrombosis	J:200670
Yap1^tm1.1Fcam/Yap1^tm1.1Fcam Tg(KRT14-cre)1Amc/0 (involves: 129S4/SvJae * C57BL/6 * CBA)	impaired skin barrier function	J:171057
Ybx1^tm1Ley/Ybx1^tm1Ley (either: 129X1/SvJ-Ybx1^tm1Ley or (involves: 129X1/SvJ * C57BL/6))	cyanosis	J:99099
Ybx1^tm1Tuch/Ybx1^tm1Tuch (involves: 129S/SvEv * C57BL/6)	edema	J:117725
Ydjc^{tm1.1(KOMP)Vlcg}/Ydjc^{tm1.1(KOMP)Vlcg} (C57BL/6N-Ydjc^{tm1.1(KOMP)Vlcg}/J)	decreased circulating glucose level	J:211773
	increased circulating alkaline phosphatase level	J:211773
	increased circulating HDL cholesterol level	J:211773
	increased circulating sodium level	J:211773
Yif1a^em1(IMPC)J/Yif1a^em1(IMPC)J (C57BL/6NJ-Yif1a^em1(IMPC)J/Mmjax)	increased circulating alkaline phosphatase level	J:211773
Ykt6^em1(IMPC)J/Ykt6⁺ (C57BL/6NJ-Ykt6^em1(IMPC)J/Mmjax)	decreased circulating calcium level	J:211773
Ylpm1^{tm1b(KOMP)Wtsi}/Ylpm1⁺ (C57BL/6N-Ylpm1^{tm1b(KOMP)Wtsi}/J)	increased fasting circulating glucose level	J:211773
Yme1l1^tm1Tlan/Yme1l1^tm1Tlan Tg(Ckmm-cre)5Khn/0 (involves: C57BL/6 * C57BL/6NCrl * FVB)	decreased circulating insulin level	J:229455
	impaired glucose tolerance	J:229455
Yme1l1^tm1Tlan/Yme1l1^tm1Tlan Tg(Myh6-cre)2182Mds/0 (involves: C57BL/6 * C57BL/6NCrl * FVB/N)	increased circulating troponin T level	J:229455
Yod1^tm1bNarl/Yod1^tm1bNarl (C57BL/6N-Yod1^tm1bNarl/Narl)	increased circulating alanine transaminase level	J:211773
Yod1^tm1bNarl/Yod1^tm1bNarl (C57BL/6N-Yod1^tm1bNarl/Narl)	increased circulating aspartate transaminase level	J:211773
Ypel3^{tm1.1(KOMP)Vlcg}/Ypel3^{tm1.1(KOMP)Vlcg} (C57BL/6N-Ypel3^{tm1.1(KOMP)Vlcg}/Ucd)	increased circulating alkaline phosphatase level	J:211773
Ypel4^{tm1a(EUCOMM)Wtsi}/Ypel4^{tm1a(EUCOMM)Wtsi} (C57BL/6N-Ypel4^{tm1a(EUCOMM)Wtsi}/Wtsi)	increased circulating free fatty acids level	J:211773
Ythdf1^tm1.1Sjj/Ythdf1^tm1.1Sjj Tg(Atoh1-cre/Esr1*)14Fsh/0 (involves: FVB/N)	abnormal protein level	J:276416
Ythdf3^em1(IMPC)Mbp/Ythdf3^em1(IMPC)Mbp (C57BL/6N-Ythdf3^em1(IMPC)Mbp/MbpMmucd)	increased circulating alanine transaminase level	J:211773
Ywhab^em1Gpt/Ywhab^em1Gpt Alb^em1(icre)Gpt/Alb⁺ (C57BL/6JGpt-Ywhab^em1Gpt Alb^em1(icre)Gpt)	decreased liver glycogen level	J:323777
	enhanced gluconeogenesis	J:323777
	impaired glucose tolerance	J:323777
	increased circulating glucose level	J:323777
Ywhab^{tm1b(EUCOMM)Hmgu}/Ywhab^{tm1b(EUCOMM)Hmgu} (C57BL/6N-Ywhab^{tm1b(EUCOMM)Hmgu}/Ieg)	decreased blood urea nitrogen level	J:211773
	decreased circulating cholesterol level	J:211773
	decreased circulating glucose level	J:211773
	decreased circulating HDL cholesterol level	J:211773
	decreased circulating iron level	J:211773
	decreased circulating total protein level	J:211773
	increased circulating bilirubin level	J:211773
Ywhae^tm1Awb/Ywhae^tm1Awb (involves: 129S6/SvEvTac)	cyanosis	J:192860
Ywhaz^{tm1b(EUCOMM)Hmgu}/Ywhaz⁺ (C57BL/6N-Ywhaz^{tm1b(EUCOMM)Hmgu}/Tcp)	edema	J:211773
Ywhaz^{tm1b(EUCOMM)Hmgu}/Ywhaz^{tm1b(EUCOMM)Hmgu} (C57BL/6N-Ywhaz^{tm1b(EUCOMM)Hmgu}/Tcp)	edema	J:211773
Yy1^tm1Yshi/Yy1^tm2Yshi (involves: 129S4/SvJae)	cyanosis	J:108369
Zap70^m1Saka/Zap70^m1Saka (involves: BALB/c)	joint swelling	J:86607
Zbed6^tm1.2Sson/Zbed6^tm1.2Sson (involves: BALB/c * C57BL/6)	increased insulin sensitivity	J:265506
	increased respiratory quotient	J:265506
Zbtb4^{tm1.1(KOMP)Vlcg}/Zbtb4^{tm1.1(KOMP)Vlcg} (B6N(Cg)-Zbtb4^{tm1.1(KOMP)Vlcg}/J)	increased circulating chloride level	J:211773
	increased circulating sodium level	J:211773
Zbtb16^tm1Ppp/Zbtb16^tm1Ppp (involves: 129S1/Sv)	increased circulating testosterone level	J:91129
Zbtb20^tm1.1Wpjz/Zbtb20^tm1.1Wpjz (involves: 129S4/SvJae * C57BL/6)	abnormal blood homeostasis	J:148992
	abnormal glycogen homeostasis	J:148992
	decreased circulating insulin level	J:148992
	decreased circulating leptin level	J:148992
	decreased liver glycogen level	J:148992
	hypoglycemia	J:148992
	improved glucose tolerance	J:148992
	increased blood urea nitrogen level	J:148992
	increased circulating alkaline phosphatase level	J:148992
	increased circulating aspartate transaminase level	J:148992
	increased circulating bilirubin level	J:148992
	increased circulating glucagon level	J:148992
	increased circulating ketone body level	J:148992
	increased circulating potassium level	J:148992
	increased insulin sensitivity	J:148992
Zbtb22^em1Yga/Zbtb22^em1Yga (Not Specified)	abnormal homeostasis	J:344976
	decreased circulating triglyceride level	J:344976
	decreased fasting circulating glucose level	J:344976
	decreased liver triglyceride level	J:344976
	decreased susceptibility to diet-induced obesity	J:344976
	improved glucose tolerance	J:344976
	increased energy expenditure	J:344976
	increased insulin sensitivity	J:344976
Zbtb24^{tm1b(EUCOMM)Hmgu}/Zbtb24⁺ (C57BL/6N-Zbtb24^{tm1b(EUCOMM)Hmgu}/Ieg)	decreased circulating chloride level	J:211773
	increased circulating HDL cholesterol level	J:211773
Zbtb32^{tm1b(KOMP)Mbp}/Zbtb32^{tm1b(KOMP)Mbp} (C57BL/6N-Zbtb32^{tm1b(KOMP)Mbp}/J)	increased circulating insulin level	J:211773
	increased circulating sodium level	J:211773
Zbtb43^{tm1b(KOMP)Mbp}/Zbtb43⁺ (C57BL/6N-Zbtb43^{tm1b(KOMP)Mbp}/J)	decreased circulating glucose level	J:211773
Zbtb43^{tm1b(KOMP)Mbp}/Zbtb43^{tm1b(KOMP)Mbp} (C57BL/6N-Zbtb43^{tm1b(KOMP)Mbp}/J)	decreased circulating glucose level	J:211773
	decreased circulating serum albumin level	J:211773
	increased circulating alanine transaminase level	J:211773
	increased circulating aspartate transaminase level	J:211773
	increased circulating phosphate level	J:211773
Zbtb44^em1(IMPC)J/Zbtb44^em1(IMPC)J (C57BL/6NJ-Zbtb44^em1(IMPC)J/Mmjax)	increased circulating phosphate level	J:211773
Zbtb48^em1(IMPC)Mbp/Zbtb48^em1(IMPC)Mbp (C57BL/6NCrl-Zbtb48^em1(IMPC)Mbp/Mmucd)	impaired glucose tolerance	J:211773
Zc3h4^em1(IMPC)Mbp/Zc3h4⁺ (C57BL/6NCrl-Zc3h4^em1(IMPC)Mbp/Mmucd)	increased circulating serum albumin level	J:211773
Zc3h7a^em1(IMPC)J/Zc3h7a^em1(IMPC)J (C57BL/6NJ-Zc3h7a^em1(IMPC)J/Mmjax)	decreased circulating total protein level	J:211773
Zc3h8^{em1(IMPC)Ccpcz}/Zc3h8⁺ (C57BL/6N-Zc3h8^{em1(IMPC)Ccpcz}/Ccpcz)	increased circulating total protein level	J:211773
Zc3h11a^em1(IMPC)Mbp/Zc3h11a⁺ (C57BL/6NCrl-Zc3h11a^em1(IMPC)Mbp/Mmucd)	increased circulating alanine transaminase level	J:211773
Zc3h12a^{tm1b(EUCOMM)Hmgu}/Zc3h12a⁺ (C57BL/6N-Zc3h12a^{tm1b(EUCOMM)Hmgu}/Ieg)	increased circulating lipase level	J:211773
Zc3h12a^{tm1c(EUCOMM)Hmgu}/Zc3h12a^{tm1c(EUCOMM)Hmgu} Speer6-ps1^{Tg(Alb-cre)21Mgn}/Speer6-ps1⁺ (involves: C57BL/6 * C57BL/6N * DBA)	increased bile salt level	J:304105
	increased circulating alkaline phosphatase level	J:304105
Zc3h12a^tm1Fum/Zc3h12a^tm1Fum (C57BL/6-Zc3h12a^tm1Fum)	abnormal circulating chemokine level	J:176866
Zc3h12a^tm1Fum/Zc3h12a^tm1Fum (C57BL/6-Zc3h12a^tm1Fum)	increased circulating tumor necrosis factor level	J:176866
Zc3h12c^em1(IMPC)Tcp/Zc3h12c^em1(IMPC)Tcp (C57BL/6NCrl-Zc3h12c^em1(IMPC)Tcp/Tcp)	increased circulating triglyceride level	J:211773
Zc3h12c^{tm2d(EUCOMM)Hmgu}/Zc3h12c^{tm2d(EUCOMM)Hmgu} (involves: 129S4/SvJaeSor * C57BL/6N)	increased circulating interferon-gamma level	J:277714
Zc3h12d^{tm1b(EUCOMM)Hmgu}/Zc3h12d^{tm1b(EUCOMM)Hmgu} (C57BL/6N-Zc3h12d^{tm1b(EUCOMM)Hmgu}/Orl)	increased circulating alanine transaminase level	J:211773
Zc3h13^em1(IMPC)J/Zc3h13⁺ (C57BL/6NJ-Zc3h13^em1(IMPC)J/Mmjax)	increased circulating cholesterol level	J:211773
	increased circulating HDL cholesterol level	J:211773
Zcchc3^em1(IMPC)J/Zcchc3^em1(IMPC)J (C57BL/6NJ-Zcchc3^em1(IMPC)J/Mmjax)	increased circulating bilirubin level	J:211773
	increased circulating serum albumin level	J:211773
Zcchc3^em1Hbsh/Zcchc3^em1Hbsh (involves: C57BL/6)	decreased circulating CXCL10 level	J:271802
	decreased circulating interferon-beta level	J:271802
	decreased circulating interleukin-6 level	J:271802
Zdhhc1^tm1Yyiw/Zdhhc1^tm1Yyiw (involves: 129S6/SvEvTac)	abnormal circulating cytokine level	J:284987
	decreased circulating interferon-alpha level	J:284987
	decreased circulating interferon-beta level	J:284987
	decreased circulating interleukin-6 level	J:284987
	decreased circulating tumor necrosis factor level	J:284987
Zdhhc2^em1Eko/Zdhhc2^em1Eko (C57BL/6-Zdhhc2^em1Eko)	abnormal cytokine level	J:303593
	abnormal interferon level	J:303593
	abnormal interleukin level	J:303593
	abnormal tumor necrosis factor level	J:303593
Zdhhc2^{tm1b(KOMP)Wtsi}/Zdhhc2^{tm1b(KOMP)Wtsi} (C57BL/6N-Zdhhc2^{tm1b(KOMP)Wtsi}/Nju)	increased fasting circulating glucose level	J:211773
Zdhhc4^em1Smoc/Zdhhc4^em1Smoc (C57BL/6-Zdhhc4^em1Smoc)	abnormal lipid homeostasis	J:270120
	decreased circulating glucose level	J:270120
	impaired adaptive thermogenesis	J:270120
	increased circulating free fatty acids level	J:270120
	increased circulating triglyceride level	J:270120
Zdhhc5^tm1.1Smoc/Zdhhc5^tm1.1Smoc Tg(Adipoq-cre)1Evdr/0 (involves: 129S4/SvJaeSor * C57BL/6 * FVB/NJ)	abnormal lipid homeostasis	J:270120
	decreased circulating glucose level	J:270120
	increased circulating free fatty acids level	J:270120
	increased circulating triglyceride level	J:270120
Zdhhc11^{tm1.1(KOMP)Vlcg}/Zdhhc11^{tm1.1(KOMP)Vlcg} (involves: C57BL/6NTac)	decreased circulating interleukin-6 level	J:310891
Zdhhc13^skc4/Zdhhc13^skc4 (involves: 129S6/SvEvTac * C3H * C57BL/6)	increased blood urea nitrogen level	J:161519
	increased circulating alanine transaminase level	J:161519
	increased circulating aspartate transaminase level	J:161519
	increased circulating bilirubin level	J:161519
	increased circulating creatine kinase level	J:161519
Zdhhc20^{em1(IMPC)Hmgu}/Zdhhc20^{em1(IMPC)Hmgu} (C57BL/6N-Zdhhc20^{em1(IMPC)Hmgu}/Ieg)	increased circulating calcium level	J:211773
Zeb1^tm1.1Ajg/Zeb1^tm2.1Ajg (C57BL/6-Zeb1^tm1.1Ajg/Zeb1^tm2.1Ajg)	abnormal circulating hormone level	J:177274
	abnormal circulating lipid level	J:177274
	decreased oxygen consumption	J:177274
	impaired glucose tolerance	J:177274
	increased circulating adiponectin level	J:177274
	increased circulating corticosterone level	J:177274
	increased circulating free fatty acids level	J:177274
	increased circulating insulin level	J:177274
	increased circulating leptin level	J:177274
	increased circulating triglyceride level	J:177274
	insulin resistance	J:177274
Zeb1^tm1.2Mpst/Zeb1^tm1.2Mpst (involves: C57BL/6 * CBA)	edema	J:239147
Zeb1^tm1.2Mpst/Zeb1^tm1.2Mpst (involves: C57BL/6 * CBA)	hydrops fetalis	J:239147
Zeb1^tm1Yhi/Zeb1^tm1Yhi (either: (involves: 129 * C3H * C57BL/6) or (involves: 129 * C57BL/6 * ICR))	ascites	J:139194
Zeb1^tm2Yhi/Zeb1^tm2Yhi (B6.129-Zeb1^tm2Yhi)	cyanosis	J:45575
Zeb1^tm2Yhi/Zeb1^tm2Yhi (B6.129-Zeb1^tm2Yhi)	hydrops fetalis	J:45575
Zeb1^Tw/Zeb1⁺ (B6.Cg-Zeb1^Tw)	abnormal circulating hormone level	J:177274
	abnormal circulating lipid level	J:177274
	impaired glucose tolerance	J:177274
	increased circulating adiponectin level	J:177274
	increased circulating corticosterone level	J:177274
	increased circulating free fatty acids level	J:177274
	increased circulating insulin level	J:177274
	increased circulating leptin level	J:177274
	increased circulating triglyceride level	J:177274
	insulin resistance	J:177274
Zer1^em1(IMPC)J/Zer1^em1(IMPC)J (C57BL/6NJ-Zer1^em1(IMPC)J/Mmjax)	improved glucose tolerance	J:211773
Zfand2b^tm1Otin/Zfand2b^tm1Otin (involves: 129S7/SvEvBrd * C57BL/6)	abnormal protein level	J:233169
Zfand3^em1(IMPC)J/Zfand3^em1(IMPC)J (C57BL/6NJ-Zfand3^em1(IMPC)J/Mmjax)	decreased circulating calcium level	J:211773
	decreased circulating glucose level	J:211773
	decreased circulating total protein level	J:211773
	increased circulating creatinine level	J:211773
Zfand5^{Gt(ROSA)72Sor}/Zfand5^{Gt(ROSA)72Sor} (involves: 129S4/SvJaeSor)	pulmonary edema	J:117491
Zfand6^em1(IMPC)Mbp/Zfand6^em1(IMPC)Mbp (C57BL/6N-Zfand6^em1(IMPC)Mbp/MbpMmucd)	decreased circulating cholesterol level	J:211773
	decreased circulating HDL cholesterol level	J:211773
	decreased circulating serum albumin level	J:211773
	decreased circulating total protein level	J:211773
	increased circulating bilirubin level	J:211773
Zfhx3^{Gt(RRJ548)Byg}/Zfhx3^{Gt(RRJ548)Byg} (involves: 129P2/OlaHsd)	decreased growth hormone level	J:143958
	decreased thyroid-stimulating hormone level	J:143958
Zfhx4^tm1.1Rnis/Zfhx4^tm1.1Rnis (involves: C57BL * C57BL/6NCrlj * CBA/JNCrlj * DBA)	cyanosis	J:316165
Zfp13^{tm1a(EUCOMM)Hmgu}/Zfp13^{tm1a(EUCOMM)Hmgu} (C57BL/6N-Zfp13^{tm1a(EUCOMM)Hmgu}/Ics)	decreased circulating creatinine level	J:165965
Zfp35^tm1Naka/Zfp35^tm1Naka (either: B6.Cg-Zfp35^tm1Naka or C.Cg-Zfp35^tm1Naka)	increased circulating interleukin-4 level	J:153828
	increased circulating interleukin-5 level	J:153828
	increased circulating interleukin-13 level	J:153828
Zfp36^{tm1(KOMP)Vlcg}/Zfp36⁺ (C57BL/6N-Zfp36^{tm1(KOMP)Vlcg}/Nju)	increased fasting circulating glucose level	J:211773
Zfp36^tm1Pjb/Zfp36^tm1Pjb (B6.Cg-Zfp36^tm1Pjb)	abnormal nitric oxide homeostasis	J:214114
Zfp36^tm4.1Pjb/Zfp36^tm4.1Pjb Lyz2^tm1(cre)Ifo/Lyz2⁺ (involves: 129P2/OlaHsd * C57BL/6 * C57BL/6N)	decreased body temperature	J:188677
	increased blood urea nitrogen level	J:188677
	increased circulating alanine transaminase level	J:188677
	increased circulating lactate dehydrogenase level	J:188677
	increased circulating tumor necrosis factor level	J:188677
Zfp36l3^tm1Pjb/Y (involves: C57BL/6 * C57BL/6NTac)	abnormal iron level	J:230794
Zfp36l3^tm1Pjb/Y (involves: C57BL/6 * C57BL/6NTac)	abnormal zinc homeostasis	J:230794
Zfp36l3^tm1Pjb/Zfp36l3^tm1Pjb (involves: C57BL/6 * C57BL/6NTac)	abnormal iron level	J:230794
	abnormal zinc homeostasis	J:230794
Zfp42^{tm1b(KOMP)Mbp}/Zfp42⁺ (C57BL/6N-Zfp42^{tm1b(KOMP)Mbp}/J)	decreased circulating serum albumin level	J:211773
Zfp54^{em1(IMPC)Wtsi}/Zfp54^{em1(IMPC)Wtsi} (C57BL/6N-Zfp54^{em1(IMPC)Wtsi}/Wtsi)	increased circulating serum albumin level	J:211773
Zfp60^{tm1b(KOMP)Mbp}/Zfp60^{tm1b(KOMP)Mbp} (C57BL/6N-Zfp60^{tm1b(KOMP)Mbp}/J)	increased circulating alkaline phosphatase level	J:211773
Zfp61^{tm1b(EUCOMM)Hmgu}/Zfp61^{tm1b(EUCOMM)Hmgu} (C57BL/6N-Zfp61^{tm1b(EUCOMM)Hmgu}/Ieg)	increased circulating calcium level	J:211773
	increased circulating creatinine level	J:211773
Zfp69^{tm1b(EUCOMM)Hmgu}/Zfp69^{tm1b(EUCOMM)Hmgu} (C57BL/6N-Zfp69^{tm1b(EUCOMM)Hmgu}/Ieg)	decreased circulating iron level	J:211773
Zfp84^{tm1b(KOMP)Wtsi}/Zfp84^{tm1b(KOMP)Wtsi} (C57BL/6N-Zfp84^{tm1b(KOMP)Wtsi}/Wtsi)	decreased circulating cholesterol level	J:211773
	decreased circulating HDL cholesterol level	J:211773
Zfp91^em1(IMPC)Tcp/Zfp91^em1(IMPC)Tcp (C57BL/6N-Zfp91^em1(IMPC)Tcp/Tcp)	edema	J:211773
Zfp106^{tm1a(KOMP)Wtsi}/Zfp106⁺ (B6JTyr;B6N-Zfp106^{tm1a(KOMP)Wtsi}/Wtsi)	increased circulating calcium level	J:175295
Zfp148^Gt(XB878)Byg/Zfp148^Gt(XB878)Byg (involves: 129P2/OlaHsd * C57BL/6)	cyanosis	J:198319
Zfp148^tm1.1Jmer/Zfp148^tm1.1Jmer Tg(Vil1-cre)997Gum/0 (involves: C57BL/6 * C57BL/6J * SJL)	decreased serotonin level	J:198847
Zfp182^{tm1b(KOMP)Wtsi}/Zfp182^{tm1b(KOMP)Wtsi} (C57BL/6N-Zfp182^{tm1b(KOMP)Wtsi}/Wtsi)	decreased circulating HDL cholesterol level	J:211773
Zfp202^em1(IMPC)J/Zfp202^em1(IMPC)J (C57BL/6NJ-Zfp202^em1(IMPC)J/Mmjax)	increased circulating cholesterol level	J:211773
	increased fasting circulating glucose level	J:211773
Zfp207^{tm1b(EUCOMM)Hmgu}/Zfp207⁺ (C57BL/6N-Zfp207^{tm1b(EUCOMM)Hmgu}/H)	decreased circulating serum albumin level	J:211773
Zfp217^em1Sjia/Zfp217⁺ (involves: C57BL/6J)	decreased susceptibility to diet-induced obesity	J:307358
	improved glucose tolerance	J:307358
	increased carbon dioxide production	J:307358
	increased energy expenditure	J:307358
	increased insulin sensitivity	J:307358
	increased oxygen consumption	J:307358
Zfp219^em1(IMPC)J/Zfp219^em1(IMPC)J (C57BL/6NJ-Zfp219^em1(IMPC)J/J)	decreased circulating glucose level	J:211773
	increased urine glucose level	J:211773
Zfp251^em1Hgseo/Zfp251^em1Hgseo (C57BL/6J-Zfp251^em1Hgseo)	impaired glucose tolerance	J:334395
	increased fasting circulating glucose level	J:334395
	increased insulin sensitivity	J:334395
Zfp260^{tm1b(NCOM)Mfgc}/Zfp260^{tm1b(NCOM)Mfgc} (C57BL/6N-Zfp260^{tm1b(NCOM)Mfgc}/Tcp)	edema	J:211773
Zfp266^{tm1b(EUCOMM)Wtsi}/Zfp266^{tm1b(EUCOMM)Wtsi} (C57BL/6N-Zfp266^{tm1b(EUCOMM)Wtsi}/Wtsi)	increased circulating alkaline phosphatase level	J:211773
Zfp280d^{em1(IMPC)Hmgu}/Zfp280d^{em1(IMPC)Hmgu} (C57BL/6N-Zfp280d^{em1(IMPC)Hmgu}/Ieg)	increased circulating alkaline phosphatase level	J:211773
	increased circulating aspartate transaminase level	J:211773
Zfp281^em1(IMPC)Mbp/Zfp281⁺ (C57BL/6N-Zfp281^em1(IMPC)Mbp/MbpMmucd)	increased circulating alkaline phosphatase level	J:211773
Zfp334^{tm1.1(KOMP)Vlcg}/Zfp334^{tm1.1(KOMP)Vlcg} (C57BL/6N-Zfp334^{tm1.1(KOMP)Vlcg}/J)	increased circulating bilirubin level	J:211773
Zfp341^{tm1a(KOMP)Wtsi}/Zfp341^{tm1a(KOMP)Wtsi} (C57BL/6N-Zfp341^{tm1a(KOMP)Wtsi}/Wtsi)	increased circulating amylase level	J:211773
	increased circulating chloride level	J:211773
	increased circulating sodium level	J:211773
Zfp346^{tm1.1(KOMP)Vlcg}/Zfp346⁺ (C57BL/6N-Zfp346^{tm1.1(KOMP)Vlcg}/J)	increased circulating free fatty acids level	J:211773
Zfp354a^em1(IMPC)Mbp/Zfp354a^em1(IMPC)Mbp (C57BL/6NCrl-Zfp354a^em1(IMPC)Mbp/MbpMmucd)	increased circulating creatinine level	J:211773
Zfp367^{tm1a(KOMP)Wtsi}/Zfp367^{tm1a(KOMP)Wtsi} (B6JTyr;B6N-Zfp367^{tm1a(KOMP)Wtsi}/Wtsi)	increased circulating creatinine level	J:175295
Zfp383^{em1(IMPC)Wtsi}/Zfp383^{em1(IMPC)Wtsi} (C57BL/6N-Zfp383^{em1(IMPC)Wtsi}/Wtsi)	increased circulating alanine transaminase level	J:211773
Zfp385a^tm1Ber/Zfp385a^tm1Ber (involves: 129S1/Sv * 129X1/SvJ * CD-1)	abnormal blood coagulation	J:93829
Zfp422^em1(IMPC)J/Zfp422^em1(IMPC)J (C57BL/6NJ-Zfp422^em1(IMPC)J/J)	improved glucose tolerance	J:211773
Zfp423^em1(IMPC)J/Zfp423⁺ (C57BL/6NJ-Zfp423^em1(IMPC)J/Mmjax)	decreased circulating alanine transaminase level	J:211773
	increased circulating alkaline phosphatase level	J:211773
Zfp423^tm1.2Ngc/Zfp423^tm1.2Ngc (involves: 129S1/Sv * C57BL/6 * CD-1)	dehydration	J:111316
Zfp445^{tm1b(EUCOMM)Hmgu}/Zfp445^{tm1b(EUCOMM)Hmgu} (C57BL/6N-Zfp445^{tm1b(EUCOMM)Hmgu}/Ieg)	increased circulating calcium level	J:211773
Zfp462^em1(IMPC)Tcp/Zfp462⁺ (C57BL/6N-Zfp462^em1(IMPC)Tcp/Tcp)	impaired glucose tolerance	J:211773
Zfp462^em1(IMPC)Tcp/Zfp462^em1(IMPC)Tcp (C57BL/6N-Zfp462^em1(IMPC)Tcp/Tcp)	edema	J:211773
Zfp467^{tm1.1(KOMP)Vlcg}/Zfp467^{tm1.1(KOMP)Vlcg} (B6(Cg)-Zfp467^{tm1.1(KOMP)Vlcg})	improved glucose tolerance	J:302865
Zfp469^em1(IMPC)Mbp/Zfp469^em1(IMPC)Mbp (C57BL/6N-Zfp469^em1(IMPC)Mbp/MbpMmucd)	increased circulating alkaline phosphatase level	J:211773
Zfp503^em1(IMPC)Mbp/Zfp503⁺ (C57BL/6N-Zfp503^em1(IMPC)Mbp/Ucd)	decreased circulating creatinine level	J:211773
	decreased circulating glucose level	J:211773
	edema	J:211773
Zfp503^em1(IMPC)Mbp/Zfp503^em1(IMPC)Mbp (C57BL/6N-Zfp503^em1(IMPC)Mbp/Ucd)	edema	J:211773
Zfp513^em1(IMPC)J/Zfp513^em1(IMPC)J (C57BL/6NJ-Zfp513^em1(IMPC)J/Mmjax)	decreased circulating bilirubin level	J:211773
	increased circulating alkaline phosphatase level	J:211773
	increased circulating glucose level	J:211773
Zfp532^em1(IMPC)J/Zfp532⁺ (C57BL/6NJ-Zfp532^em1(IMPC)J/J)	decreased circulating alanine transaminase level	J:211773
	decreased circulating aspartate transaminase level	J:211773
	increased circulating HDL cholesterol level	J:211773
Zfp536^{tm1.1(KOMP)Wtsi}/Zfp536⁺ (C57BL/6N-Zfp536^{tm1.1(KOMP)Wtsi}/Ucd)	increased circulating chloride level	J:211773
Zfp536^{tm1.1(KOMP)Wtsi}/Zfp536^{tm1.1(KOMP)Wtsi} (C57BL/6N-Zfp536^{tm1.1(KOMP)Wtsi}/Ucd)	cyanosis	J:211773
Zfp541^em1(IMPC)J/Zfp541^em1(IMPC)J (C57BL/6NJ-Zfp541^em1(IMPC)J/Mmjax)	increased circulating triglyceride level	J:211773
Zfp558^em1(IMPC)Mbp/Zfp558^em1(IMPC)Mbp (C57BL/6NCrl-Zfp558^em1(IMPC)Mbp/Mmucd)	decreased circulating alkaline phosphatase level	J:211773
	decreased circulating creatinine level	J:211773
	decreased circulating glucose level	J:211773
	decreased circulating HDL cholesterol level	J:211773
	decreased circulating serum albumin level	J:211773
	decreased circulating total protein level	J:211773
Zfp579^em1(IMPC)J/Zfp579^em1(IMPC)J (C57BL/6NJ-Zfp579^em1(IMPC)J/J)	increased circulating serum albumin level	J:211773
	increased circulating total protein level	J:211773
Zfp593^em1(IMPC)J/Zfp593^em1(IMPC)J (C57BL/6NJ-Zfp593^em1(IMPC)J/Mmjax)	increased circulating phosphate level	J:211773
Zfp595^{tm1b(KOMP)Wtsi}/Zfp595^{tm1b(KOMP)Wtsi} (C57BL/6N-Zfp595^{tm1b(KOMP)Wtsi}/Bay)	decreased circulating glucose level	J:211773
Zfp612^em1(IMPC)J/Zfp612^em1(IMPC)J (C57BL/6NJ-Zfp612^em1(IMPC)J/J)	decreased circulating creatinine level	J:211773
Zfp616^{tm1b(KOMP)Wtsi}/Zfp616^{tm1b(KOMP)Wtsi} (C57BL/6N-Zfp616^{tm1b(KOMP)Wtsi}/Wtsi)	increased fasting circulating glucose level	J:211773
Zfp637^{em1(IMPC)Wtsi}/Zfp637^{em1(IMPC)Wtsi} (C57BL/6N-Zfp637^{em1(IMPC)Wtsi}/Wtsi)	increased circulating free fatty acids level	J:211773
Zfp638^em1(IMPC)J/Zfp638⁺ (C57BL/6NJ-Zfp638^em1(IMPC)J/Mmjax)	abnormal cholesterol homeostasis	J:211773
Zfp644^{em1(IMPC)Ccpcz}/Zfp644^{em1(IMPC)Ccpcz} (C57BL/6N-Zfp644^{em1(IMPC)Ccpcz}/Ccpcz)	decreased circulating chloride level	J:211773
	increased blood urea nitrogen level	J:211773
	increased circulating alkaline phosphatase level	J:211773
	increased circulating potassium level	J:211773
Zfp664^{tm1b(EUCOMM)Wtsi}/Zfp664^{tm1b(EUCOMM)Wtsi} (C57BL/6N-Zfp664^{tm1b(EUCOMM)Wtsi}/Wtsi)	impaired glucose tolerance	J:211773
	increased circulating alkaline phosphatase level	J:211773
Zfp691^em1(IMPC)J/Zfp691^em1(IMPC)J (C57BL/6NJ-Zfp691^em1(IMPC)J/Mmjax)	increased circulating serum albumin level	J:211773
Zfp692^em1(IMPC)J/Zfp692^em1(IMPC)J (C57BL/6NJ-Zfp692^em1(IMPC)J/J)	decreased circulating creatinine level	J:211773
Zfp704^{tm1a(EUCOMM)Wtsi}/Zfp704^{tm1a(EUCOMM)Wtsi} (Not Specified)	decreased circulating triglyceride level	J:165965
Zfp715^{tm1a(EUCOMM)Hmgu}/Zfp715^{tm1a(EUCOMM)Hmgu} (C57BL/6N-Zfp715^{tm1a(EUCOMM)Hmgu}/H)	decreased circulating cholesterol level	J:165965
	increased circulating cholesterol level	J:165965
Zfp750^{tm1b(EUCOMM)Wtsi}/Zfp750^{tm1b(EUCOMM)Wtsi} (B6(Cg)-Zfp750^{tm1b(EUCOMM)Wtsi})	abnormal ceramide level	J:335426
	abnormal cholesterol homeostasis	J:335426
	abnormal enzyme/coenzyme level	J:335426
	abnormal phospholipid level	J:335426
	abnormal sphingomyelin level	J:335426
	decreased triglyceride level	J:335426
	dehydration	J:335426
	impaired skin barrier function	J:335426
Zfp760^{tm1a(EUCOMM)Hmgu}/Zfp760⁺ (C57BL/6N-Zfp760^{tm1a(EUCOMM)Hmgu}/Ieg)	increased circulating serum albumin level	J:165965
Zfp763^{em1(IMPC)Wtsi}/Zfp763^{em1(IMPC)Wtsi} (C57BL/6N-Zfp763^{em1(IMPC)Wtsi}/Wtsi)	increased circulating glycerol level	J:211773
Zfp787^em1(IMPC)J/Zfp787^em1(IMPC)J (C57BL/6NJ-Zfp787^em1(IMPC)J/Mmjax)	abnormal cholesterol homeostasis	J:211773
	decreased circulating HDL cholesterol level	J:211773
	impaired glucose tolerance	J:211773
	increased fasting circulating glucose level	J:211773
Zfp821^em1(IMPC)J/Zfp821^em1(IMPC)J (C57BL/6NJ-Zfp821^em1(IMPC)J/Mmjax)	decreased circulating calcium level	J:211773
Zfp950^{Gt(ROSA)76Sor}/Zfp950^{Gt(ROSA)76Sor} (involves: 129S4/SvJaeSor)	increased blood urea nitrogen level	J:117491
Zfp961^{tm1.1(KOMP)Mbp}/Zfp961^{tm1.1(KOMP)Mbp} (C57BL/6N-Zfp961^{tm1.1(KOMP)Mbp}/J)	decreased circulating glucose level	J:211773
	decreased circulating iron level	J:211773
	increased circulating alkaline phosphatase level	J:211773
Zfpm1^tm1.1Esv/Zfpm1^tm1.1Esv (involves: 129S6/SvEvTac * C57BL/6)	pericardial edema	J:156475
Zfpm1^tm1.1Geab/Zfpm1^tm1.1Geab (Not Specified)	abnormal circulating chemokine level	J:162629
Zfpm2^tm1Jml/Zfpm2^tm1Jml (involves: 129X1/SvJ)	pericardial edema	J:63121
Zfpm2^tm1Jml/Zfpm2^tm1Jml (involves: 129X1/SvJ)	skin edema	J:63121
Zfpm2^tm1Sho/Zfpm2^tm1Sho (involves: 129S1/Sv)	hydrops fetalis	J:62879
Zfpm2^tm1Sho/Zfpm2^tm2Sho Nkx2-5^tm1(cre)Rjs/Nkx2-5⁺ (involves: 129S1/Sv * 129S7/SvEvBrd)	pericardial effusion	J:150452
	skin edema	J:150452
Zfyve19^em1(IMPC)J/Zfyve19^em1(IMPC)J (C57BL/6NJ-Zfyve19^em1(IMPC)J/Mmjax)	increased circulating glucose level	J:211773
Zfyve26^em1(IMPC)J/Zfyve26^em1(IMPC)J (C57BL/6NJ-Zfyve26^em1(IMPC)J/J)	decreased circulating calcium level	J:211773
Zfyve28^{tm1b(EUCOMM)Wtsi}/Zfyve28^{tm1b(EUCOMM)Wtsi} (C57BL/6N-Zfyve28^{tm1b(EUCOMM)Wtsi}/Wtsi)	increased circulating iron level	J:211773
Zg16^tm1Lex/Zg16^tm1Lex (B6.129S-Zg16^tm1Lex)	increased circulating interferon-gamma level	J:239095
Zg16^tm1Lex/Zg16^tm1Lex (B6.129S-Zg16^tm1Lex)	increased circulating interleukin-6 level	J:239095
Zglp1^tm1Eem/Zglp1^tm1Eem (involves: 129S1/Sv * 129X1/SvJ)	increased circulating follicle stimulating hormone level	J:116977
Zglp1^tm1Eem/Zglp1^tm1Eem (involves: 129S1/Sv * 129X1/SvJ)	increased circulating luteinizing hormone level	J:116977
Zgpat^{tm1b(EUCOMM)Hmgu}/Zgpat^{tm1b(EUCOMM)Hmgu} (C57BL/6N-Zgpat^{tm1b(EUCOMM)Hmgu}/Tcp)	increased fasting circulating glucose level	J:211773
Zhx2^BALB/cJ/Zhx2^BALB/cJ (BALB/cJ)	abnormal circulating protein level	J:5803
Zhx3^{tm1.1(KOMP)Vlcg}/Zhx3^{tm1.1(KOMP)Vlcg} (C57BL/6N-Zhx3^{tm1.1(KOMP)Vlcg}/Ucd)	increased circulating aspartate transaminase level	J:211773
Zkscan14^{tm1a(EUCOMM)Wtsi}/Zkscan14⁺ (C57BL/6N-Zkscan14^{tm1a(EUCOMM)Wtsi}/Wtsi)	decreased circulating alanine transaminase level	J:175295
	decreased circulating aspartate transaminase level	J:175295
Zmat4^em1(IMPC)J/Zmat4^em1(IMPC)J (C57BL/6NJ-Zmat4^em1(IMPC)J/Mmjax)	decreased circulating calcium level	J:211773
Zmat5^{em1(IMPC)Hmgu}/Zmat5⁺ (C57BL/6NCrl-Zmat5^{em1(IMPC)Hmgu}/Ieg)	increased circulating aspartate transaminase level	J:211773
Zmpste24^tm1Otin/Zmpste24^tm1Otin (involves: 129P2/Ola * C57BL/6)	increased circulating aspartate transaminase level	J:76209
	increased circulating creatine kinase level	J:76209
	increased circulating glutamate dehydrogenase level	J:76209
Zmpste24^tm1Otin/Zmpste24^tm1Otin (involves: 129P2/OlaHsd)	decreased circulating insulin-like growth factor I level	J:164373
Zmpste24^tm1Otin/Zmpste24^tm1Otin (involves: 129P2/OlaHsd)	increased circulating growth hormone level	J:164373
Zmpste24^tm1Sgy/Zmpste24^tm1Sgy (involves: 129S4/SvJae * C57BL/6)	decreased circulating glucose level	J:79501
	decreased circulating total protein level	J:79501
Zmym2^em1(IMPC)Bay/Zmym2^em1(IMPC)Bay (C57BL/6N-Zmym2^em1(IMPC)Bay/BayMmucd)	edema	J:211773
Zmym2^em1(IMPC)J/Zmym2⁺ (C57BL/6NJ-Zmym2^em1(IMPC)J/Mmjax)	increased circulating alkaline phosphatase level	J:211773
Zmym4^{em1(IMPC)Wtsi}/Zmym4⁺ (C57BL/6N-Zmym4^{em1(IMPC)Wtsi}/Wtsi)	decreased circulating fructosamine level	J:211773
	increased circulating amylase level	J:211773
	increased circulating calcium level	J:211773
	increased circulating cholesterol level	J:211773
	increased circulating glycerol level	J:211773
	increased circulating HDL cholesterol level	J:211773
Zmynd8^{tm1a(EUCOMM)Wtsi}/Zmynd8⁺ (B6JTyr;B6N-Zmynd8^{tm1a(EUCOMM)Wtsi}/Wtsi)	decreased circulating magnesium level	J:175295
	decreased circulating serum albumin level	J:175295
Zmynd10^{tm1(KOMP)Wtsi}/Zmynd10^{tm1(KOMP)Wtsi} (involves: C57BL/6J * C57BL/6N)	pulmonary edema	J:261915
Zmynd11^{em1(IMPC)Wtsi}/Zmynd11⁺ (C57BL/6N-Zmynd11^{em1(IMPC)Wtsi}/WtsiIeg)	increased circulating thyroxine level	J:211773
Znhit1^em1(IMPC)J/Znhit1⁺ (C57BL/6NJ-Znhit1^em1(IMPC)J/Mmjax)	increased circulating phosphate level	J:211773
Znhit2^em1(IMPC)J/Znhit2⁺ (C57BL/6NJ-Znhit2^em1(IMPC)J/Mmjax)	decreased circulating bilirubin level	J:211773
	increased circulating glucose level	J:211773
Znhit6^em1(IMPC)Mbp/Znhit6⁺ (C57BL/6N-Znhit6^em1(IMPC)Mbp/Ucd)	decreased circulating calcium level	J:211773
zoef/zoef (involves: C57BL/6 * FVB/N)	cardiac edema	J:173681
zoef/zoef (involves: C57BL/6 * FVB/N)	nuchal edema	J:173681
Zranb1^{tm1d(EUCOMM)Hmgu}/Zranb1^{tm1d(EUCOMM)Hmgu} (involves: 129S4/SvJaeSor * BALB/cJ * C57BL/6N)	decreased circulating interferon-gamma level	J:235701
	decreased circulating interleukin-17 level	J:235701
Zranb2^{tm1a(EUCOMM)Wtsi}/Zranb2⁺ (B6JTyr;B6N-Zranb2^{tm1a(EUCOMM)Wtsi}/Wtsi)	decreased circulating fructosamine level	J:175295
Zranb3^em1(IMPC)Mbp/Zranb3^em1(IMPC)Mbp (C57BL/6N-Zranb3^em1(IMPC)Mbp/MbpMmucd)	increased circulating triglyceride level	J:211773
Zscan10^{Gt(285B6)1.1Cmhd}/Zscan10^{Gt(285B6)1.1Cmhd} (involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * FVB/N)	decreased body temperature	J:221010
	decreased circulating calcium level	J:221010
	decreased circulating chloride level	J:221010
	decreased circulating corticosterone level	J:221010
	decreased circulating serum albumin level	J:221010
	increased blood urea nitrogen level	J:221010
	increased circulating creatinine level	J:221010
	increased circulating lactate dehydrogenase level	J:221010
Zscan21^{tm2b(EUCOMM)Wtsi}/Zscan21⁺ (C57BL/6N-Zscan21^{tm2b(EUCOMM)Wtsi}/Bay)	decreased respiratory quotient	J:211773
Zswim8^em#Dpbl/Zswim8^em#Dpbl (C57BL/6J-Zswim8^em#Dpbl)	cyanosis	J:338969
Zwilch^{tm1.1(KOMP)Vlcg}/Zwilch⁺ (C57BL/6N-Zwilch^{tm1.1(KOMP)Vlcg}/J)	decreased circulating iron level	J:211773
Zzef1^{tm2.1(KOMP)Vlcg}/Zzef1^{tm2.1(KOMP)Vlcg} (C57BL/6N-Zzef1^{tm2.1(KOMP)Vlcg}/Ucd)	increased circulating alkaline phosphatase level	J:211773

Contributing Projects: Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO)
Citing These Resources Funding Information Warranty Disclaimer, Privacy Notice, Licensing, & Copyright Send questions and comments to User Support.	last database update 04/16/2024 MGI 6.23